SAMPLE_ID,PROTOCOL_NAME,SAMPLE_NAMES,SAMPLE_DATA_TYPE,ASSAY_OUTCOME,CAS,PUBCHEM_CID,SMILES
NCGC00255864-01,tox21-er-bla-agonist-p2,Tetradecylpyridinium bromide,activity,inactive,1155-74-4,62379.0,[Br-].CCCCCCCCCCCCCC[n+]1ccccc1
NCGC00255879-01,tox21-er-bla-agonist-p2,Isoborneol,activity,inactive,124-76-5,6321405.0,C[C@]12CC[C@H](C[C@H]1O)C2(C)C
NCGC00256067-01,tox21-er-bla-agonist-p2,"3,5-Diethyl-1-phenyl-2-propyl-1,2-dihydropyridine",activity,inactive,34562-31-7,118703.0,CCC2=CN(c1ccccc1)C(CCC)C(=C2)CC
NCGC00256074-01,tox21-er-bla-agonist-p2,Butyl hydroxyacetate,activity,inactive,7397-62-8,81882.0,OCC(=O)OCCCC
NCGC00255047-01,tox21-er-bla-agonist-p2,Benzocaine,activity,inactive,94-09-7,2337.0,Nc1ccc(cc1)C(=O)OCC
NCGC00254400-01,tox21-er-bla-agonist-p2,Dodecyltrimethylammonium chloride,activity,inactive,112-00-5,8152.0,[Cl-].C[N+](C)(C)CCCCCCCCCCCC
NCGC00254378-01,tox21-er-bla-agonist-p2,CP-671305,activity,inactive,445295-04-5,9955578.0,O=C(O)[C@@H](C)Oc4ccc(CNC(=O)c3cccnc3Oc1ccc2OCOc2c1)c(F)c4
NCGC00254463-01,tox21-er-bla-agonist-p2,Methenamine,activity,inactive,100-97-0,4101.0,C1N3CN2CN(CN1C2)C3
NCGC00254588-01,tox21-er-bla-agonist-p2,Cymoxanil,activity,inactive,57966-95-7,5364079.0,N#C/C(=N\OC)C(=O)NC(=O)NCC
NCGC00254764-01,tox21-er-bla-agonist-p2,Disulfoton,activity,inactive,298-04-4,3118.0,CCSCCSP(=S)(OCC)OCC
NCGC00255168-01,tox21-er-bla-agonist-p2,Oxytetracycline,activity,inactive,79-57-2,54675779.0,NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@@](C)(O)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00017401-02,tox21-er-bla-agonist-p2,Dihydroergocristine,activity,inactive,17479-19-5,107715.0,CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]8(O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O)C(C)C
NCGC00091071-01,tox21-er-bla-agonist-p2,"p,p'-DDT",activity,active agonist,50-29-3,3036.0,Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl
NCGC00091320-02,tox21-er-bla-agonist-p2,Decanoic acid,activity,inactive,334-48-5,2969.0,O=C(O)CCCCCCCCC
NCGC00095003-01,tox21-er-bla-agonist-p2,Thioxolone,activity,inactive,4991-65-5,72139.0,Oc1cc2OC(=O)Sc2cc1
NCGC00160395-01,tox21-er-bla-agonist-p2,Dibenzepin hydrochloride,activity,inactive,315-80-0,443945.0,Cl.CN(C)CCN3c1ccccc1N(C)c2ccccc2C3=O
NCGC00181122-01,tox21-er-bla-agonist-p2,2-Dodecylisoquinolinium tosylate,activity,inactive,5412-37-3,21517.0,[O-]S(=O)(=O)c1ccc(C)cc1.CCCCCCCCCCCC[n+]1cc2ccccc2cc1
NCGC00183852-01,tox21-er-bla-agonist-p2,Diponium bromide,activity,inactive,2001-81-2,71809.0,[Br-].CC[N+](CC)(CC)CCOC(=O)C(C1CCCC1)C2CCCC2
NCGC00254722-01,tox21-er-bla-agonist-p2,Diflufenican,activity,inactive,83164-33-4,91735.0,Fc3ccc(NC(=O)c2cccnc2Oc1cccc(c1)C(F)(F)F)c(F)c3
NCGC00259389-01,tox21-er-bla-agonist-p2,4-Methoxy-2-methyl-N-phenylaniline,activity,inactive,41317-15-1,162461.0,COc2cc(C)c(Nc1ccccc1)cc2
NCGC00259518-01,tox21-er-bla-agonist-p2,Diflubenzuron,activity,inactive,35367-38-5,37123.0,Clc2ccc(NC(=O)NC(=O)c1c(F)cccc1F)cc2
NCGC00259658-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexyl salicylate",activity,inactive,118-56-9,8362.0,O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O
NCGC00260109-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, 4-hydroxy-, monosodium salt",activity,inactive,825-90-1,4379756.0,[Na+].Oc1ccc(cc1)S(=O)([O-])=O
NCGC00016350-01,tox21-er-bla-agonist-p2,Guaifenesin,activity,inactive,93-14-1,3516.0,OCC(O)COc1ccccc1OC
NCGC00090702-02,tox21-er-bla-agonist-p2,5-Amino-2-methylphenol,activity,inactive,2835-95-2,17818.0,Nc1cc(O)c(C)cc1
NCGC00160680-01,tox21-er-bla-agonist-p2,Noreximide,activity,inactive,6319-06-8,65584.0,O=C2NC(=O)[C@@H]3[C@H]1C=C[C@H](C1)[C@H]23
NCGC00183861-01,tox21-er-bla-agonist-p2,"Octanoic acid, 2-propyl-, (2R)-",activity,inactive,185517-21-9,208925.0,O=C(O)[C@@H](CCCCCC)CCC
NCGC00017049-01,tox21-er-bla-agonist-p2,Dipyrone,activity,inactive,68-89-3,522325.0,[Na+].[O-]S(=O)(=O)CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00017113-01,tox21-er-bla-agonist-p2,Flunixin meglumine,activity,inactive,42461-84-7,60196270.0,CNC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO.FC(F)(F)c2cccc(Nc1ncccc1C(=O)O)c2C
NCGC00021141-04,tox21-er-bla-agonist-p2,Phenyltoloxamine citrate,activity,inactive,1176-08-5,298107.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOc2ccccc2Cc1ccccc1
NCGC00037064-02,tox21-er-bla-agonist-p2,Zearalanol,activity,active agonist,26538-44-3,2999413.0,Oc1cc(O)cc2CCCCC[C@@H](O)CCC[C@H](C)OC(=O)c12
NCGC00256897-01,tox21-er-bla-agonist-p2,2-Ethylhexyl trans-4-methoxycinnamate,activity,inactive,83834-59-7,5355130.0,COc1ccc(/C=C/C(=O)OCC(CC)CCCC)cc1
NCGC00256919-01,tox21-er-bla-agonist-p2,2-Phenylethyl butanoate,activity,inactive,103-52-6,7658.0,CCCC(=O)OCCc1ccccc1
NCGC00258472-01,tox21-er-bla-agonist-p2,alpha-Ketoglutaric acid,activity,inactive,328-50-7,51.0,OC(=O)C(=O)CCC(=O)O
NCGC00257249-01,tox21-er-bla-agonist-p2,Cyclopentanol,activity,inactive,96-41-3,7298.0,OC1CCCC1
NCGC00257300-01,tox21-er-bla-agonist-p2,Trimethylolpropane triacrylate,activity,active agonist,15625-89-5,27423.0,O=C(C=C)OCC(COC(=O)C=C)(CC)COC(=O)C=C
NCGC00257869-01,tox21-er-bla-agonist-p2,Capsaicin,activity,inactive,404-86-4,1548943.0,Oc1ccc(cc1OC)CNC(=O)CCCC/C=C/C(C)C
NCGC00257875-01,tox21-er-bla-agonist-p2,"2,5-Dichlorobenzoic acid",activity,inactive,50-79-3,5784.0,OC(=O)c1cc(Cl)ccc1Cl
NCGC00258255-01,tox21-er-bla-agonist-p2,Tetrabutylphosphonium bromide,activity,inactive,3115-68-2,76564.0,[Br-].CCCC[P+](CCCC)(CCCC)CCCC
NCGC00255787-01,tox21-er-bla-agonist-p2,Isocyclocitral,activity,inactive,1335-66-6,101150.0,CC1CC(C)=CC(C)C1C=O
NCGC00255807-01,tox21-er-bla-agonist-p2,Di(propylene glycol) tert-butyl ether,activity,inactive,132739-31-2,164333.0,OCCCOC(C)COC(C)(C)C
NCGC00255887-01,tox21-er-bla-agonist-p2,Octyl beta-D-glucopyranoside,activity,inactive,29836-26-8,62852.0,OC[C@H]1O[C@@H](OCCCCCCCC)[C@H](O)[C@@H](O)[C@@H]1O
NCGC00255996-01,tox21-er-bla-agonist-p2,Sulfosuccinic acid,activity,inactive,5138-18-1,21220.0,OC(=O)CC(C(=O)O)S(=O)(=O)O
NCGC00256008-01,tox21-er-bla-agonist-p2,Dipropan-2-yl butanedioate,activity,inactive,924-88-9,70213.0,CC(C)OC(=O)CCC(=O)OC(C)C
NCGC00256029-01,tox21-er-bla-agonist-p2,"2,6-Dichloro-3-methylaniline",activity,inactive,64063-37-2,116529.0,Clc1c(C)ccc(Cl)c1N
NCGC00256034-01,tox21-er-bla-agonist-p2,Ethyl 3-acetyl-4-oxopentanoate,activity,inactive,18835-02-4,87820.0,O=C(C)C(CC(=O)OCC)C(C)=O
NCGC00255701-01,tox21-er-bla-agonist-p2,Clofibric acid,activity,inactive,882-09-7,2797.0,Clc1ccc(OC(C)(C)C(=O)O)cc1
NCGC00260415-01,tox21-er-bla-agonist-p2,Nonanoyl chloride,activity,inactive,764-85-2,69819.0,ClC(=O)CCCCCCCC
NCGC00260579-01,tox21-er-bla-agonist-p2,NTP Mix56 CT1 3-EQP,activity,inactive,NOCAS_49475,,
NCGC00260618-01,tox21-er-bla-agonist-p2,NTP Mix118 ER1 5-EQP,activity,active agonist,NOCAS_49514,,
NCGC00260645-01,tox21-er-bla-agonist-p2,NTP Mix86 ER AR1 18-EQP,activity,active agonist,NOCAS_49541,,
NCGC00259073-01,tox21-er-bla-agonist-p2,"3,4-Dimethylphenol",activity,inactive,95-65-8,7249.0,Cc1cc(O)ccc1C
NCGC00259178-01,tox21-er-bla-agonist-p2,Tetraethylene glycol,activity,inactive,112-60-7,8200.0,OCCOCCOCCOCCO
NCGC00259237-01,tox21-er-bla-agonist-p2,Clofentezine,activity,inactive,74115-24-5,73670.0,Clc3ccccc3c1nnc(nn1)c2ccccc2Cl
NCGC00259332-01,tox21-er-bla-agonist-p2,Isosafrole,activity,inactive,120-58-1,8439.0,CC=Cc1ccc2OCOc2c1
NCGC00259483-01,tox21-er-bla-agonist-p2,Tribufos,activity,inactive,78-48-8,5125.0,CCCCSP(=O)(SCCCC)SCCCC
NCGC00259598-01,tox21-er-bla-agonist-p2,"5,5-Dimethylhydantoin",activity,inactive,77-71-4,6491.0,O=C1NC(=O)C(C)(C)N1
NCGC00260123-01,tox21-er-bla-agonist-p2,Sodium 4-aminobenzenesulfonate,activity,inactive,515-74-2,23664644.0,[Na+].Nc1ccc(cc1)S(=O)([O-])=O
NCGC00258710-01,tox21-er-bla-agonist-p2,Cycloheximide,activity,inactive,66-81-9,6197.0,O=C2CC(C[C@@H](O)[C@@H]1C[C@@H](C)C[C@H](C)C1=O)CC(=O)N2
NCGC00254747-01,tox21-er-bla-agonist-p2,Quinoxyfen,activity,inactive,124495-18-7,3391107.0,Fc1ccc(cc1)Oc2ccnc3cc(Cl)cc(Cl)c23
NCGC00254767-01,tox21-er-bla-agonist-p2,Propetamphos,activity,inactive,31218-83-4,5372405.0,COP(=S)(NCC)OC(\C)=C\C(=O)OC(C)C
NCGC00254859-01,tox21-er-bla-agonist-p2,Dimethyl sulfoxide,activity,inactive,67-68-5,679.0,CS(C)=O
NCGC00255064-01,tox21-er-bla-agonist-p2,Fenoxaprop-ethyl,activity,inactive,66441-23-4,47938.0,O=C(OCC)C(C)Oc1ccc(cc1)Oc2nc3ccc(Cl)cc3o2
NCGC00255127-01,tox21-er-bla-agonist-p2,Ampicillin,activity,inactive,69-53-4,6249.0,OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C
NCGC00255303-01,tox21-er-bla-agonist-p2,Acetic acid,activity,inactive,64-19-7,176.0,CC(=O)O
NCGC00255435-01,tox21-er-bla-agonist-p2,Diethyl phosphite,activity,inactive,762-04-9,12977.0,CCOP(O)OCC
NCGC00255794-01,tox21-er-bla-agonist-p2,"2,5,8,11,14-Pentaoxapentadecane",activity,inactive,143-24-8,8925.0,COCCOCCOCCOCCOC
NCGC00254596-01,tox21-er-bla-agonist-p2,PFOA,activity,inactive,335-67-1,9554.0,FC(F)(C(F)(F)C(=O)O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00092334-01,tox21-er-bla-agonist-p2,Zatebradine hydrochloride,activity,inactive,91940-87-3,3045335.0,Cl.COc1ccc(cc1OC)CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O
NCGC00166290-02,tox21-er-bla-agonist-p2,Polyoxyethylen-9-lauryl ether,activity,inactive,3055-99-0,656641.0,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
NCGC00093802-04,tox21-er-bla-agonist-p2,Dehydroepiandrosterone,activity,active agonist,53-43-0,5881.0,O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00094144-03,tox21-er-bla-agonist-p2,Metyrosine,activity,inactive,672-87-7,441350.0,Oc1ccc(C[C@](C)(N)C(=O)O)cc1
NCGC00167421-01,tox21-er-bla-agonist-p2,Sevoflurane,activity,inactive,28523-86-6,5206.0,FC(F)(F)C(OCF)C(F)(F)F
NCGC00159452-02,tox21-er-bla-agonist-p2,Sorbinil,activity,inactive,68367-52-2,337359.0,Fc2ccc3OCC[C@]1(NC(=O)NC1=O)c3c2
NCGC00159462-02,tox21-er-bla-agonist-p2,Ritonavir,activity,inactive,155213-67-5,392622.0,CC(C)c4nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)C(C)C)cs4
NCGC00163843-03,tox21-er-bla-agonist-p2,Mesotrione,activity,inactive,104206-82-8,175967.0,O=C2CCCC(=O)C2C(=O)c1ccc(cc1[N+]([O-])=O)S(C)(=O)=O
NCGC00167460-01,tox21-er-bla-agonist-p2,Ceftizoxime sodium,activity,inactive,68401-82-1,23663938.0,[Na+].Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=CCS[C@@H]23)C([O-])=O
NCGC00159463-02,tox21-er-bla-agonist-p2,Phenacaine,activity,inactive,101-93-9,17756783.0,CCOc1ccc(cc1)NC(=C)Nc2ccc(OCC)cc2
NCGC00163935-02,tox21-er-bla-agonist-p2,Dimethenamid,activity,inactive,87674-68-8,91744.0,Cc1csc(C)c1N(C(C)COC)C(=O)CCl
NCGC00094811-01,tox21-er-bla-agonist-p2,Sodium zomepirac,activity,inactive,64092-48-4,16220118.0,[Na+].Cc2cc(CC([O-])=O)n(C)c2C(=O)c1ccc(Cl)cc1
NCGC00160370-01,tox21-er-bla-agonist-p2,Crotoniazide,activity,inactive,7007-96-7,5360232.0,O=C(N\N=C\C=CC)c1ccncc1
NCGC00167983-01,tox21-er-bla-agonist-p2,Desonide,activity,inactive,638-94-8,5311066.0,OCC(=O)[C@@]54OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00164553-01,tox21-er-bla-agonist-p2,Clofarabine,activity,inactive,123318-82-1,119182.0,Nc3nc(Cl)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F
NCGC00160464-01,tox21-er-bla-agonist-p2,Rolicyclidine,activity,inactive,2201-39-0,62436.0,C1CCC(CC1)(c2ccccc2)N3CCCC3
NCGC00168253-01,tox21-er-bla-agonist-p2,"3,6-Diacetylmorphine",activity,inactive,561-27-3,5462328.0,CC(=O)Oc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@H](C=C[C@@H]45)OC(C)=O
NCGC00095187-01,tox21-er-bla-agonist-p2,Ramelteon,activity,inactive,196597-26-9,9881626.0,CCC(=O)NCCC3CCc2ccc1OCCc1c23
NCGC00160537-04,tox21-er-bla-agonist-p2,Flutolanil,activity,inactive,66332-96-5,47898.0,CC(C)Oc1cccc(c1)NC(=O)c2ccccc2C(F)(F)F
NCGC00160580-01,tox21-er-bla-agonist-p2,Osalmid,activity,inactive,526-18-1,4602.0,O=C(Nc1ccc(O)cc1)c2ccccc2O
NCGC00168773-01,tox21-er-bla-agonist-p2,Darunavir,activity,inactive,206361-99-1,213039.0,Nc1ccc(cc1)S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)O[C@H]3CO[C@H]4OCC[C@@H]34
NCGC00142622-03,tox21-er-bla-agonist-p2,Dexpanthenol,activity,inactive,81-13-0,131204.0,CC(C)(CO)[C@@H](O)C(=O)NCCCO
NCGC00159345-02,tox21-er-bla-agonist-p2,Atropine,activity,inactive,51-55-8,174174.0,CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)C(CO)c2ccccc2
NCGC00167552-01,tox21-er-bla-agonist-p2,Piperocaine hydrochloride,activity,inactive,533-28-8,10781.0,Cl.CC2CCCCN2CCCOC(=O)c1ccccc1
NCGC00159382-02,tox21-er-bla-agonist-p2,dl-Menthol,activity,inactive,89-78-1,16666.0,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
NCGC00163169-01,tox21-er-bla-agonist-p2,Pizotyline,activity,inactive,15574-96-6,27400.0,CN1CC/C(CC1)=C3\c4ccccc4CCc2sccc23
NCGC00182026-01,tox21-er-bla-agonist-p2,Tiludronate disodium,activity,inactive,149845-07-8,60936.0,[Na+].[Na+].Clc1ccc(SC(P([O-])(=O)O)P([O-])(=O)O)cc1
NCGC00182039-01,tox21-er-bla-agonist-p2,Cilazapril,activity,inactive,88768-40-5,56330.0,O=C(OCC)[C@H](CCc1ccccc1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(=O)O
NCGC00183003-01,tox21-er-bla-agonist-p2,Depolipon,activity,inactive,16488-48-5,27891.0,[Cl-].CC[NH+](CC)CCOC(=O)c1ccc(NCCCC)cc1
NCGC00183283-01,tox21-er-bla-agonist-p2,Iomeprol,activity,inactive,78649-41-9,3731.0,Ic1c(c(I)c(c(I)c1N(C)C(=O)CO)C(=O)NCC(O)CO)C(=O)NCC(O)CO
NCGC00185745-01,tox21-er-bla-agonist-p2,Cefroxadine,activity,inactive,51762-05-1,5284529.0,N[C@H](C1=CCC=CC1)C(=O)N[C@@H]3C(=O)N2C(=C(OC)CS[C@@H]23)C(=O)O
NCGC00254236-01,tox21-er-bla-agonist-p2,"4,4'-Sulfonylbis[2-(prop-2-en-1-yl)phenol]",activity,inactive,41481-66-7,833466.0,Oc1ccc(cc1CC=C)S(=O)(=O)c2cc(CC=C)c(O)cc2
NCGC00254272-01,tox21-er-bla-agonist-p2,Chlorpromazine hydrochloride,activity,inactive,69-09-0,6240.0,Cl.CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12
NCGC00253932-01,tox21-er-bla-agonist-p2,Acrylamide,activity,inactive,79-06-1,6579.0,C=CC(N)=O
NCGC00254396-01,tox21-er-bla-agonist-p2,Cotinine,activity,inactive,486-56-6,854019.0,CN2C(=O)CC[C@H]2c1cnccc1
NCGC00254019-01,tox21-er-bla-agonist-p2,Phenol,activity,inactive,108-95-2,996.0,Oc1ccccc1
NCGC00254844-01,tox21-er-bla-agonist-p2,"5,7-Dimethoxy-2H-chromen-2-one",activity,inactive,487-06-9,2775.0,COc2cc(cc1OC(=O)C=Cc12)OC
NCGC00254123-01,tox21-er-bla-agonist-p2,"1,3-Dichloro-2-propanol",activity,inactive,96-23-1,7289.0,ClCC(O)CCl
NCGC00181354-01,tox21-er-bla-agonist-p2,Tretinoin tocoferil,activity,inactive,40516-48-1,5282180.0,CC=3CCCC(C)(C)C=3/C=CC(\C)=C\C=CC(/C)=C/C(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00182072-02,tox21-er-bla-agonist-p2,Mephenoxalone,activity,inactive,70-07-5,6257.0,COc2ccccc2OCC1CNC(=O)O1
NCGC00182851-01,tox21-er-bla-agonist-p2,Meprednisone,activity,inactive,1247-42-3,5284587.0,OCC(=O)[C@@]3(O)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00259866-01,tox21-er-bla-agonist-p2,Catechol,activity,active agonist,120-80-9,289.0,Oc1ccccc1O
NCGC00258439-01,tox21-er-bla-agonist-p2,o-Cresyl glycidyl ether,activity,inactive,2210-79-9,16640.0,Cc2ccccc2OCC1CO1
NCGC00260227-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylpyridinium bromide,activity,inactive,26576-85-2,12248306.0,[Br-].Cc1ccc[n+](CCCC)c1
NCGC00258632-01,tox21-er-bla-agonist-p2,"2-Amino-5,6-dimethylbenzothiazole",activity,inactive,29927-08-0,34757.0,Cc1cc2nc(N)sc2cc1C
NCGC00161419-02,tox21-er-bla-agonist-p2,Trimetrexate trihydrochloride,activity,inactive,NOCAS_47817,45006154.0,Cl.Cl.Cl.COc1cc(cc(OC)c1OC)NCc2ccc3nc(N)nc(N)c3c2C
NCGC00258965-01,tox21-er-bla-agonist-p2,Ametryn,activity,inactive,834-12-8,13263.0,CSc1nc(NCC)nc(NC(C)C)n1
NCGC00258085-01,tox21-er-bla-agonist-p2,Octanedioic acid,activity,inactive,505-48-6,10457.0,O=C(O)CCCCCCC(=O)O
NCGC00257125-01,tox21-er-bla-agonist-p2,Dimethyltin dichloride,activity,inactive,753-73-1,12955.0,C[Sn](C)(Cl)Cl
NCGC00260046-01,tox21-er-bla-agonist-p2,Chlorowax 500C,activity,inactive,NOCAS_33326,6537498.0,ClC(CC(Cl)CC)C(Cl)C(Cl)C(Cl)C(C)Cl
NCGC00255571-01,tox21-er-bla-agonist-p2,Erythromycin estolate,activity,inactive,3521-62-8,441371.0,O=S(=O)(O)OCCCCCCCCCCCC.CCC(=O)O[C@@H]3[C@H](C[C@@H](C)O[C@H]3O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C
NCGC00260649-01,tox21-er-bla-agonist-p2,NTP Mix90 ER AR1 18-EQP,activity,active agonist,NOCAS_49545,,
NCGC00257801-01,tox21-er-bla-agonist-p2,(-)-Enterodiol,activity,inactive,80226-00-2,115089.0,Oc2cc(C[C@@H](CO)[C@@H](Cc1cccc(O)c1)CO)ccc2
NCGC00259235-01,tox21-er-bla-agonist-p2,Cyproterone acetate,activity,inactive,427-51-0,9880.0,CC(=O)[C@@]4(OC(C)=O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C
NCGC00256882-01,tox21-er-bla-agonist-p2,Diethoxy(methyl)[3-(oxiran-2-ylmethoxy)propyl]silane,activity,inactive,2897-60-1,62467.0,C[Si](CCCOCC1CO1)(OCC)OCC
NCGC00257425-01,tox21-er-bla-agonist-p2,sec-Butylparaben,activity,active agonist,17696-61-6,86607.0,Oc1ccc(cc1)C(=O)OC(C)CC
NCGC00259903-01,tox21-er-bla-agonist-p2,2-Ethylhexylparaben,activity,active agonist,5153-25-3,107377.0,Oc1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00257910-01,tox21-er-bla-agonist-p2,2-Bromopropane,activity,inactive,75-26-3,6358.0,BrC(C)C
NCGC00258101-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium thiocyanate,activity,inactive,331717-63-6,16211115.0,N#C[S-].C[n+]1ccn(CC)c1
NCGC00257266-01,tox21-er-bla-agonist-p2,5-(Hydroxymethyl)-2-furfural,activity,inactive,67-47-0,237332.0,O=Cc1ccc(CO)o1
NCGC00257443-01,tox21-er-bla-agonist-p2,4-Thiocresol,activity,inactive,106-45-6,7811.0,Cc1ccc(S)cc1
NCGC00258619-01,tox21-er-bla-agonist-p2,Triethylenetetramine,activity,inactive,112-24-3,5565.0,NCCNCCNCCN
NCGC00257726-01,tox21-er-bla-agonist-p2,Myristicin,activity,inactive,607-91-0,4276.0,C=CCc1cc2OCOc2c(c1)OC
NCGC00259157-01,tox21-er-bla-agonist-p2,Dimethyl malonate,activity,inactive,108-59-8,7943.0,O=C(OC)CC(=O)OC
NCGC00255601-01,tox21-er-bla-agonist-p2,4-Cyclohexylcyclohexanol,activity,inactive,2433-14-9,75518.0,OC1CCC(CC1)C2CCCCC2
NCGC00255631-01,tox21-er-bla-agonist-p2,Sodium iodide,activity,inactive,7681-82-5,5238.0,I[Na]
NCGC00256018-01,tox21-er-bla-agonist-p2,Prop-2-en-1-yl heptanoate,activity,inactive,142-19-8,8878.0,O=C(CCCCCC)OCC=C
NCGC00256923-01,tox21-er-bla-agonist-p2,"1,4-Heptanolide",activity,inactive,105-21-5,7742.0,O=C1CCC(CCC)O1
NCGC00256816-01,tox21-er-bla-agonist-p2,"3,3',5-Triiodo-l-thyronine sodium salt",activity,active agonist,55-06-1,23666110.0,[Na+].[O-]C(=O)[C@@H](N)Cc2cc(I)c(Oc1cc(I)c(O)cc1)c(I)c2
NCGC00256817-01,tox21-er-bla-agonist-p2,Octyl prop-2-enoate,activity,inactive,2499-59-4,17258.0,CCCCCCCCOC(=O)C=C
NCGC00256991-01,tox21-er-bla-agonist-p2,"1,2,3-Benzotriazin-4(1H)-one",activity,inactive,90-16-4,7006.0,O=C2N=NNc1ccccc12
NCGC00257032-01,tox21-er-bla-agonist-p2,N-Isopropyl-N'-phenyl-p-phenylenediamine,activity,inactive,101-72-4,7573.0,CC(C)Nc1ccc(cc1)Nc2ccccc2
NCGC00257062-01,tox21-er-bla-agonist-p2,5-Ethylidene-2-norbornene,activity,inactive,16219-75-3,27756.0,CC=C2CC1C=CC2C1
NCGC00257813-01,tox21-er-bla-agonist-p2,"2,3,5,6-Tetrachloropyridine",activity,inactive,2402-79-1,16990.0,Clc1cc(Cl)c(Cl)nc1Cl
NCGC00257165-01,tox21-er-bla-agonist-p2,6-Methyl coumarin,activity,inactive,92-48-8,7092.0,Cc1ccc2OC(=O)C=Cc2c1
NCGC00257632-01,tox21-er-bla-agonist-p2,6-Amino-4-hydroxynaphthalene-2-sulfonic acid,activity,inactive,90-51-7,7022.0,O=S(=O)(O)c1cc(O)c2cc(N)ccc2c1
NCGC00257929-01,tox21-er-bla-agonist-p2,N-Ethyl-N-phenyl benzylamine,activity,inactive,92-59-1,7098.0,CCN(Cc1ccccc1)c2ccccc2
NCGC00257299-01,tox21-er-bla-agonist-p2,"Carbonochloridic acid, 2-ethylhexyl ester",activity,inactive,24468-13-1,62783.0,O=C(Cl)OCC(CCCC)CC
NCGC00257357-01,tox21-er-bla-agonist-p2,Fulvestrant,activity,inactive,129453-61-8,104741.0,FC(F)(F)C(F)(F)CCCS(=O)CCCCCCCCC[C@@H]2Cc1cc(O)ccc1[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@H]23
NCGC00258747-01,tox21-er-bla-agonist-p2,Musk ambrette,activity,active agonist,83-66-9,6753.0,COc1c(cc(c(C)c1[N+]([O-])=O)[N+]([O-])=O)C(C)(C)C
NCGC00258352-01,tox21-er-bla-agonist-p2,Potassium persulfate,activity,inactive,7727-21-1,24412.0,[K+].[K+].O=S(=O)([O-])OOS([O-])(=O)=O
NCGC00258355-01,tox21-er-bla-agonist-p2,Allyl bromide,activity,inactive,106-95-6,7841.0,BrCC=C
NCGC00258561-01,tox21-er-bla-agonist-p2,3-Ethylamino-4-methylphenol,activity,inactive,120-37-6,8428.0,Oc1ccc(C)c(NCC)c1
NCGC00259051-01,tox21-er-bla-agonist-p2,"3,3',5,5'-Tetramethylbenzidine",activity,inactive,54827-17-7,41206.0,Cc1cc(cc(C)c1N)c2cc(C)c(N)c(C)c2
NCGC00259031-01,tox21-er-bla-agonist-p2,Tricaprylin,activity,inactive,538-23-8,10850.0,O=C(CCCCCCC)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC
NCGC00259246-01,tox21-er-bla-agonist-p2,2-Ethoxyethanol,activity,inactive,110-80-5,8076.0,CCOCCO
NCGC00259252-01,tox21-er-bla-agonist-p2,Carbazole,activity,inactive,86-74-8,6854.0,c1cccc2nc3ccccc3c12
NCGC00259733-01,tox21-er-bla-agonist-p2,Thifensulfuron-methyl,activity,inactive,79277-27-3,73674.0,O=S(=O)(NC(=O)Nc1nc(C)nc(OC)n1)c2ccsc2C(=O)OC
NCGC00260144-01,tox21-er-bla-agonist-p2,Polybrominated biphenyls,activity,inactive,59536-65-1,158629.0,Brc2ccc(c1cc(Br)c(Br)c(Br)c1)c(Br)c2Br
NCGC00259423-01,tox21-er-bla-agonist-p2,Diethyl phthalate,activity,inactive,84-66-2,6781.0,O=C(OCC)c1ccccc1C(=O)OCC
NCGC00260110-01,tox21-er-bla-agonist-p2,Ammonium dodecyl sulfate,activity,inactive,2235-54-3,16700.0,[NH4+].[O-]S(=O)(=O)OCCCCCCCCCCCC
NCGC00259711-01,tox21-er-bla-agonist-p2,Fluridone,activity,inactive,59756-60-4,43079.0,CN1C=C(C(=O)C(=C1)c2cc(ccc2)C(F)(F)F)c3ccccc3
NCGC00260210-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpiperidinium bis(trifluoromethylsulfonyl)imide,activity,inactive,623580-02-9,12184311.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.C[N+]1(CCCC)CCCCC1
NCGC00260214-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpiperidinium hexafluorophosphate,activity,inactive,NOCAS_49385,57369982.0,F[P-](F)(F)(F)(F)F.C[N+]1(CCCC)CCCCC1
NCGC00260400-01,tox21-er-bla-agonist-p2,Phloretin,activity,active agonist,60-82-2,4788.0,O=C(CCc1ccc(O)cc1)c2c(O)cc(O)cc2O
NCGC00260458-01,tox21-er-bla-agonist-p2,2-Fluorobiphenyl,activity,inactive,321-60-8,67579.0,Fc2ccccc2c1ccccc1
NCGC00260241-01,tox21-er-bla-agonist-p2,1-Butylpyridinium tetrafluoroborate,activity,inactive,203389-28-0,2734180.0,F[B-](F)(F)F.CCCC[n+]1ccccc1
NCGC00013103-01,tox21-er-bla-agonist-p2,Phenylalanine,activity,inactive,150-30-1,994.0,NC(Cc1ccccc1)C(=O)O
NCGC00016723-01,tox21-er-bla-agonist-p2,Ornidazole,activity,inactive,16773-42-5,28061.0,Cc1ncc([N+]([O-])=O)n1CC(O)CCl
NCGC00016649-01,tox21-er-bla-agonist-p2,Atropine-N-oxide hydrochloride,activity,inactive,4574-60-1,6419888.0,Cl.C[N+]2([O-])[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3
NCGC00015996-02,tox21-er-bla-agonist-p2,Tiapride hydrochloride,activity,inactive,51012-33-0,5702214.0,Cl.O=S(C)(=O)c1cc(c(OC)cc1)C(=O)NCCN(CC)CC
NCGC00164611-01,tox21-er-bla-agonist-p2,Gestodene,activity,active agonist,60282-87-3,3033968.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2C=C[C@@]1(O)C#C)=C4
NCGC00254698-01,tox21-er-bla-agonist-p2,Dialifor,activity,active agonist,10311-84-9,25146.0,CCOP(=S)(OCC)SC(CCl)N2C(=O)c1ccccc1C2=O
NCGC00254876-01,tox21-er-bla-agonist-p2,2-Phenylethyl propionate,activity,inactive,122-70-3,31225.0,CCC(=O)OCCc1ccccc1
NCGC00254892-01,tox21-er-bla-agonist-p2,Dazomet,activity,inactive,533-74-4,10788.0,S=C1SCN(C)CN1C
NCGC00254995-01,tox21-er-bla-agonist-p2,gamma-Decanolactone,activity,inactive,706-14-9,12813.0,O=C1CCC(CCCCCC)O1
NCGC00254612-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorophenol sodium salt",activity,inactive,136-32-3,23662264.0,[Na+].[O-]c1cc(Cl)c(Cl)cc1Cl
NCGC00254354-01,tox21-er-bla-agonist-p2,PK 11195,activity,inactive,85532-75-8,1345.0,CC(CC)N(C)C(=O)c2cc1ccccc1c(n2)c3ccccc3Cl
NCGC00255187-01,tox21-er-bla-agonist-p2,Norethindrone,activity,active agonist,68-22-4,6230.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00254193-01,tox21-er-bla-agonist-p2,SSR146977,activity,inactive,264618-44-2,53316379.0,CN(C)C(=O)NC4(CCN(CCC[C@]1(CCCN(C1)C(=O)c2ccccc2)c3ccc(Cl)c(Cl)c3)CC4)c5ccccc5
NCGC00016099-04,tox21-er-bla-agonist-p2,Xamoterol,activity,inactive,81801-12-9,155774.0,O=C(NCCNCC(O)COc1ccc(O)cc1)N2CCOCC2
NCGC00016507-01,tox21-er-bla-agonist-p2,Thonzonium bromide,activity,inactive,553-08-2,11102.0,[Br-].COc1ccc(cc1)CN(CC[N+](C)(C)CCCCCCCCCCCCCCCC)c2ncccn2
NCGC00016639-01,tox21-er-bla-agonist-p2,Ifosfamide,activity,inactive,3778-73-2,3690.0,O=P1(NCCCl)OCCCN1CCCl
NCGC00017291-05,tox21-er-bla-agonist-p2,Riboflavin,activity,inactive,83-88-5,493570.0,OC[C@@H](O)[C@@H](O)[C@@H](O)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12
NCGC00024910-01,tox21-er-bla-agonist-p2,Cycloheximide,activity,inactive,66-81-9,6197.0,O=C2CC(C[C@@H](O)[C@@H]1C[C@@H](C)C[C@H](C)C1=O)CC(=O)N2
NCGC00095978-02,tox21-er-bla-agonist-p2,Lufenuron,activity,inactive,103055-07-8,71777.0,Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F
NCGC00160517-01,tox21-er-bla-agonist-p2,Diaveridine,activity,inactive,5355-16-8,21453.0,Nc2nc(N)ncc2Cc1ccc(OC)c(OC)c1
NCGC00181320-01,tox21-er-bla-agonist-p2,Mersalyl acid,activity,inactive,486-67-9,443130.0,O[Hg]CC(OC)CNC(=O)c1ccccc1OCC(=O)O
NCGC00182078-02,tox21-er-bla-agonist-p2,Tolperisone hydrochloride,activity,inactive,3644-61-9,92965.0,Cl.CC(CN1CCCCC1)C(=O)c2ccc(C)cc2
NCGC00183859-01,tox21-er-bla-agonist-p2,Prifinium bromide,activity,inactive,4630-95-9,20749.0,[Br-].CC[N+]3(CC)CC/C(=C(\c1ccccc1)c2ccccc2)C3C
NCGC00247730-01,tox21-er-bla-agonist-p2,Fenethylline hydrochloride,activity,inactive,1892-80-4,102710.0,Cl.CC(Cc1ccccc1)NCCn3cnc2c3C(=O)N(C)C(=O)N2C
NCGC00260582-01,tox21-er-bla-agonist-p2,NTP Mix42 CT1 3-EQP,activity,inactive,NOCAS_49478,,
NCGC00016668-02,tox21-er-bla-agonist-p2,Salicylic acid dihydrogen phosphate,activity,inactive,6064-83-1,3418.0,OP(=O)(O)Oc1ccccc1C(=O)O
NCGC00096081-01,tox21-er-bla-agonist-p2,beta-Carotene,activity,inactive,7235-40-7,5280489.0,CC=2CCCC(C)(C)C=2/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C
NCGC00159473-02,tox21-er-bla-agonist-p2,Fenfluramine,activity,inactive,458-24-2,3337.0,FC(F)(F)c1cccc(CC(C)NCC)c1
NCGC00182997-01,tox21-er-bla-agonist-p2,Melinamide,activity,inactive,14417-88-0,20054967.0,CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC(C)c1ccccc1
NCGC00253917-01,tox21-er-bla-agonist-p2,4-Nitrobenzoic acid,activity,inactive,62-23-7,6108.0,O=[N+]([O-])c1ccc(cc1)C(=O)O
NCGC00090680-01,tox21-er-bla-agonist-p2,Carbaryl,activity,inactive,63-25-2,6129.0,CNC(=O)Oc2cccc1ccccc12
NCGC00090776-02,tox21-er-bla-agonist-p2,Dicyclopentadiene,activity,inactive,77-73-6,6492.0,C=2CC3C1C=CC(C1)C3C=2
NCGC00090987-02,tox21-er-bla-agonist-p2,1-Naphthaleneacetic acid,activity,inactive,86-87-3,6862.0,O=C(O)Cc2cccc1ccccc12
NCGC00023945-05,tox21-er-bla-agonist-p2,3'-Azido-3'-deoxythymidine,activity,inactive,30516-87-1,35370.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2
NCGC00016892-01,tox21-er-bla-agonist-p2,Iopamidol,activity,inactive,60166-93-0,65492.0,O=C(Nc1c(I)c(c(I)c(c1I)C(=O)NC(CO)CO)C(=O)NC(CO)CO)[C@H](C)O
NCGC00258378-01,tox21-er-bla-agonist-p2,Allyl chloride,activity,active agonist,107-05-1,7850.0,C=CCCl
NCGC00258403-01,tox21-er-bla-agonist-p2,Bromobenzene,activity,inactive,108-86-1,7961.0,Brc1ccccc1
NCGC00258507-01,tox21-er-bla-agonist-p2,Benzotrifluoride,activity,inactive,98-08-8,7368.0,FC(F)(F)c1ccccc1
NCGC00257157-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarbonyl dichloride",activity,inactive,99-63-8,7451.0,O=C(Cl)c1cccc(c1)C(Cl)=O
NCGC00257442-01,tox21-er-bla-agonist-p2,Nonanal,activity,inactive,124-19-6,31289.0,CCCCCCCCC=O
NCGC00258176-01,tox21-er-bla-agonist-p2,2-Nitroethanol,activity,inactive,625-48-9,12252.0,[O-][N+](=O)CCO
NCGC00258329-01,tox21-er-bla-agonist-p2,"2,6-Dichlorophenol",activity,inactive,87-65-0,6899.0,Clc1cccc(Cl)c1O
NCGC00256754-01,tox21-er-bla-agonist-p2,(6Z)-Non-6-en-1-ol,activity,inactive,35854-86-5,5362792.0,CC\C=C/CCCCCO
NCGC00255886-01,tox21-er-bla-agonist-p2,Dibutyl ethanedioate,activity,inactive,2050-60-4,16306.0,O=C(OCCCC)C(=O)OCCCC
NCGC00256094-01,tox21-er-bla-agonist-p2,"4-Amino-2,5-dimethoxy-N-phenylbenzenesulfonamide",activity,inactive,52298-44-9,104143.0,O=S(=O)(Nc1ccccc1)c2cc(OC)c(N)cc2OC
NCGC00256207-01,tox21-er-bla-agonist-p2,Chlordimeform hydrochloride,activity,inactive,19750-95-9,12336279.0,Cl.Clc1cc(C)c(/N=C/N(C)C)cc1
NCGC00256278-01,tox21-er-bla-agonist-p2,"5,5'-Bi-2-benzofuran-1,1',3,3'-tetrone",activity,inactive,2420-87-3,75494.0,O=C1OC(=O)c2cc(ccc12)c3ccc4C(=O)OC(=O)c4c3
NCGC00256364-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorophenoxyacetic acid",activity,inactive,93-76-5,1480.0,Clc1cc(OCC(=O)O)c(Cl)cc1Cl
NCGC00258803-01,tox21-er-bla-agonist-p2,2-Chlorotoluene,activity,inactive,95-49-8,7238.0,Cc1ccccc1Cl
NCGC00259455-01,tox21-er-bla-agonist-p2,"3,3'-Dichlorobenzidine dihydrochloride",activity,active agonist,612-83-9,11933.0,Cl.Cl.Nc1ccc(cc1Cl)c2ccc(N)c(Cl)c2
NCGC00259731-01,tox21-er-bla-agonist-p2,Warfarin,activity,inactive,81-81-2,54678486.0,CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3
NCGC00259758-01,tox21-er-bla-agonist-p2,Decanoic acid,activity,inactive,334-48-5,2969.0,O=C(O)CCCCCCCCC
NCGC00259857-01,tox21-er-bla-agonist-p2,Quercetin,activity,active agonist,117-39-5,5280343.0,Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O
NCGC00259972-01,tox21-er-bla-agonist-p2,Acesulfame potassium,activity,inactive,55589-62-3,11074431.0,[K+].CC1=CC(=O)[N-]S(=O)(=O)O1
NCGC00260041-01,tox21-er-bla-agonist-p2,Cadmium oxide,activity,inactive,1306-19-0,14782.0,[Cd]=O
NCGC00254661-01,tox21-er-bla-agonist-p2,"2,2,4,4,6,6-Hexamethyl-1,3,5,2,4,6-triazatrisilinane",activity,inactive,1009-93-4,66094.0,C[Si]1(C)N[Si](C)(C)N[Si](C)(C)N1
NCGC00254803-01,tox21-er-bla-agonist-p2,Chloramine T hydrate (1:x),activity,inactive,149358-73-6,53316400.0,[Na+].O.O.Cc1ccc(cc1)S(=O)(=O)[N-]Cl
NCGC00255140-01,tox21-er-bla-agonist-p2,Cyclocytidine,activity,inactive,31698-14-3,25051.0,N=C2N=C3O[C@H]1[C@H](O)[C@@H](CO)O[C@H]1N3C=C2
NCGC00255172-01,tox21-er-bla-agonist-p2,4-Ethoxy-2-nitroaniline,activity,inactive,616-86-4,69229.0,CCOc1ccc(N)c(c1)[N+]([O-])=O
NCGC00255184-01,tox21-er-bla-agonist-p2,Ethisterone,activity,active agonist,434-03-7,5284557.0,O=C4CC[C@@]3(C)C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00255344-01,tox21-er-bla-agonist-p2,S-Metolachlor,activity,inactive,87392-12-9,11140605.0,ClCC(=O)N([C@@H](C)COC)c1c(C)cccc1CC
NCGC00255494-01,tox21-er-bla-agonist-p2,"9,12-Tetradecadien-1-ol, acetate, (Z,E)-",activity,inactive,31654-77-0,5365642.0,CC(=O)OCCCCCCCC/C=C\C\C=C\C
NCGC00255566-01,tox21-er-bla-agonist-p2,Azinphos-ethyl,activity,active agonist,2642-71-9,17531.0,CCOP(=S)(OCC)SCN1N=Nc2ccccc2C1=O
NCGC00255877-01,tox21-er-bla-agonist-p2,Triethoxymethylsilane,activity,inactive,2031-67-6,16241.0,CCO[Si](C)(OCC)OCC
NCGC00166266-02,tox21-er-bla-agonist-p2,"1,3-Bis(4-carboxyphenoxy)propane",activity,inactive,3753-81-9,68610.0,O=C(O)c1ccc(cc1)OCCCOc2ccc(cc2)C(=O)O
NCGC00159397-02,tox21-er-bla-agonist-p2,Iodoantipyrine,activity,inactive,129-81-7,8522.0,O=C2C(I)=C(C)N(C)N2c1ccccc1
NCGC00163182-01,tox21-er-bla-agonist-p2,Norcodeine,activity,inactive,467-15-2,9925873.0,COc1ccc2C[C@H]4NCC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00163224-01,tox21-er-bla-agonist-p2,Butylscopolammonium bromide,activity,inactive,149-64-4,6852391.0,[Br-].OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)CCCC
NCGC00166403-01,tox21-er-bla-agonist-p2,Sodium triphosphate hydrate (5:1:6),activity,inactive,15091-98-2,23064738.0,[Na+].[Na+].[Na+].[Na+].[Na+].O.O.O.O.O.O.[O-]P(=O)(OP(=O)([O-])[O-])OP(=O)([O-])[O-]
NCGC00159437-02,tox21-er-bla-agonist-p2,Clobutinol hydrochloride,activity,inactive,1215-83-4,92876.0,Cl.Clc1ccc(CC(C)(O)C(C)CN(C)C)cc1
NCGC00159504-02,tox21-er-bla-agonist-p2,Thymol iodide,activity,inactive,552-22-7,11088.0,IOc1cc(C)c(cc1C(C)C)c2cc(C(C)C)c(OI)cc2C
NCGC00164400-01,tox21-er-bla-agonist-p2,Danazol,activity,active agonist,17230-88-5,28417.0,C#C[C@]3(O)CC[C@H]2[C@@H]4CCC1=Cc5oncc5C[C@]1(C)[C@H]4CC[C@@]23C
NCGC00160451-01,tox21-er-bla-agonist-p2,Ibufenac,activity,inactive,1553-60-2,15250.0,CC(C)Cc1ccc(cc1)CC(=O)O
NCGC00160457-01,tox21-er-bla-agonist-p2,Pivagabine,activity,inactive,69542-93-4,68888.0,O=C(NCCCC(=O)O)C(C)(C)C
NCGC00167494-01,tox21-er-bla-agonist-p2,Androstenediol,activity,active agonist,521-17-5,10634.0,O[C@H]4CC[C@@]3(C)C(=CC[C@@H]1[C@@H]3CC[C@]2(C)[C@@H](O)CC[C@@H]12)C4
NCGC00160496-01,tox21-er-bla-agonist-p2,Amanozine,activity,inactive,537-17-7,10832.0,Nc2ncnc(Nc1ccccc1)n2
NCGC00095176-03,tox21-er-bla-agonist-p2,Modafinil,activity,inactive,68693-11-8,4236.0,O=S(CC(N)=O)C(c1ccccc1)c2ccccc2
NCGC00160554-01,tox21-er-bla-agonist-p2,Bithionoloxide,activity,inactive,844-26-8,68939.0,Oc1c(cc(Cl)cc1Cl)S(=O)c2cc(Cl)cc(Cl)c2O
NCGC00166000-01,tox21-er-bla-agonist-p2,Iohexol,activity,inactive,66108-95-0,3730.0,OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCC(O)CO
NCGC00167529-01,tox21-er-bla-agonist-p2,Itopride hydrochloride,activity,inactive,122892-31-3,129791.0,Cl.COc1cc(ccc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2
NCGC00159326-02,tox21-er-bla-agonist-p2,Lincomycin hydrochloride,activity,inactive,859-18-7,64710.0,Cl.O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@@H]1SC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@@H](C)O
NCGC00160645-01,tox21-er-bla-agonist-p2,Butamirate citrate,activity,inactive,18109-81-4,28891.0,CCC(C(=O)OCCOCCN(CC)CC)c1ccccc1.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00159338-03,tox21-er-bla-agonist-p2,N-Acetylgalactosamine,activity,inactive,1811-31-0,60196345.0,O[C@@H]([C@H](C=O)NC(C)=O)[C@H](O)[C@@H](O)CO
NCGC00159349-02,tox21-er-bla-agonist-p2,Norgestrel,activity,active agonist,797-63-7,13109.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00166253-02,tox21-er-bla-agonist-p2,dl-alpha-Tocopheryl acetate,activity,inactive,52225-20-4,86472.0,CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00159396-02,tox21-er-bla-agonist-p2,Trimetozine,activity,inactive,635-41-6,12478.0,O=C(c1cc(OC)c(OC)c(OC)c1)N2CCOCC2
NCGC00163146-01,tox21-er-bla-agonist-p2,Aconitine,activity,inactive,302-27-2,245005.0,CC(=O)O[C@@]37[C@@H](O)[C@H](OC)[C@@]6(O)C[C@@H]([C@]14C2[N@@](CC)C[C@](COC)([C@H](O)C[C@@H]1OC)[C@H]4[C@@H](OC)[C@@H]23)[C@@H]7[C@H]6OC(=O)c5ccccc5
NCGC00182037-01,tox21-er-bla-agonist-p2,Alacepril,activity,inactive,74258-86-9,71992.0,O=C(N[C@@H](Cc1ccccc1)C(=O)O)[C@@H]2CCCN2C(=O)[C@H](C)CSC(C)=O
NCGC00182550-01,tox21-er-bla-agonist-p2,Lorcaserin,activity,inactive,616202-92-7,11658860.0,Clc2cc1c(CCNC[C@@H]1C)cc2
NCGC00183841-01,tox21-er-bla-agonist-p2,Amoproxan,activity,inactive,22661-76-3,31473.0,COc1cc(cc(OC)c1OC)C(=O)OC(CN2CCOCC2)COCCC(C)C
NCGC00183860-01,tox21-er-bla-agonist-p2,Mefruside,activity,inactive,7195-27-9,4047.0,CC2(CN(C)S(=O)(=O)c1ccc(Cl)c(c1)S(N)(=O)=O)CCCO2
NCGC00184993-01,tox21-er-bla-agonist-p2,Amfenac sodium,activity,inactive,61941-56-8,23665728.0,[Na+].Nc1c(cccc1CC([O-])=O)C(=O)c2ccccc2
NCGC00255360-01,tox21-er-bla-agonist-p2,Dulcin,activity,inactive,150-69-6,9013.0,CCOc1ccc(cc1)NC(N)=O
NCGC00254280-01,tox21-er-bla-agonist-p2,Phorate,activity,inactive,298-02-2,4790.0,CCSCSP(=S)(OCC)OCC
NCGC00255403-01,tox21-er-bla-agonist-p2,(3Z)-Hex-3-en-1-yl salicylate,activity,inactive,65405-77-8,5371102.0,Oc1ccccc1C(=O)OCC/C=C\CC
NCGC00249609-01,tox21-er-bla-agonist-p2,4-Hydroperoxy cyclophosphamide,activity,inactive,39800-16-3,38347.0,O=P1(NC(CCO1)OO)N(CCCl)CCCl
NCGC00253916-01,tox21-er-bla-agonist-p2,Methyl methanesulfonate,activity,inactive,66-27-3,4156.0,CS(=O)(=O)OC
NCGC00253939-01,tox21-er-bla-agonist-p2,Methylparaben,activity,inactive,99-76-3,7456.0,Oc1ccc(cc1)C(=O)OC
NCGC00253948-01,tox21-er-bla-agonist-p2,SB413217A,activity,active agonist,NOCAS_47325,18173271.0,Cl.Fc1ccc(cc1)/C=C/C(=O)NC2CCC(CC2)CCN3CCc4ccc(cc4CC3)c5nc(C)on5
NCGC00253954-01,tox21-er-bla-agonist-p2,Furfural,activity,inactive,98-01-1,7362.0,O=Cc1ccco1
NCGC00253989-01,tox21-er-bla-agonist-p2,Triethyl citrate,activity,inactive,77-93-0,6506.0,OC(CC(=O)OCC)(CC(=O)OCC)C(=O)OCC
NCGC00254008-01,tox21-er-bla-agonist-p2,Tributylamine,activity,inactive,102-82-9,7622.0,CCCCN(CCCC)CCCC
NCGC00254101-01,tox21-er-bla-agonist-p2,4-Nitrotoluene,activity,inactive,99-99-0,7473.0,Cc1ccc(cc1)[N+](=O)[O-]
NCGC00254118-01,tox21-er-bla-agonist-p2,"1,2,4-Trimethylbenzene",activity,inactive,95-63-6,7247.0,Cc1cc(C)c(C)cc1
NCGC00254534-01,tox21-er-bla-agonist-p2,UK-333747,activity,inactive,197077-55-7,9867605.0,[O-][n+]1cccc(c1)c4nnc(COC)n4c2c(Cl)c(Cl)cc3NC(=O)C(=O)Nc23
NCGC00182968-01,tox21-er-bla-agonist-p2,Paroxetine,activity,inactive,61869-08-7,43815.0,Fc1ccc(cc1)[C@@H]4CCNC[C@H]4COc2ccc3OCOc3c2
NCGC00259615-01,tox21-er-bla-agonist-p2,Trimellitic anhydride,activity,inactive,552-30-7,11089.0,O=C(O)c1ccc2C(=O)OC(=O)c2c1
NCGC00259908-01,tox21-er-bla-agonist-p2,Benzidine,activity,inactive,92-87-5,7111.0,Nc1ccc(cc1)c2ccc(N)cc2
NCGC00258178-01,tox21-er-bla-agonist-p2,"2,3,5-Trichlorophenol",activity,inactive,933-78-8,13619.0,Oc1cc(Cl)cc(Cl)c1Cl
NCGC00260566-01,tox21-er-bla-agonist-p2,NTP Mix74 CT1 62-EQP,activity,inactive,NOCAS_49462,,
NCGC00258531-01,tox21-er-bla-agonist-p2,Pyrilamine,activity,inactive,91-84-9,4992.0,COc1ccc(cc1)CN(CCN(C)C)c2ccccn2
NCGC00254169-01,tox21-er-bla-agonist-p2,Mancozeb,activity,inactive,8018-01-7,3034368.0,[Mn+2].[Zn+2].[S-]C(=S)NCCNC(=S)[S-].[S-]C(=S)NCCNC([S-])=S
NCGC00016335-01,tox21-er-bla-agonist-p2,Dienestrol,activity,active agonist,84-17-3,667476.0,Oc1ccc(cc1)C(=C\C)/C(=C/C)c2ccc(O)cc2
NCGC00091032-03,tox21-er-bla-agonist-p2,Cyproterone acetate,activity,inactive,427-51-0,9880.0,CC(=O)[C@@]4(OC(C)=O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C
NCGC00257155-01,tox21-er-bla-agonist-p2,Mecoprop,activity,inactive,93-65-2,7153.0,Clc1cc(C)c(OC(C)C(=O)O)cc1
NCGC00257162-01,tox21-er-bla-agonist-p2,Diallylamine,activity,inactive,124-02-7,31279.0,C=CCNCC=C
NCGC00257684-01,tox21-er-bla-agonist-p2,"N,N-Dimethylmethanamine hydrochloride",activity,inactive,593-81-7,10313079.0,Cl.CN(C)C
NCGC00260437-01,tox21-er-bla-agonist-p2,Zirconocene dichloride,activity,inactive,1291-32-3,22833502.0,Cl[Zr](Cl)(C1C=CC=C1)C2=CC=CC2
NCGC00256225-01,tox21-er-bla-agonist-p2,"Dibenzyl diazene-1,2-dicarboxylate",activity,inactive,2449-05-0,75557.0,O=C(OCc1ccccc1)/N=N/C(=O)OCc2ccccc2
NCGC00256628-01,tox21-er-bla-agonist-p2,"(2E,4E)-Hexa-2,4-dien-1-ol",activity,inactive,17102-64-6,641256.0,C\C=C\C=C\CO
NCGC00257601-01,tox21-er-bla-agonist-p2,"2-Methylpropane-1,3-diol",activity,inactive,2163-42-0,75103.0,CC(CO)CO
NCGC00257627-01,tox21-er-bla-agonist-p2,2-Amino-4-chloro-5-nitrophenol,activity,inactive,6358-07-2,3894848.0,O=[N+]([O-])c1cc(O)c(N)cc1Cl
NCGC00258014-01,tox21-er-bla-agonist-p2,3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid,activity,inactive,4767-03-7,78501.0,O=C(O)C(C)(CO)CO
NCGC00257862-01,tox21-er-bla-agonist-p2,3-Hydroxy-N-phenylaniline,activity,active agonist,101-18-8,7546.0,Oc2cccc(Nc1ccccc1)c2
NCGC00257766-01,tox21-er-bla-agonist-p2,"Propanol, 1(or 2)-(2-methoxymethylethoxy)-, acetate",activity,inactive,88917-22-0,3035467.0,O=C(C)OC(CC)OCCCOC
NCGC00258260-01,tox21-er-bla-agonist-p2,3-Aminophenol,activity,inactive,591-27-5,11568.0,Nc1cccc(O)c1
NCGC00258482-01,tox21-er-bla-agonist-p2,Tetrakis(hydroxymethyl)phosphonium sulfate,activity,inactive,55566-30-8,41478.0,OC[P+](CO)(CO)CO.[O-]S([O-])(=O)=O.OC[P+](CO)(CO)CO
NCGC00258695-01,tox21-er-bla-agonist-p2,Pentabromodiphenyl ether,activity,inactive,32534-81-9,36159.0,Brc2cc(Oc1ccc(Br)cc1Br)c(Br)cc2Br
NCGC00258697-01,tox21-er-bla-agonist-p2,Isopropyl phenylacetate,activity,inactive,4861-85-2,62553.0,CC(C)OC(=O)Cc1ccccc1
NCGC00258328-01,tox21-er-bla-agonist-p2,"(Z,E)-1,2-Dichloroethylene",activity,inactive,540-59-0,10900.0,ClC=CCl
NCGC00258813-01,tox21-er-bla-agonist-p2,Phenylephrine hydrochloride,activity,inactive,61-76-7,5284443.0,Cl.O[C@@H](CNC)c1cc(O)ccc1
NCGC00259650-01,tox21-er-bla-agonist-p2,Dodecyltrimethylammonium chloride,activity,inactive,112-00-5,8152.0,[Cl-].C[N+](C)(C)CCCCCCCCCCCC
NCGC00260118-01,tox21-er-bla-agonist-p2,"1-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, monosodium salt",activity,inactive,52556-42-0,23677323.0,[Na+].[O-]S(=O)(=O)CC(O)COCC=C
NCGC00259923-01,tox21-er-bla-agonist-p2,"2,4,6-Tris(tert-butyl)phenol",activity,inactive,732-26-3,12902.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(C)(C)C
NCGC00259161-01,tox21-er-bla-agonist-p2,Tolbutamide,activity,inactive,64-77-7,5505.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC
NCGC00260334-01,tox21-er-bla-agonist-p2,Ponceau 3R,activity,inactive,3564-09-8,5359885.0,[Na+].[Na+].[O-]S(=O)(=O)c2cc3cc(c(O)c(/N=N/c1cc(C)c(C)cc1C)c3cc2)S([O-])(=O)=O
NCGC00013067-01,tox21-er-bla-agonist-p2,Cinchonine,activity,inactive,118-10-5,2724372.0,O[C@@H](c2ccnc1ccccc12)[C@H]4CC3CCN4C[C@@H]3C=C
NCGC00015256-01,tox21-er-bla-agonist-p2,Chloroquine bis(phosphate),activity,inactive,50-63-5,64927.0,O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
NCGC00016282-01,tox21-er-bla-agonist-p2,Methacholine chloride,activity,inactive,62-51-1,6114.0,[Cl-].C[N+](C)(C)CC(C)OC(=O)C
NCGC00016322-08,tox21-er-bla-agonist-p2,Dapsone,activity,inactive,80-08-0,2955.0,Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
NCGC00016819-01,tox21-er-bla-agonist-p2,Gliquidone,activity,inactive,33342-05-1,91610.0,O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)CCN4C(=O)c3cc(ccc3C(C)(C)C4=O)OC
NCGC00016535-01,tox21-er-bla-agonist-p2,Alprostadil,activity,inactive,745-65-3,5280723.0,O[C@@H]1CC(=O)[C@H](CCCCCCC(=O)O)[C@H]1/C=C/[C@@H](O)CCCCC
NCGC00016023-11,tox21-er-bla-agonist-p2,Theobromine,activity,inactive,83-67-0,5429.0,Cn1cnc2c1C(=O)NC(=O)N2C
NCGC00254434-01,tox21-er-bla-agonist-p2,"3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctan-1-ol",activity,inactive,647-42-7,69537.0,FC(F)(C(F)(F)CCO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254373-01,tox21-er-bla-agonist-p2,Endrin,activity,inactive,72-20-8,12358480.0,ClC1=C(Cl)[C@@]5(Cl)C(Cl)(Cl)[C@]1(Cl)[C@H]4[C@@H]3C[C@@H]([C@H]2O[C@H]23)[C@H]45
NCGC00255262-01,tox21-er-bla-agonist-p2,Lynestrenol,activity,active agonist,52-76-6,5284486.0,C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@]2(O)C#C
NCGC00255269-01,tox21-er-bla-agonist-p2,Methylprednisolone,activity,inactive,83-43-2,6741.0,OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C
NCGC00015955-09,tox21-er-bla-agonist-p2,Albuterol,activity,inactive,18559-94-9,2083.0,OCc1cc(ccc1O)C(O)CNC(C)(C)C
NCGC00016160-02,tox21-er-bla-agonist-p2,Loxapine succinate,activity,inactive,27833-64-3,71399.0,O=C(O)CCC(=O)O.CN1CCN(CC1)C3=Nc4ccccc4Oc2ccc(Cl)cc23
NCGC00022043-04,tox21-er-bla-agonist-p2,Deoxycorticosterone acetate,activity,inactive,56-47-3,5952.0,CC(=O)OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00160570-01,tox21-er-bla-agonist-p2,Butonate,activity,inactive,126-22-7,31343.0,O=P(OC)(OC)C(OC(=O)CCC)C(Cl)(Cl)Cl
NCGC00164057-01,tox21-er-bla-agonist-p2,Bronopol,activity,inactive,52-51-7,2450.0,[O-][N+](=O)C(Br)(CO)CO
NCGC00164522-01,tox21-er-bla-agonist-p2,Methisazone,activity,inactive,1910-68-5,6713324.0,NC(=S)N\N=C2/c1ccccc1N(C)C2=O
NCGC00167565-01,tox21-er-bla-agonist-p2,Carbazochrome sodium sulfonate,activity,inactive,51460-26-5,53395145.0,[Na+].NC(=O)N\N=C1/C=C2CC(N(C)C2=CC1=O)S([O-])(=O)=O
NCGC00168748-01,tox21-er-bla-agonist-p2,Rotigotine,activity,inactive,99755-59-6,59227.0,Oc2cccc1C[C@H](CCc12)N(CCC)CCc3cccs3
NCGC00253942-01,tox21-er-bla-agonist-p2,"2,5-Dimethyl-2,5-di-(tert-butylperoxy)hexane",activity,inactive,78-63-7,6545.0,CC(C)(C)OOC(C)(C)CCC(C)(C)OOC(C)(C)C
NCGC00259289-01,tox21-er-bla-agonist-p2,Tetrachlorophthalic anhydride,activity,inactive,117-08-8,8326.0,O=C1OC(=O)c2c1c(Cl)c(Cl)c(Cl)c2Cl
NCGC00260658-01,tox21-er-bla-agonist-p2,NTP Mix24 AR2 2-EQP,activity,inactive,NOCAS_49554,,
NCGC00095138-01,tox21-er-bla-agonist-p2,Cefdinir,activity,inactive,91832-40-5,6398970.0,Nc1scc(n1)/C(=N\O)C(=O)N[C@@H]3C(=O)N2C(=C(C=C)CS[C@@H]23)C(=O)O
NCGC00166118-01,tox21-er-bla-agonist-p2,3-(Aminomethyl)pyridine,activity,inactive,3731-52-0,31018.0,NCc1cccnc1
NCGC00181013-01,tox21-er-bla-agonist-p2,Mizolastine,activity,inactive,108612-45-9,65906.0,O=C1C=CN=C(N1)N(C)C2CCN(CC2)c4nc5ccccc5n4Cc3ccc(F)cc3
NCGC00181048-01,tox21-er-bla-agonist-p2,Dolasetron mesylate,activity,inactive,115956-13-3,3033817.0,CS(=O)(=O)O.O=C(O[C@H]1C[C@H]3C[C@H]2C[C@@H](C1)N3CC2=O)c5cnc4ccccc45
NCGC00182035-01,tox21-er-bla-agonist-p2,1-[2-({[5-Diethylamino)-2-{[4-(dimethylsulfamoyl)phenyl]diazenyl}phenyl]sulfonyl}amino)ethyl]pyridinium chloride,activity,inactive,38051-02-4,217048.0,[Cl-].CN(C)S(=O)(=O)c1ccc(cc1)/N=N/c2ccc(cc2S(=O)(=O)NCC[n+]3ccccc3)N(CC)CC
NCGC00254281-01,tox21-er-bla-agonist-p2,"2,5-Dimethylphenol",activity,inactive,95-87-4,7267.0,Cc1cc(O)c(C)cc1
NCGC00254316-01,tox21-er-bla-agonist-p2,Perfluoroundecanoic acid,activity,inactive,2058-94-8,77222.0,FC(F)(C(F)(F)C(=O)O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254318-01,tox21-er-bla-agonist-p2,"1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich",activity,inactive,68515-49-1,33599.0,CC(C)CCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCC(C)C
NCGC00016937-01,tox21-er-bla-agonist-p2,Ozagrel hydrochloride,activity,inactive,78712-43-3,6438130.0,Cl.O=C(O)/C=C/c2ccc(Cn1ccnc1)cc2
NCGC00017059-01,tox21-er-bla-agonist-p2,"Mebhydrolin 1,5-naphtalenedisulfonate",activity,inactive,6153-33-9,22529.0,O=S(=O)(O)c2cccc1c2cccc1S(=O)(=O)O.CN3Cc4c1ccccc1n(Cc2ccccc2)c4CC3.CN3Cc4c1ccccc1n(Cc2ccccc2)c4CC3
NCGC00017070-01,tox21-er-bla-agonist-p2,Nafcillin sodium monohydrate,activity,inactive,7177-50-6,23704143.0,[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c1c2ccccc2ccc1OCC)[C@H]4SC3(C)C
NCGC00024643-03,tox21-er-bla-agonist-p2,Ifenprodil,activity,inactive,23210-56-2,3689.0,OC(C(C)N1CCC(CC1)Cc2ccccc2)c3ccc(O)cc3
NCGC00024667-04,tox21-er-bla-agonist-p2,Methyldopa sesquihydrate,activity,inactive,41372-08-1,38852.0,O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1
NCGC00037856-01,tox21-er-bla-agonist-p2,Medronic acid,activity,inactive,1984-15-2,16124.0,O=P(O)(O)CP(=O)(O)O
NCGC00256776-01,tox21-er-bla-agonist-p2,Dipiperidinomethane,activity,inactive,880-09-1,70151.0,C1CCCCN1CN2CCCCC2
NCGC00256937-01,tox21-er-bla-agonist-p2,Isopropyl tetradecanoic acid,activity,inactive,110-27-0,8042.0,CC(C)OC(=O)CCCCCCCCCCCCC
NCGC00258487-01,tox21-er-bla-agonist-p2,4-Methyl-2-nitrophenol,activity,inactive,119-33-5,8391.0,O=[N+]([O-])c1cc(C)ccc1O
NCGC00258620-01,tox21-er-bla-agonist-p2,Sodium 1-octanesulfonate,activity,inactive,5324-84-5,23669624.0,[Na+].O=S(=O)([O-])CCCCCCCC
NCGC00257292-01,tox21-er-bla-agonist-p2,Hexylparaben,activity,active agonist,1083-27-8,14127.0,Oc1ccc(cc1)C(=O)OCCCCCC
NCGC00257671-01,tox21-er-bla-agonist-p2,"N-Phenyl-1,4-benzenediamine hydrochloride",activity,inactive,2198-59-6,75146.0,Cl.Nc2ccc(Nc1ccccc1)cc2
NCGC00257716-01,tox21-er-bla-agonist-p2,Methyl acetoacetate,activity,inactive,105-45-3,7757.0,CC(=O)CC(=O)OC
NCGC00257901-01,tox21-er-bla-agonist-p2,Adipamide,activity,inactive,628-94-4,12364.0,O=C(N)CCCCC(N)=O
NCGC00258313-01,tox21-er-bla-agonist-p2,"2-Nitro-1,1'-biphenyl",activity,inactive,86-00-0,6829.0,O=[N+]([O-])c2ccccc2c1ccccc1
NCGC00256648-01,tox21-er-bla-agonist-p2,p-Mentha-8-thiol-3-one,activity,inactive,38462-22-5,61982.0,CC1CC(=O)C(CC1)C(S)(C)C
NCGC00256727-01,tox21-er-bla-agonist-p2,1-Bromo-3-methoxybenzene,activity,inactive,2398-37-0,16971.0,COc1cc(Br)ccc1
NCGC00255730-01,tox21-er-bla-agonist-p2,3-[Ethyl(phenyl)amino]propanenitrile,activity,inactive,148-87-8,8995.0,CCN(CCC#N)c1ccccc1
NCGC00255762-01,tox21-er-bla-agonist-p2,Florasulam,activity,inactive,145701-23-1,11700495.0,Fc3cccc(F)c3NS(=O)(=O)c1nc2c(F)cnc(OC)n2n1
NCGC00256467-01,tox21-er-bla-agonist-p2,Acetohexamide,activity,inactive,968-81-0,1989.0,O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O
NCGC00256523-01,tox21-er-bla-agonist-p2,Furosemide,activity,inactive,54-31-9,3440.0,NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O
NCGC00256113-01,tox21-er-bla-agonist-p2,2-[{2-[2-(Dimethylamino)ethoxy]ethyl}(methyl)amino]ethanol,activity,inactive,83016-70-0,3086157.0,CN(C)CCOCCN(C)CCO
NCGC00256185-01,tox21-er-bla-agonist-p2,9-Ethyl-3-nitro-9H-carbazole,activity,inactive,86-20-4,66573.0,[O-][N+](=O)c2cc3c1ccccc1n(CC)c3cc2
NCGC00255651-01,tox21-er-bla-agonist-p2,Imipramine hydrochloride,activity,inactive,113-52-0,8228.0,Cl.CN(C)CCCN2c3ccccc3CCc1ccccc12
NCGC00255683-01,tox21-er-bla-agonist-p2,2-Chloro-5-nitro-N-phenylbenzamide,activity,inactive,22978-25-2,644213.0,O=C(Nc1ccccc1)c2cc(ccc2Cl)[N+]([O-])=O
NCGC00258886-01,tox21-er-bla-agonist-p2,Dimethylcarbamoyl chloride,activity,inactive,79-44-7,6598.0,CN(C)C(Cl)=O
NCGC00258900-01,tox21-er-bla-agonist-p2,Thiosemicarbazide,activity,inactive,79-19-6,2723789.0,NC(=S)NN
NCGC00260406-01,tox21-er-bla-agonist-p2,"Acetic acid,mercapto-,ethylester",activity,inactive,623-51-8,12185.0,O=C(OCC)CS
NCGC00259084-01,tox21-er-bla-agonist-p2,Dimethyl methylphosphonate,activity,inactive,756-79-6,12958.0,CP(=O)(OC)OC
NCGC00259359-01,tox21-er-bla-agonist-p2,6-Methyl coumarin,activity,inactive,92-48-8,7092.0,Cc1ccc2OC(=O)C=Cc2c1
NCGC00259740-01,tox21-er-bla-agonist-p2,Furfural,activity,inactive,98-01-1,7362.0,O=Cc1ccco1
NCGC00260134-01,tox21-er-bla-agonist-p2,Calcium chloride,activity,inactive,10043-52-4,5284359.0,[Ca+2].[Cl-].[Cl-]
NCGC00260179-01,tox21-er-bla-agonist-p2,"1-Ethyl-2,3-dimethylimidazolium bis(trifluoromethylsulfonyl)imide",activity,inactive,174899-90-2,21932259.0,C[n+]1ccn(CC)c1C.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00260301-01,tox21-er-bla-agonist-p2,"2-Propenoic acid, sodium salt",activity,inactive,7446-81-3,4068533.0,[Na+].[O-]C(=O)C=C
NCGC00254837-01,tox21-er-bla-agonist-p2,Dikegulac,activity,inactive,18467-77-1,65420.0,O=C(O)[C@]23O[C@H]1COC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2
NCGC00254843-01,tox21-er-bla-agonist-p2,"2,6-Dimethylhept-5-enal",activity,inactive,106-72-9,61016.0,CC(CC\C=C(\C)C)C=O
NCGC00256331-01,tox21-er-bla-agonist-p2,"1,2,4-Benzenetricarboxylic acid",activity,inactive,528-44-9,10708.0,OC(=O)c1cc(ccc1C(=O)O)C(=O)O
NCGC00254895-01,tox21-er-bla-agonist-p2,"1,2,4-Trimethoxybenzene",activity,inactive,135-77-3,67284.0,COc1cc(ccc1OC)OC
NCGC00254933-01,tox21-er-bla-agonist-p2,"3,7-Dimethyloct-6-en-1-yl formate",activity,inactive,105-85-1,7778.0,C\C(C)=C\CCC(C)CCOC=O
NCGC00255173-01,tox21-er-bla-agonist-p2,Chlorfenvinphos,activity,inactive,470-90-6,10107.0,Clc1cc(Cl)ccc1C(OP(=O)(OCC)OCC)=CCl
NCGC00255682-01,tox21-er-bla-agonist-p2,Coumatetralyl,activity,inactive,5836-29-3,54678504.0,OC=1c4ccccc4OC(=O)C=1C3CCCc2ccccc23
NCGC00255792-01,tox21-er-bla-agonist-p2,"N,N'-Penta-1,3-dien-1-yl-5-ylidenedianiline hydrochloride",activity,inactive,1497-49-0,5702667.0,Cl.C(=C/Nc1ccccc1)\C=C\C=N\c2ccccc2
NCGC00256031-01,tox21-er-bla-agonist-p2,"1,1'-[Ethane-1,2-diylbis(oxy)]bis(3-methylbenzene)",activity,inactive,54914-85-1,97354.0,Cc1cc(ccc1)OCCOc2cc(C)ccc2
NCGC00256100-01,tox21-er-bla-agonist-p2,Di(ethylene glycol) dimethacrylate,activity,inactive,2358-84-1,16891.0,O=C(OCCOCCOC(=O)C(=C)C)C(=C)C
NCGC00254492-01,tox21-er-bla-agonist-p2,Pioglitazone hydrochloride,activity,inactive,112529-15-4,60560.0,Cl.CCc1ccc(nc1)CCOc3ccc(CC2SC(=O)NC2=O)cc3
NCGC00091172-01,tox21-er-bla-agonist-p2,Methanol,activity,inactive,67-56-1,887.0,CO
NCGC00159422-02,tox21-er-bla-agonist-p2,Tiopronin,activity,inactive,1953-02-2,5483.0,OC(=O)CNC(=O)C(C)S
NCGC00164245-02,tox21-er-bla-agonist-p2,Benzyldodecyldimethylammonium bromide,activity,inactive,7281-04-1,23705.0,[Br-].C[N+](C)(Cc1ccccc1)CCCCCCCCCCCC
NCGC00180997-01,tox21-er-bla-agonist-p2,Ethylphenylacetylurea,activity,inactive,90-49-3,72060.0,CCC(C(=O)NC(N)=O)c1ccccc1
NCGC00094754-01,tox21-er-bla-agonist-p2,Phenacemide,activity,inactive,63-98-9,4753.0,O=C(Cc1ccccc1)NC(N)=O
NCGC00164390-01,tox21-er-bla-agonist-p2,Milrinone,activity,inactive,78415-72-2,4197.0,N#CC1=CC(=C(C)NC1=O)c2ccncc2
NCGC00181151-01,tox21-er-bla-agonist-p2,Metocurine iodide,activity,inactive,7601-55-0,24244.0,[I-].[I-].COc7ccc1cc7Oc6cc5c(CC[N+](C)(C)[C@H]5Cc4ccc(Oc3c2c(CC[N+](C)(C)[C@@H]2C1)cc(OC)c3OC)cc4)cc6OC
NCGC00164532-01,tox21-er-bla-agonist-p2,Parapropamol,activity,inactive,1693-37-4,74325.0,Oc1ccc(NC(=O)CC)cc1
NCGC00160440-01,tox21-er-bla-agonist-p2,Lonazolac,activity,inactive,53808-88-1,68706.0,O=C(O)Cc1cn(nc1c2ccc(Cl)cc2)c3ccccc3
NCGC00164564-01,tox21-er-bla-agonist-p2,Emtricitabine,activity,inactive,143491-57-0,60877.0,FC1=CN(C(=O)N=C1N)[C@H]2O[C@@H](CO)SC2
NCGC00167480-01,tox21-er-bla-agonist-p2,N-Hydroxymethylsuccinimide,activity,inactive,5146-68-9,95286.0,O=C1CCC(=O)N1CO
NCGC00160486-01,tox21-er-bla-agonist-p2,Chloracizine,activity,inactive,800-22-6,13113.0,CCN(CC)CCC(=O)N1c3ccccc3Sc2ccc(Cl)cc12
NCGC00095166-01,tox21-er-bla-agonist-p2,Clopidol,activity,inactive,2971-90-6,18087.0,Oc1c(Cl)c(C)nc(C)c1Cl
NCGC00160563-01,tox21-er-bla-agonist-p2,Carbocloral,activity,inactive,541-79-7,10944.0,OC(NC(=O)OCC)C(Cl)(Cl)Cl
NCGC00167524-01,tox21-er-bla-agonist-p2,Amorolfine,activity,inactive,78613-35-1,54260.0,C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)CC)C[C@@H](C)O2
NCGC00096006-01,tox21-er-bla-agonist-p2,Minocycline hydrochloride,activity,inactive,13614-98-7,54685925.0,Cl.CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O
NCGC00160607-01,tox21-er-bla-agonist-p2,N-Methyl-3-piperidyl benzilate,activity,inactive,3321-80-0,62495.0,CN3CCCC(OC(=O)C(O)(c1ccccc1)c2ccccc2)C3
NCGC00166125-01,tox21-er-bla-agonist-p2,Meglumine,activity,inactive,6284-40-8,8567.0,O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO
NCGC00166210-01,tox21-er-bla-agonist-p2,Paromomycin sulfate,activity,inactive,1263-89-4,441375.0,O=S(=O)(O)O.N[C@@H]4[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]4O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O[C@@H]2O[C@H](CO)[C@@H](O[C@H]1O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]1N)[C@H]2O
NCGC00161405-01,tox21-er-bla-agonist-p2,Indorenate hydrochloride,activity,inactive,72318-55-9,71986.0,Cl.O=C(OC)C(CN)c2cnc1ccc(cc12)OC
NCGC00167549-01,tox21-er-bla-agonist-p2,N-Carbamyl-L-glutamic acid,activity,inactive,1188-38-1,121396.0,O=C(N)N[C@@H](CCC(=O)O)C(=O)O
NCGC00167574-01,tox21-er-bla-agonist-p2,Xaliproden hydrochloride,activity,inactive,90494-79-4,128918.0,Cl.FC(F)(F)c1cccc(c1)C4=CCN(CCc2cc3ccccc3cc2)CC4
NCGC00254559-01,tox21-er-bla-agonist-p2,Thidiazuron,activity,inactive,51707-55-2,40087.0,O=C(Nc1ccccc1)Nc2cnns2
NCGC00255366-01,tox21-er-bla-agonist-p2,"N,N-Dimethyloctanamide",activity,inactive,1118-92-9,14240.0,CN(C)C(=O)CCCCCCC
NCGC00254259-01,tox21-er-bla-agonist-p2,Malic acid,activity,inactive,6915-15-7,525.0,O=C(O)C(O)CC(=O)O
NCGC00255161-01,tox21-er-bla-agonist-p2,sec-Butylurea,activity,inactive,689-11-2,12715.0,CC(CC)NC(N)=O
NCGC00253920-01,tox21-er-bla-agonist-p2,"N,N-Diethylethanolamine",activity,inactive,100-37-8,7497.0,CCN(CC)CCO
NCGC00254806-01,tox21-er-bla-agonist-p2,Fenuron,activity,inactive,101-42-8,7560.0,O=C(Nc1ccccc1)N(C)C
NCGC00255239-01,tox21-er-bla-agonist-p2,C.I. Direct Black 38,activity,inactive,1937-37-7,5359662.0,[Na+].[Na+].Nc6ccc(/N=N/c1ccc(cc1)c2ccc(cc2)/N=N/c5c(cc4cc(c(/N=N/c3ccccc3)c(O)c4c5N)S([O-])(=O)=O)S([O-])(=O)=O)c(N)c6
NCGC00254064-01,tox21-er-bla-agonist-p2,2-Ethoxyethanol,activity,inactive,110-80-5,8076.0,CCOCCO
NCGC00254078-01,tox21-er-bla-agonist-p2,"2,4,6-Trichlorophenol",activity,inactive,88-06-2,6914.0,Clc1cc(Cl)cc(Cl)c1O
NCGC00254100-01,tox21-er-bla-agonist-p2,"Hexanedioic acid, diisononyl ester",activity,inactive,33703-08-1,6427097.0,CC(C)CCCCCCOC(=O)CCCCC(=O)OCCCCCCC(C)C
NCGC00255142-01,tox21-er-bla-agonist-p2,"1,5-Pentanediamine, 2-methyl-",activity,inactive,15520-10-2,85862.0,CC(CCCN)CN
NCGC00258063-01,tox21-er-bla-agonist-p2,Omeprazole,activity,inactive,73590-58-6,4594.0,Cc3c(OC)c(C)cnc3CS(=O)c1nc2cc(ccc2n1)OC
NCGC00258202-01,tox21-er-bla-agonist-p2,Caffeic acid,activity,inactive,331-39-5,2518.0,Oc1ccc(C=CC(=O)O)cc1O
NCGC00260321-01,tox21-er-bla-agonist-p2,Potassium D-gluconate,activity,inactive,299-27-4,16760467.0,[K+].O[C@H]([C@@H](O)C([O-])=O)[C@H](O)[C@H](O)CO
NCGC00258306-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium iodide,activity,inactive,178631-05-5,12036651.0,[I-].C[n+]1ccn(CCCCCC)c1
NCGC00257121-01,tox21-er-bla-agonist-p2,Isodecyl acrylate,activity,inactive,1330-61-6,14899.0,C=CC(=O)OCCCCCCCC(C)C
NCGC00259934-01,tox21-er-bla-agonist-p2,Dicumyl peroxide,activity,active agonist,80-43-3,6641.0,CC(C)(OOC(C)(C)c1ccccc1)c2ccccc2
NCGC00260036-01,tox21-er-bla-agonist-p2,Benzene,activity,inactive,71-43-2,241.0,c1ccccc1
NCGC00016525-01,tox21-er-bla-agonist-p2,Zuclopenthixol dihydrochloride,activity,inactive,58045-23-1,6433208.0,Cl.Cl.OCCN1CCN(CC1)CC\C=C2\c4ccccc4Sc3ccc(Cl)cc23
NCGC00256733-01,tox21-er-bla-agonist-p2,Methyl geranate,activity,inactive,NOCAS_47129,70917.0,O=C(C=C(C)CC\C=C(/C)C)OC
NCGC00258903-01,tox21-er-bla-agonist-p2,2-Amino-4-nitrophenol,activity,inactive,99-57-0,3613389.0,Nc1cc(ccc1O)[N+]([O-])=O
NCGC00259120-01,tox21-er-bla-agonist-p2,Methoxyacetic acid,activity,inactive,625-45-6,12251.0,O=C(O)COC
NCGC00256870-01,tox21-er-bla-agonist-p2,"trans-2,cis-6-Nonadien-1-ol",activity,inactive,28069-72-9,5362833.0,CC\C=C/CC\C=C\CO
NCGC00256638-01,tox21-er-bla-agonist-p2,Cananga oil,activity,inactive,68606-83-7,,
NCGC00258247-01,tox21-er-bla-agonist-p2,IQ,activity,inactive,76180-96-6,53462.0,Nc3nc2c(ccc1ncccc12)n3C
NCGC00259150-01,tox21-er-bla-agonist-p2,Sodium dichloroisocyanurate,activity,inactive,2893-78-9,517121.0,[Na+].ClN1C(=O)[N-]C(=O)N(Cl)C1=O
NCGC00259323-01,tox21-er-bla-agonist-p2,Propanil,activity,inactive,709-98-8,4933.0,Clc1ccc(NC(=O)CC)cc1Cl
NCGC00258170-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium dicyanamide,activity,inactive,370865-80-8,16213711.0,CCCC[N+]1(C)CCCC1.N#C\N=C=[N-]
NCGC00257190-01,tox21-er-bla-agonist-p2,Dimethyl hexahydroterephthalate,activity,inactive,94-60-0,7198.0,COC(=O)C1CCC(CC1)C(=O)OC
NCGC00257192-01,tox21-er-bla-agonist-p2,Linolenic acid,activity,inactive,463-40-1,5280934.0,O=C(O)CCCCCCC/C=C\C/C=C\C/C=C\CC
NCGC00257222-01,tox21-er-bla-agonist-p2,Furfuryl acetate,activity,inactive,623-17-6,12170.0,O=C(C)OCc1ccco1
NCGC00255390-01,tox21-er-bla-agonist-p2,"2,2'-Azobis(2-methylbutanenitrile)",activity,inactive,13472-08-7,93079.0,CC(CC)(/N=N/C(C)(CC)C#N)C#N
NCGC00256107-01,tox21-er-bla-agonist-p2,Ethenylsilanetriyl triacetate,activity,inactive,4130-08-9,77780.0,O=C(C)O[Si](OC(C)=O)(OC(=O)C)C=C
NCGC00256867-01,tox21-er-bla-agonist-p2,"Benzenemethanol, ar-methoxy-, acetate",activity,inactive,1331-83-5,7695.0,COc1ccc(COC(C)=O)cc1
NCGC00256640-01,tox21-er-bla-agonist-p2,3-[Bis(2-hydroxyethyl)amino]propanenitrile,activity,inactive,17209-72-2,96132.0,OCCN(CCC#N)CCO
NCGC00256821-01,tox21-er-bla-agonist-p2,cis-5-Octen-1-ol,activity,inactive,64275-73-6,5352837.0,CC\C=C/CCCCO
NCGC00257140-01,tox21-er-bla-agonist-p2,2-(2-Butoxyethoxy)ethyl acetate,activity,inactive,124-17-4,31288.0,CCCCOCCOCCOC(C)=O
NCGC00258003-01,tox21-er-bla-agonist-p2,2-Phenylpropan-2-ol,activity,inactive,617-94-7,12053.0,CC(O)(C)c1ccccc1
NCGC00257208-01,tox21-er-bla-agonist-p2,Pentaerythritol triacrylate,activity,active agonist,3524-68-3,19042.0,O=C(C=C)OCC(COC(=O)C=C)(CO)COC(=O)C=C
NCGC00258724-01,tox21-er-bla-agonist-p2,N-Butyl-N'-nitro-N-nitrosoguanidine,activity,inactive,13010-08-7,9570281.0,CCCCN(N=O)C(=N)N[N+]([O-])=O
NCGC00258834-01,tox21-er-bla-agonist-p2,Diphenamid,activity,inactive,957-51-7,13728.0,O=C(C(c1ccccc1)c2ccccc2)N(C)C
NCGC00258635-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium bis(trifluoromethanesulfonyl)imide,activity,inactive,223437-11-4,11048104.0,CCCC[N+]1(C)CCCC1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00259129-01,tox21-er-bla-agonist-p2,"1,2-Dinitrobenzene",activity,inactive,528-29-0,10707.0,O=[N+]([O-])c1ccccc1[N+]([O-])=O
NCGC00259968-01,tox21-er-bla-agonist-p2,"(E)-1,2-Dichloroethylene",activity,inactive,156-60-5,638186.0,Cl\C=C\Cl
NCGC00260088-01,tox21-er-bla-agonist-p2,Styrax balsam,activity,inactive,8046-19-3,,
NCGC00259351-01,tox21-er-bla-agonist-p2,2-Ethyl-6-methylaniline,activity,inactive,24549-06-2,32485.0,CCc1cccc(C)c1N
NCGC00259616-01,tox21-er-bla-agonist-p2,Azacyclotridecan-2-one,activity,inactive,947-04-6,13690.0,O=C1CCCCCCCCCCCN1
NCGC00260099-01,tox21-er-bla-agonist-p2,"Fatty acids, C16-18",activity,inactive,67701-03-5,10465.0,O=C(O)CCCCCCCCCCCCCCCC
NCGC00260117-01,tox21-er-bla-agonist-p2,"Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride",activity,inactive,44992-01-0,162071.0,[Cl-].C[N+](C)(C)CCOC(=O)C=C
NCGC00260447-01,tox21-er-bla-agonist-p2,2-Hydroxyanthraquinone,activity,active agonist,605-32-3,11796.0,Oc2ccc3C(=O)c1ccccc1C(=O)c3c2
NCGC00260503-01,tox21-er-bla-agonist-p2,"2,4-Dimethoxyaniline",activity,inactive,2735-04-8,17652.0,Nc1ccc(cc1OC)OC
NCGC00015771-04,tox21-er-bla-agonist-p2,Orphenadrine dihydrogen citrate,activity,inactive,4682-36-4,83823.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C
NCGC00016339-01,tox21-er-bla-agonist-p2,Phensuximide,activity,inactive,86-34-0,6839.0,O=C1C(CC(=O)N1C)c2ccccc2
NCGC00016386-01,tox21-er-bla-agonist-p2,Sulfamerazine,activity,inactive,127-79-7,5325.0,O=S(=O)(Nc1nc(C)ccn1)c2ccc(N)cc2
NCGC00016408-01,tox21-er-bla-agonist-p2,Sulfapyridine,activity,inactive,144-83-2,5336.0,O=S(=O)(Nc1ccccn1)c2ccc(N)cc2
NCGC00016609-01,tox21-er-bla-agonist-p2,Epitiostanol,activity,active agonist,2363-58-8,443935.0,O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H]5S[C@@H]5C[C@]4(C)[C@H]3CC[C@]12C
NCGC00016505-01,tox21-er-bla-agonist-p2,Propoxycaine hydrochloride,activity,inactive,550-83-4,11078.0,Cl.CCN(CC)CCOC(=O)c1ccc(N)cc1OCCC
NCGC00091149-01,tox21-er-bla-agonist-p2,Valproic acid,activity,inactive,99-66-1,3121.0,CCCC(CCC)C(=O)O
NCGC00159456-02,tox21-er-bla-agonist-p2,Imatinib mesylate,activity,inactive,220127-57-1,123596.0,CS(=O)(=O)O.Cc3ccc(cc3Nc1nc(ccn1)c2cccnc2)NC(=O)c4ccc(cc4)CN5CCN(C)CC5
NCGC00181322-01,tox21-er-bla-agonist-p2,"9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-",activity,inactive,141-22-0,643684.0,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O
NCGC00254921-01,tox21-er-bla-agonist-p2,"1,2-Octanediol",activity,inactive,1117-86-8,14231.0,OCC(O)CCCCCC
NCGC00256440-01,tox21-er-bla-agonist-p2,N-Phenyl-2-naphthylamine,activity,inactive,135-88-6,8679.0,c1cc3ccccc3cc1Nc2ccccc2
NCGC00255831-01,tox21-er-bla-agonist-p2,Haloxyfop,activity,inactive,69806-34-4,50895.0,O=C(O)C(C)Oc1ccc(cc1)Oc2ncc(cc2Cl)C(F)(F)F
NCGC00255875-01,tox21-er-bla-agonist-p2,Teflubenzuron,activity,inactive,83121-18-0,91734.0,Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(F)c(Cl)c2F
NCGC00254436-01,tox21-er-bla-agonist-p2,tert-Butylbenzene,activity,inactive,98-06-6,7366.0,CC(C)(C)c1ccccc1
NCGC00255100-01,tox21-er-bla-agonist-p2,Eugenyl phenylacetate,activity,inactive,10402-33-2,25238.0,COc2cc(ccc2OC(=O)Cc1ccccc1)CC=C
NCGC00255196-01,tox21-er-bla-agonist-p2,Fluchloralin,activity,inactive,33245-39-5,36392.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCCl)CCC)C(F)(F)F
NCGC00016389-01,tox21-er-bla-agonist-p2,Oxyphenbutazone,activity,inactive,129-20-4,4641.0,Oc1ccc(cc1)N3C(=O)C(CCCC)C(=O)N3c2ccccc2
NCGC00016442-01,tox21-er-bla-agonist-p2,Fluorometholone,activity,inactive,426-13-1,9878.0,CC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C
NCGC00167515-01,tox21-er-bla-agonist-p2,Enocitabine,activity,inactive,55726-47-1,71734.0,CCCCCCCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
NCGC00183033-01,tox21-er-bla-agonist-p2,beta-Estradiol 17-propionate,activity,active agonist,3758-34-7,19571.0,CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C
NCGC00183132-01,tox21-er-bla-agonist-p2,Mannuronic acid lactone,activity,inactive,7424-09-1,55250378.0,OC2O[C@H]1[C@@H](O)[C@H](OC1=O)[C@@H]2O
NCGC00247684-01,tox21-er-bla-agonist-p2,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,activity,inactive,64-52-8,60977.0,CC(=O)OC2(CCN(CCc1ccccc1)CC2)c3ccccc3
NCGC00254023-01,tox21-er-bla-agonist-p2,5-Fluorouracil,activity,inactive,51-21-8,3385.0,FC1=CNC(=O)NC1=O
NCGC00254914-01,tox21-er-bla-agonist-p2,Imazethapyr,activity,inactive,81335-77-5,54740.0,CC1(N=C(NC1=O)c2ncc(CC)cc2C(=O)O)C(C)C
NCGC00260077-01,tox21-er-bla-agonist-p2,"(9Z)-N,N-Bis(2-hydroxyethyl)octadec-9-enamide",activity,inactive,93-83-4,5371728.0,O=C(CCCCCCC/C=C\CCCCCCCC)N(CCO)CCO
NCGC00015196-04,tox21-er-bla-agonist-p2,Cirazoline,activity,inactive,59939-16-1,2765.0,O(CC1=NCCN1)c2ccccc2C3CC3
NCGC00015999-10,tox21-er-bla-agonist-p2,Tolbutamide,activity,inactive,64-77-7,5505.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC
NCGC00016279-01,tox21-er-bla-agonist-p2,Aminohippuric acid,activity,inactive,61-78-9,2148.0,O=C(NCC(=O)O)c1ccc(N)cc1
NCGC00090858-02,tox21-er-bla-agonist-p2,4-Chlorobenzoic acid,activity,inactive,74-11-3,6318.0,OC(=O)c1ccc(Cl)cc1
NCGC00094762-03,tox21-er-bla-agonist-p2,Piperazine,activity,inactive,110-85-0,4837.0,C1CNCCN1
NCGC00166141-01,tox21-er-bla-agonist-p2,Carbinoxamine maleate,activity,inactive,3505-38-2,5282409.0,O=C(O)/C=C\C(=O)O.Clc1ccc(cc1)C(OCCN(C)C)c2ccccn2
NCGC00183005-01,tox21-er-bla-agonist-p2,Zanapezil fumerate,activity,inactive,263248-42-6,5282215.0,O=C(O)/C=C/C(=O)O.O=C(CCC2CCN(Cc1ccccc1)CC2)c3ccc4CCCCNc4c3
NCGC00254414-01,tox21-er-bla-agonist-p2,Docusate sodium,activity,inactive,577-11-7,23673837.0,[Na+].O=S(=O)([O-])C(CC(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC
NCGC00090731-05,tox21-er-bla-agonist-p2,2-Phenoxyethanol,activity,inactive,122-99-6,31236.0,OCCOc1ccccc1
NCGC00017055-01,tox21-er-bla-agonist-p2,Calcium folinate pentahydrate,activity,inactive,6035-45-6,20835958.0,[Ca+2].O.O.O.O.O.[O-]C(=O)[C@H](CCC([O-])=O)NC(=O)c1ccc(cc1)NCC3CNC=2NC(N)=NC(=O)C=2N3C=O
NCGC00018268-03,tox21-er-bla-agonist-p2,Itraconazole,activity,inactive,84625-61-6,55283.0,CC(CC)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OC[C@H]6CO[C@@](Cn5ncnc5)(O6)c7ccc(Cl)cc7Cl
NCGC00022304-05,tox21-er-bla-agonist-p2,N-Acetyl-L-cysteine,activity,inactive,616-91-1,12035.0,CC(=O)N[C@@H](CS)C(O)=O
NCGC00025132-01,tox21-er-bla-agonist-p2,Levcromakalim,activity,inactive,94535-50-9,93504.0,O=C3CCCN3[C@@H]1c2cc(ccc2OC(C)(C)[C@H]1O)C#N
NCGC00025172-01,tox21-er-bla-agonist-p2,Roquinimex,activity,inactive,84088-42-6,54676478.0,CN(c1ccccc1)C(=O)C3=C(O)c2ccccc2N(C)C3=O
NCGC00025283-01,tox21-er-bla-agonist-p2,Acifran,activity,inactive,72420-38-3,51576.0,CC1(OC(=CC1=O)C(=O)O)c2ccccc2
NCGC00256902-01,tox21-er-bla-agonist-p2,Methyl citronellate,activity,inactive,2270-60-2,61290.0,O=C(CC(C)CC\C=C(/C)C)OC
NCGC00256983-01,tox21-er-bla-agonist-p2,2-Propoxyethanol,activity,inactive,2807-30-9,17756.0,CCCOCCO
NCGC00258385-01,tox21-er-bla-agonist-p2,Isoflurane,activity,inactive,26675-46-7,3763.0,FC(F)(F)C(Cl)OC(F)F
NCGC00258553-01,tox21-er-bla-agonist-p2,Methyl acrylate,activity,inactive,96-33-3,7294.0,C=CC(=O)OC
NCGC00258643-01,tox21-er-bla-agonist-p2,4-Methylbenzoic acid,activity,inactive,99-94-5,7470.0,Cc1ccc(cc1)C(O)=O
NCGC00257897-01,tox21-er-bla-agonist-p2,4-Nitrobenzamide,activity,inactive,619-80-7,12091.0,O=[N+]([O-])c1ccc(cc1)C(N)=O
NCGC00258132-01,tox21-er-bla-agonist-p2,Ethylammonium nitrate,activity,inactive,22113-86-6,193581.0,CCN.[O-][N+](=O)O
NCGC00256380-01,tox21-er-bla-agonist-p2,FD&C Red 4,activity,inactive,4548-53-2,5463878.0,[Na+].[Na+].Cc1cc(C)c(cc1S(=O)([O-])=O)/N=N/c3cc(c2ccccc2c3O)S([O-])(=O)=O
NCGC00256466-01,tox21-er-bla-agonist-p2,1-Nitropropane,activity,inactive,108-03-2,7903.0,[O-][N+](=O)CCC
NCGC00255805-01,tox21-er-bla-agonist-p2,2-Naphthoxyacetic acid,activity,inactive,120-23-0,8422.0,O=C(O)COc1ccc2ccccc2c1
NCGC00256099-01,tox21-er-bla-agonist-p2,"N-(Alkyl C10-C16)-N,N-dimethylglycine betaine",activity,inactive,66455-29-6,4292413.0,C[N+](C)(CCCCCCCCCCCC)CC([O-])=O
NCGC00260397-01,tox21-er-bla-agonist-p2,Betaine monohydrate,activity,inactive,590-47-6,24884197.0,O.C[N+](C)(C)CC([O-])=O
NCGC00260455-01,tox21-er-bla-agonist-p2,2-Amino-m-cresol,activity,inactive,2835-97-4,3014138.0,Cc1cccc(O)c1N
NCGC00260498-01,tox21-er-bla-agonist-p2,1-Methylguanine,activity,inactive,938-85-2,70315.0,N=C2Nc1ncnc1C(=O)N2C
NCGC00260591-01,tox21-er-bla-agonist-p2,NTP Mix47 CT1 3-EQP,activity,inactive,NOCAS_49487,,
NCGC00259294-01,tox21-er-bla-agonist-p2,Triacetin,activity,inactive,102-76-1,5541.0,O=C(C)OC(COC(C)=O)COC(=O)C
NCGC00259347-01,tox21-er-bla-agonist-p2,"Tris(2,3-dibromopropyl) phosphate",activity,inactive,126-72-7,31356.0,BrCC(Br)COP(=O)(OCC(Br)CBr)OCC(Br)CBr
NCGC00259350-01,tox21-er-bla-agonist-p2,Cyclododecanol,activity,inactive,1724-39-6,15595.0,OC1CCCCCCCCCCC1
NCGC00259521-01,tox21-er-bla-agonist-p2,"1,2-Dichloro-4-(trifluoromethyl)benzene",activity,inactive,328-84-7,9481.0,Clc1ccc(cc1Cl)C(F)(F)F
NCGC00259814-01,tox21-er-bla-agonist-p2,Sulfisoxazole,activity,inactive,127-69-5,5344.0,Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C
NCGC00259846-01,tox21-er-bla-agonist-p2,Dibromoacetic acid,activity,inactive,631-64-1,12433.0,BrC(Br)C(=O)O
NCGC00260069-01,tox21-er-bla-agonist-p2,l-Taurine,activity,inactive,107-35-7,1123.0,NCCS(=O)(=O)O
NCGC00260287-01,tox21-er-bla-agonist-p2,1-Octadecene,activity,inactive,112-88-9,8217.0,CCCCCCCCCCCCCCCCC=C
NCGC00254667-01,tox21-er-bla-agonist-p2,Clopyralid-olamine,activity,inactive,57754-85-5,162839.0,Clc1ccc(Cl)nc1C(=O)O.NCCO
NCGC00255041-01,tox21-er-bla-agonist-p2,Dichlorprop,activity,inactive,120-36-5,8427.0,Clc1cc(Cl)ccc1OC(C)C(=O)O
NCGC00255208-01,tox21-er-bla-agonist-p2,(E)-3-Hexen-1-ol,activity,inactive,928-97-2,5284503.0,CC\C=C\CCO
NCGC00255284-01,tox21-er-bla-agonist-p2,Ethyl phthalyl ethyl glycolate,activity,inactive,84-72-0,6785.0,O=C(OCC)c1ccccc1C(=O)OCC(=O)OCC
NCGC00255292-01,tox21-er-bla-agonist-p2,Triphenylphosphine oxide,activity,inactive,791-28-6,13097.0,O=P(c1ccccc1)(c2ccccc2)c3ccccc3
NCGC00255328-01,tox21-er-bla-agonist-p2,Norepinephrine,activity,inactive,51-41-2,439260.0,Oc1ccc(cc1O)[C@@H](O)CN
NCGC00255422-01,tox21-er-bla-agonist-p2,"2-Ethyl-2-nitro-1,3-propanediol",activity,inactive,597-09-1,11696.0,O=[N+]([O-])C(CC)(CO)CO
NCGC00255510-01,tox21-er-bla-agonist-p2,Sodium decyl sulfate,activity,inactive,142-87-0,23665771.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCC
NCGC00255630-01,tox21-er-bla-agonist-p2,"3,7-Dimethyloctan-3-yl acetate",activity,inactive,20780-48-7,89385.0,O=C(C)OC(C)(CCCC(C)C)CC
NCGC00256079-01,tox21-er-bla-agonist-p2,Sodium 2-methylprop-2-ene-1-sulfonate,activity,inactive,1561-92-8,23663624.0,[Na+].C=C(C)CS([O-])(=O)=O
NCGC00091935-01,tox21-er-bla-agonist-p2,Ergotamine D-tartrate,activity,inactive,379-79-3,9787.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2C[C@@H](C=C1c3cccc4ncc(C[C@H]12)c34)C(=O)N[C@]5(C)O[C@]8(O)N(C5=O)[C@@H](Cc6ccccc6)C(=O)N7CCC[C@H]78.CN2C[C@@H](C=C1c3cccc4ncc(C[C@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O
NCGC00166284-01,tox21-er-bla-agonist-p2,Dikegulac sodium,activity,inactive,52508-35-7,23667639.0,[Na+].[O-]C(=O)[C@]23O[C@H]1COC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2
NCGC00166312-01,tox21-er-bla-agonist-p2,Closantel,activity,inactive,57808-65-8,42574.0,Clc3cc(NC(=O)c1cc(I)cc(I)c1O)c(C)cc3C(C#N)c2ccc(Cl)cc2
NCGC00094090-01,tox21-er-bla-agonist-p2,Cysteamine hydrochloride,activity,inactive,156-57-0,9082.0,Cl.NCCS
NCGC00159403-02,tox21-er-bla-agonist-p2,Nandrolone decanoate,activity,active agonist,360-70-3,9677.0,CCCCCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@]23C
NCGC00163221-01,tox21-er-bla-agonist-p2,Ambenonium chloride,activity,inactive,115-79-7,8288.0,[Cl-].[Cl-].Clc2ccccc2C[N+](CC)(CC)CCNC(=O)C(=O)NCC[N+](Cc1ccccc1Cl)(CC)CC
NCGC00159453-02,tox21-er-bla-agonist-p2,Zileuton,activity,inactive,111406-87-2,60490.0,NC(=O)N(O)C(C)c1cc2ccccc2s1
NCGC00094524-01,tox21-er-bla-agonist-p2,Simazine,activity,inactive,122-34-9,5216.0,Clc1nc(NCC)nc(NCC)n1
NCGC00164491-01,tox21-er-bla-agonist-p2,Lidofenin,activity,inactive,59160-29-1,42963.0,O=C(Nc1c(C)cccc1C)CN(CC(=O)O)CC(=O)O
NCGC00164512-01,tox21-er-bla-agonist-p2,Guaiacol carbonate,activity,inactive,553-17-3,11104.0,COc2ccccc2OC(=O)Oc1ccccc1OC
NCGC00160393-01,tox21-er-bla-agonist-p2,(6R)-Tetrahydrobiopterin dihydrochloride,activity,inactive,69056-38-8,636369.0,Cl.Cl.C[C@H](O)[C@H](O)[C@@H]1NC=2C(=O)N=C(N)NC=2NC1
NCGC00164537-01,tox21-er-bla-agonist-p2,Droxidopa,activity,inactive,23651-95-8,6999030.0,Oc1ccc(cc1O)[C@H](O)[C@H](N)C(=O)O
NCGC00095158-01,tox21-er-bla-agonist-p2,Secnidazole,activity,inactive,3366-95-8,71815.0,Cc1ncc([N+]([O-])=O)n1CC(O)C
NCGC00164605-01,tox21-er-bla-agonist-p2,Ampiroxicam,activity,inactive,99464-64-9,2176.0,O=C(OCC)OC(C)OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3
NCGC00164615-01,tox21-er-bla-agonist-p2,Prulifloxacin,activity,active agonist,123447-62-1,65947.0,CC=5OC(=O)OC=5CN1CCN(CC1)c2cc3c(cc2F)C(=O)C(=C4SC(C)N34)C(=O)O
NCGC00095163-01,tox21-er-bla-agonist-p2,Sarafloxacin hydrochloride,activity,inactive,91296-87-6,56207.0,Cl.Fc1ccc(cc1)N2C=C(C(=O)O)C(=O)c3cc(F)c(cc23)N4CCNCC4
NCGC00164737-01,tox21-er-bla-agonist-p2,Dexrazone,activity,inactive,24584-09-6,71384.0,O=C2CN(C[C@H](C)N1CC(=O)NC(=O)C1)CC(=O)N2
NCGC00165883-02,tox21-er-bla-agonist-p2,Rufinamide,activity,inactive,106308-44-5,129228.0,NC(=O)c2cn(Cc1c(F)cccc1F)nn2
NCGC00181034-01,tox21-er-bla-agonist-p2,Liarozole hydrochloride,activity,inactive,145858-50-0,71454.0,Cl.Clc1cc(ccc1)C(c2ccc3ncnc3c2)n4ccnc4
NCGC00095304-02,tox21-er-bla-agonist-p2,Furazolidone,activity,active agonist,67-45-8,5323714.0,[O-][N+](=O)c2oc(/C=N/N1CCOC1=O)cc2
NCGC00167520-01,tox21-er-bla-agonist-p2,Cilomilast,activity,inactive,153259-65-5,151170.0,O=C(O)[C@H]1CC[C@@](C#N)(CC1)c3cc(OC2CCCC2)c(cc3)OC
NCGC00166111-01,tox21-er-bla-agonist-p2,Estriol,activity,active agonist,50-27-1,5756.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]12)c4cc3
NCGC00178154-03,tox21-er-bla-agonist-p2,Dirithromycin,activity,inactive,62013-04-1,6917067.0,CN(C)[C@H]4C[C@@H](C)O[C@@H](O[C@@H]3[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@]3(C)O)[C@@H]4O
NCGC00160678-01,tox21-er-bla-agonist-p2,Fenoverine,activity,inactive,37561-27-6,72098.0,O=C(CN3CCN(Cc1ccc2OCOc2c1)CC3)N4c6ccccc6Sc5ccccc45
NCGC00161601-01,tox21-er-bla-agonist-p2,Sulindac sulfide,activity,inactive,49627-27-2,5352624.0,CSc1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C
NCGC00166238-01,tox21-er-bla-agonist-p2,Benznidazole,activity,inactive,22994-85-0,31593.0,O=C(Cn1ccnc1[N+]([O-])=O)NCc2ccccc2
NCGC00166246-01,tox21-er-bla-agonist-p2,Acrylic acid,activity,inactive,79-10-7,6581.0,C=CC(=O)O
NCGC00159389-03,tox21-er-bla-agonist-p2,Amithiozone,activity,inactive,104-06-3,9568512.0,O=C(C)Nc1ccc(cc1)\C=N\NC(N)=S
NCGC00091021-02,tox21-er-bla-agonist-p2,Trichloroacetic acid,activity,inactive,76-03-9,6421.0,ClC(Cl)(Cl)C(=O)O
NCGC00091225-02,tox21-er-bla-agonist-p2,Halazone,activity,inactive,80-13-7,3552.0,O=S(=O)(N(Cl)Cl)c1ccc(cc1)C(=O)O
NCGC00091650-03,tox21-er-bla-agonist-p2,2-Amino-5-nitrophenol,activity,inactive,121-88-0,4984721.0,Nc1ccc(cc1O)[N+]([O-])=O
NCGC00182987-01,tox21-er-bla-agonist-p2,Esonarimod,activity,inactive,101973-77-7,127998.0,Cc1ccc(cc1)C(=O)CC(CSC(C)=O)C(=O)O
NCGC00183843-01,tox21-er-bla-agonist-p2,Amineptine,activity,inactive,57574-09-1,34870.0,O=C(O)CCCCCCNC2c3ccccc3CCc1ccccc12
NCGC00254172-01,tox21-er-bla-agonist-p2,SR144190,activity,inactive,181640-09-5,60196402.0,Cl.O=C(N3C[C@](CCN1CCC(NC(=O)N(C)C)(CC1)c2ccccc2)(OCC3)c4ccc(F)c(F)c4)c5ccccc5
NCGC00254664-01,tox21-er-bla-agonist-p2,Acifluorfen,activity,inactive,50594-66-6,44073.0,Clc2cc(ccc2Oc1cc(C(=O)O)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00255164-01,tox21-er-bla-agonist-p2,Strychnine hemisulphate salt,activity,inactive,60-41-3,22833295.0,O=S(=O)(O)O.O=C2C[C@@H]6OCC=C5CN3CC[C@@]47c1ccccc1N2[C@H]7[C@H]6[C@H]5C[C@H]34.O=C2C[C@@H]7OCC=C6CN4CC[C@@]53c1ccccc1N2[C@H]3[C@H]7[C@H]6C[C@H]45
NCGC00254331-01,tox21-er-bla-agonist-p2,Sodium myristyl sulfate,activity,inactive,1191-50-0,23665770.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCCCC
NCGC00253961-01,tox21-er-bla-agonist-p2,4-Cumylphenol,activity,active agonist,599-64-4,11742.0,CC(C)(c1ccc(O)cc1)c2ccccc2
NCGC00182971-01,tox21-er-bla-agonist-p2,Hexafluorenium dibromide,activity,inactive,317-52-2,9434.0,[Br-].[Br-].C[N+](C)(CCCCCC[N+](C)(C)C3c1ccccc1c2ccccc23)C6c4ccccc4c5ccccc56
NCGC00183034-01,tox21-er-bla-agonist-p2,Cefoxitin sodium salt,activity,inactive,33564-30-6,23667300.0,[Na+].[O-]C(=O)C=2N3C(=O)[C@](NC(=O)Cc1cccs1)(OC)[C@H]3SCC=2COC(N)=O
NCGC00257816-01,tox21-er-bla-agonist-p2,2-Methoxy-3-aminodibenzofuran,activity,inactive,5834-17-3,22086.0,COc1cc2c3ccccc3oc2cc1N
NCGC00258044-01,tox21-er-bla-agonist-p2,4-Butyrolactone,activity,inactive,96-48-0,7302.0,O=C1CCCO1
NCGC00258954-01,tox21-er-bla-agonist-p2,Methyl linoleate,activity,inactive,112-63-0,5284421.0,O=C(CCCCCCC/C=C\C/C=C\CCCCC)OC
NCGC00259013-01,tox21-er-bla-agonist-p2,"2,4-Dinitrophenol",activity,inactive,51-28-5,1493.0,O=[N+]([O-])c1cc(ccc1O)[N+]([O-])=O
NCGC00166317-01,tox21-er-bla-agonist-p2,Phosphamidon,activity,inactive,13171-21-6,25750.0,COP(=O)(OC)OC(C)=C(Cl)C(=O)N(CC)CC
NCGC00259750-01,tox21-er-bla-agonist-p2,Isobornyl methacrylate,activity,inactive,7534-94-3,904857.0,C=C(C)C(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C
NCGC00260311-01,tox21-er-bla-agonist-p2,"Phenol, isopropylated, phosphate (3:1)",activity,inactive,68937-41-7,75628.0,CC(C)c1ccc(cc1)OP(=O)(Oc2ccc(cc2)C(C)C)Oc3ccc(cc3)C(C)C
NCGC00255593-01,tox21-er-bla-agonist-p2,"3,5,6-Trichloro-2-pyridinol",activity,inactive,6515-38-4,23017.0,Clc1cc(Cl)c(Cl)nc1O
NCGC00255602-01,tox21-er-bla-agonist-p2,"Benzoic acid, 4-cyano-",activity,inactive,619-65-8,12087.0,OC(=O)c1ccc(C#N)cc1
NCGC00256563-01,tox21-er-bla-agonist-p2,1-Naphthol,activity,inactive,90-15-3,7005.0,Oc2cccc1ccccc12
NCGC00016098-07,tox21-er-bla-agonist-p2,Xylazine,activity,inactive,7361-61-7,5707.0,Cc2cccc(C)c2NC1=NCCCS1
NCGC00256860-01,tox21-er-bla-agonist-p2,1-Furfurylpyrrole,activity,inactive,1438-94-4,15037.0,c2cn(Cc1ccco1)cc2
NCGC00257643-01,tox21-er-bla-agonist-p2,4-Methylbenzyl alcohol,activity,inactive,589-18-4,11505.0,Cc1ccc(CO)cc1
NCGC00258012-01,tox21-er-bla-agonist-p2,"3a,4,7,7a-Tetrahydroindene",activity,inactive,3048-65-5,62475.0,C1=CCC2CC=CCC12
NCGC00257152-01,tox21-er-bla-agonist-p2,Dibromoacetic acid,activity,inactive,631-64-1,12433.0,BrC(Br)C(=O)O
NCGC00257547-01,tox21-er-bla-agonist-p2,4-(Dimethylamino)phenylthiocyanate,activity,inactive,7152-80-9,23540.0,N#CSc1ccc(cc1)N(C)C
NCGC00259204-01,tox21-er-bla-agonist-p2,"2',3'-Dideoxycytidine",activity,inactive,7481-89-2,24066.0,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
NCGC00183023-01,tox21-er-bla-agonist-p2,Nitrefazole,activity,inactive,21721-92-6,71900.0,[O-][N+](=O)c1ccc(cc1)n2cc(nc2C)[N+]([O-])=O
NCGC00255847-01,tox21-er-bla-agonist-p2,Pentyl valerate,activity,inactive,2173-56-0,62433.0,O=C(CCCC)OCCCCC
NCGC00255925-01,tox21-er-bla-agonist-p2,"1-tert-Butyl-3,4,5-trimethyl-2,6-dinitrobenzene",activity,inactive,145-39-1,67350.0,O=[N+]([O-])c1c(C)c(C)c(C)c(c1C(C)(C)C)[N+]([O-])=O
NCGC00256150-01,tox21-er-bla-agonist-p2,2-(Trifluoromethoxy)benzenesulfonamide,activity,inactive,37526-59-3,2777208.0,O=S(N)(=O)c1ccccc1OC(F)(F)F
NCGC00256569-01,tox21-er-bla-agonist-p2,17alpha-Estradiol,activity,active agonist,57-91-0,68570.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@H](O)CC[C@@H]12)c4cc3
NCGC00256588-01,tox21-er-bla-agonist-p2,Promethazine hydrochloride,activity,inactive,58-33-3,6014.0,Cl.CN(C)C(C)CN1c3ccccc3Sc2ccccc12
NCGC00256611-01,tox21-er-bla-agonist-p2,2-Heptanone,activity,inactive,110-43-0,8051.0,CC(=O)CCCCC
NCGC00256861-01,tox21-er-bla-agonist-p2,2-Ethylhexyl octadecanoate,activity,inactive,22047-49-0,13132266.0,O=C(CCCCCCCCCCCCCCCCC)OCC(CCCC)CC
NCGC00257594-01,tox21-er-bla-agonist-p2,"3,4-Dichlorobenzaldehyde",activity,inactive,6287-38-3,22710.0,Clc1ccc(C=O)cc1Cl
NCGC00257843-01,tox21-er-bla-agonist-p2,Phenyl glycidyl ether,activity,inactive,122-60-1,31217.0,c2ccc(OCC1CO1)cc2
NCGC00257670-01,tox21-er-bla-agonist-p2,Dibutyltin diacetate,activity,inactive,1067-33-0,16682740.0,O=C(C)O[Sn](CCCC)(OC(=O)C)CCCC
NCGC00257694-01,tox21-er-bla-agonist-p2,"2,3-Dibromopropionic acid",activity,inactive,600-05-5,11746.0,BrC(CBr)C(=O)O
NCGC00257975-01,tox21-er-bla-agonist-p2,Isodecyl methacrylate,activity,inactive,29964-84-9,34763.0,C=C(C)C(=O)OCCCCCCCC(C)C
NCGC00257301-01,tox21-er-bla-agonist-p2,"2,2-Dichloropropane",activity,inactive,594-20-7,11660.0,CC(C)(Cl)Cl
NCGC00258174-01,tox21-er-bla-agonist-p2,"2,4-Difluoroaniline",activity,inactive,367-25-9,9709.0,Fc1ccc(N)c(F)c1
NCGC00258910-01,tox21-er-bla-agonist-p2,2-Methoxyaniline hydrochloride,activity,inactive,134-29-2,8638.0,Cl.Nc1ccccc1OC
NCGC00259050-01,tox21-er-bla-agonist-p2,2-Acetylpyridine,activity,inactive,1122-62-9,14286.0,CC(=O)c1ccccn1
NCGC00258428-01,tox21-er-bla-agonist-p2,2-Methyl-2-propanethiol,activity,inactive,75-66-1,6387.0,CC(C)(C)S
NCGC00258656-01,tox21-er-bla-agonist-p2,Orotic acid,activity,inactive,65-86-1,967.0,OC(=O)c1cc(O)nc(O)n1
NCGC00259287-01,tox21-er-bla-agonist-p2,2-Pentyl-2-cyclopenten-1-one,activity,inactive,25564-22-1,117549.0,O=C1CCC=C1CCCCC
NCGC00260155-01,tox21-er-bla-agonist-p2,Epibromohydrin,activity,inactive,3132-64-7,18430.0,BrCC1CO1
NCGC00259403-01,tox21-er-bla-agonist-p2,Phenoxyacetic acid,activity,inactive,122-59-8,19188.0,O=C(O)COc1ccccc1
NCGC00259410-01,tox21-er-bla-agonist-p2,Isodecyl acrylate,activity,inactive,1330-61-6,14899.0,C=CC(=O)OCCCCCCCC(C)C
NCGC00259630-01,tox21-er-bla-agonist-p2,Vitamin E,activity,inactive,59-02-9,14985.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(O1)c(C)c(C)c(O)c2C
NCGC00259431-01,tox21-er-bla-agonist-p2,Ferric chloride,activity,inactive,7705-08-0,166033.0,[Fe+3].[Cl-].[Cl-].[Cl-]
NCGC00260199-01,tox21-er-bla-agonist-p2,1-(2-Hydroxyethyl)-3-methylimidazolium tetrafluoroborate,activity,inactive,374564-83-7,11344909.0,C[n+]1ccn(CCO)c1.F[B-](F)(F)F
NCGC00260248-01,tox21-er-bla-agonist-p2,1-Hexylpyridinium tetrafluoroborate,activity,inactive,474368-70-2,2734181.0,F[B-](F)(F)F.CCCCCC[n+]1ccccc1
NCGC00260525-01,tox21-er-bla-agonist-p2,3-Chloro-4-fluorobenzoyl chloride,activity,inactive,65055-17-6,2736548.0,Fc1ccc(cc1Cl)C(Cl)=O
NCGC00013895-01,tox21-er-bla-agonist-p2,Benzbromarone,activity,inactive,3562-84-3,2333.0,Brc1cc(cc(Br)c1O)C(=O)c2c3ccccc3oc2CC
NCGC00015897-02,tox21-er-bla-agonist-p2,Ranolazine,activity,inactive,95635-55-5,56959.0,OC(CN1CCN(CC1)CC(=O)Nc2c(C)cccc2C)COc3ccccc3OC
NCGC00015089-08,tox21-er-bla-agonist-p2,Amiloride,activity,inactive,2609-46-3,16231.0,Clc1nc(C(=O)NC(=N)N)c(N)nc1N
NCGC00015558-06,tox21-er-bla-agonist-p2,Isoproterenol,activity,inactive,7683-59-2,3779.0,Oc1ccc(cc1O)C(O)CNC(C)C
NCGC00015570-04,tox21-er-bla-agonist-p2,Imiloxan,activity,inactive,81167-16-0,133621.0,CCn3ccnc3CC1COc2ccccc2O1
NCGC00016569-01,tox21-er-bla-agonist-p2,Tranexamic acid,activity,inactive,1197-18-8,5526.0,NCC1CCC(CC1)C(=O)O
NCGC00016438-01,tox21-er-bla-agonist-p2,Procarbazine hydrochloride,activity,inactive,366-70-1,9703.0,Cl.CC(C)NC(=O)c1ccc(CNNC)cc1
NCGC00255617-01,tox21-er-bla-agonist-p2,Benfuracarb,activity,inactive,82560-54-1,54886.0,CC(C)N(CCC(=O)OCC)SN(C)C(=O)Oc1cccc2CC(C)(C)Oc12
NCGC00255939-01,tox21-er-bla-agonist-p2,Flurochloridone,activity,inactive,61213-25-0,91677.0,FC(F)(F)c1cccc(c1)N2CC(CCl)C(Cl)C2=O
NCGC00254644-01,tox21-er-bla-agonist-p2,Quinclorac,activity,inactive,84087-01-4,91739.0,O=C(O)c1c(Cl)ccc2cc(Cl)cnc12
NCGC00025302-01,tox21-er-bla-agonist-p2,Altanserin hydrochloride,activity,inactive,1135280-78-2,24978536.0,Cl.Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=S)CC4
NCGC00094048-01,tox21-er-bla-agonist-p2,Iofetamine hydrochloride,activity,inactive,82691-32-5,55305.0,Cl.Ic1ccc(CC(C)NC(C)C)cc1
NCGC00164571-01,tox21-er-bla-agonist-p2,Dutasteride,activity,inactive,164656-23-9,6918296.0,FC(F)(F)c5cc(NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C)c(cc5)C(F)(F)F
NCGC00167540-01,tox21-er-bla-agonist-p2,3-Methylindole,activity,inactive,83-34-1,6736.0,Cc2cnc1ccccc12
NCGC00015254-12,tox21-er-bla-agonist-p2,Clozapine,activity,inactive,5786-21-0,2818.0,CN1CCN(CC1)C2=Nc4cc(Cl)ccc4Nc3ccccc23
NCGC00027930-04,tox21-er-bla-agonist-p2,Moclobemide,activity,inactive,71320-77-9,4235.0,Clc1ccc(cc1)C(=O)NCCN2CCOCC2
NCGC00090965-04,tox21-er-bla-agonist-p2,Propylparaben,activity,active agonist,94-13-3,7175.0,Oc1ccc(cc1)C(=O)OCCC
NCGC00095124-01,tox21-er-bla-agonist-p2,Rosiglitazone,activity,inactive,122320-73-4,77999.0,CN(CCOc2ccc(CC1SC(=O)NC1=O)cc2)c3ccccn3
NCGC00254377-01,tox21-er-bla-agonist-p2,Chloramben,activity,inactive,133-90-4,8630.0,Clc1cc(C(=O)O)c(Cl)c(N)c1
NCGC00090910-03,tox21-er-bla-agonist-p2,Pyrene,activity,inactive,129-00-0,31423.0,c1ccc2ccc3cccc4ccc1c2c34
NCGC00017040-01,tox21-er-bla-agonist-p2,Thioproperazine dimethanesulfonate,activity,inactive,2347-80-0,92178.0,CS(=O)(=O)O.CS(=O)(=O)O.CN(C)S(=O)(=O)c2cc3N(CCCN1CCN(C)CC1)c4ccccc4Sc3cc2
NCGC00017045-01,tox21-er-bla-agonist-p2,Trimeprazine tartrate,activity,inactive,4330-99-8,6604495.0,O=C(O)[C@H](O)[C@H](O)C(=O)O.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12.CN(C)C[C@H](C)CN1c3ccccc3Sc2ccccc12
NCGC00024596-05,tox21-er-bla-agonist-p2,Carbidopa,activity,inactive,28860-95-9,34359.0,Oc1ccc(C[C@](C)(NN)C(=O)O)cc1O
NCGC00256997-01,tox21-er-bla-agonist-p2,"3,3-Dimethyl-1-butene",activity,inactive,558-37-2,11210.0,C=CC(C)(C)C
NCGC00258447-01,tox21-er-bla-agonist-p2,"2,3,4,5-Tetrachloronitrobenzene",activity,inactive,879-39-0,13428.0,Clc1c(cc(Cl)c(Cl)c1Cl)[N+]([O-])=O
NCGC00258637-01,tox21-er-bla-agonist-p2,1-Iodo-3-nitrobenzene,activity,inactive,645-00-1,12574.0,Ic1cccc(c1)[N+](=O)[O-]
NCGC00257635-01,tox21-er-bla-agonist-p2,"3,5,5-Trimethylhexanoic acid",activity,inactive,3302-10-1,90960.0,CC(CC(C)(C)C)CC(=O)O
NCGC00257770-01,tox21-er-bla-agonist-p2,Diisopropylamine,activity,inactive,108-18-9,7912.0,CC(C)NC(C)C
NCGC00257909-01,tox21-er-bla-agonist-p2,Bromoethane,activity,inactive,74-96-4,6332.0,BrCC
NCGC00258201-01,tox21-er-bla-agonist-p2,Amino(imino)methanesulfinic acid,activity,inactive,1758-73-2,61274.0,N=C(N)S(=O)O
NCGC00258283-01,tox21-er-bla-agonist-p2,1-Ethoxy-4-nitrobenzene,activity,active agonist,100-29-8,7495.0,CCOc1ccc(cc1)[N+]([O-])=O
NCGC00256622-01,tox21-er-bla-agonist-p2,Allyl Ionone,activity,inactive,79-78-7,5365976.0,CC1(C)CCC=C(C)C1/C=C/C(=O)CCC=C
NCGC00256426-01,tox21-er-bla-agonist-p2,Terbufos,activity,inactive,13071-79-9,25670.0,CC(C)(C)SCSP(=S)(OCC)OCC
NCGC00256432-01,tox21-er-bla-agonist-p2,Niacinamide,activity,inactive,98-92-0,936.0,NC(=O)c1cccnc1
NCGC00256446-01,tox21-er-bla-agonist-p2,Gibberellic acid,activity,inactive,77-06-5,6466.0,O=C(O)[C@H]3[C@@H]5[C@]1(C)C(=O)O[C@]5(C=C[C@@H]1O)[C@@H]4CC[C@]2(O)C[C@]34CC2=C
NCGC00256518-01,tox21-er-bla-agonist-p2,Monocrotaline,activity,inactive,315-22-0,9415.0,O=C1OCC3=CCN2CC[C@@H](OC(=O)[C@H](C)[C@@](C)(O)[C@@]1(C)O)[C@H]23
NCGC00255848-01,tox21-er-bla-agonist-p2,Diatrizoic acid,activity,inactive,117-96-4,2140.0,O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C(=O)O
NCGC00255870-01,tox21-er-bla-agonist-p2,3-Amino-4-methylbenzamide,activity,inactive,19406-86-1,88043.0,Cc1ccc(cc1N)C(N)=O
NCGC00256086-01,tox21-er-bla-agonist-p2,Lepidine,activity,inactive,491-35-0,10285.0,Cc1ccnc2ccccc12
NCGC00256140-01,tox21-er-bla-agonist-p2,Isooctyl 3-mercaptopropionate,activity,inactive,30374-01-7,104386.0,CC(C)CCCCCOC(=O)CCS
NCGC00256155-01,tox21-er-bla-agonist-p2,(R)-alpha-Phellandrene,activity,inactive,4221-98-1,442482.0,CC=1C=C[C@H](CC=1)C(C)C
NCGC00255653-01,tox21-er-bla-agonist-p2,(E)-4-Tridecen-l-yl acetate,activity,inactive,72269-48-8,5365748.0,CC(=O)OCCC\C=C\CCCCCCCC
NCGC00255685-01,tox21-er-bla-agonist-p2,Chloramine-T trihydrate,activity,inactive,7080-50-4,517414.0,[Na+].O.O.O.Cc1ccc(cc1)S(=O)(=O)[N-]Cl
NCGC00260427-01,tox21-er-bla-agonist-p2,1-Thioglycerol,activity,inactive,96-27-5,7291.0,OCC(O)CS
NCGC00259219-01,tox21-er-bla-agonist-p2,2-Pentanone,activity,inactive,107-87-9,7895.0,CC(=O)CCC
NCGC00259270-01,tox21-er-bla-agonist-p2,Pentaethylene glycol,activity,inactive,4792-15-8,62551.0,OCCOCCOCCOCCOCCO
NCGC00259449-01,tox21-er-bla-agonist-p2,1-Dodecanamine,activity,inactive,124-22-1,13583.0,CCCCCCCCCCCCN
NCGC00259462-01,tox21-er-bla-agonist-p2,Procymidone,activity,inactive,32809-16-8,36242.0,Clc1cc(cc(Cl)c1)N2C(=O)C3(C)CC3(C)C2=O
NCGC00259667-01,tox21-er-bla-agonist-p2,Ethephon,activity,inactive,16672-87-0,27982.0,ClCCP(=O)(O)O
NCGC00260371-01,tox21-er-bla-agonist-p2,"Heptadecane,1-bromo-",activity,inactive,3508-00-7,19022.0,BrCCCCCCCCCCCCCCCCC
NCGC00254721-01,tox21-er-bla-agonist-p2,Molinate,activity,inactive,2212-67-1,16653.0,O=C(SCC)N1CCCCCC1
NCGC00254884-01,tox21-er-bla-agonist-p2,Metolachlor,activity,inactive,51218-45-2,4169.0,ClCC(=O)N(C(C)COC)c1c(C)cccc1CC
NCGC00254932-01,tox21-er-bla-agonist-p2,"1,3,5-Triisopropylbenzene",activity,inactive,717-74-8,12860.0,CC(C)c1cc(cc(c1)C(C)C)C(C)C
NCGC00255105-01,tox21-er-bla-agonist-p2,3-Octanone,activity,inactive,106-68-3,246728.0,CCC(=O)CCCCC
NCGC00255320-01,tox21-er-bla-agonist-p2,"2,5-Dimethyl-1,4-dithiane-2,5-diol",activity,inactive,55704-78-4,62105.0,CC1(O)CSC(C)(O)CS1
NCGC00255339-01,tox21-er-bla-agonist-p2,"2,4-D-Butotyl",activity,inactive,1929-73-3,16002.0,Clc1cc(Cl)ccc1OCC(=O)OCCOCCCC
NCGC00255459-01,tox21-er-bla-agonist-p2,5-Ethyl-5-methylhydantoin,activity,inactive,5394-36-5,82162.0,O=C1NC(=O)NC1(C)CC
NCGC00255756-01,tox21-er-bla-agonist-p2,Tetrahydro-2H-pyran-2-one,activity,inactive,542-28-9,10953.0,O=C1CCCCO1
NCGC00091076-01,tox21-er-bla-agonist-p2,Acetal,activity,inactive,105-57-7,7765.0,CC(OCC)OCC
NCGC00091179-01,tox21-er-bla-agonist-p2,Acetone,activity,inactive,67-64-1,180.0,CC(C)=O
NCGC00093356-03,tox21-er-bla-agonist-p2,Cytarabine,activity,inactive,147-94-4,6253.0,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
NCGC00159413-02,tox21-er-bla-agonist-p2,Dimethylaminoethanol,activity,inactive,108-01-0,7902.0,CN(C)CCO
NCGC00094159-01,tox21-er-bla-agonist-p2,Naphazoline hydrochloride,activity,inactive,550-99-2,11957635.0,Cl.c2cc(CC1=NCCN1)cc3ccccc23
NCGC00094285-01,tox21-er-bla-agonist-p2,R-3-PPP hydrochloride,activity,inactive,85976-54-1,11957669.0,Cl.CCCN1CCC[C@H](C1)c2cccc(O)c2
NCGC00159454-02,tox21-er-bla-agonist-p2,Ticrynafen,activity,inactive,40180-04-9,38409.0,O=C(c1ccc(OCC(=O)O)c(Cl)c1Cl)c2cccs2
NCGC00159480-03,tox21-er-bla-agonist-p2,Ketamine,activity,inactive,6740-88-1,3821.0,CNC1(CCCCC1=O)c2ccccc2Cl
NCGC00164071-01,tox21-er-bla-agonist-p2,Isopropyl tetradecanoic acid,activity,inactive,110-27-0,8042.0,CC(C)OC(=O)CCCCCCCCCCCCC
NCGC00181161-01,tox21-er-bla-agonist-p2,Ethyl salicylate,activity,inactive,118-61-6,8365.0,Oc1ccccc1C(=O)OCC
NCGC00160366-01,tox21-er-bla-agonist-p2,Thioglycolic acid anilide,activity,inactive,4822-44-0,10382.0,O=C(Nc1ccccc1)CS
NCGC00095042-06,tox21-er-bla-agonist-p2,Thiotepa,activity,inactive,52-24-4,5453.0,S=P(N1CC1)(N2CC2)N3CC3
NCGC00181165-01,tox21-er-bla-agonist-p2,Sodium decanehydroxamate,activity,inactive,35440-53-0,60196349.0,[Na+].[O-]NC(=O)CCCCCCCCC
NCGC00095088-01,tox21-er-bla-agonist-p2,Thiouracil,activity,inactive,141-90-2,1269845.0,O=C1C=CNC(=S)N1
NCGC00160449-01,tox21-er-bla-agonist-p2,Fenclozic acid,activity,inactive,17969-20-9,28858.0,O=C(O)Cc1csc(n1)c2ccc(Cl)cc2
NCGC00165718-01,tox21-er-bla-agonist-p2,Atosiban,activity,inactive,90779-69-4,5311010.0,NC(=O)CNC(=O)[C@H](CCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]3CSSCCC(=O)N[C@H](Cc2ccc(OCC)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N3
NCGC00166105-01,tox21-er-bla-agonist-p2,Benzyl nicotinate,activity,inactive,94-44-0,7191.0,O=C(OCc1ccccc1)c2cccnc2
NCGC00160657-01,tox21-er-bla-agonist-p2,Frentizole,activity,inactive,26130-02-9,33334.0,COc2ccc3nc(NC(=O)Nc1ccccc1)sc3c2
NCGC00166222-02,tox21-er-bla-agonist-p2,"N,N'-Dibenzylethane-1,2-diamine dihydrochloride",activity,inactive,3412-76-8,2728761.0,Cl.Cl.C(NCc1ccccc1)CNCc2ccccc2
NCGC00166240-01,tox21-er-bla-agonist-p2,Cyacetacide,activity,inactive,140-87-4,8820.0,N#CCC(=O)NN
NCGC00166247-01,tox21-er-bla-agonist-p2,Carbocyanine,activity,inactive,605-91-4,5709754.0,[I-].CC[n+]3c4ccccc4ccc3C=CC=C2C=Cc1ccccc1N2CC
NCGC00182551-01,tox21-er-bla-agonist-p2,Cythioate,activity,inactive,115-93-5,8293.0,O=S(N)(=O)c1ccc(OP(=S)(OC)OC)cc1
NCGC00183136-01,tox21-er-bla-agonist-p2,Docusate sodium,activity,inactive,577-11-7,23673837.0,[Na+].O=S(=O)([O-])C(CC(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC
NCGC00184997-01,tox21-er-bla-agonist-p2,Raltegravir,activity,inactive,518048-05-0,54671008.0,Cc1nnc(o1)C(=O)NC(C)(C)C3=NC(C(=O)NCc2ccc(F)cc2)=C(O)C(=O)N3C
NCGC00185910-01,tox21-er-bla-agonist-p2,(S)-Ketamine,activity,inactive,33643-46-8,182137.0,CN[C@@]1(CCCCC1=O)c2ccccc2Cl
NCGC00186460-01,tox21-er-bla-agonist-p2,Bardoxolone methyl,activity,active agonist,218600-53-4,400769.0,O=C(OC)[C@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5[C@@](C)(C)C(=O)C(=C[C@]5(C)C4=CC(=O)[C@@H]3[C@@H]2C[C@](C)(C)CC1)C#N
NCGC00255263-01,tox21-er-bla-agonist-p2,"3,6,9,12-Tetraoxahexadecan-1-ol",activity,inactive,1559-34-8,73791.0,OCCOCCOCCOCCOCCCC
NCGC00247699-01,tox21-er-bla-agonist-p2,"(S)-(+)-2,5-Dimethoxy-4-methylamphetamine hydrochloride",activity,inactive,50505-89-0,60196326.0,Cl.COc1cc(C)c(cc1C[C@H](C)N)OC
NCGC00254289-01,tox21-er-bla-agonist-p2,"N,N,N',N'-Tetrakis(2-Hydroxypropyl)ethylenediamine",activity,inactive,102-60-3,7615.0,CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O
NCGC00254309-01,tox21-er-bla-agonist-p2,N-Nitrosodiethylamine,activity,inactive,55-18-5,5921.0,CCN(CC)N=O
NCGC00254310-01,tox21-er-bla-agonist-p2,Sucrose octaacetate,activity,inactive,126-14-7,31340.0,CC(=O)O[C@H]1[C@H](O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)O[C@]2(COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]2OC(C)=O
NCGC00254034-01,tox21-er-bla-agonist-p2,Aspirin,activity,inactive,50-78-2,2244.0,O=C(C)Oc1ccccc1C(=O)O
NCGC00254887-01,tox21-er-bla-agonist-p2,Dibutyl sulfide,activity,inactive,544-40-1,11002.0,CCCCSCCCC
NCGC00254113-01,tox21-er-bla-agonist-p2,2-Methoxy-5-methylaniline,activity,inactive,120-71-8,8445.0,Nc1cc(C)ccc1OC
NCGC00016462-01,tox21-er-bla-agonist-p2,Crotamiton,activity,inactive,483-63-6,2883.0,CCN(C(=O)C=CC)c1ccccc1C
NCGC00259357-01,tox21-er-bla-agonist-p2,alpha-Lipoic acid,activity,inactive,1077-28-7,864.0,O=C(O)CCCCC1CCSS1
NCGC00258485-01,tox21-er-bla-agonist-p2,"3,5-Dichlorophenol",activity,inactive,591-35-5,11571.0,Oc1cc(Cl)cc(Cl)c1
NCGC00258629-01,tox21-er-bla-agonist-p2,13-cis-Retinal,activity,active agonist,472-86-6,6436079.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=CC(/C)=C\C=O
NCGC00256842-01,tox21-er-bla-agonist-p2,"Bicyclo[4.1.0]hept-3-ene, 3,7,7-trimethyl-",activity,inactive,13466-78-9,26049.0,CC2(C)C1CC=C(C)CC12
NCGC00259524-01,tox21-er-bla-agonist-p2,"2-Methyl-2,4-pentanediol",activity,inactive,107-41-5,7870.0,CC(O)CC(C)(C)O
NCGC00259546-01,tox21-er-bla-agonist-p2,Gemfibrozil,activity,inactive,25812-30-0,3463.0,O=C(O)C(C)(C)CCCOc1cc(C)ccc1C
NCGC00259556-01,tox21-er-bla-agonist-p2,Quizalofop-ethyl,activity,inactive,76578-14-8,53518.0,O=C(OCC)C(C)Oc1ccc(cc1)Oc2cnc3cc(Cl)ccc3n2
NCGC00258332-01,tox21-er-bla-agonist-p2,Dichloroacetyl chloride,activity,inactive,79-36-7,6593.0,ClC(Cl)C(Cl)=O
NCGC00258591-01,tox21-er-bla-agonist-p2,"1,2-Bis(phenylthio)ethane",activity,inactive,622-20-8,69317.0,C(CSc1ccccc1)Sc2ccccc2
NCGC00260193-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium tosylate,activity,inactive,328090-25-1,10636633.0,C[n+]1ccn(CC)c1.[O-]S(=O)(=O)c1ccc(C)cc1
NCGC00260423-01,tox21-er-bla-agonist-p2,"3-Pyrazolidinone,1-phenyl-",activity,inactive,92-43-3,7090.0,O=C1CCN(N1)c2ccccc2
NCGC00260496-01,tox21-er-bla-agonist-p2,Quinoxaline,activity,inactive,91-19-0,7045.0,c1cccc2nccnc12
NCGC00255690-01,tox21-er-bla-agonist-p2,"p,p'-DDA",activity,inactive,83-05-6,6730.0,Clc1ccc(cc1)C(C(=O)O)c2ccc(Cl)cc2
NCGC00259160-01,tox21-er-bla-agonist-p2,Diphenylamine,activity,inactive,122-39-4,11487.0,c1ccccc1Nc2ccccc2
NCGC00256894-01,tox21-er-bla-agonist-p2,5-Cyclohexadecen-1-one,activity,inactive,37609-25-9,162268.0,O=C1CCCCCCCCCCC=CCCC1
NCGC00258186-01,tox21-er-bla-agonist-p2,4-Methylcatechol,activity,active agonist,452-86-8,9958.0,Cc1cc(O)c(O)cc1
NCGC00258783-01,tox21-er-bla-agonist-p2,6-Azacytidine,activity,inactive,3131-60-0,65114.0,O=C2N=C(N)C=NN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
NCGC00260627-01,tox21-er-bla-agonist-p2,NTP Mix103 ER1 10-EQC,activity,inactive,NOCAS_49523,,
NCGC00015070-04,tox21-er-bla-agonist-p2,4-Hydroxyandrostenedione,activity,active agonist,566-48-3,11273.0,O=C2CC[C@H]3[C@@H]4CCC1=C(O)C(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00257610-01,tox21-er-bla-agonist-p2,Tetrabromophthalic anhydride,activity,inactive,632-79-1,12443.0,O=C1OC(=O)c2c1c(Br)c(Br)c(Br)c2Br
NCGC00254911-01,tox21-er-bla-agonist-p2,Azamethiphos,activity,inactive,35575-96-3,71482.0,O=P(OC)(OC)SCN1c2ncc(Cl)cc2OC1=O
NCGC00255523-01,tox21-er-bla-agonist-p2,Benalaxyl,activity,inactive,71626-11-4,51369.0,CC(N(C(=O)Cc1ccccc1)c2c(C)cccc2C)C(=O)OC
NCGC00256087-01,tox21-er-bla-agonist-p2,Titanium(4+) bis[(2E)-4-oxohex-2-en-2-olate] dipropan-2-olate,activity,inactive,27858-32-8,60196424.0,CC(C)O[Ti](OC(/C)=C/C(=O)OCC)(OC(C)C)OC(\C)=C\C(=O)OCC
NCGC00256548-01,tox21-er-bla-agonist-p2,Tolbutamide,activity,inactive,64-77-7,5505.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC
NCGC00256633-01,tox21-er-bla-agonist-p2,2-Phenylethyl benzoate,activity,inactive,94-47-3,7194.0,O=C(OCCc1ccccc1)c2ccccc2
NCGC00256260-01,tox21-er-bla-agonist-p2,3-Phenylbutyraldehyde,activity,inactive,16251-77-7,85979.0,CC(CC=O)c1ccccc1
NCGC00256660-01,tox21-er-bla-agonist-p2,Carbamide peroxide,activity,inactive,124-43-6,31294.0,NC(N)=O.OO
NCGC00257250-01,tox21-er-bla-agonist-p2,2-Ethylhexyl 4-(dimethylamino)benzoate,activity,inactive,21245-02-3,30541.0,CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00257724-01,tox21-er-bla-agonist-p2,2-Benzimidazolylurea,activity,inactive,24370-25-0,32346.0,NC(=O)Nc1nc2ccccc2n1
NCGC00257542-01,tox21-er-bla-agonist-p2,Potassium iodide,activity,inactive,7681-11-0,4875.0,[K+].[I-]
NCGC00258084-01,tox21-er-bla-agonist-p2,3-Methyl-2-pentanone,activity,inactive,565-61-7,11262.0,CC(CC)C(C)=O
NCGC00258258-01,tox21-er-bla-agonist-p2,"3,4,5-Trichloronitrobenzene",activity,inactive,20098-48-0,88365.0,Clc1cc(cc(Cl)c1Cl)[N+]([O-])=O
NCGC00258505-01,tox21-er-bla-agonist-p2,"2,5-Dichloroanisole",activity,inactive,1984-58-3,16125.0,COc1cc(Cl)ccc1Cl
NCGC00258631-01,tox21-er-bla-agonist-p2,N-Acetyl-L-cysteine,activity,inactive,616-91-1,12035.0,CC(=O)N[C@@H](CS)C(O)=O
NCGC00258823-01,tox21-er-bla-agonist-p2,"1,2,3,4-Butanetetracarboxylic acid",activity,inactive,1703-58-8,15560.0,OC(=O)CC(C(CC(=O)O)C(=O)O)C(=O)O
NCGC00258027-01,tox21-er-bla-agonist-p2,2-Methylpyridine 1-oxide,activity,inactive,931-19-1,13602.0,[O-][n+]1ccccc1C
NCGC00259606-01,tox21-er-bla-agonist-p2,17beta-Estradiol,activity,active agonist,50-28-2,5757.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3
NCGC00259632-01,tox21-er-bla-agonist-p2,"1,2-Ethanediol diacetate",activity,inactive,111-55-7,8121.0,CC(=O)OCCOC(=O)C
NCGC00260061-01,tox21-er-bla-agonist-p2,Ethyl acetate,activity,inactive,141-78-6,8857.0,CC(=O)OCC
NCGC00260519-01,tox21-er-bla-agonist-p2,Guanazole,activity,inactive,1455-77-2,15078.0,Nc1nnc(N)n1
NCGC00260281-01,tox21-er-bla-agonist-p2,Copper cyanide,activity,inactive,544-92-3,2724144.0,[Cu+].[C-]#N
NCGC00013051-01,tox21-er-bla-agonist-p2,tert-Butylhydroquinone,activity,inactive,1948-33-0,16043.0,CC(C)(C)c1cc(O)ccc1O
NCGC00016314-01,tox21-er-bla-agonist-p2,Mepenzolate bromide,activity,inactive,76-90-4,6461.0,[Br-].O=C(OC1CCC[N+](C)(C)C1)C(O)(c2ccccc2)c3ccccc3
NCGC00015997-06,tox21-er-bla-agonist-p2,l-Taurine,activity,inactive,107-35-7,1123.0,NCCS(=O)(=O)O
NCGC00254946-01,tox21-er-bla-agonist-p2,S-Bioallethrin,activity,inactive,28434-00-6,62829.0,O=C2C[C@H](OC(=O)[C@@H]1[C@@H](/C=C(\C)C)C1(C)C)C(C)=C2CC=C
NCGC00255476-01,tox21-er-bla-agonist-p2,"2,4-Dithiobiuret",activity,inactive,541-53-7,2758725.0,NC(=S)NC(N)=S
NCGC00254368-01,tox21-er-bla-agonist-p2,PHA-00543613,activity,inactive,478149-53-0,9930121.0,O=C(N[C@H]2CN1CCC2CC1)c3cc4ccoc4cn3
NCGC00254401-01,tox21-er-bla-agonist-p2,1-Undecanol,activity,inactive,112-42-5,8184.0,CCCCCCCCCCCO
NCGC00255230-01,tox21-er-bla-agonist-p2,"1,4-Benzenediamine, N-(1-methylheptyl)-N'-phenyl-",activity,inactive,15233-47-3,85821.0,CC(CCCCCC)Nc1ccc(cc1)Nc2ccccc2
NCGC00016814-01,tox21-er-bla-agonist-p2,Tobramycin,activity,inactive,32986-56-4,36294.0,N[C@@H]3C[C@H](O)[C@@H](CN)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00016931-01,tox21-er-bla-agonist-p2,Isradipine,activity,inactive,75695-93-1,3784.0,O=C(OC)C3=C(C)NC(C)=C(C(=O)OC(C)C)C3c1cccc2nonc12
NCGC00159483-02,tox21-er-bla-agonist-p2,Hydroxychloroquine sulfate,activity,inactive,747-36-4,12947.0,O=S(=O)(O)O.CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
NCGC00160640-01,tox21-er-bla-agonist-p2,Bretazenil,activity,inactive,84379-13-5,107926.0,CC(C)(C)OC(=O)c1ncn3c1[C@@H]4CCCN4C(=O)c2c3cccc2Br
NCGC00182047-01,tox21-er-bla-agonist-p2,Fludarabine,activity,inactive,21679-14-1,657237.0,Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
NCGC00182067-02,tox21-er-bla-agonist-p2,Fluprednisolone,activity,inactive,53-34-9,5876.0,OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00253962-01,tox21-er-bla-agonist-p2,"3,3'-Dimethylbenzidine",activity,active agonist,119-93-7,8413.0,Cc1cc(ccc1N)c2ccc(N)c(C)c2
NCGC00254727-01,tox21-er-bla-agonist-p2,"4-Hydroxy-2,5-dimethyl-3(2H)furanone",activity,inactive,3658-77-3,19309.0,CC=1OC(C)C(=O)C=1O
NCGC00254797-01,tox21-er-bla-agonist-p2,Prometon,activity,inactive,1610-18-0,4928.0,COc1nc(NC(C)C)nc(NC(C)C)n1
NCGC00016101-02,tox21-er-bla-agonist-p2,Xylometazoline hydrochloride,activity,inactive,1218-35-5,5282386.0,Cl.CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2
NCGC00091125-01,tox21-er-bla-agonist-p2,Gallic acid,activity,inactive,149-91-7,370.0,Oc1cc(cc(O)c1O)C(=O)O
NCGC00160459-01,tox21-er-bla-agonist-p2,Xilobam,activity,inactive,50528-97-7,17756940.0,O=C(NC1=CCCN1C)Nc2c(C)cccc2C
NCGC00164636-01,tox21-er-bla-agonist-p2,Triptorelin pamoate,activity,inactive,124508-66-3,60196291.0,OC(=O)C1=CC2=C(C=CC=C2)C(CC2=C(O)C(=CC3=C2C=CC=C3)C(O)=O)=C1O.CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(=O)NCC(N)=O
NCGC00181763-01,tox21-er-bla-agonist-p2,Pinaverium bromide,activity,inactive,53251-94-8,40703.0,[Br-].COc4cc(C[N+]3(CCOCCC1CCC2CC1C2(C)C)CCOCC3)c(Br)cc4OC
NCGC00183094-01,tox21-er-bla-agonist-p2,Mivacurium,activity,inactive,133814-19-4,5281042.0,COc1cc(cc(OC)c1OC)C[C@@H]5c6cc(OC)c(OC)cc6CC[N+]5(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc2cc(OC)c(OC)c(OC)c2
NCGC00254256-01,tox21-er-bla-agonist-p2,Bis(2-chloroethyl) ether,activity,inactive,111-44-4,8115.0,ClCCOCCCl
NCGC00017021-01,tox21-er-bla-agonist-p2,Deferoxamine mesylate,activity,inactive,138-14-7,62881.0,ON(CCCCCNC(=O)CCC(=O)N(O)CCCCCN)C(=O)CCC(=O)NCCCCCN(O)C(C)=O.CS(=O)(=O)O
NCGC00017082-02,tox21-er-bla-agonist-p2,Diclofenac sodium,activity,inactive,15307-79-6,5018304.0,[Na+].Clc2cccc(Cl)c2Nc1ccccc1CC([O-])=O
NCGC00018256-02,tox21-er-bla-agonist-p2,Oxyphenonium bromide,activity,inactive,50-10-2,5748.0,[Br-].OC(C(=O)OCC[N+](C)(CC)CC)(c1ccccc1)C2CCCCC2
NCGC00256789-01,tox21-er-bla-agonist-p2,Cornmint oil,activity,inactive,68917-18-0,,
NCGC00256959-01,tox21-er-bla-agonist-p2,Triphenylborane,activity,active agonist,960-71-4,70400.0,c1ccccc1B(c2ccccc2)c3ccccc3
NCGC00257174-01,tox21-er-bla-agonist-p2,Sulfanilamide,activity,inactive,63-74-1,5333.0,Nc1ccc(cc1)S(=O)(N)=O
NCGC00257648-01,tox21-er-bla-agonist-p2,2-Methyl-3-butyn-2-ol,activity,inactive,115-19-5,8258.0,C#CC(C)(C)O
NCGC00257970-01,tox21-er-bla-agonist-p2,4-(Butan-2-yl)phenol,activity,inactive,99-71-8,7453.0,Oc1ccc(cc1)C(C)CC
NCGC00258083-01,tox21-er-bla-agonist-p2,2-Methylpentanedioic acid,activity,inactive,18069-17-5,12046.0,CC(CCC(O)=O)C(=O)O
NCGC00258216-01,tox21-er-bla-agonist-p2,Chloro(methyl)diphenylsilane,activity,inactive,144-79-6,67349.0,C[Si](Cl)(c1ccccc1)c2ccccc2
NCGC00255757-01,tox21-er-bla-agonist-p2,"1-(6-tert-Butyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone",activity,inactive,13171-00-1,61585.0,CC(=O)c2cc(cc1c2CCC1(C)C)C(C)(C)C
NCGC00256389-01,tox21-er-bla-agonist-p2,3-Nitropropionic acid,activity,inactive,504-88-1,1678.0,[O-][N+](=O)CCC(=O)O
NCGC00255768-01,tox21-er-bla-agonist-p2,"3,5-Diaminobenzoic acid",activity,inactive,535-87-5,12062.0,Nc1cc(cc(N)c1)C(=O)O
NCGC00255927-01,tox21-er-bla-agonist-p2,Bupropion hydrochloride,activity,inactive,31677-93-7,62884.0,Cl.O=C(c1cc(Cl)ccc1)C(C)NC(C)(C)C
NCGC00256016-01,tox21-er-bla-agonist-p2,"1,3-Dimethoxybenzene",activity,inactive,151-10-0,9025.0,COc1cccc(OC)c1
NCGC00256117-01,tox21-er-bla-agonist-p2,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, monosodium salt hydrate",activity,inactive,312693-54-2,60196419.0,[Na+].O.[O-]S(=O)(=O)c2cc1cc(cc(O)c1c(N)c2)S(=O)(=O)O
NCGC00256121-01,tox21-er-bla-agonist-p2,4-Hydroxy-7-(phenylamino)naphthalene-2-sulfonic acid,activity,inactive,119-40-4,67065.0,O=S(=O)(O)c1cc(O)c2ccc(cc2c1)Nc3ccccc3
NCGC00256240-01,tox21-er-bla-agonist-p2,Erythrosin B,activity,inactive,15905-32-5,3259.0,Ic4c5Oc1c(I)c(O)c(I)cc1C3(OC(=O)c2ccccc23)c5cc(I)c4O
NCGC00260420-01,tox21-er-bla-agonist-p2,"Cyclohexanone,2-acetyl-",activity,inactive,874-23-7,13400.0,O=C1CCCCC1C(=O)C
NCGC00260467-01,tox21-er-bla-agonist-p2,"p-N,N-Dimethylaminophenethanol",activity,inactive,50438-75-0,93252.0,CN(C)c1ccc(CCO)cc1
NCGC00259058-01,tox21-er-bla-agonist-p2,Tolazamide,activity,inactive,1156-19-0,5503.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
NCGC00259108-01,tox21-er-bla-agonist-p2,Acetazolamide,activity,inactive,59-66-5,1986.0,O=S(N)(=O)c1nnc(NC(C)=O)s1
NCGC00259214-01,tox21-er-bla-agonist-p2,Hexazinone,activity,inactive,51235-04-2,39965.0,CN(C)C2=NC(=O)N(C1CCCCC1)C(=O)N2C
NCGC00259386-01,tox21-er-bla-agonist-p2,Hexamethylphosphoramide,activity,inactive,680-31-9,12679.0,CN(C)P(=O)(N(C)C)N(C)C
NCGC00259640-01,tox21-er-bla-agonist-p2,2-Naphthylamine,activity,inactive,91-59-8,7057.0,Nc1ccc2ccccc2c1
NCGC00259838-01,tox21-er-bla-agonist-p2,1-Nitropropane,activity,inactive,108-03-2,7903.0,[O-][N+](=O)CCC
NCGC00259988-01,tox21-er-bla-agonist-p2,Safrole,activity,inactive,94-59-7,5144.0,C=CCc1ccc2OCOc2c1
NCGC00260207-01,tox21-er-bla-agonist-p2,1-Methyl-3-propylimidazolium hexafluorophosphate,activity,inactive,216300-12-8,60196380.0,C[n+]1ccn(CCC)c1.F[P-](F)(F)(F)(F)F
NCGC00258736-01,tox21-er-bla-agonist-p2,Methyl tert-butyl ether,activity,inactive,1634-04-4,15413.0,CC(C)(C)OC
NCGC00254634-01,tox21-er-bla-agonist-p2,"1,1,3,3,5,5,7,7-Octamethyltetrasiloxane",activity,inactive,1000-05-1,6328651.0,C[SiH](C)O[Si](C)(C)O[Si](C)(C)O[SiH](C)C
NCGC00254677-01,tox21-er-bla-agonist-p2,Mepiquat chloride,activity,inactive,24307-26-4,62781.0,[Cl-].C[N+]1(C)CCCCC1
NCGC00254924-01,tox21-er-bla-agonist-p2,"(2,4-Dichlorophenyl)acetonitrile",activity,inactive,6306-60-1,80566.0,Clc1cc(Cl)ccc1CC#N
NCGC00255259-01,tox21-er-bla-agonist-p2,FD&C Green No. 1,activity,inactive,4680-78-8,20803.0,[Na+].CC/[N+](Cc1cccc(c1)S([O-])(=O)=O)=C2\C=C/C(C=C2)=C(/c3ccccc3)c4ccc(cc4)N(Cc5cccc(c5)S([O-])(=O)=O)CC
NCGC00255385-01,tox21-er-bla-agonist-p2,"2,3-Quinolinedicarboxylic acid",activity,inactive,643-38-9,69508.0,O=C(O)c1cc2ccccc2nc1C(=O)O
NCGC00255487-01,tox21-er-bla-agonist-p2,beta-Terpineol,activity,inactive,138-87-4,8748.0,CC1(O)CCC(CC1)C(=C)C
NCGC00255490-01,tox21-er-bla-agonist-p2,"1,2-Diethoxybenzene",activity,inactive,2050-46-6,74904.0,CCOc1ccccc1OCC
NCGC00255594-01,tox21-er-bla-agonist-p2,Fenazaquin,activity,inactive,120928-09-8,86356.0,CC(C)(C)c1ccc(cc1)CCOc3ncnc2ccccc23
NCGC00255628-01,tox21-er-bla-agonist-p2,(Z)-11-Tetradecenyl acetate,activity,inactive,20711-10-8,5367692.0,CC(=O)OCCCCCCCCCC/C=C\CC
NCGC00255960-01,tox21-er-bla-agonist-p2,2-Hydroxyethyl disulfide,activity,inactive,1892-29-1,15906.0,OCCSSCCO
NCGC00255962-01,tox21-er-bla-agonist-p2,Triethoxypentylsilane,activity,inactive,2761-24-2,17695.0,CCO[Si](OCC)(OCC)CCCCC
NCGC00256010-01,tox21-er-bla-agonist-p2,Bromocresol green sodium salt,activity,inactive,62625-32-5,6024631.0,[Na+].CC=1C(\C=C(Br)C(=O)C=1Br)=C(/c2cc(Br)c(O)c(Br)c2C)c3ccccc3S([O-])(=O)=O
NCGC00254527-01,tox21-er-bla-agonist-p2,PFOSA,activity,active agonist,754-91-6,69785.0,FC(F)(C(F)(F)S(N)(=O)=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00091519-04,tox21-er-bla-agonist-p2,p-Cresol,activity,inactive,106-44-5,2879.0,Cc1ccc(O)cc1
NCGC00091835-01,tox21-er-bla-agonist-p2,Nitrogen mustard hydrochloride,activity,inactive,55-86-7,5935.0,Cl.ClCCN(C)CCCl
NCGC00093739-04,tox21-er-bla-agonist-p2,Cotinine,activity,inactive,486-56-6,854019.0,CN2C(=O)CC[C@H]2c1cnccc1
NCGC00163239-01,tox21-er-bla-agonist-p2,"N,N,N,N',N',N'-Hexamethylhexane-1,6-diaminium",activity,inactive,60-26-4,3604.0,C[N+](C)(C)CCCCCC[N+](C)(C)C
NCGC00163309-01,tox21-er-bla-agonist-p2,Adenosine triphosphate,activity,inactive,56-65-5,5957.0,O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n2cnc1c(N)ncnc12)[C@H](O)[C@@H]3O
NCGC00163815-04,tox21-er-bla-agonist-p2,Oryzalin,activity,inactive,19044-88-3,29393.0,O=S(N)(=O)c1cc(c(c(c1)[N+]([O-])=O)N(CCC)CCC)[N+]([O-])=O
NCGC00181010-01,tox21-er-bla-agonist-p2,Mabuterol hydrochloride,activity,inactive,54240-36-7,6917754.0,Cl.Nc1c(cc(cc1Cl)C(O)CNC(C)(C)C)C(F)(F)F
NCGC00181015-01,tox21-er-bla-agonist-p2,Bropirimine,activity,inactive,56741-95-8,65457.0,BrC1=C(NC(N)=NC1=O)c2ccccc2
NCGC00181027-01,tox21-er-bla-agonist-p2,Disodium 5-methyltetrahydrofolate,activity,inactive,68792-52-9,40114.0,[Na+].[Na+].[O-]C(=O)C(CCC([O-])=O)NC(=O)c1ccc(cc1)NCC3CNc2nc(N)nc(O)c2N3C
NCGC00181133-02,tox21-er-bla-agonist-p2,Desmopressin,activity,inactive,16679-58-6,16051933.0,NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00181135-01,tox21-er-bla-agonist-p2,Pentamycin,activity,inactive,6834-98-6,60196306.0,CCCCC[C@@H](O)C1C(=O)OC(C)[C@H](O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O
NCGC00167588-02,tox21-er-bla-agonist-p2,Goserelin acetate,activity,inactive,145781-92-6,16052011.0,CC(=O)O.O=C1CC[C@H](N1)C(=O)N[C@@H](Cc2cncn2)C(=O)N[C@@H](Cc4cnc3ccccc34)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N6CCC[C@H]6C(=O)NNC(N)=O
NCGC00164562-01,tox21-er-bla-agonist-p2,Levosimendan,activity,inactive,141505-33-1,3033825.0,N#C/C(C#N)=N\Nc1ccc(cc1)C2=NNC(=O)C[C@H]2C
NCGC00160491-01,tox21-er-bla-agonist-p2,Azabuperone,activity,inactive,2856-81-7,18484.0,Fc1ccc(cc1)C(=O)CCCN2CC3CCCN3CC2
NCGC00164620-01,tox21-er-bla-agonist-p2,Nadifloxacin,activity,inactive,124858-35-1,4410.0,O=C(O)C3=CN2C(C)CCc1c(c(F)cc(c12)C3=O)N4CCC(O)CC4
NCGC00160529-01,tox21-er-bla-agonist-p2,Tizanidine,activity,inactive,51322-75-9,5487.0,Clc2ccc3nsnc3c2NC1=NCCN1
NCGC00165846-02,tox21-er-bla-agonist-p2,Nefazodone hydrochloride,activity,inactive,82752-99-6,54911.0,Cl.Clc1cccc(c1)N4CCN(CCCN3N=C(CC)N(CCOc2ccccc2)C3=O)CC4
NCGC00181038-01,tox21-er-bla-agonist-p2,Diethylaminoethyl-sephacel,activity,inactive,9013-34-7,60196302.0,O[C@@H]1O[C@H](COCCN(CC)CC)[C@@H](O)[C@H](O)[C@H]1OCCN(CC)CC
NCGC00168349-01,tox21-er-bla-agonist-p2,Iodophthalein sodium,activity,inactive,2217-44-9,75194.0,[Na+].[Na+].IC1=CC(\C=C(I)C1=O)=C(/c2cc(I)c([O-])c(I)c2)c3ccccc3C([O-])=O
NCGC00183332-01,tox21-er-bla-agonist-p2,Dihydroergocriptine,activity,inactive,25447-66-9,114948.0,CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@H]56)C7=O)C(C)C
NCGC00183364-01,tox21-er-bla-agonist-p2,Leuprolide acetate salt,activity,inactive,74381-53-6,657180.0,CC(=O)O.O=C(NCC)[C@@H]6CCCN6C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3cnc2ccccc23)NC(=O)[C@H](Cc4cncn4)NC(=O)[C@@H]5CCC(=O)N5
NCGC00254591-01,tox21-er-bla-agonist-p2,"1,4-Diaminoanthraquinone",activity,inactive,128-95-0,31420.0,O=C2c1ccccc1C(=O)c3c2c(N)ccc3N
NCGC00255046-01,tox21-er-bla-agonist-p2,Zileuton,activity,inactive,111406-87-2,60490.0,NC(=O)N(O)C(C)c1cc2ccccc2s1
NCGC00238452-01,tox21-er-bla-agonist-p2,Enzastaurin,activity,inactive,170364-57-5,176167.0,Cn2cc(c1ccccc12)C=3C(=O)NC(=O)C=3c7cn(C5CCN(Cc4ncccc4)CC5)c6ccccc67
NCGC00255093-01,tox21-er-bla-agonist-p2,Citronellal,activity,inactive,106-23-0,7794.0,C\C(C)=C\CCC(C)CC=O
NCGC00181752-01,tox21-er-bla-agonist-p2,Cefquinome sulfate,activity,inactive,118443-89-3,60196337.0,CO\N=C(/c1nc(N)sn1)C(=O)N[C@@H]5C(=O)N4C(C([O-])=O)=C(C[n+]3ccn2ncccc23)CS[C@@H]45.O=S(=O)(O)O
NCGC00181780-01,tox21-er-bla-agonist-p2,5alpha-Androstan-3beta-ol,activity,active agonist,1224-92-6,92877.0,C[C@@]34CC[C@H]1[C@@H](CC[C@H]2C[C@@H](O)CC[C@]12C)[C@@H]4CCC3
NCGC00016697-01,tox21-er-bla-agonist-p2,Trimetazidine dihydrochloride,activity,inactive,13171-25-0,83201.0,Cl.Cl.COc2ccc(CN1CCNCC1)c(OC)c2OC
NCGC00024964-02,tox21-er-bla-agonist-p2,Fulvestrant,activity,inactive,129453-61-8,104741.0,FC(F)(F)C(F)(F)CCCS(=O)CCCCCCCCC[C@@H]2Cc1cc(O)ccc1[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@H]23
NCGC00260453-01,tox21-er-bla-agonist-p2,Phthalazine,activity,inactive,253-52-1,9207.0,c1cccc2cnncc12
NCGC00258554-01,tox21-er-bla-agonist-p2,Thallium acetate,activity,inactive,563-68-8,11247.0,[Tl+].[O-]C(C)=O
NCGC00014670-01,tox21-er-bla-agonist-p2,Domperidone,activity,inactive,57808-66-9,3151.0,Clc4cc5NC(=O)N(C3CCN(CCCN1c2ccccc2NC1=O)CC3)c5cc4
NCGC00257620-01,tox21-er-bla-agonist-p2,1-Nitropyrene,activity,active agonist,5522-43-0,21694.0,[O-][N+](=O)c4ccc1ccc2cccc3ccc4c1c23
NCGC00258825-01,tox21-er-bla-agonist-p2,"2,4,6-Tribromophenol",activity,inactive,118-79-6,1483.0,Brc1cc(Br)cc(Br)c1O
NCGC00259142-01,tox21-er-bla-agonist-p2,Tris(2-butoxyethyl) phosphate,activity,inactive,78-51-3,6540.0,CCCCOCCOP(=O)(OCCOCCCC)OCCOCCCC
NCGC00256984-01,tox21-er-bla-agonist-p2,Cyclododecanone,activity,inactive,830-13-7,13246.0,O=C1CCCCCCCCCCC1
NCGC00258137-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium chloride",activity,inactive,98892-75-2,2734167.0,[Cl-].CCCCn1cc[n+](C)c1C
NCGC00257350-01,tox21-er-bla-agonist-p2,Sodium tetrafluoroborate,activity,inactive,13755-29-8,4343483.0,[Na+].F[B-](F)(F)F
NCGC00257398-01,tox21-er-bla-agonist-p2,(2-Dodecenyl)succinic anhydride,activity,inactive,19780-11-1,5362708.0,O=C1OC(=O)CC1C/C=C/CCCCCCCCC
NCGC00255486-01,tox21-er-bla-agonist-p2,Acetyl-L-carnitine hydrochloride,activity,inactive,5080-50-2,6917959.0,Cl.O=C(C)O[C@H](CC([O-])=O)C[N+](C)(C)C
NCGC00255416-01,tox21-er-bla-agonist-p2,2-(1-Methylbutyl)phenol,activity,inactive,87-26-3,99016.0,Oc1ccccc1C(C)CCC
NCGC00256575-01,tox21-er-bla-agonist-p2,HC Blue 2,activity,inactive,33229-34-4,36383.0,OCCN(CCO)c1ccc(NCCO)c(c1)[N+]([O-])=O
NCGC00256205-01,tox21-er-bla-agonist-p2,3-Bromo-4-fluorobenzaldehyde,activity,inactive,77771-02-9,173604.0,Fc1ccc(C=O)cc1Br
NCGC00256701-01,tox21-er-bla-agonist-p2,1H-Benzotriazol-1-ol,activity,inactive,2592-95-2,75771.0,On2nnc1ccccc12
NCGC00256841-01,tox21-er-bla-agonist-p2,3-Thiatetradecanoic acid,activity,inactive,116296-31-2,4420067.0,O=C(O)CSCCCCCCCCCCC
NCGC00256986-01,tox21-er-bla-agonist-p2,1-Phenoxy-2-propanol,activity,inactive,770-35-4,92839.0,CC(O)COc1ccccc1
NCGC00257430-01,tox21-er-bla-agonist-p2,Cycloheximide,activity,inactive,66-81-9,6197.0,O=C2CC(C[C@@H](O)[C@@H]1C[C@@H](C)C[C@H](C)C1=O)CC(=O)N2
NCGC00257902-01,tox21-er-bla-agonist-p2,Berberine chloride,activity,inactive,633-65-8,12456.0,[Cl-].COc2ccc1cc3c4cc5OCOc5cc4CC[n+]3cc1c2OC
NCGC00257956-01,tox21-er-bla-agonist-p2,p-Cresol,activity,inactive,106-44-5,2879.0,Cc1ccc(O)cc1
NCGC00257949-01,tox21-er-bla-agonist-p2,Piperonyl sulfoxide,activity,inactive,120-62-7,8442.0,CCCCCCCCS(=O)C(C)Cc1ccc2OCOc2c1
NCGC00257580-01,tox21-er-bla-agonist-p2,"Aristolochic acid, sodium salt (77% AA I, 21% AA II)",activity,inactive,10190-99-5,154914.0,[Na+].[O-]C(=O)c3cc4OCOc4c2c3c(cc1c2cccc1OC)[N+]([O-])=O
NCGC00258065-01,tox21-er-bla-agonist-p2,C.I. Solvent Yellow 14,activity,inactive,842-07-9,5858445.0,Oc3ccc1ccccc1c3/N=N/c2ccccc2
NCGC00258234-01,tox21-er-bla-agonist-p2,1-Butoxy-2-propanol,activity,inactive,5131-66-8,21210.0,CC(O)COCCCC
NCGC00258516-01,tox21-er-bla-agonist-p2,Dehydroepiandrosterone acetate,activity,active agonist,853-23-6,14709.0,CC(=O)O[C@H]4CC[C@@]2(C)C(=CC[C@H]1[C@@H]3CCC(=O)[C@@]3(C)CC[C@@H]12)C4
NCGC00258530-01,tox21-er-bla-agonist-p2,"O,O-Diethyl chlorothiophosphate",activity,inactive,2524-04-1,17305.0,ClP(=S)(OCC)OCC
NCGC00258746-01,tox21-er-bla-agonist-p2,"1,2-Dimethylhydrazine dihydrochloride",activity,inactive,306-37-6,9380.0,Cl.Cl.CNNC
NCGC00258757-01,tox21-er-bla-agonist-p2,"4,7-Methanoisobenzofuran-1,3-dione, 3a,4,7,7a-tetrahydromethyl-, (3aR,4S,7R,7aS)-rel-",activity,inactive,25134-21-8,6602188.0,O=C2OC(=O)[C@]3(C)[C@@H]1C=C[C@@H](C1)[C@H]23
NCGC00258582-01,tox21-er-bla-agonist-p2,Propanoic anhydride,activity,inactive,123-62-6,31263.0,CCC(=O)OC(=O)CC
NCGC00258379-01,tox21-er-bla-agonist-p2,Diethylmethylsulfonium bis(trifluoromethylsulfonyl)imide,activity,inactive,792188-85-3,53316418.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.CC[S+](C)CC
NCGC00258043-01,tox21-er-bla-agonist-p2,Benzylhydrazine dihydrochloride,activity,inactive,20570-96-1,146540.0,Cl.Cl.NNCc1ccccc1
NCGC00259742-01,tox21-er-bla-agonist-p2,Maleic acid,activity,inactive,110-16-7,444266.0,O=C(O)/C=C\C(=O)O
NCGC00259379-01,tox21-er-bla-agonist-p2,Heptanoic acid,activity,inactive,111-14-8,8094.0,CCCCCCC(=O)O
NCGC00259430-01,tox21-er-bla-agonist-p2,Decane,activity,inactive,124-18-5,15600.0,CCCCCCCCCC
NCGC00259673-01,tox21-er-bla-agonist-p2,1-Dodecanol,activity,inactive,112-53-8,8193.0,CCCCCCCCCCCCO
NCGC00260562-01,tox21-er-bla-agonist-p2,NTP Mix70 CT1 62-EQP,activity,inactive,NOCAS_49458,,
NCGC00260602-01,tox21-er-bla-agonist-p2,NTP Mix5 AR1 8-EQC,activity,inconclusive agonist,NOCAS_49498,,
NCGC00260293-01,tox21-er-bla-agonist-p2,D-Gluconic acid,activity,inactive,526-95-4,10690.0,O[C@H]([C@@H](O)C(=O)O)[C@H](O)[C@H](O)CO
NCGC00015594-02,tox21-er-bla-agonist-p2,Loxoprofen,activity,inactive,68767-14-6,3965.0,O=C(O)C(C)c2ccc(CC1CCCC1=O)cc2
NCGC00016267-01,tox21-er-bla-agonist-p2,Isocarboxazid,activity,inactive,59-63-2,3759.0,Cc1cc(no1)C(=O)NNCc2ccccc2
NCGC00016799-01,tox21-er-bla-agonist-p2,Suxibuzone,activity,inactive,27470-51-5,5362.0,O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3
NCGC00016455-01,tox21-er-bla-agonist-p2,Dyphylline,activity,inactive,479-18-5,3182.0,OCC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C
NCGC00016654-01,tox21-er-bla-agonist-p2,Flurbiprofen,activity,inactive,5104-49-4,3394.0,Fc2cc(ccc2c1ccccc1)C(C)C(=O)O
NCGC00016850-01,tox21-er-bla-agonist-p2,Bezafibrate,activity,inactive,41859-67-0,39042.0,O=C(NCCc1ccc(OC(C)(C)C(=O)O)cc1)c2ccc(Cl)cc2
NCGC00016304-01,tox21-er-bla-agonist-p2,Norethynodrel,activity,active agonist,68-23-5,6231.0,O=C1CCC4=C(C1)CC[C@@H]3[C@@H]4CC[C@@]2(C)[C@H]3CC[C@@]2(O)C#C
NCGC00095975-01,tox21-er-bla-agonist-p2,N-Methylbenzylamine hydrochloride,activity,inactive,13426-94-3,9855548.0,Cl.CNCc1ccccc1
NCGC00167985-01,tox21-er-bla-agonist-p2,Anilinium nitrate,activity,inactive,542-15-4,60196370.0,O[N+]([O-])=O.[NH3+]c1ccccc1
NCGC00185756-01,tox21-er-bla-agonist-p2,Estramustine phosphate sodium,activity,active agonist,52205-73-9,444000.0,[Na+].[Na+].ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OP([O-])([O-])=O)c4cc3
NCGC00255199-01,tox21-er-bla-agonist-p2,"5,6-Benzoflavone",activity,inactive,6051-87-2,2361.0,O=C3C=C(Oc2ccc1ccccc1c23)c4ccccc4
NCGC00256248-01,tox21-er-bla-agonist-p2,tert-Butyl 4-hydroxybenzoate,activity,active agonist,25804-49-3,117640.0,Oc1ccc(cc1)C(=O)OC(C)(C)C
NCGC00255612-01,tox21-er-bla-agonist-p2,Zinc chloride,activity,inactive,7646-85-7,5727.0,Cl[Zn]Cl
NCGC00254469-01,tox21-er-bla-agonist-p2,Dalapon,activity,inactive,75-99-0,6418.0,CC(Cl)(Cl)C(=O)O
NCGC00254392-01,tox21-er-bla-agonist-p2,Pentadecane,activity,inactive,629-62-9,12391.0,CCCCCCCCCCCCCCC
NCGC00254817-01,tox21-er-bla-agonist-p2,Parbenate,activity,inactive,10287-53-3,25127.0,CN(C)c1ccc(cc1)C(=O)OCC
NCGC00254944-01,tox21-er-bla-agonist-p2,Fenhexamid,activity,active agonist,126833-17-8,213031.0,O=C(Nc1ccc(O)c(Cl)c1Cl)C2(C)CCCCC2
NCGC00255305-01,tox21-er-bla-agonist-p2,Chlormezanone,activity,inactive,80-77-3,2717.0,O=C1CCS(=O)(=O)C(N1C)c2ccc(Cl)cc2
NCGC00254146-01,tox21-er-bla-agonist-p2,Triethylene glycol bis(2-ethylhexanoate),activity,inactive,94-28-0,7185.0,O=C(OCCOCCOCCOC(=O)C(CC)CCCC)C(CC)CCCC
NCGC00254173-01,tox21-er-bla-agonist-p2,Volinanserin,activity,inactive,139290-65-6,5311271.0,COc1cccc(c1OC)[C@H](O)C3CCN(CCc2ccc(F)cc2)CC3
NCGC00065934-02,tox21-er-bla-agonist-p2,Oxcarbazepine,activity,inactive,28721-07-5,34312.0,NC(=O)N3c1ccccc1C(=O)Cc2ccccc23
NCGC00090780-04,tox21-er-bla-agonist-p2,Butyl benzyl phthalate,activity,active agonist,85-68-7,2347.0,O=C(OCc1ccccc1)c2ccccc2C(=O)OCCCC
NCGC00093857-01,tox21-er-bla-agonist-p2,Etazolate hydrochloride,activity,inactive,35838-58-5,37274.0,Cl.C/C(C)=N\Nc2c(cnc1c2cnn1CC)C(=O)OCC
NCGC00159469-02,tox21-er-bla-agonist-p2,Methoxyphenamine,activity,inactive,93-30-1,4117.0,COc1ccccc1CC(C)NC
NCGC00160479-01,tox21-er-bla-agonist-p2,Ftorpropazine,activity,inactive,33414-36-7,219081.0,OCCN1CCN(CC1)CCC(=O)N2c4ccccc4Sc3ccc(cc23)C(F)(F)F
NCGC00167465-01,tox21-er-bla-agonist-p2,Calcipotriene,activity,inactive,112965-21-6,5288783.0,C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@@H](O)C4CC4
NCGC00167498-01,tox21-er-bla-agonist-p2,Thiamphenicol glycinate hydrochloride,activity,inactive,2611-61-2,197006.0,Cl.O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl
NCGC00181913-02,tox21-er-bla-agonist-p2,Difeterol,activity,inactive,14587-50-9,208836.0,OC(C(C)N(C)CCOC(c1ccccc1)c2ccccc2)c3ccccc3
NCGC00254076-01,tox21-er-bla-agonist-p2,2-Naphthylamine,activity,inactive,91-59-8,7057.0,Nc1ccc2ccccc2c1
NCGC00255067-01,tox21-er-bla-agonist-p2,4-Propylanisole,activity,inactive,104-45-0,7702.0,COc1ccc(CCC)cc1
NCGC00022612-04,tox21-er-bla-agonist-p2,Cefaclor,activity,inactive,53994-73-3,51039.0,ClC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C=3C(=O)O
NCGC00061506-02,tox21-er-bla-agonist-p2,Nicotredole,activity,inactive,29876-14-0,65768.0,O=C(NCCc2cnc1ccccc12)c3cccnc3
NCGC00094087-01,tox21-er-bla-agonist-p2,Mizoribine,activity,inactive,50924-49-7,104762.0,NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2O
NCGC00094140-01,tox21-er-bla-agonist-p2,Sodium (2E)-4-(4-chlorophenyl)-4-hydroxybut-2-enoate hydrate,activity,inactive,1049737-99-6,16219744.0,[Na+].O.OC(/C=C/C([O-])=O)c1ccc(Cl)cc1
NCGC00142625-06,tox21-er-bla-agonist-p2,Vitamin E,activity,inactive,59-02-9,14985.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(O1)c(C)c(C)c(O)c2C
NCGC00160128-02,tox21-er-bla-agonist-p2,Pepstatin,activity,inactive,26305-03-3,5478883.0,OC(=O)C[C@H](O)[C@@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)CC(C)C
NCGC00160652-02,tox21-er-bla-agonist-p2,3beta-Acetoxy-5-pregnene-20-one,activity,active agonist,1778-02-5,2723722.0,CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@H](CC[C@@]12C)OC(C)=O
NCGC00164569-01,tox21-er-bla-agonist-p2,Capecitabine,activity,inactive,154361-50-9,60953.0,O=C(OCCCCC)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O
NCGC00164626-01,tox21-er-bla-agonist-p2,Tiagabine hydrochloride,activity,inactive,145821-59-6,91274.0,Cl.Cc3ccsc3C(=C\CCN1CCC[C@H](C1)C(=O)O)\c2sccc2C
NCGC00182989-01,tox21-er-bla-agonist-p2,Glyclopyramide,activity,inactive,631-27-6,71793.0,O=C(NS(=O)(=O)c1ccc(Cl)cc1)NN2CCCC2
NCGC00254449-01,tox21-er-bla-agonist-p2,Pirinixic acid,activity,inactive,50892-23-4,5694.0,Cc2cccc(Nc1cc(Cl)nc(SCC(=O)O)n1)c2C
NCGC00075916-01,tox21-er-bla-agonist-p2,Eterobarb,activity,inactive,27511-99-5,33925.0,COCN1C(=O)C(CC)(C(=O)N(COC)C1=O)c2ccccc2
NCGC00018211-03,tox21-er-bla-agonist-p2,Flumequine,activity,inactive,42835-25-6,3374.0,O=C(O)C3=CN1c2c(cc(F)cc2CCC1C)C3=O
NCGC00025303-03,tox21-er-bla-agonist-p2,Raclopride,activity,inactive,84225-95-6,3033769.0,CCN2CCC[C@H]2CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC
NCGC00256866-01,tox21-er-bla-agonist-p2,Ethyl 2-methylpentanoate,activity,inactive,39255-32-8,62902.0,CCCC(C)C(=O)OCC
NCGC00256901-01,tox21-er-bla-agonist-p2,Linalyl cinnamate,activity,inactive,78-37-5,6533.0,C/C(C)=C\CCC(C)(C=C)OC(=O)C=Cc1ccccc1
NCGC00258569-01,tox21-er-bla-agonist-p2,5-Amino-3-sulfosalicylic acid,activity,inactive,6201-87-2,22574.0,Oc1c(cc(N)cc1S(O)(=O)=O)C(=O)O
NCGC00257181-01,tox21-er-bla-agonist-p2,Dimethylnaphthalene,activity,inactive,28804-88-8,11317.0,Cc1c2ccccc2ccc1C
NCGC00257312-01,tox21-er-bla-agonist-p2,PharmaGSID_48510,activity,inactive,460081-99-6,10160166.0,O=C(O)c1cc(ccc1)N(Cc2cccnc2)c3ccc(OC(F)F)c(OC(F)F)c3
NCGC00257436-01,tox21-er-bla-agonist-p2,Ethyl tetradecanoate,activity,inactive,124-06-1,31283.0,O=C(CCCCCCCCCCCCC)OCC
NCGC00257530-01,tox21-er-bla-agonist-p2,Indole-3-butyric acid,activity,inactive,133-32-4,8617.0,O=C(O)CCCc2cnc1ccccc12
NCGC00258087-01,tox21-er-bla-agonist-p2,Phenylacetic acid,activity,inactive,103-82-2,999.0,OC(=O)Cc1ccccc1
NCGC00258299-01,tox21-er-bla-agonist-p2,DINP,activity,inactive,28553-12-0,590836.0,CC(C)CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCC(C)C
NCGC00256412-01,tox21-er-bla-agonist-p2,Dehydroepiandrosterone,activity,active agonist,53-43-0,5881.0,O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00256230-01,tox21-er-bla-agonist-p2,Nootkatone,activity,inactive,4674-50-4,1268142.0,C=C(C)[C@@H]1CCC2=CC(=O)C[C@@H](C)[C@]2(C)C1
NCGC00256306-01,tox21-er-bla-agonist-p2,Sodium 3-(trihydroxysilyl)propyl methylphosphonate,activity,inactive,84962-98-1,4385787.0,[Na+].O[Si](O)(O)CCCOP([O-])(C)=O
NCGC00256313-01,tox21-er-bla-agonist-p2,4-Methylpyridin-2-amine,activity,inactive,695-34-1,1533.0,Cc1ccnc(N)c1
NCGC00258951-01,tox21-er-bla-agonist-p2,4-Methylpyridine,activity,inactive,108-89-4,7963.0,Cc1ccncc1
NCGC00259313-01,tox21-er-bla-agonist-p2,2-Tolualdehyde,activity,inactive,529-20-4,10722.0,Cc1ccccc1C=O
NCGC00259497-01,tox21-er-bla-agonist-p2,Primidone,activity,inactive,125-33-7,4909.0,CCC1(C(=O)NCNC1=O)c2ccccc2
NCGC00259671-01,tox21-er-bla-agonist-p2,Oxalic acid,activity,inactive,144-62-7,971.0,O=C(O)C(=O)O
NCGC00259786-01,tox21-er-bla-agonist-p2,3-Chloroaniline,activity,inactive,108-42-9,7932.0,Nc1cc(Cl)ccc1
NCGC00259821-01,tox21-er-bla-agonist-p2,MCPA,activity,inactive,94-74-6,7204.0,Clc1cc(C)c(OCC(=O)O)cc1
NCGC00260273-01,tox21-er-bla-agonist-p2,Tropine,activity,inactive,120-29-6,449293.0,CN2[C@H]1CC[C@@H]2C[C@H](O)C1
NCGC00254768-01,tox21-er-bla-agonist-p2,Acibenzolar-S-methyl,activity,inactive,135158-54-2,86412.0,O=C(SC)c1cccc2nnsc12
NCGC00254787-01,tox21-er-bla-agonist-p2,4-Chloropyridine 1-oxide,activity,inactive,1121-76-2,70724.0,[O-][n+]1ccc(Cl)cc1
NCGC00254815-01,tox21-er-bla-agonist-p2,Dimethomorph,activity,inactive,110488-70-5,86298.0,O=C(C=C(c1ccc(Cl)cc1)c2ccc(OC)c(OC)c2)N3CCOCC3
NCGC00256463-01,tox21-er-bla-agonist-p2,Tridecanedioic acid,activity,inactive,505-52-2,10458.0,O=C(O)CCCCCCCCCCCC(=O)O
NCGC00254922-01,tox21-er-bla-agonist-p2,4-Dodecylphenol,activity,active agonist,104-43-8,66030.0,Oc1ccc(CCCCCCCCCCCC)cc1
NCGC00254957-01,tox21-er-bla-agonist-p2,"2,6-Di-tert-butyl-4-methoxyphenol",activity,inactive,489-01-0,10269.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)OC
NCGC00255005-01,tox21-er-bla-agonist-p2,"2-Chloro-4,6-diamino-1,3,5-triazine",activity,inactive,3397-62-4,18831.0,Nc1nc(N)nc(Cl)n1
NCGC00255052-01,tox21-er-bla-agonist-p2,Thiamethoxam,activity,inactive,153719-23-4,107646.0,Clc2ncc(CN/1COCN(C)C\1=N\[N+]([O-])=O)s2
NCGC00255092-01,tox21-er-bla-agonist-p2,Ethyl isovalerate,activity,inactive,108-64-5,7945.0,CC(C)CC(=O)OCC
NCGC00255541-01,tox21-er-bla-agonist-p2,"1,3-Divinyl-1,1,3,3-tetramethyl disiloxane",activity,inactive,2627-95-4,75819.0,C[Si](C)(O[Si](C)(C)C=C)C=C
NCGC00092362-01,tox21-er-bla-agonist-p2,Ecopipam,activity,inactive,112108-01-7,107930.0,Oc3cc4[C@@H]1[C@H](CCc2ccccc12)N(C)CCc4cc3Cl
NCGC00094042-01,tox21-er-bla-agonist-p2,Indatraline hydrochloride,activity,inactive,96850-13-4,10314472.0,Cl.Clc1ccc(cc1Cl)[C@@H]3C[C@@H](NC)c2ccccc23
NCGC00092315-01,tox21-er-bla-agonist-p2,ZD 2079,activity,inactive,178600-17-4,158793.0,Cl.O=C(O)Cc2ccc(OCCNC[C@H](O)c1ccccc1)cc2
NCGC00163360-01,tox21-er-bla-agonist-p2,D-Nicotine,activity,inactive,25162-00-9,157672.0,CN2CCC[C@@H]2c1cnccc1
NCGC00159438-02,tox21-er-bla-agonist-p2,Selenomethionine,activity,inactive,1464-42-2,15103.0,O=C(O)C(N)CC[Se]C
NCGC00163754-02,tox21-er-bla-agonist-p2,Metalaxyl,activity,inactive,57837-19-1,42586.0,CC(N(C(=O)COC)c1c(C)cccc1C)C(=O)OC
NCGC00094509-01,tox21-er-bla-agonist-p2,Tropisetron methyliodide,activity,inactive,115626-53-4,60196275.0,CN4[C@H]1CC[C@@H]4CC(C1)OC(=O)c3cnc2ccccc23.CI
NCGC00164530-01,tox21-er-bla-agonist-p2,Cinromide,activity,inactive,58473-74-8,688145.0,Brc1cc(/C=C/C(=O)NCC)ccc1
NCGC00181294-01,tox21-er-bla-agonist-p2,Thiamine disulfide,activity,inactive,67-16-3,5432.0,Nc2nc(C)ncc2CN(C=O)C(C)=C(CCO)SSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N
NCGC00181303-02,tox21-er-bla-agonist-p2,Neomycin sulfate,activity,inactive,1405-10-3,24978553.0,O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.N[C@@H]4[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]4O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O[C@@H]2O[C@H](CO)[C@@H](O[C@H]1O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]1N)[C@H]2O
NCGC00181323-01,tox21-er-bla-agonist-p2,trans-Squalene,activity,inactive,111-02-4,638072.0,C\C(C)=C\CCC(\C)=C\CCC(\C)=C\CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C
NCGC00164576-02,tox21-er-bla-agonist-p2,Lopinavir,activity,inactive,192725-17-0,92727.0,CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)N4CCCNC4=O
NCGC00168256-01,tox21-er-bla-agonist-p2,Prazepam,activity,inactive,2955-38-6,4890.0,Clc1ccc3c(c1)C(=NCC(=O)N3CC2CC2)c4ccccc4
NCGC00095193-01,tox21-er-bla-agonist-p2,Chlorophyllide Cu complex sodium salt,activity,inactive,11006-34-1,23725082.0,[Cu+2].[Na+].[Na+].[Na+].[O-]C(=O)c1c(C)c2[n-]c1c(CC([O-])=O)c5nc(cc4[n-]c(cc3nc(c2)C(CC)=C3C)c(C=C)c4C)C(C)C5CCC([O-])=O
NCGC00160507-01,tox21-er-bla-agonist-p2,Lanatoside B,activity,inactive,17575-21-2,24180680.0,O=C1C=C(CO1)[C@H]9[C@@H](O)C[C@@]8(O)[C@]9(C)CC[C@H]3[C@H]8CCC2CC(CC[C@@]23C)O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](OC(C)=O)C5)[C@@H](O)C6)[C@@H](O)C7
NCGC00160518-01,tox21-er-bla-agonist-p2,Orbifloxacin,activity,inactive,113617-63-3,60605.0,C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(F)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4
NCGC00095537-01,tox21-er-bla-agonist-p2,D-Arabinitol,activity,inactive,488-82-4,94154.0,O[C@H](CO)[C@H](O)[C@H](O)CO
NCGC00095741-01,tox21-er-bla-agonist-p2,Guanidine carbonate,activity,inactive,593-85-1,11650.0,NC(=N)N.N=C(N)N.O=C(O)O
NCGC00159321-02,tox21-er-bla-agonist-p2,Clopidogrel hydrogen sulfate,activity,active agonist,135046-48-9,115366.0,O=S(=O)(O)O.Clc1ccccc1[C@H](N2CCc3sccc3C2)C(=O)OC
NCGC00159370-02,tox21-er-bla-agonist-p2,1-Docosanol,activity,inactive,661-19-8,12620.0,CCCCCCCCCCCCCCCCCCCCCCO
NCGC00163111-01,tox21-er-bla-agonist-p2,"3,5-Diiodo-L-tyrosine",activity,inactive,300-39-0,9305.0,Ic1cc(C[C@H](N)C(=O)O)cc(I)c1O
NCGC00163160-01,tox21-er-bla-agonist-p2,Talipexole,activity,inactive,101626-70-4,5374.0,C=CCN1CCc2sc(N)nc2CC1
NCGC00091663-03,tox21-er-bla-agonist-p2,"4-Chloro-1,2-diaminobenzene",activity,inactive,95-83-0,7263.0,Nc1cc(Cl)ccc1N
NCGC00183120-01,tox21-er-bla-agonist-p2,Nalpha-Acetyl-L-glutamine,activity,inactive,2490-97-3,25561.0,O=C(C)NC(CCC(N)=O)C(=O)O
NCGC00183138-01,tox21-er-bla-agonist-p2,Sucrose octasulfate-aluminum complex,activity,inactive,54182-58-0,60196357.0,O[Al](O)[Al](O)O.O[Al](O)[Al](O)O.O[Al](O)[Al](O)O.O[Al](O)[Al](O)O.[H][C@]1(COS(=O)(=O)O[Al](O)O)O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@@]2([H])O[C@]([H])(COS(=O)(=O)O[Al](O)O)[C@@]([H])(OS(=O)(=O)O[Al](O)O)[C@]([H])(OS(=O)(=O)O[Al](O)O)[C@@]2([H])OS(=O)(=O)O[Al](O)O)[C@@]([H])(OS(=O)(=O)O[Al](O)O)[C@]1([H])OS(=O)(=O)O[Al](O)O
NCGC00183857-01,tox21-er-bla-agonist-p2,Temafloxacin,activity,inactive,108319-06-8,60021.0,Fc1ccc(c(F)c1)N2C=C(C(=O)O)C(=O)c3cc(F)c(cc23)N4CC(C)NCC4
NCGC00187606-01,tox21-er-bla-agonist-p2,C.I. Acid Blue 74,activity,inactive,860-22-0,5284351.0,[Na+].[Na+].[O-]S(=O)(=O)c1cc2C(=O)C(\Nc2cc1)=C4/Nc3ccc(cc3C4=O)S([O-])(=O)=O
NCGC00254203-01,tox21-er-bla-agonist-p2,Folic acid,activity,inactive,59-30-3,6037.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2cnc3NC(N)=NC(=O)c3n2
NCGC00254210-01,tox21-er-bla-agonist-p2,SR125047,activity,inactive,NOCAS_47342,60196403.0,Cl.COc1cccc(c1)c2ccc(cc2Cl)/C=C\CN3CCCCCC3
NCGC00254641-01,tox21-er-bla-agonist-p2,Monomethyl phthalate,activity,inactive,4376-18-5,20392.0,COC(=O)c1ccccc1C(=O)O
NCGC00255372-01,tox21-er-bla-agonist-p2,Dimethyl phosphate,activity,inactive,813-78-5,13134.0,O=P(O)(OC)OC
NCGC00247693-01,tox21-er-bla-agonist-p2,N-[1-(2-Hydroxy-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide hydrochloride,activity,inactive,1473-95-6,60196321.0,Cl.OC(CN1CCC(CC1)N(c2ccccc2)C(=O)CC)c3ccccc3
NCGC00254307-01,tox21-er-bla-agonist-p2,Methimazole,activity,inactive,60-56-0,1349907.0,S=C1NC=CN1C
NCGC00254352-01,tox21-er-bla-agonist-p2,Monobenzyl phthalate,activity,inactive,2528-16-7,31736.0,O=C(O)c2ccccc2C(=O)OCc1ccccc1
NCGC00253966-01,tox21-er-bla-agonist-p2,4-Methyl-2-pentanol,activity,inactive,108-11-2,7910.0,CC(C)CC(C)O
NCGC00254934-01,tox21-er-bla-agonist-p2,Cyanazine,activity,inactive,21725-46-2,30773.0,Clc1nc(NCC)nc(NC(C)(C)C#N)n1
NCGC00183039-01,tox21-er-bla-agonist-p2,Nystatin,activity,inactive,1400-61-9,60196358.0,O=C(O)[C@@H]3[C@@H](O)C[C@@]2(O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)C=CC=CCCC=CC=CC=CC=C[C@H](O[C@H]1O[C@@H](C)[C@H](O)[C@@H](N)[C@H]1O)CC3O2
NCGC00183048-01,tox21-er-bla-agonist-p2,Cefcapene pivoxil hydrochloride,activity,inactive,147816-23-7,6918126.0,Cl.Nc1scc(n1)\C(=C\CC)C(=O)N[C@@H]3C(=O)N2C(=C(COC(N)=O)CS[C@@H]23)C(=O)OCOC(=O)C(C)(C)C
NCGC00183050-01,tox21-er-bla-agonist-p2,Bethanidine sulfate,activity,inactive,114-85-2,16051931.0,O=S(=O)(O)O.C\N=C(/NC)NCc1ccccc1.C\N=C(\NCc1ccccc1)NC
NCGC00016558-01,tox21-er-bla-agonist-p2,Lymecycline,activity,inactive,992-21-2,54688689.0,O=C(O)[C@H](CCCCN)NCNC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2CC4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O
NCGC00016725-01,tox21-er-bla-agonist-p2,Josamycin,activity,inactive,16846-24-5,5284579.0,CC(C)CC(=O)O[C@@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]3[C@@H](C)O[C@@H](O[C@@H]2C(OC)[C@H](OC(C)=O)CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@@H]2CC=O)[C@H](O)[C@H]3N(C)C
NCGC00259752-01,tox21-er-bla-agonist-p2,3'-Azido-3'-deoxythymidine,activity,inactive,30516-87-1,35370.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2
NCGC00090751-01,tox21-er-bla-agonist-p2,Sodium zomepirac,activity,inactive,64092-48-4,16220118.0,[Na+].Cc2cc(CC([O-])=O)n(C)c2C(=O)c1ccc(Cl)cc1
NCGC00260346-01,tox21-er-bla-agonist-p2,"2-Propenal,3,3-diphenyl-",activity,inactive,1210-39-5,71027.0,O=C\C=C(/c1ccccc1)c2ccccc2
NCGC00258539-01,tox21-er-bla-agonist-p2,Danthron,activity,inactive,117-10-2,2950.0,Oc3cccc2C(=O)c1cccc(O)c1C(=O)c23
NCGC00259153-01,tox21-er-bla-agonist-p2,Isovaleric acid,activity,inactive,503-74-2,10430.0,CC(C)CC(=O)O
NCGC00166241-01,tox21-er-bla-agonist-p2,"2,6-Diiodo-4-nitrophenol",activity,inactive,305-85-1,9370.0,Ic1cc(cc(I)c1O)[N+]([O-])=O
NCGC00016423-03,tox21-er-bla-agonist-p2,Gossypol,activity,inactive,303-45-7,3503.0,CC(C)c4c3cc(C)c(c1c(C)cc2c(c1O)c(C=O)c(O)c(O)c2C(C)C)c(O)c3c(C=O)c(O)c4O
NCGC00016675-01,tox21-er-bla-agonist-p2,Oxprenolol hydrochloride,activity,inactive,6452-73-9,71172.0,Cl.CC(C)NCC(O)COc1ccccc1OCC=C
NCGC00256000-01,tox21-er-bla-agonist-p2,4-Acetylphenyl acetate,activity,inactive,13031-43-1,83063.0,O=C(C)Oc1ccc(cc1)C(C)=O
NCGC00259815-01,tox21-er-bla-agonist-p2,Hexylparaben,activity,active agonist,1083-27-8,14127.0,Oc1ccc(cc1)C(=O)OCCCCCC
NCGC00259827-01,tox21-er-bla-agonist-p2,"2,6-Dimethyl-2,4,6-octatriene",activity,inactive,673-84-7,5368821.0,C\C(C)=C\C=C\C(\C)=C\C
NCGC00260145-01,tox21-er-bla-agonist-p2,Selenium dioxide,activity,inactive,7446-08-4,24007.0,O=[SeH2]=O
NCGC00254165-01,tox21-er-bla-agonist-p2,Phosmet,activity,inactive,732-11-6,12901.0,COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O
NCGC00258725-01,tox21-er-bla-agonist-p2,Butyl anthranilate,activity,inactive,7756-96-9,24433.0,Nc1ccccc1C(=O)OCCCC
NCGC00260237-01,tox21-er-bla-agonist-p2,1-Butyl-4-methylpyridinium iodide,activity,inactive,32353-64-3,11995188.0,[I-].Cc1cc[n+](CCCC)cc1
NCGC00260360-01,tox21-er-bla-agonist-p2,2-Ethoxyethyl methacrylate,activity,inactive,2370-63-0,71404.0,CCOCCOC(=O)C(=C)C
NCGC00256635-01,tox21-er-bla-agonist-p2,(3Z)-Hex-3-en-1-yl benzoate,activity,inactive,25152-85-6,5367706.0,O=C(OCC/C=C\CC)c1ccccc1
NCGC00256501-01,tox21-er-bla-agonist-p2,"2,6-Dichloro-1,4-benzenediamine",activity,inactive,609-20-1,11860.0,Clc1cc(N)cc(Cl)c1N
NCGC00256593-01,tox21-er-bla-agonist-p2,Ethyl methylphenylglycidate,activity,inactive,77-83-8,6501.0,CCOC(=O)C2OC2(C)c1ccccc1
NCGC00258788-01,tox21-er-bla-agonist-p2,Dazomet,activity,inactive,533-74-4,10788.0,S=C1SCN(C)CN1C
NCGC00255507-01,tox21-er-bla-agonist-p2,"3,5,5-Trimethylhexyl acetate",activity,inactive,58430-94-7,42745.0,O=C(C)OCCC(C)CC(C)(C)C
NCGC00255639-01,tox21-er-bla-agonist-p2,"1,3,5-Triazin-2-amine, 4-methoxy-6-methyl-",activity,inactive,1668-54-8,15466.0,Cc1nc(N)nc(OC)n1
NCGC00256750-01,tox21-er-bla-agonist-p2,Linalyl benzoate,activity,active agonist,126-64-7,31353.0,C/C(C)=C\CCC(C)(OC(=O)c1ccccc1)C=C
NCGC00256791-01,tox21-er-bla-agonist-p2,Triethanolamine Laurate,activity,inactive,2224-49-9,62441.0,OCCN(CCO)CCO.CCCCCCCCCCCC(=O)O
NCGC00256696-01,tox21-er-bla-agonist-p2,2-Phenylpropionaldehyde dimethyl acetal,activity,inactive,90-87-9,62336.0,COC(OC)C(C)c1ccccc1
NCGC00256715-01,tox21-er-bla-agonist-p2,Propylene glycol dipelargonate,activity,inactive,41395-83-9,38855.0,CC(COC(=O)CCCCCCCC)OC(=O)CCCCCCCC
NCGC00255942-01,tox21-er-bla-agonist-p2,Thiofanox,activity,inactive,39196-18-4,38235.0,O=C(O\N=C(\CSC)C(C)(C)C)NC
NCGC00257187-01,tox21-er-bla-agonist-p2,Sulfathiazole,activity,inactive,72-14-0,5340.0,O=S(=O)(Nc1nccs1)c2ccc(N)cc2
NCGC00257657-01,tox21-er-bla-agonist-p2,4-Methyl-3-nitroaniline,activity,inactive,119-32-4,8390.0,O=[N+]([O-])c1cc(N)ccc1C
NCGC00257882-01,tox21-er-bla-agonist-p2,4-Nitrophthalic anhydride,activity,inactive,5466-84-2,230976.0,[O-][N+](=O)c1ccc2C(=O)OC(=O)c2c1
NCGC00257351-01,tox21-er-bla-agonist-p2,Methyl 2-methylbenzoate,activity,inactive,89-71-4,33094.0,COC(=O)c1ccccc1C
NCGC00258173-01,tox21-er-bla-agonist-p2,1-Bromopropane,activity,inactive,106-94-5,7840.0,BrCCC
NCGC00258920-01,tox21-er-bla-agonist-p2,Chloramben,activity,inactive,133-90-4,8630.0,Clc1cc(C(=O)O)c(Cl)c(N)c1
NCGC00259040-01,tox21-er-bla-agonist-p2,Tris(2-hydroxyethyl) isocyanurate,activity,inactive,839-90-7,13286.0,OCCN1C(=O)N(CCO)C(=O)N(CCO)C1=O
NCGC00258023-01,tox21-er-bla-agonist-p2,"4,4'-Biphenyldiol",activity,active agonist,92-88-6,7112.0,Oc1ccc(cc1)c2ccc(O)cc2
NCGC00260080-01,tox21-er-bla-agonist-p2,Poly(2-hydroxypropyl methacrylate),activity,inactive,25703-79-1,13539.0,CC(=C)C(=O)OCC(C)O
NCGC00259567-01,tox21-er-bla-agonist-p2,4-Chloro-2-methylphenol,activity,inactive,1570-64-5,14855.0,Cc1cc(Cl)ccc1O
NCGC00260094-01,tox21-er-bla-agonist-p2,Indigo,activity,inactive,482-89-3,5318432.0,O=C3c4ccccc4N/C3=C2/Nc1ccccc1C2=O
NCGC00259707-01,tox21-er-bla-agonist-p2,Urea,activity,inactive,57-13-6,1176.0,NC(N)=O
NCGC00260412-01,tox21-er-bla-agonist-p2,1-Bromo-4-chlorobutane,activity,inactive,6940-78-9,81364.0,BrCCCCCl
NCGC00260622-01,tox21-er-bla-agonist-p2,NTP Mix99 ER1 10-EQC,activity,active agonist,NOCAS_49518,,
NCGC00260512-01,tox21-er-bla-agonist-p2,O6-Methylguanine,activity,inactive,20535-83-5,65275.0,COc1nc(N)nc2ncnc12
NCGC00015238-02,tox21-er-bla-agonist-p2,Chlorzoxazone,activity,inactive,95-25-0,2733.0,Clc1cc2NC(=O)Oc2cc1
NCGC00013414-03,tox21-er-bla-agonist-p2,Procodazole,activity,inactive,23249-97-0,65708.0,O=C(O)CCc1nc2ccccc2n1
NCGC00014617-01,tox21-er-bla-agonist-p2,Benzylhydrochlorothiazide,activity,inactive,1824-50-6,2348.0,NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)Cc2ccccc2)cc3Cl
NCGC00015884-09,tox21-er-bla-agonist-p2,Rilmenidine,activity,inactive,54187-04-1,68712.0,C1CC1C(NC2=NCCO2)C3CC3
NCGC00017019-01,tox21-er-bla-agonist-p2,Phenethicillin potassium,activity,inactive,132-93-4,23675317.0,[K+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)C(C)Oc1ccccc1)[C@H]3SC2(C)C
NCGC00016479-06,tox21-er-bla-agonist-p2,Etofylline,activity,inactive,519-37-9,1892.0,O=C2c1n(cnc1N(C)C(=O)N2C)CCO
NCGC00016643-01,tox21-er-bla-agonist-p2,Trioxsalen,activity,inactive,3902-71-4,5585.0,Cc1oc2c(C)c3OC(=O)C=C(C)c3cc2c1
NCGC00016513-01,tox21-er-bla-agonist-p2,Debrisoquin sulfate,activity,inactive,581-88-4,11391.0,O=S(=O)(O)O.N=C(N)N1Cc2ccccc2CC1.N=C(N)N1Cc2ccccc2CC1
NCGC00161826-01,tox21-er-bla-agonist-p2,Phenylmercuric borate,activity,active agonist,102-98-7,16683761.0,OB(O)O[Hg]c1ccccc1
NCGC00182065-02,tox21-er-bla-agonist-p2,Dimemorfan phosphate,activity,inactive,36304-84-4,198165.0,O=P(O)(O)O.Cc3ccc4C[C@@H]1N(C)CC[C@]2(CCCC[C@H]12)c4c3
NCGC00247722-01,tox21-er-bla-agonist-p2,(+)-Epibatidine hydrochloride,activity,inactive,152885-09-1,60196333.0,Cl.Clc1ccc(cn1)[C@@H]3C[C@H]2CC[C@@H]3N2
NCGC00254730-01,tox21-er-bla-agonist-p2,Maneb,activity,inactive,12427-38-2,3032581.0,[Mn+2].[S-]C(=S)NCCNC(=S)[S-]
NCGC00255180-01,tox21-er-bla-agonist-p2,Triclopyr-butotyl,activity,inactive,64700-56-7,47455.0,Clc1cc(Cl)c(Cl)nc1OCC(=O)OCCOCCCC
NCGC00255299-01,tox21-er-bla-agonist-p2,Phenothrin,activity,inactive,26002-80-2,4767.0,C/C(C)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00255342-01,tox21-er-bla-agonist-p2,Mestranol,activity,active agonist,72-33-3,6291.0,COc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3
NCGC00255457-01,tox21-er-bla-agonist-p2,Flurbiprofen,activity,inactive,5104-49-4,3394.0,Fc2cc(ccc2c1ccccc1)C(C)C(=O)O
NCGC00016058-05,tox21-er-bla-agonist-p2,MDL 72222,activity,inactive,40796-97-2,671690.0,CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)c2cc(Cl)cc(Cl)c2
NCGC00159474-02,tox21-er-bla-agonist-p2,Fluprednisolone,activity,inactive,53-34-9,5876.0,OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00182044-01,tox21-er-bla-agonist-p2,Toltrazuril sulfone,activity,inactive,69004-04-2,3050408.0,O=C3N(c2cc(C)c(Oc1ccc(cc1)S(=O)(=O)C(F)(F)F)cc2)C(=O)NC(=O)N3C
NCGC00259898-01,tox21-er-bla-agonist-p2,Olivetol,activity,inactive,500-66-3,10377.0,Oc1cc(CCCCC)cc(O)c1
NCGC00260348-01,tox21-er-bla-agonist-p2,"5-Methyl-2,3-hexanedione",activity,inactive,13706-86-0,26204.0,CC(=O)C(=O)CC(C)C
NCGC00090903-01,tox21-er-bla-agonist-p2,Sulfasalazine,activity,inactive,599-79-1,5359476.0,O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3
NCGC00093685-01,tox21-er-bla-agonist-p2,Ubenimex hydrochloride,activity,inactive,65391-42-6,60196274.0,Cl.N[C@H](Cc1ccccc1)[C@H](O)C(=O)N[C@H](CC(C)C)C(=O)O
NCGC00160503-01,tox21-er-bla-agonist-p2,Tritiozine,activity,inactive,35619-65-9,65790.0,S=C(c1cc(OC)c(OC)c(OC)c1)N2CCOCC2
NCGC00161345-04,tox21-er-bla-agonist-p2,Docosahexaenoic acid,activity,inactive,6217-54-5,445580.0,O=C(O)CC/C=C\C\C=C/C/C=C\C/C=C\C/C=C\C/C=C\CC
NCGC00167845-01,tox21-er-bla-agonist-p2,Sodium dichloroacetate,activity,inactive,2156-56-1,517326.0,[Na+].ClC(Cl)C([O-])=O
NCGC00168247-01,tox21-er-bla-agonist-p2,D-Amphetamine-d3 hemisulfate,activity,inactive,119039-59-7,60196298.0,N[C@H](Cc1ccccc1)C([2H])([2H])[2H].O=S(=O)(O)O.[2H]C([2H])([2H])[C@H](N)Cc1ccccc1
NCGC00182704-01,tox21-er-bla-agonist-p2,Luliconazole,activity,inactive,187164-19-8,3003141.0,N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3
NCGC00183851-01,tox21-er-bla-agonist-p2,Mebanazine,activity,inactive,3979-76-8,60196350.0,NNC(C)c1ccccc1.O=S(=O)(O)O
NCGC00090686-07,tox21-er-bla-agonist-p2,Nitrofurazone,activity,inactive,59-87-0,5447130.0,O=[N+]([O-])c1ccc(/C=N/NC(N)=O)o1
NCGC00090793-02,tox21-er-bla-agonist-p2,Naphthalene,activity,inactive,91-20-3,931.0,c1cccc2ccccc12
NCGC00090827-04,tox21-er-bla-agonist-p2,2-Methoxyphenol,activity,inactive,90-05-1,460.0,Oc1ccccc1OC
NCGC00090974-03,tox21-er-bla-agonist-p2,Diethyl phthalate,activity,inactive,84-66-2,6781.0,O=C(OCC)c1ccccc1C(=O)OCC
NCGC00016973-01,tox21-er-bla-agonist-p2,Letrozole,activity,inactive,112809-51-5,3902.0,N#Cc1ccc(cc1)C(c2ccc(C#N)cc2)n3cncn3
NCGC00017073-01,tox21-er-bla-agonist-p2,Carbenoxolone sodium,activity,inactive,7421-40-1,636402.0,[Na+].[Na+].[O-]C(=O)CCC(=O)O[C@H]4CC[C@]3(C)[C@H]5C(=O)C=C1[C@@](C)(CC[C@@]2(C)CC[C@@](C)(C[C@@H]12)C([O-])=O)[C@]5(C)CC[C@H]3C4(C)C
NCGC00018221-08,tox21-er-bla-agonist-p2,Cinchophen,activity,inactive,132-60-5,8593.0,O=C(O)c1cc(nc2ccccc12)c3ccccc3
NCGC00073457-03,tox21-er-bla-agonist-p2,Metomidate hydrochloride,activity,inactive,35944-74-2,118264.0,Cl.CC(c1ccccc1)n2cncc2C(=O)OC
NCGC00016902-01,tox21-er-bla-agonist-p2,Etifenin,activity,inactive,63245-28-3,170344.0,O=C(Nc1c(cccc1CC)CC)CN(CC(=O)O)CC(=O)O
NCGC00256771-01,tox21-er-bla-agonist-p2,"7-Methyl-2H-1,5-benzodioxepin-3(4H)-one",activity,inactive,28940-11-6,120101.0,Cc1cc2OCC(=O)COc2cc1
NCGC00256958-01,tox21-er-bla-agonist-p2,3-Chloroaniline,activity,inactive,108-42-9,7932.0,Nc1cc(Cl)ccc1
NCGC00258393-01,tox21-er-bla-agonist-p2,2-Methylnaphthalene,activity,inactive,91-57-6,7055.0,Cc1ccc2ccccc2c1
NCGC00258404-01,tox21-er-bla-agonist-p2,Halothane,activity,inactive,151-67-7,3562.0,BrC(Cl)C(F)(F)F
NCGC00258509-01,tox21-er-bla-agonist-p2,Orthanilic acid,activity,inactive,88-21-1,6926.0,Nc1ccccc1S(O)(=O)=O
NCGC00257534-01,tox21-er-bla-agonist-p2,Paraldehyde,activity,inactive,123-63-7,31264.0,CC1OC(C)OC(C)O1
NCGC00257662-01,tox21-er-bla-agonist-p2,alpha-Pinene,activity,inactive,80-56-8,6654.0,CC2(C)C1CC=C(C)C2C1
NCGC00257802-01,tox21-er-bla-agonist-p2,Pentane,activity,inactive,109-66-0,8003.0,CCCCC
NCGC00258203-01,tox21-er-bla-agonist-p2,Mexacarbate,activity,inactive,315-18-4,9414.0,O=C(Oc1cc(C)c(c(C)c1)N(C)C)NC
NCGC00256720-01,tox21-er-bla-agonist-p2,Ammonium carbamate,activity,inactive,1111-78-0,517232.0,[NH4+].[O-]C(N)=O
NCGC00256473-01,tox21-er-bla-agonist-p2,3-Sulfolene,activity,inactive,77-79-2,6498.0,O=S1(=O)CC=CC1
NCGC00255785-01,tox21-er-bla-agonist-p2,2-Morpholinoethylamine,activity,inactive,2038-03-1,408285.0,NCCN1CCOCC1
NCGC00255907-01,tox21-er-bla-agonist-p2,Octyl acetate,activity,inactive,112-14-1,8164.0,CCCCCCCCOC(C)=O
NCGC00256056-01,tox21-er-bla-agonist-p2,4-Ethenylphenyl acetate,activity,inactive,2628-16-2,75821.0,O=C(C)Oc1ccc(cc1)C=C
NCGC00256157-01,tox21-er-bla-agonist-p2,"Sodium 5-oxo-1-(4-sulfophenyl)-4,5-dihydro-1H-pyrazole-3-carboxylate",activity,inactive,52126-51-9,23695324.0,[Na+].O=S(=O)(O)c1ccc(cc1)N2N=C(CC2=O)C([O-])=O
NCGC00256233-01,tox21-er-bla-agonist-p2,"5-Amino-1,2-dihydro-3H-1,2,4-triazole-3-thione",activity,inactive,16691-43-3,2723869.0,S=C1N=C(N)NN1
NCGC00256334-01,tox21-er-bla-agonist-p2,Finasteride,activity,inactive,98319-26-7,57363.0,CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C
NCGC00256348-01,tox21-er-bla-agonist-p2,Indole,activity,inactive,120-72-9,798.0,c1cccc2nccc12
NCGC00258984-01,tox21-er-bla-agonist-p2,"1,3-Dichloropropanone",activity,active agonist,534-07-6,10793.0,ClCC(=O)CCl
NCGC00259022-01,tox21-er-bla-agonist-p2,Salicylic acid,activity,inactive,69-72-7,338.0,OC(=O)c1ccccc1O
NCGC00260444-01,tox21-er-bla-agonist-p2,Pentyl nitrite,activity,inactive,463-04-7,10026.0,CCCCCON=O
NCGC00260608-01,tox21-er-bla-agonist-p2,NTP Mix11 AR1 8-EQP,activity,inactive,NOCAS_49504,,
NCGC00259560-01,tox21-er-bla-agonist-p2,Sodium chloroacetate,activity,inactive,3926-62-3,23665759.0,[Na+].[O-]C(=O)CCl
NCGC00259613-01,tox21-er-bla-agonist-p2,Dichlormid,activity,inactive,37764-25-3,37829.0,ClC(Cl)C(=O)N(CC=C)CC=C
NCGC00259661-01,tox21-er-bla-agonist-p2,Styrene oxide,activity,inactive,96-09-3,7276.0,c1ccccc1C2CO2
NCGC00259823-01,tox21-er-bla-agonist-p2,"2,3,6-Trimethylphenol",activity,inactive,2416-94-6,17016.0,Cc1ccc(C)c(O)c1C
NCGC00260137-01,tox21-er-bla-agonist-p2,Ferbam,activity,inactive,14484-64-1,26710.0,[Fe+3].S=C([S-])N(C)C.CN(C)C([S-])=S.CN(C)C([S-])=S
NCGC00258658-01,tox21-er-bla-agonist-p2,Trehalose dihydrate,activity,inactive,6138-23-4,181978.0,O.O.O[C@H]1[C@H](O[C@H](CO)[C@@H](O)[C@@H]1O)O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
NCGC00254735-01,tox21-er-bla-agonist-p2,Terbacil,activity,inactive,5902-51-2,22188.0,O=C1NC(C)=C(Cl)C(=O)N1C(C)(C)C
NCGC00256268-01,tox21-er-bla-agonist-p2,"2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, phosphate",activity,inactive,52628-03-2,90551.0,O=C(OCCOP(O)(O)=O)C(=C)C
NCGC00254888-01,tox21-er-bla-agonist-p2,"N,N'-Dibutylthiourea",activity,inactive,109-46-6,2723622.0,CCCCNC(=S)NCCCC
NCGC00255296-01,tox21-er-bla-agonist-p2,C.I. Disperse Blue 27,activity,inactive,15791-78-3,5360487.0,[O-][N+](=O)c4ccc(O)c2c4C(=O)c1c(ccc(O)c1C2=O)Nc3ccc(CCO)cc3
NCGC00255563-01,tox21-er-bla-agonist-p2,Methylparaoxon,activity,inactive,950-35-6,13708.0,[O-][N+](=O)c1ccc(OP(=O)(OC)OC)cc1
NCGC00254536-01,tox21-er-bla-agonist-p2,"2,6,10-Trimethyl-2,6,10-triazaundecane",activity,inactive,3855-32-1,77463.0,CN(C)CCCN(C)CCCN(C)C
NCGC00166280-01,tox21-er-bla-agonist-p2,Bismuth subgallate,activity,active agonist,99-26-3,16682999.0,O=C(O)c2cc1O[Bi](O)Oc1c(O)c2
NCGC00093889-03,tox21-er-bla-agonist-p2,Physostigmine,activity,inactive,57-47-6,5983.0,CNC(=O)Oc1cc2c(cc1)N(C)[C@H]3N(C)CC[C@@]23C
NCGC00159400-05,tox21-er-bla-agonist-p2,Nicotinyl alcohol,activity,inactive,100-55-0,7510.0,OCc1cccnc1
NCGC00159518-02,tox21-er-bla-agonist-p2,Rabeprazole sodium,activity,inactive,117976-90-6,14720269.0,[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1
NCGC00164333-01,tox21-er-bla-agonist-p2,"Sorbitan, monooctadecanoate",activity,inactive,1338-41-6,16218600.0,O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O
NCGC00164513-01,tox21-er-bla-agonist-p2,Benzoylpas,activity,inactive,13898-58-3,10718.0,OC(=O)c1ccc(cc1O)NC(=O)c2ccccc2
NCGC00167798-01,tox21-er-bla-agonist-p2,Oxaliplatin,activity,inactive,61825-94-3,9887053.0,O=C3O[Pt]1(N[C@@H]2CCCC[C@H]2N1)OC3=O
NCGC00167491-01,tox21-er-bla-agonist-p2,Lenalidomide,activity,inactive,191732-72-6,216326.0,O=C1NC(=O)CCC1N3Cc2c(cccc2N)C3=O
NCGC00160493-01,tox21-er-bla-agonist-p2,Fosenazide,activity,inactive,16543-10-5,27918.0,O=P(CC(=O)NN)(c1ccccc1)c2ccccc2
NCGC00095192-01,tox21-er-bla-agonist-p2,Tegaserod,activity,inactive,145158-71-0,5362436.0,N=C(NCCCCC)N\N=C\c2cnc1ccc(cc12)OC
NCGC00166002-01,tox21-er-bla-agonist-p2,N-(2-chloroethyl)-N-(propan-2-yl)propan-2-amine hydrochloride,activity,inactive,4261-68-1,77942.0,Cl.CC(C)N(CCCl)C(C)C
NCGC00160598-01,tox21-er-bla-agonist-p2,Penthrichloral,activity,inactive,5684-90-2,71839.0,ClC(Cl)(Cl)C1OCC(CO)(CO1)CO
NCGC00160609-01,tox21-er-bla-agonist-p2,"Glycyrrhizic acid, monosodium salt",activity,inactive,11052-19-0,60196360.0,[Na+].O=C(O)[C@H]7O[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@H](O[C@@H]6O[C@H]5CC[C@@]2(C)C(CC[C@@]1(C)[C@]3(C)CC[C@@]4(C)CC[C@@](C)(C[C@H]4C3=CC(=O)[C@@H]12)C(=O)O)C5(C)C)C([O-])=O)[C@H](O)[C@@H](O)[C@@H]7O
NCGC00168774-01,tox21-er-bla-agonist-p2,Rasagiline mesylate,activity,inactive,161735-79-1,3052775.0,CS(=O)(=O)O.C#CCN[C@@H]2CCc1ccccc12
NCGC00159318-03,tox21-er-bla-agonist-p2,Chlordiazepoxide,activity,inactive,58-25-3,2712.0,Clc1ccc2N=C(C[N+]([O-])=C(c2c1)c3ccccc3)NC
NCGC00166200-01,tox21-er-bla-agonist-p2,Dichloralurea,activity,inactive,116-52-9,8313.0,ClC(Cl)(Cl)C(O)NC(=O)NC(O)C(Cl)(Cl)Cl
NCGC00166209-01,tox21-er-bla-agonist-p2,"(7S)-7-(Hexadecanoyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide",activity,inactive,35418-55-4,3032281.0,C[N+](C)(C)CCOP([O-])(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
NCGC00181090-01,tox21-er-bla-agonist-p2,1-(4-Hydroxyphenyl)-2-methyl-2-methylaminoethanol hydrochloride,activity,inactive,74217-46-2,3084014.0,Cl.OC(c1ccc(O)cc1)C(C)NC
NCGC00160682-01,tox21-er-bla-agonist-p2,Isocaine,activity,active agonist,94-14-4,7176.0,Nc1ccc(cc1)C(=O)OCC(C)C
NCGC00167557-01,tox21-er-bla-agonist-p2,DL-Methionine methylsulfonium chloride,activity,inactive,3493-12-7,14220.0,[Cl-].C[S+](C)CCC(N)C(=O)O
NCGC00182546-01,tox21-er-bla-agonist-p2,Gefarnate,activity,inactive,51-77-4,5282182.0,C\C(C)=C\CCC(\C)=C\COC(=O)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C
NCGC00183121-01,tox21-er-bla-agonist-p2,Zinc pyrithione,activity,active agonist,13463-41-7,26041.0,[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]
NCGC00183838-01,tox21-er-bla-agonist-p2,Perisoxal citrate,activity,inactive,14838-45-0,167180.0,OC(CN1CCCCC1)c2cc(on2)c3ccccc3.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00247674-01,tox21-er-bla-agonist-p2,Mescaline hydrochloride,activity,inactive,832-92-8,71580.0,Cl.COc1c(cc(cc1OC)CCN)OC
NCGC00254263-01,tox21-er-bla-agonist-p2,Sodium saccharin hydrate,activity,inactive,82385-42-0,443755.0,[Na+].O.O=C1[N-]S(=O)(=O)c2ccccc12
NCGC00247710-01,tox21-er-bla-agonist-p2,Dexfenfluramine hydrochloride,activity,inactive,3239-45-0,66264.0,Cl.FC(F)(F)c1cccc(C[C@H](C)NCC)c1
NCGC00249414-01,tox21-er-bla-agonist-p2,Fonazine,activity,inactive,7456-24-8,3089.0,CN(C)S(=O)(=O)c1cc2N(CC(C)N(C)C)c3ccccc3Sc2cc1
NCGC00254336-01,tox21-er-bla-agonist-p2,"1,2,4-Trichlorobenzene",activity,inactive,120-82-1,13.0,Clc1cc(Cl)c(Cl)cc1
NCGC00254346-01,tox21-er-bla-agonist-p2,"(2Z)-3,7-Dimethylocta-2,6-dien-1-ol",activity,inactive,106-25-2,643820.0,C\C(C)=C\CCC(/C)=C\CO
NCGC00254773-01,tox21-er-bla-agonist-p2,1-Nonanol,activity,inactive,143-08-8,8914.0,CCCCCCCCCO
NCGC00253980-01,tox21-er-bla-agonist-p2,p-Cresol,activity,inactive,106-44-5,2879.0,Cc1ccc(O)cc1
NCGC00255295-01,tox21-er-bla-agonist-p2,Carbutamide,activity,inactive,339-43-5,9564.0,Nc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC
NCGC00254446-01,tox21-er-bla-agonist-p2,Octanoic acid,activity,inactive,124-07-2,379.0,O=C(O)CCCCCCC
NCGC00254495-01,tox21-er-bla-agonist-p2,Flutamide,activity,inactive,13311-84-7,3397.0,O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C
NCGC00254530-01,tox21-er-bla-agonist-p2,Perfluoroheptanoic acid,activity,inactive,375-85-9,67818.0,FC(F)(C(F)(F)C(=O)O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00181350-02,tox21-er-bla-agonist-p2,Vatalanib dihydrochloride,activity,inactive,212141-51-0,22386467.0,Cl.Cl.Clc1ccc(cc1)Nc4nnc(Cc2ccncc2)c3ccccc34
NCGC00182046-01,tox21-er-bla-agonist-p2,Efonidipine,activity,inactive,111011-63-3,119171.0,O=P1(OCC(C)(C)CO1)C=5C(c2cccc(c2)[N+]([O-])=O)C(C(=O)OCCN(Cc3ccccc3)c4ccccc4)=C(C)NC=5C
NCGC00182064-02,tox21-er-bla-agonist-p2,Ceftezole sodium,activity,inactive,41136-22-5,23688977.0,[Na+].[O-]C(=O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nncs2
NCGC00182965-01,tox21-er-bla-agonist-p2,Biperiden hydrochloride,activity,inactive,1235-82-1,92151.0,Cl.OC(CCN1CCCCC1)(c2ccccc2)C4CC3C=CC4C3
NCGC00260044-01,tox21-er-bla-agonist-p2,Chlorogenic acid,activity,inactive,327-97-9,9476.0,O[C@@H]2[C@H](O)C[C@](O)(C[C@H]2OC(=O)C=Cc1ccc(O)c(O)c1)C(=O)O
NCGC00256608-01,tox21-er-bla-agonist-p2,"3,3'-Dichlorobenzidine dihydrochloride",activity,active agonist,612-83-9,11933.0,Cl.Cl.Nc1ccc(cc1Cl)c2ccc(N)c(Cl)c2
NCGC00259171-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) phosphate,activity,inactive,298-07-7,9275.0,CCCCC(COP(O)(=O)OCC(CC)CCCC)CC
NCGC00257944-01,tox21-er-bla-agonist-p2,Quinapril hydrochloride,activity,inactive,82586-55-8,54891.0,Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O
NCGC00259290-01,tox21-er-bla-agonist-p2,6-Propyl-2-thiouracil,activity,inactive,51-52-5,657298.0,S=C1NC(CCC)=CC(=O)N1
NCGC00259669-01,tox21-er-bla-agonist-p2,1-Naphthol,activity,inactive,90-15-3,7005.0,Oc2cccc1ccccc12
NCGC00259965-01,tox21-er-bla-agonist-p2,Michler's ketone,activity,active agonist,90-94-8,7031.0,CN(C)c1ccc(cc1)C(=O)c2ccc(cc2)N(C)C
NCGC00259970-01,tox21-er-bla-agonist-p2,2-Ethylhexyl 4-(dimethylamino)benzoate,activity,inactive,21245-02-3,30541.0,CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00258758-01,tox21-er-bla-agonist-p2,3-Propylidenephthalide,activity,inactive,17369-59-4,6259976.0,CC\C=C1\OC(=O)c2ccccc12
NCGC00255895-01,tox21-er-bla-agonist-p2,"1,4-Dioxacyclohexadecane-5,16-dione",activity,inactive,54982-83-1,41270.0,O=C1CCCCCCCCCCC(=O)OCCO1
NCGC00257067-01,tox21-er-bla-agonist-p2,2-(2-Aminoethoxy)ethanol,activity,inactive,929-06-6,13578.0,NCCOCCO
NCGC00256905-01,tox21-er-bla-agonist-p2,"trans,trans-Farnesyl acetate",activity,inactive,4128-17-0,638500.0,CC(=O)OC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C
NCGC00258498-01,tox21-er-bla-agonist-p2,Echinacoside,activity,inactive,82854-37-3,5281771.0,Oc1ccc(cc1O)/C=C/C(=O)O[C@@H]5[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@H]5O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O
NCGC00258368-01,tox21-er-bla-agonist-p2,Phosphoric trichloride,activity,inactive,10025-87-3,24813.0,ClP(Cl)(Cl)=O
NCGC00258706-01,tox21-er-bla-agonist-p2,tert-Amyl methyl ether,activity,active agonist,994-05-8,61247.0,CC(C)(CC)OC
NCGC00256559-01,tox21-er-bla-agonist-p2,3-Methylpyridine,activity,inactive,108-99-6,7970.0,Cc1cccnc1
NCGC00259039-01,tox21-er-bla-agonist-p2,Methyl dodecanoate,activity,inactive,111-82-0,8139.0,O=C(CCCCCCCCCCC)OC
NCGC00254681-01,tox21-er-bla-agonist-p2,Bendiocarb,activity,inactive,22781-23-3,2314.0,CNC(=O)Oc1cccc2OC(C)(C)Oc12
NCGC00255467-01,tox21-er-bla-agonist-p2,"1,4-Dihydroxy-2-naphthoic acid",activity,inactive,31519-22-9,671.0,O=C(O)c2cc(O)c1ccccc1c2O
NCGC00255620-01,tox21-er-bla-agonist-p2,2-Phenylpropan-1-ol,activity,inactive,1123-85-9,14295.0,OCC(C)c1ccccc1
NCGC00255636-01,tox21-er-bla-agonist-p2,"3-Penten-2-one, 3-methyl-",activity,inactive,565-62-8,5364579.0,C\C=C(/C)C(C)=O
NCGC00255645-01,tox21-er-bla-agonist-p2,Etidronic acid monohydrate,activity,inactive,25211-86-3,12521030.0,O.CC(O)(P(O)(=O)O)P(=O)(O)O
NCGC00254923-01,tox21-er-bla-agonist-p2,Atrazine,activity,inactive,1912-24-9,2256.0,Clc1nc(NCC)nc(NC(C)C)n1
NCGC00256751-01,tox21-er-bla-agonist-p2,Methyl 4-methoxybenzoate,activity,inactive,121-98-2,8499.0,COc1ccc(cc1)C(=O)OC
NCGC00256784-01,tox21-er-bla-agonist-p2,2-Methyldihydrofuran-3(2H)-one,activity,inactive,3188-00-9,18522.0,CC1OCCC1=O
NCGC00256851-01,tox21-er-bla-agonist-p2,N-Isopropylphthalimide,activity,inactive,304-17-6,67535.0,CC(C)N2C(=O)c1ccccc1C2=O
NCGC00256864-01,tox21-er-bla-agonist-p2,Panthenol,activity,inactive,16485-10-2,4678.0,CC(C)(CO)C(O)C(=O)NCCCO
NCGC00256676-01,tox21-er-bla-agonist-p2,3-Methyl-2-butenyl benzoate,activity,inactive,5205-11-8,21265.0,C/C(C)=C\COC(=O)c1ccccc1
NCGC00256512-01,tox21-er-bla-agonist-p2,Hexachlorocyclopentadiene,activity,inactive,77-47-4,6478.0,ClC=1C(Cl)=C(Cl)C(Cl)(Cl)C=1Cl
NCGC00257135-01,tox21-er-bla-agonist-p2,N-pentylpentan-1-amine,activity,inactive,2050-92-2,16316.0,CCCCCNCCCCC
NCGC00257224-01,tox21-er-bla-agonist-p2,Decamethylcyclopentasiloxane,activity,inactive,541-02-6,10913.0,C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1
NCGC00257499-01,tox21-er-bla-agonist-p2,Triethylene glycol dimethacrylate,activity,inactive,109-16-0,7979.0,O=C(OCCOCCOCCOC(=O)C(=C)C)C(=C)C
NCGC00257718-01,tox21-er-bla-agonist-p2,Dodecylphenol,activity,active agonist,27193-86-8,171144.0,Oc1ccccc1CCCCCCCCCCCC
NCGC00257998-01,tox21-er-bla-agonist-p2,(9Z)-Octadec-9-enamide,activity,inactive,301-02-0,5283387.0,NC(=O)CCCCCCC/C=C\CCCCCCCC
NCGC00258228-01,tox21-er-bla-agonist-p2,"2,3-Dimethylbutane",activity,inactive,79-29-8,6589.0,CC(C)C(C)C
NCGC00258291-01,tox21-er-bla-agonist-p2,3-Nitroacetophenone,activity,inactive,121-89-1,8494.0,O=[N+]([O-])c1cc(ccc1)C(C)=O
NCGC00258918-01,tox21-er-bla-agonist-p2,Corticosterone,activity,inactive,50-22-6,5753.0,OCC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00258333-01,tox21-er-bla-agonist-p2,Dibutyl maleate,activity,inactive,105-76-0,5271569.0,O=C(\C=C/C(=O)OCCCC)OCCCC
NCGC00258444-01,tox21-er-bla-agonist-p2,"N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine",activity,inactive,793-24-8,13101.0,CC(C)CC(C)Nc1ccc(cc1)Nc2ccccc2
NCGC00258093-01,tox21-er-bla-agonist-p2,17beta-Trenbolone,activity,active agonist,10161-33-8,25015.0,O=C3C=C4CC[C@@H]1C(C=C[C@]2(C)[C@@H](O)CC[C@@H]12)=C4CC3
NCGC00258095-01,tox21-er-bla-agonist-p2,2-Hydroxybenzophenone,activity,inactive,117-99-7,8348.0,O=C(c1ccccc1O)c2ccccc2
NCGC00259726-01,tox21-er-bla-agonist-p2,Sodium zomepirac,activity,inactive,64092-48-4,16220118.0,[Na+].Cc2cc(CC([O-])=O)n(C)c2C(=O)c1ccc(Cl)cc1
NCGC00259757-01,tox21-er-bla-agonist-p2,1-Tridecanol,activity,inactive,112-70-9,8207.0,CCCCCCCCCCCCCO
NCGC00259398-01,tox21-er-bla-agonist-p2,Azodicarbonamide,activity,inactive,123-77-3,31269.0,NC(=O)/N=N/C(N)=O
NCGC00259626-01,tox21-er-bla-agonist-p2,Glycerol,activity,inactive,56-81-5,753.0,OCC(O)CO
NCGC00259642-01,tox21-er-bla-agonist-p2,"3,7-Dimethyl-2,6-octadienal",activity,inactive,5392-40-5,8843.0,C\C(C)=C\CCC(C)=CC=O
NCGC00259687-01,tox21-er-bla-agonist-p2,Resmethrin,activity,inactive,10453-86-8,5053.0,O=C(OCc2cc(Cc1ccccc1)oc2)C3C(/C=C(\C)C)C3(C)C
NCGC00259697-01,tox21-er-bla-agonist-p2,"1-Chloro-3,3-dimethyl-butan-2-one",activity,inactive,13547-70-1,83572.0,CC(C)(C)C(=O)CCl
NCGC00259490-01,tox21-er-bla-agonist-p2,m-Cresol,activity,inactive,108-39-4,342.0,Cc1cc(O)ccc1
NCGC00259709-01,tox21-er-bla-agonist-p2,Vinclozolin,activity,inactive,50471-44-8,39676.0,O=C1N(C(=O)OC1(C)C=C)c2cc(Cl)cc(Cl)c2
NCGC00260197-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide,activity,inactive,382150-50-7,10411334.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.C[n+]1ccn(CCCCCC)c1
NCGC00260203-01,tox21-er-bla-agonist-p2,1-Methyl-3-propylimidazolium bromide,activity,inactive,85100-76-1,60196377.0,Br.CCCN1C=CN(C)C1
NCGC00260274-01,tox21-er-bla-agonist-p2,trans-Stilbene,activity,inactive,103-30-0,638088.0,C(=C/c1ccccc1)\c2ccccc2
NCGC00260403-01,tox21-er-bla-agonist-p2,3-Ethyltoluene,activity,inactive,620-14-4,12100.0,Cc1cccc(CC)c1
NCGC00260338-01,tox21-er-bla-agonist-p2,"2,3,7,8-Tetrachlorodibenzo-p-dioxin",activity,inactive,1746-01-6,15625.0,Clc1cc2Oc3cc(Cl)c(Cl)cc3Oc2cc1Cl
NCGC00015247-04,tox21-er-bla-agonist-p2,1-(3-Chlorophenyl)piperazine,activity,inactive,6640-24-0,1355.0,Clc1cc(ccc1)N2CCNCC2
NCGC00015876-07,tox21-er-bla-agonist-p2,Ranitidine,activity,inactive,66357-35-5,3001055.0,[O-][N+](=O)\C=C(/NC)NCCSCc1ccc(CN(C)C)o1
NCGC00016868-09,tox21-er-bla-agonist-p2,Acemetacin,activity,inactive,53164-05-9,1981.0,Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)OCC(=O)O)c3C)OC
NCGC00091501-01,tox21-er-bla-agonist-p2,Resorcinol,activity,inactive,108-46-3,5054.0,Oc1cccc(O)c1
NCGC00164586-01,tox21-er-bla-agonist-p2,Pitofenone hydrochloride,activity,inactive,1248-42-6,121097.0,Cl.O=C(OC)c1ccccc1C(=O)c3ccc(OCCN2CCCCC2)cc3
NCGC00181007-01,tox21-er-bla-agonist-p2,Cefoselis sulfate,activity,inactive,122841-12-7,44151582.0,O=S(=O)(O)O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(C[n+]2ccc(N)n2CCO)CS[C@@H]34)C([O-])=O
NCGC00255623-01,tox21-er-bla-agonist-p2,1-Ethoxy-2-propanol,activity,inactive,1569-02-4,15287.0,CC(O)COCC
NCGC00255804-01,tox21-er-bla-agonist-p2,"2-Chloro-N,N-dimethyl-3-oxobutanamide",activity,inactive,5810-11-7,93011.0,O=C(C)C(Cl)C(=O)N(C)C
NCGC00254621-01,tox21-er-bla-agonist-p2,Fluometuron,activity,inactive,2164-17-2,16562.0,O=C(Nc1cc(ccc1)C(F)(F)F)N(C)C
NCGC00255086-01,tox21-er-bla-agonist-p2,"3,4-Dihydro-2H-pyran",activity,inactive,110-87-2,8080.0,C1=CCCCO1
NCGC00256244-01,tox21-er-bla-agonist-p2,Butyl 3-mercaptopropionate,activity,inactive,16215-21-7,85335.0,CCCCOC(=O)CCS
NCGC00256431-01,tox21-er-bla-agonist-p2,Tricaprylin,activity,inactive,538-23-8,10850.0,O=C(CCCCCCC)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC
NCGC00254387-01,tox21-er-bla-agonist-p2,CI-1044,activity,inactive,NOCAS_47291,9843744.0,Nc2cc3C(=N[C@@H](NC(=O)c1cccnc1)C(=O)N4CCc(c2)c34)c5ccccc5
NCGC00254421-01,tox21-er-bla-agonist-p2,PD 0200347,activity,inactive,NOCAS_47292,10198808.0,Cl.NCC1(CCCCC1)CC=2NC(=O)ON=2
NCGC00254496-01,tox21-er-bla-agonist-p2,"2',3'-Dideoxyinosine",activity,inactive,69655-05-6,50599.0,O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1
NCGC00254606-01,tox21-er-bla-agonist-p2,Pyraflufen-ethyl,activity,inactive,129630-19-9,182951.0,Cn2nc(c1cc(OCC(=O)OCC)c(Cl)cc1F)c(Cl)c2OC(F)F
NCGC00255077-01,tox21-er-bla-agonist-p2,Prochloraz,activity,inactive,67747-09-5,73665.0,O=C(N(CCOc1c(Cl)cc(Cl)cc1Cl)CCC)n2ccnc2
NCGC00255323-01,tox21-er-bla-agonist-p2,Methyl trans-styryl ketone,activity,inactive,1896-62-4,637759.0,CC(=O)/C=C/c1ccccc1
NCGC00255371-01,tox21-er-bla-agonist-p2,FD&C Red 3,activity,inactive,16423-68-0,27872.0,[Na+].[Na+].[O-]C(=O)c4ccccc4C=2c3cc(I)c([O-])c(I)c3OC=1C=2C=C(I)C(=O)C=1I
NCGC00015716-05,tox21-er-bla-agonist-p2,Nylidrin,activity,inactive,447-41-6,4567.0,OC(c1ccc(O)cc1)C(C)NC(C)CCc2ccccc2
NCGC00159404-02,tox21-er-bla-agonist-p2,Sulisobenzone,activity,inactive,4065-45-6,19988.0,OS(=O)(=O)c1cc(c(O)cc1OC)C(=O)c2ccccc2
NCGC00160662-01,tox21-er-bla-agonist-p2,Ambrisentan,activity,inactive,177036-94-1,6918493.0,O=C(O)[C@@H](Oc1nc(C)cc(C)n1)C(OC)(c2ccccc2)c3ccccc3
NCGC00166248-01,tox21-er-bla-agonist-p2,Acid green 50,activity,inactive,3087-16-9,91525.0,[Na+].C/[N+](C)=C1\C=C\C(C=C1)=C(/c2c3ccc(cc3cc(c2O)S([O-])(=O)=O)S([O-])(=O)=O)c4ccc(cc4)N(C)C
NCGC00167435-01,tox21-er-bla-agonist-p2,Nilvadipine,activity,inactive,75530-68-6,4494.0,CC=1NC(C#N)=C(C(C=1C(=O)OC(C)C)c2cccc(c2)[N+]([O-])=O)C(=O)OC
NCGC00182063-02,tox21-er-bla-agonist-p2,Cadralazine,activity,inactive,64241-34-5,2515.0,O=C(OCC)NNc1ccc(nn1)N(CC(C)O)CC
NCGC00255117-01,tox21-er-bla-agonist-p2,Palladium(II) chloride,activity,inactive,7647-10-1,24290.0,Cl[Pd]Cl
NCGC00255126-01,tox21-er-bla-agonist-p2,Etoposide,activity,inactive,33419-42-0,5284558.0,COc1cc(cc(OC)c1O)[C@@H]5c2cc7OCOc7cc2C(O[C@@H]3O[C@@H]4CO[C@@H](C)O[C@H]4[C@H](O)[C@H]3O)C6COC(=O)[C@H]56
NCGC00259426-01,tox21-er-bla-agonist-p2,Oxadiazon,activity,inactive,19666-30-9,29732.0,O=C2OC(=NN2c1cc(OC(C)C)c(Cl)cc1Cl)C(C)(C)C
NCGC00260480-01,tox21-er-bla-agonist-p2,C.I. Direct Red 28,activity,inactive,573-58-0,11313.0,[Na+].[Na+].[O-]S(=O)(=O)c5cc(/N=N/c1ccc(cc1)c2ccc(cc2)/N=N/c3cc(c4ccccc4c3N)S([O-])(=O)=O)c(N)c6ccccc56
NCGC00013272-01,tox21-er-bla-agonist-p2,Cresol,activity,inactive,1319-77-3,2879.0,Cc1ccc(O)cc1
NCGC00015703-03,tox21-er-bla-agonist-p2,Mecamylamine,activity,inactive,60-40-2,4032.0,CNC2(C)C1CCC(C1)C2(C)C
NCGC00016562-01,tox21-er-bla-agonist-p2,Ethopropazine hydrochloride,activity,inactive,1094-08-2,122824.0,Cl.CCN(CC)C(C)CN1c3ccccc3Sc2ccccc12
NCGC00016798-06,tox21-er-bla-agonist-p2,Timolol,activity,inactive,26839-75-8,33624.0,O[C@H](COc1nsnc1N2CCOCC2)CNC(C)(C)C
NCGC00091104-02,tox21-er-bla-agonist-p2,Aspartame,activity,inactive,22839-47-0,134601.0,O=C(O)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC
NCGC00094199-02,tox21-er-bla-agonist-p2,Nomifensine maleate,activity,inactive,32795-47-4,5358907.0,O=C(O)/C=C\C(=O)O.Nc3cccc1c3CN(C)CC1c2ccccc2
NCGC00241104-01,tox21-er-bla-agonist-p2,Doramapimod,activity,inactive,285983-48-4,156422.0,CC(C)(C)c4cc(NC(=O)Nc3ccc(OCCN1CCOCC1)c2ccccc23)n(n4)c5ccc(C)cc5
NCGC00254327-01,tox21-er-bla-agonist-p2,Hexaflumuron,activity,inactive,86479-06-3,91741.0,Clc1cc(cc(Cl)c1OC(F)(F)C(F)F)NC(=O)NC(=O)c2c(F)cccc2F
NCGC00016964-01,tox21-er-bla-agonist-p2,Lomefloxacin hydrochloride,activity,inactive,98079-52-8,68624.0,Cl.O=C(O)C2=CN(CC)c1c(F)c(c(F)cc1C2=O)N3CC(C)NCC3
NCGC00090692-02,tox21-er-bla-agonist-p2,Dimethyl phthalate,activity,inactive,131-11-3,8554.0,COC(=O)c1ccccc1C(=O)OC
NCGC00017136-01,tox21-er-bla-agonist-p2,Doxazosin mesylate,activity,inactive,77883-43-3,62978.0,CS(=O)(=O)O.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4
NCGC00017245-02,tox21-er-bla-agonist-p2,Ellagic acid,activity,inactive,476-66-4,5281855.0,Oc1c4OC(=O)c2cc(O)c(O)c3OC(=O)c(cc1O)c4c23
NCGC00018230-03,tox21-er-bla-agonist-p2,Dropropizine,activity,inactive,17692-31-8,3169.0,OC(CN1CCN(CC1)c2ccccc2)CO
NCGC00065890-02,tox21-er-bla-agonist-p2,Nevirapine,activity,inactive,129618-40-2,4463.0,O=C3Nc1c(C)ccnc1N(C2CC2)c4ncccc34
NCGC00256800-01,tox21-er-bla-agonist-p2,12-Oxahexadecanolide,activity,inactive,6707-60-4,23173.0,O=C1CCCCCCCCCCOCCCCO1
NCGC00258432-01,tox21-er-bla-agonist-p2,Benzoyl hydrazine,activity,inactive,613-94-5,11955.0,O=C(NN)c1ccccc1
NCGC00257218-01,tox21-er-bla-agonist-p2,"1,2-Dichloro-4-(trifluoromethyl)benzene",activity,inactive,328-84-7,9481.0,Clc1ccc(cc1Cl)C(F)(F)F
NCGC00257335-01,tox21-er-bla-agonist-p2,2-(4-Hydroxybenzyl)phenol,activity,active agonist,2467-03-0,75576.0,Oc2ccccc2Cc1ccc(O)cc1
NCGC00257403-01,tox21-er-bla-agonist-p2,Menthol,activity,inactive,1490-04-6,1254.0,CC(C)C1CCC(C)CC1O
NCGC00257419-01,tox21-er-bla-agonist-p2,Diacetone alcohol,activity,inactive,123-42-2,31256.0,CC(=O)CC(C)(C)O
NCGC00257904-01,tox21-er-bla-agonist-p2,cis-Stilbene,activity,inactive,645-49-8,5356785.0,C(=C\c1ccccc1)\c2ccccc2
NCGC00258096-01,tox21-er-bla-agonist-p2,3-Hydroxybenzophenone,activity,active agonist,13020-57-0,83050.0,O=C(c1cc(O)ccc1)c2ccccc2
NCGC00256492-01,tox21-er-bla-agonist-p2,2-Ethylhexylparaben,activity,active agonist,5153-25-3,107377.0,Oc1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00256519-01,tox21-er-bla-agonist-p2,3-Hydroxy-4-butyrophenetidide,activity,inactive,1083-57-4,14130.0,CCOc1ccc(cc1)NC(=O)CC(C)O
NCGC00255795-01,tox21-er-bla-agonist-p2,2-(tert-Butylamino)ethanol,activity,inactive,4620-70-6,78361.0,CC(C)(C)NCCO
NCGC00255871-01,tox21-er-bla-agonist-p2,"1,2,2,6,6-Pentamethylpiperidin-4-ol",activity,inactive,2403-89-6,75472.0,CC1(C)CC(O)CC(C)(C)N1C
NCGC00256014-01,tox21-er-bla-agonist-p2,"2,2'-[Cyclohexane-1,4-diylbis(methanediyloxymethanediyl)]dioxirane",activity,inactive,14228-73-0,61718.0,C2CC(COCC1CO1)CCC2COCC3CO3
NCGC00256060-01,tox21-er-bla-agonist-p2,N-(Isobutoxymethyl)acrylamide,activity,inactive,16669-59-3,27979.0,CC(C)COCNC(=O)C=C
NCGC00256174-01,tox21-er-bla-agonist-p2,Terpinyl propionate,activity,inactive,80-27-3,62328.0,CCC(=O)OC(C)(C)C1CC=C(C)CC1
NCGC00259139-01,tox21-er-bla-agonist-p2,Furfuryl acetate,activity,inactive,623-17-6,12170.0,O=C(C)OCc1ccco1
NCGC00259777-01,tox21-er-bla-agonist-p2,Isopropalin,activity,inactive,33820-53-0,36606.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCC)CCC)C(C)C
NCGC00260184-01,tox21-er-bla-agonist-p2,"1-Ethyl-2,3-dimethylimidazolium tetrafluoroborate",activity,inactive,307492-75-7,21977262.0,C[n+]1ccn(CC)c1C.F[B-](F)(F)F
NCGC00260285-01,tox21-er-bla-agonist-p2,"2,6-Dimethyl-4-heptanol",activity,inactive,108-82-7,7957.0,CC(C)CC(O)CC(C)C
NCGC00258661-01,tox21-er-bla-agonist-p2,"1,1,1,2-Tetrachloroethane",activity,inactive,630-20-6,12418.0,ClCC(Cl)(Cl)Cl
NCGC00258682-01,tox21-er-bla-agonist-p2,Methyl thioglycolate,activity,inactive,2365-48-2,16907.0,O=C(OC)CS
NCGC00254745-01,tox21-er-bla-agonist-p2,2-Phenoxyethanol,activity,inactive,122-99-6,31236.0,OCCOc1ccccc1
NCGC00255443-01,tox21-er-bla-agonist-p2,"3,3'-Diaminobenzidine",activity,inactive,91-95-2,7071.0,Nc1ccc(cc1N)c2ccc(N)c(N)c2
NCGC00255586-01,tox21-er-bla-agonist-p2,Ethyl benzoate,activity,inactive,93-89-0,7165.0,O=C(OCC)c1ccccc1
NCGC00091119-02,tox21-er-bla-agonist-p2,Oleic acid,activity,inactive,112-80-1,445639.0,O=C(O)CCCCCCC/C=C\CCCCCCCC
NCGC00163219-01,tox21-er-bla-agonist-p2,Carbachol,activity,inactive,51-83-2,5831.0,[Cl-].C[N+](C)(C)CCOC(=O)N
NCGC00167423-01,tox21-er-bla-agonist-p2,Bevonium metilsulfate,activity,inactive,5205-82-3,31799.0,[O-]S(=O)(=O)OC.OC(C(=O)OCC1CCCC[N+]1(C)C)(c2ccccc2)c3ccccc3
NCGC00167461-01,tox21-er-bla-agonist-p2,Bendazac sodium,activity,inactive,23255-99-4,23662369.0,[Na+].[O-]C(=O)COc3nn(Cc1ccccc1)c2ccccc23
NCGC00159482-02,tox21-er-bla-agonist-p2,Levobupivacaine hydrochloride,activity,inactive,27262-48-2,117965.0,Cl.Cc2cccc(C)c2NC(=O)[C@@H]1CCCCN1CCCC
NCGC00094812-01,tox21-er-bla-agonist-p2,Acetarsol,activity,inactive,97-44-9,1985.0,Oc1ccc(cc1NC(C)=O)[As](O)(O)=O
NCGC00159507-02,tox21-er-bla-agonist-p2,Alclofenac,activity,active agonist,22131-79-9,30951.0,Clc1cc(ccc1OCC=C)CC(=O)O
NCGC00094983-01,tox21-er-bla-agonist-p2,Betaine hydrochloride,activity,inactive,590-46-5,11545.0,[Cl-].C[N+](C)(C)CC(=O)O
NCGC00166115-01,tox21-er-bla-agonist-p2,Dibutyltin dilaurate,activity,inactive,77-58-7,16682738.0,O=C(O[Sn](CCCC)(OC(=O)CCCCCCCCCCC)CCCC)CCCCCCCCCCC
NCGC00168749-01,tox21-er-bla-agonist-p2,Difluprednate,activity,inactive,23674-86-4,443936.0,CC(=O)OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00168781-01,tox21-er-bla-agonist-p2,Tadalafil,activity,inactive,171596-29-5,110635.0,O=C6N(C)CC(=O)N4[C@@H]6Cc1c5ccccc5nc1[C@H]4c2ccc3OCOc3c2
NCGC00159319-02,tox21-er-bla-agonist-p2,Zonisamide,activity,inactive,68291-97-4,5734.0,NS(=O)(=O)Cc2noc1ccccc12
NCGC00166145-02,tox21-er-bla-agonist-p2,Oxytocin acetate,activity,active agonist,6233-83-6,12004215.0,CC(=O)O.NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]3CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N3
NCGC00160676-01,tox21-er-bla-agonist-p2,Aprofene,activity,inactive,3563-01-7,71128.0,CC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2
NCGC00167580-01,tox21-er-bla-agonist-p2,Coenzyme A trilithium dihydrate,activity,inactive,102778-59-6,24868287.0,[Li+].[Li+].[Li+].O.O.SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP([O-])(=O)OP([O-])(=O)OC[C@H]3O[C@@H](n2cnc1c(N)ncnc12)[C@H](O)[C@@H]3OP([O-])(=O)O
NCGC00091643-08,tox21-er-bla-agonist-p2,2-Mercaptobenzothiazole,activity,inactive,149-30-4,697993.0,Sc1nc2ccccc2s1
NCGC00091645-03,tox21-er-bla-agonist-p2,4-Hydroxy-3-methoxybenzaldehyde,activity,inactive,121-33-5,1183.0,Oc1ccc(cc1OC)C=O
NCGC00091743-01,tox21-er-bla-agonist-p2,Allyl isothiocyanate,activity,inactive,57-06-7,5971.0,C=CC\N=C=S
NCGC00182990-01,tox21-er-bla-agonist-p2,Tandospirone,activity,inactive,87760-53-0,91273.0,O=C4N(CCCCN1CCN(CC1)c2ncccn2)C(=O)[C@@H]5[C@H]3CC[C@H](C3)[C@H]45
NCGC00183865-01,tox21-er-bla-agonist-p2,Flugestone,activity,inactive,337-03-1,3034658.0,CC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)C1(F)[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00254808-01,tox21-er-bla-agonist-p2,Clofentezine,activity,inactive,74115-24-5,73670.0,Clc3ccccc3c1nnc(nn1)c2ccccc2Cl
NCGC00254420-01,tox21-er-bla-agonist-p2,"1,5,9-Cyclododecatriene",activity,inactive,4904-61-4,638081.0,C1C=CCCC=CCCC=CC1
NCGC00258294-01,tox21-er-bla-agonist-p2,"2,2-Dimethylbutanoic acid",activity,inactive,595-37-9,11684.0,CC(C)(CC)C(=O)O
NCGC00258442-01,tox21-er-bla-agonist-p2,"N,N-Diethylbenzene-1,4-diamine",activity,inactive,93-05-0,7120.0,CCN(CC)c1ccc(N)cc1
NCGC00258843-01,tox21-er-bla-agonist-p2,17alpha-Ethinylestradiol,activity,active agonist,57-63-6,5991.0,Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3
NCGC00259134-01,tox21-er-bla-agonist-p2,1-Undecanol,activity,inactive,112-42-5,8184.0,CCCCCCCCCCCO
NCGC00259277-01,tox21-er-bla-agonist-p2,Carvyl acetate,activity,inactive,97-42-7,7335.0,O=C(C)OC1CC(CC=C1C)C(=C)C
NCGC00259360-01,tox21-er-bla-agonist-p2,Phenyl salicylate,activity,inactive,118-55-8,8361.0,Oc2ccccc2C(=O)Oc1ccccc1
NCGC00256651-01,tox21-er-bla-agonist-p2,Sodium valproate,activity,inactive,1069-66-5,16760703.0,[Na+].[O-]C(=O)C(CCC)CCC
NCGC00257747-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, C10-14-alkyl derivs., sodium salts",activity,inactive,69669-44-9,23707968.0,[Na+].O=S([O-])(=O)c1ccc(cc1)C(CC)CCCCCCCCC
NCGC00258091-01,tox21-er-bla-agonist-p2,Tridecanoic acid,activity,inactive,638-53-9,12530.0,O=C(O)CCCCCCCCCCCC
NCGC00258109-01,tox21-er-bla-agonist-p2,Bisphenol E,activity,active agonist,2081-08-5,608116.0,CC(c1ccc(O)cc1)c2ccc(O)cc2
NCGC00013315-01,tox21-er-bla-agonist-p2,Buclizine dihydrochloride,activity,inactive,129-74-8,65463.0,Cl.Cl.CC(C)(C)c1ccc(cc1)CN2CCN(CC2)C(c3ccc(Cl)cc3)c4ccccc4
NCGC00258603-01,tox21-er-bla-agonist-p2,Dibenzyl phosphate,activity,inactive,1623-08-1,74189.0,O=P(O)(OCc1ccccc1)OCc2ccccc2
NCGC00164127-03,tox21-er-bla-agonist-p2,"4-(1,1,3,3-Tetramethylbutyl)phenol",activity,active agonist,140-66-9,8814.0,Oc1ccc(cc1)C(C)(C)CC(C)(C)C
NCGC00254194-01,tox21-er-bla-agonist-p2,SSR103800,activity,inactive,1075752-90-7,60196405.0,Cl.FC(F)(F)c1ccc(Cl)c(c1Cl)C(=O)N[C@@H]([C@@H]3CN2CCC3CC2)c4ccccc4
NCGC00255261-01,tox21-er-bla-agonist-p2,"Phthalic acid, diundecyl ester, branched and linear",activity,inactive,85507-79-5,19283.0,O=C(OCCCCCCCCCCC)c1ccccc1C(=O)OCCCCCCCCCCC
NCGC00255542-01,tox21-er-bla-agonist-p2,Vincamine,activity,inactive,1617-90-9,15376.0,O=C(OC)[C@@]5(O)C[C@@]4(CCCN3CCc2c1ccccc1n5c2[C@@H]34)CC
NCGC00255827-01,tox21-er-bla-agonist-p2,Isocarbophos,activity,inactive,24353-61-5,90479.0,S=P(N)(Oc1ccccc1C(=O)OC(C)C)OC
NCGC00255590-01,tox21-er-bla-agonist-p2,Sodium hexafluorosilicate,activity,inactive,16893-85-9,28127.0,[Na+].[Na+].F[Si-2](F)(F)(F)(F)F
NCGC00256578-01,tox21-er-bla-agonist-p2,Cyclohexanone oxime,activity,inactive,100-64-1,7517.0,O\N=C1/CCCCC1
NCGC00256799-01,tox21-er-bla-agonist-p2,Vanillin isobutyrate,activity,inactive,20665-85-4,539829.0,COc1cc(ccc1OC(=O)C(C)C)C=O
NCGC00256692-01,tox21-er-bla-agonist-p2,"4'-tert-Butyl-2',6'-dimethylacetophenone",activity,inactive,2040-10-0,74879.0,Cc1cc(cc(C)c1C(=O)C)C(C)(C)C
NCGC00257836-01,tox21-er-bla-agonist-p2,Valeronitrile,activity,inactive,110-59-8,8061.0,CCCCC#N
NCGC00257955-01,tox21-er-bla-agonist-p2,"1,1,2-Trichloro-1,2,2-trifluoroethane",activity,inactive,76-13-1,6428.0,ClC(F)(F)C(Cl)(Cl)F
NCGC00257481-01,tox21-er-bla-agonist-p2,Dodecane,activity,inactive,112-40-3,8182.0,CCCCCCCCCCCC
NCGC00257291-01,tox21-er-bla-agonist-p2,Limonene,activity,inactive,138-86-3,22311.0,CC1=CCC(CC1)C(C)=C
NCGC00257556-01,tox21-er-bla-agonist-p2,Thiophene,activity,inactive,110-02-1,8030.0,c1cccs1
NCGC00257368-01,tox21-er-bla-agonist-p2,4-Methoxy-2-methyl-N-phenylaniline,activity,inactive,41317-15-1,162461.0,COc2cc(C)c(Nc1ccccc1)cc2
NCGC00258138-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium hexafluorophosphate",activity,inactive,227617-70-1,11243457.0,CCCCn1cc[n+](C)c1C.F[P-](F)(F)(F)(F)F
NCGC00258241-01,tox21-er-bla-agonist-p2,"2,4,6-Trichloronitrobenzene",activity,inactive,18708-70-8,29228.0,O=[N+]([O-])c1c(Cl)cc(Cl)cc1Cl
NCGC00258387-01,tox21-er-bla-agonist-p2,3-Chlorophenol,activity,inactive,108-43-0,7933.0,Oc1cc(Cl)ccc1
NCGC00258041-01,tox21-er-bla-agonist-p2,Atropine,activity,inactive,51-55-8,174174.0,CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)C(CO)c2ccccc2
NCGC00259527-01,tox21-er-bla-agonist-p2,3-(Methylthio)propanal,activity,inactive,3268-49-3,18635.0,O=CCCSC
NCGC00259404-01,tox21-er-bla-agonist-p2,"2,6-Dinitrotoluene",activity,inactive,606-20-2,11813.0,Cc1c(cccc1[N+](=O)[O-])[N+]([O-])=O
NCGC00259902-01,tox21-er-bla-agonist-p2,Tetranitromethane,activity,inactive,509-14-8,10509.0,O=[N+]([O-])C([N+]([O-])=O)([N+](=O)[O-])[N+]([O-])=O
NCGC00259210-01,tox21-er-bla-agonist-p2,"Toluene-2,6-diisocyanate",activity,inactive,91-08-7,7040.0,O=C=N/c1cccc(/N=C=O)c1C
NCGC00260644-01,tox21-er-bla-agonist-p2,NTP Mix85 ER AR1 18-EQC,activity,active agonist,NOCAS_49540,,
NCGC00260294-01,tox21-er-bla-agonist-p2,"Ethanedioic acid, calcium salt (1:1)",activity,inactive,563-72-4,33005.0,[Ca+2].[O-]C(=O)C([O-])=O
NCGC00013260-01,tox21-er-bla-agonist-p2,Yohimbine,activity,inactive,146-48-5,8969.0,O=C(OC)[C@H]2[C@@H](O)CC[C@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23
NCGC00015925-02,tox21-er-bla-agonist-p2,Sulfaphenazole,activity,inactive,526-08-9,5335.0,Nc1ccc(cc1)S(=O)(=O)Nc3ccnn3c2ccccc2
NCGC00016336-01,tox21-er-bla-agonist-p2,Syrosingopine,activity,inactive,84-36-6,6769.0,O=C(OCC)Oc1c(OC)cc(cc1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC
NCGC00016544-01,tox21-er-bla-agonist-p2,Dehydroepiandrosterone acetate,activity,active agonist,853-23-6,14709.0,CC(=O)O[C@H]4CC[C@@]2(C)C(=CC[C@H]1[C@@H]3CCC(=O)[C@@]3(C)CC[C@@H]12)C4
NCGC00016752-01,tox21-er-bla-agonist-p2,Clindamycin hydrochloride,activity,inactive,21462-39-5,16051951.0,Cl.O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O[C@@H]1SC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl
NCGC00016824-01,tox21-er-bla-agonist-p2,Clocortolone pivalate,activity,inactive,34097-16-0,5282493.0,CC(C)(C)C(=O)OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(Cl)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00016667-01,tox21-er-bla-agonist-p2,Benoxinate hydrochloride,activity,inactive,5987-82-6,6420040.0,Cl.CCN(CC)CCOC(=O)c1cc(OCCCC)c(N)cc1
NCGC00255966-01,tox21-er-bla-agonist-p2,Triphenylbismuth,activity,inactive,603-33-8,11774.0,c1ccccc1[Bi](c2ccccc2)c3ccccc3
NCGC00256083-01,tox21-er-bla-agonist-p2,4-(3-Phenylpropyl)pyridine,activity,inactive,2057-49-0,74937.0,C(CCc1ccncc1)c2ccccc2
NCGC00254388-01,tox21-er-bla-agonist-p2,"o,p'-DDT",activity,active agonist,789-02-6,13089.0,Clc2ccccc2C(c1ccc(Cl)cc1)C(Cl)(Cl)Cl
NCGC00016737-01,tox21-er-bla-agonist-p2,Epirizole,activity,inactive,18694-40-1,3242.0,Cc1cc(nc(n1)n2nc(C)cc2OC)OC
NCGC00090827-02,tox21-er-bla-agonist-p2,2-Methoxyphenol,activity,inactive,90-05-1,460.0,Oc1ccccc1OC
NCGC00159451-02,tox21-er-bla-agonist-p2,Tinoridine,activity,inactive,24237-54-5,5480.0,O=C(OCC)c1c2CCN(Cc2sc1N)Cc3ccccc3
NCGC00165971-01,tox21-er-bla-agonist-p2,Perflunafene,activity,inactive,306-94-5,9386.0,FC2(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)C(F)(F)C(F)(F)C2(F)F
NCGC00166015-01,tox21-er-bla-agonist-p2,C.I. Basic Violet 14,activity,inactive,632-99-5,12447.0,Cl.N=C1C=C/C(C=C1)=C(\c2ccc(N)c(C)c2)c3ccc(N)cc3
NCGC00166203-01,tox21-er-bla-agonist-p2,Bromociclen,activity,inactive,1715-40-8,15583.0,ClC2(Cl)C1(Cl)CC(CBr)C2(Cl)C(Cl)=C1Cl
NCGC00182622-02,tox21-er-bla-agonist-p2,Efloxate,activity,inactive,119-41-5,8395.0,O=C(OCC)COc1ccc2c(c1)OC(=CC2=O)c3ccccc3
NCGC00254943-01,tox21-er-bla-agonist-p2,Propyl ether,activity,inactive,111-43-3,8114.0,CCCOCCC
NCGC00255076-01,tox21-er-bla-agonist-p2,"1,2,3,6-Tetrahydrophthalimide",activity,inactive,85-40-5,6808.0,O=C1NC(=O)C2CC=CCC12
NCGC00259647-01,tox21-er-bla-agonist-p2,Prometon,activity,inactive,1610-18-0,4928.0,COc1nc(NC(C)C)nc(NC(C)C)n1
NCGC00260434-01,tox21-er-bla-agonist-p2,Cresyl diphenyl phosphate,activity,inactive,26444-49-5,6528.0,O=P(Oc1ccccc1)(Oc2ccc(C)cc2)Oc3ccccc3
NCGC00260613-01,tox21-er-bla-agonist-p2,NTP Mix16 AR1 8-EQC,activity,inconclusive agonist,NOCAS_49509,,
NCGC00260616-01,tox21-er-bla-agonist-p2,NTP Mix19 AR1 8-EQC,activity,inconclusive agonist,NOCAS_49512,,
NCGC00015064-02,tox21-er-bla-agonist-p2,L-Arginine,activity,inactive,74-79-3,6322.0,N[C@@H](CCCNC(=N)N)C(=O)O
NCGC00015234-11,tox21-er-bla-agonist-p2,Carbamazepine,activity,inactive,298-46-4,2554.0,NC(=O)N2c3ccccc3C=Cc1ccccc12
NCGC00016032-06,tox21-er-bla-agonist-p2,alpha-Lipoic acid,activity,inactive,1077-28-7,864.0,O=C(O)CCCCC1CCSS1
NCGC00159449-03,tox21-er-bla-agonist-p2,Thiphenamil,activity,inactive,82-99-5,11061.0,CCN(CC)CCSC(=O)C(c1ccccc1)c2ccccc2
NCGC00160434-01,tox21-er-bla-agonist-p2,Esaprazole,activity,inactive,64204-55-3,68835.0,O=C(CN1CCNCC1)NC2CCCCC2
NCGC00181169-01,tox21-er-bla-agonist-p2,Pentisomicin,activity,inactive,55870-64-9,60196308.0,N[C@@H]3CC=C(CN)O[C@@H]3O[C@H]2[C@@H](O)[C@@H](O[C@H]1OC[C@@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00182040-01,tox21-er-bla-agonist-p2,Bevantolol hydrochloride,activity,inactive,42864-78-8,39324.0,Cl.COc1cc(ccc1OC)CCNCC(O)COc2cc(C)ccc2
NCGC00183271-01,tox21-er-bla-agonist-p2,Bucillamine,activity,inactive,65002-17-7,656604.0,O=C(N[C@@H](CS)C(=O)O)C(C)(C)S
NCGC00253968-01,tox21-er-bla-agonist-p2,Ethyl butyrate,activity,inactive,105-54-4,7762.0,CCCC(=O)OCC
NCGC00254511-01,tox21-er-bla-agonist-p2,Sodium hexyldecyl sulfate,activity,inactive,1120-01-0,23695542.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCCCCCC
NCGC00090781-02,tox21-er-bla-agonist-p2,Dioctyl phthalate,activity,inactive,117-84-0,8346.0,O=C(OCCCCCCCC)c1ccccc1C(=O)OCCCCCCCC
NCGC00017096-01,tox21-er-bla-agonist-p2,Morantel tartrate,activity,inactive,26155-31-7,60196268.0,Cc2ccsc2\C=C\C1=NCCCN1C.O=C(O)[C@H](O)[C@H](O)C(=O)O
NCGC00025060-04,tox21-er-bla-agonist-p2,Methotrexate,activity,inactive,59-05-2,126941.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)nc(N)nc3N
NCGC00025315-01,tox21-er-bla-agonist-p2,Ipsapirone,activity,inactive,95847-70-4,56971.0,O=C4c1ccccc1S(=O)(=O)N4CCCCN2CCN(CC2)c3ncccn3
NCGC00256830-01,tox21-er-bla-agonist-p2,(3Z)-Hex-3-en-1-yl propanoate,activity,inactive,33467-74-2,5365049.0,O=C(CC)OCC/C=C\CC
NCGC00256895-01,tox21-er-bla-agonist-p2,Octanenitrile,activity,inactive,124-12-9,31286.0,CCCCCCCC#N
NCGC00257006-01,tox21-er-bla-agonist-p2,Azacyclotridecan-2-one,activity,inactive,947-04-6,13690.0,O=C1CCCCCCCCCCCN1
NCGC00257030-01,tox21-er-bla-agonist-p2,Butanal oxime,activity,inactive,110-69-0,8069.0,CCC\C=N/O
NCGC00257211-01,tox21-er-bla-agonist-p2,Triphenylphosphine,activity,inactive,603-35-0,11776.0,c1ccccc1P(c2ccccc2)c3ccccc3
NCGC00257581-01,tox21-er-bla-agonist-p2,1-Chloropropan-2-one,activity,inactive,78-95-5,6571.0,CC(=O)CCl
NCGC00257738-01,tox21-er-bla-agonist-p2,Isobutyl acrylate,activity,inactive,106-63-8,7819.0,C=CC(=O)OCC(C)C
NCGC00257977-01,tox21-er-bla-agonist-p2,Tributylamine,activity,inactive,102-82-9,7622.0,CCCCN(CCCC)CCCC
NCGC00256639-01,tox21-er-bla-agonist-p2,"2,3,5-Trimethylphenol",activity,inactive,697-82-5,12769.0,Cc1cc(C)cc(O)c1C
NCGC00255745-01,tox21-er-bla-agonist-p2,Pyromellitic acid,activity,inactive,89-05-4,6961.0,OC(=O)c1cc(c(cc1C(=O)O)C(=O)O)C(=O)O
NCGC00255858-01,tox21-er-bla-agonist-p2,Flamprop-isopropyl,activity,active agonist,52756-22-6,40520.0,Fc1ccc(cc1Cl)N(C(=O)c2ccccc2)C(C)C(=O)OC(C)C
NCGC00256211-01,tox21-er-bla-agonist-p2,2-(Dimethylamino)-2-methylpropan-1-ol,activity,inactive,7005-47-2,23435.0,CN(C)C(C)(C)CO
NCGC00256213-01,tox21-er-bla-agonist-p2,Todralazine hydrochloride,activity,inactive,3778-76-5,19604.0,Cl.O=C(OCC)NNc2nncc1ccccc12
NCGC00255654-01,tox21-er-bla-agonist-p2,Fluocinolone acetonide,activity,inactive,67-73-2,6215.0,OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00258863-01,tox21-er-bla-agonist-p2,"1,2,4-Trichlorobenzene",activity,inactive,120-82-1,13.0,Clc1cc(Cl)c(Cl)cc1
NCGC00258960-01,tox21-er-bla-agonist-p2,Diazinon,activity,inactive,333-41-5,3017.0,Cc1cc(OP(=S)(OCC)OCC)nc(n1)C(C)C
NCGC00260510-01,tox21-er-bla-agonist-p2,2-Chloroanthraquinone,activity,inactive,131-09-9,8553.0,Clc2ccc3C(=O)c1ccccc1C(=O)c3c2
NCGC00260515-01,tox21-er-bla-agonist-p2,Zirconyl chloride octahydrate,activity,inactive,13520-92-8,159678.0,O.O.O.O.O.O.O.O.Cl[Zr](Cl)=O
NCGC00260583-01,tox21-er-bla-agonist-p2,NTP Mix33 CT1 1-EQP,activity,inactive,NOCAS_49479,,
NCGC00259481-01,tox21-er-bla-agonist-p2,p-Cymene,activity,inactive,99-87-6,7463.0,Cc1ccc(cc1)C(C)C
NCGC00259552-01,tox21-er-bla-agonist-p2,"2-Ethyl-1,3-hexanediol",activity,inactive,94-96-2,7211.0,CCCC(O)C(CC)CO
NCGC00259723-01,tox21-er-bla-agonist-p2,"N,N-Dimethylacetamide",activity,inactive,127-19-5,31374.0,CN(C)C(C)=O
NCGC00259724-01,tox21-er-bla-agonist-p2,Phenethyl anthranilate,activity,inactive,133-18-6,8615.0,Nc2ccccc2C(=O)OCCc1ccccc1
NCGC00259760-01,tox21-er-bla-agonist-p2,N-pentylpentan-1-amine,activity,inactive,2050-92-2,16316.0,CCCCCNCCCCC
NCGC00259845-01,tox21-er-bla-agonist-p2,DINP branched,activity,inactive,68515-48-0,590836.0,CC(C)CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCC(C)C
NCGC00260167-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium trifluoromethanesulfonate,activity,inactive,174899-66-2,2734246.0,CCCCn1cc[n+](C)c1.FC(F)(F)S([O-])(=O)=O
NCGC00254693-01,tox21-er-bla-agonist-p2,"2,3-Butanediol",activity,inactive,513-85-9,262.0,CC(O)C(C)O
NCGC00254750-01,tox21-er-bla-agonist-p2,3-Phenyl-2-propen-1-ol,activity,inactive,104-54-1,308.0,OCC=Cc1ccccc1
NCGC00254871-01,tox21-er-bla-agonist-p2,Omethoate,activity,inactive,1113-02-6,14210.0,COP(=O)(OC)SCC(=O)NC
NCGC00256385-01,tox21-er-bla-agonist-p2,1-Hexanol,activity,inactive,111-27-3,8103.0,CCCCCCO
NCGC00254976-01,tox21-er-bla-agonist-p2,Iminodiacetonitrile,activity,inactive,628-87-5,69413.0,N#CCNCC#N
NCGC00255020-01,tox21-er-bla-agonist-p2,(2-Methylphenoxy)acetic acid,activity,inactive,1878-49-5,74651.0,O=C(O)COc1ccccc1C
NCGC00255203-01,tox21-er-bla-agonist-p2,"2-Butenedioic acid (2Z)-, monomethyl ester",activity,inactive,3052-50-4,5354456.0,O=C(O)/C=C\C(=O)OC
NCGC00255341-01,tox21-er-bla-agonist-p2,"1,3-Cyclopentadiene",activity,inactive,542-92-7,7612.0,C1=CC=CC1
NCGC00255708-01,tox21-er-bla-agonist-p2,Methyl nicotinate,activity,inactive,93-60-7,7151.0,COC(=O)c1cccnc1
NCGC00091819-02,tox21-er-bla-agonist-p2,Benzaldehyde,activity,inactive,100-52-7,240.0,O=Cc1ccccc1
NCGC00166400-01,tox21-er-bla-agonist-p2,Hydroxymethanesulfinic acid monosodium salt dihydrate,activity,inactive,6035-47-8,23677960.0,O.O.[Na]OCS(=O)O
NCGC00167463-01,tox21-er-bla-agonist-p2,Cefmenoxime hydrochloride,activity,inactive,75738-58-8,11954009.0,Cl.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(C(=O)O)=C(CSc2nnnn2C)CS[C@@H]34.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2C)CS[C@@H]34)C(=O)O
NCGC00164378-01,tox21-er-bla-agonist-p2,Cyanamide,activity,inactive,420-04-2,9864.0,N#CN
NCGC00164535-01,tox21-er-bla-agonist-p2,Phenmetrazine hydrochloride,activity,inactive,1707-14-8,92159.0,Cl.CC2NCCOC2c1ccccc1
NCGC00160526-01,tox21-er-bla-agonist-p2,Befuraline,activity,inactive,41717-30-0,68664.0,O=C(c1cc2ccccc2o1)N4CCN(Cc3ccccc3)CC4
NCGC00167536-01,tox21-er-bla-agonist-p2,Tosufloxacin toluenesulfonic acid,activity,inactive,115964-29-9,93858.0,O=S(=O)(O)c1ccc(C)cc1.O=C(O)C2=CN(c1nc(c(F)cc1C2=O)N3CCC(N)C3)c4ccc(F)cc4F
NCGC00159341-04,tox21-er-bla-agonist-p2,Lamivudine,activity,inactive,134678-17-4,73339.0,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)SC2
NCGC00091031-01,tox21-er-bla-agonist-p2,Meprobamate,activity,inactive,57-53-4,4064.0,O=C(N)OCC(C)(COC(=O)N)CCC
NCGC00183008-01,tox21-er-bla-agonist-p2,Israpafant,activity,inactive,117279-73-9,119175.0,CC(C)Cc1ccc(cc1)CCc2cc5c(s2)n3c(C)nnc3C(C)N=C5c4ccccc4Cl
NCGC00183855-01,tox21-er-bla-agonist-p2,Fenclofenac,activity,inactive,34645-84-6,65394.0,Clc2cc(Cl)ccc2Oc1ccccc1CC(=O)O
NCGC00254177-01,tox21-er-bla-agonist-p2,17beta-Estradiol,activity,active agonist,50-28-2,5757.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3
NCGC00255055-01,tox21-er-bla-agonist-p2,"2,5-Dimercapto-1,3,4-thiadiazole",activity,inactive,1072-71-5,2723630.0,Sc1nnc(S)s1
NCGC00254250-01,tox21-er-bla-agonist-p2,PFOS-K,activity,inactive,2795-39-3,23669238.0,[K+].FC(F)(C(F)(F)S([O-])(=O)=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254252-01,tox21-er-bla-agonist-p2,Myrcene,activity,inactive,123-35-3,31253.0,C/C(C)=C\CCC(=C)C=C
NCGC00254769-01,tox21-er-bla-agonist-p2,Iprodione,activity,inactive,36734-19-7,37517.0,O=C2CN(C(=O)NC(C)C)C(=O)N2c1cc(Cl)cc(Cl)c1
NCGC00255308-01,tox21-er-bla-agonist-p2,Polydimethylsiloxane,activity,inactive,9016-00-6,24771.0,C[Si](C)=O
NCGC00254028-01,tox21-er-bla-agonist-p2,Triphenyl phosphite,activity,inactive,101-02-0,7540.0,O(P(Oc1ccccc1)Oc2ccccc2)c3ccccc3
NCGC00254836-01,tox21-er-bla-agonist-p2,"3,7-Dimethyloctane-1,7-diol",activity,inactive,107-74-4,249494.0,OCCC(C)CCCC(C)(C)O
NCGC00255112-01,tox21-er-bla-agonist-p2,"Butanoic acid, 3,3-dimethyl-2-oxo-",activity,inactive,815-17-8,13150.0,CC(C)(C)C(=O)C(=O)O
NCGC00254032-01,tox21-er-bla-agonist-p2,Trelanserin,activity,inactive,189003-92-7,9869105.0,NC(=O)CN2c1cc(F)ccc1C(=CC2=O)CCN3CCN(CC3)c5nccc4sccc45
NCGC00254885-01,tox21-er-bla-agonist-p2,2-Chloro-N-phenylacetamide,activity,inactive,587-65-5,11485.0,O=C(Nc1ccccc1)CCl
NCGC00182973-01,tox21-er-bla-agonist-p2,Chromonar hydrochloride,activity,inactive,655-35-6,9800972.0,Cl.O=C(OCC)COc1ccc2c(c1)OC(=O)C(CCN(CC)CC)=C2C
NCGC00181768-01,tox21-er-bla-agonist-p2,Chlormadinone,activity,inactive,1961-77-9,5284533.0,CC(=O)[C@@]3(O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00181771-01,tox21-er-bla-agonist-p2,Ibutilide fumarate,activity,inactive,122647-32-9,5281065.0,O=S(C)(=O)Nc1ccc(cc1)C(O)CCCN(CC)CCCCCCC.O=C(O)/C=C/C(=O)O.CCN(CCCCCCC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1
NCGC00257820-01,tox21-er-bla-agonist-p2,Benzyl chloride,activity,inactive,100-44-7,7503.0,ClCc1ccccc1
NCGC00258068-01,tox21-er-bla-agonist-p2,Pyrilamine maleate,activity,inactive,59-33-6,5284451.0,O=C(O)/C=C\C(=O)O.COc1ccc(cc1)CN(CCN(C)C)c2ccccn2
NCGC00255777-01,tox21-er-bla-agonist-p2,"Ethane-1,2-diyl bis(sulfanylacetate)",activity,inactive,123-81-9,61059.0,O=C(OCCOC(=O)CS)CS
NCGC00095606-01,tox21-er-bla-agonist-p2,"(2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone",activity,inactive,14073-97-3,26447.0,CC(C)[C@@H]1CC[C@@H](C)CC1=O
NCGC00258719-01,tox21-er-bla-agonist-p2,Azoxybenzene,activity,inactive,495-48-7,10316.0,[O-]/[N+](=N/c1ccccc1)c2ccccc2
NCGC00256102-01,tox21-er-bla-agonist-p2,4-Methoxy-2-nitroaniline,activity,inactive,96-96-8,66793.0,COc1ccc(N)c(c1)[N+]([O-])=O
NCGC00257522-01,tox21-er-bla-agonist-p2,4-Methylumbelliferone,activity,inactive,90-33-5,5280567.0,Oc1ccc2c(c1)OC(=O)C=C2C
NCGC00182069-02,tox21-er-bla-agonist-p2,Glycopyrrolate bromide,activity,inactive,596-51-0,11693.0,[Br-].C[N+]3(C)CCC(OC(=O)C(O)(c1ccccc1)C2CCCC2)C3
NCGC00256670-01,tox21-er-bla-agonist-p2,2-Hydroxyfluorene,activity,active agonist,2443-58-5,75547.0,Oc1ccc2c3ccccc3Cc2c1
NCGC00257327-01,tox21-er-bla-agonist-p2,2-Ethylhexyl nitrate,activity,inactive,27247-96-7,62823.0,O=[N+]([O-])OCC(CCCC)CC
NCGC00256801-01,tox21-er-bla-agonist-p2,3-Phenylpropyl acetate,activity,inactive,122-72-5,31226.0,CC(=O)OCCCc1ccccc1
NCGC00015467-11,tox21-er-bla-agonist-p2,Glybenclamide,activity,inactive,10238-21-8,3488.0,O=C(NC1CCCCC1)NS(=O)(=O)c3ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc3
NCGC00257732-01,tox21-er-bla-agonist-p2,Dimethyl decanedioate,activity,inactive,106-79-6,7829.0,O=C(CCCCCCCCC(=O)OC)OC
NCGC00258851-01,tox21-er-bla-agonist-p2,Methylenebutanedioic acid,activity,inactive,97-65-4,811.0,O=C(O)C(=C)CC(=O)O
NCGC00255445-01,tox21-er-bla-agonist-p2,"2,2-Dimethoxy-1,2-diphenylethanone",activity,active agonist,24650-42-8,90571.0,COC(OC)(C(=O)c1ccccc1)c2ccccc2
NCGC00256586-01,tox21-er-bla-agonist-p2,N-Nitroso-N-methylurea,activity,inactive,684-93-5,12699.0,NC(=O)N(C)N=O
NCGC00256298-01,tox21-er-bla-agonist-p2,Butyl 2-methylbutyrate,activity,inactive,15706-73-7,61812.0,O=C(OCCCC)C(C)CC
NCGC00257058-01,tox21-er-bla-agonist-p2,4-Hydroxybenzoic acid,activity,inactive,99-96-7,135.0,OC(=O)c1ccc(O)cc1
NCGC00257060-01,tox21-er-bla-agonist-p2,Linalool,activity,inactive,78-70-6,6549.0,CC(O)(C=C)CC\C=C(\C)C
NCGC00257823-01,tox21-er-bla-agonist-p2,Thiocarbanilide,activity,inactive,102-08-9,700999.0,S=C(Nc1ccccc1)Nc2ccccc2
NCGC00257906-01,tox21-er-bla-agonist-p2,"1-Fluoro-2,4-dinitrobenzene",activity,inactive,70-34-8,6264.0,Fc1ccc(cc1[N+](=O)[O-])[N+]([O-])=O
NCGC00257466-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium chloride,activity,inactive,479500-35-1,11769095.0,[Cl-].CCCC[N+]1(C)CCCC1
NCGC00257922-01,tox21-er-bla-agonist-p2,3-(Trimethoxysilyl)-N-[3-(trimethoxysilyl)propyl]propan-1-amine,activity,inactive,82985-35-1,157882.0,CO[Si](CCCNCCC[Si](OC)(OC)OC)(OC)OC
NCGC00258524-01,tox21-er-bla-agonist-p2,"1,4-Dioxane",activity,inactive,123-91-1,31275.0,C1COCCO1
NCGC00258742-01,tox21-er-bla-agonist-p2,Trichlorofluoromethane,activity,inactive,75-69-4,6389.0,ClC(Cl)(Cl)F
NCGC00258995-01,tox21-er-bla-agonist-p2,Daidzein,activity,active agonist,486-66-8,5281708.0,Oc1ccc(cc1)C3=COc2cc(O)ccc2C3=O
NCGC00258639-01,tox21-er-bla-agonist-p2,Cyclohexane,activity,inactive,110-82-7,8078.0,C1CCCCC1
NCGC00258854-01,tox21-er-bla-agonist-p2,"3-Hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropanoate",activity,inactive,1115-20-4,14218.0,CC(C)(CO)COC(=O)C(C)(C)CO
NCGC00259501-01,tox21-er-bla-agonist-p2,Triisopropanolamine,activity,inactive,122-20-3,24730.0,CC(O)CN(CC(C)O)CC(O)C
NCGC00259507-01,tox21-er-bla-agonist-p2,"2,3-Dihydro-2,2-dimethyl-7-benzofuranol",activity,inactive,1563-38-8,15278.0,Oc1cccc2CC(C)(C)Oc12
NCGC00260158-01,tox21-er-bla-agonist-p2,Methyldopa,activity,inactive,555-30-6,38853.0,Oc1ccc(C[C@](C)(N)C(=O)O)cc1O
NCGC00259464-01,tox21-er-bla-agonist-p2,Myclobutanil,activity,inactive,88671-89-0,6336.0,Clc1ccc(cc1)C(CCCC)(Cn2cncn2)C#N
NCGC00259672-01,tox21-er-bla-agonist-p2,Dimethoxane,activity,inactive,828-00-2,13232.0,O=C(C)OC1CC(C)OC(C)O1
NCGC00259112-01,tox21-er-bla-agonist-p2,"2,4-D isopropyl ester",activity,inactive,94-11-1,7173.0,Clc1cc(Cl)ccc1OCC(=O)OC(C)C
NCGC00260611-01,tox21-er-bla-agonist-p2,NTP Mix14 AR1 8-EQC,activity,inactive,NOCAS_49507,,
NCGC00015208-09,tox21-er-bla-agonist-p2,"Caffeine, citrated",activity,inactive,69-22-7,6241.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.O=C2c1n(C)cnc1N(C)C(=O)N2C
NCGC00015226-07,tox21-er-bla-agonist-p2,"o,p'-DDD",activity,active agonist,53-19-0,4211.0,Clc2ccccc2C(C(Cl)Cl)c1ccc(Cl)cc1
NCGC00015766-08,tox21-er-bla-agonist-p2,Oxymetazoline,activity,inactive,1491-59-4,4636.0,CC(C)(C)c2cc(C)c(CC1=NCCN1)c(C)c2O
NCGC00093347-02,tox21-er-bla-agonist-p2,Mestranol,activity,active agonist,72-33-3,6291.0,COc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3
NCGC00255722-01,tox21-er-bla-agonist-p2,N-Butyl-p-toluenesulfonamide,activity,inactive,1907-65-9,61285.0,Cc1ccc(cc1)S(=O)(=O)NCCCC
NCGC00255771-01,tox21-er-bla-agonist-p2,"2,4-Diisopropylphenol",activity,inactive,2934-05-6,18048.0,CC(C)c1cc(ccc1O)C(C)C
NCGC00254398-01,tox21-er-bla-agonist-p2,Phenanthrene,activity,inactive,85-01-8,995.0,c2cc3ccc1ccccc1c3cc2
NCGC00254906-01,tox21-er-bla-agonist-p2,Aziprotryne,activity,inactive,4658-28-0,3032472.0,CSc1nc(/N=[N+]=[N-])nc(NC(C)C)n1
NCGC00017366-04,tox21-er-bla-agonist-p2,Pergolide methanesulfonate,activity,inactive,66104-23-2,47812.0,CS(=O)(=O)O.CSC[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CCC)c34
NCGC00021146-06,tox21-er-bla-agonist-p2,Ketanserin,activity,inactive,74050-98-9,3822.0,Fc1ccc(cc1)C(=O)C4CCN(CCN2C(=O)c3ccccc3NC2=O)CC4
NCGC00024379-04,tox21-er-bla-agonist-p2,Emetine,activity,inactive,483-18-1,10219.0,COc4cc5CCN[C@H](C[C@H]1C[C@H]2c3cc(OC)c(OC)cc3CCN2C[C@@H]1CC)c5cc4OC
NCGC00090762-01,tox21-er-bla-agonist-p2,Rifabutin,activity,inactive,72559-06-9,6323490.0,CC(C)CN1CCC3(CC1)NC4=C2NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO[C@@]6(C)Oc5c(C)c(O)c(C2=O)c(C4=N3)c5C6=O
NCGC00095128-01,tox21-er-bla-agonist-p2,Orlistat,activity,inactive,96829-58-2,5284600.0,O=C(O[C@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)CCCCCCCCCCC)C(CC(C)C)NC=O
NCGC00160487-01,tox21-er-bla-agonist-p2,1-Piperidinocyclohexanecarbonitrile,activity,inactive,3867-15-0,62529.0,N#CC1(CCCCC1)N2CCCCC2
NCGC00163335-01,tox21-er-bla-agonist-p2,D-Leucine,activity,inactive,328-38-1,439524.0,CC(C)C[C@@H](N)C(=O)O
NCGC00166307-01,tox21-er-bla-agonist-p2,Ergocalciferol,activity,inactive,50-14-6,5280793.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C
NCGC00259927-01,tox21-er-bla-agonist-p2,Simazine,activity,inactive,122-34-9,5216.0,Clc1nc(NCC)nc(NCC)n1
NCGC00259969-01,tox21-er-bla-agonist-p2,Dihexyl phthalate,activity,inactive,84-75-3,6786.0,O=C(OCCCCCC)c1ccccc1C(=O)OCCCCCC
NCGC00015605-06,tox21-er-bla-agonist-p2,Lamotrigine,activity,inactive,84057-84-1,3878.0,Clc1cccc(c1Cl)c2nnc(N)nc2N
NCGC00159341-03,tox21-er-bla-agonist-p2,Lamivudine,activity,inactive,134678-17-4,73339.0,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)SC2
NCGC00167535-01,tox21-er-bla-agonist-p2,Tenofovir disoproxil fumarate,activity,inactive,202138-50-9,5486830.0,O=C(O)C=CC(=O)O.CC(C)OC(=O)OCOP(=O)(OCOC(=O)OC(C)C)CO[C@H](C)Cn2cnc1c(N)ncnc12
NCGC00167744-01,tox21-er-bla-agonist-p2,Methylperone,activity,inactive,3575-80-2,15387.0,Fc1ccc(cc1)C(=O)CCCN2CCC(C)CC2
NCGC00254004-01,tox21-er-bla-agonist-p2,Carminic acid,activity,inactive,1260-17-9,10255083.0,O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c4c(O)c3C(=O)c2c(C)c(C(=O)O)c(O)cc2C(=O)c3c(O)c4O
NCGC00254103-01,tox21-er-bla-agonist-p2,"3,4-Dichloronitrobenzene",activity,inactive,99-54-7,7443.0,Clc1ccc(cc1Cl)[N+]([O-])=O
NCGC00090771-01,tox21-er-bla-agonist-p2,beta-Cyclodextrin,activity,inactive,7585-39-9,444041.0,OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O
NCGC00016977-01,tox21-er-bla-agonist-p2,Dorzolamide hydrochloride,activity,inactive,130693-82-2,6918132.0,Cl.NS(=O)(=O)c1cc2[C@H](C[C@H](C)S(=O)(=O)c2s1)NCC
NCGC00017147-01,tox21-er-bla-agonist-p2,Cefepime chloride hydrochloride hydrate,activity,inactive,123171-59-5,9571075.0,[Cl-].Cl.O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(C[N+]2(C)CCCC2)CS[C@@H]34)C(=O)O
NCGC00021124-04,tox21-er-bla-agonist-p2,Butetamate,activity,inactive,14007-64-8,27368.0,CCC(C(=O)OCCN(CC)CC)c1ccccc1
NCGC00021151-02,tox21-er-bla-agonist-p2,Xanthinol niacinate,activity,inactive,437-74-1,9912.0,O=C(O)c1cccnc1.OCCN(C)CC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C
NCGC00022715-03,tox21-er-bla-agonist-p2,6-Propyl-2-thiouracil,activity,inactive,51-52-5,657298.0,S=C1NC(CCC)=CC(=O)N1
NCGC00256782-01,tox21-er-bla-agonist-p2,Fenchyl acetate,activity,inactive,13851-11-1,107217.0,CC(=O)OC2C(C)(C)C1CCC2(C)C1
NCGC00256845-01,tox21-er-bla-agonist-p2,Phenethyl tiglate,activity,inactive,55719-85-2,5357002.0,C\C=C(/C)C(=O)OCCc1ccccc1
NCGC00257016-01,tox21-er-bla-agonist-p2,2-Hydroxy-2-methylpropanenitrile,activity,inactive,75-86-5,6406.0,N#CC(C)(C)O
NCGC00257202-01,tox21-er-bla-agonist-p2,"2',3'-Dideoxycytidine",activity,inactive,7481-89-2,24066.0,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
NCGC00257254-01,tox21-er-bla-agonist-p2,Benzylacetone,activity,inactive,2550-26-7,17355.0,CC(=O)CCc1ccccc1
NCGC00257336-01,tox21-er-bla-agonist-p2,4-Butylcyclohexanol,activity,inactive,70568-60-4,4132186.0,OC1CCC(CCCC)CC1
NCGC00257407-01,tox21-er-bla-agonist-p2,Tris(2-chloroisopropyl)phosphate,activity,inactive,13674-84-5,26176.0,ClCC(C)OP(=O)(OC(C)CCl)OC(C)CCl
NCGC00257577-01,tox21-er-bla-agonist-p2,"3,5-Dichloroaniline",activity,inactive,626-43-7,12281.0,Nc1cc(Cl)cc(Cl)c1
NCGC00257602-01,tox21-er-bla-agonist-p2,Phenicarbazide,activity,inactive,103-03-7,61002.0,NC(=O)NNc1ccccc1
NCGC00257642-01,tox21-er-bla-agonist-p2,3-Pentenenitrile,activity,inactive,4635-87-4,20750.0,CC=CCC#N
NCGC00257728-01,tox21-er-bla-agonist-p2,1-Nitro-2-methylnaphthalene,activity,inactive,881-03-8,13432.0,[O-][N+](=O)c2c(C)ccc1ccccc12
NCGC00257748-01,tox21-er-bla-agonist-p2,3-Mercaptopropanoic acid,activity,inactive,107-96-0,6514.0,O=C(O)CCS
NCGC00257953-01,tox21-er-bla-agonist-p2,"1,4-Dichlorobenzene",activity,inactive,106-46-7,4685.0,Clc1ccc(Cl)cc1
NCGC00258016-01,tox21-er-bla-agonist-p2,Diisopropyl adipate,activity,inactive,6938-94-9,23368.0,CC(C)OC(=O)CCCCC(=O)OC(C)C
NCGC00258111-01,tox21-er-bla-agonist-p2,"2,2',6,6'-Tetrachlorobisphenol A",activity,active agonist,79-95-8,6619.0,Clc1cc(cc(Cl)c1O)C(C)(C)c2cc(Cl)c(O)c(Cl)c2
NCGC00258305-01,tox21-er-bla-agonist-p2,2-Chlorobenzotrifluoride,activity,inactive,88-16-4,6921.0,FC(F)(F)c1ccccc1Cl
NCGC00258356-01,tox21-er-bla-agonist-p2,2-Chloroaniline,activity,inactive,95-51-2,7240.0,Nc1ccccc1Cl
NCGC00256659-01,tox21-er-bla-agonist-p2,Iprovalicarb,activity,inactive,140923-17-7,10958189.0,CC(C)[C@H](NC(=O)OC(C)C)C(=O)NC(C)c1ccc(C)cc1
NCGC00256375-01,tox21-er-bla-agonist-p2,"N,N-Dimethylacetamide",activity,inactive,127-19-5,31374.0,CN(C)C(C)=O
NCGC00256497-01,tox21-er-bla-agonist-p2,4-Chlorophenol,activity,inactive,106-48-9,4684.0,Oc1ccc(Cl)cc1
NCGC00255841-01,tox21-er-bla-agonist-p2,Phosfolan,activity,inactive,947-02-4,13689.0,O=P(OCC)(/N=C1\SCCS1)OCC
NCGC00255894-01,tox21-er-bla-agonist-p2,N-methyl-alpha-phenylbenzeneacetamide,activity,inactive,954-21-2,70381.0,O=C(NC)C(c1ccccc1)c2ccccc2
NCGC00255980-01,tox21-er-bla-agonist-p2,Swep,activity,inactive,1918-18-9,15969.0,Clc1ccc(NC(=O)OC)cc1Cl
NCGC00256098-01,tox21-er-bla-agonist-p2,"3-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonic acid",activity,inactive,119-17-5,67060.0,O=S(=O)(O)c1cccc(c1)N2N=C(C)CC2=O
NCGC00256204-01,tox21-er-bla-agonist-p2,alpha-Cedrene,activity,inactive,469-61-4,442348.0,CC1=CC[C@]23CC1C(C)(C)[C@@H]3CC[C@H]2C
NCGC00256311-01,tox21-er-bla-agonist-p2,N-Butylphosphorothioic triamide,activity,inactive,94317-64-3,93502.0,CCCCNP(N)(N)=S
NCGC00256324-01,tox21-er-bla-agonist-p2,2-Methylbutanal,activity,inactive,96-17-3,7284.0,CC(CC)C=O
NCGC00255676-01,tox21-er-bla-agonist-p2,4-Tolyl acetate,activity,inactive,140-39-6,8797.0,O=C(C)Oc1ccc(C)cc1
NCGC00259585-01,tox21-er-bla-agonist-p2,Nitrapyrin,activity,inactive,1929-82-4,16004.0,ClC(Cl)(Cl)c1cccc(Cl)n1
NCGC00260097-01,tox21-er-bla-agonist-p2,Chrysene,activity,inactive,218-01-9,9171.0,c1cc4ccccc4c2ccc3ccccc3c12
NCGC00258740-01,tox21-er-bla-agonist-p2,Bis(2-butyl) ether,activity,inactive,6863-58-7,23294.0,CC(CC)OC(C)CC
NCGC00258751-01,tox21-er-bla-agonist-p2,N-Methyldiethanolamine,activity,inactive,105-59-9,7767.0,OCCN(C)CCO
NCGC00258767-01,tox21-er-bla-agonist-p2,2-Oxobutanedioic acid,activity,inactive,328-42-7,970.0,O=C(O)C(=O)CC(=O)O
NCGC00254630-01,tox21-er-bla-agonist-p2,Clodinafop-propargyl mixt.,activity,inactive,105512-06-9,92431.0,O=C(OCC#C)[C@@H](C)Oc1ccc(cc1)Oc2ncc(Cl)cc2F
NCGC00254795-01,tox21-er-bla-agonist-p2,Benzyl butyrate,activity,inactive,103-37-7,7650.0,CCCC(=O)OCc1ccccc1
NCGC00256374-01,tox21-er-bla-agonist-p2,Acetazolamide,activity,inactive,59-66-5,1986.0,O=S(N)(=O)c1nnc(NC(C)=O)s1
NCGC00254898-01,tox21-er-bla-agonist-p2,Dimethyl maleate,activity,inactive,624-48-6,5271565.0,COC(=O)/C=C\C(=O)OC
NCGC00255238-01,tox21-er-bla-agonist-p2,Tetrapropylammonium bromide,activity,inactive,1941-30-6,74745.0,[Br-].CCC[N+](CCC)(CCC)CCC
NCGC00255589-01,tox21-er-bla-agonist-p2,Butylnaphthalenesulfonic acid sodium salt,activity,inactive,25638-17-9,60196422.0,[Na+].[O-]S(=O)(=O)c2cccc1ccc(cc12)CCCC
NCGC00255874-01,tox21-er-bla-agonist-p2,Monopotassium phthalate,activity,inactive,877-24-7,23676735.0,[K+].OC(=O)c1ccccc1C([O-])=O
NCGC00094108-02,tox21-er-bla-agonist-p2,Methoxamine hydrochloride,activity,inactive,61-16-5,6081.0,Cl.COc1ccc(cc1C(O)C(C)N)OC
NCGC00159410-04,tox21-er-bla-agonist-p2,D-Galactitol,activity,inactive,608-66-2,11850.0,O[C@H]([C@@H](O)CO)[C@@H](O)[C@H](O)CO
NCGC00094280-01,tox21-er-bla-agonist-p2,Quazinone,activity,inactive,70018-51-8,6603980.0,C[C@@H]1C(=O)N=C2Nc3cccc(Cl)c3CN12
NCGC00159442-02,tox21-er-bla-agonist-p2,Galactose,activity,inactive,59-23-4,6036.0,O[C@H]1[C@@H](O)[C@@H](CO)OC(O)[C@@H]1O
NCGC00163724-03,tox21-er-bla-agonist-p2,Methidathion,activity,inactive,950-37-8,13709.0,O=C1SC(=NN1CSP(=S)(OC)OC)OC
NCGC00164086-01,tox21-er-bla-agonist-p2,Hexamethyldisiloxane,activity,inactive,107-46-0,24764.0,C[Si](C)(C)O[Si](C)(C)C
NCGC00164256-01,tox21-er-bla-agonist-p2,Monocrotaline,activity,inactive,315-22-0,9415.0,O=C1OCC3=CCN2CC[C@@H](OC(=O)[C@H](C)[C@@](C)(O)[C@@]1(C)O)[C@H]23
NCGC00181020-01,tox21-er-bla-agonist-p2,Zeaxanthin,activity,inactive,144-68-3,5280899.0,CC2(C)C[C@H](O)CC(C)=C2/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C
NCGC00094820-01,tox21-er-bla-agonist-p2,Iproniazid sulfate,activity,active agonist,36504-56-0,5702132.0,O=C(NNC(C)C)c1ccncc1.O=S(=O)(O)O
NCGC00167982-01,tox21-er-bla-agonist-p2,Pirarubicin,activity,active agonist,72496-41-4,11296583.0,OCC(=O)[C@]4(O)Cc3c(c(O)c2C(=O)c1c(OC)cccc1C(=O)c2c3O)[C@H](C4)O[C@H]6C[C@H](N)[C@H](O[C@@H]5CCCCO5)[C@H](C)O6
NCGC00095007-01,tox21-er-bla-agonist-p2,Ceftriaxone disodium trihydrate,activity,inactive,104376-79-6,60196280.0,[Na+].[Na+].O.O.O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSC2=NC(=O)C([O-])=NN2C)CS[C@@H]34)C([O-])=O
NCGC00164548-01,tox21-er-bla-agonist-p2,Danofloxacin,activity,inactive,112398-08-0,71335.0,CN5C[C@@H]4C[C@H]5CN4c1cc2N(C=C(C(=O)O)C(=O)c2cc1F)C3CC3
NCGC00164588-01,tox21-er-bla-agonist-p2,Malotilate,activity,inactive,59937-28-9,4006.0,CC(C)OC(=O)C(/C(=O)OC(C)C)=C1/SC=CS1
NCGC00095162-01,tox21-er-bla-agonist-p2,Tylosin tartrate,activity,inactive,74610-55-2,60196281.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN(C)[C@@H]2[C@@H](O)[C@@H](O[C@H](C)[C@H]2O[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1)O[C@H]4[C@@H](CC=O)C[C@@H](C)C(=O)C=CC(C)=C[C@H](CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]4C
NCGC00160542-01,tox21-er-bla-agonist-p2,Lifibrate,activity,inactive,22204-91-7,31060.0,CN3CCC(OC(=O)C(Oc1ccc(Cl)cc1)Oc2ccc(Cl)cc2)CC3
NCGC00095276-01,tox21-er-bla-agonist-p2,Dibekacin,activity,inactive,34493-98-6,470999.0,N[C@@H]3CC[C@@H](CN)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00165968-01,tox21-er-bla-agonist-p2,Reparixin,activity,inactive,266359-83-5,9838712.0,C[C@@H](C(=O)NS(C)(=O)=O)c1ccc(CC(C)C)cc1
NCGC00095905-01,tox21-er-bla-agonist-p2,Trichlomethine,activity,inactive,555-77-1,5561.0,ClCCN(CCCl)CCCl
NCGC00160617-01,tox21-er-bla-agonist-p2,Cocarboxylase chloride,activity,inactive,154-87-0,9068.0,[Cl-].O=P(O)(O)OP(=O)(O)OCCc2sc[n+](Cc1cnc(C)nc1N)c2C
NCGC00159316-02,tox21-er-bla-agonist-p2,Dexamethasone valerate,activity,inactive,33755-46-3,63047.0,OCC(=O)[C@@]4(OC(=O)CCCC)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00159318-02,tox21-er-bla-agonist-p2,Chlordiazepoxide,activity,inactive,58-25-3,2712.0,Clc1ccc2N=C(C[N+]([O-])=C(c2c1)c3ccccc3)NC
NCGC00159323-02,tox21-er-bla-agonist-p2,Oxazepam,activity,inactive,604-75-1,4616.0,Clc1ccc2NC(=O)C(O)N=C(c2c1)c3ccccc3
NCGC00166169-01,tox21-er-bla-agonist-p2,Imidacloprid,activity,inactive,138261-41-3,86418.0,[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1
NCGC00166217-01,tox21-er-bla-agonist-p2,1-Bromoheptadecafluorooctane,activity,inactive,423-55-2,9873.0,FC(F)(C(F)(F)C(Br)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00159372-02,tox21-er-bla-agonist-p2,Butanedioic acid,activity,inactive,110-15-6,1110.0,O=C(O)CCC(=O)O
NCGC00159388-02,tox21-er-bla-agonist-p2,Pentaerythritol tetranitrate,activity,inactive,78-11-5,6518.0,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+]([O-])=O)CO[N+]([O-])=O
NCGC00254184-01,tox21-er-bla-agonist-p2,Bisphenol B,activity,active agonist,77-40-7,66166.0,Oc1ccc(cc1)C(C)(CC)c2ccc(O)cc2
NCGC00254286-01,tox21-er-bla-agonist-p2,1-Hexadecanol,activity,inactive,36653-82-4,2682.0,CCCCCCCCCCCCCCCCO
NCGC00255165-01,tox21-er-bla-agonist-p2,Methoxyphenylacetic acid,activity,inactive,1701-77-5,107202.0,COC(C(=O)O)c1ccccc1
NCGC00253931-01,tox21-er-bla-agonist-p2,SSR162369,activity,inactive,NOCAS_47346,9842616.0,FC1(F)C[C@@H](C#N)N(C1)C(=O)CNC2CC4CCC(C2)N4c3ncccn3
NCGC00254016-01,tox21-er-bla-agonist-p2,"3,3'-Dimethoxybenzidine dihydrochloride",activity,inactive,20325-40-0,62311.0,Cl.Cl.Nc1ccc(cc1OC)c2ccc(N)c(OC)c2
NCGC00255246-01,tox21-er-bla-agonist-p2,Metconazole,activity,inactive,125116-23-6,86210.0,Clc1ccc(cc1)CC3CCC(C)(C)C3(O)Cn2cncn2
NCGC00182074-02,tox21-er-bla-agonist-p2,Nicomolol,activity,inactive,27959-26-8,34081.0,O=C(OCC4(COC(=O)c1cccnc1)CCCC(COC(=O)c2cccnc2)(COC(=O)c3cccnc3)C4O)c5cccnc5
NCGC00257934-01,tox21-er-bla-agonist-p2,"2,4-Dimethylaniline",activity,inactive,95-68-1,7250.0,Cc1ccc(N)c(C)c1
NCGC00260641-01,tox21-er-bla-agonist-p2,NTP Mix82 ER AR1 18-EQC,activity,active agonist,NOCAS_49537,,
NCGC00255596-01,tox21-er-bla-agonist-p2,"2,4-D-isobutyl",activity,inactive,1713-15-1,15580.0,Clc1cc(Cl)ccc1OCC(=O)OCC(C)C
NCGC00160583-01,tox21-er-bla-agonist-p2,"1,3,5-Triazine-2,4-diamine, N2-(4-chlorophenyl)-",activity,inactive,500-42-5,10374.0,Clc1ccc(cc1)Nc2ncnc(N)n2
NCGC00258875-01,tox21-er-bla-agonist-p2,"1,4-Diazabicyclo[2.2.2]octane",activity,inactive,280-57-9,9237.0,C1CN2CCN1CC2
NCGC00258150-01,tox21-er-bla-agonist-p2,1-Dodecyl-3-methylimidazolium hexafluorophosphate,activity,inactive,219947-93-0,10250129.0,F[P-](F)(F)(F)(F)F.C[n+]1ccn(CCCCCCCCCCCC)c1
NCGC00167584-01,tox21-er-bla-agonist-p2,Nicametate citrate,activity,inactive,1641-74-3,92897.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CC)CCOC(=O)c1cccnc1
NCGC00255811-01,tox21-er-bla-agonist-p2,"1,3,5-Benzenetricarbonyl trichloride",activity,inactive,4422-95-1,78138.0,O=C(Cl)c1cc(cc(c1)C(Cl)=O)C(Cl)=O
NCGC00256041-01,tox21-er-bla-agonist-p2,"1H-Isoindole-1,3(2H)-diimine",activity,inactive,3468-11-9,18980.0,N=C1NC(=N)c2ccccc12
NCGC00259718-01,tox21-er-bla-agonist-p2,Flutamide,activity,inactive,13311-84-7,3397.0,O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C
NCGC00259925-01,tox21-er-bla-agonist-p2,"2,3',4,4'-Tetrahydroxybenzophenone",activity,active agonist,61445-50-9,12472902.0,Oc1ccc(cc1O)C(=O)c2ccc(O)cc2O
NCGC00164388-01,tox21-er-bla-agonist-p2,Imidazolidinyl urea,activity,inactive,39236-46-9,38258.0,OCN2C(=O)NC(=O)C2NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO
NCGC00256662-01,tox21-er-bla-agonist-p2,2-Thienyl disulfide,activity,inactive,6911-51-9,23347.0,s1cccc1SSc2cccs2
NCGC00257178-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) phosphate,activity,inactive,298-07-7,9275.0,CCCCC(COP(O)(=O)OCC(CC)CCCC)CC
NCGC00256615-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-5-nitroimidazole",activity,inactive,551-92-8,3090.0,O=[N+]([O-])c1cnc(C)n1C
NCGC00256881-01,tox21-er-bla-agonist-p2,Benzyl tiglate,activity,inactive,37526-88-8,250096.0,C\C=C(/C)C(=O)OCc1ccccc1
NCGC00257621-01,tox21-er-bla-agonist-p2,Isoprene,activity,inactive,78-79-5,6557.0,C=C(C)C=C
NCGC00259596-01,tox21-er-bla-agonist-p2,Propylene carbonate,activity,inactive,108-32-7,7924.0,O=C1OCC(C)O1
NCGC00257226-01,tox21-er-bla-agonist-p2,Ethyl anthranilate,activity,inactive,87-25-2,6877.0,Nc1ccccc1C(=O)OCC
NCGC00260526-01,tox21-er-bla-agonist-p2,tert-Butylphenyl diphenyl phosphate,activity,inactive,56803-37-3,70425.0,CC(C)(C)c3ccc(OP(=O)(Oc1ccccc1)Oc2ccccc2)cc3
NCGC00259064-01,tox21-er-bla-agonist-p2,Triisopropyl orthoborate,activity,inactive,5419-55-6,21531.0,CC(C)OB(OC(C)C)OC(C)C
NCGC00255512-01,tox21-er-bla-agonist-p2,Binapacryl,activity,inactive,485-31-4,10234.0,O=C(Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(C)CC)\C=C(/C)C
NCGC00255763-01,tox21-er-bla-agonist-p2,"Disodium 3-hydroxynaphthalene-2,7-disulfonate",activity,inactive,135-51-3,8673.0,[Na+].[Na+].[O-]S(=O)(=O)c1cc2cc(c(O)cc2cc1)S([O-])(=O)=O
NCGC00255920-01,tox21-er-bla-agonist-p2,"N,N-Diisopropylaniline",activity,inactive,4107-98-6,61329.0,CC(C)N(C(C)C)c1ccccc1
NCGC00257233-01,tox21-er-bla-agonist-p2,Oleic acid,activity,inactive,112-80-1,445639.0,O=C(O)CCCCCCC/C=C\CCCCCCCC
NCGC00257523-01,tox21-er-bla-agonist-p2,Chlorotoluene,activity,inactive,25168-05-2,7931.0,Cc1cc(Cl)ccc1
NCGC00257736-01,tox21-er-bla-agonist-p2,Fluoxetine hydrochloride,activity,inactive,56296-78-7,62857.0,Cl.FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2
NCGC00257936-01,tox21-er-bla-agonist-p2,"1,2-Dibromo-3-chloropropane",activity,inactive,96-12-8,7280.0,BrC(CBr)CCl
NCGC00257895-01,tox21-er-bla-agonist-p2,8-Methylquinoline,activity,inactive,611-32-5,11910.0,Cc1cccc2cccnc12
NCGC00257361-01,tox21-er-bla-agonist-p2,Acesulfame potassium,activity,inactive,55589-62-3,11074431.0,[K+].CC1=CC(=O)[N-]S(=O)(=O)O1
NCGC00258584-01,tox21-er-bla-agonist-p2,Undecanoic acid,activity,inactive,112-37-8,8180.0,O=C(O)CCCCCCCCCC
NCGC00258592-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium trifluoromethanesulfonate,activity,inactive,145022-44-2,2758874.0,C[n+]1ccn(CC)c1.FC(F)(F)S([O-])(=O)=O
NCGC00258402-01,tox21-er-bla-agonist-p2,Triprolidine hydrochloride monohydrate,activity,inactive,6138-79-0,5284472.0,Cl.O.Cc1ccc(cc1)C(=C\CN2CCCC2)/c3ccccn3
NCGC00258625-01,tox21-er-bla-agonist-p2,Benzyl chloroformate,activity,inactive,501-53-1,10387.0,ClC(=O)OCc1ccccc1
NCGC00258634-01,tox21-er-bla-agonist-p2,1-Methoxy-4-methylbenzene,activity,inactive,104-93-8,7731.0,Cc1ccc(OC)cc1
NCGC00259133-01,tox21-er-bla-agonist-p2,"2,6-Di-tert-butyl-4-ethylphenol",activity,inactive,4130-42-1,20087.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC
NCGC00259516-01,tox21-er-bla-agonist-p2,Oleic acid,activity,inactive,112-80-1,445639.0,O=C(O)CCCCCCC/C=C\CCCCCCCC
NCGC00259597-01,tox21-er-bla-agonist-p2,3-(Dimethylamino)propylamine,activity,inactive,109-55-7,7993.0,NCCCN(C)C
NCGC00259989-01,tox21-er-bla-agonist-p2,Triethylene glycol,activity,inactive,112-27-6,8172.0,OCCOCCOCCO
NCGC00259414-01,tox21-er-bla-agonist-p2,Manganese(II) acetate,activity,inactive,638-38-0,12525.0,[Mn+2].[O-]C(C)=O.[O-]C(C)=O
NCGC00260278-01,tox21-er-bla-agonist-p2,Hydroxylamine sulfate (2:1),activity,inactive,10039-54-0,24846.0,[NH3+]O.[NH3+]O.[O-]S([O-])(=O)=O
NCGC00260421-01,tox21-er-bla-agonist-p2,"2,4-dinitro Benzenesulfonic acid dihydrate",activity,inactive,89-02-1,2724588.0,O.O.OS(=O)(=O)c1ccc(cc1[N+]([O-])=O)[N+]([O-])=O
NCGC00260659-01,tox21-er-bla-agonist-p2,NTP Mix25 AR2 2-EQP,activity,inactive,NOCAS_49555,,
NCGC00260545-01,tox21-er-bla-agonist-p2,Dicyclohexylcarbodiimide,activity,inactive,538-75-0,10868.0,N(=C=N\C1CCCCC1)\C2CCCCC2
NCGC00260192-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium tetrafluoroborate,activity,inactive,143314-16-3,2769348.0,F[B-](F)(F)F.C[n+]1ccn(CC)c1
NCGC00015246-02,tox21-er-bla-agonist-p2,Cinnarizine,activity,inactive,298-57-7,1547484.0,c1ccccc1C(c2ccccc2)N3CCN(CC3)C/C=C/c4ccccc4
NCGC00015443-06,tox21-er-bla-agonist-p2,Flecainide,activity,inactive,54143-55-4,3356.0,FC(F)(F)COc2cc(C(=O)NCC1CCCCN1)c(OCC(F)(F)F)cc2
NCGC00015067-04,tox21-er-bla-agonist-p2,Aspirin,activity,inactive,50-78-2,2244.0,O=C(C)Oc1ccccc1C(=O)O
NCGC00016353-03,tox21-er-bla-agonist-p2,Butyl 4-aminobenzoate,activity,inactive,94-25-7,2482.0,Nc1ccc(cc1)C(=O)OCCCC
NCGC00094949-01,tox21-er-bla-agonist-p2,Fosfomycin calcium,activity,inactive,26016-98-8,93095.0,[Ca+2].[O-]P([O-])(=O)[C@H]1O[C@H]1C
NCGC00159490-02,tox21-er-bla-agonist-p2,Oxytetracycline dihydrate,activity,inactive,6153-64-6,54680691.0,O.O.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@@](C)(O)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00186050-01,tox21-er-bla-agonist-p2,Ziprasidone,activity,inactive,146939-27-7,60854.0,O=C4Cc5cc(CCN1CCN(CC1)c3nsc2ccccc23)c(Cl)cc5N4
NCGC00255703-01,tox21-er-bla-agonist-p2,"1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo, sodium salt",activity,inactive,2657-00-3,75868.0,[Na+].[O-]S(=O)(=O)c2cccc1c2C=C\C(=[N+]=[N-])C1=O
NCGC00255873-01,tox21-er-bla-agonist-p2,Pirimiphos-ethyl,activity,inactive,23505-41-1,31957.0,CCN(CC)c1nc(C)cc(OP(=S)(OCC)OCC)n1
NCGC00255975-01,tox21-er-bla-agonist-p2,Lauryl thiocyanate,activity,inactive,765-15-1,69827.0,N#CSCCCCCCCCCCCC
NCGC00256046-01,tox21-er-bla-agonist-p2,Ocimene,activity,inactive,NOCAS_47051,18756.0,C=CC(C)=CC\C=C(\C)C
NCGC00254751-01,tox21-er-bla-agonist-p2,Propanil,activity,inactive,709-98-8,4933.0,Clc1ccc(NC(=O)CC)cc1Cl
NCGC00254805-01,tox21-er-bla-agonist-p2,Imazapic,activity,inactive,104098-48-8,91770.0,O=C1N=C(NC1(C)C(C)C)c2ncc(C)cc2C(=O)O
NCGC00254840-01,tox21-er-bla-agonist-p2,"1,4-Butanediol diacrylate",activity,inactive,1070-70-8,70613.0,O=C(OCCCCOC(=O)C=C)C=C
NCGC00255034-01,tox21-er-bla-agonist-p2,Myclobutanil,activity,inactive,88671-89-0,6336.0,Clc1ccc(cc1)C(CCCC)(Cn2cncn2)C#N
NCGC00256256-01,tox21-er-bla-agonist-p2,"1,1-Dimethoxy-3,7-dimethylocta-2,6-diene",activity,inactive,7549-37-3,24191.0,COC(C=C(C)CC\C=C(/C)C)OC
NCGC00254386-01,tox21-er-bla-agonist-p2,"Sorbitan, mono-(9Z)-9-octadecenoate",activity,inactive,1338-43-8,9920342.0,O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O
NCGC00254997-01,tox21-er-bla-agonist-p2,"2,4-DB-sodium",activity,inactive,10433-59-7,23700088.0,[Na+].Clc1cc(Cl)ccc1OCCCC([O-])=O
NCGC00255226-01,tox21-er-bla-agonist-p2,Isofenphos,activity,inactive,25311-71-1,32872.0,S=P(Oc1ccccc1C(=O)OC(C)C)(NC(C)C)OCC
NCGC00025247-01,tox21-er-bla-agonist-p2,Salmeterol,activity,inactive,89365-50-4,5152.0,OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2
NCGC00091278-03,tox21-er-bla-agonist-p2,"2-Nitro-1,4-phenylenediamine",activity,inactive,5307-14-2,4338370.0,O=[N+]([O-])c1cc(N)ccc1N
NCGC00091643-07,tox21-er-bla-agonist-p2,2-Mercaptobenzothiazole,activity,inactive,149-30-4,697993.0,Sc1nc2ccccc2s1
NCGC00091861-01,tox21-er-bla-agonist-p2,Dacarbazine,activity,inactive,4342-03-4,5281007.0,CN(C)/N=N/c1ncnc1C(N)=O
NCGC00162068-04,tox21-er-bla-agonist-p2,Opipramol dihydrochloride,activity,inactive,909-39-7,71587.0,Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23
NCGC00163450-02,tox21-er-bla-agonist-p2,Ilomastat,activity,inactive,142880-36-2,132519.0,ONC(=O)C[C@@H](CC(C)C)C(=O)N[C@@H](Cc2cnc1ccccc12)C(=O)NC
NCGC00165999-01,tox21-er-bla-agonist-p2,Cyclamic acid,activity,inactive,100-88-9,7533.0,OS(=O)(=O)NC1CCCCC1
NCGC00183597-01,tox21-er-bla-agonist-p2,Betamethasone butyrate propionate,activity,inactive,5534-02-1,71470.0,CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00259528-01,tox21-er-bla-agonist-p2,Carminic acid,activity,inactive,1260-17-9,10255083.0,O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c4c(O)c3C(=O)c2c(C)c(C(=O)O)c(O)cc2C(=O)c3c(O)c4O
NCGC00260323-01,tox21-er-bla-agonist-p2,"Carbonic acid, strontium salt (1:1)",activity,inactive,1633-05-2,15407.0,[Sr+2].[O-]C([O-])=O
NCGC00016946-01,tox21-er-bla-agonist-p2,Alfuzosin hydrochloride,activity,inactive,81403-68-1,71764.0,Cl.O=C(NCCCN(C)c2nc1cc(OC)c(OC)cc1c(N)n2)C3CCCO3
NCGC00016960-03,tox21-er-bla-agonist-p2,Glimepiride,activity,inactive,93479-97-1,3476.0,CC=3CN(C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C(=O)C=3CC
NCGC00024563-02,tox21-er-bla-agonist-p2,Azasetron,activity,inactive,123040-69-7,2264.0,Clc1cc(c2OCC(=O)N(C)c2c1)C(=O)NC4CN3CCC4CC3
NCGC00091396-02,tox21-er-bla-agonist-p2,Benzoin,activity,inactive,119-53-9,8400.0,OC(C(=O)c1ccccc1)c2ccccc2
NCGC00167433-01,tox21-er-bla-agonist-p2,Rocuronium bromide,activity,inactive,119302-91-9,441351.0,[Br-].C=CC[N+]1(CCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](O)[C@H](C[C@]23C)N4CCOCC4)[C@H]6OC(C)=O
NCGC00182061-02,tox21-er-bla-agonist-p2,Bamifylline Hydrochloride,activity,inactive,20684-06-4,68549.0,Cl.CCN(CCO)CCn2c3C(=O)N(C)C(=O)N(C)c3nc2Cc1ccccc1
NCGC00247691-01,tox21-er-bla-agonist-p2,"(-)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",activity,inactive,42011-76-7,60196320.0,Cl.COc1cc(CC)c(cc1C[C@@H](C)N)OC
NCGC00254465-01,tox21-er-bla-agonist-p2,Butyryl trihexyl citrate,activity,inactive,82469-79-2,133914.0,O=C(OCCCCCC)C(CC(=O)OCCCCCC)(CC(=O)OCCCCCC)OC(=O)CCC
NCGC00016926-01,tox21-er-bla-agonist-p2,Prednicarbate,activity,inactive,73771-04-7,6714002.0,CCC(=O)OCC(=O)[C@@]4(OC(=O)OCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00017005-01,tox21-er-bla-agonist-p2,Tocainide hydrochloride,activity,inactive,35891-93-1,108173.0,Cl.O=C(Nc1c(C)cccc1C)C(C)N
NCGC00018938-03,tox21-er-bla-agonist-p2,Dazoxiben,activity,inactive,78218-09-4,53001.0,O=C(O)c2ccc(OCCn1ccnc1)cc2
NCGC00024607-01,tox21-er-bla-agonist-p2,"2,4-Diamino-6-hydroxypyrimidine",activity,inactive,56-06-4,2944.0,NC1=CC(=O)N=C(N)N1
NCGC00024780-04,tox21-er-bla-agonist-p2,Tilarginine acetate,activity,inactive,53308-83-1,135242.0,N[C@@H](CCCNC(=N)NC)C(=O)O.CC(=O)O
NCGC00258477-01,tox21-er-bla-agonist-p2,Bromodichloroacetic acid,activity,inactive,71133-14-7,114809.0,BrC(Cl)(Cl)C(=O)O
NCGC00258568-01,tox21-er-bla-agonist-p2,"1,5-Cyclooctadiene",activity,inactive,111-78-4,82916.0,C1=CCCC=CCC1
NCGC00257256-01,tox21-er-bla-agonist-p2,Tetrahydrofurfuryl alcohol,activity,inactive,97-99-4,7360.0,OCC1CCCO1
NCGC00257687-01,tox21-er-bla-agonist-p2,"1,2-Diformylhydrazine",activity,inactive,628-36-4,12342.0,O=CNNC=O
NCGC00257812-01,tox21-er-bla-agonist-p2,ICRF-159,activity,inactive,21416-67-1,30623.0,O=C2CN(CC(C)N1CC(=O)NC(=O)C1)CC(=O)N2
NCGC00257887-01,tox21-er-bla-agonist-p2,5-Methyl-2-nitroaniline,activity,inactive,578-46-1,11356.0,O=[N+]([O-])c1ccc(C)cc1N
NCGC00258076-01,tox21-er-bla-agonist-p2,2-Chlorocyclohexanone,activity,inactive,822-87-7,13203.0,O=C1CCCCC1Cl
NCGC00258263-01,tox21-er-bla-agonist-p2,"2,3-Dibromopropanol",activity,inactive,96-13-9,7281.0,BrC(CBr)CO
NCGC00258287-01,tox21-er-bla-agonist-p2,Diethylacetamide,activity,inactive,685-91-6,12703.0,CCN(CC)C(C)=O
NCGC00255882-01,tox21-er-bla-agonist-p2,Ethyl bromophenylacetate,activity,inactive,2882-19-1,97780.0,O=C(OCC)C(Br)c1ccccc1
NCGC00255983-01,tox21-er-bla-agonist-p2,Ethirimol,activity,inactive,23947-60-6,32152.0,CCNc1nc(C)c(CCCC)c(O)n1
NCGC00256040-01,tox21-er-bla-agonist-p2,Methyl butyrate,activity,inactive,623-42-7,12180.0,CCCC(=O)OC
NCGC00256078-01,tox21-er-bla-agonist-p2,"1,3-Butyleneglycol dimethacrylate",activity,inactive,1189-08-8,70916.0,O=C(OC(C)CCOC(=O)C(=C)C)C(=C)C
NCGC00256359-01,tox21-er-bla-agonist-p2,Sodium chlorite,activity,inactive,7758-19-2,23668197.0,[Na+].[O-]Cl=O
NCGC00255678-01,tox21-er-bla-agonist-p2,"2-Chloro-4,5-dimethylphenol",activity,inactive,1124-04-5,70754.0,Cc1cc(O)c(Cl)cc1C
NCGC00259045-01,tox21-er-bla-agonist-p2,Glycidyl methacrylate,activity,inactive,106-91-2,7837.0,CC(=C)C(=O)OCC1CO1
NCGC00260452-01,tox21-er-bla-agonist-p2,9-Cyanophenanthrene,activity,inactive,2510-55-6,17279.0,N#Cc2cc3ccccc3c1ccccc12
NCGC00260537-01,tox21-er-bla-agonist-p2,Bisphenol A,activity,active agonist,80-05-7,6623.0,CC(C)(c1ccc(O)cc1)c2ccc(O)cc2
NCGC00260571-01,tox21-er-bla-agonist-p2,NTP Mix79 CT1 62-EQP,activity,inactive,NOCAS_49467,,
NCGC00259199-01,tox21-er-bla-agonist-p2,3-Pyridinamine,activity,inactive,462-08-8,10009.0,Nc1cccnc1
NCGC00259308-01,tox21-er-bla-agonist-p2,Allyl methacrylate,activity,inactive,96-05-9,7274.0,C=C(C)C(=O)OCC=C
NCGC00259653-01,tox21-er-bla-agonist-p2,Tripropylene glycol,activity,inactive,24800-44-0,22833317.0,OC(OC(C)COC(O)CC)CC
NCGC00259695-01,tox21-er-bla-agonist-p2,2-[2-(Hexyloxy)ethoxy]ethanol,activity,inactive,112-59-4,8199.0,OCCOCCOCCCCCC
NCGC00259881-01,tox21-er-bla-agonist-p2,Sulisobenzone,activity,inactive,4065-45-6,19988.0,OS(=O)(=O)c1cc(c(O)cc1OC)C(=O)c2ccccc2
NCGC00260127-01,tox21-er-bla-agonist-p2,"3,16-Dioxa-8,9,10,11-tetrathia-4,15-disilaoctadecane, 4,4,15,15-tetraethoxy-",activity,inactive,40372-72-3,162012.0,CCO[Si](OCC)(OCC)CCCSSSSCCC[Si](OCC)(OCC)OCC
NCGC00260182-01,tox21-er-bla-agonist-p2,"1-Ethyl-2,3-dimethylimidazolium hexafluorophosphate",activity,inactive,292140-86-4,50878556.0,C[n+]1ccn(CC)c1C.F[P-](F)(F)(F)(F)F
NCGC00258650-01,tox21-er-bla-agonist-p2,Rhein,activity,inactive,478-43-3,10168.0,O=C(O)c3cc2C(=O)c1cccc(O)c1C(=O)c2c(O)c3
NCGC00258730-01,tox21-er-bla-agonist-p2,"1,1-Dichloro-1-nitroethane",activity,inactive,594-72-9,11674.0,CC(Cl)(Cl)[N+]([O-])=O
NCGC00258741-01,tox21-er-bla-agonist-p2,"2,3-Dichlorobenzoic acid",activity,inactive,50-45-3,5765.0,Clc1c(cccc1Cl)C(=O)O
NCGC00254774-01,tox21-er-bla-agonist-p2,"3,4-Dichloro-5-isothiazolecarboxylic acid",activity,inactive,18480-53-0,49837.0,OC(=O)c1snc(Cl)c1Cl
NCGC00254826-01,tox21-er-bla-agonist-p2,Etridiazole,activity,inactive,2593-15-9,17432.0,ClC(Cl)(Cl)c1nc(OCC)sn1
NCGC00256378-01,tox21-er-bla-agonist-p2,5-Methyl-2-furancarboxylic acid,activity,inactive,1917-15-3,74710.0,O=C(O)c1ccc(C)o1
NCGC00255291-01,tox21-er-bla-agonist-p2,Dibutyl butanedioate,activity,inactive,141-03-7,8830.0,O=C(CCC(=O)OCCCC)OCCCC
NCGC00255539-01,tox21-er-bla-agonist-p2,Bupirimate,activity,inactive,41483-43-6,38884.0,CCNc1nc(C)c(CCCC)c(OS(=O)(=O)N(C)C)n1
NCGC00255853-01,tox21-er-bla-agonist-p2,1-Bromododecane,activity,inactive,143-15-7,8919.0,BrCCCCCCCCCCCC
NCGC00256027-01,tox21-er-bla-agonist-p2,Barium bis(2-ethylhexanoate),activity,inactive,2457-01-4,102821.0,[Ba+2].[O-]C(=O)C(CC)CCCC.CCC(CCCC)C([O-])=O
NCGC00254499-01,tox21-er-bla-agonist-p2,CP-634384,activity,inactive,290352-28-2,9819350.0,O=C(O)C(=O)Nc3cc(C)c(Oc2ccc(O)c1CCCc12)c(C)c3
NCGC00254595-01,tox21-er-bla-agonist-p2,4'-Methoxyacetophenone,activity,inactive,100-06-1,7476.0,COc1ccc(cc1)C(C)=O
NCGC00159407-02,tox21-er-bla-agonist-p2,Glutethimide,activity,inactive,77-21-4,3487.0,CCC1(CCC(=O)NC1=O)c2ccccc2
NCGC00167437-01,tox21-er-bla-agonist-p2,Ramosetron hydrochloride,activity,inactive,132907-72-3,107999.0,Cl.O=C(c2cn(C)c1ccccc12)[C@H]3Cc4ncnc4CC3
NCGC00181006-01,tox21-er-bla-agonist-p2,1-(4-Hydroxyphenyl)-2-methyl-2-methylaminoethanol hydrochloride,activity,inactive,74217-46-2,3084014.0,Cl.OC(c1ccc(O)cc1)C(C)NC
NCGC00164480-01,tox21-er-bla-agonist-p2,Mecloralurea,activity,inactive,1954-79-6,71808.0,CNC(=O)NC(O)C(Cl)(Cl)Cl
NCGC00167971-01,tox21-er-bla-agonist-p2,Tiotropium bromide,activity,inactive,136310-93-5,5487426.0,[Br-].OC(C(=O)OC1C[C@@H]2[N+](C)(C)[C@H](C1)[C@H]3O[C@@H]23)(c4cccs4)c5cccs5
NCGC00160394-01,tox21-er-bla-agonist-p2,(S)-Mephenytoin,activity,inactive,70989-04-7,107921.0,CC[C@]1(NC(=O)N(C)C1=O)c2ccccc2
NCGC00167477-01,tox21-er-bla-agonist-p2,Fidarestat,activity,inactive,136087-85-9,160024.0,NC(=O)[C@@H]2C[C@]1(NC(=O)NC1=O)c3cc(F)ccc3O2
NCGC00167487-01,tox21-er-bla-agonist-p2,Bicalutamide,activity,inactive,90357-06-5,56069.0,Fc1ccc(cc1)S(=O)(=O)C[C@](C)(O)C(=O)Nc2cc(c(C#N)cc2)C(F)(F)F
NCGC00095136-01,tox21-er-bla-agonist-p2,Olmesartan medoxomil,activity,inactive,144689-63-4,130881.0,CC=5OC(=O)OC=5COC(=O)c4c(nc(CCC)n4Cc1ccc(cc1)c3ccccc3c2nnnn2)C(C)(C)O
NCGC00164595-01,tox21-er-bla-agonist-p2,Voglibose,activity,inactive,83480-29-9,444020.0,O[C@H]1[C@@H](NC(CO)CO)C[C@](O)(CO)[C@@H](O)[C@@H]1O
NCGC00164600-01,tox21-er-bla-agonist-p2,Artesunate,activity,inactive,88495-63-0,60196289.0,O=C(O)CCC(=O)O[C@@H]1O[C@@H]3O[C@@]2(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)C34OO2
NCGC00168250-01,tox21-er-bla-agonist-p2,Estazolam,activity,inactive,29975-16-4,3261.0,Clc2cc3C(=NCc1nncn1c3cc2)c4ccccc4
NCGC00165976-01,tox21-er-bla-agonist-p2,Squalane,activity,inactive,111-01-3,8089.0,CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C
NCGC00166095-01,tox21-er-bla-agonist-p2,Bismuth oxide,activity,inactive,1304-76-3,14776.0,O=[Bi]O[Bi]=O
NCGC00181109-01,tox21-er-bla-agonist-p2,Decoquinate,activity,inactive,18507-89-6,29112.0,O=C(OCC)c1cnc2cc(OCC)c(cc2c1O)OCCCCCCCCCC
NCGC00159346-02,tox21-er-bla-agonist-p2,Terbinafine,activity,inactive,91161-71-6,1549008.0,CC(C)(C)C#C\C=C\CN(C)Cc2cccc1ccccc12
NCGC00161326-04,tox21-er-bla-agonist-p2,Calcifediol,activity,inactive,19356-17-3,5283731.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)CCCC(C)(C)O
NCGC00166260-01,tox21-er-bla-agonist-p2,Bumetrizole,activity,inactive,3896-11-5,62531.0,CC(C)(C)c1cc(C)cc(c1O)n2nc3ccc(Cl)cc3n2
NCGC00159394-02,tox21-er-bla-agonist-p2,Nicofuranose,activity,inactive,15351-13-0,25495.0,O[C@]5(COC(=O)c1cccnc1)O[C@H](COC(=O)c2cccnc2)[C@@H](OC(=O)c3cccnc3)[C@@H]5OC(=O)c4cccnc4
NCGC00254986-01,tox21-er-bla-agonist-p2,Fluazifop-butyl,activity,inactive,69806-50-4,50897.0,O=C(OCCCC)C(C)Oc1ccc(cc1)Oc2ccc(cn2)C(F)(F)F
NCGC00185741-01,tox21-er-bla-agonist-p2,Nepafenac,activity,inactive,78281-72-8,151075.0,Nc1c(cccc1CC(N)=O)C(=O)c2ccccc2
NCGC00254181-01,tox21-er-bla-agonist-p2,Urea,activity,inactive,57-13-6,1176.0,NC(N)=O
NCGC00186006-01,tox21-er-bla-agonist-p2,Nefiracetam,activity,inactive,77191-36-7,71157.0,O=C2CCCN2CC(=O)Nc1c(C)cccc1C
NCGC00186461-01,tox21-er-bla-agonist-p2,Dichloro(ethylenediamine)platinum(II),activity,inactive,14096-51-6,,[Cl-][Pt]1([Cl-])NCCN1
NCGC00254618-01,tox21-er-bla-agonist-p2,(S)-(-)-beta-Citronellol,activity,inactive,7540-51-4,7793.0,C\C(C)=C\CC[C@H](C)CCO
NCGC00247677-01,tox21-er-bla-agonist-p2,(+)-Metazocine fumarate (2:1),activity,inactive,133005-40-0,60196312.0,O=C(O)/C=C/C(=O)O.Oc2ccc3C[C@H]1[C@H](C)[C@](C)(CCN1C)c3c2.Oc2ccc3C[C@H]1[C@H](C)[C@](C)(CCN1C)c3c2
NCGC00253941-01,tox21-er-bla-agonist-p2,Anthralin,activity,inactive,1143-38-0,2202.0,Oc2cccc1Cc3cccc(O)c3C(=O)c12
NCGC00253987-01,tox21-er-bla-agonist-p2,1-Dodecanol,activity,inactive,112-53-8,8193.0,CCCCCCCCCCCCO
NCGC00255300-01,tox21-er-bla-agonist-p2,Metam-sodium,activity,inactive,137-42-8,5366415.0,[Na+].[S-]C(=S)NC
NCGC00254116-01,tox21-er-bla-agonist-p2,Nitrilotriacetic acid,activity,inactive,139-13-9,8758.0,OC(=O)CN(CC(=O)O)CC(=O)O
NCGC00254945-01,tox21-er-bla-agonist-p2,3-Phenylprop-2-en-1-yl acetate,activity,inactive,103-54-8,7660.0,CC(=O)OCC=Cc1ccccc1
NCGC00181334-03,tox21-er-bla-agonist-p2,Sodium dibunate,activity,inactive,14992-59-7,23672302.0,[Na+].CC(C)(C)c1ccc2c(c1)ccc(c2S([O-])(=O)=O)C(C)(C)C
NCGC00181341-01,tox21-er-bla-agonist-p2,Emedastine difumarate,activity,inactive,87233-62-3,5282485.0,CN1CCCN(CC1)c3nc2ccccc2n3CCOCC.O=C(O)\C=C\C(=O)O.O=C(O)\C=C\C(=O)O
NCGC00182712-01,tox21-er-bla-agonist-p2,Noristerat,activity,active agonist,3836-23-5,229295.0,CCCCCCC(=O)O[C@@]3(C#C)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@@]23C
NCGC00016849-01,tox21-er-bla-agonist-p2,Etodolac,activity,inactive,41340-25-4,3308.0,O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC
NCGC00259469-01,tox21-er-bla-agonist-p2,"1,2,4,5-Tetramethylbenzene",activity,inactive,95-93-2,7269.0,Cc1cc(C)c(C)cc1C
NCGC00258226-01,tox21-er-bla-agonist-p2,"1,6-Dimethylnaphthalene",activity,inactive,575-43-9,11328.0,Cc2cccc1cc(C)ccc12
NCGC00258310-01,tox21-er-bla-agonist-p2,"2,4-Dichlorobenzoic acid",activity,inactive,50-84-0,5787.0,OC(=O)c1ccc(Cl)cc1Cl
NCGC00260558-01,tox21-er-bla-agonist-p2,NTP Mix66 CT1 62-EQP,activity,inactive,NOCAS_49454,,
NCGC00255635-01,tox21-er-bla-agonist-p2,N-[3-(Dimethylamino)propyl]methacrylamide,activity,inactive,5205-93-6,78882.0,CN(C)CCCNC(=O)C(=C)C
NCGC00258865-01,tox21-er-bla-agonist-p2,Benzal chloride,activity,inactive,98-87-3,7411.0,ClC(Cl)c1ccccc1
NCGC00256849-01,tox21-er-bla-agonist-p2,Hexyl butyrate,activity,inactive,2639-63-6,17525.0,O=C(CCC)OCCCCCC
NCGC00258975-01,tox21-er-bla-agonist-p2,N-Isopropyl-N'-phenyl-p-phenylenediamine,activity,inactive,101-72-4,7573.0,CC(C)Nc1ccc(cc1)Nc2ccccc2
NCGC00259566-01,tox21-er-bla-agonist-p2,Malaoxon,activity,inactive,1634-78-2,15415.0,COP(=O)(OC)SC(CC(=O)OCC)C(=O)OCC
NCGC00254308-01,tox21-er-bla-agonist-p2,"N,N-Diethylaniline",activity,inactive,91-66-7,7061.0,CCN(CC)c1ccccc1
NCGC00256494-01,tox21-er-bla-agonist-p2,"2-Methyl-2,4-pentanediol",activity,inactive,107-41-5,7870.0,CC(O)CC(C)(C)O
NCGC00181158-01,tox21-er-bla-agonist-p2,o-(Chloromercuri)phenol,activity,active agonist,90-03-9,6999.0,Cl[Hg]c1ccccc1O
NCGC00256585-01,tox21-er-bla-agonist-p2,4-Nitrosodiphenylamine,activity,active agonist,156-10-5,9074.0,O=Nc2ccc(Nc1ccccc1)cc2
NCGC00257204-01,tox21-er-bla-agonist-p2,Cyclododecanol,activity,inactive,1724-39-6,15595.0,OC1CCCCCCCCCCC1
NCGC00015424-04,tox21-er-bla-agonist-p2,Fluspirilene,activity,inactive,1841-19-6,3396.0,Fc1ccc(cc1)C(CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3)c5ccc(F)cc5
NCGC00015060-14,tox21-er-bla-agonist-p2,Azathioprine,activity,inactive,446-86-6,2265.0,O=[N+]([O-])c3ncn(C)c3Sc2ncnc1ncnc12
NCGC00255528-01,tox21-er-bla-agonist-p2,"2,5-Dimethoxy-4-chloroaniline",activity,inactive,6358-64-1,22833.0,COc1cc(N)c(cc1Cl)OC
NCGC00256773-01,tox21-er-bla-agonist-p2,2-Methoxy-4-propylphenol,activity,inactive,2785-87-7,17739.0,Oc1ccc(cc1OC)CCC
NCGC00256142-01,tox21-er-bla-agonist-p2,2-Benzyl-2-(dimethylamino)-1-[4-(morpholin-4-yl)phenyl]butan-1-one,activity,active agonist,119313-12-1,86171.0,CN(C)C(Cc1ccccc1)(CC)C(=O)c2ccc(cc2)N3CCOCC3
NCGC00256468-01,tox21-er-bla-agonist-p2,1-Ethyl-1-nitrosourea,activity,inactive,759-73-9,12967.0,NC(=O)N(CC)N=O
NCGC00256656-01,tox21-er-bla-agonist-p2,"Phenol, 4-methyl-, reaction products with dicyclopentadiene and isobutylene",activity,inactive,68610-51-5,,
NCGC00257884-01,tox21-er-bla-agonist-p2,4-Acetamidobenzoic acid,activity,inactive,556-08-1,19266.0,O=C(C)Nc1ccc(cc1)C(=O)O
NCGC00257754-01,tox21-er-bla-agonist-p2,Allyl alcohol,activity,inactive,107-18-6,7858.0,C=CCO
NCGC00259000-01,tox21-er-bla-agonist-p2,"2,3,5,6-Tetrachlorobenzene-1,4-dicarbonyl dichloride",activity,inactive,719-32-4,12868.0,Clc1c(C(Cl)=O)c(Cl)c(Cl)c(C(Cl)=O)c1Cl
NCGC00258655-01,tox21-er-bla-agonist-p2,N-Ethylmorpholine,activity,inactive,100-74-3,7525.0,CCN1CCOCC1
NCGC00258034-01,tox21-er-bla-agonist-p2,1-Bromo-4-methoxy-2-methylbenzene,activity,inactive,27060-75-9,117915.0,Cc1cc(OC)ccc1Br
NCGC00258205-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(2-chloroaniline)",activity,inactive,101-14-4,7543.0,Nc2ccc(Cc1ccc(N)c(Cl)c1)cc2Cl
NCGC00259282-01,tox21-er-bla-agonist-p2,"1,1,3-Trimethyl-2-thiourea",activity,inactive,2489-77-2,2779938.0,CN(C)C(=S)NC
NCGC00259746-01,tox21-er-bla-agonist-p2,Phenformin hydrochloride,activity,inactive,834-28-6,13266.0,Cl.N=C(N)NC(=N)NCCc1ccccc1
NCGC00260143-01,tox21-er-bla-agonist-p2,Sodium nitrate,activity,inactive,7631-99-4,24268.0,[Na+].[O-][N+]([O-])=O
NCGC00259561-01,tox21-er-bla-agonist-p2,Propyl acetate,activity,inactive,109-60-4,7997.0,CC(=O)OCCC
NCGC00259446-01,tox21-er-bla-agonist-p2,FD&C Yellow 6,activity,inactive,2783-94-0,5359810.0,[Na+].[Na+].O=S([O-])(=O)c3ccc(/N=N/c1c2ccc(cc2ccc1O)S([O-])(=O)=O)cc3
NCGC00259885-01,tox21-er-bla-agonist-p2,Carbosulfan,activity,inactive,55285-14-8,41384.0,CCCCN(CCCC)SN(C)C(=O)Oc1cccc2CC(C)(C)Oc12
NCGC00259450-01,tox21-er-bla-agonist-p2,Dimethyl hydrogen phosphite,activity,inactive,868-85-9,6327114.0,O=P(OC)OC
NCGC00259482-01,tox21-er-bla-agonist-p2,Hexanal,activity,inactive,66-25-1,6184.0,CCCCCC=O
NCGC00260217-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpiperidinium bromide,activity,inactive,88840-42-0,60196385.0,[Br-].CCC[N+]1(C)CCCCC1
NCGC00260275-01,tox21-er-bla-agonist-p2,N-Phenylhydroxylamine,activity,inactive,100-65-2,7518.0,ONc1ccccc1
NCGC00260365-01,tox21-er-bla-agonist-p2,"3-Cyclobutene-1,2-dione,3,4-dihydroxy-",activity,inactive,2892-51-5,17913.0,OC1=C(O)C(=O)C1=O
NCGC00260385-01,tox21-er-bla-agonist-p2,Epinephrine bitartrate,activity,inactive,51-42-3,5815.0,Oc1ccc(cc1O)[C@@H](O)CNC.O=C(O)[C@H](O)[C@@H](O)C(=O)O
NCGC00015439-06,tox21-er-bla-agonist-p2,Flumazenil,activity,inactive,78755-81-4,3373.0,O=C(OCC)c3ncn2c3CN(C)C(=O)c1cc(F)ccc12
NCGC00016387-02,tox21-er-bla-agonist-p2,Chenodeoxycholic acid,activity,inactive,474-25-9,10133.0,O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]1[C@]4(C)CC[C@@H]2[C@@]3(C)CC[C@@H](O)C[C@H]3C[C@@H](O)[C@@H]12
NCGC00016804-01,tox21-er-bla-agonist-p2,Etofenamate,activity,inactive,30544-47-9,35375.0,FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)OCCOCCO
NCGC00016627-01,tox21-er-bla-agonist-p2,Lidoflazine,activity,inactive,3416-26-0,3926.0,Cc4cccc(C)c4NC(=O)CN3CCN(CCCC(c1ccc(F)cc1)c2ccc(F)cc2)CC3
NCGC00016686-01,tox21-er-bla-agonist-p2,Natamycin,activity,inactive,7681-93-8,5284447.0,O=C(O)[C@@H]3[C@@H](O)C[C@@]2(O)C[C@@H](O)C[C@H]4O[C@@H]4C=CC(=O)O[C@H](C)CC=CC=CC=CC=C[C@H](O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O)C[C@@H]3O2
NCGC00167576-01,tox21-er-bla-agonist-p2,Aprindine hydrochloride,activity,inactive,33237-74-0,71413.0,Cl.CCN(CC)CCCN(c1ccccc1)C2Cc3ccccc3C2
NCGC00255277-01,tox21-er-bla-agonist-p2,Chlorhexidine diacetate,activity,inactive,56-95-1,9562059.0,Clc2ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)cc2.CC(=O)O.CC(=O)O
NCGC00254557-01,tox21-er-bla-agonist-p2,"1,4-Cyclohexanedicarboxylic acid",activity,inactive,1076-97-7,14106.0,OC(=O)C1CCC(CC1)C(=O)O
NCGC00255356-01,tox21-er-bla-agonist-p2,Bromadiolone,activity,inactive,28772-56-7,54680085.0,Brc1ccc(cc1)c2ccc(cc2)C(O)CC(C3=C(O)c4ccccc4OC3=O)c5ccccc5
NCGC00254185-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorophenol",activity,inactive,95-95-4,7271.0,Oc1cc(Cl)c(Cl)cc1Cl
NCGC00254254-01,tox21-er-bla-agonist-p2,C10-21 sulfonic acids phenyl esters,activity,inactive,91082-17-6,20478723.0,O=S(=O)(Oc1ccccc1)CCCCCCCCCCCCCCC
NCGC00091120-01,tox21-er-bla-agonist-p2,Griseofulvin,activity,inactive,126-07-8,441140.0,O=C2c3c(O[C@]12C(=CC(=O)C[C@H]1C)OC)c(Cl)c(OC)cc3OC
NCGC00095183-01,tox21-er-bla-agonist-p2,Pravastatin sodium,activity,inactive,81131-70-6,16759173.0,[Na+].[O-]C(=O)C[C@H](O)C[C@H](O)CC[C@H]2[C@@H](C)C=CC1=C[C@@H](O)C[C@H](OC(=O)[C@@H](C)CC)[C@@H]12
NCGC00160498-01,tox21-er-bla-agonist-p2,Clostebol,activity,active agonist,1093-58-9,68947.0,ClC=4C(=O)CC[C@@]3(C)C=4CC[C@@H]1[C@@H]3CC[C@]2(C)[C@@H](O)CC[C@@H]12
NCGC00161344-03,tox21-er-bla-agonist-p2,Eicosapentaenoic acid,activity,inactive,10417-94-4,446284.0,O=C(O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC
NCGC00181008-01,tox21-er-bla-agonist-p2,Olsalazine sodium,activity,inactive,6054-98-4,54727588.0,[Na+].[Na+].O=C([O-])c1cc(ccc1O)/N=N/c2cc(C([O-])=O)c(O)cc2
NCGC00181094-01,tox21-er-bla-agonist-p2,Sodium tyropanoate,activity,inactive,7246-21-1,541384.0,[Na+].O=C(Nc1c(I)c(CC(CC)C([O-])=O)c(I)cc1I)CCC
NCGC00181135-02,tox21-er-bla-agonist-p2,Pentamycin,activity,inactive,6834-98-6,60196306.0,CCCCC[C@@H](O)C1C(=O)OC(C)[C@H](O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O
NCGC00253991-01,tox21-er-bla-agonist-p2,MK-274,activity,inactive,NOCAS_47328,53316396.0,[K+].O.FC(F)(F)C(F)(F)COc3ccc(F)cc3c1cccc(c1)c2nc([n-]n2)C(N)=O
NCGC00255004-01,tox21-er-bla-agonist-p2,Glyceryl stearates,activity,inactive,11099-07-3,24699.0,OCC(O)COC(=O)CCCCCCCCCCCCCCCCC
NCGC00259364-01,tox21-er-bla-agonist-p2,Ifosfamide,activity,inactive,3778-73-2,3690.0,O=P1(NCCCl)OCCCN1CCCl
NCGC00259377-01,tox21-er-bla-agonist-p2,2-Mercaptobenzimidazole,activity,inactive,583-39-1,707035.0,S=C1Nc2ccccc2N1
NCGC00260191-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium iodide,activity,inactive,35935-34-3,11075478.0,[I-].C[n+]1ccn(CC)c1
NCGC00260576-01,tox21-er-bla-agonist-p2,NTP Mix53 CT1 3-EQP,activity,inactive,NOCAS_49472,,
NCGC00260655-01,tox21-er-bla-agonist-p2,NTP Mix21 AR2 2-EQP,activity,active agonist,NOCAS_49551,,
NCGC00015610-02,tox21-er-bla-agonist-p2,Leflunomide,activity,inactive,75706-12-6,3899.0,Cc2oncc2C(=O)Nc1ccc(cc1)C(F)(F)F
NCGC00016813-01,tox21-er-bla-agonist-p2,Pivmecillinam hydrochloride,activity,inactive,32887-03-9,115162.0,Cl.CC(C)(C)C(=O)OCOC(=O)[C@@H]2N3C(=O)[C@@H](/N=C/N1CCCCCC1)[C@H]3SC2(C)C
NCGC00017116-01,tox21-er-bla-agonist-p2,Fenoprofen calcium,activity,inactive,71720-56-4,6604557.0,[Ca+2].O.O.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2.[O-]C(=O)[C@@H](C)c2cc(Oc1ccccc1)ccc2
NCGC00090825-01,tox21-er-bla-agonist-p2,"1,2-Dichlorobenzene",activity,inactive,95-50-1,7239.0,Clc1ccccc1Cl
NCGC00093851-01,tox21-er-bla-agonist-p2,Edelfosine,activity,inactive,70641-51-9,6918215.0,C[N+](C)(C)CCOP([O-])(=O)OC[C@@H](COCCCCCCCCCCCCCCCCCC)OC
NCGC00159391-02,tox21-er-bla-agonist-p2,Sulfobromophthalein,activity,inactive,71-67-0,6282.0,[Na+].[Na+].[O-]S(=O)(=O)c1cc(ccc1O)C3(OC(=O)c2c(Br)c(Br)c(Br)c(Br)c23)c4ccc(O)c(c4)S([O-])(=O)=O
NCGC00163735-04,tox21-er-bla-agonist-p2,Boscalid,activity,inactive,188425-85-6,213013.0,O=C(Nc2ccccc2c1ccc(Cl)cc1)c3cccnc3Cl
NCGC00165774-02,tox21-er-bla-agonist-p2,Cloprostenol sodium,activity,inactive,55028-72-3,17756794.0,[Na+].O[C@H]2C[C@@H](O)[C@H](/C=C/[C@@H](O)COc1cccc(Cl)c1)[C@H]2C\C=C/CCCC([O-])=O
NCGC00254291-01,tox21-er-bla-agonist-p2,CP-544439,activity,inactive,230954-09-3,9866250.0,O=S(=O)(NC1(CCOCC1)C(=O)NO)c3ccc(Oc2ccc(F)cc2)cc3
NCGC00254353-01,tox21-er-bla-agonist-p2,Triethylene glycol diacetate,activity,inactive,111-21-7,8098.0,O=C(C)OCCOCCOCCOC(C)=O
NCGC00016957-01,tox21-er-bla-agonist-p2,Aceclofenac,activity,inactive,89796-99-6,71771.0,Clc2cccc(Cl)c2Nc1ccccc1CC(=O)OCC(=O)O
NCGC00090917-01,tox21-er-bla-agonist-p2,Isopropanol,activity,inactive,67-63-0,3776.0,CC(C)O
NCGC00017010-01,tox21-er-bla-agonist-p2,Methylatropine nitrate,activity,inactive,52-88-0,657381.0,C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3.[O-][N+]([O-])=O
NCGC00017056-01,tox21-er-bla-agonist-p2,Quercetin dihydrate,activity,active agonist,6151-25-3,5284452.0,O.O.Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O
NCGC00256932-01,tox21-er-bla-agonist-p2,Potassium 2-ethylhexanoate,activity,inactive,3164-85-0,23669619.0,[K+].[O-]C(=O)C(CC)CCCC
NCGC00258588-01,tox21-er-bla-agonist-p2,Sulfamethizole,activity,inactive,144-82-1,5328.0,Cc2nnc(NS(=O)(=O)c1ccc(N)cc1)s2
NCGC00257115-01,tox21-er-bla-agonist-p2,"Dimethyl 3,3'-thiodipropionate",activity,inactive,4131-74-2,77781.0,COC(=O)CCSCCC(=O)OC
NCGC00257193-01,tox21-er-bla-agonist-p2,"1,3-Dimethyl-2-nitrobenzene",activity,inactive,81-20-9,6672.0,Cc1cccc(C)c1[N+](=O)[O-]
NCGC00257325-01,tox21-er-bla-agonist-p2,"3,5,5-Trimethyl-1-hexanol",activity,inactive,3452-97-9,18938.0,CC(C)(C)CC(C)CCO
NCGC00257480-01,tox21-er-bla-agonist-p2,Phenyl benzoate,activity,inactive,93-99-2,7169.0,O=C(Oc1ccccc1)c2ccccc2
NCGC00257495-01,tox21-er-bla-agonist-p2,Cyclopentanone,activity,inactive,120-92-3,8452.0,O=C1CCCC1
NCGC00257502-01,tox21-er-bla-agonist-p2,Benzyl benzoate,activity,inactive,120-51-4,2345.0,O=C(OCc1ccccc1)c2ccccc2
NCGC00257693-01,tox21-er-bla-agonist-p2,Isophytol,activity,inactive,505-32-8,10453.0,CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C=C
NCGC00257880-01,tox21-er-bla-agonist-p2,Benzyl sulfide,activity,inactive,538-74-9,10867.0,C(SCc1ccccc1)c2ccccc2
NCGC00257954-01,tox21-er-bla-agonist-p2,D-Limonene,activity,inactive,5989-27-5,440917.0,CC1=CC[C@@H](CC1)C(C)=C
NCGC00258206-01,tox21-er-bla-agonist-p2,1-Octene,activity,inactive,111-66-0,8125.0,C=CCCCCCC
NCGC00256372-01,tox21-er-bla-agonist-p2,C.I. Acid Orange 10,activity,inactive,1936-15-8,9566064.0,[Na+].[Na+].[O-]S(=O)(=O)c3cc(cc2ccc(O)c(/N=N/c1ccccc1)c23)S([O-])(=O)=O
NCGC00256023-01,tox21-er-bla-agonist-p2,"2,6,6-Trimethyl-1-cyclohexene-1-acetaldehyde",activity,inactive,472-66-2,61124.0,CC=1CCCC(C)(C)C=1CC=O
NCGC00256037-01,tox21-er-bla-agonist-p2,Sodium dibutylcarbamodithioate,activity,inactive,136-30-1,546717.0,[Na+].[S-]C(=S)N(CCCC)CCCC
NCGC00256045-01,tox21-er-bla-agonist-p2,5-Phenyl-1H-tetrazole,activity,inactive,18039-42-4,87425.0,c1ccc(cc1)c2nnnn2
NCGC00256242-01,tox21-er-bla-agonist-p2,Buflomedil hydrochloride,activity,inactive,35543-24-9,6420013.0,Cl.COc2cc(OC)cc(OC)c2C(=O)CCCN1CCCC1
NCGC00255679-01,tox21-er-bla-agonist-p2,"1,4-Dioxane-2,5-dione, 3,6-dimethyl-",activity,inactive,95-96-5,7272.0,CC1OC(=O)C(C)OC1=O
NCGC00258908-01,tox21-er-bla-agonist-p2,Dicamba,activity,inactive,1918-00-9,3030.0,COc1c(c(Cl)ccc1Cl)C(=O)O
NCGC00260569-01,tox21-er-bla-agonist-p2,NTP Mix77 CT1 62-EQP,activity,inactive,NOCAS_49465,,
NCGC00260636-01,tox21-er-bla-agonist-p2,NTP Mix112 ER1 10-EQC,activity,active agonist,NOCAS_49532,,
NCGC00259069-01,tox21-er-bla-agonist-p2,Dipentyl phthalate,activity,inactive,131-18-0,8561.0,O=C(OCCCCC)c1ccccc1C(=O)OCCCCC
NCGC00259255-01,tox21-er-bla-agonist-p2,2-Butanone oxime,activity,inactive,96-29-7,7292.0,C/C(CC)=N\O
NCGC00259503-01,tox21-er-bla-agonist-p2,Dodecanedioic acid,activity,inactive,693-23-2,12736.0,O=C(O)CCCCCCCCCCC(=O)O
NCGC00259795-01,tox21-er-bla-agonist-p2,Dimethoate,activity,inactive,60-51-5,3082.0,COP(=S)(OC)SCC(=O)NC
NCGC00259800-01,tox21-er-bla-agonist-p2,Caprylyl chloride,activity,inactive,111-64-8,8124.0,ClC(=O)CCCCCCC
NCGC00260232-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylpyridinium iodide,activity,inactive,258273-67-5,45268380.0,[I-].Cc1ccc[n+](CCCC)c1
NCGC00258743-01,tox21-er-bla-agonist-p2,Benzyl isothiocyanate,activity,inactive,622-78-6,2346.0,S=C=N\Cc1ccccc1
NCGC00254622-01,tox21-er-bla-agonist-p2,Pyriproxyfen,activity,inactive,95737-68-1,91753.0,CC(COc2ccc(Oc1ccccc1)cc2)Oc3ccccn3
NCGC00255316-01,tox21-er-bla-agonist-p2,Nomifensine,activity,inactive,24526-64-5,4528.0,Nc3cccc1c3CN(C)CC1c2ccccc2
NCGC00255397-01,tox21-er-bla-agonist-p2,4'-Fluoro-4-aminodiphenyl,activity,inactive,324-93-6,9462.0,Nc1ccc(cc1)c2ccc(F)cc2
NCGC00255582-01,tox21-er-bla-agonist-p2,Undec-10-enal,activity,inactive,112-45-8,8187.0,C=CCCCCCCCCC=O
NCGC00255973-01,tox21-er-bla-agonist-p2,Trifluoromethanesulfonic acid,activity,inactive,1493-13-6,62406.0,FC(F)(F)S(=O)(=O)O
NCGC00254554-01,tox21-er-bla-agonist-p2,Neodymium(III) chloride,activity,inactive,10024-93-8,66204.0,Cl[Nd](Cl)Cl
NCGC00091398-02,tox21-er-bla-agonist-p2,Nitrobenzene,activity,inactive,98-95-3,7416.0,[O-][N+](=O)c1ccccc1
NCGC00094540-01,tox21-er-bla-agonist-p2,"1,4-Dichlorobenzene",activity,inactive,106-46-7,4685.0,Clc1ccc(Cl)cc1
NCGC00181000-01,tox21-er-bla-agonist-p2,Suplatast tosylate,activity,inactive,94055-76-2,71773.0,Cc1ccc(cc1)S(=O)([O-])=O.C[S+](C)CCC(=O)Nc1ccc(OCC(O)COCC)cc1
NCGC00181019-01,tox21-er-bla-agonist-p2,Testosterone isocaproate,activity,active agonist,15262-86-9,231084.0,CC(C)CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00164482-01,tox21-er-bla-agonist-p2,Molracetam,activity,inactive,94746-78-8,779179.0,O=C(CN1CCN(CC1)C(=O)c2ccc(OC)cc2)N3CCOCC3
NCGC00181159-02,tox21-er-bla-agonist-p2,Trabectedin,activity,inactive,114899-77-3,108150.0,CC(=O)Oc1c5c(c2OCOc2c1C)[C@@H]7COC(=O)[C@@]4(NCCc3cc(O)c(cc34)OC)CS[C@H]5[C@H]8[C@H]6c9c(C[C@H](N6C)[C@H](O)N78)cc(C)c(OC)c9O
NCGC00181040-01,tox21-er-bla-agonist-p2,dl-Coniine,activity,inactive,3238-60-6,9985.0,CCCC1CCCCN1
NCGC00181052-01,tox21-er-bla-agonist-p2,Quinine hemisulfate salt monohydrate,activity,inactive,207671-44-1,16211610.0,O.O.O=S(=O)(O)O.COc1cc2c(cc1)nccc2[C@@H](O)[C@@H]4C[C@@H]3CC[N@]4C[C@@H]3C=C.COc1cc2c(cc1)nccc2[C@@H](O)[C@@H]4C[C@@H]3CC[N@]4C[C@@H]3C=C
NCGC00167530-01,tox21-er-bla-agonist-p2,Arbekacin sulfate,activity,inactive,104931-87-5,175989.0,O=S(=O)(O)O.NCC[C@H](O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)CC[C@H]1N)[C@H](O)[C@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O
NCGC00167538-01,tox21-er-bla-agonist-p2,Clorprenaline hydrochloride,activity,inactive,6933-90-0,23360.0,Cl.OC(CNC(C)C)c1ccccc1Cl
NCGC00166056-01,tox21-er-bla-agonist-p2,Ethyl nicotinate,activity,inactive,614-18-6,69188.0,O=C(OCC)c1cccnc1
NCGC00142615-03,tox21-er-bla-agonist-p2,Epinephrine,activity,inactive,51-43-4,5816.0,Oc1ccc(cc1O)[C@@H](O)CNC
NCGC00182025-01,tox21-er-bla-agonist-p2,Dipotassium glycerophosphate,activity,inactive,927-19-5,80278.0,[K+].[K+].[O-]P([O-])(=O)OCC(O)CO
NCGC00183095-01,tox21-er-bla-agonist-p2,Tigecycline,activity,inactive,220620-09-7,54686904.0,CC(C)(C)NCC(=O)Nc1cc(N(C)C)c2C[C@H]3C[C@H]4[C@@H](C(O)=C(C(=O)[C@@]4(O)C(O)=C3C(=O)c2c1O)C(N)=O)N(C)C
NCGC00255007-01,tox21-er-bla-agonist-p2,Propyl propionate,activity,inactive,106-36-5,7803.0,CCC(=O)OCCC
NCGC00185750-01,tox21-er-bla-agonist-p2,Astromicin,activity,inactive,55779-06-1,5284517.0,NCC(=O)N(C)[C@H]2[C@@H](O)[C@H](O[C@H]1O[C@@H](CC[C@H]1N)[C@H](C)N)[C@@H](N)[C@H](O)[C@@H]2OC
NCGC00247686-01,tox21-er-bla-agonist-p2,N-(4-Fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidyl] propanamide,activity,inactive,90736-23-5,62300.0,Fc1ccc(cc1)N(C3CCN(CCc2ccccc2)CC3)C(=O)CC
NCGC00247703-01,tox21-er-bla-agonist-p2,(-)-Metazocine fumarate (1:1),activity,inactive,120693-79-0,60196329.0,O=C(O)/C=C/C(=O)O.Oc2ccc3C[C@@H]1[C@@H](C)[C@@](C)(CCN1C)c3c2
NCGC00254687-01,tox21-er-bla-agonist-p2,"2,2'-[Benzene-1,3-diylbis(oxy)]diethanol",activity,inactive,102-40-9,66885.0,OCCOc1cccc(OCCO)c1
NCGC00247733-01,tox21-er-bla-agonist-p2,Buprenorphine hydrochloride,activity,inactive,53152-21-9,11969480.0,Cl.CC(C)(C)[C@@](C)(O)[C@H]7C[C@]64CC[C@]7(OC)[C@@H]1Oc3c(O)ccc2C[C@H]6N(CC[C@]14c23)CC5CC5
NCGC00255386-01,tox21-er-bla-agonist-p2,Musk ketone,activity,inactive,81-14-1,6669.0,O=[N+]([O-])c1c(C)c(c(C)c(c1C(C)(C)C)[N+]([O-])=O)C(C)=O
NCGC00254061-01,tox21-er-bla-agonist-p2,Diethanolamine,activity,inactive,111-42-2,8113.0,OCCNCCO
NCGC00254881-01,tox21-er-bla-agonist-p2,Methyl 2-octynoate,activity,inactive,111-12-6,8092.0,O=C(C#CCCCCC)OC
NCGC00254070-01,tox21-er-bla-agonist-p2,Surinabant,activity,inactive,288104-79-0,9849616.0,O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(Br)cc3)c4CC
NCGC00181348-01,tox21-er-bla-agonist-p2,Teicoplanin,activity,inactive,61036-62-2,16129710.0,[H][C@@]1(O[C@H]2[C@@H]3NC(=O)[C@]([H])(NC(=O)[C@]4([H])NC(=O)[C@@]5([H])NC(=O)[C@@H](CC6=CC=C(OC7=C(O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8NC(=O)CC\C=C/CCCCC)C(OC8=C(Cl)C=C2C=C8)=CC4=C7)C(Cl)=C6)NC(=O)[C@@H](N)C2=CC(OC4=CC5=CC(O)=C4)=C(O)C=C2)C2=CC(=C(O)C=C2)C2=C(C=C(O)C=C2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)[C@@H](NC3=O)C(O)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O
NCGC00182710-02,tox21-er-bla-agonist-p2,Flurbiprofen axetil,activity,inactive,91503-79-6,3395.0,Fc2cc(ccc2c1ccccc1)C(C)C(=O)OC(C)OC(C)=O
NCGC00016620-01,tox21-er-bla-agonist-p2,Midodrine hydrochloride,activity,inactive,3092-17-9,18340.0,Cl.COc1ccc(cc1C(O)CNC(=O)CN)OC
NCGC00260432-01,tox21-er-bla-agonist-p2,"1,8-Dinitronaphthalene",activity,inactive,602-38-0,11764.0,[O-][N+](=O)c1cccc2cccc([N+]([O-])=O)c12
NCGC00258691-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(2-methylcyclohexanamine)",activity,inactive,6864-37-5,91555.0,CC2CC(CC1CCC(N)C(C)C1)CCC2N
NCGC00259018-01,tox21-er-bla-agonist-p2,Bisphenol AF,activity,active agonist,1478-61-1,73864.0,Oc1ccc(cc1)C(c2ccc(O)cc2)(C(F)(F)F)C(F)(F)F
NCGC00260022-01,tox21-er-bla-agonist-p2,(2-Dodecenyl)succinic anhydride,activity,inactive,19780-11-1,5362708.0,O=C1OC(=O)CC1C/C=C/CCCCCCCCC
NCGC00258454-01,tox21-er-bla-agonist-p2,2-Amino-4-thiazoleacetic acid,activity,inactive,29676-71-9,34665.0,OC(=O)Cc1csc(N)n1
NCGC00260254-01,tox21-er-bla-agonist-p2,1-Ethyl-1-methylpyrrolidinium trifluoromethanesulfonate,activity,inactive,893443-18-0,60196393.0,C[N+]1(CC)CCCC1.FC(F)(F)S([O-])(=O)=O
NCGC00257422-01,tox21-er-bla-agonist-p2,Bromotrichloromethane,activity,inactive,75-62-7,6383.0,BrC(Cl)(Cl)Cl
NCGC00257019-01,tox21-er-bla-agonist-p2,Ammonium perchlorate,activity,inactive,7790-98-9,24639.0,[NH4+].[O-]Cl(=O)(=O)=O
NCGC00257343-01,tox21-er-bla-agonist-p2,(2-Nitro-1-propenyl)benzene,activity,inactive,705-60-2,1549520.0,C\C(=C/c1ccccc1)[N+]([O-])=O
NCGC00015060-06,tox21-er-bla-agonist-p2,Azathioprine,activity,inactive,446-86-6,2265.0,O=[N+]([O-])c3ncn(C)c3Sc2ncnc1ncnc12
NCGC00258434-01,tox21-er-bla-agonist-p2,2-Aminopyridine,activity,inactive,504-29-0,10439.0,Nc1ccccn1
NCGC00256567-01,tox21-er-bla-agonist-p2,2-[2-(2-Butoxyethoxy)ethoxy]ethanol,activity,inactive,143-22-6,8923.0,OCCOCCOCCOCCCC
NCGC00258830-01,tox21-er-bla-agonist-p2,Amitriptyline hydrochloride,activity,inactive,549-18-8,11065.0,Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12
NCGC00259090-01,tox21-er-bla-agonist-p2,N-(Cyclohexylthio)phthalimide,activity,inactive,17796-82-6,28777.0,O=C3c1ccccc1C(=O)N3SC2CCCCC2
NCGC00164168-02,tox21-er-bla-agonist-p2,Diphenyl isophthalate,activity,inactive,744-45-6,69779.0,O=C(Oc1ccccc1)c2cccc(c2)C(=O)Oc3ccccc3
NCGC00255859-01,tox21-er-bla-agonist-p2,Sodium methyl sulfate,activity,inactive,512-42-5,2735086.0,[Na+].[O-]S(=O)(=O)OC
NCGC00255546-01,tox21-er-bla-agonist-p2,"cis-1,2,3,6-Tetrahydrophthalimide",activity,inactive,1469-48-3,92888.0,O=C1NC(=O)[C@@H]2CC=CC[C@H]12
NCGC00255190-01,tox21-er-bla-agonist-p2,Triflumuron,activity,inactive,64628-44-0,47445.0,O=C(NC(=O)Nc1ccc(OC(F)(F)F)cc1)c2ccccc2Cl
NCGC00256047-01,tox21-er-bla-agonist-p2,"4-(2,5-Diethoxy-4-nitrophenyl)morpholine",activity,inactive,86-16-8,66571.0,[O-][N+](=O)c1cc(OCC)c(cc1OCC)N2CCOCC2
NCGC00256122-01,tox21-er-bla-agonist-p2,"Bis[(2-ethyl-2,5-dimethylhexanoyl)oxy](dimethyl)stannane",activity,inactive,68928-76-7,60196425.0,C[Sn](C)(OC(=O)C(C)(CC)CCC(C)C)OC(=O)C(C)(CC)CCC(C)C
NCGC00256159-01,tox21-er-bla-agonist-p2,Petitgrain oil,activity,inactive,8014-17-3,,
NCGC00256856-01,tox21-er-bla-agonist-p2,(3aR)-(+)-Sclareolide,activity,inactive,564-20-5,929262.0,O=C1C[C@@H]2[C@@]3(C)CCCC(C)(C)[C@@H]3CC[C@@]2(C)O1
NCGC00256904-01,tox21-er-bla-agonist-p2,Cyclopentanethiol,activity,inactive,1679-07-8,15510.0,SC1CCCC1
NCGC00256940-01,tox21-er-bla-agonist-p2,Tetrachlorophthalic anhydride,activity,inactive,117-08-8,8326.0,O=C1OC(=O)c2c1c(Cl)c(Cl)c(Cl)c2Cl
NCGC00257035-01,tox21-er-bla-agonist-p2,Tetraethylene glycol,activity,inactive,112-60-7,8200.0,OCCOCCOCCOCCO
NCGC00257860-01,tox21-er-bla-agonist-p2,"1,2-Epoxydecane",activity,inactive,2404-44-6,16993.0,CCCCCCCCC1CO1
NCGC00257316-01,tox21-er-bla-agonist-p2,3-Chloropropionitrile,activity,inactive,542-76-7,10963.0,ClCCC#N
NCGC00257749-01,tox21-er-bla-agonist-p2,1-Decene,activity,inactive,872-05-9,13381.0,CCCCCCCCC=C
NCGC00257574-01,tox21-er-bla-agonist-p2,Hydroxyvalerenic acid,activity,inactive,1619-16-5,6537505.0,O=C(O)C(\C)=C\[C@@H]2CC[C@@H](C)[C@@H]1C2=C(C)C[C@H]1O
NCGC00259060-01,tox21-er-bla-agonist-p2,Monocrotaline,activity,inactive,315-22-0,9415.0,O=C1OCC3=CCN2CC[C@@H](OC(=O)[C@H](C)[C@@](C)(O)[C@@]1(C)O)[C@H]23
NCGC00259703-01,tox21-er-bla-agonist-p2,C.I. Acid Orange 10,activity,inactive,1936-15-8,9566064.0,[Na+].[Na+].[O-]S(=O)(=O)c3cc(cc2ccc(O)c(/N=N/c1ccccc1)c23)S([O-])(=O)=O
NCGC00260016-01,tox21-er-bla-agonist-p2,"1,2-Dihydro-2,2,4-trimethylquinoline, polymer",activity,inactive,26780-96-1,8981.0,CC2=CC(C)(C)Nc1ccccc12
NCGC00260450-01,tox21-er-bla-agonist-p2,tert-Butyl-3-aminobenzoate,activity,active agonist,92146-82-2,2737408.0,Nc1cc(ccc1)C(=O)OC(C)(C)C
NCGC00260584-01,tox21-er-bla-agonist-p2,NTP Mix43 CT1 3-EQP,activity,inactive,NOCAS_49480,,
NCGC00260286-01,tox21-er-bla-agonist-p2,"N,N-Dimethyltetradecylamine",activity,inactive,112-75-4,8211.0,CN(C)CCCCCCCCCCCCCC
NCGC00016242-01,tox21-er-bla-agonist-p2,Metyrapone,activity,inactive,54-36-4,4174.0,CC(C)(c1cccnc1)C(=O)c2cccnc2
NCGC00016375-01,tox21-er-bla-agonist-p2,Sulfadimethoxine,activity,inactive,122-11-2,5323.0,COc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2
NCGC00016773-01,tox21-er-bla-agonist-p2,Ritodrine hydrochloride,activity,inactive,23239-51-2,31728.0,Cl.O[C@H](c1ccc(O)cc1)[C@H](C)NCCc2ccc(O)cc2
NCGC00016448-01,tox21-er-bla-agonist-p2,Hecogenin,activity,inactive,467-55-0,91453.0,O=C4C[C@@H]1[C@@]6(C)CC[C@H](O)C[C@@H]6CC[C@H]1[C@@H]5C[C@@H]3O[C@]2(CC[C@@H](C)CO2)[C@@H](C)[C@@H]3[C@@]45C
NCGC00016528-01,tox21-er-bla-agonist-p2,Proguanil hydrochloride,activity,inactive,637-32-1,9570076.0,Cl.Clc1ccc(NC(=N)NC(=N)NC(C)C)cc1
NCGC00256052-01,tox21-er-bla-agonist-p2,Triethoxy(2-methylpropyl)silane,activity,inactive,17980-47-1,87391.0,CCO[Si](OCC)(OCC)CC(C)C
NCGC00254713-01,tox21-er-bla-agonist-p2,Pentachlorothioanisole,activity,inactive,1825-19-0,15766.0,Clc1c(SC)c(Cl)c(Cl)c(Cl)c1Cl
NCGC00255245-01,tox21-er-bla-agonist-p2,Hexyl acetate,activity,inactive,142-92-7,8908.0,O=C(C)OCCCCCC
NCGC00256419-01,tox21-er-bla-agonist-p2,Apigenin,activity,active agonist,520-36-5,5280443.0,Oc1ccc(cc1)C3=CC(=O)c2c(cc(O)cc2O)O3
NCGC00255647-01,tox21-er-bla-agonist-p2,"2,4-Dinitrophenyl thiocyanate",activity,active agonist,1594-56-5,15325.0,N#CSc1ccc(cc1[N+]([O-])=O)[N+]([O-])=O
NCGC00254366-01,tox21-er-bla-agonist-p2,Isopropalin,activity,inactive,33820-53-0,36606.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCC)CCC)C(C)C
NCGC00254480-01,tox21-er-bla-agonist-p2,UK-156819,activity,inactive,162706-14-1,9926621.0,O=C(O)CCCCn2c1ccccc1c(c2C)c3cccnc3
NCGC00254500-01,tox21-er-bla-agonist-p2,Butyl benzoate,activity,inactive,136-60-7,8698.0,O=C(OCCCC)c1ccccc1
NCGC00255293-01,tox21-er-bla-agonist-p2,Farnesol,activity,inactive,4602-84-0,445070.0,C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CO
NCGC00255547-01,tox21-er-bla-agonist-p2,Ethyl 2-methylbenzoate,activity,inactive,87-24-1,66598.0,O=C(OCC)c1ccccc1C
NCGC00093668-01,tox21-er-bla-agonist-p2,Benazoline oxalate,activity,inactive,1021868-82-5,60196273.0,O=C(O)C(=O)O.c1cc(cc2ccccc12)C3=NCCN3
NCGC00095019-01,tox21-er-bla-agonist-p2,Edoxudine,activity,inactive,15176-29-1,66377.0,CCC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00095086-01,tox21-er-bla-agonist-p2,Periciazine,activity,inactive,2622-26-6,4747.0,OC1CCN(CC1)CCCN2c4ccccc4Sc3ccc(C#N)cc23
NCGC00159446-02,tox21-er-bla-agonist-p2,Carbutamide,activity,inactive,339-43-5,9564.0,Nc1ccc(cc1)S(=O)(=O)NC(=O)NCCCC
NCGC00159544-01,tox21-er-bla-agonist-p2,Zaldaride,activity,inactive,109826-26-8,65909.0,O=C2Nc1ccccc1N2C3CCN(CC3)CC5(C)OCc6ccccc6n4cccc45
NCGC00167725-01,tox21-er-bla-agonist-p2,Tianeptine sodium,activity,inactive,30123-17-2,23663953.0,[Na+].[O-]C(=O)CCCCCCNC2c1ccc(Cl)cc1S(=O)(=O)N(C)c3ccccc23
NCGC00168353-01,tox21-er-bla-agonist-p2,Fenobam,activity,inactive,57653-26-6,162834.0,O=C2N=C(NC(=O)Nc1cccc(Cl)c1)N(C)C2
NCGC00181351-01,tox21-er-bla-agonist-p2,Tenovin-1,activity,inactive,380315-80-0,1013376.0,S=C(Nc1ccc(cc1)NC(C)=O)NC(=O)c2ccc(cc2)C(C)(C)C
NCGC00254079-01,tox21-er-bla-agonist-p2,Acenaphthene,activity,inactive,83-32-9,6734.0,c1cc2cccc3CCc(c1)c23
NCGC00260594-01,tox21-er-bla-agonist-p2,NTP Mix38 CT1 2-EQP,activity,inactive,NOCAS_49490,,
NCGC00260634-01,tox21-er-bla-agonist-p2,NTP Mix110 ER1 10-EQC,activity,inconclusive agonist,NOCAS_49530,,
NTOC00000202-01,tox21-er-bla-agonist-p2,Eledoisin,activity,inactive,69-25-0,10328936.0,O=C(N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)[C@@H](C)CC)[C@@H]3CCCN3C(=O)[C@@H]2CCC(=O)N2
NCGC00015095-09,tox21-er-bla-agonist-p2,Amitriptyline hydrochloride,activity,inactive,549-18-8,11065.0,Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12
NCGC00018237-03,tox21-er-bla-agonist-p2,Trichlorfon,activity,inactive,52-68-6,5853.0,OC(C(Cl)(Cl)Cl)P(=O)(OC)OC
NCGC00182982-01,tox21-er-bla-agonist-p2,Dalcotidine,activity,inactive,120958-90-9,129319.0,CCNC(=O)NCCCOc2cc(CN1CCCCC1)ccc2
NCGC00245236-02,tox21-er-bla-agonist-p2,Methaqualone,activity,inactive,72-44-6,6292.0,Cc1ccccc1N3C(C)=Nc2ccccc2C3=O
NCGC00090773-04,tox21-er-bla-agonist-p2,Mono(2-ethylhexyl) phthalate,activity,inactive,4376-20-9,20393.0,O=C(O)c1ccccc1C(=O)OCC(CC)CCCC
NCGC00090964-02,tox21-er-bla-agonist-p2,Tetraethylenepentamine,activity,inactive,112-57-2,8197.0,NCCNCCNCCNCCN
NCGC00016981-01,tox21-er-bla-agonist-p2,Troleandomycin,activity,inactive,2751-09-9,5284630.0,CC(=O)O[C@@H]4[C@H](C[C@@H](C)O[C@H]4O[C@@H]3[C@@H](C)[C@H](O[C@H]1C[C@H](OC)[C@@H](OC(C)=O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(CO2)C[C@@H]3C)N(C)C
NCGC00017337-02,tox21-er-bla-agonist-p2,Capsaicin,activity,inactive,404-86-4,1548943.0,Oc1ccc(cc1OC)CNC(=O)CCCC/C=C/C(C)C
NCGC00018248-04,tox21-er-bla-agonist-p2,Meloxicam,activity,inactive,71125-38-7,54677470.0,Cc3cnc(NC(=O)C2=C(O)c1ccccc1S(=O)(=O)N2C)s3
NCGC00022819-03,tox21-er-bla-agonist-p2,Ipratropium bromide hydrate,activity,inactive,66985-17-9,441337.0,[Br-].O.C[N+]2(C1CC(CC2CC1)OC(=O)C(CO)c3ccccc3)C(C)C
NCGC00024853-05,tox21-er-bla-agonist-p2,Levosulpiride,activity,inactive,23672-07-3,688272.0,CCN2CCC[C@H]2CNC(=O)c1cc(ccc1OC)S(N)(=O)=O
NCGC00258407-01,tox21-er-bla-agonist-p2,3-Methylbenzonitrile,activity,inactive,620-22-4,12104.0,N#Cc1cccc(C)c1
NCGC00258518-01,tox21-er-bla-agonist-p2,"1,3-Dichloro-2-butene",activity,inactive,926-57-8,637892.0,C\C(Cl)=C\CCl
NCGC00258534-01,tox21-er-bla-agonist-p2,2-Chloronaphthalene,activity,inactive,91-58-7,7056.0,Clc1ccc2ccccc2c1
NCGC00257111-01,tox21-er-bla-agonist-p2,"Ethanol, 2,2'-[(3-chlorophenyl)imino]bis-",activity,inactive,92-00-2,66688.0,Clc1cc(ccc1)N(CCO)CCO
NCGC00257160-01,tox21-er-bla-agonist-p2,Dibutyltin dichloride,activity,active agonist,683-18-1,12688.0,CCCC[Sn](Cl)(Cl)CCCC
NCGC00257214-01,tox21-er-bla-agonist-p2,MCPB,activity,inactive,94-81-5,7207.0,Clc1cc(C)c(OCCCC(=O)O)cc1
NCGC00257811-01,tox21-er-bla-agonist-p2,"1,4-Bis(trichloromethyl)benzene",activity,inactive,68-36-0,6233.0,ClC(Cl)(Cl)c1ccc(cc1)C(Cl)(Cl)Cl
NCGC00257819-01,tox21-er-bla-agonist-p2,4-Nitroacetophenone,activity,inactive,100-19-6,7487.0,O=[N+]([O-])c1ccc(cc1)C(C)=O
NCGC00257838-01,tox21-er-bla-agonist-p2,Bis(2-chloroethoxy)methane,activity,inactive,111-91-1,8147.0,ClCCOCOCCCl
NCGC00257855-01,tox21-er-bla-agonist-p2,2-(2-Methylpropyl)thiazole,activity,inactive,18640-74-9,62725.0,CC(C)Cc1nccs1
NCGC00258000-01,tox21-er-bla-agonist-p2,"1,2,3,4-Tetrahydronaphthalen-1-one",activity,inactive,529-34-0,10724.0,O=C2CCCc1ccccc12
NCGC00258166-01,tox21-er-bla-agonist-p2,1-Hexylpyridinium chloride,activity,inactive,6220-15-1,2734172.0,[Cl-].CCCCCC[n+]1ccccc1
NCGC00258238-01,tox21-er-bla-agonist-p2,"1,3-Diisopropenylbenzene",activity,inactive,3748-13-8,77353.0,CC(=C)c1cccc(c1)C(=C)C
NCGC00258364-01,tox21-er-bla-agonist-p2,Ethyl methacrylate,activity,inactive,97-63-2,7343.0,C=C(C)C(=O)OCC
NCGC00256411-01,tox21-er-bla-agonist-p2,C.I. Acid Blue 74,activity,inactive,860-22-0,5284351.0,[Na+].[Na+].[O-]S(=O)(=O)c1cc2C(=O)C(\Nc2cc1)=C4/Nc3ccc(cc3C4=O)S([O-])(=O)=O
NCGC00255806-01,tox21-er-bla-agonist-p2,Fluoroglycofen-ethyl,activity,inactive,77501-90-7,53672.0,Clc2cc(ccc2Oc1cc(C(=O)OCC(=O)OCC)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00255812-01,tox21-er-bla-agonist-p2,"3,3'-[Oxybis(ethane-2,1-diyloxy)]dipropan-1-amine",activity,inactive,4246-51-9,20239.0,NCCCOCCOCCOCCCN
NCGC00255842-01,tox21-er-bla-agonist-p2,MON-4660,activity,inactive,71526-07-3,3482402.0,ClC(Cl)C(=O)N2CCOC12CCCCC1
NCGC00255956-01,tox21-er-bla-agonist-p2,Limonene dioxide,activity,inactive,96-08-2,7275.0,CC12CCC(CC2O1)C3OC3C
NCGC00256212-01,tox21-er-bla-agonist-p2,Tributylphosphine,activity,inactive,998-40-3,13831.0,CCCCP(CCCC)CCCC
NCGC00256220-01,tox21-er-bla-agonist-p2,N-Benzyl-N-hydroxy-1-phenylmethanamine,activity,inactive,621-07-8,69297.0,ON(Cc1ccccc1)Cc2ccccc2
NCGC00255706-01,tox21-er-bla-agonist-p2,Sodium 2-nitrophenolate,activity,inactive,824-39-5,69985.0,[Na+].O=[N+]([O-])c1ccccc1[O-]
NCGC00258785-01,tox21-er-bla-agonist-p2,1-Naphthylamine,activity,inactive,134-32-7,8640.0,Nc2cccc1ccccc12
NCGC00258807-01,tox21-er-bla-agonist-p2,N-Nitrosodiethylamine,activity,inactive,55-18-5,5921.0,CCN(CC)N=O
NCGC00259043-01,tox21-er-bla-agonist-p2,12-Hydroxyoctadecanoic acid,activity,inactive,106-14-9,7789.0,O=C(O)CCCCCCCCCCC(O)CCCCCC
NCGC00260518-01,tox21-er-bla-agonist-p2,Dibenzosuberone,activity,active agonist,1210-35-1,14589.0,O=C1c3ccccc3CCc2ccccc12
NCGC00260601-01,tox21-er-bla-agonist-p2,NTP Mix4 AR1 8-EQC,activity,inactive,NOCAS_49497,,
NCGC00260663-01,tox21-er-bla-agonist-p2,NTP Mix28 AR2 3-EQP,activity,inactive,NOCAS_49559,,
NCGC00259097-01,tox21-er-bla-agonist-p2,Methyl isothiocyanate,activity,inactive,556-61-6,11167.0,C\N=C=S
NCGC00259155-01,tox21-er-bla-agonist-p2,Methenamine,activity,inactive,100-97-0,4101.0,C1N3CN2CN(CN1C2)C3
NCGC00259259-01,tox21-er-bla-agonist-p2,1-Phenoxy-2-propanol,activity,inactive,770-35-4,92839.0,CC(O)COc1ccccc1
NCGC00259293-01,tox21-er-bla-agonist-p2,Aldicarb sulfoxide,activity,inactive,1646-87-3,9568700.0,CC(C)(\C=N\OC(=O)NC)S(C)=O
NCGC00259381-01,tox21-er-bla-agonist-p2,Methyl benzoate,activity,inactive,93-58-3,7150.0,COC(=O)c1ccccc1
NCGC00259441-01,tox21-er-bla-agonist-p2,5-(Hydroxymethyl)-2-furfural,activity,inactive,67-47-0,237332.0,O=Cc1ccc(CO)o1
NCGC00259470-01,tox21-er-bla-agonist-p2,Pentaerythritol,activity,inactive,115-77-5,8285.0,OCC(CO)(CO)CO
NCGC00260262-01,tox21-er-bla-agonist-p2,Barium nitrate,activity,inactive,10022-31-8,24798.0,[Ba+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O
NCGC00260282-01,tox21-er-bla-agonist-p2,Cyclododecane,activity,inactive,294-62-2,9268.0,C1CCCCCCCCCCC1
NCGC00258771-01,tox21-er-bla-agonist-p2,"1,1-(1,4-Phenylene)bis-ethanone",activity,inactive,1009-61-6,13888.0,O=C(C)c1ccc(cc1)C(C)=O
NCGC00254975-01,tox21-er-bla-agonist-p2,2-Hydroxy-1-[4-(2-hydroxyethoxy)phenyl]-2-methylpropan-1-one,activity,inactive,106797-53-9,86266.0,CC(C)(O)C(=O)c1ccc(OCCO)cc1
NCGC00255353-01,tox21-er-bla-agonist-p2,"Pyridine, 2,3-dichloro-5-(trichloromethyl)-",activity,inactive,69045-83-6,94647.0,Clc1cc(cnc1Cl)C(Cl)(Cl)Cl
NCGC00255405-01,tox21-er-bla-agonist-p2,Butyl 4-oxopentanoate,activity,inactive,2052-15-5,16331.0,O=C(CCC(C)=O)OCCCC
NCGC00159441-02,tox21-er-bla-agonist-p2,Deslanoside,activity,inactive,17598-65-1,28620.0,O=C1C=C(CO1)[C@H]2CC[C@@]9(O)[C@]2(C)[C@H](O)C[C@H]4[C@H]9CC[C@@H]3C[C@H](CC[C@@]34C)O[C@@H]8O[C@H](C)[C@@H](O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)C6)[C@@H](O)C7)[C@@H](O)C8
NCGC00094515-01,tox21-er-bla-agonist-p2,Zimeldine dihydrochloride hydrate,activity,inactive,61129-30-4,6420041.0,Cl.Cl.O.Brc1ccc(cc1)C(=C\CN(C)C)\c2cccnc2
NCGC00163930-04,tox21-er-bla-agonist-p2,Tralkoxydim,activity,inactive,87820-88-0,91746.0,CC\C(=N\OCC)C1=C(O)CC(CC1=O)c2c(C)cc(C)cc2C
NCGC00164140-03,tox21-er-bla-agonist-p2,Docusate sodium,activity,inactive,577-11-7,23673837.0,[Na+].O=S(=O)([O-])C(CC(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC
NCGC00160373-01,tox21-er-bla-agonist-p2,Dianiline,activity,inactive,58338-59-3,42725.0,O=C(Nc1ccccc1N)c2ccc(N)cc2
NCGC00160376-01,tox21-er-bla-agonist-p2,Metocinium iodide,activity,inactive,2424-71-7,71518.0,[I-].OC(C(=O)OCC[N+](C)(C)C)(c1ccccc1)c2ccccc2
NCGC00164496-01,tox21-er-bla-agonist-p2,Alafosfalin,activity,inactive,60668-24-8,71957.0,C[C@H](NC(=O)[C@H](C)N)P(=O)(O)O
NCGC00167737-01,tox21-er-bla-agonist-p2,Lazabemide hydrochloride,activity,inactive,103878-83-7,163727.0,Cl.Clc1cnc(cc1)C(=O)NCCN
NCGC00181304-01,tox21-er-bla-agonist-p2,Imexon,activity,inactive,59643-91-3,68791.0,O=C1N=C(N)C2CN12
NCGC00095095-01,tox21-er-bla-agonist-p2,Sennoside A,activity,inactive,81-27-6,73111.0,O=C(O)c3cc(O)c4C(=O)c2c(cccc2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](c4c3)[C@@H]8c6cccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c6C(=O)c7c8cc(cc7O)C(=O)O
NCGC00160445-01,tox21-er-bla-agonist-p2,Bromisovalum,activity,inactive,496-67-3,2447.0,CC(C)C(Br)C(=O)NC(N)=O
NCGC00160446-01,tox21-er-bla-agonist-p2,Cinflumide,activity,inactive,64379-93-7,6434871.0,O=C(/C=C/c1cccc(F)c1)NC2CC2
NCGC00167479-01,tox21-er-bla-agonist-p2,"N,N'-1,2-Ethylenediylbiscysteine, diethyl ester dihydrochloride",activity,inactive,14344-58-2,60196295.0,Cl.Cl.O=C(OCC)C(CS)NCCNC(CS)C(=O)OCC
NCGC00167484-01,tox21-er-bla-agonist-p2,Ciclesonide,activity,inactive,141845-82-1,6918155.0,CC(C)C(=O)OCC(=O)[C@]35O[C@@H](O[C@@H]5C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4[C@@H](O)C[C@@]23C)C6CCCCC6
NCGC00168262-02,tox21-er-bla-agonist-p2,(S)-(-)-Cathinone hydrochloride,activity,inactive,72739-14-1,11956149.0,Cl.O=C([C@H](C)N)c1ccccc1
NCGC00095172-01,tox21-er-bla-agonist-p2,Securinine,activity,inactive,5610-40-2,442872.0,O=C1C=C2C=C[C@@H]3C[C@@]2(O1)[C@H]4CCCCN34
NCGC00160546-01,tox21-er-bla-agonist-p2,Haloxon,activity,inactive,321-55-1,9454.0,O=P(OCCCl)(OCCCl)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C
NCGC00160628-01,tox21-er-bla-agonist-p2,Rutin trihydrate,activity,inactive,153-18-4,5280805.0,Oc1ccc(cc1O)C=4Oc5cc(O)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O
NCGC00160664-01,tox21-er-bla-agonist-p2,Nitroxoline,activity,inactive,4008-48-4,19910.0,[O-][N+](=O)c1ccc(O)c2ncccc12
NCGC00167575-01,tox21-er-bla-agonist-p2,Anagrelide hydrochloride,activity,inactive,58579-51-4,60196296.0,Cl.Oc1cn2Cc3c(Nc2n1)ccc(Cl)c3Cl
NCGC00091616-01,tox21-er-bla-agonist-p2,2-Ethoxybenzamide,activity,inactive,938-73-8,3282.0,CCOc1ccccc1C(N)=O
NCGC00186049-01,tox21-er-bla-agonist-p2,Sematilide monohydrochloride,activity,inactive,101526-62-9,58504.0,Cl.O=S(C)(=O)Nc1ccc(cc1)C(=O)NCCN(CC)CC
NCGC00254494-01,tox21-er-bla-agonist-p2,CP-607366,activity,inactive,289716-94-5,9861124.0,Clc2ccc(Oc1ccc(F)cc1CNC)cc2Cl
NCGC00254915-01,tox21-er-bla-agonist-p2,N-Methylethanolamine,activity,inactive,109-83-1,8016.0,CNCCO
NCGC00255119-01,tox21-er-bla-agonist-p2,"N-(2-Fluorenyl)-2,2,2-trifluoroacetamide",activity,inactive,363-17-7,9690.0,FC(F)(F)C(=O)Nc1ccc2c3ccccc3Cc2c1
NCGC00255135-01,tox21-er-bla-agonist-p2,"Sodium 1,4-diisobutyl sulfosuccinate",activity,inactive,127-39-9,23683016.0,[Na+].O=S(=O)([O-])C(CC(=O)OCC(C)C)C(=O)OCC(C)C
NCGC00182050-01,tox21-er-bla-agonist-p2,Pyrethrins,activity,inactive,8003-34-7,,
NCGC00182850-01,tox21-er-bla-agonist-p2,Alpidem,activity,inactive,82626-01-5,54897.0,CCCN(CCC)C(=O)Cc1c(nc2ccc(Cl)cn12)c3ccc(Cl)cc3
NCGC00181770-01,tox21-er-bla-agonist-p2,Garenoxacin mesylate hydrate,activity,inactive,223652-90-2,157690.0,O.CS(=O)(=O)O.C[C@H]1NCc2cc(ccc12)c3ccc4c(c3OC(F)F)N(C=C(C4=O)C(=O)O)C5CC5
NCGC00259548-01,tox21-er-bla-agonist-p2,Sulfacetamide,activity,inactive,144-80-9,5320.0,Nc1ccc(cc1)S(=O)(=O)NC(C)=O
NCGC00259639-01,tox21-er-bla-agonist-p2,"1,8-Cineol",activity,inactive,470-82-6,2758.0,CC2(C)OC1(C)CCC2CC1
NCGC00259951-01,tox21-er-bla-agonist-p2,Diethyl sulfate,activity,inactive,64-67-5,6163.0,O=S(=O)(OCC)OCC
NCGC00260124-01,tox21-er-bla-agonist-p2,Vinyltrimethoxysilane,activity,inactive,2768-02-7,76004.0,C=C[Si](OC)(OC)OC
NCGC00258172-01,tox21-er-bla-agonist-p2,"2,5-Hexanedione",activity,inactive,110-13-4,8035.0,CC(=O)CCC(C)=O
NCGC00260416-01,tox21-er-bla-agonist-p2,"Tridecane,1-bromo-",activity,inactive,765-09-3,13000.0,BrCCCCCCCCCCCCC
NCGC00256871-01,tox21-er-bla-agonist-p2,Citronellyl butyrate,activity,inactive,141-16-2,8835.0,C\C(C)=C\CCC(C)CCOC(=O)CCC
NCGC00016666-01,tox21-er-bla-agonist-p2,Hydrocotarnine hydrobromide,activity,inactive,5985-00-2,6419942.0,Br.CN1Cc2c(OC)c3OCOc3cc2CC1
NCGC00016740-13,tox21-er-bla-agonist-p2,Prazosin,activity,inactive,19216-56-9,4893.0,O=C(N1CCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3)c4ccco4
NCGC00257268-01,tox21-er-bla-agonist-p2,Bromocriptine mesylate,activity,inactive,22260-51-1,31100.0,CS(=O)(=O)O.Brc3nc2cccc1C4=C[C@H](CN(C)[C@@H]4Cc3c12)C(=O)N[C@@]7(O[C@]6(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@H]56)C7=O)C(C)C
NCGC00258484-01,tox21-er-bla-agonist-p2,Mexenone,activity,inactive,1641-17-4,71645.0,O=C(c1ccc(cc1O)OC)c2ccc(C)cc2
NCGC00255461-01,tox21-er-bla-agonist-p2,Flutriafol,activity,inactive,76674-21-0,91727.0,OC(Cn1cncn1)(c2ccccc2F)c3ccc(F)cc3
NCGC00257815-01,tox21-er-bla-agonist-p2,1-Ethyl-1-methylpyrrolidinium hexafluorophosphate,activity,inactive,121057-90-7,23082568.0,F[P-](F)(F)(F)(F)F.C[N+]1(CC)CCCC1
NCGC00256943-01,tox21-er-bla-agonist-p2,"2-Ethyl-1,3-hexanediol",activity,inactive,94-96-2,7211.0,CCCC(O)C(CC)CO
NCGC00257867-01,tox21-er-bla-agonist-p2,Valerenic acid,activity,inactive,3569-10-6,6440940.0,O=C(O)C(\C)=C\[C@@H]1CC[C@@H](C)[C@H]2CCC(C)=C12
NCGC00257379-01,tox21-er-bla-agonist-p2,alpha-Pinene,activity,inactive,80-56-8,6654.0,CC2(C)C1CC=C(C)C2C1
NCGC00015872-05,tox21-er-bla-agonist-p2,Quipazine maleate,activity,inactive,5786-68-5,5702242.0,O=C(O)/C=C\C(=O)O.n1c3ccccc3ccc1N2CCNCC2
NCGC00258320-01,tox21-er-bla-agonist-p2,"1,3-Benzenedimethanamine",activity,inactive,1477-55-0,15133.0,NCc1cccc(CN)c1
NCGC00254131-01,tox21-er-bla-agonist-p2,SR58611,activity,inactive,929601-09-2,21935081.0,Cl.Clc1cccc(c1)C(O)CNC2Cc3cc(ccc3CC2)OCC(=O)OCC
NCGC00255809-01,tox21-er-bla-agonist-p2,3-Mercaptopropyltrimethoxysilane,activity,inactive,4420-74-0,20473.0,CO[Si](CCCS)(OC)OC
NCGC00255717-01,tox21-er-bla-agonist-p2,Triethoxy(phenyl)silane,activity,inactive,780-69-8,13075.0,CCO[Si](OCC)(OCC)c1ccccc1
NCGC00255591-01,tox21-er-bla-agonist-p2,"C.I. Acid Violet 12, disodium salt",activity,inactive,6625-46-3,5483526.0,[Na+].[Na+].[O-]S(=O)(=O)c3cc2cc(c(/N=N/c1ccccc1OC)c(O)c2c(c3)NC(C)=O)S([O-])(=O)=O
NCGC00256724-01,tox21-er-bla-agonist-p2,2-methyl-6-methylideneoct-7-en-2-yl acetate,activity,inactive,1118-39-4,14235.0,C=CC(=C)CCCC(C)(C)OC(C)=O
NCGC00256583-01,tox21-er-bla-agonist-p2,3-Methylbenzoic acid,activity,inactive,99-04-7,7418.0,Cc1cccc(c1)C(O)=O
NCGC00256247-01,tox21-er-bla-agonist-p2,Ethyl [3-(triethoxysilyl)propyl]carbamate,activity,inactive,17945-05-0,87367.0,CCO[Si](OCC)(OCC)CCCNC(=O)OCC
NCGC00256667-01,tox21-er-bla-agonist-p2,alpha-Phellandrene,activity,inactive,99-83-2,7460.0,CC=1C=CC(CC=1)C(C)C
NCGC00256287-01,tox21-er-bla-agonist-p2,4-Ethyl-2-methoxyphenol,activity,inactive,2785-89-9,62465.0,Oc1ccc(cc1OC)CC
NCGC00257095-01,tox21-er-bla-agonist-p2,Trimethoxy[3-(oxiran-2-ylmethoxy)propyl]silane,activity,inactive,2530-83-8,17317.0,CO[Si](CCCOCC1CO1)(OC)OC
NCGC00257004-01,tox21-er-bla-agonist-p2,"N,N-Dimethyl-4-nitrosoaniline",activity,inactive,138-89-6,8749.0,CN(C)c1ccc(N=O)cc1
NCGC00257605-01,tox21-er-bla-agonist-p2,alpha-Methyl cinnamaldehyde,activity,inactive,101-39-3,7557.0,CC(=Cc1ccccc1)C=O
NCGC00257833-01,tox21-er-bla-agonist-p2,"1,3,5-Trichlorobenzene",activity,inactive,108-70-3,7950.0,Clc1cc(Cl)cc(Cl)c1
NCGC00257847-01,tox21-er-bla-agonist-p2,"2',3',4'-Trichloroacetophenone",activity,inactive,13608-87-2,26132.0,Clc1ccc(C(C)=O)c(Cl)c1Cl
NCGC00257640-01,tox21-er-bla-agonist-p2,2-Methylbenzoic acid,activity,inactive,118-90-1,8373.0,Cc1ccccc1C(O)=O
NCGC00257914-01,tox21-er-bla-agonist-p2,N-Isopropylaniline,activity,inactive,768-52-5,13032.0,CC(C)Nc1ccccc1
NCGC00257856-01,tox21-er-bla-agonist-p2,"2,4-D, Dimethylamine salt",activity,inactive,2008-39-1,16180.0,Clc1cc(Cl)ccc1OCC(=O)O.CNC
NCGC00257485-01,tox21-er-bla-agonist-p2,"Acetic acid, mercapto-, isooctyl ester",activity,inactive,25103-09-7,34306.0,CC(C)CCCCCOC(=O)CS
NCGC00257725-01,tox21-er-bla-agonist-p2,2-Amino-4-phenylthiazole hydrobromide hydrate,activity,inactive,52253-69-7,40301.0,Br.O.Nc1nc(cs1)c2ccccc2
NCGC00257519-01,tox21-er-bla-agonist-p2,"2,3,6-Trichlorobenzoic acid",activity,inactive,50-31-7,5759.0,Clc1c(C(=O)O)c(Cl)ccc1Cl
NCGC00257532-01,tox21-er-bla-agonist-p2,4-Phenoxyphenol,activity,active agonist,831-82-3,13254.0,Oc2ccc(Oc1ccccc1)cc2
NCGC00258551-01,tox21-er-bla-agonist-p2,"1-Chloro-2-propanol, technical grade (~75% 1-chloro-2-propanol; ~25% 2-chloro-1-propanol)",activity,inactive,NOCAS_21988,31370.0,CC(O)CCl
NCGC00258784-01,tox21-er-bla-agonist-p2,Hydroxypropyl methacrylate,activity,inactive,27813-02-1,13539.0,CC(=C)C(=O)OCC(C)O
NCGC00258988-01,tox21-er-bla-agonist-p2,Tripropylene glycol monomethyl ether,activity,inactive,25498-49-1,25054.0,COC(C)COC(C)COC(C)CO
NCGC00258197-01,tox21-er-bla-agonist-p2,Methanesulfonyl chloride,activity,inactive,124-63-0,31297.0,CS(Cl)(=O)=O
NCGC00259340-01,tox21-er-bla-agonist-p2,Indomethacin,activity,inactive,53-86-1,3715.0,Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC
NCGC00259779-01,tox21-er-bla-agonist-p2,1-(2-Aminoethyl)piperazine,activity,inactive,140-31-8,8795.0,NCCN1CCNCC1
NCGC00259788-01,tox21-er-bla-agonist-p2,"o,p'-DDT",activity,active agonist,789-02-6,13089.0,Clc2ccccc2C(c1ccc(Cl)cc1)C(Cl)(Cl)Cl
NCGC00259807-01,tox21-er-bla-agonist-p2,Diethylbenzene,activity,inactive,25340-17-4,8657.0,CCc1ccccc1CC
NCGC00260279-01,tox21-er-bla-agonist-p2,Dodine,activity,inactive,2439-10-3,17110.0,CC(=O)O.N=C(N)NCCCCCCCCCCCC
NCGC00260435-01,tox21-er-bla-agonist-p2,"Bis(eta(5)-2,4-cyclopentadien-1-yl) chromium",activity,inactive,1271-24-5,79154.0,[Cr+2].[c-]1cccc1.c1[c-]ccc1
NCGC00260666-01,tox21-er-bla-agonist-p2,NTP Mix30 AR2 7-EQP,activity,active agonist,NOCAS_49562,,
NCGC00260475-01,tox21-er-bla-agonist-p2,2-Nitrobenzaldehyde,activity,inactive,552-89-6,11101.0,O=[N+]([O-])c1ccccc1C=O
NCGC00260589-01,tox21-er-bla-agonist-p2,NTP Mix46 CT1 3-EQP,activity,inactive,NOCAS_49485,,
NCGC00259665-01,tox21-er-bla-agonist-p2,Dibenzofuran,activity,inactive,132-64-9,568.0,c1cccc2oc3ccccc3c12
NCGC00021268-03,tox21-er-bla-agonist-p2,Hydroxyprogesterone caproate,activity,inactive,630-56-8,169870.0,CC(=O)[C@@]3(OC(=O)CCCCC)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00090753-01,tox21-er-bla-agonist-p2,Azithromycin,activity,inactive,83905-01-5,447043.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@]2(C)O)[C@@H]3O
NCGC00255801-01,tox21-er-bla-agonist-p2,"6-Ethoxy-2,3,4-trimethyl-1,2,3,4-tetrahydroquinoline",activity,inactive,16489-90-0,86013.0,CCOc1ccc2NC(C)(C)CC(C)c2c1
NCGC00254570-01,tox21-er-bla-agonist-p2,Maleic hydrazide,activity,inactive,123-33-1,21954.0,O=C1C=CC(=O)NN1
NCGC00254741-01,tox21-er-bla-agonist-p2,4-Chlorophenylurea,activity,inactive,140-38-5,8796.0,Clc1ccc(NC(N)=O)cc1
NCGC00255205-01,tox21-er-bla-agonist-p2,Methyl carbamate,activity,inactive,598-55-0,11722.0,NC(=O)OC
NCGC00254514-01,tox21-er-bla-agonist-p2,17alpha-Ethinylestradiol,activity,active agonist,57-63-6,5991.0,Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3
NCGC00254926-01,tox21-er-bla-agonist-p2,Etoxazole,activity,inactive,153233-91-1,153974.0,CC(C)(C)c1cc(OCC)c(cc1)C2N=C(OC2)c3c(F)cccc3F
NCGC00255166-01,tox21-er-bla-agonist-p2,Scopolamine hydrobromide,activity,inactive,114-49-8,6603108.0,Br.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34
NCGC00016371-01,tox21-er-bla-agonist-p2,Dichlorphenamide,activity,inactive,120-97-8,3038.0,Clc1c(cc(cc1Cl)S(N)(=O)=O)S(N)(=O)=O
NCGC00016404-01,tox21-er-bla-agonist-p2,Hexetidine,activity,inactive,141-94-6,3607.0,CCC(CCCC)CN1CC(C)(N)CN(CC(CCCC)CC)C1
NCGC00016580-01,tox21-er-bla-agonist-p2,Vancomycin hydrochloride,activity,inactive,1404-93-9,16051954.0,Cl.CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)C(O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC=C(O)C(=C3)C3=C(C=C(O)C=C3O)[C@@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2
NCGC00017137-01,tox21-er-bla-agonist-p2,Ceftazidime pentahydrate,activity,inactive,78439-06-2,6536864.0,O.O.O.O.O.O=C(O)C(C)(C)O\N=C(\c1csc(N)n1)C(=O)N[C@@H]4C(=O)N3C(=C(C[n+]2ccccc2)CS[C@@H]34)C([O-])=O
NCGC00022680-04,tox21-er-bla-agonist-p2,Chlormadinone acetate,activity,inactive,302-22-7,9324.0,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00094995-01,tox21-er-bla-agonist-p2,Adiphenine hydrochloride,activity,inactive,50-42-0,5763.0,Cl.CCN(CC)CCOC(=O)C(c1ccccc1)c2ccccc2
NCGC00160683-01,tox21-er-bla-agonist-p2,Ftaxilide,activity,inactive,19368-18-4,71895.0,O=C(Nc1c(C)cccc1C)c2ccccc2C(=O)O
NCGC00254833-01,tox21-er-bla-agonist-p2,R-(-)-Carvone,activity,inactive,6485-40-1,439570.0,CC1=CC[C@H](CC1=O)C(C)=C
NCGC00260599-01,tox21-er-bla-agonist-p2,NTP Mix2 AR1 4-EQP,activity,inactive,NOCAS_49495,,
NCGC00013426-01,tox21-er-bla-agonist-p2,Cholic acid piperazine (1:1),activity,inactive,6266-73-5,60196259.0,O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]2[C@]4(C)[C@@H](O)C[C@@H]1[C@@]3(C)CC[C@@H](O)C[C@H]3C[C@@H](O)[C@H]12.C1CNCCN1
NCGC00013722-01,tox21-er-bla-agonist-p2,Scopolamine hydrobromide,activity,inactive,114-49-8,6603108.0,Br.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34
NCGC00016846-01,tox21-er-bla-agonist-p2,Suprofen,activity,inactive,40828-46-4,5359.0,O=C(c1ccc(cc1)C(C)C(=O)O)c2cccs2
NCGC00021274-03,tox21-er-bla-agonist-p2,Estradiol benzoate,activity,active agonist,50-50-0,222757.0,O=C(Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3)c5ccccc5
NCGC00094665-01,tox21-er-bla-agonist-p2,Ephedrine hydrochloride,activity,inactive,50-98-6,65326.0,Cl.O[C@@H]([C@H](C)NC)c1ccccc1
NCGC00166273-01,tox21-er-bla-agonist-p2,Levamisole resinate,activity,inactive,NOCAS_47831,10569.0,CC(C)C=3CC[C@H]1C(=CC[C@H]2[C@@](C)(CCC[C@]12C)C(=O)O)C=3
NCGC00182057-02,tox21-er-bla-agonist-p2,Detomidine hydrochloride,activity,inactive,90038-01-0,56031.0,Cl.Cc2cccc(Cc1cncn1)c2C
NCGC00090766-01,tox21-er-bla-agonist-p2,Prednisone,activity,inactive,53-03-2,5865.0,OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00090802-01,tox21-er-bla-agonist-p2,beta-Propiolactone,activity,inactive,57-57-8,2365.0,O=C1CCO1
NCGC00017037-01,tox21-er-bla-agonist-p2,Oxalamine citrate,activity,inactive,1949-20-8,264891.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CC)CCc1nc(no1)c2ccccc2
NCGC00018107-04,tox21-er-bla-agonist-p2,2-Thiosalicylic acid,activity,inactive,147-93-3,5443.0,OC(=O)c1ccccc1S
NCGC00018122-08,tox21-er-bla-agonist-p2,Tomelukast,activity,inactive,88107-10-2,3969.0,CC(=O)c2ccc(OCCCCc1nnnn1)c(CCC)c2O
NCGC00023509-03,tox21-er-bla-agonist-p2,Lovastatin,activity,inactive,75330-75-5,53232.0,C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23
NCGC00024749-01,tox21-er-bla-agonist-p2,Pirlindole mesylate,activity,inactive,207572-66-5,2829432.0,CS(=O)(=O)O.Cc1ccc2c(c1)c3CCCC4NCCn2c34
NCGC00256763-01,tox21-er-bla-agonist-p2,Anisyl propionate,activity,inactive,7549-33-9,61417.0,COc1ccc(COC(=O)CC)cc1
NCGC00258469-01,tox21-er-bla-agonist-p2,Phthalic acid,activity,inactive,88-99-3,1017.0,OC(=O)c1ccccc1C(=O)O
NCGC00257110-01,tox21-er-bla-agonist-p2,"2,4-Dichloroaniline",activity,inactive,554-00-7,11123.0,Clc1cc(Cl)c(N)cc1
NCGC00257364-01,tox21-er-bla-agonist-p2,3-Pyridinamine,activity,inactive,462-08-8,10009.0,Nc1cccnc1
NCGC00257525-01,tox21-er-bla-agonist-p2,Hexanedihydrazide,activity,inactive,1071-93-8,66117.0,NNC(=O)CCCCC(=O)NN
NCGC00257616-01,tox21-er-bla-agonist-p2,Trimethoxymethane,activity,inactive,149-73-5,9005.0,COC(OC)OC
NCGC00257756-01,tox21-er-bla-agonist-p2,Cyclopentane,activity,inactive,287-92-3,9253.0,C1CCCC1
NCGC00257789-01,tox21-er-bla-agonist-p2,"1,3-Dichloropropene",activity,inactive,542-75-6,24883.0,ClC=CCCl
NCGC00257920-01,tox21-er-bla-agonist-p2,N-Ethyl-4-methylbenzenesulfonamide,activity,inactive,80-39-7,6637.0,Cc1ccc(cc1)S(=O)(=O)NCC
NCGC00258106-01,tox21-er-bla-agonist-p2,Triethylsulfonium bis(trifluoromethanesulfonyl)imide,activity,inactive,321746-49-0,16211135.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.CC[S+](CC)CC
NCGC00258153-01,tox21-er-bla-agonist-p2,Choline bis(trifluoromethylsulfonyl)imde,activity,inactive,827027-25-8,53260965.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.C[N+](C)(C)CCO
NCGC00256718-01,tox21-er-bla-agonist-p2,Methylpolysilicone,activity,inactive,9004-73-3,6327366.0,C[Si](C)(C)O[SiH](C)O[Si](C)(C)C
NCGC00255724-01,tox21-er-bla-agonist-p2,2-(3-Phenylpropyl)pyridine,activity,inactive,2110-18-1,459494.0,C(CCc1ccccn1)c2ccccc2
NCGC00255760-01,tox21-er-bla-agonist-p2,Nuarimol,activity,active agonist,63284-71-9,91683.0,OC(c1ccccc1Cl)(c2cncnc2)c3ccc(F)cc3
NCGC00256376-01,tox21-er-bla-agonist-p2,Salicylamide,activity,inactive,65-45-2,5147.0,O=C(N)c1ccccc1O
NCGC00256490-01,tox21-er-bla-agonist-p2,Fluvastatin,activity,inactive,93957-54-1,446155.0,O=C(O)C[C@H](O)C[C@H](O)/C=C/c2c(c1ccccc1n2C(C)C)c3ccc(F)cc3
NCGC00255945-01,tox21-er-bla-agonist-p2,Quetiapine fumarate,activity,inactive,111974-72-2,5281025.0,O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23.OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23
NCGC00256051-01,tox21-er-bla-agonist-p2,N-(2-Hydroxyethyl)acetamide,activity,inactive,142-26-7,8880.0,CC(=O)NCCO
NCGC00256158-01,tox21-er-bla-agonist-p2,"Octahydro-1H-4,7-methanoindene-1,5-diyldimethanediyl bisprop-2-enoate",activity,inactive,42594-17-2,3036974.0,C=CC(=O)OCC2CCC3C1CC(CC1COC(=O)C=C)C23
NCGC00256235-01,tox21-er-bla-agonist-p2,1-(Methylsulfanyl)dodecane,activity,inactive,3698-89-3,77287.0,CSCCCCCCCCCCCC
NCGC00256337-01,tox21-er-bla-agonist-p2,"2,4-D isopropyl ester",activity,inactive,94-11-1,7173.0,Clc1cc(Cl)ccc1OCC(=O)OC(C)C
NCGC00260606-01,tox21-er-bla-agonist-p2,NTP Mix9 AR1 8-EQC,activity,inactive,NOCAS_49502,,
NCGC00260071-01,tox21-er-bla-agonist-p2,Melphalan,activity,inactive,148-82-3,460612.0,O=C(O)[C@@H](N)Cc1ccc(cc1)N(CCCl)CCCl
NCGC00258726-01,tox21-er-bla-agonist-p2,"2,2-Dimethyl-3-pentanol",activity,inactive,3970-62-5,19871.0,CC(C)(C)C(O)CC
NCGC00255079-01,tox21-er-bla-agonist-p2,Anilazine,activity,inactive,101-05-3,7541.0,Clc2nc(Nc1ccccc1Cl)nc(Cl)n2
NCGC00255125-01,tox21-er-bla-agonist-p2,Bispyribac-sodium,activity,inactive,125401-92-5,23682789.0,[Na+].COc1nc(nc(OC)c1)Oc3cccc(Oc2nc(cc(OC)n2)OC)c3C([O-])=O
NCGC00255154-01,tox21-er-bla-agonist-p2,2-Allylphenol,activity,inactive,1745-81-9,15624.0,Oc1ccccc1CC=C
NCGC00255232-01,tox21-er-bla-agonist-p2,Cyclosporin A,activity,inactive,59865-13-3,5284373.0,C[C@H](C\C=C\C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C)C(C)C
NCGC00255241-01,tox21-er-bla-agonist-p2,Vinyl neodecanoate,activity,inactive,51000-52-3,22833395.0,C=COC(=O)C(C)(CCC(C)C)CC
NCGC00255257-01,tox21-er-bla-agonist-p2,"4-Chloro-3,5-dimethylphenol",activity,inactive,88-04-0,2723.0,Oc1cc(C)c(Cl)c(C)c1
NCGC00255364-01,tox21-er-bla-agonist-p2,C.I. Acid Orange 3,activity,inactive,6373-74-6,5284435.0,[Na+].O=S([O-])(=O)c2cc(ccc2Nc1ccccc1)Nc3ccc(cc3[N+]([O-])=O)[N+]([O-])=O
NCGC00255560-01,tox21-er-bla-agonist-p2,"Silane, triethoxy(3-isocyanatopropyl)-",activity,inactive,24801-88-5,90613.0,CCO[Si](OCC)(OCC)CCC\N=C=O
NCGC00255923-01,tox21-er-bla-agonist-p2,Isobornyl propanoate,activity,inactive,2756-56-1,23617864.0,CCC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C
NCGC00179456-02,tox21-er-bla-agonist-p2,Glycopyrrolate bromide,activity,inactive,596-51-0,11693.0,[Br-].C[N+]3(C)CCC(OC(=O)C(O)(c1ccccc1)C2CCCC2)C3
NCGC00094763-01,tox21-er-bla-agonist-p2,Polymycin B sulfate,activity,inactive,1405-20-5,60196276.0,O=S(=O)(O)O.C[C@H](CC)CCCCC(=O)N[C@H](CCN)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]2CCNC(=O)C(NC(=O)[C@@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC2=O)CCN)[C@@H](C)O
NCGC00160362-01,tox21-er-bla-agonist-p2,Acetylsalicylamide,activity,inactive,5663-71-8,10252.0,O=C(NC(C)=O)c1ccccc1O
NCGC00181318-01,tox21-er-bla-agonist-p2,Hydroxocobalamin acetate,activity,inactive,22465-48-1,60196309.0,NC(=O)CC[C@@H]8C=2N=C(C(C)=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@](C)(N1[Co]OC(C)=O)[C@@H]7N=C(C(C)=C3N=C(C=2)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NCC(C)OP(=O)(O)O[C@@H]6[C@@H](CO)O[C@H](n5cnc4cc(C)c(C)cc45)[C@@H]6O)[C@H]7CC(N)=O)[C@@]8(C)CC(N)=O
NCGC00167501-01,tox21-er-bla-agonist-p2,Methaqualone,activity,inactive,72-44-6,6292.0,Cc1ccccc1N3C(C)=Nc2ccccc2C3=O
NCGC00164606-01,tox21-er-bla-agonist-p2,Trocimine,activity,inactive,14368-24-2,26650.0,COc1cc(cc(OC)c1OC)C(=O)N2CCCCCCC2
NCGC00095170-01,tox21-er-bla-agonist-p2,Oxiconazole nitrate,activity,inactive,64211-46-7,9556529.0,[O-][N+](=O)O.Clc3ccc(C(=N\OCc1ccc(Cl)cc1Cl)\Cn2ccnc2)c(Cl)c3
NCGC00095239-01,tox21-er-bla-agonist-p2,"1,3,5-Trimethoxybenzene",activity,inactive,621-23-8,69301.0,COc1cc(cc(OC)c1)OC
NCGC00095254-04,tox21-er-bla-agonist-p2,dl-alpha-Tocopheryl acetate,activity,inactive,52225-20-4,86472.0,CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00160569-01,tox21-er-bla-agonist-p2,Dibemethine,activity,inactive,102-05-6,21583.0,CN(Cc1ccccc1)Cc2ccccc2
NCGC00096063-01,tox21-er-bla-agonist-p2,Kanamycin B,activity,inactive,4696-76-8,439318.0,N[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00160641-01,tox21-er-bla-agonist-p2,Sulazepam,activity,inactive,2898-13-7,17931.0,Clc1ccc2c(c1)C(=NCC(=S)N2C)c3ccccc3
NCGC00181104-02,tox21-er-bla-agonist-p2,Dithiazanine chloride,activity,inactive,54646-38-7,60196347.0,[Cl-].CCN3c4ccccc4SC3=CC=CC=Cc2sc1ccccc1[n+]2CC
NCGC00160674-01,tox21-er-bla-agonist-p2,Aconiazide,activity,inactive,13410-86-1,6433573.0,O=C(N/N=C/c1ccccc1OCC(=O)O)c2ccncc2
NCGC00166219-01,tox21-er-bla-agonist-p2,Bipenamol,activity,inactive,79467-22-4,43961.0,NCc2ccccc2Sc1ccccc1CO
NCGC00183124-01,tox21-er-bla-agonist-p2,Prednisolone 21-hemisuccinate,activity,inactive,2920-86-7,656804.0,O=C(O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00183657-01,tox21-er-bla-agonist-p2,Rosaramicin,activity,inactive,35834-26-5,12922658.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]1[C@@H](C)[C@H](O)CC(=O)OC(CC)C(C)C2O[C@@]2(C)C=CC(=O)[C@H](C)C[C@@H]1CC=O)[C@@H]3O
NCGC00254965-01,tox21-er-bla-agonist-p2,Chlorpyrifos oxon,activity,active agonist,5598-15-2,21804.0,Clc1cc(Cl)c(Cl)nc1OP(=O)(OCC)OCC
NCGC00185744-01,tox21-er-bla-agonist-p2,Metoprolol succinate,activity,inactive,98418-47-4,62937.0,O=C(O)CCC(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC
NCGC00247353-03,tox21-er-bla-agonist-p2,(-)-Phenazocine hydrobromide,activity,inactive,58918-34-6,13501022.0,Br.Oc3ccc4C[C@@H]2[C@H](C)[C@@](C)(CCN2CCc1ccccc1)c4c3
NCGC00254228-01,tox21-er-bla-agonist-p2,CP-122721,activity,inactive,145742-28-5,9821217.0,FC(F)(F)Oc3cc(CN[C@H]1CCCN[C@H]1c2ccccc2)c(OC)cc3
NCGC00254357-01,tox21-er-bla-agonist-p2,"Propanol, 1(or 2)-(2-methoxymethylethoxy)-",activity,inactive,34590-94-8,22833331.0,COCCCOC(O)CC
NCGC00254010-01,tox21-er-bla-agonist-p2,Dipentyl phthalate,activity,inactive,131-18-0,8561.0,O=C(OCCCCC)c1ccccc1C(=O)OCCCCC
NCGC00254834-01,tox21-er-bla-agonist-p2,"1,3-Propanediamine, N,N,N',N'-tetramethyl-",activity,inactive,110-95-2,8084.0,CN(C)CCCN(C)C
NCGC00255101-01,tox21-er-bla-agonist-p2,2-Hydroxyethylhydrazine,activity,inactive,109-84-2,8017.0,NNCCO
NCGC00254043-01,tox21-er-bla-agonist-p2,L-Tartaric acid,activity,inactive,87-69-4,444305.0,O=C(O)[C@H](O)[C@@H](O)C(O)=O
NCGC00255222-01,tox21-er-bla-agonist-p2,Tegafur,activity,inactive,37076-68-9,5386.0,FC1=CN(C(=O)NC1=O)C2CCCO2
NCGC00255324-01,tox21-er-bla-agonist-p2,"N,N-Dicyclohexyl-2-benzothiazolesulfenamide",activity,inactive,4979-32-2,21080.0,c1cccc2sc(nc12)SN(C3CCCCC3)C4CCCCC4
NCGC00181342-01,tox21-er-bla-agonist-p2,Imidapril hydrochloride,activity,inactive,89396-94-1,5485193.0,Cl.OC(=O)[C@@H]2CN(C)C(=O)N2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC
NCGC00181349-01,tox21-er-bla-agonist-p2,Strontium ranelate heptahydrate,activity,inactive,796104-87-5,24871329.0,[Sr+2].[Sr+2].O.O.O.O.O.O.O.O=C([O-])CN(CC([O-])=O)c1sc(c(CC([O-])=O)c1C#N)C([O-])=O
NCGC00183019-01,tox21-er-bla-agonist-p2,Egualen sodium,activity,inactive,97683-31-3,23663963.0,[Na+].CC(C)c1cccc2c(cc(c2c1)S([O-])(=O)=O)CC
NCGC00259493-01,tox21-er-bla-agonist-p2,Salicylamide,activity,inactive,65-45-2,5147.0,O=C(N)c1ccccc1O
NCGC00260053-01,tox21-er-bla-agonist-p2,D&C Yellow 11,activity,inactive,8003-22-3,6731.0,O=C4c1ccccc1C(=O)C4c2ccc3ccccc3n2
NCGC00260539-01,tox21-er-bla-agonist-p2,"1-Hexadecanamine, N,N-dimethyl-",activity,inactive,112-69-6,16221.0,CN(C)CCCCCCCCCCCCCCCC
NCGC00257345-01,tox21-er-bla-agonist-p2,4-Butyloxyaniline,activity,inactive,4344-55-2,20352.0,Nc1ccc(OCCCC)cc1
NCGC00260313-01,tox21-er-bla-agonist-p2,"Phenol, isopropylated, phosphate (3:1)",activity,inactive,68937-41-7,75628.0,CC(C)c1ccc(cc1)OP(=O)(Oc2ccc(cc2)C(C)C)Oc3ccc(cc3)C(C)C
NCGC00255845-01,tox21-er-bla-agonist-p2,Atorvastatin calcium,activity,inactive,134523-03-8,60822.0,[Ca+2].O[C@H](CCn1c(c(c(c1C(C)C)C(=O)Nc2ccccc2)c3ccccc3)c4ccc(F)cc4)C[C@@H](O)CC([O-])=O.[O-]C(=O)C[C@H](O)C[C@H](O)CCn4c(c1ccc(F)cc1)c(c2ccccc2)c(C(=O)Nc3ccccc3)c4C(C)C
NCGC00257544-01,tox21-er-bla-agonist-p2,Iodine,activity,inactive,7553-56-2,807.0,II
NCGC00256909-01,tox21-er-bla-agonist-p2,Benzyl 3-methylbutyl ether,activity,inactive,122-73-6,31227.0,CC(C)CCOCc1ccccc1
NCGC00256933-01,tox21-er-bla-agonist-p2,"2,3,6-Trichlorophenol",activity,inactive,933-75-5,13618.0,Oc1c(Cl)ccc(Cl)c1Cl
NCGC00257387-01,tox21-er-bla-agonist-p2,4-Hexyloxyaniline,activity,inactive,39905-57-2,38360.0,Nc1ccc(OCCCCCC)cc1
NCGC00015877-06,tox21-er-bla-agonist-p2,Ritanserin,activity,inactive,87051-43-2,5074.0,Fc1ccc(cc1)/C(c2ccc(F)cc2)=C3/CCN(CC3)CCC4=C(C)N=C5SC=CN5C4=O
NCGC00254175-01,tox21-er-bla-agonist-p2,Biphenyl,activity,inactive,92-52-4,7095.0,c1cc(ccc1)c2ccccc2
NCGC00255448-01,tox21-er-bla-agonist-p2,m-Cumenyl methylcarbamate,activity,inactive,64-00-6,6143.0,O=C(Oc1cc(ccc1)C(C)C)NC
NCGC00255452-01,tox21-er-bla-agonist-p2,"3,3,4,4-Tetrachlorotetrahydrothiophene 1,1-dioxide",activity,active agonist,3737-41-5,77328.0,ClC1(Cl)CS(=O)(=O)CC1(Cl)Cl
NCGC00255572-01,tox21-er-bla-agonist-p2,Sodium octyl sulfate,activity,inactive,142-31-4,2735107.0,[Na+].[O-]S(=O)(=O)OCCCCCCCC
NCGC00255625-01,tox21-er-bla-agonist-p2,"5-Nonanone, 2,8-dimethyl-",activity,inactive,2050-99-9,62421.0,CC(C)CCC(=O)CCC(C)C
NCGC00256066-01,tox21-er-bla-agonist-p2,"3,5-Dichlorosalicylic acid",activity,inactive,320-72-9,9445.0,Oc1c(cc(Cl)cc1Cl)C(=O)O
NCGC00256900-01,tox21-er-bla-agonist-p2,2-Methylundecanal,activity,inactive,110-41-8,61031.0,CC(CCCCCCCCC)C=O
NCGC00256890-01,tox21-er-bla-agonist-p2,"3,3-Dimethylacrylic acid",activity,inactive,541-47-9,10931.0,C\C(C)=C/C(=O)O
NCGC00257005-01,tox21-er-bla-agonist-p2,Dibutyl phosphite,activity,inactive,1809-19-4,6327349.0,CCCCOP(=O)OCCCC
NCGC00257584-01,tox21-er-bla-agonist-p2,Methyl 3-sulfanylpropanoate,activity,inactive,2935-90-2,18050.0,O=C(OC)CCS
NCGC00258208-01,tox21-er-bla-agonist-p2,Methoprene,activity,inactive,40596-69-8,5366546.0,CC(C)OC(=O)\C=C(/C)\C=C\CC(C)CCCC(C)(C)OC
NCGC00258289-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium hexafluorophosphate,activity,inactive,304680-35-1,2734175.0,F[P-](F)(F)(F)(F)F.C[n+]1ccn(CCCCCC)c1
NCGC00258316-01,tox21-er-bla-agonist-p2,D-Fructose,activity,inactive,57-48-7,439709.0,O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO
NCGC00258375-01,tox21-er-bla-agonist-p2,2-Nitrobenzyl chloride,activity,inactive,612-23-7,11921.0,O=[N+]([O-])c1ccccc1CCl
NCGC00258412-01,tox21-er-bla-agonist-p2,Triethanolamine stearate,activity,active agonist,4568-28-9,20701.0,OCC[NH+](CCO)CCO.[O-]C(=O)CCCCCCCCCCCCCCCCC
NCGC00258604-01,tox21-er-bla-agonist-p2,Sodium malate,activity,inactive,40876-98-0,23685849.0,[Na+].O=C(OCC)C([O-])CC(=O)OCC
NCGC00258804-01,tox21-er-bla-agonist-p2,alpha-Cyclodextrin,activity,inactive,10016-20-3,444913.0,O[C@@H]2[C@@H](O)[C@@H]1O[C@H]7O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]2O[C@@H]1CO)[C@H](O)[C@H]3O)[C@H](O)[C@H]4O)[C@H](O)[C@H]5O)[C@H](O)[C@H]6O)[C@H](O)[C@H]7O
NCGC00258827-01,tox21-er-bla-agonist-p2,"2,5-Dimethylphenol",activity,inactive,95-87-4,7267.0,Cc1cc(O)c(C)cc1
NCGC00258156-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium bromide,activity,inactive,85100-78-3,2734237.0,[Br-].C[n+]1ccn(CCCCCC)c1
NCGC00259775-01,tox21-er-bla-agonist-p2,Anthracene,activity,inactive,120-12-7,8418.0,c1ccc2cc3ccccc3cc2c1
NCGC00260265-01,tox21-er-bla-agonist-p2,1-Bromopentane,activity,inactive,110-53-2,8057.0,BrCCCCC
NCGC00260605-01,tox21-er-bla-agonist-p2,NTP Mix8 AR1 8-EQC,activity,inactive,NOCAS_49501,,
NCGC00015908-05,tox21-er-bla-agonist-p2,Spiroxatrine,activity,inactive,1054-88-2,5268.0,O=C5NCN(c1ccccc1)C25CCN(CC2)CC3COc4ccccc4O3
NCGC00016769-01,tox21-er-bla-agonist-p2,Famprofazone,activity,inactive,22881-35-2,3326.0,CC(Cc1ccccc1)N(C)CC3=C(C(=O)N(c2ccccc2)N3C)C(C)C
NCGC00016161-03,tox21-er-bla-agonist-p2,Lorglumide sodium,activity,inactive,1021868-76-7,23681233.0,[Na+].Clc1ccc(cc1Cl)C(=O)NC(CCC([O-])=O)C(=O)N(CCCCC)CCCCC
NCGC00016035-02,tox21-er-bla-agonist-p2,Trazodone hydrochloride,activity,inactive,25332-39-2,62935.0,Cl.Clc1cccc(c1)N2CCN(CC2)CCCN3N=C4C=CC=CN4C3=O
NCGC00018102-06,tox21-er-bla-agonist-p2,Flunarizine,activity,inactive,52468-60-7,941361.0,Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)C/C=C/c4ccccc4
NCGC00166218-01,tox21-er-bla-agonist-p2,"4,4'-Dinitrodiphenylurea",activity,inactive,587-90-6,9509.0,O=C(Nc1ccc(cc1)[N+]([O-])=O)Nc2ccc(cc2)[N+]([O-])=O
NCGC00166304-01,tox21-er-bla-agonist-p2,"N,N-Dimethylcysteamine hydrochloride",activity,inactive,13242-44-9,25798.0,Cl.CN(C)CCS
NCGC00166112-01,tox21-er-bla-agonist-p2,"N,N-Dimethyl-N-(3-(trimethoxysilyl)propyl) octadecan-1-aminium chloride",activity,active agonist,27668-52-6,62827.0,[Cl-].CO[Si](CCC[N+](C)(C)CCCCCCCCCCCCCCCCCC)(OC)OC
NCGC00166405-01,tox21-er-bla-agonist-p2,Benzyldimethyltetradecylammonium chloride dihydrate,activity,inactive,147228-81-7,177843.0,[Cl-].O.O.C[N+](C)(Cc1ccccc1)CCCCCCCCCCCCCC
NCGC00182045-01,tox21-er-bla-agonist-p2,Pentostatin,activity,inactive,53910-25-1,439693.0,O[C@@H]3CNC=Nc2c3ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
NCGC00181098-01,tox21-er-bla-agonist-p2,Nelarabine,activity,inactive,121032-29-9,3011155.0,Nc3nc2c(ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O)c(OC)n3
NCGC00181772-01,tox21-er-bla-agonist-p2,Barnidipine hydrochloride,activity,inactive,104757-53-1,443868.0,Cl.[O-][N+](=O)c1cccc(c1)[C@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)O[C@H]4CCN(Cc3ccccc3)C4
NCGC00181159-01,tox21-er-bla-agonist-p2,Trabectedin,activity,inactive,114899-77-3,108150.0,CC(=O)Oc1c5c(c2OCOc2c1C)[C@@H]7COC(=O)[C@@]4(NCCc3cc(O)c(cc34)OC)CS[C@H]5[C@H]8[C@H]6c9c(C[C@H](N6C)[C@H](O)N78)cc(C)c(OC)c9O
NCGC00255790-01,tox21-er-bla-agonist-p2,Indole-3-pyruvic acid,activity,inactive,392-12-1,803.0,O=C(O)C(=O)Cc2cnc1ccccc12
NCGC00255408-01,tox21-er-bla-agonist-p2,Roxithromycin,activity,inactive,80214-83-1,444037.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)\C(=N\OCOCCOC)[C@H](C)C[C@@]2(C)O)[C@@H]3O
NCGC00256215-01,tox21-er-bla-agonist-p2,Dibutan-2-yl disulfide,activity,inactive,5943-30-6,94314.0,CC(CC)SSC(C)CC
NCGC00254659-01,tox21-er-bla-agonist-p2,Triphenyltin hydroxide,activity,active agonist,76-87-9,6327657.0,O[Sn](c1ccccc1)(c2ccccc2)c3ccccc3
NCGC00254842-01,tox21-er-bla-agonist-p2,Butachlor,activity,inactive,23184-66-9,31677.0,ClCC(=O)N(COCCCC)c1c(cccc1CC)CC
NCGC00255182-01,tox21-er-bla-agonist-p2,Sulprofos,activity,inactive,35400-43-2,37125.0,CSc1ccc(OP(=S)(OCC)SCCC)cc1
NCGC00254248-01,tox21-er-bla-agonist-p2,Benodanil,activity,inactive,15310-01-7,27195.0,O=C(Nc1ccccc1)c2ccccc2I
NCGC00016485-01,tox21-er-bla-agonist-p2,Tetrahydrozoline hydrochloride,activity,inactive,522-48-5,10648.0,Cl.C2CCC(C1=NCCN1)c3ccccc23
NCGC00016676-01,tox21-er-bla-agonist-p2,Proglumide,activity,inactive,6620-60-6,4922.0,O=C(NC(CCC(=O)O)C(=O)N(CCC)CCC)c1ccccc1
NCGC00091902-08,tox21-er-bla-agonist-p2,Malathion,activity,inactive,121-75-5,4004.0,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
NCGC00179503-02,tox21-er-bla-agonist-p2,Clomiphene,activity,inactive,911-45-5,2800.0,CCN(CCOc1ccc(cc1)C(c2ccccc2)=C(Cl)c3ccccc3)CC
NCGC00181330-01,tox21-er-bla-agonist-p2,Nitrovin,activity,active agonist,804-36-4,13118.0,O=[N+]([O-])c2ccc(C=C/C(C=Cc1ccc(o1)[N+]([O-])=O)=N\NC(=N)N)o2
NCGC00183874-01,tox21-er-bla-agonist-p2,Paliperidone,activity,inactive,144598-75-4,9802545.0,CC=5N=C1[C@H](O)CCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34
NCGC00255090-01,tox21-er-bla-agonist-p2,"(3,5-Dimethyl-1H-pyrazol-1-yl)methanol",activity,inactive,85264-33-1,96393.0,Cc1cc(C)nn1CO
NCGC00259491-01,tox21-er-bla-agonist-p2,Formamide,activity,inactive,75-12-7,713.0,NC=O
NCGC00259937-01,tox21-er-bla-agonist-p2,UT-632,activity,inactive,2386-87-0,16949.0,O=C(OCC1CC2OC2CC1)C3CCC4OC4C3
NCGC00015823-02,tox21-er-bla-agonist-p2,Piroxicam,activity,inactive,36322-90-4,54676228.0,OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3
NCGC00016645-01,tox21-er-bla-agonist-p2,Methacycline hydrochloride,activity,inactive,3963-95-9,54685047.0,Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1C(=C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00017158-02,tox21-er-bla-agonist-p2,Isometheptene mucate,activity,inactive,7492-31-1,15605556.0,O[C@H]([C@@H](O)[C@@H](O)[C@H](O)C(=O)O)C(=O)O.C/C(C)=C\CCC(C)NC.C/C(C)=C\CCC(C)NC
NCGC00024613-01,tox21-er-bla-agonist-p2,Alrestatin,activity,inactive,51411-04-2,2120.0,O=C(O)CN3C(=O)c2cccc1cccc(c12)C3=O
NCGC00160540-01,tox21-er-bla-agonist-p2,Ethiazide,activity,inactive,1824-58-4,15763.0,NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)CC)cc2Cl
NCGC00160596-02,tox21-er-bla-agonist-p2,Aluminum monostearate,activity,inactive,7047-84-9,16682987.0,O[Al](O)OC(=O)CCCCCCCCCCCCCCCCC
NCGC00164237-01,tox21-er-bla-agonist-p2,Aviglycine hydrochloride,activity,inactive,55720-26-8,16211101.0,Cl.N[C@@H](/C=C/OCCN)C(=O)O
NCGC00164479-01,tox21-er-bla-agonist-p2,Nandrolone,activity,active agonist,434-22-0,9904.0,O=C4CC[C@H]3C(CC[C@@H]1[C@@H]3CC[C@]2(C)[C@@H](O)CC[C@@H]12)=C4
NCGC00254262-01,tox21-er-bla-agonist-p2,Diisopropyl methylphosphonate,activity,inactive,1445-75-6,3073.0,CP(=O)(OC(C)C)OC(C)C
NCGC00016958-01,tox21-er-bla-agonist-p2,Iodixanol,activity,inactive,92339-11-2,3724.0,OCC(O)CNC(=O)c1c(I)c(c(I)c(C(=O)NCC(O)CO)c1I)N(CC(O)CN(C(C)=O)c2c(I)c(c(I)c(c2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C(C)=O
NCGC00017104-01,tox21-er-bla-agonist-p2,Metaraminol bitartrate,activity,inactive,33402-03-8,60196269.0,O[C@H](c1cc(O)ccc1)[C@H](C)N.O=C(O)[C@H](O)[C@H](O)C(=O)O
NCGC00024504-05,tox21-er-bla-agonist-p2,Kainic acid,activity,inactive,487-79-6,10255.0,CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O
NCGC00024609-01,tox21-er-bla-agonist-p2,Flurofamide,activity,inactive,70788-28-2,51173.0,O=C(NP(N)(N)=O)c1ccc(F)cc1
NCGC00025179-05,tox21-er-bla-agonist-p2,Mifepristone,activity,inactive,84371-65-3,55245.0,CN(C)c1ccc(cc1)[C@H]5C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC)[C@@H]4CCC3=CC(=O)CCC3=C45
NCGC00025347-01,tox21-er-bla-agonist-p2,Medetomidine hydrochloride,activity,inactive,86347-15-1,68601.0,Cl.CC(c1cccc(C)c1C)c2cncn2
NCGC00256853-01,tox21-er-bla-agonist-p2,3-(2-Methyl-3-furylthio)-4-heptanone,activity,inactive,61295-41-8,43598.0,CCC(Sc1ccoc1C)C(=O)CCC
NCGC00256915-01,tox21-er-bla-agonist-p2,dl-Carvone,activity,inactive,99-49-0,7439.0,CC1=CCC(CC1=O)C(C)=C
NCGC00257021-01,tox21-er-bla-agonist-p2,12-Hydroxyoctadecanoic acid,activity,inactive,106-14-9,7789.0,O=C(O)CCCCCCCCCCC(O)CCCCCC
NCGC00258423-01,tox21-er-bla-agonist-p2,"N,N-Dimethylpentanamide",activity,inactive,6225-06-5,80365.0,CN(C)C(=O)CCCC
NCGC00257295-01,tox21-er-bla-agonist-p2,Dodecyl acetate,activity,inactive,112-66-3,8205.0,CC(=O)OCCCCCCCCCCCC
NCGC00257476-01,tox21-er-bla-agonist-p2,Calcium L-ascorbate dihydrate,activity,inactive,5743-28-2,54682536.0,[Ca+2].O.O.OC=1C(=O)O[C@H]([C@@H](O)CO)C=1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-]
NCGC00257488-01,tox21-er-bla-agonist-p2,Sulisobenzone,activity,inactive,4065-45-6,19988.0,OS(=O)(=O)c1cc(c(O)cc1OC)C(=O)c2ccccc2
NCGC00257539-01,tox21-er-bla-agonist-p2,Thioacetamide,activity,inactive,62-55-5,2723949.0,CC(N)=S
NCGC00257565-01,tox21-er-bla-agonist-p2,Tetramethylsilane,activity,inactive,75-76-3,6396.0,C[Si](C)(C)C
NCGC00257729-01,tox21-er-bla-agonist-p2,Carveol,activity,inactive,99-48-9,7438.0,CC(=C)C1CC=C(C)C(O)C1
NCGC00257808-01,tox21-er-bla-agonist-p2,4-Bromobiphenyl,activity,inactive,92-66-0,7101.0,Brc1ccc(cc1)c2ccccc2
NCGC00257825-01,tox21-er-bla-agonist-p2,Formanilide,activity,inactive,103-70-8,7671.0,O=CNc1ccccc1
NCGC00257888-01,tox21-er-bla-agonist-p2,3-Bromotoluene,activity,inactive,591-17-3,11560.0,Cc1cc(Br)ccc1
NCGC00258187-01,tox21-er-bla-agonist-p2,2-Bromobutane,activity,inactive,78-76-2,6554.0,BrC(C)CC
NCGC00258337-01,tox21-er-bla-agonist-p2,Ethylene urea,activity,inactive,120-93-4,8453.0,O=C1NCCN1
NCGC00255742-01,tox21-er-bla-agonist-p2,"1,6-Hexanediol dimethacrylate",activity,inactive,6606-59-3,81080.0,C=C(C)C(=O)OCCCCCCOC(=O)C(=C)C
NCGC00255890-01,tox21-er-bla-agonist-p2,Calcium bromide,activity,inactive,7789-41-5,24608.0,Br[Ca]Br
NCGC00260485-01,tox21-er-bla-agonist-p2,"1,8-Diazabicyclo[5.4.0]undec-7-ene",activity,inactive,6674-22-2,81184.0,C1CCC2=NCCCN2CC1
NCGC00260619-01,tox21-er-bla-agonist-p2,NTP Mix117 ER1 5-EQP,activity,active agonist,NOCAS_49515,,
NCGC00259076-01,tox21-er-bla-agonist-p2,Acrylamide,activity,inactive,79-06-1,6579.0,C=CC(N)=O
NCGC00259167-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-5-nitroimidazole",activity,inactive,551-92-8,3090.0,O=[N+]([O-])c1cnc(C)n1C
NCGC00259184-01,tox21-er-bla-agonist-p2,"p,p'-Ethyl-DDD",activity,inactive,72-56-0,6295.0,ClC(Cl)C(c1ccc(CC)cc1)c2ccc(cc2)CC
NCGC00259221-01,tox21-er-bla-agonist-p2,Trimethoxy[3-(oxiran-2-ylmethoxy)propyl]silane,activity,inactive,2530-83-8,17317.0,CO[Si](CCCOCC1CO1)(OC)OC
NCGC00259233-01,tox21-er-bla-agonist-p2,6-Nitrobenzimidazole,activity,inactive,94-52-0,7195.0,[O-][N+](=O)c1cc2ncnc2cc1
NCGC00259335-01,tox21-er-bla-agonist-p2,Butanal oxime,activity,inactive,110-69-0,8069.0,CCC\C=N/O
NCGC00259348-01,tox21-er-bla-agonist-p2,1-Octanethiol,activity,inactive,111-88-6,8144.0,CCCCCCCCS
NCGC00259368-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium chloride,activity,inactive,479500-35-1,11769095.0,[Cl-].CCCC[N+]1(C)CCCC1
NCGC00259694-01,tox21-er-bla-agonist-p2,Dimethyl phthalate,activity,inactive,131-11-3,8554.0,COC(=O)c1ccccc1C(=O)OC
NCGC00260045-01,tox21-er-bla-agonist-p2,"Chlorinated paraffins (C12, 60% chlorine)",activity,inactive,NOCAS_24824,5284361.0,ClC(CC(Cl)C(Cl)CCC(Cl)CC)C(Cl)C(Cl)CCl
NCGC00254941-01,tox21-er-bla-agonist-p2,gamma-Nonanolactone,activity,inactive,104-61-0,7710.0,O=C1CCC(CCCCC)O1
NCGC00255049-01,tox21-er-bla-agonist-p2,Xanthone,activity,inactive,90-47-1,7020.0,O=C1c3ccccc3Oc2ccccc12
NCGC00255377-01,tox21-er-bla-agonist-p2,Biotin,activity,inactive,58-85-5,171548.0,O=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1
NCGC00255638-01,tox21-er-bla-agonist-p2,Ethyl 3-(N-butylacetamido)propionate,activity,inactive,52304-36-6,104150.0,O=C(CCN(CCCC)C(C)=O)OCC
NCGC00255738-01,tox21-er-bla-agonist-p2,Isoproturon,activity,inactive,34123-59-6,36679.0,O=C(Nc1ccc(cc1)C(C)C)N(C)C
NCGC00254516-01,tox21-er-bla-agonist-p2,Aldicarb oxime,activity,inactive,1646-75-9,15436.0,O\N=C/C(C)(C)SC
NCGC00092377-02,tox21-er-bla-agonist-p2,Apafant,activity,inactive,105219-56-5,65889.0,Clc1ccccc1C4=NCc2nnc(C)n2c3sc(cc34)CCC(=O)N5CCOCC5
NCGC00094205-01,tox21-er-bla-agonist-p2,Octoclothepine maleate,activity,inactive,4789-68-8,11957654.0,O=C(O)/C=C\C(=O)O.CN1CCN(CC1)C2Cc4ccccc4Sc3ccc(Cl)cc23
NCGC00159447-05,tox21-er-bla-agonist-p2,Salicylic acid,activity,inactive,69-72-7,338.0,OC(=O)c1ccccc1O
NCGC00167456-01,tox21-er-bla-agonist-p2,Bisibutiamine,activity,inactive,3286-46-2,20055424.0,Nc2nc(C)ncc2CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SSC(/CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N
NCGC00181301-01,tox21-er-bla-agonist-p2,Acetyl tributyl citrate,activity,inactive,77-90-7,6505.0,CCCCOC(=O)CC(CC(=O)OCCCC)(OC(C)=O)C(=O)OCCCC
NCGC00095049-01,tox21-er-bla-agonist-p2,Exalamide,activity,inactive,53370-90-4,3316.0,NC(=O)c1ccccc1OCCCCCC
NCGC00168345-01,tox21-er-bla-agonist-p2,Etryptamine,activity,inactive,2235-90-7,8367.0,CCC(N)Cc2cnc1ccccc12
NCGC00160581-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexanol",activity,inactive,116-02-9,8298.0,CC1(C)CC(C)CC(O)C1
NCGC00166097-01,tox21-er-bla-agonist-p2,3-Phenyl-2-propen-1-ol,activity,inactive,104-54-1,308.0,OCC=Cc1ccccc1
NCGC00166227-01,tox21-er-bla-agonist-p2,Xenalipin,activity,inactive,84392-17-6,55251.0,OC(=O)c2ccccc2c1ccc(cc1)C(F)(F)F
NCGC00159390-02,tox21-er-bla-agonist-p2,Permethrin,activity,inactive,52645-53-1,40326.0,Cl/C(Cl)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00091268-01,tox21-er-bla-agonist-p2,Oxytetracycline hydrochloride,activity,inactive,2058-46-0,54680782.0,Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@@](C)(O)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00183846-01,tox21-er-bla-agonist-p2,Toborinone,activity,inactive,143343-83-3,60790.0,COc1ccc(cc1OC)CNCC(O)COc2ccc3NC(=O)C=Cc3c2
NCGC00254155-01,tox21-er-bla-agonist-p2,"p,p'-DDE",activity,inactive,72-55-9,3035.0,Clc1ccc(cc1)\C(=C(/Cl)Cl)c2ccc(Cl)cc2
NCGC00254594-01,tox21-er-bla-agonist-p2,"1,3-Diphenyl-1,3-propanedione",activity,inactive,120-46-7,8433.0,O=C(CC(=O)c1ccccc1)c2ccccc2
NCGC00187584-01,tox21-er-bla-agonist-p2,FD&C Yellow 5,activity,inactive,1934-21-0,5359657.0,[Na+].[Na+].[Na+].[O-]S(=O)(=O)c1ccc(cc1)/N=N/C3=C(NN(c2ccc(cc2)S([O-])(=O)=O)C3=O)C([O-])=O
NCGC00253982-01,tox21-er-bla-agonist-p2,Carbamazepine,activity,inactive,298-46-4,2554.0,NC(=O)N2c3ccccc3C=Cc1ccccc12
NCGC00253984-01,tox21-er-bla-agonist-p2,Bronopol,activity,inactive,52-51-7,2450.0,[O-][N+](=O)C(Br)(CO)CO
NCGC00253986-01,tox21-er-bla-agonist-p2,2-Methylaniline,activity,inactive,95-53-4,7242.0,Cc1ccccc1N
NCGC00254027-01,tox21-er-bla-agonist-p2,Isoproterenol hydrochloride,activity,inactive,51-30-9,5807.0,Cl.Oc1ccc(cc1O)C(O)CNC(C)C
NCGC00254051-01,tox21-er-bla-agonist-p2,PharmaGSID_47333,activity,inactive,NOCAS_47333,9951932.0,Cc1ncc(cn1)[C@H](CC(=O)O)CCCCCCc2ccc3CCCNc3n2
NCGC00254904-01,tox21-er-bla-agonist-p2,Octamethyltrisiloxane,activity,inactive,107-51-7,24705.0,C[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C
NCGC00182070-02,tox21-er-bla-agonist-p2,Ioxilan,activity,inactive,107793-72-6,3743.0,OCC(O)CNC(=O)c1c(I)c(N(CC(O)CO)C(C)=O)c(I)c(c1I)C(=O)NCCO
NCGC00182710-01,tox21-er-bla-agonist-p2,Flurbiprofen axetil,activity,inactive,91503-79-6,3395.0,Fc2cc(ccc2c1ccccc1)C(C)C(=O)OC(C)OC(C)=O
NCGC00016612-01,tox21-er-bla-agonist-p2,Sulfadoxine,activity,inactive,2447-57-6,17134.0,O=S(=O)(Nc1ncnc(OC)c1OC)c2ccc(N)cc2
NCGC00016323-01,tox21-er-bla-agonist-p2,Sulfachloropyridazine,activity,inactive,80-32-0,6634.0,O=S(=O)(Nc1ccc(Cl)nn1)c2ccc(N)cc2
NCGC00181097-01,tox21-er-bla-agonist-p2,Dimefline hydrochloride,activity,inactive,2740-04-7,443942.0,Cl.CN(C)Cc3c(ccc1c3OC(=C(C)C1=O)c2ccccc2)OC
NCGC00257212-01,tox21-er-bla-agonist-p2,"1,2-Diphenoxyethane",activity,inactive,104-66-5,7713.0,C(COc1ccccc1)Oc2ccccc2
NCGC00258451-01,tox21-er-bla-agonist-p2,2-Hydrazino-4-phenylthiazole,activity,inactive,34176-52-8,98613.0,NNc1nc(cs1)c2ccccc2
NCGC00260229-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylpyridinium chloride,activity,inactive,125652-55-3,19876500.0,[Cl-].Cc1ccc[n+](CCCC)c1
NCGC00258991-01,tox21-er-bla-agonist-p2,4-Methoxy-2-methylaniline,activity,inactive,102-50-1,7610.0,Nc1ccc(OC)cc1C
NCGC00258145-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium thiocyanate,activity,inactive,344790-87-0,11424151.0,CCCCn1cc[n+](C)c1.[S-]C#N
NCGC00015762-06,tox21-er-bla-agonist-p2,Oxolinic acid,activity,inactive,14698-29-4,4628.0,O=C(O)C2=CN(CC)c1cc3OCOc3cc1C2=O
NCGC00258762-01,tox21-er-bla-agonist-p2,"4,4'-Propane-2,2-diylbis(2,6-dimethylphenol)",activity,active agonist,5613-46-7,79717.0,Cc1cc(cc(C)c1O)C(C)(C)c2cc(C)c(O)c(C)c2
NCGC00259111-01,tox21-er-bla-agonist-p2,Bendiocarb,activity,inactive,22781-23-3,2314.0,CNC(=O)Oc1cccc2OC(C)(C)Oc12
NCGC00255820-01,tox21-er-bla-agonist-p2,Aluminum hydroxide acetate (1:1:2),activity,inactive,142-03-0,16682993.0,O[Al](OC(=O)C)OC(C)=O
NCGC00256887-01,tox21-er-bla-agonist-p2,1-(5-Isopropyl-2-methyl-cyclohex-2-enyl)-propan-1-one,activity,inactive,31375-17-4,35785.0,CC(C)C1CC=C(C)C(C1)C(=O)CC
NCGC00256931-01,tox21-er-bla-agonist-p2,4-tert-Butylcyclohexanol,activity,inactive,98-52-2,7391.0,CC(C)(C)C1CCC(O)CC1
NCGC00255999-01,tox21-er-bla-agonist-p2,"1,6-Dichlorohexane",activity,inactive,2163-00-0,16551.0,ClCCCCCCCl
NCGC00257200-01,tox21-er-bla-agonist-p2,Terbutryn,activity,inactive,886-50-0,13450.0,CSc1nc(NCC)nc(NC(C)(C)C)n1
NCGC00257408-01,tox21-er-bla-agonist-p2,Glyceryl monooleate,activity,inactive,25496-72-4,5319879.0,OCC(CO)OC(=O)CCCCCCC/C=C\CCCCCCCC
NCGC00257903-01,tox21-er-bla-agonist-p2,2-Methyl-2-ethoxypropane,activity,inactive,637-92-3,12512.0,CC(C)(C)OCC
NCGC00257714-01,tox21-er-bla-agonist-p2,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-[(1-oxo-2-propenyl)oxy]-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1)",activity,active agonist,28961-43-5,115157.0,O=C(OCCOCC(COCCOC(=O)C=C)(CC)COCCOC(=O)C=C)C=C
NCGC00257549-01,tox21-er-bla-agonist-p2,Monomethyl succinate,activity,inactive,3878-55-5,77487.0,O=C(O)CCC(=O)OC
NCGC00258059-01,tox21-er-bla-agonist-p2,alpha-Methylbenzyl alcohol,activity,inactive,98-85-1,7409.0,CC(O)c1ccccc1
NCGC00258735-01,tox21-er-bla-agonist-p2,"1,2-Propanediol, dibenzoate",activity,inactive,19224-26-1,517637.0,CC(OC(=O)c1ccccc1)COC(=O)c2ccccc2
NCGC00258744-01,tox21-er-bla-agonist-p2,"1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one",activity,inactive,7779-30-8,5371084.0,CC1(C)CCC=C(C)C1/C=C/C(=O)CC
NCGC00258565-01,tox21-er-bla-agonist-p2,Methyl 3-chlorobenzoate,activity,inactive,2905-65-9,17946.0,Clc1cc(ccc1)C(=O)OC
NCGC00258445-01,tox21-er-bla-agonist-p2,3-Methylbutanal,activity,inactive,590-86-3,11552.0,CC(C)CC=O
NCGC00258037-01,tox21-er-bla-agonist-p2,Sulfuric acid,activity,inactive,7664-93-9,1118.0,O=S(=O)(O)O
NCGC00259762-01,tox21-er-bla-agonist-p2,Furosemide,activity,inactive,54-31-9,3440.0,NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O
NCGC00260304-01,tox21-er-bla-agonist-p2,"2,4-Hexadienoic acid, potassium salt, (2E,4E)-",activity,inactive,24634-61-5,23676745.0,[K+].[O-]C(=O)\C=C\C=C\C
NCGC00260457-01,tox21-er-bla-agonist-p2,Pyrazine,activity,inactive,290-37-9,9261.0,c1cnccn1
NCGC00257588-01,tox21-er-bla-agonist-p2,Chlorobutanedioic acid,activity,inactive,16045-92-4,27655.0,O=C(O)CC(Cl)C(=O)O
NCGC00015630-02,tox21-er-bla-agonist-p2,Metolazone,activity,inactive,17560-51-9,4170.0,NS(=O)(=O)c1cc2C(=O)N(C(C)Nc2cc1Cl)c3ccccc3C
NCGC00016313-01,tox21-er-bla-agonist-p2,Quinethazone,activity,inactive,73-49-4,6307.0,NS(=O)(=O)c1cc2C(=O)NC(Nc2cc1Cl)CC
NCGC00016504-01,tox21-er-bla-agonist-p2,Droperidol,activity,inactive,548-73-2,3168.0,Fc1ccc(cc1)C(=O)CCCN2CC=C(CC2)N3c4ccccc4NC3=O
NCGC00090729-01,tox21-er-bla-agonist-p2,Acesulfame potassium,activity,inactive,55589-62-3,11074431.0,[K+].CC1=CC(=O)[N-]S(=O)(=O)O1
NCGC00163158-01,tox21-er-bla-agonist-p2,"(-)-(5S,8R)-Lisuride",activity,inactive,159701-44-7,6321253.0,CCN(CC)C(=O)N[C@@H]2C=C1c3cccc4ncc(C[C@@H]1N(C)C2)c34
NCGC00188438-01,tox21-er-bla-agonist-p2,Sulfadiazine silver,activity,inactive,22199-08-2,441244.0,[Ag+].O=S(=O)([N-]c1ncccn1)c2ccc(N)cc2
NCGC00254553-01,tox21-er-bla-agonist-p2,Cyfluthrin,activity,inactive,68359-37-5,104926.0,Cl\C(Cl)=C/C3C(C(=O)OC(C#N)c2ccc(F)c(Oc1ccccc1)c2)C3(C)C
NCGC00255014-01,tox21-er-bla-agonist-p2,Fipronil,activity,inactive,120068-37-3,3352.0,FC(F)(F)S(=O)c1c(N)n(nc1C#N)c2c(Cl)cc(cc2Cl)C(F)(F)F
NCGC00255326-01,tox21-er-bla-agonist-p2,"3,4,5,6-Tetrachloro-2-pyridinecarbonitrile",activity,active agonist,17824-83-8,87323.0,Clc1c(Cl)c(C#N)nc(Cl)c1Cl
NCGC00255504-01,tox21-er-bla-agonist-p2,Nickel(II) chloride,activity,inactive,7718-54-9,24385.0,Cl[Ni]Cl
NCGC00254151-01,tox21-er-bla-agonist-p2,HMR1426,activity,inactive,262376-75-0,9882837.0,Clc1cc2CC3SC(=NC3(O)c2cc1)c4ccccc4
NCGC00016119-02,tox21-er-bla-agonist-p2,Bretylium tosylate,activity,inactive,61-75-6,6100.0,Brc1ccccc1C[N+](C)(C)CC.[O-]S(=O)(=O)c1ccc(C)cc1
NCGC00016498-01,tox21-er-bla-agonist-p2,Dyclonine hydrochloride,activity,inactive,536-43-6,68304.0,Cl.CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2
NCGC00024027-05,tox21-er-bla-agonist-p2,Methysergide,activity,inactive,361-37-5,9681.0,CC[C@@H](CO)NC(=O)[C@@H]3C=C2c4cccc1c4c(cn1C)C[C@H]2N(C)C3
NCGC00024868-03,tox21-er-bla-agonist-p2,Bisoprolol fumarate,activity,inactive,104344-23-2,5281064.0,O=C(O)/C=C/C(=O)O.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C
NCGC00091175-01,tox21-er-bla-agonist-p2,Anthranilic acid,activity,inactive,118-92-3,227.0,OC(=O)c1ccccc1N
NCGC00092314-01,tox21-er-bla-agonist-p2,Tricirbine,activity,inactive,35943-35-2,65399.0,CN4N=C(N)c2cn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c3ncnc4c23
NCGC00160388-01,tox21-er-bla-agonist-p2,Fluperlapine,activity,inactive,67121-76-0,49381.0,CN1CCN(CC1)C2=Nc4cc(F)ccc4Cc3ccccc23
NCGC00164493-01,tox21-er-bla-agonist-p2,Dipyrithione,activity,inactive,3696-28-4,3109.0,[O-][n+]2ccccc2SSc1cccc[n+]1[O-]
NCGC00181011-01,tox21-er-bla-agonist-p2,Gimeracil,activity,inactive,103766-25-2,54679224.0,ClC1=CNC(=O)C=C1O
NCGC00181775-01,tox21-er-bla-agonist-p2,Toluidine blue,activity,inactive,92-31-9,7083.0,[Cl-].CN(C)c1ccc2nc3cc(C)c(N)cc3[s+]c2c1
NCGC00182029-01,tox21-er-bla-agonist-p2,Fosfluconazole,activity,inactive,194798-83-9,214356.0,Fc1ccc(c(F)c1)C(OP(=O)(O)O)(Cn2cncn2)Cn3cncn3
NCGC00259771-01,tox21-er-bla-agonist-p2,Bisphenol B,activity,active agonist,77-40-7,66166.0,Oc1ccc(cc1)C(C)(CC)c2ccc(O)cc2
NCGC00259891-01,tox21-er-bla-agonist-p2,4-Hydroxybenzoic acid,activity,inactive,99-96-7,135.0,OC(=O)c1ccc(O)cc1
NCGC00260060-01,tox21-er-bla-agonist-p2,Ethidium bromide,activity,active agonist,1239-45-8,14710.0,[Br-].CC[n+]3c4cc(N)ccc4c1ccc(N)cc1c3c2ccccc2
NCGC00260159-01,tox21-er-bla-agonist-p2,Stoddard solvent,activity,inactive,8052-41-3,,
NCGC00017033-01,tox21-er-bla-agonist-p2,Novobiocin sodium,activity,inactive,1476-53-5,23663939.0,[Na+].C/C(C)=C\Cc1cc(ccc1O)C(=O)NC3=C([O-])c4ccc(O[C@@H]2OC(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@H]2O)c(C)c4OC3=O
NCGC00091499-05,tox21-er-bla-agonist-p2,Di(2-ethylhexyl) phthalate,activity,inactive,117-81-7,8343.0,CCC(CCCC)COC(=O)c1ccccc1C(=O)OCC(CC)CCCC
NCGC00095021-01,tox21-er-bla-agonist-p2,Heptaminol hydrochloride,activity,inactive,543-15-7,10969.0,Cl.CC(C)(O)CCCC(N)C
NCGC00160483-01,tox21-er-bla-agonist-p2,Ftormetazine,activity,inactive,33414-30-1,969494.0,CN1CCN(CC1)CCC(=O)N2c4ccccc4Sc3ccc(cc23)C(F)(F)F
NCGC00160613-01,tox21-er-bla-agonist-p2,Pidolic acid,activity,inactive,98-79-3,7405.0,O=C(O)[C@@H]1CCC(=O)N1
NCGC00164540-01,tox21-er-bla-agonist-p2,Clofexamide,activity,inactive,1223-36-5,28554.0,Clc1ccc(OCC(=O)NCCN(CC)CC)cc1
NCGC00166412-01,tox21-er-bla-agonist-p2,Thymopentin,activity,inactive,69558-55-0,451417.0,Oc1ccc(C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)O)cc1
NCGC00167466-01,tox21-er-bla-agonist-p2,Lomustine,activity,inactive,13010-47-4,3950.0,O=C(NC1CCCCC1)N(CCCl)N=O
NCGC00183122-01,tox21-er-bla-agonist-p2,Medroxyprogesterone,activity,inactive,520-85-4,10631.0,CC(=O)[C@@]3(O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00254054-01,tox21-er-bla-agonist-p2,Sodium azide,activity,inactive,26628-22-8,33557.0,[Na+].[N-]=[N+]=[N-]
NCGC00090749-04,tox21-er-bla-agonist-p2,"(Z,E)-Diethylstilbestrol",activity,active agonist,6898-97-1,3054.0,Oc1ccc(cc1)C(CC)=C(CC)c2ccc(O)cc2
NCGC00090789-02,tox21-er-bla-agonist-p2,Ethanolamine,activity,inactive,141-43-5,700.0,NCCO
NCGC00090957-01,tox21-er-bla-agonist-p2,Octanoic acid,activity,inactive,124-07-2,379.0,O=C(O)CCCCCCC
NCGC00016965-01,tox21-er-bla-agonist-p2,Finasteride,activity,inactive,98319-26-7,57363.0,CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C
NCGC00021144-02,tox21-er-bla-agonist-p2,Bucladesine,activity,inactive,362-74-3,9687.0,CCCC(=O)Nc4ncnc3c4ncn3[C@@H]2O[C@@H]1COP(=O)(O)O[C@H]1[C@H]2OC(=O)CCC
NCGC00024809-02,tox21-er-bla-agonist-p2,Pronethalol,activity,inactive,54-80-8,4930.0,CC(C)NCC(O)c1ccc2ccccc2c1
NCGC00256985-01,tox21-er-bla-agonist-p2,Ammonium sulfamate,activity,inactive,7773-06-0,24482.0,[NH4+].[O-]S(N)(=O)=O
NCGC00258470-01,tox21-er-bla-agonist-p2,"2,4-Pentanediol",activity,inactive,625-69-4,12262.0,CC(O)CC(C)O
NCGC00257195-01,tox21-er-bla-agonist-p2,"2H-3,1-Benzoxazine-2,4(1H)-dione",activity,inactive,118-48-9,8359.0,O=C1OC(=O)Nc2ccccc12
NCGC00257236-01,tox21-er-bla-agonist-p2,4-tert-Butylaniline,activity,inactive,769-92-6,69861.0,CC(C)(C)c1ccc(N)cc1
NCGC00257307-01,tox21-er-bla-agonist-p2,3-Chloro-2-methylpropene,activity,inactive,563-47-3,11241.0,C=C(C)CCl
NCGC00257501-01,tox21-er-bla-agonist-p2,PharmaGSID_48514,activity,inactive,NOCAS_48514,60196438.0,[Na+].O=C([N-]S(=O)(=O)/C=C/c1ccc(OC)cc1)c2ccc(C)cc2Cl
NCGC00257537-01,tox21-er-bla-agonist-p2,2-Fluoroacetamide,activity,inactive,640-19-7,12542.0,FCC(N)=O
NCGC00257541-01,tox21-er-bla-agonist-p2,2'-Acetonaphthone,activity,inactive,93-08-3,7122.0,CC(=O)c1ccc2ccccc2c1
NCGC00257663-01,tox21-er-bla-agonist-p2,Cyclopentanol,activity,inactive,96-41-3,7298.0,OC1CCCC1
NCGC00257948-01,tox21-er-bla-agonist-p2,4-(4-Hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde,activity,inactive,31906-04-4,91604.0,O=CC1CC=C(CCCC(C)(C)O)CC1
NCGC00258062-01,tox21-er-bla-agonist-p2,6-Nitroquinoline,activity,inactive,613-50-3,11945.0,[O-][N+](=O)c1ccc2ncccc2c1
NCGC00256631-01,tox21-er-bla-agonist-p2,Fluorometholone,activity,inactive,426-13-1,9878.0,CC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C
NCGC00256653-01,tox21-er-bla-agonist-p2,Peppermint oil,activity,inconclusive,8006-90-4,,
NCGC00256377-01,tox21-er-bla-agonist-p2,2-Bromobenzothiazole,activity,inactive,2516-40-7,612040.0,Brc1nc2ccccc2s1
NCGC00256119-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorobenzenesulfonic acid",activity,inactive,6378-25-2,80786.0,Clc1cc(c(Cl)cc1Cl)S(=O)(=O)O
NCGC00256131-01,tox21-er-bla-agonist-p2,Ethyl undec-10-enoate,activity,inactive,692-86-4,12729.0,O=C(CCCCCCCCC=C)OCC
NCGC00256144-01,tox21-er-bla-agonist-p2,Potassium tetrathionate,activity,inactive,13932-13-3,61701.0,[K+].[K+].O=S(=O)([O-])SSS([O-])(=O)=O
NCGC00256200-01,tox21-er-bla-agonist-p2,Potassium perchlorate,activity,inactive,7778-74-7,516900.0,[K+].[O-]Cl(=O)(=O)=O
NCGC00256270-01,tox21-er-bla-agonist-p2,"2,6-Di-tert-butyl-4-[(dimethylamino)methyl]phenol",activity,inactive,88-27-7,66609.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CN(C)C
NCGC00258819-01,tox21-er-bla-agonist-p2,Sodium diethyldithiocarbamate trihydrate,activity,inactive,20624-25-3,517546.0,O.[Na+].O.O.CCN(CC)C([S-])=S
NCGC00258889-01,tox21-er-bla-agonist-p2,Benzyl benzoate,activity,inactive,120-51-4,2345.0,O=C(OCc1ccccc1)c2ccccc2
NCGC00258898-01,tox21-er-bla-agonist-p2,5-Methyl-2-hexanone,activity,inactive,110-12-3,8034.0,CC(C)CCC(C)=O
NCGC00260425-01,tox21-er-bla-agonist-p2,1-Benzoylacetone,activity,inactive,93-91-4,7166.0,O=C(CC(C)=O)c1ccccc1
NCGC00259083-01,tox21-er-bla-agonist-p2,4-Ethylphenol,activity,inactive,123-07-9,31242.0,CCc1ccc(O)cc1
NCGC00259114-01,tox21-er-bla-agonist-p2,Hydrochlorothiazide,activity,inactive,58-93-5,3639.0,NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl
NCGC00259132-01,tox21-er-bla-agonist-p2,2-Butoxyethyl acetate,activity,inactive,112-07-2,8160.0,O=C(C)OCCOCCCC
NCGC00259268-01,tox21-er-bla-agonist-p2,Sorbic acid,activity,inactive,110-44-1,643460.0,C\C=C\C=C\C(=O)O
NCGC00259582-01,tox21-er-bla-agonist-p2,"4,4'-Dibromodiphenyl ether",activity,inactive,2050-47-7,16305.0,Brc2ccc(Oc1ccc(Br)cc1)cc2
NCGC00259700-01,tox21-er-bla-agonist-p2,1-Ethyl-1-nitrosourea,activity,inactive,759-73-9,12967.0,NC(=O)N(CC)N=O
NCGC00260018-01,tox21-er-bla-agonist-p2,"2,2',4,4',5,5'-Hexabromodiphenyl ether",activity,inactive,68631-49-2,155166.0,Brc2cc(Oc1cc(Br)c(Br)cc1Br)c(Br)cc2Br
NCGC00260266-01,tox21-er-bla-agonist-p2,"Pentane,1,5-dibromo-",activity,inactive,111-24-0,8100.0,BrCCCCCBr
NCGC00260389-01,tox21-er-bla-agonist-p2,tetra-Aminopyrimidine sulfate,activity,inactive,5392-28-9,79358.0,Nc1c(N)nc(N)nc1N.O=S(=O)(O)O
NCGC00254620-01,tox21-er-bla-agonist-p2,Dimethylolurea,activity,inactive,140-95-4,8827.0,OCNC(=O)NCO
NCGC00255391-01,tox21-er-bla-agonist-p2,Sodium 2-mercaptobenzothiolate,activity,inactive,2492-26-4,3714831.0,[Na+].[S-]c1nc2ccccc2s1
NCGC00255505-01,tox21-er-bla-agonist-p2,"2-Chloro-1,4-dimethoxybenzene",activity,inactive,2100-42-7,246724.0,COc1ccc(cc1Cl)OC
NCGC00255619-01,tox21-er-bla-agonist-p2,"2-Naphthalenecarboxamide, 3-hydroxy-N-(2-methoxyphenyl)-",activity,inactive,135-62-6,67274.0,COc3ccccc3NC(=O)c1cc2ccccc2cc1O
NCGC00255815-01,tox21-er-bla-agonist-p2,Triphenylbismuthine dichloride,activity,active agonist,594-30-9,299728.0,Cl[Bi](Cl)(c1ccccc1)(c2ccccc2)c3ccccc3
NCGC00093976-03,tox21-er-bla-agonist-p2,Idarubicin hydrochloride,activity,active agonist,57852-57-0,636362.0,Cl.CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2ccccc2C(=O)c3c(O)c5C4
NCGC00163481-02,tox21-er-bla-agonist-p2,Swainsonine,activity,inactive,72741-87-8,51683.0,O[C@@H]1CCCN2C[C@@H](O)[C@@H](O)[C@@H]12
NCGC00094561-01,tox21-er-bla-agonist-p2,Phenothrin,activity,inactive,26002-80-2,4767.0,C/C(C)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00159481-02,tox21-er-bla-agonist-p2,Sofalcone,activity,inactive,64506-49-6,5282219.0,C/C(C)=C\COc1ccc(cc1)/C=C/C(=O)c2ccc(cc2OCC(=O)O)OC\C=C(/C)C
NCGC00160239-01,tox21-er-bla-agonist-p2,Thebaine,activity,inactive,115-37-7,5324289.0,COC1=CC=C3[C@H]2Cc4ccc(OC)c5O[C@@H]1[C@]3(CCN2C)c45
NCGC00164507-01,tox21-er-bla-agonist-p2,Nifuroxime,activity,inactive,6236-05-1,22601.0,O=[N+]([O-])c1ccc(/C=N\O)o1
NCGC00164514-01,tox21-er-bla-agonist-p2,Ambazone,activity,inactive,539-21-9,1549158.0,N=C(N)N\N=C1\C=C/C(=N\NC(N)=S)C=C1
NCGC00164542-01,tox21-er-bla-agonist-p2,Talinolol,activity,inactive,57460-41-0,68770.0,O=C(NC1CCCCC1)Nc2ccc(OCC(O)CNC(C)(C)C)cc2
NCGC00160439-01,tox21-er-bla-agonist-p2,Pyrrocaine,activity,inactive,2210-77-7,24361.0,O=C(Nc1c(C)cccc1C)CN2CCCC2
NCGC00160455-01,tox21-er-bla-agonist-p2,Etofylline clofibrate,activity,inactive,54504-70-0,41109.0,Clc1ccc(cc1)OC(C)(C)C(=O)OCCn3cnc2c3C(=O)N(C)C(=O)N2C
NCGC00164559-01,tox21-er-bla-agonist-p2,Duloxetine hydrochloride,activity,inactive,136434-34-9,60834.0,Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3
NCGC00164582-01,tox21-er-bla-agonist-p2,Feprazone,activity,inactive,30748-29-9,35455.0,C/C(C)=C\CC2C(=O)N(c1ccccc1)N(C2=O)c3ccccc3
NCGC00095121-01,tox21-er-bla-agonist-p2,Nateglinide,activity,inactive,105816-04-4,5311309.0,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@H](Cc2ccccc2)C(=O)O
NCGC00095157-04,tox21-er-bla-agonist-p2,Oxfendazole,activity,inactive,53716-50-0,40854.0,O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3
NCGC00160556-01,tox21-er-bla-agonist-p2,Rafoxanide,activity,inactive,22662-39-1,31475.0,Clc2cc(ccc2Oc1ccc(Cl)cc1)NC(=O)c3cc(I)cc(I)c3O
NCGC00167522-01,tox21-er-bla-agonist-p2,Hexoprenaline sulfate,activity,inactive,32266-10-7,325003.0,Oc1ccc(cc1O)C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2.O=S(=O)(O)O
NCGC00167523-01,tox21-er-bla-agonist-p2,Ormetoprim,activity,inactive,6981-18-6,23418.0,Nc2nc(N)ncc2Cc1cc(OC)c(OC)cc1C
NCGC00167537-01,tox21-er-bla-agonist-p2,Donepezil hydrochloride,activity,inactive,120011-70-3,5741.0,Cl.COc1cc2C(=O)C(Cc2cc1OC)CC4CCN(Cc3ccccc3)CC4
NCGC00166106-01,tox21-er-bla-agonist-p2,Nicotinic acid 1-oxide,activity,inactive,2398-81-4,16976.0,[O-][n+]1cccc(c1)C(O)=O
NCGC00091632-02,tox21-er-bla-agonist-p2,2-Amino-6-nitrobenzothiazole,activity,inactive,6285-57-0,22704.0,[O-][N+](=O)c1ccc2nc(N)sc2c1
NCGC00182988-01,tox21-er-bla-agonist-p2,Acreozast,activity,inactive,123548-56-1,129991.0,Clc1c(cc(cc1NC(=O)COC(C)=O)C#N)NC(=O)COC(C)=O
NCGC00183873-01,tox21-er-bla-agonist-p2,Granisetron hydrochloride,activity,inactive,107007-99-8,6918003.0,Cl.CN4[C@@H]1CCC[C@H]4C[C@H](C1)NC(=O)c3nn(C)c2ccccc23
NCGC00184999-01,tox21-er-bla-agonist-p2,Sultopride hydrochloride,activity,inactive,23694-17-9,3082221.0,Cl.CCN2CCCC2CNC(=O)c1cc(ccc1OC)S(=O)(=O)CC
NCGC00185757-01,tox21-er-bla-agonist-p2,Diethylmethyl(2-3-methyl-2-phenylvaleryloxy)-ethyl)ammonium bromide,activity,inactive,90-22-2,7010.0,[Br-].CC[N+](C)(CC)CCOC(=O)C(C(C)CC)c1ccccc1
NCGC00255271-01,tox21-er-bla-agonist-p2,Nilutamide,activity,inactive,63612-50-0,4493.0,FC(F)(F)c1cc(ccc1[N+]([O-])=O)N2C(=O)C(C)(C)NC2=O
NCGC00189075-01,tox21-er-bla-agonist-p2,PD 0325901,activity,inactive,391210-10-9,9826528.0,OC[C@@H](O)CONC(=O)c2ccc(F)c(F)c2Nc1ccc(I)cc1F
NCGC00229704-01,tox21-er-bla-agonist-p2,Raltitrexed,activity,inactive,112887-68-0,104758.0,O=C(N[C@@H](CCC(=O)O)C(=O)O)c1ccc(s1)N(C)Cc2ccc3N=C(C)NC(=O)c3c2
NCGC00247718-01,tox21-er-bla-agonist-p2,1-Phenylcyclohexylamine hydrochloride,activity,inactive,1934-71-0,200391.0,Cl.NC1(CCCCC1)c2ccccc2
NCGC00253938-01,tox21-er-bla-agonist-p2,"2,4-Dimethylphenol",activity,inactive,105-67-9,7771.0,Cc1ccc(O)c(C)c1
NCGC00255201-01,tox21-er-bla-agonist-p2,Trilostane,activity,inactive,13647-35-3,656583.0,N#CC=2C[C@]4(C)[C@H]5CC[C@]1(C)[C@@H](O)CC[C@H]1[C@@H]5CC[C@@]34O[C@@H]3C=2O
NCGC00255288-01,tox21-er-bla-agonist-p2,Dimethylamine,activity,inactive,124-40-3,674.0,CNC
NCGC00254839-01,tox21-er-bla-agonist-p2,Diphenyl phthalate,activity,inactive,84-62-8,6778.0,O=C(Oc1ccccc1)c3ccccc3C(=O)Oc2ccccc2
NCGC00254851-01,tox21-er-bla-agonist-p2,D-Glucuronolactone,activity,inactive,32449-92-6,2724333.0,O[C@@H]2O[C@@H]1[C@@H](O)C(=O)O[C@@H]1[C@H]2O
NCGC00254862-01,tox21-er-bla-agonist-p2,Dichlofluanid,activity,inactive,1085-98-9,14145.0,CN(C)S(=O)(=O)N(SC(Cl)(Cl)F)c1ccccc1
NCGC00254126-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) terephthalate,activity,inactive,6422-86-2,22932.0,CCC(CCCC)COC(=O)c1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00254950-01,tox21-er-bla-agonist-p2,Picloram,activity,inactive,1918-02-1,15965.0,Nc1c(Cl)c(nc(Cl)c1Cl)C(=O)O
NCGC00182077-02,tox21-er-bla-agonist-p2,Roxithromycin,activity,inactive,80214-83-1,444037.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)\C(=N\OCOCCOC)[C@H](C)C[C@@]2(C)O)[C@@H]3O
NCGC00183026-01,tox21-er-bla-agonist-p2,Dicethiamine hydrochloride,activity,inactive,616-96-6,3035267.0,Cl.Nc1nc(C)ncc1CN(C=O)C(/C)=C(/CCOC(=O)OCC)SC(=O)OCC
NCGC00257962-01,tox21-er-bla-agonist-p2,"1,1,2-Trichloropropane",activity,inactive,598-77-6,11733.0,CC(Cl)C(Cl)Cl
NCGC00260507-01,tox21-er-bla-agonist-p2,(+)Camphorquinone,activity,inactive,10373-78-1,25208.0,CC2(C)C1CCC2(C)C(=O)C1=O
NCGC00259035-01,tox21-er-bla-agonist-p2,Flusilazole,activity,inactive,85509-19-9,73675.0,C[Si](Cn1cncn1)(c2ccc(F)cc2)c3ccc(F)cc3
NCGC00258282-01,tox21-er-bla-agonist-p2,Diphenyl disulfide,activity,inactive,882-33-7,13436.0,S(Sc1ccccc1)c2ccccc2
NCGC00259444-01,tox21-er-bla-agonist-p2,"2,4,6-Tris(dimethylaminomethyl)phenol",activity,inactive,90-72-2,7026.0,Oc1c(cc(cc1CN(C)C)CN(C)C)CN(C)C
NCGC00255525-01,tox21-er-bla-agonist-p2,Fluorodifen,activity,inactive,15457-05-3,27295.0,[O-][N+](=O)c1ccc(cc1)Oc2ccc(cc2[N+]([O-])=O)C(F)(F)F
NCGC00255585-01,tox21-er-bla-agonist-p2,3-Methyl-2-cyclohexen-1-one,activity,inactive,1193-18-6,14511.0,CC=1CCCC(=O)C=1
NCGC00016583-01,tox21-er-bla-agonist-p2,Oxybutynin chloride,activity,inactive,1508-65-2,91505.0,Cl.OC(C(=O)OCC#CCN(CC)CC)(c1ccccc1)C2CCCCC2
NCGC00256307-01,tox21-er-bla-agonist-p2,3-(Octyloxy)propan-1-amine,activity,inactive,15930-66-2,85192.0,NCCCOCCCCCCCC
NCGC00257507-01,tox21-er-bla-agonist-p2,"1-(2,3,8,8-Tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone",activity,inactive,54464-57-2,108242.0,CC(=O)C2(C)CC1=C(CCCC1(C)C)CC2C
NCGC00257009-01,tox21-er-bla-agonist-p2,Lamivudine,activity,inactive,134678-17-4,73339.0,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)SC2
NCGC00258388-01,tox21-er-bla-agonist-p2,"(2E,4E)-2,4-Hexadienal",activity,inactive,142-83-6,637564.0,C\C=C\C=C\C=O
NCGC00258483-01,tox21-er-bla-agonist-p2,Cimicifugoside,activity,inactive,27994-11-2,6537499.0,C[C@@H]4CC2(OC(O)C1(C)OC12)OC5C[C@@]6(C)C7=CC[C@H]9[C@](C)(C)C(O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)CC[C@]89C[C@@]78CC[C@]6(C)C45
NCGC00257667-01,tox21-er-bla-agonist-p2,"1,1-Ethanediol diacetate",activity,inactive,542-10-9,222536.0,CC(=O)OC(C)OC(=O)C
NCGC00254383-01,tox21-er-bla-agonist-p2,Zenarestat,activity,inactive,112733-06-9,5724.0,Brc3ccc(CN2C(=O)c1ccc(Cl)cc1N(CC(=O)O)C2=O)c(F)c3
NCGC00255765-01,tox21-er-bla-agonist-p2,3-Hydroxy-N-(3-nitrophenyl)naphthalene-2-carboxamide,activity,inactive,135-65-9,67277.0,[O-][N+](=O)c1cccc(c1)NC(=O)c2cc3ccccc3cc2O
NCGC00254828-01,tox21-er-bla-agonist-p2,2-Ethyl-1-butanol,activity,inactive,97-95-0,7358.0,CCC(CC)CO
NCGC00256668-01,tox21-er-bla-agonist-p2,"3,5-Dimethyl-1,2-cyclopentanedione",activity,inactive,13494-07-0,61634.0,O=C1C(=O)C(C)CC1C
NCGC00256880-01,tox21-er-bla-agonist-p2,(4-Methylphenoxy) acetic acid ethyl ester,activity,inactive,67028-40-4,4047281.0,O=C(COc1ccc(C)cc1)OCC
NCGC00256995-01,tox21-er-bla-agonist-p2,Propylene carbonate,activity,inactive,108-32-7,7924.0,O=C1OCC(C)O1
NCGC00257154-01,tox21-er-bla-agonist-p2,3-(Triethoxysilyl)propionitrile,activity,inactive,919-31-3,13522.0,CCO[Si](OCC)(OCC)CCC#N
NCGC00257163-01,tox21-er-bla-agonist-p2,2-[4-(Diethylamino)-2-hydroxybenzoyl]benzoic acid,activity,inactive,5809-23-4,79878.0,O=C(c1ccc(cc1O)N(CC)CC)c2ccccc2C(=O)O
NCGC00257653-01,tox21-er-bla-agonist-p2,Diacetyl hydrazine,activity,inactive,3148-73-0,72884.0,CC(=O)NNC(C)=O
NCGC00257235-01,tox21-er-bla-agonist-p2,FR073317,activity,inactive,NOCAS_48166,60196435.0,NC(=O)OC[C@H]4c1c(cc(C=O)cc1OC)N3C[C@H]2[C@H](N2C(C)=O)[C@@]4(OC(C)=O)O3
NCGC00257692-01,tox21-er-bla-agonist-p2,"2,3-Dichloroquinoxaline",activity,inactive,2213-63-0,16659.0,Clc1nc2ccccc2nc1Cl
NCGC00257285-01,tox21-er-bla-agonist-p2,2-Ethyl-6-methylaniline,activity,inactive,24549-06-2,32485.0,CCc1cccc(C)c1N
NCGC00257018-01,tox21-er-bla-agonist-p2,"3-Hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropanoate",activity,inactive,1115-20-4,14218.0,CC(C)(CO)COC(=O)C(C)(C)CO
NCGC00258269-01,tox21-er-bla-agonist-p2,Sodium 5-sulfoisophthalate,activity,inactive,6362-79-4,23670844.0,[Na+].O=S([O-])(=O)c1cc(cc(c1)C(=O)O)C(=O)O
NCGC00258413-01,tox21-er-bla-agonist-p2,"2-(Hydroxymethyl)-1H-Isoindole-1,3(2H)-dione",activity,inactive,118-29-6,8354.0,O=C2c1ccccc1C(=O)N2CO
NCGC00258026-01,tox21-er-bla-agonist-p2,4-Ethyltoluene,activity,inactive,622-96-8,12160.0,Cc1ccc(CC)cc1
NCGC00260133-01,tox21-er-bla-agonist-p2,Benzidine dihydrochloride,activity,inactive,531-85-1,10754.0,Cl.Cl.Nc1ccc(cc1)c2ccc(N)cc2
NCGC00259480-01,tox21-er-bla-agonist-p2,"2,3,4,6-Tetrachlorophenol",activity,inactive,58-90-2,6028.0,Clc1cc(Cl)c(Cl)c(Cl)c1O
NCGC00259701-01,tox21-er-bla-agonist-p2,"3,3'-Dimethoxybenzidine dihydrochloride",activity,inactive,20325-40-0,62311.0,Cl.Cl.Nc1ccc(cc1OC)c2ccc(N)c(OC)c2
NCGC00259217-01,tox21-er-bla-agonist-p2,"4,4'-Bipyridine",activity,inactive,553-26-4,11107.0,c1cc(ccn1)c2ccncc2
NCGC00260660-01,tox21-er-bla-agonist-p2,NTP Mix26 AR2 2-EQP,activity,inactive,NOCAS_49556,,
NCGC00260550-01,tox21-er-bla-agonist-p2,NTP Mix58 CT1 62-EQP,activity,inactive,NOCAS_49446,,
NCGC00260245-01,tox21-er-bla-agonist-p2,1-Ethylpyridinium iodide,activity,inactive,872-90-2,12038941.0,[I-].CC[n+]1ccccc1
NCGC00016049-02,tox21-er-bla-agonist-p2,Tetracaine hydrochloride,activity,inactive,136-47-0,8695.0,Cl.CN(C)CCOC(=O)c1ccc(NCCCC)cc1
NCGC00016721-01,tox21-er-bla-agonist-p2,Fenoterol hydrobromide,activity,inactive,1944-12-3,5702161.0,Br.Oc1cc(cc(O)c1)C(O)CNC(C)Cc2ccc(O)cc2
NCGC00016563-01,tox21-er-bla-agonist-p2,Meclozine dihydrochloride,activity,inactive,1104-22-9,64713.0,Cl.Cl.Cc1cccc(c1)CN2CCN(CC2)C(c3ccc(Cl)cc3)c4ccccc4
NCGC00016787-01,tox21-er-bla-agonist-p2,Rescinnamine,activity,inactive,24815-24-5,32681.0,COc1cc(cc(OC)c1OC)C=CC(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC
NCGC00016508-01,tox21-er-bla-agonist-p2,Methazolamide,activity,inactive,554-57-4,4100.0,CN1N=C(S\C1=N/C(C)=O)S(=O)(N)=O
NCGC00016509-01,tox21-er-bla-agonist-p2,Trimethobenzamide hydrochloride,activity,inactive,554-92-7,68385.0,Cl.COc1c(cc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2)OC
NCGC00016106-04,tox21-er-bla-agonist-p2,Zardaverine,activity,inactive,101975-10-4,5723.0,FC(F)Oc1ccc(cc1OC)C=2C=CC(=O)NN=2
NCGC00091881-01,tox21-er-bla-agonist-p2,Toxaphene,activity,active agonist,8001-35-2,5284469.0,ClC2(Cl)C1(Cl)C(Cl)C(Cl)C2(Cl)C(=C)C1(CCl)CCl
NCGC00167510-01,tox21-er-bla-agonist-p2,Doripenem,activity,inactive,148016-81-3,73303.0,O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@@H](CNS(N)(=O)=O)NC1)[C@H](C)[C@@H]23)C(=O)O
NCGC00181053-01,tox21-er-bla-agonist-p2,Disodium 2-hydroxybutanedioate,activity,inactive,676-46-0,8736.0,[Na+].[Na+].[O-]C(=O)C(O)CC([O-])=O
NCGC00255599-01,tox21-er-bla-agonist-p2,Oxycarboxin,activity,inactive,5259-88-1,21330.0,CC=1OCCS(=O)(=O)C=1C(=O)Nc2ccccc2
NCGC00255898-01,tox21-er-bla-agonist-p2,Diphenylmercury(II),activity,inactive,587-85-9,11488.0,c1ccccc1[Hg]c2ccccc2
NCGC00255266-01,tox21-er-bla-agonist-p2,Cytembena,activity,inactive,21739-91-3,23665583.0,[Na+].COc1ccc(cc1)C(=O)C(/Br)=C\C([O-])=O
NCGC00254535-01,tox21-er-bla-agonist-p2,PharmaGSID_47259,activity,inactive,149062-75-9,18992283.0,Cl.Clc2cc(Cl)cc1N=C3CCCCCN3Cc12
NCGC00015099-05,tox21-er-bla-agonist-p2,Alprenolol,activity,inactive,13655-52-2,2119.0,CC(C)NCC(O)COc1ccccc1CC=C
NCGC00094630-01,tox21-er-bla-agonist-p2,Colistimethate sodium,activity,inactive,8068-28-8,46224595.0,[Na+].[Na+].[Na+].[Na+].[Na+].CC[C@@H](C)CCCCC(=O)N[C@@H](CCNCS([O-])(=O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCNCS([O-])(=O)=O)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCNCS([O-])(=O)=O)NC(=O)[C@H](CCNCS([O-])(=O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS([O-])(=O)=O)NC1=O)[C@@H](C)O
NCGC00160677-01,tox21-er-bla-agonist-p2,Butinoline,activity,inactive,968-61-6,68943.0,OC(C#CCN1CCCC1)(c2ccccc2)c3ccccc3
NCGC00163298-01,tox21-er-bla-agonist-p2,Lisofylline,activity,inactive,6493-06-7,57782.0,CC(O)CCCCN2C(=O)c1n(C)cnc1N(C)C2=O
NCGC00182055-02,tox21-er-bla-agonist-p2,Bazedoxifene,activity,active agonist,198481-33-3,154256.0,CC(=O)O.Oc1ccc(cc1)c5c(C)c2cc(O)ccc2n5Cc3ccc(cc3)OCCN4CCCCCC4
NCGC00182995-01,tox21-er-bla-agonist-p2,Etomidoline,activity,inactive,21590-92-1,3309.0,O=C4c1ccccc1C(Nc3ccc(OCCN2CCCCC2)cc3)N4CC
NCGC00186464-01,tox21-er-bla-agonist-p2,Aliskiren hydrochloride,activity,inactive,173399-03-6,23625795.0,Cl.NC(=O)C(C)(C)CNC(=O)[C@@H](C[C@H](O)[C@@H](N)C[C@H](Cc1cc(OCCCOC)c(cc1)OC)C(C)C)C(C)C
NCGC00259407-01,tox21-er-bla-agonist-p2,Methylcyclopentadiene dimer,activity,inactive,26472-00-4,3437714.0,CC=2CC3C1C=C(C)C(C1)C3C=2
NCGC00259514-01,tox21-er-bla-agonist-p2,Azinphos-methyl,activity,inactive,86-50-0,2268.0,COP(=S)(OC)SCN1N=Nc2ccccc2C1=O
NCGC00159334-02,tox21-er-bla-agonist-p2,Isosorbide mononitrate,activity,inactive,16051-77-7,27661.0,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O
NCGC00181118-01,tox21-er-bla-agonist-p2,Sulfabromomethazine,activity,inactive,116-45-0,8310.0,O=S(=O)(Nc1nc(C)c(Br)c(C)n1)c2ccc(N)cc2
NCGC00247734-01,tox21-er-bla-agonist-p2,alpha-Methylfentanyl hydrochloride,activity,inactive,1443-44-3,24194381.0,Cl.CCC(=O)N(C1CCN(CC1)C(C)Cc2ccccc2)c3ccccc3
NCGC00254610-01,tox21-er-bla-agonist-p2,Simetryn,activity,inactive,1014-70-6,13905.0,CSc1nc(NCC)nc(NCC)n1
NCGC00017032-01,tox21-er-bla-agonist-p2,Gentamicin sulfate,activity,inactive,1405-41-0,44420324.0,O=S(=O)(O)O.CC(NC)[C@@H]1CC[C@@H](N)[C@H](O1)O[C@H]3[C@H](O)[C@@H](O[C@H]2OC[C@](C)(O)[C@H](NC)[C@H]2O)[C@H](N)C[C@@H]3N
NCGC00021191-07,tox21-er-bla-agonist-p2,Cortisone acetate,activity,inactive,50-04-4,5745.0,CC(=O)OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00025273-01,tox21-er-bla-agonist-p2,Nemonapride,activity,inactive,75272-39-8,9952220.0,Clc1cc(c(OC)cc1NC)C(=O)N[C@H]3CCN(Cc2ccccc2)[C@H]3C
NCGC00256912-01,tox21-er-bla-agonist-p2,Tridec-2-enenitrile,activity,inactive,22629-49-8,90818.0,CCCCCCCCCCC=CC#N
NCGC00257086-01,tox21-er-bla-agonist-p2,Phenoxyacetic acid,activity,inactive,122-59-8,19188.0,O=C(O)COc1ccccc1
NCGC00257153-01,tox21-er-bla-agonist-p2,Thioglycolic acid,activity,inactive,68-11-1,1133.0,O=C(O)CS
NCGC00257319-01,tox21-er-bla-agonist-p2,"2,3-Dimethylphenol",activity,inactive,526-75-0,10687.0,Cc1cccc(O)c1C
NCGC00257359-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium chloride,activity,inactive,79917-90-1,2734161.0,[Cl-].CCCCn1cc[n+](C)c1
NCGC00257458-01,tox21-er-bla-agonist-p2,2-(2-Butoxyethoxy)ethyl thiocyanate,activity,inactive,112-56-1,8196.0,N#CSCCOCCOCCCC
NCGC00257464-01,tox21-er-bla-agonist-p2,Kaempferol,activity,active agonist,520-18-3,5280863.0,Oc1ccc(cc1)C=3Oc2cc(O)cc(O)c2C(=O)C=3O
NCGC00257781-01,tox21-er-bla-agonist-p2,Sodium 2-hydroxyethanesulfonate,activity,inactive,1562-00-1,517063.0,[Na+].[O-]S(=O)(=O)CCO
NCGC00257878-01,tox21-er-bla-agonist-p2,2-Tolunitrile,activity,inactive,529-19-1,10721.0,N#Cc1ccccc1C
NCGC00257924-01,tox21-er-bla-agonist-p2,3-Chloro-2-methylaniline,activity,inactive,87-60-5,6894.0,Nc1cccc(Cl)c1C
NCGC00257985-01,tox21-er-bla-agonist-p2,Benzoyl chloride,activity,inactive,98-88-4,7412.0,ClC(=O)c1ccccc1
NCGC00258261-01,tox21-er-bla-agonist-p2,1-Nitrohexane,activity,inactive,646-14-0,12589.0,[O-][N+](=O)CCCCCC
NCGC00256630-01,tox21-er-bla-agonist-p2,Hexyl octanoate,activity,inactive,1117-55-1,14228.0,O=C(CCCCCCC)OCCCCCC
NCGC00256690-01,tox21-er-bla-agonist-p2,4-Phenyltoluene,activity,inactive,644-08-6,12566.0,Cc1ccc(cc1)c2ccccc2
NCGC00256488-01,tox21-er-bla-agonist-p2,"Hexachloro-1,3-butadiene",activity,inactive,87-68-3,6901.0,Cl/C(Cl)=C(\Cl)C(\Cl)=C(\Cl)Cl
NCGC00256535-01,tox21-er-bla-agonist-p2,"2-Butyne-1,4-diol",activity,inactive,110-65-6,8066.0,OCC#CCO
NCGC00255800-01,tox21-er-bla-agonist-p2,3-(Aminomethyl)pyridine,activity,inactive,3731-52-0,31018.0,NCc1cccnc1
NCGC00255911-01,tox21-er-bla-agonist-p2,"1,2-Diphenylethanone",activity,inactive,451-40-1,9948.0,O=C(Cc1ccccc1)c2ccccc2
NCGC00256042-01,tox21-er-bla-agonist-p2,4-Chlorobenzonitrile,activity,inactive,623-03-0,12163.0,N#Cc1ccc(Cl)cc1
NCGC00256085-01,tox21-er-bla-agonist-p2,Acetylpyrazine,activity,inactive,22047-25-2,30914.0,CC(=O)c1cnccn1
NCGC00256148-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) phosphonate,activity,inactive,3658-48-8,6327514.0,CCCCC(COP(=O)OCC(CC)CCCC)CC
NCGC00259194-01,tox21-er-bla-agonist-p2,Cyanoacetic acid,activity,inactive,372-09-8,9740.0,N#CCC(=O)O
NCGC00259378-01,tox21-er-bla-agonist-p2,Maleic hydrazide,activity,inactive,123-33-1,21954.0,O=C1C=CC(=O)NN1
NCGC00259408-01,tox21-er-bla-agonist-p2,Streptozocin,activity,inactive,18883-66-4,29327.0,O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O
NCGC00260029-01,tox21-er-bla-agonist-p2,Acetone,activity,inactive,67-64-1,180.0,CC(C)=O
NCGC00260271-01,tox21-er-bla-agonist-p2,"2,6,6-Trimethylcyclohexa-1,3-dienylmethanal",activity,inactive,116-26-7,61041.0,CC=1C=CCC(C)(C)C=1C=O
NCGC00254877-01,tox21-er-bla-agonist-p2,Glutaric anhydride,activity,inactive,108-55-4,7940.0,O=C1CCCC(=O)O1
NCGC00256222-01,tox21-er-bla-agonist-p2,3-(4-tert-Butylphenyl)propanal,activity,inactive,18127-01-0,64832.0,CC(C)(C)c1ccc(CCC=O)cc1
NCGC00254994-01,tox21-er-bla-agonist-p2,Forchlorfenuron,activity,inactive,68157-60-8,93379.0,Clc2cc(NC(=O)Nc1ccccc1)ccn2
NCGC00254996-01,tox21-er-bla-agonist-p2,Fluroxypyr,activity,inactive,69377-81-7,50465.0,O=C(O)COc1nc(F)c(Cl)c(N)c1Cl
NCGC00255414-01,tox21-er-bla-agonist-p2,2-Methoxy-4-nitroaniline,activity,inactive,97-52-9,7337.0,Nc1ccc(cc1OC)[N+]([O-])=O
NCGC00255421-01,tox21-er-bla-agonist-p2,2-((Dimethylamino)methyl)phenol,activity,inactive,120-65-0,32897.0,Oc1ccccc1CN(C)C
NCGC00091507-01,tox21-er-bla-agonist-p2,Pyrogallol,activity,active agonist,87-66-1,1057.0,Oc1cccc(O)c1O
NCGC00093354-03,tox21-er-bla-agonist-p2,Niacinamide,activity,inactive,98-92-0,936.0,NC(=O)c1cccnc1
NCGC00166305-01,tox21-er-bla-agonist-p2,Peracetic acid,activity,inactive,79-21-0,6585.0,CC(=O)OO
NCGC00094157-01,tox21-er-bla-agonist-p2,Neboglamine,activity,inactive,163000-63-3,3074827.0,O=C(NC1CCC(C)(C)CC1)[C@@H](N)CCC(=O)O
NCGC00094357-01,tox21-er-bla-agonist-p2,Succinylcholine chloride,activity,inactive,71-27-2,22475.0,[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
NCGC00163522-01,tox21-er-bla-agonist-p2,Capreomycin IB,activity,inactive,33490-33-4,20055082.0,NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)C(\NC1=O)=C\NC(N)=O)[C@@H]2CCNC(N)=N2
NCGC00159496-02,tox21-er-bla-agonist-p2,Sildenafil citrate,activity,inactive,171599-83-0,62853.0,CN1CCN(CC1)S(=O)(=O)c4cc(C3=Nc2c(CCC)nn(C)c2C(=O)N3)c(OCC)cc4.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00181028-01,tox21-er-bla-agonist-p2,Pantethine,activity,inactive,16816-67-4,4677.0,O=C(NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO)CCNC(=O)C(O)C(C)(C)CO
NCGC00167505-01,tox21-er-bla-agonist-p2,Eptifibatide,activity,inactive,188627-80-7,448812.0,NC(=O)[C@@H]3CSSCCC(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2cnc1ccccc12)C(=O)N4CCC[C@H]4C(=O)N3
NCGC00095122-01,tox21-er-bla-agonist-p2,Irbesartan,activity,inactive,138402-11-6,3749.0,CCCCC5=NC1(CCCC1)C(=O)N5Cc2ccc(cc2)c3ccccc3c4nnnn4
NCGC00165970-01,tox21-er-bla-agonist-p2,Etiracetam,activity,inactive,33996-58-6,59708.0,O=C1CCCN1C(CC)C(N)=O
NCGC00166024-01,tox21-er-bla-agonist-p2,Hexadecylamine,activity,inactive,143-27-1,8926.0,CCCCCCCCCCCCCCCCN
NCGC00160622-04,tox21-er-bla-agonist-p2,D-delta-Tocopherol,activity,inactive,119-13-1,92094.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1
NCGC00168785-01,tox21-er-bla-agonist-p2,Diclazuril,activity,inactive,101831-37-2,456389.0,Clc1ccc(cc1)C(C#N)c2c(Cl)cc(cc2Cl)N3N=CC(=O)NC3=O
NCGC00167546-02,tox21-er-bla-agonist-p2,S-Adenosylmethionine chloride,activity,inactive,24346-00-7,90473.0,[Cl-].O=C(O)[C@@H](N)CC[S+](C)C[C@H]3O[C@@H](n2cnc1c(N)ncnc12)[C@H](O)[C@@H]3O
NCGC00091330-01,tox21-er-bla-agonist-p2,Anthralin,activity,inactive,1143-38-0,2202.0,Oc2cccc1Cc3cccc(O)c3C(=O)c12
NCGC00183013-01,tox21-er-bla-agonist-p2,Doranidazole,activity,inactive,149838-23-3,164486.0,OC[C@@H](O)[C@H](CO)OCn1ccnc1[N+]([O-])=O
NCGC00183131-01,tox21-er-bla-agonist-p2,Cefpodoxime proxetil,activity,inactive,87239-81-4,6526396.0,Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(COC)CS[C@@H]23)C(=O)OC(C)OC(=O)OC(C)C
NCGC00255025-01,tox21-er-bla-agonist-p2,alpha-Terpinene,activity,inactive,99-86-5,7462.0,CC(C)C1=CC=C(C)CC1
NCGC00254235-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-3-nitrobenzene",activity,inactive,83-41-0,6739.0,Cc1c(C)cccc1[N+](=O)[O-]
NCGC00253988-01,tox21-er-bla-agonist-p2,alpha-Cyclodextrin,activity,inactive,10016-20-3,444913.0,O[C@@H]2[C@@H](O)[C@@H]1O[C@H]7O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]2O[C@@H]1CO)[C@H](O)[C@H]3O)[C@H](O)[C@H]4O)[C@H](O)[C@H]5O)[C@H](O)[C@H]6O)[C@H](O)[C@H]7O
NCGC00254111-01,tox21-er-bla-agonist-p2,AVE3247,activity,inactive,NOCAS_47383,60196409.0,[Na+].Clc1ccc(s1)c6onc(Cn4c5ccc(cc5nc4C(=O)NC2CCN(CC2)C3CC3)C([O-])=O)c6
NCGC00259600-01,tox21-er-bla-agonist-p2,Pentylcinnamaldehyde,activity,inactive,122-40-7,31209.0,O=CC(CCCCC)=Cc1ccccc1
NCGC00259820-01,tox21-er-bla-agonist-p2,Ammonium nitrate,activity,inactive,6484-52-2,22985.0,[NH4+].[O-][N+]([O-])=O
NCGC00258756-01,tox21-er-bla-agonist-p2,Hydroxyflutamide,activity,inactive,52806-53-8,91649.0,O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)(C)O
NCGC00258814-01,tox21-er-bla-agonist-p2,17alpha-Estradiol,activity,active agonist,57-91-0,68570.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@H](O)CC[C@@H]12)c4cc3
NCGC00160414-01,tox21-er-bla-agonist-p2,Benzobarbital,activity,inactive,744-80-9,12938.0,O=C2NC(=O)C(CC)(C(=O)N2C(=O)c1ccccc1)c3ccccc3
NCGC00015223-08,tox21-er-bla-agonist-p2,Carboplatin,activity,inactive,41575-94-4,426756.0,O=C2O[Pt](N)(N)OC(=O)C12CCC1
NCGC00259502-01,tox21-er-bla-agonist-p2,2-(4-Hydroxybenzyl)phenol,activity,active agonist,2467-03-0,75576.0,Oc2ccccc2Cc1ccc(O)cc1
NCGC00259753-01,tox21-er-bla-agonist-p2,Acephate,activity,inactive,30560-19-1,1982.0,O=C(C)NP(=O)(OC)SC
NCGC00260375-01,tox21-er-bla-agonist-p2,(S)-(-)-1-Amino-1-phenylpropane,activity,inactive,3789-59-1,6993773.0,N[C@@H](CC)c1ccccc1
NCGC00260479-01,tox21-er-bla-agonist-p2,9-Bromophenanthrene,activity,inactive,573-17-1,11309.0,Brc2cc3ccccc3c1ccccc12
NCGC00260527-01,tox21-er-bla-agonist-p2,Isodecyl diphenyl phosphate,activity,inactive,29761-21-5,34697.0,CC(C)CCCCCCCOP(=O)(Oc1ccccc1)Oc2ccccc2
NCGC00015455-03,tox21-er-bla-agonist-p2,Felodipine,activity,active agonist,72509-76-3,3333.0,CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(Cl)c2Cl)C(=O)OC
NCGC00256475-01,tox21-er-bla-agonist-p2,Anise oil,activity,inactive,8007-70-3,,
NCGC00257706-01,tox21-er-bla-agonist-p2,Ethyl bromoacetate,activity,inactive,105-36-2,7748.0,BrCC(=O)OCC
NCGC00259271-01,tox21-er-bla-agonist-p2,Pentamidine isethionate,activity,inactive,140-64-7,8813.0,OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N
NCGC00257600-01,tox21-er-bla-agonist-p2,"N-(6-Aminohexyl)hexane-1,6-diamine",activity,inactive,143-23-7,8924.0,NCCCCCCNCCCCCCN
NCGC00257753-01,tox21-er-bla-agonist-p2,Methyl triclosan,activity,inactive,4640-01-1,627458.0,Clc2cc(Cl)ccc2Oc1ccc(Cl)cc1OC
NCGC00258810-01,tox21-er-bla-agonist-p2,4-Nitrobenzoic acid,activity,inactive,62-23-7,6108.0,O=[N+]([O-])c1ccc(cc1)C(=O)O
NCGC00259165-01,tox21-er-bla-agonist-p2,Diethylene glycol,activity,inactive,111-46-6,8117.0,OCCOCCO
NCGC00254321-01,tox21-er-bla-agonist-p2,Cytarabine hydrochloride,activity,inactive,69-74-9,6252.0,Cl.NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
NCGC00255834-01,tox21-er-bla-agonist-p2,Phenylmercuric lactate,activity,active agonist,122-64-5,16683023.0,CC(O)C(=O)O[Hg]c1ccccc1
NCGC00256053-01,tox21-er-bla-agonist-p2,Aluminum hydroxide acetate (1:2:1),activity,inactive,7360-44-3,16683978.0,O[Al](O)OC(C)=O
NCGC00256097-01,tox21-er-bla-agonist-p2,Tetramethylpyrazine,activity,inactive,1124-11-4,14296.0,Cc1nc(C)c(C)nc1C
NCGC00256557-01,tox21-er-bla-agonist-p2,"3-Chloro-1,2-propanediol",activity,inactive,96-24-2,7290.0,OCC(O)CCl
NCGC00256927-01,tox21-er-bla-agonist-p2,3-Dimethylaminopropionitrile,activity,inactive,1738-25-6,15615.0,N#CCCN(C)C
NCGC00256671-01,tox21-er-bla-agonist-p2,4-Pentanolide,activity,inactive,108-29-2,7921.0,O=C1CCC(C)O1
NCGC00255993-01,tox21-er-bla-agonist-p2,Procaine hydrochloride,activity,inactive,51-05-8,5795.0,Cl.Nc1ccc(cc1)C(=O)OCCN(CC)CC
NCGC00257817-01,tox21-er-bla-agonist-p2,Zinc diethyldithiocarbamate,activity,active agonist,14324-55-1,26633.0,[Zn+2].S=C([S-])N(CC)CC.CCN(CC)C([S-])=S
NCGC00257228-01,tox21-er-bla-agonist-p2,Propofol,activity,inactive,2078-54-8,4943.0,CC(C)c1cccc(C(C)C)c1O
NCGC00257474-01,tox21-er-bla-agonist-p2,Allyl alcohol,activity,inactive,107-18-6,7858.0,C=CCO
NCGC00257873-01,tox21-er-bla-agonist-p2,"Isobutyl (2,4,5-trichlorophenoxy)acetate",activity,inactive,4938-72-1,21058.0,Clc1cc(OCC(=O)OCC(C)C)c(Cl)cc1Cl
NCGC00257538-01,tox21-er-bla-agonist-p2,tert-Butylamine,activity,inactive,75-64-9,6385.0,CC(C)(C)N
NCGC00257567-01,tox21-er-bla-agonist-p2,(3-Chloropropyl)trimethoxysilane,activity,inactive,2530-87-2,62449.0,CO[Si](CCCCl)(OC)OC
NCGC00258335-01,tox21-er-bla-agonist-p2,1-(2-Butoxy-1-methylethoxy)propan-2-ol,activity,inactive,29911-28-2,24752.0,OC(C)COC(C)COCCCC
NCGC00258366-01,tox21-er-bla-agonist-p2,1-Chlorodecane,activity,inactive,1002-69-3,13848.0,CCCCCCCCCCCl
NCGC00258395-01,tox21-er-bla-agonist-p2,Methyl chlorocarbonate,activity,inactive,79-22-1,6586.0,ClC(=O)OC
NCGC00258587-01,tox21-er-bla-agonist-p2,Ethyl chloroformate,activity,inactive,541-41-3,10928.0,ClC(=O)OCC
NCGC00258614-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide,activity,inactive,174899-82-2,11731903.0,C[n+]1ccn(CC)c1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00258644-01,tox21-er-bla-agonist-p2,2-Butanol,activity,inactive,78-92-2,6568.0,CC(O)CC
NCGC00258024-01,tox21-er-bla-agonist-p2,2-Methylpentane,activity,inactive,107-83-5,7892.0,CC(C)CCC
NCGC00259241-01,tox21-er-bla-agonist-p2,N-Butylbenzenesulfonamide,activity,inactive,3622-84-2,19241.0,O=S(=O)(NCCCC)c1ccccc1
NCGC00259522-01,tox21-er-bla-agonist-p2,"N,N,N',N'-Tetrakis(2-Hydroxypropyl)ethylenediamine",activity,inactive,102-60-3,7615.0,CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O
NCGC00259563-01,tox21-er-bla-agonist-p2,"2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane",activity,inactive,79-92-5,6616.0,CC2(C)C(=C)C1CCC2C1
NCGC00260040-01,tox21-er-bla-agonist-p2,Butyraldehyde,activity,inactive,123-72-8,261.0,CCCC=O
NCGC00260259-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpyrrolidinium trifluoromethanesulfonate,activity,inactive,NOCAS_49390,60196396.0,C[N+]1(CCC)CCCC1.FC(F)(F)S([O-])(=O)=O
NCGC00260621-01,tox21-er-bla-agonist-p2,NTP Mix97 ER1 10-EQC,activity,active agonist,NOCAS_49517,,
NCGC00015754-08,tox21-er-bla-agonist-p2,Nilutamide,activity,inactive,63612-50-0,4493.0,FC(F)(F)c1cc(ccc1[N+]([O-])=O)N2C(=O)C(C)(C)NC2=O
NCGC00015760-06,tox21-er-bla-agonist-p2,Octopamine,activity,inactive,104-14-3,4581.0,OC(CN)c1ccc(O)cc1
NCGC00016600-01,tox21-er-bla-agonist-p2,Clofazimine,activity,inactive,2030-63-9,2794.0,Clc1ccc(cc1)NC3=CC4=Nc2ccccc2N(C4=C\C3=N\C(C)C)c5ccc(Cl)cc5
NCGC00016494-01,tox21-er-bla-agonist-p2,Amylocaine hydrochloride,activity,inactive,532-59-2,10766.0,Cl.CN(C)CC(C)(OC(=O)c1ccccc1)CC
NCGC00016692-01,tox21-er-bla-agonist-p2,Bromperidol,activity,inactive,10457-90-6,2448.0,Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Br)cc3
NCGC00017259-04,tox21-er-bla-agonist-p2,Nicergoline,activity,inactive,27848-84-6,34040.0,Brc1cc(cnc1)C(=O)OC[C@@H]3C[C@]4(OC)c5cccc2c5c(cn2C)C[C@H]4N(C)C3
NCGC00167467-01,tox21-er-bla-agonist-p2,Vecuronium bromide,activity,inactive,50700-72-6,39764.0,[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(C)=O
NCGC00167541-01,tox21-er-bla-agonist-p2,"(3alpha,5beta)-Cholestan-3-ol",activity,inactive,516-92-7,91465.0,CC(C)CCC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@@H]2C[C@H](O)CC[C@]12C
NCGC00254579-01,tox21-er-bla-agonist-p2,Tri-allate,activity,inactive,2303-17-5,5543.0,Cl/C(Cl)=C(\Cl)CSC(=O)N(C(C)C)C(C)C
NCGC00255163-01,tox21-er-bla-agonist-p2,1-Propanol,activity,inactive,71-23-8,1031.0,CCCO
NCGC00255575-01,tox21-er-bla-agonist-p2,"2,2'-Dipyridyl",activity,inactive,366-18-7,1474.0,c1nc(ccc1)c2ccccn2
NCGC00254365-01,tox21-er-bla-agonist-p2,Valproic acid,activity,inactive,99-66-1,3121.0,CCCC(CCC)C(=O)O
NCGC00255062-01,tox21-er-bla-agonist-p2,Propyzamide,activity,inactive,23950-58-5,32154.0,Clc1cc(cc(Cl)c1)C(=O)NC(C)(C)C#C
NCGC00159517-02,tox21-er-bla-agonist-p2,Nefazodone hydrochloride,activity,inactive,82752-99-6,54911.0,Cl.Clc1cccc(c1)N4CCN(CCCN3N=C(CC)N(CCOc2ccccc2)C3=O)CC4
NCGC00160481-01,tox21-er-bla-agonist-p2,Tioxidazole,activity,inactive,61570-90-9,72157.0,O=C(OC)Nc1nc2ccc(cc2s1)OCCC
NCGC00164607-01,tox21-er-bla-agonist-p2,Bentiromide sodium,activity,inactive,41748-47-4,23680486.0,[Na+].Oc3ccc(C[C@H](NC(=O)c1ccccc1)C(=O)Nc2ccc(cc2)C([O-])=O)cc3
NCGC00168778-01,tox21-er-bla-agonist-p2,Solifenacin hydrochloride,activity,inactive,180468-39-7,154058.0,Cl.O=C(O[C@H]2CN1CCC2CC1)N4CCc5ccccc5[C@@H]4c3ccccc3
NCGC00183877-01,tox21-er-bla-agonist-p2,Unoprostone isopropyl ester,activity,inactive,120373-24-2,5282175.0,O[C@@H]1C[C@H](O)[C@H](C/C=C\CCCC(=O)OC(C)C)[C@H]1CCC(=O)CCCCCCC
NCGC00260317-01,tox21-er-bla-agonist-p2,"4,7-Methano-1H-indene, octahydro-, (3aR,4S,7R,7aS)-rel-",activity,inactive,2825-82-3,12561739.0,C2C[C@H]3[C@@H]1CC[C@H](C1)[C@H]3C2
NCGC00015984-03,tox21-er-bla-agonist-p2,Tropisetron,activity,inactive,89565-68-4,656665.0,CN4[C@H]1CC[C@@H]4CC(C1)OC(=O)c3cnc2ccccc23
NCGC00016283-01,tox21-er-bla-agonist-p2,Diphemanil methylsulfate,activity,inactive,62-97-5,6126.0,[O-]S(=O)(=O)OC.C[N+]1(C)CC\C(CC1)=C(\c2ccccc2)c3ccccc3
NCGC00016925-06,tox21-er-bla-agonist-p2,Omeprazole,activity,inactive,73590-58-6,4594.0,Cc3c(OC)c(C)cnc3CS(=O)c1nc2cc(ccc2n1)OC
NCGC00025158-01,tox21-er-bla-agonist-p2,(S)-(+)-Dimethindene maleate,activity,inactive,1217457-81-2,56972160.0,C[C@@H](C=1c2ccccc2CC=1CCN(C)C)c3ccccn3.O=C(O)/C=C\C(=O)O
NCGC00091708-04,tox21-er-bla-agonist-p2,Cochineal,activity,inactive,1343-78-8,10255083.0,O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)c4c(O)c3C(=O)c2c(C)c(C(=O)O)c(O)cc2C(=O)c3c(O)c4O
NCGC00094894-01,tox21-er-bla-agonist-p2,Mefexamide hydrochloride,activity,inactive,3413-64-7,3083802.0,Cl.CCN(CC)CCNC(=O)COc1ccc(cc1)OC
NCGC00095002-01,tox21-er-bla-agonist-p2,Gluconolactone,activity,inactive,90-80-2,7027.0,O[C@H]1[C@H](O)[C@@H](O)C(=O)O[C@@H]1CO
NCGC00095156-01,tox21-er-bla-agonist-p2,Carbadox,activity,inactive,6804-07-5,5353472.0,O=C(OC)N\N=C\c2c[n+]([O-])c1ccccc1[n+]2[O-]
NCGC00160407-01,tox21-er-bla-agonist-p2,Lornoxicam,activity,inactive,70374-39-9,17756939.0,O=C2c1sc(Cl)cc1S(=O)(=O)N(C)C2C(=O)Nc3ccccn3
NCGC00160555-01,tox21-er-bla-agonist-p2,Nifursol,activity,inactive,16915-70-1,9570327.0,O=[N+]([O-])c2ccc(/C=N/NC(=O)c1cc(cc([N+]([O-])=O)c1O)[N+]([O-])=O)o2
NCGC00167442-01,tox21-er-bla-agonist-p2,Tamsulosin hydrochloride,activity,inactive,106463-17-6,5362376.0,Cl.O=S(N)(=O)c1cc(ccc1OC)C[C@@H](C)NCCOc2ccccc2OCC
NCGC00254065-01,tox21-er-bla-agonist-p2,Di-tert-butyl peroxide,activity,inactive,110-05-4,8033.0,CC(C)(C)OOC(C)(C)C
NCGC00090686-04,tox21-er-bla-agonist-p2,Nitrofurazone,activity,inactive,59-87-0,5447130.0,O=[N+]([O-])c1ccc(/C=N/NC(N)=O)o1
NCGC00017006-01,tox21-er-bla-agonist-p2,Tridihexethyl chloride,activity,inactive,4310-35-4,20298.0,[Cl-].OC(CC[N+](CC)(CC)CC)(c1ccccc1)C2CCCCC2
NCGC00017121-01,tox21-er-bla-agonist-p2,Gabexate mesilate,activity,inactive,56974-61-9,6604561.0,O=C(Oc1ccc(cc1)C(=O)OCC)CCCCCNC(=N)N.CS(=O)(=O)O
NCGC00017400-05,tox21-er-bla-agonist-p2,Dihydroergotamine,activity,inactive,511-12-6,10531.0,CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O
NCGC00022408-03,tox21-er-bla-agonist-p2,Flumethasone pivalate,activity,inactive,2002-29-1,16158.0,CC(C)(C)C(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3C4(C)C[C@H](O)[C@@]2(F)C3C[C@H](F)C1=CC(=O)C=CC12C
NCGC00024599-02,tox21-er-bla-agonist-p2,Cinanserin,activity,inactive,1166-34-3,5475158.0,CN(C)CCCSc2ccccc2NC(=O)/C=C/c1ccccc1
NCGC00256911-01,tox21-er-bla-agonist-p2,Pyridoxine hydrochloride,activity,inactive,58-56-0,6019.0,Cl.Oc1c(CO)c(cnc1C)CO
NCGC00258377-01,tox21-er-bla-agonist-p2,1-Chloronaphthalene,activity,inactive,90-13-1,7003.0,Clc2cccc1ccccc12
NCGC00257416-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) decanedioate,activity,inactive,122-62-3,31218.0,O=C(CCCCCCCCC(=O)OCC(CC)CCCC)OCC(CCCC)CC
NCGC00257429-01,tox21-er-bla-agonist-p2,Diphenyl phosphate,activity,inactive,838-85-7,13282.0,OP(=O)(Oc1ccccc1)Oc2ccccc2
NCGC00257553-01,tox21-er-bla-agonist-p2,d-Tryptophan,activity,inactive,153-94-6,9060.0,O=C(O)[C@H](N)Cc2cnc1ccccc12
NCGC00257717-01,tox21-er-bla-agonist-p2,Pyridine hydrochloride,activity,inactive,628-13-7,10176127.0,Cl.c1ccccn1
NCGC00257743-01,tox21-er-bla-agonist-p2,Bromoform,activity,inactive,75-25-2,5558.0,BrC(Br)Br
NCGC00257932-01,tox21-er-bla-agonist-p2,Butyl 4-aminobenzoate,activity,inactive,94-25-7,2482.0,Nc1ccc(cc1)C(=O)OCCCC
NCGC00255719-01,tox21-er-bla-agonist-p2,Isodrin,activity,inactive,465-73-6,60196420.0,ClC3=C(Cl)[C@]4(Cl)[C@@H]2[C@@H]1C[C@H](C=C1)[C@@H]2[C@@]3(Cl)C4(Cl)Cl
NCGC00255868-01,tox21-er-bla-agonist-p2,2-Aminoethyl hydrogen sulfate,activity,inactive,926-39-6,70223.0,O=S(=O)(O)OCCN
NCGC00255889-01,tox21-er-bla-agonist-p2,4-Pentenoic acid,activity,inactive,591-80-0,61138.0,C=CCCC(=O)O
NCGC00255953-01,tox21-er-bla-agonist-p2,2-Methoxynaphthalene,activity,inactive,93-04-9,7119.0,COc1ccc2ccccc2c1
NCGC00255961-01,tox21-er-bla-agonist-p2,"Methyl 2,3-dibromopropionate",activity,inactive,1729-67-5,95428.0,BrC(CBr)C(=O)OC
NCGC00256032-01,tox21-er-bla-agonist-p2,"1-(2,6-Dichlorophenyl)-2-indolinone",activity,active agonist,15362-40-0,27211.0,Clc1cccc(Cl)c1N2c3ccccc3CC2=O
NCGC00256109-01,tox21-er-bla-agonist-p2,Prop-2-en-1-yl 3-cyclohexylpropanoate,activity,inactive,2705-87-5,17617.0,O=C(CCC1CCCCC1)OCC=C
NCGC00256134-01,tox21-er-bla-agonist-p2,"N,N',N''-Tricyclohexyl-1-methylsilanetriamine",activity,inactive,15901-40-3,85178.0,C[Si](NC1CCCCC1)(NC2CCCCC2)NC3CCCCC3
NCGC00256228-01,tox21-er-bla-agonist-p2,"(2,2,6,6-Tetramethyl-4-oxopiperidin-1-yl)oxidanyl",activity,inactive,2896-70-0,520789.0,[O]N(C(C)(C)C1)C(C)(C)CC1=O
NCGC00256229-01,tox21-er-bla-agonist-p2,4-(Hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one,activity,inactive,13047-13-7,92238.0,O=C1NN(CC1(C)CO)c2ccccc2
NCGC00256254-01,tox21-er-bla-agonist-p2,"Dipropyl 3,4,5,6-tetrachlorobenzene-1,2-dicarboxylate",activity,inactive,6928-67-2,81346.0,Clc1c(c(c(Cl)c(Cl)c1Cl)C(=O)OCCC)C(=O)OCCC
NCGC00258794-01,tox21-er-bla-agonist-p2,2-Methylbutanal,activity,inactive,96-17-3,7284.0,CC(CC)C=O
NCGC00258855-01,tox21-er-bla-agonist-p2,1-Decanamine,activity,inactive,2016-57-1,8916.0,CCCCCCCCCCN
NCGC00259041-01,tox21-er-bla-agonist-p2,2-Hydroxy-2-methylpropanenitrile,activity,inactive,75-86-5,6406.0,N#CC(C)(C)O
NCGC00260564-01,tox21-er-bla-agonist-p2,NTP Mix72 CT1 62-EQP,activity,inactive,NOCAS_49460,,
NCGC00260620-01,tox21-er-bla-agonist-p2,NTP Mix96 ER1 10-EQP,activity,active agonist,NOCAS_49516,,
NCGC00259479-01,tox21-er-bla-agonist-p2,Acetaminophen,activity,inactive,103-90-2,1983.0,Oc1ccc(NC(C)=O)cc1
NCGC00259583-01,tox21-er-bla-agonist-p2,Triphenyl phosphite,activity,inactive,101-02-0,7540.0,O(P(Oc1ccccc1)Oc2ccccc2)c3ccccc3
NCGC00259586-01,tox21-er-bla-agonist-p2,"2,4,6-Trichlorophenol",activity,inactive,88-06-2,6914.0,Clc1cc(Cl)cc(Cl)c1O
NCGC00259712-01,tox21-er-bla-agonist-p2,Imidodicarbonic diamide,activity,inactive,108-19-0,7913.0,NC(=O)NC(N)=O
NCGC00259774-01,tox21-er-bla-agonist-p2,3-Chloropropionitrile,activity,inactive,542-76-7,10963.0,ClCCC#N
NCGC00260051-01,tox21-er-bla-agonist-p2,Cobaltocene,activity,inactive,1277-43-6,92884.0,[Co+2].[c-]1cccc1.c1[c-]ccc1
NCGC00254962-01,tox21-er-bla-agonist-p2,Pentachloronitrobenzene,activity,inactive,82-68-8,6720.0,Clc1c(c(Cl)c(Cl)c(Cl)c1Cl)[N+]([O-])=O
NCGC00255468-01,tox21-er-bla-agonist-p2,"2,3-Pyridinedicarboxylic acid",activity,inactive,89-00-9,1066.0,OC(=O)c1ncccc1C(=O)O
NCGC00255584-01,tox21-er-bla-agonist-p2,2-Phenylcyclohexanol,activity,inactive,1444-64-0,15046.0,OC2CCCCC2c1ccccc1
NCGC00255610-01,tox21-er-bla-agonist-p2,Dibenzyl oxalate,activity,inactive,7579-36-4,82058.0,O=C(OCc1ccccc1)C(=O)OCc2ccccc2
NCGC00255732-01,tox21-er-bla-agonist-p2,Butyl lactate,activity,inactive,138-22-7,8738.0,OC(C)C(=O)OCCCC
NCGC00254526-01,tox21-er-bla-agonist-p2,Nitrobenzene,activity,inactive,98-95-3,7416.0,[O-][N+](=O)c1ccccc1
NCGC00093569-01,tox21-er-bla-agonist-p2,3-Aminopropionitrile fumarate,activity,inactive,2079-89-2,5462653.0,NCCC#N.O=C(O)/C=C/C(=O)O.N#CCCN
NCGC00094104-01,tox21-er-bla-agonist-p2,Stilonium iodide,activity,inactive,77257-42-2,6433339.0,[I-].CC[N+](CCOc1ccc(cc1)/C=C/c2ccccc2)(CC)CC
NCGC00159466-02,tox21-er-bla-agonist-p2,Alprazolam,activity,inactive,28981-97-7,2118.0,Clc1cc2C(=NCc3nnc(C)n3c2cc1)c4ccccc4
NCGC00164339-02,tox21-er-bla-agonist-p2,"N,N,N',N'-Tetrakis(2-Hydroxypropyl)ethylenediamine",activity,inactive,102-60-3,7615.0,CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O
NCGC00164502-01,tox21-er-bla-agonist-p2,Nifuraldezone,activity,inactive,3270-71-1,18637.0,O=[N+]([O-])c1ccc(/C=N/NC(=O)C(N)=O)o1
NCGC00167586-01,tox21-er-bla-agonist-p2,Piroctone olamine,activity,inactive,68890-66-4,60196297.0,CC=1C=C(CC(C)CC(C)(C)C)N(O)C(=O)C=1.NCCCO
NCGC00181305-01,tox21-er-bla-agonist-p2,Magnesium salicylate tetrahydrate,activity,inactive,18917-95-8,3045402.0,O.O.O.O.O=C3O[Mg]2(Oc1ccccc1C(=O)O2)Oc4ccccc34
NCGC00095098-01,tox21-er-bla-agonist-p2,Teniposide,activity,inactive,29767-20-2,5284623.0,COc1cc(cc(OC)c1O)[C@@H]6c2cc8OCOc8cc2C(O[C@@H]4O[C@@H]3COC(O[C@H]3[C@H](O)[C@H]4O)c5cccs5)C7COC(=O)[C@H]67
NCGC00164568-01,tox21-er-bla-agonist-p2,Montelukast sodium,activity,inactive,151767-02-1,23663996.0,[Na+].CC(C)(O)c5ccccc5CC[C@@H](SCC1(CC([O-])=O)CC1)c2cccc(c2)/C=C/c3ccc4ccc(Cl)cc4n3
NCGC00164624-01,tox21-er-bla-agonist-p2,Adefovir dipivoxil,activity,inactive,142340-99-6,60871.0,CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)COCCn2cnc1c(N)ncnc12
NCGC00160539-01,tox21-er-bla-agonist-p2,Adefovir,activity,inactive,106941-25-7,60172.0,O=P(O)(O)COCCn2cnc1c(N)ncnc12
NCGC00095322-03,tox21-er-bla-agonist-p2,Ubidecarenone,activity,inactive,303-98-0,5281915.0,COC1=C(OC)C(=O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C)C1=O
NCGC00095782-01,tox21-er-bla-agonist-p2,Methylephedrine,activity,inactive,552-79-4,64782.0,O[C@@H]([C@H](C)N(C)C)c1ccccc1
NCGC00254545-01,tox21-er-bla-agonist-p2,Isopentyl butyrate,activity,inactive,106-27-4,7795.0,CC(C)CCOC(=O)CCC
NCGC00188429-01,tox21-er-bla-agonist-p2,Acitazanolast,activity,inactive,114607-46-4,2006.0,O=C(O)C(=O)Nc1cccc(c1)c2nnnn2
NCGC00255279-01,tox21-er-bla-agonist-p2,2-(N-Ethyl-m-toluidino)ethanol,activity,inactive,91-88-3,7067.0,CCN(CCO)c1cc(C)ccc1
NCGC00247330-02,tox21-er-bla-agonist-p2,Methamphetamine hydrochloride,activity,inactive,300-42-5,12213639.0,Cl.C[C@@H](NC)Cc1ccccc1
NCGC00254640-01,tox21-er-bla-agonist-p2,C.I. Disperse Yellow 64,activity,inactive,10319-14-9,25152.0,O=C4c1ccccc1C(=O)C4c2nc3ccccc3c(Br)c2O
NCGC00254269-01,tox21-er-bla-agonist-p2,CP-456773,activity,inactive,210826-40-7,9910393.0,OC(C)(C)c1coc(c1)S(=O)(=O)NC(=O)Nc3c4CCCc4cc2CCCc23
NCGC00254276-01,tox21-er-bla-agonist-p2,3'-Azido-3'-deoxythymidine,activity,inactive,30516-87-1,35370.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2
NCGC00254695-01,tox21-er-bla-agonist-p2,Dichlobenil,activity,inactive,1194-65-6,3031.0,N#Cc1c(Cl)cccc1Cl
NCGC00253943-01,tox21-er-bla-agonist-p2,Theobromine,activity,inactive,83-67-0,5429.0,Cn1cnc2c1C(=O)NC(=O)N2C
NCGC00255213-01,tox21-er-bla-agonist-p2,Ethylphenylacetylurea,activity,inactive,90-49-3,72060.0,CCC(C(=O)NC(N)=O)c1ccccc1
NCGC00254399-01,tox21-er-bla-agonist-p2,Acenaphthylene,activity,inactive,208-96-8,9161.0,c1cc2cccc3C=Cc(c1)c23
NCGC00254873-01,tox21-er-bla-agonist-p2,Thiabendazole,activity,inactive,148-79-8,5430.0,n1c3ccccc3nc1c2cscn2
NCGC00254942-01,tox21-er-bla-agonist-p2,Quizalofop-ethyl,activity,inactive,76578-14-8,53518.0,O=C(OCC)C(C)Oc1ccc(cc1)Oc2cnc3cc(Cl)ccc3n2
NCGC00182056-02,tox21-er-bla-agonist-p2,Dioctyldimethylammonium chloride,activity,inactive,5538-94-3,62581.0,[Cl-].C[N+](C)(CCCCCCCC)CCCCCCCC
NCGC00183029-01,tox21-er-bla-agonist-p2,Troxipide,activity,inactive,30751-05-4,5597.0,O=C(NC1CCCNC1)c2cc(OC)c(OC)c(OC)c2
NCGC00259269-01,tox21-er-bla-agonist-p2,3-Methyl-2-butanone,activity,inactive,563-80-4,11251.0,CC(C)C(C)=O
NCGC00259336-01,tox21-er-bla-agonist-p2,"2,4-Dimethylphenol",activity,inactive,105-67-9,7771.0,Cc1ccc(O)c(C)c1
NCGC00258359-01,tox21-er-bla-agonist-p2,2-Nitrobenzamide,activity,inactive,610-15-1,11876.0,O=[N+]([O-])c1ccccc1C(N)=O
NCGC00016395-01,tox21-er-bla-agonist-p2,Diphenylpyraline hydrochloride,activity,inactive,132-18-3,66063.0,Cl.CN3CCC(OC(c1ccccc1)c2ccccc2)CC3
NCGC00260139-01,tox21-er-bla-agonist-p2,6-Mercaptopurine,activity,inactive,50-44-2,667490.0,S=C2NC=Nc1ncnc12
NCGC00256566-01,tox21-er-bla-agonist-p2,"4-Chloro-1,3-diaminobenzene",activity,inactive,5131-60-2,21209.0,Nc1ccc(Cl)c(N)c1
NCGC00260632-01,tox21-er-bla-agonist-p2,NTP Mix108 ER1 10-EQC,activity,active agonist,NOCAS_49528,,
NCGC00164484-02,tox21-er-bla-agonist-p2,Oxiglutatione,activity,active agonist,27025-41-8,65359.0,O=C(N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)CC[C@H](N)C(=O)O
NCGC00181103-01,tox21-er-bla-agonist-p2,Propiverine hydrochloride,activity,inactive,54556-98-8,441412.0,Cl.CN3CCC(OC(=O)C(OCCC)(c1ccccc1)c2ccccc2)CC3
NCGC00256526-01,tox21-er-bla-agonist-p2,2-Tolualdehyde,activity,inactive,529-20-4,10722.0,Cc1ccccc1C=O
NCGC00257745-01,tox21-er-bla-agonist-p2,"N,N-Dimethyl-p-phenylenediamine",activity,inactive,99-98-9,7472.0,Nc1ccc(cc1)N(C)C
NCGC00256858-01,tox21-er-bla-agonist-p2,Hexyl hexanoate,activity,inactive,6378-65-0,22873.0,O=C(CCCCC)OCCCCCC
NCGC00257047-01,tox21-er-bla-agonist-p2,Linalyl acetate,activity,inactive,115-95-7,8294.0,O=C(C)OC(C)(CC\C=C(\C)C)C=C
NCGC00013037-01,tox21-er-bla-agonist-p2,Thanite,activity,inactive,115-31-1,13218779.0,N#CSCC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C
NCGC00258496-01,tox21-er-bla-agonist-p2,"1,3,5-Trioxane",activity,inactive,110-88-3,8081.0,C1OCOCO1
NCGC00257493-01,tox21-er-bla-agonist-p2,8-Hydroxyquinoline sulfate,activity,active agonist,134-31-6,517000.0,O=S(=O)(O)O.Oc1cccc2cccnc12.Oc1cccc2cccnc12
NCGC00254955-01,tox21-er-bla-agonist-p2,Ethylene glycol phenyl ether methacrylate,activity,inactive,10595-06-9,66357.0,C=C(C)C(=O)OCCOc1ccccc1
NCGC00255555-01,tox21-er-bla-agonist-p2,MCPA-2-ethylhexyl,activity,inactive,29450-45-1,93128.0,Clc1cc(C)c(OCC(=O)OCC(CC)CCCC)cc1
NCGC00255430-01,tox21-er-bla-agonist-p2,4-Methylbenzophenone,activity,inactive,134-84-9,8652.0,Cc1ccc(cc1)C(=O)c2ccccc2
NCGC00256772-01,tox21-er-bla-agonist-p2,tert-Butyl hydrogen phthalate,activity,inactive,33693-84-4,134976.0,O=C(O)c1ccccc1C(=O)OC(C)(C)C
NCGC00256338-01,tox21-er-bla-agonist-p2,Dimethyl hydrogen phosphite,activity,inactive,868-85-9,6327114.0,O=P(OC)OC
NCGC00256824-01,tox21-er-bla-agonist-p2,m-Cresol,activity,inactive,108-39-4,342.0,Cc1cc(O)ccc1
NCGC00257176-01,tox21-er-bla-agonist-p2,1-Nitro-2-(trifluoromethyl)benzene,activity,inactive,384-22-5,9795.0,O=[N+]([O-])c1ccccc1C(F)(F)F
NCGC00257207-01,tox21-er-bla-agonist-p2,Tris(2-hydroxyethyl) isocyanurate,activity,inactive,839-90-7,13286.0,OCCN1C(=O)N(CCO)C(=O)N(CCO)C1=O
NCGC00257700-01,tox21-er-bla-agonist-p2,"1,4-Diethylbenzene",activity,inactive,105-05-5,7734.0,CCc1ccc(CC)cc1
NCGC00257531-01,tox21-er-bla-agonist-p2,Silica,activity,inactive,7631-86-9,24261.0,O=[Si]=O
NCGC00258543-01,tox21-er-bla-agonist-p2,"1,4-Benzenedicarboxylic acid, monomethyl ester",activity,inactive,1679-64-7,15513.0,COC(=O)c1ccc(cc1)C(=O)O
NCGC00258737-01,tox21-er-bla-agonist-p2,3-Chloropropanoic acid,activity,inactive,107-94-8,7899.0,ClCCC(=O)O
NCGC00258348-01,tox21-er-bla-agonist-p2,"N,N'-Dimethylurea",activity,inactive,96-31-1,7293.0,CNC(=O)NC
NCGC00258362-01,tox21-er-bla-agonist-p2,Styrene,activity,inactive,100-42-5,7501.0,C=Cc1ccccc1
NCGC00258797-01,tox21-er-bla-agonist-p2,Potassium 6-hydroxynaphthalene-2-sulfonate,activity,inactive,833-66-9,23677963.0,[K+].[O-]S(=O)(=O)c1ccc2cc(O)ccc2c1
NCGC00259130-01,tox21-er-bla-agonist-p2,Potassium nitrate,activity,inactive,7757-79-1,24434.0,[K+].[O-][N+]([O-])=O
NCGC00259191-01,tox21-er-bla-agonist-p2,Asulam,activity,inactive,3337-71-1,18752.0,Nc1ccc(cc1)S(=O)(=O)NC(=O)OC
NCGC00259945-01,tox21-er-bla-agonist-p2,Tetradifon,activity,inactive,116-29-0,8305.0,Clc1cc(c(Cl)cc1Cl)S(=O)(=O)c2ccc(Cl)cc2
NCGC00259310-01,tox21-er-bla-agonist-p2,Urethane,activity,inactive,51-79-6,5641.0,NC(=O)OCC
NCGC00259593-01,tox21-er-bla-agonist-p2,"3,7-Dimethylocta-1,6-diene",activity,inactive,2436-90-0,17090.0,C=CC(C)CC\C=C(\C)C
NCGC00259419-01,tox21-er-bla-agonist-p2,6-Methyl-2-thiouracil,activity,inactive,56-04-2,667493.0,O=C1C=C(C)NC(=S)N1
NCGC00259495-01,tox21-er-bla-agonist-p2,4-Ethoxyaniline,activity,inactive,156-43-4,9076.0,CCOc1ccc(N)cc1
NCGC00260021-01,tox21-er-bla-agonist-p2,"2,5-Dimethylfuran",activity,inactive,625-86-5,12266.0,Cc1ccc(C)o1
NCGC00259124-01,tox21-er-bla-agonist-p2,Chloromethyl methyl ether,activity,inactive,107-30-2,7864.0,COCCl
NCGC00260422-01,tox21-er-bla-agonist-p2,Isatin,activity,inactive,91-56-5,7054.0,O=C1c2ccccc2NC1=O
NCGC00260669-01,tox21-er-bla-agonist-p2,5-(Hydroxymethyl)-2-furoic acid,activity,inactive,6338-41-6,80642.0,OC(=O)c1ccc(CO)o1
NCGC00260585-01,tox21-er-bla-agonist-p2,NTP Mix44 CT1 3-EQP,activity,inactive,NOCAS_49481,,
NCGC00260586-01,tox21-er-bla-agonist-p2,NTP Mix45 CT1 3-EQP,activity,inactive,NOCAS_49482,,
NCGC00260296-01,tox21-er-bla-agonist-p2,1-Hexadecene,activity,inactive,629-73-2,12395.0,CCCCCCCCCCCCCCC=C
NCGC00257645-01,tox21-er-bla-agonist-p2,N-Cyclohexyl-4-methylbenzenesulfonamide,activity,inactive,80-30-8,6633.0,O=S(=O)(NC1CCCCC1)c2ccc(C)cc2
NCGC00015227-04,tox21-er-bla-agonist-p2,Dexchlorpheniramine hydrochloride,activity,inactive,5502-69-2,60196361.0,Cl.Clc1ccc(cc1)[C@H](CCN(C)C)c2ccccn2
NCGC00013683-01,tox21-er-bla-agonist-p2,Chlorprothixene,activity,inactive,113-59-7,667466.0,CN(C)CC\C=C1/c3ccccc3Sc2ccc(Cl)cc12
NCGC00015708-04,tox21-er-bla-agonist-p2,Maprotiline,activity,inactive,10262-69-8,4011.0,CNCCCC24CCC(c1ccccc12)c3ccccc34
NCGC00016202-02,tox21-er-bla-agonist-p2,Sodium nitroprusside dihydrate,activity,inactive,13755-38-9,11953895.0,[Na+].[Na+].O.O.N#C[Fe-2](C#N)(C#N)(N=O)(C#N)C#N
NCGC00016330-01,tox21-er-bla-agonist-p2,Methylprednisolone,activity,inactive,83-43-2,6741.0,OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C
NCGC00255698-01,tox21-er-bla-agonist-p2,alpha-Cypermethrin,activity,inactive,67375-30-8,3086172.0,Cl/C(Cl)=C/[C@@H]3[C@H](C(=O)O[C@@H](C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00255832-01,tox21-er-bla-agonist-p2,"N,N'-Dimethylthiourea",activity,inactive,534-13-4,2723631.0,CNC(=S)NC
NCGC00254450-01,tox21-er-bla-agonist-p2,3-Pyridinecarbonitrile,activity,inactive,100-54-9,79.0,N#Cc1cccnc1
NCGC00254379-01,tox21-er-bla-agonist-p2,CP-612372,activity,inactive,353280-07-6,9865929.0,CC(C)(O)c1ccc(cc1)CNC(=O)c4cccnc4Oc2ccc3nonc3c2
NCGC00254637-01,tox21-er-bla-agonist-p2,Metribuzin,activity,inactive,21087-64-9,30479.0,O=C1C(=NN=C(SC)N1N)C(C)(C)C
NCGC00254969-01,tox21-er-bla-agonist-p2,4-Methylumbelliferone hydrate,activity,inactive,103764-33-6,60196415.0,O.Oc1ccc2c(c1)OC(=O)C=C2C
NCGC00254127-01,tox21-er-bla-agonist-p2,5-Chloro-2-methyl-3(2H)-isothiazolone,activity,inactive,26172-55-4,33344.0,ClC1=CC(=O)N(C)S1
NCGC00254138-01,tox21-er-bla-agonist-p2,Propyl gallate,activity,active agonist,121-79-9,4947.0,Oc1cc(cc(O)c1O)C(=O)OCCC
NCGC00254296-01,tox21-er-bla-agonist-p2,10-Undecenoic acid,activity,inactive,112-38-9,5634.0,O=C(O)CCCCCCCCC=C
NCGC00016599-01,tox21-er-bla-agonist-p2,Flucytosine,activity,inactive,2022-85-7,3366.0,FC1=CNC(=O)N=C1N
NCGC00016693-01,tox21-er-bla-agonist-p2,Doxycycline hydrochloride,activity,inactive,10592-13-9,54685920.0,Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@H](C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00016854-03,tox21-er-bla-agonist-p2,Vinpocetine,activity,inactive,42971-09-5,443955.0,O=C(OCC)C1=C[C@@]5(CCCN4CCc3c(n1c2ccccc23)[C@@H]45)CC
NCGC00017063-01,tox21-er-bla-agonist-p2,Amodiaquin dihydrochloride dihydrate,activity,inactive,6398-98-7,64646.0,Cl.Cl.O.O.CCN(CC)Cc1cc(ccc1O)Nc2ccnc3cc(Cl)ccc23
NCGC00160599-01,tox21-er-bla-agonist-p2,Pyrathiazine,activity,inactive,84-08-2,10646.0,c2ccc3Sc4ccccc4N(CCN1CCCC1)c3c2
NCGC00164580-01,tox21-er-bla-agonist-p2,Clobetasol,activity,inactive,25122-41-2,5311051.0,ClCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00167447-01,tox21-er-bla-agonist-p2,Prosultiamine,activity,inactive,59-58-5,4963.0,Nc1nc(C)ncc1CN(C=O)C(C)=C(CCO)SSCCC
NCGC00181773-01,tox21-er-bla-agonist-p2,Parecoxib sodium,activity,inactive,198470-85-8,15895902.0,[Na+].CCC(=O)[N-]S(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2
NCGC00183020-01,tox21-er-bla-agonist-p2,Minopafant,activity,inactive,128420-61-1,130990.0,[Cl-].COc1ccccc1C(=O)N(Cc2cccc[n+]2CC)C(=O)OC[C@@H](COC(=O)N3CCC(CC3)OC(=O)NCCCCCCCCCCCCCCCCCC)OC
NCGC00253945-01,tox21-er-bla-agonist-p2,Fenofibrate,activity,inactive,49562-28-9,3339.0,O=C(c1ccc(Cl)cc1)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2
NCGC00254927-01,tox21-er-bla-agonist-p2,Ancymidol,activity,inactive,12771-68-5,25572.0,OC(C1CC1)(c2cncnc2)c3ccc(OC)cc3
NCGC00260673-01,tox21-er-bla-agonist-p2,"4,4'-Diaminoazobenzene",activity,inactive,538-41-0,10855.0,Nc2ccc(/N=N/c1ccc(N)cc1)cc2
NCGC00013042-01,tox21-er-bla-agonist-p2,8-Quinolinol Salicylic acid (1:1),activity,active agonist,2439-07-8,142766.0,O=C(O)c1ccccc1O.Oc1cccc2cccnc12
NCGC00016291-01,tox21-er-bla-agonist-p2,Tetracycline hydrochloride,activity,inactive,64-75-5,54704426.0,Cl.NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O
NCGC00018100-04,tox21-er-bla-agonist-p2,Fasudil hydrochloride,activity,inactive,105628-07-7,163751.0,Cl.O=S(=O)(c2cccc1cnccc12)N3CCCNCC3
NCGC00090939-02,tox21-er-bla-agonist-p2,Toluene,activity,inactive,108-88-3,1140.0,Cc1ccccc1
NCGC00094614-03,tox21-er-bla-agonist-p2,"4-Chloro-3,5-dimethylphenol",activity,inactive,88-04-0,2723.0,Oc1cc(C)c(Cl)c(C)c1
NCGC00163470-03,tox21-er-bla-agonist-p2,Tacrolimus,activity,inactive,104987-11-3,445643.0,O[C@@H]1CC[C@H](C[C@H]1OC)\C=C(/C)[C@H]2OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@]3(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]3C)OC
NCGC00164528-01,tox21-er-bla-agonist-p2,1-Monolaurin,activity,inactive,142-18-7,14871.0,OCC(O)COC(=O)CCCCCCCCCCC
NCGC00090759-01,tox21-er-bla-agonist-p2,Cisplatin,activity,inactive,15663-27-1,2767.0,Cl[Pt](Cl)(N)N
NCGC00025200-01,tox21-er-bla-agonist-p2,SDZ 21009,activity,inactive,39731-05-0,193949.0,CC(C)(C)NCC(O)COc2cccc1nc(cc12)C(=O)OC(C)C
NCGC00257049-01,tox21-er-bla-agonist-p2,"4,4'-Dibromodiphenyl ether",activity,inactive,2050-47-7,16305.0,Brc2ccc(Oc1ccc(Br)cc1)cc2
NCGC00257149-01,tox21-er-bla-agonist-p2,"1,2,3,4-Butanetetracarboxylic acid",activity,inactive,1703-58-8,15560.0,OC(=O)CC(C(CC(=O)O)C(=O)O)C(=O)O
NCGC00257378-01,tox21-er-bla-agonist-p2,"N-Ethyl-N-(3-methylphenyl)ethane-1,2-diamine",activity,inactive,19248-13-6,87984.0,CCN(CCN)c1cc(C)ccc1
NCGC00257447-01,tox21-er-bla-agonist-p2,D-Glucitol,activity,inactive,50-70-4,5780.0,O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)CO
NCGC00257514-01,tox21-er-bla-agonist-p2,4-Methylpent-3-en-2-one,activity,inactive,141-79-7,8858.0,C\C(C)=C/C(C)=O
NCGC00258054-01,tox21-er-bla-agonist-p2,4-Hydrazinobenzoic acid hydrochloride,activity,inactive,24589-77-3,90547.0,Cl.NNc1ccc(cc1)C(=O)O
NCGC00258323-01,tox21-er-bla-agonist-p2,Diethyl carbonate,activity,inactive,105-58-8,7766.0,O=C(OCC)OCC
NCGC00256445-01,tox21-er-bla-agonist-p2,Hydrazine sulfate,activity,inactive,10034-93-2,24842.0,NN.O=S(=O)(O)O
NCGC00256447-01,tox21-er-bla-agonist-p2,4-Phenylphenol,activity,active agonist,92-69-3,7103.0,Oc1ccc(cc1)c2ccccc2
NCGC00255852-01,tox21-er-bla-agonist-p2,Bromcresol green,activity,inactive,76-60-8,6451.0,Brc1cc(c(C)c(Br)c1O)C3(OS(=O)(=O)c2ccccc23)c4cc(Br)c(O)c(Br)c4C
NCGC00256095-01,tox21-er-bla-agonist-p2,2-[2-(2-Propoxyethoxy)ethoxy]ethanol,activity,inactive,23305-64-8,11355992.0,OCCOCCOCCOCCC
NCGC00256168-01,tox21-er-bla-agonist-p2,"1-Amino-4-bromo-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",activity,inactive,116-81-4,22628.0,O=S(=O)(O)c3cc(Br)c2c(C(=O)c1ccccc1C2=O)c3N
NCGC00256190-01,tox21-er-bla-agonist-p2,N2-(4-Nitrophenyl)-L-glutamine hydrochloride,activity,inactive,67953-08-6,21118222.0,Cl.O=C(O)[C@H](CCC(N)=O)Nc1ccc(cc1)[N+]([O-])=O
NCGC00255672-01,tox21-er-bla-agonist-p2,8-Hydroxyquinoline citrate,activity,inactive,134-30-5,61080.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.Oc1cccc2cccnc12
NCGC00258873-01,tox21-er-bla-agonist-p2,Tolyltriazole,activity,inactive,29385-43-1,122499.0,Cc1cccc2nnnc12
NCGC00259046-01,tox21-er-bla-agonist-p2,"p,p'-DDT",activity,active agonist,50-29-3,3036.0,Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl
NCGC00260460-01,tox21-er-bla-agonist-p2,Methyl trifluoromethanesulfonate,activity,inactive,333-27-7,9526.0,FC(F)(F)S(=O)(=O)OC
NCGC00260481-01,tox21-er-bla-agonist-p2,2-Benzoxazolinone,activity,inactive,59-49-4,6043.0,O=C1Nc2ccccc2O1
NCGC00260554-01,tox21-er-bla-agonist-p2,NTP Mix62 CT1 62-EQP,activity,inactive,NOCAS_49450,,
NCGC00260639-01,tox21-er-bla-agonist-p2,NTP Mix115 ER1 10-EQC,activity,active agonist,NOCAS_49535,,
NCGC00259248-01,tox21-er-bla-agonist-p2,1-Pentadecanol,activity,inactive,629-76-5,12397.0,CCCCCCCCCCCCCCCO
NCGC00259292-01,tox21-er-bla-agonist-p2,"4,4'-Sulfonyldiphenol",activity,active agonist,80-09-1,6626.0,Oc1ccc(cc1)S(=O)(=O)c2ccc(O)cc2
NCGC00259337-01,tox21-er-bla-agonist-p2,2-Methylpentanedinitrile,activity,inactive,4553-62-2,20686.0,CC(CCC#N)C#N
NCGC00259684-01,tox21-er-bla-agonist-p2,"1,2-Diaminopropane",activity,inactive,78-90-0,6567.0,CC(N)CN
NCGC00259744-01,tox21-er-bla-agonist-p2,Nitrilotriacetic acid,activity,inactive,139-13-9,8758.0,OC(=O)CN(CC(=O)O)CC(=O)O
NCGC00260063-01,tox21-er-bla-agonist-p2,Ferrocene,activity,inactive,102-54-5,7611.0,[Fe+2].[c-]1cccc1.c1[c-]ccc1
NCGC00260131-01,tox21-er-bla-agonist-p2,"1-Amino-2,4-dibromoanthraquinone",activity,inactive,81-49-2,6681.0,O=C2c1ccccc1C(=O)c3c2c(N)c(Br)cc3Br
NCGC00260169-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium tetrafluoroborate,activity,inactive,174501-65-6,2734178.0,CCCCn1cc[n+](C)c1.F[B-](F)(F)F
NCGC00260240-01,tox21-er-bla-agonist-p2,1-Butylpyridinium iodide,activity,inactive,874-81-7,14007922.0,[I-].CCCC[n+]1ccccc1
NCGC00260339-01,tox21-er-bla-agonist-p2,dl-Tryptophan,activity,inactive,54-12-6,1148.0,O=C(O)C(N)Cc2cnc1ccccc12
NCGC00254645-01,tox21-er-bla-agonist-p2,Chloroneb,activity,inactive,2675-77-6,17581.0,COc1cc(Cl)c(cc1Cl)OC
NCGC00254674-01,tox21-er-bla-agonist-p2,"3,3'-Iminobispropanenitrile",activity,inactive,111-94-4,8149.0,N#CCCNCCC#N
NCGC00254776-01,tox21-er-bla-agonist-p2,"4-Hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl",activity,inactive,2226-96-2,137994.0,OC1CC(C)(C)N([O])C(C)(C)C1
NCGC00256486-01,tox21-er-bla-agonist-p2,Dodecanoic acid,activity,inactive,143-07-7,3893.0,O=C(O)CCCCCCCCCCC
NCGC00254948-01,tox21-er-bla-agonist-p2,Acetamiprid,activity,inactive,135410-20-7,213021.0,Clc1ccc(CN(C)C(/C)=N\C#N)cn1
NCGC00255144-01,tox21-er-bla-agonist-p2,"1,3,5-Triethylhexahydro-s-triazine",activity,inactive,7779-27-3,24512.0,CCN1CN(CN(CC)C1)CC
NCGC00256175-01,tox21-er-bla-agonist-p2,"Ethyl 5-oxo-1-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylate",activity,inactive,89-33-8,66636.0,O=C(OCC)C=1CC(=O)N(N=1)c2ccccc2
NCGC00254575-01,tox21-er-bla-agonist-p2,6-Methylpyridin-2-amine,activity,inactive,1824-81-3,15765.0,Cc1cccc(N)n1
NCGC00254586-01,tox21-er-bla-agonist-p2,Cyanamide,activity,inactive,420-04-2,9864.0,N#CN
NCGC00091908-01,tox21-er-bla-agonist-p2,"1,5-Dicaffeoylquinic acid",activity,inactive,30964-13-7,122685.0,O[C@H]2[C@H](O)C[C@](C[C@H]2OC(=O)C=Cc1ccc(O)c(O)c1)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O
NCGC00159414-02,tox21-er-bla-agonist-p2,Terpin,activity,inactive,80-53-5,6651.0,CC1(O)CCC(CC1)C(C)(C)O
NCGC00159420-02,tox21-er-bla-agonist-p2,Oxyphenisatin acetate,activity,inactive,115-33-3,8269.0,CC(=O)Oc1ccc(cc1)C2(c3ccccc3NC2=O)c4ccc(OC(C)=O)cc4
NCGC00159421-02,tox21-er-bla-agonist-p2,Dihydralazine,activity,inactive,484-23-1,10230.0,NNc2nnc(NN)c1ccccc12
NCGC00094306-02,tox21-er-bla-agonist-p2,Propantheline bromide,activity,inactive,50-34-0,9279.0,[Br-].CC(C)[N+](C)(CCOC(=O)C1c3ccccc3Oc2ccccc12)C(C)C
NCGC00094594-01,tox21-er-bla-agonist-p2,Bacitracin,activity,inactive,1405-87-4,60196264.0,O=C(O)C[C@H]3NC(=O)[C@@H](Cc1cncn1)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@@H](CCCN)NC(=O)[C@@H](CCCCNC(=O)[C@@H](CC(N)=O)NC3=O)NC(=O)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]4N=C(SC4)[C@H](N)[C@H](C)CC)[C@@H](C)CC)[C@H](C)CC
NCGC00159476-02,tox21-er-bla-agonist-p2,Tribromsalan,activity,inactive,87-10-5,14868.0,Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2
NCGC00164077-02,tox21-er-bla-agonist-p2,4-Aminoazobenzene,activity,inactive,60-09-3,6051.0,Nc2ccc(/N=N/c1ccccc1)cc2
NCGC00094824-01,tox21-er-bla-agonist-p2,Vincamine,activity,inactive,1617-90-9,15376.0,O=C(OC)[C@@]5(O)C[C@@]4(CCCN3CCc2c1ccccc1n5c2[C@@H]34)CC
NCGC00160400-01,tox21-er-bla-agonist-p2,Tetridamine,activity,inactive,17289-49-5,28446.0,CNc1c2CCCCc2nn1C
NCGC00164526-01,tox21-er-bla-agonist-p2,Camylofin,activity,inactive,54-30-8,5902.0,CC(C)CCOC(=O)C(NCCN(CC)CC)c1ccccc1
NCGC00164578-01,tox21-er-bla-agonist-p2,Etoricoxib,activity,inactive,202409-33-4,123619.0,CS(=O)(=O)c1ccc(cc1)c3cc(Cl)cnc3c2cnc(C)cc2
NCGC00164599-01,tox21-er-bla-agonist-p2,D-Tagatose,activity,inactive,87-81-0,2724552.0,O[C@H]1[C@@H](O)[C@H](O)CO[C@@]1(O)CO
NCGC00165787-02,tox21-er-bla-agonist-p2,Daltroban,activity,inactive,79094-20-5,54343.0,O=S(=O)(NCCc1ccc(CC(=O)O)cc1)c2ccc(Cl)cc2
NCGC00181030-01,tox21-er-bla-agonist-p2,Uracil,activity,inactive,66-22-8,1174.0,O=C1C=CNC(=O)N1
NCGC00095280-01,tox21-er-bla-agonist-p2,Enoxaparin sodium,activity,inactive,679809-58-6,60196282.0,[Na+].[Na+].[Na+].[Na+].C[C@@H]1[C@@H](NC(C)=O)[C@@H](OC2[C@H](O)[C@@H](O)[C@H](OC3[C@H]4CO[C@H](O4)[C@H](NS([O-])(=O)=O)[C@H]3O)OC2C([O-])=O)O[C@H](CO)[C@H]1O[C@@H]1CC([C@@H](O[C@H]2O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]3OC(=C[C@H](O)[C@H]3O)C([O-])=O)[C@H](O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C([O-])=O
NCGC00166237-01,tox21-er-bla-agonist-p2,Mepiroxol,activity,inactive,6968-72-5,71668.0,[O-][n+]1cccc(CO)c1
NCGC00167555-01,tox21-er-bla-agonist-p2,Sodium butyrate,activity,inactive,156-54-7,5222465.0,[Na+].[O-]C(=O)CCC
NCGC00091050-02,tox21-er-bla-agonist-p2,Phenylmercuric acetate,activity,active agonist,62-38-4,16682730.0,CC(=O)O[Hg]c1ccccc1
NCGC00183272-01,tox21-er-bla-agonist-p2,Bunazosin hydrochloride,activity,inactive,52712-76-2,115305.0,Cl.O=C(CCC)N1CCCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3
NCGC00254573-01,tox21-er-bla-agonist-p2,Methyl 1-naphthaleneacetate,activity,inactive,2876-78-0,17891.0,O=C(OC)Cc2cccc1ccccc12
NCGC00254206-01,tox21-er-bla-agonist-p2,Sodium dehydroacetate,activity,inactive,4418-26-2,23675081.0,[Na+].C/C([O-])=C1/C(=O)C=C(C)OC1=O
NCGC00254295-01,tox21-er-bla-agonist-p2,Amiodarone hydrochloride,activity,inactive,19774-82-4,441325.0,Cl.CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC
NCGC00255223-01,tox21-er-bla-agonist-p2,Chloromethyl styrene,activity,inactive,30030-25-2,170249.0,ClCc1cccc(C=C)c1
NCGC00255145-01,tox21-er-bla-agonist-p2,Propantheline bromide,activity,inactive,50-34-0,9279.0,[Br-].CC(C)[N+](C)(CCOC(=O)C1c3ccccc3Oc2ccccc12)C(C)C
NCGC00183017-01,tox21-er-bla-agonist-p2,Ethyl 4-nitrophenyl ethylphosphonate,activity,inactive,546-71-4,66067.0,[O-][N+](=O)c1ccc(OP(=O)(OCC)CC)cc1
NCGC00259373-01,tox21-er-bla-agonist-p2,Napropamide,activity,inactive,15299-99-7,27189.0,CCN(CC)C(=O)C(C)Oc2cccc1ccccc12
NCGC00257891-01,tox21-er-bla-agonist-p2,1-Chloro-1-nitropropane,activity,inactive,600-25-9,11750.0,CCC(Cl)[N+]([O-])=O
NCGC00257931-01,tox21-er-bla-agonist-p2,Cyclohexanone cyanohydrin,activity,inactive,931-97-5,13610.0,N#CC1(O)CCCCC1
NCGC00260314-01,tox21-er-bla-agonist-p2,"Perfluoro compounds, C5-18",activity,inactive,86508-42-1,120203.0,FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00164567-01,tox21-er-bla-agonist-p2,Perospirone hydrochloride,activity,inactive,129273-38-7,115367.0,Cl.O=C4N(CCCCN1CCN(CC1)c3nsc2ccccc23)C(=O)[C@@H]5CCCC[C@H]45
NCGC00255796-01,tox21-er-bla-agonist-p2,Mercury(II) iodide,activity,active agonist,7774-29-0,181518.0,[Hg+2].[I-].[I-]
NCGC00259789-01,tox21-er-bla-agonist-p2,Fluconazole,activity,inactive,86386-73-4,3365.0,OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F
NCGC00257151-01,tox21-er-bla-agonist-p2,Tetradecane,activity,inactive,629-59-4,12389.0,CCCCCCCCCCCCCC
NCGC00257421-01,tox21-er-bla-agonist-p2,Lead(II) acetate trihydrate,activity,inactive,6080-56-4,22456.0,[O-]C(C)=O.[O-]C(C)=O.[Pb+2].O.O.O
NCGC00258343-01,tox21-er-bla-agonist-p2,6-Hydroxy-2-naphthyl disulfide,activity,active agonist,6088-51-3,22463.0,Oc1ccc2cc(ccc2c1)SSc3ccc4cc(O)ccc4c3
NCGC00256521-01,tox21-er-bla-agonist-p2,"2,3,4,6-Tetrachlorophenol",activity,inactive,58-90-2,6028.0,Clc1cc(Cl)c(Cl)c(Cl)c1O
NCGC00256930-01,tox21-er-bla-agonist-p2,N-Phenyl-1-naphthylamine,activity,active agonist,90-30-2,7013.0,c1ccc3ccccc3c1Nc2ccccc2
NCGC00260024-01,tox21-er-bla-agonist-p2,Isopropanol,activity,inactive,67-63-0,3776.0,CC(C)O
NCGC00254669-01,tox21-er-bla-agonist-p2,Diclosulam,activity,inactive,145701-21-9,3081304.0,Clc3cccc(Cl)c3NS(=O)(=O)c1nc2cc(F)nc(OCC)n2n1
NCGC00255667-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, 2,4-dimethyl-, sodium salt",activity,inactive,827-21-4,23677979.0,[Na+].Cc1cc(C)ccc1S(=O)([O-])=O
NCGC00256043-01,tox21-er-bla-agonist-p2,Methyl 2-methoxybenzoate,activity,inactive,606-45-1,61151.0,COc1ccccc1C(=O)OC
NCGC00256768-01,tox21-er-bla-agonist-p2,1-Benzylquinolinium chloride,activity,inactive,15619-48-4,85025.0,[Cl-].c2cccc3ccc[n+](Cc1ccccc1)c23
NCGC00256143-01,tox21-er-bla-agonist-p2,gamma-Cyclodextrin,activity,inactive,17465-86-0,5287407.0,OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@@H]9[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O
NCGC00256947-01,tox21-er-bla-agonist-p2,4-Chlorophenyl methyl sulfide,activity,inactive,123-09-1,31243.0,CSc1ccc(Cl)cc1
NCGC00257380-01,tox21-er-bla-agonist-p2,"1,3-Isobenzofurandione, 5-methyl-",activity,inactive,19438-61-0,88069.0,Cc1ccc2C(=O)OC(=O)c2c1
NCGC00257668-01,tox21-er-bla-agonist-p2,"N,N-Dimethyldecanamide",activity,inactive,14433-76-2,26690.0,CN(C)C(=O)CCCCCCCCC
NCGC00257705-01,tox21-er-bla-agonist-p2,Piroxicam,activity,inactive,36322-90-4,54676228.0,OC=2c1ccccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3
NCGC00257713-01,tox21-er-bla-agonist-p2,alpha-Methylstyrene,activity,inactive,98-83-9,7407.0,C=C(C)c1ccccc1
NCGC00257492-01,tox21-er-bla-agonist-p2,2-Acrylamido-2-methyl-1-propanesulfonic acid,activity,inactive,15214-89-8,65360.0,O=C(NC(C)(C)CS(=O)(=O)O)C=C
NCGC00257506-01,tox21-er-bla-agonist-p2,1-Heptanol,activity,inactive,111-70-6,8129.0,CCCCCCCO
NCGC00258165-01,tox21-er-bla-agonist-p2,1-Hexylpyridinium bromide,activity,inactive,74440-81-6,2734239.0,[Br-].CCCCCC[n+]1ccccc1
NCGC00258125-01,tox21-er-bla-agonist-p2,Pentabromoethane,activity,inactive,75-95-6,60967.0,BrC(Br)C(Br)(Br)Br
NCGC00258278-01,tox21-er-bla-agonist-p2,Hexachloroethane,activity,inactive,67-72-1,6214.0,ClC(Cl)(Cl)C(Cl)(Cl)Cl
NCGC00258700-01,tox21-er-bla-agonist-p2,Ampicillin trihydrate,activity,inactive,7177-48-2,23565.0,O.O.O.OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C
NCGC00258391-01,tox21-er-bla-agonist-p2,3-Nitrobenzyl chloride,activity,inactive,619-23-8,12078.0,O=[N+]([O-])c1cc(CCl)ccc1
NCGC00258414-01,tox21-er-bla-agonist-p2,Decanenitrile,activity,inactive,1975-78-6,74791.0,CCCCCCCCCC#N
NCGC00258617-01,tox21-er-bla-agonist-p2,Ethylbenzene,activity,inactive,100-41-4,7500.0,CCc1ccccc1
NCGC00258452-01,tox21-er-bla-agonist-p2,Allylthiourea,activity,inactive,109-57-9,1549517.0,NC(=S)NCC=C
NCGC00258660-01,tox21-er-bla-agonist-p2,4-Methyl-2-pentanone,activity,inactive,108-10-1,7909.0,CC(C)CC(C)=O
NCGC00258872-01,tox21-er-bla-agonist-p2,2-[2-(2-Ethoxyethoxy)ethoxy]ethanol,activity,inactive,112-50-5,8190.0,OCCOCCOCCOCC
NCGC00258046-01,tox21-er-bla-agonist-p2,Choline chloride,activity,inactive,67-48-1,6209.0,[Cl-].C[N+](C)(C)CCO
NCGC00259309-01,tox21-er-bla-agonist-p2,(-)-alpha-Pinene,activity,inactive,7785-26-4,440968.0,CC2(C)[C@H]1CC=C(C)[C@@H]2C1
NCGC00259599-01,tox21-er-bla-agonist-p2,1-Methoxy-2-propylamine,activity,inactive,37143-54-7,123458.0,CC(N)COC
NCGC00259467-01,tox21-er-bla-agonist-p2,Butanedioic acid,activity,inactive,110-15-6,1110.0,O=C(O)CCC(=O)O
NCGC00260010-01,tox21-er-bla-agonist-p2,Sodium azide,activity,inactive,26628-22-8,33557.0,[Na+].[N-]=[N+]=[N-]
NCGC00260501-01,tox21-er-bla-agonist-p2,3-Nitrobenzaldehyde,activity,inactive,99-61-6,7449.0,O=[N+]([O-])c1cc(C=O)ccc1
NCGC00260514-01,tox21-er-bla-agonist-p2,p-Phenylazophenol,activity,active agonist,1689-82-3,5354198.0,Oc2ccc(/N=N/c1ccccc1)cc2
NCGC00260577-01,tox21-er-bla-agonist-p2,NTP Mix54 CT1 3-EQP,activity,inactive,NOCAS_49473,,
NCGC00015611-10,tox21-er-bla-agonist-p2,Lidocaine,activity,inactive,137-58-6,3676.0,O=C(Nc1c(C)cccc1C)CN(CC)CC
NCGC00015255-04,tox21-er-bla-agonist-p2,Fenclonine,activity,inactive,7424-00-2,4652.0,Clc1ccc(CC(N)C(=O)O)cc1
NCGC00013744-02,tox21-er-bla-agonist-p2,"4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-5-(1-piperidinylmethyl)-",activity,inactive,902261-63-6,248057.0,O=C2NC=Nc3ncc(CN1CCCCC1)c23.C1CCCCN1
NCGC00015830-02,tox21-er-bla-agonist-p2,Phenylethylhydrazine sulfate,activity,inactive,156-51-4,61100.0,O=S(=O)(O)O.NNCCc1ccccc1
NCGC00016557-01,tox21-er-bla-agonist-p2,Ethaverine hydrochloride,activity,inactive,985-13-7,5702159.0,Cl.CCOc1ccc(cc1OCC)Cc3nccc2cc(OCC)c(cc23)OCC
NCGC00016410-06,tox21-er-bla-agonist-p2,Thiabendazole,activity,inactive,148-79-8,5430.0,n1c3ccccc3nc1c2cscn2
NCGC00016630-01,tox21-er-bla-agonist-p2,Clidinium bromide,activity,inactive,3485-62-9,19004.0,[Br-].OC(c1ccccc1)(c2ccccc2)C(=O)OC4C[N+]3(C)CCC4CC3
NCGC00016009-10,tox21-er-bla-agonist-p2,Tolazamide,activity,inactive,1156-19-0,5503.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
NCGC00256339-01,tox21-er-bla-agonist-p2,Sodium diethyldithiocarbamate trihydrate,activity,inactive,20624-25-3,517546.0,O.[Na+].O.O.CCN(CC)C([S-])=S
NCGC00256381-01,tox21-er-bla-agonist-p2,Chlorotrianisene,activity,inactive,569-57-3,11289.0,COc1ccc(cc1)C(\Cl)=C(/c2ccc(OC)cc2)c3ccc(OC)cc3
NCGC00255855-01,tox21-er-bla-agonist-p2,Tetraethylurea,activity,inactive,1187-03-7,14465.0,CCN(CC)C(=O)N(CC)CC
NCGC00254471-01,tox21-er-bla-agonist-p2,9-Phenanthrol,activity,active agonist,484-17-3,10229.0,Oc2cc3ccccc3c1ccccc12
NCGC00254613-01,tox21-er-bla-agonist-p2,Dimethenamid,activity,inactive,87674-68-8,91744.0,Cc1csc(C)c1N(C(C)COC)C(=O)CCl
NCGC00255104-01,tox21-er-bla-agonist-p2,Propoxur,activity,inactive,114-26-1,4944.0,CC(C)Oc1ccccc1OC(=O)NC
NCGC00255460-01,tox21-er-bla-agonist-p2,Atropine sulfate monohydrate,activity,inactive,5908-99-6,656678.0,O.CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)C(CO)c2ccccc2.O=S(=O)(O)O.OCC(c1ccccc1)C(=O)O[C@@H]2C[C@@H]3CC[C@H](C2)N3C
NCGC00254132-01,tox21-er-bla-agonist-p2,SAR377142,activity,inactive,NOCAS_47385,60196410.0,CC(C)N4CCC(NC(=O)c3cc1cc(OCCOC)ncc1n3CC(=O)Nc2ccc(Cl)cn2)CC4.CC(=O)O
NCGC00015619-09,tox21-er-bla-agonist-p2,Loratadine,activity,inactive,79794-75-5,3957.0,Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3
NCGC00016243-01,tox21-er-bla-agonist-p2,Idoxuridine,activity,inactive,54-42-2,5905.0,IC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00016519-01,tox21-er-bla-agonist-p2,Thiocolchicoside,activity,inactive,602-41-5,9915886.0,CC(=O)N[C@H]3CCc2cc(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c(OC)c(OC)c2C4=CC=C(SC)C(=O)C=C34
NCGC00017115-01,tox21-er-bla-agonist-p2,Thiethylperazine malate,activity,inactive,52239-63-1,11954258.0,O=C(O)C(O)CC(=O)O.O=C(O)C(O)CC(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(SCC)cc23
NCGC00090757-02,tox21-er-bla-agonist-p2,Melphalan,activity,inactive,148-82-3,460612.0,O=C(O)[C@@H](N)Cc1ccc(cc1)N(CCCl)CCCl
NCGC00094600-01,tox21-er-bla-agonist-p2,Benztropine,activity,inactive,86-13-5,1201549.0,CN4[C@H]1CC[C@@H]4C[C@@H](C1)OC(c2ccccc2)c3ccccc3
NCGC00163597-03,tox21-er-bla-agonist-p2,Myriocin,activity,inactive,35891-70-4,6438394.0,O[C@@H]([C@H](O)C\C=C\CCCCCCC(=O)CCCCCC)[C@@](N)(CO)C(=O)O
NCGC00166121-01,tox21-er-bla-agonist-p2,Tetradonium bromide,activity,inactive,1119-97-7,14250.0,[Br-].C[N+](C)(C)CCCCCCCCCCCCCC
NCGC00166153-01,tox21-er-bla-agonist-p2,Climbazole,activity,inactive,38083-17-9,37907.0,CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2ccnc2
NCGC00178241-02,tox21-er-bla-agonist-p2,Cisplatin,activity,inactive,15663-27-1,2767.0,Cl[Pt](Cl)(N)N
NCGC00254069-01,tox21-er-bla-agonist-p2,GSK163929B,activity,inactive,NOCAS_47311,53257735.0,CNS(=O)(=O)c1cc(c(Cl)cc1F)C(=O)N2CCC(CC2)(CCN6C3CCC6CC(C3)n4c5ccccc5nc4C)c7cccc(F)c7
NCGC00254753-01,tox21-er-bla-agonist-p2,4'-Sulfamylacetanilide,activity,inactive,121-61-9,8482.0,O=S(N)(=O)c1ccc(NC(C)=O)cc1
NCGC00260083-01,tox21-er-bla-agonist-p2,Sodium bromate,activity,inactive,7789-38-0,23668195.0,[Na+].[O-]Br(=O)=O
NCGC00260085-01,tox21-er-bla-agonist-p2,Sodium dichromate(VI) dihydrate,activity,inactive,7789-12-0,108005.0,[Na+].[Na+].O.O.[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O
NCGC00260171-01,tox21-er-bla-agonist-p2,1-Decyl-3-methylimidazolium chloride,activity,active agonist,171058-18-7,2734225.0,[Cl-].C[n+]1ccn(CCCCCCCCCC)c1
NCGC00015547-02,tox21-er-bla-agonist-p2,Imazodan,activity,inactive,84243-58-3,55918.0,O=C1CCC(=NN1)c2ccc(cc2)n3ccnc3
NCGC00016374-02,tox21-er-bla-agonist-p2,Carbarsone,activity,inactive,121-59-5,8480.0,O=C(N)Nc1ccc(cc1)[As](O)(O)=O
NCGC00016623-01,tox21-er-bla-agonist-p2,Moroxidine hydrochloride,activity,inactive,3160-91-6,76621.0,Cl.N=C(N)NC(=N)N1CCOCC1
NCGC00159351-02,tox21-er-bla-agonist-p2,Cholesterol,activity,inactive,57-88-5,5997.0,CC(C)CCC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00254673-01,tox21-er-bla-agonist-p2,Coumaphos,activity,inactive,56-72-4,2871.0,CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C
NCGC00016948-01,tox21-er-bla-agonist-p2,Ofloxacin,activity,inactive,82419-36-1,4583.0,CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)C(C)COc34
NCGC00017135-01,tox21-er-bla-agonist-p2,Ketorolac tromethamine,activity,inactive,74103-07-4,6604122.0,OCC(N)(CO)CO.O=C(O)[C@@H]1CCn2c(ccc12)C(=O)c3ccccc3
NCGC00258384-01,tox21-er-bla-agonist-p2,2-Acetylaminofluorene,activity,inactive,53-96-3,5897.0,CC(=O)Nc1ccc2c3ccccc3Cc2c1
NCGC00258410-01,tox21-er-bla-agonist-p2,Metsulfuron-methyl,activity,inactive,74223-64-6,52999.0,Cc2nc(NC(=O)NS(=O)(=O)c1ccccc1C(=O)OC)nc(OC)n2
NCGC00257114-01,tox21-er-bla-agonist-p2,1-Chloro-4-(trifluoromethyl)benzene,activity,inactive,98-56-6,7394.0,FC(F)(F)c1ccc(Cl)cc1
NCGC00257259-01,tox21-er-bla-agonist-p2,Isopropyl phenyl ketone,activity,inactive,611-70-1,69144.0,O=C(C(C)C)c1ccccc1
NCGC00257874-01,tox21-er-bla-agonist-p2,"2,6-Dichlorobenzoic acid",activity,inactive,50-30-6,5758.0,OC(=O)c1c(Cl)cccc1Cl
NCGC00258152-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium hexafluorophosphate,activity,inactive,155371-19-0,2758873.0,F[P-](F)(F)(F)(F)F.C[n+]1ccn(CC)c1
NCGC00258209-01,tox21-er-bla-agonist-p2,1-tert-Butoxy-2-propanol,activity,inactive,57018-52-7,92629.0,CC(C)(C)OCC(C)O
NCGC00258340-01,tox21-er-bla-agonist-p2,"N'-Methyl-N,N-diphenylurea",activity,inactive,13114-72-2,25711.0,O=C(NC)N(c1ccccc1)c2ccccc2
NCGC00258341-01,tox21-er-bla-agonist-p2,Dodecyl glycidyl ether,activity,inactive,2461-18-9,17163.0,CCCCCCCCCCCCOCC1CO1
NCGC00256677-01,tox21-er-bla-agonist-p2,Phenoxyethyl propionate,activity,inactive,23495-12-7,31954.0,CCC(=O)OCCOc1ccccc1
NCGC00255737-01,tox21-er-bla-agonist-p2,"Urea, phenyl-",activity,inactive,64-10-8,6145.0,O=C(N)Nc1ccccc1
NCGC00256532-01,tox21-er-bla-agonist-p2,N-Nitrosohexamethyleneimine,activity,inactive,932-83-2,13613.0,O=NN1CCCCCC1
NCGC00255972-01,tox21-er-bla-agonist-p2,Gold trichloride,activity,active agonist,13453-07-1,26030.0,Cl[Au](Cl)Cl
NCGC00256271-01,tox21-er-bla-agonist-p2,"1,4-Dichloro-2,5-dimethylbenzene",activity,inactive,1124-05-6,70755.0,Clc1cc(C)c(Cl)cc1C
NCGC00256353-01,tox21-er-bla-agonist-p2,Griseofulvin,activity,inactive,126-07-8,441140.0,O=C2c3c(O[C@]12C(=CC(=O)C[C@H]1C)OC)c(Cl)c(OC)cc3OC
NCGC00255658-01,tox21-er-bla-agonist-p2,2-tert-Butylcyclohexyl acetate,activity,inactive,88-41-5,62334.0,O=C(C)OC1CCCCC1C(C)(C)C
NCGC00258792-01,tox21-er-bla-agonist-p2,Benzylacetone,activity,inactive,2550-26-7,17355.0,CC(=O)CCc1ccccc1
NCGC00258849-01,tox21-er-bla-agonist-p2,4-Cumylphenol,activity,active agonist,599-64-4,11742.0,CC(C)(c1ccc(O)cc1)c2ccccc2
NCGC00260429-01,tox21-er-bla-agonist-p2,2-Ethylbutyraldehyde,activity,inactive,97-96-1,7359.0,CCC(CC)C=O
NCGC00260448-01,tox21-er-bla-agonist-p2,D&C Violet 2,activity,inactive,81-48-1,6680.0,Cc1ccc(cc1)Nc4ccc(O)c3c4C(=O)c2ccccc2C3=O
NCGC00259131-01,tox21-er-bla-agonist-p2,Phenylacetaldehyde,activity,inactive,122-78-1,998.0,O=CCc1ccccc1
NCGC00259135-01,tox21-er-bla-agonist-p2,Permethrin,activity,inactive,52645-53-1,40326.0,Cl/C(Cl)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00259243-01,tox21-er-bla-agonist-p2,2-(Dimethylamino)ethyl methacrylate,activity,inactive,2867-47-2,17869.0,CN(C)CCOC(=O)C(=C)C
NCGC00260261-01,tox21-er-bla-agonist-p2,4-Nitrobenzylbromide,activity,inactive,100-11-8,66011.0,O=[N+]([O-])c1ccc(CBr)cc1
NCGC00254939-01,tox21-er-bla-agonist-p2,"Carbonochloridic acid, oxydi-2,1-ethanediyl ester",activity,inactive,106-75-2,7828.0,O=C(Cl)OCCOCCOC(Cl)=O
NCGC00255081-01,tox21-er-bla-agonist-p2,2-[Methacryloyloxy]ethyl acetoacetate,activity,inactive,21282-97-3,88855.0,O=C(CC(C)=O)OCCOC(=O)C(=C)C
NCGC00255417-01,tox21-er-bla-agonist-p2,"Benzonitrile, 2-hydroxy-",activity,inactive,611-20-1,11907.0,N#Cc1ccccc1O
NCGC00255640-01,tox21-er-bla-agonist-p2,"2-Methyl-2-nitro-1,3-propanediol",activity,inactive,77-49-6,6480.0,[O-][N+](=O)C(C)(CO)CO
NCGC00256217-01,tox21-er-bla-agonist-p2,"N-(2,5-Dimethoxyphenyl)-3-oxobutanamide",activity,inactive,6375-27-5,80777.0,COc1ccc(cc1NC(=O)CC(C)=O)OC
NCGC00091146-02,tox21-er-bla-agonist-p2,Phenothiazine,activity,inactive,92-84-2,7108.0,c1ccc2Sc3ccccc3Nc2c1
NCGC00166276-01,tox21-er-bla-agonist-p2,Aceneuramic acid,activity,inactive,131-48-6,14017587.0,O[C@H]([C@H](NC(C)=O)[C@@H](O)CC(=O)C(=O)O)[C@H](O)[C@H](O)CO
NCGC00166302-01,tox21-er-bla-agonist-p2,L-(-)-Sorbose,activity,inactive,87-79-6,6904.0,O[C@H](C(=O)CO)[C@H](O)[C@@H](O)CO
NCGC00159429-02,tox21-er-bla-agonist-p2,Ubidecarenone,activity,inactive,303-98-0,5281915.0,COC1=C(OC)C(=O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C)C1=O
NCGC00163616-01,tox21-er-bla-agonist-p2,Rosaramicin,activity,inactive,35834-26-5,12922658.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]1[C@@H](C)[C@H](O)CC(=O)OC(CC)C(C)C2O[C@@]2(C)C=CC(=O)[C@H](C)C[C@@H]1CC=O)[C@@H]3O
NCGC00094619-04,tox21-er-bla-agonist-p2,Chloramphenicol sodium succinate,activity,inactive,982-57-0,656833.0,[Na+].O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](COC(=O)CCC([O-])=O)NC(=O)C(Cl)Cl
NCGC00159485-02,tox21-er-bla-agonist-p2,Calcium disodium ethylenediaminetetraacetate,activity,inactive,62-33-9,6093170.0,[Ca+2].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O
NCGC00094843-01,tox21-er-bla-agonist-p2,N-Acetylglucosamine,activity,inactive,7512-17-6,439174.0,OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O
NCGC00094941-01,tox21-er-bla-agonist-p2,Foscarnet trisodium,activity,active agonist,63585-09-1,44561.0,[Na+].[Na+].[Na+].[O-]C(=O)P([O-])([O-])=O
NCGC00160377-01,tox21-er-bla-agonist-p2,Tosifen,activity,inactive,32295-18-4,36102.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)N[C@@H](C)Cc2ccccc2
NCGC00167840-01,tox21-er-bla-agonist-p2,Loxoribine,activity,inactive,121288-39-9,60737.0,NC3=NC2=C(N(CC=C)C(=O)N2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)C(=O)N3
NCGC00164523-01,tox21-er-bla-agonist-p2,Medazepam,activity,inactive,2898-12-6,4041.0,Clc1ccc2c(c1)C(=NCCN2C)c3ccccc3
NCGC00164541-01,tox21-er-bla-agonist-p2,Sulfacarbamide,activity,inactive,547-44-4,11033.0,Nc1ccc(cc1)S(=O)(=O)NC(N)=O
NCGC00160476-01,tox21-er-bla-agonist-p2,Fluacizine,activity,inactive,30223-48-4,161562.0,CCN(CC)CCC(=O)N1c3ccccc3Sc2ccc(cc12)C(F)(F)F
NCGC00168262-01,tox21-er-bla-agonist-p2,(S)-(-)-Cathinone hydrochloride,activity,inactive,72739-14-1,11956149.0,Cl.O=C([C@H](C)N)c1ccccc1
NCGC00165864-02,tox21-er-bla-agonist-p2,Pipamperone dihydrochloride,activity,inactive,2448-68-2,11705034.0,Cl.Cl.Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)(C(N)=O)N3CCCCC3
NCGC00160552-01,tox21-er-bla-agonist-p2,alpha-L-Lyxo-hex-5-ulofuranosyl alpha-D-glucopyranoside,activity,inactive,NOCAS_46224,60196286.0,O[C@H]2[C@@H](O)[C@H](O)O[C@]2(CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
NCGC00095903-01,tox21-er-bla-agonist-p2,Escitalopram oxalate,activity,inactive,219861-08-2,146571.0,O=C(O)C(=O)O.CN(C)CCC[C@]2(OCc1cc(ccc12)C#N)c3ccc(F)cc3
NCGC00160592-01,tox21-er-bla-agonist-p2,Lorbamate,activity,inactive,24353-88-6,32322.0,NC(=O)OCC(C)(COC(=O)NC1CC1)CCC
NCGC00168352-01,tox21-er-bla-agonist-p2,Tetramethrin,activity,inactive,7696-12-0,83975.0,C\C(C)=C/C3C(C(=O)OCN2C(=O)C=1CCCCC=1C2=O)C3(C)C
NCGC00166140-01,tox21-er-bla-agonist-p2,Pyrithioxin dihydrochloride,activity,inactive,10049-83-9,82325.0,Cl.Cl.Oc1c(CO)c(cnc1C)CSSCc2cnc(C)c(O)c2CO
NCGC00091009-04,tox21-er-bla-agonist-p2,17-Methyltestosterone,activity,active agonist,58-18-4,6010.0,O=C4CC[C@@]3(C)C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@]1(C)O)=C4
NCGC00091049-04,tox21-er-bla-agonist-p2,Linoleic acid,activity,inactive,60-33-3,5280450.0,O=C(O)CCCCCCC/C=C\C/C=C\CCCCC
NCGC00091585-03,tox21-er-bla-agonist-p2,"2-Ethylhexyl-2-cyano-3,3-diphenylacrylate",activity,inactive,6197-30-4,22571.0,CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2
NCGC00181797-01,tox21-er-bla-agonist-p2,Vancomycin hydrochloride,activity,inactive,1404-93-9,16051954.0,Cl.CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)C(O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC=C(O)C(=C3)C3=C(C=C(O)C=C3O)[C@@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2
NCGC00183362-01,tox21-er-bla-agonist-p2,Pentagastrin,activity,inactive,5534-95-2,9853654.0,NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)CCNC(=O)OC(C)(C)C)Cc3cnc2ccccc23
NCGC00255015-01,tox21-er-bla-agonist-p2,(4-Methoxyphenyl)methanol,activity,inactive,105-13-5,7738.0,COc1ccc(CO)cc1
NCGC00254633-01,tox21-er-bla-agonist-p2,EPTC,activity,inactive,759-94-4,12968.0,CCCN(CCC)C(=O)SCC
NCGC00254739-01,tox21-er-bla-agonist-p2,"2,2,4-Trimethylpentane-1,3-diyl dibenzoate",activity,active agonist,68052-23-3,107080.0,CC(C)C(OC(=O)c1ccccc1)C(C)(C)COC(=O)c2ccccc2
NCGC00254755-01,tox21-er-bla-agonist-p2,Flufenpyr-ethyl,activity,inactive,188489-07-8,3083546.0,O=C(OCC)COc1cc(c(F)cc1Cl)N2N=CC(=C(C)C2=O)C(F)(F)F
NCGC00255221-01,tox21-er-bla-agonist-p2,Topiramate,activity,inactive,97240-79-4,5284627.0,NS(=O)(=O)OC[C@]23OC[C@H]1OC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2
NCGC00254105-01,tox21-er-bla-agonist-p2,"2,6-Dimethylaniline",activity,inactive,87-62-7,6896.0,Cc1cccc(C)c1N
NCGC00254539-01,tox21-er-bla-agonist-p2,Diethylstilbestrol,activity,active agonist,56-53-1,448537.0,Oc1ccc(cc1)C(\CC)=C(/CC)c2ccc(O)cc2
NCGC00181335-01,tox21-er-bla-agonist-p2,Diethylstilbestrol diphosphate,activity,active agonist,522-40-7,3032325.0,OP(=O)(O)Oc1ccc(cc1)C(\CC)=C(/CC)c2ccc(OP(=O)(O)O)cc2
NCGC00182062-02,tox21-er-bla-agonist-p2,Bucillamine,activity,inactive,65002-17-7,656604.0,O=C(N[C@@H](CS)C(=O)O)C(C)(C)S
NCGC00182979-01,tox21-er-bla-agonist-p2,Perlapine,activity,inactive,1977-11-3,16106.0,CN1CCN(CC1)C2=Nc4ccccc4Cc3ccccc23
NCGC00183031-01,tox21-er-bla-agonist-p2,Calcium pantothenate,activity,inactive,137-08-6,443753.0,[Ca+2].CC(C)(CO)[C@@H](O)C(=O)NCCC([O-])=O.[O-]C(=O)CCNC(=O)[C@H](O)C(C)(C)CO
NCGC00260211-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpiperidinium tetrafluoroborate,activity,inactive,886439-34-5,60196382.0,F[B-](F)(F)F.C[N+]1(CCCC)CCCCC1
NCGC00256728-01,tox21-er-bla-agonist-p2,Equilin,activity,active agonist,474-86-2,223368.0,Oc3cc4CC=C1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)c4cc3
NCGC00259228-01,tox21-er-bla-agonist-p2,Thiophanate-methyl,activity,inactive,23564-05-8,3032791.0,S=C(Nc1ccccc1NC(=S)NC(=O)OC)NC(=O)OC
NCGC00016781-04,tox21-er-bla-agonist-p2,Ambroxolhydrochloride,activity,inactive,23828-92-4,108013.0,Cl.O[C@@H]2CC[C@@H](NCc1cc(Br)cc(Br)c1N)CC2
NCGC00257271-01,tox21-er-bla-agonist-p2,6-Hydroxy-2-naphthyl disulfide,activity,active agonist,6088-51-3,22463.0,Oc1ccc2cc(ccc2c1)SSc3ccc4cc(O)ccc4c3
NCGC00260523-01,tox21-er-bla-agonist-p2,Sodium selenite,activity,inactive,10102-18-8,24934.0,[Na+].[Na+].[O-][Se]([O-])=O
NCGC00256643-01,tox21-er-bla-agonist-p2,"Nitric acid, magnesium salt",activity,inactive,13446-18-9,202877.0,O.[Mg+2].O.O.O.O.O.[O-][N+]([O-])=O.[O-][N+]([O-])=O
NCGC00257533-01,tox21-er-bla-agonist-p2,Glycolic acid,activity,inactive,79-14-1,757.0,O=C(O)CO
NCGC00258227-01,tox21-er-bla-agonist-p2,"1,2,3,5-Tetrachlorobenzene",activity,inactive,634-90-2,12468.0,Clc1cc(Cl)c(Cl)c(Cl)c1
NCGC00247694-01,tox21-er-bla-agonist-p2,N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl]-N-phenylpropanamide hydrochloride,activity,inactive,117332-94-2,60196322.0,Cl.CCC(=O)N(c1ccccc1)C2CCN(CC2)C(C)Cc3cccs3
NCGC00255551-01,tox21-er-bla-agonist-p2,Sodium trichloroacetate,activity,inactive,650-51-1,23681045.0,[Na+].ClC(Cl)(Cl)C([O-])=O
NCGC00256957-01,tox21-er-bla-agonist-p2,N-Butylbenzenesulfonamide,activity,inactive,3622-84-2,19241.0,O=S(=O)(NCCCC)c1ccccc1
NCGC00256183-01,tox21-er-bla-agonist-p2,"4,4'-Propane-2,2-diyldicyclohexanol",activity,active agonist,80-04-6,94932.0,OC1CCC(CC1)C(C)(C)C2CCC(O)CC2
NCGC00256001-01,tox21-er-bla-agonist-p2,Isopropyl-o-cresol,activity,inactive,499-75-2,10364.0,Cc1ccc(cc1O)C(C)C
NCGC00256039-01,tox21-er-bla-agonist-p2,Potassium 4-[(3-oxobutanoyl)amino]benzenesulfonate,activity,inactive,70321-85-6,23674215.0,[K+].O=S([O-])(=O)c1ccc(NC(=O)CC(C)=O)cc1
NCGC00257040-01,tox21-er-bla-agonist-p2,3-Aminopropyltriethoxysilane,activity,inactive,919-30-2,13521.0,CCO[Si](OCC)(OCC)CCCN
NCGC00257171-01,tox21-er-bla-agonist-p2,2-Nitroaniline,activity,inactive,88-74-4,6946.0,O=[N+]([O-])c1ccccc1N
NCGC00257529-01,tox21-er-bla-agonist-p2,Propanedinitrile,activity,inactive,109-77-3,8010.0,N#CCC#N
NCGC00257989-01,tox21-er-bla-agonist-p2,"2,4,4-Trimethyl-1-pentene",activity,inactive,107-39-1,7868.0,C=C(C)CC(C)(C)C
NCGC00257080-01,tox21-er-bla-agonist-p2,Triethyl phosphite,activity,inactive,122-52-1,31215.0,CCOP(OCC)OCC
NCGC00258556-01,tox21-er-bla-agonist-p2,2-Ethoxyaniline,activity,inactive,94-70-2,7203.0,CCOc1ccccc1N
NCGC00258622-01,tox21-er-bla-agonist-p2,4-Methyl-3-nitrobenzoic acid,activity,inactive,96-98-0,7319.0,Cc1ccc(cc1[N+](=O)[O-])C(=O)O
NCGC00258464-01,tox21-er-bla-agonist-p2,"2,3,5,6-Tetrachlorophenol",activity,inactive,935-95-5,13636.0,Oc1c(Cl)c(Cl)cc(Cl)c1Cl
NCGC00259749-01,tox21-er-bla-agonist-p2,5-Methyl-2-furancarboxylic acid,activity,inactive,1917-15-3,74710.0,O=C(O)c1ccc(C)o1
NCGC00259822-01,tox21-er-bla-agonist-p2,Carbamazepine,activity,inactive,298-46-4,2554.0,NC(=O)N2c3ccccc3C=Cc1ccccc12
NCGC00259472-01,tox21-er-bla-agonist-p2,Ethylenediaminetetraacetic acid ferric sodium salt,activity,inactive,15708-41-5,27461.0,[Fe+3].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O
NCGC00260017-01,tox21-er-bla-agonist-p2,2-(4-Aminophenyl)-6-methylbenzothiazole sulfonic acid,activity,inactive,130-17-6,174223.0,O=S(=O)(O)c1c(C)ccc2nc(sc12)c3ccc(N)cc3
NCGC00260430-01,tox21-er-bla-agonist-p2,3-Methoxy-4-methylaniline,activity,inactive,16452-01-0,27882.0,Cc1ccc(N)cc1OC
NCGC00260465-01,tox21-er-bla-agonist-p2,9-Fluorenone,activity,inactive,486-25-9,10241.0,O=C3c1ccccc1c2ccccc23
NCGC00260493-01,tox21-er-bla-agonist-p2,Acenaphthenequinone,activity,inactive,82-86-0,6724.0,O=C3c2cccc1cccc(c12)C3=O
NCGC00260556-01,tox21-er-bla-agonist-p2,NTP Mix64 CT1 62-EQP,activity,inactive,NOCAS_49452,,
NCGC00260288-01,tox21-er-bla-agonist-p2,Potassium acetate,activity,inactive,127-08-2,517044.0,[K+].[O-]C(C)=O
NCGC00260183-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylmidazolium bromide,activity,inactive,65039-08-9,2734235.0,[Br-].C[n+]1ccn(CC)c1
NCGC00015209-05,tox21-er-bla-agonist-p2,Cyclophosphamide monohydrate,activity,inactive,6055-19-2,22420.0,O.O=P1(NCCCO1)N(CCCl)CCCl
NCGC00013273-01,tox21-er-bla-agonist-p2,Pyridoxamine dihydrochloride,activity,inactive,524-36-7,10664.0,Cl.Cl.Oc1c(CN)c(cnc1C)CO
NCGC00013369-03,tox21-er-bla-agonist-p2,Pamoic acid,activity,active agonist,130-85-8,8546.0,O=C(O)c4cc1ccccc1c(Cc2c3ccccc3cc(C(=O)O)c2O)c4O
NCGC00013796-01,tox21-er-bla-agonist-p2,Atropine N-oxide,activity,inactive,4438-22-6,3000668.0,C[N+]2([O-])[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3
NCGC00014633-01,tox21-er-bla-agonist-p2,Floxacillin sodium salt,activity,inactive,1847-24-1,23667629.0,[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1c(F)cccc1Cl)[C@H]4SC3(C)C
NCGC00015442-02,tox21-er-bla-agonist-p2,5-Fluorouracil,activity,inactive,51-21-8,3385.0,FC1=CNC(=O)NC1=O
NCGC00015513-04,tox21-er-bla-agonist-p2,Histamine,activity,inactive,51-45-6,774.0,NCCc1cncn1
NCGC00016065-07,tox21-er-bla-agonist-p2,Tropicamide,activity,inactive,1508-75-4,5593.0,OCC(c1ccccc1)C(=O)N(CC)Cc2ccncc2
NCGC00016324-01,tox21-er-bla-agonist-p2,Sulfamethoxypyridazine,activity,inactive,80-35-3,5330.0,O=S(=O)(Nc1ccc(OC)nn1)c2ccc(N)cc2
NCGC00016347-01,tox21-er-bla-agonist-p2,Benzthiazide,activity,inactive,91-33-8,2343.0,NS(=O)(=O)c3cc1c(N=C(NS1(=O)=O)CSCc2ccccc2)cc3Cl
NCGC00016495-01,tox21-er-bla-agonist-p2,Hexylcaine hydrochloride,activity,inactive,532-76-3,102426.0,Cl.CC(CNC1CCCCC1)OC(=O)c2ccccc2
NCGC00016534-01,tox21-er-bla-agonist-p2,Cyclopenthiazide,activity,inactive,742-20-1,2904.0,NS(=O)(=O)c3cc1c(NC(NS1(=O)=O)CC2CCCC2)cc3Cl
NCGC00159365-02,tox21-er-bla-agonist-p2,m-Cresyl acetate,activity,inactive,122-46-3,67406.0,O=C(C)Oc1cc(C)ccc1
NCGC00255850-01,tox21-er-bla-agonist-p2,Isoxathion,activity,inactive,18854-01-8,29307.0,S=P(Oc1cc(on1)c2ccccc2)(OCC)OCC
NCGC00254731-01,tox21-er-bla-agonist-p2,Oxyfluorfen,activity,inactive,42874-03-3,39327.0,Clc2cc(ccc2Oc1ccc([N+]([O-])=O)c(OCC)c1)C(F)(F)F
NCGC00256196-01,tox21-er-bla-agonist-p2,(2E)-2-Decenal,activity,inactive,3913-81-3,5283345.0,CCCCCCC\C=C\C=O
NCGC00255197-01,tox21-er-bla-agonist-p2,Triphenylethylene,activity,active agonist,58-72-0,6025.0,C(/c1ccccc1)=C(/c2ccccc2)c3ccccc3
NCGC00254403-01,tox21-er-bla-agonist-p2,"5,5-Dimethylhydantoin",activity,inactive,77-71-4,6491.0,O=C1NC(=O)C(C)(C)N1
NCGC00254426-01,tox21-er-bla-agonist-p2,CP-471358,activity,inactive,NOCAS_47265,9869142.0,O=S(=O)(N(CCC(=O)O)C1(CCCC1)C(=O)NO)c3ccc(Oc2ccc(F)cc2)cc3
NCGC00254468-01,tox21-er-bla-agonist-p2,4-Hydroxy-3-methoxybenzaldehyde,activity,inactive,121-33-5,1183.0,Oc1ccc(cc1OC)C=O
NCGC00254544-01,tox21-er-bla-agonist-p2,Heptachlor epoxide,activity,inactive,1024-57-3,13930.0,ClC3=C(Cl)C4(Cl)C2C(C1OC1C2Cl)C3(Cl)C4(Cl)Cl
NCGC00254611-01,tox21-er-bla-agonist-p2,"1,5-Naphthalenedisulfonic acid, disodium salt hydrate",activity,inactive,207569-02-6,51346588.0,[Na+].[Na+].O.[O-]S(=O)(=O)c2cccc1c2cccc1S([O-])(=O)=O
NCGC00254813-01,tox21-er-bla-agonist-p2,6-Chlorothymol,activity,inactive,89-68-9,6982.0,Oc1cc(C)c(Cl)cc1C(C)C
NCGC00254864-01,tox21-er-bla-agonist-p2,Methyl formate,activity,inactive,107-31-3,7865.0,O=COC
NCGC00255369-01,tox21-er-bla-agonist-p2,Cybutryne,activity,inactive,28159-98-0,91590.0,CSc2nc(NC1CC1)nc(NC(C)(C)C)n2
NCGC00255485-01,tox21-er-bla-agonist-p2,Chloropropylate,activity,inactive,5836-10-2,22094.0,OC(c1ccc(Cl)cc1)(c2ccc(Cl)cc2)C(=O)OC(C)C
NCGC00015207-07,tox21-er-bla-agonist-p2,Cilostazol,activity,inactive,73963-72-1,2754.0,O=C1CCc2cc(ccc2N1)OCCCCc4nnnn4C3CCCCC3
NCGC00015452-09,tox21-er-bla-agonist-p2,Flutamide,activity,inactive,13311-84-7,3397.0,O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)C
NCGC00024778-01,tox21-er-bla-agonist-p2,Bifemelane,activity,inactive,90293-01-9,2377.0,CNCCCCOc2ccccc2Cc1ccccc1
NCGC00091430-01,tox21-er-bla-agonist-p2,Oxymetholone,activity,active agonist,434-07-1,5281034.0,O=C3C[C@@H]4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@]1(C)O)[C@@]4(C)C\C3=C\O
NCGC00159343-02,tox21-er-bla-agonist-p2,Tramadol,activity,inactive,36282-47-0,33741.0,O[C@@]1(CCCC[C@@H]1CN(C)C)c2cc(OC)ccc2
NCGC00159373-02,tox21-er-bla-agonist-p2,Thymol,activity,inactive,89-83-8,6989.0,CC(C)c1ccc(C)cc1O
NCGC00160492-01,tox21-er-bla-agonist-p2,Quifenadine,activity,inactive,10447-39-9,65600.0,OC(C2CN1CCC2CC1)(c3ccccc3)c4ccccc4
NCGC00164554-03,tox21-er-bla-agonist-p2,Mupirocin,activity,inactive,12650-69-0,446596.0,O=C(O)CCCCCCCCOC(=O)\C=C(/C)C[C@@H]2OC[C@H](C[C@@H]1O[C@H]1[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]2O
NCGC00181168-01,tox21-er-bla-agonist-p2,Trifluomeprazine 2-butenedioate,activity,inactive,71609-19-3,60196307.0,O=C(O)C=CC(=O)O.FC(F)(F)c1cc2N(CC(C)CN(C)C)c3ccccc3Sc2cc1
NCGC00181300-01,tox21-er-bla-agonist-p2,Riboflavin tetrabutyrate,activity,inactive,752-56-7,92140.0,CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12
NCGC00182032-01,tox21-er-bla-agonist-p2,Aviptadil,activity,inactive,40077-57-4,,
NCGC00247728-01,tox21-er-bla-agonist-p2,Psilocin,activity,inactive,520-53-6,4980.0,CN(C)CCc2cnc1cccc(O)c12
NCGC00254982-01,tox21-er-bla-agonist-p2,Ethyl propionate,activity,inactive,105-37-3,7749.0,CCC(=O)OCC
NCGC00259690-01,tox21-er-bla-agonist-p2,Bisphenol A diglycidyl ether,activity,inactive,1675-54-3,2286.0,CC(C)(c2ccc(OCC1CO1)cc2)c4ccc(OCC3CO3)cc4
NCGC00090777-05,tox21-er-bla-agonist-p2,Methoprene,activity,inactive,40596-69-8,5366546.0,CC(C)OC(=O)\C=C(/C)\C=C\CC(C)CCCC(C)(C)OC
NCGC00091070-01,tox21-er-bla-agonist-p2,Diisopropylamine,activity,inactive,108-18-9,7912.0,CC(C)NC(C)C
NCGC00095316-01,tox21-er-bla-agonist-p2,Dipyrocetyl,activity,inactive,486-79-3,68093.0,O=C(C)Oc1cccc(c1OC(C)=O)C(=O)O
NCGC00164547-01,tox21-er-bla-agonist-p2,Zafirlukast,activity,inactive,107753-78-6,5717.0,Cc1ccccc1S(=O)(=O)NC(=O)c5ccc(Cc3cn(C)c2ccc(cc23)NC(=O)OC4CCCC4)c(OC)c5
NCGC00254077-01,tox21-er-bla-agonist-p2,Piperazine,activity,inactive,110-85-0,4837.0,C1CNCCN1
NCGC00016928-01,tox21-er-bla-agonist-p2,Imipenem,activity,inactive,64221-86-9,104838.0,O[C@H](C)[C@H]2C(=O)N1C(=C(C[C@@H]12)SCCNC=N)C(=O)O
NCGC00090961-02,tox21-er-bla-agonist-p2,1-Butanol,activity,inactive,71-36-3,263.0,CCCCO
NCGC00017046-01,tox21-er-bla-agonist-p2,Ticarcillin disodium,activity,inactive,4697-14-7,470375.0,[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)[C@@H](c1ccsc1)C([O-])=O)[C@H]3SC2(C)C
NCGC00017098-01,tox21-er-bla-agonist-p2,Indapamide,activity,inactive,26807-65-8,3702.0,NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C
NCGC00025236-01,tox21-er-bla-agonist-p2,Remacemide hydrochloride,activity,inactive,111686-79-4,60510.0,Cl.NCC(=O)NC(C)(Cc1ccccc1)c2ccccc2
NCGC00016887-01,tox21-er-bla-agonist-p2,Meptazinol hydrochloride,activity,inactive,59263-76-2,65483.0,Cl.CN1CCCCC(CC)(C1)c2cccc(O)c2
NCGC00016924-02,tox21-er-bla-agonist-p2,Sulmazole,activity,inactive,73384-60-8,5353.0,CS(=O)c3ccc(c1nc2ncccc2n1)c(OC)c3
NCGC00256764-01,tox21-er-bla-agonist-p2,6-Pentyl-2H-pyran-2-one,activity,inactive,27593-23-3,33960.0,O=C1C=CC=C(CCCCC)O1
NCGC00256928-01,tox21-er-bla-agonist-p2,Benzyl salicylate,activity,inactive,118-58-1,8363.0,Oc2ccccc2C(=O)OCc1ccccc1
NCGC00258557-01,tox21-er-bla-agonist-p2,Heptylamine,activity,inactive,111-68-2,8127.0,CCCCCCCN
NCGC00258623-01,tox21-er-bla-agonist-p2,Trichloroacetyl chloride,activity,inactive,76-02-8,6420.0,ClC(Cl)(Cl)C(Cl)=O
NCGC00257191-01,tox21-er-bla-agonist-p2,Dodecanedioic acid,activity,inactive,693-23-2,12736.0,O=C(O)CCCCCCCCCCC(=O)O
NCGC00257248-01,tox21-er-bla-agonist-p2,PharmaGSID_48516,activity,inactive,NOCAS_48516,23700188.0,[Na+].O=C([N-]S(=O)(=O)/C=C/c1ccccc1)c2ccc(F)cc2Cl
NCGC00257305-01,tox21-er-bla-agonist-p2,Procymidone,activity,inactive,32809-16-8,36242.0,Clc1cc(cc(Cl)c1)N2C(=O)C3(C)CC3(C)C2=O
NCGC00257582-01,tox21-er-bla-agonist-p2,"2-Ethyl-2-(hydroxymethyl)-1,3-propanediol",activity,inactive,77-99-6,6510.0,CCC(CO)(CO)CO
NCGC00257851-01,tox21-er-bla-agonist-p2,"2,3,4-Trichlorophenol",activity,active agonist,15950-66-0,27582.0,Oc1ccc(Cl)c(Cl)c1Cl
NCGC00257965-01,tox21-er-bla-agonist-p2,Sodium salicylate,activity,inactive,54-21-7,16760658.0,[Na+].O=C([O-])c1ccccc1O
NCGC00258080-01,tox21-er-bla-agonist-p2,Heptanenitrile,activity,inactive,629-08-3,12372.0,CCCCCCC#N
NCGC00258357-01,tox21-er-bla-agonist-p2,5-Chloro-2-methyl-1H-benzimidazole,activity,inactive,2818-69-1,76063.0,Clc1ccc2nc(C)nc2c1
NCGC00255725-01,tox21-er-bla-agonist-p2,"1,2-Propanediol, 3-(2-propenyloxy)-",activity,inactive,123-34-2,78950.0,OCC(O)COCC=C
NCGC00256417-01,tox21-er-bla-agonist-p2,4-Hydroxy-3-nitrophenylarsonic acid,activity,inactive,121-19-7,5104.0,O=[N+]([O-])c1cc(ccc1O)[As](O)(O)=O
NCGC00256479-01,tox21-er-bla-agonist-p2,"1,8-Cineol",activity,inactive,470-82-6,2758.0,CC2(C)OC1(C)CCC2CC1
NCGC00255833-01,tox21-er-bla-agonist-p2,"Methyl 4,4,4-trimethylacetoacetate",activity,inactive,55107-14-7,99597.0,CC(C)(C)C(=O)CC(=O)OC
NCGC00255892-01,tox21-er-bla-agonist-p2,Penconazole,activity,inactive,66246-88-6,91693.0,Clc2ccc(C(CCC)Cn1cncn1)c(Cl)c2
NCGC00256275-01,tox21-er-bla-agonist-p2,Sodium 3-chloro-2-hydroxypropane-1-sulfonate,activity,inactive,126-83-0,23662382.0,[Na+].ClCC(O)CS([O-])(=O)=O
NCGC00260650-01,tox21-er-bla-agonist-p2,NTP Mix91 ER AR1 18-EQP,activity,active agonist,NOCAS_49546,,
NCGC00259057-01,tox21-er-bla-agonist-p2,Finasteride,activity,inactive,98319-26-7,57363.0,CC(C)(C)NC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2NC(=O)C=C[C@]12C
NCGC00259887-01,tox21-er-bla-agonist-p2,Prometryn,activity,inactive,7287-19-6,4929.0,CSc1nc(NC(C)C)nc(NC(C)C)n1
NCGC00259949-01,tox21-er-bla-agonist-p2,Acenaphthene,activity,inactive,83-32-9,6734.0,c1cc2cccc3CCc(c1)c23
NCGC00260049-01,tox21-er-bla-agonist-p2,Cisplatin,activity,inactive,15663-27-1,2767.0,Cl[Pt](Cl)(N)N
NCGC00260067-01,tox21-er-bla-agonist-p2,Guggulsterones Z,activity,inactive,39025-23-5,6450278.0,C\C=C4/C(=O)C[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=CC(=O)CC[C@@]12C
NCGC00260115-01,tox21-er-bla-agonist-p2,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, monosodium salt",activity,inactive,5460-09-3,23664361.0,[Na+].[O-]S(=O)(=O)c2cc1cc(cc(O)c1c(N)c2)S(=O)(=O)O
NCGC00260263-01,tox21-er-bla-agonist-p2,alpha-Amylcinnamyl alcohol,activity,inactive,101-85-9,6076971.0,CCCCCC(/CO)=C/c1ccccc1
NCGC00254734-01,tox21-er-bla-agonist-p2,Thiophanate-methyl,activity,inactive,23564-05-8,3032791.0,S=C(Nc1ccccc1NC(=S)NC(=O)OC)NC(=O)OC
NCGC00256436-01,tox21-er-bla-agonist-p2,4-Dimethylaminoantipyrine,activity,inactive,58-15-1,6009.0,CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00254905-01,tox21-er-bla-agonist-p2,Pirimicarb,activity,inactive,23103-98-2,31645.0,Cc1nc(nc(OC(=O)N(C)C)c1C)N(C)C
NCGC00254954-01,tox21-er-bla-agonist-p2,Sethoxydim,activity,inactive,74051-80-2,52923.0,CCC\C(=N\OCC)C1=C(O)CC(CC(C)SCC)CC1=O
NCGC00255123-01,tox21-er-bla-agonist-p2,meso-Hexestrol,activity,active agonist,84-16-2,192197.0,Oc1ccc(cc1)[C@@H](CC)[C@@H](CC)c2ccc(O)cc2
NCGC00255229-01,tox21-er-bla-agonist-p2,Spironolactone,activity,inactive,52-01-7,5833.0,CC(=O)S[C@@H]4CC1=CC(=O)CC[C@]1(C)[C@H]5CC[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45
NCGC00255249-01,tox21-er-bla-agonist-p2,Tomelukast,activity,inactive,88107-10-2,3969.0,CC(=O)c2ccc(OCCCCc1nnnn1)c(CCC)c2O
NCGC00255301-01,tox21-er-bla-agonist-p2,Diacetone acrylamide,activity,inactive,2873-97-4,17888.0,C=CC(=O)NC(C)(C)CC(=O)C
NCGC00255335-01,tox21-er-bla-agonist-p2,Danazol,activity,active agonist,17230-88-5,28417.0,C#C[C@]3(O)CC[C@H]2[C@@H]4CCC1=Cc5oncc5C[C@]1(C)[C@H]4CC[C@@]23C
NCGC00255355-01,tox21-er-bla-agonist-p2,"2-Methyl-1,3-benzenediol",activity,inactive,608-25-3,11843.0,Oc1cccc(O)c1C
NCGC00255388-01,tox21-er-bla-agonist-p2,Bromuconazole,activity,inactive,116255-48-2,3444.0,BrC2CC(Cn1cncn1)(OC2)c3ccc(Cl)cc3Cl
NCGC00255597-01,tox21-er-bla-agonist-p2,"1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-",activity,inactive,118-47-8,67045.0,O=S(=O)(O)c1ccc(cc1)N2N=C(CC2=O)C(=O)O
NCGC00091456-01,tox21-er-bla-agonist-p2,2-Methylimidazole,activity,inactive,693-98-1,12749.0,Cc1nccn1
NCGC00091923-02,tox21-er-bla-agonist-p2,Scopolamine hydrobromide trihydrate,activity,inactive,6533-68-2,20055509.0,Br.O.O.O.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34
NCGC00091952-01,tox21-er-bla-agonist-p2,Pheniramine maleate,activity,inactive,132-20-7,25150753.0,[O-]C(=O)/C=C\C([O-])=O.C[NH+](C)CCC(c1ccccc1)c2[nH+]cccc2
NCGC00163217-01,tox21-er-bla-agonist-p2,Bethanechol,activity,inactive,590-63-6,11548.0,[Cl-].C[N+](C)(C)CC(C)OC(=O)N
NCGC00094439-01,tox21-er-bla-agonist-p2,Tetraethylammonium chloride,activity,inactive,56-34-8,5946.0,[Cl-].CC[N+](CC)(CC)CC
NCGC00094736-01,tox21-er-bla-agonist-p2,Nitromide,activity,inactive,121-81-3,4511.0,O=[N+]([O-])c1cc(cc(c1)[N+]([O-])=O)C(N)=O
NCGC00160275-02,tox21-er-bla-agonist-p2,Geliomycin,activity,inactive,20004-62-0,5282060.0,Oc5cc1c3c4c(C(=O)c2c(O)cc(O)c(C(=O)C1(C)C)c23)c(O)cc(C)c45
NCGC00095041-01,tox21-er-bla-agonist-p2,Urethane,activity,inactive,51-79-6,5641.0,NC(=O)OCC
NCGC00160378-01,tox21-er-bla-agonist-p2,Pranolium chloride,activity,inactive,42879-47-0,39328.0,[Cl-].CC(C)[N+](C)(C)CC(O)COc2cccc1ccccc12
NCGC00160405-01,tox21-er-bla-agonist-p2,Risedronate sodium,activity,inactive,115436-72-1,9862176.0,[Na+].[Na+].[O-]P(=O)(O)C(O)(Cc1cccnc1)P([O-])(=O)O
NCGC00095078-01,tox21-er-bla-agonist-p2,Clobetasol propionate,activity,inactive,25122-46-7,32798.0,ClCC(=O)[C@@]4(OC(=O)CC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00160501-01,tox21-er-bla-agonist-p2,Pimeclone,activity,inactive,534-84-9,197861.0,O=C2CCCCC2CN1CCCCC1
NCGC00168260-01,tox21-er-bla-agonist-p2,Normorphine,activity,inactive,466-97-7,443403.0,Oc1ccc2C[C@@H]4NCC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00095182-01,tox21-er-bla-agonist-p2,Gemifloxacin mesylate,activity,inactive,204519-65-3,9588170.0,CS(=O)(=O)O.CO\N=C1/CN(CC1CN)c2nc3c(cc2F)C(=O)C(=CN3C4CC4)C(=O)O
NCGC00095599-01,tox21-er-bla-agonist-p2,Arbutin,activity,inactive,497-76-7,440936.0,Oc1ccc(cc1)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
NCGC00160622-01,tox21-er-bla-agonist-p2,D-delta-Tocopherol,activity,inactive,119-13-1,92094.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1
NCGC00161399-01,tox21-er-bla-agonist-p2,Pinokalant hydrochloride,activity,inactive,143482-60-4,56846451.0,Cl.COc5ccc(CCN(CCc1ccc(OC)c(OC)c1OC)C(=O)C(C2=NCCc3cc(OC)c(OC)cc23)c4ccccc4)c(OC)c5OC
NCGC00182985-01,tox21-er-bla-agonist-p2,Trolnitrate,activity,inactive,7077-34-1,11499.0,O=[N+]([O-])OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O
NCGC00183856-01,tox21-er-bla-agonist-p2,Phenyl 11-iodo-10-undecynoate,activity,inactive,2020-25-9,4783.0,O=C(Oc1ccccc1)CCCCCCCCC#CI
NCGC00184996-01,tox21-er-bla-agonist-p2,Gadodiamide hydrate,activity,inactive,122795-43-1,60754.0,[Gd+3].O.CNC(=O)CN(CC([O-])=O)CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O
NCGC00185777-01,tox21-er-bla-agonist-p2,Potassium antimony(III) tartrate hydrate,activity,inactive,331753-56-1,60196359.0,[K+].[K+].[SbH3-3].[SbH3-3].O.O.O.[O-]C(=O)C(O)C(O)C(=O)[O-].[O-]C(=O)C(O)C(O)C([O-])=O
NCGC00254196-01,tox21-er-bla-agonist-p2,"2,2-Bis(bromomethyl)-1,3-propanediol",activity,inactive,3296-90-0,18692.0,OCC(CBr)(CBr)CO
NCGC00254212-01,tox21-er-bla-agonist-p2,"2-Norbornene-5,6-dicarboxylic anhydride",activity,inactive,826-62-0,13223.0,O=C1OC(=O)C3C1C2CC3C=C2
NCGC00255345-01,tox21-er-bla-agonist-p2,Physostigmine,activity,inactive,57-47-6,5983.0,CNC(=O)Oc1cc2c(cc1)N(C)[C@H]3N(C)CC[C@@]23C
NCGC00255347-01,tox21-er-bla-agonist-p2,Thiophanate,activity,inactive,23564-06-9,3032792.0,S=C(Nc1ccccc1NC(=S)NC(=O)OCC)NC(=O)OCC
NCGC00247675-01,tox21-er-bla-agonist-p2,"3,4,5-Trimethoxyamphetamine hydrochloride",activity,inactive,5688-80-2,60196310.0,Cl.COc1c(cc(cc1OC)CC(C)C)OC
NCGC00247690-01,tox21-er-bla-agonist-p2,"(+)-2,5-Dimethoxy-4-ethylamphetamine hydrochloride",activity,inactive,50505-91-4,60196319.0,Cl.COc1cc(CC)c(cc1C[C@H](C)N)OC
NCGC00254284-01,tox21-er-bla-agonist-p2,Octabenzone,activity,inactive,1843-05-6,15797.0,O=C(c1ccc(cc1O)OCCCCCCCC)c2ccccc2
NCGC00255155-01,tox21-er-bla-agonist-p2,"1,1-Bis(3,4-dimethylphenyl)ethane",activity,inactive,1742-14-9,74448.0,Cc1ccc(cc1C)C(C)c2ccc(C)c(C)c2
NCGC00255183-01,tox21-er-bla-agonist-p2,Polypropylene glycol,activity,inactive,25322-69-4,1030.0,CC(O)CO
NCGC00254812-01,tox21-er-bla-agonist-p2,"Myristyltrimethylammonium chlorideN,N,N-Trimethyltetradecan-1-aminium chloride",activity,inactive,4574-04-3,20708.0,[Cl-].C[N+](C)(C)CCCCCCCCCCCCCC
NCGC00259322-01,tox21-er-bla-agonist-p2,Hexachloroacetone,activity,inactive,116-16-5,8303.0,ClC(Cl)(Cl)C(=O)C(Cl)(Cl)Cl
NCGC00015827-06,tox21-er-bla-agonist-p2,Pentylenetetrazol,activity,inactive,54-95-5,5917.0,C1CCCc2nnnn2C1
NCGC00256745-01,tox21-er-bla-agonist-p2,"1,1,1,2,2,3,3,4,4-Nonafluoro-6-iodohexane",activity,inactive,2043-55-2,74887.0,FC(F)(C(F)(F)CCI)C(F)(F)C(F)(F)F
NCGC00258952-01,tox21-er-bla-agonist-p2,Isophorone diamine,activity,inactive,2855-13-2,17857.0,NCC1(C)CC(C)(C)CC(N)C1
NCGC00017257-09,tox21-er-bla-agonist-p2,Metergoline,activity,inactive,17692-51-2,28693.0,O=C(OCc1ccccc1)NC[C@@H]3C[C@@H]4c5cccc2c5c(cn2C)C[C@H]4N(C)C3
NCGC00255441-01,tox21-er-bla-agonist-p2,Ethiofencarb,activity,inactive,29973-13-5,34766.0,O=C(Oc1ccccc1CSCC)NC
NCGC00258311-01,tox21-er-bla-agonist-p2,4-(Dimethylamino)azobenzene,activity,inactive,60-11-7,6053.0,CN(C)c2ccc(/N=N/c1ccccc1)cc2
NCGC00256917-01,tox21-er-bla-agonist-p2,Ethylene acrylate,activity,active agonist,2274-11-5,75282.0,O=C(C=C)OCCOC(=O)C=C
NCGC00258358-01,tox21-er-bla-agonist-p2,alpha-Hydroxybenzeneacetonitrile,activity,inactive,532-28-5,10758.0,OC(C#N)c1ccccc1
NCGC00257550-01,tox21-er-bla-agonist-p2,N-(3-Chloro-4-methylphenyl)acetamide,activity,inactive,7149-79-3,23537.0,Cc1ccc(NC(C)=O)cc1Cl
NCGC00256752-01,tox21-er-bla-agonist-p2,Geranic acid,activity,inactive,459-80-3,9989.0,O=C(O)C=C(C)CC\C=C(/C)C
NCGC00256163-01,tox21-er-bla-agonist-p2,3-Methylbutyl 3-methylbutanoate,activity,inactive,659-70-1,12613.0,CC(C)CCOC(=O)CC(C)C
NCGC00256828-01,tox21-er-bla-agonist-p2,6-(1-Methylethyl)quinoline,activity,inactive,135-79-5,67285.0,CC(C)c1ccc2ncccc2c1
NCGC00255885-01,tox21-er-bla-agonist-p2,Tetrabutylammonium bromide,activity,inactive,1643-19-2,74236.0,[Br-].CCCC[N+](CCCC)(CCCC)CCCC
NCGC00257044-01,tox21-er-bla-agonist-p2,3-(Trifluoromethyl)aniline,activity,inactive,98-16-8,7375.0,FC(F)(F)c1cc(N)ccc1
NCGC00258167-01,tox21-er-bla-agonist-p2,1-Hexylpyridinium hexafluorophosphate,activity,inactive,797789-00-5,2734177.0,F[P-](F)(F)(F)(F)F.CCCCCC[n+]1ccccc1
NCGC00258210-01,tox21-er-bla-agonist-p2,Ethylene glycol diethyl ether,activity,inactive,629-14-1,12375.0,CCOCCOCC
NCGC00258134-01,tox21-er-bla-agonist-p2,Dimethylammonium nitrate,activity,inactive,30781-73-8,13379149.0,CNC.[O-][N+](=O)O
NCGC00258511-01,tox21-er-bla-agonist-p2,1-Methyl-3-phenoxybenzene,activity,inactive,3586-14-9,19165.0,Cc2cc(Oc1ccccc1)ccc2
NCGC00258936-01,tox21-er-bla-agonist-p2,Rifampicin,activity,inactive,13292-46-1,5458213.0,CN1CCN(CC1)/N=C/c3c2NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO[C@@]5(C)Oc4c(C)c(O)c(c2O)c(c3O)c4C5=O
NCGC00258544-01,tox21-er-bla-agonist-p2,Diaminomaleonitrile,activity,inactive,1187-42-4,2723951.0,N#CC(\N)=C(\N)C#N
NCGC00258552-01,tox21-er-bla-agonist-p2,"1,2-Benzenedicarbonitrile",activity,inactive,91-15-6,7042.0,N#Cc1ccccc1C#N
NCGC00258580-01,tox21-er-bla-agonist-p2,3-Aminobenzenesulfonic acid,activity,inactive,121-47-1,8474.0,Nc1cc(ccc1)S(O)(=O)=O
NCGC00258021-01,tox21-er-bla-agonist-p2,"5,5'-[Propane-2,2-diylbis(benzene-4,1-diyloxy)]bis(2-benzofuran-1,3-dione)",activity,inactive,38103-06-9,94483.0,O=C1OC(=O)c2ccc(cc12)Oc3ccc(cc3)C(C)(C)c4ccc(cc4)Oc5ccc6C(=O)OC(=O)c6c5
NCGC00259796-01,tox21-er-bla-agonist-p2,Ethyl 3-phenylglycidate,activity,inactive,121-39-1,8469.0,CCOC(=O)C2OC2c1ccccc1
NCGC00259664-01,tox21-er-bla-agonist-p2,"3,4-Dichloroaniline",activity,inactive,95-76-1,7257.0,Nc1cc(Cl)c(Cl)cc1
NCGC00259882-01,tox21-er-bla-agonist-p2,"2',3'-Dideoxyinosine",activity,inactive,69655-05-6,50599.0,O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1
NCGC00259683-01,tox21-er-bla-agonist-p2,2-Bromobenzothiazole,activity,inactive,2516-40-7,612040.0,Brc1nc2ccccc2s1
NCGC00259478-01,tox21-er-bla-agonist-p2,2-Methylpropanenitrile,activity,inactive,78-82-0,6559.0,CC(C)C#N
NCGC00260064-01,tox21-er-bla-agonist-p2,Gallic acid,activity,inactive,149-91-7,370.0,Oc1cc(cc(O)c1O)C(=O)O
NCGC00259122-01,tox21-er-bla-agonist-p2,Isobutyl isobutyrate,activity,inactive,97-85-8,7351.0,CC(C)C(=O)OCC(C)C
NCGC00260299-01,tox21-er-bla-agonist-p2,"Acetic acid, mercapto-, monoammonium salt",activity,inactive,5421-46-5,21534.0,[NH4+].[O-]C(=O)CS
NCGC00260216-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpiperidinium iodide,activity,inactive,37971-78-1,60196384.0,[I-].C[N+]1(CCCC)CCCCC1
NCGC00260547-01,tox21-er-bla-agonist-p2,1-(1-Naphthyl)-2-thiourea,activity,inactive,86-88-4,736366.0,NC(=S)Nc2cccc1ccccc12
NCGC00015204-05,tox21-er-bla-agonist-p2,Carmustine,activity,inactive,154-93-8,2578.0,O=C(NCCCl)N(CCCl)N=O
NCGC00015243-02,tox21-er-bla-agonist-p2,Clemizole hydrochloride,activity,inactive,1163-36-6,5309446.0,Cl.Clc1ccc(cc1)Cn3c4ccccc4nc3CN2CCCC2
NCGC00013287-06,tox21-er-bla-agonist-p2,Carzenide,activity,inactive,138-41-0,8739.0,O=S(N)(=O)c1ccc(cc1)C(=O)O
NCGC00016059-05,tox21-er-bla-agonist-p2,Thioridazine,activity,inactive,50-52-2,5452.0,CN4CCCCC4CCN1c3ccccc3Sc2ccc(SC)cc12
NCGC00016344-03,tox21-er-bla-agonist-p2,5-Aminosalicylic acid,activity,inactive,89-57-6,4075.0,OC(=O)c1cc(N)ccc1O
NCGC00016411-01,tox21-er-bla-agonist-p2,Butacaine,activity,inactive,149-16-6,2480.0,Nc1ccc(cc1)C(=O)OCCCN(CCCC)CCCC
NCGC00016011-08,tox21-er-bla-agonist-p2,Tyramine,activity,inactive,51-67-2,5610.0,Oc1ccc(CCN)cc1
NCGC00091367-01,tox21-er-bla-agonist-p2,Danthron,activity,inactive,117-10-2,2950.0,Oc3cccc2C(=O)c1cccc(O)c1C(=O)c23
NCGC00017089-01,tox21-er-bla-agonist-p2,Monensin sodium,activity,inactive,22373-78-0,23667299.0,[Na+].OC[C@]1(O)O[C@@H]([C@@H](C)C[C@H]1C)[C@H]2C[C@H](C)[C@@H](O2)[C@]3(CC)CC[C@@H](O3)[C@]5(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@H](O4)[C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O5
NCGC00182711-01,tox21-er-bla-agonist-p2,Picosulfate sodium,activity,inactive,10040-45-6,68654.0,[Na+].[Na+].[O-]S(=O)(=O)Oc1ccc(cc1)C(c2ccc(OS([O-])(=O)=O)cc2)c3ccccn3
NCGC00255609-01,tox21-er-bla-agonist-p2,Chlorfenethol,activity,inactive,80-06-8,6624.0,OC(C)(c1ccc(Cl)cc1)c2ccc(Cl)cc2
NCGC00255783-01,tox21-er-bla-agonist-p2,"6H-Dibenzo[c,e][1,2]oxaphosphinine 6-oxide",activity,inactive,35948-25-5,6328250.0,O=P2Oc3ccccc3c1ccccc12
NCGC00256019-01,tox21-er-bla-agonist-p2,4-[2-(Acryloyloxy)ethoxy]-4-oxobutanoic acid,activity,inactive,50940-49-3,175956.0,O=C(CCC(=O)O)OCCOC(=O)C=C
NCGC00255418-01,tox21-er-bla-agonist-p2,Kinetin,activity,inactive,525-79-1,3830.0,N1C=NC3=NC=NC3=C1NCc2ccco2
NCGC00256253-01,tox21-er-bla-agonist-p2,Tribenzylamine,activity,inactive,620-40-6,24321.0,C(N(Cc1ccccc1)Cc2ccccc2)c3ccccc3
NCGC00255559-01,tox21-er-bla-agonist-p2,Bran,activity,inactive,68916-76-7,,
NCGC00254470-01,tox21-er-bla-agonist-p2,PFDA,activity,inactive,335-76-2,9555.0,FC(F)(C(F)(F)C(=O)O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254389-01,tox21-er-bla-agonist-p2,Hexanedioic acid,activity,inactive,124-04-9,196.0,OC(=O)CCCCC(=O)O
NCGC00255379-01,tox21-er-bla-agonist-p2,"5-(5-Nitro-2-furyl)-1,3,4-oxadiazole-2-ol",activity,inactive,2122-86-3,16463.0,Oc1nnc(o1)c2oc(cc2)[N+]([O-])=O
NCGC00254208-01,tox21-er-bla-agonist-p2,Fandosentan potassium salt,activity,inactive,221246-12-4,23674746.0,[K+].FC(F)(F)c5ccccc5N2C(=C(c1ccccc1S2(=O)=O)c3cc(CC)c4OCOc4c3)C([O-])=O
NCGC00016000-13,tox21-er-bla-agonist-p2,Disulfiram,activity,inactive,97-77-8,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC
NCGC00016334-01,tox21-er-bla-agonist-p2,meso-Hexestrol,activity,active agonist,84-16-2,192197.0,Oc1ccc(cc1)[C@@H](CC)[C@@H](CC)c2ccc(O)cc2
NCGC00016754-01,tox21-er-bla-agonist-p2,Spectinomycin dihydrochloride,activity,inactive,21736-83-4,64740.0,Cl.Cl.C[C@H]1O[C@H]2O[C@@H]3[C@@H](O)[C@H](NC)[C@H](O)[C@H](NC)[C@H]3O[C@@]2(O)C(=O)C1
NCGC00073294-02,tox21-er-bla-agonist-p2,Quinocide,activity,inactive,525-61-1,68928.0,CC(N)CCCNc1cc(cc2cccnc12)OC
NCGC00090750-04,tox21-er-bla-agonist-p2,"4,4'-Dichlorodiphenyl sulfone",activity,inactive,80-07-9,6625.0,O=S(=O)(c1ccc(Cl)cc1)c2ccc(Cl)cc2
NCGC00091228-01,tox21-er-bla-agonist-p2,Glyoxal,activity,inactive,107-22-2,7860.0,O=CC=O
NCGC00093759-01,tox21-er-bla-agonist-p2,Aptiganel hydrochloride,activity,inactive,137160-11-3,60839.0,Cl.CN(C(=N)Nc2cccc1ccccc12)c3cc(CC)ccc3
NCGC00094925-01,tox21-er-bla-agonist-p2,Estradiol acetate,activity,active agonist,4245-41-4,9818306.0,CC(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3
NCGC00094935-01,tox21-er-bla-agonist-p2,Acetyl-L-leucine,activity,inactive,1188-21-2,70912.0,O=C(C)N[C@@H](CC(C)C)C(=O)O
NCGC00254011-01,tox21-er-bla-agonist-p2,Zamifenacin,activity,inactive,127308-82-1,3086618.0,c1cc(cc2OCOc12)CCN5CCC[C@@H](OC(c3ccccc3)c4ccccc4)C5
NCGC00016872-06,tox21-er-bla-agonist-p2,Ticlopidine,activity,active agonist,55142-85-3,5472.0,Clc3ccccc3CN1CCc2sccc2C1
NCGC00159430-03,tox21-er-bla-agonist-p2,Hexobarbital,activity,inactive,56-29-1,3608.0,CC1(C(=O)N=C(O)N(C)C1=O)C2=CCCCC2
NCGC00160443-01,tox21-er-bla-agonist-p2,Nifenalol,activity,inactive,7413-36-7,6317.0,O=[N+]([O-])c1ccc(cc1)C(O)CNC(C)C
NCGC00181916-01,tox21-er-bla-agonist-p2,Sulfaethoxypyridazine,activity,inactive,963-14-4,13755.0,O=S(=O)(Nc1ccc(OCC)nn1)c2ccc(N)cc2
NCGC00185754-01,tox21-er-bla-agonist-p2,Terlipressin,activity,inactive,14636-12-5,72081.0,NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]3CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N3
NCGC00242596-01,tox21-er-bla-agonist-p2,Pralatrexate,activity,inactive,146464-95-1,148121.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)C(CC#C)Cc2nc3c(nc2)nc(N)nc3N
NCGC00090767-02,tox21-er-bla-agonist-p2,alpha-Cyclodextrin,activity,inactive,10016-20-3,444913.0,O[C@@H]2[C@@H](O)[C@@H]1O[C@H]7O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O[C@H]2O[C@@H]1CO)[C@H](O)[C@H]3O)[C@H](O)[C@H]4O)[C@H](O)[C@H]5O)[C@H](O)[C@H]6O)[C@H](O)[C@H]7O
NCGC00090770-05,tox21-er-bla-agonist-p2,5-Bromo-2'-deoxyuridine,activity,inactive,59-14-3,6035.0,BrC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00016964-02,tox21-er-bla-agonist-p2,Lomefloxacin hydrochloride,activity,inactive,98079-52-8,68624.0,Cl.O=C(O)C2=CN(CC)c1c(F)c(c(F)cc1C2=O)N3CC(C)NCC3
NCGC00017119-01,tox21-er-bla-agonist-p2,Metoprolol tartrate,activity,inactive,56392-17-7,441308.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC
NCGC00017142-01,tox21-er-bla-agonist-p2,Clofilium tosylate,activity,inactive,92953-10-1,175533.0,Clc1ccc(CCCC[N+](CC)(CC)CCCCCCC)cc1.[O-]S(=O)(=O)c1ccc(C)cc1
NCGC00017148-01,tox21-er-bla-agonist-p2,Verteporfin,activity,inactive,129497-78-5,9940086.0,O=C(OC)CCc6c(C)c1nc6cc5nc(cc4nc(cc2nc(c1)C(C=C)=C2C)C3=CC=C([C@@H](C(=O)OC)[C@]34C)C(=O)OC)C(C)=C5CCC(=O)O
NCGC00018098-04,tox21-er-bla-agonist-p2,Iodoquinol,activity,inactive,83-73-8,3728.0,Oc1c(I)cc(I)c2cccnc12
NCGC00018249-04,tox21-er-bla-agonist-p2,Ethoxzolamide,activity,inactive,452-35-7,3295.0,NS(=O)(=O)c1nc2ccc(cc2s1)OCC
NCGC00018251-03,tox21-er-bla-agonist-p2,Methyl aminolevulinate hydrochloride,activity,inactive,79416-27-6,157921.0,Cl.O=C(CN)CCC(=O)OC
NCGC00025098-01,tox21-er-bla-agonist-p2,Loreclezole hydrochloride,activity,inactive,NOCAS_45676,45073437.0,Cl.Cl\C(=C/n1cncn1)c2ccc(Cl)cc2Cl
NCGC00016903-01,tox21-er-bla-agonist-p2,Terazosin hydrochloride,activity,inactive,63074-08-8,44383.0,Cl.O=C(N1CCN(CC1)c3nc2cc(OC)c(OC)cc2c(N)n3)C4CCCO4
NCGC00258590-01,tox21-er-bla-agonist-p2,Butyl ether,activity,inactive,142-96-1,8909.0,CCCCOCCCC
NCGC00257034-01,tox21-er-bla-agonist-p2,2-Butoxyethyl acetate,activity,inactive,112-07-2,8160.0,O=C(C)OCCOCCCC
NCGC00257106-01,tox21-er-bla-agonist-p2,2-Methyl-5-nitrobenzenesulfonic acid,activity,inactive,121-03-9,8458.0,Cc1ccc(cc1S(O)(=O)=O)[N+]([O-])=O
NCGC00257837-01,tox21-er-bla-agonist-p2,N-Nitrosodiethanolamine,activity,inactive,1116-54-7,14223.0,OCCN(N=O)CCO
NCGC00258001-01,tox21-er-bla-agonist-p2,Methyl 2-hydroxypropanoate,activity,inactive,547-64-8,11040.0,CC(O)C(=O)OC
NCGC00258117-01,tox21-er-bla-agonist-p2,D-Tagatose,activity,inactive,87-81-0,2724552.0,O[C@H]1[C@@H](O)[C@H](O)CO[C@@]1(O)CO
NCGC00255709-01,tox21-er-bla-agonist-p2,"1,3-Dipropan-2-ylurea",activity,inactive,4128-37-4,20084.0,CC(C)NC(=O)NC(C)C
NCGC00256537-01,tox21-er-bla-agonist-p2,Nicotinic acid,activity,inactive,59-67-6,938.0,O=C(O)c1cccnc1
NCGC00256538-01,tox21-er-bla-agonist-p2,Isosafrole,activity,inactive,120-58-1,8439.0,CC=Cc1ccc2OCOc2c1
NCGC00255786-01,tox21-er-bla-agonist-p2,Glyoxime,activity,inactive,557-30-2,5354753.0,ON=CC=NO
NCGC00255830-01,tox21-er-bla-agonist-p2,Dimethylglyoxime,activity,inactive,95-45-4,5356010.0,C/C(=N\O)C(\C)=N\O
NCGC00255836-01,tox21-er-bla-agonist-p2,Pyrinuron,activity,inactive,53558-25-1,40813.0,[O-][N+](=O)c1ccc(cc1)NC(=O)NCc2cccnc2
NCGC00255909-01,tox21-er-bla-agonist-p2,Heptyl butanoate,activity,inactive,5870-93-9,62592.0,CCCCCCCOC(=O)CCC
NCGC00255954-01,tox21-er-bla-agonist-p2,1-Phenylpropan-1-one,activity,inactive,93-55-0,7148.0,O=C(CC)c1ccccc1
NCGC00256182-01,tox21-er-bla-agonist-p2,"2,4-Dichloro-1-(chloromethyl)benzene",activity,inactive,94-99-5,7212.0,ClCc1ccc(Cl)cc1Cl
NCGC00256218-01,tox21-er-bla-agonist-p2,"(2,4,6-Trioxo-1,3,5-triazinane-1,3,5-triyl)triethane-2,1-diyl trisprop-2-enoate",activity,active agonist,40220-08-4,170286.0,C=CC(=O)OCCN1C(=O)N(CCOC(=O)C=C)C(=O)N(CCOC(=O)C=C)C1=O
NCGC00256246-01,tox21-er-bla-agonist-p2,Propan-2-yl 2-ethylhexanoate,activity,inactive,67024-46-8,106701.0,CC(C)OC(=O)C(CCCC)CC
NCGC00256295-01,tox21-er-bla-agonist-p2,2-tert-Butylcyclohexanol,activity,inactive,13491-79-7,26068.0,CC(C)(C)C1CCCCC1O
NCGC00256333-01,tox21-er-bla-agonist-p2,"2,4-Diaminophenol dihydrochloride",activity,inactive,137-09-7,8715.0,Cl.Cl.Nc1ccc(O)c(N)c1
NCGC00258846-01,tox21-er-bla-agonist-p2,Ethylene thiourea,activity,inactive,96-45-7,2723650.0,S=C1NCCN1
NCGC00258883-01,tox21-er-bla-agonist-p2,Sulfanilamide,activity,inactive,63-74-1,5333.0,Nc1ccc(cc1)S(=O)(N)=O
NCGC00259072-01,tox21-er-bla-agonist-p2,"2,4-Dichloroaniline",activity,inactive,554-00-7,11123.0,Clc1cc(Cl)c(N)cc1
NCGC00259086-01,tox21-er-bla-agonist-p2,Malic acid,activity,inactive,6915-15-7,525.0,O=C(O)C(O)CC(=O)O
NCGC00259397-01,tox21-er-bla-agonist-p2,Busulfan,activity,inactive,55-98-1,2478.0,O=S(C)(=O)OCCCCOS(C)(=O)=O
NCGC00259475-01,tox21-er-bla-agonist-p2,Phenacetin,activity,inactive,62-44-2,4754.0,CCOc1ccc(cc1)NC(C)=O
NCGC00260267-01,tox21-er-bla-agonist-p2,1-Bromohexane,activity,inactive,111-25-1,8101.0,BrCCCCCC
NCGC00260354-01,tox21-er-bla-agonist-p2,Oxazolone,activity,inactive,15646-46-5,1712094.0,O=C1OC(=N/C1=C\OCC)c2ccccc2
NCGC00256406-01,tox21-er-bla-agonist-p2,4'-(Chloroacetyl)acetanilide,activity,inactive,140-49-8,8805.0,O=C(C)Nc1ccc(cc1)C(=O)CCl
NCGC00255122-01,tox21-er-bla-agonist-p2,Atenolol,activity,inactive,29122-68-7,2249.0,CC(C)NCC(O)COc1ccc(cc1)CC(N)=O
NCGC00255331-01,tox21-er-bla-agonist-p2,FD&C Green No. 3,activity,inactive,2353-45-9,16887.0,[Na+].[Na+].CC/[N+](Cc1cccc(c1)S([O-])(=O)=O)=C2\C=C/C(C=C2)=C(\c3ccc(cc3)N(Cc4cccc(c4)S([O-])(=O)=O)CC)c5ccc(O)cc5S([O-])(=O)=O
NCGC00255574-01,tox21-er-bla-agonist-p2,Imidazolidinyl urea,activity,inactive,39236-46-9,38258.0,OCN2C(=O)NC(=O)C2NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO
NCGC00255576-01,tox21-er-bla-agonist-p2,Decyl beta-D-glucopyranoside,activity,inactive,58846-77-8,62142.0,OC[C@H]1O[C@@H](OCCCCCCCCCC)[C@H](O)[C@@H](O)[C@@H]1O
NCGC00255893-01,tox21-er-bla-agonist-p2,Metobromuron,activity,inactive,3060-89-7,18290.0,Brc1ccc(NC(=O)N(C)OC)cc1
NCGC00256022-01,tox21-er-bla-agonist-p2,Ethyl octyl sulfide,activity,inactive,3698-94-0,77288.0,CCCCCCCCSCC
NCGC00254517-01,tox21-er-bla-agonist-p2,Dimethyl succinate,activity,inactive,106-65-0,7820.0,COC(=O)CCC(=O)OC
NCGC00091146-04,tox21-er-bla-agonist-p2,Phenothiazine,activity,inactive,92-84-2,7108.0,c1ccc2Sc3ccccc3Nc2c1
NCGC00091888-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexyl salicylate",activity,inactive,118-56-9,8362.0,O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O
NCGC00166299-01,tox21-er-bla-agonist-p2,Bismuth subsalicylate,activity,inactive,14882-18-9,16682734.0,O[Bi]2Oc1ccccc1C(=O)O2
NCGC00167450-01,tox21-er-bla-agonist-p2,Trilostane,activity,inactive,13647-35-3,656583.0,N#CC=2C[C@]4(C)[C@H]5CC[C@]1(C)[C@@H](O)CC[C@H]1[C@@H]5CC[C@@]34O[C@@H]3C=2O
NCGC00094646-01,tox21-er-bla-agonist-p2,Dibenzothiophene,activity,inactive,132-65-0,3023.0,c1cccc2sc3ccccc3c12
NCGC00094707-01,tox21-er-bla-agonist-p2,Lactulose,activity,inactive,4618-18-2,11333.0,O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@]2(O)CO
NCGC00164497-01,tox21-er-bla-agonist-p2,Glyoctamide,activity,inactive,1038-59-1,13953.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCCCC2
NCGC00164515-01,tox21-er-bla-agonist-p2,Sulfonmethane,activity,inactive,115-24-2,8262.0,CC(C)(S(=O)(=O)CC)S(=O)(=O)CC
NCGC00164518-01,tox21-er-bla-agonist-p2,Sulfonethylmethane,activity,inactive,76-20-0,6433.0,O=S(=O)(CC)C(C)(CC)S(=O)(=O)CC
NCGC00160412-01,tox21-er-bla-agonist-p2,Indocate,activity,inactive,31386-25-1,65776.0,CN(C)CCOC(=O)c1cc3c(cc1)n(Cc2ccccc2)c(C)c3C
NCGC00167475-01,tox21-er-bla-agonist-p2,Diethylpropion hydrochloride,activity,inactive,134-80-5,91442.0,Cl.O=C(C(C)N(CC)CC)c1ccccc1
NCGC00095139-01,tox21-er-bla-agonist-p2,Valsartan,activity,inactive,137862-53-4,5284633.0,O=C(O)[C@@H](C(C)C)N(Cc1ccc(cc1)c2ccccc2c3nnnn3)C(=O)CCCC
NCGC00095147-01,tox21-er-bla-agonist-p2,Troxerutin,activity,inactive,7085-55-4,5486699.0,OCCOc1ccc(cc1OCCO)C=4Oc5cc(OCCO)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O
NCGC00095153-01,tox21-er-bla-agonist-p2,Trandolapril,activity,inactive,87679-37-6,5484727.0,O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@H]3CCCC[C@H]23)C(=O)O
NCGC00160480-01,tox21-er-bla-agonist-p2,Pecazine,activity,inactive,60-89-9,6075.0,CN1CCCC(C1)CN2c4ccccc4Sc3ccccc23
NCGC00160543-01,tox21-er-bla-agonist-p2,Pregnandiol,activity,active agonist,80-92-2,12358742.0,CC(O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@@H]2C[C@@H](O)CC[C@]12C
NCGC00164630-01,tox21-er-bla-agonist-p2,Penciclovir,activity,inactive,39809-25-1,4725.0,OCC(CO)CCn2cnc1c2NC(N)=NC1=O
NCGC00167519-01,tox21-er-bla-agonist-p2,Ramatroban,activity,inactive,116649-85-5,123879.0,Fc1ccc(cc1)S(=O)(=O)N[C@H]3Cc4c2ccccc2n(CCC(=O)O)c4CC3
NCGC00095942-01,tox21-er-bla-agonist-p2,Mevastatin,activity,inactive,73573-88-3,64715.0,C[C@@H](CC)C(=O)O[C@H]2CCC=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23
NCGC00095992-01,tox21-er-bla-agonist-p2,Gramicidin S,activity,inactive,113-73-5,73357.0,CC(C)C[C@@H]5NC(=O)[C@H](CCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@@H](NC(=O)[C@@H]3CCCN3C(=O)[C@@H](Cc4ccccc4)NC5=O)C(C)C)C(C)C
NCGC00160616-01,tox21-er-bla-agonist-p2,Protirelin,activity,inactive,24305-27-9,638678.0,O=C(N)[C@@H]3CCCN3C(=O)[C@H](Cc1cncn1)NC(=O)[C@@H]2CCC(=O)N2
NCGC00166080-01,tox21-er-bla-agonist-p2,N-Acetyl-L-glutamic acid,activity,inactive,1188-37-0,70914.0,O=C(C)N[C@@H](CCC(=O)O)C(=O)O
NCGC00160643-01,tox21-er-bla-agonist-p2,Piperoxan,activity,inactive,59-39-2,6040.0,c1ccc2OC(COc2c1)CN3CCCCC3
NCGC00183281-01,tox21-er-bla-agonist-p2,Pentanoic acid,activity,inactive,109-52-4,7991.0,CCCCC(=O)O
NCGC00254987-01,tox21-er-bla-agonist-p2,2-Butanethiol,activity,inactive,513-53-1,10560.0,CC(S)CC
NCGC00247341-02,tox21-er-bla-agonist-p2,Premethadone,activity,inactive,125-79-1,31331.0,CN(C)C(C)CC(C#N)(c1ccccc1)c2ccccc2
NCGC00255358-01,tox21-er-bla-agonist-p2,Kinoprene,activity,inactive,42588-37-4,6434236.0,C\C(=C/C(=O)OCC#C)\C=C\CC(C)CCCC(C)C
NCGC00247696-01,tox21-er-bla-agonist-p2,N-Phenyl-N-[1-(2-thienyl)methyl-4-piperidyl]propanamide hydrochloride,activity,inactive,117332-93-1,46783063.0,Cl.CCC(=O)N(c1ccccc1)C3CCN(Cc2cccs2)CC3
NCGC00247724-01,tox21-er-bla-agonist-p2,Bufotenine,activity,inactive,487-93-4,10257.0,CN(C)CCc2cnc1ccc(O)cc12
NCGC00253964-01,tox21-er-bla-agonist-p2,Dimethyl glutarate,activity,inactive,1119-40-0,14242.0,O=C(CCCC(=O)OC)OC
NCGC00255202-01,tox21-er-bla-agonist-p2,2-Hydrazino-4-(4-aminophenyl) thiazole,activity,inactive,26049-71-8,93098.0,NNc1nc(cs1)c2ccc(N)cc2
NCGC00255311-01,tox21-er-bla-agonist-p2,"Phosphonic acid, [[bis(2-hydroxyethyl)amino]methyl]-, diethyl ester",activity,inactive,2781-11-5,17722.0,O=P(CN(CCO)CCO)(OCC)OCC
NCGC00254090-01,tox21-er-bla-agonist-p2,MK-968,activity,inactive,NOCAS_47334,24809526.0,Fc1ccccc1[C@@H](F)CO[C@H]2CC[C@@H](CC2)NC=3NC=NC4=NN=CC=34
NCGC00183051-01,tox21-er-bla-agonist-p2,Cholin acetate,activity,inactive,14586-35-7,11643980.0,O=C([O-])C.C[N+](C)(C)CCO
NCGC00016352-01,tox21-er-bla-agonist-p2,Benzocaine,activity,inactive,94-09-7,2337.0,Nc1ccc(cc1)C(=O)OCC
NCGC00257865-01,tox21-er-bla-agonist-p2,Decyl methacrylate,activity,inactive,3179-47-3,18510.0,C=C(C)C(=O)OCCCCCCCCCC
NCGC00259805-01,tox21-er-bla-agonist-p2,"3,3-Dimethyl-1-butene",activity,inactive,558-37-2,11210.0,C=CC(C)(C)C
NCGC00258508-01,tox21-er-bla-agonist-p2,"1,1,1-Trimethoxyethane",activity,inactive,1445-45-0,15050.0,CC(OC)(OC)OC
NCGC00260409-01,tox21-er-bla-agonist-p2,"2,6-Dichlorobenzenesulfonylchloride",activity,inactive,6579-54-0,522183.0,O=S(Cl)(=O)c1c(Cl)cccc1Cl
NCGC00260461-01,tox21-er-bla-agonist-p2,2-Fluorophenol,activity,inactive,367-12-4,9707.0,Fc1ccccc1O
NCGC00256725-01,tox21-er-bla-agonist-p2,"(1R,5R)-3,3,5-trimethylcyclohexanol",activity,inactive,933-48-2,1550823.0,CC1(C)C[C@@H](C)C[C@@H](O)C1
NCGC00016792-01,tox21-er-bla-agonist-p2,Kanamycin A sulfate,activity,inactive,25389-94-0,441374.0,O=S(=O)(O)O.O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00259424-01,tox21-er-bla-agonist-p2,Fluometuron,activity,inactive,2164-17-2,16562.0,O=C(Nc1cc(ccc1)C(F)(F)F)N(C)C
NCGC00259649-01,tox21-er-bla-agonist-p2,Phosphamidon,activity,inactive,13171-21-6,25750.0,COP(=O)(OC)OC(C)=C(Cl)C(=O)N(CC)CC
NCGC00255549-01,tox21-er-bla-agonist-p2,"Ethanol, 2,2'-((1-methylethylidene)bis((2,6-dibromo-4,1-phenylene)oxy))bis-",activity,inactive,4162-45-2,20113.0,Brc1cc(cc(Br)c1OCCO)C(C)(C)c2cc(Br)c(OCCO)c(Br)c2
NCGC00255773-01,tox21-er-bla-agonist-p2,N-Methylhydrazinecarbothioamide,activity,inactive,6610-29-3,2723853.0,CNC(=S)NN
NCGC00257680-01,tox21-er-bla-agonist-p2,"2,4-Dinitroaniline",activity,inactive,97-02-9,7321.0,O=[N+]([O-])c1cc(ccc1N)[N+]([O-])=O
NCGC00256612-01,tox21-er-bla-agonist-p2,Phenyl salicylate,activity,inactive,118-55-8,8361.0,Oc2ccccc2C(=O)Oc1ccccc1
NCGC00257077-01,tox21-er-bla-agonist-p2,2-Naphthalenol,activity,active agonist,135-19-3,8663.0,Oc1ccc2ccccc2c1
NCGC00257317-01,tox21-er-bla-agonist-p2,"2,4,4'-Trihydroxybenzophenone",activity,active agonist,1470-79-7,73852.0,O=C(c1ccc(O)cc1O)c2ccc(O)cc2
NCGC00257388-01,tox21-er-bla-agonist-p2,N-Butylpyridinium chloride,activity,inactive,1124-64-7,2734171.0,[Cl-].CCCC[n+]1ccccc1
NCGC00260111-01,tox21-er-bla-agonist-p2,"O,O-Dimethyl chlorothiophosphate",activity,inactive,2524-03-0,17304.0,ClP(=S)(OC)OC
NCGC00256554-01,tox21-er-bla-agonist-p2,Propranolol hydrochloride,activity,inactive,318-98-9,62882.0,Cl.CC(C)NCC(O)COc2cccc1ccccc12
NCGC00256613-01,tox21-er-bla-agonist-p2,4-Methylpyridine,activity,inactive,108-89-4,7963.0,Cc1ccncc1
NCGC00255454-01,tox21-er-bla-agonist-p2,Triazophos,activity,inactive,24017-47-8,32184.0,CCOP(=S)(OCC)Oc1ncn(n1)c2ccccc2
NCGC00255474-01,tox21-er-bla-agonist-p2,"N-(2,4-Dimethylphenyl)formamide",activity,inactive,60397-77-5,92363.0,O=CNc1ccc(C)cc1C
NCGC00255554-01,tox21-er-bla-agonist-p2,Cloquintocet-mexyl,activity,inactive,99607-70-2,93528.0,CC(CCCCC)OC(=O)COc1ccc(Cl)c2cccnc12
NCGC00256805-01,tox21-er-bla-agonist-p2,"N,N-Bis(2-hydroxyethyl)formamide",activity,inactive,25209-66-9,91333.0,O=CN(CCO)CCO
NCGC00256452-01,tox21-er-bla-agonist-p2,"o,p'-DDD",activity,active agonist,53-19-0,4211.0,Clc2ccccc2C(C(Cl)Cl)c1ccc(Cl)cc1
NCGC00256679-01,tox21-er-bla-agonist-p2,"3-Methylcyclohexane-1,2-dione",activity,inactive,3008-43-3,3321360.0,O=C1C(=O)CCCC1C
NCGC00257381-01,tox21-er-bla-agonist-p2,Ethyltriacetoxysilane,activity,inactive,17689-77-9,87244.0,O=C(C)O[Si](OC(C)=O)(OC(=O)C)CC
NCGC00257385-01,tox21-er-bla-agonist-p2,Dichlormid,activity,inactive,37764-25-3,37829.0,ClC(Cl)C(=O)N(CC=C)CC=C
NCGC00257393-01,tox21-er-bla-agonist-p2,Amitriptyline hydrochloride,activity,inactive,549-18-8,11065.0,Cl.CN(C)CC\C=C1\c3ccccc3CCc2ccccc12
NCGC00257615-01,tox21-er-bla-agonist-p2,Butyl 2-ethylhexyl phthalate,activity,inactive,85-69-8,6818.0,O=C(OCCCC)c1ccccc1C(=O)OCC(CC)CCCC
NCGC00257437-01,tox21-er-bla-agonist-p2,Tripropylene glycol,activity,inactive,24800-44-0,22833317.0,OC(OC(C)COC(O)CC)CC
NCGC00257446-01,tox21-er-bla-agonist-p2,FR145237,activity,inactive,146011-65-6,9850056.0,Fc5cc(F)cc(F)c5NC(=O)N(Cc1ccccc1)Cc3oc2ccc(C)cc2c3c4ccc(Cl)cc4
NCGC00257941-01,tox21-er-bla-agonist-p2,2-Methyl-4-nitroaniline,activity,inactive,99-52-5,7441.0,Cc1cc(ccc1N)[N+]([O-])=O
NCGC00258114-01,tox21-er-bla-agonist-p2,(5-Chloro-2-hydroxyphenyl)phenylmethanone,activity,active agonist,85-19-8,6799.0,Oc2ccc(Cl)cc2C(=O)c1ccccc1
NCGC00258927-01,tox21-er-bla-agonist-p2,Metolachlor,activity,inactive,51218-45-2,4169.0,ClCC(=O)N(C(C)COC)c1c(C)cccc1CC
NCGC00258526-01,tox21-er-bla-agonist-p2,"4,4'-Thiodiphenol",activity,active agonist,2664-63-3,17570.0,Oc1ccc(cc1)Sc2ccc(O)cc2
NCGC00259102-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) nonanedioate,activity,inactive,103-24-2,7642.0,O=C(CCCCCCCC(=O)OCC(CC)CCCC)OCC(CCCC)CC
NCGC00258600-01,tox21-er-bla-agonist-p2,2-Amino-4-chlorophenol,activity,inactive,95-85-2,7265.0,Nc1cc(Cl)ccc1O
NCGC00259288-01,tox21-er-bla-agonist-p2,3-(Trimethoxysilyl)propyl methacrylate,activity,inactive,2530-85-0,17318.0,CO[Si](CCCOC(=O)C(=C)C)(OC)OC
NCGC00259966-01,tox21-er-bla-agonist-p2,Resorcinol,activity,inactive,108-46-3,5054.0,Oc1cccc(O)c1
NCGC00259772-01,tox21-er-bla-agonist-p2,"1,3-Dimethyl-4-nitrobenzene",activity,inactive,89-87-2,6991.0,Cc1cc(C)ccc1[N+](=O)[O-]
NCGC00259853-01,tox21-er-bla-agonist-p2,Aniline hydrochloride,activity,inactive,142-04-1,8870.0,Cl.Nc1ccccc1
NCGC00259468-01,tox21-er-bla-agonist-p2,"(1R,2S,5R)-(-)-Menthol",activity,inactive,2216-51-5,16666.0,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
NCGC00260062-01,tox21-er-bla-agonist-p2,Ethyl acrylate,activity,inactive,140-88-5,8821.0,C=CC(=O)OCC
NCGC00259716-01,tox21-er-bla-agonist-p2,Dimethylnaphthalene,activity,inactive,28804-88-8,11317.0,Cc1c2ccccc2ccc1C
NCGC00260472-01,tox21-er-bla-agonist-p2,Maleimide,activity,inactive,541-59-3,10935.0,O=C1C=CC(=O)N1
NCGC00260508-01,tox21-er-bla-agonist-p2,10-Chloro-9-anthraldehyde,activity,active agonist,10527-16-9,82703.0,O=Cc2c1ccccc1c(Cl)c3ccccc23
NCGC00260290-01,tox21-er-bla-agonist-p2,"Hexanoic acid, 2-ethyl-, calcium salt",activity,inactive,136-51-6,61082.0,[Ca+2].[O-]C(=O)C(CC)CCCC.CCC(CCCC)C([O-])=O
NCGC00260331-01,tox21-er-bla-agonist-p2,Molybdenum trioxide,activity,inactive,1313-27-5,14802.0,O=[Mo](=O)=O
NCGC00013034-01,tox21-er-bla-agonist-p2,Estradiol cypionate,activity,active agonist,313-06-4,9403.0,Oc4cc5CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CCC3CCCC3)c5cc4
NCGC00015195-03,tox21-er-bla-agonist-p2,Clobenztropine,activity,inactive,5627-46-3,1687.0,CN4C1CCC4CC(C1)OC(c2ccccc2)c3ccc(Cl)cc3
NCGC00015793-03,tox21-er-bla-agonist-p2,Palmitoylethanolamide,activity,inactive,544-31-0,4671.0,O=C(CCCCCCCCCCCCCCC)NCCO
NCGC00016252-01,tox21-er-bla-agonist-p2,Sulfaguanidine,activity,inactive,57-67-0,5324.0,Nc1ccc(cc1)S(=O)(=O)NC(=N)N
NCGC00016561-01,tox21-er-bla-agonist-p2,Meticrane,activity,inactive,1084-65-7,4165.0,NS(=O)(=O)c2cc1c(CCCS1(=O)=O)cc2C
NCGC00016383-01,tox21-er-bla-agonist-p2,Trimethadione,activity,inactive,127-48-0,5576.0,CN1C(=O)OC(C)(C)C1=O
NCGC00016640-03,tox21-er-bla-agonist-p2,Todralazine hydrochloride,activity,inactive,3778-76-5,19604.0,Cl.O=C(OCC)NNc2nncc1ccccc12
NCGC00016711-01,tox21-er-bla-agonist-p2,Cloperastine hydrochloride,activity,inactive,14984-68-0,161104.0,Cl.Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3
NCGC00095133-01,tox21-er-bla-agonist-p2,Famciclovir,activity,inactive,104227-87-4,3324.0,CC(=O)OCC(COC(C)=O)CCn2cnc1cnc(N)nc12
NCGC00163674-01,tox21-er-bla-agonist-p2,Rifamycin SV sodium salt,activity,inactive,14897-39-3,23702994.0,[Na+].CC(=O)O[C@@H]4[C@H](C)[C@@H](OC)C=CO[C@@]3(C)Oc2c(C)c(O)c1c(O)c(cc([O-])c1c2C3=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]4C
NCGC00166170-01,tox21-er-bla-agonist-p2,Carbophenothion,activity,inactive,786-19-6,13081.0,Clc1ccc(SCSP(=S)(OCC)OCC)cc1
NCGC00181355-01,tox21-er-bla-agonist-p2,Carpronium chloride,activity,inactive,13254-33-6,25804.0,[Cl-].C[N+](C)(C)CCCC(=O)OC
NCGC00186467-01,tox21-er-bla-agonist-p2,"3,7-Bis(3,4-dimethoxyphenyl)tetrahydro-1H,5H-[1,2,4]triazolo[1,2-a][1,2,4]triazole-1,5-dithione",activity,inactive,907169-79-3,3003870.0,COc1ccc(cc1OC)C2NC(=S)N3C(NC(=S)N23)c4ccc(OC)c(OC)c4
NCGC00256118-01,tox21-er-bla-agonist-p2,2-Phenylmercaptoethanol,activity,inactive,699-12-7,69685.0,OCCSc1ccccc1
NCGC00254758-01,tox21-er-bla-agonist-p2,Thiodicarb,activity,inactive,59669-26-0,9601227.0,CN(SN(C)C(=O)O\N=C(/C)SC)C(=O)O\N=C(/C)SC
NCGC00255169-01,tox21-er-bla-agonist-p2,Thimerosal,activity,active agonist,54-64-8,16684434.0,[Na+].[O-]C(=O)c1ccccc1S[Hg]CC
NCGC00015397-02,tox21-er-bla-agonist-p2,Ethamivan,activity,inactive,304-84-7,9363.0,Oc1ccc(cc1OC)C(=O)N(CC)CC
NCGC00016830-01,tox21-er-bla-agonist-p2,Midecamycin,activity,inactive,35457-80-8,5282169.0,CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]3[C@@H](C)O[C@@H](O[C@@H]2[C@@H](OC)[C@H](OC(=O)CC)CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@@H]2CC=O)[C@H](O)[C@H]3N(C)C
NCGC00091830-04,tox21-er-bla-agonist-p2,Fenamiphos,activity,inactive,22224-92-6,31070.0,Cc1cc(ccc1SC)OP(=O)(NC(C)C)OCC
NCGC00164516-01,tox21-er-bla-agonist-p2,Eprobemide,activity,inactive,87940-60-1,65659.0,Clc1ccc(cc1)C(=O)NCCCN2CCOCC2
NCGC00165802-02,tox21-er-bla-agonist-p2,Ganaxolone,activity,inactive,38398-32-2,6918305.0,CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2C[C@](C)(O)CC[C@]12C
NCGC00166292-01,tox21-er-bla-agonist-p2,alpha-Fenchone,activity,inactive,1195-79-5,14525.0,CC2(C)C(=O)C1(C)CCC2C1
NCGC00186046-01,tox21-er-bla-agonist-p2,Caroverine hydrochloride,activity,inactive,23465-76-1,65709.0,COc1ccc(cc1)CC3=Nc2ccccc2N(CCN(CC)CC)C3=O
NCGC00247719-01,tox21-er-bla-agonist-p2,1-Benzylpiperazine difumarate,activity,inactive,106133-22-6,6442928.0,O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.c1ccccc1CN2CCNCC2
NCGC00016772-01,tox21-er-bla-agonist-p2,Terbutaline hemisulfate,activity,inactive,23031-32-5,441334.0,Oc1cc(cc(O)c1)C(O)CNC(C)(C)C.O=S(=O)(O)O.CC(C)(C)NCC(O)c1cc(O)cc(O)c1
NCGC00095161-01,tox21-er-bla-agonist-p2,Rebamipide,activity,inactive,90098-04-7,5042.0,Clc1ccc(cc1)C(=O)NC(CC3=CC(=O)Nc2ccccc23)C(=O)O
NCGC00159513-02,tox21-er-bla-agonist-p2,Cefprozil monohydrate,activity,inactive,121123-17-9,92088.0,O.Oc1ccc(cc1)[C@@H](N)C(=O)N[C@@H]3C(=O)N2C(=C(C=CC)CS[C@@H]23)C(=O)O
NCGC00160383-01,tox21-er-bla-agonist-p2,Lenperone,activity,inactive,24678-13-5,32593.0,Fc1ccc(cc1)C(=O)C3CCN(CCCC(=O)c2ccc(F)cc2)CC3
NCGC00160577-01,tox21-er-bla-agonist-p2,Laurixamine,activity,inactive,7617-74-5,65596.0,NCCCOCCCCCCCCCCCC
NCGC00247711-01,tox21-er-bla-agonist-p2,Amobarbital,activity,inactive,57-43-2,2164.0,O=C1NC(=O)NC(=O)C1(CCC(C)C)CC
NCGC00254458-01,tox21-er-bla-agonist-p2,Dimethyl adipate,activity,inactive,627-93-0,12329.0,O=C(CCCCC(=O)OC)OC
NCGC00254558-01,tox21-er-bla-agonist-p2,Fenarimol,activity,active agonist,60168-88-9,43226.0,OC(c1ccccc1Cl)(c2cncnc2)c3ccc(Cl)cc3
NCGC00254563-01,tox21-er-bla-agonist-p2,Napropamide,activity,inactive,15299-99-7,27189.0,CCN(CC)C(=O)C(C)Oc2cccc1ccccc12
NCGC00016942-01,tox21-er-bla-agonist-p2,Roxithromycin,activity,inactive,80214-83-1,444037.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)\C(=N\OCOCCOC)[C@H](C)C[C@@]2(C)O)[C@@H]3O
NCGC00016956-01,tox21-er-bla-agonist-p2,Ioversol,activity,inactive,87771-40-2,3741.0,OCC(O)CNC(=O)c1c(I)c(N(CCO)C(=O)CO)c(I)c(c1I)C(=O)NCC(O)CO
NCGC00090868-01,tox21-er-bla-agonist-p2,Halothane,activity,inactive,151-67-7,3562.0,BrC(Cl)C(F)(F)F
NCGC00016966-01,tox21-er-bla-agonist-p2,Sertaconazole nitrate,activity,inactive,99592-39-9,200103.0,[O-][N+](=O)O.Clc1ccc(c(Cl)c1)C(Cn2ccnc2)OCc4csc3c(Cl)cccc34
NCGC00017028-02,tox21-er-bla-agonist-p2,Doxylamine succinate,activity,inactive,562-10-7,11224.0,O=C(O)CCC(=O)O.CN(C)CCOC(C)(c1ccccn1)c2ccccc2
NCGC00016879-01,tox21-er-bla-agonist-p2,Torsemide,activity,inactive,56211-40-6,41781.0,O=S(=O)(NC(=O)NC(C)C)c2cnccc2Nc1cc(C)ccc1
NCGC00016916-09,tox21-er-bla-agonist-p2,Norfloxacin,activity,inactive,70458-96-7,4539.0,O=C(O)C2=CN(CC)c1cc(c(F)cc1C2=O)N3CCNCC3
NCGC00258558-01,tox21-er-bla-agonist-p2,Retinal,activity,active agonist,116-31-4,638015.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=C\C(\C)=C\C=O
NCGC00258593-01,tox21-er-bla-agonist-p2,Dinonyl phthalate,activity,inactive,84-76-4,6787.0,O=C(OCCCCCCCCC)c1ccccc1C(=O)OCCCCCCCCC
NCGC00257166-01,tox21-er-bla-agonist-p2,Methyl styryl ketone,activity,inactive,122-57-6,15909.0,CC(=O)C=Cc1ccccc1
NCGC00257309-01,tox21-er-bla-agonist-p2,Dimethyldiallylammonium chloride,activity,inactive,7398-69-8,33286.0,[Cl-].C=CC[N+](C)(C)CC=C
NCGC00257404-01,tox21-er-bla-agonist-p2,Furfuryl isopropyl sulfide,activity,inactive,1883-78-9,61282.0,CC(C)SCc1ccco1
NCGC00257915-01,tox21-er-bla-agonist-p2,Diethyl ethylphosphonate,activity,inactive,78-38-6,6534.0,O=P(CC)(OCC)OCC
NCGC00258051-01,tox21-er-bla-agonist-p2,Dipyrone,activity,inactive,68-89-3,522325.0,[Na+].[O-]S(=O)(=O)CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00258056-01,tox21-er-bla-agonist-p2,Isonicotinic acid,activity,inactive,55-22-1,5922.0,O=C(O)c1ccncc1
NCGC00258372-01,tox21-er-bla-agonist-p2,2-Aminobenzothiazole,activity,inactive,136-95-8,8706.0,Nc1nc2ccccc2s1
NCGC00256545-01,tox21-er-bla-agonist-p2,Methyl hesperidin,activity,inactive,11013-97-1,5284419.0,COc1ccc(cc1OC)[C@@H]2CC(=O)c3c(O)cc(cc3O2)O[C@@H]5O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]5O
NCGC00255822-01,tox21-er-bla-agonist-p2,1-Aminocyclohexanecarbonitrile,activity,inactive,5496-10-6,79635.0,N#CC1(N)CCCCC1
NCGC00255949-01,tox21-er-bla-agonist-p2,4-Methyl-1-phenylpyrazolidin-3-one,activity,inactive,2654-57-1,98282.0,O=C1NN(CC1C)c2ccccc2
NCGC00255958-01,tox21-er-bla-agonist-p2,"1,6-Dibromohexane",activity,inactive,629-03-8,12368.0,BrCCCCCCBr
NCGC00256050-01,tox21-er-bla-agonist-p2,Dimethyl nonanedioate,activity,inactive,1732-10-1,15612.0,O=C(CCCCCCCC(=O)OC)OC
NCGC00256194-01,tox21-er-bla-agonist-p2,Butyrophenone,activity,inactive,495-40-9,10315.0,O=C(CCC)c1ccccc1
NCGC00256264-01,tox21-er-bla-agonist-p2,"N,N,N-Trimethyl-3-[(2-methylacryloyl)amino]propan-1-aminium chloride",activity,inactive,51410-72-1,106428.0,[Cl-].C[N+](C)(C)CCCNC(=O)C(=C)C
NCGC00256297-01,tox21-er-bla-agonist-p2,Trimethylsilyl silicate,activity,inactive,56275-01-5,91783.0,C[Si](C)(C)O[Si](O)(O)O
NCGC00256318-01,tox21-er-bla-agonist-p2,Hexamethylphosphoramide,activity,inactive,680-31-9,12679.0,CN(C)P(=O)(N(C)C)N(C)C
NCGC00258930-01,tox21-er-bla-agonist-p2,1-Bromo-4-fluorobenzene,activity,inactive,460-00-4,9993.0,Fc1ccc(Br)cc1
NCGC00258986-01,tox21-er-bla-agonist-p2,Clopyralid,activity,inactive,1702-17-6,15553.0,Clc1ccc(Cl)nc1C(=O)O
NCGC00259226-01,tox21-er-bla-agonist-p2,Indole,activity,inactive,120-72-9,798.0,c1cccc2nccc12
NCGC00259717-01,tox21-er-bla-agonist-p2,"2,4-Bis(2-methylbutan-2-yl)phenol",activity,inactive,120-95-6,8455.0,Oc1ccc(cc1C(C)(C)CC)C(C)(C)CC
NCGC00259899-01,tox21-er-bla-agonist-p2,N-Methyl-2-pyrrolidone,activity,inactive,872-50-4,13387.0,O=C1CCCN1C
NCGC00260122-01,tox21-er-bla-agonist-p2,1-Stearoyl-rac-glycerol,activity,inactive,123-94-4,24699.0,OCC(O)COC(=O)CCCCCCCCCCCCCCCCC
NCGC00260283-01,tox21-er-bla-agonist-p2,Sodium propionate,activity,inactive,137-40-6,2723816.0,[Na+].[O-]C(=O)CC
NCGC00260333-01,tox21-er-bla-agonist-p2,Oxolinic acid,activity,inactive,14698-29-4,4628.0,O=C(O)C2=CN(CC)c1cc3OCOc3cc1C2=O
NCGC00258673-01,tox21-er-bla-agonist-p2,"2',3'-Dideoxyadenosine",activity,inactive,4097-22-7,20039.0,Nc3ncnc2c3ncn2[C@H]1CC[C@@H](CO)O1
NCGC00258765-01,tox21-er-bla-agonist-p2,Heptane,activity,inactive,142-82-5,8900.0,CCCCCCC
NCGC00254781-01,tox21-er-bla-agonist-p2,"5,5'-Oxybis(2-benzofuran-1,3-dione)",activity,inactive,1823-59-2,74574.0,O=C1OC(=O)c2ccc(cc12)Oc3ccc4C(=O)OC(=O)c4c3
NCGC00254902-01,tox21-er-bla-agonist-p2,Boric acid,activity,inactive,10043-35-3,7628.0,OB(O)O
NCGC00255548-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexanol",activity,inactive,116-02-9,8298.0,CC1(C)CC(C)CC(O)C1
NCGC00255621-01,tox21-er-bla-agonist-p2,2-Methylanthraquinone,activity,inactive,84-54-8,6773.0,Cc2ccc3C(=O)c1ccccc1C(=O)c3c2
NCGC00254593-01,tox21-er-bla-agonist-p2,Tebufenozide,activity,inactive,112410-23-8,91773.0,CCc1ccc(cc1)C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C
NCGC00091819-01,tox21-er-bla-agonist-p2,Benzaldehyde,activity,inactive,100-52-7,240.0,O=Cc1ccccc1
NCGC00092328-01,tox21-er-bla-agonist-p2,Carmoxirole,activity,inactive,98323-83-2,57364.0,O=C(O)c3ccc4ncc(CCCCN1CC=C(CC1)c2ccccc2)c4c3
NCGC00181012-01,tox21-er-bla-agonist-p2,Cefuzonam hydrochloride,activity,inactive,NOCAS_46800,60196300.0,Cl.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(CS[C@@H]23)CSc4cnns4)C(=O)O
NCGC00181025-01,tox21-er-bla-agonist-p2,Transfluthrin,activity,inactive,118712-89-3,656612.0,Cl/C(Cl)=C/[C@@H]2[C@@H](C(=O)OCc1c(F)c(F)cc(F)c1F)C2(C)C
NCGC00164431-01,tox21-er-bla-agonist-p2,Terpineol,activity,inactive,8000-41-7,17100.0,CC1=CCC(CC1)C(O)(C)C
NCGC00181161-02,tox21-er-bla-agonist-p2,Ethyl salicylate,activity,inactive,118-61-6,8365.0,Oc1ccccc1C(=O)OCC
NCGC00181166-01,tox21-er-bla-agonist-p2,Sodium 2-mercaptoethanesulfonate,activity,inactive,19767-45-4,23662354.0,[Na+].[O-]S(=O)(=O)CCS
NCGC00181170-01,tox21-er-bla-agonist-p2,Bendamustine,activity,inactive,16506-27-7,65628.0,ClCCN(CCCl)c1cc2nc(CCCC(=O)O)n(C)c2cc1
NCGC00181035-01,tox21-er-bla-agonist-p2,Potassium pentanoate,activity,inactive,19455-21-1,23668516.0,[K+].[O-]C(=O)CCCC
NCGC00166071-01,tox21-er-bla-agonist-p2,L-Alloisoleucine,activity,inactive,1509-34-8,99288.0,C[C@H](CC)[C@H](N)C(=O)O
NCGC00166138-01,tox21-er-bla-agonist-p2,Ethynodiol diacetate,activity,active agonist,297-76-7,9270.0,CC(=O)O[C@@]4(C#C)CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=C[C@H](CC[C@@H]12)OC(C)=O
NCGC00162267-02,tox21-er-bla-agonist-p2,Naloxone,activity,inactive,465-65-6,5284596.0,O=C1CC[C@@]5(O)[C@H]2Cc4ccc(O)c3O[C@@H]1[C@]5(CCN2CC=C)c34
NCGC00091635-01,tox21-er-bla-agonist-p2,Fenthion,activity,inactive,55-38-9,3346.0,Cc1cc(ccc1SC)OP(=S)(OC)OC
NCGC00182043-01,tox21-er-bla-agonist-p2,Gonadorelin hydrochloride,activity,inactive,51952-41-1,60196354.0,Cl.O=C(NCC(N)=O)[C@H]6CCCN6C(=O)[C@@H](CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc3cnc2ccccc23)NC(=O)[C@H](Cc4cncn4)NC(=O)[C@H]5CCC(=O)N5
NCGC00182706-01,tox21-er-bla-agonist-p2,Paricalcitol,activity,inactive,131918-61-1,5281104.0,O[C@@H]3CC(=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)(C)O)/C[C@@H](O)C3
NCGC00183123-01,tox21-er-bla-agonist-p2,Maltotriose,activity,inactive,1109-28-0,192826.0,O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]2O
NCGC00254178-01,tox21-er-bla-agonist-p2,tert-Butylhydroquinone,activity,inactive,1948-33-0,16043.0,CC(C)(C)c1cc(O)ccc1O
NCGC00185909-01,tox21-er-bla-agonist-p2,"Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (2R)-",activity,inactive,33643-49-1,644025.0,CN[C@]1(CCCCC1=O)c2ccccc2Cl
NCGC00185990-01,tox21-er-bla-agonist-p2,Ketorolac tromethamine,activity,inactive,74103-07-4,6604122.0,OCC(N)(CO)CO.O=C(O)[C@@H]1CCn2c(ccc12)C(=O)c3ccccc3
NCGC00254207-01,tox21-er-bla-agonist-p2,Triacetin,activity,inactive,102-76-1,5541.0,O=C(C)OC(COC(C)=O)COC(=O)C
NCGC00247708-01,tox21-er-bla-agonist-p2,N-Normorphine hydrochloride,activity,inactive,3372-02-9,21124389.0,Cl.Oc1ccc2C[C@H]4NCC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00247713-01,tox21-er-bla-agonist-p2,Mecloqualone,activity,inactive,340-57-8,9567.0,Clc1ccccc1N3C(C)=Nc2ccccc2C3=O
NCGC00253934-01,tox21-er-bla-agonist-p2,"1,4-Dichlorobenzene",activity,inactive,106-46-7,4685.0,Clc1ccc(Cl)cc1
NCGC00254409-01,tox21-er-bla-agonist-p2,"1,1,2,2-Tetrahydroperfluoro-1-decanol",activity,inactive,678-39-7,69619.0,FC(F)(C(F)(F)CCO)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00255231-01,tox21-er-bla-agonist-p2,"Ionone, methyl-",activity,inactive,1335-46-2,5371084.0,CC1(C)CCC=C(C)C1/C=C/C(=O)CC
NCGC00254068-01,tox21-er-bla-agonist-p2,2-tert-Butyl-4-methoxyphenol,activity,inactive,121-00-6,8456.0,CC(C)(C)c1cc(ccc1O)OC
NCGC00255337-01,tox21-er-bla-agonist-p2,(Z)-11-Hexadecenal,activity,inactive,53939-28-9,5364495.0,CCCC\C=C/CCCCCCCCCC=O
NCGC00182066-02,tox21-er-bla-agonist-p2,Fluprednidene acetate,activity,inactive,1255-35-2,60196346.0,CC(=O)OCC(=O)[C@@]4(O)C(=C)CC3C2CCC1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C
NCGC00258086-01,tox21-er-bla-agonist-p2,2-Oxopentanoic acid,activity,inactive,1821-02-9,74563.0,CCCC(=O)C(=O)O
NCGC00258297-01,tox21-er-bla-agonist-p2,4-Methoxy-3-nitro-N-phenylbenzamide,activity,inactive,97-32-5,7331.0,COc1ccc(cc1[N+]([O-])=O)C(=O)Nc2ccccc2
NCGC00258336-01,tox21-er-bla-agonist-p2,2-Phenoxypropan-1-ol,activity,inactive,4169-04-4,20129.0,CC(CO)Oc1ccccc1
NCGC00014044-01,tox21-er-bla-agonist-p2,Dimetacrine,activity,inactive,4757-55-5,94280.0,CN(C)CCCN3c1ccccc1C(C)(C)c2ccccc23
NCGC00258704-01,tox21-er-bla-agonist-p2,Cyclohexene oxide,activity,inactive,286-20-4,9246.0,C1CCCC2OC12
NCGC00258708-01,tox21-er-bla-agonist-p2,Flurprimidol,activity,inactive,56425-91-3,73668.0,OC(C(C)C)(c1cncnc1)c2ccc(OC(F)(F)F)cc2
NCGC00256739-01,tox21-er-bla-agonist-p2,Ipconazole,activity,inactive,125225-28-7,86211.0,Clc1ccc(cc1)CC3CCC(C(C)C)C3(O)Cn2cncn2
NCGC00258888-01,tox21-er-bla-agonist-p2,Ethoxyquin,activity,inactive,91-53-2,3293.0,CCOc1ccc2NC(C)(C)C=C(C)c2c1
NCGC00168254-01,tox21-er-bla-agonist-p2,Midazolam hydrochloride,activity,inactive,59467-96-8,43032.0,Cl.Fc4ccccc4C2=NCc1cnc(C)n1c3ccc(Cl)cc23
NCGC00257382-01,tox21-er-bla-agonist-p2,Hydroxyflutamide,activity,inactive,52806-53-8,91649.0,O=C(Nc1cc(c(cc1)[N+]([O-])=O)C(F)(F)F)C(C)(C)O
NCGC00256674-01,tox21-er-bla-agonist-p2,Citronellyl propionate,activity,active agonist,141-14-0,8834.0,C\C(C)=C\CCC(C)CCOC(=O)CC
NCGC00257711-01,tox21-er-bla-agonist-p2,Trimethoprim,activity,inactive,738-70-5,5578.0,Nc2nc(N)ncc2Cc1cc(OC)c(OC)c(OC)c1
NCGC00258909-01,tox21-er-bla-agonist-p2,Amitraz,activity,inactive,33089-61-1,36324.0,Cc2ccc(/N=C/N(C)/C=N/c1ccc(C)cc1C)c(C)c2
NCGC00257842-01,tox21-er-bla-agonist-p2,N-Acetyl-o-toluidine,activity,inactive,120-66-1,8443.0,O=C(C)Nc1ccccc1C
NCGC00258211-01,tox21-er-bla-agonist-p2,Bromoacetic acid,activity,inactive,79-08-3,6227.0,BrCC(=O)O
NCGC00257508-01,tox21-er-bla-agonist-p2,Methylcyclopentadiene dimer,activity,inactive,26472-00-4,3437714.0,CC=2CC3C1C=C(C)C(C1)C3C=2
NCGC00258815-01,tox21-er-bla-agonist-p2,Chlorfenson,activity,inactive,80-33-1,6635.0,Clc1ccc(cc1)S(=O)(=O)Oc2ccc(Cl)cc2
NCGC00255543-01,tox21-er-bla-agonist-p2,Ascorbyl palmitate,activity,inactive,137-66-6,54680660.0,OC=1C(=O)O[C@H]([C@@H](O)COC(=O)CCCCCCCCCCCCCCC)C=1O
NCGC00255957-01,tox21-er-bla-agonist-p2,"(2S,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone",activity,inactive,14073-97-3,26447.0,CC(C)[C@@H]1CC[C@@H](C)CC1=O
NCGC00256954-01,tox21-er-bla-agonist-p2,Sodium chloroacetate,activity,inactive,3926-62-3,23665759.0,[Na+].[O-]C(=O)CCl
NCGC00256929-01,tox21-er-bla-agonist-p2,Methyl decanoate,activity,inactive,110-42-9,8050.0,O=C(CCCCCCCCC)OC
NCGC00257916-01,tox21-er-bla-agonist-p2,"1,2-Dichloropropane",activity,inactive,78-87-5,6564.0,CC(Cl)CCl
NCGC00257746-01,tox21-er-bla-agonist-p2,t-Butylchloride,activity,inactive,507-20-0,10486.0,CC(C)(C)Cl
NCGC00257356-01,tox21-er-bla-agonist-p2,Anastrozole,activity,inactive,120511-73-1,2187.0,N#CC(C)(C)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2
NCGC00258110-01,tox21-er-bla-agonist-p2,"2,2-Diphenylpropane",activity,inactive,778-22-3,13065.0,CC(C)(c1ccccc1)c2ccccc2
NCGC00258906-01,tox21-er-bla-agonist-p2,Methacrylonitrile,activity,inactive,126-98-7,31368.0,C=C(C)C#N
NCGC00258293-01,tox21-er-bla-agonist-p2,"1,3-Propylene oxide",activity,inactive,503-30-0,10423.0,C1CCO1
NCGC00258733-01,tox21-er-bla-agonist-p2,4-Nitrohippuric acid,activity,inactive,2645-07-0,17549.0,O=[N+]([O-])c1ccc(cc1)C(=O)NCC(=O)O
NCGC00259101-01,tox21-er-bla-agonist-p2,"2,4-Dichlorophenyl benzenesulfonate",activity,active agonist,97-16-5,7327.0,Clc2cc(Cl)ccc2OS(=O)(=O)c1ccccc1
NCGC00258997-01,tox21-er-bla-agonist-p2,3-Aminopropyltriethoxysilane,activity,inactive,919-30-2,13521.0,CCO[Si](OCC)(OCC)CCCN
NCGC00258398-01,tox21-er-bla-agonist-p2,2-Methylenepentanedinitrile,activity,inactive,1572-52-7,74080.0,N#CC(=C)CCC#N
NCGC00258653-01,tox21-er-bla-agonist-p2,"(2E)-2,3-Dibromo-2-butene-1,4-diol",activity,inactive,21285-46-1,18603.0,BrC(CO)=C(Br)CO
NCGC00259138-01,tox21-er-bla-agonist-p2,"2,4-Dichlorophenol",activity,inactive,120-83-2,8449.0,Clc1cc(Cl)c(O)cc1
NCGC00259229-01,tox21-er-bla-agonist-p2,Hexyl methacrylate,activity,inactive,142-09-6,8872.0,O=C(OCCCCCC)C(=C)C
NCGC00260079-01,tox21-er-bla-agonist-p2,Phosphorus pentachloride,activity,inactive,10026-13-8,24819.0,ClP(Cl)(Cl)(Cl)Cl
NCGC00259371-01,tox21-er-bla-agonist-p2,Butylated hydroxyanisole,activity,inactive,25013-16-5,8456.0,CC(C)(C)c1cc(ccc1O)OC
NCGC00260327-01,tox21-er-bla-agonist-p2,Sodium cyclamate,activity,inactive,139-05-9,23665706.0,[Na+].O=S([O-])(=O)NC1CCCCC1
NCGC00260391-01,tox21-er-bla-agonist-p2,1-iodohexadecane,activity,inactive,544-77-4,11007.0,CCCCCCCCCCCCCCCCI
NCGC00260664-01,tox21-er-bla-agonist-p2,NTP Mix29 AR2 5-EQP-HF,activity,inconclusive agonist (fluorescent),NOCAS_49560,,
NCGC00260165-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide,activity,inactive,174899-83-3,11258643.0,CCCCn1cc[n+](C)c1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00015428-08,tox21-er-bla-agonist-p2,Fluoxetine,activity,inactive,54910-89-3,3386.0,FC(F)(F)c2ccc(OC(CCNC)c1ccccc1)cc2
NCGC00016244-09,tox21-er-bla-agonist-p2,Isoniazid,activity,inactive,54-85-3,3767.0,O=C(NN)c1ccncc1
NCGC00016329-01,tox21-er-bla-agonist-p2,Phenindione,activity,inactive,83-12-5,4760.0,O=C2c1ccccc1C(=O)C2c3ccccc3
NCGC00016764-01,tox21-er-bla-agonist-p2,Benfotiamine,activity,inactive,22457-89-2,2320.0,Nc2nc(C)ncc2CN(C=O)C(C)=C(CCOP(=O)(O)O)SC(=O)c1ccccc1
NCGC00016851-01,tox21-er-bla-agonist-p2,Nadolol,activity,inactive,42200-33-9,39147.0,CC(C)(C)NCC(O)COc2cccc1C[C@@H](O)[C@@H](O)Cc12
NCGC00016680-01,tox21-er-bla-agonist-p2,Oleandomycin phosphate,activity,inactive,7060-74-4,20056627.0,O=P(O)(O)O.CN(C)[C@H]4C[C@@H](C)O[C@@H](O[C@@H]3[C@@H](C)[C@H](O[C@H]1C[C@H](OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@@]2(CO2)C[C@@H]3C)[C@@H]4O
NCGC00016257-04,tox21-er-bla-agonist-p2,4-Dimethylaminoantipyrine,activity,inactive,58-15-1,6009.0,CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00159486-02,tox21-er-bla-agonist-p2,Hippuric acid,activity,inactive,495-69-2,464.0,O=C(NCC(=O)O)c1ccccc1
NCGC00160525-01,tox21-er-bla-agonist-p2,Zaleplon,activity,inactive,151319-34-5,5719.0,CC(=O)N(CC)c1cccc(c1)c2ccnc3c(cnn23)C#N
NCGC00255652-01,tox21-er-bla-agonist-p2,Sodium 2-phenylphenate tetrahydrate,activity,inactive,6152-33-6,517383.0,[Na+].O.O.O.O.[O-]c2ccccc2c1ccccc1
NCGC00255256-01,tox21-er-bla-agonist-p2,Butyl-N-(4-hydroxybutyl)nitrosamine,activity,inactive,3817-11-6,19665.0,O=NN(CCCC)CCCCO
NCGC00255280-01,tox21-er-bla-agonist-p2,Procarbazine,activity,inactive,671-16-9,4915.0,CC(C)NC(=O)c1ccc(CNNC)cc1
NCGC00254382-01,tox21-er-bla-agonist-p2,UK-416244,activity,inactive,402910-27-4,9969177.0,Cc1cc(ccc1SC)Oc2ccc(cc2CN(C)C)S(N)(=O)=O
NCGC00254778-01,tox21-er-bla-agonist-p2,Acephate,activity,inactive,30560-19-1,1982.0,O=C(C)NP(=O)(OC)SC
NCGC00015012-02,tox21-er-bla-agonist-p2,Alaproclate,activity,inactive,60719-82-6,2081.0,Clc1ccc(CC(C)(C)OC(=O)C(C)N)cc1
NCGC00015998-04,tox21-er-bla-agonist-p2,Thiothixene,activity,inactive,5591-45-7,5454.0,CN(C)S(=O)(=O)c2cc3C(=CCCN1CCN(C)CC1)c4ccccc4Sc3cc2
NCGC00016861-05,tox21-er-bla-agonist-p2,Dexibuprofen,activity,inactive,51146-56-6,39912.0,C[C@H](C(=O)O)c1ccc(CC(C)C)cc1
NCGC00017103-02,tox21-er-bla-agonist-p2,Pyrantel tartrate,activity,active agonist,33401-94-4,6434144.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2CCCN=C2/C=C/c1cccs1
NCGC00090918-04,tox21-er-bla-agonist-p2,"4-Nonylphenol, branched",activity,active agonist,84852-15-3,338733.0,Oc1ccc(CCCCCCC(C)C)cc1
NCGC00091423-02,tox21-er-bla-agonist-p2,3-Acetamidophenol,activity,inactive,621-42-1,12124.0,Oc1cccc(NC(C)=O)c1
NCGC00094507-01,tox21-er-bla-agonist-p2,Olprinone hydrochloride,activity,inactive,119615-63-3,115227.0,Cl.N#CC3=CC(c1ccc2nccn2c1)=C(C)NC3=O
NCGC00160603-01,tox21-er-bla-agonist-p2,4-Styrylpyridine,activity,inactive,103-31-1,101576.0,C(=Cc1ccncc1)c2ccccc2
NCGC00163906-02,tox21-er-bla-agonist-p2,Pentachloroaniline,activity,inactive,527-20-8,10693.0,Clc1c(N)c(Cl)c(Cl)c(Cl)c1Cl
NCGC00166079-01,tox21-er-bla-agonist-p2,C.I. Solvent Red 24,activity,active agonist,85-83-6,5876571.0,Cc4ccccc4/N=N/c3ccc(/N=N/c1c2ccccc2ccc1O)c(C)c3
NCGC00182707-02,tox21-er-bla-agonist-p2,Atipamezole hydrochloride,activity,inactive,104075-48-1,13649426.0,Cl.CCC1(Cc2ccccc2C1)c3cncn3
NCGC00254853-01,tox21-er-bla-agonist-p2,Trimethoxypropylsilane,activity,inactive,1067-25-0,61254.0,CO[Si](CCC)(OC)OC
NCGC00259798-01,tox21-er-bla-agonist-p2,Allyl isothiocyanate,activity,inactive,57-06-7,5971.0,C=CC\N=C=S
NCGC00260239-01,tox21-er-bla-agonist-p2,1-Butyl-4-methylpyridinium trifluoromethanesulfonate,activity,inactive,882172-79-4,60196392.0,Cc1cc[n+](CCCC)cc1.FC(F)(F)S([O-])(=O)=O
NCGC00260370-01,tox21-er-bla-agonist-p2,2-Chloro-1-fluoro-4-nitrobenzene,activity,inactive,350-30-1,67688.0,Fc1ccc(cc1Cl)[N+]([O-])=O
NCGC00018292-04,tox21-er-bla-agonist-p2,Stallimycin,activity,inactive,636-47-5,3115.0,O=C(Nc1cc(C(=O)NCCC(=N)N)n(C)c1)c3cc(NC(=O)c2cc(NC=O)cn2C)cn3C
NCGC00091018-01,tox21-er-bla-agonist-p2,Epitestosterone,activity,active agonist,481-30-1,10204.0,O=C4CC[C@@]3(C)C(CC[C@@H]1[C@@H]3CC[C@]2(C)[C@H](O)CC[C@@H]12)=C4
NCGC00094532-06,tox21-er-bla-agonist-p2,"2,4-DB",activity,inactive,94-82-6,1489.0,Clc1cc(Cl)ccc1OCCCC(=O)O
NCGC00166102-01,tox21-er-bla-agonist-p2,Calcium levulinate,activity,inactive,5743-49-7,68651.0,[Ca+2].O.O.O=C([O-])CCC(C)=O.CC(=O)CCC([O-])=O
NCGC00167528-01,tox21-er-bla-agonist-p2,Alosetron hydrochloride,activity,inactive,122852-69-1,60758.0,Cl.Cc4ncnc4CN1CCc3c(C1=O)c2ccccc2n3C
NCGC00090814-01,tox21-er-bla-agonist-p2,4-Chlorophenol,activity,inactive,106-48-9,4684.0,Oc1ccc(Cl)cc1
NCGC00017100-01,tox21-er-bla-agonist-p2,Yohimbic acid monohydrate,activity,inactive,207801-27-2,6419962.0,O.O=C(O)[C@H]2[C@@H](O)CC[C@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23
NCGC00024349-03,tox21-er-bla-agonist-p2,Naphazoline,activity,inactive,835-31-4,610682.0,c2cc(CC1=NCCN1)cc3ccccc23
NCGC00024885-01,tox21-er-bla-agonist-p2,Olvanil,activity,inactive,58493-49-5,5311093.0,Oc1ccc(cc1OC)CNC(=O)CCCCCCC/C=C\CCCCCCCC
NCGC00042134-02,tox21-er-bla-agonist-p2,Afalanine,activity,inactive,2901-75-9,2000.0,O=C(O)C(NC(C)=O)Cc1ccccc1
NCGC00016909-01,tox21-er-bla-agonist-p2,Glafenine hydrochloride,activity,inactive,65513-72-6,3085326.0,Cl.OCC(O)COC(=O)c3ccccc3Nc1ccnc2cc(Cl)ccc12
NCGC00256935-01,tox21-er-bla-agonist-p2,2-Ethyl-2-hexenal,activity,inactive,645-62-5,12582.0,CCC(=CCCC)C=O
NCGC00258488-01,tox21-er-bla-agonist-p2,Castor oil,activity,inactive,8001-79-4,,
NCGC00258513-01,tox21-er-bla-agonist-p2,Pyridine,activity,inactive,110-86-1,1049.0,c1ccccn1
NCGC00258627-01,tox21-er-bla-agonist-p2,Pheniramine maleate,activity,inactive,132-20-7,25150753.0,[O-]C(=O)/C=C\C([O-])=O.C[NH+](C)CCC(c1ccccc1)c2[nH+]cccc2
NCGC00257386-01,tox21-er-bla-agonist-p2,Iopanoic acid,activity,active agonist,96-83-3,3735.0,Ic1cc(I)c(N)c(I)c1CC(CC)C(=O)O
NCGC00257551-01,tox21-er-bla-agonist-p2,4-Methylpentan-1-ol,activity,inactive,626-89-1,12296.0,CC(C)CCCO
NCGC00257633-01,tox21-er-bla-agonist-p2,"1,1,1-Trichloro-2,2,2-trifluoroethane",activity,inactive,354-58-5,9635.0,ClC(Cl)(Cl)C(F)(F)F
NCGC00257988-01,tox21-er-bla-agonist-p2,Ethyl cyanoacetate,activity,inactive,105-56-6,7764.0,N#CCC(=O)OCC
NCGC00256714-01,tox21-er-bla-agonist-p2,Aluminum butan-2-olate (2Z)-4-ethoxy-4-oxobut-2-en-2-olate (1:2:1),activity,inactive,24772-51-8,60196434.0,O=C(/C=C(/C)O[Al](OC(C)CC)OC(C)CC)OCC
NCGC00256450-01,tox21-er-bla-agonist-p2,Diphenyl oxide,activity,inactive,101-84-8,7583.0,c1ccccc1Oc2ccccc2
NCGC00255846-01,tox21-er-bla-agonist-p2,"4,4'-(Oxydiethylene)bis(morpholine)",activity,inactive,6425-39-4,80900.0,O(CCN1CCOCC1)CCN2CCOCC2
NCGC00255905-01,tox21-er-bla-agonist-p2,Potassium ethyl xanthate,activity,inactive,140-89-6,2735045.0,[K+].[S-]C(=S)OCC
NCGC00255926-01,tox21-er-bla-agonist-p2,Cytosine,activity,inactive,71-30-7,597.0,NC=1C=CNC(=O)N=1
NCGC00256005-01,tox21-er-bla-agonist-p2,Phenol Red sodium salt,activity,inactive,34487-61-1,23686673.0,[Na+].Oc1ccc(cc1)C3(OS(=O)(=O)c2ccccc23)c4ccc([O-])cc4
NCGC00256070-01,tox21-er-bla-agonist-p2,N-Cyclohexyl-N-methylcyclohexanamine,activity,inactive,7560-83-0,24210.0,CN(C1CCCCC1)C2CCCCC2
NCGC00256116-01,tox21-er-bla-agonist-p2,"Propanoic acid, 3-ethoxy-3-imino-, ethyl ester, hydrochloride",activity,inactive,2318-25-4,75345.0,Cl.O=C(CC(=N)OCC)OCC
NCGC00256258-01,tox21-er-bla-agonist-p2,"Triprop-2-en-1-yl benzene-1,2,4-tricarboxylate",activity,inactive,2694-54-4,75903.0,O=C(OCC=C)c1cc(C(=O)OCC=C)c(cc1)C(=O)OCC=C
NCGC00256299-01,tox21-er-bla-agonist-p2,"(5-Ethyl-1,3-dioxan-5-yl)methanol",activity,inactive,5187-23-5,78860.0,OCC1(CC)COCOC1
NCGC00256342-01,tox21-er-bla-agonist-p2,"1,1,3-Trimethyl-2-thiourea",activity,inactive,2489-77-2,2779938.0,CN(C)C(=S)NC
NCGC00256361-01,tox21-er-bla-agonist-p2,Ciprofibrate,activity,inactive,52214-84-3,2763.0,ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1
NCGC00258805-01,tox21-er-bla-agonist-p2,beta-Butyrolactone,activity,inactive,3068-88-0,18303.0,O=C1CC(C)O1
NCGC00260486-01,tox21-er-bla-agonist-p2,Tetracyanoethylene,activity,inactive,670-54-2,12635.0,N#C/C(C#N)=C(/C#N)C#N
NCGC00259314-01,tox21-er-bla-agonist-p2,2-Nitrofluorene,activity,inactive,607-57-8,11831.0,[O-][N+](=O)c1ccc2c3ccccc3Cc2c1
NCGC00259572-01,tox21-er-bla-agonist-p2,"1,2,3-Trichloropropane",activity,inactive,96-18-4,7285.0,ClCC(Cl)CCl
NCGC00259602-01,tox21-er-bla-agonist-p2,2-Ethylhexyl acrylate,activity,inactive,103-11-7,7636.0,O=C(C=C)OCC(CCCC)CC
NCGC00259685-01,tox21-er-bla-agonist-p2,Tris(2-chloroethyl) phosphite,activity,inactive,140-08-9,8783.0,ClCCOP(OCCCl)OCCCl
NCGC00259870-01,tox21-er-bla-agonist-p2,Dipropylene glycol,activity,inactive,25265-71-8,6537503.0,CCC(O)OC(O)CC
NCGC00260027-01,tox21-er-bla-agonist-p2,4-Carboxybenzaldehyde,activity,inactive,619-66-9,12088.0,OC(=O)c1ccc(C=O)cc1
NCGC00260147-01,tox21-er-bla-agonist-p2,Tin(II) chloride,activity,inactive,7772-99-8,5284466.0,[Sn+2].[Cl-].[Cl-]
NCGC00260200-01,tox21-er-bla-agonist-p2,1-Methyl-3-octadecylimidazolium hexafluorophosphate,activity,inactive,219947-96-3,24944555.0,F[P-](F)(F)(F)(F)F.C[n+]1ccn(CCCCCCCCCCCCCCCCCC)c1
NCGC00260220-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpiperidinium tetrafluoroborate,activity,inactive,879866-95-2,60196388.0,CCC[N+]1(C)CCCCC1.F[B-](F)(F)F
NCGC00260269-01,tox21-er-bla-agonist-p2,1-Bromotetradecane,activity,inactive,112-71-0,8208.0,BrCCCCCCCCCCCCCC
NCGC00260292-01,tox21-er-bla-agonist-p2,"9-Octadecenoic acid (9Z)-, butyl ester",activity,inactive,142-77-8,5354342.0,O=C(CCCCCCC/C=C\CCCCCCCC)OCCCC
NCGC00260305-01,tox21-er-bla-agonist-p2,Diisopropylbenzene,activity,inactive,25321-09-9,11345.0,CC(C)c1ccccc1C(C)C
NCGC00260384-01,tox21-er-bla-agonist-p2,Chloroquine bis(phosphate),activity,inactive,50-63-5,64927.0,O=P(O)(O)O.O=P(O)(O)O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
NCGC00256269-01,tox21-er-bla-agonist-p2,Ranitidine,activity,inactive,66357-35-5,3001055.0,[O-][N+](=O)\C=C(/NC)NCCSCc1ccc(CN(C)C)o1
NCGC00255240-01,tox21-er-bla-agonist-p2,Fensulfothion,activity,inactive,115-90-2,8292.0,O=S(C)c1ccc(OP(=S)(OCC)OCC)cc1
NCGC00255419-01,tox21-er-bla-agonist-p2,Sodium dichloroacetate,activity,inactive,2156-56-1,517326.0,[Na+].ClC(Cl)C([O-])=O
NCGC00255464-01,tox21-er-bla-agonist-p2,Terpineol,activity,inactive,8000-41-7,17100.0,CC1=CCC(CC1)C(O)(C)C
NCGC00093656-01,tox21-er-bla-agonist-p2,Brivudine,activity,inactive,69304-47-8,446727.0,Br\C=C\C1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00167428-01,tox21-er-bla-agonist-p2,Ibandronate sodium,activity,inactive,138844-81-2,23670359.0,[Na+].OC(CCN(C)CCCCC)(P(O)([O-])=O)P(=O)(O)O
NCGC00094179-02,tox21-er-bla-agonist-p2,Methapyrilene hydrochloride,activity,inactive,135-23-9,8667.0,Cl.CN(C)CCN(Cc1cccs1)c2ccccn2
NCGC00167458-01,tox21-er-bla-agonist-p2,Cefonicid sodium,activity,inactive,61270-78-8,43593.0,[Na+].[Na+].[O-]S(=O)(=O)Cn4nnnc4SCC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](O)c1ccccc1)C=3C([O-])=O
NCGC00167468-01,tox21-er-bla-agonist-p2,Benorylate,activity,inactive,5003-48-5,21102.0,O=C(C)Oc2ccccc2C(=O)Oc1ccc(NC(C)=O)cc1
NCGC00163927-04,tox21-er-bla-agonist-p2,Triclopyr,activity,inactive,55335-06-3,41428.0,Clc1cc(Cl)c(Cl)nc1OCC(=O)O
NCGC00094859-01,tox21-er-bla-agonist-p2,Bekanamycin sulfate,activity,inactive,29701-07-3,636396.0,O=S(=O)(O)O.N[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00160353-01,tox21-er-bla-agonist-p2,Nafenopin,activity,inactive,3771-19-5,19592.0,O=C(O)C(C)(C)Oc1ccc(cc1)C3CCCc2ccccc23
NCGC00095073-01,tox21-er-bla-agonist-p2,Ramifenazone,activity,inactive,3615-24-5,5037.0,CC(C)NC=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00164613-01,tox21-er-bla-agonist-p2,Epalrestat,activity,inactive,82159-09-9,1584822.0,OC(=O)CN1C(=O)C(\SC1=S)=CC(\C)=C\c2ccccc2
NCGC00095837-01,tox21-er-bla-agonist-p2,trans-Nerolidol,activity,inactive,40716-66-3,5284507.0,C/C(C)=C\CCC(\C)=C\CCC(C)(O)C=C
NCGC00160668-01,tox21-er-bla-agonist-p2,Sulfabenz,activity,inactive,127-77-5,31390.0,Nc1ccc(cc1)S(=O)(=O)Nc2ccccc2
NCGC00181128-01,tox21-er-bla-agonist-p2,Phentoloxamine PAS,activity,inactive,NOCAS_48767,223866.0,O=C(O)c1ccc(N)cc1O.CN(C)CCOc2ccccc2Cc1ccccc1
NCGC00159332-02,tox21-er-bla-agonist-p2,Cephalothin,activity,active agonist,153-61-7,6024.0,O=C(O)C=2N3C(=O)[C@@H](NC(=O)Cc1cccs1)[C@H]3SCC=2COC(C)=O
NCGC00167562-01,tox21-er-bla-agonist-p2,Buquinolate,activity,inactive,5486-03-3,21651.0,CC(C)COc1cc2ncc(c(O)c2cc1OCC(C)C)C(=O)OCC
NCGC00159383-02,tox21-er-bla-agonist-p2,Propyl benzoate,activity,inactive,2315-68-6,16846.0,O=C(OCCC)c1ccccc1
NCGC00159395-02,tox21-er-bla-agonist-p2,Phenicarbazide,activity,inactive,103-03-7,61002.0,NC(=O)NNc1ccccc1
NCGC00183834-01,tox21-er-bla-agonist-p2,"Diethyl 2,2'-(hexane-1,6-diylbis{6'-[(2,3,4,6-tetra-O-acetyl-a-D-mannopyranosyl)oxy]biphenyl-3',3-diyl})diacetate",activity,inactive,243120-89-0,53315139.0,CC(=O)O[C@H]6[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O[C@@H]6Oc2ccc(cc2c1cccc(CC(=O)OCC)c1)CCCCCCc4ccc(O[C@H]3O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]3OC(C)=O)c(c4)c5cccc(CC(=O)OCC)c5
NCGC00254991-01,tox21-er-bla-agonist-p2,Sulfentrazone,activity,inactive,122836-35-5,86369.0,CS(=O)(=O)Nc1cc(c(Cl)cc1Cl)N2N=C(C)N(C2=O)C(F)F
NCGC00183872-01,tox21-er-bla-agonist-p2,Brotizolam,activity,inactive,57801-81-7,2451.0,Clc4ccccc4C2=NCc1nnc(C)n1c3sc(Br)cc23
NCGC00254552-01,tox21-er-bla-agonist-p2,Prallethrin,activity,inactive,23031-36-9,16760153.0,O=C2C[C@@H](OC(=O)[C@H]1[C@H](/C=C(\C)C)C1(C)C)C(C)=C2CC#C
NCGC00255255-01,tox21-er-bla-agonist-p2,Metformin,activity,inactive,657-24-9,4091.0,N=C(N)NC(=N)N(C)C
NCGC00254670-01,tox21-er-bla-agonist-p2,8-Hydroxyquinoline-5-sulfonic acid hydrate (1:x),activity,inactive,207386-92-3,2723649.0,O.O=S(=O)(O)c1ccc(O)c2ncccc12
NCGC00254294-01,tox21-er-bla-agonist-p2,Butylparaben,activity,active agonist,94-26-8,7184.0,Oc1ccc(cc1)C(=O)OCCCC
NCGC00255392-01,tox21-er-bla-agonist-p2,"Benzenamine, N-(1-ethylpropyl)-4,5-dimethyl-",activity,inactive,56038-89-2,91984.0,CCC(CC)Nc1cc(C)c(C)cc1
NCGC00254800-01,tox21-er-bla-agonist-p2,Chlorethoxyfos,activity,inactive,54593-83-8,91655.0,CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl
NCGC00254058-01,tox21-er-bla-agonist-p2,Naphthalene,activity,inactive,91-20-3,931.0,c1cccc2ccccc12
NCGC00254872-01,tox21-er-bla-agonist-p2,(S)-4-Isopropenyl-1-cyclohexene-1-carboxaldehyde,activity,inactive,18031-40-8,2724159.0,CC(=C)[C@@H]1CC=C(C=O)CC1
NCGC00254510-01,tox21-er-bla-agonist-p2,Chlorthal-dimethyl,activity,inactive,1861-32-1,2943.0,Clc1c(C(=O)OC)c(Cl)c(Cl)c(C(=O)OC)c1Cl
NCGC00254109-01,tox21-er-bla-agonist-p2,MK-812,activity,inactive,851916-42-2,60196412.0,CO[C@@H]4COCC[C@@H]4[NH2+][C@H]1C[C@](CC1)(C(=O)N2Cc3cc(cnc3CC2)C(F)(F)F)C(C)C.[O-]C(=O)CCC(=O)O
NCGC00181788-01,tox21-er-bla-agonist-p2,Cefetamet pivoxil HCl,activity,inactive,111696-23-2,5485221.0,Cl.CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)C(=N\OC)\c1csc(N)n1)C=3C(=O)OCOC(=O)C(C)(C)C
NCGC00257959-01,tox21-er-bla-agonist-p2,"1,4-Dithiane",activity,inactive,505-29-3,10452.0,C1CSCCS1
NCGC00258020-01,tox21-er-bla-agonist-p2,Diisooctyl phthalate,activity,inactive,27554-26-3,33934.0,CC(C)CCCCCOC(=O)c1ccccc1C(=O)OCCCCCC(C)C
NCGC00258229-01,tox21-er-bla-agonist-p2,"3,4-Dichlorophenol",activity,active agonist,95-77-2,7258.0,Oc1cc(Cl)c(Cl)cc1
NCGC00258462-01,tox21-er-bla-agonist-p2,Octylparaben,activity,active agonist,1219-38-1,14642.0,Oc1ccc(cc1)C(=O)OCCCCCCCC
NCGC00255529-01,tox21-er-bla-agonist-p2,Diisopropyl phthalate,activity,inactive,605-45-8,11799.0,CC(C)OC(=O)c1ccccc1C(=O)OC(C)C
NCGC00259078-01,tox21-er-bla-agonist-p2,"4-Nonylphenol, branched",activity,active agonist,84852-15-3,338733.0,Oc1ccc(CCCCCCC(C)C)cc1
NCGC00259778-01,tox21-er-bla-agonist-p2,Cadmium chloride,activity,active agonist,10108-64-2,24633.0,[Cd+2].[Cl-].[Cl-]
NCGC00260336-01,tox21-er-bla-agonist-p2,C.I. Basic Violet 14,activity,inactive,632-99-5,12447.0,Cl.N=C1C=C/C(C=C1)=C(\c2ccc(N)c(C)c2)c3ccc(N)cc3
NCGC00256698-01,tox21-er-bla-agonist-p2,"1,8-Octanedithiol",activity,inactive,1191-62-4,14493.0,SCCCCCCCCS
NCGC00256681-01,tox21-er-bla-agonist-p2,Sodium 4-vinylbenzenesulfonate,activity,inactive,2695-37-6,3571582.0,[Na+].O=S([O-])(=O)c1ccc(C=C)cc1
NCGC00257390-01,tox21-er-bla-agonist-p2,4-tert-Butylbenzenethiol,activity,inactive,2396-68-1,75454.0,CC(C)(C)c1ccc(S)cc1
NCGC00258994-01,tox21-er-bla-agonist-p2,Isopropyl acetate,activity,inactive,108-21-4,7915.0,CC(=O)OC(C)C
NCGC00257978-01,tox21-er-bla-agonist-p2,Cobalt(II) acetate,activity,inactive,71-48-7,6277.0,[Co+2].[O-]C(C)=O.[O-]C(C)=O
NCGC00258525-01,tox21-er-bla-agonist-p2,Chlorothiazide,activity,inactive,58-94-6,2720.0,NS(=O)(=O)c2cc1c(N=CNS1(=O)=O)cc2Cl
NCGC00256544-01,tox21-er-bla-agonist-p2,"2,5-Dithiobiurea",activity,inactive,142-46-1,2724564.0,NC(=S)NNC(N)=S
NCGC00259218-01,tox21-er-bla-agonist-p2,3-Pyridinecarbonitrile,activity,inactive,100-54-9,79.0,N#Cc1cccnc1
NCGC00256564-01,tox21-er-bla-agonist-p2,Hydroquinone dimethyl ether,activity,inactive,150-78-7,9016.0,COc1ccc(OC)cc1
NCGC00256597-01,tox21-er-bla-agonist-p2,Pentanoic acid,activity,inactive,109-52-4,7991.0,CCCCC(=O)O
NCGC00256863-01,tox21-er-bla-agonist-p2,Choline hydroxide,activity,inactive,123-41-1,31255.0,[OH-].C[N+](C)(C)CCO
NCGC00257112-01,tox21-er-bla-agonist-p2,"2,3-Dihydro-2,2-dimethyl-7-benzofuranol",activity,inactive,1563-38-8,15278.0,Oc1cccc2CC(C)(C)Oc12
NCGC00257375-01,tox21-er-bla-agonist-p2,4-Hydroxyacetophenone,activity,inactive,99-93-4,7469.0,O=C(C)c1ccc(O)cc1
NCGC00257625-01,tox21-er-bla-agonist-p2,Oxymetholone,activity,active agonist,434-07-1,5281034.0,O=C3C[C@@H]4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@]1(C)O)[C@@]4(C)C\C3=C\O
NCGC00257628-01,tox21-er-bla-agonist-p2,"1,1,2,2-Tetrachloroethane",activity,inactive,79-34-5,6591.0,ClC(Cl)C(Cl)Cl
NCGC00257641-01,tox21-er-bla-agonist-p2,2-Amino-4-chlorobenzothiazole,activity,inactive,19952-47-7,29872.0,Clc2cccc1sc(N)nc12
NCGC00257679-01,tox21-er-bla-agonist-p2,"2,6-Toluenediamine",activity,inactive,823-40-5,13205.0,Nc1cccc(N)c1C
NCGC00257685-01,tox21-er-bla-agonist-p2,"1,1-Dichloro-3,3-dimethylbutan-2-one",activity,inactive,22591-21-5,31432.0,CC(C)(C)C(=O)C(Cl)Cl
NCGC00257262-01,tox21-er-bla-agonist-p2,"N-(4-Chloro-2,5-dimethoxyphenyl)-3-oxobutanamide",activity,inactive,4433-79-8,78170.0,COc1cc(NC(=O)CC(C)=O)c(cc1Cl)OC
NCGC00257778-01,tox21-er-bla-agonist-p2,Polyethylene glycol di-(9Z)-9-octadecenyl ether,activity,inactive,9005-07-6,5378708.0,O=C(CCCCCCC/C=C\CCCCCCCC)OCCOC(=O)CCCCCCC/C=C\CCCCCCCC
NCGC00257986-01,tox21-er-bla-agonist-p2,"1,1'-Oxybis(4-nitrobenzene)",activity,inactive,101-63-3,7568.0,[O-][N+](=O)c1ccc(cc1)Oc2ccc(cc2)[N+]([O-])=O
NCGC00258219-01,tox21-er-bla-agonist-p2,Chlormadinone acetate,activity,inactive,302-22-7,9324.0,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(Cl)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00259094-01,tox21-er-bla-agonist-p2,4-Dimethylaminoantipyrine,activity,inactive,58-15-1,6009.0,CN(C)C=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00258344-01,tox21-er-bla-agonist-p2,Bromochloromethane,activity,inactive,74-97-5,6333.0,BrCCl
NCGC00258822-01,tox21-er-bla-agonist-p2,Triethylene glycol diacetate,activity,inactive,111-21-7,8098.0,O=C(C)OCCOCCOCCOC(C)=O
NCGC00258441-01,tox21-er-bla-agonist-p2,N-Acetyl-m-toluidine,activity,inactive,537-92-8,10843.0,O=C(C)Nc1cc(C)ccc1
NCGC00259312-01,tox21-er-bla-agonist-p2,"2,3,6-Trichlorophenol",activity,inactive,933-75-5,13618.0,Oc1c(Cl)ccc(Cl)c1Cl
NCGC00259331-01,tox21-er-bla-agonist-p2,Amitrole,activity,inactive,61-82-5,1639.0,Nc1ncnn1
NCGC00259801-01,tox21-er-bla-agonist-p2,"2,4,6-Trimethylphenol",activity,inactive,527-60-6,10698.0,Cc1cc(C)c(O)c(C)c1
NCGC00259987-01,tox21-er-bla-agonist-p2,Nitrofen,activity,inactive,1836-75-5,15787.0,Clc2cc(Cl)ccc2Oc1ccc(cc1)[N+]([O-])=O
NCGC00259435-01,tox21-er-bla-agonist-p2,Propranolol hydrochloride,activity,inactive,318-98-9,62882.0,Cl.CC(C)NCC(O)COc2cccc1ccccc12
NCGC00260674-01,tox21-er-bla-agonist-p2,"1,4-Cyclohexanedicarboxylic acid, 2,5-dioxo-, dimethyl ester",activity,inactive,6289-46-9,94866.0,COC(=O)C1CC(=O)C(CC1=O)C(=O)OC
NCGC00260536-01,tox21-er-bla-agonist-p2,Butyl benzyl phthalate,activity,active agonist,85-68-7,2347.0,O=C(OCc1ccccc1)c2ccccc2C(=O)OCCCC
NCGC00260181-01,tox21-er-bla-agonist-p2,"1-Ethyl-2,3-dimethylimidazolium bromide",activity,inactive,98892-76-3,60196374.0,Br.CN1C=CN(CC)C1C
NCGC00015824-07,tox21-er-bla-agonist-p2,Enprofylline,activity,inactive,41078-02-8,1676.0,O=C2NC(=O)N(CCC)c1ncnc12
NCGC00015928-04,tox21-er-bla-agonist-p2,Sulindac sulfone,activity,inactive,59973-80-7,5472495.0,CS(=O)(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C
NCGC00016284-01,tox21-er-bla-agonist-p2,Primaquine diphosphate,activity,inactive,63-45-6,6135.0,O=P(O)(O)O.O=P(O)(O)O.CC(CCCN)Nc1cc(cc2cccnc12)OC
NCGC00016391-05,tox21-er-bla-agonist-p2,Clioquinol,activity,inactive,130-26-7,2788.0,Oc1c(I)cc(Cl)c2cccnc12
NCGC00021569-04,tox21-er-bla-agonist-p2,Enalapril,activity,inactive,75847-73-3,5388962.0,OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)OCC
NCGC00255577-01,tox21-er-bla-agonist-p2,"2,4-Dichlorotoluene",activity,inactive,95-73-8,7254.0,Clc1cc(Cl)c(C)cc1
NCGC00254699-01,tox21-er-bla-agonist-p2,Fenbuconazole,activity,inactive,114369-43-6,86138.0,Clc3ccc(CCC(Cn1cncn1)(C#N)c2ccccc2)cc3
NCGC00254811-01,tox21-er-bla-agonist-p2,Lufenuron,activity,inactive,103055-07-8,71777.0,Clc2cc(NC(=O)NC(=O)c1c(F)cccc1F)c(Cl)cc2OC(F)(F)C(F)C(F)(F)F
NCGC00256448-01,tox21-er-bla-agonist-p2,Triisopropanolamine,activity,inactive,122-20-3,24730.0,CC(O)CN(CC(C)O)CC(O)C
NCGC00256357-01,tox21-er-bla-agonist-p2,2-Nitrophenol,activity,inactive,88-75-5,6947.0,O=[N+]([O-])c1ccccc1O
NCGC00254917-01,tox21-er-bla-agonist-p2,Barium chloride,activity,inactive,10361-37-2,25204.0,Cl[Ba]Cl
NCGC00015159-06,tox21-er-bla-agonist-p2,Betaxolol,activity,inactive,63659-18-7,2369.0,CC(C)NCC(O)COc1ccc(cc1)CCOCC2CC2
NCGC00015368-06,tox21-er-bla-agonist-p2,Dicyclomine,activity,inactive,77-19-0,3042.0,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
NCGC00016490-06,tox21-er-bla-agonist-p2,Flufenamic acid,activity,inactive,530-78-9,3371.0,FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)O
NCGC00090874-04,tox21-er-bla-agonist-p2,Piperonyl butoxide,activity,inactive,51-03-6,5794.0,CCCc1cc2OCOc2cc1COCCOCCOCCCC
NCGC00092299-01,tox21-er-bla-agonist-p2,Mifobate,activity,inactive,76541-72-5,60910.0,Clc1ccc(cc1)C(OP(=O)(OC)OC)P(=O)(OC)OC
NCGC00094956-01,tox21-er-bla-agonist-p2,Cephaloridine,activity,inactive,50-59-9,5773.0,[O-]C(=O)C=3N4C(=O)[C@@H](NC(=O)Cc1cccs1)[C@H]4SCC=3C[n+]2ccccc2
NCGC00095010-01,tox21-er-bla-agonist-p2,Thonzylamine hydrochloride,activity,inactive,63-56-9,6136.0,Cl.COc1ccc(cc1)CN(CCN(C)C)c2ncccn2
NCGC00096014-01,tox21-er-bla-agonist-p2,Salsalate,activity,inactive,552-94-3,5161.0,O=C(Oc1ccccc1C(=O)O)c2ccccc2O
NCGC00160527-01,tox21-er-bla-agonist-p2,Mosapride citrate,activity,inactive,112885-42-4,119583.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.Clc1cc(c(OCC)cc1N)C(=O)NCC3CN(Cc2ccc(F)cc2)CCO3
NCGC00167973-01,tox21-er-bla-agonist-p2,Eperisone hydrochloride,activity,inactive,56839-43-1,123698.0,Cl.CC(CN1CCCCC1)C(=O)c2ccc(CC)cc2
NCGC00168347-01,tox21-er-bla-agonist-p2,Betaprodine,activity,inactive,468-59-7,5284516.0,C[C@@H]1CN(C)CC[C@]1(OC(=O)CC)c2ccccc2
NCGC00181336-01,tox21-er-bla-agonist-p2,Fludarabine,activity,inactive,21679-14-1,657237.0,Nc3nc(F)nc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
NCGC00259638-01,tox21-er-bla-agonist-p2,Geranyl acetate,activity,inactive,105-87-3,1549026.0,C\C(C)=C\CCC(\C)=C\COC(C)=O
NCGC00095191-01,tox21-er-bla-agonist-p2,Oseltamivir tartrate,activity,inactive,NOCAS_45954,16667738.0,O=C(O)C(O)C(O)C(=O)O.O=C(OCC)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
NCGC00095896-01,tox21-er-bla-agonist-p2,Canthaxanthin,activity,active agonist,514-78-3,5281227.0,O=C2CCC(C)(C)C(/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C)=C2C
NCGC00159465-02,tox21-er-bla-agonist-p2,Cefazolin,activity,inactive,25953-19-9,33255.0,O=C(O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nnc(C)s2
NCGC00159505-02,tox21-er-bla-agonist-p2,"Octadecanoic acid, monoester with 1,2-propanediol",activity,inactive,1323-39-3,14878.0,CC(O)COC(=O)CCCCCCCCCCCCCCCCC
NCGC00166306-01,tox21-er-bla-agonist-p2,Argipressin acetate,activity,active agonist,129979-57-3,9549168.0,CC(=O)O.NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00178782-02,tox21-er-bla-agonist-p2,Dicloxacillin sodium salt monohydrate,activity,inactive,13412-64-1,23675786.0,[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1c(Cl)cccc1Cl)[C@H]4SC3(C)C
NCGC00181043-01,tox21-er-bla-agonist-p2,Clobetasone butyrate,activity,inactive,25122-57-0,71386.0,ClCC(=O)[C@@]3(OC(=O)CCC)[C@@H](C)C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)C(=O)C[C@@]23C
NCGC00183598-01,tox21-er-bla-agonist-p2,Ximelagatran,activity,inactive,192939-46-1,9574101.0,O=C(NCc1ccc(cc1)C(\N)=N\O)[C@@H]3CCN3C(=O)[C@H](NCC(=O)OCC)C2CCCCC2
NCGC00254690-01,tox21-er-bla-agonist-p2,MGK-264,activity,inactive,113-48-4,8227.0,CCC(CCCC)CN3C(=O)C2C1CC(C=C1)C2C3=O
NCGC00018241-04,tox21-er-bla-agonist-p2,Betamipron,activity,inactive,3440-28-6,71651.0,O=C(NCCC(=O)O)c1ccccc1
NCGC00018271-03,tox21-er-bla-agonist-p2,Homochlorcyclizine,activity,inactive,848-53-3,3627.0,Clc1ccc(cc1)C(c2ccccc2)N3CCCN(C)CC3
NCGC00025335-01,tox21-er-bla-agonist-p2,Reboxetine mesylate,activity,inactive,98769-84-7,127150.0,CS(=O)(=O)O.CCOc3ccccc3O[C@H](c1ccccc1)[C@H]2CNCCO2
NCGC00256810-01,tox21-er-bla-agonist-p2,Midodrine hydrochloride,activity,inactive,3092-17-9,18340.0,Cl.COc1ccc(cc1C(O)CNC(=O)CN)OC
NCGC00256934-01,tox21-er-bla-agonist-p2,Triisopropyl orthoborate,activity,inactive,5419-55-6,21531.0,CC(C)OB(OC(C)C)OC(C)C
NCGC00258374-01,tox21-er-bla-agonist-p2,3-Methoxyaniline,activity,inactive,536-90-3,10824.0,Nc1cccc(OC)c1
NCGC00258596-01,tox21-er-bla-agonist-p2,"(1S,2R,5S)-(+)-Menthol",activity,inactive,15356-60-2,165675.0,CC(C)[C@H]1CC[C@H](C)C[C@@H]1O
NCGC00257834-01,tox21-er-bla-agonist-p2,1-Pentene,activity,inactive,109-67-1,8004.0,CCCC=C
NCGC00257935-01,tox21-er-bla-agonist-p2,"2,5-Dichloroaniline",activity,inactive,95-82-9,7262.0,Clc1ccc(Cl)c(N)c1
NCGC00255741-01,tox21-er-bla-agonist-p2,Ethyl orthoformate,activity,inactive,122-51-0,31214.0,CCOC(OCC)OCC
NCGC00255746-01,tox21-er-bla-agonist-p2,Butyl cyanoacetate,activity,inactive,5459-58-5,79571.0,O=C(CC#N)OCCCC
NCGC00256425-01,tox21-er-bla-agonist-p2,1-Methoxy-2-nitrobenzene,activity,inactive,91-23-6,7048.0,COc1ccccc1[N+]([O-])=O
NCGC00256536-01,tox21-er-bla-agonist-p2,Allyl isothiocyanate,activity,inactive,57-06-7,5971.0,C=CC\N=C=S
NCGC00255876-01,tox21-er-bla-agonist-p2,Monotridecyl phosphate,activity,inactive,5116-94-9,82161.0,OP(O)(=O)OCCCCCCCCCCCCC
NCGC00256132-01,tox21-er-bla-agonist-p2,1-(2-Hydroxyethyl)pyrrolidin-2-one,activity,inactive,3445-11-2,76980.0,O=C1CCCN1CCO
NCGC00256167-01,tox21-er-bla-agonist-p2,N-Ethyl-4-menthane-3-carboxamide,activity,inactive,39711-79-0,62907.0,CC(C)C1CCC(C)CC1C(=O)NCC
NCGC00255649-01,tox21-er-bla-agonist-p2,"Cyclohexanemethanol, 4-methyl-",activity,inactive,34885-03-5,118193.0,CC1CCC(CO)CC1
NCGC00259021-01,tox21-er-bla-agonist-p2,Methyl octanoate,activity,inactive,111-11-5,8091.0,O=C(CCCCCCC)OC
NCGC00260466-01,tox21-er-bla-agonist-p2,4-Hydroxyquinazoline,activity,inactive,491-36-1,63112.0,O=C2NC=Nc1ccccc12
NCGC00259625-01,tox21-er-bla-agonist-p2,Acrylonitrile,activity,inactive,107-13-1,7855.0,C=CC#N
NCGC00259734-01,tox21-er-bla-agonist-p2,Boric acid,activity,inactive,10043-35-3,7628.0,OB(O)O
NCGC00259834-01,tox21-er-bla-agonist-p2,Phosphoric acid,activity,inactive,7664-38-2,1004.0,O=P(O)(O)O
NCGC00256285-01,tox21-er-bla-agonist-p2,"2-Ethylanthracene-9,10-dione",activity,inactive,84-51-5,6772.0,CCc2ccc3C(=O)c1ccccc1C(=O)c3c2
NCGC00254947-01,tox21-er-bla-agonist-p2,Dimethyl phthalate,activity,inactive,131-11-3,8554.0,COC(=O)c1ccccc1C(=O)OC
NCGC00255185-01,tox21-er-bla-agonist-p2,Betamethasone valerate,activity,inactive,2152-44-5,16533.0,OCC(=O)[C@@]4(OC(=O)CCCC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00255598-01,tox21-er-bla-agonist-p2,4-tert-Butylbenzoic acid,activity,inactive,98-73-7,7403.0,CC(C)(C)c1ccc(cc1)C(=O)O
NCGC00254614-01,tox21-er-bla-agonist-p2,Carboxin,activity,inactive,5234-68-4,21307.0,O=C(Nc1ccccc1)C=2SCCOC=2C
NCGC00092310-03,tox21-er-bla-agonist-p2,Amisulpride,activity,inactive,71675-85-9,2159.0,CCN2CCCC2CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC
NCGC00166300-01,tox21-er-bla-agonist-p2,Pyridoxal phosphate hydrate,activity,inactive,41468-25-1,38882.0,O.Oc1c(C=O)c(cnc1C)COP(=O)(O)O
NCGC00167426-01,tox21-er-bla-agonist-p2,Caramiphen edisylate,activity,inactive,125-86-0,517304.0,O=S(=O)(O)CCS(=O)(=O)O.CCN(CC)CCOC(=O)C1(CCCC1)c2ccccc2.CCN(CCOC(=O)C1(CCCC1)c2ccccc2)CC
NCGC00163903-03,tox21-er-bla-agonist-p2,PFBS-K,activity,inactive,29420-49-3,23675274.0,[K+].FC(F)(C(F)(F)S([O-])(=O)=O)C(F)(F)C(F)(F)F
NCGC00094779-01,tox21-er-bla-agonist-p2,Salicyl alcohol,activity,inactive,90-01-7,5146.0,OCc1ccccc1O
NCGC00160363-01,tox21-er-bla-agonist-p2,Bumecaine,activity,inactive,30103-44-7,65770.0,CCCCN2CCCC2C(=O)Nc1c(C)cc(C)cc1C
NCGC00160409-01,tox21-er-bla-agonist-p2,Formetorex,activity,inactive,15302-18-8,65614.0,CC(NC=O)Cc1ccccc1
NCGC00160419-01,tox21-er-bla-agonist-p2,Clofenoxyde,activity,inactive,3030-53-3,194699.0,ClCC(=O)c1ccc(cc1)Oc2ccc(cc2)C(=O)CCl
NCGC00095117-01,tox21-er-bla-agonist-p2,Clarithromycin,activity,inactive,81103-11-9,5284534.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2C(C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)OC)[C@@H]3O
NCGC00160458-01,tox21-er-bla-agonist-p2,Lozilurea,activity,inactive,71475-35-9,68907.0,Clc1cc(CNC(=O)NCC)ccc1
NCGC00164555-01,tox21-er-bla-agonist-p2,Entacapone,activity,inactive,130929-57-6,5281081.0,Oc1cc(\C=C(/C#N)C(=O)N(CC)CC)cc([N+]([O-])=O)c1O
NCGC00164584-01,tox21-er-bla-agonist-p2,Cetraxate hydrochloride,activity,inactive,27724-96-5,34001.0,Cl.NC[C@H]1CC[C@@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2
NCGC00164597-01,tox21-er-bla-agonist-p2,Ropivacaine hydrochloride,activity,inactive,98717-15-8,175804.0,Cl.CCCN2CCCC[C@H]2C(=O)Nc1c(C)cccc1C
NCGC00168248-01,tox21-er-bla-agonist-p2,Benzoylecgonine,activity,inactive,519-09-5,448223.0,CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)O
NCGC00095778-01,tox21-er-bla-agonist-p2,Glycyrrhizin,activity,inactive,1405-86-3,14982.0,O=C(O)[C@H]7O[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@H](O[C@@H]6O[C@H]2CC[C@]3(C)[C@H]4C(=O)C=C1[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]1(C)[C@]4(C)CC[C@H]3C2(C)C)C(=O)O)C(=O)O)[C@H](O)[C@@H](O)[C@@H]7O
NCGC00160566-01,tox21-er-bla-agonist-p2,Broquinaldol,activity,inactive,15599-52-7,65620.0,Oc1c(Br)cc(Br)c2ccc(C)nc12
NCGC00168786-02,tox21-er-bla-agonist-p2,Deserpidine,activity,inactive,131-01-1,8550.0,COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccccc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC
NCGC00160656-01,tox21-er-bla-agonist-p2,Verazide,activity,inactive,93-47-0,9574235.0,O=C(N/N=C/c1ccc(OC)c(OC)c1)c2ccncc2
NCGC00159342-02,tox21-er-bla-agonist-p2,Benzathine penicillin G,activity,inactive,1538-09-6,15232.0,OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SC2(C)C.O=C(O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SC2(C)C.c1ccccc1CNCCNCc2ccccc2
NCGC00161636-01,tox21-er-bla-agonist-p2,Iodophthalein,activity,inactive,386-17-4,75195.0,IC1=CC(\C=C(I)C1=O)=C(/c2cc(I)c(O)c(I)c2)c3ccccc3C(=O)O
NCGC00091009-03,tox21-er-bla-agonist-p2,17-Methyltestosterone,activity,active agonist,58-18-4,6010.0,O=C4CC[C@@]3(C)C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@]1(C)O)=C4
NCGC00181910-01,tox21-er-bla-agonist-p2,"N,N-Dimethyl-2-(2-phenylacetamido)acetamide",activity,inactive,25439-20-7,32995.0,O=C(Cc1ccccc1)NCC(=O)N(C)C
NCGC00182031-01,tox21-er-bla-agonist-p2,Etizolam,activity,inactive,40054-69-1,3307.0,Clc1ccccc1C4=NCc2nnc(C)n2c3sc(cc34)CC
NCGC00183014-01,tox21-er-bla-agonist-p2,Sulfamethomidine,activity,inactive,3772-76-7,19596.0,Cc2nc(NS(=O)(=O)c1ccc(N)cc1)cc(OC)n2
NCGC00183835-01,tox21-er-bla-agonist-p2,Cloforex,activity,inactive,14261-75-7,26602.0,Clc1ccc(CC(C)(C)NC(=O)OCC)cc1
NCGC00183864-01,tox21-er-bla-agonist-p2,Adesulfone sodium,activity,inactive,144-75-2,8954.0,[Na+].[Na+].O=S(=O)(c1ccc(NCS([O-])=O)cc1)c2ccc(NCS([O-])=O)cc2
NCGC00255013-01,tox21-er-bla-agonist-p2,"Chlorinated paraffins: C12, 60% chlorine",activity,inactive,NOCAS_24824,22833489.0,ClC(CC(Cl)C(Cl)C(Cl)CC)C(Cl)C(C)Cl
NCGC00255019-01,tox21-er-bla-agonist-p2,Butralin,activity,inactive,33629-47-9,36565.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1NC(C)CC)C(C)(C)C
NCGC00247354-02,tox21-er-bla-agonist-p2,Alfentanil hydrochloride,activity,inactive,69049-06-5,64761.0,Cl.CCC(=O)N(c1ccccc1)C2(COC)CCN(CC2)CCN3N=NN(CC)C3=O
NCGC00247676-01,tox21-er-bla-agonist-p2,N-Norcodeine hydrochloride,activity,inactive,14648-14-7,60196311.0,Cl.COc1ccc2C[C@H]4NCC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00254285-01,tox21-er-bla-agonist-p2,Pentyl acetate,activity,inactive,628-63-7,12348.0,CC(=O)OCCCCC
NCGC00247706-01,tox21-er-bla-agonist-p2,"(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate hydrochloride",activity,inactive,1639-60-7,15424.0,Cl.CN(C)C[C@@H](C)[C@@](OC(=O)CC)(Cc1ccccc1)c2ccccc2
NCGC00247727-01,tox21-er-bla-agonist-p2,"N,N-Dipropyltryptamine hydrochloride",activity,inactive,7558-73-8,24721009.0,Cl.CCCN(CCC)CCc2cnc1ccccc12
NCGC00255389-01,tox21-er-bla-agonist-p2,Procarbazine hydrochloride,activity,inactive,366-70-1,9703.0,Cl.CC(C)NC(=O)c1ccc(CNNC)cc1
NCGC00255297-01,tox21-er-bla-agonist-p2,Oxadixyl,activity,inactive,77732-09-3,53735.0,O=C2OCCN2N(C(=O)COC)c1c(C)cccc1C
NCGC00254953-01,tox21-er-bla-agonist-p2,(E)-11-Tetradecen-1-ol acetate,activity,inactive,33189-72-9,5367650.0,CC(=O)OCCCCCCCCCC\C=C\CC
NCGC00181785-01,tox21-er-bla-agonist-p2,Aprepitant,activity,inactive,170729-80-3,60196364.0,C[C@@H](O[C@H]2OCCN(CC1=NC(=O)N=N1)[C@H]2C3CCC(F)CC3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F
NCGC00181796-01,tox21-er-bla-agonist-p2,Octreotide,activity,inactive,83150-76-9,6400441.0,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]5CSSC[C@H](NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc4cnc3ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)O)C(=O)N5
NCGC00260096-01,tox21-er-bla-agonist-p2,Yangonin,activity,inactive,500-62-9,5281575.0,COC=2C=C(/C=C/c1ccc(OC)cc1)OC(=O)C=2
NCGC00256699-01,tox21-er-bla-agonist-p2,trans-2-Methoxycinnamaldehyde,activity,inactive,60125-24-8,641298.0,COc1ccccc1/C=C/C=O
NCGC00256737-01,tox21-er-bla-agonist-p2,Timolol maleate salt,activity,inactive,26921-17-5,5281056.0,O[C@H](COc1nsnc1N2CCOCC2)CNC(C)(C)C.O=C(O)/C=C\C(=O)O
NCGC00167492-01,tox21-er-bla-agonist-p2,Lercanidipine hydrochloride,activity,inactive,132866-11-6,157917.0,Cl.CC=3NC(C)=C(C(C=3C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c2ccccc2)c4cccc(c4)[N+]([O-])=O)C(=O)OC
NCGC00181023-01,tox21-er-bla-agonist-p2,Nolatrexed dihydrochloride,activity,inactive,152946-68-4,108188.0,Cl.Cl.NC3=Nc2ccc(C)c(Sc1ccncc1)c2C(=O)N3
NCGC00256825-01,tox21-er-bla-agonist-p2,"Manganese, tricarbonyl[(1,2,3,4,5-.eta.)-1-methyl-2,4-cyclopentadien-1-yl]-",activity,inactive,12108-13-3,60196372.0,[Mn+].[C-]#[O+].[O+]#[C-].CC1C=[C-]C=C1.[O+]#[C-]
NCGC00258195-01,tox21-er-bla-agonist-p2,2-Amino-6-ethoxybenzothiazole,activity,inactive,94-45-1,7192.0,CCOc1ccc2nc(N)sc2c1
NCGC00258490-01,tox21-er-bla-agonist-p2,"D-Gluco-heptonic acid, monosodium salt",activity,inactive,31138-65-5,23664054.0,[Na+].O[C@H]([C@@H](O)[C@@H](O)C([O-])=O)[C@H](O)[C@H](O)CO
NCGC00258752-01,tox21-er-bla-agonist-p2,Triasulfuron,activity,inactive,82097-50-5,73282.0,Cc2nc(NC(=O)NS(=O)(=O)c1ccccc1OCCCl)nc(OC)n2
NCGC00258998-01,tox21-er-bla-agonist-p2,Chloralose,activity,inactive,15879-93-3,7057995.0,OC[C@@H](O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl
NCGC00255989-01,tox21-er-bla-agonist-p2,Indene,activity,inactive,95-13-6,7219.0,c1cccc2CC=Cc12
NCGC00256614-01,tox21-er-bla-agonist-p2,Sodium thiocyanate,activity,inactive,540-72-7,516871.0,[Na+].[S-]C#N
NCGC00256281-01,tox21-er-bla-agonist-p2,"Urea, (3-silylpropyl)-, Si-(ethoxy and methoxy) derivs.",activity,inactive,116912-64-2,90258.0,CCO[Si](OCC)(OCC)CCCNC(N)=O
NCGC00257091-01,tox21-er-bla-agonist-p2,Hexamethylcyclotrisiloxane,activity,inactive,541-05-9,10914.0,C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1
NCGC00257805-01,tox21-er-bla-agonist-p2,2-Amino-4-methoxybenzothiazole,activity,inactive,5464-79-9,21622.0,COc1cccc2sc(N)nc12
NCGC00257374-01,tox21-er-bla-agonist-p2,4-tert-Butylphenyl salicylate,activity,inactive,87-18-3,66597.0,Oc2ccccc2C(=O)Oc1ccc(cc1)C(C)(C)C
NCGC00257739-01,tox21-er-bla-agonist-p2,2-Pentenenitrile,activity,inactive,13284-42-9,25833.0,CCC=CC#N
NCGC00257527-01,tox21-er-bla-agonist-p2,2-Hydroxyacetophenone,activity,inactive,118-93-4,8375.0,O=C(C)c1ccccc1O
NCGC00258520-01,tox21-er-bla-agonist-p2,Ribavirin,activity,inactive,36791-04-5,37542.0,NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
NCGC00259015-01,tox21-er-bla-agonist-p2,4-Nitrotoluene,activity,inactive,99-99-0,7473.0,Cc1ccc(cc1)[N+](=O)[O-]
NCGC00258816-01,tox21-er-bla-agonist-p2,1-Nitro-2-(trifluoromethyl)benzene,activity,inactive,384-22-5,9795.0,O=[N+]([O-])c1ccccc1C(F)(F)F
NCGC00258640-01,tox21-er-bla-agonist-p2,Diethylene glycol diacrylate,activity,inactive,4074-88-8,19996.0,O=C(OCCOCCOC(=O)C=C)C=C
NCGC00258476-01,tox21-er-bla-agonist-p2,Allopurinol,activity,inactive,315-30-0,2094.0,Oc2ncnc1nncc12
NCGC00258478-01,tox21-er-bla-agonist-p2,Barbituric acid,activity,inactive,67-52-7,6211.0,O=C1CC(=O)NC(=O)N1
NCGC00258675-01,tox21-er-bla-agonist-p2,4-Hexyl-4'-cyanobiphenyl,activity,inactive,41122-70-7,38764.0,N#Cc1ccc(cc1)c2ccc(CCCCCC)cc2
NCGC00259276-01,tox21-er-bla-agonist-p2,Linolenic acid,activity,inactive,463-40-1,5280934.0,O=C(O)CCCCCCC/C=C\C/C=C\C/C=C\CC
NCGC00259148-01,tox21-er-bla-agonist-p2,"N,N,N',N',N'',N''-Hexakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine",activity,inactive,3089-11-0,62479.0,COCN(COC)c1nc(nc(n1)N(COC)COC)N(COC)COC
NCGC00259747-01,tox21-er-bla-agonist-p2,Phenylhydrazine hydrochloride,activity,inactive,59-88-1,60962.0,Cl.NNc1ccccc1
NCGC00259465-01,tox21-er-bla-agonist-p2,Nefiracetam,activity,inactive,77191-36-7,71157.0,O=C2CCCN2CC(=O)Nc1c(C)cccc1C
NCGC00259474-01,tox21-er-bla-agonist-p2,4-Hydroxy-3-methoxybenzaldehyde,activity,inactive,121-33-5,1183.0,Oc1ccc(cc1OC)C=O
NCGC00259929-01,tox21-er-bla-agonist-p2,Cyclohexylamine,activity,inactive,108-91-8,7965.0,NC1CCCCC1
NCGC00260359-01,tox21-er-bla-agonist-p2,"1,2-Pyrrolidinedicarboxylicacid,4-fluoro-,1-(1,1-dimethylethyl)ester,(2S,4S)-",activity,inactive,203866-13-1,2756017.0,CC(C)(C)OC(=O)N1C[C@@H](F)C[C@H]1C(=O)O
NCGC00260380-01,tox21-er-bla-agonist-p2,"Dodecane,1-iodo-",activity,inactive,4292-19-7,20282.0,CCCCCCCCCCCCI
NCGC00260676-01,tox21-er-bla-agonist-p2,Tri-o-cresyl phosphate,activity,inactive,78-30-8,6527.0,Cc3ccccc3OP(=O)(Oc1ccccc1C)Oc2ccccc2C
NCGC00015643-07,tox21-er-bla-agonist-p2,Metoclopramide,activity,inactive,364-62-5,4168.0,Nc1cc(OC)c(cc1Cl)C(=O)NCCN(CC)CC
NCGC00015680-11,tox21-er-bla-agonist-p2,Melatonin,activity,inactive,73-31-4,896.0,CC(=O)NCCc2cnc1ccc(cc12)OC
NCGC00015335-07,tox21-er-bla-agonist-p2,Diphenhydramine,activity,inactive,58-73-1,3100.0,CN(C)CCOC(c1ccccc1)c2ccccc2
NCGC00016288-01,tox21-er-bla-agonist-p2,Bemegride,activity,inactive,64-65-3,2310.0,CCC1(C)CC(=O)NC(=O)C1
NCGC00016715-01,tox21-er-bla-agonist-p2,Trapidil,activity,inactive,15421-84-8,5531.0,CCN(CC)c1cc(C)nc2ncnn12
NCGC00016617-01,tox21-er-bla-agonist-p2,Mebeverine hydrochloride,activity,inactive,2753-45-9,17683.0,Cl.COc1cc(ccc1OC)C(=O)OCCCCN(CC)C(C)Cc2ccc(OC)cc2
NCGC00016817-01,tox21-er-bla-agonist-p2,Etomidate,activity,inactive,33125-97-2,36339.0,CC(c1ccccc1)n2cncc2C(=O)OCC
NCGC00016688-02,tox21-er-bla-agonist-p2,Vitamin E,activity,inactive,59-02-9,14985.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(O1)c(C)c(C)c(O)c2C
NCGC00016708-01,tox21-er-bla-agonist-p2,Selegiline hydrochloride,activity,inactive,14611-52-0,26758.0,Cl.C#CCN(C)[C@H](C)Cc1ccccc1
NCGC00181107-01,tox21-er-bla-agonist-p2,Arotinolol hydrochloride,activity,inactive,68377-91-3,155032.0,Cl.OC(CSc1nc(cs1)c2ccc(s2)C(N)=O)CNC(C)(C)C
NCGC00255170-01,tox21-er-bla-agonist-p2,Trimethylamine,activity,inactive,75-50-3,1146.0,CN(C)C
NCGC00254501-01,tox21-er-bla-agonist-p2,Tolazamide,activity,inactive,1156-19-0,5503.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2
NCGC00254416-01,tox21-er-bla-agonist-p2,Safrole,activity,inactive,94-59-7,5144.0,C=CCc1ccc2OCOc2c1
NCGC00254479-01,tox21-er-bla-agonist-p2,Besonprodil,activity,inactive,253450-09-8,156328.0,Fc1ccc(cc1)CC2CCN(CC2)CCS(=O)c3ccc4NC(=O)Oc4c3
NCGC00016585-01,tox21-er-bla-agonist-p2,Procyclidine hydrochloride,activity,inactive,1508-76-5,207841.0,Cl.OC(CCN1CCCC1)(c2ccccc2)C3CCCCC3
NCGC00159439-02,tox21-er-bla-agonist-p2,Lorazepam,activity,inactive,846-49-1,3958.0,Clc3ccccc3C2=NC(O)C(=O)Nc1ccc(Cl)cc12
NCGC00164527-01,tox21-er-bla-agonist-p2,Lysine,activity,inactive,56-87-1,5962.0,N[C@@H](CCCCN)C(=O)O
NCGC00166066-01,tox21-er-bla-agonist-p2,Didecyldimethylammonium bromide,activity,inactive,2390-68-3,16957.0,[Br-].C[N+](C)(CCCCCCCCCC)CCCCCCCCCC
NCGC00166399-01,tox21-er-bla-agonist-p2,Imidocarb dipropionate,activity,inactive,55750-06-6,9983292.0,CCC(=O)O.CCC(=O)O.O=C(Nc1cc(ccc1)C2=NCCN2)Nc3cccc(c3)C4=NCCN4
NCGC00183103-01,tox21-er-bla-agonist-p2,Tocophersolan,activity,inactive,9002-96-4,9938056.0,O=C(OCCO)CCC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00018140-02,tox21-er-bla-agonist-p2,Miglustat,activity,inactive,72599-27-0,51634.0,OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1CCCC
NCGC00094861-01,tox21-er-bla-agonist-p2,Brucine,activity,inactive,357-57-3,442021.0,COc1cc2c(cc1OC)N5C(=O)C[C@@H]4OCC=C3CN7CC[C@]26[C@@H]7C[C@@H]3[C@@H]4[C@H]56
NCGC00095935-01,tox21-er-bla-agonist-p2,Cortisone,activity,inactive,53-06-5,222786.0,OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00159420-03,tox21-er-bla-agonist-p2,Oxyphenisatin acetate,activity,inactive,115-33-3,8269.0,CC(=O)Oc1ccc(cc1)C2(c3ccccc3NC2=O)c4ccc(OC(C)=O)cc4
NCGC00159432-02,tox21-er-bla-agonist-p2,Indigocarmine,activity,inactive,483-20-5,5282430.0,O=S(=O)(O)c1cc2C(=O)C(\Nc2cc1)=C4/Nc3ccc(cc3C4=O)S(=O)(=O)O
NCGC00164560-01,tox21-er-bla-agonist-p2,Abacavir,activity,inactive,136470-78-5,5742631.0,OC[C@@H]1C=C[C@H](C1)n3cnc2c(nc(N)nc23)NC4CC4
NCGC00254529-01,tox21-er-bla-agonist-p2,Butylbenzene,activity,inactive,104-51-8,7705.0,CCCCc1ccccc1
NCGC00016955-01,tox21-er-bla-agonist-p2,Ramipril,activity,inactive,87333-19-5,5362129.0,O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@@H]3CCC[C@H]23)C(=O)O
NCGC00090698-04,tox21-er-bla-agonist-p2,"1,3-Diphenylguanidine",activity,inactive,102-06-7,7594.0,N=C(Nc1ccccc1)Nc2ccccc2
NCGC00090874-02,tox21-er-bla-agonist-p2,Piperonyl butoxide,activity,inactive,51-03-6,5794.0,CCCc1cc2OCOc2cc1COCCOCCOCCCC
NCGC00023100-03,tox21-er-bla-agonist-p2,Alphaxalone,activity,inactive,23930-19-0,104845.0,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
NCGC00024378-05,tox21-er-bla-agonist-p2,Lobeline,activity,inactive,90-69-7,101616.0,CN2[C@H](CCC[C@H]2C[C@H](O)c1ccccc1)CC(=O)c3ccccc3
NCGC00024501-02,tox21-er-bla-agonist-p2,D-Glutamic acid,activity,inactive,6893-26-1,23327.0,OC(=O)CC[C@@H](N)C(=O)O
NCGC00024703-02,tox21-er-bla-agonist-p2,"Tropanyl 3,5-dimethylbenzoate",activity,inactive,85181-40-4,68600.0,CN3[C@H]1CC[C@@H]3CC(C1)OC(=O)c2cc(C)cc(C)c2
NCGC00066947-05,tox21-er-bla-agonist-p2,Triadimenol,activity,inactive,55219-65-3,41368.0,CC(C)(C)C(O)C(Oc1ccc(Cl)cc1)n2cncn2
NCGC00256765-01,tox21-er-bla-agonist-p2,"Isocyanic acid, polymethylenepolyphenylene ester",activity,inactive,9016-87-9,7570.0,O=C=N/c1ccc(cc1)Cc2ccc(/N=C=O)cc2
NCGC00256956-01,tox21-er-bla-agonist-p2,Methacrylonitrile,activity,inactive,126-98-7,31368.0,C=C(C)C#N
NCGC00257142-01,tox21-er-bla-agonist-p2,5-Aminosalicylic acid,activity,inactive,89-57-6,4075.0,OC(=O)c1cc(N)ccc1O
NCGC00257169-01,tox21-er-bla-agonist-p2,Azodicarbonamide,activity,inactive,123-77-3,31269.0,NC(=O)/N=N/C(N)=O
NCGC00257324-01,tox21-er-bla-agonist-p2,Methyl dihydrojasmonate,activity,inactive,24851-98-7,102861.0,COC(=O)CC1CCC(=O)C1CCCCC
NCGC00257369-01,tox21-er-bla-agonist-p2,Methoxyacetic acid,activity,inactive,625-45-6,12251.0,O=C(O)COC
NCGC00257496-01,tox21-er-bla-agonist-p2,Pentaerythritol,activity,inactive,115-77-5,8285.0,OCC(CO)(CO)CO
NCGC00257637-01,tox21-er-bla-agonist-p2,Norharman,activity,inactive,244-63-3,64961.0,c2cncc3nc1ccccc1c23
NCGC00257681-01,tox21-er-bla-agonist-p2,Sotalol hydrochloride,activity,inactive,959-24-0,66245.0,Cl.O=S(C)(=O)Nc1ccc(cc1)C(O)CNC(C)C
NCGC00257701-01,tox21-er-bla-agonist-p2,"1,2-Dichlorobutane",activity,inactive,616-21-7,12017.0,CCC(Cl)CCl
NCGC00257712-01,tox21-er-bla-agonist-p2,"2,3-Dimethylaniline",activity,inactive,87-59-2,6893.0,Cc1cccc(N)c1C
NCGC00258004-01,tox21-er-bla-agonist-p2,"1,6-Hexanediol",activity,inactive,629-11-8,12374.0,OCCCCCCO
NCGC00256749-01,tox21-er-bla-agonist-p2,Halofenozide,activity,inactive,112226-61-6,114994.0,O=C(NN(C(=O)c1ccccc1)C(C)(C)C)c2ccc(Cl)cc2
NCGC00256407-01,tox21-er-bla-agonist-p2,Aspartame,activity,inactive,22839-47-0,134601.0,O=C(O)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC
NCGC00256442-01,tox21-er-bla-agonist-p2,Cyproterone acetate,activity,inactive,427-51-0,9880.0,CC(=O)[C@@]4(OC(C)=O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C
NCGC00255791-01,tox21-er-bla-agonist-p2,Sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate,activity,inactive,75277-39-3,2724248.0,[Na+].OCCN1CCN(CC1)CCS([O-])(=O)=O
NCGC00255863-01,tox21-er-bla-agonist-p2,"1,3-Cyclohexanedione",activity,inactive,504-02-9,10434.0,O=C1CCCC(=O)C1
NCGC00255943-01,tox21-er-bla-agonist-p2,p-Methylacetophenone,activity,inactive,122-00-9,8500.0,Cc1ccc(cc1)C(=O)C
NCGC00256069-01,tox21-er-bla-agonist-p2,"1,10-Decanediol dimethacrylate",activity,inactive,6701-13-9,81196.0,C=C(C)C(=O)OCCCCCCCCCCOC(=O)C(=C)C
NCGC00256124-01,tox21-er-bla-agonist-p2,"Disodium benzene-1,3-disulfonate",activity,inactive,831-59-4,71577.0,[Na+].[Na+].O=S([O-])(=O)c1cccc(c1)S([O-])(=O)=O
NCGC00256179-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexanone",activity,inactive,873-94-9,13398.0,CC1CC(=O)CC(C)(C)C1
NCGC00260609-01,tox21-er-bla-agonist-p2,NTP Mix12 AR1 8-EQC,activity,inactive,NOCAS_49505,,
NCGC00259119-01,tox21-er-bla-agonist-p2,Chloropicrin,activity,inactive,76-06-2,6423.0,ClC(Cl)(Cl)[N+]([O-])=O
NCGC00259154-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorophenoxyacetic acid",activity,inactive,93-76-5,1480.0,Clc1cc(OCC(=O)O)c(Cl)cc1Cl
NCGC00259192-01,tox21-er-bla-agonist-p2,Ethyltriacetoxysilane,activity,inactive,17689-77-9,87244.0,O=C(C)O[Si](OC(C)=O)(OC(=O)C)CC
NCGC00259245-01,tox21-er-bla-agonist-p2,"4-Chloro-1,3-diaminobenzene",activity,inactive,5131-60-2,21209.0,Nc1ccc(Cl)c(N)c1
NCGC00260101-01,tox21-er-bla-agonist-p2,Dichlorodiphenylsilane,activity,inactive,80-10-4,6627.0,Cl[Si](Cl)(c1ccccc1)c2ccccc2
NCGC00260253-01,tox21-er-bla-agonist-p2,1-Ethyl-1-methylpyrrolidinium bromide,activity,inactive,69227-51-6,112264.0,[Br-].C[N+]1(CC)CCCC1
NCGC00254684-01,tox21-er-bla-agonist-p2,AM580,activity,inactive,102121-60-8,2126.0,O=C(O)c1ccc(cc1)NC(=O)c2ccc3c(c2)C(C)(C)CCC3(C)C
NCGC00256224-01,tox21-er-bla-agonist-p2,1-(2-Isocyanatopropan-2-yl)-3-(prop-1-en-2-yl)benzene,activity,inactive,2094-99-7,604152.0,C=C(C)c1cccc(c1)C(C)(C)\N=C=O
NCGC00256239-01,tox21-er-bla-agonist-p2,"2-Amino-2,4-dimethylpentanenitrile",activity,inactive,26842-43-3,92251.0,CC(C)CC(C)(N)C#N
NCGC00256352-01,tox21-er-bla-agonist-p2,Amitrole,activity,inactive,61-82-5,1639.0,Nc1ncnn1
NCGC00255087-01,tox21-er-bla-agonist-p2,2-Isopropoxyphenol,activity,inactive,4812-20-8,20949.0,CC(C)Oc1ccccc1O
NCGC00255270-01,tox21-er-bla-agonist-p2,Tris(2-chloropropyl) phosphate,activity,inactive,6145-73-9,22522.0,ClC(C)COP(=O)(OCC(Cl)C)OCC(C)Cl
NCGC00255282-01,tox21-er-bla-agonist-p2,"2,6-Dichlorobenzamide",activity,inactive,2008-58-4,16183.0,O=C(N)c1c(Cl)cccc1Cl
NCGC00255285-01,tox21-er-bla-agonist-p2,Diphenylhydantoin sodium,activity,inactive,630-93-3,657302.0,[Na+].O=C1[N-]C(=O)C(N1)(c2ccccc2)c3ccccc3
NCGC00255561-01,tox21-er-bla-agonist-p2,Dimetilan,activity,inactive,644-64-4,12572.0,O=C(N(C)C)n1nc(OC(=O)N(C)C)cc1C
NCGC00255641-01,tox21-er-bla-agonist-p2,4-Aminobenzamide,activity,inactive,2835-68-9,76079.0,O=C(N)c1ccc(N)cc1
NCGC00093792-01,tox21-er-bla-agonist-p2,Methyl L-DOPA hydrochloride,activity,inactive,1421-65-4,10131132.0,Cl.Oc1ccc(C[C@H](N)C(=O)OC)cc1O
NCGC00159398-02,tox21-er-bla-agonist-p2,Potassium warfarin,activity,inactive,2610-86-8,23706212.0,[K+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3
NCGC00159477-02,tox21-er-bla-agonist-p2,Phenylacetic acid,activity,inactive,103-82-2,999.0,OC(=O)Cc1ccccc1
NCGC00160369-01,tox21-er-bla-agonist-p2,Phanquinone,activity,inactive,84-12-8,6764.0,O=C2c1ncccc1c3cccnc3C2=O
NCGC00164503-01,tox21-er-bla-agonist-p2,Myralact,activity,inactive,15518-87-3,71873.0,OCCNCCCCCCCCCCCCCC.O=C(O)C(C)O
NCGC00164581-01,tox21-er-bla-agonist-p2,Estramustine,activity,active agonist,2998-57-4,259331.0,ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3
NCGC00095129-01,tox21-er-bla-agonist-p2,Valdecoxib,activity,inactive,181695-72-7,119607.0,NS(=O)(=O)c1ccc(cc1)c3c(C)onc3c2ccccc2
NCGC00095130-01,tox21-er-bla-agonist-p2,Moxifloxacin hydrochloride,activity,inactive,186826-86-8,101526.0,Cl.O=C(O)C2=CN(c1c(OC)c(c(F)cc1C2=O)N3C[C@@H]4CCCN[C@@H]4C3)C5CC5
NCGC00159320-03,tox21-er-bla-agonist-p2,Triamcinolone diacetate,activity,inactive,67-78-7,6216.0,CC(=O)OCC(=O)[C@@]3(O)[C@@H](C[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@@]4(F)[C@@H](O)C[C@@]23C)OC(C)=O
NCGC00166263-01,tox21-er-bla-agonist-p2,Antimony(V) sulfide,activity,inactive,1315-04-4,16683083.0,S=[Sb](=S)S[Sb](=S)=S
NCGC00183866-01,tox21-er-bla-agonist-p2,Oxypertine hydrochloride,activity,inactive,17506-66-0,24194514.0,Cl.COc3cc4nc(C)c(CCN1CCN(CC1)c2ccccc2)c4cc3OC
NCGC00254156-01,tox21-er-bla-agonist-p2,Sodium erythorbate (1:1),activity,inactive,6381-77-7,23683938.0,[Na+].OC=1C(=O)O[C@H]([C@H](O)CO)C=1[O-]
NCGC00188433-01,tox21-er-bla-agonist-p2,Hygromycin B,activity,inactive,31282-04-9,20054942.0,O[C@H]4[C@H](N)C[C@H](NC)[C@@H](O)[C@@H]4O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]1OC3(O[C@@H]12)O[C@@H]([C@H](O)[C@H](O)[C@H]3O)C(N)CO
NCGC00188863-01,tox21-er-bla-agonist-p2,Dronedarone,activity,inactive,141626-36-0,208898.0,CCCCN(CCCC)CCCOc1ccc(cc1)C(=O)c2c3cc(ccc3oc2CCCC)NS(C)(=O)=O
NCGC00247672-01,tox21-er-bla-agonist-p2,Etryptamine acetate,activity,inactive,118-68-3,8366.0,CC(=O)O.CCC(N)Cc2cnc1ccccc12
NCGC00254647-01,tox21-er-bla-agonist-p2,4-Pyridinecarbonitrile,activity,inactive,100-48-1,7506.0,N#Cc1ccncc1
NCGC00254671-01,tox21-er-bla-agonist-p2,Dimethylarsinic acid,activity,inactive,75-60-5,2513.0,C[As](C)(O)=O
NCGC00254314-01,tox21-er-bla-agonist-p2,Triisononyl trimellitate,activity,inactive,53894-23-8,104635.0,CC(C)CCCCCCOC(=O)c1cc(C(=O)OCCCCCCC(C)C)c(cc1)C(=O)OCCCCCCC(C)C
NCGC00254317-01,tox21-er-bla-agonist-p2,"2,4-Dinitrotoluene",activity,inactive,121-14-2,8461.0,Cc1ccc(cc1[N+](=O)[O-])[N+]([O-])=O
NCGC00254018-01,tox21-er-bla-agonist-p2,Michler's ketone,activity,active agonist,90-94-8,7031.0,CN(C)c1ccc(cc1)C(=O)c2ccc(cc2)N(C)C
NCGC00254088-01,tox21-er-bla-agonist-p2,Dibutyl decanedioate,activity,inactive,109-43-3,7986.0,O=C(CCCCCCCCC(=O)OCCCC)OCCCC
NCGC00183025-01,tox21-er-bla-agonist-p2,Biliscopin,activity,inactive,51022-74-3,3740.0,O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)COCCOCCOCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I
NCGC00183027-01,tox21-er-bla-agonist-p2,Propanidid,activity,inactive,1421-14-3,15004.0,COc1cc(ccc1OCC(=O)N(CC)CC)CC(=O)OCCC
NCGC00183030-01,tox21-er-bla-agonist-p2,Terodiline hydrochloride,activity,inactive,7082-21-5,23479.0,Cl.CC(C)(C)NC(C)CC(c1ccccc1)c2ccccc2
NCGC00181760-01,tox21-er-bla-agonist-p2,Lobenzarit sodium,activity,inactive,64808-48-6,47462.0,[Na+].[Na+].O=C([O-])c2ccc(Cl)cc2Nc1ccccc1C([O-])=O
NCGC00259681-01,tox21-er-bla-agonist-p2,N-Nitrosomorpholine,activity,inactive,59-89-2,6046.0,O=NN1CCOCC1
NCGC00260031-01,tox21-er-bla-agonist-p2,Actinomycin D,activity,inactive,50-76-0,457193.0,CC(C)[C@H]6NC(=O)[C@@H](NC(=O)c1ccc(C)c2OC3=C(C)C(=O)C(N)=C(C3=Nc12)C(=O)N[C@@H]5C(=O)N[C@@H](C(=O)N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C6=O
NCGC00260163-01,tox21-er-bla-agonist-p2,Ethyltributylphosphonium diethylphosphate,activity,inactive,20445-94-7,60196373.0,[O-]P(=O)(OCC)OCC.CC[P+](CCCC)(CCCC)CCCC
NCGC00258185-01,tox21-er-bla-agonist-p2,di-tert-Butyl-4-hydroxymethyl phenol,activity,inactive,88-26-6,6929.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CO
NCGC00258369-01,tox21-er-bla-agonist-p2,Hydrocortisone,activity,inactive,50-23-7,5754.0,OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00260300-01,tox21-er-bla-agonist-p2,Aminotrimethylene phosphonic acid,activity,inactive,6419-19-8,16698.0,OP(=O)(O)CN(CP(=O)(O)O)CP(=O)(O)O
NCGC00260548-01,tox21-er-bla-agonist-p2,Hexabromobenzene,activity,inactive,87-82-1,6905.0,Brc1c(Br)c(Br)c(Br)c(Br)c1Br
NCGC00258564-01,tox21-er-bla-agonist-p2,Azithromycin,activity,inactive,83905-01-5,447043.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@]2(C)O)[C@@H]3O
NCGC00258798-01,tox21-er-bla-agonist-p2,l-Tryptophan,activity,inactive,73-22-3,6305.0,O=C(O)[C@@H](N)Cc2cnc1ccccc12
NCGC00256707-01,tox21-er-bla-agonist-p2,Methyl (2E)-non-2-enoate,activity,inactive,14952-06-8,5368076.0,O=C(\C=C\CCCCCC)OC
NCGC00259092-01,tox21-er-bla-agonist-p2,Apigenin,activity,active agonist,520-36-5,5280443.0,Oc1ccc(cc1)C3=CC(=O)c2c(cc(O)cc2O)O3
NCGC00016413-01,tox21-er-bla-agonist-p2,Dydrogesterone,activity,inactive,152-62-5,9051.0,CC(=O)[C@H]2CC[C@H]3[C@@H]4C=CC1=CC(=O)CC[C@@]1(C)[C@@H]4CC[C@]23C
NCGC00259559-01,tox21-er-bla-agonist-p2,"2,6-Diethylaniline",activity,inactive,579-66-8,11369.0,CCc1cccc(CC)c1N
NCGC00259652-01,tox21-er-bla-agonist-p2,Dicyclohexyl sodium sulfosuccinate,activity,inactive,23386-52-9,23692768.0,[Na+].O=C(OC1CCCCC1)C(CC(=O)OC2CCCCC2)S([O-])(=O)=O
NCGC00258351-01,tox21-er-bla-agonist-p2,"1,3,5-Tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazinane-2,4,6-trione",activity,inactive,40601-76-1,93221.0,CC(C)(C)c4cc(C)c(CN3C(=O)N(Cc1c(C)c(O)c(cc1C)C(C)(C)C)C(=O)N(Cc2c(C)cc(c(O)c2C)C(C)(C)C)C3=O)c(C)c4O
NCGC00260511-01,tox21-er-bla-agonist-p2,9-Anthracenemethanol,activity,inactive,1468-95-7,73848.0,OCc2c3ccccc3cc1ccccc12
NCGC00016836-01,tox21-er-bla-agonist-p2,Apramycin,activity,inactive,37321-09-8,3081545.0,O[C@@H]4[C@@H](O)[C@H](N)[C@@H](CO)O[C@@H]4O[C@H]2O[C@H]3C[C@@H](N)[C@@H](O[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O)O[C@@H]3[C@H](O)[C@@H]2NC
NCGC00256922-01,tox21-er-bla-agonist-p2,Triisodecyl trimellitate,activity,inactive,36631-30-8,169794.0,CC(C)CCCCCCCOC(=O)c1cc(C(=O)OCCCCCCCC(C)C)c(cc1)C(=O)OCCCCCCCC(C)C
NCGC00257696-01,tox21-er-bla-agonist-p2,Phthalic anhydride,activity,inactive,85-44-9,6811.0,O=C1OC(=O)c2ccccc12
NCGC00258446-01,tox21-er-bla-agonist-p2,"2,3,4,4'-Tetrahydroxybenzophenone",activity,active agonist,31127-54-5,919792.0,Oc2ccc(C(=O)c1ccc(O)cc1)c(O)c2O
NCGC00255029-01,tox21-er-bla-agonist-p2,Pyraclostrobin,activity,active agonist,175013-18-0,6422843.0,O=C(OC)N(OC)c3ccccc3COc1ccn(n1)c2ccc(Cl)cc2
NCGC00256604-01,tox21-er-bla-agonist-p2,N-Butylurea,activity,inactive,592-31-4,11595.0,NC(=O)NCCCC
NCGC00256794-01,tox21-er-bla-agonist-p2,Isocetyl stearate,activity,inactive,25339-09-7,91410.0,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C
NCGC00256644-01,tox21-er-bla-agonist-p2,Geranyl tiglate,activity,inactive,7785-33-3,5367785.0,C\C(C)=C\CCC(\C)=C\COC(=O)C(\C)=C\C
NCGC00256811-01,tox21-er-bla-agonist-p2,Hexyl propanoate,activity,inactive,2445-76-3,88454.0,O=C(CC)OCCCCCC
NCGC00257177-01,tox21-er-bla-agonist-p2,2-Ethylhexyl methacrylate,activity,inactive,688-84-6,12713.0,O=C(OCC(CCCC)CC)C(=C)C
NCGC00258005-01,tox21-er-bla-agonist-p2,"1,4-Dichloro-2-butene",activity,inactive,764-41-0,15122.0,ClCC=CCCl
NCGC00257905-01,tox21-er-bla-agonist-p2,Prop-2-en-1-yl (3-methylbutoxy)acetate,activity,inactive,67634-00-8,106729.0,CC(C)CCOCC(=O)OCC=C
NCGC00257918-01,tox21-er-bla-agonist-p2,"1,1,2,2-Tetrabromoethane",activity,inactive,79-27-6,6588.0,BrC(Br)C(Br)Br
NCGC00257946-01,tox21-er-bla-agonist-p2,Dibromodichloromethane,activity,inactive,594-18-3,11659.0,BrC(Br)(Cl)Cl
NCGC00257333-01,tox21-er-bla-agonist-p2,Polyoxyethylene monoleate,activity,inactive,9004-96-0,5364420.0,O=C(CCCCCCC/C=C\CCCCCCCC)OCCO
NCGC00258184-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpyrrolidinium bis(trifluoromethylsulfonyl)imide,activity,inactive,223437-05-6,25171607.0,C[N+]1(CCC)CCCC1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00258240-01,tox21-er-bla-agonist-p2,Hydrastine,activity,inactive,118-08-1,197835.0,CN2CCc1cc5OCOc5cc1[C@@H]2[C@H]4OC(=O)c3c(OC)c(ccc34)OC
NCGC00258468-01,tox21-er-bla-agonist-p2,Isomalt,activity,inactive,64519-82-0,88735.0,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
NCGC00258140-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium tetrafluoroborate",activity,inactive,402846-78-0,2734244.0,CCCCn1cc[n+](C)c1C.F[B-](F)(F)F
NCGC00258141-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium dicyanamide,activity,inactive,448245-52-1,11171745.0,CCCCn1cc[n+](C)c1.N#C\N=C=[N-]
NCGC00259553-01,tox21-er-bla-agonist-p2,Naphthalene,activity,inactive,91-20-3,931.0,c1cccc2ccccc12
NCGC00259787-01,tox21-er-bla-agonist-p2,Triethylene glycol dimethacrylate,activity,inactive,109-16-0,7979.0,O=C(OCCOCCOCCOC(=O)C(=C)C)C(=C)C
NCGC00259799-01,tox21-er-bla-agonist-p2,Methamidophos,activity,inactive,10265-92-6,4096.0,NP(=O)(OC)SC
NCGC00259412-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(2,6-di-t-butylphenol)",activity,inactive,118-82-1,8372.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)Cc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C
NCGC00259877-01,tox21-er-bla-agonist-p2,Methyl hesperidin,activity,inactive,11013-97-1,5284419.0,COc1ccc(cc1OC)[C@@H]2CC(=O)c3c(O)cc(cc3O2)O[C@@H]5O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]5O
NCGC00259451-01,tox21-er-bla-agonist-p2,3-(Triethoxysilyl)propionitrile,activity,inactive,919-31-3,13522.0,CCO[Si](OCC)(OCC)CCC#N
NCGC00260652-01,tox21-er-bla-agonist-p2,NTP Mix93 ER AR1 18-EQP,activity,active agonist,NOCAS_49548,,
NCGC00260656-01,tox21-er-bla-agonist-p2,NTP Mix22 AR2 2-EQP,activity,inactive,NOCAS_49552,,
NCGC00260587-01,tox21-er-bla-agonist-p2,NTP Mix36 CT1 2-EQP,activity,inactive,NOCAS_49483,,
NCGC00015400-02,tox21-er-bla-agonist-p2,Enoximone,activity,inactive,77671-31-9,53708.0,O=C(C=1NC(=O)NC=1C)c2ccc(SC)cc2
NCGC00016587-01,tox21-er-bla-agonist-p2,Metixene hydrochloride,activity,inactive,1553-34-0,64722.0,Cl.CN1CCCC(C1)CC2c4ccccc4Sc3ccccc23
NCGC00016833-01,tox21-er-bla-agonist-p2,Halofantrine hydrochloride,activity,inactive,36167-63-2,37392.0,Cl.CCCCN(CCCC)CCC(O)c2cc1c(Cl)cc(Cl)cc1c3cc(ccc23)C(F)(F)F
NCGC00016669-01,tox21-er-bla-agonist-p2,Scopolamine N-oxide hydrobromide,activity,inactive,6106-81-6,6419978.0,Br.OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)[O-]
NCGC00025295-01,tox21-er-bla-agonist-p2,Zacopride hydrochloride,activity,inactive,99617-34-2,9928181.0,Cl.Clc1cc(c(OC)cc1N)C(=O)NC3CN2CCC3CC2
NCGC00163242-01,tox21-er-bla-agonist-p2,(+)-Tubocurarine chloride hydrochloride,activity,inactive,57-94-3,16051918.0,[Cl-].Cl.Oc7ccc1cc7Oc5cc6[C@H](Cc4ccc(Oc2c3[C@@H](C1)[N+](C)(C)CCc3cc(OC)c2O)cc4)N(C)CCc6cc5OC
NCGC00247679-01,tox21-er-bla-agonist-p2,(+)-alpha-Methadol hydrochloride,activity,inactive,49570-63-0,206311.0,Cl.O[C@H](CC)C(C[C@@H](C)N(C)C)(c1ccccc1)c2ccccc2
NCGC00255171-01,tox21-er-bla-agonist-p2,Loratadine,activity,inactive,79794-75-5,3957.0,Clc3cc4CCc1cccnc1C(=C2/CCN(CC2)C(=O)OCC)\c4cc3
NCGC00254474-01,tox21-er-bla-agonist-p2,Benzidine,activity,inactive,92-87-5,7111.0,Nc1ccc(cc1)c2ccc(N)cc2
NCGC00254551-01,tox21-er-bla-agonist-p2,"1,1-Dimethyl-2-phenylethyl butanoate",activity,inactive,10094-34-5,24915.0,CCCC(=O)OC(C)(C)Cc1ccccc1
NCGC00255449-01,tox21-er-bla-agonist-p2,Dimethylbenzylcarbinyl acetate,activity,inactive,151-05-3,9024.0,CC(=O)OC(C)(C)Cc1ccccc1
NCGC00254300-01,tox21-er-bla-agonist-p2,Sodium dodecylbenzenesulfonate,activity,inactive,25155-30-0,23707968.0,[Na+].O=S([O-])(=O)c1ccc(cc1)C(CC)CCCCCCCCC
NCGC00014648-01,tox21-er-bla-agonist-p2,Spiclomazine hydrochloride,activity,inactive,27007-85-8,122820.0,Cl.Clc4ccc5Sc1ccccc1N(CCCN2CCC3(CC2)NC(=O)CS3)c5c4
NCGC00015410-04,tox21-er-bla-agonist-p2,Efaroxan,activity,inactive,89197-32-0,72016.0,CCC1(Cc2ccccc2O1)C3=NCCN3
NCGC00015851-02,tox21-er-bla-agonist-p2,Protriptyline hydrochloride,activity,inactive,1225-55-4,6603149.0,Cl.CNCCCC2c3ccccc3C=Cc1ccccc12
NCGC00016087-06,tox21-er-bla-agonist-p2,Vigabatrin,activity,inactive,60643-86-9,5665.0,C=CC(N)CCC(=O)O
NCGC00016869-01,tox21-er-bla-agonist-p2,Sisomicin sulfate,activity,inactive,53179-09-2,20055515.0,O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.NC3CC=C(CN)OC3O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H]2O.NC3CC=C(CN)OC3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00091110-01,tox21-er-bla-agonist-p2,Glutaraldehyde,activity,inactive,111-30-8,3485.0,O=CCCCC=O
NCGC00094980-01,tox21-er-bla-agonist-p2,Monensin sodium,activity,inactive,22373-78-0,23667299.0,[Na+].OC[C@]1(O)O[C@@H]([C@@H](C)C[C@H]1C)[C@H]2C[C@H](C)[C@@H](O2)[C@]3(CC)CC[C@@H](O3)[C@]5(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@H](O4)[C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O5
NCGC00159338-02,tox21-er-bla-agonist-p2,N-Acetylgalactosamine,activity,inactive,1811-31-0,60196345.0,O[C@@H]([C@H](C=O)NC(C)=O)[C@H](O)[C@@H](O)CO
NCGC00164234-01,tox21-er-bla-agonist-p2,Propyl gallate,activity,active agonist,121-79-9,4947.0,Oc1cc(cc(O)c1O)C(=O)OCCC
NCGC00181139-01,tox21-er-bla-agonist-p2,Isometheptene hydrochloride,activity,inactive,6168-86-1,22549.0,Cl.CC(CC\C=C(\C)C)NC
NCGC00183000-01,tox21-er-bla-agonist-p2,Lanperisone hydrochloride,activity,inactive,116287-13-9,198707.0,C[C@H](CN1CCCC1)C(=O)c2ccc(cc2)C(F)(F)F
NCGC00254863-01,tox21-er-bla-agonist-p2,"3,7-Dimethyloctan-1-ol",activity,inactive,106-21-8,7792.0,CC(C)CCCC(C)CCO
NCGC00015092-02,tox21-er-bla-agonist-p2,6-Aminocaproic acid,activity,inactive,60-32-2,564.0,NCCCCCC(=O)O
NCGC00164402-01,tox21-er-bla-agonist-p2,Beclomethasone,activity,inactive,4419-39-0,20469.0,OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(Cl)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00181338-01,tox21-er-bla-agonist-p2,"3,3',5'-Triiodo-L-thyronine",activity,inactive,5817-39-0,644280.0,Ic2cc(Oc1ccc(C[C@H](N)C(=O)O)cc1I)cc(I)c2O
NCGC00247682-01,tox21-er-bla-agonist-p2,L-alpha-Acetyl-N-normethadol hydrochloride,activity,inactive,55096-75-8,60196314.0,Cl.C[C@@H](NC)CC(c1ccccc1)(c2ccccc2)[C@@H](OC(C)=O)CC
NCGC00254002-01,tox21-er-bla-agonist-p2,4-Methylaniline,activity,inactive,106-49-0,7813.0,Cc1ccc(N)cc1
NCGC00254225-01,tox21-er-bla-agonist-p2,Sodium dodecyl sulfate,activity,inactive,151-21-3,3423265.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCC
NCGC00254704-01,tox21-er-bla-agonist-p2,2-Ethyl-3-hydroxy-4H-pyran-4-one,activity,inactive,4940-11-8,21059.0,OC1=C(CC)OC=CC1=O
NCGC00090851-04,tox21-er-bla-agonist-p2,5-Azacytidine,activity,inactive,320-67-2,9444.0,NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
NCGC00022003-03,tox21-er-bla-agonist-p2,Diflorasone diacetate,activity,inactive,33564-31-7,71414.0,CC(=O)OCC(=O)[C@@]4(OC(C)=O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00024589-02,tox21-er-bla-agonist-p2,Cimaterol,activity,inactive,54239-37-1,2755.0,N#Cc1cc(ccc1N)C(O)CNC(C)C
NCGC00042523-02,tox21-er-bla-agonist-p2,N-Oxydiethylenebenzothiazole-2-sulfenamide,activity,inactive,102-77-2,7619.0,c1cccc2sc(nc12)SN3CCOCC3
NCGC00256819-01,tox21-er-bla-agonist-p2,Isobutyl 3-phenylacrylate,activity,inactive,122-67-8,31223.0,CC(C)COC(=O)C=Cc1ccccc1
NCGC00256822-01,tox21-er-bla-agonist-p2,gamma-Dodecalactone,activity,inactive,2305-05-7,16821.0,O=C1CCC(CCCCCCCC)O1
NCGC00257141-01,tox21-er-bla-agonist-p2,Methylenebutanedioic acid,activity,inactive,97-65-4,811.0,O=C(O)C(=C)CC(=O)O
NCGC00257457-01,tox21-er-bla-agonist-p2,Ethyl oleate,activity,inactive,111-62-6,5363269.0,O=C(CCCCCCC/C=C\CCCCCCCC)OCC
NCGC00257513-01,tox21-er-bla-agonist-p2,2-Methylbutanoic acid,activity,inactive,116-53-0,8314.0,CC(CC)C(=O)O
NCGC00257563-01,tox21-er-bla-agonist-p2,Fonofos,activity,inactive,944-22-9,13676.0,S=P(Sc1ccccc1)(CC)OCC
NCGC00257623-01,tox21-er-bla-agonist-p2,1-Acetyl-2-phenylhydrazine,activity,inactive,114-83-0,8247.0,CC(=O)NNc1ccccc1
NCGC00257964-01,tox21-er-bla-agonist-p2,Dibromomethane,activity,inactive,74-95-3,3024.0,BrCBr
NCGC00258029-01,tox21-er-bla-agonist-p2,Benzophenonetetracarboxylic dianhydride,activity,inactive,2421-28-5,75498.0,O=C1OC(=O)c2cc(ccc12)C(=O)c3ccc4C(=O)OC(=O)c4c3
NCGC00258098-01,tox21-er-bla-agonist-p2,2-Hydroxy-5-methylbenzophenone,activity,inactive,1470-57-1,73851.0,O=C(c1cc(C)ccc1O)c2ccccc2
NCGC00258124-01,tox21-er-bla-agonist-p2,Linalyl anthranilate,activity,inactive,7149-26-0,23535.0,Nc1ccccc1C(=O)OC(C)(C=C)CC\C=C(/C)C
NCGC00258190-01,tox21-er-bla-agonist-p2,Ethyl vinyl ketone,activity,inactive,1629-58-9,15394.0,C=CC(=O)CC
NCGC00258194-01,tox21-er-bla-agonist-p2,"2,3-Dichloro-1-propene",activity,inactive,78-88-6,6565.0,C=C(Cl)CCl
NCGC00258231-01,tox21-er-bla-agonist-p2,3-Pentanone,activity,inactive,96-22-0,7288.0,CCC(=O)CC
NCGC00256395-01,tox21-er-bla-agonist-p2,2-Amino-4-nitrophenol,activity,inactive,99-57-0,3613389.0,Nc1cc(ccc1O)[N+]([O-])=O
NCGC00256493-01,tox21-er-bla-agonist-p2,"2,3-Dichloro-p-dioxane",activity,inactive,3883-43-0,5284382.0,Cl[C@H]1OCCO[C@@H]1Cl
NCGC00256540-01,tox21-er-bla-agonist-p2,"2,4,6-Tribromophenol",activity,inactive,118-79-6,1483.0,Brc1cc(Br)cc(Br)c1O
NCGC00256199-01,tox21-er-bla-agonist-p2,"2,3-Butanedithiol",activity,inactive,4532-64-3,548353.0,CC(S)C(C)S
NCGC00256237-01,tox21-er-bla-agonist-p2,"1,2-Bis(2-chloroethoxy)ethane",activity,inactive,112-26-5,8171.0,ClCCOCCOCCCl
NCGC00256321-01,tox21-er-bla-agonist-p2,Formamide,activity,inactive,75-12-7,713.0,NC=O
NCGC00258933-01,tox21-er-bla-agonist-p2,1-Dodecene,activity,inactive,112-41-4,8183.0,CCCCCCCCCCC=C
NCGC00260442-01,tox21-er-bla-agonist-p2,(E)-3-(2-Furyl)acrolein,activity,inactive,39511-08-5,1549521.0,O=C\C=C\c1ccco1
NCGC00259048-01,tox21-er-bla-agonist-p2,"1,2,3,4-Tetrachlorobenzene",activity,inactive,634-66-2,12463.0,Clc1ccc(Cl)c(Cl)c1Cl
NCGC00260135-01,tox21-er-bla-agonist-p2,"Dimethyldithiocarbamic acid, dimethylamine",activity,inactive,598-64-1,221511.0,CNC.CN(C)C(=S)S
NCGC00260362-01,tox21-er-bla-agonist-p2,"Nonane,1-chloro-",activity,inactive,2473-01-0,17185.0,CCCCCCCCCCl
NCGC00255167-01,tox21-er-bla-agonist-p2,Formononetin,activity,active agonist,485-72-3,5280378.0,COc1ccc(cc1)C3=COc2cc(O)ccc2C3=O
NCGC00166283-01,tox21-er-bla-agonist-p2,Protoporphyrin disodium,activity,active agonist,50865-01-5,71484.0,[Na+].[Na+].[O-]C(=O)CCc2c(C)c1cc5nc(cc4nc(cc3nc(cc2n1)C(CCC([O-])=O)=C3C)c(C)c4C=C)C(C)=C5C=C
NCGC00159423-02,tox21-er-bla-agonist-p2,Phytonadione,activity,inactive,84-80-0,5284607.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCCC(\C)=C\CC2=C(C)C(=O)c1ccccc1C2=O
NCGC00094855-01,tox21-er-bla-agonist-p2,Althiazide,activity,inactive,5588-16-9,2122.0,NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)CSCC=C)cc2Cl
NCGC00159559-02,tox21-er-bla-agonist-p2,Eplerenone,activity,inactive,107724-20-9,443872.0,O=C(OC)[C@@H]4CC1=CC(=O)CC[C@]1(C)[C@@]65O[C@@H]6C[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45
NCGC00167966-01,tox21-er-bla-agonist-p2,Hyaluronic acid,activity,inactive,9004-61-9,24728612.0,CC(=O)N[C@H]4C(O)O[C@H](CO)[C@@H](O)[C@@H]4O[C@@H]3OC([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@H]1O[C@H](C(=O)O)C(O)[C@H](O)[C@H]1O)[C@H]2NC(C)=O)[C@H](O)[C@H]3O)C(=O)O
NCGC00094984-04,tox21-er-bla-agonist-p2,Biotin,activity,inactive,58-85-5,171548.0,O=C1N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]2N1
NCGC00160438-01,tox21-er-bla-agonist-p2,Fanetizole,activity,inactive,79069-94-6,54339.0,C(CNc1nc(cs1)c2ccccc2)c3ccccc3
NCGC00160591-01,tox21-er-bla-agonist-p2,Hexyl nicotinate,activity,inactive,23597-82-2,90202.0,O=C(OCCCCCC)c1cccnc1
NCGC00160604-01,tox21-er-bla-agonist-p2,D-Fructose,activity,inactive,57-48-7,439709.0,O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO
NCGC00166059-01,tox21-er-bla-agonist-p2,Aluminum hydroxide acetate (1:1:2),activity,inactive,142-03-0,16682993.0,O[Al](OC(=O)C)OC(C)=O
NCGC00096054-03,tox21-er-bla-agonist-p2,Alendronate sodium,activity,inactive,121268-17-5,23681107.0,[Na+].O.O.O.OC(CCCN)(P(O)([O-])=O)P(=O)(O)O
NCGC00166149-01,tox21-er-bla-agonist-p2,(E)-Nitenpyram,activity,inactive,150824-47-8,3034287.0,Clc1ccc(CN(CC)C(=C\[N+]([O-])=O)\NC)cn1
NCGC00166212-01,tox21-er-bla-agonist-p2,2-Chloro-5-methylphenol,activity,inactive,615-74-7,12008.0,Cc1ccc(Cl)c(O)c1
NCGC00159352-02,tox21-er-bla-agonist-p2,"Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt",activity,inactive,7414-83-7,23894.0,[Na+].[Na+].CC(O)(P(O)([O-])=O)P([O-])(=O)O
NCGC00159355-02,tox21-er-bla-agonist-p2,Desoxycorticosterone pivalate,activity,inactive,808-48-0,11876263.0,CC(C)(C)C(=O)OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00162179-02,tox21-er-bla-agonist-p2,cis-Flupentixol,activity,inactive,53772-82-0,5281881.0,FC(F)(F)c2cc3C(=C\CCN1CCN(CCO)CC1)/c4ccccc4Sc3cc2
NCGC00091766-01,tox21-er-bla-agonist-p2,Ethyl acetate,activity,inactive,141-78-6,8857.0,CC(=O)OCC
NCGC00182085-01,tox21-er-bla-agonist-p2,Tirofiban hydrochloride monohydrate,activity,inactive,150915-40-5,60946.0,Cl.O.O=C(O)[C@@H](NS(=O)(=O)CCCC)Cc1ccc(cc1)OCCCCC2CCNCC2
NCGC00183844-01,tox21-er-bla-agonist-p2,Sitafloxacin,activity,inactive,127254-12-0,44341259.0,N[C@H]2CN(CC12CC1)c3c(F)cc4c(c3Cl)[N@@](C=C(C4=O)C(=O)O)C5C[C@H]5F
NCGC00254150-01,tox21-er-bla-agonist-p2,Aplaviroc hydrochloride,activity,inactive,461023-63-2,6918686.0,Cl.O=C(O)c1ccc(cc1)Oc2ccc(cc2)CN3CCC4(CC3)C(=O)N[C@@H](C(=O)N4CCCC)[C@H](O)C5CCCCC5
NCGC00188432-01,tox21-er-bla-agonist-p2,Fursultiamine,activity,inactive,804-30-8,3002119.0,Cc2ncc(CN(C=O)C(/C)=C(/SSCC1CCCO1)CCO)c(N)n2
NCGC00188441-01,tox21-er-bla-agonist-p2,Cellulose acetate phthalate,activity,inactive,9004-38-0,53315792.0,O=C(O)c1ccccc1C(=O)O[C@@H]4[C@@H](O)[C@H](O[C@@H]3O[C@H](COC(C)=O)[C@@H](O)[C@H](OC(=O)c2ccccc2C(=O)O)[C@H]3O)[C@@H](COC(C)=O)O[C@H]4O
NCGC00254205-01,tox21-er-bla-agonist-p2,Vernolate,activity,inactive,1929-77-7,16003.0,O=C(SCCC)N(CCC)CCC
NCGC00255349-01,tox21-er-bla-agonist-p2,Aloe-emodin,activity,inactive,481-72-1,10207.0,Oc3cccc2C(=O)c1cc(cc(O)c1C(=O)c23)CO
NCGC00254265-01,tox21-er-bla-agonist-p2,"2-Methyl-4,6-dinitrophenol",activity,inactive,534-52-1,10800.0,O=[N+]([O-])c1cc(cc(C)c1O)[N+]([O-])=O
NCGC00254273-01,tox21-er-bla-agonist-p2,"1,2,3-Trichlorobenzene",activity,inactive,87-61-6,6895.0,Clc1cccc(Cl)c1Cl
NCGC00255396-01,tox21-er-bla-agonist-p2,"1,2,3,5-Tetramethylbenzene",activity,inactive,527-53-7,10695.0,Cc1cc(C)c(C)c(C)c1
NCGC00254429-01,tox21-er-bla-agonist-p2,CP-642931,activity,inactive,NOCAS_47267,10132209.0,C[C@@H](O)c1nccc(n1)N2[C@H](C)CN(C[C@@H]2C)c3nc(C)nc(C)n3
NCGC00254094-01,tox21-er-bla-agonist-p2,Isoniazid,activity,inactive,54-85-3,3767.0,O=C(NN)c1ccncc1
NCGC00255129-01,tox21-er-bla-agonist-p2,"3-[3,5-DI(tert-butyl)-4-hydroxyphenyl]propanohydrazide",activity,inactive,32687-77-7,64865.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CCC(=O)NN
NCGC00181339-01,tox21-er-bla-agonist-p2,Cefpirome sulfate,activity,inactive,98753-19-6,11954008.0,O=S(=O)(O)O.Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]5C(=O)N4C(=C(C[n+]3cccc2CCCc23)CS[C@@H]45)C([O-])=O
NCGC00181340-01,tox21-er-bla-agonist-p2,Azosemide,activity,inactive,27589-33-9,2273.0,NS(=O)(=O)c2cc(c(NCc1cccs1)cc2Cl)c3nnnn3
NCGC00181346-01,tox21-er-bla-agonist-p2,Cilastatin sodium,activity,inactive,81129-83-1,23663403.0,[Na+].O=C(N/C(=C\CCCCSC[C@H](N)C(=O)O)C([O-])=O)[C@H]1CC1(C)C
NCGC00183021-01,tox21-er-bla-agonist-p2,Pifoxime,activity,inactive,31224-92-7,9570475.0,O=C(COc1ccc(cc1)C(\C)=N\O)N2CCCCC2
NCGC00181784-01,tox21-er-bla-agonist-p2,Iloprost,activity,inactive,78919-13-8,6435378.0,O[C@@H]2C[C@@H]1C/C(C[C@@H]1C2/C=C/[C@@H](O)C(C)CC#CC)=C\CCCC(=O)O
NCGC00259655-01,tox21-er-bla-agonist-p2,"1,3-Benzenediamine",activity,inactive,108-45-2,7935.0,Nc1cccc(N)c1
NCGC00259790-01,tox21-er-bla-agonist-p2,Phenylmercuric acetate,activity,active agonist,62-38-4,16682730.0,CC(=O)O[Hg]c1ccccc1
NCGC00259811-01,tox21-er-bla-agonist-p2,"3-Chloro-1,2-propanediol",activity,inactive,96-24-2,7290.0,OCC(O)CCl
NCGC00260076-01,tox21-er-bla-agonist-p2,Nickelocene,activity,inactive,1271-28-9,62390.0,[Ni+2].[c-]1cccc1.c1[c-]ccc1
NCGC00258182-01,tox21-er-bla-agonist-p2,Sulfolane,activity,inactive,126-33-0,31347.0,O=S1(=O)CCCC1
NCGC00013841-01,tox21-er-bla-agonist-p2,Cyclobenzaprine hydrochloride,activity,inactive,6202-23-9,22576.0,Cl.CN(C)CC\C=C2/c3ccccc3C=Cc1ccccc12
NCGC00259117-01,tox21-er-bla-agonist-p2,Isobutyl methacrylate,activity,inactive,97-86-9,7352.0,CC(=C)C(=O)OCC(C)C
NCGC00244580-01,tox21-er-bla-agonist-p2,Dodecylbenzenesulfonic acid,activity,inactive,27176-87-0,29249.0,OS(=O)(=O)c1ccc(cc1)C(CC)CCCCCCCCC
NCGC00257096-01,tox21-er-bla-agonist-p2,1-Dodecene,activity,inactive,112-41-4,8183.0,CCCCCCCCCCC=C
NCGC00015096-07,tox21-er-bla-agonist-p2,Amiodarone,activity,inactive,1951-25-3,2157.0,CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC
NCGC00257330-01,tox21-er-bla-agonist-p2,lambda-Cyhalothrin,activity,inactive,91465-08-6,6440554.0,Cl\C(=C/[C@H]3[C@@H](C(=O)O[C@H](C#N)c2cccc(Oc1ccccc1)c2)C3(C)C)C(F)(F)F
NCGC00258651-01,tox21-er-bla-agonist-p2,TXP,activity,inactive,25155-23-1,33133.0,Cc1cc(cc(C)c1)OP(=O)(Oc2cc(C)cc(C)c2)Oc3cc(C)cc(C)c3
NCGC00258722-01,tox21-er-bla-agonist-p2,Isopropyl mercaptan,activity,inactive,75-33-2,6364.0,CC(C)S
NCGC00258860-01,tox21-er-bla-agonist-p2,N-(2-Methylphenyl)-3-oxobutanamide,activity,inactive,93-68-5,7154.0,O=C(Nc1ccccc1C)CC(C)=O
NCGC00255608-01,tox21-er-bla-agonist-p2,"(2R,6S)-Fenpropimorph",activity,inactive,67564-91-4,93365.0,C[C@H]2CN(CC(C)Cc1ccc(cc1)C(C)(C)C)C[C@@H](C)O2
NCGC00255930-01,tox21-er-bla-agonist-p2,"1,1,3,3,5-Pentamethyl-4,6-dinitro-2,3-dihydro-1H-indene",activity,active agonist,116-66-5,67005.0,[O-][N+](=O)c1cc2c(c(c1C)[N+]([O-])=O)C(C)(C)CC2(C)C
NCGC00256721-01,tox21-er-bla-agonist-p2,Potassium chlorate,activity,inactive,3811-04-9,6426889.0,[K+].[O-]Cl(=O)=O
NCGC00257170-01,tox21-er-bla-agonist-p2,"2-(Morpholin-4-yldithio)-1,3-benzothiazole",activity,inactive,95-32-9,7231.0,c1cccc2sc(nc12)SSN3CCOCC3
NCGC00257737-01,tox21-er-bla-agonist-p2,Aroclor 1260,activity,inactive,11096-82-5,38018.0,Clc2ccc(c1ccc(Cl)c(Cl)c1Cl)c(Cl)c2Cl
NCGC00257363-01,tox21-er-bla-agonist-p2,"1-Chloro-3,3-dimethyl-butan-2-one",activity,inactive,13547-70-1,83572.0,CC(C)(C)C(=O)CCl
NCGC00257587-01,tox21-er-bla-agonist-p2,Methylhydrazine sulfate,activity,inactive,302-15-8,165286.0,CNN.O=S(=O)(O)O
NCGC00258685-01,tox21-er-bla-agonist-p2,Sodium hydroxymethanesulfinate,activity,inactive,149-44-0,23689980.0,[Na+].[O-]S(=O)CO
NCGC00258833-01,tox21-er-bla-agonist-p2,Linuron,activity,inactive,330-55-2,9502.0,Clc1ccc(NC(=O)N(C)OC)cc1Cl
NCGC00259188-01,tox21-er-bla-agonist-p2,Phenol,activity,inactive,108-95-2,996.0,Oc1ccccc1
NCGC00259231-01,tox21-er-bla-agonist-p2,1-Phenyl-2-thiourea,activity,inactive,103-85-5,676454.0,S=C(N)Nc1ccccc1
NCGC00259508-01,tox21-er-bla-agonist-p2,"Manganese, tricarbonyl[(1,2,3,4,5-.eta.)-1-methyl-2,4-cyclopentadien-1-yl]-",activity,inactive,12108-13-3,60196372.0,[Mn+].[C-]#[O+].[O+]#[C-].CC1C=[C-]C=C1.[O+]#[C-]
NCGC00259920-01,tox21-er-bla-agonist-p2,2-Nitroaniline,activity,inactive,88-74-4,6946.0,O=[N+]([O-])c1ccccc1N
NCGC00259109-01,tox21-er-bla-agonist-p2,Pentachloroanisole,activity,inactive,1825-21-4,15767.0,Clc1c(OC)c(Cl)c(Cl)c(Cl)c1Cl
NCGC00260270-01,tox21-er-bla-agonist-p2,"Hexadecane,1-bromo-",activity,inactive,112-82-3,8213.0,BrCCCCCCCCCCCCCCCC
NCGC00260462-01,tox21-er-bla-agonist-p2,"2,4,6-Trichloropyrimidine",activity,inactive,3764-01-0,77378.0,Clc1cc(Cl)nc(Cl)n1
NCGC00260552-01,tox21-er-bla-agonist-p2,NTP Mix60 CT1 62-EQP,activity,inactive,NOCAS_49448,,
NCGC00013226-01,tox21-er-bla-agonist-p2,Fluoperazine dihydrochloride,activity,inactive,440-17-5,66064.0,Cl.Cl.FC(F)(F)c2cc3N(CCCN1CCN(C)CC1)c4ccccc4Sc3cc2
NCGC00013628-01,tox21-er-bla-agonist-p2,Rolitetracycline hydrochloride,activity,inactive,68060-64-0,54724367.0,Cl.O=C(NCN1CCCC1)C4=C(O)[C@@H](N(C)C)[C@@H]5CC3C(C(=O)c2c(O)cccc2[C@@]3(C)O)=C(O)[C@]5(O)C4=O
NCGC00015864-02,tox21-er-bla-agonist-p2,Procaine hydrochloride,activity,inactive,51-05-8,5795.0,Cl.Nc1ccc(cc1)C(=O)OCCN(CC)CC
NCGC00015409-02,tox21-er-bla-agonist-p2,Edrophonium chloride,activity,inactive,116-38-1,8307.0,[Cl-].C[N+](C)(CC)c1cccc(O)c1
NCGC00015768-02,tox21-er-bla-agonist-p2,Oxiracetam,activity,inactive,62613-82-5,4626.0,OC1CC(=O)N(CC(=O)N)C1
NCGC00015116-10,tox21-er-bla-agonist-p2,Aniracetam,activity,inactive,72432-10-1,2196.0,O=C2CCCN2C(=O)c1ccc(OC)cc1
NCGC00016560-01,tox21-er-bla-agonist-p2,Ethambutol dihydrochloride,activity,inactive,1070-11-7,14051.0,Cl.Cl.CC[C@@H](CO)NCCN[C@H](CO)CC
NCGC00016141-02,tox21-er-bla-agonist-p2,"Clodronic acid, disodium salt",activity,inactive,22560-50-5,31195.0,[Na+].[Na+].ClC(Cl)(P(O)([O-])=O)P([O-])(=O)O
NCGC00162178-02,tox21-er-bla-agonist-p2,Fiduxosin hydrochloride,activity,inactive,208993-54-8,172306.0,Cl.COc1cccc2OC[C@H]3CN(C[C@H]3c12)CCCCN5C(=O)Nc4c6nc(cnc6sc4C5=O)c7ccccc7
NCGC00182545-01,tox21-er-bla-agonist-p2,Spirapril hydrochloride,activity,inactive,94841-17-5,6850814.0,Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3
NCGC00255896-01,tox21-er-bla-agonist-p2,Sodium abietate,activity,inactive,14351-66-7,23678979.0,[Na+].CC(C)C=3CC[C@H]1C(=CC[C@H]2[C@@](C)(CCC[C@]12C)C([O-])=O)C=3
NCGC00256030-01,tox21-er-bla-agonist-p2,5-Methylquinoxaline,activity,inactive,13708-12-8,61670.0,Cc1cccc2nccnc12
NCGC00254550-01,tox21-er-bla-agonist-p2,Tribufos,activity,inactive,78-48-8,5125.0,CCCCSP(=O)(SCCCC)SCCCC
NCGC00254784-01,tox21-er-bla-agonist-p2,"1,5-Pentanediol",activity,inactive,111-29-5,8105.0,OCCCCCO
NCGC00255060-01,tox21-er-bla-agonist-p2,(-)-beta-Pinene,activity,inactive,18172-67-3,440967.0,CC2(C)[C@H]1CCC(=C)[C@@H]2C1
NCGC00256427-01,tox21-er-bla-agonist-p2,Retinol palmitate,activity,inactive,79-81-2,5280531.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=C\C(\C)=C\COC(=O)CCCCCCCCCCCCCCC
NCGC00254624-01,tox21-er-bla-agonist-p2,Pirimiphos-methyl,activity,inactive,29232-93-7,34526.0,CCN(CC)c1nc(C)cc(OP(=S)(OC)OC)n1
NCGC00255450-01,tox21-er-bla-agonist-p2,C.I. Direct Red 81 disodium salt,activity,inactive,2610-11-9,44135445.0,[Na+].[Na+].[O-]S(=O)(=O)c1ccc(cc1)/N=N/c2ccc(cc2)/N=N/c3c(O)c4ccc(cc4cc3S([O-])(=O)=O)NC(=O)c5ccccc5
NCGC00254639-01,tox21-er-bla-agonist-p2,Bensulide,activity,inactive,741-58-2,12932.0,O=S(=O)(NCCSP(=S)(OC(C)C)OC(C)C)c1ccccc1
NCGC00255244-01,tox21-er-bla-agonist-p2,"2,4,6-Trinitro-1,3-dimethyl-5-tert-butylbenzene",activity,inactive,81-15-2,62329.0,O=[N+]([O-])c1c(C)c(c(C)c(c1C(C)(C)C)[N+]([O-])=O)[N+]([O-])=O
NCGC00255281-01,tox21-er-bla-agonist-p2,Naptalam,activity,inactive,132-66-1,8594.0,O=C(O)c1ccccc1C(=O)Nc3cccc2ccccc23
NCGC00254096-01,tox21-er-bla-agonist-p2,Prednisone,activity,inactive,53-03-2,5865.0,OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00015713-07,tox21-er-bla-agonist-p2,Nitrendipine,activity,inactive,39562-70-4,4507.0,CC=1NC(C)=C(C(C=1C(=O)OCC)c2cccc(c2)[N+]([O-])=O)C(=O)OC
NCGC00255011-01,tox21-er-bla-agonist-p2,Bromacil,activity,inactive,314-40-9,9411.0,CCC(C)N1C(=O)C(Br)=C(C)NC1=O
NCGC00255082-01,tox21-er-bla-agonist-p2,Trifloxysulfuron-sodium,activity,inactive,199119-58-9,23676736.0,[Na+].O=S(=O)([N-]C(=O)Nc1nc(OC)cc(OC)n1)c2ncccc2OCC(F)(F)F
NCGC00015560-06,tox21-er-bla-agonist-p2,Idazoxan,activity,inactive,79944-58-4,54459.0,c1ccc2OC(COc2c1)C3=NCCN3
NCGC00016323-04,tox21-er-bla-agonist-p2,Sulfachloropyridazine,activity,inactive,80-32-0,6634.0,O=S(=O)(Nc1ccc(Cl)nn1)c2ccc(N)cc2
NCGC00091826-01,tox21-er-bla-agonist-p2,N-Isopropyl-N'-phenyl-p-phenylenediamine,activity,inactive,101-72-4,7573.0,CC(C)Nc1ccc(cc1)Nc2ccccc2
NCGC00163319-01,tox21-er-bla-agonist-p2,Adenosine-5-phosphate,activity,inactive,61-19-8,6083.0,O=P(O)(O)OC[C@H]3O[C@@H](n2cnc1c(N)ncnc12)[C@H](O)[C@@H]3O
NCGC00183032-01,tox21-er-bla-agonist-p2,Citicoline sodium,activity,inactive,33818-15-4,36605.0,[Na+].C[N+](C)(C)CCOP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@@H](N1C=CC(N)=NC1=O)[C@H](O)[C@@H]2O
NCGC00017129-01,tox21-er-bla-agonist-p2,Tolmetin sodium,activity,inactive,64490-92-2,23677829.0,[Na+].O.O.O=C([O-])Cc2ccc(C(=O)c1ccc(C)cc1)n2C
NCGC00257011-01,tox21-er-bla-agonist-p2,2-Methylpentanedinitrile,activity,inactive,4553-62-2,20686.0,CC(CCC#N)C#N
NCGC00258638-01,tox21-er-bla-agonist-p2,Butanoic anhydride,activity,inactive,106-31-0,7798.0,CCCC(=O)OC(=O)CCC
NCGC00257669-01,tox21-er-bla-agonist-p2,Undecylbenzene,activity,inactive,6742-54-7,23194.0,CCCCCCCCCCCc1ccccc1
NCGC00257844-01,tox21-er-bla-agonist-p2,"Chlordane, technical grade",activity,active agonist,12789-03-6,5993.0,ClC2=C(Cl)C3(Cl)C1CC(Cl)C(Cl)C1C2(Cl)C3(Cl)Cl
NCGC00257911-01,tox21-er-bla-agonist-p2,"1,1-Dichloroethylene",activity,inactive,75-35-4,6366.0,C=C(Cl)Cl
NCGC00257923-01,tox21-er-bla-agonist-p2,"N,N'-Diethylcarbanilide",activity,inactive,85-98-3,6828.0,CCN(C(=O)N(CC)c1ccccc1)c2ccccc2
NCGC00258066-01,tox21-er-bla-agonist-p2,Phthalamide,activity,inactive,88-96-0,6956.0,O=C(N)c1ccccc1C(N)=O
NCGC00258314-01,tox21-er-bla-agonist-p2,1-Nitro-3-(trifluoromethyl)benzene,activity,inactive,98-46-4,7386.0,O=[N+]([O-])c1cc(ccc1)C(F)(F)F
NCGC00256735-01,tox21-er-bla-agonist-p2,dl-Norgestrel,activity,active agonist,6533-00-2,16051930.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2CCC1(O)C#C)=C4
NCGC00256429-01,tox21-er-bla-agonist-p2,2-(Chloromethyl)pyridine hydrochloride,activity,inactive,6959-47-3,23392.0,Cl.ClCc1ccccn1
NCGC00256530-01,tox21-er-bla-agonist-p2,Thiourea,activity,inactive,62-56-6,2723790.0,NC(N)=S
NCGC00255867-01,tox21-er-bla-agonist-p2,Quinmerac,activity,inactive,90717-03-6,91749.0,O=C(O)c1c(Cl)ccc2cc(C)cnc12
NCGC00255933-01,tox21-er-bla-agonist-p2,Parinol,activity,inactive,17781-31-6,28768.0,OC(c1ccc(Cl)cc1)(c2cccnc2)c3ccc(Cl)cc3
NCGC00256017-01,tox21-er-bla-agonist-p2,Sodium nicotinate,activity,inactive,54-86-4,23687810.0,[Na+].[O-]C(=O)c1cccnc1
NCGC00256021-01,tox21-er-bla-agonist-p2,Nitarsone,activity,inactive,98-72-6,66826.0,O=[N+]([O-])c1ccc(cc1)[As](O)(O)=O
NCGC00256038-01,tox21-er-bla-agonist-p2,"3,3'-Sulphonyldianiline",activity,inactive,599-61-1,11741.0,Nc1cc(ccc1)S(=O)(=O)c2cc(N)ccc2
NCGC00256073-01,tox21-er-bla-agonist-p2,(S)-Limonene,activity,inactive,5989-54-8,439250.0,CC1=CC[C@H](CC1)C(C)=C
NCGC00256209-01,tox21-er-bla-agonist-p2,1-{Bis[3-(dimethylamino)propyl]amino}propan-2-ol,activity,inactive,67151-63-7,106705.0,CN(C)CCCN(CC(C)O)CCCN(C)C
NCGC00258824-01,tox21-er-bla-agonist-p2,Isoproterenol hydrochloride,activity,inactive,51-30-9,5807.0,Cl.Oc1ccc(cc1O)C(O)CNC(C)C
NCGC00259118-01,tox21-er-bla-agonist-p2,Thiram,activity,inactive,137-26-8,5455.0,CN(C)C(=S)SSC(=S)N(C)C
NCGC00259140-01,tox21-er-bla-agonist-p2,3-Methylbenzoic acid,activity,inactive,99-04-7,7418.0,Cc1cccc(c1)C(O)=O
NCGC00259169-01,tox21-er-bla-agonist-p2,Sodium benzenethiolate,activity,inactive,930-69-8,4110039.0,[Na+].[S-]c1ccccc1
NCGC00259396-01,tox21-er-bla-agonist-p2,Dichlorprop,activity,inactive,120-36-5,8427.0,Clc1cc(Cl)ccc1OC(C)C(=O)O
NCGC00259486-01,tox21-er-bla-agonist-p2,D-Glucitol,activity,inactive,50-70-4,5780.0,O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)CO
NCGC00259611-01,tox21-er-bla-agonist-p2,Triethanolamine,activity,inactive,102-71-6,7618.0,OCCN(CCO)CCO
NCGC00259686-01,tox21-er-bla-agonist-p2,"3,4-Dihydrocoumarin",activity,inactive,119-84-6,660.0,O=C1CCc2ccccc2O1
NCGC00259816-01,tox21-er-bla-agonist-p2,"1,4-Butanediol diglycidyl ether",activity,inactive,2425-79-8,17046.0,C(CCCOCC1CO1)OCC2CO2
NCGC00258701-01,tox21-er-bla-agonist-p2,5-Methyl-3-isoxazolamine,activity,inactive,1072-67-9,66172.0,Cc1cc(N)no1
NCGC00254869-01,tox21-er-bla-agonist-p2,Methabenzthiazuron,activity,inactive,18691-97-9,29216.0,CNC(=O)N(C)c1nc2ccccc2s1
NCGC00255024-01,tox21-er-bla-agonist-p2,Diazoxon,activity,inactive,962-58-3,13754.0,Cc1cc(OP(=O)(OCC)OCC)nc(n1)C(C)C
NCGC00255063-01,tox21-er-bla-agonist-p2,4-(4-Methoxyphenyl)-2-butanone,activity,inactive,104-20-1,61007.0,COc1ccc(CCC(C)=O)cc1
NCGC00255089-01,tox21-er-bla-agonist-p2,Clothianidin,activity,inactive,210880-92-5,213027.0,Clc1ncc(CN/C(=N/[N+]([O-])=O)NC)s1
NCGC00255094-01,tox21-er-bla-agonist-p2,4-Acetylaminophenylacetic acid,activity,inactive,18699-02-0,2018.0,O=C(C)Nc1ccc(cc1)CC(=O)O
NCGC00255415-01,tox21-er-bla-agonist-p2,Oxypurinol,activity,inactive,2465-59-0,4644.0,O=C1NC(=O)Nc2nncc12
NCGC00255837-01,tox21-er-bla-agonist-p2,4-Isopropylphenol,activity,inactive,99-89-8,7465.0,CC(C)c1ccc(O)cc1
NCGC00254599-01,tox21-er-bla-agonist-p2,Permethrin,activity,inactive,52645-53-1,40326.0,Cl/C(Cl)=C/C3C(C(=O)OCc2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00093588-03,tox21-er-bla-agonist-p2,cAMP,activity,inactive,60-92-4,6076.0,Nc4ncnc3c4ncn3[C@@H]2O[C@@H]1COP(=O)(O)O[C@H]1[C@H]2O
NCGC00159491-02,tox21-er-bla-agonist-p2,Rimantadine hydrochloride,activity,inactive,1501-84-4,15165.0,Cl.CC(N)C12CC3CC(C1)CC(C2)C3
NCGC00094713-01,tox21-er-bla-agonist-p2,Medroxyprogesterone acetate,activity,inactive,71-58-9,6279.0,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00164380-02,tox21-er-bla-agonist-p2,4-Hydroxyandrostenedione,activity,active agonist,566-48-3,11273.0,O=C2CC[C@H]3[C@@H]4CCC1=C(O)C(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00095022-01,tox21-er-bla-agonist-p2,Diosmin,activity,inactive,520-27-4,5281613.0,COc1ccc(cc1O)C2=CC(=O)c3c(O)cc(cc3O2)O[C@@H]5O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]5O
NCGC00095042-04,tox21-er-bla-agonist-p2,Thiotepa,activity,inactive,52-24-4,5453.0,S=P(N1CC1)(N2CC2)N3CC3
NCGC00095105-01,tox21-er-bla-agonist-p2,Acetrizoic acid,activity,inactive,85-36-9,6806.0,O=C(C)Nc1c(I)c(c(I)cc1I)C(=O)O
NCGC00164575-01,tox21-er-bla-agonist-p2,Telithromycin,activity,inactive,191114-48-4,3002190.0,CN(C)[C@H]5C[C@@H](C)O[C@@H](O[C@@H]3[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]4(C)OC(=O)N(CCCCn1cc(nc1)c2cccnc2)[C@@H]4[C@@H](C)C(=O)[C@H](C)C[C@@]3(C)OC)[C@@H]5O
NCGC00095134-01,tox21-er-bla-agonist-p2,Ezetimibe,activity,inactive,163222-33-1,150311.0,Fc1ccc(cc1)[C@@H](O)CC[C@H]3C(=O)N(c2ccc(F)cc2)[C@@H]3c4ccc(O)cc4
NCGC00160485-01,tox21-er-bla-agonist-p2,Diamthazole,activity,inactive,95-27-2,8708.0,CCN(CC)CCOc1ccc2nc(sc2c1)N(C)C
NCGC00166021-01,tox21-er-bla-agonist-p2,Ammonium hexafluorosilicate,activity,inactive,16919-19-0,28145.0,[NH4+].[NH4+].F[Si-2](F)(F)(F)(F)F
NCGC00095832-01,tox21-er-bla-agonist-p2,Hygromycin B,activity,inactive,31282-04-9,20054942.0,O[C@H]4[C@H](N)C[C@H](NC)[C@@H](O)[C@@H]4O[C@@H]2O[C@H](CO)[C@H](O)[C@@H]1OC3(O[C@@H]12)O[C@@H]([C@H](O)[C@H](O)[C@H]3O)C(N)CO
NCGC00166114-02,tox21-er-bla-agonist-p2,Eosin,activity,inactive,17372-87-1,11048.0,[Na+].[Na+].[O-]C(=O)c4ccccc4C=2c3cc(Br)c([O-])c(Br)c3OC=1C=2C=C(Br)C(=O)C=1Br
NCGC00166124-01,tox21-er-bla-agonist-p2,Benzyl cinnamate,activity,inactive,103-41-3,7652.0,O=C(OCc1ccccc1)C=Cc2ccccc2
NCGC00161408-01,tox21-er-bla-agonist-p2,Anagrelide hydrochloride,activity,inactive,58579-51-4,60196296.0,Cl.Oc1cn2Cc3c(Nc2n1)ccc(Cl)c3Cl
NCGC00167559-01,tox21-er-bla-agonist-p2,Androstenone,activity,active agonist,18339-16-7,6852393.0,O=C2C[C@@H]3CC[C@H]1[C@@H]4CC=C[C@@]4(C)CC[C@@H]1[C@@]3(C)CC2
NCGC00162222-01,tox21-er-bla-agonist-p2,Cifenline succinate,activity,inactive,100678-32-8,57952.0,O=C(O)CCC(=O)O.C2C(C1=NCCN1)C2(c3ccccc3)c4ccccc4
NCGC00091205-03,tox21-er-bla-agonist-p2,"2,3-Dinitrotoluene",activity,inactive,602-01-7,11761.0,O=[N+]([O-])c1cccc(C)c1[N+]([O-])=O
NCGC00182543-01,tox21-er-bla-agonist-p2,Xipamide,activity,inactive,14293-44-8,26618.0,O=S(N)(=O)c1cc(c(O)cc1Cl)C(=O)Nc2c(C)cccc2C
NCGC00254139-01,tox21-er-bla-agonist-p2,Tris(2-chloroethyl) phosphate,activity,inactive,115-96-8,8295.0,ClCCOP(=O)(OCCCl)OCCCl
NCGC00254998-01,tox21-er-bla-agonist-p2,"9-Octadecenoic acid, 12-hydroxy-, (9Z,12R)-",activity,inactive,141-22-0,643684.0,CCCCCC[C@@H](O)C/C=C\CCCCCCCC(=O)O
NCGC00254198-01,tox21-er-bla-agonist-p2,4-Vinyl-1-cyclohexene dioxide,activity,inactive,106-87-6,7833.0,O1CC1C2CC3OC3CC2
NCGC00247725-01,tox21-er-bla-agonist-p2,"N,N-Diethyltryptamine fumarate",activity,inactive,NOCAS_48895,60196334.0,O=C(O)/C=C/C(=O)O.CCN(CC)CCc2cnc1ccccc12.CCN(CC)CCc2cnc1ccccc12
NCGC00254290-01,tox21-er-bla-agonist-p2,N-Methyldioctylamine,activity,inactive,4455-26-9,78202.0,CN(CCCCCCCC)CCCCCCCC
NCGC00254332-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) nonanedioate,activity,inactive,103-24-2,7642.0,O=C(CCCCCCCC(=O)OCC(CC)CCCC)OCC(CCCC)CC
NCGC00254333-01,tox21-er-bla-agonist-p2,Tridemorph,activity,inactive,24602-86-6,32518.0,CC1CN(CCCCCCCCCCCCC)CC(C)O1
NCGC00254063-01,tox21-er-bla-agonist-p2,Tetracycline,activity,inactive,60-54-8,54675776.0,NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O
NCGC00254089-01,tox21-er-bla-agonist-p2,GSK232420A,activity,inactive,864283-48-7,11472813.0,NC(=O)CN(CC(F)(F)F)c1cc(c(cc1)C#N)C(F)(F)F
NCGC00255330-01,tox21-er-bla-agonist-p2,Ethyl 1-naphthaleneacetate,activity,inactive,2122-70-5,62428.0,O=C(OCC)Cc2cccc1ccccc12
NCGC00016636-01,tox21-er-bla-agonist-p2,Flavoxate hydrochloride,activity,inactive,3717-88-2,441345.0,Cl.O=C(OCCN1CCCCC1)c4cccc2c4OC(=C(C)C2=O)c3ccccc3
NCGC00259568-01,tox21-er-bla-agonist-p2,Ethyl anthranilate,activity,inactive,87-25-2,6877.0,Nc1ccccc1C(=O)OCC
NCGC00259719-01,tox21-er-bla-agonist-p2,Trimethylolpropane triacrylate,activity,active agonist,15625-89-5,27423.0,O=C(C=C)OCC(COC(=O)C=C)(CC)COC(=O)C=C
NCGC00258074-01,tox21-er-bla-agonist-p2,Sodium tetrafluoroborate,activity,inactive,13755-29-8,4343483.0,[Na+].F[B-](F)(F)F
NCGC00257367-01,tox21-er-bla-agonist-p2,Daidzein,activity,active agonist,486-66-8,5281708.0,Oc1ccc(cc1)C3=COc2cc(O)ccc2C3=O
NCGC00254274-01,tox21-er-bla-agonist-p2,Dimethipin,activity,inactive,55290-64-7,41385.0,O=S1(=O)CCS(=O)(=O)C(C)=C1C
NCGC00255503-01,tox21-er-bla-agonist-p2,6-Chloro-2-picolinic acid,activity,inactive,4684-94-0,20812.0,OC(=O)c1cccc(Cl)n1
NCGC00257104-01,tox21-er-bla-agonist-p2,"1,6-Hexanediamine",activity,inactive,124-09-4,16402.0,NCCCCCCN
NCGC00256741-01,tox21-er-bla-agonist-p2,beta-Cyclocitral,activity,inactive,432-25-7,9895.0,CC=1CCCC(C)(C)C=1C=O
NCGC00257326-01,tox21-er-bla-agonist-p2,PharmaGSID_48507,activity,inactive,NOCAS_48507,60196436.0,Cl.CC(C)(O)CNc1ncc3c(n1)N(C)C(=O)C=C3Oc2ccc(F)cc2F
NCGC00257598-01,tox21-er-bla-agonist-p2,Temazepam,activity,inactive,846-50-4,5391.0,Clc1ccc2c(c1)C(=NC(O)C(=O)N2C)c3ccccc3
NCGC00256812-01,tox21-er-bla-agonist-p2,5-Methyl-2-phenyl-2-hexenal,activity,inactive,21834-92-4,576026.0,CC(C)CC=C(C=O)c1ccccc1
NCGC00256987-01,tox21-er-bla-agonist-p2,Furfuryl alcohol,activity,inactive,98-00-0,7361.0,OCc1ccco1
NCGC00258548-01,tox21-er-bla-agonist-p2,Ensulizole,activity,inactive,27503-81-7,33919.0,O=S(=O)(O)c1cc2nc(nc2cc1)c3ccccc3
NCGC00258073-01,tox21-er-bla-agonist-p2,"2,4-Dimethylaniline hydrochloride",activity,inactive,21436-96-4,88898.0,Cl.Cc1ccc(N)c(C)c1
NCGC00258286-01,tox21-er-bla-agonist-p2,6-Hydroxy-2-naphthoic acid,activity,inactive,16712-64-4,85557.0,O=C(O)c1ccc2cc(O)ccc2c1
NCGC00256531-01,tox21-er-bla-agonist-p2,2-Methylimidazole,activity,inactive,693-98-1,12749.0,Cc1nccn1
NCGC00256592-01,tox21-er-bla-agonist-p2,1-Chlorooctane,activity,inactive,111-85-3,8142.0,CCCCCCCCCl
NCGC00254415-01,tox21-er-bla-agonist-p2,3-Methylaniline,activity,inactive,108-44-1,7934.0,Cc1cc(N)ccc1
NCGC00255655-01,tox21-er-bla-agonist-p2,Octadecyl sulfate sodium salt,activity,inactive,1120-04-3,23673604.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCCCCCCCC
NCGC00255477-01,tox21-er-bla-agonist-p2,Potassium 1-naphthaleneacetate,activity,inactive,15165-79-4,23700091.0,[K+].[O-]C(=O)Cc2cccc1ccccc12
NCGC00255567-01,tox21-er-bla-agonist-p2,Hexyl salicylate,activity,inactive,6259-76-3,14205677.0,O=C(O)c1ccccc1OCCCCCC
NCGC00256759-01,tox21-er-bla-agonist-p2,2-Phenylethyl 2-methylbutanoate,activity,inactive,24817-51-4,520148.0,CC(CC)C(=O)OCCc1ccccc1
NCGC00257814-01,tox21-er-bla-agonist-p2,"2,6-Dimethylnaphthalene",activity,inactive,581-42-0,11387.0,Cc1ccc2cc(C)ccc2c1
NCGC00258008-01,tox21-er-bla-agonist-p2,Cyclohexanethiol,activity,inactive,1569-69-3,15290.0,SC1CCCCC1
NCGC00257734-01,tox21-er-bla-agonist-p2,4-tert-Butylcyclohexyl acetate,activity,inactive,32210-23-4,36081.0,O=C(C)OC1CCC(CC1)C(C)(C)C
NCGC00257889-01,tox21-er-bla-agonist-p2,Allyl acetate,activity,inactive,591-87-7,11584.0,CC(=O)OCC=C
NCGC00258916-01,tox21-er-bla-agonist-p2,3-Dimethylaminopropionitrile,activity,inactive,1738-25-6,15615.0,N#CCCN(C)C
NCGC00258296-01,tox21-er-bla-agonist-p2,"2,6-Dichlorobenzaldehyde",activity,inactive,83-38-5,6737.0,O=Cc1c(Cl)cccc1Cl
NCGC00258613-01,tox21-er-bla-agonist-p2,Methyl isocyanate,activity,inactive,624-83-9,12228.0,C\N=C=O
NCGC00258971-01,tox21-er-bla-agonist-p2,Nicotinic acid,activity,inactive,59-67-6,938.0,O=C(O)c1cccnc1
NCGC00258437-01,tox21-er-bla-agonist-p2,2-Methylbutyl acetate,activity,inactive,624-41-9,12209.0,CC(=O)OCC(C)CC
NCGC00258474-01,tox21-er-bla-agonist-p2,Furan,activity,inactive,110-00-9,8029.0,c1ccco1
NCGC00258876-01,tox21-er-bla-agonist-p2,Tetrahydrofurfuryl alcohol,activity,inactive,97-99-4,7360.0,OCC1CCCO1
NCGC00259272-01,tox21-er-bla-agonist-p2,"4,4'-Methylenedianiline",activity,inactive,101-77-9,7577.0,Nc2ccc(Cc1ccc(N)cc1)cc2
NCGC00260160-01,tox21-er-bla-agonist-p2,Allyl propyl disulfide,activity,inactive,2179-59-1,16591.0,CCCSSCC=C
NCGC00259388-01,tox21-er-bla-agonist-p2,Acifluorfen,activity,inactive,50594-66-6,44073.0,Clc2cc(ccc2Oc1cc(C(=O)O)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00259825-01,tox21-er-bla-agonist-p2,Triethylene glycol bis(2-ethylhexanoate),activity,inactive,94-28-0,7185.0,O=C(OCCOCCOCCOC(=O)C(CC)CCCC)C(CC)CCCC
NCGC00259429-01,tox21-er-bla-agonist-p2,Saccharin,activity,inactive,81-07-2,5143.0,O=C2NS(=O)(=O)c1ccccc12
NCGC00015861-04,tox21-er-bla-agonist-p2,Propentofylline,activity,inactive,55242-55-2,4938.0,CC(=O)CCCCN2C(=O)c1n(cnc1N(C)C2=O)CCC
NCGC00014485-01,tox21-er-bla-agonist-p2,Etymemazine hydrochloride,activity,inactive,3737-33-5,71822.0,Cl.CN(C)CC(C)CN1c3ccccc3Sc2ccc(CC)cc12
NCGC00015572-04,tox21-er-bla-agonist-p2,3-Iodobenzylguanidine hemisulfate,activity,inactive,87862-25-7,11957572.0,Ic1cc(CNC(=N)N)ccc1.O=S(=O)(O)O.N=C(N)NCc1cc(I)ccc1
NCGC00016285-02,tox21-er-bla-agonist-p2,Sulfanilamide,activity,inactive,63-74-1,5333.0,Nc1ccc(cc1)S(=O)(N)=O
NCGC00016338-01,tox21-er-bla-agonist-p2,Dibucaine,activity,inactive,85-79-0,3025.0,CCN(CC)CCNC(=O)c1cc(OCCCC)nc2ccccc12
NCGC00016751-01,tox21-er-bla-agonist-p2,Gliclazide,activity,inactive,21187-98-4,3475.0,Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
NCGC00016815-01,tox21-er-bla-agonist-p2,Tiaprofenic acid,activity,inactive,33005-95-7,5468.0,O=C(c1ccc(s1)C(C)C(=O)O)c2ccccc2
NCGC00016827-01,tox21-er-bla-agonist-p2,Acebutolol hydrochloride,activity,inactive,34381-68-5,441307.0,Cl.CC(C)NCC(O)COc1ccc(cc1C(C)=O)NC(=O)CCC
NCGC00016853-01,tox21-er-bla-agonist-p2,Nabumetone,activity,inactive,42924-53-8,4409.0,CC(=O)CCc1ccc2cc(ccc2c1)OC
NCGC00016261-03,tox21-er-bla-agonist-p2,Pyridoxine,activity,inactive,65-23-6,1054.0,Oc1c(CO)c(cnc1C)CO
NCGC00091933-01,tox21-er-bla-agonist-p2,Zinc pyrithione,activity,active agonist,13463-41-7,26041.0,[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]
NCGC00159479-02,tox21-er-bla-agonist-p2,Methyl nicotinate,activity,inactive,93-60-7,7151.0,COC(=O)c1cccnc1
NCGC00165973-01,tox21-er-bla-agonist-p2,1-Thioglycerol,activity,inactive,96-27-5,7291.0,OCC(O)CS
NCGC00181137-01,tox21-er-bla-agonist-p2,Sulfathiourea,activity,inactive,515-49-1,3000579.0,Nc1ccc(cc1)S(=O)(=O)NC(N)=S
NCGC00256296-01,tox21-er-bla-agonist-p2,4-Chloro-3-nitrobenzaldehyde,activity,inactive,16588-34-4,85505.0,O=[N+]([O-])c1cc(ccc1Cl)C=O
NCGC00255050-01,tox21-er-bla-agonist-p2,Chloroacetaldehyde,activity,inactive,107-20-0,33.0,ClCC=O
NCGC00256105-01,tox21-er-bla-agonist-p2,Ditridecyl phthalate (mixture of branched chain isomers),activity,inactive,75359-31-8,60196427.0,CC(C)CC(C)CC(C)CC(C)COC(=O)c1ccccc1C(=O)OCC(C)CC(C)CC(C)CC(C)C
NCGC00254369-01,tox21-er-bla-agonist-p2,N-Nitrosodipropylamine,activity,inactive,621-64-7,12130.0,CCCN(CCC)N=O
NCGC00254404-01,tox21-er-bla-agonist-p2,Ziram,activity,active agonist,137-30-4,8722.0,[Zn+2].S=C([S-])N(C)C.CN(C)C([S-])=S
NCGC00254712-01,tox21-er-bla-agonist-p2,Pyrimethanil,activity,inactive,53112-28-0,91650.0,Cc2cc(C)nc(Nc1ccccc1)n2
NCGC00254835-01,tox21-er-bla-agonist-p2,Benzylamine,activity,inactive,100-46-9,7504.0,NCc1ccccc1
NCGC00255317-01,tox21-er-bla-agonist-p2,HC Red 3,activity,inactive,2871-01-4,3465817.0,[O-][N+](=O)c1cc(N)ccc1NCCO
NCGC00255321-01,tox21-er-bla-agonist-p2,4-Hydroxyandrostenedione,activity,active agonist,566-48-3,11273.0,O=C2CC[C@H]3[C@@H]4CCC1=C(O)C(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00255375-01,tox21-er-bla-agonist-p2,Tripropylene glycol diacrylate,activity,active agonist,42978-66-5,4128060.0,O=C(OC(C)COC(C)COC(C)COC(=O)C=C)C=C
NCGC00159384-02,tox21-er-bla-agonist-p2,6-Chlorothymol,activity,inactive,89-68-9,6982.0,Oc1cc(C)c(Cl)cc1C(C)C
NCGC00166088-01,tox21-er-bla-agonist-p2,Decitabine,activity,inactive,2353-33-5,451668.0,NC1=NC(=O)N(C=N1)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00166134-01,tox21-er-bla-agonist-p2,Estradiol cypionate,activity,active agonist,313-06-4,9403.0,Oc4cc5CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CCC3CCCC3)c5cc4
NCGC00167550-01,tox21-er-bla-agonist-p2,Narasin,activity,inactive,55134-13-9,65452.0,O=C(O)[C@H](CC)[C@@H]1O[C@H]([C@@H](C)C[C@@H]1C)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]5O[C@]4(C=C[C@@H](O)[C@]2(CC[C@](C)(O2)[C@H]3CC[C@](O)(CC)[C@H](C)O3)O4)[C@H](C)C[C@@H]5C
NCGC00181080-01,tox21-er-bla-agonist-p2,Phenacaine hydrochloride,activity,inactive,620-99-5,12113.0,Cl.CCOc1ccc(cc1)NC(\C)=N\c2ccc(OCC)cc2
NCGC00183276-01,tox21-er-bla-agonist-p2,Hydrocortisone buteprate,activity,inactive,72590-77-3,636398.0,CCC(=O)OCC(=O)[C@@]4(OC(=O)CCC)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00185743-01,tox21-er-bla-agonist-p2,Cloflucarban,activity,inactive,369-77-7,9719.0,FC(F)(F)c1cc(ccc1Cl)NC(=O)Nc2ccc(Cl)cc2
NCGC00188430-01,tox21-er-bla-agonist-p2,Moperone,activity,inactive,1050-79-9,60196367.0,O=S(=O)(O)O.Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(C)cc3
NCGC00259498-01,tox21-er-bla-agonist-p2,2-Aminobenzimidazole,activity,inactive,934-32-7,13624.0,Nc1nc2ccccc2n1
NCGC00259904-01,tox21-er-bla-agonist-p2,"2,5-Dithiobiurea",activity,inactive,142-46-1,2724564.0,NC(=S)NNC(N)=S
NCGC00260034-01,tox21-er-bla-agonist-p2,Annatto,activity,inactive,1393-63-1,,
NCGC00260502-01,tox21-er-bla-agonist-p2,3-Acetylphenanthrene,activity,inactive,2039-76-1,74867.0,CC(=O)c2ccc3ccc1ccccc1c3c2
NCGC00094557-01,tox21-er-bla-agonist-p2,2-Chloro-4-nitrobenzamide,activity,inactive,3011-89-0,2075.0,O=C(N)c1ccc(cc1Cl)[N+]([O-])=O
NCGC00159357-02,tox21-er-bla-agonist-p2,Mephobarbital,activity,inactive,115-38-8,8271.0,O=C1NC(=O)N(C)C(=O)C1(CC)c2ccccc2
NCGC00166308-01,tox21-er-bla-agonist-p2,Difloxacin hydrochloride,activity,inactive,91296-86-5,56205.0,Cl.CN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4
NCGC00166329-01,tox21-er-bla-agonist-p2,sn-Glycerol 3-phosphate bis(cyclohexylammonium),activity,inactive,29849-82-9,16219444.0,NC1CCCCC1.OC[C@@H](O)COP(=O)(O)O.NC1CCCCC1
NCGC00166415-01,tox21-er-bla-agonist-p2,Palonosetron hydrochloride,activity,inactive,135729-62-3,6918303.0,Cl.O=C1N(C[C@H]3CCCc2cccc1c23)[C@@H]5CN4CCC5CC4
NCGC00254081-01,tox21-er-bla-agonist-p2,MK-578,activity,inactive,313994-79-5,5481119.0,CCn5nc(Cc1ccccc1)cc5C4CCN(C[C@H]3C[C@@H](C[C@@H]3c2cccc(F)c2)N(C)[C@@H](C(=O)O)C(C)C)CC4
NCGC00016951-01,tox21-er-bla-agonist-p2,Clebopride maleate,activity,inactive,84370-95-6,6420010.0,O=C(O)/C=C\C(=O)O.Clc1cc(c(OC)cc1N)C(=O)NC3CCN(Cc2ccccc2)CC3
NCGC00090698-02,tox21-er-bla-agonist-p2,"1,3-Diphenylguanidine",activity,inactive,102-06-7,7594.0,N=C(Nc1ccccc1)Nc2ccccc2
NCGC00090704-03,tox21-er-bla-agonist-p2,Indium trichloride,activity,inactive,10025-82-8,24812.0,Cl[In](Cl)Cl
NCGC00090820-01,tox21-er-bla-agonist-p2,4-Acetamidobenzoic acid,activity,inactive,556-08-1,19266.0,O=C(C)Nc1ccc(cc1)C(=O)O
NCGC00090887-02,tox21-er-bla-agonist-p2,Phenyl salicylate,activity,inactive,118-55-8,8361.0,Oc2ccccc2C(=O)Oc1ccccc1
NCGC00018113-03,tox21-er-bla-agonist-p2,Sodium 4-phenylbutyrate,activity,inactive,1716-12-7,5258.0,[Na+].[O-]C(=O)CCCc1ccccc1
NCGC00016877-01,tox21-er-bla-agonist-p2,Praziquantel,activity,inactive,55268-74-1,4891.0,O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4
NCGC00256844-01,tox21-er-bla-agonist-p2,3-Phenylpropyl cinnamate,activity,inactive,122-68-9,61051.0,O=C(C=Cc1ccccc1)OCCCc2ccccc2
NCGC00258457-01,tox21-er-bla-agonist-p2,Dibenzyl ether,activity,inactive,103-50-4,7657.0,C(OCc1ccccc1)c2ccccc2
NCGC00257063-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexyl salicylate",activity,inactive,118-56-9,8362.0,O=C(OC1CC(C)CC(C)(C)C1)c2ccccc2O
NCGC00257370-01,tox21-er-bla-agonist-p2,4-Methoxy-2-methylaniline,activity,inactive,102-50-1,7610.0,Nc1ccc(OC)cc1C
NCGC00257548-01,tox21-er-bla-agonist-p2,"1,10-Phenanthroline hydrochloride hydrate",activity,inactive,18851-33-7,2723715.0,Cl.O.c1ccnc3c1ccc2cccnc23
NCGC00257585-01,tox21-er-bla-agonist-p2,1-Bromo-4-ethylbenzene,activity,inactive,1585-07-5,15313.0,CCc1ccc(Br)cc1
NCGC00257976-01,tox21-er-bla-agonist-p2,Perchloromethylmercaptan,activity,inactive,594-42-3,11666.0,ClC(Cl)(Cl)SCl
NCGC00258265-01,tox21-er-bla-agonist-p2,"Hexanol, acetate, branched and linear",activity,inactive,88230-35-7,8908.0,O=C(C)OCCCCCC
NCGC00258318-01,tox21-er-bla-agonist-p2,Diethyl (2E)-but-2-enedioate,activity,inactive,623-91-6,638144.0,O=C(/C=C/C(=O)OCC)OCC
NCGC00256722-01,tox21-er-bla-agonist-p2,Clove leaf oil,activity,inactive,8000-34-8,,
NCGC00256487-01,tox21-er-bla-agonist-p2,Nefiracetam,activity,inactive,77191-36-7,71157.0,O=C2CCCN2CC(=O)Nc1c(C)cccc1C
NCGC00256002-01,tox21-er-bla-agonist-p2,Acetyltriethyl citrate,activity,inactive,77-89-4,6504.0,O=C(C)OC(CC(=O)OCC)(CC(=O)OCC)C(=O)OCC
NCGC00256009-01,tox21-er-bla-agonist-p2,"Propane-1,2-diyl diacetate",activity,inactive,623-84-7,12198.0,CC(COC(=O)C)OC(=O)C
NCGC00256262-01,tox21-er-bla-agonist-p2,Bis(2-butoxyethyl) decanedioate,activity,inactive,141-19-5,67329.0,O=C(OCCOCCCC)CCCCCCCCC(=O)OCCOCCCC
NCGC00256267-01,tox21-er-bla-agonist-p2,"N-(2,4-Dimethylphenyl)acetamide",activity,inactive,2050-43-3,16303.0,O=C(C)Nc1ccc(C)cc1C
NCGC00255669-01,tox21-er-bla-agonist-p2,4-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy-acetic acid,activity,inactive,79558-09-1,6603901.0,Oc2c(ccc(OCCCOc1ccc(OCC(=O)O)cc1)c2CCC)C(C)=O
NCGC00258874-01,tox21-er-bla-agonist-p2,2-Phenylethanol,activity,inactive,60-12-8,6054.0,OCCc1ccccc1
NCGC00260407-01,tox21-er-bla-agonist-p2,"Pentadecane,1-bromo-",activity,inactive,629-72-1,12394.0,BrCCCCCCCCCCCCCCC
NCGC00260578-01,tox21-er-bla-agonist-p2,NTP Mix55 CT1 3-EQP,activity,inactive,NOCAS_49474,,
NCGC00259106-01,tox21-er-bla-agonist-p2,Cyclododecanone,activity,inactive,830-13-7,13246.0,O=C1CCCCCCCCCCC1
NCGC00259196-01,tox21-er-bla-agonist-p2,N-Ethyl-3-methylaniline,activity,inactive,102-27-2,7603.0,CCNc1cc(C)ccc1
NCGC00259545-01,tox21-er-bla-agonist-p2,Dehydroepiandrosterone,activity,active agonist,53-43-0,5881.0,O=C4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00259783-01,tox21-er-bla-agonist-p2,3-Methyl-2-buten-1-ol,activity,inactive,556-82-1,11173.0,C/C(C)=C\CO
NCGC00258698-01,tox21-er-bla-agonist-p2,7-Methylquinoline,activity,inactive,612-60-2,11927.0,Cc1cc2ncccc2cc1
NCGC00258738-01,tox21-er-bla-agonist-p2,Hematoxylin,activity,inactive,517-28-2,320930.0,Oc2cc3C[C@]4(O)COc1c(O)c(O)ccc1[C@@H]4c3cc2O
NCGC00254814-01,tox21-er-bla-agonist-p2,Iodenphos,activity,active agonist,18181-70-9,28935.0,Clc1cc(I)c(Cl)cc1OP(=S)(OC)OC
NCGC00255033-01,tox21-er-bla-agonist-p2,Ethephon,activity,inactive,16672-87-0,27982.0,ClCCP(=O)(O)O
NCGC00255038-01,tox21-er-bla-agonist-p2,alpha-Hexyl-gamma-butyrolactone,activity,inactive,18436-37-8,86736.0,O=C1OCCC1CCCCCC
NCGC00255251-01,tox21-er-bla-agonist-p2,"3,4,4'-Triaminodiphenyl ether",activity,inactive,6264-66-0,80434.0,Nc1ccc(cc1)Oc2ccc(N)c(N)c2
NCGC00255359-01,tox21-er-bla-agonist-p2,N-Phenyldiethanolamine,activity,inactive,120-07-0,8416.0,OCCN(CCO)c1ccccc1
NCGC00255428-01,tox21-er-bla-agonist-p2,Fenoxaprop-P-ethyl,activity,inactive,71283-80-2,91707.0,O=C(OCC)[C@@H](C)Oc1ccc(cc1)Oc2nc3ccc(Cl)cc3o2
NCGC00255495-01,tox21-er-bla-agonist-p2,Sodium pyruvate,activity,inactive,113-24-6,23662274.0,[Na+].CC(=O)C([O-])=O
NCGC00255556-01,tox21-er-bla-agonist-p2,Sodium warfarin,activity,inactive,129-06-6,16204922.0,[Na+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3
NCGC00256112-01,tox21-er-bla-agonist-p2,Diphenyl phosphorochloridate,activity,inactive,2524-64-3,75654.0,ClP(=O)(Oc1ccccc1)Oc2ccccc2
NCGC00092386-03,tox21-er-bla-agonist-p2,Sertraline hydrochloride,activity,inactive,79559-97-0,63009.0,Cl.Clc1ccc(cc1Cl)[C@@H]3CC[C@H](NC)c2ccccc23
NCGC00094071-01,tox21-er-bla-agonist-p2,4-Methylpyrazole hydrochloride,activity,inactive,56010-88-9,11957593.0,Cl.Cc1cnnc1
NCGC00159468-02,tox21-er-bla-agonist-p2,Sodium propionate,activity,inactive,137-40-6,2723816.0,[Na+].[O-]C(=O)CC
NCGC00094856-01,tox21-er-bla-agonist-p2,Adenine,activity,inactive,73-24-5,190.0,Nc1ncnc2ncnc12
NCGC00160350-01,tox21-er-bla-agonist-p2,Linotroban,activity,inactive,120824-08-0,65940.0,OC(=O)COc2ccc(CCNS(=O)(=O)c1ccccc1)s2
NCGC00095043-01,tox21-er-bla-agonist-p2,Tetroquinone,activity,inactive,319-89-1,5424.0,OC=1C(=O)C(O)=C(O)C(=O)C=1O
NCGC00181311-01,tox21-er-bla-agonist-p2,S-Adenosylmethionine chloride,activity,inactive,24346-00-7,90473.0,[Cl-].O=C(O)[C@@H](N)CC[S+](C)C[C@H]3O[C@@H](n2cnc1c(N)ncnc12)[C@H](O)[C@@H]3O
NCGC00167490-01,tox21-er-bla-agonist-p2,Lumefantrine,activity,inactive,82186-77-4,6437380.0,CCCCN(CCCC)CC(O)c4cc(Cl)cc3c4c1ccc(Cl)cc1\C3=C\c2ccc(Cl)cc2
NCGC00164612-01,tox21-er-bla-agonist-p2,Propyphenazone,activity,inactive,479-92-5,3778.0,CC(C)C=2C(=O)N(c1ccccc1)N(C)C=2C
NCGC00181082-01,tox21-er-bla-agonist-p2,Benzactyzine methylbromide,activity,inactive,3166-62-9,20056743.0,OC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2.BrC
NCGC00160573-01,tox21-er-bla-agonist-p2,Menbutone,activity,inactive,3562-99-0,71818.0,O=C(O)CCC(=O)c1ccc(OC)c2ccccc12
NCGC00095787-01,tox21-er-bla-agonist-p2,Inosine,activity,inactive,58-63-9,6021.0,Oc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
NCGC00160661-01,tox21-er-bla-agonist-p2,Lidamidine,activity,inactive,66871-56-5,47510.0,O=C(Nc1c(C)cccc1C)NC(=N)NC
NCGC00159361-02,tox21-er-bla-agonist-p2,Menthyl anthranilate,activity,active agonist,134-09-8,8633.0,O=C(OC1CC(C)CCC1C(C)C)c2ccccc2N
NCGC00166242-01,tox21-er-bla-agonist-p2,Ethyl nitrite,activity,inactive,109-95-5,8026.0,CCON=O
NCGC00091016-02,tox21-er-bla-agonist-p2,Carbon tetrachloride,activity,inactive,56-23-5,5943.0,ClC(Cl)(Cl)Cl
NCGC00182033-01,tox21-er-bla-agonist-p2,Felypressin,activity,inactive,56-59-7,14257662.0,NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00182557-01,tox21-er-bla-agonist-p2,Sevelamer hydrochloride,activity,inactive,152751-57-0,60196339.0,Cl.Cl.CCC(CN)CC(C)CCNCC(O)CNCC(C)CC(CN)CC
NCGC00182998-01,tox21-er-bla-agonist-p2,Bisoxatin acetate,activity,active agonist,14008-48-1,26391.0,CC(=O)Oc1ccc(cc1)C2(Oc3ccccc3NC2=O)c4ccc(OC(C)=O)cc4
NCGC00183137-01,tox21-er-bla-agonist-p2,Sulfadiazine silver,activity,inactive,22199-08-2,441244.0,[Ag+].O=S(=O)([N-]c1ncccn1)c2ccc(N)cc2
NCGC00183367-01,tox21-er-bla-agonist-p2,Hydrocortisone acetate,activity,inactive,50-03-3,5702068.0,CC(=O)OCC(=O)[C@@]4(O)CCC3C2CCC1=CC(=O)CC[C@]1(C)C2[C@@H](O)C[C@@]34C
NCGC00254143-01,tox21-er-bla-agonist-p2,Isophorone diisocyanate,activity,inactive,4098-71-9,169132.0,O=C=N\C1CC(C)(C)CC(C)(C1)C\N=C=O
NCGC00254145-01,tox21-er-bla-agonist-p2,Citronellol,activity,inactive,106-22-9,8842.0,C\C(C)=C\CCC(C)CCO
NCGC00185746-01,tox21-er-bla-agonist-p2,Loracarbef hydrate,activity,inactive,121961-22-6,5284584.0,O.O=C(O)C1=C(Cl)CC[C@H]3N1C(=O)[C@H]3NC(=O)[C@H](N)c2ccccc2
NCGC00185755-01,tox21-er-bla-agonist-p2,Cefatrizine,activity,inactive,51627-14-6,6410758.0,Oc1ccc(cc1)[C@@H](N)C(=O)N[C@@H]4C(=O)N3C(=C(CSc2cnnn2)CS[C@@H]34)C(=O)O
NCGC00254195-01,tox21-er-bla-agonist-p2,SAR102608,activity,inactive,1068967-96-3,25099474.0,Cc1nc(ncc1C(=O)Nn3cc(C)c2cc(F)ccc23)c4ccccn4
NCGC00247688-01,tox21-er-bla-agonist-p2,(dl)-trans-3-Methylfentanyl hydrochloride,activity,inactive,78995-09-2,60196317.0,Cl.CCC(=O)N([C@H]2CCN(CCc1ccccc1)C[C@@H]2C)c3ccccc3
NCGC00254686-01,tox21-er-bla-agonist-p2,Endosulfan sulfate,activity,inactive,1031-07-8,13940.0,ClC2=C(Cl)C3(Cl)C1COS(=O)(=O)OCC1C2(Cl)C3(Cl)Cl
NCGC00247720-01,tox21-er-bla-agonist-p2,Codeine hydrochloride,activity,inactive,1422-07-7,15984075.0,Cl.COc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00255068-01,tox21-er-bla-agonist-p2,Benomyl,activity,inactive,17804-35-2,28780.0,O=C(OC)Nc2nc1ccccc1n2C(=O)NCCCC
NCGC00255080-01,tox21-er-bla-agonist-p2,"1,3-Isobenzofurandione, tetrahydromethyl-",activity,inactive,11070-44-3,3033842.0,O=C1OC(=O)C2(C)CCCC=C12
NCGC00254006-01,tox21-er-bla-agonist-p2,tert-Butyl perbenzoate,activity,inactive,614-45-9,11966.0,CC(C)(C)OOC(=O)c1ccccc1
NCGC00254448-01,tox21-er-bla-agonist-p2,2-(Hexyloxy)ethanol,activity,inactive,112-25-4,8170.0,OCCOCCCCCC
NCGC00254036-01,tox21-er-bla-agonist-p2,Dimethyl terephthalate,activity,inactive,120-61-6,8441.0,COC(=O)c1ccc(cc1)C(=O)OC
NCGC00254044-01,tox21-er-bla-agonist-p2,Ethion,activity,inactive,563-12-2,3286.0,S=P(SCSP(=S)(OCC)OCC)(OCC)OCC
NCGC00255236-01,tox21-er-bla-agonist-p2,Dinotefuran,activity,inactive,165252-70-0,197701.0,[O-][N+](=O)/N=C(/NC)NCC1CCOC1
NCGC00254106-01,tox21-er-bla-agonist-p2,"2,3-Diaminotoluene",activity,inactive,2687-25-4,17593.0,Cc1cccc(N)c1N
NCGC00181754-01,tox21-er-bla-agonist-p2,Deferasirox,activity,inactive,201530-41-8,5493381.0,O=C(O)c1ccc(cc1)n3nc(nc3c2ccccc2O)c4ccccc4O
NCGC00181755-01,tox21-er-bla-agonist-p2,Delapril hydrochloride,activity,inactive,83435-67-0,5362115.0,Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C2Cc3ccccc3C2
NCGC00258426-01,tox21-er-bla-agonist-p2,Dinex,activity,inactive,131-89-5,8540.0,[O-][N+](=O)c1cc(c(O)c(c1)[N+]([O-])=O)C2CCCCC2
NCGC00255524-01,tox21-er-bla-agonist-p2,2-Chloro-N-(2-methyl-4-bromophenyl)acetamide,activity,inactive,96686-51-0,2097895.0,Brc1cc(C)c(NC(=O)CCl)cc1
NCGC00258857-01,tox21-er-bla-agonist-p2,"(2Z)-2,3-Dichloro-4-oxobut-2-enoic acid",activity,inactive,87-56-9,2771871.0,O=CC(\Cl)=C(\Cl)C(=O)O
NCGC00256823-01,tox21-er-bla-agonist-p2,2-Methyl-4-phenylbutan-2-ol,activity,inactive,103-05-9,7632.0,CC(C)(O)CCc1ccccc1
NCGC00258045-01,tox21-er-bla-agonist-p2,Chenodeoxycholic acid,activity,inactive,474-25-9,10133.0,O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]1[C@]4(C)CC[C@@H]2[C@@]3(C)CC[C@@H](O)C[C@H]3C[C@@H](O)[C@@H]12
NCGC00259346-01,tox21-er-bla-agonist-p2,Haloxyfop-methyl,activity,inactive,69806-40-2,50896.0,O=C(OC)C(C)Oc1ccc(cc1)Oc2ncc(cc2Cl)C(F)(F)F
NCGC00168267-01,tox21-er-bla-agonist-p2,"Benzeneethanamine, 4-bromo-2,5-dimethoxy-alpha-methyl-, hydrobromide (1:1)",activity,inactive,53581-53-6,62064.0,Br.COc1cc(CC(C)N)c(cc1Br)OC
NCGC00260604-01,tox21-er-bla-agonist-p2,NTP Mix7 AR1 8-EQC,activity,inactive,NOCAS_49500,,
NCGC00257075-01,tox21-er-bla-agonist-p2,Pindone,activity,inactive,83-26-1,6732.0,CC(C)(C)C(=O)C2C(=O)c1ccccc1C2=O
NCGC00247692-01,tox21-er-bla-agonist-p2,"1-(7-Methoxy-1,3-benzodioxol-5-yl)propan-2-amine hydrochloride",activity,inactive,60676-84-8,118031.0,Cl.CC(N)Cc1cc2OCOc2c(c1)OC
NCGC00254230-01,tox21-er-bla-agonist-p2,Cariporide mesylate,activity,inactive,159138-81-5,178019.0,O=S(C)(=O)c1cc(ccc1C(C)C)C(=O)/N=C(\N)N.CS(=O)(=O)O
NCGC00255723-01,tox21-er-bla-agonist-p2,4-Chlorobenzenesulfonic acid,activity,inactive,98-66-8,7400.0,OS(=O)(=O)c1ccc(Cl)cc1
NCGC00256092-01,tox21-er-bla-agonist-p2,3-Methyl-5-phenylpentan-1-ol,activity,inactive,55066-48-3,108312.0,CC(CCc1ccccc1)CCO
NCGC00256760-01,tox21-er-bla-agonist-p2,N-Methyloctan-1-amine,activity,inactive,2439-54-5,75538.0,CNCCCCCCCC
NCGC00256591-01,tox21-er-bla-agonist-p2,4-Chloro-2-methylaniline hydrochloride,activity,inactive,3165-93-3,18487.0,Cl.Cc1cc(Cl)ccc1N
NCGC00256208-01,tox21-er-bla-agonist-p2,2-tert-Butylcyclohexanone,activity,inactive,1728-46-7,102681.0,O=C1CCCCC1C(C)(C)C
NCGC00256459-01,tox21-er-bla-agonist-p2,Penicillin VK,activity,inactive,132-98-9,23676814.0,[K+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)COc1ccccc1)[C@H]3SC2(C)C
NCGC00256680-01,tox21-er-bla-agonist-p2,2-Cyclohexylethyl acetate,activity,inactive,21722-83-8,30771.0,CC(=O)OCCC1CCCCC1
NCGC00256686-01,tox21-er-bla-agonist-p2,3-Methoxy-5-methylphenol,activity,inactive,3209-13-0,76674.0,Oc1cc(C)cc(OC)c1
NCGC00256886-01,tox21-er-bla-agonist-p2,Diethylstilbestrol dipropionate,activity,active agonist,130-80-3,657220.0,O=C(Oc1ccc(cc1)C(\CC)=C(/CC)c2ccc(OC(=O)CC)cc2)CC
NCGC00257126-01,tox21-er-bla-agonist-p2,"2,2-Dimethyl-3-methylenebicyclo[2.2.1]heptane",activity,inactive,79-92-5,6616.0,CC2(C)C(=C)C1CCC2C1
NCGC00257148-01,tox21-er-bla-agonist-p2,N-(2-Methoxyphenyl)-3-oxobutanamide,activity,inactive,92-15-9,7078.0,COc1ccccc1NC(=O)CC(C)=O
NCGC00257622-01,tox21-er-bla-agonist-p2,Diphenylurea,activity,inactive,102-07-8,7595.0,O=C(Nc1ccccc1)Nc2ccccc2
NCGC00257907-01,tox21-er-bla-agonist-p2,Sulfamethoxazole,activity,inactive,723-46-6,5329.0,Cc2cc(NS(=O)(=O)c1ccc(N)cc1)no2
NCGC00257673-01,tox21-er-bla-agonist-p2,N-Acetyl-p-toluidine,activity,inactive,103-89-9,7684.0,O=C(C)Nc1ccc(C)cc1
NCGC00257921-01,tox21-er-bla-agonist-p2,Methyl methacrylate,activity,inactive,80-62-6,6658.0,C=C(C)C(=O)OC
NCGC00257933-01,tox21-er-bla-agonist-p2,2-Bromotoluene,activity,inactive,95-46-5,7236.0,Cc1ccccc1Br
NCGC00257974-01,tox21-er-bla-agonist-p2,Ethylene glycol dimethyl ether,activity,inactive,110-71-4,8071.0,COCCOC
NCGC00257765-01,tox21-er-bla-agonist-p2,N-[(Benzyloxy)carbonyl]-L-aspartic acid,activity,inactive,1152-61-0,2723942.0,O=C(O)[C@H](CC(=O)O)NC(=O)OCc1ccccc1
NCGC00257572-01,tox21-er-bla-agonist-p2,alpha-Bromotoluene,activity,inactive,100-39-0,7498.0,BrCc1ccccc1
NCGC00257578-01,tox21-er-bla-agonist-p2,2-Methylpropanal,activity,inactive,78-84-2,6561.0,CC(C)C=O
NCGC00258168-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium hexafluorophosphate,activity,inactive,330671-29-9,53316409.0,CCCC[N+]1(C)CCCC1.F[P-](F)(F)(F)(F)F
NCGC00258078-01,tox21-er-bla-agonist-p2,"2,2-Dimethylbutanedioic acid",activity,inactive,597-43-3,11701.0,CC(C)(CC(O)=O)C(=O)O
NCGC00258248-01,tox21-er-bla-agonist-p2,2-Hydroxypropyl 2-methylacrylate,activity,inactive,923-26-2,13539.0,CC(=C)C(=O)OCC(C)O
NCGC00258339-01,tox21-er-bla-agonist-p2,"2,2'-Diethylhexylamine",activity,inactive,106-20-7,7791.0,CCCCC(CNCC(CC)CCCC)CC
NCGC00258533-01,tox21-er-bla-agonist-p2,"1,2-Phenylenediamine dihydrochloride",activity,inactive,615-28-1,11990.0,Cl.Cl.Nc1ccccc1N
NCGC00258664-01,tox21-er-bla-agonist-p2,Dalapon-sodium,activity,inactive,127-20-8,517058.0,[Na+].CC(Cl)(Cl)C([O-])=O
NCGC00258884-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-4-nitrobenzene",activity,inactive,99-51-4,7440.0,Cc1ccc(cc1C)[N+](=O)[O-]
NCGC00259551-01,tox21-er-bla-agonist-p2,Tris(2-ethylhexyl) trimellitate,activity,inactive,3319-31-1,18725.0,CCC(CCCC)COC(=O)c1cc(C(=O)OCC(CC)CCCC)c(cc1)C(=O)OCC(CC)CCCC
NCGC00259584-01,tox21-er-bla-agonist-p2,"4,4'-Oxydianiline",activity,inactive,101-80-4,7579.0,Nc1ccc(cc1)Oc2ccc(N)cc2
NCGC00259864-01,tox21-er-bla-agonist-p2,Aspartame,activity,inactive,22839-47-0,134601.0,O=C(O)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC
NCGC00260356-01,tox21-er-bla-agonist-p2,DL-Glutamic acid monohydrate,activity,inactive,19285-83-7,16219385.0,O.OC(=O)CCC(N)C(=O)O
NCGC00260405-01,tox21-er-bla-agonist-p2,1-O-Methylglycerol,activity,inactive,623-39-2,92822.0,OCC(O)COC
NCGC00260516-01,tox21-er-bla-agonist-p2,Hydroxylamine hydrochloride,activity,inactive,5470-11-1,443297.0,Cl.NO
NCGC00260597-01,tox21-er-bla-agonist-p2,NTP Mix51 CT1 3-EQP,activity,inactive,NOCAS_49493,,
NCGC00260614-01,tox21-er-bla-agonist-p2,NTP Mix17 AR1 8-EQC,activity,inactive,NOCAS_49510,,
NCGC00015857-05,tox21-er-bla-agonist-p2,Piribedil,activity,inactive,3605-01-4,4850.0,c1cc(cc2OCOc12)CN3CCN(CC3)c4ncccn4
NCGC00016356-01,tox21-er-bla-agonist-p2,Lactobionic acid,activity,inactive,96-82-2,7314.0,O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO
NCGC00016000-08,tox21-er-bla-agonist-p2,Disulfiram,activity,inactive,97-77-8,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC
NCGC00016254-01,tox21-er-bla-agonist-p2,Testosterone propionate,activity,active agonist,57-85-2,5995.0,CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00016305-01,tox21-er-bla-agonist-p2,Sulfadiazine,activity,inactive,68-35-9,5215.0,O=S(=O)(Nc1ncccn1)c2ccc(N)cc2
NCGC00021148-02,tox21-er-bla-agonist-p2,Metoprolol tartrate,activity,inactive,56392-17-7,441308.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CC(C)NCC(O)COc1ccc(CCOC)cc1.CC(C)NCC(O)COc1ccc(cc1)CCOC
NCGC00094816-01,tox21-er-bla-agonist-p2,Carnitine hydrochloride,activity,inactive,461-05-2,9794197.0,Cl.C[N+](C)(C)CC(O)CC(=O)[O-]
NCGC00181746-01,tox21-er-bla-agonist-p2,Butenafine hydrochloride,activity,inactive,101827-46-7,443867.0,Cl.CN(Cc1ccc(cc1)C(C)(C)C)Cc3cccc2ccccc23
NCGC00254447-01,tox21-er-bla-agonist-p2,Disulfiram,activity,inactive,97-77-8,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC
NCGC00254585-01,tox21-er-bla-agonist-p2,beta-Nitrostyrene,activity,inactive,102-96-5,7626.0,[O-][N+](=O)C=Cc1ccccc1
NCGC00254931-01,tox21-er-bla-agonist-p2,Cyhalofop-butyl,activity,inactive,122008-85-9,180089.0,O=C(OCCCC)[C@@H](C)Oc1ccc(cc1)Oc2ccc(cc2F)C#N
NCGC00255091-01,tox21-er-bla-agonist-p2,Fluazifop-P-butyl,activity,inactive,79241-46-6,3033674.0,O=C(OCCCC)[C@@H](C)Oc1ccc(cc1)Oc2ccc(cn2)C(F)(F)F
NCGC00016940-01,tox21-er-bla-agonist-p2,Simvastatin,activity,inactive,79902-63-9,54454.0,CC(C)(CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23
NCGC00090745-02,tox21-er-bla-agonist-p2,Boric acid,activity,inactive,10043-35-3,7628.0,OB(O)O
NCGC00090986-03,tox21-er-bla-agonist-p2,4-Octylphenol,activity,inactive,1806-26-4,15730.0,Oc1ccc(CCCCCCCC)cc1
NCGC00095622-01,tox21-er-bla-agonist-p2,Hypoxanthine,activity,inactive,68-94-0,790.0,O=C2NC=Nc1ncnc12
NCGC00164127-02,tox21-er-bla-agonist-p2,"4-(1,1,3,3-Tetramethylbutyl)phenol",activity,active agonist,140-66-9,8814.0,Oc1ccc(cc1)C(C)(C)CC(C)(C)C
NCGC00164598-01,tox21-er-bla-agonist-p2,Cefpodoxime proxetil,activity,inactive,87239-81-4,6526396.0,Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(COC)CS[C@@H]23)C(=O)OC(C)OC(=O)OC(C)C
NCGC00166146-01,tox21-er-bla-agonist-p2,Quinestrol,activity,active agonist,152-43-2,9046.0,C#C[C@]5(O)CC[C@@H]2[C@]5(C)CC[C@@H]3c4ccc(OC1CCCC1)cc4CC[C@@H]23
NCGC00166270-01,tox21-er-bla-agonist-p2,"1,3,5-Trihydroxybenzene dihydrate",activity,inactive,6099-90-7,80196.0,O.O.Oc1cc(O)cc(O)c1
NCGC00182993-01,tox21-er-bla-agonist-p2,Betiatide,activity,inactive,103725-47-9,185457.0,O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1
NCGC00253993-01,tox21-er-bla-agonist-p2,AVE3295,activity,inactive,478263-98-8,24852044.0,[Na+].CC[C@H](NC(=O)c3cc(F)ccc3[N-]S(=O)(=O)c1cccc2cccnc12)c4ccccc4
NCGC00255028-01,tox21-er-bla-agonist-p2,"2,6-Pyridinedicarboxylic acid",activity,inactive,499-83-2,10367.0,OC(=O)c1cccc(n1)C(=O)O
NCGC00167544-01,tox21-er-bla-agonist-p2,Bisoctrizole,activity,inactive,103597-45-1,3571576.0,CC(C)(C)CC(C)(C)c4cc(Cc1cc(cc(c1O)n2nc3ccccc3n2)C(C)(C)CC(C)(C)C)c(O)c(c4)n5nc6ccccc6n5
NCGC00181005-01,tox21-er-bla-agonist-p2,Somatostatin,activity,inactive,38916-34-6,16161315.0,O=C6N[C@@H](CO)C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc4cnc3ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(O)C)C(=O)N[C@@H](Cc5ccccc5)C(=O)N[C@H]6C(O)C)C
NCGC00185782-01,tox21-er-bla-agonist-p2,Ubistatin A,activity,inactive,759437-26-8,5468154.0,O=S(=O)(O)c1cc(c(O)c2ncccc12)C(=O)Nc6ccc(/C=C/c3ccc(cc3S(=O)(=O)O)NC(=O)c4cc(c5cccnc5c4O)S(=O)(=O)O)c(c6)S(=O)(=O)O
NCGC00016939-01,tox21-er-bla-agonist-p2,Levocabastine hydrochloride,activity,inactive,79547-78-7,54384.0,Cl.Fc1ccc(cc1)[C@@]2(CC[C@H](CC2)N3CC[C@@]([C@H](C)C3)(c4ccccc4)C(=O)O)C#N
NCGC00017134-01,tox21-er-bla-agonist-p2,Meclocycline sulfosalicylate,activity,inactive,73816-42-9,54676538.0,O=C(O)c1cc(ccc1O)S(=O)(=O)O.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)ccc(Cl)c1C(=C)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00017256-04,tox21-er-bla-agonist-p2,Galanthamine,activity,inactive,357-70-0,9651.0,O[C@H]1C=C[C@@]42CCN(C)Cc3ccc(OC)c(O[C@H]2C1)c34
NCGC00018097-04,tox21-er-bla-agonist-p2,Paroxypropione,activity,inactive,70-70-2,6271.0,O=C(CC)c1ccc(O)cc1
NCGC00256792-01,tox21-er-bla-agonist-p2,2-Methyl-3-furanthiol,activity,inactive,28588-74-1,34286.0,Cc1occc1S
NCGC00256988-01,tox21-er-bla-agonist-p2,Triethyl phosphate,activity,inactive,78-40-0,6535.0,CCOP(=O)(OCC)OCC
NCGC00258515-01,tox21-er-bla-agonist-p2,p-Synephrine,activity,inactive,94-07-5,7172.0,OC(CNC)c1ccc(O)cc1
NCGC00258550-01,tox21-er-bla-agonist-p2,3-Ethoxyaniline,activity,inactive,621-33-0,12120.0,CCOc1cccc(N)c1
NCGC00257331-01,tox21-er-bla-agonist-p2,4-Butylchlorobenzene,activity,inactive,15499-27-1,524314.0,Clc1ccc(CCCC)cc1
NCGC00257366-01,tox21-er-bla-agonist-p2,Ethyl 4-methylbenzoate,activity,inactive,94-08-6,66743.0,O=C(OCC)c1ccc(C)cc1
NCGC00257424-01,tox21-er-bla-agonist-p2,Phenol red,activity,inactive,143-74-8,4766.0,Oc1ccc(cc1)C3(OS(=O)(=O)c2ccccc23)c4ccc(O)cc4
NCGC00257644-01,tox21-er-bla-agonist-p2,3-Nitrobenzamide,activity,inactive,645-09-0,12576.0,O=[N+]([O-])c1cc(ccc1)C(N)=O
NCGC00258212-01,tox21-er-bla-agonist-p2,"1,2-Dimethylbenzene",activity,inactive,95-47-6,7237.0,Cc1ccccc1C
NCGC00258349-01,tox21-er-bla-agonist-p2,"2,4,4-Trimethyl-2-pentene",activity,inactive,107-40-4,7869.0,C\C(C)=C/C(C)(C)C
NCGC00256713-01,tox21-er-bla-agonist-p2,Ethyl 2-methoxybenzoate,activity,inactive,7335-26-4,81784.0,COc1ccccc1C(=O)OCC
NCGC00255710-01,tox21-er-bla-agonist-p2,"N,N-Dibutyl-N-methylbutan-1-aminium chloride",activity,inactive,56375-79-2,91822.0,[Cl-].CCCC[N+](C)(CCCC)CCCC
NCGC00256408-01,tox21-er-bla-agonist-p2,Riboflavin,activity,inactive,83-88-5,493570.0,OC[C@@H](O)[C@@H](O)[C@@H](O)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12
NCGC00256465-01,tox21-er-bla-agonist-p2,Deltamethrin,activity,inactive,52918-63-5,40585.0,Br/C(Br)=C/[C@H]3[C@@H](C(=O)O[C@H](C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00256520-01,tox21-er-bla-agonist-p2,Methyl linoleate,activity,inactive,112-63-0,5284421.0,O=C(CCCCCCC/C=C\C/C=C\CCCCC)OC
NCGC00256525-01,tox21-er-bla-agonist-p2,dl-Menthol,activity,inactive,89-78-1,16666.0,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
NCGC00255769-01,tox21-er-bla-agonist-p2,3-Acetylpyridine,activity,inactive,350-03-8,9589.0,CC(=O)c1cccnc1
NCGC00255924-01,tox21-er-bla-agonist-p2,"1,2-Diphenylethanedione",activity,inactive,134-81-6,8651.0,O=C(C(=O)c1ccccc1)c2ccccc2
NCGC00256136-01,tox21-er-bla-agonist-p2,2-(tert-Butylamino)ethyl 2-methylprop-2-enoate,activity,inactive,3775-90-4,19601.0,CC(C)(C)NCCOC(=O)C(=C)C
NCGC00256192-01,tox21-er-bla-agonist-p2,"2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-amine",activity,inactive,68298-46-4,91697.0,Nc1cccc2CC(C)(C)Oc12
NCGC00256210-01,tox21-er-bla-agonist-p2,Decyl prop-2-enoate,activity,inactive,2156-96-9,16541.0,C=CC(=O)OCCCCCCCCCC
NCGC00258891-01,tox21-er-bla-agonist-p2,Imazethapyr,activity,inactive,81335-77-5,54740.0,CC1(N=C(NC1=O)c2ncc(CC)cc2C(=O)O)C(C)C
NCGC00260433-01,tox21-er-bla-agonist-p2,"2-Amino-4,6-dinitrophenol",activity,inactive,96-91-3,4921319.0,Nc1cc(cc([N+]([O-])=O)c1O)[N+]([O-])=O
NCGC00260449-01,tox21-er-bla-agonist-p2,Clarithromycin,activity,inactive,81103-11-9,5284534.0,CN(C)[C@H]3C[C@@H](C)O[C@@H](O[C@@H]2C(C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)OC)[C@@H]3O
NCGC00260482-01,tox21-er-bla-agonist-p2,Ethyl 2-chloroacetoacetate,activity,inactive,609-15-4,11858.0,O=C(C)C(Cl)C(=O)OCC
NCGC00260500-01,tox21-er-bla-agonist-p2,Triethylgermanium chloride,activity,inactive,994-28-5,70438.0,CC[Ge](Cl)(CC)CC
NCGC00259062-01,tox21-er-bla-agonist-p2,Diethyl maleate,activity,inactive,141-05-9,5271566.0,O=C(\C=C/C(=O)OCC)OCC
NCGC00259265-01,tox21-er-bla-agonist-p2,Niacinamide,activity,inactive,98-92-0,936.0,NC(=O)c1cccnc1
NCGC00259286-01,tox21-er-bla-agonist-p2,Salicylaldehyde,activity,inactive,90-02-8,6998.0,O=Cc1ccccc1O
NCGC00259643-01,tox21-er-bla-agonist-p2,Methyl methanesulfonate,activity,inactive,66-27-3,4156.0,CS(=O)(=O)OC
NCGC00259670-01,tox21-er-bla-agonist-p2,Cyclohexanone,activity,inactive,108-94-1,7967.0,O=C1CCCCC1
NCGC00259780-01,tox21-er-bla-agonist-p2,Di(2-ethylhexyl) adipate,activity,inactive,103-23-1,7641.0,O=C(CCCCC(=O)OCC(CC)CCCC)OCC(CCCC)CC
NCGC00256384-01,tox21-er-bla-agonist-p2,Chloromethyl methyl ether,activity,inactive,107-30-2,7864.0,COCCl
NCGC00255000-01,tox21-er-bla-agonist-p2,Methoxyfenozide,activity,inactive,161050-58-4,105010.0,Cc1c(cccc1OC)C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C
NCGC00255132-01,tox21-er-bla-agonist-p2,Bioresmethrin,activity,inactive,28434-01-7,162381.0,O=C(OCc2cc(Cc1ccccc1)oc2)[C@@H]3[C@@H](/C=C(\C)C)C3(C)C
NCGC00255659-01,tox21-er-bla-agonist-p2,Fenchlorphos,activity,inactive,299-84-3,9298.0,Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Cl
NCGC00255978-01,tox21-er-bla-agonist-p2,Pramipexole dihydrochloride monohydrate,activity,inactive,191217-81-9,166589.0,Cl.Cl.O.CCCN[C@@H]1Cc2sc(N)nc2CC1
NCGC00091162-02,tox21-er-bla-agonist-p2,2-Aminothiazole,activity,inactive,96-50-4,2155.0,Nc1nccs1
NCGC00181009-01,tox21-er-bla-agonist-p2,Timepidium bromide,activity,inactive,35035-05-3,160243.0,[Br-].COC1C\C(C[N+](C)(C)C1)=C(/c2sccc2)c3cccs3
NCGC00181134-01,tox21-er-bla-agonist-p2,Haloprogin,activity,inactive,777-11-7,3561.0,Clc1cc(OCC#CI)c(Cl)cc1Cl
NCGC00181162-01,tox21-er-bla-agonist-p2,C.I. Direct Blue 53,activity,inactive,314-13-6,6321418.0,[Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)c6cc(c(N)c5c6ccc(/N=N/c1ccc(cc1C)c4ccc(/N=N/c3ccc2c(cc(c(N)c2c3O)S([O-])(=O)=O)S([O-])(=O)=O)c(C)c4)c5O)S([O-])(=O)=O
NCGC00164509-01,tox21-er-bla-agonist-p2,Oxfenicine,activity,inactive,32462-30-9,36143.0,N[C@@H](c1ccc(O)cc1)C(=O)O
NCGC00167581-01,tox21-er-bla-agonist-p2,Cefodizime sodium,activity,inactive,86329-79-5,9852176.0,[Na+].[Na+].Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSc2nc(C)c(CC([O-])=O)s2)CS[C@@H]34)C([O-])=O
NCGC00167980-01,tox21-er-bla-agonist-p2,Pranoprofen,activity,inactive,52549-17-4,4888.0,O=C(O)C(C)c1cc2Cc3cccnc3Oc2cc1
NCGC00160397-01,tox21-er-bla-agonist-p2,Irsogladine maleate,activity,inactive,84504-69-8,5282435.0,Nc1nc(nc(N)n1)c2cc(Cl)ccc2Cl.O=C(O)/C=C\C(=O)O
NCGC00168759-02,tox21-er-bla-agonist-p2,Ataluren,activity,inactive,775304-57-9,11219835.0,O=C(O)c1cccc(c1)c2nc(on2)c3ccccc3F
NCGC00161336-02,tox21-er-bla-agonist-p2,Potassium ricinoleate,activity,inactive,7492-30-0,23716429.0,[K+].CCCCCC[C@@H](O)C/C=C\CCCCCCCC([O-])=O
NCGC00183098-01,tox21-er-bla-agonist-p2,Ceftezole sodium,activity,inactive,41136-22-5,23688977.0,[Na+].[O-]C(=O)C=3N4C(=O)[C@@H](NC(=O)Cn1cnnn1)[C@H]4SCC=3CSc2nncs2
NCGC00183658-01,tox21-er-bla-agonist-p2,Quadrisol,activity,inactive,71109-09-6,72158.0,O=C(O)C(C)c2ccc(c1ccccc12)C3CCCCC3
NCGC00183829-01,tox21-er-bla-agonist-p2,Minodronic acid,activity,inactive,180064-38-4,130956.0,O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O
NCGC00183871-01,tox21-er-bla-agonist-p2,N-Acetyl sulfamethoxazole,activity,inactive,21312-10-7,65280.0,Cc2cc(NS(=O)(=O)c1ccc(NC(C)=O)cc1)no2
NCGC00254164-01,tox21-er-bla-agonist-p2,2-Anisidine,activity,inactive,90-04-0,7000.0,Nc1ccccc1OC
NCGC00254231-01,tox21-er-bla-agonist-p2,SSR69071,activity,inactive,344930-95-6,9872438.0,CC(C)c1cc(cc5c1C(=O)N(COC3=CC(=O)N4C=CC=C(OCCN2CCCCC2)C4=N3)S5(=O)=O)OC
NCGC00254287-01,tox21-er-bla-agonist-p2,Ethyl heptanoate,activity,inactive,106-30-9,7797.0,O=C(CCCCCC)OCC
NCGC00254299-01,tox21-er-bla-agonist-p2,FD&C Yellow 6,activity,inactive,2783-94-0,5359810.0,[Na+].[Na+].O=S([O-])(=O)c3ccc(/N=N/c1c2ccc(cc2ccc1O)S([O-])(=O)=O)cc3
NCGC00254311-01,tox21-er-bla-agonist-p2,CP-608039,activity,inactive,NOCAS_47305,9828356.0,Cc5cc(COc4ccc(Cl)cc4CNc3ncnc2c3ncn2[C@@H]1O[C@H](C(=O)NC)[C@@H](N)[C@H]1O)on5
NCGC00249416-01,tox21-er-bla-agonist-p2,Oberadilol,activity,inactive,114856-44-9,3047798.0,Clc3cc(OCC(O)CNC(C)(C)CNc1ccc(cc1)C2=NNC(=O)CC2C)c(C#N)cc3
NCGC00254746-01,tox21-er-bla-agonist-p2,D-Lactic acid,activity,inactive,10326-41-7,61503.0,O=C(O)[C@@H](C)O
NCGC00254033-01,tox21-er-bla-agonist-p2,AVE9423,activity,inactive,862243-29-6,24798733.0,O=C(O)c1ccccc1N4C=C(C(=O)c3cc(Nc2c(F)cc(F)cc2Cl)c(Cl)cc34)C(=O)O
NCGC00254121-01,tox21-er-bla-agonist-p2,Pentamidine isethionate,activity,inactive,140-64-7,8813.0,OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N
NCGC00254122-01,tox21-er-bla-agonist-p2,"1,6-Diisocyanatohexane",activity,inactive,822-06-0,13192.0,O=C=N/CCCCCC\N=C=O
NCGC00181343-01,tox21-er-bla-agonist-p2,Ivabradine hydrochloride,activity,inactive,148849-67-6,3045381.0,Cl.COc3cc4C[C@H](CN(C)CCCN1CCc2cc(OC)c(OC)cc2CC1=O)c4cc3OC
NCGC00182976-01,tox21-er-bla-agonist-p2,Fentiazac,activity,inactive,18046-21-4,28871.0,O=C(O)Cc1sc(nc1c2ccc(Cl)cc2)c3ccccc3
NCGC00181774-01,tox21-er-bla-agonist-p2,Chrysarobin,activity,inactive,491-59-8,10288.0,Oc2c3c(cc1cccc(O)c12)cc(C)cc3O
NCGC00016384-10,tox21-er-bla-agonist-p2,Sulfisoxazole,activity,inactive,127-69-5,5344.0,Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C
NCGC00016712-01,tox21-er-bla-agonist-p2,Alcuronium chloride,activity,inactive,15180-03-7,21158559.0,[Cl-].[Cl-].OC\C=C6\C[N@+]4(CC=C)CC[C@@]58c%11ccccc%11N7C=C9[C@H]1C[C@H]2[C@@]%10(CC[N@@+]2(CC=C)C\C1=C\CO)c3ccccc3N(C=C([C@H]6C[C@H]45)[C@H]78)[C@@H]9%10
NCGC00259402-01,tox21-er-bla-agonist-p2,Benzothiazole,activity,inactive,95-16-9,7222.0,c1cccc2scnc12
NCGC00090760-08,tox21-er-bla-agonist-p2,Methoxychlor,activity,active agonist,72-43-5,4115.0,COc1ccc(cc1)C(c2ccc(OC)cc2)C(Cl)(Cl)Cl
NCGC00015562-18,tox21-er-bla-agonist-p2,Indomethacin,activity,inactive,53-86-1,3715.0,Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC
NCGC00256147-01,tox21-er-bla-agonist-p2,N-(3-Aminophenyl)propanamide,activity,inactive,22987-10-6,89953.0,O=C(Nc1cccc(N)c1)CC
NCGC00258598-01,tox21-er-bla-agonist-p2,Sodium sulfate anyhdrous,activity,inactive,7757-82-6,24436.0,[Na+].[Na+].[O-]S([O-])(=O)=O
NCGC00256734-01,tox21-er-bla-agonist-p2,"1,4-Bis[(ethenyloxy)methyl]cyclohexane",activity,inactive,17351-75-6,3437285.0,C=COCC1CCC(COC=C)CC1
NCGC00256780-01,tox21-er-bla-agonist-p2,4-Hydroxy-5-methyl-3-furanone,activity,inactive,19322-27-1,4564493.0,CC=1OCC(=O)C=1O
NCGC00257288-01,tox21-er-bla-agonist-p2,Pentylcinnamaldehyde,activity,inactive,122-40-7,31209.0,O=CC(CCCCC)=Cc1ccccc1
NCGC00256908-01,tox21-er-bla-agonist-p2,Sclareol,activity,inactive,515-03-7,163263.0,C=C[C@](C)(O)CC[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2CC[C@@]1(C)O
NCGC00256606-01,tox21-er-bla-agonist-p2,"2,4-Dihydroxybenzophenone",activity,active agonist,131-56-6,8572.0,O=C(c1ccc(O)cc1O)c2ccccc2
NCGC00259126-01,tox21-er-bla-agonist-p2,Benzenethiol,activity,inactive,108-98-5,7969.0,Sc1ccccc1
NCGC00255469-01,tox21-er-bla-agonist-p2,2-Amino-N-(1-methylethyl)benzamide,activity,inactive,30391-89-0,94411.0,O=C(NC(C)C)c1ccccc1N
NCGC00255798-01,tox21-er-bla-agonist-p2,2-(2-Ethylhexyloxy)ethanol,activity,inactive,1559-35-9,15260.0,OCCOCC(CCCC)CC
NCGC00256547-01,tox21-er-bla-agonist-p2,Tetradecanoic acid,activity,inactive,544-63-8,11005.0,O=C(O)CCCCCCCCCCCCC
NCGC00256238-01,tox21-er-bla-agonist-p2,Sodium bis(2-methylpropyl)phosphinodithioate,activity,inactive,13360-78-6,23672293.0,[Na+].[S-]P(=S)(CC(C)C)CC(C)C
NCGC00256839-01,tox21-er-bla-agonist-p2,Ethyl nonanoate,activity,inactive,123-29-5,31251.0,O=C(CCCCCCCC)OCC
NCGC00257800-01,tox21-er-bla-agonist-p2,Magnesium chloride hexahydrate,activity,inactive,7791-18-6,643991.0,O.O.O.O.O.O.Cl[Mg]Cl
NCGC00257827-01,tox21-er-bla-agonist-p2,p-Benzoquinone dioxime,activity,inactive,105-11-3,7737.0,O\N=C1/C=C/C(=N\O)C=C1
NCGC00257308-01,tox21-er-bla-agonist-p2,4-Propylcyclohexanone,activity,inactive,40649-36-3,142482.0,CCCC1CCC(=O)CC1
NCGC00257562-01,tox21-er-bla-agonist-p2,2-Cyclohexen-1-one,activity,inactive,930-68-7,13594.0,O=C1C=CCCC1
NCGC00257029-01,tox21-er-bla-agonist-p2,Nonane,activity,inactive,111-84-2,8141.0,CCCCCCCCC
NCGC00258127-01,tox21-er-bla-agonist-p2,Tetramethylsuccinonitrile,activity,inactive,3333-52-6,18745.0,CC(C)(C#N)C(C)(C)C#N
NCGC00258585-01,tox21-er-bla-agonist-p2,L-5-Hydroxytryptophan,activity,inactive,4350-09-8,439280.0,O=C(O)[C@@H](N)Cc2cnc1ccc(O)cc12
NCGC00258429-01,tox21-er-bla-agonist-p2,2-Chloro-1-methyl-4-nitrobenzene,activity,inactive,121-86-8,8491.0,Cc1ccc(cc1Cl)[N+]([O-])=O
NCGC00258677-01,tox21-er-bla-agonist-p2,"2-(Hydroxymethyl)-2-methyl-1,3-propanediol",activity,inactive,77-85-0,6502.0,CC(CO)(CO)CO
NCGC00259267-01,tox21-er-bla-agonist-p2,Sodium dodecylbenzenesulfonate,activity,inactive,25155-30-0,23707968.0,[Na+].O=S([O-])(=O)c1ccc(cc1)C(CC)CCCCCCCCC
NCGC00259299-01,tox21-er-bla-agonist-p2,Nitrobenzene,activity,inactive,98-95-3,7416.0,[O-][N+](=O)c1ccccc1
NCGC00259520-01,tox21-er-bla-agonist-p2,Sodium dimethyldithiocarbamate,activity,inactive,128-04-1,560256.0,[Na+].CN(C)C([S-])=S
NCGC00260008-01,tox21-er-bla-agonist-p2,4-Bromoaniline,activity,inactive,106-40-1,7807.0,Nc1ccc(Br)cc1
NCGC00260218-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpiperidinium hexafluorophosphate,activity,inactive,NOCAS_49386,60196386.0,CCC[N+]1(C)CCCCC1.F[P-](F)(F)(F)(F)F
NCGC00260404-01,tox21-er-bla-agonist-p2,"Benzaldehyde,3-hydroxy-4-methoxy-",activity,inactive,621-59-0,12127.0,Oc1cc(ccc1OC)C=O
NCGC00260573-01,tox21-er-bla-agonist-p2,NTP Mix81 CT1 62-EQP,activity,inactive,NOCAS_49469,,
NCGC00015982-05,tox21-er-bla-agonist-p2,Gaboxadol,activity,inactive,64603-91-4,3448.0,O=C2NOC=1CNCCC=12
NCGC00014483-01,tox21-er-bla-agonist-p2,Nortriptyline hdrochloride,activity,inactive,894-71-3,441358.0,Cl.CNCC\C=C1\c3ccccc3CCc2ccccc12
NCGC00016281-06,tox21-er-bla-agonist-p2,Phenacetin,activity,inactive,62-44-2,4754.0,CCOc1ccc(cc1)NC(C)=O
NCGC00016346-01,tox21-er-bla-agonist-p2,Sparteine,activity,inactive,90-39-1,644020.0,C3CCCN4C[C@@H]2C[C@@H](CN1CCCC[C@H]12)[C@@H]34
NCGC00016795-06,tox21-er-bla-agonist-p2,Minaprine dihydrochloride,activity,inactive,25953-17-7,33254.0,Cl.Cl.Cc2cc(nnc2NCCN1CCOCC1)c3ccccc3
NCGC00017022-05,tox21-er-bla-agonist-p2,Pentamidine isethionate,activity,inactive,140-64-7,8813.0,OCCS(=O)(=O)O.OCCS(=O)(=O)O.N=C(N)c1ccc(cc1)OCCCCCOc2ccc(cc2)C(=N)N
NCGC00167432-01,tox21-er-bla-agonist-p2,Fosinopril sodium,activity,inactive,88889-14-9,23681451.0,[Na+].O=C(CP(=O)(CCCCc1ccccc1)OC(OC(=O)CC)C(C)C)N2C[C@@H](C[C@H]2C([O-])=O)C3CCCCC3
NCGC00255188-01,tox21-er-bla-agonist-p2,Tolcapone,activity,inactive,134308-13-7,4659569.0,Oc1cc(cc([N+]([O-])=O)c1O)C(=O)c2ccc(C)cc2
NCGC00255228-01,tox21-er-bla-agonist-p2,Eosin,activity,inactive,17372-87-1,11048.0,[Na+].[Na+].[O-]C(=O)c4ccccc4C=2c3cc(Br)c([O-])c(Br)c3OC=1C=2C=C(Br)C(=O)C=1Br
NCGC00255367-01,tox21-er-bla-agonist-p2,"4,5-Dichloro-2-octyl-3(2H)-isothiazolone",activity,inactive,64359-81-5,91688.0,ClC=1SN(CCCCCCCC)C(=O)C=1Cl
NCGC00254424-01,tox21-er-bla-agonist-p2,l-Tryptophan,activity,inactive,73-22-3,6305.0,O=C(O)[C@@H](N)Cc2cnc1ccccc12
NCGC00255133-01,tox21-er-bla-agonist-p2,Carbimazole,activity,inactive,22232-54-8,31072.0,S=C1N(C=CN1C)C(=O)OCC
NCGC00015264-08,tox21-er-bla-agonist-p2,Clomipramine,activity,inactive,303-49-1,2801.0,CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12
NCGC00016523-03,tox21-er-bla-agonist-p2,Iodipamide,activity,inactive,606-17-7,3739.0,O=C(Nc1c(I)c(c(I)cc1I)C(=O)O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)cc2I
NCGC00025004-02,tox21-er-bla-agonist-p2,GR 103691,activity,inactive,162408-66-4,4302960.0,CC(=O)c1ccc(cc1)c2ccc(cc2)C(=O)NCCCCN3CCN(CC3)c4ccccc4OC
NCGC00090952-07,tox21-er-bla-agonist-p2,Bisphenol A,activity,active agonist,80-05-7,6623.0,CC(C)(c1ccc(O)cc1)c2ccc(O)cc2
NCGC00094516-01,tox21-er-bla-agonist-p2,Coumaphos,activity,inactive,56-72-4,2871.0,CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C
NCGC00167525-01,tox21-er-bla-agonist-p2,Tazarotene,activity,inactive,118292-40-3,5381.0,O=C(OCC)c1ccc(nc1)C#Cc2ccc3SCCC(C)(C)c3c2
NCGC00183366-01,tox21-er-bla-agonist-p2,Norethindrone acetate,activity,active agonist,51-98-9,5832.0,CC(=O)O[C@@]3(C#C)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@@]23C
NCGC00016315-02,tox21-er-bla-agonist-p2,Pyrithyldione,activity,inactive,77-04-3,4994.0,CCC1(CC)C(=O)C=CNC1=O
NCGC00254482-01,tox21-er-bla-agonist-p2,Geranyl acetate,activity,inactive,105-87-3,1549026.0,C\C(C)=C\CCC(\C)=C\COC(C)=O
NCGC00017066-01,tox21-er-bla-agonist-p2,Dextromethorphan hydrobromide monohydrate,activity,inactive,6700-34-1,60196267.0,Br.O.COc2ccc3C[C@@H]1C4CCCC[C@]4(CCN1C)c3c2
NCGC00018164-02,tox21-er-bla-agonist-p2,Azaserine,activity,inactive,115-02-6,5284344.0,OC(=O)[C@@H](N)COC(=O)/C=[N+]=[N-]
NCGC00018167-03,tox21-er-bla-agonist-p2,Cladribine,activity,inactive,4291-63-8,20279.0,Nc3nc(Cl)nc2c3ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
NCGC00256757-01,tox21-er-bla-agonist-p2,Fipexide hydrochloride,activity,inactive,34161-23-4,161803.0,Cl.Clc1ccc(cc1)OCC(=O)N2CCN(CC2)Cc3ccc4OCOc4c3
NCGC00256787-01,tox21-er-bla-agonist-p2,4-Methylphenyl 3-methylbutanoate,activity,inactive,55066-56-3,62092.0,O=C(Oc1ccc(C)cc1)CC(C)C
NCGC00256924-01,tox21-er-bla-agonist-p2,3-Phenylprop-2-en-1-yl 2-methylpropanoate,activity,inactive,103-59-3,7663.0,CC(C)C(=O)OCC=Cc1ccccc1
NCGC00258479-01,tox21-er-bla-agonist-p2,Acetanilide,activity,inactive,103-84-4,904.0,O=C(C)Nc1ccccc1
NCGC00258602-01,tox21-er-bla-agonist-p2,Carbarsone,activity,inactive,121-59-5,8480.0,O=C(N)Nc1ccc(cc1)[As](O)(O)=O
NCGC00258636-01,tox21-er-bla-agonist-p2,Trolamine salicylate,activity,inactive,2174-16-5,25213.0,OC(=O)c1ccccc1O.OCCN(CCO)CCO
NCGC00257036-01,tox21-er-bla-agonist-p2,Benzenethiol,activity,inactive,108-98-5,7969.0,Sc1ccccc1
NCGC00257054-01,tox21-er-bla-agonist-p2,"1,2,4-Tribromobenzene",activity,inactive,615-54-3,12002.0,Brc1cc(Br)c(Br)cc1
NCGC00257320-01,tox21-er-bla-agonist-p2,"1,1':3',1''-Terphenyl",activity,inactive,92-06-8,7076.0,c1cc(ccc1)c2cccc(c2)c3ccccc3
NCGC00257609-01,tox21-er-bla-agonist-p2,Cadmium acetate dihydrate,activity,active agonist,5743-04-4,6537495.0,O.[Cd+2].O.[O-]C(C)=O.[O-]C(C)=O
NCGC00256649-01,tox21-er-bla-agonist-p2,4-Butylphenol,activity,inactive,1638-22-8,15420.0,Oc1ccc(CCCC)cc1
NCGC00256706-01,tox21-er-bla-agonist-p2,"5-Acetyl-2,4-dimethylthiazole",activity,inactive,38205-60-6,520888.0,O=C(C)c1sc(C)nc1C
NCGC00255739-01,tox21-er-bla-agonist-p2,"Sodium 2,4,7-tri(propan-2-yl)naphthalene-1-sulfonate",activity,inactive,1323-19-9,60196428.0,[Na+].CC(C)c1cc2c(cc1)c(cc(C(C)C)c2S([O-])(=O)=O)C(C)C
NCGC00256471-01,tox21-er-bla-agonist-p2,Divinylbenzene,activity,inactive,1321-74-0,66666.0,C=Cc1ccccc1C=C
NCGC00255772-01,tox21-er-bla-agonist-p2,Ethyl 4-chloro-3-oxobutanoate,activity,inactive,638-07-3,69484.0,O=C(CCl)CC(=O)OCC
NCGC00255881-01,tox21-er-bla-agonist-p2,Profluralin,activity,inactive,26399-36-0,33500.0,CCCN(CC1CC1)c2c(cc(cc2[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O
NCGC00255901-01,tox21-er-bla-agonist-p2,Tetraethylammonium bromide,activity,inactive,71-91-0,6285.0,[Br-].CC[N+](CC)(CC)CC
NCGC00256139-01,tox21-er-bla-agonist-p2,Jasmone,activity,inactive,488-10-8,1549018.0,CC=1CCC(=O)C=1C\C=C/CC
NCGC00255668-01,tox21-er-bla-agonist-p2,Bornyl acetate,activity,inactive,76-49-3,442460.0,CC(=O)O[C@@H]1CC2CCC1(C)C2(C)C
NCGC00258839-01,tox21-er-bla-agonist-p2,2-(2-Aminoethoxy)ethanol,activity,inactive,929-06-6,13578.0,NCCOCCO
NCGC00258932-01,tox21-er-bla-agonist-p2,6-Methyl-5-hepten-2-one,activity,inactive,110-93-0,9862.0,C/C(C)=C\CCC(C)=O
NCGC00260401-01,tox21-er-bla-agonist-p2,Procainamide hydrochloride,activity,inactive,614-39-1,66068.0,Cl.O=C(NCCN(CC)CC)c1ccc(N)cc1
NCGC00260464-01,tox21-er-bla-agonist-p2,"1,4-Dimethylamino-4-nitrostilbene",activity,inactive,4584-57-0,5377793.0,CN(C)c1ccc(cc1)\C=C\c2ccc(cc2)[N+]([O-])=O
NCGC00260543-01,tox21-er-bla-agonist-p2,"Octadecane, 1-chloro-",activity,inactive,3386-33-2,18815.0,CCCCCCCCCCCCCCCCCCCl
NCGC00260560-01,tox21-er-bla-agonist-p2,NTP Mix68 CT1 62-EQP,activity,inactive,NOCAS_49456,,
NCGC00259095-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorophenol",activity,inactive,95-95-4,7271.0,Oc1cc(Cl)c(Cl)cc1Cl
NCGC00259164-01,tox21-er-bla-agonist-p2,Anise oil,activity,inactive,8007-70-3,,
NCGC00259380-01,tox21-er-bla-agonist-p2,"2,3-Dimethylphenol",activity,inactive,526-75-0,10687.0,Cc1cccc(O)c1C
NCGC00259496-01,tox21-er-bla-agonist-p2,Pentachloronitrobenzene,activity,inactive,82-68-8,6720.0,Clc1c(c(Cl)c(Cl)c(Cl)c1Cl)[N+]([O-])=O
NCGC00259580-01,tox21-er-bla-agonist-p2,Methyldopa sesquihydrate,activity,inactive,41372-08-1,38852.0,O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1
NCGC00260102-01,tox21-er-bla-agonist-p2,"1,2-Benzenedicarboxylic acid, 4-sulfo-",activity,inactive,89-08-7,6962.0,OS(=O)(=O)c1cc(c(cc1)C(=O)O)C(=O)O
NCGC00260142-01,tox21-er-bla-agonist-p2,Nickel(II) sulfate hexahydrate,activity,inactive,10101-97-0,5284429.0,O.O.O.O.[Ni+2].O.O.[O-]S([O-])(=O)=O
NCGC00258666-01,tox21-er-bla-agonist-p2,Chloroacetic acid,activity,inactive,79-11-8,300.0,ClCC(=O)O
NCGC00256350-01,tox21-er-bla-agonist-p2,Nitrosoheptamethyleneimine,activity,inactive,20917-49-1,30360.0,O=NN1CCCCCCC1
NCGC00254913-01,tox21-er-bla-agonist-p2,(Z)-3-Hexen-1-ol,activity,inactive,928-96-1,5281167.0,CC\C=C/CCO
NCGC00255162-01,tox21-er-bla-agonist-p2,Neodecanoic acid,activity,inactive,26896-20-8,62817.0,CC(C)CCC(C)(CC)C(=O)O
NCGC00255437-01,tox21-er-bla-agonist-p2,"7-Methoxy-3,7-dimethyloctanal",activity,inactive,3613-30-7,19223.0,COC(C)(C)CCCC(C)CC=O
NCGC00093372-02,tox21-er-bla-agonist-p2,d-Tryptophan,activity,inactive,153-94-6,9060.0,O=C(O)[C@H](N)Cc2cnc1ccccc12
NCGC00163334-03,tox21-er-bla-agonist-p2,D-Isoleucine,activity,inactive,319-78-8,11051686.0,CC(CC)[C@@H](N)C(=O)O
NCGC00159432-03,tox21-er-bla-agonist-p2,Indigocarmine,activity,inactive,483-20-5,5282430.0,O=S(=O)(O)c1cc2C(=O)C(\Nc2cc1)=C4/Nc3ccc(cc3C4=O)S(=O)(=O)O
NCGC00164336-01,tox21-er-bla-agonist-p2,Levothyroxine,activity,inactive,51-48-9,5819.0,O=C(O)[C@@H](N)Cc2cc(I)c(Oc1cc(I)c(O)c(I)c1)c(I)c2
NCGC00164344-01,tox21-er-bla-agonist-p2,Symclosene,activity,inactive,87-90-1,6909.0,ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O
NCGC00160357-01,tox21-er-bla-agonist-p2,"Sorbitan, monododecanoate",activity,inactive,1338-39-2,22833303.0,O[C@H](COC(=O)CCCCCCCCCCC)C1OC[C@H](O)[C@H]1O
NCGC00164489-01,tox21-er-bla-agonist-p2,Amiphenazole,activity,inactive,490-55-1,10275.0,Nc2nc(N)sc2c1ccccc1
NCGC00160462-01,tox21-er-bla-agonist-p2,Guanoxan,activity,inactive,2165-19-7,16564.0,N=C(N)NCC1COc2ccccc2O1
NCGC00167473-01,tox21-er-bla-agonist-p2,Capreomycin IB,activity,inactive,33490-33-4,20055082.0,NCCC[C@H](N)CC(=O)NC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)C(\NC1=O)=C\NC(N)=O)[C@@H]2CCNC(N)=N2
NCGC00164623-01,tox21-er-bla-agonist-p2,Olopatadine hydrochloride,activity,inactive,140462-76-6,5282402.0,Cl.O=C(O)Cc1ccc2OCc3ccccc3C(=C\CCN(C)C)\c2c1
NCGC00160545-01,tox21-er-bla-agonist-p2,Benmoxin,activity,inactive,7654-03-7,71671.0,CC(NNC(=O)c1ccccc1)c2ccccc2
NCGC00165979-01,tox21-er-bla-agonist-p2,Cinnamic acid,activity,inactive,140-10-3,444539.0,O=C(O)/C=C/c1ccccc1
NCGC00160595-01,tox21-er-bla-agonist-p2,Clazolam,activity,inactive,7492-29-7,24107.0,Clc1ccc2N(C)C(=O)CN3CCc4ccccc4C3c2c1
NCGC00166103-01,tox21-er-bla-agonist-p2,D-(-)-Lyxose,activity,inactive,1114-34-7,439240.0,O[C@H]1[C@H](O)COC(O)[C@H]1O
NCGC00159329-02,tox21-er-bla-agonist-p2,Testolactone,activity,active agonist,968-93-4,13769.0,O=C3C=C4CC[C@@H]1[C@H](CC[C@]2(C)OC(=O)CC[C@@H]12)[C@@]4(C)C=C3
NCGC00160649-01,tox21-er-bla-agonist-p2,Glycyclamide,activity,inactive,664-95-9,12628.0,O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(C)cc2
NCGC00160669-01,tox21-er-bla-agonist-p2,Pexantel,activity,inactive,10001-13-5,667497.0,O=C(N1CCN(C)CC1)C2CCCCC2
NCGC00159368-02,tox21-er-bla-agonist-p2,1-Hexadecanol,activity,inactive,36653-82-4,2682.0,CCCCCCCCCCCCCCCCO
NCGC00091059-01,tox21-er-bla-agonist-p2,1-Chlorobutane,activity,inactive,109-69-3,8005.0,CCCCCl
NCGC00091328-01,tox21-er-bla-agonist-p2,Furfural,activity,inactive,98-01-1,7362.0,O=Cc1ccco1
NCGC00091563-01,tox21-er-bla-agonist-p2,Thiram,activity,inactive,137-26-8,5455.0,CN(C)C(=S)SSC(=S)N(C)C
NCGC00181909-01,tox21-er-bla-agonist-p2,Sulcaine,activity,inactive,41653-21-8,3300.0,O=C(CN1CCCCC1)Nc2ccc(cc2)C(=O)OCC
NCGC00184998-01,tox21-er-bla-agonist-p2,Dopexamine,activity,inactive,86197-47-9,55483.0,Oc2ccc(CCNCCCCCCNCCc1ccccc1)cc2O
NCGC00254216-01,tox21-er-bla-agonist-p2,Methotrexate,activity,inactive,59-05-2,126941.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)nc(N)nc3N
NCGC00254247-01,tox21-er-bla-agonist-p2,Dimethoxane,activity,inactive,828-00-2,13232.0,O=C(C)OC1CC(C)OC(C)O1
NCGC00254702-01,tox21-er-bla-agonist-p2,"N,N-Diethyl-N-methylethanaminium chloride",activity,inactive,10052-47-8,82326.0,[Cl-].CC[N+](C)(CC)CC
NCGC00249610-01,tox21-er-bla-agonist-p2,Pivoxil Sulbactam,activity,inactive,69388-79-0,50491.0,O=S1(=O)C2CC(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)C1(C)C
NCGC00253927-01,tox21-er-bla-agonist-p2,Methacrylamide,activity,inactive,79-39-0,6595.0,C=C(C)C(N)=O
NCGC00254323-01,tox21-er-bla-agonist-p2,Triethylene glycol dimethyl ether,activity,inactive,112-49-2,8189.0,COCCOCCOCCOC
NCGC00255073-01,tox21-er-bla-agonist-p2,"1,3-Cyclohexanedimethanamine",activity,inactive,2579-20-6,17406.0,NCC1CCCC(CN)C1
NCGC00255186-01,tox21-er-bla-agonist-p2,Propylene glycol monobutyl ether,activity,inactive,29387-86-8,3032854.0,CCC(O)OCCCC
NCGC00181334-01,tox21-er-bla-agonist-p2,Sodium dibunate,activity,inactive,14992-59-7,23672302.0,[Na+].CC(C)(C)c1ccc2c(c1)ccc(c2S([O-])(=O)=O)C(C)(C)C
NCGC00183036-01,tox21-er-bla-agonist-p2,Cephradine,activity,inactive,38821-53-3,38103.0,CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)C1=CCC=CC1)C=3C(=O)O
NCGC00016486-01,tox21-er-bla-agonist-p2,Canadine,activity,inactive,522-97-4,34458.0,COc1c(OC)ccc2CC3N(Cc12)CCc4cc5OCOc5cc34
NCGC00258149-01,tox21-er-bla-agonist-p2,1-Dodecyl-3-methylimidazolium chloride,activity,inactive,114569-84-5,2734227.0,[Cl-].C[n+]1ccn(CCCCCCCCCCCC)c1
NCGC00260445-01,tox21-er-bla-agonist-p2,5-Methyl-2-thiouracil,activity,inactive,636-26-0,720471.0,CC1=CNC(=S)NC1=O
NCGC00260470-01,tox21-er-bla-agonist-p2,Tropolone,activity,inactive,533-75-5,10789.0,OC1=CC=CC=CC1=O
NCGC00015838-03,tox21-er-bla-agonist-p2,Propionylpromazine hydrochloride,activity,inactive,7681-67-6,24351.0,Cl.CCC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1
NCGC00016568-01,tox21-er-bla-agonist-p2,Citiolone,activity,inactive,1195-16-0,14520.0,O=C1SCCC1NC(=O)C
NCGC00259519-01,tox21-er-bla-agonist-p2,sec-Butylparaben,activity,active agonist,17696-61-6,86607.0,Oc1ccc(cc1)C(=O)OC(C)CC
NCGC00258621-01,tox21-er-bla-agonist-p2,Bromoxynil octanoate,activity,inactive,1689-99-2,15533.0,Brc1cc(cc(Br)c1OC(=O)CCCCCCC)C#N
NCGC00256195-01,tox21-er-bla-agonist-p2,1-Cyclohexylpyrrolidin-2-one,activity,inactive,6837-24-7,81278.0,O=C2CCCN2C1CCCCC1
NCGC00257486-01,tox21-er-bla-agonist-p2,(+)-alpha-Pinene,activity,inactive,7785-70-8,82227.0,CC2(C)[C@@H]1CC=C(C)[C@H]2C1
NCGC00160431-01,tox21-er-bla-agonist-p2,2-[(4-Chloro-3-methylphenyl)amino]benzoic acid,activity,inactive,898128-45-5,5507.0,Cc2cc(Nc1ccccc1C(=O)O)ccc2Cl
NCGC00256579-01,tox21-er-bla-agonist-p2,Dimethyl methylphosphonate,activity,inactive,756-79-6,12958.0,CP(=O)(OC)OC
NCGC00257510-01,tox21-er-bla-agonist-p2,Cyclobutyl phenyl ketone,activity,inactive,5407-98-7,79414.0,O=C(c1ccccc1)C2CCC2
NCGC00256884-01,tox21-er-bla-agonist-p2,Indapamide,activity,inactive,26807-65-8,3702.0,NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C
NCGC00257966-01,tox21-er-bla-agonist-p2,2-Aminobenzamide,activity,inactive,88-68-6,6942.0,O=C(N)c1ccccc1N
NCGC00015429-08,tox21-er-bla-agonist-p2,Felbamate,activity,inactive,25451-15-4,3331.0,NC(=O)OCC(COC(N)=O)c1ccccc1
NCGC00258547-01,tox21-er-bla-agonist-p2,6-Mercaptopurine monohydrate,activity,inactive,6112-76-1,6537489.0,O.S=C1NC=NC2N=CNC12
NCGC00258611-01,tox21-er-bla-agonist-p2,Trichloroacetonitrile,activity,inactive,545-06-2,11011.0,ClC(Cl)(Cl)C#N
NCGC00256558-01,tox21-er-bla-agonist-p2,4-Ethylphenol,activity,inactive,123-07-9,31242.0,CCc1ccc(O)cc1
NCGC00258869-01,tox21-er-bla-agonist-p2,2-(2-Butoxyethoxy)ethyl thiocyanate,activity,inactive,112-56-1,8196.0,N#CSCCOCCOCCCC
NCGC00255788-01,tox21-er-bla-agonist-p2,Laurocapram,activity,inactive,59227-89-3,42981.0,O=C1CCCCCN1CCCCCCCCCCCC
NCGC00255751-01,tox21-er-bla-agonist-p2,Tetrachlorothiophene,activity,inactive,6012-97-1,22344.0,Clc1sc(Cl)c(Cl)c1Cl
NCGC00256762-01,tox21-er-bla-agonist-p2,Hydroxycitronellal dimethyl acetal,activity,inactive,141-92-4,8863.0,COC(CC(C)CCCC(C)(C)O)OC
NCGC00256857-01,tox21-er-bla-agonist-p2,Methyl 3-nonenoate,activity,inactive,13481-87-3,61631.0,O=C(CC=CCCCCC)OC
NCGC00256403-01,tox21-er-bla-agonist-p2,Allantoin,activity,inactive,97-59-6,204.0,O=C1NC(=O)NC1NC(=O)N
NCGC00256626-01,tox21-er-bla-agonist-p2,"2,6-Difluorobenzonitrile",activity,inactive,1897-52-5,74695.0,N#Cc1c(F)cccc1F
NCGC00256647-01,tox21-er-bla-agonist-p2,2-Acetoxy-5-nitrobenzyl chloride,activity,inactive,5174-32-3,21619272.0,O=C(C)Oc1ccc(cc1CCl)[N+]([O-])=O
NCGC00256717-01,tox21-er-bla-agonist-p2,Betamethasone 21-phosphate disodium,activity,inactive,151-73-5,65478.0,[Na+].[Na+].[O-]P([O-])(=O)OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00257107-01,tox21-er-bla-agonist-p2,"(E,E)-2,4-Decadienal",activity,inactive,25152-84-5,5283349.0,CCCCC\C=C\C=C\C=O
NCGC00257395-01,tox21-er-bla-agonist-p2,"2,2',4,4'-Tetrahydroxybenzophenone",activity,active agonist,131-55-5,8571.0,O=C(c1ccc(O)cc1O)c2ccc(O)cc2O
NCGC00257678-01,tox21-er-bla-agonist-p2,4-Methylthiazole,activity,inactive,693-95-8,12748.0,Cc1cscn1
NCGC00257322-01,tox21-er-bla-agonist-p2,FR130739,activity,inactive,136042-19-8,23668568.0,[Na+].CCCCc5nc1cccnc1n5Cc2ccc(cc2)c4ccccc4c3[n-]nnn3
NCGC00257354-01,tox21-er-bla-agonist-p2,tert-Nonanethiol,activity,inactive,25360-10-5,520196.0,CC(C)(S)CCCCCC
NCGC00258055-01,tox21-er-bla-agonist-p2,Isobutylparaben,activity,active agonist,4247-02-3,20240.0,Oc1ccc(cc1)C(=O)OCC(C)C
NCGC00258188-01,tox21-er-bla-agonist-p2,Benzaldehyde,activity,inactive,100-52-7,240.0,O=Cc1ccccc1
NCGC00258406-01,tox21-er-bla-agonist-p2,3-Methyl-2-nitrobenzoic acid,activity,inactive,5437-38-7,21575.0,O=[N+]([O-])c1c(C)cccc1C(=O)O
NCGC00258831-01,tox21-er-bla-agonist-p2,Octanoic acid,activity,inactive,124-07-2,379.0,O=C(O)CCCCCCC
NCGC00259082-01,tox21-er-bla-agonist-p2,3-Sulfolene,activity,inactive,77-79-2,6498.0,O=S1(=O)CC=CC1
NCGC00259088-01,tox21-er-bla-agonist-p2,Sodium 6-hydroxynaphthalene-2-sulfonate,activity,inactive,135-76-2,23667648.0,[Na+].[O-]S(=O)(=O)c1ccc2cc(O)ccc2c1
NCGC00259198-01,tox21-er-bla-agonist-p2,"N-[3-(Trimethoxysilyl)propyl]ethane-1,2-diamine",activity,inactive,1760-24-3,15659.0,CO[Si](CCCNCCN)(OC)OC
NCGC00259523-01,tox21-er-bla-agonist-p2,1-Piperazineethanol,activity,inactive,103-76-4,7677.0,OCCN1CCNCC1
NCGC00259544-01,tox21-er-bla-agonist-p2,2-Isopropyl-6-methyl-4-pyrimidone,activity,inactive,2814-20-2,17777.0,O=C1C=C(C)NC(=N1)C(C)C
NCGC00260153-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium trifluoromethanesulfonate,activity,inactive,367522-96-1,12195864.0,CCCC[N+]1(C)CCCC1.FC(F)(F)S([O-])(=O)=O
NCGC00259641-01,tox21-er-bla-agonist-p2,Chlorpheniramine maleate,activity,inactive,113-92-8,5284366.0,[O-]C(=O)\C=C/C(=O)O.Clc1ccc(cc1)C(CC[NH+](C)C)c2ccccn2
NCGC00259648-01,tox21-er-bla-agonist-p2,4-(2-Phenylpropan-2-yl)-N-[4-(2-phenylpropan-2-yl)phenyl]aniline,activity,inactive,10081-67-1,82343.0,CC(C)(c1ccccc1)c2ccc(cc2)Nc3ccc(cc3)C(C)(C)c4ccccc4
NCGC00259484-01,tox21-er-bla-agonist-p2,2-[4-(Diethylamino)-2-hydroxybenzoyl]benzoic acid,activity,inactive,5809-23-4,79878.0,O=C(c1ccc(cc1O)N(CC)CC)c2ccccc2C(=O)O
NCGC00260012-01,tox21-er-bla-agonist-p2,Triethyl phosphate,activity,inactive,78-40-0,6535.0,CCOP(=O)(OCC)OCC
NCGC00260343-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium bromide,activity,inactive,85100-77-2,25153273.0,Br.CN1C=CN(CCCC)C1
NCGC00013718-01,tox21-er-bla-agonist-p2,Homatropine HBr,activity,inactive,51-56-9,6419941.0,Br.CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(O)c2ccccc2
NCGC00015038-03,tox21-er-bla-agonist-p2,4-Aminofolic acid,activity,inactive,54-62-6,169371.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2nc3c(nc2)nc(N)nc3N
NCGC00015471-02,tox21-er-bla-agonist-p2,Ganciclovir,activity,inactive,82410-32-0,3454.0,OCC(CO)OCn2cnc1c2N=C(N)NC1=O
NCGC00016634-01,tox21-er-bla-agonist-p2,Acetopromazine maleate,activity,inactive,3598-37-6,6420038.0,O=C(O)/C=C\C(=O)O.CC(=O)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1
NCGC00183127-01,tox21-er-bla-agonist-p2,Mestanolone,activity,active agonist,521-11-9,10633.0,O=C3C[C@@H]4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@]1(C)O)[C@@]4(C)CC3
NCGC00255603-01,tox21-er-bla-agonist-p2,"7-Octen-2-ol, 2-methyl-6-methylene-, dihydro deriv.",activity,inactive,53219-21-9,29096.0,CC(C)(O)CCCC(C)C=C
NCGC00255607-01,tox21-er-bla-agonist-p2,S-Methoprene,activity,inactive,65733-16-6,1711973.0,CC(C)OC(=O)\C=C(/C)\C=C\C[C@@H](C)CCCC(C)(C)OC
NCGC00254660-01,tox21-er-bla-agonist-p2,4-Methoxybenzeneethanol,activity,inactive,702-23-8,69705.0,COc1ccc(CCO)cc1
NCGC00255380-01,tox21-er-bla-agonist-p2,Nordihydroguaiaretic acid,activity,active agonist,500-38-9,4534.0,Oc2ccc(CC(C)C(C)Cc1ccc(O)c(O)c1)cc2O
NCGC00256279-01,tox21-er-bla-agonist-p2,2-(Propan-2-yl)-9H-thioxanthen-9-one,activity,inactive,5495-84-1,79633.0,CC(C)c1cc2C(=O)c3ccccc3Sc2cc1
NCGC00254663-01,tox21-er-bla-agonist-p2,1-Monolaurin,activity,inactive,142-18-7,14871.0,OCC(O)COC(=O)CCCCCCCCCCC
NCGC00254875-01,tox21-er-bla-agonist-p2,Dimethyl acetylsuccinate,activity,inactive,10420-33-4,112039.0,COC(=O)CC(C(=O)OC)C(C)=O
NCGC00255037-01,tox21-er-bla-agonist-p2,Chlorpropham,activity,inactive,101-21-3,2728.0,Clc1cc(NC(=O)OC(C)C)ccc1
NCGC00016274-04,tox21-er-bla-agonist-p2,Phenazone,activity,inactive,60-80-0,2206.0,O=C2C=C(C)N(C)N2c1ccccc1
NCGC00094372-03,tox21-er-bla-agonist-p2,Salmeterol xinafoate,activity,inactive,94749-08-3,56801.0,OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2.O=C(O)c2ccc1ccccc1c2O
NCGC00259391-01,tox21-er-bla-agonist-p2,1-Tetradecanol,activity,inactive,112-72-1,8209.0,CCCCCCCCCCCCCCO
NCGC00259835-01,tox21-er-bla-agonist-p2,Propyl gallate,activity,active agonist,121-79-9,4947.0,Oc1cc(cc(O)c1O)C(=O)OCCC
NCGC00016532-02,tox21-er-bla-agonist-p2,Dimethadione,activity,inactive,695-53-4,3081.0,O=C1NC(=O)C(C)(C)O1
NCGC00024822-02,tox21-er-bla-agonist-p2,C.I. Direct Blue 53,activity,inactive,314-13-6,6321418.0,[Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)c6cc(c(N)c5c6ccc(/N=N/c1ccc(cc1C)c4ccc(/N=N/c3ccc2c(cc(c(N)c2c3O)S([O-])(=O)=O)S([O-])(=O)=O)c(C)c4)c5O)S([O-])(=O)=O
NCGC00094484-01,tox21-er-bla-agonist-p2,Trifluperidol hydrochloride,activity,inactive,2062-77-3,11647992.0,Cl.FC(F)(F)c1cccc(c1)C3(O)CCN(CCCC(=O)c2ccc(F)cc2)CC3
NCGC00163886-03,tox21-er-bla-agonist-p2,Fenchlorphos,activity,inactive,299-84-3,9298.0,Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Cl
NCGC00185747-01,tox21-er-bla-agonist-p2,Niceritrol,activity,inactive,5868-05-3,4476.0,O=C(OCC(COC(=O)c1cccnc1)(COC(=O)c2cccnc2)COC(=O)c3cccnc3)c4cccnc4
NCGC00254347-01,tox21-er-bla-agonist-p2,Methyl 2-aminobenzoate,activity,inactive,134-20-3,8635.0,Nc1ccccc1C(=O)OC
NCGC00254522-01,tox21-er-bla-agonist-p2,Urethane,activity,inactive,51-79-6,5641.0,NC(=O)OCC
NCGC00090704-01,tox21-er-bla-agonist-p2,Indium trichloride,activity,inactive,10025-82-8,24812.0,Cl[In](Cl)Cl
NCGC00017039-01,tox21-er-bla-agonist-p2,Deptropine citrate,activity,inactive,2169-75-7,6604492.0,CN5[C@H]1CC[C@@H]5C[C@@H](C1)OC3c4ccccc4CCc2ccccc23.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00017332-05,tox21-er-bla-agonist-p2,"(1S,9R)-beta-Hydrastine",activity,inactive,29617-43-4,656743.0,CN2CCc1cc5OCOc5cc1[C@H]2[C@@H]4OC(=O)c3c(OC)c(ccc34)OC
NCGC00024493-02,tox21-er-bla-agonist-p2,D-Alanine,activity,inactive,338-69-2,71080.0,C[C@@H](N)C(=O)O
NCGC00257014-01,tox21-er-bla-agonist-p2,Terephthalic acid,activity,inactive,100-21-0,7489.0,OC(=O)c1ccc(cc1)C(=O)O
NCGC00257015-01,tox21-er-bla-agonist-p2,"2,6-Dimethyl-2,4,6-octatriene",activity,inactive,673-84-7,5368821.0,C\C(C)=C\C=C\C(\C)=C\C
NCGC00258523-01,tox21-er-bla-agonist-p2,"1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane",activity,inactive,3322-93-8,18728.0,BrC1CCC(CC1Br)C(Br)CBr
NCGC00258532-01,tox21-er-bla-agonist-p2,"1,2,3-Benzenetricarboxylic acid",activity,inactive,36362-97-7,11288.0,OC(=O)c1c(cccc1C(=O)O)C(=O)O
NCGC00257136-01,tox21-er-bla-agonist-p2,1-Bromo-4-fluorobenzene,activity,inactive,460-00-4,9993.0,Fc1ccc(Br)cc1
NCGC00257302-01,tox21-er-bla-agonist-p2,1-Methoxy-2-propylamine,activity,inactive,37143-54-7,123458.0,CC(N)COC
NCGC00257373-01,tox21-er-bla-agonist-p2,"3,5-Dichloroaniline",activity,inactive,626-43-7,12281.0,Nc1cc(Cl)cc(Cl)c1
NCGC00257555-01,tox21-er-bla-agonist-p2,N-Methyl-4-nitroaniline,activity,inactive,100-15-2,7483.0,CNc1ccc(cc1)[N+]([O-])=O
NCGC00257592-01,tox21-er-bla-agonist-p2,Isopropyl glycidyl ether,activity,inactive,4016-14-2,19920.0,CC(C)OCC1CO1
NCGC00257708-01,tox21-er-bla-agonist-p2,1-Methylpyrene,activity,inactive,2381-21-7,16932.0,Cc4ccc1ccc2cccc3ccc4c1c23
NCGC00257971-01,tox21-er-bla-agonist-p2,Etidronic acid,activity,inactive,2809-21-4,3305.0,CC(O)(P(O)(=O)O)P(=O)(O)O
NCGC00258242-01,tox21-er-bla-agonist-p2,"2,4-Difluoronitrobenzene",activity,inactive,446-35-5,67967.0,Fc1cc(F)ccc1[N+](=O)[O-]
NCGC00256641-01,tox21-er-bla-agonist-p2,3-Cyclohexylpropan-1-ol,activity,inactive,1124-63-6,70763.0,OCCCC1CCCCC1
NCGC00256729-01,tox21-er-bla-agonist-p2,Nutmeg oil,activity,inconclusive,8008-45-5,,
NCGC00255747-01,tox21-er-bla-agonist-p2,1-Ethyl-2-pyrrolidinone,activity,inactive,2687-91-4,17595.0,O=C1CCCN1CC
NCGC00256485-01,tox21-er-bla-agonist-p2,Chloralose,activity,inactive,15879-93-3,7057995.0,OC[C@@H](O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl
NCGC00255799-01,tox21-er-bla-agonist-p2,Methyl red,activity,inactive,493-52-7,10303.0,CN(C)c2ccc(/N=N/c1ccccc1C(=O)O)cc2
NCGC00255802-01,tox21-er-bla-agonist-p2,3-(Triethoxysilyl)propane-1-thiol,activity,inactive,14814-09-6,84658.0,CCO[Si](OCC)(OCC)CCCS
NCGC00255917-01,tox21-er-bla-agonist-p2,Sodium 1-naphthalenesulfonate,activity,inactive,130-14-3,23661867.0,[Na+].[O-]S(=O)(=O)c2cccc1ccccc12
NCGC00255990-01,tox21-er-bla-agonist-p2,N-Butylaniline,activity,inactive,1126-78-9,14310.0,CCCCNc1ccccc1
NCGC00256187-01,tox21-er-bla-agonist-p2,"1,4-Bis(methoxymethyl)benzene",activity,inactive,6770-38-3,81239.0,COCc1ccc(cc1)COC
NCGC00256206-01,tox21-er-bla-agonist-p2,"Chromium acetate, basic",activity,inactive,39430-51-8,11284883.0,O=C(C)O[Cr](OC(C)=O)OC(=O)C.CC(=O)O[Cr](O)OC(C)=O.CC(=O)O[Cr](O)OC(C)=O
NCGC00256245-01,tox21-er-bla-agonist-p2,1-Butoxy-1-oxopropan-2-yl butanoate,activity,inactive,7492-70-8,24114.0,O=C(CCC)OC(C)C(=O)OCCCC
NCGC00256343-01,tox21-er-bla-agonist-p2,N-Nitrosomorpholine,activity,inactive,59-89-2,6046.0,O=NN1CCOCC1
NCGC00256362-01,tox21-er-bla-agonist-p2,Diphenylacetonitrile,activity,inactive,86-29-3,6837.0,N#CC(c1ccccc1)c2ccccc2
NCGC00260399-01,tox21-er-bla-agonist-p2,Methylpyruvate,activity,inactive,600-22-6,11748.0,CC(=O)C(=O)OC
NCGC00259172-01,tox21-er-bla-agonist-p2,3-Ethylphenol,activity,inactive,620-17-7,12101.0,CCc1cc(O)ccc1
NCGC00259329-01,tox21-er-bla-agonist-p2,2-Amino-2-methylpropan-1-ol,activity,inactive,124-68-5,11807.0,CC(C)(N)CO
NCGC00259460-01,tox21-er-bla-agonist-p2,Heptachlor,activity,inactive,76-44-8,3589.0,ClC2=C(Cl)C3(Cl)C1C=CC(Cl)C1C2(Cl)C3(Cl)Cl
NCGC00259549-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-3-nitrobenzene",activity,inactive,83-41-0,6739.0,Cc1c(C)cccc1[N+](=O)[O-]
NCGC00259601-01,tox21-er-bla-agonist-p2,Gibberellic acid,activity,inactive,77-06-5,6466.0,O=C(O)[C@H]3[C@@H]5[C@]1(C)C(=O)O[C@]5(C=C[C@@H]1O)[C@@H]4CC[C@]2(O)C[C@]34CC2=C
NCGC00260035-01,tox21-er-bla-agonist-p2,C.I. Basic Oange 2,activity,inactive,532-82-1,10771.0,Cl.Nc2ccc(\N=N/c1ccccc1)c(N)c2
NCGC00254619-01,tox21-er-bla-agonist-p2,Alachlor,activity,inactive,15972-60-8,2078.0,ClCC(=O)N(COC)c1c(cccc1CC)CC
NCGC00254912-01,tox21-er-bla-agonist-p2,Penoxsulam,activity,inactive,219714-96-2,11784975.0,FC(F)(F)c1cccc(OCC(F)F)c1S(=O)(=O)Nc2nc3c(cnc(OC)n3n2)OC
NCGC00254964-01,tox21-er-bla-agonist-p2,Ytterbium(III) chloride,activity,inactive,10361-91-8,61510.0,Cl[Yb](Cl)Cl
NCGC00255204-01,tox21-er-bla-agonist-p2,Calcium dodecylbenzene sulfonate,activity,inactive,26264-06-2,24180685.0,[Ca+2].O=S([O-])(=O)c1ccc(cc1)C(CC)CCCCCCCCC.CCC(CCCCCCCCC)c1ccc(cc1)S([O-])(=O)=O
NCGC00255290-01,tox21-er-bla-agonist-p2,Pentaerythritol tetranitrate,activity,inactive,78-11-5,6518.0,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+]([O-])=O)CO[N+]([O-])=O
NCGC00255569-01,tox21-er-bla-agonist-p2,Bromofos,activity,active agonist,2104-96-3,16422.0,Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Br
NCGC00091124-02,tox21-er-bla-agonist-p2,6-Methyl-2-thiouracil,activity,inactive,56-04-2,667493.0,O=C1C=C(C)NC(=S)N1
NCGC00091400-01,tox21-er-bla-agonist-p2,Allylthiourea,activity,inactive,109-57-9,1549517.0,NC(=S)NCC=C
NCGC00166289-01,tox21-er-bla-agonist-p2,Hydroxystilbamidine bis(methanesulfonate),activity,inactive,223769-64-0,16212515.0,Oc2cc(ccc2C=Cc1ccc(cc1)C(=N)N)C(=N)N.CS(=O)(=O)O.CS(=O)(=O)O
NCGC00093926-03,tox21-er-bla-agonist-p2,Doxifluridine,activity,active agonist,3094-09-5,18343.0,FC1=CN(C(=O)NC1=O)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O
NCGC00094063-01,tox21-er-bla-agonist-p2,Itriglumide sodium,activity,inactive,NOCAS_45775,23704140.0,[Na+].[O-]C(=O)C[C@@H](CC(=O)Nc1c(C)cc(C)cc1C(=O)N3CCC2(CCCC2)CC3)c5cccc4ccccc45
NCGC00159406-02,tox21-er-bla-agonist-p2,Norepinephrine bitartrate,activity,inactive,69815-49-2,12305037.0,Oc1ccc(cc1O)[C@@H](O)CN.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
NCGC00159426-02,tox21-er-bla-agonist-p2,Carbocysteine,activity,inactive,2387-59-9,1080.0,OC(=O)C(N)CSCC(O)=O
NCGC00163256-01,tox21-er-bla-agonist-p2,Tiotidine,activity,inactive,69014-14-8,50287.0,N/C(N)=N/c1nc(CSCCNC(=N\C#N)\NC)cs1
NCGC00159433-02,tox21-er-bla-agonist-p2,Pamidronic acid,activity,inactive,40391-99-9,4674.0,OC(CCN)(P(O)(=O)O)P(=O)(O)O
NCGC00163798-03,tox21-er-bla-agonist-p2,Triethylene glycol,activity,inactive,112-27-6,8172.0,OCCOCCOCCO
NCGC00094572-01,tox21-er-bla-agonist-p2,Amitraz,activity,inactive,33089-61-1,36324.0,Cc2ccc(/N=C/N(C)/C=N/c1ccc(C)cc1C)c(C)c2
NCGC00094688-01,tox21-er-bla-agonist-p2,Glucosamine hydrochloride,activity,inactive,66-84-2,2723635.0,Cl.O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1N
NCGC00094692-01,tox21-er-bla-agonist-p2,Hetacillin potassium,activity,inactive,5321-32-4,23702555.0,[K+].O=C([O-])[C@@H]3N4C(=O)[C@@H](N1C(=O)C(NC1(C)C)c2ccccc2)[C@H]4SC3(C)C
NCGC00181152-01,tox21-er-bla-agonist-p2,Nedaplatin,activity,inactive,95734-82-0,72120.0,O=C1O[Pt](N)(N)OC1
NCGC00094929-01,tox21-er-bla-agonist-p2,Tolperisone hydrochloride,activity,inactive,3644-61-9,92965.0,Cl.CC(CN1CCCCC1)C(=O)c2ccc(C)cc2
NCGC00164521-01,tox21-er-bla-agonist-p2,Carbazochrome,activity,inactive,69-81-8,5360410.0,NC(=O)N\N=C1\C=C2C(=CC1=O)N(C)CC2O
NCGC00095143-01,tox21-er-bla-agonist-p2,Rosuvastatin calcium,activity,inactive,147098-20-2,16114800.0,[Ca+2].O=S(C)(=O)N(C)c1nc(c(/C=C/C(O)CC(O)CC([O-])=O)c(n1)C(C)C)c2ccc(F)cc2.[O-]C(=O)CC(O)CC(O)/C=C/c2c(nc(nc2c1ccc(F)cc1)N(C)S(C)(=O)=O)C(C)C
NCGC00168266-02,tox21-er-bla-agonist-p2,"1-(1,3-Benzodioxol-5-yl)-N-methylpropan-2-amine hydrochloride",activity,inactive,64057-70-1,71285.0,Cl.CC(NC)Cc1ccc2OCOc2c1
NCGC00095227-01,tox21-er-bla-agonist-p2,Alizarin,activity,active agonist,72-48-0,6293.0,O=C3c1ccccc1C(=O)c2c3ccc(O)c2O
NCGC00160508-01,tox21-er-bla-agonist-p2,Isosorbide,activity,inactive,652-67-5,12597.0,O[C@H]1CO[C@@H]2[C@H](O)CO[C@H]12
NCGC00160614-01,tox21-er-bla-agonist-p2,Glucuronamide,activity,inactive,61914-43-0,636367.0,O[C@H]1[C@H](O)[C@H](O[C@@H](O)[C@@H]1O)C(N)=O
NCGC00160658-01,tox21-er-bla-agonist-p2,Adafenoxate,activity,inactive,82168-26-1,64517.0,Clc1ccc(cc1)OCC(=O)OCCNC24CC3CC(CC(C2)C3)C4
NCGC00161620-01,tox21-er-bla-agonist-p2,Colistin A,activity,inactive,7722-44-3,202195.0,C[C@H](CC)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC1=O)CCN)[C@@H](C)O)[C@@H](C)O
NCGC00166244-01,tox21-er-bla-agonist-p2,beta-Chloralose,activity,inactive,16376-36-6,5284343.0,OC[C@@H](O)[C@H]1O[C@@H]2O[C@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl
NCGC00166256-01,tox21-er-bla-agonist-p2,Alovudine,activity,inactive,25526-93-6,33039.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](F)[C@@H](CO)O2
NCGC00091352-02,tox21-er-bla-agonist-p2,Endrin,activity,inactive,72-20-8,12358480.0,ClC1=C(Cl)[C@@]5(Cl)C(Cl)(Cl)[C@]1(Cl)[C@H]4[C@@H]3C[C@@H]([C@H]2O[C@H]23)[C@H]45
NCGC00182038-01,tox21-er-bla-agonist-p2,Zofenopril calcium,activity,inactive,81938-43-4,3033690.0,[Ca+2].O=C([C@H](C)CSC(=O)c1ccccc1)N3C[C@@H](Sc2ccccc2)C[C@H]3C([O-])=O.C[C@H](CSC(=O)c1ccccc1)C(=O)N3C[C@@H](Sc2ccccc2)C[C@H]3C([O-])=O
NCGC00254163-01,tox21-er-bla-agonist-p2,"4,4'-Methylenedianiline",activity,inactive,101-77-9,7577.0,Nc2ccc(Cc1ccc(N)cc1)cc2
NCGC00254197-01,tox21-er-bla-agonist-p2,Diallyl phthalate,activity,inactive,131-17-9,8560.0,O=C(OCC=C)c1ccccc1C(=O)OCC=C
NCGC00189077-01,tox21-er-bla-agonist-p2,Methsuximide,activity,inactive,77-41-8,6476.0,CC1(CC(=O)N(C)C1=O)c2ccccc2
NCGC00254643-01,tox21-er-bla-agonist-p2,"2,4,6-Tris(allyloxy)-1,3,5-triazine",activity,inactive,101-37-1,7555.0,C=CCOc1nc(nc(OCC=C)n1)OCC=C
NCGC00255361-01,tox21-er-bla-agonist-p2,Imazmethabenz,activity,inactive,81405-85-8,54744.0,O=C1N=C(NC1(C)C(C)C)c2cc(C)ccc2C(=O)OC
NCGC00247687-01,tox21-er-bla-agonist-p2,dl-cis-3-Methylfentanyl hydrochloride,activity,inactive,78995-18-3,60196316.0,Cl.CCC(=O)N([C@@H]2CCN(CCc1ccccc1)C[C@@H]2C)c3ccccc3
NCGC00254682-01,tox21-er-bla-agonist-p2,Formetanate hydrochloride,activity,inactive,23422-53-9,31899.0,Cl.O=C(Oc1cccc(c1)/N=C/N(C)C)NC
NCGC00254791-01,tox21-er-bla-agonist-p2,Diniconazole,activity,inactive,83657-24-3,6436605.0,OC(\C(=C/c1ccc(Cl)cc1Cl)n2cncn2)C(C)(C)C
NCGC00254413-01,tox21-er-bla-agonist-p2,Terbuthylazine,activity,active agonist,5915-41-3,22206.0,Clc1nc(NCC)nc(NC(C)(C)C)n1
NCGC00254899-01,tox21-er-bla-agonist-p2,Diflufenzopyr-sodium,activity,inactive,109293-98-3,23676752.0,[Na+].Fc1cc(cc(F)c1)NC(=O)N\N=C(/C)c2ncccc2C([O-])=O
NCGC00255121-01,tox21-er-bla-agonist-p2,Flucythrinate,activity,inactive,70124-77-5,12797557.0,FC(F)Oc1ccc(cc1)[C@H](C(C)C)C(=O)OC(C#N)c3cc(Oc2ccccc2)ccc3
NCGC00182058-03,tox21-er-bla-agonist-p2,1-alpha-Hydroxyergocalciferol,activity,inactive,54573-75-0,5281107.0,C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)/C=C/[C@H](C)C(C)C
NCGC00259328-01,tox21-er-bla-agonist-p2,Acetyl tributyl citrate,activity,inactive,77-90-7,6505.0,CCCCOC(=O)CC(CC(=O)OCCCC)(OC(C)=O)C(=O)OCCCC
NCGC00260138-01,tox21-er-bla-agonist-p2,Heptamethyleneimine,activity,inactive,1121-92-2,14276.0,C1CCCCCCN1
NCGC00016311-10,tox21-er-bla-agonist-p2,Phentolamine,activity,inactive,50-60-2,5775.0,Cc1ccc(cc1)N(CC2=NCCN2)c3cc(O)ccc3
NCGC00259761-01,tox21-er-bla-agonist-p2,Sodium phenolate,activity,inactive,139-02-6,4445035.0,[Na+].[O-]c1ccccc1
NCGC00257355-01,tox21-er-bla-agonist-p2,Heptanophenone,activity,inactive,1671-75-6,74282.0,O=C(CCCCCC)c1ccccc1
NCGC00256556-01,tox21-er-bla-agonist-p2,"6,10-Dimethyl-5,9-undecadiene-2-one",activity,inactive,689-67-8,19633.0,C/C(C)=C\CCC(C)=CCCC(C)=O
NCGC00260561-01,tox21-er-bla-agonist-p2,NTP Mix69 CT1 62-EQP,activity,inactive,NOCAS_49457,,
NCGC00260574-01,tox21-er-bla-agonist-p2,NTP Mix52 CT1 3-EQP,activity,inactive,NOCAS_49470,,
NCGC00260610-01,tox21-er-bla-agonist-p2,NTP Mix13 AR1 8-EQC,activity,active agonist,NOCAS_49506,,
NCGC00256834-01,tox21-er-bla-agonist-p2,S-Furfuryl thioacetate,activity,inactive,13678-68-7,61660.0,O=C(C)SCc1ccco1
NCGC00257276-01,tox21-er-bla-agonist-p2,"3-(Dodecenyl)dihydro-2,5-furandione",activity,inactive,25377-73-5,32933.0,O=C1OC(=O)CC1C=CCCCCCCCCCC
NCGC00259070-01,tox21-er-bla-agonist-p2,Isophorone diisocyanate,activity,inactive,4098-71-9,169132.0,O=C=N\C1CC(C)(C)CC(C)(C1)C\N=C=O
NCGC00254854-01,tox21-er-bla-agonist-p2,2-Acetylpyrrole,activity,inactive,1072-83-9,14079.0,CC(=O)c1cccn1
NCGC00255558-01,tox21-er-bla-agonist-p2,"1,3-Propanediol, 2,2-dimethyl-, dibenzoate",activity,inactive,4196-89-8,20169.0,CC(C)(COC(=O)c1ccccc1)COC(=O)c2ccccc2
NCGC00255826-01,tox21-er-bla-agonist-p2,"Oxirane, 2-[2-(4-chlorophenyl)ethyl]-2-(1,1-dimethylethyl)-",activity,inactive,80443-63-6,94684.0,CC(C)(C)C2(CCc1ccc(Cl)cc1)CO2
NCGC00256848-01,tox21-er-bla-agonist-p2,Sodium 4-octylbenzenesulfonate,activity,inactive,6149-03-7,23670838.0,[Na+].O=S([O-])(=O)c1ccc(CCCCCCCC)cc1
NCGC00255883-01,tox21-er-bla-agonist-p2,Karbutilate,activity,inactive,4849-32-5,312440.0,O=C(Oc1cccc(c1)NC(=O)N(C)C)NC(C)(C)C
NCGC00257129-01,tox21-er-bla-agonist-p2,Sodium ethasulfate,activity,inactive,126-92-1,23662383.0,[Na+].O=S([O-])(=O)OCC(CCCC)CC
NCGC00257194-01,tox21-er-bla-agonist-p2,Phenmedipham,activity,inactive,13684-63-4,24744.0,O=C(Oc1cccc(c1)NC(=O)OC)Nc2cc(C)ccc2
NCGC00257672-01,tox21-er-bla-agonist-p2,1-(2-Hydroxyethyl)-3-methylimidazolium chloride,activity,inactive,61755-34-8,11499271.0,[Cl-].C[n+]1ccn(CCO)c1
NCGC00257334-01,tox21-er-bla-agonist-p2,2-Carboxyethyl acrylate,activity,inactive,24615-84-7,90558.0,O=C(O)CCOC(=O)C=C
NCGC00257900-01,tox21-er-bla-agonist-p2,1-Nitrobutane,activity,inactive,627-05-4,12302.0,[O-][N+](=O)CCCC
NCGC00258126-01,tox21-er-bla-agonist-p2,4-Nitrobenzyl chloride,activity,inactive,100-14-1,7482.0,O=[N+]([O-])c1ccc(CCl)cc1
NCGC00258517-01,tox21-er-bla-agonist-p2,Diethylene glycol dibutyl ether,activity,inactive,112-73-2,8210.0,CCCCOCCOCCOCCCC
NCGC00258327-01,tox21-er-bla-agonist-p2,2-Methyl-3-nitroaniline,activity,inactive,603-83-8,11783.0,Cc1c(cccc1N)[N+]([O-])=O
NCGC00258546-01,tox21-er-bla-agonist-p2,"2,2'-Dihydroxy-4-methoxybenzophenone",activity,inactive,131-53-3,8569.0,O=C(c1ccc(cc1O)OC)c2ccccc2O
NCGC00258759-01,tox21-er-bla-agonist-p2,2-Methylpropanoic acid,activity,inactive,79-31-2,6590.0,CC(C)C(=O)O
NCGC00259032-01,tox21-er-bla-agonist-p2,Cyclohexanol,activity,inactive,108-93-0,7966.0,OC1CCCCC1
NCGC00258155-01,tox21-er-bla-agonist-p2,Methylammonium nitrate,activity,inactive,22113-87-7,159924.0,CN.[O-][N+](=O)O
NCGC00258040-01,tox21-er-bla-agonist-p2,3-Amino-9-ethylcarbazole hydrochloride,activity,active agonist,6109-97-3,62130.0,Cl.Nc2cc3c1ccccc1n(CC)c3cc2
NCGC00259239-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium chloride,activity,inactive,79917-90-1,2734161.0,[Cl-].CCCCn1cc[n+](C)c1
NCGC00260130-01,tox21-er-bla-agonist-p2,"Borate(1-), tetrafluoro-, hydrogen",activity,inactive,16872-11-0,28118.0,[H+].F[B-](F)(F)F
NCGC00259831-01,tox21-er-bla-agonist-p2,(E)-Anethole,activity,inactive,4180-23-8,637563.0,COc1ccc(/C=C/C)cc1
NCGC00259170-01,tox21-er-bla-agonist-p2,Sodium thiocyanate,activity,inactive,540-72-7,516871.0,[Na+].[S-]C#N
NCGC00260381-01,tox21-er-bla-agonist-p2,"Ethanedione,di-2-furanyl-",activity,inactive,492-94-4,68119.0,O=C(C(=O)c1ccco1)c2ccco2
NCGC00260340-01,tox21-er-bla-agonist-p2,Tetradecanal,activity,inactive,124-25-4,31291.0,CCCCCCCCCCCCCC=O
NCGC00016277-01,tox21-er-bla-agonist-p2,Niridazole,activity,inactive,61-57-4,6093.0,[O-][N+](=O)c1cnc(s1)N2CCNC2=O
NCGC00016255-01,tox21-er-bla-agonist-p2,Sulfinpyrazone,activity,inactive,57-96-5,5342.0,O=C4C(CCS(=O)c1ccccc1)C(=O)N(c2ccccc2)N4c3ccccc3
NCGC00093552-01,tox21-er-bla-agonist-p2,Apraclonidine hydrochloride,activity,inactive,73218-79-8,51763.0,Cl.Clc2cc(N)cc(Cl)c2NC1=NCCN1
NCGC00160375-01,tox21-er-bla-agonist-p2,Maleylsulfathiazole,activity,inactive,515-57-1,96424.0,O=S(=O)(Nc1nccs1)c2ccc(NC(=O)C=CC(=O)O)cc2
NCGC00255562-01,tox21-er-bla-agonist-p2,Naproxen,activity,inactive,22204-53-1,156391.0,O=C(O)[C@@H](C)c1ccc2cc(ccc2c1)OC
NCGC00255656-01,tox21-er-bla-agonist-p2,Dicapthon,activity,inactive,2463-84-5,17168.0,Clc1cc(ccc1OP(=S)(OC)OC)[N+]([O-])=O
NCGC00254852-01,tox21-er-bla-agonist-p2,(Z)-Hexadec-9-enoic acid,activity,inactive,373-49-9,445638.0,O=C(O)CCCCCCC/C=C\CCCCCC
NCGC00256322-01,tox21-er-bla-agonist-p2,"N,N'-Dicyclohexylthiourea",activity,inactive,1212-29-9,727200.0,S=C(NC1CCCCC1)NC2CCCCC2
NCGC00254740-01,tox21-er-bla-agonist-p2,Codlelure,activity,inactive,33956-49-9,1787910.0,C\C=C\C=C\CCCCCCCO
NCGC00255480-01,tox21-er-bla-agonist-p2,Trimethoxyphenylsilane,activity,inactive,2996-92-1,18137.0,CO[Si](OC)(OC)c1ccccc1
NCGC00255531-01,tox21-er-bla-agonist-p2,Triethyltin bromide,activity,active agonist,2767-54-6,17701.0,Br[Sn](CC)(CC)CC
NCGC00254160-01,tox21-er-bla-agonist-p2,Tris(2-ethylhexyl) phosphate,activity,inactive,78-42-2,6537.0,CCCCC(COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC)CC
NCGC00254240-01,tox21-er-bla-agonist-p2,Didecyldimethylammonium chloride,activity,inactive,7173-51-5,23558.0,[Cl-].C[N+](C)(CCCCCCCCCC)CCCCCCCCCC
NCGC00181024-01,tox21-er-bla-agonist-p2,Indocyanine green,activity,inactive,3599-32-4,5284572.0,[Na+].[O-]S(=O)(=O)CCCC[N+]=6c2ccc1ccccc1c2C(C)(C)C=6/C=C\C=C/C=C\C=C5\N(CCCCS([O-])(=O)=O)c4ccc3ccccc3c4C5(C)C
NCGC00183129-01,tox21-er-bla-agonist-p2,Enalapril acid,activity,inactive,76420-72-9,37888454.0,OC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N[C@H](CCc1ccccc1)C(=O)O
NCGC00183869-01,tox21-er-bla-agonist-p2,Gusperimus trihydrochloride,activity,inactive,85468-01-5,55361.0,Cl.Cl.Cl.O=C(NCCCCNCCCN)C(O)NC(=O)CCCCCCNC(=N)N
NCGC00260499-01,tox21-er-bla-agonist-p2,Picolinic acid,activity,inactive,98-98-6,1018.0,O=C(O)c1ccccn1
NCGC00024665-03,tox21-er-bla-agonist-p2,Metitepine,activity,inactive,20229-30-5,4106.0,CN1CCN(CC1)C2Cc4ccccc4Sc3ccc(SC)cc23
NCGC00159360-02,tox21-er-bla-agonist-p2,Betamethasone dipropionate,activity,active agonist,5593-20-4,21800.0,CCC(=O)OCC(=O)[C@@]4(OC(=O)CC)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00159440-02,tox21-er-bla-agonist-p2,Temazepam,activity,inactive,846-50-4,5391.0,Clc1ccc2c(c1)C(=NC(O)C(=O)N2C)c3ccccc3
NCGC00160484-01,tox21-er-bla-agonist-p2,Etafenone,activity,inactive,90-54-0,3275.0,CCN(CCOc2ccccc2C(=O)CCc1ccccc1)CC
NCGC00163509-01,tox21-er-bla-agonist-p2,MK-571 sodium,activity,inactive,115103-85-0,16760569.0,[Na+].CN(C)C(=O)CCSC(SCCC([O-])=O)c1cccc(c1)/C=C/c2ccc3ccc(Cl)cc3n2
NCGC00167560-01,tox21-er-bla-agonist-p2,"3,4-Diaminopyridine",activity,inactive,54-96-6,5918.0,Nc1ccncc1N
NCGC00181163-01,tox21-er-bla-agonist-p2,trans-Squalene,activity,inactive,111-02-4,638072.0,C\C(C)=C\CCC(\C)=C\CCC(\C)=C\CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)C
NCGC00016961-01,tox21-er-bla-agonist-p2,Atovaquone,activity,inactive,95233-18-4,74989.0,Clc1ccc(cc1)[C@H]2CC[C@@H](CC2)C=4C(=O)c3ccccc3C(=O)C=4O
NCGC00090705-08,tox21-er-bla-agonist-p2,"2',3'-Dideoxycytidine",activity,inactive,7481-89-2,24066.0,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
NCGC00024717-06,tox21-er-bla-agonist-p2,L-Nitroarginine methyl ester,activity,inactive,50903-99-6,39836.0,N[C@@H](CCCNC(\N)=N\[N+]([O-])=O)C(=O)OC
NCGC00016912-01,tox21-er-bla-agonist-p2,Terconazole,activity,inactive,67915-31-5,441383.0,CC(C)N1CCN(CC1)c2ccc(cc2)OC[C@H]4CO[C@@](Cn3ncnc3)(O4)c5ccc(Cl)cc5Cl
NCGC00258418-01,tox21-er-bla-agonist-p2,Zinc(II) acetate dihydrate,activity,inactive,5970-45-6,2724192.0,O.[Zn+2].O.[O-]C(C)=O.[O-]C(C)=O
NCGC00258486-01,tox21-er-bla-agonist-p2,2-Aminophenol,activity,inactive,95-55-6,5801.0,Nc1ccccc1O
NCGC00258494-01,tox21-er-bla-agonist-p2,Luminol,activity,inactive,521-31-3,10638.0,Oc2nnc(O)c1cccc(N)c12
NCGC00257082-01,tox21-er-bla-agonist-p2,"4,4'-Dithiodimorpholine",activity,inactive,103-34-4,7648.0,S(SN1CCOCC1)N2CCOCC2
NCGC00257215-01,tox21-er-bla-agonist-p2,Maleic acid,activity,inactive,110-16-7,444266.0,O=C(O)/C=C\C(=O)O
NCGC00257234-01,tox21-er-bla-agonist-p2,1-Chloro-2-nitro-4-(trifluoromethyl)benzene,activity,inactive,121-17-5,8462.0,O=[N+]([O-])c1cc(ccc1Cl)C(F)(F)F
NCGC00257764-01,tox21-er-bla-agonist-p2,3-Methoxypropionitrile,activity,inactive,110-67-8,61032.0,N#CCCOC
NCGC00257783-01,tox21-er-bla-agonist-p2,Acrolein diethylacetal,activity,inactive,3054-95-3,62477.0,C=CC(OCC)OCC
NCGC00257785-01,tox21-er-bla-agonist-p2,Trimethadione,activity,inactive,127-48-0,5576.0,CN1C(=O)OC(C)(C)C1=O
NCGC00257832-01,tox21-er-bla-agonist-p2,Acetic anhydride,activity,inactive,108-24-7,7918.0,CC(=O)OC(C)=O
NCGC00258038-01,tox21-er-bla-agonist-p2,Sulfuryl chloride,activity,inactive,7791-25-5,24648.0,ClS(Cl)(=O)=O
NCGC00255718-01,tox21-er-bla-agonist-p2,1-(o-Tolyl)biguanide,activity,inactive,93-69-6,7155.0,N=C(N)NC(=N)Nc1ccccc1C
NCGC00255816-01,tox21-er-bla-agonist-p2,"2,4-Diaminobenzenesulfonic acid",activity,inactive,88-63-1,66623.0,Nc1cc(N)ccc1S(O)(=O)=O
NCGC00256059-01,tox21-er-bla-agonist-p2,Theaspirane,activity,inactive,36431-72-8,61953.0,CC2=CCCC(C)(C)C12CCC(C)O1
NCGC00256065-01,tox21-er-bla-agonist-p2,tert-Butylperoxy 2-ethylhexyl carbonate,activity,inactive,34443-12-4,61931.0,CC(C)(C)OOC(=O)OCC(CCCC)CC
NCGC00256081-01,tox21-er-bla-agonist-p2,"3,3'-(Ethylenedioxy)dipropiononitrile",activity,inactive,3386-87-6,76921.0,N#CCCOCCOCCC#N
NCGC00256363-01,tox21-er-bla-agonist-p2,Pebulate,activity,inactive,1114-71-2,14215.0,O=C(SCCC)N(CCCC)CC
NCGC00258921-01,tox21-er-bla-agonist-p2,Tris(2-ethylhexyl) phosphate,activity,inactive,78-42-2,6537.0,CCCCC(COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC)CC
NCGC00260473-01,tox21-er-bla-agonist-p2,N-Butylnitrite,activity,inactive,544-16-1,10996.0,CCCCON=O
NCGC00260513-01,tox21-er-bla-agonist-p2,"Dibenz[a,c]anthracene",activity,inactive,215-58-7,9164.0,c3cc4c1ccccc1c2cc5ccccc5cc2c4cc3
NCGC00259305-01,tox21-er-bla-agonist-p2,Sulfotepp,activity,inactive,3689-24-5,19395.0,CCOP(=S)(OCC)OP(=S)(OCC)OCC
NCGC00259315-01,tox21-er-bla-agonist-p2,N-Ethylaniline,activity,inactive,103-69-5,7670.0,CCNc1ccccc1
NCGC00259714-01,tox21-er-bla-agonist-p2,D&C Red 27,activity,inactive,13473-26-2,83511.0,Brc4c5Oc1c(Br)c(O)c(Br)cc1C3(OC(=O)c2c3c(Cl)c(Cl)c(Cl)c2Cl)c5cc(Br)c4O
NCGC00260087-01,tox21-er-bla-agonist-p2,C.I. Solvent Black 5,activity,inconclusive,11099-03-9,,
NCGC00260141-01,tox21-er-bla-agonist-p2,Nickel dibutyldithiocarbamate,activity,inactive,13927-77-0,4523766.0,S=C(S[Ni]SC(=S)N(CCCC)CCCC)N(CCCC)CCCC
NCGC00260156-01,tox21-er-bla-agonist-p2,dl-Menthol,activity,inactive,89-78-1,16666.0,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
NCGC00260330-01,tox21-er-bla-agonist-p2,Hexamethylmelamine,activity,inactive,645-05-6,2123.0,CN(C)c1nc(nc(n1)N(C)C)N(C)C
NCGC00258646-01,tox21-er-bla-agonist-p2,3-Nitrobenzoyl chloride,activity,inactive,121-90-4,8495.0,O=[N+]([O-])c1cc(ccc1)C(Cl)=O
NCGC00255134-01,tox21-er-bla-agonist-p2,Carbophenothion,activity,inactive,786-19-6,13081.0,Clc1ccc(SCSP(=S)(OCC)OCC)cc1
NCGC00255314-01,tox21-er-bla-agonist-p2,4-Thiazolecarbonitrile,activity,inactive,1452-15-9,15069.0,N#Cc1cscn1
NCGC00255370-01,tox21-er-bla-agonist-p2,Leflunomide,activity,inactive,75706-12-6,3899.0,Cc2oncc2C(=O)Nc1ccc(cc1)C(F)(F)F
NCGC00256180-01,tox21-er-bla-agonist-p2,Bisphenol A glycidyl methacrylate,activity,inactive,1565-94-2,15284.0,C=C(C)C(=O)OCC(O)COc1ccc(cc1)C(C)(C)c2ccc(OCC(O)COC(=O)C(=C)C)cc2
NCGC00091387-01,tox21-er-bla-agonist-p2,Ethidium bromide,activity,active agonist,1239-45-8,14710.0,[Br-].CC[n+]3c4cc(N)ccc4c1ccc(N)cc1c3c2ccccc2
NCGC00166291-01,tox21-er-bla-agonist-p2,Lycopene,activity,active agonist,502-65-8,446925.0,C/C(C)=C\CCC(\C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CC\C=C(/C)C
NCGC00093811-01,tox21-er-bla-agonist-p2,Sodium prasterone sulfate dihydrate,activity,inactive,78590-17-7,23694217.0,[Na+].O.O.[O-]S(=O)(=O)O[C@H]4CC[C@@]2(C)C(=CC[C@H]1[C@@H]3CCC(=O)[C@@]3(C)CC[C@@H]12)C4
NCGC00159419-02,tox21-er-bla-agonist-p2,Barbital,activity,inactive,57-44-3,2294.0,O=C1NC(=O)NC(=O)C1(CC)CC
NCGC00163287-01,tox21-er-bla-agonist-p2,Eltanolone,activity,active agonist,128-20-1,92786.0,CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]1[C@H]3CC[C@H]2C[C@H](O)CC[C@]12C
NCGC00163745-03,tox21-er-bla-agonist-p2,Chlorfenvinphos,activity,inactive,470-90-6,10107.0,Clc1cc(Cl)ccc1C(OP(=O)(OCC)OCC)=CCl
NCGC00167455-01,tox21-er-bla-agonist-p2,Zofenopril,activity,inactive,81872-10-8,72179.0,O=C([C@@H](C)CSC(=O)c1ccccc1)N3C[C@@H](Sc2ccccc2)C[C@H]3C(=O)O
NCGC00160364-01,tox21-er-bla-agonist-p2,Benzylsulfamide,activity,inactive,104-22-3,66909.0,Nc1ccc(cc1)S(=O)(=O)NCc2ccccc2
NCGC00160421-01,tox21-er-bla-agonist-p2,Tetrabenazine,activity,inactive,58-46-8,6018.0,CC(C)CC2CN3CCc1cc(OC)c(OC)cc1C3CC2=O
NCGC00095055-01,tox21-er-bla-agonist-p2,Salinomycin sodium,activity,inactive,55721-31-8,23703990.0,[Na+].[O-]C(=O)[C@H](CC)[C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]5O[C@]4(C=C[C@@H](O)[C@]2(CC[C@](C)(O2)[C@H]3CC[C@](O)(CC)[C@H](C)O3)O4)[C@H](C)C[C@@H]5C
NCGC00160424-01,tox21-er-bla-agonist-p2,Clobenzorex hydrochloride,activity,inactive,5843-53-8,160796.0,Cl.Clc2ccccc2CNC(C)Cc1ccccc1
NCGC00160448-01,tox21-er-bla-agonist-p2,Tibrofan,activity,inactive,15686-72-3,27448.0,O=C(Nc1ccc(Br)cc1)c2cc(Br)c(Br)s2
NCGC00160450-01,tox21-er-bla-agonist-p2,4-Acetylaminophenylacetic acid,activity,inactive,18699-02-0,2018.0,O=C(C)Nc1ccc(cc1)CC(=O)O
NCGC00167476-01,tox21-er-bla-agonist-p2,Calcium hopantenate,activity,inactive,17097-76-6,28280.0,[Ca+2].CC(C)(CO)[C@@H](O)C(=O)NCCCC([O-])=O.[O-]C(=O)CCCNC(=O)[C@H](O)C(C)(C)CO
NCGC00095140-01,tox21-er-bla-agonist-p2,Sibutramine hydrochloride,activity,inactive,84485-00-7,64764.0,Cl.CN(C)C(CC(C)C)C1(CCC1)c2ccc(Cl)cc2
NCGC00164619-01,tox21-er-bla-agonist-p2,Anastrozole,activity,inactive,120511-73-1,2187.0,N#CC(C)(C)c1cc(cc(c1)C(C)(C)C#N)Cn2cncn2
NCGC00165791-02,tox21-er-bla-agonist-p2,Epinastine hydrochloride,activity,inactive,108929-04-0,157313.0,Cl.NC2=NCC3c4ccccc4Cc1ccccc1N23
NCGC00095290-01,tox21-er-bla-agonist-p2,Diallyl trisulfide,activity,inactive,2050-87-5,16315.0,C=CCSSSCC=C
NCGC00160568-01,tox21-er-bla-agonist-p2,Halethazole hydrochloride,activity,inactive,2607-31-0,24188465.0,Cl.CCN(CC)CCOc1ccc(cc1)c2nc3cc(Cl)ccc3s2
NCGC00160603-02,tox21-er-bla-agonist-p2,4-Styrylpyridine,activity,inactive,103-31-1,101576.0,C(=Cc1ccncc1)c2ccccc2
NCGC00160611-01,tox21-er-bla-agonist-p2,1-Ethyl-2-pyrrolidinone,activity,inactive,2687-91-4,17595.0,O=C1CCCN1CC
NCGC00168776-01,tox21-er-bla-agonist-p2,Delavirdine,activity,inactive,136817-59-9,5625.0,O=C(c1cc2cc(NS(C)(=O)=O)ccc2n1)N3CCN(CC3)c4ncccc4NC(C)C
NCGC00178168-02,tox21-er-bla-agonist-p2,Diazepam,activity,inactive,439-14-5,3016.0,Clc1ccc2c(c1)C(=NCC(=O)N2C)c3ccccc3
NCGC00091051-01,tox21-er-bla-agonist-p2,4-Aminobenzoic acid,activity,inactive,150-13-0,978.0,OC(=O)c1ccc(N)cc1
NCGC00091066-01,tox21-er-bla-agonist-p2,3-Methylbutyl nitrite,activity,inactive,110-46-3,8053.0,CC(C)CCON=O
NCGC00091261-03,tox21-er-bla-agonist-p2,4-Amino-2-nitrophenol,activity,inactive,119-34-6,3417419.0,O=[N+]([O-])c1cc(N)ccc1O
NCGC00183001-01,tox21-er-bla-agonist-p2,Tolvaptan,activity,inactive,150683-30-0,216237.0,Cc1ccccc1C(=O)Nc2ccc(c(C)c2)C(=O)N4CCCC(O)c3cc(Cl)ccc34
NCGC00183654-01,tox21-er-bla-agonist-p2,Etidocaine,activity,inactive,36637-18-0,37497.0,O=C(Nc1c(C)cccc1C)C(CC)N(CC)CCC
NCGC00254174-01,tox21-er-bla-agonist-p2,SAR150640,activity,inactive,433212-21-6,16654936.0,Cl.CS(=O)(=O)Nc1cc(ccc1O)OC[C@@H](O)CN[C@H]2CC[C@@H](CC2)c3ccc(cc3)C(=O)OCC
NCGC00189074-01,tox21-er-bla-agonist-p2,C.I. 1040,activity,inactive,212631-79-3,6918454.0,O=C(NOCC1CC1)c3ccc(F)c(F)c3Nc2ccc(I)cc2Cl
NCGC00247670-01,tox21-er-bla-agonist-p2,(R)-(+)-Cathinone hydrochloride,activity,inactive,76333-53-4,156395.0,Cl.O=C([C@@H](C)N)c1ccccc1
NCGC00254642-01,tox21-er-bla-agonist-p2,Metam-sodium hydrate,activity,inactive,6734-80-1,24180709.0,[Na+].O.O.O.[S-]C(=S)NC
NCGC00254694-01,tox21-er-bla-agonist-p2,Metalaxyl,activity,inactive,57837-19-1,42586.0,CC(N(C(=O)COC)c1c(C)cccc1C)C(=O)OC
NCGC00254297-01,tox21-er-bla-agonist-p2,CP-728663,activity,inactive,368832-42-2,9888347.0,CC[C@H]4CC[C@H](NCc1cc3c(cc1OC)[C@H]2C[C@H]2C(=O)N3C)[C@@H](N4)c5ccccc5
NCGC00255401-01,tox21-er-bla-agonist-p2,Mefenamic acid,activity,inactive,61-68-7,4044.0,O=C(O)c2ccccc2Nc1cccc(C)c1C
NCGC00253913-01,tox21-er-bla-agonist-p2,4-Butyrolactone,activity,inactive,96-48-0,7302.0,O=C1CCCO1
NCGC00254334-01,tox21-er-bla-agonist-p2,Dioctyl succinate,activity,inactive,2432-87-3,75516.0,CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC
NCGC00254789-01,tox21-er-bla-agonist-p2,3-((2-Ethylhexyl)oxy)propionitrile,activity,inactive,10213-75-9,25053.0,CCCCC(COCCC#N)CC
NCGC00255098-01,tox21-er-bla-agonist-p2,"2,4-Dichloro-3,5-dimethylphenol",activity,inactive,133-53-9,8621.0,Cc1cc(O)c(Cl)c(C)c1Cl
NCGC00254114-01,tox21-er-bla-agonist-p2,"2,4-Dinitrophenol",activity,inactive,51-28-5,1493.0,O=[N+]([O-])c1cc(ccc1O)[N+]([O-])=O
NCGC00181743-02,tox21-er-bla-agonist-p2,Lypressin,activity,inactive,50-57-7,644076.0,NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00182048-01,tox21-er-bla-agonist-p2,Pipothiazine palmitate,activity,inactive,37517-26-3,37767.0,CN(C)S(=O)(=O)c2cc3N(CCCN1CCC(CCOC(=O)CCCCCCCCCCCCCCC)CC1)c4ccccc4Sc3cc2
NCGC00183022-01,tox21-er-bla-agonist-p2,4'-Piperidinylcarbonylmethoxyacetophenone,activity,inactive,31188-99-5,35751.0,O=C(COc1ccc(cc1)C(C)=O)N2CCCCC2
NCGC00258312-01,tox21-er-bla-agonist-p2,Rifabutin,activity,inactive,72559-06-9,6323490.0,CC(C)CN1CCC3(CC1)NC4=C2NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO[C@@]6(C)Oc5c(C)c(O)c(C2=O)c(C4=N3)c5C6=O
NCGC00094088-01,tox21-er-bla-agonist-p2,Clorgyline hydrochloride,activity,inactive,17780-75-5,28767.0,Cl.Clc1cc(Cl)ccc1OCCCN(C)CC#C
NCGC00258837-01,tox21-er-bla-agonist-p2,"2,4-Dihydroxybenzophenone",activity,active agonist,131-56-6,8572.0,O=C(c1ccc(O)cc1O)c2ccccc2
NCGC00257003-01,tox21-er-bla-agonist-p2,3-(Dimethylamino)propylamine,activity,inactive,109-55-7,7993.0,NCCCN(C)C
NCGC00258899-01,tox21-er-bla-agonist-p2,Dapsone,activity,inactive,80-08-0,2955.0,Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
NCGC00016809-01,tox21-er-bla-agonist-p2,Moricizine hydrochloride,activity,inactive,29560-58-5,34632.0,Cl.O=C(OCC)Nc1cc2N(c3ccccc3Sc2cc1)C(=O)CCN4CCOCC4
NCGC00259295-01,tox21-er-bla-agonist-p2,Butyl glycidyl ether,activity,inactive,2426-08-6,17049.0,CCCCOCC1CO1
NCGC00259629-01,tox21-er-bla-agonist-p2,4-Methylpent-3-en-2-one,activity,inactive,141-79-7,8858.0,C\C(C)=C/C(C)=O
NCGC00183881-01,tox21-er-bla-agonist-p2,Moxifloxacin hydrochloride monohydrate,activity,inactive,192927-63-2,9890250.0,Cl.O.O=C(O)C2=CN(c1c(OC)c(c(F)cc1C2=O)N3C[C@@H]4CCCN[C@@H]4C3)C5CC5
NCGC00254326-01,tox21-er-bla-agonist-p2,Tripropylene glycol monomethyl ether,activity,inactive,25498-49-1,25054.0,COC(C)COC(C)COC(C)CO
NCGC00260198-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium tetrafluoroborate,activity,inactive,244193-50-8,2734179.0,F[B-](F)(F)F.C[n+]1ccn(CCCCCC)c1
NCGC00260201-01,tox21-er-bla-agonist-p2,1-Methyl-3-octylimidazolium bromide,activity,inactive,61545-99-1,60196376.0,Br.CN1C=CN(CCCCCCCC)C1
NCGC00255976-01,tox21-er-bla-agonist-p2,4-tert-Butylcyclohexanone,activity,inactive,98-53-3,7392.0,O=C1CCC(CC1)C(C)(C)C
NCGC00256570-01,tox21-er-bla-agonist-p2,5-Nitroacenaphthene,activity,inactive,602-87-9,11769.0,[O-][N+](=O)c1ccc2CCc3cccc1c23
NCGC00256665-01,tox21-er-bla-agonist-p2,"5,5-Dimethyl-2-phenoxy-1,3,2-dioxaphosphinane",activity,inactive,3057-08-7,76464.0,CC2(C)COP(Oc1ccccc1)OC2
NCGC00257223-01,tox21-er-bla-agonist-p2,3-(Methylthio)propanal,activity,inactive,3268-49-3,18635.0,O=CCCSC
NCGC00256790-01,tox21-er-bla-agonist-p2,4-Ethoxyphenol,activity,inactive,622-62-8,12150.0,CCOc1ccc(O)cc1
NCGC00258123-01,tox21-er-bla-agonist-p2,Furfural acetone,activity,inactive,623-15-4,212930.0,O=C(C)C=Cc1ccco1
NCGC00257145-01,tox21-er-bla-agonist-p2,Pentachlorobenzene,activity,inactive,608-93-5,11855.0,Clc1cc(Cl)c(Cl)c(Cl)c1Cl
NCGC00257229-01,tox21-er-bla-agonist-p2,Aldoxycarb,activity,inactive,1646-88-4,9570093.0,CC(C)(/C=N/OC(=O)NC)S(C)(=O)=O
NCGC00257460-01,tox21-er-bla-agonist-p2,Letrozole,activity,inactive,112809-51-5,3902.0,N#Cc1ccc(cc1)C(c2ccc(C#N)cc2)n3cncn3
NCGC00168269-02,tox21-er-bla-agonist-p2,"2,5-Dimethoxyamphetamine hydrochloride",activity,inactive,24973-25-9,62786.0,Cl.COc1ccc(cc1CC(C)N)OC
NCGC00255550-01,tox21-er-bla-agonist-p2,3-Phenyl-1-propanol,activity,inactive,122-97-4,31234.0,OCCCc1ccccc1
NCGC00255622-01,tox21-er-bla-agonist-p2,"(-)-alpha,beta-Thujone",activity,inactive,76231-76-0,261491.0,C[C@H]1C(=O)C[C@@]2(C[C@H]12)C(C)C
NCGC00255916-01,tox21-er-bla-agonist-p2,3-Amino-4-chlorobenzoic acid,activity,inactive,2840-28-0,76092.0,Nc1cc(ccc1Cl)C(=O)O
NCGC00256128-01,tox21-er-bla-agonist-p2,"4-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid",activity,inactive,60875-16-3,109029.0,O=C(O)c1ccc(cc1)N2N=C(C)CC2=O
NCGC00256627-01,tox21-er-bla-agonist-p2,2-Methyl-1-phenylpropan-2-ol,activity,inactive,100-86-7,7531.0,OC(C)(C)Cc1ccccc1
NCGC00256283-01,tox21-er-bla-agonist-p2,Propylene glycol diacetate,activity,inactive,7473-98-5,81984.0,O=C(c1ccccc1)C(C)(C)O
NCGC00256007-01,tox21-er-bla-agonist-p2,2-Methylphenethyl alcohol,activity,inactive,19819-98-8,88267.0,OCCc1ccccc1C
NCGC00257037-01,tox21-er-bla-agonist-p2,"1,2,3,4-Tetrachlorobenzene",activity,inactive,634-66-2,12463.0,Clc1ccc(Cl)c(Cl)c1Cl
NCGC00258019-01,tox21-er-bla-agonist-p2,"2-(2H-Benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl)phenol",activity,inactive,25973-55-1,33263.0,CC(C)(CC)c1cc(c(O)c(c1)C(C)(C)CC)n2nc3ccccc3n2
NCGC00257225-01,tox21-er-bla-agonist-p2,Ergotamine D-tartrate,activity,inactive,379-79-3,9787.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2C[C@@H](C=C1c3cccc4ncc(C[C@H]12)c34)C(=O)N[C@]5(C)O[C@]8(O)N(C5=O)[C@@H](Cc6ccccc6)C(=O)N7CCC[C@H]78.CN2C[C@@H](C=C1c3cccc4ncc(C[C@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O
NCGC00257289-01,tox21-er-bla-agonist-p2,Ethyl 3-phenylglycidate,activity,inactive,121-39-1,8469.0,CCOC(=O)C2OC2c1ccccc1
NCGC00257994-01,tox21-er-bla-agonist-p2,Trimethyl phosphite,activity,inactive,121-45-9,8472.0,COP(OC)OC
NCGC00257593-01,tox21-er-bla-agonist-p2,Carbon tetrachloride,activity,inactive,56-23-5,5943.0,ClC(Cl)(Cl)Cl
NCGC00257068-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarbonitrile",activity,inactive,626-17-5,12276.0,N#Cc1cccc(C#N)c1
NCGC00258519-01,tox21-er-bla-agonist-p2,"2-Chloro-1,3-dinitro-5-(trifluoromethyl)benzene",activity,inactive,393-75-9,9809.0,O=[N+]([O-])c1cc(cc([N+]([O-])=O)c1Cl)C(F)(F)F
NCGC00258346-01,tox21-er-bla-agonist-p2,Dimethylisopropylamine,activity,inactive,996-35-0,70452.0,CC(C)N(C)C
NCGC00258766-01,tox21-er-bla-agonist-p2,2-Methyl-1-propanol,activity,inactive,78-83-1,6560.0,CC(C)CO
NCGC00258361-01,tox21-er-bla-agonist-p2,4-Chloro-2-nitroaniline,activity,inactive,89-63-4,6979.0,Nc1ccc(Cl)cc1[N+]([O-])=O
NCGC00259012-01,tox21-er-bla-agonist-p2,Di-tert-butyl peroxide,activity,inactive,110-05-4,8033.0,CC(C)(C)OOC(C)(C)C
NCGC00259203-01,tox21-er-bla-agonist-p2,"2,6-Diaminopyridine",activity,inactive,141-86-6,8861.0,Nc1cccc(N)n1
NCGC00259725-01,tox21-er-bla-agonist-p2,Penicillin VK,activity,inactive,132-98-9,23676814.0,[K+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)COc1ccccc1)[C@H]3SC2(C)C
NCGC00259736-01,tox21-er-bla-agonist-p2,D-Camphor,activity,inactive,464-49-3,159055.0,CC2(C)[C@H]1CC(=O)[C@]2(C)CC1
NCGC00259307-01,tox21-er-bla-agonist-p2,1-Dodecanethiol,activity,inactive,112-55-0,8195.0,CCCCCCCCCCCCS
NCGC00259802-01,tox21-er-bla-agonist-p2,Diazoaminobenzene,activity,inactive,136-35-6,8689.0,N(=N/Nc1ccccc1)\c2ccccc2
NCGC00259833-01,tox21-er-bla-agonist-p2,Indole-3-acetic acid,activity,inactive,87-51-4,802.0,O=C(O)Cc2cnc1ccccc12
NCGC00259628-01,tox21-er-bla-agonist-p2,Paclobutrazol,activity,inactive,76738-62-0,616765.0,OC(C(Cc1ccc(Cl)cc1)n2cncn2)C(C)(C)C
NCGC00259859-01,tox21-er-bla-agonist-p2,"2,4,4'-Trihydroxybenzophenone",activity,active agonist,1470-79-7,73852.0,O=C(c1ccc(O)cc1O)c2ccc(O)cc2
NCGC00260219-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpiperidinium iodide,activity,inactive,17874-63-4,60196387.0,[I-].CCC[N+]1(C)CCCCC1
NCGC00260387-01,tox21-er-bla-agonist-p2,"4H-3,1-Benzoxazin-4-one,2-methyl-",activity,inactive,525-76-8,68236.0,CC2=Nc1ccccc1C(=O)O2
NCGC00260559-01,tox21-er-bla-agonist-p2,NTP Mix67 CT1 62-EQP,activity,inactive,NOCAS_49455,,
NCGC00015829-02,tox21-er-bla-agonist-p2,Promazine hydrochloride,activity,inactive,53-60-1,5887.0,Cl.CN(C)CCCN1c3ccccc3Sc2ccccc12
NCGC00016066-07,tox21-er-bla-agonist-p2,Urapidil,activity,inactive,34661-75-1,5639.0,COc3ccccc3N2CCN(CCCNC1=CC(=O)N(C)C(=O)N1C)CC2
NCGC00016226-01,tox21-er-bla-agonist-p2,Pralidoxime chloride,activity,inactive,51-15-0,5359226.0,[Cl-].O\N=C\c1cccc[n+]1C
NCGC00016230-01,tox21-er-bla-agonist-p2,Homatropine HBr,activity,inactive,51-56-9,6419941.0,Br.CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(O)c2ccccc2
NCGC00016241-06,tox21-er-bla-agonist-p2,Furosemide,activity,inactive,54-31-9,3440.0,NS(=O)(=O)c2cc(c(NCc1ccco1)cc2Cl)C(=O)O
NCGC00016247-01,tox21-er-bla-agonist-p2,Cantharidin,activity,inactive,56-25-7,6708701.0,O=C2OC(=O)[C@]3(C)C1CCC(O1)[C@]23C
NCGC00016821-01,tox21-er-bla-agonist-p2,Etoposide,activity,inactive,33419-42-0,5284558.0,COc1cc(cc(OC)c1O)[C@@H]5c2cc7OCOc7cc2C(O[C@@H]3O[C@@H]4CO[C@@H](C)O[C@H]4[C@H](O)[C@H]3O)C6COC(=O)[C@H]56
NCGC00024498-02,tox21-er-bla-agonist-p2,D-Aspartic acid,activity,inactive,1783-96-6,83887.0,O=C(O)C[C@@H](N)C(=O)O
NCGC00095074-01,tox21-er-bla-agonist-p2,"2,2'-Thiobisethanol",activity,inactive,111-48-8,5447.0,OCCSCCO
NCGC00255744-01,tox21-er-bla-agonist-p2,"1,2-Ethanediamine dihydriodide",activity,inactive,5700-49-2,21921.0,I.I.NCCN
NCGC00254937-01,tox21-er-bla-agonist-p2,Dimethoxydimethylsilane,activity,inactive,1112-39-6,66187.0,C[Si](C)(OC)OC
NCGC00255384-01,tox21-er-bla-agonist-p2,Proxan-sodium,activity,inactive,140-93-2,23690438.0,[Na+].CC(C)OC([S-])=S
NCGC00254878-01,tox21-er-bla-agonist-p2,"1,3,6-Hexanetricarbonitrile",activity,inactive,1772-25-4,15678.0,N#CCCCC(CCC#N)C#N
NCGC00254958-01,tox21-er-bla-agonist-p2,Phenoxyethyl isobutyrate,activity,inactive,103-60-6,61005.0,CC(C)C(=O)OCCOc1ccccc1
NCGC00017097-01,tox21-er-bla-agonist-p2,Naproxen sodium,activity,inactive,26159-34-2,23681059.0,[Na+].[O-]C(=O)[C@@H](C)c1ccc2cc(ccc2c1)OC
NCGC00095148-01,tox21-er-bla-agonist-p2,Canrenone,activity,inactive,976-71-6,13789.0,O=C5CC[C@@]3(CC[C@H]2[C@@H]4C=CC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C)O5
NCGC00185775-01,tox21-er-bla-agonist-p2,Salidroside,activity,inactive,10338-51-9,159278.0,Oc2ccc(CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)cc2
NCGC00247355-02,tox21-er-bla-agonist-p2,Sufentanil citrate,activity,inactive,60561-17-3,65494.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCC(=O)N(c1ccccc1)C2(COC)CCN(CC2)CCc3cccs3
NCGC00254780-01,tox21-er-bla-agonist-p2,Clopyralid,activity,inactive,1702-17-6,15553.0,Clc1ccc(Cl)nc1C(=O)O
NCGC00260050-01,tox21-er-bla-agonist-p2,Cobalt sulfate heptahydrate,activity,inactive,10026-24-1,61444.0,O.O.O.O.[Co+2].O.O.O.[O-]S([O-])(=O)=O
NCGC00016701-01,tox21-er-bla-agonist-p2,Azapropazone,activity,inactive,13539-59-8,26098.0,CN(C)C2=Nc1ccc(C)cc1N3C(=O)C(CCC)C(=O)N23
NCGC00159324-02,tox21-er-bla-agonist-p2,2-Ethylhexyl salicylate,activity,inactive,118-60-5,8364.0,Oc1ccccc1C(=O)OCC(CC)CCCC
NCGC00160351-01,tox21-er-bla-agonist-p2,Isbogrel,activity,inactive,89667-40-3,5284442.0,O=C(O)CCCC\C=C(\c1cccnc1)c2ccccc2
NCGC00160416-01,tox21-er-bla-agonist-p2,Chlormidazole,activity,inactive,3689-76-7,71821.0,Clc1ccc(cc1)Cn2c3ccccc3nc2C
NCGC00166025-01,tox21-er-bla-agonist-p2,3-Methyl-1-pentyn-3-ol,activity,inactive,77-75-8,6494.0,C#CC(C)(O)CC
NCGC00254149-01,tox21-er-bla-agonist-p2,N-Methylacetamide,activity,inactive,79-16-3,6582.0,CC(=O)NC
NCGC00018242-04,tox21-er-bla-agonist-p2,Sulfacetamide,activity,inactive,144-80-9,5320.0,Nc1ccc(cc1)S(=O)(=O)NC(C)=O
NCGC00256963-01,tox21-er-bla-agonist-p2,Terpinolene,activity,inactive,586-62-9,11463.0,C/C(C)=C1\CC=C(C)CC1
NCGC00258521-01,tox21-er-bla-agonist-p2,"6-Amino-1,3-dimethyl-5-nitroso- 2,4(1H,3H)-pyrimidinedione",activity,inactive,6632-68-4,81133.0,CN1C(N)=C(N=O)C(=O)N(C)C1=O
NCGC00258571-01,tox21-er-bla-agonist-p2,Dopamine hydrochloride,activity,inactive,62-31-7,65340.0,Cl.Oc1ccc(CCN)cc1O
NCGC00257303-01,tox21-er-bla-agonist-p2,Quinine hydrochloride dihydrate,activity,inactive,6119-47-7,2723885.0,Cl.O.O.COc1cc2c(cc1)nccc2[C@@H](O)[C@@H]4CC3CCN4C[C@@H]3C=C
NCGC00257349-01,tox21-er-bla-agonist-p2,Manganese(II) acetate,activity,inactive,638-38-0,12525.0,[Mn+2].[O-]C(C)=O.[O-]C(C)=O
NCGC00257603-01,tox21-er-bla-agonist-p2,1-Naphthaleneacetamide,activity,inactive,86-86-2,6861.0,NC(=O)Cc2cccc1ccccc12
NCGC00257604-01,tox21-er-bla-agonist-p2,"2,2-Dichloroacetamide",activity,inactive,683-72-7,12694.0,ClC(Cl)C(N)=O
NCGC00257704-01,tox21-er-bla-agonist-p2,Diphenylcarbonate,activity,inactive,102-09-0,7597.0,O=C(Oc1ccccc1)Oc2ccccc2
NCGC00257826-01,tox21-er-bla-agonist-p2,3-Phenylprop-2-enal,activity,inactive,104-55-2,307.0,O=CC=Cc1ccccc1
NCGC00258133-01,tox21-er-bla-agonist-p2,2-Hydroxyethylammonium formate,activity,inactive,53226-35-0,171257.0,O=CO.NCCO
NCGC00256663-01,tox21-er-bla-agonist-p2,4-(4-Hydroxy-3-methoxyphenyl)-2-butanone,activity,inactive,122-48-5,31211.0,Oc1ccc(cc1OC)CCC(C)=O
NCGC00256476-01,tox21-er-bla-agonist-p2,Diisopropanolamine,activity,inactive,110-97-4,8086.0,CC(O)CNCC(C)O
NCGC00256507-01,tox21-er-bla-agonist-p2,1-Phenyl-2-thiourea,activity,inactive,103-85-5,676454.0,S=C(N)Nc1ccccc1
NCGC00255951-01,tox21-er-bla-agonist-p2,"1,4-Dihydroxyanthracene-9,10-dione",activity,inactive,81-64-1,6688.0,O=C2c1ccccc1C(=O)c3c2c(O)ccc3O
NCGC00255971-01,tox21-er-bla-agonist-p2,Potassium nitrite,activity,inactive,7758-09-0,516910.0,[K+].[O-]N=O
NCGC00256026-01,tox21-er-bla-agonist-p2,2-Butyloctan-1-ol,activity,inactive,3913-02-8,19800.0,CCCCCCC(CO)CCCC
NCGC00256103-01,tox21-er-bla-agonist-p2,"1,2-Dimethoxybenzene",activity,inactive,91-16-7,7043.0,COc1ccccc1OC
NCGC00256130-01,tox21-er-bla-agonist-p2,"N'-[3-(Dimethylamino)propyl]-N,N-dimethylpropane-1,3-diamine",activity,inactive,6711-48-4,81207.0,CN(C)CCCNCCCN(C)C
NCGC00256291-01,tox21-er-bla-agonist-p2,C.I. Acid Blue 22,activity,inactive,28631-66-5,60196416.0,[Na+].[Na+].[O-]S(=O)(=O)c1ccc(cc1)Nc2ccc(cc2)\C(=C4/C=C/C(=N\c3ccc(cc3S(=O)(=O)O)S([O-])(=O)=O)C=C4)c5ccc(N)c(C)c5
NCGC00258867-01,tox21-er-bla-agonist-p2,Ethyl methylphenylglycidate,activity,inactive,77-83-8,6501.0,CCOC(=O)C2OC2(C)c1ccccc1
NCGC00259030-01,tox21-er-bla-agonist-p2,Nonane,activity,inactive,111-84-2,8141.0,CCCCCCCCC
NCGC00260505-01,tox21-er-bla-agonist-p2,"1,4-Dichlorophthalazine",activity,inactive,4752-10-7,78490.0,Clc2nnc(Cl)c1ccccc12
NCGC00260549-01,tox21-er-bla-agonist-p2,NTP Mix57 CT1 62-EQP,activity,inactive,NOCAS_49445,,
NCGC00260563-01,tox21-er-bla-agonist-p2,NTP Mix71 CT1 62-EQP,activity,inactive,NOCAS_49459,,
NCGC00260590-01,tox21-er-bla-agonist-p2,NTP Mix34 CT1 1-EQP,activity,inactive,NOCAS_49486,,
NCGC00259304-01,tox21-er-bla-agonist-p2,3'-Methyl-4-dimethylaminoazobenzene,activity,inactive,55-80-1,5934.0,CN(C)c2ccc(/N=N/c1cc(C)ccc1)cc2
NCGC00260308-01,tox21-er-bla-agonist-p2,"2,5-Furandione, dihydro-3-(octadecenyl)-",activity,inactive,28777-98-2,5354626.0,O=C1OC(=O)CC1\C=C\CCCCCCCCCCCCCCCC
NCGC00258676-01,tox21-er-bla-agonist-p2,4-Pentenenitrile,activity,inactive,592-51-8,11604.0,C=CCCC#N
NCGC00254589-01,tox21-er-bla-agonist-p2,Propamocarb hydrochloride,activity,inactive,25606-41-1,15575641.0,Cl.O=C(NCCCN(C)C)OCCC
NCGC00091163-03,tox21-er-bla-agonist-p2,tert-Dodecanethiol,activity,inactive,25103-58-6,32793.0,CC(C)(C(C)(C)C(C)C)C(C)(C)S
NCGC00091426-02,tox21-er-bla-agonist-p2,4-Nitroaniline,activity,inactive,100-01-6,7475.0,O=[N+]([O-])c1ccc(N)cc1
NCGC00163344-01,tox21-er-bla-agonist-p2,Dexfosfoserine,activity,inactive,407-41-0,68841.0,O=P(O)(O)OC[C@H](N)C(=O)O
NCGC00094446-03,tox21-er-bla-agonist-p2,Levamisole hydrochloride,activity,active agonist,16595-80-5,27944.0,Cl.N1=C3SCCN3C[C@@H]1c2ccccc2
NCGC00159509-02,tox21-er-bla-agonist-p2,Perindopril,activity,inactive,82834-16-0,107807.0,O=C(OCC)[C@H](CCC)N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C(=O)O
NCGC00181141-01,tox21-er-bla-agonist-p2,Santonic acid,activity,inactive,510-35-0,283654.0,O=C(O)C(C)C13CCC2(C)C(C(C)C(=O)CC12)C3=O
NCGC00160399-01,tox21-er-bla-agonist-p2,Fentiazac,activity,inactive,18046-21-4,28871.0,O=C(O)Cc1sc(nc1c2ccc(Cl)cc2)c3ccccc3
NCGC00160524-01,tox21-er-bla-agonist-p2,Aminoquinol,activity,inactive,10023-54-8,170327.0,CCN(CC)CCCC(C)Nc2cc(C=Cc1ccccc1Cl)nc3cc(Cl)ccc23
NCGC00181031-01,tox21-er-bla-agonist-p2,"7-Hydroxy-3,7-dimethyloctanal",activity,inactive,107-75-5,7888.0,O=CCC(C)CCCC(C)(C)O
NCGC00165972-01,tox21-er-bla-agonist-p2,1-Phenyl-1-propanol,activity,inactive,93-54-9,7147.0,OC(CC)c1ccccc1
NCGC00095843-01,tox21-er-bla-agonist-p2,alpha-Tomatine,activity,active agonist,17406-45-0,28523.0,[H][C@]12C[C@@]3([H])[C@]4([H])CC[C@@]5([H])C[C@H](CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1([H])[C@H](C)[C@]1(CC[C@H](C)CN1)O2)O[C@@H]1O[C@H](CO)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
NCGC00096009-01,tox21-er-bla-agonist-p2,Clavulanate lithium,activity,inactive,61177-44-4,23714647.0,[Li+].O=C([O-])[C@H]1C(=C\CO)\O[C@@H]2CC(=O)N12
NCGC00166143-01,tox21-er-bla-agonist-p2,Cyheptamide,activity,inactive,7199-29-3,23603.0,NC(=O)C2c3ccccc3CCc1ccccc12
NCGC00166250-01,tox21-er-bla-agonist-p2,Anazolene sodium,activity,inactive,3861-73-2,19731.0,[Na+].[Na+].[Na+].[O-]S(=O)(=O)c1cccc5c1c(Nc2ccccc2)ccc5/N=N/c4cc(cc3cc(cc(O)c34)S([O-])(=O)=O)S([O-])(=O)=O
NCGC00162319-02,tox21-er-bla-agonist-p2,Quinelorane,activity,inactive,97466-90-5,57242.0,Nc1ncc2C[C@H]3N(CCC[C@@H]3Cc2n1)CCC
NCGC00091020-03,tox21-er-bla-agonist-p2,Sodium dodecyl sulfate,activity,inactive,151-21-3,3423265.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCC
NCGC00091058-04,tox21-er-bla-agonist-p2,Linolenic acid,activity,inactive,463-40-1,5280934.0,O=C(O)CCCCCCC/C=C\C/C=C\C/C=C\CC
NCGC00091612-04,tox21-er-bla-agonist-p2,Triacetin,activity,inactive,102-76-1,5541.0,O=C(C)OC(COC(C)=O)COC(=O)C
NCGC00091641-01,tox21-er-bla-agonist-p2,6-Mercaptopurine,activity,inactive,50-44-2,667490.0,S=C2NC=Nc1ncnc12
NCGC00091737-01,tox21-er-bla-agonist-p2,Sorbic acid,activity,inactive,110-44-1,643460.0,C\C=C\C=C\C(=O)O
NCGC00091775-03,tox21-er-bla-agonist-p2,"2-Methyl-4,6-dinitrophenol",activity,inactive,534-52-1,10800.0,O=[N+]([O-])c1cc(cc(C)c1O)[N+]([O-])=O
NCGC00181798-01,tox21-er-bla-agonist-p2,"Eprinomectin (B1a, B1b mixture)",activity,inactive,1142337-10-7,44460585.0,CC(=O)N[C@H]1[C@@H](OC)C[C@@H](O[C@H]1C)O[C@@H]2[C@@H](OC)C[C@@H](O[C@H]2C)O[C@@H]3C(C)=CC[C@@H]6C[C@H](OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OCC(=CC=C[C@@H]3C)[C@@]45O)C[C@@]7(O6)C=C[C@H](C)[C@H](O7)C(C)CC
NCGC00182705-01,tox21-er-bla-agonist-p2,Azatadine,activity,inactive,3964-81-6,19861.0,CN1CC\C(CC1)=C2\c4ncccc4CCc3ccccc23
NCGC00183108-01,tox21-er-bla-agonist-p2,Propamidine,activity,inactive,104-32-5,64949.0,N=C(N)c1ccc(cc1)OCCCOc2ccc(cc2)C(=N)N
NCGC00185763-01,tox21-er-bla-agonist-p2,Methylprednisolone succinate,activity,inactive,2375-03-3,23680530.0,[Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C
NCGC00185767-01,tox21-er-bla-agonist-p2,Spiramycin II,activity,inactive,24916-51-6,5284620.0,CN(C)[C@H]1CC[C@H](O[C@@H]1C)O[C@H]4C=CC=CC[C@@H](C)OC(=O)C[C@@H](OC(C)=O)[C@H](OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]3O)N(C)C)[C@@H](CC=O)C[C@H]4C
NCGC00186465-01,tox21-er-bla-agonist-p2,MK-2206,activity,active agonist,1032350-13-2,24964624.0,NC1(CCC1)c2ccc(cc2)c3nc5C=CN6C(=O)NN=C6c5cc3c4ccccc4
NCGC00188443-01,tox21-er-bla-agonist-p2,Dapiprazole hydrochloride,activity,active agonist,72822-13-0,6917787.0,Cl.Cc4ccccc4N3CCN(CCc1nnc2CCCCn12)CC3
NCGC00254635-01,tox21-er-bla-agonist-p2,"Dipropyl pyridine-2,5-dicarboxylate",activity,inactive,136-45-8,8693.0,O=C(OCCC)c1cnc(cc1)C(=O)OCCC
NCGC00254221-01,tox21-er-bla-agonist-p2,Dibenzofuran,activity,inactive,132-64-9,568.0,c1cccc2oc3ccccc3c12
NCGC00255156-01,tox21-er-bla-agonist-p2,Dipentaerythritol,activity,inactive,126-58-9,31352.0,OCC(COCC(CO)(CO)CO)(CO)CO
NCGC00254298-01,tox21-er-bla-agonist-p2,CP-422935,activity,inactive,NOCAS_47299,60196413.0,CS(=O)(=O)O.CCOc1cccc(c1)[C@@]2(CC[C@@H](C)CC2)N3CCN(CC3)c4ccccc4
NCGC00254777-01,tox21-er-bla-agonist-p2,4-Methoxy-4-methyl-2-pentanone,activity,inactive,107-70-0,7884.0,CC(=O)CC(C)(C)OC
NCGC00254431-01,tox21-er-bla-agonist-p2,Cyclopamine,activity,inactive,4449-51-8,442972.0,CC4=C5C[C@@H]1[C@@]6(C)CC[C@H](O)CC6=CC[C@H]1[C@@H]5CC[C@@]24O[C@@H]3C[C@H](C)CN[C@H]3[C@H]2C
NCGC00254060-01,tox21-er-bla-agonist-p2,Trichloroacetic acid,activity,inactive,76-03-9,6421.0,ClC(Cl)(Cl)C(=O)O
NCGC00254452-01,tox21-er-bla-agonist-p2,CJ-013790,activity,inactive,179465-71-5,53316393.0,NC(=O)N(O)[C@@H]3C=C[C@H](Oc2cc(Oc1ccc(F)cc1)ccc2)C3
NCGC00255131-01,tox21-er-bla-agonist-p2,"2,6-Diisopropylaniline",activity,inactive,24544-04-5,32484.0,CC(C)c1cccc(C(C)C)c1N
NCGC00016767-02,tox21-er-bla-agonist-p2,Etandazole,activity,inactive,22668-01-5,3276.0,O=C(Cn1ccnc1[N+]([O-])=O)NCCO
NCGC00260129-01,tox21-er-bla-agonist-p2,Iron(II) sulfate,activity,inactive,7720-78-7,24393.0,[Fe+2].[O-]S([O-])(=O)=O
NCGC00259284-01,tox21-er-bla-agonist-p2,Isobutyl acetate,activity,inactive,110-19-0,8038.0,CC(=O)OCC(C)C
NCGC00257232-01,tox21-er-bla-agonist-p2,7-Amino-4-hydroxynaphthalene-2-sulfonic acid,activity,inactive,87-02-5,6868.0,O=S(=O)(O)c1cc(O)c2ccc(N)cc2c1
NCGC00258081-01,tox21-er-bla-agonist-p2,3-Hydroxybenzoic acid,activity,inactive,99-06-9,7420.0,OC(=O)c1cc(O)ccc1
NCGC00257244-01,tox21-er-bla-agonist-p2,4-(Hexyloxy)phenol,activity,inactive,18979-55-0,29354.0,Oc1ccc(OCCCCCC)cc1
NCGC00257596-01,tox21-er-bla-agonist-p2,Sulfallate,activity,inactive,95-06-7,7216.0,C=C(Cl)CSC(=S)N(CC)CC
NCGC00091044-02,tox21-er-bla-agonist-p2,N-Hydroxybenzamide,activity,inactive,495-18-1,10313.0,O=C(NO)c1ccccc1
NCGC00255518-01,tox21-er-bla-agonist-p2,Monolinuron,activity,inactive,1746-81-2,15629.0,Clc1ccc(NC(=O)N(C)OC)cc1
NCGC00255714-01,tox21-er-bla-agonist-p2,Oxfendazole,activity,inactive,53716-50-0,40854.0,O=C(OC)Nc1nc2cc(ccc2n1)S(=O)c3ccccc3
NCGC00255716-01,tox21-er-bla-agonist-p2,5-Methoxy-5-oxopentanoic acid,activity,inactive,1501-27-5,73917.0,OC(=O)CCCC(=O)OC
NCGC00255570-01,tox21-er-bla-agonist-p2,4-Hexylaniline,activity,inactive,33228-45-4,36382.0,Nc1ccc(CCCCCC)cc1
NCGC00255581-01,tox21-er-bla-agonist-p2,Nicosulfuron,activity,inactive,111991-09-4,73281.0,O=S(=O)(NC(=O)Nc1nc(OC)cc(OC)n1)c2ncccc2C(=O)N(C)C
NCGC00255614-01,tox21-er-bla-agonist-p2,Kasugamycin hydrochloride,activity,inactive,19408-46-9,88045.0,Cl.O=C(O)C(=N)N[C@H]2C[C@H](N)[C@@H](O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O)O[C@@H]2C
NCGC00256562-01,tox21-er-bla-agonist-p2,Trimethyl phosphate,activity,inactive,512-56-1,10541.0,O=P(OC)(OC)OC
NCGC00256396-01,tox21-er-bla-agonist-p2,"1-Chloro-2,4-dinitrobenzene",activity,inactive,97-00-7,6.0,O=[N+]([O-])c1cc(ccc1Cl)[N+]([O-])=O
NCGC00256219-01,tox21-er-bla-agonist-p2,Tetracosafluorotetradecahydrophenanthrene,activity,inactive,306-91-2,78972.0,FC2(F)C3(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C3(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C1(F)C2(F)F
NCGC00255903-01,tox21-er-bla-agonist-p2,3-Methoxy-3-methylbutan-1-ol,activity,inactive,56539-66-3,62118.0,CC(C)(CCO)OC
NCGC00257406-01,tox21-er-bla-agonist-p2,PharmaGSID_48511,activity,inactive,1062243-51-9,25015677.0,CN5CCC(NC(=O)c4ccc(Nc1nc2N(CC(F)(F)C(=O)N(C)c2cn1)C3CCCC3)c(OC)c4)CC5
NCGC00257413-01,tox21-er-bla-agonist-p2,Dodecylphenol,activity,active agonist,27193-86-8,171144.0,Oc1ccccc1CCCCCCCCCCCC
NCGC00257467-01,tox21-er-bla-agonist-p2,"2,6-Diaminopyridine",activity,inactive,141-86-6,8861.0,Nc1cccc(N)n1
NCGC00257720-01,tox21-er-bla-agonist-p2,Enflurane,activity,inactive,13838-16-9,3226.0,FC(Cl)C(F)(F)OC(F)F
NCGC00257315-01,tox21-er-bla-agonist-p2,Aldicarb sulfoxide,activity,inactive,1646-87-3,9568700.0,CC(C)(\C=N\OC(=O)NC)S(C)=O
NCGC00257341-01,tox21-er-bla-agonist-p2,Phenylparaben,activity,active agonist,17696-62-7,87250.0,O=C(Oc1ccccc1)c2ccc(O)cc2
NCGC00258256-01,tox21-er-bla-agonist-p2,2-(Dibutylamino)ethanol,activity,inactive,102-81-8,7621.0,CCCCN(CCCC)CCO
NCGC00258527-01,tox21-er-bla-agonist-p2,4-Hydroxy-4'-chlorobenzophenone,activity,active agonist,42019-78-3,123504.0,O=C(c1ccc(Cl)cc1)c2ccc(O)cc2
NCGC00258528-01,tox21-er-bla-agonist-p2,(2-Nitrophenyl)acetonitrile,activity,inactive,610-66-2,11888.0,O=[N+]([O-])c1ccccc1CC#N
NCGC00258950-01,tox21-er-bla-agonist-p2,"1,2-Diphenoxyethane",activity,inactive,104-66-5,7713.0,C(COc1ccccc1)Oc2ccccc2
NCGC00259016-01,tox21-er-bla-agonist-p2,4-Hydroxy-3-nitrophenylarsonic acid,activity,inactive,121-19-7,5104.0,O=[N+]([O-])c1cc(ccc1O)[As](O)(O)=O
NCGC00258409-01,tox21-er-bla-agonist-p2,Isopropyl methanesulfonate,activity,inactive,926-06-7,13551.0,CC(C)OS(C)(=O)=O
NCGC00258473-01,tox21-er-bla-agonist-p2,Diethylformamide,activity,inactive,617-84-5,12051.0,CCN(CC)C=O
NCGC00258887-01,tox21-er-bla-agonist-p2,1-Hexanol,activity,inactive,111-27-3,8103.0,CCCCCCO
NCGC00259738-01,tox21-er-bla-agonist-p2,Dimethyl succinate,activity,inactive,106-65-0,7820.0,COC(=O)CCC(=O)OC
NCGC00259756-01,tox21-er-bla-agonist-p2,Bromoacetonitrile,activity,inactive,590-17-0,11534.0,BrCC#N
NCGC00259610-01,tox21-er-bla-agonist-p2,Metalaxyl,activity,inactive,57837-19-1,42586.0,CC(N(C(=O)COC)c1c(C)cccc1C)C(=O)OC
NCGC00259633-01,tox21-er-bla-agonist-p2,"2,2'-Azobis(2-methylpropanenitrile)",activity,inactive,78-67-1,6547.0,N#CC(C)(C)/N=N/C(C)(C)C#N
NCGC00260105-01,tox21-er-bla-agonist-p2,"Benzenesulfonyl chloride, 4-(acetylamino)-",activity,inactive,121-60-8,8481.0,O=S(Cl)(=O)c1ccc(NC(C)=O)cc1
NCGC00259439-01,tox21-er-bla-agonist-p2,"1,3-Dichloro-2-propanol",activity,inactive,96-23-1,7289.0,ClCC(O)CCl
NCGC00259440-01,tox21-er-bla-agonist-p2,N-Phenyl-2-naphthylamine,activity,inactive,135-88-6,8679.0,c1cc3ccccc3cc1Nc2ccccc2
NCGC00259682-01,tox21-er-bla-agonist-p2,Sodium chlorate,activity,inactive,7775-09-9,516902.0,[Na+].[O-]Cl(=O)=O
NCGC00260258-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpyrrolidinium iodide,activity,inactive,56511-19-4,12059922.0,[I-].C[N+]1(CCC)CCCC1
NCGC00260551-01,tox21-er-bla-agonist-p2,NTP Mix59 CT1 62-EQP,activity,inactive,NOCAS_49447,,
NCGC00015191-07,tox21-er-bla-agonist-p2,Chlormezanone,activity,inactive,80-77-3,2717.0,O=C1CCS(=O)(=O)C(N1C)c2ccc(Cl)cc2
NCGC00013489-01,tox21-er-bla-agonist-p2,Sulfaquinoxaline,activity,inactive,59-40-5,5338.0,Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2
NCGC00015810-02,tox21-er-bla-agonist-p2,Papaverine hydrochloride,activity,inactive,61-25-6,6084.0,Cl.COc1ccc(cc1OC)Cc3nccc2cc(OC)c(cc23)OC
NCGC00016328-01,tox21-er-bla-agonist-p2,Ampyrone,activity,inactive,83-07-8,2151.0,O=C2C(N)=C(C)N(C)N2c1ccccc1
NCGC00016770-01,tox21-er-bla-agonist-p2,Miconazole,activity,inactive,22916-47-8,4189.0,Clc3ccc(C(OCc1ccc(Cl)cc1Cl)Cn2ccnc2)c(Cl)c3
NCGC00016774-01,tox21-er-bla-agonist-p2,Nifurtimox,activity,inactive,23256-30-6,31772.0,O=S2(=O)CC(C)N(/N=C/c1ccc(o1)[N+]([O-])=O)CC2
NCGC00016866-01,tox21-er-bla-agonist-p2,Pipemidic acid,activity,inactive,51940-44-4,4831.0,O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCNCC3
NCGC00163179-01,tox21-er-bla-agonist-p2,U-69593,activity,inactive,96744-75-1,105104.0,O=C(Cc1ccccc1)N(C)[C@H]2CC[C@]4(C[C@@H]2N3CCCC3)CCCO4
NCGC00256317-01,tox21-er-bla-agonist-p2,2-Nitrofluorene,activity,inactive,607-57-8,11831.0,[O-][N+](=O)c1ccc2c3ccccc3Cc2c1
NCGC00254846-01,tox21-er-bla-agonist-p2,Cyprodinil,activity,inactive,121552-61-2,86367.0,Cc2cc(nc(Nc1ccccc1)n2)C3CC3
NCGC00254376-01,tox21-er-bla-agonist-p2,CP-085958,activity,inactive,134002-60-1,9956127.0,O=C(O)c1cccc(c1)C[C@@H]2COc3ccc(cc3[C@@H]2O)OCc4nc5cc(F)ccc5s4
NCGC00254491-01,tox21-er-bla-agonist-p2,Tebuconazole,activity,inactive,107534-96-3,86102.0,OC(Cn1cncn1)(CCc2ccc(Cl)cc2)C(C)(C)C
NCGC00255048-01,tox21-er-bla-agonist-p2,Dithiopyr,activity,inactive,97886-45-8,91757.0,FC(F)(F)c1nc(c(c(CC(C)C)c1C(=O)SC)C(=O)SC)C(F)F
NCGC00255108-01,tox21-er-bla-agonist-p2,Cortisone,activity,inactive,53-06-5,222786.0,OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00017042-01,tox21-er-bla-agonist-p2,Pyrvinium pamoate,activity,inactive,3546-41-6,54680693.0,[O-]C(=O)c4cc1ccccc1c(Cc2c3ccccc3cc(C([O-])=O)c2O)c4O.CN(C)c1ccc2[n+](C)c(ccc2c1)/C=C/c4cc(C)n(c3ccccc3)c4C.CN(C)c1ccc2[n+](C)c(ccc2c1)/C=C/c4cc(C)n(c3ccccc3)c4C
NCGC00095201-01,tox21-er-bla-agonist-p2,Chaulmosulfone,activity,inactive,473-32-5,6708773.0,O=C(CCCCCCCCCCCCC1CCCC1)Nc2ccc(cc2)S(=O)(=O)c3ccc(cc3)NC(=O)CCCCCCCCCCCCC4CCCC4
NCGC00095772-01,tox21-er-bla-agonist-p2,Thiamylal sodium,activity,inactive,337-47-3,23677058.0,[Na+].O=C1NC([S-])=NC(=O)C1(CC=C)C(C)CCC
NCGC00166408-01,tox21-er-bla-agonist-p2,Diisopropylaminomethyl-polystyrene,activity,inactive,NOCAS_48702,,
NCGC00182555-01,tox21-er-bla-agonist-p2,Timiperone,activity,inactive,57648-21-2,3033151.0,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)N3c4ccccc4NC3=S
NCGC00183854-01,tox21-er-bla-agonist-p2,Oxendolone,activity,inactive,33765-68-3,443947.0,CC[C@H]2C[C@H]3[C@@H]4CCC1=CC(=O)CC[C@@H]1[C@H]4CC[C@]3(C)[C@H]2O
NCGC00254736-01,tox21-er-bla-agonist-p2,2-(Dihydrocyclopentadienyloxy)ethyl methacrylate,activity,inactive,68169-03-9,3058839.0,C=C(C)C(=O)OCCOC3CC1CC3C2C=CCC12
NCGC00255009-01,tox21-er-bla-agonist-p2,Tepraloxydim,activity,inactive,149979-41-9,6259842.0,CC/C(=N\OC\C=C\Cl)C=1C(=O)CC(CC=1O)C2CCOCC2
NCGC00259803-01,tox21-er-bla-agonist-p2,2-Amino-5-methylbenzenesulfonic acid,activity,inactive,88-44-8,6934.0,Nc1ccc(C)cc1S(O)(=O)=O
NCGC00259889-01,tox21-er-bla-agonist-p2,Bis(2-methoxyethyl) ether,activity,inactive,111-96-6,8150.0,COCCOCCOC
NCGC00260341-01,tox21-er-bla-agonist-p2,"1,1,3-Trichloropropanone",activity,active agonist,921-03-9,13530.0,ClC(Cl)C(=O)CCl
NCGC00094937-01,tox21-er-bla-agonist-p2,Carprofen,activity,inactive,53716-49-7,2581.0,O=C(O)C(C)c1ccc2c3cc(Cl)ccc3nc2c1
NCGC00160514-01,tox21-er-bla-agonist-p2,Idebenone,activity,inactive,58186-27-9,3686.0,COC1=C(OC)C(=O)C(C)=C(CCCCCCCCCCO)C1=O
NCGC00254271-01,tox21-er-bla-agonist-p2,Dimethyl malonate,activity,inactive,108-59-8,7943.0,O=C(OC)CC(=O)OC
NCGC00016995-01,tox21-er-bla-agonist-p2,Betazole hydrochloride,activity,inactive,138-92-1,16051987.0,Cl.NCCc1ccnn1
NCGC00017093-01,tox21-er-bla-agonist-p2,Cephapirin sodium,activity,inactive,24356-60-3,23675312.0,[Na+].[O-]C(=O)C=2N3C(=O)[C@@H](NC(=O)CSc1ccncc1)[C@H]3SCC=2COC(C)=O
NCGC00017120-01,tox21-er-bla-agonist-p2,Cefmetazole sodium,activity,inactive,56796-39-5,23666711.0,[Na+].N#CCSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C([O-])=O
NCGC00021139-03,tox21-er-bla-agonist-p2,"5,5-Diphenylhydantoin",activity,inactive,57-41-0,1775.0,O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3
NCGC00024733-02,tox21-er-bla-agonist-p2,Aceclidine,activity,inactive,827-61-2,1979.0,CC(=O)OC2CN1CCC2CC1
NCGC00024915-02,tox21-er-bla-agonist-p2,SCH 50911,activity,inactive,160415-07-6,5311429.0,CC1(C)NC[C@H](CC(=O)O)OC1
NCGC00256869-01,tox21-er-bla-agonist-p2,Isopentyl benzoate,activity,inactive,94-46-2,7193.0,CC(C)CCOC(=O)c1ccccc1
NCGC00257205-01,tox21-er-bla-agonist-p2,"3,4-Dinitrotoluene",activity,inactive,610-39-9,11883.0,O=[N+]([O-])c1cc(C)ccc1[N+]([O-])=O
NCGC00257264-01,tox21-er-bla-agonist-p2,"1,2,4,5-Tetramethylbenzene",activity,inactive,95-93-2,7269.0,Cc1cc(C)c(C)cc1C
NCGC00257298-01,tox21-er-bla-agonist-p2,PharmaGSID_48172,activity,inactive,NOCAS_48172,60196440.0,O=C(O)/C=C/C(=O)O.O=C5c1ccccc1C(=O)N5CCc2nc(on2)c4ccc(CN3CCCCCC3)s4
NCGC00257571-01,tox21-er-bla-agonist-p2,"1,3,5-Benzenetricarboxylic acid",activity,inactive,554-95-0,11138.0,OC(=O)c1cc(cc(c1)C(=O)O)C(=O)O
NCGC00257654-01,tox21-er-bla-agonist-p2,Phenethyl isothiocyanate,activity,inactive,2257-09-2,16741.0,S=C=N\CCc1ccccc1
NCGC00257896-01,tox21-er-bla-agonist-p2,"2,3-Dichloro-1-propanol",activity,inactive,616-23-9,12018.0,ClCC(Cl)CO
NCGC00257996-01,tox21-er-bla-agonist-p2,"2,6-Di-tert-butylphenol",activity,inactive,128-39-2,31405.0,CC(C)(C)c1cccc(c1O)C(C)(C)C
NCGC00258181-01,tox21-er-bla-agonist-p2,"2,2-Dimethoxypropane",activity,inactive,77-76-9,6495.0,CC(C)(OC)OC
NCGC00256682-01,tox21-er-bla-agonist-p2,Isopropyl citrate,activity,inactive,NOCAS_47140,57483158.0,OC(CC(=O)O)(CC(=O)O)C(=O)OC(C)C
NCGC00256708-01,tox21-er-bla-agonist-p2,Orange terpenes,activity,inactive,8028-48-6,,
NCGC00256401-01,tox21-er-bla-agonist-p2,"p,p'-Ethyl-DDD",activity,inactive,72-56-0,6295.0,ClC(Cl)C(c1ccc(CC)cc1)c2ccc(cc2)CC
NCGC00255928-01,tox21-er-bla-agonist-p2,Triethylene glycol bis(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate,activity,inactive,36443-68-2,91620.0,CC(C)(C)c1cc(cc(C)c1O)CCC(=O)OCCOCCOCCOC(=O)CCc2cc(C)c(O)c(c2)C(C)(C)C
NCGC00255977-01,tox21-er-bla-agonist-p2,Diphenyl sulfide,activity,inactive,139-66-2,8766.0,c1ccccc1Sc2ccccc2
NCGC00256096-01,tox21-er-bla-agonist-p2,Octylphosphonic acid,activity,inactive,4724-48-5,78452.0,O=P(O)(O)CCCCCCCC
NCGC00255670-01,tox21-er-bla-agonist-p2,Sulfometuron-methyl,activity,inactive,74222-97-2,52997.0,O=C(Nc1nc(C)cc(C)n1)NS(=O)(=O)c2ccccc2C(=O)OC
NCGC00258882-01,tox21-er-bla-agonist-p2,1-Chloro-3-nitrobenzene,activity,inactive,121-73-3,8489.0,O=[N+]([O-])c1cc(Cl)ccc1
NCGC00260396-01,tox21-er-bla-agonist-p2,3-Methylhexane,activity,inactive,589-34-4,11507.0,CC(CC)CCC
NCGC00259156-01,tox21-er-bla-agonist-p2,Trichlorfon,activity,inactive,52-68-6,5853.0,OC(C(Cl)(Cl)Cl)P(=O)(OC)OC
NCGC00259463-01,tox21-er-bla-agonist-p2,Ethylene glycol dimethacrylate,activity,inactive,97-90-5,7355.0,O=C(OCCOC(=O)C(=C)C)C(=C)C
NCGC00259909-01,tox21-er-bla-agonist-p2,Thiobencarb,activity,inactive,28249-77-6,34192.0,Clc1ccc(CSC(=O)N(CC)CC)cc1
NCGC00260015-01,tox21-er-bla-agonist-p2,"1,2-Dichloroethane",activity,inactive,107-06-2,11.0,ClCCCl
NCGC00260055-01,tox21-er-bla-agonist-p2,Diethylamine,activity,inactive,109-89-7,8021.0,CCNCC
NCGC00260224-01,tox21-er-bla-agonist-p2,1-Butyl-2-methylpyridinium chloride,activity,inactive,112400-85-8,21988023.0,[Cl-].Cc1cccc[n+]1CCCC
NCGC00258750-01,tox21-er-bla-agonist-p2,Tyramine hydrochloride,activity,inactive,60-19-5,66449.0,Cl.Oc1ccc(CCN)cc1
NCGC00254710-01,tox21-er-bla-agonist-p2,Monocrotophos,activity,inactive,6923-22-4,5371562.0,O=P(OC)(OC)OC(\C)=C\C(=O)NC
NCGC00254810-01,tox21-er-bla-agonist-p2,Fenitrothion,activity,inactive,122-14-5,31200.0,S=P(Oc1cc(C)c(cc1)[N+]([O-])=O)(OC)OC
NCGC00255407-01,tox21-er-bla-agonist-p2,4-Heptylphenol,activity,inactive,1987-50-4,16143.0,Oc1ccc(CCCCCCC)cc1
NCGC00255611-01,tox21-er-bla-agonist-p2,"2-Propene-1-sulfonic acid, sodium salt",activity,inactive,2495-39-8,23690996.0,[Na+].[O-]S(=O)(=O)CC=C
NCGC00255994-01,tox21-er-bla-agonist-p2,(1R)-endo-(+)-Fenchyl alcohol,activity,inactive,2217-02-9,6997371.0,C[C@@]12CC[C@@H](C1)C(C)(C)[C@@H]2O
NCGC00254520-01,tox21-er-bla-agonist-p2,"4-Nonylphenol, branched",activity,active agonist,84852-15-3,338733.0,Oc1ccc(CCCCCCC(C)C)cc1
NCGC00166323-01,tox21-er-bla-agonist-p2,Trifluridine,activity,inactive,70-00-8,6256.0,FC(F)(F)C1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00093898-02,tox21-er-bla-agonist-p2,Fenspiride hydrochloride,activity,inactive,5053-08-7,68626.0,Cl.O=C3NCC1(CCN(CC1)CCc2ccccc2)O3
NCGC00167424-01,tox21-er-bla-agonist-p2,Tipepidine,activity,inactive,5169-78-8,5484.0,CN1CCC\C(C1)=C(/c2sccc2)c3cccs3
NCGC00159510-02,tox21-er-bla-agonist-p2,Aripiprazole,activity,inactive,129722-12-9,60795.0,Clc4cccc(N3CCN(CCCCOc1ccc2CCC(=O)Nc2c1)CC3)c4Cl
NCGC00164362-01,tox21-er-bla-agonist-p2,Sodium dodecylbenzenesulfonate,activity,inactive,25155-30-0,23707968.0,[Na+].O=S([O-])(=O)c1ccc(cc1)C(CC)CCCCCCCCC
NCGC00164445-01,tox21-er-bla-agonist-p2,Troglitazone,activity,inactive,97322-87-7,5591.0,Cc1c(O)c(C)c(C)c2OC(C)(CCc12)COc4ccc(CC3SC(=O)NC3=O)cc4
NCGC00181153-01,tox21-er-bla-agonist-p2,Treosulfan,activity,inactive,299-75-2,9296.0,CS(=O)(=O)OCC(O)C(O)COS(C)(=O)=O
NCGC00160374-01,tox21-er-bla-agonist-p2,Trimethidinium methyl sulfate,activity,inactive,14149-43-0,26483.0,CC12CCC(C[N+](C)(CCC[N+](C)(C)C)C1)C2(C)C.[O-]S(=O)(=O)OC.[O-]S(=O)(=O)OC
NCGC00164492-01,tox21-er-bla-agonist-p2,Sulfisomidine,activity,inactive,515-64-0,5343.0,Cc2cc(NS(=O)(=O)c1ccc(N)cc1)nc(C)n2
NCGC00164617-01,tox21-er-bla-agonist-p2,Adapalene,activity,inactive,106685-40-9,60164.0,O=C(O)c1ccc2cc(ccc2c1)c3cc(c(OC)cc3)C46CC5CC(CC(C4)C5)C6
NCGC00168249-01,tox21-er-bla-agonist-p2,Clobazam,activity,inactive,22316-47-8,2789.0,Clc1ccc2c(c1)N(C(=O)CC(=O)N2C)c3ccccc3
NCGC00168251-01,tox21-er-bla-agonist-p2,Ethylmorphine,activity,inactive,76-58-4,5359271.0,CCOc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00095661-01,tox21-er-bla-agonist-p2,Cellobiose,activity,inactive,528-50-7,10712.0,O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@@H](O)[C@@H]2O
NCGC00160615-01,tox21-er-bla-agonist-p2,Sucrose octaacetate,activity,inactive,126-14-7,31340.0,CC(=O)O[C@H]1[C@H](O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)O[C@]2(COC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]2OC(C)=O
NCGC00160653-02,tox21-er-bla-agonist-p2,Glysobuzole,activity,inactive,3567-08-6,234310.0,O=S(=O)(Nc1nnc(CC(C)C)s1)c2ccc(OC)cc2
NCGC00160663-01,tox21-er-bla-agonist-p2,Flazalone,activity,inactive,21221-18-1,36663.0,O=C(C1CN(C)CCC1(O)c2ccc(F)cc2)c3ccc(F)cc3
NCGC00091062-04,tox21-er-bla-agonist-p2,L-5-Hydroxytryptophan,activity,inactive,4350-09-8,439280.0,O=C(O)[C@@H](N)Cc2cnc1ccc(O)cc12
NCGC00181917-01,tox21-er-bla-agonist-p2,Carbenicillin indanyl,activity,inactive,35531-88-5,93184.0,OC(=O)[C@@H]4N5C(=O)[C@@H](NC(=O)C(c1ccccc1)C(=O)Oc2cc3CCCc3cc2)[C@H]5SC4(C)C
NCGC00183275-01,tox21-er-bla-agonist-p2,Goserelin acetate,activity,inactive,145781-92-6,16052011.0,CC(=O)O.O=C1CC[C@H](N1)C(=O)N[C@@H](Cc2cncn2)C(=O)N[C@@H](Cc4cnc3ccccc34)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N6CCC[C@H]6C(=O)NNC(N)=O
NCGC00183828-01,tox21-er-bla-agonist-p2,Phenoxypropazine,activity,inactive,3818-37-9,71467.0,CC(COc1ccccc1)NN
NCGC00254148-01,tox21-er-bla-agonist-p2,5-Heptyldihydro-2(3H)-furanone,activity,inactive,104-67-6,7714.0,O=C1CCC(CCCCCCC)O1
NCGC00254720-01,tox21-er-bla-agonist-p2,"2,2,6,6-Tetramethyl-4-piperidone",activity,inactive,826-36-8,13220.0,O=C1CC(C)(C)NC(C)(C)C1
NCGC00253923-01,tox21-er-bla-agonist-p2,4-Aminobenzoic acid,activity,inactive,150-13-0,978.0,OC(=O)c1ccc(N)cc1
NCGC00254775-01,tox21-er-bla-agonist-p2,Bifenazate,activity,inactive,149877-41-8,176879.0,COc1ccc(cc1NNC(=O)OC(C)C)c2ccccc2
NCGC00255307-01,tox21-er-bla-agonist-p2,Chrysin,activity,active agonist,480-40-0,5281607.0,Oc2cc(O)cc1OC(=CC(=O)c12)c3ccccc3
NCGC00254038-01,tox21-er-bla-agonist-p2,Busulfan,activity,inactive,55-98-1,2478.0,O=S(C)(=O)OCCCCOS(C)(=O)=O
NCGC00255319-01,tox21-er-bla-agonist-p2,D-Xylose,activity,inactive,58-86-6,135191.0,O[C@H]1[C@H](O)COC(O)[C@@H]1O
NCGC00255327-01,tox21-er-bla-agonist-p2,Diatrizoate sodium,activity,inactive,737-31-5,23672589.0,[Na+].O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C([O-])=O
NCGC00259418-01,tox21-er-bla-agonist-p2,Benzyl salicylate,activity,inactive,118-58-1,8363.0,Oc2ccccc2C(=O)OCc1ccccc1
NCGC00258128-01,tox21-er-bla-agonist-p2,Chromium picolinate,activity,inactive,14639-25-9,151932.0,[Cr+3].[O-]C(=O)c1ccccn1.[O-]C(=O)c1ccccn1.[O-]C(=O)c1ccccn1
NCGC00258268-01,tox21-er-bla-agonist-p2,1-Octanesulfonyl chloride,activity,inactive,7795-95-1,82261.0,ClS(=O)(=O)CCCCCCCC
NCGC00259537-01,tox21-er-bla-agonist-p2,Carboxin,activity,inactive,5234-68-4,21307.0,O=C(Nc1ccccc1)C=2SCCOC=2C
NCGC00256657-01,tox21-er-bla-agonist-p2,2-Octen-4-one,activity,inactive,4643-27-0,521196.0,CC=CC(=O)CCCC
NCGC00256697-01,tox21-er-bla-agonist-p2,"Hydrazinecarboxylic acid, phenylmethyl ester",activity,inactive,5331-43-1,79242.0,NNC(=O)OCc1ccccc1
NCGC00258039-01,tox21-er-bla-agonist-p2,"Tridecylamine, branched and linear",activity,inactive,86089-17-0,22833454.0,CCC(CCCCCCCN)CCC
NCGC00258104-01,tox21-er-bla-agonist-p2,"4,4'-Dihydoxybenzophenone",activity,active agonist,611-99-4,69150.0,O=C(c1ccc(O)cc1)c2ccc(O)cc2
NCGC00258578-01,tox21-er-bla-agonist-p2,"2,5-Dimethylaniline",activity,inactive,95-78-3,7259.0,Cc1cc(N)c(C)cc1
NCGC00254467-01,tox21-er-bla-agonist-p2,"1,2-Benzisothiazolin-3-one",activity,inactive,2634-33-5,17520.0,O=C2NSc1ccccc12
NCGC00254305-01,tox21-er-bla-agonist-p2,Sulfluramid,activity,inactive,4151-50-2,77797.0,FC(F)(C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)S(=O)(=O)NCC
NCGC00254841-01,tox21-er-bla-agonist-p2,"Acetic acid, C8-10-branched alkyl esters, C9-rich",activity,inactive,108419-33-6,22833466.0,O=C(C)OCCC(C)C(CC)CC
NCGC00256344-01,tox21-er-bla-agonist-p2,1-Piperazineethanol,activity,inactive,103-76-4,7677.0,OCCN1CCNCC1
NCGC00256169-01,tox21-er-bla-agonist-p2,"1,3,5-Tris[3-(trimethoxysilyl)propyl]-1,3,5-triazinane-2,4,6-trione",activity,inactive,26115-70-8,117734.0,CO[Si](OC)(OC)CCCN1C(=O)N(CCC[Si](OC)(OC)OC)C(=O)N(CCC[Si](OC)(OC)OC)C1=O
NCGC00256188-01,tox21-er-bla-agonist-p2,{2-[2-(Ethenyloxy)ethoxy]ethoxy}ethene,activity,inactive,764-99-8,12998.0,C=COCCOCCOC=C
NCGC00256601-01,tox21-er-bla-agonist-p2,Gemfibrozil,activity,inactive,25812-30-0,3463.0,O=C(O)C(C)(C)CCCOc1cc(C)ccc1C
NCGC00256793-01,tox21-er-bla-agonist-p2,alpha-Farnesene,activity,inactive,502-61-4,5281516.0,C/C(C)=C\CCC(\C)=C\C\C=C(/C)C=C
NCGC00256624-01,tox21-er-bla-agonist-p2,Hexyl isobutyrate,activity,inactive,2349-07-7,16872.0,O=C(OCCCCCC)C(C)C
NCGC00256992-01,tox21-er-bla-agonist-p2,Trichloromethylstannane,activity,inactive,993-16-8,101940.0,C[Sn](Cl)(Cl)Cl
NCGC00257845-01,tox21-er-bla-agonist-p2,Clioquinol,activity,inactive,130-26-7,2788.0,Oc1c(I)cc(Cl)c2cccnc12
NCGC00257702-01,tox21-er-bla-agonist-p2,"2,2,4-Trimethyl-1,3-pentanediol monoisobutyrate",activity,inactive,25265-77-4,6490.0,CC(C)(COC(=O)C(C)C)C(O)C(C)C
NCGC00257744-01,tox21-er-bla-agonist-p2,4-Nitrophthalimide,activity,inactive,89-40-7,6969.0,[O-][N+](=O)c1ccc2C(=O)NC(=O)c2c1
NCGC00257365-01,tox21-er-bla-agonist-p2,DINP branched,activity,inactive,68515-48-0,590836.0,CC(C)CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCC(C)C
NCGC00258179-01,tox21-er-bla-agonist-p2,1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide,activity,inactive,223436-99-5,53316417.0,C[N+]1(CC)CCCC1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00258235-01,tox21-er-bla-agonist-p2,"1,1,4,7,7-Pentamethyldiethylenetriamine",activity,inactive,3030-47-5,18196.0,CN(C)CCN(C)CCN(C)C
NCGC00258686-01,tox21-er-bla-agonist-p2,Methapyrilene hydrochloride,activity,inactive,135-23-9,8667.0,Cl.CN(C)CCN(Cc1cccs1)c2ccccn2
NCGC00258566-01,tox21-er-bla-agonist-p2,Ethyl linolenate,activity,inactive,1191-41-9,6371716.0,O=C(CCCCCCC\C=C\C\C=C\C\C=C\CC)OCC
NCGC00258198-01,tox21-er-bla-agonist-p2,Chloroacetyl chloride,activity,inactive,79-04-9,6577.0,ClCC(Cl)=O
NCGC00259532-01,tox21-er-bla-agonist-p2,2-Ethylhexyl glycidyl ether,activity,inactive,2461-15-6,17162.0,CCC(CCCC)COCC1CO1
NCGC00259637-01,tox21-er-bla-agonist-p2,"1,6-Hexanediamine",activity,inactive,124-09-4,16402.0,NCCCCCCN
NCGC00260042-01,tox21-er-bla-agonist-p2,Casanthrol,activity,inconclusive agonist,8024-48-4,,
NCGC00259162-01,tox21-er-bla-agonist-p2,"3,4-Dichloronitrobenzene",activity,inactive,99-54-7,7443.0,Clc1ccc(cc1Cl)[N+]([O-])=O
NCGC00015219-03,tox21-er-bla-agonist-p2,Choline bromide,activity,inactive,1927-06-6,74724.0,[Br-].C[N+](C)(C)CCO
NCGC00015036-03,tox21-er-bla-agonist-p2,Amantadine,activity,inactive,768-94-5,2130.0,NC13CC2CC(CC(C1)C2)C3
NCGC00015508-08,tox21-er-bla-agonist-p2,Hydrochlorothiazide,activity,inactive,58-93-5,3639.0,NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl
NCGC00016357-01,tox21-er-bla-agonist-p2,Iopanoic acid,activity,active agonist,96-83-3,3735.0,Ic1cc(I)c(N)c(I)c1CC(CC)C(=O)O
NCGC00016366-01,tox21-er-bla-agonist-p2,Azacyclonol,activity,inactive,115-46-8,15723.0,OC(c1ccccc1)(C2CCNCC2)c3ccccc3
NCGC00016388-01,tox21-er-bla-agonist-p2,Noscapine,activity,inactive,128-62-1,275196.0,COc3c5OCOc5cc4CCN(C)[C@@H]([C@H]2OC(=O)c1c(OC)c(ccc12)OC)c34
NCGC00016613-01,tox21-er-bla-agonist-p2,Antazoline hydrochloride,activity,inactive,2508-72-7,17275.0,Cl.C(c1ccccc1)N(CC2=NCCN2)c3ccccc3
NCGC00016618-01,tox21-er-bla-agonist-p2,Dimethisoquin hydrochloride,activity,inactive,2773-92-4,9883104.0,Cl.CN(C)CCOc2nc(cc1ccccc12)CCCC
NCGC00016629-01,tox21-er-bla-agonist-p2,Cyclacillin,activity,inactive,3485-14-1,19003.0,OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)C1(N)CCCCC1)[C@H]3SC2(C)C
NCGC00016661-01,tox21-er-bla-agonist-p2,Cyclopentolate hydrochloride,activity,inactive,5870-29-1,22162.0,Cl.OC1(CCCC1)C(C(=O)OCCN(C)C)c2ccccc2
NCGC00160567-01,tox21-er-bla-agonist-p2,Acetomenaphthone,activity,inactive,573-20-6,11310.0,CC(=O)Oc1cc(C)c(OC(C)=O)c2ccccc12
NCGC00181123-01,tox21-er-bla-agonist-p2,Cinepazide maleate,activity,inactive,26328-04-1,5358941.0,O=C(CN1CCN(CC1)C(=O)C=Cc2cc(OC)c(OC)c(OC)c2)N3CCCC3.O=C(O)/C=C\C(=O)O
NCGC00255334-01,tox21-er-bla-agonist-p2,p-Cymen-8-ol,activity,inactive,1197-01-9,14529.0,Cc1ccc(cc1)C(O)(C)C
NCGC00256379-01,tox21-er-bla-agonist-p2,Benzyl acetate,activity,inactive,140-11-4,8785.0,CC(=O)OCc1ccccc1
NCGC00256477-01,tox21-er-bla-agonist-p2,N-Nitroso-N-methylurethane,activity,inactive,615-53-2,12001.0,CN(N=O)C(=O)OCC
NCGC00254439-01,tox21-er-bla-agonist-p2,PharmaGSID_47261,activity,inactive,177785-47-6,462368.0,O=C(O)[C@@H](N2Sc1ccccc1C2=O)[C@@H](C)CC
NCGC00255289-01,tox21-er-bla-agonist-p2,"1-O-Hexyl-2,3,5-trimethylhydroquinone",activity,inactive,148081-72-5,119193.0,Cc1cc(OCCCCCC)c(C)c(C)c1O
NCGC00254411-01,tox21-er-bla-agonist-p2,Dimethyl sulfate,activity,inactive,77-78-1,6497.0,O=S(=O)(OC)OC
NCGC00254725-01,tox21-er-bla-agonist-p2,Flumiclorac-pentyl,activity,inactive,87546-18-7,443048.0,O=C(OCCCCC)COc1cc(c(F)cc1Cl)N3C(=O)C=2CCCCC=2C3=O
NCGC00254804-01,tox21-er-bla-agonist-p2,Tefluthrin,activity,inactive,79538-32-2,5281874.0,Cl\C(=C/C2C(C(=O)OCc1c(F)c(F)c(C)c(F)c1F)C2(C)C)C(F)(F)F
NCGC00159389-02,tox21-er-bla-agonist-p2,Amithiozone,activity,inactive,104-06-3,9568512.0,O=C(C)Nc1ccc(cc1)\C=N\NC(N)=S
NCGC00160456-01,tox21-er-bla-agonist-p2,2-Iodohippuric acid,activity,inactive,147-58-0,8614.0,O=C(NCC(=O)O)c1ccccc1I
NCGC00164539-01,tox21-er-bla-agonist-p2,Azaclorzine,activity,inactive,49864-70-2,39526.0,Clc1cc2N(c3ccccc3Sc2cc1)C(=O)CCN4CC5CCCN5CC4
NCGC00164601-01,tox21-er-bla-agonist-p2,Liranaftate,activity,inactive,88678-31-3,3936.0,COc1cccc(n1)N(C)C(=S)Oc2cc3CCCCc3cc2
NCGC00167578-01,tox21-er-bla-agonist-p2,Mitiglinide calcium dihydrate,activity,inactive,207844-01-7,6918235.0,[Ca+2].O.O.[O-]C(=O)[C@@H](Cc1ccccc1)CC(=O)N2C[C@@H]3CCCC[C@@H]3C2.[O-]C(=O)[C@@H](Cc1ccccc1)CC(=O)N2C[C@@H]3CCCC[C@@H]3C2
NCGC00181915-01,tox21-er-bla-agonist-p2,Mepranoprofen arbamel,activity,inactive,118635-52-2,164072.0,CN(C)C(=O)COC(=O)C(C)c1cc2Cc3ccc(C)nc3Oc2cc1
NCGC00187909-01,tox21-er-bla-agonist-p2,Perifosine,activity,inactive,157716-52-4,148177.0,[O-]P(=O)(OCCCCCCCCCCCCCCCCCC)OC1CC[N+](C)(C)CC1
NCGC00253981-01,tox21-er-bla-agonist-p2,"2,3,6-Trimethylphenol",activity,inactive,2416-94-6,17016.0,Cc1ccc(C)c(O)c1C
NCGC00259254-01,tox21-er-bla-agonist-p2,Ergotamine D-tartrate,activity,inactive,379-79-3,9787.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN2C[C@@H](C=C1c3cccc4ncc(C[C@H]12)c34)C(=O)N[C@]5(C)O[C@]8(O)N(C5=O)[C@@H](Cc6ccccc6)C(=O)N7CCC[C@H]78.CN2C[C@@H](C=C1c3cccc4ncc(C[C@H]12)c34)C(=O)N[C@]8(C)O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O
NCGC00260489-01,tox21-er-bla-agonist-p2,3-Indazolinone,activity,inactive,7364-25-2,81829.0,O=C1NNc2ccccc12
NCGC00015340-02,tox21-er-bla-agonist-p2,Desipramine hydrochloride,activity,inactive,58-28-6,65327.0,Cl.CNCCCN2c3ccccc3CCc1ccccc12
NCGC00016397-01,tox21-er-bla-agonist-p2,Benzydamine hydrochloride,activity,inactive,132-69-4,65464.0,Cl.CN(C)CCCOc3nn(Cc1ccccc1)c2ccccc23
NCGC00017141-01,tox21-er-bla-agonist-p2,Lisinopril dihydrate,activity,inactive,83915-83-7,5362118.0,O.O.OC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)N[C@@H](CCc1ccccc1)C(=O)O
NCGC00094738-01,tox21-er-bla-agonist-p2,Norethindrone,activity,active agonist,68-22-4,6230.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00254625-01,tox21-er-bla-agonist-p2,Copper(I) iodide,activity,inactive,7681-65-4,24350.0,[Cu]I
NCGC00022472-05,tox21-er-bla-agonist-p2,Corticosterone,activity,inactive,50-22-6,5753.0,OCC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00024870-02,tox21-er-bla-agonist-p2,Remoxipride,activity,inactive,80125-14-0,54477.0,CCN2CCC[C@H]2CNC(=O)c1c(OC)ccc(Br)c1OC
NCGC00016916-01,tox21-er-bla-agonist-p2,Norfloxacin,activity,inactive,70458-96-7,4539.0,O=C(O)C2=CN(CC)c1cc(c(F)cc1C2=O)N3CCNCC3
NCGC00256798-01,tox21-er-bla-agonist-p2,2-Phenylethyl hexanoate,activity,inactive,6290-37-5,61384.0,CCCCCC(=O)OCCc1ccccc1
NCGC00256818-01,tox21-er-bla-agonist-p2,Cremophor(R) EL,activity,inactive,61791-12-6,,
NCGC00257023-01,tox21-er-bla-agonist-p2,3-Methoxypropylamine,activity,inactive,5332-73-0,1672.0,NCCCOC
NCGC00258449-01,tox21-er-bla-agonist-p2,N-tert-Butyl-2-benzothiazolesulfenamide,activity,inactive,95-31-8,7230.0,CC(C)(C)NSc1nc2ccccc2s1
NCGC00258465-01,tox21-er-bla-agonist-p2,1-Chloro-2-(ethylthio)ethane,activity,inactive,693-07-2,12733.0,CCSCCCl
NCGC00257046-01,tox21-er-bla-agonist-p2,2-[2-(Hexyloxy)ethoxy]ethanol,activity,inactive,112-59-4,8199.0,OCCOCCOCCCCCC
NCGC00257130-01,tox21-er-bla-agonist-p2,"1,2-Cyclohexanediamine",activity,inactive,694-83-7,4610.0,NC1CCCCC1N
NCGC00257252-01,tox21-er-bla-agonist-p2,N-(Cyclohexylthio)phthalimide,activity,inactive,17796-82-6,28777.0,O=C3c1ccccc1C(=O)N3SC2CCCCC2
NCGC00257265-01,tox21-er-bla-agonist-p2,Diisodecylphenyl phosphite,activity,inactive,25550-98-5,16212880.0,CC(C)CCCCCCCOP(OCCCCCCCC(C)C)Oc1ccccc1
NCGC00257384-01,tox21-er-bla-agonist-p2,C12-14-Alkyl glycidyl ether,activity,inactive,68609-97-2,17163.0,CCCCCCCCCCCCOCC1CO1
NCGC00257699-01,tox21-er-bla-agonist-p2,D-Glucose,activity,inactive,50-99-7,5793.0,O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O
NCGC00257750-01,tox21-er-bla-agonist-p2,"2-Methyl-5-nitro-1H-isoindole-1,3(2H)-dione",activity,inactive,41663-84-7,92321.0,[O-][N+](=O)c1ccc2C(=O)N(C)C(=O)c2c1
NCGC00257960-01,tox21-er-bla-agonist-p2,"2,5-Furandione",activity,inactive,108-31-6,7923.0,O=C1C=CC(=O)O1
NCGC00258158-01,tox21-er-bla-agonist-p2,Propylammonium nitrate,activity,inactive,22113-88-8,10197675.0,CCCN.[O-][N+](=O)O
NCGC00258330-01,tox21-er-bla-agonist-p2,"1,3-Dimethyl-5-nitrobenzene",activity,inactive,99-12-7,7426.0,Cc1cc(C)cc(c1)[N+](=O)[O-]
NCGC00255712-01,tox21-er-bla-agonist-p2,Ethyltriethoxysilane,activity,inactive,78-07-9,6515.0,CCO[Si](OCC)(OCC)CC
NCGC00256533-01,tox21-er-bla-agonist-p2,Carbazole,activity,inactive,86-74-8,6854.0,c1cccc2nc3ccccc3c12
NCGC00255797-01,tox21-er-bla-agonist-p2,Selegiline hydrochloride,activity,inactive,14611-52-0,26758.0,Cl.C#CCN(C)[C@H](C)Cc1ccccc1
NCGC00255828-01,tox21-er-bla-agonist-p2,Methfuroxam,activity,inactive,28730-17-8,34313.0,Cc2c(C)oc(C)c2C(=O)Nc1ccccc1
NCGC00255955-01,tox21-er-bla-agonist-p2,"Sodium 2,5-dimethylbenzenesulfonate",activity,inactive,827-19-0,23691974.0,[Na+].Cc1ccc(C)cc1S(=O)([O-])=O
NCGC00255968-01,tox21-er-bla-agonist-p2,Butyl (2S)-2-hydroxypropanoate,activity,inactive,34451-19-9,6999977.0,O[C@@H](C)C(=O)OCCCC
NCGC00256088-01,tox21-er-bla-agonist-p2,"2,2-Dimethylpropane-1,3-diyl bis(2-methylprop-2-enoate)",activity,inactive,1985-51-9,16135.0,O=C(OCC(C)(C)COC(=O)C(=C)C)C(=C)C
NCGC00256280-01,tox21-er-bla-agonist-p2,1-(Morpholin-4-yl)prop-2-en-1-one,activity,inactive,5117-12-4,98723.0,O=C(C=C)N1CCOCC1
NCGC00256308-01,tox21-er-bla-agonist-p2,2-Hexyldecanoic acid,activity,inactive,25354-97-6,32912.0,O=C(O)C(CCCCCCCC)CCCCCC
NCGC00256345-01,tox21-er-bla-agonist-p2,Phenacetin,activity,inactive,62-44-2,4754.0,CCOc1ccc(cc1)NC(C)=O
NCGC00260428-01,tox21-er-bla-agonist-p2,Methylcyclopentane,activity,inactive,96-37-7,7296.0,CC1CCCC1
NCGC00260629-01,tox21-er-bla-agonist-p2,NTP Mix105 ER1 10-EQC,activity,inactive,NOCAS_49525,,
NCGC00259420-01,tox21-er-bla-agonist-p2,3-Chloro-4-methylaniline,activity,inactive,95-74-9,7255.0,Nc1cc(Cl)c(C)cc1
NCGC00259861-01,tox21-er-bla-agonist-p2,Isophorone,activity,inactive,78-59-1,6544.0,O=C1C=C(C)CC(C)(C)C1
NCGC00260215-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpiperidinium bis(trifluoromethylsulfonyl)imide,activity,inactive,608140-12-1,16726630.0,CCC[N+]1(C)CCCCC1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00260276-01,tox21-er-bla-agonist-p2,"(E)-1,4-Dibromo-2-butene",activity,inactive,821-06-7,641245.0,BrC\C=C\CBr
NCGC00258663-01,tox21-er-bla-agonist-p2,Isoascorbic acid,activity,inactive,89-65-6,54675810.0,OC=1C(=O)O[C@H]([C@H](O)CO)C=1O
NCGC00258773-01,tox21-er-bla-agonist-p2,1-Methoxy-4-methyl-2-nitrobenzene,activity,inactive,119-10-8,67058.0,COc1ccc(C)cc1[N+]([O-])=O
NCGC00254657-01,tox21-er-bla-agonist-p2,Profenofos,activity,inactive,41198-08-7,38779.0,Brc1cc(Cl)c(OP(=O)(OCC)SCCC)cc1
NCGC00254697-01,tox21-er-bla-agonist-p2,Chlorbromuron,activity,inactive,13360-45-7,25912.0,Clc1cc(NC(=O)N(C)OC)ccc1Br
NCGC00254724-01,tox21-er-bla-agonist-p2,Bibenzyl,activity,inactive,103-29-7,7647.0,C(Cc1ccccc1)c2ccccc2
NCGC00254870-01,tox21-er-bla-agonist-p2,Ethyl dodecanoate,activity,inactive,106-33-2,7800.0,O=C(CCCCCCCCCCC)OCC
NCGC00254889-01,tox21-er-bla-agonist-p2,Bis(2-carboxyethyl) sulfide,activity,inactive,111-17-1,8096.0,OC(=O)CCSCCC(O)=O
NCGC00255466-01,tox21-er-bla-agonist-p2,"3,4-Dichlorophenylurea",activity,inactive,2327-02-8,16854.0,Clc1ccc(NC(N)=O)cc1Cl
NCGC00255479-01,tox21-er-bla-agonist-p2,Procyazine,activity,inactive,32889-48-8,36274.0,Clc2nc(NC1CC1)nc(NC(C)(C)C#N)n2
NCGC00255552-01,tox21-er-bla-agonist-p2,"6-Chloro-2,3-dihydrobenzoxazol-2-one",activity,inactive,19932-84-4,29858.0,Clc1ccc2NC(=O)Oc2c1
NCGC00255661-01,tox21-er-bla-agonist-p2,Nimesulide,activity,inactive,51803-78-2,4495.0,[O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(C)(=O)=O
NCGC00254513-01,tox21-er-bla-agonist-p2,CP-457677,activity,inactive,214535-77-0,10407399.0,CC(C)(O)c1ccc(cc1)CNC(=O)c3cccnc3Oc2ccc(F)cc2
NCGC00091088-05,tox21-er-bla-agonist-p2,"2,3-Benzofuran",activity,inactive,271-89-6,9223.0,c1cccc2occc12
NCGC00093850-01,tox21-er-bla-agonist-p2,Eflornithine hydrochloride,activity,inactive,96020-91-6,57004.0,Cl.FC(F)C(N)(CCCN)C(=O)O
NCGC00164243-01,tox21-er-bla-agonist-p2,Chloramine-T trihydrate,activity,inactive,7080-50-4,517414.0,[Na+].O.O.O.Cc1ccc(cc1)S(=O)(=O)[N-]Cl
NCGC00159521-02,tox21-er-bla-agonist-p2,Zoledronate,activity,inactive,118072-93-8,68740.0,OP(=O)(O)C(O)(Cn1ccnc1)P(=O)(O)O
NCGC00181136-01,tox21-er-bla-agonist-p2,Pyrrolnitrin,activity,active agonist,1018-71-9,13916.0,Clc2cncc2c1cccc(Cl)c1[N+]([O-])=O
NCGC00094976-01,tox21-er-bla-agonist-p2,Glutathione,activity,inactive,70-18-8,124886.0,O=C(NCC(=O)O)[C@@H](NC(=O)CC[C@H](N)C(=O)O)CS
NCGC00164506-01,tox21-er-bla-agonist-p2,Tiliquinol,activity,inactive,5541-67-3,71208.0,Oc1ccc(C)c2cccnc12
NCGC00094981-03,tox21-er-bla-agonist-p2,Benzyl benzoate,activity,inactive,120-51-4,2345.0,O=C(OCc1ccccc1)c2ccccc2
NCGC00095109-01,tox21-er-bla-agonist-p2,Venlafaxine,activity,inactive,93413-69-5,5656.0,OC1(CCCCC1)C(CN(C)C)c2ccc(OC)cc2
NCGC00164591-01,tox21-er-bla-agonist-p2,Artemether,activity,inactive,71963-77-4,20054835.0,C[C@]12O[C@H]4O[C@H](OC)[C@H](C)[C@@H]3CC[C@@H](C)[C@H](CC1)C34OO2
NCGC00160516-01,tox21-er-bla-agonist-p2,Pidotimod,activity,inactive,121808-62-6,65944.0,OC(=O)[C@@H]2CSCN2C(=O)[C@@H]1CCC(=O)N1
NCGC00095777-01,tox21-er-bla-agonist-p2,Dehydrocholic acid,activity,inactive,81-23-2,6674.0,O=C(O)CC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)C(=O)C[C@H]2[C@H]3C(=O)C[C@@H]1CC(=O)CC[C@@]12C
NCGC00166232-01,tox21-er-bla-agonist-p2,4-Tolyl acetate,activity,inactive,140-39-6,8797.0,O=C(C)Oc1ccc(C)cc1
NCGC00159380-02,tox21-er-bla-agonist-p2,Benzoyl peroxide,activity,inactive,94-36-0,7187.0,O=C(OOC(=O)c1ccccc1)c2ccccc2
NCGC00159393-02,tox21-er-bla-agonist-p2,N-Acetyl-L-tyrosine,activity,inactive,537-55-3,68310.0,Oc1ccc(C[C@H](NC(C)=O)C(=O)O)cc1
NCGC00183277-01,tox21-er-bla-agonist-p2,Micronomicin sulfate,activity,inactive,66803-19-8,171808.0,O=S(=O)(O)O.N[C@@H]3CC[C@@H](CNC)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00183365-01,tox21-er-bla-agonist-p2,Poly-L-ornithine hydrochloride,activity,inactive,26982-21-8,76654.0,Cl.NCCC[C@H](N)C(=O)O
NCGC00255022-01,tox21-er-bla-agonist-p2,Pentadecan-15-olide,activity,inactive,106-02-5,235414.0,O=C1CCCCCCCCCCCCCCO1
NCGC00254180-01,tox21-er-bla-agonist-p2,6-Propyl-2-thiouracil,activity,inactive,51-52-5,657298.0,S=C1NC(CCC)=CC(=O)N1
NCGC00254607-01,tox21-er-bla-agonist-p2,Benzyl cinnamate,activity,inactive,103-41-3,7652.0,O=C(OCc1ccccc1)C=Cc2ccccc2
NCGC00254325-01,tox21-er-bla-agonist-p2,FD&C Yellow 5,activity,inactive,1934-21-0,5359657.0,[Na+].[Na+].[Na+].[O-]S(=O)(=O)c1ccc(cc1)/N=N/C3=C(NN(c2ccc(cc2)S([O-])(=O)=O)C3=O)C([O-])=O
NCGC00255306-01,tox21-er-bla-agonist-p2,1-Bromooctane,activity,inactive,111-83-1,8140.0,BrCCCCCCCC
NCGC00254026-01,tox21-er-bla-agonist-p2,"3,7-Dimethyl-2,6-octadienal",activity,inactive,5392-40-5,8843.0,C\C(C)=C\CCC(C)=CC=O
NCGC00254042-01,tox21-er-bla-agonist-p2,2-(Butan-2-yl)phenol,activity,inactive,89-72-5,6984.0,Oc1ccccc1C(C)CC
NCGC00181337-01,tox21-er-bla-agonist-p2,"2,4-Dichlorobenzyl alcohol",activity,inactive,1777-82-8,15684.0,OCc1ccc(Cl)cc1Cl
NCGC00183016-01,tox21-er-bla-agonist-p2,Cefteram,activity,inactive,82547-58-8,5464257.0,Nc1scc(n1)/C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(Cn2nc(C)nn2)CS[C@@H]34)C(=O)O
NCGC00016672-01,tox21-er-bla-agonist-p2,Chloropyramine hydrochloride,activity,inactive,6170-42-9,80311.0,Cl.Clc1ccc(cc1)CN(CCN(C)C)c2ccccn2
NCGC00258060-01,tox21-er-bla-agonist-p2,Methylhydroquinone,activity,inactive,95-71-6,7253.0,Oc1ccc(O)c(C)c1
NCGC00258570-01,tox21-er-bla-agonist-p2,Bisphenol Z,activity,active agonist,843-55-0,232446.0,Oc1ccc(cc1)C2(CCCCC2)c3ccc(O)cc3
NCGC00258764-01,tox21-er-bla-agonist-p2,Nandrolone,activity,active agonist,434-22-0,9904.0,O=C4CC[C@H]3C(CC[C@@H]1[C@@H]3CC[C@]2(C)[C@@H](O)CC[C@@H]12)=C4
NCGC00256599-01,tox21-er-bla-agonist-p2,3-Chloro-4-methylaniline,activity,inactive,95-74-9,7255.0,Nc1cc(Cl)c(C)cc1
NCGC00259688-01,tox21-er-bla-agonist-p2,C.I. Acid Red 114,activity,inactive,6459-94-5,5479172.0,[Na+].[Na+].[O-]S(=O)(=O)c5cc(cc6ccc(O)c(/N=N/c1ccc(cc1C)c4ccc(/N=N/c3ccc(OS(=O)(=O)c2ccc(C)cc2)cc3)c(C)c4)c56)S([O-])(=O)=O
NCGC00257098-01,tox21-er-bla-agonist-p2,Olivetol,activity,inactive,500-66-3,10377.0,Oc1cc(CCCCC)cc(O)c1
NCGC00257245-01,tox21-er-bla-agonist-p2,Tetrabutylphosphonium chloride,activity,inactive,2304-30-5,75311.0,[Cl-].CCCC[P+](CCCC)(CCCC)CCCC
NCGC00260251-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium tetrafluoroborate,activity,inactive,345984-11-4,44717198.0,CCCC[N+]1(C)CCCC1.F[B-](F)(F)F
NCGC00260483-01,tox21-er-bla-agonist-p2,5-Nitroisatin,activity,inactive,611-09-6,4669250.0,[O-][N+](=O)c1cc2c(cc1)NC(=O)C2=O
NCGC00255484-01,tox21-er-bla-agonist-p2,Dipentaerythritol pentaacrylate,activity,active agonist,60506-81-2,108956.0,O=C(OCC(COCC(CO)(COC(=O)C=C)COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C)C=C
NCGC00255673-01,tox21-er-bla-agonist-p2,Secbumeton,activity,inactive,26259-45-0,33443.0,COc1nc(NCC)nc(NC(C)CC)n1
NCGC00016496-01,tox21-er-bla-agonist-p2,Etilefrine hydrochloride,activity,inactive,534-87-2,164652.0,Cl.OC(CNCC)c1cc(O)ccc1
NCGC00257881-01,tox21-er-bla-agonist-p2,"2,2'4,4'-Tetrabromodiphenyl ether",activity,inactive,5436-43-1,95170.0,Brc2cc(Br)ccc2Oc1ccc(Br)cc1Br
NCGC00258852-01,tox21-er-bla-agonist-p2,Lactofen,activity,inactive,77501-63-4,62276.0,Clc2cc(ccc2Oc1cc(C(=O)OC(C)C(=O)OCC)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00256778-01,tox21-er-bla-agonist-p2,1-Cyclohexylethanol,activity,inactive,1193-81-3,137829.0,CC(O)C1CCCCC1
NCGC00257243-01,tox21-er-bla-agonist-p2,(-)-Epigallocatechin gallate,activity,inactive,989-51-5,65064.0,Oc1cc(cc(O)c1O)C(=O)O[C@@H]3Cc2c(cc(O)cc2O)O[C@@H]3c4cc(O)c(O)c(O)c4
NCGC00258450-01,tox21-er-bla-agonist-p2,Sodium deoxycholate,activity,inactive,302-95-4,23668196.0,[Na+].[O-]C(=O)CC[C@@H](C)[C@H]2CC[C@H]1[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]12C
NCGC00258131-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium chloride,activity,inactive,65039-09-0,2734160.0,[Cl-].C[n+]1ccn(CC)c1
NCGC00259017-01,tox21-er-bla-agonist-p2,Prochloraz,activity,inactive,67747-09-5,73665.0,O=C(N(CCOc1c(Cl)cc(Cl)cc1Cl)CCC)n2ccnc2
NCGC00259047-01,tox21-er-bla-agonist-p2,"N,N-Diethylaniline",activity,inactive,91-66-7,7061.0,CCN(CC)c1ccccc1
NCGC00259182-01,tox21-er-bla-agonist-p2,Riboflavin,activity,inactive,83-88-5,493570.0,OC[C@@H](O)[C@@H](O)[C@@H](O)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12
NCGC00255680-01,tox21-er-bla-agonist-p2,"Acetic acid, (diethoxyphosphinyl)-, ethyl ester",activity,inactive,867-13-0,13345.0,O=P(CC(=O)OCC)(OCC)OCC
NCGC00255857-01,tox21-er-bla-agonist-p2,Pyrazophos,activity,inactive,13457-18-6,26033.0,O=C(OCC)c1cn2nc(cc2nc1C)OP(=S)(OCC)OCC
NCGC00255509-01,tox21-er-bla-agonist-p2,"N,N'-Disalicylidene-1,2-diaminopropane",activity,inactive,94-91-7,5359281.0,Oc2ccccc2/C=N/C(C)C/N=C/c1ccccc1O
NCGC00255854-01,tox21-er-bla-agonist-p2,4-Ethoxy-4-oxobut-2-enoic acid,activity,inactive,3249-53-4,41331.0,OC(=O)C=CC(=O)OCC
NCGC00256781-01,tox21-er-bla-agonist-p2,"1,3-Nonanediol monoacetate",activity,inactive,1322-17-4,234237.0,O=C(C)OCCC(O)CCCCCC
NCGC00257839-01,tox21-er-bla-agonist-p2,2-(4-Nitrophenyl)ethanol,activity,inactive,100-27-6,7494.0,O=[N+]([O-])c1ccc(CCO)cc1
NCGC00258058-01,tox21-er-bla-agonist-p2,3-Methoxycatechol,activity,active agonist,934-00-9,13622.0,COc1cccc(O)c1O
NCGC00258502-01,tox21-er-bla-agonist-p2,(1-Chloro-2-methylpropan-2-yl)benzene,activity,inactive,515-40-2,68191.0,ClCC(C)(C)c1ccccc1
NCGC00258537-01,tox21-er-bla-agonist-p2,Acrolein,activity,inactive,107-02-8,7847.0,C=CC=O
NCGC00258382-01,tox21-er-bla-agonist-p2,Naphthenic acids,activity,active agonist,1338-24-5,20849290.0,OC(=O)CCC1CCC(C1)CC
NCGC00258405-01,tox21-er-bla-agonist-p2,"2,3-Dichloronitrobenzene",activity,inactive,3209-22-1,18555.0,Clc1c(cccc1Cl)[N+]([O-])=O
NCGC00258612-01,tox21-er-bla-agonist-p2,3-Cyclohexene-1-carboxaldehyde,activity,inactive,100-50-5,7508.0,O=CC1CC=CCC1
NCGC00258416-01,tox21-er-bla-agonist-p2,Sodium barbital,activity,inactive,144-02-5,23681217.0,[Na+].CCC1(CC)C(=O)N=C([O-])NC1=O
NCGC00258647-01,tox21-er-bla-agonist-p2,Sodium hydroxymethanesulfonate,activity,inactive,870-72-4,2723822.0,[Na+].[O-]S(=O)(=O)CO
NCGC00259721-01,tox21-er-bla-agonist-p2,Methyl dihydrojasmonate,activity,inactive,24851-98-7,102861.0,COC(=O)CC1CCC(=O)C1CCCCC
NCGC00259767-01,tox21-er-bla-agonist-p2,Etodolac,activity,inactive,41340-25-4,3308.0,O=C(O)CC3(CC)OCCc2c3nc1c(cccc12)CC
NCGC00260026-01,tox21-er-bla-agonist-p2,"3,3'-Dimethoxybenzidine-4,4'-diisocyanate",activity,inactive,91-93-0,7069.0,COc1cc(ccc1/N=C=O)c2ccc(\N=C=O)c(OC)c2
NCGC00260030-01,tox21-er-bla-agonist-p2,Acetonitrile,activity,inactive,75-05-8,6342.0,CC#N
NCGC00259631-01,tox21-er-bla-agonist-p2,Terbutryn,activity,inactive,886-50-0,13450.0,CSc1nc(NCC)nc(NC(C)(C)C)n1
NCGC00259879-01,tox21-er-bla-agonist-p2,trans-Retinoic acid,activity,active agonist,302-79-4,444795.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=C\C(\C)=C\C(=O)O
NCGC00260367-01,tox21-er-bla-agonist-p2,"4,4,4-Trifluoro-1-phenyl-1,3-butanedione",activity,inactive,326-06-7,67589.0,O=C(CC(=O)C(F)(F)F)c1ccccc1
NCGC00260575-01,tox21-er-bla-agonist-p2,NTP Mix39 CT1 2-EQP,activity,inactive,NOCAS_49471,,
NCGC00260187-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium ethyl sulfate,activity,inactive,342573-75-5,12095229.0,C[n+]1ccn(CC)c1.[O-]S(=O)(=O)OCC
NCGC00016590-01,tox21-er-bla-agonist-p2,Azaperone,activity,inactive,1649-18-9,15443.0,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3
NCGC00016500-01,tox21-er-bla-agonist-p2,Diperodon hydrochloride,activity,inactive,537-12-2,10830.0,Cl.O=C(Nc1ccccc1)OCC(OC(=O)Nc2ccccc2)CN3CCCCC3
NCGC00024485-02,tox21-er-bla-agonist-p2,(E)-4-amino-2-butenoic acid,activity,inactive,38090-53-8,5310987.0,NC\C=C\C(=O)O
NCGC00167449-01,tox21-er-bla-agonist-p2,Desogestrel,activity,active agonist,54024-22-5,40973.0,C=C3C[C@@]1(CC)[C@@H](CC[C@@]1(O)C#C)[C@@H]4CCC2=CCCC[C@@H]2[C@@H]34
NCGC00255735-01,tox21-er-bla-agonist-p2,Mecarbam,activity,inactive,2595-54-2,17434.0,CCOP(=S)(OCC)SCC(=O)N(C)C(=O)OCC
NCGC00256162-01,tox21-er-bla-agonist-p2,4-Ethyloct-1-yn-3-ol,activity,inactive,5877-42-9,93012.0,C#CC(O)C(CCCC)CC
NCGC00256453-01,tox21-er-bla-agonist-p2,Dibenzo-p-dioxin,activity,inactive,262-12-4,9216.0,c1ccc2Oc3ccccc3Oc2c1
NCGC00254473-01,tox21-er-bla-agonist-p2,Di(2-ethylhexyl) adipate,activity,inactive,103-23-1,7641.0,O=C(CCCCC(=O)OCC(CC)CCCC)OCC(CCCC)CC
NCGC00254115-01,tox21-er-bla-agonist-p2,Isophorone,activity,inactive,78-59-1,6544.0,O=C1C=C(C)CC(C)(C)C1
NCGC00254251-01,tox21-er-bla-agonist-p2,Mepanipyrim,activity,inactive,110235-47-7,86296.0,Cc2cc(nc(Nc1ccccc1)n2)C#CC
NCGC00015043-07,tox21-er-bla-agonist-p2,4-Aminobutanoic acid,activity,inactive,56-12-2,119.0,NCCCC(=O)O
NCGC00091940-01,tox21-er-bla-agonist-p2,Phenformin hydrochloride,activity,inactive,834-28-6,13266.0,Cl.N=C(N)NC(=N)NCCc1ccccc1
NCGC00092366-02,tox21-er-bla-agonist-p2,Relcovaptan,activity,inactive,150375-75-0,60196272.0,NC(=O)[C@H]1CCCN1C(=O)[C@H]3N(c2ccc(Cl)cc2[C@@]3(O)c4ccccc4Cl)S(=O)(=O)c5cc(OC)c(OC)cc5
NCGC00093950-01,tox21-er-bla-agonist-p2,l-Histidine hydrochloride,activity,inactive,645-35-2,66091.0,Cl.N[C@@H](Cc1cncn1)C(=O)O
NCGC00181307-01,tox21-er-bla-agonist-p2,Febantel,activity,inactive,58306-30-2,5361251.0,O=C(OC)N/C(NC(=O)OC)=N\c2ccc(Sc1ccccc1)cc2NC(=O)COC
NCGC00183100-01,tox21-er-bla-agonist-p2,Diflucortolone valerate,activity,inactive,59198-70-8,91670.0,CCCCC(=O)OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00188689-01,tox21-er-bla-agonist-p2,Asenapine,activity,inactive,65576-45-6,3036780.0,Clc1cc3c(cc1)Oc2ccccc2[C@@H]4CN(C)C[C@@H]34
NCGC00253956-01,tox21-er-bla-agonist-p2,"4,4'-Oxydianiline",activity,inactive,101-80-4,7579.0,Nc1ccc(cc1)Oc2ccc(N)cc2
NCGC00254760-01,tox21-er-bla-agonist-p2,4-Chloro-2-methylaniline,activity,inactive,95-69-2,7251.0,Cc1cc(Cl)ccc1N
NCGC00259806-01,tox21-er-bla-agonist-p2,HC Blue 2,activity,inactive,33229-34-4,36383.0,OCCN(CCO)c1ccc(NCCO)c(c1)[N+]([O-])=O
NCGC00260352-01,tox21-er-bla-agonist-p2,Rifamycin SV sodium salt,activity,inactive,14897-39-3,23702994.0,[Na+].CC(=O)O[C@@H]4[C@H](C)[C@@H](OC)C=CO[C@@]3(C)Oc2c(C)c(O)c1c(O)c(cc([O-])c1c2C3=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]4C
NCGC00016385-01,tox21-er-bla-agonist-p2,Sulfabenzamide,activity,inactive,127-71-9,5319.0,Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2
NCGC00016710-01,tox21-er-bla-agonist-p2,Clemastine fumarate,activity,inactive,14976-57-9,5281069.0,CN3CCC[C@@H]3CCO[C@](C)(c1ccccc1)c2ccc(Cl)cc2.O=C(O)/C=C/C(=O)O
NCGC00024772-01,tox21-er-bla-agonist-p2,3-Morpholinosydnonimine hydrochloride,activity,inactive,16142-27-1,197942.0,[Cl-].Nc1c[n+](no1)N2CCOCC2
NCGC00095089-01,tox21-er-bla-agonist-p2,Fluconazole,activity,inactive,86386-73-4,3365.0,OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F
NCGC00181085-01,tox21-er-bla-agonist-p2,Miripirium chloride,activity,inactive,2748-88-1,17671.0,[Cl-].Cc1cc[n+](CCCCCCCCCCCCCC)cc1
NCGC00090739-02,tox21-er-bla-agonist-p2,"1,2-Propylene glycol",activity,inactive,57-55-6,1030.0,CC(O)CO
NCGC00022848-06,tox21-er-bla-agonist-p2,Hydrocortisone,activity,inactive,50-23-7,5754.0,OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00027960-02,tox21-er-bla-agonist-p2,Capobenic acid,activity,inactive,21434-91-3,30627.0,COc1c(cc(cc1OC)C(=O)NCCCCCC(=O)O)OC
NCGC00016886-01,tox21-er-bla-agonist-p2,Ioxaglic acid,activity,inactive,59017-64-0,3742.0,Ic1c(c(I)c(c(I)c1N(C)C(C)=O)C(=O)NC)C(=O)NCC(=O)Nc2c(I)c(C(=O)NCCO)c(I)c(C(=O)O)c2I
NCGC00256946-01,tox21-er-bla-agonist-p2,Butyl acrylate,activity,inactive,141-32-2,8846.0,C=CC(=O)OCCCC
NCGC00258595-01,tox21-er-bla-agonist-p2,"1,2-Epoxyhexadecane",activity,inactive,7320-37-8,23741.0,CCCCCCCCCCCCCCC1CO1
NCGC00258615-01,tox21-er-bla-agonist-p2,"4-(Butan-2-yl)-2,6-di-tert-butylphenol",activity,inactive,17540-75-9,86583.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(C)CC
NCGC00257150-01,tox21-er-bla-agonist-p2,Decanedioic acid,activity,inactive,111-20-6,5192.0,O=C(O)CCCCCCCCC(=O)O
NCGC00257576-01,tox21-er-bla-agonist-p2,3-Nitrophenol,activity,inactive,554-84-7,11137.0,O=[N+]([O-])c1cccc(O)c1
NCGC00257666-01,tox21-er-bla-agonist-p2,alpha-Terpineol,activity,inactive,98-55-5,17100.0,CC1=CCC(CC1)C(O)(C)C
NCGC00257848-01,tox21-er-bla-agonist-p2,Butyryl chloride,activity,inactive,141-75-3,8855.0,CCCC(Cl)=O
NCGC00258032-01,tox21-er-bla-agonist-p2,(2R)-2-Aminobutan-1-ol,activity,inactive,5856-63-3,2723856.0,CC[C@@H](N)CO
NCGC00258142-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium hexafluorophosphate,activity,inactive,174501-64-5,2734174.0,CCCCn1cc[n+](C)c1.F[P-](F)(F)(F)(F)F
NCGC00256434-01,tox21-er-bla-agonist-p2,Cyclohexanol,activity,inactive,108-93-0,7966.0,OC1CCCCC1
NCGC00255814-01,tox21-er-bla-agonist-p2,Styrene glycol,activity,inactive,93-56-1,7149.0,OC(CO)c1ccccc1
NCGC00255897-01,tox21-er-bla-agonist-p2,Clomipramine hydrochloride,activity,inactive,17321-77-6,68539.0,Cl.CN(C)CCCN2c3ccccc3CCc1ccc(Cl)cc12
NCGC00255959-01,tox21-er-bla-agonist-p2,Etrimfos,activity,inactive,38260-54-7,37995.0,CCc1nc(OCC)cc(OP(=S)(OC)OC)n1
NCGC00256012-01,tox21-er-bla-agonist-p2,Isopropyl triethanolamine titanate,activity,inactive,36673-16-2,3744660.0,CC(C)O[Ti](OCCN(CCO)CCO)(OC(C)C)OCCN(CCO)CCO
NCGC00256223-01,tox21-er-bla-agonist-p2,Ethyl hydrocinnamate,activity,inactive,2021-28-5,16237.0,O=C(CCc1ccccc1)OCC
NCGC00256257-01,tox21-er-bla-agonist-p2,2-(2-Ethoxyethoxy)ethyl prop-2-enoate,activity,inactive,7328-17-8,81766.0,CCOCCOCCOC(=O)C=C
NCGC00256326-01,tox21-er-bla-agonist-p2,4-Methoxyaniline hydrochloride,activity,inactive,20265-97-8,2734956.0,Cl.Nc1ccc(OC)cc1
NCGC00255687-01,tox21-er-bla-agonist-p2,"2,6-Dimethyl-2-heptanol",activity,inactive,13254-34-7,83268.0,CC(C)(O)CCCC(C)C
NCGC00255693-01,tox21-er-bla-agonist-p2,"2,4-D-ethyl ester",activity,inactive,533-23-3,10780.0,Clc1cc(Cl)ccc1OCC(=O)OCC
NCGC00258786-01,tox21-er-bla-agonist-p2,Benomyl,activity,inactive,17804-35-2,28780.0,O=C(OC)Nc2nc1ccccc1n2C(=O)NCCCC
NCGC00258791-01,tox21-er-bla-agonist-p2,Sulfasalazine,activity,inactive,599-79-1,5359476.0,O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3
NCGC00258935-01,tox21-er-bla-agonist-p2,Ibuprofen,activity,inactive,15687-27-1,3672.0,CC(C(=O)O)c1ccc(CC(C)C)cc1
NCGC00259123-01,tox21-er-bla-agonist-p2,Isoxaben,activity,inactive,82558-50-7,73672.0,CCC(C)(CC)c2cc(NC(=O)c1c(OC)cccc1OC)on2
NCGC00259355-01,tox21-er-bla-agonist-p2,"N,N'-Dicyclohexylthiourea",activity,inactive,1212-29-9,727200.0,S=C(NC1CCCCC1)NC2CCCCC2
NCGC00259627-01,tox21-er-bla-agonist-p2,Doxylamine succinate,activity,inactive,562-10-7,11224.0,O=C(O)CCC(=O)O.CN(C)CCOC(C)(c1ccccn1)c2ccccc2
NCGC00259755-01,tox21-er-bla-agonist-p2,"1,6-Diisocyanatohexane",activity,inactive,822-06-0,13192.0,O=C=N/CCCCCC\N=C=O
NCGC00259922-01,tox21-er-bla-agonist-p2,Pyrogallol,activity,active agonist,87-66-1,1057.0,Oc1cccc(O)c1O
NCGC00260140-01,tox21-er-bla-agonist-p2,3-Methylcholanthrene,activity,active agonist,56-49-5,1674.0,Cc2ccc3cc1c5ccccc5ccc1c4CCc2c34
NCGC00260335-01,tox21-er-bla-agonist-p2,Amaranth,activity,inactive,915-67-3,5359521.0,[Na+].[Na+].[Na+].[O-]S(=O)(=O)c4ccc(/N=N\c1c2ccc(cc2cc(c1O)S([O-])(=O)=O)S([O-])(=O)=O)c3ccccc34
NCGC00258689-01,tox21-er-bla-agonist-p2,Abscisic acid,activity,inactive,14375-45-2,5375199.0,OC1(/C=C/C(/C)=C\C(=O)O)C(C)=CC(=O)CC1(C)C
NCGC00258702-01,tox21-er-bla-agonist-p2,Quercetin dihydrate,activity,active agonist,6151-25-3,5284452.0,O.O.Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O
NCGC00258760-01,tox21-er-bla-agonist-p2,Dimethylaminopropyl chloride hydrochloride,activity,inactive,5407-04-5,94308.0,Cl.ClCCCN(C)C
NCGC00254627-01,tox21-er-bla-agonist-p2,Chloridazon,activity,inactive,1698-60-8,15546.0,O=C2C(Cl)=C(N)C=NN2c1ccccc1
NCGC00254650-01,tox21-er-bla-agonist-p2,4-Chlorophenoxyacetic acid,activity,inactive,122-88-3,26229.0,Clc1ccc(OCC(=O)O)cc1
NCGC00254678-01,tox21-er-bla-agonist-p2,Benfluralin,activity,inactive,1861-40-1,2319.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCCC)CC)C(F)(F)F
NCGC00254707-01,tox21-er-bla-agonist-p2,(S)-Citronellene,activity,inactive,10281-55-7,10887985.0,C=C[C@@H](C)CC\C=C(\C)C
NCGC00255237-01,tox21-er-bla-agonist-p2,Fosamine ammonium,activity,inactive,25954-13-6,33256.0,[NH4+].NC(=O)P([O-])(=O)OCC
NCGC00255278-01,tox21-er-bla-agonist-p2,2-Methyl-2-nitro-1-propanol,activity,inactive,76-39-1,6442.0,[O-][N+](=O)C(C)(C)CO
NCGC00255535-01,tox21-er-bla-agonist-p2,"3-(Hydroxymethyl)pentane-2,4-diol",activity,inactive,921-20-0,61234.0,CC(O)C(CO)C(C)O
NCGC00255604-01,tox21-er-bla-agonist-p2,2-Phenoxyethyl acrylate,activity,inactive,48145-04-6,39485.0,C=CC(=O)OCCOc1ccccc1
NCGC00255829-01,tox21-er-bla-agonist-p2,3-Acetyldihydro-2(3H)-furanone,activity,inactive,517-23-7,10601.0,CC(=O)C1CCOC1=O
NCGC00256020-01,tox21-er-bla-agonist-p2,"2,3-Hexanedione",activity,inactive,3848-24-6,19707.0,CC(=O)C(=O)CCC
NCGC00163349-01,tox21-er-bla-agonist-p2,Levonordefrin,activity,inactive,829-74-3,164739.0,Oc1ccc(cc1O)[C@@H](O)[C@H](C)N
NCGC00094337-02,tox21-er-bla-agonist-p2,Sotalol hydrochloride,activity,inactive,959-24-0,66245.0,Cl.O=S(C)(=O)Nc1ccc(cc1)C(O)CNC(C)C
NCGC00094502-01,tox21-er-bla-agonist-p2,Urapidil hydrochloride,activity,inactive,64887-14-5,167980.0,Cl.COc3ccccc3N2CCN(CCCNC1=CC(=O)N(C)C(=O)N1C)CC2
NCGC00159448-02,tox21-er-bla-agonist-p2,4-Methoxy-(2E)-cinnamic acid,activity,inactive,943-89-5,699414.0,COc1ccc(/C=C/C(=O)O)cc1
NCGC00159458-03,tox21-er-bla-agonist-p2,Atorvastatin calcium,activity,inactive,134523-03-8,60822.0,[Ca+2].O[C@H](CCn1c(c(c(c1C(C)C)C(=O)Nc2ccccc2)c3ccccc3)c4ccc(F)cc4)C[C@@H](O)CC([O-])=O.[O-]C(=O)C[C@H](O)C[C@H](O)CCn4c(c1ccc(F)cc1)c(c2ccccc2)c(C(=O)Nc3ccccc3)c4C(C)C
NCGC00159467-02,tox21-er-bla-agonist-p2,Allococaine hydrochloride,activity,inactive,NOCAS_46063,15558682.0,Cl.CN3[C@H]1CC[C@@H]3[C@H]([C@@H](C1)OC(=O)c2ccccc2)C(=O)OC
NCGC00094719-04,tox21-er-bla-agonist-p2,Methenamine,activity,inactive,100-97-0,4101.0,C1N3CN2CN(CN1C2)C3
NCGC00094948-01,tox21-er-bla-agonist-p2,Metampicillin sodium,activity,inactive,6489-61-8,25195407.0,[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N=C)c1ccccc1)[C@H]3SC2(C)C
NCGC00167969-01,tox21-er-bla-agonist-p2,Rubitecan,activity,inactive,91421-42-0,472335.0,[O-][N+](=O)c4cccc5nc1c(CN2C(=O)C=3COC(=O)[C@](O)(CC)C=3C=C12)cc45
NCGC00095045-01,tox21-er-bla-agonist-p2,Sulfanitran,activity,inactive,122-16-7,5334.0,O=S(=O)(Nc1ccc(cc1)[N+]([O-])=O)c2ccc(NC(C)=O)cc2
NCGC00095053-01,tox21-er-bla-agonist-p2,Mepartricin,activity,inactive,11121-32-7,9941647.0,CNc1ccc(cc1)C(=O)CC(O)CCC(C)C3OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC4(O)CC(O)C(C(=O)OC)C(CC(O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C=CC=CC=CC=CC=CC=CC=CC3C)O4
NCGC00160468-01,tox21-er-bla-agonist-p2,Tripalmitin,activity,inactive,555-44-2,11147.0,O=C(CCCCCCCCCCCCCCC)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC
NCGC00181050-01,tox21-er-bla-agonist-p2,Hydroxyethyl glucose,activity,inactive,9005-27-0,57331769.0,O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OCCO
NCGC00167542-01,tox21-er-bla-agonist-p2,Tiamulin,activity,inactive,55297-95-5,16212198.0,CCN(CC)CCSCC(=O)O[C@@H]3C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]21CCC(=O)[C@H]1[C@@]3(C)C(C)CC2
NCGC00166077-01,tox21-er-bla-agonist-p2,Bitoscanate,activity,active agonist,4044-65-9,19958.0,S=C=N/c1ccc(cc1)\N=C=S
NCGC00181117-01,tox21-er-bla-agonist-p2,Virginiamycin S1,activity,inactive,23152-29-6,15559221.0,Oc1cccnc1C(=O)N[C@@H]5C(=O)N[C@H](CC)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](Cc3ccccc3)C(=O)N6CCC(=O)CC6C(=O)N[C@@H](c4ccccc4)C(=O)OC5C
NCGC00167577-01,tox21-er-bla-agonist-p2,Sivelestat sodium tetrahydrate,activity,inactive,201677-61-4,23663985.0,[Na+].O.O.O.O.O=S(=O)(Nc1ccccc1C(=O)NCC([O-])=O)c2ccc(OC(=O)C(C)(C)C)cc2
NCGC00159379-03,tox21-er-bla-agonist-p2,2-Hydroxyethyl salicylate,activity,inactive,87-28-5,6880.0,Oc1ccccc1C(=O)OCCO
NCGC00091285-01,tox21-er-bla-agonist-p2,Tricaprylin,activity,inactive,538-23-8,10850.0,O=C(CCCCCCC)OC(COC(=O)CCCCCCC)COC(=O)CCCCCCC
NCGC00182549-01,tox21-er-bla-agonist-p2,Vicriviroc maleate,activity,inactive,599179-03-0,60196343.0,O=C(O)/C=C\C(=O)O.FC(F)(F)c1ccc(cc1)[C@@H](COC)N2CCN(C[C@H]2C)C3(C)CCN(CC3)C(=O)c4c(C)ncnc4C
NCGC00183007-01,tox21-er-bla-agonist-p2,Risarestat,activity,inactive,79714-31-1,133264.0,CCCCCOc1ccc(cc1OCC)C2SC(=O)NC2=O
NCGC00183837-01,tox21-er-bla-agonist-p2,Monatepil,activity,inactive,103377-41-9,60810.0,Fc1ccc(cc1)N2CCN(CC2)CCCC(=O)NC3c5ccccc5SCc4ccccc34
NCGC00254159-01,tox21-er-bla-agonist-p2,"1,2-Propylene glycol",activity,inactive,57-55-6,1030.0,CC(O)CO
NCGC00254283-01,tox21-er-bla-agonist-p2,Decane,activity,inactive,124-18-5,15600.0,CCCCCCCCCC
NCGC00254304-01,tox21-er-bla-agonist-p2,CP-100829,activity,inactive,135080-03-4,9885850.0,O=C(C2c1cc(F)c(Cl)cc1N(C(N)=O)C2=O)c3cc(Cl)cs3
NCGC00254338-01,tox21-er-bla-agonist-p2,"2,5-Di-tert-butylbenzene-1,4-diol",activity,inactive,88-58-4,2374.0,CC(C)(C)c1cc(O)c(cc1O)C(C)(C)C
NCGC00254355-01,tox21-er-bla-agonist-p2,Sodium L-ascorbate,activity,inactive,134-03-2,23667548.0,[Na+].OC=1C(=O)O[C@H]([C@@H](O)CO)C=1[O-]
NCGC00255298-01,tox21-er-bla-agonist-p2,2-Bromo-4-hydroxyacetophenone,activity,inactive,2491-38-5,4964.0,O=C(CBr)c1ccc(O)cc1
NCGC00254012-01,tox21-er-bla-agonist-p2,PharmaGSID_47330,activity,inactive,NOCAS_47330,9865233.0,N#Cc1cccc(F)c1c2cc(ccc2F)c3cnc4nc(cnn34)C(C)(C)O
NCGC00254052-01,tox21-er-bla-agonist-p2,Ilepatril,activity,inactive,473289-62-2,9824131.0,CC(C)[C@H](SC(C)=O)C(=O)N[C@H]3Cc1ccccc1[C@H]2CCC[C@@H](C(=O)O)N2C3=O
NCGC00255318-01,tox21-er-bla-agonist-p2,Potassium dichloroisocyanurate,activity,inactive,2244-21-5,23665761.0,[K+].ClN1C([O-])=NC(=O)N(Cl)C1=O
NCGC00182053-02,tox21-er-bla-agonist-p2,Acrivastine,activity,inactive,87848-99-5,5284514.0,O=C(O)/C=C/c1cccc(n1)\C(=C\CN2CCCC2)c3ccc(C)cc3
NCGC00257828-01,tox21-er-bla-agonist-p2,Acetal,activity,inactive,105-57-7,7765.0,CC(OCC)OCC
NCGC00260221-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpiperidinium trifluoromethanesulfonate,activity,inactive,NOCAS_49387,44373822.0,O/C(=N/C(CCCCCCCCCCCCCC)CO)CCCCCCCCCCCCCC
NCGC00015053-05,tox21-er-bla-agonist-p2,Docebenone,activity,inactive,80809-81-0,1967.0,O=C1C(C)=C(C)C(=O)C(C)=C1CCCCC#CCCCC#CCO
NCGC00257928-01,tox21-er-bla-agonist-p2,"1,2,3,4-Tetrahydroisoquinoline",activity,inactive,91-21-4,7046.0,c1ccc2CCNCc2c1
NCGC00159494-02,tox21-er-bla-agonist-p2,Riboflavin,activity,inactive,83-88-5,493570.0,OC[C@@H](O)[C@@H](O)[C@@H](O)CN2C3=NC(=O)NC(=O)C3=Nc1cc(C)c(C)cc12
NCGC00260642-01,tox21-er-bla-agonist-p2,NTP Mix83 ER AR1 18-EQC,activity,inconclusive agonist,NOCAS_49538,,
NCGC00257237-01,tox21-er-bla-agonist-p2,Diazolidinyl urea,activity,inactive,78491-02-8,62277.0,OCN1C(=O)N(CO)C(=O)C1N(CO)C(=O)NCO
NCGC00257568-01,tox21-er-bla-agonist-p2,"Ethanamine, 2-chloro-N,N-diethyl-, hydrochloride",activity,inactive,869-24-9,13363.0,Cl.CCN(CC)CCCl
NCGC00256952-01,tox21-er-bla-agonist-p2,2-Acetylpyridine,activity,inactive,1122-62-9,14286.0,CC(=O)c1ccccn1
NCGC00257829-01,tox21-er-bla-agonist-p2,"3-Acetyl-2,5-dimethylfuran",activity,inactive,10599-70-9,61527.0,Cc1cc(C(=O)C)c(C)o1
NCGC00258370-01,tox21-er-bla-agonist-p2,Thiamphenicol,activity,inactive,15318-45-3,27200.0,O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl
NCGC00258506-01,tox21-er-bla-agonist-p2,"1,5-Dinitronaphthalene",activity,inactive,605-71-0,11803.0,[O-][N+](=O)c2cccc1c2cccc1[N+]([O-])=O
NCGC00257676-01,tox21-er-bla-agonist-p2,Dexamethasone,activity,inactive,50-02-2,5743.0,OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00255453-01,tox21-er-bla-agonist-p2,"4-Amino-2,6-dichlorophenol",activity,inactive,5930-28-9,80037.0,Clc1cc(N)cc(Cl)c1O
NCGC00255491-01,tox21-er-bla-agonist-p2,4-Morpholinepropanamine,activity,inactive,123-00-2,61055.0,NCCCN1CCOCC1
NCGC00255431-01,tox21-er-bla-agonist-p2,"6-Acetyl-1,1,2,4,4,7-hexamethyltetralin",activity,inactive,21145-77-7,89440.0,CC(=O)c1cc2c(cc1C)C(C)(C)C(C)CC2(C)C
NCGC00256847-01,tox21-er-bla-agonist-p2,Labetalol hydrochloride,activity,inactive,32780-64-6,71412.0,Cl.O=C(N)c1cc(ccc1O)C(O)CNC(C)CCc2ccccc2
NCGC00256687-01,tox21-er-bla-agonist-p2,"3,4-Hexanedione",activity,inactive,4437-51-8,62539.0,CCC(=O)C(=O)CC
NCGC00256990-01,tox21-er-bla-agonist-p2,N-(2-Methylphenyl)-3-oxobutanamide,activity,inactive,93-68-5,7154.0,O=C(Nc1ccccc1C)CC(C)=O
NCGC00257120-01,tox21-er-bla-agonist-p2,Phenyl phosphorus dichloride,activity,inactive,644-97-3,12573.0,ClP(Cl)c1ccccc1
NCGC00257061-01,tox21-er-bla-agonist-p2,D-Camphor,activity,inactive,464-49-3,159055.0,CC2(C)[C@H]1CC(=O)[C@]2(C)CC1
NCGC00257613-01,tox21-er-bla-agonist-p2,Palmatine chloride hydrate,activity,inactive,171869-95-7,16212317.0,[Cl-].O.COc1cc2c3cc4ccc(OC)c(OC)c4c[n+]3CCc2cc1OC
NCGC00257196-01,tox21-er-bla-agonist-p2,"N,N-Dimethyldodecan-1-amine",activity,inactive,112-18-5,8168.0,CN(C)CCCCCCCCCCCC
NCGC00257427-01,tox21-er-bla-agonist-p2,FR167356,activity,inactive,174185-16-1,10068207.0,Clc1cccc(Cl)c1C(=O)Nc3cccc2c3oc(C)c2C(C)(C)O
NCGC00257455-01,tox21-er-bla-agonist-p2,Glycyrrhizin,activity,inactive,1405-86-3,14982.0,O=C(O)[C@H]7O[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@H](O[C@@H]6O[C@H]2CC[C@]3(C)[C@H]4C(=O)C=C1[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]1(C)[C@]4(C)CC[C@H]3C2(C)C)C(=O)O)C(=O)O)[C@H](O)[C@@H](O)[C@@H]7O
NCGC00257543-01,tox21-er-bla-agonist-p2,Cetylpyridinium chloride,activity,inactive,123-03-5,31239.0,[Cl-].CCCCCCCCCCCCCCCC[n+]1ccccc1
NCGC00257993-01,tox21-er-bla-agonist-p2,Chlorendic anhydride,activity,inactive,115-27-5,8265.0,ClC2=C(Cl)C3(Cl)C1C(C(=O)OC1=O)C2(Cl)C3(Cl)Cl
NCGC00257560-01,tox21-er-bla-agonist-p2,Ethyl methanesulfonate,activity,inactive,62-50-0,6113.0,CS(=O)(=O)OCC
NCGC00258253-01,tox21-er-bla-agonist-p2,l-Cysteine hydrochloride,activity,inactive,52-89-1,60960.0,Cl.O=C(O)[C@@H](N)CS
NCGC00258480-01,tox21-er-bla-agonist-p2,"2,4-D isooctyl ester",activity,inactive,25168-26-7,61286.0,Clc1cc(Cl)ccc1OCC(=O)OCC(CC)CCCC
NCGC00258922-01,tox21-er-bla-agonist-p2,"N,N,4-Trimethylaniline",activity,inactive,99-97-8,7471.0,Cc1ccc(cc1)N(C)C
NCGC00258321-01,tox21-er-bla-agonist-p2,Dithiooxamide,activity,inactive,79-40-3,2777982.0,NC(=S)C(N)=S
NCGC00258801-01,tox21-er-bla-agonist-p2,Dimethyltin dichloride,activity,inactive,753-73-1,12955.0,C[Sn](C)(Cl)Cl
NCGC00259019-01,tox21-er-bla-agonist-p2,(-)-Epigallocatechin gallate,activity,inactive,989-51-5,65064.0,Oc1cc(cc(O)c1O)C(=O)O[C@@H]3Cc2c(cc(O)cc2O)O[C@@H]3c4cc(O)c(O)c(O)c4
NCGC00258811-01,tox21-er-bla-agonist-p2,"N,N-Dimethylformamide",activity,inactive,68-12-2,6228.0,CN(C)C=O
NCGC00259061-01,tox21-er-bla-agonist-p2,Dalapon,activity,inactive,75-99-0,6418.0,CC(Cl)(Cl)C(=O)O
NCGC00258427-01,tox21-er-bla-agonist-p2,Triethylamine,activity,inactive,121-44-8,8471.0,CCN(CC)CC
NCGC00258866-01,tox21-er-bla-agonist-p2,4'-(Chloroacetyl)acetanilide,activity,inactive,140-49-8,8805.0,O=C(C)Nc1ccc(cc1)C(=O)CCl
NCGC00258871-01,tox21-er-bla-agonist-p2,MCPB,activity,inactive,94-81-5,7207.0,Clc1cc(C)c(OCCCC(=O)O)cc1
NCGC00259085-01,tox21-er-bla-agonist-p2,2-Ethylhexyl methacrylate,activity,inactive,688-84-6,12713.0,O=C(OCC(CCCC)CC)C(=C)C
NCGC00259291-01,tox21-er-bla-agonist-p2,Glutaraldehyde,activity,inactive,111-30-8,3485.0,O=CCCCC=O
NCGC00260136-01,tox21-er-bla-agonist-p2,Nabam-sodium,activity,inactive,142-59-6,3032297.0,[Na+].[Na+].[S-]C(=S)NCCNC(=S)[S-]
NCGC00259569-01,tox21-er-bla-agonist-p2,"1,4-Benzoquinone",activity,inactive,106-51-4,4650.0,O=C1C=CC(=O)C=C1
NCGC00260065-01,tox21-er-bla-agonist-p2,Ginkgo biloba extract,activity,inactive,90045-36-6,,
NCGC00260257-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpyrrolidinium hexfluorophosphate,activity,inactive,327022-58-2,60196395.0,C[N+]1(CCC)CCCC1.F[P-](F)(F)(F)(F)F
NCGC00260223-01,tox21-er-bla-agonist-p2,1-Butyl-2-methylpyridinium tetrafluoroborate,activity,inactive,286453-46-1,60196389.0,Cc1cccc[n+]1CCCC.F[B-](F)(F)F
NCGC00260374-01,tox21-er-bla-agonist-p2,4-Fluoroaniline,activity,inactive,371-40-4,9731.0,Fc1ccc(N)cc1
NCGC00015268-05,tox21-er-bla-agonist-p2,Clonidine,activity,inactive,4205-90-7,2803.0,Clc2cccc(Cl)c2\N=C1/NCCN1
NCGC00015755-03,tox21-er-bla-agonist-p2,Nimustine,activity,inactive,42471-28-3,39214.0,Nc1nc(C)ncc1CNC(=O)N(CCCl)N=O
NCGC00016308-01,tox21-er-bla-agonist-p2,Isopropamide,activity,inactive,7492-32-2,3775.0,CC(C)[N+](C)(CCC(c1ccccc1)(C(N)=O)c2ccccc2)C(C)C
NCGC00016345-01,tox21-er-bla-agonist-p2,4-Methylumbelliferone,activity,inactive,90-33-5,5280567.0,Oc1ccc2c(c1)OC(=O)C=C2C
NCGC00016296-01,tox21-er-bla-agonist-p2,Dicumarol,activity,inactive,66-76-2,54676038.0,OC=3c4ccccc4OC(=O)C=3CC1=C(O)c2ccccc2OC1=O
NCGC00092300-01,tox21-er-bla-agonist-p2,Cinalukast,activity,inactive,128312-51-6,6436135.0,O=C(O)C(CC)(CC)CC(=O)Nc3cc(/C=C/c1nc(cs1)C2CCC2)ccc3
NCGC00095056-03,tox21-er-bla-agonist-p2,Retinol palmitate,activity,inactive,79-81-2,5280531.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=C\C(\C)=C\COC(=O)CCCCCCCCCCCCCCC
NCGC00183878-01,tox21-er-bla-agonist-p2,Zaltoprofen,activity,inactive,74711-43-6,5720.0,O=C(O)C(C)c1cc2CC(=O)c3ccccc3Sc2cc1
NCGC00255626-01,tox21-er-bla-agonist-p2,"3,5-Dichlorosalicyl-3,4-dichloroanilide",activity,active agonist,1154-59-2,14385.0,Clc2ccc(NC(=O)c1cc(Cl)cc(Cl)c1O)cc2Cl
NCGC00255216-01,tox21-er-bla-agonist-p2,Trinexapac-ethyl,activity,inactive,95266-40-3,92421.0,O=C(OCC)C1CC(=O)/C(C(=O)C1)=C(/O)C2CC2
NCGC00254418-01,tox21-er-bla-agonist-p2,Simvastatin,activity,inactive,79902-63-9,54454.0,CC(C)(CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23
NCGC00254893-01,tox21-er-bla-agonist-p2,4-Chlorophenyl isocyanate,activity,inactive,104-12-1,7693.0,Clc1ccc(/N=C=O)cc1
NCGC00015675-08,tox21-er-bla-agonist-p2,Milrinone,activity,inactive,78415-72-2,4197.0,N#CC1=CC(=C(C)NC1=O)c2ccncc2
NCGC00015725-02,tox21-er-bla-agonist-p2,Nimesulide,activity,inactive,51803-78-2,4495.0,[O-][N+](=O)c2cc(Oc1ccccc1)c(cc2)NS(C)(=O)=O
NCGC00016987-01,tox21-er-bla-agonist-p2,Ajmaline,activity,inactive,4360-12-7,441080.0,CN5c1ccccc1[C@@]26C[C@H]4C([C@H]2O)[C@H]3C[C@H](N4[C@H](O)[C@H]3CC)[C@H]56
NCGC00163355-01,tox21-er-bla-agonist-p2,Indigo,activity,inactive,482-89-3,5318432.0,O=C3c4ccccc4N/C3=C2/Nc1ccccc1C2=O
NCGC00183044-01,tox21-er-bla-agonist-p2,Minocycline,activity,inactive,10118-90-8,54675783.0,CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O
NCGC00259910-01,tox21-er-bla-agonist-p2,Chlorotrianisene,activity,inactive,569-57-3,11289.0,COc1ccc(cc1)C(\Cl)=C(/c2ccc(OC)cc2)c3ccc(OC)cc3
NCGC00260209-01,tox21-er-bla-agonist-p2,1-Methyl-3-tetradecylimidazolium hexafluorophosphate,activity,inactive,219947-94-1,60196381.0,F[P-](F)(F)(F)(F)F.C[n+]1ccn(CCCCCCCCCCCCCC)c1
NCGC00260648-01,tox21-er-bla-agonist-p2,NTP Mix89 ER AR1 18-EQP,activity,active agonist,NOCAS_49544,,
NCGC00016685-05,tox21-er-bla-agonist-p2,Ronidazole,activity,inactive,7681-76-7,5094.0,Cn1c(cnc1COC(N)=O)[N+]([O-])=O
NCGC00025002-02,tox21-er-bla-agonist-p2,AF-DX 116,activity,inactive,102394-31-0,107867.0,O=C(CN1CCCCC1CN(CC)CC)N4c2ccccc2C(=O)Nc3cccnc34
NCGC00095190-01,tox21-er-bla-agonist-p2,Irinotecan hydrochloride,activity,inactive,100286-90-6,74990.0,Cl.CC[C@]3(O)C=4C=C5c6nc7ccc(OC(=O)N1CCC(CC1)N2CCCCC2)cc7c(CC)c6CN5C(=O)C=4COC3=O
NCGC00164592-01,tox21-er-bla-agonist-p2,Argatroban,activity,inactive,74863-84-6,152951.0,C[C@H]1C[C@H](C(=O)O)N(CC1)C(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)c3cccc2C[C@@H](C)CNc23
NCGC00167500-01,tox21-er-bla-agonist-p2,Etretinate,activity,inactive,54350-48-0,5282375.0,Cc1c(C)c(/C=CC(\C)=C\C=C\C(\C)=C\C(=O)OCC)c(C)cc1OC
NCGC00182030-01,tox21-er-bla-agonist-p2,Sulbenicillin disodium,activity,inactive,28002-18-8,45357485.0,[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)[C@@H](c1ccccc1)S([O-])(=O)=O)[C@H]3SC2(C)C
NCGC00016947-01,tox21-er-bla-agonist-p2,Bambuterol hydrochloride,activity,inactive,81732-46-9,54765.0,Cl.O=C(Oc1cc(cc(c1)OC(=O)N(C)C)C(O)CNC(C)(C)C)N(C)C
NCGC00021301-04,tox21-er-bla-agonist-p2,Fluocinolone acetonide,activity,inactive,67-73-2,6215.0,OCC(=O)[C@]45OC(C)(C)O[C@@H]5C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00024094-04,tox21-er-bla-agonist-p2,Ipriflavone,activity,inactive,35212-22-7,3747.0,CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3
NCGC00256774-01,tox21-er-bla-agonist-p2,"2-Methyl-4-propyl-1,3-oxathiane",activity,inactive,67715-80-4,101010.0,CC1OCCC(CCC)S1
NCGC00256852-01,tox21-er-bla-agonist-p2,Sodium pantothenate,activity,inactive,867-81-2,23679004.0,[Na+].CC(C)(CO)[C@@H](O)C(=O)NCCC([O-])=O
NCGC00256974-01,tox21-er-bla-agonist-p2,Glycidyl methacrylate,activity,inactive,106-91-2,7837.0,CC(=C)C(=O)OCC1CO1
NCGC00258453-01,tox21-er-bla-agonist-p2,Dibromonitromethane,activity,inactive,598-91-4,69026.0,BrC(Br)[N+]([O-])=O
NCGC00258491-01,tox21-er-bla-agonist-p2,"2,4,5-Trichloronitrobenzene",activity,inactive,89-69-0,6983.0,Clc1cc([N+]([O-])=O)c(Cl)cc1Cl
NCGC00258599-01,tox21-er-bla-agonist-p2,Tetrachlorocyclopropene,activity,inactive,6262-42-6,80428.0,ClC1=C(Cl)C1(Cl)Cl
NCGC00257118-01,tox21-er-bla-agonist-p2,4-Nitro-N-phenylaniline,activity,inactive,836-30-6,13271.0,[O-][N+](=O)c2ccc(Nc1ccccc1)cc2
NCGC00257338-01,tox21-er-bla-agonist-p2,Enterolactone,activity,inactive,78473-71-9,10685477.0,Oc1cccc(c1)C[C@H]3C(=O)OC[C@@H]3Cc2cc(O)ccc2
NCGC00257854-01,tox21-er-bla-agonist-p2,"4,4'-Diaminodicyclohexylmethane",activity,inactive,1761-71-3,15660.0,NC2CCC(CC1CCC(N)CC1)CC2
NCGC00258354-01,tox21-er-bla-agonist-p2,Albuterol,activity,inactive,18559-94-9,2083.0,OCc1cc(ccc1O)C(O)CNC(C)(C)C
NCGC00256511-01,tox21-er-bla-agonist-p2,Tetradifon,activity,inactive,116-29-0,8305.0,Clc1cc(c(Cl)cc1Cl)S(=O)(=O)c2ccc(Cl)cc2
NCGC00255888-01,tox21-er-bla-agonist-p2,Phenylphosphonic acid,activity,inactive,1571-33-1,15295.0,OP(O)(=O)c1ccccc1
NCGC00255910-01,tox21-er-bla-agonist-p2,Methyl (E)-cinnamate,activity,inactive,1754-62-7,637520.0,O=C(/C=C/c1ccccc1)OC
NCGC00255922-01,tox21-er-bla-agonist-p2,4-Morpholinepropanesulfonic acid,activity,inactive,1132-61-2,70807.0,O=S(=O)(O)CCCN1CCOCC1
NCGC00256025-01,tox21-er-bla-agonist-p2,"1H-Benzo[de]isoquinoline-1,3(2H)-dione",activity,inactive,81-83-4,66491.0,O=C3NC(=O)c2cccc1cccc3c12
NCGC00256054-01,tox21-er-bla-agonist-p2,3-Methoxybutan-1-ol,activity,inactive,2517-43-3,17291.0,CC(CCO)OC
NCGC00256057-01,tox21-er-bla-agonist-p2,"2,2'-(Tetradecylimino)diethanol",activity,inactive,18924-66-8,12942137.0,OCCN(CCCCCCCCCCCCCC)CCO
NCGC00256090-01,tox21-er-bla-agonist-p2,Magnesium dibenzoate,activity,inactive,553-70-8,62371.0,[Mg+2].[O-]C(=O)c1ccccc1.[O-]C(=O)c1ccccc1
NCGC00255674-01,tox21-er-bla-agonist-p2,4-Chloro-2-cyclopentylphenol,activity,inactive,13347-42-7,61594.0,Clc1ccc(O)c(c1)C2CCCC2
NCGC00258787-01,tox21-er-bla-agonist-p2,Dimethyl glutarate,activity,inactive,1119-40-0,14242.0,O=C(CCCC(=O)OC)OC
NCGC00258826-01,tox21-er-bla-agonist-p2,"2,6-Dimethylphenol",activity,inactive,576-26-1,11335.0,Cc1cccc(C)c1O
NCGC00259063-01,tox21-er-bla-agonist-p2,Cyanoguanidine,activity,inactive,461-58-5,10005.0,N=C(N)NC#N
NCGC00259207-01,tox21-er-bla-agonist-p2,Linalool,activity,inactive,78-70-6,6549.0,CC(O)(C=C)CC\C=C(\C)C
NCGC00259375-01,tox21-er-bla-agonist-p2,Benzyl acetate,activity,inactive,140-11-4,8785.0,CC(=O)OCc1ccccc1
NCGC00259705-01,tox21-er-bla-agonist-p2,"6,10-Dimethyl-5,9-undecadiene-2-one",activity,inactive,689-67-8,19633.0,C/C(C)=C\CCC(C)=CCCC(C)=O
NCGC00259720-01,tox21-er-bla-agonist-p2,Linoleic acid,activity,inactive,60-33-3,5280450.0,O=C(O)CCCCCCC/C=C\C/C=C\CCCCC
NCGC00259858-01,tox21-er-bla-agonist-p2,tert-Butylhydroquinone,activity,inactive,1948-33-0,16043.0,CC(C)(C)c1cc(O)ccc1O
NCGC00254703-01,tox21-er-bla-agonist-p2,2-Hexyl-1-decanol,activity,inactive,2425-77-6,95337.0,CCCCCCC(CCCCCCCC)CO
NCGC00254716-01,tox21-er-bla-agonist-p2,Ethyl linalool,activity,inactive,10339-55-6,6433547.0,CC(O)(CC\C=C(/C)CC)C=C
NCGC00254759-01,tox21-er-bla-agonist-p2,Hymexazol,activity,inactive,10004-44-1,24781.0,CC1=CC(=O)NO1
NCGC00254850-01,tox21-er-bla-agonist-p2,"Benzenemethanol, alpha-methyl-, acetate",activity,inactive,93-92-5,62341.0,CC(=O)OC(C)c1ccccc1
NCGC00254916-01,tox21-er-bla-agonist-p2,"2,5-Dimethylbenzenesulfonic acid",activity,inactive,609-54-1,11868.0,Cc1ccc(C)cc1S(O)(=O)=O
NCGC00255350-01,tox21-er-bla-agonist-p2,Troclosene,activity,inactive,2782-57-2,16726.0,ClN1C(=O)NC(=O)N(Cl)C1=O
NCGC00255357-01,tox21-er-bla-agonist-p2,N-Benzyladenine,activity,inactive,1214-39-7,62389.0,N2=CN=C3N=CNC(NCc1ccccc1)=C23
NCGC00255538-01,tox21-er-bla-agonist-p2,"N'-(2,4-Dimethylphenyl)-N-methylformamidine",activity,inactive,33089-74-6,36326.0,Cc1ccc(\N=C\NC)c(C)c1
NCGC00255705-01,tox21-er-bla-agonist-p2,Arbutin,activity,inactive,497-76-7,440936.0,Oc1ccc(cc1)O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
NCGC00255803-01,tox21-er-bla-agonist-p2,Rhodamine B,activity,inactive,81-88-9,6694.0,[Cl-].O=C(O)c4ccccc4c1c3ccc(cc3[o+]c2cc(ccc12)N(CC)CC)N(CC)CC
NCGC00256048-01,tox21-er-bla-agonist-p2,2-Hydroxy-3-phenoxypropyl prop-2-enoate,activity,inactive,16969-10-1,4443516.0,C=CC(=O)OCC(O)COc1ccccc1
NCGC00091086-02,tox21-er-bla-agonist-p2,3-Bromo-1-propanol,activity,inactive,627-18-9,12308.0,BrCCCO
NCGC00091099-02,tox21-er-bla-agonist-p2,Dibromomannitol,activity,inactive,488-41-5,656655.0,O[C@H]([C@H](O)CBr)[C@H](O)[C@H](O)CBr
NCGC00091922-02,tox21-er-bla-agonist-p2,Sodium dichromate(VI) dihydrate,activity,inactive,7789-12-0,108005.0,[Na+].[Na+].O.O.[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O
NCGC00094136-01,tox21-er-bla-agonist-p2,Dizocilpine maleate,activity,inactive,77086-22-7,6420042.0,O=C(O)/C=C\C(=O)O.C[C@@]42N[C@H](Cc1ccccc12)c3ccccc34
NCGC00167454-01,tox21-er-bla-agonist-p2,Pilsicainide,activity,inactive,88069-67-4,4820.0,Cc3cccc(C)c3NC(=O)CC12CCCN2CCC1
NCGC00094607-01,tox21-er-bla-agonist-p2,Carbenicillin disodium,activity,inactive,4800-94-6,20933.0,[Na+].[Na+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)C(c1ccccc1)C([O-])=O)[C@H]3SC2(C)C
NCGC00159498-02,tox21-er-bla-agonist-p2,Metipranolol,activity,active agonist,22664-55-7,31477.0,O=C(C)Oc1c(C)c(C)c(cc1C)OCC(O)CNC(C)C
NCGC00159533-01,tox21-er-bla-agonist-p2,Eltoprazine hydrochloride,activity,inactive,98206-09-8,3025067.0,Cl.c1cc(c2OCCOc2c1)N3CCNCC3
NCGC00164327-02,tox21-er-bla-agonist-p2,Sodium ethasulfate,activity,inactive,126-92-1,23662383.0,[Na+].O=S([O-])(=O)OCC(CCCC)CC
NCGC00181149-01,tox21-er-bla-agonist-p2,3-Anilinopropan-1-ol,activity,inactive,31121-11-6,410467.0,OCCCNc1ccccc1
NCGC00160489-01,tox21-er-bla-agonist-p2,Opiniazide,activity,inactive,2779-55-7,71116.0,O=C(N\N=C/c1ccc(OC)c(OC)c1C(=O)O)c2ccncc2
NCGC00165912-02,tox21-er-bla-agonist-p2,Tofisopam,activity,inactive,22345-47-7,5502.0,COc1ccc(cc1OC)C3=NN=C(C)C(CC)c2cc(OC)c(cc23)OC
NCGC00160571-01,tox21-er-bla-agonist-p2,1-(2-Ethylcrotonoyl)urea,activity,inactive,5982-97-8,7214.0,CCC(=CC)C(=O)NC(N)=O
NCGC00165996-01,tox21-er-bla-agonist-p2,Praxadine hydrochloride,activity,inactive,4023-02-3,2734672.0,Cl.N=C(N)n1cccn1
NCGC00095993-01,tox21-er-bla-agonist-p2,Coenzyme B12,activity,inactive,13870-90-1,20055083.0,CC(CNC(=O)CCC1(C)C(CC(N)=O)C2N([Co+]C[C@H]3O[C@H]([C@H](O)[C@@H]3O)N3C=NC4=C3N=CN=C4N)\C1=C(C)/C1=N/C(=C\C3=N\C(=C(C)/C4=NC2(C)C(C)(CC(N)=O)C4CCC(N)=O)\C(C)(CC(N)=O)C3CCC(N)=O)/C(C)(C)C1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2
NCGC00160601-01,tox21-er-bla-agonist-p2,Anilamate,activity,inactive,5591-49-1,21798.0,O=C(Oc2ccccc2C(=O)Nc1ccccc1)NC
NCGC00168746-01,tox21-er-bla-agonist-p2,Methyldigoxin,activity,inactive,30685-43-9,443946.0,O=C1C=C(CO1)[C@H]2CC[C@@]8(O)[C@]2(C)[C@H](O)C[C@H]4[C@H]8CC[C@@H]3C[C@H](CC[C@@]34C)O[C@@H]7O[C@H](C)[C@@H](O[C@H]6C[C@H](O)[C@H](O[C@H]5C[C@H](O)[C@H](OC)[C@@H](C)O5)[C@@H](C)O6)[C@@H](O)C7
NCGC00168771-01,tox21-er-bla-agonist-p2,Fosamprenavir calcium,activity,inactive,226700-81-8,131535.0,[Ca+2].O=C(N[C@@H](Cc1ccccc1)[C@@H](CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)OP([O-])([O-])=O)O[C@H]3CCOC3
NCGC00181130-01,tox21-er-bla-agonist-p2,Eletriptan,activity,inactive,143322-58-1,77993.0,CN4CCC[C@@H]4Cc2cnc3ccc(CCS(=O)(=O)c1ccccc1)cc23
NCGC00181912-01,tox21-er-bla-agonist-p2,Iomazenil,activity,inactive,127985-21-1,10251042.0,O=C(OCC)c3ncn2c3CN(C)C(=O)c1c(I)cccc12
NCGC00183839-01,tox21-er-bla-agonist-p2,Rapacuronium bromide,activity,inactive,156137-99-4,5311398.0,[Br-].C=CC[N+]1(CCCCC1)[C@H]6C[C@@H]5[C@](C)(CC[C@H]2[C@H]5CC[C@H]3C[C@H](OC(C)=O)[C@H](C[C@]23C)N4CCCCC4)[C@H]6OC(=O)CC
NCGC00183868-01,tox21-er-bla-agonist-p2,Fentiazac,activity,inactive,18046-21-4,28871.0,O=C(O)Cc1sc(nc1c2ccc(Cl)cc2)c3ccccc3
NCGC00185768-01,tox21-er-bla-agonist-p2,rac Benidipine hydrochloride,activity,inactive,91599-74-5,656667.0,Cl.[O-][N+](=O)c1cccc(c1)[C@@H]2C(C(=O)OC)=C(C)NC(C)=C2C(=O)O[C@@H]4CCCN(Cc3ccccc3)C4
NCGC00185776-01,tox21-er-bla-agonist-p2,Sodium aurothiomalate hydrate,activity,inactive,39377-38-3,53315431.0,[Na+].[Na+].O.[O-]C(=O)CC(S[Au])C(=O)[O-]
NCGC00188437-01,tox21-er-bla-agonist-p2,Sultamicillin tosylate,activity,inactive,83105-70-8,444021.0,O=S(=O)(O)c1ccc(C)cc1.O=C1C[C@@H]5N1[C@@H](C(=O)OCOC(=O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@H](N)c2ccccc2)[C@H]4SC3(C)C)C(C)(C)S5(=O)=O
NCGC00254723-01,tox21-er-bla-agonist-p2,Dysprosium(III) chloride,activity,inactive,10025-74-8,66207.0,Cl[Dy](Cl)Cl
NCGC00255211-01,tox21-er-bla-agonist-p2,Irganox 1010,activity,active agonist,6683-19-8,64819.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CCC(=O)OCC(COC(=O)CCc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)(COC(=O)CCc3cc(c(O)c(c3)C(C)(C)C)C(C)(C)C)COC(=O)CCc4cc(c(O)c(c4)C(C)(C)C)C(C)(C)C
NCGC00254440-01,tox21-er-bla-agonist-p2,Troglitazone,activity,inactive,97322-87-7,5591.0,Cc1c(O)c(C)c(C)c2OC(C)(CCc12)COc4ccc(CC3SC(=O)NC3=O)cc4
NCGC00255329-01,tox21-er-bla-agonist-p2,Isopentyl alcohol,activity,inactive,123-51-3,31260.0,CC(C)CCO
NCGC00182709-02,tox21-er-bla-agonist-p2,Landiolol hydrochloride,activity,inactive,144481-98-1,164457.0,Cl.CC3(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N1CCOCC1)cc2)O3
NCGC00016372-01,tox21-er-bla-agonist-p2,4-Hydroxy-3-nitrophenylarsonic acid,activity,inactive,121-19-7,5104.0,O=[N+]([O-])c1cc(ccc1O)[As](O)(O)=O
NCGC00258589-01,tox21-er-bla-agonist-p2,2-Bromo-1-ethanol,activity,inactive,540-51-2,10898.0,BrCCO
NCGC00258818-01,tox21-er-bla-agonist-p2,Diacetone alcohol,activity,inactive,123-42-2,31256.0,CC(=O)CC(C)(C)O
NCGC00258985-01,tox21-er-bla-agonist-p2,Nitrosoheptamethyleneimine,activity,inactive,20917-49-1,30360.0,O=NN1CCCCCCC1
NCGC00259025-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarbonitrile",activity,inactive,626-17-5,12276.0,N#Cc1cccc(C#N)c1
NCGC00016714-01,tox21-er-bla-agonist-p2,Thiamphenicol,activity,inactive,15318-45-3,27200.0,O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl
NCGC00258220-01,tox21-er-bla-agonist-p2,Nicotinic acid hydrazide,activity,inactive,553-53-7,11112.0,O=C(NN)c1cccnc1
NCGC00259242-01,tox21-er-bla-agonist-p2,2-Methylpyridine,activity,inactive,109-06-8,7975.0,Cc1ccccn1
NCGC00259657-01,tox21-er-bla-agonist-p2,Biphenyl,activity,inactive,92-52-4,7095.0,c1cc(ccc1)c2ccccc2
NCGC00259836-01,tox21-er-bla-agonist-p2,tert-Butyl perbenzoate,activity,inactive,614-45-9,11966.0,CC(C)(C)OOC(=O)c1ccccc1
NCGC00257146-01,tox21-er-bla-agonist-p2,Primidone,activity,inactive,125-33-7,4909.0,CCC1(C(=O)NCNC1=O)c2ccccc2
NCGC00257260-01,tox21-er-bla-agonist-p2,4-Butylaniline,activity,inactive,104-13-2,7694.0,Nc1ccc(CCCC)cc1
NCGC00257246-01,tox21-er-bla-agonist-p2,Zearalenone,activity,active agonist,17924-92-4,5281576.0,Oc1cc(O)cc2C=CCCCC(=O)CCC[C@H](C)OC(=O)c12
NCGC00258401-01,tox21-er-bla-agonist-p2,Ketoprofen,activity,inactive,22071-15-4,3825.0,CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2
NCGC00259011-01,tox21-er-bla-agonist-p2,2-Anisidine,activity,inactive,90-04-0,7000.0,Nc1ccccc1OC
NCGC00254278-01,tox21-er-bla-agonist-p2,Diisobutyl adipate,activity,inactive,141-04-8,8831.0,CC(C)COC(=O)CCCCC(=O)OCC(C)C
NCGC00255398-01,tox21-er-bla-agonist-p2,4-(2-Hydroxyethyl)morpholine,activity,inactive,622-40-2,61163.0,OCCN1CCOCC1
NCGC00256170-01,tox21-er-bla-agonist-p2,"4-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonic acid",activity,inactive,89-36-1,66638.0,O=S(=O)(O)c1ccc(cc1)N2N=C(C)CC2=O
NCGC00256571-01,tox21-er-bla-agonist-p2,Azaserine,activity,inactive,115-02-6,5284344.0,OC(=O)[C@@H](N)COC(=O)/C=[N+]=[N-]
NCGC00256664-01,tox21-er-bla-agonist-p2,Bromopentafluorobenzene,activity,inactive,344-04-7,9578.0,Fc1c(F)c(F)c(F)c(Br)c1F
NCGC00256491-01,tox21-er-bla-agonist-p2,Heptanal,activity,inactive,111-71-7,8130.0,CCCCCCC=O
NCGC00257092-01,tox21-er-bla-agonist-p2,Butanedioic acid,activity,inactive,110-15-6,1110.0,O=C(O)CCC(=O)O
NCGC00257108-01,tox21-er-bla-agonist-p2,2-Amino-5-methylbenzenesulfonic acid,activity,inactive,88-44-8,6934.0,Nc1ccc(C)cc1S(O)(=O)=O
NCGC00257161-01,tox21-er-bla-agonist-p2,2-Ethylhexyl glycidyl ether,activity,inactive,2461-15-6,17162.0,CCC(CCCC)COCC1CO1
NCGC00257179-01,tox21-er-bla-agonist-p2,1-Dodecanethiol,activity,inactive,112-55-0,8195.0,CCCCCCCCCCCCS
NCGC00257197-01,tox21-er-bla-agonist-p2,Thifensulfuron-methyl,activity,inactive,79277-27-3,73674.0,O=S(=O)(NC(=O)Nc1nc(C)nc(OC)n1)c2ccsc2C(=O)OC
NCGC00257227-01,tox21-er-bla-agonist-p2,Butyl glycidyl ether,activity,inactive,2426-08-6,17049.0,CCCCOCC1CO1
NCGC00257967-01,tox21-er-bla-agonist-p2,2-(2-Ethoxyethoxy)ethanol,activity,inactive,111-90-0,8146.0,OCCOCCOCC
NCGC00257470-01,tox21-er-bla-agonist-p2,4-Hexen-3-one,activity,inactive,2497-21-4,17244.0,CCC(=O)C=CC
NCGC00257982-01,tox21-er-bla-agonist-p2,2-Amino-4-chloro-5-methylbenzenesulfonic acid,activity,inactive,88-51-7,6935.0,Cc1cc(c(N)cc1Cl)S(=O)(=O)O
NCGC00257554-01,tox21-er-bla-agonist-p2,"2-Amino-5-(5-nitro-2-furyl)-1,3,4-oxadiazole",activity,inactive,3775-55-1,77406.0,Nc1nnc(o1)c2oc(cc2)[N+]([O-])=O
NCGC00257995-01,tox21-er-bla-agonist-p2,"2-(Hydroxymethyl)-2-nitro-1,3-propanediol",activity,inactive,126-11-4,31337.0,O=[N+]([O-])C(CO)(CO)CO
NCGC00258136-01,tox21-er-bla-agonist-p2,Tributylmethylammonium bis(trifluoromethylsulfonyl)imde,activity,inactive,405514-94-5,44630019.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.CCCC[N+](C)(CCCC)CCCC
NCGC00258709-01,tox21-er-bla-agonist-p2,"1,3-Dimethylbutylamine",activity,inactive,108-09-8,7908.0,CC(C)CC(C)N
NCGC00258389-01,tox21-er-bla-agonist-p2,3-Methyl-4-nitrobenzoic acid,activity,inactive,3113-71-1,18370.0,Cc1cc(ccc1[N+](=O)[O-])C(=O)O
NCGC00258799-01,tox21-er-bla-agonist-p2,1-Heptanol,activity,inactive,111-70-6,8129.0,CCCCCCCO
NCGC00258618-01,tox21-er-bla-agonist-p2,"2,2'-(tert-Butylimino)diethanol",activity,inactive,2160-93-2,62430.0,CC(C)(C)N(CCO)CCO
NCGC00259842-01,tox21-er-bla-agonist-p2,Ammonium perchlorate,activity,inactive,7790-98-9,24639.0,[NH4+].[O-]Cl(=O)(=O)=O
NCGC00259849-01,tox21-er-bla-agonist-p2,4-Nitro-N-phenylaniline,activity,inactive,836-30-6,13271.0,[O-][N+](=O)c2ccc(Nc1ccccc1)cc2
NCGC00260104-01,tox21-er-bla-agonist-p2,"1-Hexadecanaminium, N,N,N-trimethyl-, chloride",activity,inactive,112-02-7,8154.0,[Cl-].C[N+](C)(C)CCCCCCCCCCCCCCCC
NCGC00260358-01,tox21-er-bla-agonist-p2,6-Chlorohexan-1-ol,activity,inactive,2009-83-8,74828.0,ClCCCCCCO
NCGC00260417-01,tox21-er-bla-agonist-p2,Beryllium sulfate tetrahydrate,activity,inactive,7787-56-6,62672.0,O.O.O.O.[Be+2].[O-]S([O-])(=O)=O
NCGC00260463-01,tox21-er-bla-agonist-p2,Ethylene sulfide,activity,inactive,420-12-2,9865.0,C1CS1
NCGC00015242-04,tox21-er-bla-agonist-p2,Chlorothiazide,activity,inactive,58-94-6,2720.0,NS(=O)(=O)c2cc1c(N=CNS1(=O)=O)cc2Cl
NCGC00015412-06,tox21-er-bla-agonist-p2,Ebselen,activity,inactive,60940-34-3,3194.0,O=C1c3ccccc3[Se]N1c2ccccc2
NCGC00015444-04,tox21-er-bla-agonist-p2,Fenoldopam,activity,active agonist,67227-56-9,3341.0,Oc1ccc(cc1)C3CNCCc2c3cc(O)c(O)c2Cl
NCGC00016783-01,tox21-er-bla-agonist-p2,Alfadolone acetate,activity,inactive,23930-37-2,24733.0,CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C
NCGC00016823-01,tox21-er-bla-agonist-p2,Pivampicillin,activity,inactive,33817-20-8,33478.0,CC(C)(C)C(=O)OCOC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C
NCGC00016865-01,tox21-er-bla-agonist-p2,Carteolol hydrochloride,activity,inactive,51781-21-6,40127.0,Cl.CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12
NCGC00024780-01,tox21-er-bla-agonist-p2,Tilarginine acetate,activity,inactive,53308-83-1,135242.0,N[C@@H](CCCNC(=N)NC)C(=O)O.CC(=O)O
NCGC00181154-01,tox21-er-bla-agonist-p2,Nitarsone,activity,inactive,98-72-6,66826.0,O=[N+]([O-])c1ccc(cc1)[As](O)(O)=O
NCGC00255813-01,tox21-er-bla-agonist-p2,(RS)-(+/-)-sulpiride,activity,inactive,15676-16-1,5355.0,CCN2CCCC2CNC(=O)c1cc(ccc1OC)S(N)(=O)=O
NCGC00255912-01,tox21-er-bla-agonist-p2,Aminoguanidine hydrochloride,activity,inactive,1937-19-5,2734687.0,Cl.N=C(N)NN
NCGC00254605-01,tox21-er-bla-agonist-p2,Thiacloprid,activity,inactive,111988-49-9,115224.0,Clc2ncc(CN1CCS/C1=N\C#N)cc2
NCGC00256277-01,tox21-er-bla-agonist-p2,"Bis{2-[2-(propan-2-yl)-1,3-oxazolidin-3-yl]ethyl} hexane-1,6-diylbiscarbamate",activity,inactive,59719-67-4,108381.0,CC(C)C2OCCN2CCOC(=O)NCCCCCCNC(=O)OCCN1CCOC1C(C)C
NCGC00256392-01,tox21-er-bla-agonist-p2,Piperine,activity,inactive,94-62-2,638024.0,O=C(/C=C/C=C/c1ccc2OCOc2c1)N3CCCCC3
NCGC00254719-01,tox21-er-bla-agonist-p2,(E)-2-Nonenal,activity,inactive,18829-56-6,5283335.0,CCCCCC\C=C\C=O
NCGC00254402-01,tox21-er-bla-agonist-p2,Enadoline,activity,inactive,124378-77-4,60768.0,O=C(Cc2cccc1occc12)N(C)[C@H]3CC[C@]5(C[C@@H]3N4CCCC4)CCCO5
NCGC00254423-01,tox21-er-bla-agonist-p2,Allura Red C.I.16035,activity,inactive,25956-17-6,5360805.0,[Na+].[Na+].Cc3cc(/N=N/c1c2ccc(cc2ccc1O)S([O-])(=O)=O)c(cc3S(=O)([O-])=O)OC
NCGC00254457-01,tox21-er-bla-agonist-p2,Warfarin,activity,inactive,81-81-2,54678486.0,CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3
NCGC00255253-01,tox21-er-bla-agonist-p2,Brucine,activity,inactive,357-57-3,442021.0,COc1cc2c(cc1OC)N5C(=O)C[C@@H]4OCC=C3CN7CC[C@]26[C@@H]7C[C@@H]3[C@@H]4[C@H]56
NCGC00254168-01,tox21-er-bla-agonist-p2,Di(propylene glycol) dibenzoate,activity,inactive,27138-31-4,101560.0,CC(OC(=O)c1ccccc1)COCC(C)OC(=O)c2ccccc2
NCGC00163919-02,tox21-er-bla-agonist-p2,Nitrothal-isopropyl,activity,inactive,10552-74-6,43704.0,O=[N+]([O-])c1cc(cc(c1)C(=O)OC(C)C)C(=O)OC(C)C
NCGC00167457-01,tox21-er-bla-agonist-p2,Gestrinone,activity,active agonist,16320-04-0,27812.0,O=C3C=C4CC[C@@H]2C(C=C[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4CC3
NCGC00247351-03,tox21-er-bla-agonist-p2,(-)-Pentazocine succinate,activity,inactive,124819-25-6,12259683.0,O=C(O)CCC(=O)O.C/C(C)=C\CN2CC[C@@]1(C)c3cc(O)ccc3C[C@@H]2[C@@H]1C
NCGC00247709-01,tox21-er-bla-agonist-p2,Thebaine,activity,inactive,115-37-7,5324289.0,COC1=CC=C3[C@H]2Cc4ccc(OC)c5O[C@@H]1[C@]3(CCN2C)c45
NCGC00016717-01,tox21-er-bla-agonist-p2,Molindone hydrochloride,activity,inactive,15622-65-8,9883259.0,Cl.O=C1C(CCc2nc(C)c(CC)c12)CN3CCOCC3
NCGC00017047-01,tox21-er-bla-agonist-p2,Alverine citrate,activity,inactive,5560-59-8,21718.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCCc1ccccc1)CCCc2ccccc2
NCGC00017071-01,tox21-er-bla-agonist-p2,Isoetharine mesylate,activity,inactive,7279-75-6,23702.0,Oc1ccc(cc1O)C(O)C(CC)NC(C)C.CS(=O)(=O)O
NCGC00159511-02,tox21-er-bla-agonist-p2,Butenafine,activity,inactive,101828-21-1,2484.0,CN(Cc1ccc(cc1)C(C)(C)C)Cc3cccc2ccccc23
NCGC00160589-01,tox21-er-bla-agonist-p2,Chlorindanol,activity,inactive,145-94-8,8961.0,Oc1ccc(Cl)c2CCCc12
NCGC00164375-01,tox21-er-bla-agonist-p2,1-Phenoxy-2-propanol,activity,inactive,770-35-4,92839.0,CC(O)COc1ccccc1
NCGC00254362-01,tox21-er-bla-agonist-p2,CP-863187,activity,inactive,668981-02-0,9949821.0,CC(C)c2nnc1ccc(cn12)c4ocnc4c3cc(F)ccc3F
NCGC00254493-01,tox21-er-bla-agonist-p2,UK-373911,activity,inactive,291305-06-1,9908126.0,NS(=O)(=O)c1ccc2c(c1)[C@H](CC[C@H]2c3ccc(Cl)c(Cl)c3)NC
NCGC00090764-02,tox21-er-bla-agonist-p2,2-Ethylhexyl 4-(dimethylamino)benzoate,activity,inactive,21245-02-3,30541.0,CN(C)c1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00024999-02,tox21-er-bla-agonist-p2,Procaterol,activity,inactive,72332-33-3,688561.0,CC(C)N[C@@H](CC)[C@H](O)c2ccc(O)c1NC(=O)C=Cc12
NCGC00072886-02,tox21-er-bla-agonist-p2,Metralindole,activity,inactive,54188-38-4,68713.0,COc1cc4c(cc1)n3CCN(C)C2=NCCc4c23
NCGC00016881-01,tox21-er-bla-agonist-p2,Netilmicin sulfate,activity,inactive,56391-57-2,60196266.0,O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.NC3CC=C(CN)OC3O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H]2O.NC3CC=C(CN)OC3O[C@H]2[C@H](O)[C@@H](O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O)[C@H](NCC)C[C@@H]2N
NCGC00256862-01,tox21-er-bla-agonist-p2,2-Phenylethyl 3-phenylprop-2-enoate,activity,inactive,103-53-7,7659.0,O=C(OCCc1ccccc1)C=Cc2ccccc2
NCGC00256877-01,tox21-er-bla-agonist-p2,2-Methoxy-4-methyl-1-(propan-2-yl)benzene,activity,inactive,1076-56-8,14104.0,COc1cc(C)ccc1C(C)C
NCGC00256989-01,tox21-er-bla-agonist-p2,Benzenesulfonic acid,activity,inactive,98-11-3,7371.0,O=S(O)(=O)c1ccccc1
NCGC00258503-01,tox21-er-bla-agonist-p2,Semicarbazide hydrochloride,activity,inactive,563-41-7,11236.0,Cl.NC(=O)NN
NCGC00257079-01,tox21-er-bla-agonist-p2,Amiloride hydrochloride,activity,inactive,2016-88-8,16230.0,Cl.Clc1nc(C(=O)NC(=N)N)c(N)nc1N
NCGC00257105-01,tox21-er-bla-agonist-p2,4-Methylbenzenesulfonyl isocyanate,activity,inactive,4083-64-1,77703.0,Cc1ccc(cc1)S(=O)(=O)/N=C=O
NCGC00257695-01,tox21-er-bla-agonist-p2,Medroxyprogesterone acetate,activity,inactive,71-58-9,6279.0,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C[C@H](C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00257793-01,tox21-er-bla-agonist-p2,Demeton,activity,inactive,8065-48-3,24723.0,CCOP(=O)(OCC)SCCSCC
NCGC00257997-01,tox21-er-bla-agonist-p2,"2,2,4-Trimethyl-1,3-pentanediol",activity,inactive,144-19-4,8946.0,CC(C)(CO)C(O)C(C)C
NCGC00258010-01,tox21-er-bla-agonist-p2,1-Chlorotetradecane,activity,inactive,2425-54-9,17043.0,CCCCCCCCCCCCCCCl
NCGC00258028-01,tox21-er-bla-agonist-p2,5-Methylpyridin-2-amine,activity,inactive,1603-41-4,15348.0,Cc1cnc(N)cc1
NCGC00255750-01,tox21-er-bla-agonist-p2,1-(Chloromethyl)-2-methylbenzene,activity,inactive,552-45-4,11093.0,Cc1ccccc1CCl
NCGC00256405-01,tox21-er-bla-agonist-p2,1-Dodecanamine,activity,inactive,124-22-1,13583.0,CCCCCCCCCCCCN
NCGC00255819-01,tox21-er-bla-agonist-p2,"Tetradecanoic acid, 2,3-dihydroxypropyl ester",activity,inactive,589-68-4,79050.0,OCC(O)COC(=O)CCCCCCCCCCCCC
NCGC00255824-01,tox21-er-bla-agonist-p2,2-(2-Methylbutan-2-yl)cyclohexyl acetate,activity,inactive,67874-72-0,62240.0,O=C(C)OC1CCCCC1C(C)(C)CC
NCGC00255981-01,tox21-er-bla-agonist-p2,6-Pentyltetrahydro-2H-pyran-2-one,activity,inactive,705-86-2,12810.0,O=C1CCCC(CCCCC)O1
NCGC00256044-01,tox21-er-bla-agonist-p2,Alloxydim-sodium,activity,inactive,55635-13-7,23703451.0,[Na+].O=C1CC(C)(C)C(=C([O-])/C1=C(\CCC)NOCC=C)C(=O)OC
NCGC00256123-01,tox21-er-bla-agonist-p2,"2-Aminobenzene-1,4-disulfonic acid",activity,inactive,98-44-2,60988.0,Nc1cc(ccc1S(O)(=O)=O)S(=O)(=O)O
NCGC00256346-01,tox21-er-bla-agonist-p2,4-Bromoaniline,activity,inactive,106-40-1,7807.0,Nc1ccc(Br)cc1
NCGC00258808-01,tox21-er-bla-agonist-p2,2-Methylaniline,activity,inactive,95-53-4,7242.0,Cc1ccccc1N
NCGC00258836-01,tox21-er-bla-agonist-p2,"2-Butyne-1,4-diol",activity,inactive,110-65-6,8066.0,OCC#CCO
NCGC00258964-01,tox21-er-bla-agonist-p2,Propyzamide,activity,inactive,23950-58-5,32154.0,Clc1cc(cc(Cl)c1)C(=O)NC(C)(C)C#C
NCGC00260533-01,tox21-er-bla-agonist-p2,Nitrofurazone,activity,inactive,59-87-0,5447130.0,O=[N+]([O-])c1ccc(/C=N/NC(N)=O)o1
NCGC00260541-01,tox21-er-bla-agonist-p2,Sodium [dodecanoyl(methyl)amino]acetate,activity,inactive,137-16-6,23668817.0,[Na+].O=C(CCCCCCCCCCC)N(C)CC([O-])=O
NCGC00260592-01,tox21-er-bla-agonist-p2,NTP Mix48 CT1 3-EQP,activity,inactive,NOCAS_49488,,
NCGC00260633-01,tox21-er-bla-agonist-p2,NTP Mix109 ER1 10-EQC,activity,active agonist,NOCAS_49529,,
NCGC00259105-01,tox21-er-bla-agonist-p2,Diphenylacetonitrile,activity,inactive,86-29-3,6837.0,N#CC(c1ccccc1)c2ccccc2
NCGC00259400-01,tox21-er-bla-agonist-p2,Anthralin,activity,inactive,1143-38-0,2202.0,Oc2cccc1Cc3cccc(O)c3C(=O)c12
NCGC00259489-01,tox21-er-bla-agonist-p2,Dimethyl carbonate,activity,inactive,616-38-6,12021.0,O=C(OC)OC
NCGC00259656-01,tox21-er-bla-agonist-p2,Benzimidazole,activity,inactive,51-17-2,5798.0,c1cccc2ncnc12
NCGC00259704-01,tox21-er-bla-agonist-p2,Sodium nitrite,activity,inactive,7632-00-0,23668193.0,[Na+].[O-]N=O
NCGC00259851-01,tox21-er-bla-agonist-p2,Diisodecyl hexanedioate,activity,inactive,27178-16-1,33733.0,CC(C)CCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC(C)C
NCGC00259865-01,tox21-er-bla-agonist-p2,Phosmet,activity,inactive,732-11-6,12901.0,COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O
NCGC00260324-01,tox21-er-bla-agonist-p2,Ammonium thiosulfate,activity,inactive,7783-18-8,6096946.0,[NH4+].[NH4+].[O-]S([S-])(=O)=O
NCGC00258649-01,tox21-er-bla-agonist-p2,Phorone,activity,inactive,504-20-1,10438.0,C\C(C)=C/C(=O)/C=C(/C)C
NCGC00254680-01,tox21-er-bla-agonist-p2,Acetamide,activity,inactive,60-35-5,178.0,CC(N)=O
NCGC00254785-01,tox21-er-bla-agonist-p2,"1,4-Dimethylnaphthalene",activity,inactive,571-58-4,11304.0,Cc1ccc(C)c2ccccc12
NCGC00254909-01,tox21-er-bla-agonist-p2,Imazamox,activity,inactive,114311-32-9,86137.0,CC1(N=C(NC1=O)c2ncc(COC)cc2C(=O)O)C(C)C
NCGC00255070-01,tox21-er-bla-agonist-p2,Tetraethyl pyrophosphate,activity,inactive,107-49-3,7873.0,CCOP(=O)(OP(=O)(OCC)OCC)OCC
NCGC00255274-01,tox21-er-bla-agonist-p2,Dipropyl disulfide,activity,inactive,629-19-6,12377.0,CCCSSCCC
NCGC00255373-01,tox21-er-bla-agonist-p2,Denatonium benzoate,activity,inactive,3734-33-6,19518.0,O=C(Nc1c(C)cccc1C)C[N+](Cc2ccccc2)(CC)CC.[O-]C(=O)c1ccccc1
NCGC00254567-01,tox21-er-bla-agonist-p2,"1,7-Dioxaspiro[5.5]undecane",activity,inactive,180-84-7,67437.0,C2COC1(CCCCO1)CC2
NCGC00092278-02,tox21-er-bla-agonist-p2,Midafotel,activity,inactive,117414-74-1,6435801.0,O=C(O)[C@H]1CN(C/C=C/P(=O)(O)O)CCN1
NCGC00094227-01,tox21-er-bla-agonist-p2,Picrotoxin,activity,inactive,124-87-8,442291.0,CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]5O[C@@]45C(=O)O[C@H]2[C@]34C
NCGC00094410-02,tox21-er-bla-agonist-p2,Triflupromazine hydrochloride,activity,inactive,1098-60-8,66069.0,Cl.FC(F)(F)c1cc2N(CCCN(C)C)c3ccccc3Sc2cc1
NCGC00163507-01,tox21-er-bla-agonist-p2,Otilonium bromide,activity,inactive,26095-59-0,72092.0,[Br-].CC[N+](C)(CC)CCOC(=O)c1ccc(cc1)NC(=O)c2ccccc2OCCCCCCCC
NCGC00167443-01,tox21-er-bla-agonist-p2,Afloqualone,activity,active agonist,56287-74-2,2040.0,Cc1ccccc1N3C(=Nc2ccc(N)cc2C3=O)CF
NCGC00159463-03,tox21-er-bla-agonist-p2,Phenacaine,activity,inactive,101-93-9,17756783.0,CCOc1ccc(cc1)NC(=C)Nc2ccc(OCC)cc2
NCGC00159470-02,tox21-er-bla-agonist-p2,D-Valine,activity,inactive,640-68-6,71563.0,CC(C)[C@@H](N)C(=O)O
NCGC00094791-01,tox21-er-bla-agonist-p2,Thimerosal,activity,active agonist,54-64-8,16684434.0,[Na+].[O-]C(=O)c1ccccc1S[Hg]CC
NCGC00159497-02,tox21-er-bla-agonist-p2,Allylestrenol,activity,active agonist,432-60-0,235905.0,C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC=C
NCGC00164494-01,tox21-er-bla-agonist-p2,Nithiamide,activity,inactive,140-40-9,8798.0,O=C(C)Nc1ncc(s1)[N+]([O-])=O
NCGC00160396-01,tox21-er-bla-agonist-p2,Pravadoline,activity,inactive,92623-83-1,56463.0,COc1ccc(cc1)C(=O)c3c4ccccc4n(CCN2CCOCC2)c3C
NCGC00164529-01,tox21-er-bla-agonist-p2,1-Stearoyl-rac-glycerol,activity,inactive,123-94-4,24699.0,OCC(O)COC(=O)CCCCCCCCCCCCCCCCC
NCGC00095116-01,tox21-er-bla-agonist-p2,Metaxalone,activity,inactive,1665-48-1,15459.0,Cc1cc(cc(C)c1)OCC2CNC(=O)O2
NCGC00160447-01,tox21-er-bla-agonist-p2,Demoxepam,activity,inactive,963-39-3,13756.0,Clc1ccc2NC(=O)C[N+]([O-])=C(c2c1)c3ccccc3
NCGC00160494-01,tox21-er-bla-agonist-p2,Nicaraven,activity,inactive,79455-30-4,71234.0,O=C(NC(C)CNC(=O)c1cccnc1)c2cccnc2
NCGC00168248-02,tox21-er-bla-agonist-p2,Benzoylecgonine,activity,inactive,519-09-5,448223.0,CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)O
NCGC00164634-01,tox21-er-bla-agonist-p2,Balsalazide,activity,inactive,80573-04-2,6335412.0,OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)C(=O)NCCC(=O)O
NCGC00165769-02,tox21-er-bla-agonist-p2,Cloricromen hydrochloride,activity,inactive,74697-28-2,16219127.0,Cl.O=C(OCC)COc2ccc1c(OC(=O)C(CCN(CC)CC)=C1C)c2Cl
NCGC00181033-01,tox21-er-bla-agonist-p2,Taltirelin,activity,inactive,103300-74-9,114750.0,O=C(N)[C@@H]3CCCN3C(=O)[C@H](Cc1cncn1)NC(=O)[C@@H]2CC(=O)N(C)C(=O)N2
NCGC00166026-01,tox21-er-bla-agonist-p2,"N,N-Diethylnicotinamide",activity,inactive,59-26-7,5497.0,O=C(N(CC)CC)c1cccnc1
NCGC00160642-01,tox21-er-bla-agonist-p2,Veralipride,activity,inactive,66644-81-3,47979.0,C=CCN2CCCC2CNC(=O)c1cc(cc(OC)c1OC)S(N)(=O)=O
NCGC00181099-01,tox21-er-bla-agonist-p2,Siccanin,activity,inactive,22733-60-4,192160.0,Cc1cc2O[C@@]4(C)CC[C@H]5C(C)(C)CCCC53CO[C@@H](c2c(O)c1)[C@H]34
NCGC00159331-02,tox21-er-bla-agonist-p2,Vitamin D3,activity,inactive,67-97-0,5280795.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)CCCC(C)C
NCGC00159387-02,tox21-er-bla-agonist-p2,Laureth 10s,activity,inactive,13081-34-0,61574.0,OCCOCCSCCCCCCCCCCCC
NCGC00182042-01,tox21-er-bla-agonist-p2,Propylhexedrine,activity,inactive,101-40-6,7558.0,CC(NC)CC1CCCCC1
NCGC00182081-02,tox21-er-bla-agonist-p2,Zotepine,activity,inactive,26615-21-4,5736.0,CN(C)CCOC1=Cc3ccccc3Sc2ccc(Cl)cc12
NCGC00182084-01,tox21-er-bla-agonist-p2,Clorsulon,activity,inactive,60200-06-8,43231.0,Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl
NCGC00182606-01,tox21-er-bla-agonist-p2,Physalien,activity,inactive,144-67-2,5281250.0,O=C(O[C@@H]2CC(C)=C(/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC1(C)C)C(C)(C)C2)CCCCCCCCCCCCCCC
NCGC00183130-01,tox21-er-bla-agonist-p2,Ritonavir,activity,inactive,155213-67-5,392622.0,CC(C)c4nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3cncs3)C(C)C)cs4
NCGC00254983-01,tox21-er-bla-agonist-p2,Ethalfluralin,activity,inactive,55283-68-6,41381.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CC(=C)C)CC)C(F)(F)F
NCGC00255003-01,tox21-er-bla-agonist-p2,Malaoxon,activity,inactive,1634-78-2,15415.0,COP(=O)(OC)SC(CC(=O)OCC)C(=O)OCC
NCGC00255248-01,tox21-er-bla-agonist-p2,"3-Pentanone, 1-(4-chlorophenyl)-4,4-dimethyl-",activity,inactive,66346-01-8,94617.0,Clc1ccc(CCC(=O)C(C)(C)C)cc1
NCGC00255362-01,tox21-er-bla-agonist-p2,Inositol,activity,inactive,87-89-8,892.0,O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1O
NCGC00247681-01,tox21-er-bla-agonist-p2,Etonitazene,activity,inactive,911-65-9,13493.0,[O-][N+](=O)c2cc3nc(Cc1ccc(OCC)cc1)n(CCN(CC)CC)c3cc2
NCGC00254260-01,tox21-er-bla-agonist-p2,"1,3-Benzenediamine",activity,inactive,108-45-2,7935.0,Nc1cccc(N)c1
NCGC00253922-01,tox21-er-bla-agonist-p2,Cyclohexylamine,activity,inactive,108-91-8,7965.0,NC1CCCCC1
NCGC00254005-01,tox21-er-bla-agonist-p2,"2,6-Dimethylphenol",activity,inactive,576-26-1,11335.0,Cc1cccc(C)c1O
NCGC00254832-01,tox21-er-bla-agonist-p2,Amitraz,activity,inactive,33089-61-1,36324.0,Cc2ccc(/N=C/N(C)/C=N/c1ccc(C)cc1C)c(C)c2
NCGC00254858-01,tox21-er-bla-agonist-p2,Tetraethyleneglycol dimethacrylate,activity,inactive,109-17-1,7980.0,O=C(OCCOCCOCCOCCOC(=O)C(=C)C)C(=C)C
NCGC00024595-03,tox21-er-bla-agonist-p2,Carbetapentane,activity,inactive,77-23-6,2562.0,CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2
NCGC00260372-01,tox21-er-bla-agonist-p2,"4,4'-Dibromobenzil",activity,inactive,35578-47-3,96430.0,O=C(c1ccc(Br)cc1)C(=O)c2ccc(Br)cc2
NCGC00258574-01,tox21-er-bla-agonist-p2,"2,5-Dimethyl-3-hexyne-2,5-diol",activity,inactive,142-30-3,8883.0,CC(O)(C)C#CC(C)(C)O
NCGC00015673-08,tox21-er-bla-agonist-p2,Minoxidil,activity,inactive,38304-91-5,4201.0,Nc1cc(nc(N)[n+]1[O-])N2CCCCC2
NCGC00259550-01,tox21-er-bla-agonist-p2,Anethole,activity,inactive,104-46-1,7703.0,COc1ccc(C=CC)cc1
NCGC00258705-01,tox21-er-bla-agonist-p2,Zearalenone,activity,active agonist,17924-92-4,5281576.0,Oc1cc(O)cc2C=CCCCC(=O)CCC[C@H](C)OC(=O)c12
NCGC00259247-01,tox21-er-bla-agonist-p2,4-Methylbenzenesulfonyl isocyanate,activity,inactive,4083-64-1,77703.0,Cc1ccc(cc1)S(=O)(=O)/N=C=O
NCGC00259828-01,tox21-er-bla-agonist-p2,Hexachlorocyclopentadiene,activity,inactive,77-47-4,6478.0,ClC=1C(Cl)=C(Cl)C(Cl)(Cl)C=1Cl
NCGC00260603-01,tox21-er-bla-agonist-p2,NTP Mix6 AR1 8-EQC,activity,inactive,NOCAS_49499,,
NCGC00015819-06,tox21-er-bla-agonist-p2,Propafenone,activity,inactive,54063-53-5,4932.0,CCCNCC(O)COc2ccccc2C(=O)CCc1ccccc1
NCGC00016327-01,tox21-er-bla-agonist-p2,Khellin,activity,inactive,82-02-0,3828.0,COc3c1c(OC(C)=CC1=O)c(OC)c2occc23
NCGC00257497-01,tox21-er-bla-agonist-p2,FR900409,activity,inactive,138472-01-2,6437875.0,CC(C(=C/C(=N\O)C(=O)N)/CC)[N+]([O-])=O
NCGC00258938-01,tox21-er-bla-agonist-p2,Butyl acrylate,activity,inactive,141-32-2,8846.0,C=CC(=O)OCCCC
NCGC00259028-01,tox21-er-bla-agonist-p2,Nalidixic acid,activity,inactive,389-08-2,4421.0,O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O
NCGC00254233-01,tox21-er-bla-agonist-p2,1-[3-(Triethoxysilyl)propyl]urea,activity,inactive,23779-32-0,90258.0,CCO[Si](OCC)(OCC)CCCNC(N)=O
NCGC00255671-01,tox21-er-bla-agonist-p2,"1,3,5,7-Tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane",activity,inactive,2554-06-5,75706.0,C[Si]1(O[Si](C)(O[Si](C)(O[Si](C)(O1)C=C)C=C)C=C)C=C
NCGC00255697-01,tox21-er-bla-agonist-p2,9-cis Retinoic acid,activity,inactive,5300-03-8,449171.0,CC=1CCCC(C)(C)C=1/C=C/C(/C)=C\C=C\C(\C)=C\C(=O)O
NCGC00255592-01,tox21-er-bla-agonist-p2,Dimethametryn,activity,inactive,22936-75-0,31573.0,CSc1nc(NCC)nc(NC(C)C(C)C)n1
NCGC00256172-01,tox21-er-bla-agonist-p2,Clonidine hydrochloride,activity,inactive,4205-91-8,20179.0,Cl.Clc2cccc(Cl)c2\N=C1/NCCN1
NCGC00256221-01,tox21-er-bla-agonist-p2,"2,2'-(Methanediyldisulfanediyl)diethanol",activity,inactive,44860-68-6,94785.0,OCCSCSCCO
NCGC00256836-01,tox21-er-bla-agonist-p2,Isopulegol,activity,inactive,89-79-2,6553885.0,CC(=C)[C@@H]1CC[C@@H](C)C[C@@H]1O
NCGC00257048-01,tox21-er-bla-agonist-p2,2-Amino-2-methylpropan-1-ol,activity,inactive,124-68-5,11807.0,CC(C)(N)CO
NCGC00257688-01,tox21-er-bla-agonist-p2,Phenylethylhydrazine sulfate,activity,inactive,156-51-4,61100.0,O=S(=O)(O)O.NNCCc1ccccc1
NCGC00257690-01,tox21-er-bla-agonist-p2,4-Chlorobenzaldehyde,activity,inactive,104-88-1,7726.0,O=Cc1ccc(Cl)cc1
NCGC00257280-01,tox21-er-bla-agonist-p2,4-Chloropentylbenzene,activity,inactive,79098-20-7,2757748.0,Clc1ccc(CCCCC)cc1
NCGC00257759-01,tox21-er-bla-agonist-p2,"1,1-Dichloroethane",activity,inactive,75-34-3,6365.0,CC(Cl)Cl
NCGC00258069-01,tox21-er-bla-agonist-p2,Sodium saccharin,activity,inactive,128-44-9,656582.0,[Na+].O=C1[N-]S(=O)(=O)c2ccccc12
NCGC00258545-01,tox21-er-bla-agonist-p2,"4-Nitro-1,3-benzenediamine",activity,inactive,5131-58-8,21208.0,O=[N+]([O-])c1ccc(N)cc1N
NCGC00259066-01,tox21-er-bla-agonist-p2,Chloranocryl,activity,inactive,2164-09-2,16560.0,Clc1ccc(NC(=O)C(=C)C)cc1Cl
NCGC00258633-01,tox21-er-bla-agonist-p2,Benzoin acetate,activity,inactive,574-06-1,95416.0,CC(=O)OC(C(=O)c1ccccc1)c2ccccc2
NCGC00259137-01,tox21-er-bla-agonist-p2,Phenoxybenzamine hydrochloride,activity,active agonist,63-92-3,5284441.0,Cl.CC(COc1ccccc1)N(Cc2ccccc2)CCCl
NCGC00260095-01,tox21-er-bla-agonist-p2,Vitamin D3,activity,inactive,67-97-0,5280795.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)CCCC(C)C
NCGC00260595-01,tox21-er-bla-agonist-p2,NTP Mix50 CT1 3-EQP,activity,inactive,NOCAS_49491,,
NCGC00015215-02,tox21-er-bla-agonist-p2,(-)-Epicatechin,activity,inactive,490-46-0,72276.0,Oc1ccc(cc1O)[C@H]2Oc3cc(O)cc(O)c3C[C@H]2O
NCGC00015964-09,tox21-er-bla-agonist-p2,Spiperone,activity,inactive,749-02-0,5265.0,Fc1ccc(cc1)C(=O)CCCN2CCC4(CC2)C(=O)NCN4c3ccccc3
NCGC00016605-01,tox21-er-bla-agonist-p2,Nifenazone,activity,inactive,2139-47-1,4487.0,O=C3C(NC(=O)c1cccnc1)=C(C)N(C)N3c2ccccc2
NCGC00016807-01,tox21-er-bla-agonist-p2,Bupropion hydrochloride,activity,inactive,31677-93-7,62884.0,Cl.O=C(c1cc(Cl)ccc1)C(C)NC(C)(C)C
NCGC00167965-01,tox21-er-bla-agonist-p2,Lutein,activity,inactive,127-40-2,5281243.0,CC2(C)C[C@H](O)CC(C)=C2/C=CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C
NCGC00254827-01,tox21-er-bla-agonist-p2,Paclobutrazol,activity,inactive,76738-62-0,616765.0,OC(C(Cc1ccc(Cl)cc1)n2cncn2)C(C)(C)C
NCGC00255404-01,tox21-er-bla-agonist-p2,Morin hydrate,activity,inactive,654055-01-3,18542136.0,O.O.Oc3ccc(C=2Oc1cc(O)cc(O)c1C(=O)C=2O)c(O)c3
NCGC00256181-01,tox21-er-bla-agonist-p2,(1-Hydroxycyclohexyl)(phenyl)methanone,activity,inactive,947-19-3,70355.0,O=C(c1ccccc1)C2(O)CCCCC2
NCGC00256232-01,tox21-er-bla-agonist-p2,Phenylphosphonic dichloride,activity,inactive,824-72-6,69990.0,ClP(=O)(Cl)c1ccccc1
NCGC00256259-01,tox21-er-bla-agonist-p2,Tetraisopropyl methylenediphosphonate,activity,inactive,1660-95-3,74266.0,O=P(CP(=O)(OC(C)C)OC(C)C)(OC(C)C)OC(C)C
NCGC00254454-01,tox21-er-bla-agonist-p2,"2,6-Diethylaniline",activity,inactive,579-66-8,11369.0,CCc1cccc(CC)c1N
NCGC00254102-01,tox21-er-bla-agonist-p2,Fluridone,activity,inactive,59756-60-4,43079.0,CN1C=C(C(=O)C(=C1)c2cc(ccc2)C(F)(F)F)c3ccccc3
NCGC00016682-02,tox21-er-bla-agonist-p2,Estropipate,activity,active agonist,7280-37-7,5284555.0,O=S(=O)(O)Oc1cc2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3c2cc1.C1CNCCN1
NCGC00025216-01,tox21-er-bla-agonist-p2,Roxindole,activity,inactive,112192-04-8,219050.0,Oc3ccc4ncc(CCCCN1CC=C(CC1)c2ccccc2)c4c3
NCGC00091345-01,tox21-er-bla-agonist-p2,Hexanedioic acid,activity,inactive,124-04-9,196.0,OC(=O)CCCCC(=O)O
NCGC00095169-01,tox21-er-bla-agonist-p2,Miltefosine,activity,inactive,58066-85-6,3599.0,C[N+](C)(C)CCOP([O-])(=O)OCCCCCCCCCCCCCCCC
NCGC00095258-01,tox21-er-bla-agonist-p2,Mitomycin C,activity,inactive,50-07-7,5746.0,NC(=O)OC[C@@H]3C=1C(=O)C(N)=C(C)C(=O)C=1N2C[C@@H]4N[C@@H]4[C@@]23OC
NCGC00159322-02,tox21-er-bla-agonist-p2,Cyclocytidine,activity,inactive,31698-14-3,25051.0,N=C2N=C3O[C@H]1[C@H](O)[C@@H](CO)O[C@H]1N3C=C2
NCGC00159376-02,tox21-er-bla-agonist-p2,Methylparaben,activity,inactive,99-76-3,7456.0,Oc1ccc(cc1)C(=O)OC
NCGC00182969-01,tox21-er-bla-agonist-p2,Pleuromutilin,activity,inactive,125-65-5,31326.0,OCC(=O)OC3CC(C)(C=C)C(O)C(C)C21CCC(=O)C1C3(C)C(C)CC2
NCGC00254014-01,tox21-er-bla-agonist-p2,SSR161421,activity,inactive,NOCAS_47374,10201497.0,COc1ccc(cc1)C(=O)Nc3nc4ccccc4c(NCc2ccccc2)c3C#N
NCGC00260628-01,tox21-er-bla-agonist-p2,NTP Mix104 ER1 10-EQC,activity,inactive,NOCAS_49524,,
NCGC00015150-03,tox21-er-bla-agonist-p2,Betaine,activity,inactive,107-43-7,247.0,C[N+](C)(C)CC([O-])=O
NCGC00015506-03,tox21-er-bla-agonist-p2,Hydroxytacrine maleate,activity,inactive,118909-22-1,5702293.0,O=C(O)/C=C\C(=O)O.Nc1c3ccccc3nc2CCCC(O)c12
NCGC00181764-01,tox21-er-bla-agonist-p2,Polaprezinc,activity,inactive,107667-60-7,51051629.0,O=C2O[Zn]N([C@H]2Cc1ncnc1)C(=O)CCN
NCGC00254600-01,tox21-er-bla-agonist-p2,4-Methyl-3-heptanol,activity,inactive,14979-39-6,26989.0,CC(CCC)C(O)CC
NCGC00090794-01,tox21-er-bla-agonist-p2,Chloroform,activity,inactive,67-66-3,6212.0,ClC(Cl)Cl
NCGC00090808-01,tox21-er-bla-agonist-p2,Amphotericin B,activity,inactive,1397-89-3,5280965.0,O=C(O)[C@@H]3[C@@H](O)C[C@@]2(O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)C=CC=CC=CC=CC=CC=CC=C[C@H](O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O)C[C@@H]3O2
NCGC00017043-02,tox21-er-bla-agonist-p2,Denatonium benzoate,activity,inactive,3734-33-6,19518.0,O=C(Nc1c(C)cccc1C)C[N+](Cc2ccccc2)(CC)CC.[O-]C(=O)c1ccccc1
NCGC00068236-02,tox21-er-bla-agonist-p2,Gatifloxacin,activity,inactive,112811-59-3,5379.0,CC1CN(CCN1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4
NCGC00256854-01,tox21-er-bla-agonist-p2,Isobutyl salicylate,activity,inactive,87-19-4,6873.0,Oc1ccccc1C(=O)OCC(C)C
NCGC00256868-01,tox21-er-bla-agonist-p2,Methyl 2-nonynoate,activity,inactive,111-80-8,8137.0,O=C(C#CCCCCCC)OC
NCGC00257595-01,tox21-er-bla-agonist-p2,Methyl ethyl ketone,activity,inactive,78-93-3,6569.0,CC(=O)CC
NCGC00257709-01,tox21-er-bla-agonist-p2,"3,5-Dichlorobenzoic acid",activity,inactive,51-36-5,5811.0,Clc1cc(cc(Cl)c1)C(=O)O
NCGC00257980-01,tox21-er-bla-agonist-p2,Tetraethyl orthosilicate,activity,inactive,78-10-4,6517.0,CCO[Si](OCC)(OCC)OCC
NCGC00258009-01,tox21-er-bla-agonist-p2,Phenylphosphinic acid,activity,inactive,1779-48-2,6327116.0,O=P(O)c1ccccc1
NCGC00258284-01,tox21-er-bla-agonist-p2,Methyl propanoate,activity,inactive,554-12-1,11124.0,CCC(=O)OC
NCGC00256666-01,tox21-er-bla-agonist-p2,4-Methoxybenzyl formate,activity,inactive,122-91-8,61054.0,COc1ccc(COC=O)cc1
NCGC00256420-01,tox21-er-bla-agonist-p2,6-Methyl-5-hepten-2-one,activity,inactive,110-93-0,9862.0,C/C(C)=C\CCC(C)=O
NCGC00256505-01,tox21-er-bla-agonist-p2,"1,4-Benzoquinone",activity,inactive,106-51-4,4650.0,O=C1C=CC(=O)C=C1
NCGC00255856-01,tox21-er-bla-agonist-p2,Lauryldiethanolamine,activity,inactive,1541-67-9,352309.0,OCCN(CCCCCCCCCCCC)CCO
NCGC00256084-01,tox21-er-bla-agonist-p2,"3,7-Dimethyloctanal",activity,inactive,5988-91-0,110747.0,CC(C)CCCC(C)CC=O
NCGC00256303-01,tox21-er-bla-agonist-p2,"1,1,2-Trimethyl-1H-benzo[e]indole",activity,inactive,41532-84-7,170530.0,CC3(C)c2c(ccc1ccccc12)N=C3C
NCGC00256332-01,tox21-er-bla-agonist-p2,Phenformin hydrochloride,activity,inactive,834-28-6,13266.0,Cl.N=C(N)NC(=N)NCCc1ccccc1
NCGC00255646-01,tox21-er-bla-agonist-p2,"3,4-Dimethylbenzaldehyde",activity,inactive,5973-71-7,22278.0,Cc1ccc(C=O)cc1C
NCGC00255702-01,tox21-er-bla-agonist-p2,Carbetamide,activity,inactive,16118-49-3,27689.0,CCNC(=O)C(C)OC(=O)Nc1ccccc1
NCGC00258996-01,tox21-er-bla-agonist-p2,1-Chloro-4-(trifluoromethyl)benzene,activity,inactive,98-56-6,7394.0,FC(F)(F)c1ccc(Cl)cc1
NCGC00259143-01,tox21-er-bla-agonist-p2,4-Toluenesulfonamide,activity,inactive,70-55-3,6269.0,Cc1ccc(cc1)S(=O)(N)=O
NCGC00259370-01,tox21-er-bla-agonist-p2,Dimethylaminoethanol,activity,inactive,108-01-0,7902.0,CN(C)CCO
NCGC00259422-01,tox21-er-bla-agonist-p2,Thiourea,activity,inactive,62-56-6,2723790.0,NC(N)=S
NCGC00259432-01,tox21-er-bla-agonist-p2,"1,2-Cyclohexanediamine",activity,inactive,694-83-7,4610.0,NC1CCCCC1N
NCGC00259759-01,tox21-er-bla-agonist-p2,Tetrahydrophthalic anhydride,activity,inactive,85-43-8,6810.0,O=C1OC(=O)C2CC=CCC12
NCGC00260386-01,tox21-er-bla-agonist-p2,"Benzoicacid,4-iodo-,ethylester",activity,inactive,51934-41-9,142891.0,Ic1ccc(cc1)C(=O)OCC
NCGC00258718-01,tox21-er-bla-agonist-p2,"6-Methyl-1,3,5-triazine-2,4-diamine",activity,inactive,542-02-9,10949.0,Nc1nc(C)nc(N)n1
NCGC00256300-01,tox21-er-bla-agonist-p2,Fluxofenim,activity,inactive,88485-37-4,91747.0,Clc1ccc(cc1)\C(=N\OCC2OCCO2)C(F)(F)F
NCGC00255008-01,tox21-er-bla-agonist-p2,Geranyl butyrate,activity,inactive,106-29-6,5355856.0,C\C(C)=C\CCC(\C)=C\COC(=O)CCC
NCGC00255085-01,tox21-er-bla-agonist-p2,"2-Butyl-2-ethyl-1,3-propanediol",activity,inactive,115-84-4,61038.0,CCCCC(CO)(CO)CC
NCGC00255254-01,tox21-er-bla-agonist-p2,Triforine,activity,inactive,26644-46-2,33565.0,ClC(Cl)(Cl)C(NC=O)N1CCN(CC1)C(NC=O)C(Cl)(Cl)Cl
NCGC00255534-01,tox21-er-bla-agonist-p2,Chlorfenac,activity,inactive,85-34-7,6805.0,Clc1c(CC(=O)O)c(Cl)ccc1Cl
NCGC00255634-01,tox21-er-bla-agonist-p2,4-(2-Methylbutan-2-yl)cyclohexanol,activity,inactive,5349-51-9,79302.0,OC1CCC(CC1)C(C)(C)CC
NCGC00255936-01,tox21-er-bla-agonist-p2,tert-Butyl 3-oxobutanoate,activity,inactive,1694-31-1,15538.0,CC(C)(C)OC(=O)CC(C)=O
NCGC00254533-01,tox21-er-bla-agonist-p2,Dapsone,activity,inactive,80-08-0,2955.0,Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2
NCGC00166281-01,tox21-er-bla-agonist-p2,Quinine,activity,inactive,130-95-0,8549.0,COc1cc2c(cc1)nccc2[C@@H](O)[C@@H]4CC3CCN4C[C@@H]3C=C
NCGC00167440-01,tox21-er-bla-agonist-p2,Bosentan,activity,inactive,147536-97-8,104865.0,CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc3nc(nc(OCCO)c3Oc2ccccc2OC)c4ncccn4
NCGC00164173-02,tox21-er-bla-agonist-p2,Octabenzone,activity,inactive,1843-05-6,15797.0,O=C(c1ccc(cc1O)OCCCCCCCC)c2ccccc2
NCGC00094851-01,tox21-er-bla-agonist-p2,Iodamide,activity,inactive,440-58-4,3723.0,O=C(C)Nc1c(I)c(c(I)c(CNC(C)=O)c1I)C(=O)O
NCGC00164495-01,tox21-er-bla-agonist-p2,Nicothiazone,activity,inactive,555-90-8,6474573.0,NC(=S)N\N=C\c1cccnc1
NCGC00167754-01,tox21-er-bla-agonist-p2,Talniflumate,activity,inactive,66898-62-2,48229.0,FC(F)(F)c1cc(ccc1)Nc2ncccc2C(=O)OC4OC(=O)c3ccccc34
NCGC00160402-01,tox21-er-bla-agonist-p2,Iodoalphionic acid,activity,inactive,577-91-3,11350.0,Ic2cc(CC(c1ccccc1)C(=O)O)cc(I)c2O
NCGC00167471-01,tox21-er-bla-agonist-p2,Anethole trithione,activity,inactive,532-11-6,2194.0,COc1ccc(cc1)C2=CC(=S)SS2
NCGC00167486-01,tox21-er-bla-agonist-p2,Pemetrexed disodium,activity,inactive,150399-23-8,6918197.0,[Na+].[Na+].[O-]C(=O)[C@H](CCC([O-])=O)NC(=O)c1ccc(cc1)CCc2cnc3NC(N)=NC(=O)c23
NCGC00160475-01,tox21-er-bla-agonist-p2,Norletimol,activity,inactive,886-08-8,5390109.0,Oc2ccccc2/C=N/Cc1ccccc1
NCGC00181039-01,tox21-er-bla-agonist-p2,Ethyl linoleate,activity,inactive,6114-21-2,5282184.0,O=C(CCCCCCC/C=C\C/C=C\CCCCC)OCC
NCGC00160557-01,tox21-er-bla-agonist-p2,Clorindione,activity,inactive,1146-99-2,70846.0,Clc1ccc(cc1)C3C(=O)c2ccccc2C3=O
NCGC00160572-01,tox21-er-bla-agonist-p2,Metazide,activity,inactive,1707-15-9,15568.0,O=C(NNCNNC(=O)c1ccncc1)c2ccncc2
NCGC00166037-02,tox21-er-bla-agonist-p2,Glycerol phosphate calcium salt,activity,inactive,58409-70-4,62820.0,[Ca+2].[O-]P([O-])(=O)OC(CO)CO
NCGC00167532-01,tox21-er-bla-agonist-p2,Balofloxacin,activity,inactive,127294-70-6,65958.0,CNC1CCCN(C1)c2c(F)cc3c(c2OC)N(C=C(C3=O)C(=O)O)C4CC4
NCGC00160606-01,tox21-er-bla-agonist-p2,Sulbentine,activity,inactive,350-12-9,67686.0,S=C3SCN(Cc1ccccc1)CN3Cc2ccccc2
NCGC00160679-01,tox21-er-bla-agonist-p2,Dinsed,activity,inactive,96-62-8,14895.0,O=S(=O)(NCCNS(=O)(=O)c1cc(ccc1)[N+]([O-])=O)c2cc(ccc2)[N+]([O-])=O
NCGC00091313-01,tox21-er-bla-agonist-p2,Hexanamide,activity,inactive,628-02-4,12332.0,CCCCCC(N)=O
NCGC00183880-01,tox21-er-bla-agonist-p2,Frovatriptan Succinate monohydrate,activity,inactive,158930-17-7,152943.0,O.O=C(O)CCC(=O)O.NC(=O)c1cc2c(cc1)nc3CC[C@H](Cc23)NC
NCGC00254141-01,tox21-er-bla-agonist-p2,1-Decanol,activity,inactive,112-30-1,8174.0,CCCCCCCCCCO
NCGC00255023-01,tox21-er-bla-agonist-p2,1-Ethenylazepan-2-one,activity,inactive,2235-00-9,75227.0,C=CN1CCCCCC1=O
NCGC00254656-01,tox21-er-bla-agonist-p2,Triethoxy[2-(7-oxabicyclo[4.1.0]hept-3-yl)ethyl]silane,activity,inactive,10217-34-2,154915.0,CCO[Si](CCC1CC2OC2CC1)(OCC)OCC
NCGC00254757-01,tox21-er-bla-agonist-p2,Carbaryl,activity,inactive,63-25-2,6129.0,CNC(=O)Oc2cccc1ccccc12
NCGC00253953-01,tox21-er-bla-agonist-p2,"2,4-Dichlorophenol",activity,inactive,120-83-2,8449.0,Clc1cc(Cl)c(O)cc1
NCGC00255200-01,tox21-er-bla-agonist-p2,Carbromal,activity,inactive,77-65-6,6488.0,CCC(Br)(CC)C(=O)NC(N)=O
NCGC00254074-01,tox21-er-bla-agonist-p2,Dimethylcarbamoyl chloride,activity,inactive,79-44-7,6598.0,CN(C)C(Cl)=O
NCGC00182713-01,tox21-er-bla-agonist-p2,Canertinib,activity,active agonist,267243-28-7,156414.0,Fc1ccc(cc1Cl)Nc4ncnc3cc(OCCCN2CCOCC2)c(NC(=O)C=C)cc34
NCGC00259728-01,tox21-er-bla-agonist-p2,"1,3-Dichlorobenzene",activity,inactive,541-73-1,10943.0,Clc1cccc(Cl)c1
NCGC00257807-01,tox21-er-bla-agonist-p2,tert-Butyl glycidyl ether,activity,inactive,7665-72-7,24314.0,CC(C)(C)OCC1CO1
NCGC00258674-01,tox21-er-bla-agonist-p2,"2,6-Naphthalenedicarboxylic acid",activity,inactive,1141-38-4,14357.0,O=C(O)c1ccc2cc(ccc2c1)C(=O)O
NCGC00015096-12,tox21-er-bla-agonist-p2,Amiodarone hydrochloride,activity,inactive,19774-82-4,441325.0,Cl.CCN(CC)CCOc1c(I)cc(cc1I)C(=O)c2c3ccccc3oc2CCCC
NCGC00015784-07,tox21-er-bla-agonist-p2,Pirenperone,activity,inactive,75444-65-4,4847.0,Fc1ccc(cc1)C(=O)C4CCN(CCC3=C(C)N=C2C=CC=CN2C3=O)CC4
NCGC00015802-08,tox21-er-bla-agonist-p2,Pimozide,activity,inactive,2062-78-4,16362.0,Fc1ccc(cc1)C(CCCN2CCC(CC2)N3c4ccccc4NC3=O)c5ccc(F)cc5
NCGC00256813-01,tox21-er-bla-agonist-p2,N-[3-(Trimethoxysilyl)propyl]aniline,activity,inactive,3068-76-6,76476.0,CO[Si](OC)(OC)CCCNc1ccccc1
NCGC00164604-01,tox21-er-bla-agonist-p2,Fluvastatin sodium,activity,inactive,93957-55-2,23663976.0,[Na+].[O-]C(=O)C[C@H](O)C[C@H](O)/C=C/c2c(c1ccccc1n2C(C)C)c3ccc(F)cc3
NCGC00257263-01,tox21-er-bla-agonist-p2,Aminoglutethimide,activity,inactive,125-84-8,2145.0,CCC1(CCC(=O)NC1=O)c2ccc(N)cc2
NCGC00255447-01,tox21-er-bla-agonist-p2,Chloroxuron,activity,inactive,1982-47-4,16115.0,Clc2ccc(Oc1ccc(NC(=O)N(C)C)cc1)cc2
NCGC00258711-01,tox21-er-bla-agonist-p2,Daunomycin hydrochloride,activity,active agonist,23541-50-6,62770.0,Cl.CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c(O)c5C4
NCGC00260446-01,tox21-er-bla-agonist-p2,"1,4-Naphthalenediamine",activity,inactive,2243-61-0,16719.0,Nc1ccc(N)c2ccccc12
NCGC00164563-01,tox21-er-bla-agonist-p2,Entecavir,activity,inactive,142217-69-4,153941.0,C=C1[C@H](CO)[C@@H](O)C[C@@H]1n3cnc2c3N=C(N)NC2=O
NCGC00159323-03,tox21-er-bla-agonist-p2,Oxazepam,activity,inactive,604-75-1,4616.0,Clc1ccc2NC(=O)C(O)N=C(c2c1)c3ccccc3
NCGC00257651-01,tox21-er-bla-agonist-p2,2-(2-Propoxyethoxy)ethanol,activity,inactive,6881-94-3,81313.0,CCCOCCOCCO
NCGC00258218-01,tox21-er-bla-agonist-p2,Tridecyl methacrylate,activity,inactive,2495-25-2,17234.0,C=C(C)C(=O)OCCCCCCCCCCCCC
NCGC00013235-01,tox21-er-bla-agonist-p2,Estradiol phosphate,activity,active agonist,4995-43-1,66435.0,O=P(O)(O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C
NCGC00255465-01,tox21-er-bla-agonist-p2,"2,7,8,9-Tricyclazole",activity,inactive,41814-78-2,39040.0,Cc1cccc2sc3nncn3c12
NCGC00256126-01,tox21-er-bla-agonist-p2,"Trisodium 2,4,6-trithioxo-1,3,5-triazinane-1,3,5-triide",activity,inactive,17766-26-6,6099917.0,[Na+].[Na+].[Na+].S=C1[N-]C(=S)[N-]C(=S)[N-]1
NCGC00256165-01,tox21-er-bla-agonist-p2,3-{[3-(Aziridin-1-yl)propanoyl]oxy}-2-({[3-(aziridin-1-yl)propanoyl]oxy}methyl)-2-(hydroxymethyl)propyl 3-(aziridin-1-yl)propanoate,activity,inactive,57116-45-7,92667.0,OCC(COC(=O)CCN1CC1)(COC(=O)CCN2CC2)COC(=O)CCN3CC3
NCGC00256584-01,tox21-er-bla-agonist-p2,"2,4-Dichlorophenyl benzenesulfonate",activity,active agonist,97-16-5,7327.0,Clc2cc(Cl)ccc2OS(=O)(=O)c1ccccc1
NCGC00256672-01,tox21-er-bla-agonist-p2,Ethyl cinnamate,activity,inactive,103-36-6,7649.0,O=C(C=Cc1ccccc1)OCC
NCGC00257083-01,tox21-er-bla-agonist-p2,Isophorone diamine,activity,inactive,2855-13-2,17857.0,NCC1(C)CC(C)(C)CC(N)C1
NCGC00257806-01,tox21-er-bla-agonist-p2,3-Acetamidophenol,activity,inactive,621-42-1,12124.0,Oc1cccc(NC(C)=O)c1
NCGC00257849-01,tox21-er-bla-agonist-p2,2-(2-Nitrophenyl)ethanol,activity,inactive,15121-84-3,27054.0,O=[N+]([O-])c1ccccc1CCO
NCGC00257629-01,tox21-er-bla-agonist-p2,5-Chloro-2-methylaniline,activity,inactive,95-79-4,7260.0,Nc1cc(Cl)ccc1C
NCGC00257558-01,tox21-er-bla-agonist-p2,4-(Methylthio)benzaldehyde,activity,inactive,3446-89-7,76985.0,CSc1ccc(C=O)cc1
NCGC00257772-01,tox21-er-bla-agonist-p2,Dichloroacetonitrile,activity,inactive,3018-12-0,18177.0,ClC(Cl)C#N
NCGC00257591-01,tox21-er-bla-agonist-p2,"1,9-Decadiene",activity,inactive,1647-16-1,15439.0,C=CCCCCCCC=C
NCGC00257070-01,tox21-er-bla-agonist-p2,Benzothiazole,activity,inactive,95-16-9,7222.0,c1cccc2scnc12
NCGC00258057-01,tox21-er-bla-agonist-p2,Melamine,activity,inactive,108-78-1,7955.0,Nc1nc(N)nc(N)n1
NCGC00258223-01,tox21-er-bla-agonist-p2,Tetraethylenepentamine,activity,inactive,112-57-2,8197.0,NCCNCCNCCNCCN
NCGC00258277-01,tox21-er-bla-agonist-p2,1-Hexene,activity,inactive,592-41-6,11597.0,C=CCCCC
NCGC00258907-01,tox21-er-bla-agonist-p2,"1-(2,3,8,8-Tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone",activity,inactive,54464-57-2,108242.0,CC(=O)C2(C)CC1=C(CCCC1(C)C)CC2C
NCGC00258301-01,tox21-er-bla-agonist-p2,"4-Methyl-2,6-dinitrophenol",activity,inactive,609-93-8,11872.0,O=[N+]([O-])c1cc(C)cc([N+]([O-])=O)c1O
NCGC00258707-01,tox21-er-bla-agonist-p2,"1,4-Hexadiene",activity,inactive,592-45-0,5365552.0,C=CC\C=C\C
NCGC00258753-01,tox21-er-bla-agonist-p2,Bis(2-chloro-1-methylethyl) ether,activity,inactive,108-60-1,7944.0,CC(CCl)OC(C)CCl
NCGC00258970-01,tox21-er-bla-agonist-p2,"1,3-Propane sultone",activity,inactive,1120-71-4,14264.0,O=S1(=O)CCCO1
NCGC00258440-01,tox21-er-bla-agonist-p2,Nitroguanidine,activity,inactive,556-88-7,11174.0,N=C(N)N[N+]([O-])=O
NCGC00259026-01,tox21-er-bla-agonist-p2,Lovastatin,activity,inactive,75330-75-5,53232.0,C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23
NCGC00258047-01,tox21-er-bla-agonist-p2,Cyclopentanone oxime,activity,inactive,1192-28-5,14500.0,O\N=C1\CCCC1
NCGC00259176-01,tox21-er-bla-agonist-p2,4-Chloroaniline hydrochloride,activity,inactive,20265-96-7,5284363.0,Cl.Nc1ccc(Cl)cc1
NCGC00260413-01,tox21-er-bla-agonist-p2,12-BromododecanoicAcid,activity,inactive,73367-80-3,175468.0,O=C(O)CCCCCCCCCCCBr
NCGC00016743-01,tox21-er-bla-agonist-p2,Piromidic acid,activity,inactive,19562-30-2,4855.0,O=C(O)C2=CN(CC)c1nc(ncc1C2=O)N3CCCC3
NCGC00016594-01,tox21-er-bla-agonist-p2,Prilocaine hydrochloride,activity,inactive,1786-81-8,92163.0,Cl.O=C(Nc1ccccc1C)C(C)NCCC
NCGC00016834-01,tox21-er-bla-agonist-p2,Fenbufen,activity,inactive,36330-85-5,3335.0,O=C(CCC(=O)O)c1ccc(cc1)c2ccccc2
NCGC00159418-02,tox21-er-bla-agonist-p2,Tegafur,activity,inactive,37076-68-9,5386.0,FC1=CN(C(=O)NC1=O)C2CCCO2
NCGC00255069-01,tox21-er-bla-agonist-p2,2-(Ethylamino)ethanol,activity,inactive,110-73-6,8072.0,CCNCCO
NCGC00254689-01,tox21-er-bla-agonist-p2,Esfenvalerate,activity,inactive,66230-04-4,10342051.0,Clc1ccc(cc1)[C@H](C(C)C)C(=O)O[C@H](C#N)c3cccc(Oc2ccccc2)c3
NCGC00254801-01,tox21-er-bla-agonist-p2,Fluroxypyr-meptyl,activity,inactive,81406-37-3,54745.0,CC(CCCCCC)OC(=O)COc1nc(F)c(Cl)c(N)c1Cl
NCGC00254860-01,tox21-er-bla-agonist-p2,Clomazone,activity,inactive,81777-89-1,54778.0,Clc2ccccc2CN1OCC(C)(C)C1=O
NCGC00255141-01,tox21-er-bla-agonist-p2,Triethylene glycol dibenzoate,activity,inactive,120-56-9,67123.0,O=C(OCCOCCOCCOC(=O)c1ccccc1)c2ccccc2
NCGC00255383-01,tox21-er-bla-agonist-p2,Lactose,activity,inactive,63-42-3,6134.0,O[C@H]2[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](CO)O[C@@H](O)[C@@H]2O
NCGC00255406-01,tox21-er-bla-agonist-p2,"trans-2,cis-6-Nonadienal",activity,inactive,557-48-2,6428555.0,CCCC\C=C\C=C/C=O
NCGC00015121-08,tox21-er-bla-agonist-p2,Phenoxybenzamine,activity,inactive,59-96-1,4768.0,CC(COc1ccccc1)N(Cc2ccccc2)CCCl
NCGC00016893-01,tox21-er-bla-agonist-p2,Clorsulon,activity,inactive,60200-06-8,43231.0,Nc1cc(c(cc1S(=O)(N)=O)S(N)(=O)=O)C(/Cl)=C(/Cl)Cl
NCGC00091011-05,tox21-er-bla-agonist-p2,Chloramphenicol,activity,inactive,56-75-7,5959.0,O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl
NCGC00094832-01,tox21-er-bla-agonist-p2,Benfluorex hydrochloride,activity,inactive,23642-66-2,198015.0,Cl.FC(F)(F)c2cccc(CC(C)NCCOC(=O)c1ccccc1)c2
NCGC00159325-02,tox21-er-bla-agonist-p2,Desloratadine,activity,inactive,100643-71-8,124087.0,Clc2cc3CCc4cccnc4\C(=C1\CCNCC1)c3cc2
NCGC00159478-02,tox21-er-bla-agonist-p2,Benzoxiquine,activity,inactive,86-75-9,6855.0,O=C(Oc1cccc2cccnc12)c3ccccc3
NCGC00160435-01,tox21-er-bla-agonist-p2,Riodipine,activity,inactive,71653-63-9,68909.0,CC=1NC(C)=C(C(C=1C(=O)OC)c2ccccc2OC(F)F)C(=O)OC
NCGC00164486-01,tox21-er-bla-agonist-p2,Cyclovalone,activity,inactive,579-23-7,11366.0,Oc1ccc(cc1OC)C=C3CCCC(=Cc2cc(OC)c(O)cc2)C3=O
NCGC00168786-01,tox21-er-bla-agonist-p2,Deserpidine,activity,inactive,131-01-1,8550.0,COc1cc(cc(OC)c1OC)C(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccccc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC
NCGC00021142-02,tox21-er-bla-agonist-p2,Cromolyn sodium,activity,inactive,15826-37-6,27503.0,[Na+].[Na+].[O-]C(=O)C=4Oc3cccc(OCC(O)COc1cccc2OC(=CC(=O)c12)C([O-])=O)c3C(=O)C=4
NCGC00165905-01,tox21-er-bla-agonist-p2,Taprostene sodium salt,activity,inactive,87440-45-7,20838960.0,[Na+].O=C(O)c1cccc(c1)/C=C3/C[C@@H]4[C@@H](/C=C/[C@@H](O)C2CCCCC2)[C@H](O)C[C@@H]4O3
NCGC00253946-01,tox21-er-bla-agonist-p2,Diethyl butanedioate,activity,inactive,123-25-1,31249.0,O=C(CCC(=O)OCC)OCC
NCGC00090682-01,tox21-er-bla-agonist-p2,alpha-Pinene,activity,inactive,80-56-8,6654.0,CC2(C)C1CC=C(C)C2C1
NCGC00021394-04,tox21-er-bla-agonist-p2,Anisotropine methylbromide,activity,inactive,80-50-2,657201.0,[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC
NCGC00025325-02,tox21-er-bla-agonist-p2,Vapiprost hydrochloride,activity,inactive,87248-13-3,6918029.0,Cl.O=C(O)CC\C=C/CC[C@@H]3[C@H]([C@@H](O)C[C@@H]3OCc1ccc(cc1)c2ccccc2)N4CCCCC4
NCGC00256829-01,tox21-er-bla-agonist-p2,"3,3-Dimethylallyl acetate",activity,inactive,1191-16-8,14489.0,CC(=O)OC\C=C(/C)C
NCGC00258392-01,tox21-er-bla-agonist-p2,tert-Butyl hydroperoxide (70% Solution in Water),activity,inactive,NOCAS_31209,6410.0,CC(C)(C)OO
NCGC00258397-01,tox21-er-bla-agonist-p2,2-(2-Ethoxyethoxy)ethyl acetate,activity,inactive,112-15-2,8165.0,CCOCCOCCOC(C)=O
NCGC00257128-01,tox21-er-bla-agonist-p2,1-Chloro-2-bromoethane,activity,inactive,107-04-0,7849.0,BrCCCl
NCGC00257352-01,tox21-er-bla-agonist-p2,Oxazepam,activity,inactive,604-75-1,4616.0,Clc1ccc2NC(=O)C(O)N=C(c2c1)c3ccccc3
NCGC00257509-01,tox21-er-bla-agonist-p2,Methyl abietate,activity,inactive,127-25-3,173058.0,CC(C)C=3CC[C@H]1C(=CC[C@H]2[C@@](C)(CCC[C@]12C)C(=O)OC)C=3
NCGC00257521-01,tox21-er-bla-agonist-p2,Nicotinyl alcohol,activity,inactive,100-55-0,7510.0,OCc1cccnc1
NCGC00257795-01,tox21-er-bla-agonist-p2,"N,N,N',N'-Tetramethylethylenediamine",activity,inactive,110-18-9,8037.0,CN(C)CCN(C)C
NCGC00257947-01,tox21-er-bla-agonist-p2,Bensulfuron-methyl,activity,inactive,83055-99-6,54960.0,O=C(Nc1nc(cc(OC)n1)OC)NS(=O)(=O)Cc2ccccc2C(=O)OC
NCGC00258252-01,tox21-er-bla-agonist-p2,1-(2-Hydroxyethyl)-2-imidazolidinone,activity,inactive,3699-54-5,77290.0,O=C1NCCN1CCO
NCGC00258334-01,tox21-er-bla-agonist-p2,Tetramethyl orthosilicate,activity,inactive,681-84-5,12682.0,CO[Si](OC)(OC)OC
NCGC00258365-01,tox21-er-bla-agonist-p2,1-Butanethiol,activity,inactive,109-79-5,8012.0,CCCCS
NCGC00256541-01,tox21-er-bla-agonist-p2,5-Azacytidine,activity,inactive,320-67-2,9444.0,NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
NCGC00255823-01,tox21-er-bla-agonist-p2,2-Heptylcyclopentanone,activity,inactive,137-03-1,8710.0,O=C1CCCC1CCCCCCC
NCGC00255849-01,tox21-er-bla-agonist-p2,N-(4-Ethoxyphenyl)-3-oxobutanamide,activity,inactive,122-82-7,61053.0,CCOc1ccc(cc1)NC(=O)CC(C)=O
NCGC00255919-01,tox21-er-bla-agonist-p2,2-Ethylhexyl cyanoacetate,activity,inactive,13361-34-7,96359.0,O=C(CC#N)OCC(CCCC)CC
NCGC00256302-01,tox21-er-bla-agonist-p2,"3-Methyl-3,4-dihydro-2H-1,4-benzoxazine",activity,inactive,32329-20-7,2763760.0,CC1Nc2ccccc2OC1
NCGC00258858-01,tox21-er-bla-agonist-p2,Linalyl acetate,activity,inactive,115-95-7,8294.0,O=C(C)OC(C)(CC\C=C(\C)C)C=C
NCGC00260402-01,tox21-er-bla-agonist-p2,"Propanoic acid,2-hydroxy-,propylester",activity,inactive,616-09-1,92821.0,CC(O)C(=O)OCCC
NCGC00260440-01,tox21-er-bla-agonist-p2,"1,8,9-Trihydroxyanthracene",activity,inactive,480-22-8,10187.0,Oc2c3c(cc1cccc(O)c12)cccc3O
NCGC00259406-01,tox21-er-bla-agonist-p2,Di(2-methoxyethyl) phthalate,activity,inactive,117-82-8,8344.0,O=C(OCCOC)c1ccccc1C(=O)OCCOC
NCGC00259564-01,tox21-er-bla-agonist-p2,N-Butylurea,activity,inactive,592-31-4,11595.0,NC(=O)NCCCC
NCGC00259868-01,tox21-er-bla-agonist-p2,Dibromoacetonitrile,activity,inactive,3252-43-5,18617.0,BrC(Br)C#N
NCGC00258665-01,tox21-er-bla-agonist-p2,p-Xylene,activity,inactive,106-42-3,7809.0,Cc1ccc(C)cc1
NCGC00258696-01,tox21-er-bla-agonist-p2,5-Vinyl-2-norbornene,activity,inactive,3048-64-4,18273.0,C=CC2CC1C=CC2C1
NCGC00254617-01,tox21-er-bla-agonist-p2,4-Methylbenzenesulfonic acid hydrate,activity,inactive,6192-52-5,521998.0,O.Cc1ccc(cc1)S(O)(=O)=O
NCGC00254685-01,tox21-er-bla-agonist-p2,"1,4-Bis(N-isopropylamino)anthraquinone",activity,inactive,14233-37-5,61719.0,CC(C)Nc3ccc(NC(C)C)c2c3C(=O)c1ccccc1C2=O
NCGC00256370-01,tox21-er-bla-agonist-p2,Phenoxybenzamine hydrochloride,activity,active agonist,63-92-3,5284441.0,Cl.CC(COc1ccccc1)N(Cc2ccccc2)CCCl
NCGC00254928-01,tox21-er-bla-agonist-p2,Diphenylamine,activity,inactive,122-39-4,11487.0,c1ccccc1Nc2ccccc2
NCGC00254971-01,tox21-er-bla-agonist-p2,"1,4-Dibromobutane",activity,inactive,110-52-1,8056.0,BrCCCCBr
NCGC00255111-01,tox21-er-bla-agonist-p2,Sulfan blue,activity,inactive,129-17-9,8507.0,[Na+].CC/[N+](CC)=C1/C=C/C(C=C1)=C(/c2ccc(cc2)N(CC)CC)c3ccc(cc3S([O-])(=O)=O)S([O-])(=O)=O
NCGC00255215-01,tox21-er-bla-agonist-p2,Sodium lauryl polyoxyethylene ether sulfate,activity,inactive,9004-82-4,23665884.0,[Na+].[O-]S(=O)(=O)OCCOCCCCCCCCCCCC
NCGC00255817-01,tox21-er-bla-agonist-p2,"2,2'-Oxybis(ethylamine)",activity,inactive,2752-17-2,75982.0,NCCOCCN
NCGC00255944-01,tox21-er-bla-agonist-p2,Tiron,activity,inactive,149-45-1,9001.0,[Na+].[Na+].Oc1c(O)cc(cc1S(=O)([O-])=O)S([O-])(=O)=O
NCGC00093935-01,tox21-er-bla-agonist-p2,Flupirtine maleate,activity,inactive,75507-68-5,6435335.0,Nc1nc(ccc1NC(=O)OCC)NCc2ccc(F)cc2.O=C(O)/C=C\C(=O)O
NCGC00094135-01,tox21-er-bla-agonist-p2,Minocycline hydrochloride,activity,inactive,13614-98-7,54685925.0,Cl.CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O
NCGC00159431-02,tox21-er-bla-agonist-p2,dl-Methionine,activity,inactive,59-51-8,876.0,O=C(O)C(N)CCSC
NCGC00159464-02,tox21-er-bla-agonist-p2,Sitosterol alpha1,activity,inactive,474-40-8,9548595.0,CC(C)C(=C\C)/CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
NCGC00159520-02,tox21-er-bla-agonist-p2,Valacyclovir hydrochloride,activity,inactive,124832-27-5,60772.0,Cl.CC(C)[C@H](N)C(=O)OCCOCn2cnc1c2N=C(N)NC1=O
NCGC00164367-01,tox21-er-bla-agonist-p2,Paclitaxel,activity,inactive,33069-62-4,36314.0,O=C(N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@H]5C[C@@]6(O)[C@@H](OC(=O)c2ccccc2)[C@H]4[C@@](C)([C@@H](O)C[C@H]3OC[C@]34OC(C)=O)C(=O)[C@H](OC(C)=O)C(=C5C)C6(C)C)c7ccccc7
NCGC00094952-01,tox21-er-bla-agonist-p2,Cefoperazone sodium,activity,inactive,62893-20-3,23663974.0,[Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]5C(=O)N4C(=C(CSc3nnnn3C)CS[C@@H]45)C([O-])=O
NCGC00164544-01,tox21-er-bla-agonist-p2,Lanoconazole,activity,inactive,101530-10-3,9927058.0,N#C\C(=C1/SCC(S1)c2ccccc2Cl)n3ccnc3
NCGC00164556-01,tox21-er-bla-agonist-p2,Fudosteine,activity,inactive,13189-98-5,134669.0,OCCCSC[C@H](N)C(=O)O
NCGC00164609-01,tox21-er-bla-agonist-p2,Floxacillin sodium hydrate,activity,inactive,34214-51-2,23706211.0,[Na+].O.O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1c(F)cccc1Cl)[C@H]4SC3(C)C
NCGC00160538-01,tox21-er-bla-agonist-p2,Octaverine,activity,inactive,549-68-8,68363.0,CCOc1cc(cc(OCC)c1OCC)c3nccc2cc(OC)c(cc23)OC
NCGC00181037-01,tox21-er-bla-agonist-p2,Isoflurane,activity,inactive,26675-46-7,3763.0,FC(F)(F)C(Cl)OC(F)F
NCGC00166020-01,tox21-er-bla-agonist-p2,Ethyl 3-aminobenzoate methanesulfonic acid salt,activity,inactive,886-86-2,261501.0,Nc1cc(ccc1)C(=O)OCC.CS(=O)(=O)O
NCGC00095996-01,tox21-er-bla-agonist-p2,Acivicin,activity,inactive,42228-92-2,294641.0,N[C@H](C(=O)O)[C@@H]1CC(Cl)=NO1
NCGC00166100-01,tox21-er-bla-agonist-p2,(-)-Camphene,activity,inactive,5794-04-7,440966.0,CC2(C)C(=C)[C@@H]1CC[C@H]2C1
NCGC00160653-01,tox21-er-bla-agonist-p2,Glysobuzole,activity,inactive,3567-08-6,234310.0,O=S(=O)(Nc1nnc(CC(C)C)s1)c2ccc(OC)cc2
NCGC00166144-02,tox21-er-bla-agonist-p2,"2,3-Dihydroxypropyl octanoate",activity,inactive,502-54-5,3033877.0,OCC(O)COC(=O)CCCCCCC
NCGC00181102-01,tox21-er-bla-agonist-p2,Metoserpate hydrochloride,activity,inactive,1178-29-6,66251.0,Cl.O=C(OC)[C@@H]2[C@@H](OC)[C@H](C[C@@H]3CN4CCc1c5ccc(OC)cc5nc1[C@H]4C[C@H]23)OC
NCGC00159356-02,tox21-er-bla-agonist-p2,Nandrolone phenpropionate,activity,active agonist,62-90-8,229455.0,O=C5CC[C@H]4C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5
NCGC00162175-01,tox21-er-bla-agonist-p2,Alinidine,activity,inactive,33178-86-8,36354.0,C=CCN(C1=NCCN1)c2c(Cl)cccc2Cl
NCGC00091038-01,tox21-er-bla-agonist-p2,Sodium deoxycholate,activity,inactive,302-95-4,23668196.0,[Na+].[O-]C(=O)CC[C@@H](C)[C@H]2CC[C@H]1[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]12C
NCGC00182080-02,tox21-er-bla-agonist-p2,Valpromide,activity,inactive,2430-27-5,71113.0,CCCC(CCC)C(N)=O
NCGC00183853-01,tox21-er-bla-agonist-p2,Mosapramine,activity,inactive,89419-40-9,4257.0,Clc5ccc6CCc1ccccc1N(CCCN2CCC4(CC2)C(=O)NC3CCCCN34)c6c5
NCGC00184995-01,tox21-er-bla-agonist-p2,Estramustine phosphate,activity,active agonist,4891-15-0,259329.0,ClCCN(CCCl)C(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OP(=O)(O)O)c4cc3
NCGC00185764-01,tox21-er-bla-agonist-p2,(+)-gamma-Tocopherol,activity,inactive,54-28-4,92729.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)c(C)c(C)c2O1
NCGC00254219-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarboxylic acid",activity,inactive,121-91-5,8496.0,OC(=O)c1cccc(c1)C(=O)O
NCGC00255346-01,tox21-er-bla-agonist-p2,"N,N-Diethylcyclohexylamine",activity,inactive,91-65-6,61571.0,CCN(CC)C1CCCCC1
NCGC00247715-01,tox21-er-bla-agonist-p2,"S-(+)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",activity,inactive,50505-93-6,60196331.0,Cl.COc1cc(C[C@H](C)N)c(cc1Br)OC
NCGC00254729-01,tox21-er-bla-agonist-p2,Chlormephos,activity,inactive,24934-91-6,32739.0,CCOP(=S)(OCC)SCCl
NCGC00255378-01,tox21-er-bla-agonist-p2,Dipentenedimercaptan,activity,inactive,4802-20-4,20936.0,CC1CCC(CC1S)C(C)CS
NCGC00254370-01,tox21-er-bla-agonist-p2,Acetophenone,activity,inactive,98-86-2,7410.0,CC(=O)c1ccccc1
NCGC00255286-01,tox21-er-bla-agonist-p2,Pyridate,activity,inactive,55512-33-9,41463.0,O=C(SCCCCCCCC)Oc2cc(Cl)nnc2c1ccccc1
NCGC00254472-01,tox21-er-bla-agonist-p2,Tris(2-ethylhexyl) trimellitate,activity,inactive,3319-31-1,18725.0,CCC(CCCC)COC(=O)c1cc(C(=O)OCC(CC)CCCC)c(cc1)C(=O)OCC(CC)CCCC
NCGC00255149-01,tox21-er-bla-agonist-p2,"alpha-(2,5-Dichlorophenoxy)propionic acid",activity,inactive,6965-71-5,97971.0,Clc1ccc(Cl)cc1OC(C)C(=O)O
NCGC00181352-01,tox21-er-bla-agonist-p2,Aspoxicillin,activity,inactive,63358-49-6,71961.0,OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](N)CC(=O)NC)c1ccc(O)cc1)[C@H]3SC2(C)C
NCGC00257968-01,tox21-er-bla-agonist-p2,"2,4-Pentanedione",activity,inactive,123-54-6,31261.0,CC(=O)CC(C)=O
NCGC00160509-01,tox21-er-bla-agonist-p2,Picodralazine,activity,inactive,17692-43-2,71890.0,NNc3nnc(Cc1ccncc1)c2ccccc23
NCGC00257084-01,tox21-er-bla-agonist-p2,Sulfotepp,activity,inactive,3689-24-5,19395.0,CCOP(=S)(OCC)OP(=S)(OCC)OCC
NCGC00016651-03,tox21-er-bla-agonist-p2,N-Acetyl-L-aspartyl-L-glutamic acid,activity,inactive,4910-46-7,210320.0,O=C(N[C@@H](CCC(=O)O)C(=O)O)C[C@H](NC(C)=O)C(=O)O
NCGC00258094-01,tox21-er-bla-agonist-p2,Heptylparaben,activity,active agonist,1085-12-7,14138.0,Oc1ccc(cc1)C(=O)OCCCCCCC
NCGC00259698-01,tox21-er-bla-agonist-p2,Dodecanoic acid,activity,inactive,143-07-7,3893.0,O=C(O)CCCCCCCCCCC
NCGC00257468-01,tox21-er-bla-agonist-p2,FR140423,activity,inactive,151506-44-4,132932.0,CS(=O)c1ccc(cc1)c3cc(nn3c2ccc(OC)cc2)C(F)F
NCGC00260052-01,tox21-er-bla-agonist-p2,Cumene,activity,inactive,98-82-8,7406.0,CC(C)c1ccccc1
NCGC00260098-01,tox21-er-bla-agonist-p2,Tribenuron-methyl,activity,inactive,101200-48-0,153909.0,Cc1nc(nc(OC)n1)N(C)C(=O)NS(=O)(=O)c2ccccc2C(=O)OC
NCGC00256216-01,tox21-er-bla-agonist-p2,Lithium 3-carboxy-5-sulfobenzoate,activity,inactive,46728-75-0,23688987.0,[Li+].OS(=O)(=O)c1cc(cc(c1)C([O-])=O)C(=O)O
NCGC00260651-01,tox21-er-bla-agonist-p2,NTP Mix92 ER AR1 18-EQP,activity,active agonist,NOCAS_49547,,
NCGC00257791-01,tox21-er-bla-agonist-p2,Camphor,activity,inactive,76-22-2,2537.0,CC2(C)C1CC(=O)C2(C)CC1
NCGC00256565-01,tox21-er-bla-agonist-p2,"1,3-Dichloropropanone",activity,active agonist,534-07-6,10793.0,ClCC(=O)CCl
NCGC00256589-01,tox21-er-bla-agonist-p2,Tetrabutyltin,activity,inactive,1461-25-2,15098.0,CCCC[Sn](CCCC)(CCCC)CCCC
NCGC00256738-01,tox21-er-bla-agonist-p2,Triphenyllead acetate,activity,active agonist,1162-06-7,16682953.0,CC(=O)O[Pb](c1ccccc1)(c2ccccc2)c3ccccc3
NCGC00257459-01,tox21-er-bla-agonist-p2,Bicalutamide,activity,inactive,90357-06-5,56069.0,Fc1ccc(cc1)S(=O)(=O)C[C@](C)(O)C(=O)Nc2cc(c(C#N)cc2)C(F)(F)F
NCGC00257132-01,tox21-er-bla-agonist-p2,Diazoaminobenzene,activity,inactive,136-35-6,8689.0,N(=N/Nc1ccccc1)\c2ccccc2
NCGC00257850-01,tox21-er-bla-agonist-p2,Desmethoxyyangonin,activity,inactive,15345-89-8,5273621.0,COC=2C=C(/C=C/c1ccccc1)OC(=O)C=2
NCGC00257972-01,tox21-er-bla-agonist-p2,N-Butyl-1-butanamine,activity,inactive,111-92-2,8148.0,CCCCNCCCC
NCGC00257462-01,tox21-er-bla-agonist-p2,D&C Red 27,activity,inactive,13473-26-2,83511.0,Brc4c5Oc1c(Br)c(O)c(Br)cc1C3(OC(=O)c2c3c(Cl)c(Cl)c(Cl)c2Cl)c5cc(Br)c4O
NCGC00257660-01,tox21-er-bla-agonist-p2,5-Bromo-2'-deoxyuridine,activity,inactive,59-14-3,6035.0,BrC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00164449-04,tox21-er-bla-agonist-p2,PFOS,activity,inactive,1763-23-1,74483.0,FC(F)(C(F)(F)S(=O)(=O)O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00255481-01,tox21-er-bla-agonist-p2,Testosterone propionate,activity,active agonist,57-85-2,5995.0,CCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00255860-01,tox21-er-bla-agonist-p2,"(2R,5R)-5-Methyl-2-(propan-2-yl)cyclohexanone",activity,inactive,491-07-6,70962.0,CC(C)[C@H]1CC[C@@H](C)CC1=O
NCGC00255498-01,tox21-er-bla-agonist-p2,"C.I. Acid Orange 8, monosodium salt",activity,inactive,5850-86-2,23682559.0,[Na+].O=S([O-])(=O)c3cc(C)c(/N=N/c1c2ccccc2ccc1O)cc3
NCGC00255075-01,tox21-er-bla-agonist-p2,Fluazinam,activity,active agonist,79622-59-6,91731.0,[O-][N+](=O)c2cc(c(Cl)c(c2Nc1ncc(cc1Cl)C(F)(F)F)[N+]([O-])=O)C(F)(F)F
NCGC00255533-01,tox21-er-bla-agonist-p2,Diallyl disulfide,activity,inactive,2179-57-9,16590.0,C=CCSSCC=C
NCGC00255432-01,tox21-er-bla-agonist-p2,"C.I. Acid Orange 24, monosodium salt",activity,inactive,1320-07-6,57351929.0,[Na+].O=S([O-])(=O)c3ccc(/N=N/c2ccc(O)c(/N=N/c1ccc(C)cc1C)c2O)cc3
NCGC00256907-01,tox21-er-bla-agonist-p2,[3-(Trifluoromethyl)phenyl]acetonitrile,activity,inactive,2338-76-3,75360.0,FC(F)(F)c1cccc(CC#N)c1
NCGC00256421-01,tox21-er-bla-agonist-p2,N-Nitrosopyrrolidine,activity,inactive,930-55-2,13591.0,O=NN1CCCC1
NCGC00256945-01,tox21-er-bla-agonist-p2,Isopropyl formate,activity,inactive,625-55-8,12257.0,CC(C)OC=O
NCGC00256305-01,tox21-er-bla-agonist-p2,"3-[(3-Sulfanylpropanoyl)oxy]-2,2-bis{[(3-sulfanylpropanoyl)oxy]methyl}propyl 3-sulfanylpropanoate",activity,inactive,7575-23-7,82056.0,SCCC(=O)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS
NCGC00257087-01,tox21-er-bla-agonist-p2,"2,2'-Azobis(2-methylpropanenitrile)",activity,inactive,78-67-1,6547.0,N#CC(C)(C)/N=N/C(C)(C)C#N
NCGC00257426-01,tox21-er-bla-agonist-p2,Piragliatin,activity,inactive,625114-41-2,10432339.0,O=C(Nc1cnccn1)[C@H](C[C@@H]2CC(=O)CC2)c3ccc(c(Cl)c3)S(C)(=O)=O
NCGC00257546-01,tox21-er-bla-agonist-p2,"N,N-dimethylpyridin-4-amine",activity,inactive,1122-58-3,14284.0,CN(C)c1ccncc1
NCGC00257990-01,tox21-er-bla-agonist-p2,4-Methyl-2-pentanol,activity,inactive,108-11-2,7910.0,CC(C)CC(C)O
NCGC00258159-01,tox21-er-bla-agonist-p2,1-Allyl-3-methylimidazolium chloride,activity,inactive,65039-10-3,11321106.0,[Cl-].C[n+]1ccn(CC=C)c1
NCGC00258077-01,tox21-er-bla-agonist-p2,"4,6-Dichloro-1,3-benzenediol",activity,inactive,137-19-9,67299.0,Oc1cc(O)c(Cl)cc1Cl
NCGC00258290-01,tox21-er-bla-agonist-p2,2-Ethylhexylamine,activity,inactive,104-75-6,7719.0,CCC(CCCC)CN
NCGC00258308-01,tox21-er-bla-agonist-p2,4-Aminoacetanilide,activity,inactive,122-80-5,31230.0,O=C(C)Nc1ccc(N)cc1
NCGC00259784-01,tox21-er-bla-agonist-p2,Griseofulvin,activity,inactive,126-07-8,441140.0,O=C2c3c(O[C@]12C(=CC(=O)C[C@H]1C)OC)c(Cl)c(OC)cc3OC
NCGC00259785-01,tox21-er-bla-agonist-p2,2-Carboxyethyl acrylate,activity,inactive,24615-84-7,90558.0,O=C(O)CCOC(=O)C=C
NCGC00260025-01,tox21-er-bla-agonist-p2,"3,3'-(1,4-Phenylene)bis-2-propenoic acid",activity,inactive,16323-43-6,85983.0,O=C(O)C=Cc1ccc(C=CC(=O)O)cc1
NCGC00260020-01,tox21-er-bla-agonist-p2,"2,4-Dihydroxybenzoic acid",activity,inactive,89-86-1,1491.0,OC(=O)c1ccc(O)cc1O
NCGC00259113-01,tox21-er-bla-agonist-p2,Prednisone,activity,inactive,53-03-2,5865.0,OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)C=C[C@]1(C)[C@H]4C(=O)C[C@@]23C
NCGC00260328-01,tox21-er-bla-agonist-p2,Dinitrosopiperazine,activity,inactive,140-79-4,8819.0,O=NN1CCN(N=O)CC1
NCGC00260667-01,tox21-er-bla-agonist-p2,"1,1,1-Trichloroethane",activity,inactive,71-55-6,6278.0,CC(Cl)(Cl)Cl
NCGC00260234-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylpyridinium tetrafluoroborate,activity,inactive,597581-48-1,17841257.0,Cc1ccc[n+](CCCC)c1.F[B-](F)(F)F
NCGC00260242-01,tox21-er-bla-agonist-p2,1-Butylpyridinium trifluoromethanesulfonate,activity,inactive,390423-43-5,2734248.0,FC(F)(F)S([O-])(=O)=O.CCCC[n+]1ccccc1
NCGC00015806-03,tox21-er-bla-agonist-p2,Pirfenidone,activity,inactive,53179-13-8,40632.0,CC2=CN(c1ccccc1)C(=O)C=C2
NCGC00015446-05,tox21-er-bla-agonist-p2,Famotidine,activity,inactive,76824-35-6,3325.0,N/C(N)=N/c1nc(CSCCC(\N)=N/S(N)(=O)=O)cs1
NCGC00015726-06,tox21-er-bla-agonist-p2,Nialamide,activity,inactive,51-12-7,4472.0,O=C(NNCCC(=O)NCc1ccccc1)c2ccncc2
NCGC00016340-01,tox21-er-bla-agonist-p2,Ethotoin,activity,inactive,86-35-1,3292.0,O=C2NC(c1ccccc1)C(=O)N2CC
NCGC00016914-01,tox21-er-bla-agonist-p2,Cefotetan,activity,inactive,69712-56-7,53025.0,NC(=O)/C(C(=O)O)=C1/SC(S1)C(=O)N[C@]4(OC)C(=O)N3C(=C(CSc2nnnn2C)CS[C@@H]34)C(=O)O
NCGC00016390-01,tox21-er-bla-agonist-p2,Piperidolate hydrochloride,activity,inactive,129-77-1,8520.0,Cl.CCN3CCCC(OC(=O)C(c1ccccc1)c2ccccc2)C3
NCGC00016461-01,tox21-er-bla-agonist-p2,alpha-Santonin,activity,inactive,481-06-1,221071.0,O=C1C=C[C@]2(C)CC[C@H]3[C@H](C)C(=O)O[C@@H]3C2=C1C
NCGC00016256-08,tox21-er-bla-agonist-p2,Pyrimethamine,activity,inactive,58-14-0,4993.0,CCc1nc(N)nc(N)c1c2ccc(Cl)cc2
NCGC00094412-02,tox21-er-bla-agonist-p2,Tulobuterol hydrochloride,activity,inactive,56776-01-3,5702285.0,Cl.OC(CNC(C)(C)C)c1ccccc1Cl
NCGC00255891-01,tox21-er-bla-agonist-p2,Phenylarsine oxide,activity,active agonist,637-03-6,4778.0,O=[As]c1ccccc1
NCGC00255932-01,tox21-er-bla-agonist-p2,4-Chlorophenyl phenyl sulfone,activity,inactive,80-00-2,6621.0,O=S(=O)(c1ccc(Cl)cc1)c2ccccc2
NCGC00255294-01,tox21-er-bla-agonist-p2,Pimozide,activity,inactive,2062-78-4,16362.0,Fc1ccc(cc1)C(CCCN2CCC(CC2)N3c4ccccc4NC3=O)c5ccc(F)cc5
NCGC00254360-01,tox21-er-bla-agonist-p2,Dioctyl phthalate,activity,inactive,117-84-0,8346.0,O=C(OCCCCCCCC)c1ccccc1C(=O)OCCCCCCCC
NCGC00254363-01,tox21-er-bla-agonist-p2,FD&C Blue No. 1,activity,inactive,3844-45-9,19700.0,[Na+].[Na+].CC/[N+](Cc1cccc(c1)S([O-])(=O)=O)=C2\C=C/C(C=C2)=C(\c3ccc(cc3)N(Cc4cccc(c4)S([O-])(=O)=O)CC)c5ccccc5S([O-])(=O)=O
NCGC00254574-01,tox21-er-bla-agonist-p2,Ametryn,activity,inactive,834-12-8,13263.0,CSc1nc(NCC)nc(NC(C)C)n1
NCGC00255191-01,tox21-er-bla-agonist-p2,Benzyl methacrylate,activity,inactive,2495-37-6,17236.0,C=C(C)C(=O)OCc1ccccc1
NCGC00255363-01,tox21-er-bla-agonist-p2,Siduron,activity,inactive,1982-49-6,16116.0,O=C(NC1CCCCC1C)Nc2ccccc2
NCGC00015252-08,tox21-er-bla-agonist-p2,Cyproheptadine,activity,inactive,129-03-3,2913.0,CN1CC\C(CC1)=C2\c4ccccc4C=Cc3ccccc23
NCGC00015437-10,tox21-er-bla-agonist-p2,Fenofibrate,activity,inactive,49562-28-9,3339.0,O=C(c1ccc(Cl)cc1)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2
NCGC00015686-05,tox21-er-bla-agonist-p2,Gallopamil hydrochloride,activity,inactive,16662-46-7,119442.0,Cl.COc1c(cc(cc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C)OC
NCGC00015826-02,tox21-er-bla-agonist-p2,Perphenazine,activity,inactive,58-39-9,4748.0,OCCN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23
NCGC00016760-01,tox21-er-bla-agonist-p2,Carbimazole,activity,inactive,22232-54-8,31072.0,S=C1N(C=CN1C)C(=O)OCC
NCGC00161622-02,tox21-er-bla-agonist-p2,Actinomycin D,activity,inactive,50-76-0,457193.0,CC(C)[C@H]6NC(=O)[C@@H](NC(=O)c1ccc(C)c2OC3=C(C)C(=O)C(N)=C(C3=Nc12)C(=O)N[C@@H]5C(=O)N[C@@H](C(=O)N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C6=O
NCGC00183827-01,tox21-er-bla-agonist-p2,Indalpine hydrochloride,activity,inactive,63845-42-1,60196352.0,Cl.C(CC1CCNCC1)c2cnc3ccccc23
NCGC00254992-01,tox21-er-bla-agonist-p2,tert-Butylacrylamide,activity,inactive,107-58-4,7877.0,CC(C)(C)NC(=O)C=C
NCGC00260456-01,tox21-er-bla-agonist-p2,4-Amino-m-cresol,activity,inactive,2835-99-6,17819.0,Cc1cc(O)ccc1N
NCGC00016841-01,tox21-er-bla-agonist-p2,Penbutolol sulfate,activity,inactive,38363-32-5,38010.0,O=S(=O)(O)O.CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2.CC(C)(C)NC[C@H](O)COc1ccccc1C2CCCC2
NCGC00159374-02,tox21-er-bla-agonist-p2,Chloral hydrate,activity,inactive,302-17-0,2707.0,ClC(Cl)(Cl)C(O)O
NCGC00160644-01,tox21-er-bla-agonist-p2,2-Methylpyridine,activity,inactive,109-06-8,7975.0,Cc1ccccn1
NCGC00167518-01,tox21-er-bla-agonist-p2,Temsirolimus,activity,inactive,162635-04-3,6918289.0,CC(CO)(CO)C(=O)O[C@@H]1CC[C@H](C[C@H]1OC)C[C@@H](C)[C@H]2OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@]3(O)O[C@H](C[C@H](OC)C(C)=CC=CC=C[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)C(C)=C[C@@H](C)C(=O)C2)CC[C@H]3C
NCGC00247701-01,tox21-er-bla-agonist-p2,"1-(1,3-Benzodioxol-5-yl)-N-hydroxypropan-2-amine hydrochloride",activity,inactive,74341-83-6,60196328.0,Cl.CC(NO)Cc1ccc2OCOc2c1
NCGC00247721-01,tox21-er-bla-agonist-p2,Dihydromorphine,activity,inactive,509-60-4,5359421.0,Oc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)CC[C@@H]45
NCGC00254171-01,tox21-er-bla-agonist-p2,SB202235,activity,inactive,139149-55-6,153939.0,NC(=O)N(O)[C@@H]2COc1cc(ccc12)OCc3ccccc3
NCGC00016943-01,tox21-er-bla-agonist-p2,Fluticasone propionate,activity,inactive,80474-14-2,54580.0,O=C(SCF)[C@@]4(OC(=O)CC)[C@H](C)C[C@H]3C2C[C@H](F)C1=CC(=O)C=C[C@]1(C)[C@@]2(F)[C@@H](O)C[C@@]34C
NCGC00016959-01,tox21-er-bla-agonist-p2,Ciprofloxacin hydrochloride,activity,inactive,93107-08-5,62999.0,Cl.O=C(O)C2=CN(c1cc(c(F)cc1C2=O)N3CCNCC3)C4CC4
NCGC00090721-03,tox21-er-bla-agonist-p2,"N,N'-Methylenebisacrylamide",activity,inactive,110-26-9,8041.0,C=CC(=O)NCNC(=O)C=C
NCGC00090965-03,tox21-er-bla-agonist-p2,Propylparaben,activity,active agonist,94-13-3,7175.0,Oc1ccc(cc1)C(=O)OCCC
NCGC00017009-01,tox21-er-bla-agonist-p2,Pentolinium ditartrate,activity,inactive,52-62-0,6604155.0,O=C(O)[C@H](O)[C@H](O)C([O-])=O.O=C(O)[C@H](O)[C@H](O)C([O-])=O.C[N+]1(CCCC1)CCCCC[N+]2(C)CCCC2
NCGC00017112-01,tox21-er-bla-agonist-p2,Ciclopirox olamine,activity,inactive,41621-49-2,38911.0,CC=2C=C(C1CCCCC1)N(O)C(=O)C=2.NCCO
NCGC00017280-10,tox21-er-bla-agonist-p2,trans-Retinoic acid,activity,active agonist,302-79-4,444795.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=C\C(\C)=C\C(=O)O
NCGC00024740-02,tox21-er-bla-agonist-p2,Anpirtoline,activity,inactive,98330-05-3,65854.0,Clc2nc(SC1CCNCC1)ccc2
NCGC00025349-02,tox21-er-bla-agonist-p2,Apomorphine,activity,inactive,58-00-4,6005.0,Oc3ccc2C[C@@H]1c4c(CCN1C)cccc4c2c3O
NCGC00016908-01,tox21-er-bla-agonist-p2,Naftifine hydrochloride,activity,inactive,65473-14-5,5281098.0,Cl.CN(C\C=C\c1ccccc1)Cc3cccc2ccccc23
NCGC00256970-01,tox21-er-bla-agonist-p2,alpha-Lipoic acid,activity,inactive,1077-28-7,864.0,O=C(O)CCCCC1CCSS1
NCGC00257007-01,tox21-er-bla-agonist-p2,Hexamethyldisiloxane,activity,inactive,107-46-0,24764.0,C[Si](C)(C)O[Si](C)(C)C
NCGC00258630-01,tox21-er-bla-agonist-p2,"1,2-Dihydro-2,2,4-trimethylquinoline",activity,inactive,147-47-7,8981.0,CC2=CC(C)(C)Nc1ccccc12
NCGC00257270-01,tox21-er-bla-agonist-p2,Hexanal,activity,inactive,66-25-1,6184.0,CCCCCC=O
NCGC00257392-01,tox21-er-bla-agonist-p2,(-)-alpha-Pinene,activity,inactive,7785-26-4,440968.0,CC2(C)[C@H]1CC=C(C)[C@@H]2C1
NCGC00257441-01,tox21-er-bla-agonist-p2,Methyl 2-methyl-3-furyl disulfide,activity,inactive,65505-17-1,47649.0,Cc1occc1SSC
NCGC00257683-01,tox21-er-bla-agonist-p2,Benzenemethanethiol,activity,inactive,100-53-8,7509.0,SCc1ccccc1
NCGC00257691-01,tox21-er-bla-agonist-p2,4-Nitrobenzoyl chloride,activity,inactive,122-04-3,8502.0,O=[N+]([O-])c1ccc(cc1)C(Cl)=O
NCGC00257775-01,tox21-er-bla-agonist-p2,Chlorotrimethylsilane,activity,inactive,75-77-4,6397.0,C[Si](C)(C)Cl
NCGC00258025-01,tox21-er-bla-agonist-p2,"1,4-Piperazinediethanol",activity,inactive,122-96-3,67151.0,OCCN1CCN(CC1)CCO
NCGC00258200-01,tox21-er-bla-agonist-p2,"2,2-Dimethylpropanoyl chloride",activity,inactive,3282-30-2,62493.0,CC(C)(C)C(Cl)=O
NCGC00255720-01,tox21-er-bla-agonist-p2,Edifenphos,activity,inactive,17109-49-8,28292.0,O=P(Sc1ccccc1)(Sc2ccccc2)OCC
NCGC00255866-01,tox21-er-bla-agonist-p2,Oxyphenisatin,activity,inactive,125-13-3,31315.0,Oc1ccc(cc1)C2(c3ccccc3NC2=O)c4ccc(O)cc4
NCGC00255991-01,tox21-er-bla-agonist-p2,N-Chlorosuccinimide,activity,inactive,128-09-6,31398.0,O=C1CCC(=O)N1Cl
NCGC00256115-01,tox21-er-bla-agonist-p2,"Propane-1,3-diyl bis(4-aminobenzoate)",activity,inactive,57609-64-0,93312.0,Nc1ccc(cc1)C(=O)OCCCOC(=O)c2ccc(N)cc2
NCGC00256249-01,tox21-er-bla-agonist-p2,Valencene,activity,inactive,4630-07-3,9855795.0,C=C(C)[C@@H]1CCC2=CCC[C@@H](C)[C@]2(C)C1
NCGC00256286-01,tox21-er-bla-agonist-p2,Piperazine dihydrochloride,activity,inactive,142-64-3,8893.0,Cl.Cl.C1CNCCN1
NCGC00260623-01,tox21-er-bla-agonist-p2,NTP Mix98 ER1 10-EQC,activity,inactive,NOCAS_49519,,
NCGC00259174-01,tox21-er-bla-agonist-p2,2-Octanol,activity,inactive,123-96-6,20083.0,CC(O)CCCCCC
NCGC00259510-01,tox21-er-bla-agonist-p2,Diallyl phthalate,activity,inactive,131-17-9,8560.0,O=C(OCC=C)c1ccccc1C(=O)OCC=C
NCGC00259675-01,tox21-er-bla-agonist-p2,2-Ethylhexyl phosphate,activity,inactive,12645-31-7,14050.0,OP(O)(=O)OCC(CCCC)CC
NCGC00260107-01,tox21-er-bla-agonist-p2,"Hexadecanoic acid, 1-methylethyl ester",activity,inactive,142-91-6,8907.0,CC(C)OC(=O)CCCCCCCCCCCCCCC
NCGC00254651-01,tox21-er-bla-agonist-p2,Hexazinone,activity,inactive,51235-04-2,39965.0,CN(C)C2=NC(=O)N(C1CCCCC1)C(=O)N2C
NCGC00254732-01,tox21-er-bla-agonist-p2,Flumetsulam,activity,inactive,98967-40-9,91759.0,Fc3cccc(F)c3NS(=O)(=O)c1nc2nc(C)ccn2n1
NCGC00254749-01,tox21-er-bla-agonist-p2,Aldicarb,activity,inactive,116-06-3,2086.0,CC(C)(\C=N\OC(=O)NC)SC
NCGC00254783-01,tox21-er-bla-agonist-p2,Pymetrozine,activity,inactive,123312-89-0,9576037.0,CC=2CN(/N=C/c1cccnc1)C(=O)NN=2
NCGC00256274-01,tox21-er-bla-agonist-p2,"2,2'-[(3-Aminopropyl)imino]diethanol",activity,inactive,4985-85-7,21088.0,OCCN(CCCN)CCO
NCGC00254966-01,tox21-er-bla-agonist-p2,Bifenthrin,activity,inactive,82657-04-3,5281872.0,Cl\C(=C/C3C(C(=O)OCc2cccc(c1ccccc1)c2C)C3(C)C)C(F)(F)F
NCGC00255440-01,tox21-er-bla-agonist-p2,Quinaldine,activity,inactive,91-63-4,7060.0,Cc1ccc2ccccc2n1
NCGC00255444-01,tox21-er-bla-agonist-p2,Butoxycarboxim,activity,inactive,34681-23-7,9571009.0,CC(C(\C)=N\OC(=O)NC)S(C)(=O)=O
NCGC00255517-01,tox21-er-bla-agonist-p2,"2-Chloro-4,6-dimethylaniline",activity,inactive,63133-82-4,113033.0,Cc1cc(C)cc(Cl)c1N
NCGC00255729-01,tox21-er-bla-agonist-p2,Ethenyl(triethoxy)silane,activity,inactive,78-08-0,6516.0,CCO[Si](OCC)(OCC)C=C
NCGC00256071-01,tox21-er-bla-agonist-p2,4-(Ethenyloxy)butan-1-ol,activity,inactive,17832-28-9,87329.0,C=COCCCCO
NCGC00091792-01,tox21-er-bla-agonist-p2,Epichlorohydrin,activity,inactive,106-89-8,7835.0,ClCC1CO1
NCGC00167420-01,tox21-er-bla-agonist-p2,Perflenapent,activity,inactive,678-26-2,12675.0,FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)F
NCGC00164446-01,tox21-er-bla-agonist-p2,Ciglitizone,activity,inactive,74772-77-3,2750.0,CC1(CCCCC1)COc3ccc(CC2SC(=O)NC2=O)cc3
NCGC00094987-01,tox21-er-bla-agonist-p2,4-Amino-3-hydroxybutyric acid,activity,inactive,924-49-2,2149.0,O=C(O)CC(O)CN
NCGC00160415-01,tox21-er-bla-agonist-p2,Guaiactamine,activity,inactive,15687-23-7,36190.0,CCN(CCOc1ccccc1OC)CC
NCGC00095048-01,tox21-er-bla-agonist-p2,Pipobroman,activity,inactive,54-91-1,4842.0,O=C(CCBr)N1CCN(CC1)C(=O)CCBr
NCGC00164557-01,tox21-er-bla-agonist-p2,Eprosartan mesylate,activity,inactive,144143-96-4,5282474.0,OC(=O)C(/Cc1cccs1)=C/c3cnc(CCCC)n3Cc2ccc(cc2)C(=O)O.CS(=O)(=O)O
NCGC00181029-01,tox21-er-bla-agonist-p2,"1,2-Ditetradecanoyl-rac-glycerol-3-phosphocholine",activity,inactive,18656-38-7,26197.0,C[N+](C)(C)CCOP([O-])(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC
NCGC00095911-03,tox21-er-bla-agonist-p2,Quetiapine,activity,inactive,111974-69-7,5002.0,OCCOCCN1CCN(CC1)C3=Nc4ccccc4Sc2ccccc23
NCGC00096077-03,tox21-er-bla-agonist-p2,Olanzapine,activity,inactive,132539-06-1,4585.0,CN1CCN(CC1)C2=Nc4ccccc4Nc3sc(C)cc23
NCGC00096080-01,tox21-er-bla-agonist-p2,Mucic acid,activity,inactive,526-99-8,3037582.0,O[C@@H]([C@H](O)[C@H](O)[C@@H](O)C(=O)O)C(=O)O
NCGC00160665-01,tox21-er-bla-agonist-p2,Proroxan,activity,inactive,33743-96-3,36303.0,O=C(CCN1CCC(C1)c2ccccc2)c3ccc4OCCOc4c3
NCGC00181110-01,tox21-er-bla-agonist-p2,Cambendazole,activity,inactive,26097-80-3,33309.0,CC(C)OC(=O)Nc1cc2nc(nc2cc1)c3cscn3
NCGC00159362-02,tox21-er-bla-agonist-p2,Huperzine A,activity,inactive,102518-79-6,854026.0,CC2=C[C@H]\3CC=1NC(=O)C=CC=1[C@@](N)(C2)C/3=C\C
NCGC00161605-01,tox21-er-bla-agonist-p2,Ascorbyl palmitate,activity,inactive,137-66-6,54680660.0,OC=1C(=O)O[C@H]([C@@H](O)COC(=O)CCCCCCCCCCCCCCC)C=1O
NCGC00162275-02,tox21-er-bla-agonist-p2,Nalbuphine,activity,inactive,20594-83-6,5311304.0,Oc1ccc2C[C@H]4N(CC[C@@]35[C@@H](Oc1c23)[C@@H](O)CC[C@@]45O)CC6CCC6
NCGC00163127-02,tox21-er-bla-agonist-p2,Acitretin,activity,active agonist,55079-83-9,5284513.0,Cc1c(C)c(/C=CC(\C)=C\C=C\C(\C)=C\C(=O)O)c(C)cc1OC
NCGC00181914-01,tox21-er-bla-agonist-p2,Alloclamide,activity,inactive,5486-77-1,71837.0,O=C(NCCN(CC)CC)c1ccc(Cl)cc1OCC=C
NCGC00183270-01,tox21-er-bla-agonist-p2,Acifluorfen-sodium,activity,inactive,62476-59-9,44072.0,[Na+].Clc2cc(ccc2Oc1cc(C([O-])=O)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00254153-01,tox21-er-bla-agonist-p2,SAR102779,activity,inactive,NOCAS_47387,60196411.0,O=C2CO[C@](CN2c1ccccc1)(CCN3CCC(NC(C)=O)(CC3)c4cccc(F)c4)c5ccc(Cl)c(Cl)c5.O=C(O)CCC(=O)O
NCGC00255002-01,tox21-er-bla-agonist-p2,Thiram,activity,inactive,137-26-8,5455.0,CN(C)C(=S)SSC(=S)N(C)C
NCGC00185766-01,tox21-er-bla-agonist-p2,Esmolol hydrochloride,activity,inactive,81161-17-3,104769.0,Cl.CC(C)NCC(O)COc1ccc(cc1)CCC(=O)OC
NCGC00255272-01,tox21-er-bla-agonist-p2,2-Hydroxyethyl octyl sulfide,activity,inactive,3547-33-9,19079.0,OCCSCCCCCCCC
NCGC00189076-01,tox21-er-bla-agonist-p2,Dibromopropamidine dihydrochloride,activity,inactive,50357-61-4,60196366.0,Cl.Cl.Brc2cc(ccc2OCCCOc1ccc(cc1Br)C(=N)N)C(=N)N
NCGC00247331-02,tox21-er-bla-agonist-p2,S-(-)-Secobarbital,activity,inactive,20224-45-7,31143.0,O=C1NC(=O)NC(=O)C1(CC=C)[C@H](C)CCC
NCGC00247695-01,tox21-er-bla-agonist-p2,cis-N-[1-[2-(2-Thienyl)ethyl]-3-methyl-4-piperidyl]-N-phenylpropanamide hydrochloride,activity,inactive,131690-45-4,60196323.0,Cl.CCC(=O)N(c1ccccc1)C2CCN(CC2C)CCc3cccs3
NCGC00255178-01,tox21-er-bla-agonist-p2,2-(Diisopropylamino)ethanol,activity,inactive,96-80-0,7313.0,CC(C)N(CCO)C(C)C
NCGC00247732-01,tox21-er-bla-agonist-p2,Psilocybin,activity,inactive,520-52-5,10624.0,O=P(O)(O)Oc2cccc1ncc(CCN(C)C)c12
NCGC00254059-01,tox21-er-bla-agonist-p2,C.I. Solvent Yellow 14,activity,inactive,842-07-9,5858445.0,Oc3ccc1ccccc1c3/N=N/c2ccccc2
NCGC00254080-01,tox21-er-bla-agonist-p2,Hexanedinitrile,activity,inactive,111-69-3,8128.0,N#CCCCCC#N
NCGC00255147-01,tox21-er-bla-agonist-p2,"1,2-Epoxydodecane",activity,inactive,2855-19-8,17858.0,CCCCCCCCCCC1CO1
NCGC00182981-01,tox21-er-bla-agonist-p2,Proxazole citrate,activity,inactive,132-35-4,8589.0,CCC(c1nc(CCN(CC)CC)on1)c2ccccc2.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00259411-01,tox21-er-bla-agonist-p2,"1,2,4-Tribromobenzene",activity,inactive,615-54-3,12002.0,Brc1cc(Br)c(Br)cc1
NCGC00257893-01,tox21-er-bla-agonist-p2,Pentabromophenol,activity,inactive,608-71-9,11852.0,Brc1c(O)c(Br)c(Br)c(Br)c1Br
NCGC00258455-01,tox21-er-bla-agonist-p2,Methysticin,activity,inactive,495-85-2,5281567.0,O=C3C=C(C[C@H](/C=C/c1ccc2OCOc2c1)O3)OC
NCGC00015590-03,tox21-er-bla-agonist-p2,Linopirdine,activity,inactive,105431-72-9,3932.0,O=C4N(c1ccccc1C4(Cc2ccncc2)Cc3ccncc3)c5ccccc5
NCGC00258163-01,tox21-er-bla-agonist-p2,1-Butylpyridinium hexafluorophosphate,activity,inactive,186088-50-6,2734176.0,F[P-](F)(F)(F)(F)F.CCCC[n+]1ccccc1
NCGC00258448-01,tox21-er-bla-agonist-p2,Bromochloroacetic acid,activity,inactive,5589-96-8,542762.0,BrC(Cl)C(=O)O
NCGC00258601-01,tox21-er-bla-agonist-p2,4-Methylimidazole,activity,inactive,822-36-6,13195.0,Cc1cncn1
NCGC00255643-01,tox21-er-bla-agonist-p2,(3Z)-3-Hexenyl acetate,activity,inactive,3681-71-8,5363388.0,O=C(C)OCC/C=C\CC
NCGC00257677-01,tox21-er-bla-agonist-p2,2-Hydroxyisobutyric acid,activity,inactive,594-61-6,11671.0,O=C(O)C(C)(C)O
NCGC00256814-01,tox21-er-bla-agonist-p2,3-Phenyl-2-propen-1-yl 3-phenylacrylate,activity,inactive,122-69-0,31224.0,O=C(C=Cc1ccccc1)OCC=Cc2ccccc2
NCGC00259251-01,tox21-er-bla-agonist-p2,4-Aminobenzoic acid,activity,inactive,150-13-0,978.0,OC(=O)c1ccc(N)cc1
NCGC00256876-01,tox21-er-bla-agonist-p2,Naphthalen-2-yl 2-aminobenzoate,activity,inactive,63449-68-3,62217.0,Nc1ccccc1C(=O)Oc2ccc3ccccc3c2
NCGC00257219-01,tox21-er-bla-agonist-p2,Sodium benzenethiolate,activity,inactive,930-69-8,4110039.0,[Na+].[S-]c1ccccc1
NCGC00013109-01,tox21-er-bla-agonist-p2,Phenol red,activity,inactive,143-74-8,4766.0,Oc1ccc(cc1)C3(OS(=O)(=O)c2ccccc23)c4ccc(O)cc4
NCGC00015947-02,tox21-er-bla-agonist-p2,Siguazodan,activity,inactive,115344-47-3,72124.0,N#CN/C(NC)=N/c1ccc(cc1)C2=NNC(=O)CC2C
NCGC00258461-01,tox21-er-bla-agonist-p2,Kavain,activity,inactive,500-64-1,5281565.0,O=C2C=C(C[C@H](/C=C/c1ccccc1)O2)OC
NCGC00257624-01,tox21-er-bla-agonist-p2,"2-Bromo-4,6-dinitroaniline",activity,inactive,1817-73-8,15752.0,Nc1c(cc(cc1Br)[N+]([O-])=O)[N+]([O-])=O
NCGC00259177-01,tox21-er-bla-agonist-p2,Pentyl acetate,activity,inactive,628-63-7,12348.0,CC(=O)OCCCCC
NCGC00255516-01,tox21-er-bla-agonist-p2,2-Octen-1-ylsuccinic anhydride,activity,inactive,42482-06-4,534543.0,O=C1OC(=O)CC1CC=CCCCCC
NCGC00256634-01,tox21-er-bla-agonist-p2,Cyclohex-3-en-1-ylmethanol,activity,inactive,1679-51-2,15512.0,OCC1CC=CCC1
NCGC00255904-01,tox21-er-bla-agonist-p2,"2,4-Dimethylcyclohex-3-ene-1-carbaldehyde",activity,inactive,68039-49-6,93375.0,CC1C=C(C)CCC1C=O
NCGC00256996-01,tox21-er-bla-agonist-p2,"N-[3-(Trimethoxysilyl)propyl]ethane-1,2-diamine",activity,inactive,1760-24-3,15659.0,CO[Si](CCCNCCN)(OC)OC
NCGC00257127-01,tox21-er-bla-agonist-p2,"1,4-Benzenedicarbonyl dichloride",activity,inactive,100-20-9,7488.0,O=C(Cl)c1ccc(cc1)C(Cl)=O
NCGC00258006-01,tox21-er-bla-agonist-p2,4-tert-Butylbenzaldehyde,activity,inactive,939-97-9,70324.0,CC(C)(C)c1ccc(C=O)cc1
NCGC00257913-01,tox21-er-bla-agonist-p2,tert-Butyl formate,activity,inactive,762-75-4,61207.0,CC(C)(C)OC=O
NCGC00257453-01,tox21-er-bla-agonist-p2,Diethylbenzene,activity,inactive,25340-17-4,8657.0,CCc1ccccc1CC
NCGC00257483-01,tox21-er-bla-agonist-p2,(2E)-2-Hexenal,activity,inactive,6728-26-3,5281168.0,CCC\C=C\C=O
NCGC00257930-01,tox21-er-bla-agonist-p2,4-Biphenylamine,activity,inactive,92-67-1,7102.0,Nc1ccc(cc1)c2ccccc2
NCGC00257511-01,tox21-er-bla-agonist-p2,17beta-Trenbolone,activity,active agonist,10161-33-8,25015.0,O=C3C=C4CC[C@@H]1C(C=C[C@]2(C)[C@@H](O)CC[C@@H]12)=C4CC3
NCGC00257733-01,tox21-er-bla-agonist-p2,Ethyl 3-ethoxypropionate,activity,inactive,763-69-9,12989.0,CCOCCC(=O)OCC
NCGC00258271-01,tox21-er-bla-agonist-p2,1-Methyl-3-propylimidazolium bis(trifluoromethylsulfonyl)imide,activity,inactive,216299-72-8,12040508.0,C[n+]1ccn(CCC)c1.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00258894-01,tox21-er-bla-agonist-p2,Docusate sodium,activity,inactive,577-11-7,23673837.0,[Na+].O=S(=O)([O-])C(CC(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC
NCGC00258288-01,tox21-er-bla-agonist-p2,"1,3-Benzenediamine dihydrochloride",activity,inactive,541-69-5,10941.0,Cl.Cl.Nc1cccc(N)c1
NCGC00258688-01,tox21-er-bla-agonist-p2,"Creosote, wood",activity,inactive,8021-39-4,460.0,Oc1ccccc1OC
NCGC00258712-01,tox21-er-bla-agonist-p2,Cimetidine,activity,inactive,51481-61-9,2756.0,N#C\N=C(/NC)NCCSCc1ncnc1C
NCGC00258779-01,tox21-er-bla-agonist-p2,"3-Chloro-2,2-dimethylpropanoyl chloride",activity,inactive,4300-97-4,61345.0,CC(C)(CCl)C(Cl)=O
NCGC00259068-01,tox21-er-bla-agonist-p2,"2,7-Acetylaminofluorene",activity,inactive,304-28-9,9352.0,CC(=O)Nc1ccc2c3ccc(cc3Cc2c1)NC(C)=O
NCGC00258417-01,tox21-er-bla-agonist-p2,Sodium 2-mercaptoethanesulfonate,activity,inactive,19767-45-4,23662354.0,[Na+].[O-]S(=O)(=O)CCS
NCGC00259306-01,tox21-er-bla-agonist-p2,Methyl decanoate,activity,inactive,110-42-9,8050.0,O=C(CCCCCCCCC)OC
NCGC00259405-01,tox21-er-bla-agonist-p2,"2,2-Bis(bromomethyl)-1,3-propanediol",activity,inactive,3296-90-0,18692.0,OCC(CBr)(CBr)CO
NCGC00259437-01,tox21-er-bla-agonist-p2,Benzoin,activity,inactive,119-53-9,8400.0,OC(C(=O)c1ccccc1)c2ccccc2
NCGC00260392-01,tox21-er-bla-agonist-p2,Atropine sulfate anhydrous (2:1) salt,activity,inactive,55-48-1,60196398.0,CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(CO)c2ccccc2.O=S(=O)(O)O.OCC(c1ccccc1)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C
NCGC00015615-02,tox21-er-bla-agonist-p2,Lansoprazole,activity,inactive,103577-45-3,3883.0,FC(F)(F)COc3ccnc(CS(=O)c1nc2ccccc2n1)c3C
NCGC00015360-05,tox21-er-bla-agonist-p2,Pentetic acid,activity,inactive,67-43-6,3053.0,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O
NCGC00015436-07,tox21-er-bla-agonist-p2,Fluphenazine,activity,inactive,69-23-8,3372.0,FC(F)(F)c2cc3N(CCCN1CCN(CCO)CC1)c4ccccc4Sc3cc2
NCGC00015529-09,tox21-er-bla-agonist-p2,Ibuprofen,activity,inactive,15687-27-1,3672.0,CC(C(=O)O)c1ccc(CC(C)C)cc1
NCGC00015954-02,tox21-er-bla-agonist-p2,Sobuzoxane,activity,inactive,98631-95-9,5233.0,CC(C)COC(=O)OCN2C(=O)CN(CCN1CC(=O)N(COC(=O)OCC(C)C)C(=O)C1)CC2=O
NCGC00016312-01,tox21-er-bla-agonist-p2,Bendroflumethiazide,activity,inactive,73-48-3,2315.0,FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)Cc3ccccc3
NCGC00016360-01,tox21-er-bla-agonist-p2,4-(Benzyloxyl)phenol,activity,active agonist,103-16-2,7638.0,Oc2ccc(OCc1ccccc1)cc2
NCGC00016572-01,tox21-er-bla-agonist-p2,Sulfamonomethoxine,activity,inactive,1220-83-3,5332.0,O=S(=O)(Nc1cc(OC)ncn1)c2ccc(N)cc2
NCGC00093867-01,tox21-er-bla-agonist-p2,Safingol,activity,inactive,15639-50-6,3058739.0,N[C@@H](CO)[C@@H](O)CCCCCCCCCCCCCCC
NCGC00161254-02,tox21-er-bla-agonist-p2,4-Hydroxy-2-nonenal,activity,inactive,75899-68-2,5283344.0,CCCCCC(O)/C=C/C=O
NCGC00168784-01,tox21-er-bla-agonist-p2,Gemcitabine hydrochloride,activity,inactive,122111-03-9,60749.0,Cl.NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F
NCGC00168787-01,tox21-er-bla-agonist-p2,Norelgestromin,activity,active agonist,53016-31-2,9568628.0,O\N=C4/CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00255918-01,tox21-er-bla-agonist-p2,Isoprocarb,activity,inactive,2631-40-5,17517.0,O=C(Oc1ccccc1C(C)C)NC
NCGC00255017-01,tox21-er-bla-agonist-p2,3-Iodo-2-propynyl-N-butylcarbamate,activity,inactive,55406-53-6,62097.0,O=C(NCCCC)OCC#CI
NCGC00254410-01,tox21-er-bla-agonist-p2,Etofenprox,activity,inactive,80844-07-1,71245.0,CCOc1ccc(cc1)C(C)(C)COCc3cc(Oc2ccccc2)ccc3
NCGC00254444-01,tox21-er-bla-agonist-p2,Pentachloropyridine,activity,inactive,2176-62-7,16584.0,Clc1c(Cl)c(Cl)nc(Cl)c1Cl
NCGC00254512-01,tox21-er-bla-agonist-p2,4-Aminofolic acid,activity,inactive,54-62-6,169371.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2nc3c(nc2)nc(N)nc3N
NCGC00254857-01,tox21-er-bla-agonist-p2,Flumetralin,activity,inactive,62924-70-3,62210.0,Clc2cccc(F)c2CN(CC)c1c(cc(cc1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O
NCGC00015985-03,tox21-er-bla-agonist-p2,Tracazolate hydrochloride,activity,inactive,NOCAS_45208,24871267.0,Cl.O=C(OCC)c1c(NCCCC)c2cnn(CC)c2nc1C
NCGC00016362-01,tox21-er-bla-agonist-p2,Benzonatate,activity,inactive,104-31-4,7699.0,O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)c1ccc(NCCCC)cc1
NCGC00159435-02,tox21-er-bla-agonist-p2,Amiloxate,activity,inactive,71617-10-2,92386.0,COc1ccc(C=CC(=O)OCCC(C)C)cc1
NCGC00159492-02,tox21-er-bla-agonist-p2,Perazine,activity,inactive,84-97-9,4744.0,CN1CCN(CC1)CCCN2c4ccccc4Sc3ccccc23
NCGC00160535-01,tox21-er-bla-agonist-p2,Fluindione,activity,inactive,957-56-2,68942.0,Fc1ccc(cc1)C3C(=O)c2ccccc2C3=O
NCGC00160562-01,tox21-er-bla-agonist-p2,Quazodine,activity,inactive,4015-32-1,19918.0,CCc2ncnc1cc(OC)c(cc12)OC
NCGC00164585-01,tox21-er-bla-agonist-p2,Halometasone hydrate,activity,inactive,1310709-74-0,56649463.0,O.OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C(Cl)=C[C@@]12C
NCGC00254788-01,tox21-er-bla-agonist-p2,Cycloate,activity,inactive,1134-23-2,14337.0,CCN(C(=O)SCC)C1CCCCC1
NCGC00015894-02,tox21-er-bla-agonist-p2,Resveratrol,activity,active agonist,501-36-0,445154.0,Oc2cc(/C=C/c1ccc(O)cc1)cc(O)c2
NCGC00159480-02,tox21-er-bla-agonist-p2,Ketamine,activity,inactive,6740-88-1,3821.0,CNC1(CCCCC1=O)c2ccccc2Cl
NCGC00159487-06,tox21-er-bla-agonist-p2,Sulbactam,activity,inactive,68373-14-8,130313.0,O=S2(=O)C(C)(C)[C@@H](N1C(=O)C[C@H]12)C(=O)O
NCGC00164637-01,tox21-er-bla-agonist-p2,Nifekalant hydrochloride,activity,inactive,130636-43-0,122188.0,Cl.CN1C(=CC(=O)N(C)C1=O)NCCN(CCCc2ccc(cc2)[N+]([O-])=O)CCO
NCGC00183831-01,tox21-er-bla-agonist-p2,Aceglatone,activity,inactive,642-83-1,688576.0,O=C1O[C@H]2[C@@H](OC(C)=O)C(=O)O[C@H]2[C@@H]1OC(C)=O
NCGC00183876-01,tox21-er-bla-agonist-p2,Tenofovir disoproxil fumarate,activity,inactive,202138-50-9,5486830.0,O=C(O)C=CC(=O)O.CC(C)OC(=O)OCOP(=O)(OCOC(=O)OC(C)C)CO[C@H](C)Cn2cnc1c(N)ncnc12
NCGC00254140-01,tox21-er-bla-agonist-p2,o-Cresol,activity,inactive,95-48-7,335.0,Cc1ccccc1O
NCGC00017004-01,tox21-er-bla-agonist-p2,Tiletamine hydrochloride,activity,inactive,14176-50-2,26534.0,Cl.O=C2CCCCC2(NCC)c1cccs1
NCGC00017057-01,tox21-er-bla-agonist-p2,Quinacrine dihydrochloride dihydrate,activity,inactive,6151-30-0,2725002.0,Cl.Cl.O.O.CCN(CC)CCCC(C)Nc1c3cc(OC)ccc3nc2cc(Cl)ccc12
NCGC00256910-01,tox21-er-bla-agonist-p2,2-Benzofurancarboxaldehyde,activity,inactive,4265-16-1,61341.0,O=Cc1cc2ccccc2o1
NCGC00257024-01,tox21-er-bla-agonist-p2,Linoleic acid,activity,inactive,60-33-3,5280450.0,O=C(O)CCCCCCC/C=C\C/C=C\CCCCC
NCGC00258421-01,tox21-er-bla-agonist-p2,Scopolamine hydrobromide trihydrate,activity,inactive,6533-68-2,20055509.0,Br.O.O.O.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34
NCGC00258628-01,tox21-er-bla-agonist-p2,"1,3-Dioxolan-2-one",activity,inactive,96-49-1,7303.0,O=C1OCCO1
NCGC00257231-01,tox21-er-bla-agonist-p2,Glutaraldehyde,activity,inactive,111-30-8,3485.0,O=CCCCC=O
NCGC00257281-01,tox21-er-bla-agonist-p2,2-Ethylhexyl sulfanylacetate,activity,inactive,7659-86-1,24309.0,CCC(CCCC)COC(=O)CS
NCGC00257723-01,tox21-er-bla-agonist-p2,"1,2-Dichloro-4-(trichloromethyl)benzene",activity,inactive,13014-24-9,25608.0,Clc1ccc(cc1Cl)C(Cl)(Cl)Cl
NCGC00257751-01,tox21-er-bla-agonist-p2,Iron(II) chloride,activity,inactive,7758-94-3,10329304.0,[Fe+2].[Cl-].[Cl-]
NCGC00257979-01,tox21-er-bla-agonist-p2,"2,2-Dimethylpropanoic acid",activity,inactive,75-98-9,6417.0,CC(C)(C)C(=O)O
NCGC00258118-01,tox21-er-bla-agonist-p2,Erythritol,activity,inactive,149-32-6,222285.0,OC[C@@H](O)[C@@H](O)CO
NCGC00258300-01,tox21-er-bla-agonist-p2,"2,2'-[1,4-Phenylenebis(oxy)]diethanol",activity,inactive,104-38-1,66912.0,OCCOc1ccc(OCCO)cc1
NCGC00255740-01,tox21-er-bla-agonist-p2,Ethiolate,activity,inactive,2941-55-1,18055.0,CCN(CC)C(=O)SCC
NCGC00255743-01,tox21-er-bla-agonist-p2,Tetrapropyl orthosilicate,activity,inactive,682-01-9,69627.0,CCCO[Si](OCCC)(OCCC)OCCC
NCGC00256416-01,tox21-er-bla-agonist-p2,Ibuprofen,activity,inactive,15687-27-1,3672.0,CC(C(=O)O)c1ccc(CC(C)C)cc1
NCGC00256423-01,tox21-er-bla-agonist-p2,Thiouracil,activity,inactive,141-90-2,1269845.0,O=C1C=CNC(=S)N1
NCGC00255947-01,tox21-er-bla-agonist-p2,"2-Isovaleryl-1,3-indanedione",activity,inactive,83-28-3,6733.0,CC(C)CC(=O)C2C(=O)c1ccccc1C2=O
NCGC00255984-01,tox21-er-bla-agonist-p2,Phenkapton,activity,inactive,2275-14-1,16773.0,Clc1ccc(Cl)cc1SCSP(=S)(OCC)OCC
NCGC00256024-01,tox21-er-bla-agonist-p2,1-Phenylethyl propionate,activity,inactive,120-45-6,8432.0,CCC(=O)OC(C)c1ccccc1
NCGC00256058-01,tox21-er-bla-agonist-p2,3-tert-Butylphenol,activity,inactive,585-34-2,11450.0,CC(C)(C)c1cc(O)ccc1
NCGC00256177-01,tox21-er-bla-agonist-p2,"4,5-Dihydroxy-1,3-dimethylimidazolidin-2-one",activity,inactive,3923-79-3,73539.0,CN1C(=O)N(C)C(O)C1O
NCGC00256349-01,tox21-er-bla-agonist-p2,Acrylonitrile,activity,inactive,107-13-1,7855.0,C=CC#N
NCGC00260490-01,tox21-er-bla-agonist-p2,Propyleneimine,activity,inactive,75-55-8,6377.0,CC1CN1
NCGC00260596-01,tox21-er-bla-agonist-p2,NTP Mix35 CT1 1-EQP,activity,inactive,NOCAS_49492,,
NCGC00259093-01,tox21-er-bla-agonist-p2,Methyl salicylate,activity,inactive,119-36-8,4133.0,Oc1ccccc1C(=O)OC
NCGC00259415-01,tox21-er-bla-agonist-p2,Chlorpropham,activity,inactive,101-21-3,2728.0,Clc1cc(NC(=O)OC(C)C)ccc1
NCGC00259488-01,tox21-er-bla-agonist-p2,"1,2,4-Benzenetricarboxylic acid",activity,inactive,528-44-9,10708.0,OC(=O)c1cc(ccc1C(=O)O)C(=O)O
NCGC00259644-01,tox21-er-bla-agonist-p2,2-Ethylhexanal,activity,inactive,123-05-7,31241.0,CCC(CCCC)C=O
NCGC00259662-01,tox21-er-bla-agonist-p2,"1,2,3-Trichlorobenzene",activity,inactive,87-61-6,6895.0,Clc1cccc(Cl)c1Cl
NCGC00259729-01,tox21-er-bla-agonist-p2,Zinc pyrithione,activity,active agonist,13463-41-7,26041.0,[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]
NCGC00260295-01,tox21-er-bla-agonist-p2,Potassium benzoate,activity,inactive,582-25-2,23661960.0,[K+].[O-]C(=O)c1ccccc1
NCGC00254648-01,tox21-er-bla-agonist-p2,Bentazone,activity,inactive,25057-89-0,2328.0,CC(C)N1C(=O)c2ccccc2NS1(=O)=O
NCGC00255424-01,tox21-er-bla-agonist-p2,Pentyl butyrate,activity,inactive,540-18-1,10890.0,O=C(CCC)OCCCCC
NCGC00255821-01,tox21-er-bla-agonist-p2,"Sodium 9,10-dioxo-9,10-dihydroanthracene-2-sulfonate",activity,inactive,131-08-8,23661981.0,[Na+].[O-]S(=O)(=O)c2ccc3C(=O)c1ccccc1C(=O)c3c2
NCGC00254497-01,tox21-er-bla-agonist-p2,Elzasonan,activity,inactive,361343-19-3,6914152.0,CN1CCN(CC1)c4ccccc4/C=C3\SCCN(c2cc(Cl)c(Cl)cc2)C3=O
NCGC00091930-01,tox21-er-bla-agonist-p2,Sodium hydrogen sulfate,activity,inactive,7681-38-1,516919.0,[Na+].[O-]S(=O)(=O)O
NCGC00094091-01,tox21-er-bla-agonist-p2,Tilarginine acetate,activity,inactive,53308-83-1,135242.0,N[C@@H](CCCNC(=N)NC)C(=O)O.CC(=O)O
NCGC00159396-03,tox21-er-bla-agonist-p2,Trimetozine,activity,inactive,635-41-6,12478.0,O=C(c1cc(OC)c(OC)c(OC)c1)N2CCOCC2
NCGC00167417-01,tox21-er-bla-agonist-p2,[(1S)-endo]-(-)-Borneol,activity,inactive,464-45-9,1201518.0,C[C@@]12CC[C@@H](C[C@H]1O)C2(C)C
NCGC00167438-01,tox21-er-bla-agonist-p2,Trospium chloride,activity,inactive,10405-02-4,5284631.0,[Cl-].OC(c1ccccc1)(c2ccccc2)C(=O)O[C@@H]3C[C@@H]5CC[C@H](C3)[N+]45CCCC4
NCGC00167446-01,tox21-er-bla-agonist-p2,Methyclothiazide,activity,inactive,135-07-9,4121.0,NS(=O)(=O)c2cc1c(NC(CCl)N(C)S1(=O)=O)cc2Cl
NCGC00094917-01,tox21-er-bla-agonist-p2,Acetaminosalol,activity,inactive,118-57-0,1984.0,Oc2ccccc2C(=O)Oc1ccc(NC(C)=O)cc1
NCGC00095005-01,tox21-er-bla-agonist-p2,Bromhexine hydrochloride,activity,inactive,611-75-6,5702220.0,Cl.CN(Cc1cc(Br)cc(Br)c1N)C2CCCCC2
NCGC00181051-01,tox21-er-bla-agonist-p2,Strychinine benzyl chloride,activity,inactive,NOCAS_46830,60196303.0,ClCc1ccccc1.O=C2C[C@@H]7OCC=C6CN4CC[C@@]53c1ccccc1N2[C@H]3[C@H]7[C@H]6C[C@H]45
NCGC00167539-01,tox21-er-bla-agonist-p2,Indole,activity,inactive,120-72-9,798.0,c1cccc2nccc12
NCGC00168783-01,tox21-er-bla-agonist-p2,Diisopropyl fluorophosphate,activity,inactive,55-91-4,5936.0,FP(=O)(OC(C)C)OC(C)C
NCGC00096051-02,tox21-er-bla-agonist-p2,Acadesine,activity,inactive,2627-69-2,17513.0,NC(=O)c2ncn([C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)c2N
NCGC00160660-01,tox21-er-bla-agonist-p2,Dazmegrel,activity,inactive,76894-77-4,53555.0,O=C(O)CCn3c1ccccc1c(Cn2ccnc2)c3C
NCGC00181093-01,tox21-er-bla-agonist-p2,Metrizoate sodium,activity,inactive,7225-61-8,23675747.0,[Na+].Ic1c(NC(C)=O)c(I)c(c(I)c1N(C)C(C)=O)C([O-])=O
NCGC00181108-01,tox21-er-bla-agonist-p2,Celiprolol hydrochloride,activity,inactive,57470-78-7,42373.0,Cl.CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(C)=O
NCGC00181116-01,tox21-er-bla-agonist-p2,Carbomycin A,activity,inactive,4564-87-8,6433412.0,CC(C)CC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]4[C@@H](C)O[C@@H](O[C@@H]2[C@@H](OC)[C@H](OC(C)=O)CC(=O)O[C@H](C)CC3OC3C=CC(=O)[C@H](C)C[C@@H]2CC=O)[C@H](O)[C@H]4N(C)C
NCGC00166258-01,tox21-er-bla-agonist-p2,Padimate,activity,inactive,21245-01-2,88836.0,CN(C)c1ccc(cc1)C(=O)OCCC(C)C
NCGC00166262-01,tox21-er-bla-agonist-p2,Ensulizole,activity,inactive,27503-81-7,33919.0,O=S(=O)(O)c1cc2nc(nc2cc1)c3ccccc3
NCGC00162369-02,tox21-er-bla-agonist-p2,Spiradoline,activity,inactive,87151-85-7,55652.0,Clc1ccc(cc1Cl)CC(=O)N(C)[C@H]2CC[C@]4(C[C@@H]2N3CCCC3)CCCO4
NCGC00091005-01,tox21-er-bla-agonist-p2,Phosphoric acid,activity,inactive,7664-38-2,1004.0,O=P(O)(O)O
NCGC00091027-01,tox21-er-bla-agonist-p2,Sodium hypochlorite,activity,inactive,7681-52-9,23665760.0,[Na+].[O-]Cl
NCGC00182552-01,tox21-er-bla-agonist-p2,Atazanavir,activity,inactive,198904-31-3,148192.0,CC(C)(C)[C@H](NC(=O)OC)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)Cc2ccc(cc2)c3ccccn3
NCGC00182708-01,tox21-er-bla-agonist-p2,Pipecuronium bromide,activity,inactive,52212-02-9,65332.0,[Br-].[Br-].C[N+]1(C)CCN(CC1)[C@H]6C[C@@]5(C)[C@@H](CC[C@@H]3[C@@H]5CC[C@]2(C)[C@@H](OC(C)=O)[C@H](C[C@H]23)N4CC[N+](C)(C)CC4)C[C@@H]6OC(C)=O
NCGC00183109-02,tox21-er-bla-agonist-p2,Maraviroc,activity,inactive,376348-65-1,60196353.0,CC(C)c1nnc(C)n1[C@H]2C[C@@H]5CC[C@H](C2)N5CC[C@H](NC(=O)C3CCC(F)(F)CC3)c4ccccc4
NCGC00183863-01,tox21-er-bla-agonist-p2,Clometacine,activity,inactive,25803-14-9,33176.0,Clc1ccc(cc1)C(=O)c3c2ccc(cc2n(CC(=O)O)c3C)OC
NCGC00254152-01,tox21-er-bla-agonist-p2,SSR150106,activity,inactive,NOCAS_47362,53316380.0,O=C(OCC)[C@@]2(Oc1ccccc1[C@@H]2N)c3ccccc3
NCGC00254157-01,tox21-er-bla-agonist-p2,Lovastatin,activity,inactive,75330-75-5,53232.0,C[C@@H](CC)C(=O)O[C@H]2C[C@@H](C)C=C3C=C[C@H](C)[C@H](CC[C@@H]1C[C@@H](O)CC(=O)O1)[C@@H]23
NCGC00254672-01,tox21-er-bla-agonist-p2,5-Nitroisophthalic acid,activity,inactive,618-88-2,12069.0,O=[N+]([O-])c1cc(cc(c1)C(=O)O)C(=O)O
NCGC00255072-01,tox21-er-bla-agonist-p2,"7-Hydroxy-3,7-dimethyloctanal",activity,inactive,107-75-5,7888.0,O=CCC(C)CCCC(C)(C)O
NCGC00255106-01,tox21-er-bla-agonist-p2,Galactosamine hydrochloride,activity,inactive,1772-03-8,2723866.0,Cl.O[C@H]1[C@@H](O)[C@@H](CO)OC(O)[C@@H]1N
NCGC00254047-01,tox21-er-bla-agonist-p2,"Tris(1,3-dichloro-2-propyl)phosphate",activity,inactive,13674-87-8,26177.0,ClCC(OP(=O)(OC(CCl)CCl)OC(CCl)CCl)CCl
NCGC00181762-01,tox21-er-bla-agonist-p2,Nequinate,activity,inactive,13997-19-8,26383.0,O=C(OC)C3=CNc2cc(OCc1ccccc1)c(CCCC)cc2C3=O
NCGC00181776-01,tox21-er-bla-agonist-p2,Dicyclopentamethylenethiuram disulfide,activity,active agonist,94-37-1,7188.0,S=C(SSC(=S)N1CCCCC1)N2CCCCC2
NCGC00181782-02,tox21-er-bla-agonist-p2,Sertindole,activity,inactive,106516-24-9,60149.0,Fc1ccc(cc1)n5cc(C3CCN(CCN2CCNC2=O)CC3)c4cc(Cl)ccc45
NCGC00016530-01,tox21-er-bla-agonist-p2,Sulfameter,activity,inactive,651-06-9,5326.0,O=S(=O)(Nc1ncc(cn1)OC)c2ccc(N)cc2
NCGC00257872-01,tox21-er-bla-agonist-p2,"2,6-Dichlorobenzoyl chloride",activity,inactive,4659-45-4,78392.0,O=C(Cl)c1c(Cl)cccc1Cl
NCGC00260647-01,tox21-er-bla-agonist-p2,NTP Mix88 ER AR1 18-EQP,activity,active agonist,NOCAS_49543,,
NCGC00258821-01,tox21-er-bla-agonist-p2,p-Bromodiphenyl ether,activity,inactive,101-55-3,7565.0,Brc2ccc(Oc1ccccc1)cc2
NCGC00259180-01,tox21-er-bla-agonist-p2,Fenarimol,activity,active agonist,60168-88-9,43226.0,OC(c1ccccc1Cl)(c2cncnc2)c3ccc(Cl)cc3
NCGC00258139-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium iodide",activity,inactive,108203-70-9,11832800.0,[I-].CCCCn1cc[n+](C)c1C
NCGC00259369-01,tox21-er-bla-agonist-p2,2-[2-(2-Methoxyethoxy)ethoxy]ethanol,activity,inactive,112-35-6,8178.0,OCCOCCOCCOC
NCGC00256028-01,tox21-er-bla-agonist-p2,Methyl [3-(trimethoxysilyl)propyl]carbamate,activity,inactive,23432-62-4,90098.0,CO[Si](CCCNC(=O)OC)(OC)OC
NCGC00257217-01,tox21-er-bla-agonist-p2,Veratraldehyde,activity,inactive,120-14-9,8419.0,COc1cc(ccc1OC)C=O
NCGC00259901-01,tox21-er-bla-agonist-p2,Suxibuzone,activity,inactive,27470-51-5,5362.0,O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3
NCGC00260152-01,tox21-er-bla-agonist-p2,Fulvestrant,activity,inactive,129453-61-8,104741.0,FC(F)(F)C(F)(F)CCCS(=O)CCCCCCCCC[C@@H]2Cc1cc(O)ccc1[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@H]23
NCGC00260638-01,tox21-er-bla-agonist-p2,NTP Mix114 ER1 10-EQC,activity,active agonist,NOCAS_49534,,
NCGC00015856-08,tox21-er-bla-agonist-p2,Prochlorperazine dimaleate,activity,inactive,84-02-6,5281032.0,O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CN1CCN(CC1)CCCN2c4ccccc4Sc3ccc(Cl)cc23
NCGC00257618-01,tox21-er-bla-agonist-p2,Polysorbate 60,activity,inactive,9005-67-8,22833389.0,OCCO[C@H]1CO[C@@H]([C@@H]1OCCO)[C@H](O)COC(=O)CCCCCCCCCCC
NCGC00257630-01,tox21-er-bla-agonist-p2,Prazepam,activity,inactive,2955-38-6,4890.0,Clc1ccc3c(c1)C(=NCC(=O)N3CC2CC2)c4ccccc4
NCGC00258267-01,tox21-er-bla-agonist-p2,"1,1-Dimethoxyethane",activity,inactive,534-15-6,10795.0,CC(OC)OC
NCGC00260368-01,tox21-er-bla-agonist-p2,12-Bromo-1-dodecanol,activity,inactive,3344-77-2,137895.0,BrCCCCCCCCCCCCO
NCGC00258298-01,tox21-er-bla-agonist-p2,N-Nitroso-N-methylethylamine,activity,inactive,10595-95-6,25418.0,CCN(C)N=O
NCGC00247678-01,tox21-er-bla-agonist-p2,(-)-alpha-Methadol hydrochloride,activity,inactive,53757-34-9,3041255.0,Cl.O[C@@H](CC)C(C[C@H](C)N(C)C)(c1ccccc1)c2ccccc2
NCGC00254967-01,tox21-er-bla-agonist-p2,"3-(Chloromethyl)-1,2,3-benzotriazin-4(3H)-one",activity,inactive,24310-41-6,90462.0,O=C1c2ccccc2N=NN1CCl
NCGC00255410-01,tox21-er-bla-agonist-p2,Isoxadifen-ethyl,activity,inactive,163520-33-0,6451155.0,CCOC(=O)C=1CC(ON=1)(c2ccccc2)c3ccccc3
NCGC00256736-01,tox21-er-bla-agonist-p2,4-Cyclohexyl-4-methyl-pentan-2-one,activity,inactive,4927-39-3,78640.0,CC(=O)CC(C)(C)C1CCCCC1
NCGC00256062-01,tox21-er-bla-agonist-p2,Propyl benzoate,activity,inactive,2315-68-6,16846.0,O=C(OCCC)c1ccccc1
NCGC00256743-01,tox21-er-bla-agonist-p2,"2-Butenoic acid, 2-methyl-, 3,7-dimethyl-6-octen-1-yl ester",activity,inactive,255714-11-5,90592.0,C\C(C)=C\CCC(C)CCOC(=O)C(C)=CC
NCGC00256918-01,tox21-er-bla-agonist-p2,"5,6,7,8-Tetrahydroquinoxaline",activity,inactive,34413-35-9,36822.0,c1nc2CCCCc2nc1
NCGC00256255-01,tox21-er-bla-agonist-p2,2-Ethyl-4-methyl-1H-imidazole,activity,inactive,931-36-2,70262.0,Cc1cnc(CC)n1
NCGC00256261-01,tox21-er-bla-agonist-p2,2-(Dodecyloxy)ethanol,activity,inactive,4536-30-5,24750.0,OCCOCCCCCCCCCCCC
NCGC00256826-01,tox21-er-bla-agonist-p2,9-Decenyl acetate,activity,inactive,50816-18-7,39801.0,CC(=O)OCCCCCCCCC=C
NCGC00256703-01,tox21-er-bla-agonist-p2,Venlafaxine hydrochloride,activity,inactive,99300-78-4,62923.0,Cl.OC1(CCCCC1)C(CN(C)C)c2ccc(OC)cc2
NCGC00256837-01,tox21-er-bla-agonist-p2,"2,4-Hexadienyl isobutyrate",activity,inactive,16491-24-0,86015.0,O=C(OCC=CC=CC)C(C)C
NCGC00257650-01,tox21-er-bla-agonist-p2,"1,2,3,4-Tetrahydronaphthalen-1-ol",activity,inactive,529-33-9,10723.0,OC2CCCc1ccccc12
NCGC00257445-01,tox21-er-bla-agonist-p2,"1,3-Benzenedimethanamine",activity,inactive,1477-55-0,15133.0,NCc1cccc(CN)c1
NCGC00257952-01,tox21-er-bla-agonist-p2,Aramite,activity,inactive,140-57-8,8809.0,CC(C)(C)c1ccc(OCC(C)OS(=O)OCCCl)cc1
NCGC00258512-01,tox21-er-bla-agonist-p2,2-Biphenylamine,activity,inactive,90-41-5,7015.0,Nc2ccccc2c1ccccc1
NCGC00259053-01,tox21-er-bla-agonist-p2,Methyl styryl ketone,activity,inactive,122-57-6,15909.0,CC(=O)C=Cc1ccccc1
NCGC00259059-01,tox21-er-bla-agonist-p2,Nitrosomethylaniline,activity,inactive,614-00-6,11957.0,O=NN(C)c1ccccc1
NCGC00258415-01,tox21-er-bla-agonist-p2,Methyl ricinoleate,activity,inactive,141-24-2,5354133.0,O=C(CCCCCCC/C=C\C[C@H](O)CCCCCC)OC
NCGC00259080-01,tox21-er-bla-agonist-p2,Bifenthrin,activity,inactive,82657-04-3,5281872.0,Cl\C(=C/C3C(C(=O)OCc2cccc(c1ccccc1)c2C)C3(C)C)C(F)(F)F
NCGC00258022-01,tox21-er-bla-agonist-p2,"Methyl 3,3-dimethylpent-4-enoate",activity,inactive,63721-05-1,114129.0,CC(C)(C=C)CC(=O)OC
NCGC00259128-01,tox21-er-bla-agonist-p2,"1,1':3',1''-Terphenyl",activity,inactive,92-06-8,7076.0,c1cc(ccc1)c2cccc(c2)c3ccccc3
NCGC00259149-01,tox21-er-bla-agonist-p2,Phenazone,activity,inactive,60-80-0,2206.0,O=C2C=C(C)N(C)N2c1ccccc1
NCGC00259769-01,tox21-er-bla-agonist-p2,4-Phenylphenol,activity,active agonist,92-69-3,7103.0,Oc1ccc(cc1)c2ccccc2
NCGC00259333-01,tox21-er-bla-agonist-p2,"2,4-Dinitrotoluene",activity,inactive,121-14-2,8461.0,Cc1ccc(cc1[N+](=O)[O-])[N+]([O-])=O
NCGC00259334-01,tox21-er-bla-agonist-p2,Butylparaben,activity,active agonist,94-26-8,7184.0,Oc1ccc(cc1)C(=O)OCCCC
NCGC00259471-01,tox21-er-bla-agonist-p2,Sodium dichloro-s-triazinetrione dihydrate,activity,inactive,51580-86-0,23667638.0,[Na+].O.O.ClN1C([O-])=NC(=O)N(Cl)C1=O
NCGC00260436-01,tox21-er-bla-agonist-p2,4-Fluoro-dl-phenylalanine,activity,inactive,51-65-0,4654.0,Fc1ccc(CC(N)C(=O)O)cc1
NCGC00260491-01,tox21-er-bla-agonist-p2,"1H-3a,7-Methanoazulen-6-ol, octahydro-3,6,8,8-tetramethyl-, (3R,3aS,6R,7R,8aS)-",activity,inactive,77-53-2,65575.0,C[C@@H]3CC[C@@H]1[C@]23C[C@H](C1(C)C)[C@](C)(O)CC2
NCGC00260521-01,tox21-er-bla-agonist-p2,2-Methylbenzothiazole,activity,inactive,120-75-2,8446.0,Cc1nc2ccccc2s1
NCGC00260567-01,tox21-er-bla-agonist-p2,NTP Mix75 CT1 62-EQP,activity,inactive,NOCAS_49463,,
NCGC00013225-01,tox21-er-bla-agonist-p2,alpha-Ketoglutaric acid,activity,inactive,328-50-7,51.0,OC(=O)C(=O)CCC(=O)O
NCGC00015822-09,tox21-er-bla-agonist-p2,Pyrilamine,activity,inactive,91-84-9,4992.0,COc1ccc(cc1)CN(CCN(C)C)c2ccccn2
NCGC00015042-03,tox21-er-bla-agonist-p2,N-Arachidonylglycine,activity,inactive,179113-91-8,5283389.0,O=C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)NCC(=O)O
NCGC00016382-01,tox21-er-bla-agonist-p2,Oxethazaine,activity,inactive,126-27-2,4621.0,CC(C)(Cc1ccccc1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc2ccccc2
NCGC00016758-01,tox21-er-bla-agonist-p2,Guanadrel sulfate,activity,inactive,22195-34-2,68552.0,O=S(=O)(O)O.N=C(N)NCC2COC1(CCCCC1)O2.N=C(N)NCC2COC1(CCCCC1)O2
NCGC00091533-04,tox21-er-bla-agonist-p2,17alpha-Ethinylestradiol,activity,active agonist,57-63-6,5991.0,Oc3cc4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)c4cc3
NCGC00160513-01,tox21-er-bla-agonist-p2,Testosterone decanoate,activity,active agonist,5721-91-5,155143.0,CCCCCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00163237-01,tox21-er-bla-agonist-p2,Decamethonium bromide,activity,inactive,541-22-0,10921.0,[Br-].[Br-].C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C
NCGC00255839-01,tox21-er-bla-agonist-p2,N-Dodecanoyl-N-methylglycine,activity,inactive,97-78-9,7348.0,O=C(CCCCCCCCCCC)N(C)CC(=O)O
NCGC00255982-01,tox21-er-bla-agonist-p2,Nitralin,activity,inactive,4726-14-1,20848.0,O=S(C)(=O)c1cc(c(c(c1)[N+]([O-])=O)N(CCC)CCC)[N+]([O-])=O
NCGC00254412-01,tox21-er-bla-agonist-p2,Fluconazole,activity,inactive,86386-73-4,3365.0,OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F
NCGC00015273-11,tox21-er-bla-agonist-p2,Chlorpromazine,activity,inactive,50-53-3,2726.0,CN(C)CCCN1c3ccccc3Sc2ccc(Cl)cc12
NCGC00016529-01,tox21-er-bla-agonist-p2,Pramoxine hydrochloride,activity,inactive,637-58-1,73957.0,Cl.CCCCOc1ccc(cc1)OCCCN2CCOCC2
NCGC00016810-01,tox21-er-bla-agonist-p2,Labetalol hydrochloride,activity,inactive,32780-64-6,71412.0,Cl.O=C(N)c1cc(ccc1O)C(O)CNC(C)CCc2ccccc2
NCGC00096122-03,tox21-er-bla-agonist-p2,Thioinosine,activity,inactive,574-25-4,676166.0,Sc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
NCGC00167439-01,tox21-er-bla-agonist-p2,Trenbolone acetate,activity,active agonist,10161-34-9,66359.0,CC(=O)O[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CCC1=C4C=C[C@]23C
NCGC00181319-01,tox21-er-bla-agonist-p2,Plicamycin,activity,inactive,18378-89-7,5284610.0,C[C@@H](O)[C@H](O)C(=O)[C@@H](OC)C6Cc7cc8cc(O[C@H]2C[C@@H](O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1)[C@@H](O)[C@@H](C)O2)c(C)c(O)c8c(O)c7C(=O)[C@H]6O[C@H]5C[C@@H](O[C@H]4C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O5
NCGC00183004-01,tox21-er-bla-agonist-p2,Alilusem potassium,activity,inactive,114417-20-8,23684123.0,[K+].Cc1ccccc1C(=O)N3CC/C(=N\OS([O-])(=O)=O)c2ccc(Cl)cc23
NCGC00254761-01,tox21-er-bla-agonist-p2,Symclosene,activity,inactive,87-90-1,6909.0,ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O
NCGC00014810-01,tox21-er-bla-agonist-p2,Pirbuterol hydrochloride,activity,inactive,38029-10-6,3061720.0,Cl.Oc1ccc(nc1CO)C(O)CNC(C)(C)C
NCGC00016481-01,tox21-er-bla-agonist-p2,Hesperidin,activity,inactive,520-26-3,10621.0,COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(cc3O2)O[C@@H]5O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]5O
NCGC00160469-01,tox21-er-bla-agonist-p2,Gamolenic acid,activity,inactive,506-26-3,5280933.0,O=C(O)CCCC\C=C/C/C=C\C/C=C\CCCCC
NCGC00016962-01,tox21-er-bla-agonist-p2,Meropenem,activity,inactive,96036-03-2,441130.0,O[C@H](C)[C@H]3C(=O)N2C(=C(S[C@H]1C[C@H](NC1)C(=O)N(C)C)[C@H](C)[C@@H]23)C(=O)O
NCGC00016991-03,tox21-er-bla-agonist-p2,Proparacaine hydrochloride,activity,inactive,5875-06-9,517321.0,Cl.CCN(CC)CCOC(=O)c1ccc(OCCC)c(N)c1
NCGC00017101-01,tox21-er-bla-agonist-p2,Cefamandole sodium,activity,inactive,30034-03-8,23672568.0,[Na+].O[C@H](c1ccccc1)C(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2C)CS[C@@H]34)C([O-])=O
NCGC00021666-03,tox21-er-bla-agonist-p2,Nalmefene,activity,inactive,55096-26-9,5284594.0,C=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45
NCGC00023339-09,tox21-er-bla-agonist-p2,Pilocarpine,activity,inactive,92-13-7,5910.0,Cn2cncc2C[C@H]1COC(=O)[C@H]1CC
NCGC00016878-01,tox21-er-bla-agonist-p2,Piretanide,activity,inactive,55837-27-9,4849.0,O=C(O)c2cc(c(Oc1ccccc1)c(c2)N3CCCC3)S(N)(=O)=O
NCGC00016890-01,tox21-er-bla-agonist-p2,Cyclosporin A,activity,inactive,59865-13-3,5284373.0,C[C@H](C\C=C\C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C)C(C)C
NCGC00256888-01,tox21-er-bla-agonist-p2,Calcium saccharin hydrate,activity,inactive,6381-91-5,22879.0,[Ca+2].O.O=C1[N-]S(=O)(=O)c2ccccc12.O=C1[N-]S(=O)(=O)c2ccccc12
NCGC00257164-01,tox21-er-bla-agonist-p2,Tromethamine,activity,inactive,77-86-1,6503.0,OCC(N)(CO)CO
NCGC00257937-01,tox21-er-bla-agonist-p2,2-Methyltetrahydrofuran,activity,inactive,96-47-9,7301.0,CC1CCCO1
NCGC00258071-01,tox21-er-bla-agonist-p2,4-Methylaniline hydrochloride,activity,inactive,540-23-8,10891.0,Cl.Cc1ccc(N)cc1
NCGC00258120-01,tox21-er-bla-agonist-p2,"1,2-Difluoro-1,1,2,2-tetrachloroethane",activity,inactive,76-12-0,6427.0,ClC(Cl)(F)C(Cl)(Cl)F
NCGC00256629-01,tox21-er-bla-agonist-p2,Hydroxyzine hydrochloride,activity,inactive,1244-76-4,71612.0,Cl.Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCCO
NCGC00256636-01,tox21-er-bla-agonist-p2,"Dihydro-1,1,2,3,3-pentamethyl-4(5H)-indanone",activity,inactive,33704-61-9,92292.0,O=C1CCCC2=C1C(C)(C)C(C)C2(C)C
NCGC00255755-01,tox21-er-bla-agonist-p2,Pencycuron,activity,inactive,66063-05-6,91692.0,Clc1ccc(cc1)CN(C(=O)Nc2ccccc2)C3CCCC3
NCGC00256390-01,tox21-er-bla-agonist-p2,Diethyl maleate,activity,inactive,141-05-9,5271566.0,O=C(\C=C/C(=O)OCC)OCC
NCGC00256404-01,tox21-er-bla-agonist-p2,Melatonin,activity,inactive,73-31-4,896.0,CC(=O)NCCc2cnc1ccc(cc12)OC
NCGC00255915-01,tox21-er-bla-agonist-p2,4-Bromobenzyl bromide,activity,inactive,589-15-1,68527.0,BrCc1ccc(Br)cc1
NCGC00256003-01,tox21-er-bla-agonist-p2,Tolylfluanid,activity,inactive,731-27-1,12898.0,CN(C)S(=O)(=O)N(SC(Cl)(Cl)F)c1ccc(C)cc1
NCGC00256135-01,tox21-er-bla-agonist-p2,"2,3,5-Trimethylpyrazine",activity,inactive,14667-55-1,26808.0,Cc1cnc(C)c(C)n1
NCGC00256164-01,tox21-er-bla-agonist-p2,Zinc neodecanoate,activity,inactive,27253-29-8,60196430.0,[Zn+2].[O-]C(=O)C(C)(CC)CCC(C)C.CC(C)CCC(C)(CC)C([O-])=O
NCGC00256166-01,tox21-er-bla-agonist-p2,4-(Propan-2-yl)benzenesulfonic acid,activity,inactive,16066-35-6,6640.0,OS(=O)(=O)c1ccc(cc1)C(C)C
NCGC00256202-01,tox21-er-bla-agonist-p2,"2,2,4,4-Tetramethylcyclobutane-1,3-diol",activity,inactive,3010-96-6,76382.0,CC1(C)C(O)C(C)(C)C1O
NCGC00255650-01,tox21-er-bla-agonist-p2,Benzadox,activity,inactive,5251-93-4,21322.0,O=C(NOCC(=O)O)c1ccccc1
NCGC00258800-01,tox21-er-bla-agonist-p2,"2,4-Diaminophenol dihydrochloride",activity,inactive,137-09-7,8715.0,Cl.Cl.Nc1ccc(O)c(N)c1
NCGC00260529-01,tox21-er-bla-agonist-p2,"4-Chloro-1,2-diaminobenzene",activity,inactive,95-83-0,7263.0,Nc1cc(Cl)ccc1N
NCGC00259181-01,tox21-er-bla-agonist-p2,Trichloroacetic acid,activity,inactive,76-03-9,6421.0,ClC(Cl)(Cl)C(=O)O
NCGC00259208-01,tox21-er-bla-agonist-p2,Terephthalic acid,activity,inactive,100-21-0,7489.0,OC(=O)c1ccc(cc1)C(=O)O
NCGC00259262-01,tox21-er-bla-agonist-p2,Hexamethyldisiloxane,activity,inactive,107-46-0,24764.0,C[Si](C)(C)O[Si](C)(C)C
NCGC00259382-01,tox21-er-bla-agonist-p2,1-Chloro-2-nitro-4-(trifluoromethyl)benzene,activity,inactive,121-17-5,8462.0,O=[N+]([O-])c1cc(ccc1Cl)C(F)(F)F
NCGC00259394-01,tox21-er-bla-agonist-p2,4-Chlorobenzotrichloride,activity,inactive,5216-25-1,21277.0,ClC(Cl)(Cl)c1ccc(Cl)cc1
NCGC00259416-01,tox21-er-bla-agonist-p2,4-Chlorophenyl methyl sulfone,activity,inactive,98-57-7,7395.0,O=S(C)(=O)c1ccc(Cl)cc1
NCGC00259442-01,tox21-er-bla-agonist-p2,"4-Amino-1,2,4-triazole",activity,inactive,584-13-4,11432.0,Nn1cnnc1
NCGC00259517-01,tox21-er-bla-agonist-p2,Propoxur,activity,inactive,114-26-1,4944.0,CC(C)Oc1ccccc1OC(=O)NC
NCGC00259571-01,tox21-er-bla-agonist-p2,Acetohexamide,activity,inactive,968-81-0,1989.0,O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O
NCGC00259730-01,tox21-er-bla-agonist-p2,"3,5-Dimethylphenol",activity,inactive,108-68-9,7948.0,Cc1cc(O)cc(C)c1
NCGC00259732-01,tox21-er-bla-agonist-p2,Hexanedinitrile,activity,inactive,111-69-3,8128.0,N#CCCCCC#N
NCGC00259854-01,tox21-er-bla-agonist-p2,o-Cresol,activity,inactive,95-48-7,335.0,Cc1ccccc1O
NCGC00260205-01,tox21-er-bla-agonist-p2,1-Methyl-3-propylimidazolium chloride,activity,inactive,79917-89-8,60196378.0,Cl.CCCN1C=CN(C)C1
NCGC00258745-01,tox21-er-bla-agonist-p2,"2,6,6-Trimethyl-2-cyclohexene-1,4-dione",activity,inactive,1125-21-9,62374.0,O=C1C=C(C)C(=O)C(C)(C)C1
NCGC00254665-01,tox21-er-bla-agonist-p2,Flusilazole,activity,inactive,85509-19-9,73675.0,C[Si](Cn1cncn1)(c2ccc(F)cc2)c3ccc(F)cc3
NCGC00254910-01,tox21-er-bla-agonist-p2,Cyclamic acid,activity,inactive,100-88-9,7533.0,OS(=O)(=O)NC1CCCCC1
NCGC00255058-01,tox21-er-bla-agonist-p2,Dichlofenthion,activity,inactive,97-17-6,7328.0,Clc1cc(Cl)ccc1OP(=S)(OCC)OCC
NCGC00255109-01,tox21-er-bla-agonist-p2,"1,2-Dibromo-2,4-dicyanobutane",activity,inactive,35691-65-7,61948.0,N#CCCC(Br)(CBr)C#N
NCGC00255312-01,tox21-er-bla-agonist-p2,Sodium fluoroacetate,activity,inactive,62-74-8,16212360.0,[Na+].[O-]C(=O)CF
NCGC00255470-01,tox21-er-bla-agonist-p2,Azaconazole,activity,inactive,60207-31-0,43233.0,Clc1cc(Cl)c(cc1)C2(OCCO2)Cn3cncn3
NCGC00256013-01,tox21-er-bla-agonist-p2,Dimethoxy(methyl)phenylsilane,activity,inactive,3027-21-2,18193.0,CO[Si](C)(OC)c1ccccc1
NCGC00254518-01,tox21-er-bla-agonist-p2,Cladribine,activity,inactive,4291-63-8,20279.0,Nc3nc(Cl)nc2c3ncn2[C@H]1C[C@H](O)[C@@H](CO)O1
NCGC00254572-01,tox21-er-bla-agonist-p2,Tridodecylamine,activity,inactive,102-87-4,7624.0,CCCCCCCCCCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC
NCGC00163241-01,tox21-er-bla-agonist-p2,Strychnine,activity,inactive,57-24-9,441071.0,O=C2C[C@@H]7OCC=C6CN4CC[C@@]53c1ccccc1N2[C@H]3[C@H]7[C@H]6C[C@H]45
NCGC00094197-01,tox21-er-bla-agonist-p2,Methylcarbamylcholine chloride,activity,inactive,14721-76-7,84605.0,[Cl-].C[N+](C)(C)CCOC(=O)NC
NCGC00094918-03,tox21-er-bla-agonist-p2,Saccharin,activity,inactive,81-07-2,5143.0,O=C2NS(=O)(=O)c1ccccc12
NCGC00167783-01,tox21-er-bla-agonist-p2,Zamifenacin fumarate,activity,inactive,127308-98-9,60196362.0,O=C(O)/C=C/C(=O)O.c1cc(cc2OCOc12)CCN5CCC[C@H](OC(c3ccccc3)c4ccccc4)C5
NCGC00160384-01,tox21-er-bla-agonist-p2,Clonixin,activity,inactive,17737-65-4,28718.0,O=C(O)c2cccnc2Nc1cccc(Cl)c1C
NCGC00164524-01,tox21-er-bla-agonist-p2,D-Glucuronolactone,activity,inactive,32449-92-6,2724333.0,O[C@@H]2O[C@@H]1[C@@H](O)C(=O)O[C@@H]1[C@H]2O
NCGC00095108-01,tox21-er-bla-agonist-p2,Mepivicaine hydrochloride,activity,inactive,1722-62-9,66070.0,Cl.O=C(Nc1c(C)cccc1C)C2CCCCN2C
NCGC00160422-01,tox21-er-bla-agonist-p2,Chlorphentermine hydrochloride,activity,inactive,151-06-4,65477.0,Cl.Clc1ccc(CC(C)(C)N)cc1
NCGC00160430-01,tox21-er-bla-agonist-p2,Dimetamfetamine,activity,inactive,17279-39-9,65682.0,CN(C)[C@@H](C)Cc1ccccc1
NCGC00160470-01,tox21-er-bla-agonist-p2,(5)-Methyl L-glutamate,activity,inactive,1499-55-4,68662.0,N[C@@H](CCC(=O)OC)C(=O)O
NCGC00160497-01,tox21-er-bla-agonist-p2,Benzoclidine,activity,inactive,16852-81-6,65630.0,O=C(OC2CN1CCC2CC1)c3ccccc3
NCGC00181046-01,tox21-er-bla-agonist-p2,Uricase from Bacillus fastidiosus,activity,inactive,9002-12-4,,
NCGC00166022-01,tox21-er-bla-agonist-p2,D-(-)-Mandelic acid,activity,inactive,611-71-2,11914.0,O[C@@H](C(=O)O)c1ccccc1
NCGC00167534-01,tox21-er-bla-agonist-p2,Pazufloxacin,activity,inactive,127045-41-4,65957.0,NC1(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)[C@@H](C)COc34
NCGC00160594-02,tox21-er-bla-agonist-p2,Iproheptine,activity,inactive,13946-02-6,19917.0,CC(C)NC(C)CCCC(C)C
NCGC00166104-01,tox21-er-bla-agonist-p2,alpha-Lipoic acid amide,activity,active agonist,940-69-2,863.0,NC(=O)CCCCC1CCSS1
NCGC00159347-02,tox21-er-bla-agonist-p2,Fluorescein sodium,activity,inactive,518-47-8,9885981.0,[Na+].[Na+].[O-]c4cc5Oc1cc([O-])ccc1C3(OC(=O)c2ccccc23)c5cc4
NCGC00160671-01,tox21-er-bla-agonist-p2,Viomycin sulfate,activity,inactive,37883-00-4,5282488.0,O=S(=O)(O)O.NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)C(\NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=C\NC(N)=O)[C@H]2C[C@H](O)N=C(N)N2
NCGC00167566-01,tox21-er-bla-agonist-p2,Bromadiolone,activity,inactive,28772-56-7,54680085.0,Brc1ccc(cc1)c2ccc(cc2)C(O)CC(C3=C(O)c4ccccc4OC3=O)c5ccccc5
NCGC00182034-01,tox21-er-bla-agonist-p2,Teprenone,activity,inactive,6809-52-5,53384398.0,C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CCC(C)=CCCC(C)=O
NCGC00182079-02,tox21-er-bla-agonist-p2,Trandolapril,activity,inactive,87679-37-6,5484727.0,O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@H]3CCCC[C@H]23)C(=O)O
NCGC00182547-01,tox21-er-bla-agonist-p2,Gadodiamide hydrate,activity,inactive,122795-43-1,60754.0,[Gd+3].O.CNC(=O)CN(CC([O-])=O)CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O
NCGC00182983-01,tox21-er-bla-agonist-p2,Fezatione,activity,inactive,15387-18-5,9568078.0,S=C2SC=C(N2/N=C/c1ccc(C)cc1)c3ccccc3
NCGC00183836-01,tox21-er-bla-agonist-p2,Emiglitate,activity,inactive,80879-63-6,72004.0,O=C(OCC)c2ccc(OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)cc2
NCGC00254543-01,tox21-er-bla-agonist-p2,Cyclophosphamide monohydrate,activity,inactive,6055-19-2,22420.0,O.O=P1(NCCCO1)N(CCCl)CCCl
NCGC00186466-01,tox21-er-bla-agonist-p2,Ethynodiol diacetate,activity,active agonist,297-76-7,9270.0,CC(=O)O[C@@]4(C#C)CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=C[C@H](CC[C@@H]12)OC(C)=O
NCGC00254204-01,tox21-er-bla-agonist-p2,Anthracene,activity,inactive,120-12-7,8418.0,c1ccc2cc3ccccc3cc2c1
NCGC00188865-01,tox21-er-bla-agonist-p2,Pazopanib,activity,inactive,444731-52-6,10113978.0,NS(=O)(=O)c1cc(ccc1C)Nc2nccc(n2)N(C)c3ccc4c(C)n(C)nc4c3
NCGC00254249-01,tox21-er-bla-agonist-p2,"PFOA, ammonium salt",activity,inactive,3825-26-1,2776282.0,[NH4+].FC(F)(C(F)(F)C([O-])=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254343-01,tox21-er-bla-agonist-p2,Thalidomide,activity,inactive,50-35-1,5426.0,O=C1NC(=O)CCC1N3C(=O)c2ccccc2C3=O
NCGC00254020-01,tox21-er-bla-agonist-p2,"2,4,6-Tris(tert-butyl)phenol",activity,inactive,732-26-3,12902.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(C)(C)C
NCGC00016589-01,tox21-er-bla-agonist-p2,Chlorcyclizine hydrochloride,activity,inactive,1620-21-9,62413.0,Cl.Clc1ccc(cc1)C(c2ccccc2)N3CCN(C)CC3
NCGC00255102-01,tox21-er-bla-agonist-p2,2-Cyanoethyl prop-2-enoate,activity,inactive,106-71-8,7825.0,C=CC(=O)OCCC#N
NCGC00257831-01,tox21-er-bla-agonist-p2,Phenylglyoxal,activity,inactive,1074-12-0,14090.0,O=C(C=O)c1ccccc1
NCGC00260631-01,tox21-er-bla-agonist-p2,NTP Mix107 ER1 10-EQC,activity,inactive,NOCAS_49527,,
NCGC00256846-01,tox21-er-bla-agonist-p2,delta-Octanolactone,activity,inactive,698-76-0,12777.0,CCCC1CCCC(=O)O1
NCGC00259848-01,tox21-er-bla-agonist-p2,"5,5-Diphenylhydantoin",activity,inactive,57-41-0,1775.0,O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3
NCGC00256340-01,tox21-er-bla-agonist-p2,1-Chloro-3-nitrobenzene,activity,inactive,121-73-3,8489.0,O=[N+]([O-])c1cc(Cl)ccc1
NCGC00257494-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(2,6-diethylaniline)",activity,inactive,13680-35-8,83656.0,CCc1cc(cc(CC)c1N)Cc2cc(CC)c(N)c(CC)c2
NCGC00257526-01,tox21-er-bla-agonist-p2,Diethylamine hydrochloride,activity,inactive,660-68-4,10197650.0,Cl.CCNCC
NCGC00258806-01,tox21-er-bla-agonist-p2,Tris(2-chloroethyl) phosphate,activity,inactive,115-96-8,8295.0,ClCCOP(=O)(OCCCl)OCCCl
NCGC00015724-10,tox21-er-bla-agonist-p2,Niflumic acid,activity,inactive,4394-00-7,4488.0,FC(F)(F)c1cc(ccc1)Nc2ncccc2C(=O)O
NCGC00254417-01,tox21-er-bla-agonist-p2,Fully acetylated glycerol monoester on 12-Hydroxystearic acid (85%); Fully acetylated glycerol monostearate represents (10%),activity,inactive,NOCAS_47394,20725980.0,O=C(C)OC(COC(C)=O)COC(=O)CCCCCCCCCCC(CCCCCC)OC(C)=O
NCGC00256072-01,tox21-er-bla-agonist-p2,"2,2,4,4-Tetramethylcyclobutane-1,3-dione",activity,inactive,933-52-8,13617.0,CC1(C)C(=O)C(C)(C)C1=O
NCGC00256803-01,tox21-er-bla-agonist-p2,Salicylic acid p-tolyl ester,activity,inactive,607-88-5,69091.0,Oc2ccccc2C(=O)Oc1ccc(C)cc1
NCGC00257415-01,tox21-er-bla-agonist-p2,Sodium dichloro-s-triazinetrione dihydrate,activity,inactive,51580-86-0,23667638.0,[Na+].O.O.ClN1C([O-])=NC(=O)N(Cl)C1=O
NCGC00257876-01,tox21-er-bla-agonist-p2,"3,4-Dichlorobenzoic acid",activity,inactive,51-44-5,5817.0,Clc1ccc(cc1Cl)C(=O)O
NCGC00258217-01,tox21-er-bla-agonist-p2,Methylsilanetriyl triacetate,activity,inactive,4253-34-3,77929.0,O=C(C)O[Si](C)(OC(C)=O)OC(=O)C
NCGC00258911-01,tox21-er-bla-agonist-p2,Ciprofibrate,activity,inactive,52214-84-3,2763.0,ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1
NCGC00258715-01,tox21-er-bla-agonist-p2,Bis(4-hydroxyphenyl)methane,activity,active agonist,620-92-8,12111.0,Oc2ccc(Cc1ccc(O)cc1)cc2
NCGC00258376-01,tox21-er-bla-agonist-p2,Nitromethane,activity,inactive,75-52-5,6375.0,[O-][N+](C)=O
NCGC00258949-01,tox21-er-bla-agonist-p2,Octamethylcyclotetrasiloxane,activity,inactive,556-67-2,11169.0,C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1
NCGC00258652-01,tox21-er-bla-agonist-p2,"1,3-Dimethylimidazolium dimethyl phosphate",activity,inactive,654058-04-5,16069365.0,C[n+]1ccn(C)c1.[O-]P(=O)(OC)OC
NCGC00259077-01,tox21-er-bla-agonist-p2,Melatonin,activity,inactive,73-31-4,896.0,CC(=O)NCCc2cnc1ccc(cc12)OC
NCGC00258097-01,tox21-er-bla-agonist-p2,"2,2'-Dihydroxy-4,4'-dimethoxybenzophenone",activity,active agonist,131-54-4,8570.0,O=C(c1ccc(cc1O)OC)c2ccc(OC)cc2O
NCGC00258143-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium methanesulfonate,activity,inactive,342789-81-5,11492381.0,CCCCn1cc[n+](C)c1.[O-]S(C)(=O)=O
NCGC00260033-01,tox21-er-bla-agonist-p2,Amphotericin B,activity,inactive,1397-89-3,5280965.0,O=C(O)[C@@H]3[C@@H](O)C[C@@]2(O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)C=CC=CC=CC=CC=CC=CC=C[C@H](O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O)C[C@@H]3O2
NCGC00260007-01,tox21-er-bla-agonist-p2,Diazepam,activity,inactive,439-14-5,3016.0,Clc1ccc2c(c1)C(=NCC(=O)N2C)c3ccccc3
NCGC00259452-01,tox21-er-bla-agonist-p2,Dodecyl 2-methylacrylate,activity,inactive,142-90-5,8906.0,C=C(C)C(=O)OCCCCCCCCCCCC
NCGC00260657-01,tox21-er-bla-agonist-p2,NTP Mix23 AR2 2-EQP,activity,inactive,NOCAS_49553,,
NCGC00260524-01,tox21-er-bla-agonist-p2,Urocanic acid,activity,inactive,104-98-3,736715.0,OC(=O)/C=C/c1cncn1
NCGC00260174-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-3-propylimidazolium iodide",activity,inactive,218151-78-1,11459786.0,[I-].Cc1[n+](C)ccn1CCC
NCGC00260344-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium nitrate,activity,inactive,143314-14-1,16211072.0,O=[N+]([O-])[O-].C[n+]1ccn(CC)c1
NCGC00013012-01,tox21-er-bla-agonist-p2,"D-Xylo-5-hexulosonic acid, calcium salt",activity,inactive,3470-36-8,12850184.0,[Ca+2].O=C([O-])[C@H](O)[C@@H](O)[C@H](O)C(=O)CO.OCC(=O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O
NCGC00013687-01,tox21-er-bla-agonist-p2,Tetrasodium pyrophosphate,activity,inactive,7722-88-5,24403.0,[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O
NCGC00013723-01,tox21-er-bla-agonist-p2,Scopolamine N-oxide hydrobromide,activity,inactive,6106-81-6,6419978.0,Br.OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)[O-]
NCGC00015149-02,tox21-er-bla-agonist-p2,Bumetanide,activity,inactive,28395-03-1,2471.0,O=S(N)(=O)c2cc(cc(NCCCC)c2Oc1ccccc1)C(=O)O
NCGC00016812-01,tox21-er-bla-agonist-p2,Butoconazole nitrate,activity,inactive,64872-77-1,47471.0,[O-][N+](=O)O.Clc1ccc(cc1)CCC(Sc2c(Cl)cccc2Cl)Cn3ccnc3
NCGC00016954-05,tox21-er-bla-agonist-p2,(-)-Quinpirole hydrochloride,activity,inactive,85798-08-9,55397.0,Cl.CCCN1CCC[C@@H]2Cc3nncc3C[C@@H]12
NCGC00016516-01,tox21-er-bla-agonist-p2,Megestrol acetate,activity,inactive,595-33-5,11683.0,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00091761-03,tox21-er-bla-agonist-p2,Butylated hydroxytoluene,activity,inactive,128-37-0,31404.0,CC(C)(C)c1cc(C)cc(c1O)C(C)(C)C
NCGC00254907-01,tox21-er-bla-agonist-p2,Dihexyl hexanedioate,activity,inactive,110-33-8,8046.0,O=C(CCCCC(=O)OCCCCCC)OCCCCCC
NCGC00254587-01,tox21-er-bla-agonist-p2,Oxytetracycline dihydrate,activity,inactive,6153-64-6,54680691.0,O.O.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@@](C)(O)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00254371-01,tox21-er-bla-agonist-p2,CI-1029,activity,inactive,207736-05-8,54687772.0,CC(C)[C@]3(CCc1ccc(N)cc1)CC(O)=C(Sc2cc(C)c(CO)cc2C(C)(C)C)C(=O)O3
NCGC00254391-01,tox21-er-bla-agonist-p2,AVE8488,activity,inactive,NOCAS_47349,53316398.0,Cl.O.Fc1ccc(cc1)[C@H]5CN(C)CCN5Cc2cc(co2)c3ccc4nc(O)oc4c3
NCGC00254999-01,tox21-er-bla-agonist-p2,Bromophos-ethyl,activity,inactive,4824-78-6,20965.0,Clc1cc(OP(=S)(OCC)OCC)c(Cl)cc1Br
NCGC00254158-01,tox21-er-bla-agonist-p2,2-Methoxy-5-nitroaniline,activity,inactive,99-59-2,7447.0,Nc1cc(ccc1OC)[N+]([O-])=O
NCGC00016705-05,tox21-er-bla-agonist-p2,Tolfenamic acid,activity,inactive,13710-19-5,610479.0,Cc2c(Nc1ccccc1C(=O)O)cccc2Cl
NCGC00016950-01,tox21-er-bla-agonist-p2,Mometasone furoate,activity,inactive,83919-23-7,441336.0,ClCC(=O)[C@@]5(OC(=O)c1ccco1)[C@H](C)C[C@@H]3[C@]5(C)C[C@H](O)[C@]2(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]23
NCGC00018204-09,tox21-er-bla-agonist-p2,Vinpocetine,activity,inactive,42971-09-5,443955.0,O=C(OCC)C1=C[C@@]5(CCCN4CCc3c(n1c2ccccc23)[C@@H]45)CC
NCGC00024633-02,tox21-er-bla-agonist-p2,AMI-193,activity,inactive,510-74-7,68186.0,Fc1ccc(cc1)OCCCN2CCC4(CC2)C(=O)NCN4c3ccccc3
NCGC00091357-01,tox21-er-bla-agonist-p2,Orotic acid,activity,inactive,65-86-1,967.0,OC(=O)c1cc(O)nc(O)n1
NCGC00091468-02,tox21-er-bla-agonist-p2,4-Chloroaniline,activity,inactive,106-47-8,7812.0,Nc1ccc(Cl)cc1
NCGC00095120-01,tox21-er-bla-agonist-p2,Carvedilol tartrate,activity,inactive,NOCAS_45916,16667700.0,O=C(O)C(O)C(O)C(=O)O.COc4ccccc4OCCNCC(O)COc2cccc3nc1ccccc1c23
NCGC00142625-03,tox21-er-bla-agonist-p2,D-alpha-Tocopheryl acetate,activity,inactive,58-95-7,86472.0,CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00168085-02,tox21-er-bla-agonist-p2,Suberoylanilide hydroxamic acid,activity,inactive,149647-78-9,5311.0,O=C(Nc1ccccc1)CCCCCCC(=O)NO
NCGC00168750-01,tox21-er-bla-agonist-p2,Oxaliplatin,activity,inactive,61825-94-3,9887053.0,O=C3O[Pt]1(N[C@@H]2CCCC[C@H]2N1)OC3=O
NCGC00254009-01,tox21-er-bla-agonist-p2,"2,4-Bis(2-methylbutan-2-yl)phenol",activity,inactive,120-95-6,8455.0,Oc1ccc(cc1C(C)(C)CC)C(C)(C)CC
NCGC00259832-01,tox21-er-bla-agonist-p2,2-Chloropyridine,activity,inactive,109-09-1,7977.0,Clc1ccccn1
NCGC00260588-01,tox21-er-bla-agonist-p2,NTP Mix37 CT1 2-EQP,activity,inactive,NOCAS_49484,,
NCGC00017246-02,tox21-er-bla-agonist-p2,Picrotoxin,activity,inactive,124-87-8,442291.0,CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]5O[C@@]45C(=O)O[C@H]2[C@]34C
NCGC00091057-01,tox21-er-bla-agonist-p2,Silybin,activity,inactive,22888-70-6,31553.0,Oc4cc(O)cc5O[C@H](c1ccc2O[C@H](CO)[C@H](Oc2c1)c3ccc(O)c(OC)c3)[C@@H](O)C(=O)c45
NCGC00166249-02,tox21-er-bla-agonist-p2,Erythrosin B,activity,inactive,15905-32-5,3259.0,Ic4c5Oc1c(I)c(O)c(I)cc1C3(OC(=O)c2ccccc23)c5cc(I)c4O
NCGC00167425-01,tox21-er-bla-agonist-p2,Deferiprone,activity,inactive,30652-11-0,2972.0,OC1=C(C)N(C)C=CC1=O
NCGC00168257-01,tox21-er-bla-agonist-p2,1-trans-delta-9-Tetrahydrocannabinol,activity,inactive,1972-08-3,16078.0,CCCCCc2cc1OC(C)(C)[C@@H]3CCC(C)=C[C@H]3c1c(O)c2
NCGC00189073-01,tox21-er-bla-agonist-p2,Selumetinib,activity,active agonist,606143-52-6,10127622.0,Brc3ccc(Nc1c(F)c2ncn(C)c2cc1C(=O)NOCCO)c(Cl)c3
NCGC00090731-01,tox21-er-bla-agonist-p2,2-Phenoxyethanol,activity,inactive,122-99-6,31236.0,OCCOc1ccccc1
NCGC00017260-05,tox21-er-bla-agonist-p2,Rauwolscine,activity,inactive,131-03-3,643606.0,O=C(OC)[C@@H]2[C@@H](O)CC[C@@H]3CN4CCc1c5ccccc5nc1[C@@H]4C[C@H]23
NCGC00017333-03,tox21-er-bla-agonist-p2,Atropine,activity,inactive,51-55-8,174174.0,CN3[C@H]1CC[C@@H]3C[C@@H](C1)OC(=O)C(CO)c2ccccc2
NCGC00018117-07,tox21-er-bla-agonist-p2,Theophylline,activity,inactive,58-55-9,2153.0,O=C2c1ncnc1N(C)C(=O)N2C
NCGC00018123-05,tox21-er-bla-agonist-p2,Acetylcholine chloride,activity,inactive,60-31-1,6060.0,[Cl-].C[N+](C)(C)CCOC(=O)C
NCGC00022391-04,tox21-er-bla-agonist-p2,6-Azaribine,activity,inactive,2169-64-4,16574.0,CC(=O)OC[C@H]2O[C@@H](N1N=CC(=O)NC1=O)[C@H](OC(C)=O)[C@@H]2OC(C)=O
NCGC00070736-02,tox21-er-bla-agonist-p2,Imiquimod,activity,inactive,99011-02-6,57469.0,CC(C)Cn3cnc2c(N)nc1ccccc1c23
NCGC00016897-01,tox21-er-bla-agonist-p2,Ceforanide,activity,inactive,60925-61-3,43507.0,NCc4ccccc4CC(=O)N[C@@H]3C(=O)N2C(=C(CSc1nnnn1CC(=O)O)CS[C@@H]23)C(=O)O
NCGC00258390-01,tox21-er-bla-agonist-p2,3-((2-Ethylhexyl)oxy)propylamine,activity,inactive,5397-31-9,21499.0,CCCCC(COCCCN)CC
NCGC00257358-01,tox21-er-bla-agonist-p2,Dimethyl carbonate,activity,inactive,616-38-6,12021.0,O=C(OC)OC
NCGC00257517-01,tox21-er-bla-agonist-p2,"4-(2,6,6-Trimethyl-cyclohex-1-enyl)-but-3-en-2-one",activity,inactive,14901-07-6,26955.0,CC=1CCCC(C)(C)C=1C=CC(C)=O
NCGC00257589-01,tox21-er-bla-agonist-p2,2-Vinylpyridine,activity,inactive,100-69-6,7521.0,C=Cc1ccccn1
NCGC00257741-01,tox21-er-bla-agonist-p2,2-Methylbenzamide,activity,inactive,527-85-5,10704.0,Cc1ccccc1C(=O)N
NCGC00258191-01,tox21-er-bla-agonist-p2,2-Fluorobenzoyl chloride,activity,inactive,393-52-2,9808.0,O=C(Cl)c1ccccc1F
NCGC00256705-01,tox21-er-bla-agonist-p2,9-Decen-1-ol,activity,inactive,13019-22-2,25612.0,C=CCCCCCCCCO
NCGC00255758-01,tox21-er-bla-agonist-p2,4-Morpholinecarboxaldehyde,activity,inactive,4394-85-8,20417.0,O=CN1CCOCC1
NCGC00256460-01,tox21-er-bla-agonist-p2,Salicylaldehyde,activity,inactive,90-02-8,6998.0,O=Cc1ccccc1O
NCGC00255784-01,tox21-er-bla-agonist-p2,Hydroxyprogesterone caproate,activity,inactive,630-56-8,169870.0,CC(=O)[C@@]3(OC(=O)CCCCC)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00255818-01,tox21-er-bla-agonist-p2,"(1,1-Dimethylethyl)urea",activity,inactive,1118-12-3,14233.0,CC(C)(C)NC(N)=O
NCGC00255997-01,tox21-er-bla-agonist-p2,2-Ethylaniline,activity,inactive,578-54-1,11357.0,CCc1ccccc1N
NCGC00256077-01,tox21-er-bla-agonist-p2,2-(Pyridin-4-yl)ethanol,activity,inactive,5344-27-4,72921.0,OCCc1ccncc1
NCGC00256125-01,tox21-er-bla-agonist-p2,Phenyl dihydrogen phosphate,activity,inactive,701-64-4,12793.0,OP(=O)(O)Oc1ccccc1
NCGC00256252-01,tox21-er-bla-agonist-p2,Propan-2-yl benzoate,activity,inactive,939-48-0,13654.0,CC(C)OC(=O)c1ccccc1
NCGC00259562-01,tox21-er-bla-agonist-p2,Bis[2-(dimethylamino)ethyl]ether,activity,inactive,3033-62-3,18204.0,CN(C)CCOCCN(C)C
NCGC00259743-01,tox21-er-bla-agonist-p2,1-Cedr-8-en-9-ylethanone,activity,inactive,32388-55-9,16220111.0,CC(=O)C=1C[C@]23C[C@@H](C=1C)C(C)(C)[C@@H]3CC[C@H]2C
NCGC00259924-01,tox21-er-bla-agonist-p2,Theophylline,activity,inactive,58-55-9,2153.0,O=C2c1ncnc1N(C)C(=O)N2C
NCGC00260318-01,tox21-er-bla-agonist-p2,"Acetic acid, antimony(3+) salt",activity,inactive,6923-52-0,23354.0,[SbH3+3].O=C([O-])C.[O-]C(C)=O.[O-]C(C)=O
NCGC00260376-01,tox21-er-bla-agonist-p2,"Pyrimidine,2,4-dichloro-",activity,inactive,3934-20-1,77531.0,Clc1ccnc(Cl)n1
NCGC00254658-01,tox21-er-bla-agonist-p2,Deisopropylatrazine,activity,inactive,1007-28-9,13878.0,Nc1nc(NCC)nc(Cl)n1
NCGC00254799-01,tox21-er-bla-agonist-p2,"2,4-Dichlorobenzyl alcohol",activity,inactive,1777-82-8,15684.0,OCc1ccc(Cl)cc1Cl
NCGC00254880-01,tox21-er-bla-agonist-p2,(E)-5-Decen-1-ol,activity,inactive,56578-18-8,5283292.0,CCCC\C=C\CCCCO
NCGC00254981-01,tox21-er-bla-agonist-p2,2-Methoxyethanol,activity,inactive,109-86-4,8019.0,OCCOC
NCGC00255061-01,tox21-er-bla-agonist-p2,Spiroxamine,activity,inactive,118134-30-8,86160.0,CC(C)(C)C1CCC2(CC1)OCC(CN(CC)CCC)O2
NCGC00255176-01,tox21-er-bla-agonist-p2,Orphenadrine hydrochloride,activity,inactive,341-69-5,9568.0,Cl.CN(C)CCOC(c1ccccc1)c2ccccc2C
NCGC00255456-01,tox21-er-bla-agonist-p2,Megestrol acetate,activity,inactive,595-33-5,11683.0,CC(=O)[C@@]3(OC(C)=O)CC[C@H]2[C@@H]4C=C(C)C1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00255530-01,tox21-er-bla-agonist-p2,C.I. Acid Orange 7,activity,inactive,633-96-5,44135675.0,[Na+].O=S([O-])(=O)c3ccc(/N=N/c1c2ccccc2ccc1O)cc3
NCGC00255675-01,tox21-er-bla-agonist-p2,4-Pentylaniline,activity,inactive,33228-44-3,93162.0,Nc1ccc(CCCCC)cc1
NCGC00256091-01,tox21-er-bla-agonist-p2,2-(Piperidin-2-yl)ethanol,activity,inactive,1484-84-0,15144.0,OCCC1CCCCN1
NCGC00166320-01,tox21-er-bla-agonist-p2,Clindamycin phosphate,activity,inactive,24729-96-2,443385.0,CS[C@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1OP(=O)(O)O)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl
NCGC00159416-02,tox21-er-bla-agonist-p2,Nandrolone,activity,active agonist,434-22-0,9904.0,O=C4CC[C@H]3C(CC[C@@H]1[C@@H]3CC[C@]2(C)[C@@H](O)CC[C@@H]12)=C4
NCGC00159434-02,tox21-er-bla-agonist-p2,Benactyzine,activity,inactive,302-40-9,9330.0,OC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2
NCGC00163886-02,tox21-er-bla-agonist-p2,Fenchlorphos,activity,inactive,299-84-3,9298.0,Clc1cc(OP(=S)(OC)OC)c(Cl)cc1Cl
NCGC00164076-01,tox21-er-bla-agonist-p2,Sodium D-gluconate,activity,inactive,527-07-1,23672301.0,[Na+].O[C@H]([C@@H](O)C([O-])=O)[C@H](O)[C@H](O)CO
NCGC00179341-02,tox21-er-bla-agonist-p2,Ondansetron,activity,inactive,99614-02-5,4595.0,O=C1C(CCc3c1c2ccccc2n3C)Cn4ccnc4C
NCGC00181001-01,tox21-er-bla-agonist-p2,"N,N-Bis(2-hydroxyethyl)dodecanamide",activity,inactive,120-40-1,8430.0,O=C(CCCCCCCCCCC)N(CCO)CCO
NCGC00159514-02,tox21-er-bla-agonist-p2,"2',3'-Dideoxyinosine",activity,inactive,69655-05-6,50599.0,O=C3NC=Nc2c3ncn2[C@H]1CC[C@@H](CO)O1
NCGC00181132-01,tox21-er-bla-agonist-p2,Halofuginone hydrochloride,activity,inactive,1217623-74-9,60196305.0,Cl.O[C@@H]3CCCN[C@H]3CC(=O)CN2C=Nc1cc(Br)c(Cl)cc1C2=O
NCGC00095000-01,tox21-er-bla-agonist-p2,Amiprilose hydrochloride,activity,inactive,60414-06-4,43261.0,Cl.CN(C)CCCO[C@@H]1[C@H]2OC(C)(C)O[C@H]2O[C@@H]1C(O)CO
NCGC00160420-01,tox21-er-bla-agonist-p2,Fotretamine,activity,inactive,37132-72-2,65800.0,C1CN(CCO1)p2(np(np(n2)(N3CC3)N4CC4)(N5CC5)N6CC6)N7CC7
NCGC00164552-01,tox21-er-bla-agonist-p2,Bromfenac sodium sesquihydrate,activity,inactive,120638-55-3,11954316.0,[Na+].[Na+].O.O.O.O=C(c1ccc(Br)cc1)c2cccc(CC([O-])=O)c2N.[O-]C(=O)Cc1cccc(c1N)C(=O)c2ccc(Br)cc2
NCGC00095209-01,tox21-er-bla-agonist-p2,Imperatorin,activity,inactive,482-44-0,10212.0,C/C(C)=C\COc1c3occc3cc2C=CC(=O)Oc12
NCGC00095233-01,tox21-er-bla-agonist-p2,Hydroxyamphetamine hydrobromide,activity,inactive,306-21-8,9377.0,Br.Oc1ccc(CC(C)N)cc1
NCGC00167511-01,tox21-er-bla-agonist-p2,Pemoline,activity,inactive,2152-34-3,4723.0,NC1=NC(=O)C(O1)c2ccccc2
NCGC00166061-01,tox21-er-bla-agonist-p2,Ethyl L-cysteinate hydrochloride,activity,inactive,868-59-7,2723617.0,Cl.O=C(OCC)[C@@H](N)CS
NCGC00142391-03,tox21-er-bla-agonist-p2,Folic acid,activity,inactive,59-30-3,6037.0,O=C(O)[C@H](CCC(=O)O)NC(=O)c1ccc(cc1)NCc2cnc3NC(N)=NC(=O)c3n2
NCGC00159337-02,tox21-er-bla-agonist-p2,Efavirenz,activity,inactive,154598-52-4,64139.0,FC(F)(F)[C@@]3(C#CC1CC1)OC(=O)Nc2ccc(Cl)cc23
NCGC00159367-03,tox21-er-bla-agonist-p2,Paraldehyde,activity,inactive,123-63-7,31264.0,CC1OC(C)OC(C)O1
NCGC00183879-01,tox21-er-bla-agonist-p2,Bisbentiamine,activity,inactive,2667-89-2,20054849.0,Nc4nc(C)ncc4CN(C=O)C(/C)=C(/CCOC(=O)c1ccccc1)SSC(/CCOC(=O)c2ccccc2)=C(/C)N(C=O)Cc3cnc(C)nc3N
NCGC00188690-01,tox21-er-bla-agonist-p2,Prasugrel hydrochloride,activity,inactive,389574-19-0,10158453.0,Cl.Fc1ccccc1C(N2CCc3sc(cc3C2)OC(C)=O)C(=O)C4CC4
NCGC00254192-01,tox21-er-bla-agonist-p2,Carabersat,activity,inactive,184653-84-7,193943.0,Fc1ccc(cc1)C(=O)N[C@H]2c3cc(ccc3OC(C)(C)[C@@H]2O)C(C)=O
NCGC00247704-01,tox21-er-bla-agonist-p2,S-(+)-Methamphetamine hydrochloride,activity,inactive,51-57-0,66124.0,Cl.C[C@H](NC)Cc1ccccc1
NCGC00247705-01,tox21-er-bla-agonist-p2,(S)-(+)-N-Ethylamphetamine hydrochloride,activity,inactive,26194-77-4,60196330.0,Cl.C[C@H](NCC)Cc1ccccc1
NCGC00247717-01,tox21-er-bla-agonist-p2,"5-Methoxy-N,N-diisopropyltryptamine hydrochloride",activity,inactive,2426-63-3,24802109.0,Cl.CC(C)N(CCc2cnc1ccc(cc12)OC)C(C)C
NCGC00254293-01,tox21-er-bla-agonist-p2,Carbosulfan,activity,inactive,55285-14-8,41384.0,CCCCN(CCCC)SN(C)C(=O)Oc1cccc2CC(C)(C)Oc12
NCGC00249418-01,tox21-er-bla-agonist-p2,HMR1171 trifluoroacetate (1:1),activity,inactive,NOCAS_48522,60196348.0,FC(F)(F)C(=O)O.CCN(CC)C(=O)c1cc(c(cc1N(CC)CCN(C)C)N2CCC(CC2)c3ccccc3)S(=O)(=O)Cc4ccccc4
NCGC00253929-01,tox21-er-bla-agonist-p2,Ingliforib,activity,inactive,186392-65-4,6451325.0,O[C@H]1CN(C[C@H]1O)C(=O)[C@H](O)[C@H](Cc2ccccc2)NC(=O)c3cc4cc(Cl)ccc4n3
NCGC00253936-01,tox21-er-bla-agonist-p2,Nitrofen,activity,inactive,1836-75-5,15787.0,Clc2cc(Cl)ccc2Oc1ccc(cc1)[N+]([O-])=O
NCGC00254048-01,tox21-er-bla-agonist-p2,alpha-Isomethylionone,activity,inactive,127-51-5,5372174.0,CC1(C)CCC=C(C)C1\C=C(/C)C(C)=O
NCGC00254119-01,tox21-er-bla-agonist-p2,Quinoline,activity,inactive,91-22-5,7047.0,c1cccc2cccnc12
NCGC00254515-01,tox21-er-bla-agonist-p2,4-Chlorobenzotrichloride,activity,inactive,5216-25-1,21277.0,ClC(Cl)(Cl)c1ccc(Cl)cc1
NCGC00181749-01,tox21-er-bla-agonist-p2,Cefminox sodium,activity,inactive,75498-96-3,60196336.0,[Na+].[O-]C(=O)[C@H](N)CSCC(=O)N[C@]3(OC)C(=O)N2C(=C(CSc1nnnn1C)CS[C@@H]23)C(=O)O
NCGC00182978-01,tox21-er-bla-agonist-p2,Tiaramide hydrochloride,activity,inactive,35941-71-0,443949.0,Cl.OCCN1CCN(CC1)C(=O)CN2c3cc(Cl)ccc3SC2=O
NCGC00181782-01,tox21-er-bla-agonist-p2,Sertindole,activity,inactive,106516-24-9,60149.0,Fc1ccc(cc1)n5cc(C3CCN(CCN2CCNC2=O)CC3)c4cc(Cl)ccc45
NCGC00259443-01,tox21-er-bla-agonist-p2,"(E,E)-2,4-Decadienal",activity,inactive,25152-84-5,5283349.0,CCCCC\C=C\C=C\C=O
NCGC00257877-01,tox21-er-bla-agonist-p2,Dimenhydrinate,activity,inactive,523-87-5,10660.0,CN(C)CCOC(c1ccccc1)c2ccccc2.O=C2c1nc(Cl)nc1N(C)C(=O)N2C
NCGC00255501-01,tox21-er-bla-agonist-p2,4-Chloromercuribenzoic acid,activity,active agonist,59-85-8,1730.0,OC(=O)c1ccc([Hg]Cl)cc1
NCGC00256966-01,tox21-er-bla-agonist-p2,Di(2-methoxyethyl) phthalate,activity,inactive,117-82-8,8344.0,O=C(OCCOC)c1ccccc1C(=O)OCCOC
NCGC00016292-01,tox21-er-bla-agonist-p2,21-Hydroxyprogesterone,activity,inactive,64-85-7,6166.0,OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00016551-01,tox21-er-bla-agonist-p2,Meprylcaine hydrochloride,activity,inactive,956-03-6,101925.0,Cl.CC(C)(COC(=O)c1ccccc1)NCCC
NCGC00256595-01,tox21-er-bla-agonist-p2,beta-Butyrolactone,activity,inactive,3068-88-0,18303.0,O=C1CC(C)O1
NCGC00247685-01,tox21-er-bla-agonist-p2,(+)-Phenazocine hydrobromide,activity,inactive,63903-74-2,3048355.0,Br.Oc3ccc4C[C@H]2[C@@H](C)[C@](C)(CCN2CCc1ccccc1)c4c3
NCGC00257449-01,tox21-er-bla-agonist-p2,Dibenzothiophene,activity,inactive,132-65-0,3023.0,c1cccc2sc3ccccc3c12
NCGC00257566-01,tox21-er-bla-agonist-p2,Methyl tetradecanoate,activity,inactive,124-10-7,31284.0,O=C(CCCCCCCCCCCCC)OC
NCGC00257579-01,tox21-er-bla-agonist-p2,2-Ethoxybenzamide,activity,inactive,938-73-8,3282.0,CCOc1ccccc1C(N)=O
NCGC00258755-01,tox21-er-bla-agonist-p2,Zearalanol,activity,active agonist,26538-44-3,2999413.0,Oc1cc(O)cc2CCCCC[C@@H](O)CCC[C@H](C)OC(=O)c12
NCGC00260298-01,tox21-er-bla-agonist-p2,D&C Red No. 7,activity,inactive,5281-04-9,9571018.0,[Ca+2].O=S([O-])(=O)c3cc(C)ccc3/N=N/c1c2ccccc2cc(C([O-])=O)c1O
NCGC00015661-02,tox21-er-bla-agonist-p2,Molsidomine,activity,inactive,25717-80-0,5353788.0,O=C(OCC)[N-]c1c[n+](no1)N2CCOCC2
NCGC00016105-03,tox21-er-bla-agonist-p2,Zaprinast,activity,inactive,37762-06-4,5722.0,CCCOc3ccccc3C2=Nc1nnnc1C(=O)N2
NCGC00258690-01,tox21-er-bla-agonist-p2,Ethyl-2-methyl acetoacetate,activity,inactive,609-14-3,701.0,O=C(C)C(C)C(=O)OCC
NCGC00258775-01,tox21-er-bla-agonist-p2,Chlorobenzene,activity,inactive,108-90-7,7964.0,Clc1ccccc1
NCGC00257652-01,tox21-er-bla-agonist-p2,(3-Chloropropyl)(triethoxy)silane,activity,inactive,5089-70-3,78771.0,CCO[Si](OCC)(OCC)CCCCl
NCGC00258967-01,tox21-er-bla-agonist-p2,N-Butylpyridinium chloride,activity,inactive,1124-64-7,2734171.0,[Cl-].CCCC[n+]1ccccc1
NCGC00183842-01,tox21-er-bla-agonist-p2,Meluadrine,activity,inactive,134865-33-1,3045414.0,O[C@@H](CNC(C)(C)C)c1ccc(O)cc1Cl
NCGC00255462-01,tox21-er-bla-agonist-p2,"1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]-2-(4-4-morpholinyl)-",activity,active agonist,71868-10-5,92387.0,CC(C)(N1CCOCC1)C(=O)c2ccc(SC)cc2
NCGC00256587-01,tox21-er-bla-agonist-p2,"2,7-Acetylaminofluorene",activity,inactive,304-28-9,9352.0,CC(=O)Nc1ccc2c3ccc(cc3Cc2c1)NC(C)=O
NCGC00256913-01,tox21-er-bla-agonist-p2,Ethyl hexadecanoate,activity,inactive,628-97-7,12366.0,O=C(CCCCCCCCCCCCCCC)OCC
NCGC00256273-01,tox21-er-bla-agonist-p2,(E)-2-Hexen-1-ol,activity,inactive,928-95-0,5318042.0,CCC\C=C\CO
NCGC00256891-01,tox21-er-bla-agonist-p2,Furalaxyl,activity,inactive,57646-30-7,42504.0,O=C(N(C(C)C(=O)OC)c1c(C)cccc1C)c2ccco2
NCGC00257085-01,tox21-er-bla-agonist-p2,"3,3',5,5'-Tetramethylbenzidine",activity,inactive,54827-17-7,41206.0,Cc1cc(cc(C)c1N)c2cc(C)c(N)c(C)c2
NCGC00257606-01,tox21-er-bla-agonist-p2,1-Octanamine,activity,inactive,111-86-4,8143.0,CCCCCCCCN
NCGC00257656-01,tox21-er-bla-agonist-p2,Phenethyl bromide,activity,inactive,103-63-9,7666.0,BrCCc1ccccc1
NCGC00257347-01,tox21-er-bla-agonist-p2,2-Phenylethanol,activity,inactive,60-12-8,6054.0,OCCc1ccccc1
NCGC00257899-01,tox21-er-bla-agonist-p2,Aniline,activity,inactive,62-53-3,6115.0,Nc1ccccc1
NCGC00258162-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium bromide",activity,inactive,475575-45-2,2734241.0,[Br-].CCCCn1cc[n+](C)c1C
NCGC00258250-01,tox21-er-bla-agonist-p2,N-Methylmethanamine hydrochloride,activity,inactive,506-59-2,10473.0,Cl.CNC
NCGC00258500-01,tox21-er-bla-agonist-p2,4-Methylbenzonitrile,activity,inactive,104-85-8,7724.0,N#Cc1ccc(C)cc1
NCGC00259056-01,tox21-er-bla-agonist-p2,4-Vinyl-1-cyclohexene dioxide,activity,inactive,106-87-6,7833.0,O1CC1C2CC3OC3CC2
NCGC00258394-01,tox21-er-bla-agonist-p2,Bis(chloromethyl) ether,activity,inactive,542-88-1,10967.0,ClCOCCl
NCGC00258790-01,tox21-er-bla-agonist-p2,3-Nitrobenzoic acid,activity,inactive,121-92-6,8497.0,O=[N+]([O-])c1cc(ccc1)C(=O)O
NCGC00258435-01,tox21-er-bla-agonist-p2,3-Aminoacetanilide,activity,inactive,102-28-3,7604.0,O=C(C)Nc1cccc(N)c1
NCGC00258645-01,tox21-er-bla-agonist-p2,Butylated hydroxytoluene,activity,inactive,128-37-0,31404.0,CC(C)(C)c1cc(C)cc(c1O)C(C)(C)C
NCGC00258847-01,tox21-er-bla-agonist-p2,Phenmedipham,activity,inactive,13684-63-4,24744.0,O=C(Oc1cccc(c1)NC(=O)OC)Nc2cc(C)ccc2
NCGC00258868-01,tox21-er-bla-agonist-p2,2-Methylimidazole,activity,inactive,693-98-1,12749.0,Cc1nccn1
NCGC00258679-01,tox21-er-bla-agonist-p2,"2,2,4-Trimethylpentane",activity,inactive,540-84-1,10907.0,CC(C)CC(C)(C)C
NCGC00258977-01,tox21-er-bla-agonist-p2,"2,6-Dimethylaniline",activity,inactive,87-62-7,6896.0,Cc1cccc(C)c1N
NCGC00258979-01,tox21-er-bla-agonist-p2,Genistein,activity,active agonist,446-72-0,5280961.0,Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O
NCGC00259152-01,tox21-er-bla-agonist-p2,Triethyl phosphite,activity,inactive,122-52-1,31215.0,CCOP(OCC)OCC
NCGC00259158-01,tox21-er-bla-agonist-p2,Pirinixic acid,activity,inactive,50892-23-4,5694.0,Cc2cccc(Nc1cc(Cl)nc(SCC(=O)O)n1)c2C
NCGC00259159-01,tox21-er-bla-agonist-p2,5-Aminosalicylic acid,activity,inactive,89-57-6,4075.0,OC(=O)c1cc(N)ccc1O
NCGC00260310-01,tox21-er-bla-agonist-p2,"Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate",activity,inactive,52829-07-9,164282.0,CC2(C)CC(OC(=O)CCCCCCCCC(=O)OC1CC(C)(C)NC(C)(C)C1)CC(C)(C)N2
NCGC00260426-01,tox21-er-bla-agonist-p2,Phenyl benzoate,activity,inactive,93-99-2,7169.0,O=C(Oc1ccccc1)c2ccccc2
NCGC00260624-01,tox21-er-bla-agonist-p2,NTP Mix100 ER1 10-EQC,activity,inactive,NOCAS_49520,,
NCGC00260451-01,tox21-er-bla-agonist-p2,"3-Pyridinepropanoicacid, 2,6-dichloro-5-fluoro-b-oxo-, ethyl ester",activity,inactive,96568-04-6,2733708.0,Fc1cc(C(=O)CC(=O)OCC)c(Cl)nc1Cl
NCGC00260670-01,tox21-er-bla-agonist-p2,Propofol,activity,inactive,2078-54-8,4943.0,CC(C)c1cccc(C(C)C)c1O
NCGC00015649-02,tox21-er-bla-agonist-p2,Moxonidine,activity,inactive,75438-57-2,4810.0,COc2nc(C)nc(Cl)c2NC1=NCCN1
NCGC00015094-02,tox21-er-bla-agonist-p2,Allopurinol,activity,inactive,315-30-0,2094.0,Oc2ncnc1nncc12
NCGC00016317-01,tox21-er-bla-agonist-p2,Chlorthalidone,activity,inactive,77-36-1,2732.0,NS(=O)(=O)c1cc(ccc1Cl)C3(O)NC(=O)c2ccccc23
NCGC00093658-01,tox21-er-bla-agonist-p2,Azepexole hydrochloride,activity,inactive,36067-72-8,169743.0,Cl.Cl.CCN1CCc2oc(N)nc2CC1
NCGC00094777-01,tox21-er-bla-agonist-p2,Rifampicin,activity,inactive,13292-46-1,5458213.0,CN1CCN(CC1)/N=C/c3c2NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO[C@@]5(C)Oc4c(C)c(O)c(c2O)c(c3O)c4C5=O
NCGC00162274-02,tox21-er-bla-agonist-p2,Naltrexone,activity,inactive,16590-41-3,5360515.0,O=C1CC[C@@]6(O)[C@H]3Cc5ccc(O)c4O[C@@H]1[C@]6(CCN3CC2CC2)c45
NCGC00167585-01,tox21-er-bla-agonist-p2,Ipidacrine hydrochloride hydrate,activity,inactive,118499-70-0,6917941.0,Cl.O.Nc1c3CCCc3nc2CCCCc12
NCGC00256127-01,tox21-er-bla-agonist-p2,"2,6-Dimethoxybenzoic acid",activity,inactive,1466-76-8,15109.0,COc1cccc(OC)c1C(=O)O
NCGC00256173-01,tox21-er-bla-agonist-p2,Isobutyl benzoate,activity,inactive,120-50-3,61048.0,CC(C)COC(=O)c1ccccc1
NCGC00256444-01,tox21-er-bla-agonist-p2,"Tris(2,3-dibromopropyl) phosphate",activity,inactive,126-72-7,31356.0,BrCC(Br)COP(=O)(OCC(Br)CBr)OCC(Br)CBr
NCGC00255411-01,tox21-er-bla-agonist-p2,"2,4-D-methyl",activity,inactive,1928-38-7,1488.0,Clc1cc(Cl)ccc1OCC(=O)OC
NCGC00255934-01,tox21-er-bla-agonist-p2,N-Formylpiperidine,activity,inactive,2591-86-8,17429.0,O=CN1CCCCC1
NCGC00254384-01,tox21-er-bla-agonist-p2,2-Chlorotoluene,activity,inactive,95-49-8,7238.0,Cc1ccccc1Cl
NCGC00254461-01,tox21-er-bla-agonist-p2,PharmaGSID_47263,activity,inactive,349495-42-7,9857035.0,Oc1ccc(cc1)C=2CNC(=O)c3c(N=2)c(C)nn3CC
NCGC00014684-03,tox21-er-bla-agonist-p2,Pifexole,activity,inactive,27199-40-2,65758.0,Clc3ccccc3c1nc(no1)c2ccncc2
NCGC00094220-02,tox21-er-bla-agonist-p2,Proadifen hydrochloride,activity,inactive,62-68-0,65341.0,Cl.CCN(CC)CCOC(=O)C(CCC)(c1ccccc1)c2ccccc2
NCGC00164501-01,tox21-er-bla-agonist-p2,Nihydrazone,activity,inactive,67-28-7,9561033.0,O=[N+]([O-])c1ccc(/C=N/NC(C)=O)o1
NCGC00165953-02,tox21-er-bla-agonist-p2,2-{[(2E)-2-(1-Azabicyclo[2.2.2]oct-3-ylidene)-2-fluoroethyl]oxy}-9H-carbazole,activity,inactive,182959-33-7,60196293.0,Cl.F/C(COc1ccc2c3ccccc3nc2c1)=C5/CN4CCC5CC4
NCGC00182082-02,tox21-er-bla-agonist-p2,Tesaglitazar,activity,inactive,251565-85-2,57823090.0,O=S(C)(=O)Oc1ccc(cc1)CCOc2ccc(C[C@@H](OCC)C(=O)O)cc2
NCGC00247336-02,tox21-er-bla-agonist-p2,Dihydroisocodeine,activity,inactive,795-38-0,5492898.0,COc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@H](O)CC[C@@H]45
NCGC00091251-01,tox21-er-bla-agonist-p2,Azoxybenzene,activity,inactive,495-48-7,10316.0,[O-]/[N+](=N/c1ccccc1)c2ccccc2
NCGC00093350-02,tox21-er-bla-agonist-p2,Amikacin,activity,inactive,37517-28-5,37768.0,NCC[C@H](O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O
NCGC00182076-02,tox21-er-bla-agonist-p2,Polythiazide,activity,inactive,346-18-9,4870.0,NS(=O)(=O)c2cc1c(NC(CSCC(F)(F)F)N(C)S1(=O)=O)cc2Cl
NCGC00182849-01,tox21-er-bla-agonist-p2,Epristeride,activity,inactive,119169-78-7,68741.0,CC(C)(C)NC(=O)[C@H]2CC[C@H]3[C@@H]4CC=C1C=C(CC[C@]1(C)[C@H]4CC[C@]23C)C(=O)O
NCGC00254015-01,tox21-er-bla-agonist-p2,(E)-Anethole,activity,inactive,4180-23-8,637563.0,COc1ccc(/C=C/C)cc1
NCGC00254135-01,tox21-er-bla-agonist-p2,"5,5-Diphenylhydantoin",activity,inactive,57-41-0,1775.0,O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3
NCGC00016944-01,tox21-er-bla-agonist-p2,Cisapride,activity,inactive,81098-60-4,2769.0,Clc1cc(c(OC)cc1N)C(=O)NC3CCN(CCCOc2ccc(F)cc2)CC3OC
NCGC00090791-03,tox21-er-bla-agonist-p2,"2',3'-Dideoxyadenosine",activity,inactive,4097-22-7,20039.0,Nc3ncnc2c3ncn2[C@H]1CC[C@@H](CO)O1
NCGC00016978-01,tox21-er-bla-agonist-p2,Repaglinide,activity,inactive,135062-02-1,65981.0,O=C(O)c1ccc(cc1OCC)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
NCGC00017258-04,tox21-er-bla-agonist-p2,Methergine,activity,inactive,113-42-8,8226.0,CC[C@@H](CO)NC(=O)[C@@H]2C=C1c3cccc4ncc(C[C@H]1N(C)C2)c34
NCGC00021222-03,tox21-er-bla-agonist-p2,Cortodoxone,activity,inactive,152-58-9,440707.0,OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00025187-01,tox21-er-bla-agonist-p2,Rimcazole dihydrochloride,activity,inactive,75859-03-9,53388.0,Cl.Cl.C[C@H]4CN(CCCn3c1ccccc1c2ccccc23)C[C@@H](C)N4
NCGC00257557-01,tox21-er-bla-agonist-p2,"(Z)-1,2-Dichloroethylene",activity,inactive,156-59-2,643833.0,Cl\C=C/Cl
NCGC00257703-01,tox21-er-bla-agonist-p2,3-Methylbut-2-enal,activity,inactive,107-86-8,61020.0,C/C(C)=C\C=O
NCGC00258042-01,tox21-er-bla-agonist-p2,Barium chloride dihydrate,activity,inactive,10326-27-9,5284346.0,[Ba+2].[Cl-].[Cl-].O.O
NCGC00258175-01,tox21-er-bla-agonist-p2,Benzamide,activity,inactive,55-21-0,2331.0,NC(=O)c1ccccc1
NCGC00258257-01,tox21-er-bla-agonist-p2,Anthranilic acid,activity,inactive,118-92-3,227.0,OC(=O)c1ccccc1N
NCGC00258276-01,tox21-er-bla-agonist-p2,Menthofuran,activity,inactive,494-90-6,329983.0,CC1Cc2occ(C)c2CC1
NCGC00256669-01,tox21-er-bla-agonist-p2,4-Isopropylbenzonitrile,activity,inactive,13816-33-6,26289.0,CC(C)c1ccc(C#N)cc1
NCGC00255734-01,tox21-er-bla-agonist-p2,Terbucarb,activity,inactive,1918-11-2,15967.0,O=C(Oc1c(cc(C)cc1C(C)(C)C)C(C)(C)C)NC
NCGC00255778-01,tox21-er-bla-agonist-p2,3-Methoxybenzaldehyde,activity,inactive,591-31-1,11569.0,COc1cc(C=O)ccc1
NCGC00255780-01,tox21-er-bla-agonist-p2,4-(4-Hydroxyphenyl)butan-2-one,activity,inactive,5471-51-2,21648.0,Oc1ccc(CCC(C)=O)cc1
NCGC00255851-01,tox21-er-bla-agonist-p2,(-)-Isolongifolene,activity,inactive,1135-66-6,11127402.0,CC2(C)C3=CCCC(C)(C)[C@]13C[C@@H]2CC1
NCGC00255992-01,tox21-er-bla-agonist-p2,"2,6-Di(butan-2-yl)phenol",activity,inactive,5510-99-6,21685.0,Oc1c(cccc1C(C)CC)C(C)CC
NCGC00256006-01,tox21-er-bla-agonist-p2,Methiuron,activity,inactive,21540-35-2,3034319.0,S=C(Nc1cc(C)ccc1)N(C)C
NCGC00256049-01,tox21-er-bla-agonist-p2,N-(4-Methoxyphenyl)-3-oxobutanamide,activity,inactive,5437-98-9,21576.0,COc1ccc(NC(=O)CC(C)=O)cc1
NCGC00256243-01,tox21-er-bla-agonist-p2,Acid Red 337,activity,inactive,67786-14-5,23668542.0,[Na+].FC(F)(F)c3ccccc3/N=N/c2c(N)ccc1cc(cc(O)c12)S([O-])(=O)=O
NCGC00256282-01,tox21-er-bla-agonist-p2,"(2Z)-3,7-Dimethylocta-2,6-dienenitrile",activity,inactive,31983-27-4,1551245.0,C\C(C)=C\CCC(/C)=C\C#N
NCGC00256310-01,tox21-er-bla-agonist-p2,"(2E,6Z)-1,1-diethoxynona-2,6-diene",activity,inactive,67674-36-6,6364671.0,CCOC(/C=C/CC/C=C\CC)OCC
NCGC00260542-01,tox21-er-bla-agonist-p2,1-Tridecene,activity,inactive,2437-56-1,17095.0,C=CCCCCCCCCCCC
NCGC00259144-01,tox21-er-bla-agonist-p2,Fenthion,activity,inactive,55-38-9,3346.0,Cc1cc(ccc1SC)OP(=S)(OC)OC
NCGC00259185-01,tox21-er-bla-agonist-p2,2-Methoxy-5-nitroaniline,activity,inactive,99-59-2,7447.0,Nc1cc(ccc1OC)[N+]([O-])=O
NCGC00259266-01,tox21-er-bla-agonist-p2,Thioglycolic acid,activity,inactive,68-11-1,1133.0,O=C(O)CS
NCGC00259614-01,tox21-er-bla-agonist-p2,Isopropyl tetradecanoic acid,activity,inactive,110-27-0,8042.0,CC(C)OC(=O)CCCCCCCCCCCCC
NCGC00259819-01,tox21-er-bla-agonist-p2,Benfluralin,activity,inactive,1861-40-1,2319.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCCC)CC)C(F)(F)F
NCGC00260252-01,tox21-er-bla-agonist-p2,1-Ethyl-1-methylpyrrolidinium tetrafluoroborate,activity,inactive,117947-85-0,18374068.0,F[B-](F)(F)F.C[N+]1(CC)CCCC1
NCGC00254623-01,tox21-er-bla-agonist-p2,4-Chloro-2-methylanisole,activity,inactive,3260-85-3,76748.0,COc1ccc(Cl)cc1C
NCGC00254752-01,tox21-er-bla-agonist-p2,Pyrithiobac-sodium,activity,inactive,123343-16-8,23682187.0,[Na+].[O-]C(=O)c2c(Sc1nc(cc(OC)n1)OC)cccc2Cl
NCGC00256391-01,tox21-er-bla-agonist-p2,Indole-3-acetic acid,activity,inactive,87-51-4,802.0,O=C(O)Cc2cnc1ccccc12
NCGC00254951-01,tox21-er-bla-agonist-p2,Fludioxonil,activity,active agonist,131341-86-1,86398.0,N#Cc3cncc3c1cccc2OC(F)(F)Oc12
NCGC00255179-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, 4,4'-oxybis-, dihydrazide",activity,inactive,80-51-3,6649.0,O=S(=O)(NN)c2ccc(Oc1ccc(cc1)S(=O)(=O)NN)cc2
NCGC00255192-01,tox21-er-bla-agonist-p2,"Pyridine, 2-chloro-5-(trichloromethyl)-",activity,inactive,69045-78-9,50293.0,ClC(Cl)(Cl)c1cnc(Cl)cc1
NCGC00255381-01,tox21-er-bla-agonist-p2,Cytarabine,activity,inactive,147-94-4,6253.0,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
NCGC00255482-01,tox21-er-bla-agonist-p2,3-Phenylhexane,activity,inactive,4468-42-2,20546.0,CCC(CCC)c1ccccc1
NCGC00255522-01,tox21-er-bla-agonist-p2,Glipizide,activity,inactive,29094-61-9,3478.0,Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
NCGC00255553-01,tox21-er-bla-agonist-p2,Nonivamide,activity,inactive,2444-46-4,2998.0,Oc1ccc(cc1OC)CNC(=O)CCCCCCCC
NCGC00255616-01,tox21-er-bla-agonist-p2,2-sec-Butylcyclohexanone,activity,inactive,14765-30-1,61771.0,CCC(C)C1CCCCC1=O
NCGC00255767-01,tox21-er-bla-agonist-p2,Diethyl oxalate,activity,inactive,95-92-1,7268.0,CCOC(=O)C(=O)OCC
NCGC00255908-01,tox21-er-bla-agonist-p2,Ethyl trifluoroacetate,activity,inactive,383-63-1,9794.0,FC(F)(F)C(=O)OCC
NCGC00091192-02,tox21-er-bla-agonist-p2,Maleic acid,activity,inactive,110-16-7,444266.0,O=C(O)/C=C\C(=O)O
NCGC00091493-01,tox21-er-bla-agonist-p2,Anethole,activity,inactive,104-46-1,7703.0,COc1ccc(C=CC)cc1
NCGC00163742-03,tox21-er-bla-agonist-p2,Limonene,activity,inactive,138-86-3,22311.0,CC1=CCC(CC1)C(C)=C
NCGC00167452-01,tox21-er-bla-agonist-p2,Pirenoxine sodium,activity,inactive,51410-30-1,23695982.0,[Na+].[O-]C(=O)c1cc(O)c2C3=Nc4ccccc4OC3=CC(=O)c2n1
NCGC00159493-02,tox21-er-bla-agonist-p2,Phenobarbital,activity,inactive,50-06-6,4763.0,O=C1NC(=O)NC(=O)C1(CC)c2ccccc2
NCGC00159553-01,tox21-er-bla-agonist-p2,Fanapanel,activity,inactive,161605-73-8,208953.0,O=P(O)(O)CN1c2cc(c(cc2NC(=O)C1=O)C(F)(F)F)N3CCOCC3
NCGC00160359-01,tox21-er-bla-agonist-p2,Cefaloram,activity,inactive,859-07-4,68940.0,O=C(O)C=2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SCC=2COC(C)=O
NCGC00160361-01,tox21-er-bla-agonist-p2,Vanitiolide,activity,inactive,17692-71-6,5399858.0,S=C(c1ccc(O)c(OC)c1)N2CCOCC2
NCGC00095015-01,tox21-er-bla-agonist-p2,Citiolone,activity,inactive,1195-16-0,14520.0,O=C1SCCC1NC(=O)C
NCGC00160408-01,tox21-er-bla-agonist-p2,Benziodarone,activity,inactive,68-90-6,6237.0,Ic1cc(cc(I)c1O)C(=O)c2c3ccccc3oc2CC
NCGC00181332-01,tox21-er-bla-agonist-p2,3beta-(2-Diethylaminoethoxy)androst-5-en-17-one hydrochloride,activity,inactive,3039-71-2,9954082.0,Cl.CCN(CC)CCO[C@H]4CC[C@@]2(C)C(=CC[C@H]1[C@@H]3CCC(=O)[C@@]3(C)CC[C@@H]12)C4
NCGC00160436-01,tox21-er-bla-agonist-p2,Fenamol,activity,inactive,5467-78-7,21640.0,Nc2nnnn2c1ccccc1
NCGC00164558-01,tox21-er-bla-agonist-p2,Pargeverine hydrochloride,activity,inactive,2765-97-1,53398649.0,Cl.CN(C)CCOC(=O)C(OCC#C)(c1ccccc1)c2ccccc2
NCGC00167474-01,tox21-er-bla-agonist-p2,Candesartan,activity,inactive,139481-59-7,2541.0,O=C(O)c4cccc5nc(OCC)n(Cc1ccc(cc1)c2ccccc2c3nnnn3)c45
NCGC00165907-02,tox21-er-bla-agonist-p2,Triparanol,activity,inactive,78-41-1,6536.0,Clc3ccc(CC(O)(c1ccc(C)cc1)c2ccc(OCCN(CC)CC)cc2)cc3
NCGC00181044-01,tox21-er-bla-agonist-p2,Selenium-L-methionine,activity,inactive,3211-76-5,105024.0,O=C(O)[C@@H](N)CC[Se]C
NCGC00167527-01,tox21-er-bla-agonist-p2,Grepafloxacin hydrochloride,activity,inactive,161967-81-3,656829.0,Cl.CC1CN(CCN1)c4cc2c(C(=O)C(=CN2C3CC3)C(=O)O)c(C)c4F
NCGC00095838-01,tox21-er-bla-agonist-p2,Sumatriptan,activity,inactive,103628-46-2,5358.0,CNS(=O)(=O)Cc1cc2c(cc1)ncc2CCN(C)C
NCGC00159392-02,tox21-er-bla-agonist-p2,"1,1,1-Trichloro-2-methyl-2-propanol",activity,inactive,57-15-8,5977.0,ClC(Cl)(Cl)C(C)(C)O
NCGC00091326-01,tox21-er-bla-agonist-p2,Acetanilide,activity,inactive,103-84-4,904.0,O=C(C)Nc1ccccc1
NCGC00091660-01,tox21-er-bla-agonist-p2,Formalin,activity,inactive,NOCAS_47796,712.0,C=O
NCGC00181915-02,tox21-er-bla-agonist-p2,Mepranoprofen arbamel,activity,inactive,118635-52-2,164072.0,CN(C)C(=O)COC(=O)C(C)c1cc2Cc3ccc(C)nc3Oc2cc1
NCGC00183845-01,tox21-er-bla-agonist-p2,Pibutidine,activity,inactive,103922-33-4,5282450.0,NC=3C(=O)C(=O)C=3NC\C=C/COc2cc(CN1CCCCC1)ccn2
NCGC00254322-01,tox21-er-bla-agonist-p2,1-Tetradecanol,activity,inactive,112-72-1,8209.0,CCCCCCCCCCCCCCO
NCGC00253949-01,tox21-er-bla-agonist-p2,SR271425,activity,active agonist,155990-20-8,9909677.0,CCN(CC)CCNc1ccc(CNC=O)c2Sc3ccc(OC)cc3C(=O)c12
NCGC00253975-01,tox21-er-bla-agonist-p2,Glycerol,activity,inactive,56-81-5,753.0,OCC(O)CO
NCGC00183035-01,tox21-er-bla-agonist-p2,Cefamandole nafate,activity,inactive,42540-40-9,23665731.0,[Na+].O=CO[C@H](c1ccccc1)C(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2C)CS[C@@H]34)C([O-])=O
NCGC00016829-05,tox21-er-bla-agonist-p2,Isoxicam,activity,inactive,34552-84-6,54677972.0,Cc1cc(no1)NC(=O)C3=C(O)c2ccccc2S(=O)(=O)N3C
NCGC00258050-01,tox21-er-bla-agonist-p2,Dimethadione,activity,inactive,695-53-4,3081.0,O=C1NC(=O)C(C)(C)O1
NCGC00258420-01,tox21-er-bla-agonist-p2,Crystal Violet lactone,activity,active agonist,1552-42-7,73773.0,CN(C)c1ccc(cc1)C3(OC(=O)c2cc(ccc23)N(C)C)c4ccc(cc4)N(C)C
NCGC00094893-01,tox21-er-bla-agonist-p2,Puromycin dihydrochloride,activity,inactive,58-58-2,443311.0,Cl.Cl.COc1ccc(cc1)C[C@H](N)C(=O)N[C@@H]4[C@@H](CO)O[C@@H](n3cnc2c3ncnc2N(C)C)[C@@H]4O
NCGC00015009-08,tox21-er-bla-agonist-p2,4-Aminopyridine,activity,inactive,504-24-5,1727.0,Nc1ccncc1
NCGC00015061-02,tox21-er-bla-agonist-p2,Acyclovir,activity,inactive,59277-89-3,2022.0,NC2=Nc1c(ncn1COCCO)C(=O)N2
NCGC00015269-03,tox21-er-bla-agonist-p2,Cilostamide,activity,inactive,68550-75-4,2753.0,CN(C1CCCCC1)C(=O)CCCOc2ccc3NC(=O)C=Cc3c2
NCGC00016805-01,tox21-er-bla-agonist-p2,Metrizamide,activity,inactive,31112-62-6,443944.0,OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(=O)c1c(I)c(NC(C)=O)c(I)c(N(C)C(C)=O)c1I
NCGC00259263-01,tox21-er-bla-agonist-p2,"1H,3H-Benzo(1,2-c:4,5-c')difuran-1,3,5,7-tetrone",activity,inactive,89-32-7,6966.0,O=C2OC(=O)c1cc3c(cc12)C(=O)OC3=O
NCGC00259715-01,tox21-er-bla-agonist-p2,"Tris(1,3-dichloro-2-propyl)phosphate",activity,inactive,13674-87-8,26177.0,ClCC(OP(=O)(OC(CCl)CCl)OC(CCl)CCl)CCl
NCGC00257089-01,tox21-er-bla-agonist-p2,Zinc pyrithione,activity,active agonist,13463-41-7,26041.0,[O-][n+]2ccccc2S[Zn]Sc1cccc[n+]1[O-]
NCGC00260306-01,tox21-er-bla-agonist-p2,"1,1':4',1''-Terphenyl",activity,inactive,92-94-4,7115.0,c1cc(ccc1)c2ccc(cc2)c3ccccc3
NCGC00255513-01,tox21-er-bla-agonist-p2,Mepronil,activity,inactive,55814-41-0,41632.0,CC(C)Oc1cccc(c1)NC(=O)c2ccccc2C
NCGC00257296-01,tox21-er-bla-agonist-p2,FR150011,activity,inactive,149413-74-1,10159191.0,O=C(O)Cc4ccccc4COc1cc2cc(oc2cc1)c3nc(cs3)C(C)(C)C
NCGC00257612-01,tox21-er-bla-agonist-p2,"3,4-Dimethylaniline",activity,inactive,95-64-7,7248.0,Cc1cc(N)ccc1C
NCGC00259141-01,tox21-er-bla-agonist-p2,Kepone,activity,active agonist,143-50-0,299.0,O=C2C1(Cl)C3(Cl)C5(Cl)C1(Cl)C4(Cl)C2(Cl)C3(Cl)C4(Cl)C5(Cl)Cl
NCGC00255499-01,tox21-er-bla-agonist-p2,Chlorthiamid,activity,inactive,1918-13-4,2734819.0,S=C(N)c1c(Cl)cccc1Cl
NCGC00255637-01,tox21-er-bla-agonist-p2,"4,4'-Dichlorobenzophenone",activity,inactive,90-98-2,7034.0,O=C(c1ccc(Cl)cc1)c2ccc(Cl)cc2
NCGC00255985-01,tox21-er-bla-agonist-p2,"1,4-Bis(2-hydroxyethoxy)-2-butyne",activity,inactive,1606-85-5,62411.0,OCCOCC#CCOCCO
NCGC00256036-01,tox21-er-bla-agonist-p2,"N-Butyl-2,2,6,6-tetramethylpiperidin-4-amine",activity,inactive,36177-92-1,118285.0,CC1(C)CC(NCCCC)CC(C)(C)N1
NCGC00257002-01,tox21-er-bla-agonist-p2,2-Ethylhexyl diphenyl phosphate,activity,inactive,1241-94-7,14716.0,CCC(CCCC)COP(=O)(Oc1ccccc1)Oc2ccccc2
NCGC00257209-01,tox21-er-bla-agonist-p2,"N,N-Dimethylacetoacetamide",activity,inactive,2044-64-6,16278.0,CC(=O)CC(=O)N(C)C
NCGC00257520-01,tox21-er-bla-agonist-p2,Benzyltrimethylammonium hydroxide,activity,inactive,100-85-6,66854.0,[OH-].C[N+](C)(C)Cc1ccccc1
NCGC00259029-01,tox21-er-bla-agonist-p2,Quinoline,activity,inactive,91-22-5,7047.0,c1cccc2cccnc12
NCGC00258090-01,tox21-er-bla-agonist-p2,"2,2,2-Trichloroacetamide",activity,inactive,594-65-0,61144.0,ClC(Cl)(Cl)C(N)=O
NCGC00259197-01,tox21-er-bla-agonist-p2,"2,4,7,9-Tetramethyl-5-decyne-4,7-diol",activity,inactive,126-86-3,31362.0,CC(O)(C#CC(C)(O)CC(C)C)CC(C)C
NCGC00259515-01,tox21-er-bla-agonist-p2,3-Methylpyridine,activity,inactive,108-99-6,7970.0,Cc1cccnc1
NCGC00259325-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt",activity,inactive,3709-43-1,19458.0,[Na+].[Na+].O=S([O-])(=O)c2cc(ccc2C=Cc1ccc(cc1S([O-])(=O)=O)[N+]([O-])=O)[N+]([O-])=O
NCGC00259367-01,tox21-er-bla-agonist-p2,Limonene,activity,inactive,138-86-3,22311.0,CC1=CCC(CC1)C(C)=C
NCGC00259841-01,tox21-er-bla-agonist-p2,Bromotrichloromethane,activity,inactive,75-62-7,6383.0,BrC(Cl)(Cl)Cl
NCGC00259844-01,tox21-er-bla-agonist-p2,Carbendazim,activity,inactive,10605-21-7,25429.0,O=C(OC)Nc1nc2ccccc2n1
NCGC00259636-01,tox21-er-bla-agonist-p2,Allantoin,activity,inactive,97-59-6,204.0,O=C1NC(=O)NC1NC(=O)N
NCGC00260009-01,tox21-er-bla-agonist-p2,3-Nitropropionic acid,activity,inactive,504-88-1,1678.0,[O-][N+](=O)CCC(=O)O
NCGC00260369-01,tox21-er-bla-agonist-p2,3'-Chloropropiophenone,activity,inactive,34841-35-5,587128.0,O=C(CC)c1cc(Cl)ccc1
NCGC00260431-01,tox21-er-bla-agonist-p2,2-Methoxycinnamaldehyde,activity,inactive,1504-74-1,641298.0,COc1ccccc1/C=C/C=O
NCGC00260441-01,tox21-er-bla-agonist-p2,"4,4'-Dimethoxydiphenylamine",activity,inactive,101-70-2,7571.0,COc2ccc(Nc1ccc(OC)cc1)cc2
NCGC00260190-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium hydrogen sulfate,activity,inactive,412009-61-1,16217215.0,C[n+]1ccn(CC)c1.[O-]S(=O)(=O)O
NCGC00014679-01,tox21-er-bla-agonist-p2,Levomequitazine,activity,inactive,88598-74-7,6992284.0,c3ccc4Sc5ccccc5N(C[C@@H]2CN1CCC2CC1)c4c3
NCGC00016757-01,tox21-er-bla-agonist-p2,Ketoprofen,activity,inactive,22071-15-4,3825.0,CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2
NCGC00016624-03,tox21-er-bla-agonist-p2,Diphenidol,activity,inactive,972-02-1,3055.0,OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3
NCGC00168263-01,tox21-er-bla-agonist-p2,Desmethyldiazepam,activity,inactive,1088-11-5,2997.0,Clc1ccc2NC(=O)CN=C(c2c1)c3ccccc3
NCGC00181126-01,tox21-er-bla-agonist-p2,Formoterol hemifumarate,activity,inactive,43229-80-7,53477580.0,Oc1ccc(cc1NC=O)[C@@H](O)CN[C@H](C)Cc2ccc(OC)cc2.O=C(O)/C=C/C(=O)O.COc1ccc(cc1)C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2
NCGC00188434-01,tox21-er-bla-agonist-p2,Mecobalamin,activity,active agonist,13422-55-4,60196341.0,[Co+2]C.NC(=O)CC7(C)C(CCC(N)=O)C=6C=C1N=C(C(CCC(N)=O)C1(C)C)C(C)=C5[N-]C(C(CC(N)=O)C5(C)CCC(=O)NCC(C)OP([O-])(=O)OC4C(CO)OC(n3cnc2cc(C)c(C)cc23)C4O)C8(C)N=C(C(C)=C7N=6)C(CCC(N)=O)C8(C)CC(N)=O
NCGC00255565-01,tox21-er-bla-agonist-p2,4-Cyclohexylcyclohexanone,activity,inactive,92-68-2,41690.0,O=C1CCC(CC1)C2CCCCC2
NCGC00254956-01,tox21-er-bla-agonist-p2,2-Ethylbutyric acid,activity,inactive,88-09-5,6915.0,CCC(CC)C(=O)O
NCGC00254537-01,tox21-er-bla-agonist-p2,Rifampicin,activity,inactive,13292-46-1,5458213.0,CN1CCN(CC1)/N=C/c3c2NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)C=CO[C@@]5(C)Oc4c(C)c(O)c(c2O)c(c3O)c4C5=O
NCGC00255393-01,tox21-er-bla-agonist-p2,"1,1-Methylenebis(4-isocyanatocyclohexane)",activity,inactive,5124-30-1,21202.0,O=C=N/C1CCC(CC1)CC2CCC(/N=C=O)CC2
NCGC00255473-01,tox21-er-bla-agonist-p2,Bromociclen,activity,inactive,1715-40-8,15583.0,ClC2(Cl)C1(Cl)CC(CBr)C2(Cl)C(Cl)=C1Cl
NCGC00254144-01,tox21-er-bla-agonist-p2,Benzal chloride,activity,inactive,98-87-3,7411.0,ClC(Cl)c1ccccc1
NCGC00015054-06,tox21-er-bla-agonist-p2,Tacrine,activity,inactive,321-64-2,1935.0,Nc1c3ccccc3nc2CCCCc12
NCGC00015563-07,tox21-er-bla-agonist-p2,Imipramine,activity,inactive,50-49-7,3696.0,CN(C)CCCN2c3ccccc3CCc1ccccc12
NCGC00077304-01,tox21-er-bla-agonist-p2,Fluanisone,activity,inactive,1480-19-9,15139.0,Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccc3OC
NCGC00164628-01,tox21-er-bla-agonist-p2,Linezolid,activity,inactive,165800-03-3,441401.0,CC(=O)NC[C@@H]1OC(=O)N(C1)c2cc(F)c(cc2)N3CCOCC3
NCGC00166113-01,tox21-er-bla-agonist-p2,Diphenylcyclopropenone,activity,inactive,886-38-4,65057.0,O=C2C(=C2c1ccccc1)c3ccccc3
NCGC00182041-01,tox21-er-bla-agonist-p2,Pantoprazole sodium,activity,inactive,138786-67-1,15008962.0,[Na+].COc3c(OC)ccnc3CS(=O)c1[n-]c2ccc(cc2n1)OC(F)F
NCGC00182059-02,tox21-er-bla-agonist-p2,Febuxostat,activity,inactive,144060-53-7,134018.0,CC(C)COc1ccc(cc1C#N)c2nc(C)c(s2)C(=O)O
NCGC00255107-01,tox21-er-bla-agonist-p2,Tetrahydrofurfuryl methacrylate,activity,inactive,2455-24-5,17151.0,O=C(OCC1CCCO1)C(=C)C
NCGC00259358-01,tox21-er-bla-agonist-p2,Phenylbutazone,activity,inactive,50-33-9,4781.0,O=C3C(CCCC)C(=O)N(c1ccccc1)N3c2ccccc2
NCGC00260476-01,tox21-er-bla-agonist-p2,4-Nitrobenzaldehyde,activity,inactive,555-16-8,541.0,O=[N+]([O-])c1ccc(C=O)cc1
NCGC00164265-01,tox21-er-bla-agonist-p2,Olaquindox,activity,inactive,23696-28-8,71905.0,OCCNC(=O)c2c(C)[n+]([O-])c1ccccc1[n+]2[O-]
NCGC00165987-02,tox21-er-bla-agonist-p2,3-Phenyl-1-propanol,activity,inactive,122-97-4,31234.0,OCCCc1ccccc1
NCGC00166147-02,tox21-er-bla-agonist-p2,Dihydrotachysterol,activity,inactive,67-96-9,5311071.0,C[C@H]3CC[C@H](O)C/C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C
NCGC00168267-02,tox21-er-bla-agonist-p2,"R-(-)-2,5-Dimethoxy-4-bromoamphetamine hydrochloride",activity,inactive,50505-92-5,60196332.0,Cl.COc1cc(C[C@@H](C)N)c(cc1Br)OC
NCGC00016985-01,tox21-er-bla-agonist-p2,Disopyramide,activity,inactive,3737-09-5,3114.0,CC(C)N(CCC(c1ccccn1)(c2ccccc2)C(N)=O)C(C)C
NCGC00017127-01,tox21-er-bla-agonist-p2,Atracurium besylate,activity,inactive,64228-81-5,47320.0,[O-]S(=O)(=O)c1ccccc1.[O-]S(=O)(=O)c1ccccc1.COc1ccc(cc1OC)CC5c6cc(OC)c(OC)cc6CC[N+]5(C)CCC(=O)OCCCCCOC(=O)CC[N+]3(C)CCc4cc(OC)c(OC)cc4C3Cc2ccc(OC)c(OC)c2
NCGC00024574-02,tox21-er-bla-agonist-p2,Binospirone mesylate,activity,inactive,124756-23-6,71346.0,CS(=O)(=O)O.O=C4CC1(CCCC1)CC(=O)N4CCNCC2COc3ccccc3O2
NCGC00024714-03,tox21-er-bla-agonist-p2,Triprolidine,activity,inactive,486-12-4,5282443.0,Cc1ccc(cc1)C(=C\CN2CCCC2)/c3ccccn3
NCGC00025132-02,tox21-er-bla-agonist-p2,Levcromakalim,activity,inactive,94535-50-9,93504.0,O=C3CCCN3[C@@H]1c2cc(ccc2OC(C)(C)[C@H]1O)C#N
NCGC00256804-01,tox21-er-bla-agonist-p2,(3Z)-Hex-3-en-1-yl 2-methylpropanoate,activity,inactive,41519-23-7,5352539.0,O=C(OCC/C=C\CC)C(C)C
NCGC00256859-01,tox21-er-bla-agonist-p2,Bis(2-methyl-3-furyl)disulfide,activity,inactive,28588-75-2,526624.0,Cc2occc2SSc1ccoc1C
NCGC00256873-01,tox21-er-bla-agonist-p2,4-Phenyl-1-cyclohexene,activity,inactive,4994-16-5,21096.0,c1cc(ccc1)C2CC=CCC2
NCGC00256926-01,tox21-er-bla-agonist-p2,"1,1'-Bi(cyclohexyl)-2-one",activity,inactive,90-42-6,7016.0,O=C1CCCCC1C2CCCCC2
NCGC00258641-01,tox21-er-bla-agonist-p2,2-Chlorobenzyl chloride,activity,inactive,611-19-8,11906.0,ClCc1ccccc1Cl
NCGC00257528-01,tox21-er-bla-agonist-p2,(2Z)-2-Pentenenitrile,activity,inactive,25899-50-7,6433944.0,CC\C=C/C#N
NCGC00257597-01,tox21-er-bla-agonist-p2,Picloram,activity,inactive,1918-02-1,15965.0,Nc1c(Cl)c(nc(Cl)c1Cl)C(=O)O
NCGC00257818-01,tox21-er-bla-agonist-p2,"N,N-Diethylhydroxylamine",activity,inactive,3710-84-7,19463.0,CCN(O)CC
NCGC00258002-01,tox21-er-bla-agonist-p2,Methyl pivalate,activity,inactive,598-98-1,69027.0,CC(C)(C)C(=O)OC
NCGC00258309-01,tox21-er-bla-agonist-p2,Silybin,activity,inactive,22888-70-6,31553.0,Oc4cc(O)cc5O[C@H](c1ccc2O[C@H](CO)[C@H](Oc2c1)c3ccc(O)c(OC)c3)[C@@H](O)C(=O)c45
NCGC00256623-01,tox21-er-bla-agonist-p2,"N,N-Diethyldodecanamide",activity,inactive,3352-87-2,18783.0,CCN(CC)C(=O)CCCCCCCCCCC
NCGC00255736-01,tox21-er-bla-agonist-p2,"1,1'-Disulfanediyldiazepan-2-one",activity,inactive,23847-08-7,90282.0,O=C2CCCCCN2SSN1CCCCCC1=O
NCGC00256472-01,tox21-er-bla-agonist-p2,1-Naphthylamine,activity,inactive,134-32-7,8640.0,Nc2cccc1ccccc12
NCGC00256503-01,tox21-er-bla-agonist-p2,Allyl methacrylate,activity,inactive,96-05-9,7274.0,C=C(C)C(=O)OCC=C
NCGC00256549-01,tox21-er-bla-agonist-p2,Pentachloroanisole,activity,inactive,1825-21-4,15767.0,Clc1c(OC)c(Cl)c(Cl)c(Cl)c1Cl
NCGC00255838-01,tox21-er-bla-agonist-p2,Rabeprazole sodium,activity,inactive,117976-90-6,14720269.0,[Na+].Cc3c(OCCCOC)ccnc3CS(=O)c1[n-]c2ccccc2n1
NCGC00255974-01,tox21-er-bla-agonist-p2,Fluoroacetic acid,activity,inactive,144-49-0,5237.0,FCC(=O)O
NCGC00256104-01,tox21-er-bla-agonist-p2,Ethenyl[tris(prop-1-en-2-yloxy)]silane,activity,inactive,15332-99-7,84872.0,CC(=C)O[Si](OC(=C)C)(OC(C)=C)C=C
NCGC00256160-01,tox21-er-bla-agonist-p2,2-sec-Butyl-3-methoxypyrazine,activity,inactive,24168-70-5,520098.0,COc1nccnc1C(C)CC
NCGC00258859-01,tox21-er-bla-agonist-p2,Allyl isovalerate,activity,inactive,2835-39-4,17816.0,CC(C)CC(=O)OCC=C
NCGC00258870-01,tox21-er-bla-agonist-p2,"1,3-Diisopropylbenzene",activity,inactive,99-62-7,7450.0,CC(C)c1cccc(c1)C(C)C
NCGC00259014-01,tox21-er-bla-agonist-p2,"N,N-Diethylethanolamine",activity,inactive,100-37-8,7497.0,CCN(CC)CCO
NCGC00260395-01,tox21-er-bla-agonist-p2,"Benzene,(2-bromoethoxy)-",activity,inactive,589-10-6,68526.0,BrCCOc1ccccc1
NCGC00260557-01,tox21-er-bla-agonist-p2,NTP Mix65 CT1 62-EQP,activity,inactive,NOCAS_49453,,
NCGC00254715-01,tox21-er-bla-agonist-p2,Phosalone,activity,inactive,2310-17-0,4793.0,CCOP(=S)(OCC)SCN1c2ccc(Cl)cc2OC1=O
NCGC00255273-01,tox21-er-bla-agonist-p2,N-Nitrosobis(2-oxopropyl)amine,activity,inactive,60599-38-4,43371.0,O=C(C)CN(CC(=O)C)N=O
NCGC00255588-01,tox21-er-bla-agonist-p2,Topramezone,activity,inactive,210631-68-8,11302979.0,Oc1n(C)ncc1C(=O)c3ccc(c(C=2CCON=2)c3C)S(C)(=O)=O
NCGC00254532-01,tox21-er-bla-agonist-p2,Propylbenzene,activity,inactive,103-65-1,7668.0,CCCc1ccccc1
NCGC00093701-01,tox21-er-bla-agonist-p2,Citicoline sodium,activity,inactive,33818-15-4,36605.0,[Na+].C[N+](C)(C)CCOP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@@H](N1C=CC(N)=NC1=O)[C@H](O)[C@@H]2O
NCGC00159409-02,tox21-er-bla-agonist-p2,Inositol,activity,inactive,87-89-8,892.0,O[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1O
NCGC00180996-01,tox21-er-bla-agonist-p2,Propyl salicylate,activity,inactive,607-90-9,69092.0,Oc1ccccc1C(=O)OCCC
NCGC00159506-02,tox21-er-bla-agonist-p2,Cyclandelate,activity,inactive,456-59-7,2893.0,O=C(OC1CC(C)CC(C)(C)C1)C(O)c2ccccc2
NCGC00164510-01,tox21-er-bla-agonist-p2,Idrocilamide,activity,inactive,6961-46-2,1550874.0,OCCNC(=O)/C=C/c1ccccc1
NCGC00094991-01,tox21-er-bla-agonist-p2,Pipenzolate bromide,activity,inactive,125-51-9,657306.0,[Br-].O=C(OC1CCC[N+](C)(CC)C1)C(O)(c2ccccc2)c3ccccc3
NCGC00160391-01,tox21-er-bla-agonist-p2,Auranofin,activity,active agonist,34031-32-8,,CC(=O)OC[C@@H]1O[C@H](S[Au]=P(CC)(CC)CC)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O
NCGC00095051-01,tox21-er-bla-agonist-p2,Semustine,activity,inactive,13909-09-6,5198.0,O=C(NC1CCC(C)CC1)N(CCCl)N=O
NCGC00095084-01,tox21-er-bla-agonist-p2,Oxyphencyclimine hydrochloride,activity,inactive,125-52-0,66061.0,Cl.CN3CCCN=C3COC(=O)C(O)(c1ccccc1)C2CCCCC2
NCGC00164565-01,tox21-er-bla-agonist-p2,Ziprasidone,activity,inactive,146939-27-7,60854.0,O=C4Cc5cc(CCN1CCN(CC1)c3nsc2ccccc23)c(Cl)cc5N4
NCGC00167506-01,tox21-er-bla-agonist-p2,Pimecrolimus,activity,active agonist,137071-32-0,16051947.0,Cl[C@@H]1CC[C@H](C[C@H]1OC)\C=C(/C)[C@H]2OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@]3(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]3C)OC
NCGC00095127-01,tox21-er-bla-agonist-p2,Miglitol,activity,inactive,72432-03-2,441314.0,OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
NCGC00164621-01,tox21-er-bla-agonist-p2,Fenpiverinium bromide,activity,inactive,125-60-0,71489.0,[Br-].NC(=O)C(CC[N+]1(C)CCCCC1)(c2ccccc2)c3ccccc3
NCGC00095194-01,tox21-er-bla-agonist-p2,Cepharanthine,activity,inactive,481-49-2,10206.0,COc8ccc1cc8Oc7ccc(C[C@H]4c5c(Oc3cc2c(CCN(C)[C@@H]2C1)cc3OC)c6OCOc6cc5CCN4C)cc7
NCGC00165810-01,tox21-er-bla-agonist-p2,Indoramin hydrochloride,activity,inactive,38821-52-2,38102.0,Cl.O=C(NC3CCN(CCc1cnc2ccccc12)CC3)c4ccccc4
NCGC00095403-01,tox21-er-bla-agonist-p2,Tomatidine hydrochloride,activity,inactive,6192-62-7,60196284.0,Cl.C[C@H]6[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]1C[C@@H](O)CC[C@]1(C)[C@H]4CC[C@]23C)O[C@]56CC[C@H](C)CN5
NCGC00165991-01,tox21-er-bla-agonist-p2,Flurothyl,activity,inactive,333-36-8,9528.0,FC(F)(F)COCC(F)(F)F
NCGC00167563-01,tox21-er-bla-agonist-p2,Mofezolac,activity,inactive,78967-07-4,4237.0,O=C(O)Cc2onc(c1ccc(OC)cc1)c2c3ccc(OC)cc3
NCGC00162445-02,tox21-er-bla-agonist-p2,Misoprostol,activity,inactive,59122-46-2,5282381.0,O[C@@H]1CC(=O)[C@H](CCCCCCC(=O)OC)[C@H]1\C=C\CC(C)(O)CCCC
NCGC00091341-01,tox21-er-bla-agonist-p2,Cadmium oxide,activity,inactive,1306-19-0,14782.0,[Cd]=O
NCGC00182991-01,tox21-er-bla-agonist-p2,Glybuzole,activity,inactive,1492-02-0,3489.0,O=S(=O)(Nc1nnc(s1)C(C)(C)C)c2ccccc2
NCGC00182992-01,tox21-er-bla-agonist-p2,Fasoracetam,activity,inactive,110958-19-5,198695.0,O=C([C@H]1CCC(=O)N1)N2CCCCC2
NCGC00183128-01,tox21-er-bla-agonist-p2,Glycyrrhizin,activity,inactive,1405-86-3,14982.0,O=C(O)[C@H]7O[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@H](O[C@@H]6O[C@H]2CC[C@]3(C)[C@H]4C(=O)C=C1[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]1(C)[C@]4(C)CC[C@H]3C2(C)C)C(=O)O)C(=O)O)[C@H](O)[C@@H](O)[C@@H]7O
NCGC00254597-01,tox21-er-bla-agonist-p2,2-Phenylethyl phenylacetate,activity,inactive,102-20-5,7601.0,O=C(OCCc1ccccc1)Cc2ccccc2
NCGC00229513-01,tox21-er-bla-agonist-p2,Romidepsin,activity,active agonist,128517-07-7,56840936.0,CC(C)[C@H]2NC(=O)C[C@@H]1OC(=O)[C@@H](NC(=O)C(=C\C)\NC(=O)[C@@H](CSSCCC=C1)NC2=O)C(C)C
NCGC00254229-01,tox21-er-bla-agonist-p2,SB243213A,activity,inactive,200940-23-4,15981450.0,Cl.Cc4ncccc4Oc1ccc(cn1)NC(=O)N3CCc2cc(C)c(cc23)C(F)(F)F
NCGC00255402-01,tox21-er-bla-agonist-p2,Lithium perfluorooctane sulfonate,activity,inactive,29457-72-5,23677927.0,[Li+].FC(F)(C(F)(F)S([O-])(=O)=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00253930-01,tox21-er-bla-agonist-p2,SB281832,activity,inactive,219790-72-4,9931156.0,OCC(CO)n4cnc(c1ccc(F)cc1)c4c3ccnc(Oc2ccccc2)n3
NCGC00254017-01,tox21-er-bla-agonist-p2,Hydrochlorothiazide,activity,inactive,58-93-5,3639.0,NS(=O)(=O)c2cc1c(NCNS1(=O)=O)cc2Cl
NCGC00254868-01,tox21-er-bla-agonist-p2,Tebupirimfos,activity,inactive,96182-53-5,93516.0,CC(C)(C)c1ncc(OP(=S)(OCC)OC(C)C)cn1
NCGC00254938-01,tox21-er-bla-agonist-p2,Diglycolic acid,activity,inactive,110-99-6,8088.0,O=C(O)COCC(=O)O
NCGC00259533-01,tox21-er-bla-agonist-p2,1-Methoxy-2-nitrobenzene,activity,inactive,91-23-6,7048.0,COc1ccccc1[N+]([O-])=O
NCGC00260081-01,tox21-er-bla-agonist-p2,S-(Propyl) chlorothioformate,activity,inactive,13889-92-4,26323.0,ClC(=O)SCCC
NCGC00014702-03,tox21-er-bla-agonist-p2,Pirinixic acid,activity,inactive,50892-23-4,5694.0,Cc2cccc(Nc1cc(Cl)nc(SCC(=O)O)n1)c2C
NCGC00159473-05,tox21-er-bla-agonist-p2,(-)-Fenfluramine hydrochloride,activity,inactive,3616-78-2,16219349.0,Cl.FC(F)(F)c1cccc(C[C@@H](C)NCC)c1
NCGC00164091-01,tox21-er-bla-agonist-p2,Sodium dichloroisocyanurate,activity,inactive,2893-78-9,517121.0,[Na+].ClN1C(=O)[N-]C(=O)N(Cl)C1=O
NCGC00016526-02,tox21-er-bla-agonist-p2,Berberine chloride,activity,inactive,633-65-8,12456.0,[Cl-].COc2ccc1cc3c4cc5OCOc5cc4CC[n+]3cc1c2OC
NCGC00257238-01,tox21-er-bla-agonist-p2,HMR1171 trifluoroacetate (1:1),activity,inactive,NOCAS_48522,60196348.0,FC(F)(F)C(=O)O.CCN(CC)C(=O)c1cc(c(cc1N(CC)CCN(C)C)N2CCC(CC2)c3ccccc3)S(=O)(=O)Cc4ccccc4
NCGC00257409-01,tox21-er-bla-agonist-p2,Isobornyl methacrylate,activity,inactive,7534-94-3,904857.0,C=C(C)C(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C
NCGC00255496-01,tox21-er-bla-agonist-p2,Dioxacarb,activity,inactive,6988-21-2,23421.0,CNC(=O)Oc1ccccc1C2OCCO2
NCGC00255753-01,tox21-er-bla-agonist-p2,Pentyl sulfide,activity,inactive,872-10-6,13382.0,CCCCCSCCCCC
NCGC00260607-01,tox21-er-bla-agonist-p2,NTP Mix10 AR1 8-EQC,activity,inactive,NOCAS_49503,,
NCGC00260654-01,tox21-er-bla-agonist-p2,NTP Mix95 ER AR1 18-EQP,activity,active agonist,NOCAS_49550,,
NCGC00256294-01,tox21-er-bla-agonist-p2,C.I. Acid Red 1,activity,inactive,3734-67-6,6507024.0,[Na+].[Na+].[O-]S(=O)(=O)c3cc2cc(c(\N=N/c1ccccc1)c(O)c2c(c3)NC(C)=O)S([O-])(=O)=O
NCGC00091284-03,tox21-er-bla-agonist-p2,"1,5-Naphthalenediamine",activity,inactive,2243-62-1,16720.0,Nc2cccc1c2cccc1N
NCGC00257043-01,tox21-er-bla-agonist-p2,Tris(2-chloroethyl) phosphite,activity,inactive,140-08-9,8783.0,ClCCOP(OCCCl)OCCCl
NCGC00257247-01,tox21-er-bla-agonist-p2,Pregnenolone carbonitrile,activity,inactive,1434-54-4,15032.0,CC(=O)[C@H]4[C@H](C#N)C[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00256529-01,tox21-er-bla-agonist-p2,Ergocalciferol,activity,inactive,50-14-6,5280793.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C
NCGC00257853-01,tox21-er-bla-agonist-p2,"1,2,3,4-Tetrahydro-9-acridinamine hydrochloride",activity,inactive,1684-40-8,2723754.0,Cl.Nc1c3ccccc3nc2CCCCc12
NCGC00256972-01,tox21-er-bla-agonist-p2,"1H,3H-Benzo(1,2-c:4,5-c')difuran-1,3,5,7-tetrone",activity,inactive,89-32-7,6966.0,O=C2OC(=O)c1cc3c(cc12)C(=O)OC3=O
NCGC00258053-01,tox21-er-bla-agonist-p2,Glycol sulfite,activity,inactive,3741-38-6,77342.0,O=S1OCCO1
NCGC00257139-01,tox21-er-bla-agonist-p2,Dibromoacetonitrile,activity,inactive,3252-43-5,18617.0,BrC(Br)C#N
NCGC00183850-01,tox21-er-bla-agonist-p2,"{4-[4-(Acetylamino)-2-oxopyrimidin-1(2H)-yl]-1,3-dioxolan-2-yl}methyl benzoate",activity,inactive,NOCAS_48792,10133071.0,O=C(OCC1OCC(O1)N2C=CC(NC(C)=O)=NC2=O)c3ccccc3
NCGC00255532-01,tox21-er-bla-agonist-p2,2-Methylbutyl isovalerate,activity,inactive,2445-77-4,62445.0,CC(CC)COC(=O)CC(C)C
NCGC00255420-01,tox21-er-bla-agonist-p2,"{4-[({2-[3-Fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid",activity,inactive,317318-84-6,9934458.0,O=C(O)COc1ccc(cc1C)SCc2sc(nc2C)c3cc(F)c(cc3)C(F)(F)F
NCGC00256106-01,tox21-er-bla-agonist-p2,Ethylene glycol diglycidyl ether,activity,inactive,2224-15-9,16683.0,C(OCCOCC1CO1)C2CO2
NCGC00257119-01,tox21-er-bla-agonist-p2,"1,4-Butanediol",activity,inactive,110-63-4,8064.0,OCCCCO
NCGC00257465-01,tox21-er-bla-agonist-p2,Resveratrol,activity,active agonist,501-36-0,445154.0,Oc2cc(/C=C/c1ccc(O)cc1)cc(O)c2
NCGC00258285-01,tox21-er-bla-agonist-p2,"2-(Chloromethyl)-1H-isoindole-1,3(2H)-dione",activity,inactive,17564-64-6,87154.0,O=C2c1ccccc1C(=O)N2CCl
NCGC00258912-01,tox21-er-bla-agonist-p2,"N,N-Dimethylcyclohexylamine",activity,inactive,98-94-2,7415.0,CN(C)C1CCCCC1
NCGC00258925-01,tox21-er-bla-agonist-p2,Resveratrol,activity,active agonist,501-36-0,445154.0,Oc2cc(/C=C/c1ccc(O)cc1)cc(O)c2
NCGC00259042-01,tox21-er-bla-agonist-p2,"Carbonochloridic acid, 2-ethylhexyl ester",activity,inactive,24468-13-1,62783.0,O=C(Cl)OCC(CCCC)CC
NCGC00258381-01,tox21-er-bla-agonist-p2,"2,2'-Thiobisethanol",activity,inactive,111-48-8,5447.0,OCCSCCO
NCGC00258597-01,tox21-er-bla-agonist-p2,2-Amino-1-phenol-4-sulfonic acid,activity,inactive,98-37-3,7385.0,Oc1ccc(cc1N)S(O)(=O)=O
NCGC00258642-01,tox21-er-bla-agonist-p2,"1,1-Dichloropropanone",activity,inactive,513-88-2,10567.0,ClC(Cl)C(C)=O
NCGC00259773-01,tox21-er-bla-agonist-p2,"3,3'-Dichlorobenzidine",activity,active agonist,91-94-1,7070.0,Nc1ccc(cc1Cl)c2ccc(N)c(Cl)c2
NCGC00259710-01,tox21-er-bla-agonist-p2,Hexanedioic acid,activity,inactive,124-04-9,196.0,OC(=O)CCCCC(=O)O
NCGC00260250-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium bromide,activity,inactive,93457-69-3,11009532.0,[Br-].CCCC[N+]1(C)CCCC1
NCGC00260228-01,tox21-er-bla-agonist-p2,1-Butyl-2-methylpyridinium iodide,activity,inactive,13311-31-4,15932798.0,[I-].Cc1cccc[n+]1CCCC
NCGC00260316-01,tox21-er-bla-agonist-p2,"Dimethyl 2,6-naphthalenedicarboxylate",activity,inactive,840-65-3,61225.0,O=C(OC)c1ccc2cc(ccc2c1)C(=O)OC
NCGC00260625-01,tox21-er-bla-agonist-p2,NTP Mix101 ER1 10-EQC,activity,inactive,NOCAS_49521,,
NCGC00260244-01,tox21-er-bla-agonist-p2,1-Ethylpyridinium trifluoromethanesulfonate,activity,inactive,3878-80-6,13638937.0,CC[n+]1ccccc1.FC(F)(F)S([O-])(=O)=O
NCGC00015380-09,tox21-er-bla-agonist-p2,Diazoxide,activity,inactive,364-98-7,3019.0,Clc1ccc2N=C(C)NS(=O)(=O)c2c1
NCGC00014313-01,tox21-er-bla-agonist-p2,Penicillin G potassium,activity,inactive,113-98-4,23664709.0,[K+].O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)Cc1ccccc1)[C@H]3SC2(C)C
NCGC00015397-06,tox21-er-bla-agonist-p2,Ethamivan,activity,inactive,304-84-7,9363.0,Oc1ccc(cc1OC)C(=O)N(CC)CC
NCGC00016272-01,tox21-er-bla-agonist-p2,Guanethidine sulfate,activity,inactive,60-02-6,60196261.0,O=S(=O)(O)O.O=S(=O)(O)O.N=C(N)NCCN1CCCCCCC1
NCGC00016738-01,tox21-er-bla-agonist-p2,Streptozocin,activity,inactive,18883-66-4,29327.0,O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O
NCGC00016398-01,tox21-er-bla-agonist-p2,Trichlormethiazide,activity,inactive,133-67-5,5560.0,NS(=O)(=O)c2cc1c(NC(NS1(=O)=O)C(Cl)Cl)cc2Cl
NCGC00016401-01,tox21-er-bla-agonist-p2,Hydroflumethiazide,activity,inactive,135-09-1,3647.0,FC(F)(F)c1cc2NCNS(=O)(=O)c2cc1S(N)(=O)=O
NCGC00016938-01,tox21-er-bla-agonist-p2,Cefixime,activity,inactive,79350-37-1,54362.0,Nc1scc(n1)/C(=N\OCC(=O)O)C(=O)N[C@@H]2C(=O)N3C(=C(C=C)CS[C@H]23)C(=O)O
NCGC00094486-01,tox21-er-bla-agonist-p2,Zolantidine dimaleate,activity,inactive,104076-39-3,11957725.0,O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.c1cccc2sc(nc12)NCCCOc4cc(CN3CCCCC3)ccc4
NCGC00163786-03,tox21-er-bla-agonist-p2,Bioresmethrin,activity,inactive,28434-01-7,162381.0,O=C(OCc2cc(Cc1ccccc1)oc2)[C@@H]3[C@@H](/C=C(\C)C)C3(C)C
NCGC00247673-01,tox21-er-bla-agonist-p2,"2-[2,5-dimethoxy-4-(propylsulfanyl)phenyl]ethanamine hydrochloride",activity,inactive,850140-15-7,46781343.0,Cl.COc1cc(SCCC)c(cc1CCN)OC
NCGC00185765-01,tox21-er-bla-agonist-p2,Encainide hydrochloride,activity,inactive,66794-74-9,48040.0,Cl.CN3CCCCC3CCc2ccccc2NC(=O)c1ccc(OC)cc1
NCGC00255707-01,tox21-er-bla-agonist-p2,Tetradonium bromide,activity,inactive,1119-97-7,14250.0,[Br-].C[N+](C)(C)CCCCCCCCCCCCCC
NCGC00255843-01,tox21-er-bla-agonist-p2,Spirotetramat,activity,inactive,203313-25-1,9969573.0,O=C(OCC)OC2=C(C(=O)N[C@@]12CC[C@H](CC1)OC)c3cc(C)ccc3C
NCGC00255059-01,tox21-er-bla-agonist-p2,Dimethoate,activity,inactive,60-51-5,3082.0,COP(=S)(OC)SCC(=O)NC
NCGC00255287-01,tox21-er-bla-agonist-p2,"Bromo-3-chloro-5,5-dimethylhydantoin",activity,inactive,16079-88-2,61828.0,O=C1N(Cl)C(=O)N(Br)C1(C)C
NCGC00256154-01,tox21-er-bla-agonist-p2,Naphthalene-2-sulfonic acid,activity,inactive,120-18-3,8420.0,O=S(=O)(O)c1ccc2ccccc2c1
NCGC00254507-01,tox21-er-bla-agonist-p2,EPN,activity,inactive,2104-64-5,16421.0,S=P(OCC)(Oc1ccc(cc1)[N+]([O-])=O)c2ccccc2
NCGC00254920-01,tox21-er-bla-agonist-p2,Sodium 2-naphthalenesulfonate,activity,inactive,532-02-5,23661868.0,[Na+].[O-]S(=O)(=O)c1ccc2ccccc2c1
NCGC00255148-01,tox21-er-bla-agonist-p2,Diisooctyl adipate,activity,inactive,1330-86-5,66932.0,CC(C)CCCCCOC(=O)CCCCC(=O)OCCCCCC(C)C
NCGC00254179-01,tox21-er-bla-agonist-p2,trans-Retinoic acid,activity,active agonist,302-79-4,444795.0,CC=1CCCC(C)(C)C=1/C=CC(\C)=C\C=C\C(\C)=C\C(=O)O
NCGC00254201-01,tox21-er-bla-agonist-p2,"N,N,4-Trimethylaniline",activity,inactive,99-97-8,7471.0,Cc1ccc(cc1)N(C)C
NCGC00017130-01,tox21-er-bla-agonist-p2,Moxalactam disodium,activity,inactive,64953-12-4,441242.0,[Na+].[Na+].O=C3N1C(=C(CO[C@@H]1[C@]3(OC)NC(=O)C(c2ccc(O)cc2)C([O-])=O)CSc4nnnn4C)C([O-])=O
NCGC00024584-03,tox21-er-bla-agonist-p2,Bromocriptine,activity,inactive,25614-03-3,31101.0,Brc3nc2cccc1C4=C[C@H](CN(C)[C@@H]4Cc3c12)C(=O)N[C@@]7(O[C@]6(O)N([C@@H](CC(C)C)C(=O)N5CCC[C@H]56)C7=O)C(C)C
NCGC00159333-02,tox21-er-bla-agonist-p2,Sparfloxacin,activity,inactive,110871-86-8,60464.0,C[C@@H]1CN(C[C@H](C)N1)c2c(F)c(N)c3c(c2F)N(C=C(C3=O)C(=O)O)C4CC4
NCGC00160655-01,tox21-er-bla-agonist-p2,Tenonitrozole,activity,inactive,3810-35-3,19646.0,O=C(Nc1ncc(s1)[N+]([O-])=O)c2cccs2
NCGC00181041-01,tox21-er-bla-agonist-p2,5-Chloro-2-methyl-3(2H)-isothiazolone,activity,inactive,26172-55-4,33344.0,ClC1=CC(=O)N(C)S1
NCGC00253918-01,tox21-er-bla-agonist-p2,Resorcinol,activity,inactive,108-46-3,5054.0,Oc1cccc(O)c1
NCGC00260382-01,tox21-er-bla-agonist-p2,"10,11-Dihydro-5H-dibenz[b,f]azepine",activity,active agonist,494-19-9,10308.0,c1cc2Nc3ccccc3CCc2cc1
NCGC00094960-03,tox21-er-bla-agonist-p2,Anthraquinone,activity,inactive,84-65-1,6780.0,O=C2c1ccccc1C(=O)c3ccccc23
NCGC00095024-01,tox21-er-bla-agonist-p2,Fipexide hydrochloride,activity,inactive,34161-23-4,161803.0,Cl.Clc1ccc(cc1)OCC(=O)N2CCN(CC2)Cc3ccc4OCOc4c3
NCGC00160605-01,tox21-er-bla-agonist-p2,Diacetamate,activity,inactive,2623-33-8,17499.0,O=C(C)Oc1ccc(cc1)NC(C)=O
NCGC00160624-01,tox21-er-bla-agonist-p2,Ethopabate,activity,inactive,59-06-3,6034.0,CCOc1cc(ccc1C(=O)OC)NC(C)=O
NCGC00254031-01,tox21-er-bla-agonist-p2,MK-547,activity,inactive,331623-06-4,60196401.0,[Na+].[Na+].[O-]C(=O)[C@@H](C)Cc1cc(OC)ccc1[C@@H]5c2nc(CCCC)ccc2[C@H](c3ccc4OCOc4c3)[C@H]5C([O-])=O
NCGC00254161-01,tox21-er-bla-agonist-p2,2-Butanone oxime,activity,inactive,96-29-7,7292.0,C/C(CC)=N\O
NCGC00254199-01,tox21-er-bla-agonist-p2,Pyrimethamine,activity,inactive,58-14-0,4993.0,CCc1nc(N)nc(N)c1c2ccc(Cl)cc2
NCGC00090714-01,tox21-er-bla-agonist-p2,Sodium xylenesulfonate,activity,inactive,1300-72-7,23668192.0,[Na+].Cc1ccc(cc1C)S(=O)([O-])=O
NCGC00018143-04,tox21-er-bla-agonist-p2,Enrofloxacin,activity,inactive,93106-60-6,71188.0,CCN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4
NCGC00023654-04,tox21-er-bla-agonist-p2,Captopril,activity,inactive,62571-86-2,44093.0,OC(=O)[C@@H]1CCCN1C(=O)[C@H](C)CS
NCGC00258399-01,tox21-er-bla-agonist-p2,"2-Amino-2-ethyl-1,3-propanediol",activity,inactive,115-70-8,8282.0,CCC(N)(CO)CO
NCGC00258400-01,tox21-er-bla-agonist-p2,2-Amino-4-(p-nitrophenyl)thiazole,activity,inactive,2104-09-8,16420.0,Nc1nc(cs1)c2ccc(cc2)[N+]([O-])=O
NCGC00258492-01,tox21-er-bla-agonist-p2,Methyl cyanoacetate,activity,inactive,105-34-0,7747.0,N#CCC(=O)OC
NCGC00258607-01,tox21-er-bla-agonist-p2,Fluorobenzene,activity,inactive,462-06-6,10008.0,Fc1ccccc1
NCGC00257405-01,tox21-er-bla-agonist-p2,Fabesetron hydrochloride,activity,inactive,129299-90-7,180494.0,Cl.Cc4ncnc4C[C@H]3CCc2c(C)c1ccccc1n2C3=O
NCGC00257512-01,tox21-er-bla-agonist-p2,Bis(2-butoxyethyl) phthalate,activity,inactive,117-83-9,8345.0,O=C(OCCOCCCC)c1ccccc1C(=O)OCCOCCCC
NCGC00257675-01,tox21-er-bla-agonist-p2,3-Bromobiphenyl,activity,inactive,2113-57-7,16449.0,Brc1cc(ccc1)c2ccccc2
NCGC00257707-01,tox21-er-bla-agonist-p2,Chlorodibromomethane,activity,inactive,124-48-1,31296.0,BrC(Br)Cl
NCGC00257740-01,tox21-er-bla-agonist-p2,Vinyltoluene,activity,inactive,25013-15-4,7529.0,Cc1cccc(C=C)c1
NCGC00257861-01,tox21-er-bla-agonist-p2,2-(Dimethylamino)ethyl acrylate,activity,inactive,2439-35-2,17111.0,CN(C)CCOC(=O)C=C
NCGC00258169-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpyrrolidinium iodide,activity,inactive,56511-17-2,11076461.0,[I-].CCCC[N+]1(C)CCCC1
NCGC00258239-01,tox21-er-bla-agonist-p2,Benzyl phenylacetate,activity,inactive,102-16-9,60999.0,O=C(OCc1ccccc1)Cc2ccccc2
NCGC00258338-01,tox21-er-bla-agonist-p2,Chromic oxide pigment,activity,inactive,NOCAS_20326,517277.0,O=[Cr]O[Cr]=O
NCGC00256689-01,tox21-er-bla-agonist-p2,Acid Yellow 11,activity,inactive,6359-82-6,23675339.0,[Na+].[O-]S(=O)(=O)c1ccc(cc1)N3N=C(C)C(\N=N/c2ccccc2)C3=O
NCGC00256522-01,tox21-er-bla-agonist-p2,Phenylacetaldehyde,activity,inactive,122-78-1,998.0,O=CCc1ccccc1
NCGC00255964-01,tox21-er-bla-agonist-p2,Mercury(II) acetate,activity,active agonist,1600-27-7,15337.0,[Hg+2].[O-]C(C)=O.[O-]C(C)=O
NCGC00256129-01,tox21-er-bla-agonist-p2,Dibutyl nonanedioate,activity,inactive,2917-73-9,18016.0,O=C(CCCCCCCC(=O)OCCCC)OCCCC
NCGC00256289-01,tox21-er-bla-agonist-p2,Nicardipine hydrochloride,activity,inactive,54527-84-3,41114.0,Cl.CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC
NCGC00258817-01,tox21-er-bla-agonist-p2,3-Methylaniline,activity,inactive,108-44-1,7934.0,Cc1cc(N)ccc1
NCGC00258923-01,tox21-er-bla-agonist-p2,2-(Butan-2-yl)phenol,activity,inactive,89-72-5,6984.0,Oc1ccccc1C(C)CC
NCGC00260544-01,tox21-er-bla-agonist-p2,Emodin,activity,active agonist,518-82-1,3220.0,Cc3cc2C(=O)c1cc(O)cc(O)c1C(=O)c2c(O)c3
NCGC00259163-01,tox21-er-bla-agonist-p2,Sodium dodecyl sulfate,activity,inactive,151-21-3,3423265.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCC
NCGC00259438-01,tox21-er-bla-agonist-p2,"2,5-Dichlorophenol",activity,inactive,583-78-8,66.0,Clc1ccc(Cl)c(O)c1
NCGC00259504-01,tox21-er-bla-agonist-p2,Carbofuran,activity,inactive,1563-66-2,2566.0,CNC(=O)Oc1cccc2CC(C)(C)Oc12
NCGC00259511-01,tox21-er-bla-agonist-p2,EPTC,activity,inactive,759-94-4,12968.0,CCCN(CCC)C(=O)SCC
NCGC00260189-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium methyl sulfate,activity,inactive,516474-01-4,16211409.0,C[n+]1ccn(CC)c1.[O-]S(=O)(=O)OC
NCGC00260277-01,tox21-er-bla-agonist-p2,Black cohosh,activity,inactive,84776-26-1,,
NCGC00254636-01,tox21-er-bla-agonist-p2,Diazinon,activity,inactive,333-41-5,3017.0,Cc1cc(OP(=S)(OCC)OCC)nc(n1)C(C)C
NCGC00254786-01,tox21-er-bla-agonist-p2,Fenpropathrin,activity,inactive,39515-41-8,47326.0,CC3(C)C(C(=O)OC(C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00254819-01,tox21-er-bla-agonist-p2,Nitrapyrin,activity,inactive,1929-82-4,16004.0,ClC(Cl)(Cl)c1cccc(Cl)n1
NCGC00256413-01,tox21-er-bla-agonist-p2,Ifosfamide,activity,inactive,3778-73-2,3690.0,O=P1(NCCCl)OCCCN1CCCl
NCGC00255036-01,tox21-er-bla-agonist-p2,"3,5-Dimethyl-1-hexyn-3-ol",activity,inactive,107-54-0,61018.0,CC(C)CC(C)(O)C#C
NCGC00255152-01,tox21-er-bla-agonist-p2,Mifepristone,activity,inactive,84371-65-3,55245.0,CN(C)c1ccc(cc1)[C@H]5C[C@@]2(C)[C@@H](CC[C@@]2(O)C#CC)[C@@H]4CCC3=CC(=O)CCC3=C45
NCGC00255159-01,tox21-er-bla-agonist-p2,beta-Caryophyllene,activity,inactive,87-44-5,5281515.0,C=C2CCC=C(C)CC[C@@H]1[C@@H]2CC1(C)C
NCGC00255376-01,tox21-er-bla-agonist-p2,Bezafibrate,activity,inactive,41859-67-0,39042.0,O=C(NCCc1ccc(OC(C)(C)C(=O)O)cc1)c2ccc(Cl)cc2
NCGC00255439-01,tox21-er-bla-agonist-p2,"2(3H)-Furanone, 5-hexyldihydro-5-methyl-",activity,inactive,7011-83-8,285097.0,O=C1CCC(C)(CCCCCC)O1
NCGC00255458-01,tox21-er-bla-agonist-p2,Phenyl 1-hydroxy-2-naphthoate,activity,inactive,132-54-7,67236.0,O=C(Oc1ccccc1)c3ccc2ccccc2c3O
NCGC00255564-01,tox21-er-bla-agonist-p2,Dinobuton,activity,active agonist,973-21-7,13783.0,CC(CC)c1cc(cc([N+]([O-])=O)c1OC(=O)OC(C)C)[N+]([O-])=O
NCGC00255913-01,tox21-er-bla-agonist-p2,"N,N'-Dibutylurea",activity,inactive,1792-17-2,74523.0,CCCCNC(=O)NCCCC
NCGC00255948-01,tox21-er-bla-agonist-p2,Sodium tridecyl sulfate,activity,inactive,3026-63-9,23668353.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCCCCCC
NCGC00256201-01,tox21-er-bla-agonist-p2,Sodium 3-nitrobenzoate,activity,inactive,827-95-2,70014.0,[Na+].O=[N+]([O-])c1cc(ccc1)C([O-])=O
NCGC00254490-01,tox21-er-bla-agonist-p2,2-[2-(2-Ethoxyethoxy)ethoxy]ethanol,activity,inactive,112-50-5,8190.0,OCCOCCOCCOCC
NCGC00254568-01,tox21-er-bla-agonist-p2,1-Chloro-2-methyl-3-nitrobenzene,activity,inactive,83-42-1,6740.0,Cc1c(cccc1Cl)[N+]([O-])=O
NCGC00254569-01,tox21-er-bla-agonist-p2,Dicamba,activity,inactive,1918-00-9,3030.0,COc1c(c(Cl)ccc1Cl)C(=O)O
NCGC00254601-01,tox21-er-bla-agonist-p2,"1,3-Dioxolane",activity,inactive,646-06-0,12586.0,C1COCO1
NCGC00091454-04,tox21-er-bla-agonist-p2,Phenol,activity,inactive,108-95-2,996.0,Oc1ccccc1
NCGC00166295-01,tox21-er-bla-agonist-p2,Lactitol,activity,active agonist,585-86-4,157355.0,OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO
NCGC00166311-01,tox21-er-bla-agonist-p2,Azaconazole,activity,inactive,60207-31-0,43233.0,Clc1cc(Cl)c(cc1)C2(OCCO2)Cn3cncn3
NCGC00093797-03,tox21-er-bla-agonist-p2,"2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-, (2S,6S,11S)-",activity,inactive,7313-87-3,6603759.0,Oc3ccc4C[C@H]2[C@@H](C)[C@](C)(CCN2CC1CC1)c4c3
NCGC00163333-01,tox21-er-bla-agonist-p2,D-Glutamine,activity,inactive,5959-95-5,145815.0,O=C(N)CC[C@@H](N)C(=O)O
NCGC00167434-01,tox21-er-bla-agonist-p2,Pemirolast potassium,activity,inactive,100299-08-9,443866.0,[K+].CC3=CC=CN1C3=NC=C(C1=O)c2[n-]nnn2
NCGC00159461-02,tox21-er-bla-agonist-p2,Amprenavir,activity,inactive,161814-49-9,10885665.0,O=C(N[C@@H](Cc1ccccc1)[C@H](O)CN(CC(C)C)S(=O)(=O)c2ccc(N)cc2)O[C@@H]3CCOC3
NCGC00163699-01,tox21-er-bla-agonist-p2,Fumagillin,activity,inactive,23110-15-8,6917655.0,C[C@@]1(O[C@@H]1C\C=C(\C)C)[C@H]3[C@H](OC)[C@H](OC(=O)\C=C\C=C\C=C\C=C\C(=O)O)CC[C@@]23CO2
NCGC00163818-04,tox21-er-bla-agonist-p2,Azoxystrobin,activity,inactive,131860-33-8,3034285.0,O=C(OC)\C(=C\OC)c3ccccc3Oc2cc(Oc1ccccc1C#N)ncn2
NCGC00159551-01,tox21-er-bla-agonist-p2,Devazepide,activity,inactive,103420-77-5,443375.0,O=C(N[C@H]2N=C(c1ccccc1N(C)C2=O)c3ccccc3)c4cc5ccccc5n4
NCGC00181133-01,tox21-er-bla-agonist-p2,Desmopressin acetate,activity,inactive,62288-83-9,16051969.0,CC(=O)O.NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00181155-01,tox21-er-bla-agonist-p2,1-Piperazinecarbodithioic acid,activity,inactive,99-00-3,66829.0,S=C(S)N1CCNCC1
NCGC00164520-01,tox21-er-bla-agonist-p2,L-Threonine,activity,inactive,72-19-5,6288.0,O=C(O)[C@@H](N)[C@@H](C)O
NCGC00167583-01,tox21-er-bla-agonist-p2,"Disodium propane-1,3-disulfonate",activity,inactive,36589-58-9,6451143.0,[Na+].[Na+].[O-]S(=O)(=O)CCCS(=O)([O-])=O
NCGC00160389-02,tox21-er-bla-agonist-p2,Cypermethrin,activity,inactive,52315-07-8,2912.0,Cl/C(Cl)=C/C3C(C(=O)OC(C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00181319-05,tox21-er-bla-agonist-p2,Plicamycin,activity,inactive,18378-89-7,5284610.0,C[C@@H](O)[C@H](O)C(=O)[C@@H](OC)C6Cc7cc8cc(O[C@H]2C[C@@H](O[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1)[C@@H](O)[C@@H](C)O2)c(C)c(O)c8c(O)c7C(=O)[C@H]6O[C@H]5C[C@@H](O[C@H]4C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O5
NCGC00160423-01,tox21-er-bla-agonist-p2,Bamethan,activity,inactive,3703-79-5,2292.0,OC(CNCCCC)c1ccc(O)cc1
NCGC00160559-01,tox21-er-bla-agonist-p2,Tolamolol,activity,inactive,38103-61-6,37910.0,NC(=O)c1ccc(cc1)OCCNCC(O)COc2ccccc2C
NCGC00166075-01,tox21-er-bla-agonist-p2,Piconol,activity,inactive,586-98-1,11474.0,OCc1ccccn1
NCGC00168775-01,tox21-er-bla-agonist-p2,Darifenacin hydrobromide,activity,inactive,133099-07-7,444030.0,Br.NC(=O)C(c1ccccc1)(c2ccccc2)[C@@H]3CCN(C3)CCc4cc5CCOc5cc4
NCGC00096053-01,tox21-er-bla-agonist-p2,Aminoguanidine hemisulfate,activity,inactive,996-19-0,2734952.0,NC(=N)NN.O=S(=O)(O)O.N=C(N)NN
NCGC00160667-01,tox21-er-bla-agonist-p2,Sulfaethidole,activity,inactive,94-19-9,7181.0,O=S(=O)(Nc1nnc(CC)s1)c2ccc(N)cc2
NCGC00159344-02,tox21-er-bla-agonist-p2,Carminomycin,activity,active agonist,50935-04-1,443831.0,CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(O)cccc2C(=O)c3c(O)c5C4
NCGC00160673-01,tox21-er-bla-agonist-p2,Propicillin,activity,inactive,551-27-9,92879.0,OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)C(CC)Oc1ccccc1)[C@H]3SC2(C)C
NCGC00163157-01,tox21-er-bla-agonist-p2,Mesoridazine,activity,inactive,5588-33-0,4078.0,CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2
NCGC00091657-02,tox21-er-bla-agonist-p2,2-Ethoxyethyl acetate,activity,inactive,111-15-9,8095.0,CC(=O)OCCOCC
NCGC00182704-02,tox21-er-bla-agonist-p2,Luliconazole,activity,inactive,187164-19-8,3003141.0,N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3
NCGC00183104-01,tox21-er-bla-agonist-p2,Nizofenone,activity,inactive,54533-86-7,4514.0,Clc1ccccc1C(=O)c2cc(ccc2n3ccnc3CN(CC)CC)[N+]([O-])=O
NCGC00254583-01,tox21-er-bla-agonist-p2,"(2,2-Dimethoxyethyl)benzene",activity,inactive,101-48-4,60995.0,COC(OC)Cc1ccccc1
NCGC00255252-01,tox21-er-bla-agonist-p2,Nizatidine,activity,inactive,76963-41-2,4513.0,CN(C)Cc1nc(CSCCNC(=C[N+]([O-])=O)NC)cs1
NCGC00255267-01,tox21-er-bla-agonist-p2,o-Toluenesulfonamide,activity,inactive,88-19-7,6924.0,Cc1ccccc1S(=O)(N)=O
NCGC00254268-01,tox21-er-bla-agonist-p2,Indium arsenide,activity,inactive,1303-11-3,91500.0,[As]#[In]
NCGC00247731-01,tox21-er-bla-agonist-p2,Ibogaine hydrochloride,activity,inactive,36415-61-9,197059.0,Cl.COc4ccc5nc1c(CC[N@]3C[C@H]2C[C@@H]1[C@@H]3[C@H](C2)CC)c5c4
NCGC00254358-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-4-nitrobenzene",activity,inactive,99-51-4,7440.0,Cc1ccc(cc1C)[N+](=O)[O-]
NCGC00253971-01,tox21-er-bla-agonist-p2,AVE5638,activity,inactive,725228-45-5,9801235.0,O=C(c2ccc(C#Cc1ccccc1F)o2)N3CCC(CC3)c4cccc(CN)c4
NCGC00254395-01,tox21-er-bla-agonist-p2,Ethoxyquin,activity,inactive,91-53-2,3293.0,CCOc1ccc2NC(C)(C)C=C(C)c2c1
NCGC00254007-01,tox21-er-bla-agonist-p2,Hydroxyurea,activity,inactive,127-07-1,3657.0,NC(=O)NO
NCGC00254460-01,tox21-er-bla-agonist-p2,Triethanolamine,activity,inactive,102-71-6,7618.0,OCCN(CCO)CCO
NCGC00255219-01,tox21-er-bla-agonist-p2,Clomiphene citrate,activity,inactive,50-41-9,60974.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN(CCOc1ccc(cc1)C(c2ccccc2)=C(Cl)c3ccccc3)CC
NCGC00254930-01,tox21-er-bla-agonist-p2,Imidacloprid,activity,inactive,138261-41-3,86418.0,[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1
NCGC00255120-01,tox21-er-bla-agonist-p2,Adenine,activity,inactive,73-24-5,190.0,Nc1ncnc2ncnc12
NCGC00182073-02,tox21-er-bla-agonist-p2,Nedocromil,activity,inactive,69049-73-6,50294.0,O=C(O)C2=CC(=O)c3cc1c(OC(=CC1=O)C(=O)O)c(CCC)c3N2CC
NCGC00182974-01,tox21-er-bla-agonist-p2,Improsulfan tosylate,activity,inactive,32784-82-0,284314.0,Cc1ccc(cc1)S(O)(=O)=O.CS(=O)(=O)OCCCNCCCOS(C)(=O)=O
NCGC00183049-01,tox21-er-bla-agonist-p2,Zelandopam,activity,inactive,139233-53-7,60196351.0,Cl.Oc1ccc(cc1O)[C@H]3CNCc2c3ccc(O)c2O
NCGC00016570-01,tox21-er-bla-agonist-p2,Mephentermine hemisulfate,activity,inactive,1212-72-2,71611.0,O=S(=O)(O)O.CC(C)(NC)Cc1ccccc1.CC(C)(NC)Cc1ccccc1
NCGC00016642-01,tox21-er-bla-agonist-p2,Piperacetazine,activity,inactive,3819-00-9,19675.0,CC(=O)c2cc3N(CCCN1CCC(CCO)CC1)c4ccccc4Sc3cc2
NCGC00258594-01,tox21-er-bla-agonist-p2,"2,4,5-Triethoxyacetophenone",activity,inactive,63213-29-6,113124.0,CCOc1cc(OCC)c(cc1OCC)C(C)=O
NCGC00260390-01,tox21-er-bla-agonist-p2,2-Nitro-4-thiocyanoaniline,activity,inactive,54029-45-7,104677.0,N#CSc1cc(c(N)cc1)[N+]([O-])=O
NCGC00255615-01,tox21-er-bla-agonist-p2,Crufomate,activity,inactive,299-86-5,9300.0,Clc1cc(ccc1OP(=O)(NC)OC)C(C)(C)C
NCGC00256658-01,tox21-er-bla-agonist-p2,"1,1'-Diazene-1,2-diyldicyclohexanecarbonitrile",activity,inactive,2094-98-6,74978.0,N#CC2(/N=N/C1(CCCCC1)C#N)CCCCC2
NCGC00256806-01,tox21-er-bla-agonist-p2,Piperonyl acetone,activity,inactive,55418-52-5,62098.0,CC(=O)CCc1ccc2OCOc2c1
NCGC00257159-01,tox21-er-bla-agonist-p2,Sulfacetamide,activity,inactive,144-80-9,5320.0,Nc1ccc(cc1)S(=O)(=O)NC(C)=O
NCGC00255446-01,tox21-er-bla-agonist-p2,4-Fluorobenzaldehyde,activity,inactive,459-57-4,68023.0,O=Cc1ccc(F)cc1
NCGC00255463-01,tox21-er-bla-agonist-p2,"2,3-Diethylpyrazine",activity,inactive,15707-24-1,27458.0,CCc1nccnc1CC
NCGC00255412-01,tox21-er-bla-agonist-p2,Triisobutyl phosphate,activity,inactive,126-71-6,31355.0,CC(C)COP(=O)(OCC(C)C)OCC(C)C
NCGC00255642-01,tox21-er-bla-agonist-p2,Undecanoic delta-lactone,activity,inactive,710-04-3,61204.0,O=C1CCCC(CCCCCC)O1
NCGC00255433-01,tox21-er-bla-agonist-p2,Spiromesifen,activity,inactive,283594-90-1,9907412.0,CC(C)(C)CC(=O)OC2=C(C(=O)OC12CCCC1)c3c(C)cc(C)cc3C
NCGC00257134-01,tox21-er-bla-agonist-p2,Butylphthalyl butylglycolate,activity,inactive,85-70-1,6819.0,O=C(OCCCC)COC(=O)c1ccccc1C(=O)OCCCC
NCGC00257186-01,tox21-er-bla-agonist-p2,Tribromsalan,activity,inactive,87-10-5,14868.0,Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2
NCGC00257866-01,tox21-er-bla-agonist-p2,Octabromodiphenyl ether,activity,inactive,32536-52-0,6537506.0,Brc1c(cc(Br)c(Br)c1Br)Oc2cc(Br)c(Br)c(Br)c2Br
NCGC00257730-01,tox21-er-bla-agonist-p2,"Oxirane, mono[(C8-10-alkyloxy)methyl] derivs.",activity,inactive,68609-96-1,99953.0,CCCCCCCCCOCC1CO1
NCGC00257731-01,tox21-er-bla-agonist-p2,Diisobutylamine,activity,inactive,110-96-3,8085.0,CC(C)CNCC(C)C
NCGC00257561-01,tox21-er-bla-agonist-p2,3-Methylbutyl cinnamate,activity,inactive,7779-65-9,62660.0,CC(C)CCOC(=O)C=Cc1ccccc1
NCGC00257575-01,tox21-er-bla-agonist-p2,6-Nitrophthalhydrazide,activity,inactive,3682-19-7,3543259.0,[O-][N+](=O)c1ccc2c(c1)C(=O)NNC2=O
NCGC00257583-01,tox21-er-bla-agonist-p2,beta-Pinene,activity,inactive,127-91-3,14896.0,CC2(C)C1CCC(=C)C2C1
NCGC00258221-01,tox21-er-bla-agonist-p2,"2,3-Dichlorobutane",activity,inactive,7581-97-7,24233.0,CC(Cl)C(C)Cl
NCGC00258245-01,tox21-er-bla-agonist-p2,Lime oil,activity,inactive,8008-26-2,,
NCGC00258307-01,tox21-er-bla-agonist-p2,2-Methyl-1-pentanol,activity,inactive,105-30-6,7745.0,CC(CCC)CO
NCGC00258324-01,tox21-er-bla-agonist-p2,Nevirapine,activity,inactive,129618-40-2,4463.0,O=C3Nc1c(C)ccnc1N(C2CC2)c4ncccc34
NCGC00258371-01,tox21-er-bla-agonist-p2,Vinyl acetate,activity,inactive,108-05-4,7904.0,CC(=O)OC=C
NCGC00258780-01,tox21-er-bla-agonist-p2,2-Methyl-3-nitrobenzoic acid,activity,inactive,1975-50-4,16096.0,Cc1c(cccc1[N+](=O)[O-])C(=O)O
NCGC00258838-01,tox21-er-bla-agonist-p2,(2E)-2-Hexenal,activity,inactive,6728-26-3,5281168.0,CCC\C=C\C=O
NCGC00259186-01,tox21-er-bla-agonist-p2,5-Ethylidene-2-norbornene,activity,inactive,16219-75-3,27756.0,CC=C2CC1C=CC2C1
NCGC00259739-01,tox21-er-bla-agonist-p2,2-Methyl-5-nitrobenzenesulfonic acid,activity,inactive,121-03-9,8458.0,Cc1ccc(cc1S(O)(=O)=O)[N+]([O-])=O
NCGC00260078-01,tox21-er-bla-agonist-p2,"1,4-Divinylbenzene",activity,inactive,105-06-6,66041.0,C=Cc1ccc(C=C)cc1
NCGC00259792-01,tox21-er-bla-agonist-p2,Sulfathiazole,activity,inactive,72-14-0,5340.0,O=S(=O)(Nc1nccs1)c2ccc(N)cc2
NCGC00259660-01,tox21-er-bla-agonist-p2,2-Phenoxyethanol,activity,inactive,122-99-6,31236.0,OCCOc1ccccc1
NCGC00259492-01,tox21-er-bla-agonist-p2,4-Methoxybenzaldehyde,activity,inactive,123-11-5,31244.0,COc1ccc(C=O)cc1
NCGC00260255-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpyrrolidinium bromide,activity,inactive,608140-09-6,16719897.0,[Br-].C[N+]1(CCC)CCCC1
NCGC00260373-01,tox21-er-bla-agonist-p2,"Hexanoylchloride,3,5,5-trimethyl-",activity,inactive,36727-29-4,161929.0,CC(CC(C)(C)C)CC(Cl)=O
NCGC00014361-03,tox21-er-bla-agonist-p2,Phosphonoacetic acid,activity,inactive,4408-78-0,546.0,O=C(O)CP(=O)(O)O
NCGC00015836-08,tox21-er-bla-agonist-p2,Pirenzepine,activity,inactive,28797-61-7,4848.0,O=C(CN1CCN(C)CC1)N4c2ccccc2C(=O)Nc3cccnc34
NCGC00016361-07,tox21-er-bla-agonist-p2,Acetaminophen,activity,inactive,103-90-2,1983.0,Oc1ccc(NC(C)=O)cc1
NCGC00016549-01,tox21-er-bla-agonist-p2,Dothiepin hydrochloride,activity,inactive,897-15-4,6420022.0,Cl.CN(C)CC\C=C1/c3ccccc3SCc2ccccc12
NCGC00016638-01,tox21-er-bla-agonist-p2,Furaltadone hydrochloride,activity,inactive,3759-92-0,92968.0,Cl.[O-][N+](=O)c1ccc(o1)/C=N/N2CC(OC2=O)CN3CCOCC3
NCGC00247714-01,tox21-er-bla-agonist-p2,Sodium 4-hydroxybutanoate,activity,inactive,502-85-2,23663870.0,[Na+].[O-]C(=O)CCCO
NCGC00255587-01,tox21-er-bla-agonist-p2,Promecarb,activity,inactive,2631-37-0,17516.0,O=C(Oc1cc(C)cc(c1)C(C)C)NC
NCGC00254592-01,tox21-er-bla-agonist-p2,Hexaconazole,activity,inactive,79983-71-4,66461.0,OC(CCCC)(Cn1cncn1)c2ccc(Cl)cc2Cl
NCGC00254638-01,tox21-er-bla-agonist-p2,Linuron,activity,inactive,330-55-2,9502.0,Clc1ccc(NC(=O)N(C)OC)cc1Cl
NCGC00254989-01,tox21-er-bla-agonist-p2,Dibenzylamine,activity,inactive,103-49-1,7656.0,C(NCc1ccccc1)c2ccccc2
NCGC00256089-01,tox21-er-bla-agonist-p2,"cis-3,7-Dimethyl-2,6-octadien-1-yl acetate",activity,inactive,141-12-8,1549025.0,C\C(C)=C\CCC(\C)=C/COC(C)=O
NCGC00254435-01,tox21-er-bla-agonist-p2,Dicyclohexyl disulfide,activity,inactive,2550-40-5,17356.0,S(SC1CCCCC1)C2CCCCC2
NCGC00255214-01,tox21-er-bla-agonist-p2,2-Chloro-4-phenylphenol,activity,active agonist,92-04-6,79688.0,Clc2cc(O)ccc2c1ccccc1
NCGC00015542-05,tox21-er-bla-agonist-p2,Ibudilast,activity,inactive,50847-11-5,3671.0,CC(C)C(=O)c1c2ccccn2nc1C(C)C
NCGC00016906-01,tox21-er-bla-agonist-p2,Dipivefrin hydrochloride,activity,inactive,64019-93-8,71486.0,Cl.O=C(Oc1cc(ccc1OC(=O)C(C)(C)C)C(O)CNC)C(C)(C)C
NCGC00023648-03,tox21-er-bla-agonist-p2,Desoximetasone,activity,inactive,382-67-2,5311067.0,OCC(=O)[C@H]4[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00091586-02,tox21-er-bla-agonist-p2,2-Bromobiphenyl,activity,inactive,2052-07-5,16329.0,Brc2ccccc2c1ccccc1
NCGC00095181-01,tox21-er-bla-agonist-p2,Topiramate,activity,inactive,97240-79-4,5284627.0,NS(=O)(=O)OC[C@]23OC[C@H]1OC(C)(C)O[C@H]1[C@@H]3OC(C)(C)O2
NCGC00096003-01,tox21-er-bla-agonist-p2,Tilmicosin,activity,inactive,108050-54-0,5282521.0,CN(C)[C@@H]1[C@@H](O)[C@@H](O[C@H](C)[C@H]1O)O[C@H]4[C@@H](CCN2C[C@@H](C)C[C@@H](C)C2)C[C@@H](C)C(=O)C=CC(C)=C[C@H](CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]4C
NCGC00159508-02,tox21-er-bla-agonist-p2,Rose bengal sodium,activity,inactive,632-69-9,32343.0,[Na+].[Na+].[O-]C(=O)c4c(Cl)c(Cl)c(Cl)c(Cl)c4C=2c3cc(I)c([O-])c(I)c3OC=1C=2C=C(I)C(=O)C=1I
NCGC00160352-01,tox21-er-bla-agonist-p2,Tenidap,activity,inactive,120210-48-2,54704052.0,O=C(c1c(O)n(C(N)=O)c2ccc(Cl)cc12)c3cccs3
NCGC00164543-01,tox21-er-bla-agonist-p2,Lomerizine dihydrochloride,activity,inactive,101477-54-7,122125.0,Cl.Cl.Fc1ccc(cc1)C(c2ccc(F)cc2)N3CCN(CC3)Cc4ccc(OC)c(OC)c4OC
NCGC00259525-01,tox21-er-bla-agonist-p2,Dibutyl phosphite,activity,inactive,1809-19-4,6327349.0,CCCCOP(=O)OCCCC
NCGC00260048-01,tox21-er-bla-agonist-p2,Chrysophanic acid,activity,inactive,481-74-3,10208.0,Oc3cccc2C(=O)c1cc(C)cc(O)c1C(=O)c23
NCGC00016982-01,tox21-er-bla-agonist-p2,Nafronyl oxalate,activity,inactive,3200-06-4,312915.0,O=C(O)C(=O)O.CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC3CCCO3
NCGC00091056-01,tox21-er-bla-agonist-p2,Styrene,activity,inactive,100-42-5,7501.0,C=Cc1ccccc1
NCGC00093969-01,tox21-er-bla-agonist-p2,Ipratropium bromide hydrate,activity,inactive,66985-17-9,441337.0,[Br-].O.C[N+]2(C1CC(CC2CC1)OC(=O)C(CO)c3ccccc3)C(C)C
NCGC00163155-01,tox21-er-bla-agonist-p2,Bopindolol,activity,inactive,62658-63-3,44112.0,CC(C)(C)NCC(OC(=O)c1ccccc1)COc3cccc2nc(C)cc23
NCGC00164128-01,tox21-er-bla-agonist-p2,"Hexadecanoic acid, 1-methylethyl ester",activity,inactive,142-91-6,8907.0,CC(C)OC(=O)CCCCCCCCCCCCCCC
NCGC00185742-01,tox21-er-bla-agonist-p2,Cefoxitin,activity,inactive,35607-66-0,441199.0,O=C(O)C=2N3C(=O)[C@](NC(=O)Cc1cccs1)(OC)[C@H]3SCC=2COC(N)=O
NCGC00016979-01,tox21-er-bla-agonist-p2,Brinzolamide,activity,inactive,138890-62-7,68844.0,NS(=O)(=O)c1cc2[C@H](CN(CCCOC)S(=O)(=O)c2s1)NCC
NCGC00018274-04,tox21-er-bla-agonist-p2,Diacerein,activity,inactive,13739-02-1,26248.0,CC(=O)Oc3cccc2C(=O)c1cc(cc(OC(C)=O)c1C(=O)c23)C(=O)O
NCGC00257168-01,tox21-er-bla-agonist-p2,3-Nitrobenzoic acid,activity,inactive,121-92-6,8497.0,O=[N+]([O-])c1cc(ccc1)C(=O)O
NCGC00257173-01,tox21-er-bla-agonist-p2,Benzimidazole,activity,inactive,51-17-2,5798.0,c1cccc2ncnc12
NCGC00257573-01,tox21-er-bla-agonist-p2,"(2E)-1,4-Dichlorobut-2-ene",activity,inactive,110-57-6,642197.0,ClC\C=C\CCl
NCGC00257804-01,tox21-er-bla-agonist-p2,"1,2-Epoxytetradecane",activity,inactive,3234-28-4,18604.0,CCCCCCCCCCCCC1CO1
NCGC00258017-01,tox21-er-bla-agonist-p2,Zinc diacrylate,activity,inactive,14643-87-9,159747.0,[Zn+2].C=CC(=O)[O-].[O-]C(=O)C=C
NCGC00258064-01,tox21-er-bla-agonist-p2,Phenobarbital,activity,inactive,50-06-6,4763.0,O=C1NC(=O)NC(=O)C1(CC)c2ccccc2
NCGC00258292-01,tox21-er-bla-agonist-p2,N-Isopropylacrylamide,activity,inactive,2210-25-5,16637.0,CC(C)NC(=O)C=C
NCGC00256678-01,tox21-er-bla-agonist-p2,Linalyl isovalerate,activity,inactive,1118-27-0,240119.0,O=C(CC(C)C)OC(C)(CC\C=C(\C)C)C=C
NCGC00256398-01,tox21-er-bla-agonist-p2,6-Nitrobenzimidazole,activity,inactive,94-52-0,7195.0,[O-][N+](=O)c1cc2ncnc2cc1
NCGC00256433-01,tox21-er-bla-agonist-p2,Benzoin,activity,inactive,119-53-9,8400.0,OC(C(=O)c1ccccc1)c2ccccc2
NCGC00256498-01,tox21-er-bla-agonist-p2,N-Nitrosodimethylamine,activity,inactive,62-75-9,6124.0,CN(C)N=O
NCGC00256500-01,tox21-er-bla-agonist-p2,3-Ethoxy-4-hydroxybenzaldehyde,activity,inactive,121-32-4,8467.0,CCOc1cc(ccc1O)C=O
NCGC00255900-01,tox21-er-bla-agonist-p2,Sodium 2-methylbenzenesulfonate,activity,inactive,15046-75-0,23681382.0,[Na+].Cc1ccccc1S(=O)([O-])=O
NCGC00256327-01,tox21-er-bla-agonist-p2,1-(2-Aminoethyl)piperazine,activity,inactive,140-31-8,8795.0,NCCN1CCNCC1
NCGC00258853-01,tox21-er-bla-agonist-p2,Tridecanedioic acid,activity,inactive,505-52-2,10458.0,O=C(O)CCCCCCCCCCCC(=O)O
NCGC00260410-01,tox21-er-bla-agonist-p2,Nonylbromide,activity,inactive,693-58-3,12742.0,CCCCCCCCCBr
NCGC00260418-01,tox21-er-bla-agonist-p2,Norgestrel,activity,active agonist,797-63-7,13109.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00260487-01,tox21-er-bla-agonist-p2,2-Bromoacetophenone,activity,inactive,70-11-1,6259.0,O=C(CBr)c1ccccc1
NCGC00260570-01,tox21-er-bla-agonist-p2,NTP Mix78 CT1 62-EQP,activity,inactive,NOCAS_49466,,
NCGC00259054-01,tox21-er-bla-agonist-p2,Cyclophosphamide monohydrate,activity,inactive,6055-19-2,22420.0,O.O=P1(NCCCO1)N(CCCl)CCCl
NCGC00259065-01,tox21-er-bla-agonist-p2,4-tert-Butylcyclohexanol,activity,inactive,98-52-2,7391.0,CC(C)(C)C1CCC(O)CC1
NCGC00259261-01,tox21-er-bla-agonist-p2,Diisopropyl methylphosphonate,activity,inactive,1445-75-6,3073.0,CP(=O)(OC(C)C)OC(C)C
NCGC00259457-01,tox21-er-bla-agonist-p2,"2,6-Dichloro-1,4-benzenediamine",activity,inactive,609-20-1,11860.0,Clc1cc(N)cc(Cl)c1N
NCGC00259573-01,tox21-er-bla-agonist-p2,Pentaerythritol triacrylate,activity,active agonist,3524-68-3,19042.0,O=C(C=C)OCC(COC(=O)C=C)(CO)COC(=O)C=C
NCGC00259603-01,tox21-er-bla-agonist-p2,2-Acetylthiazole,activity,inactive,24295-03-2,520108.0,CC(=O)c1nccs1
NCGC00255016-01,tox21-er-bla-agonist-p2,4-Methoxybenzyl acetate,activity,inactive,104-21-2,7695.0,COc1ccc(COC(C)=O)cc1
NCGC00255198-01,tox21-er-bla-agonist-p2,Nerolidol,activity,inactive,7212-44-4,8888.0,C/C(C)=C\CCC(C)=CCCC(C)(O)C=C
NCGC00255212-01,tox21-er-bla-agonist-p2,N-Nitroso-N-methyl-4-nitroaniline,activity,inactive,943-41-9,13671.0,O=NN(C)c1ccc(cc1)[N+]([O-])=O
NCGC00255365-01,tox21-er-bla-agonist-p2,Meglumine,activity,inactive,6284-40-8,8567.0,O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO
NCGC00255624-01,tox21-er-bla-agonist-p2,1-Chloro-2-(chloromethyl)-3-fluorobenzene,activity,inactive,55117-15-2,108675.0,ClCc1c(F)cccc1Cl
NCGC00255695-01,tox21-er-bla-agonist-p2,Arabinose,activity,inactive,147-81-9,66308.0,O[C@H](C=O)[C@H](O)[C@H](O)CO
NCGC00256061-01,tox21-er-bla-agonist-p2,"2-Ethylpropane-1,3-diol",activity,inactive,2612-29-5,102293.0,CCC(CO)CO
NCGC00254485-01,tox21-er-bla-agonist-p2,N-Ethylaniline,activity,inactive,103-69-5,7670.0,CCNc1ccccc1
NCGC00254504-01,tox21-er-bla-agonist-p2,Hexanoic acid,activity,inactive,142-62-1,8892.0,CCCCCC(=O)O
NCGC00092377-03,tox21-er-bla-agonist-p2,Apafant,activity,inactive,105219-56-5,65889.0,Clc1ccccc1C4=NCc2nnc(C)n2c3sc(cc34)CCC(=O)N5CCOCC5
NCGC00094384-01,tox21-er-bla-agonist-p2,Denopamine,activity,inactive,71771-90-9,5311064.0,COc1cc(ccc1OC)CCNC[C@H](O)c2ccc(O)cc2
NCGC00163494-01,tox21-er-bla-agonist-p2,Clindamycin phosphate,activity,inactive,24729-96-2,443385.0,CS[C@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1OP(=O)(O)O)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl
NCGC00159467-03,tox21-er-bla-agonist-p2,(-)-Cocaine hydrochloride,activity,inactive,53-21-4,656832.0,Cl.CN3[C@H]1CC[C@@H]3[C@H]([C@H](C1)OC(=O)c2ccccc2)C(=O)OC
NCGC00094817-01,tox21-er-bla-agonist-p2,Flopropione,activity,inactive,2295-58-1,3362.0,O=C(CC)c1c(O)cc(O)cc1O
NCGC00164447-01,tox21-er-bla-agonist-p2,Ciprofibrate,activity,inactive,52214-84-3,2763.0,ClC2(Cl)CC2c1ccc(OC(C)(C)C(=O)O)cc1
NCGC00181164-01,tox21-er-bla-agonist-p2,DL-Isoleucine,activity,inactive,443-79-8,791.0,CC(CC)C(N)C(=O)O
NCGC00160207-01,tox21-er-bla-agonist-p2,Artemisinin,activity,inactive,63968-64-9,5458876.0,O=C4O[C@@H]3O[C@@]1(C)CC[C@H]2[C@H](C)CC[C@H](C23OO1)[C@H]4C
NCGC00160295-01,tox21-er-bla-agonist-p2,Benaxibine,activity,inactive,27661-27-4,65760.0,O=C(O)c1ccc(cc1)NC2OC[C@@H](O)[C@H](O)[C@H]2O
NCGC00164487-01,tox21-er-bla-agonist-p2,"4,4'-Diamino-2,2'-stilbenedisulfonic acid",activity,inactive,81-11-8,6668.0,OS(=O)(=O)c2cc(N)ccc2C=Cc1ccc(N)cc1S(=O)(=O)O
NCGC00164500-01,tox21-er-bla-agonist-p2,Monophosphothiamine,activity,inactive,532-40-1,10761.0,[Cl-].O=P(O)(O)OCCc2sc[n+](Cc1cnc(C)nc1N)c2C
NCGC00094990-01,tox21-er-bla-agonist-p2,Acexamic acid,activity,inactive,57-08-9,2005.0,O=C(O)CCCCCNC(C)=O
NCGC00095023-01,tox21-er-bla-agonist-p2,Ethisterone,activity,active agonist,434-03-7,5284557.0,O=C4CC[C@@]3(C)C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00164546-01,tox21-er-bla-agonist-p2,Fropenem,activity,inactive,106560-14-9,65894.0,O=C2N1C(=C(S[C@@H]1[C@H]2[C@@H](C)O)[C@H]3CCCO3)C(=O)O
NCGC00181297-01,tox21-er-bla-agonist-p2,Mebrofenin,activity,inactive,78266-06-5,54158.0,Cc1cc(C)c(Br)c(C)c1NC(=O)CN(CC(=O)O)CC(=O)O
NCGC00160461-01,tox21-er-bla-agonist-p2,Quindoxin,activity,inactive,2423-66-7,72073.0,[O-][n+]2cc[n+]([O-])c1ccccc12
NCGC00165767-02,tox21-er-bla-agonist-p2,Cyclofenil,activity,inactive,2624-43-3,2898.0,CC(=O)Oc1ccc(cc1)C(/c2ccc(OC(C)=O)cc2)=C3/CCCCC3
NCGC00181047-01,tox21-er-bla-agonist-p2,Kojic acid,activity,inactive,501-30-4,3840.0,O=C1C=C(CO)OC=C1O
NCGC00160587-01,tox21-er-bla-agonist-p2,Bis(ethylxanthogen),activity,inactive,502-55-6,10404.0,CCOC(=S)SSC(=S)OCC
NCGC00095844-01,tox21-er-bla-agonist-p2,Conessine,activity,inactive,546-06-5,441082.0,CN(C)[C@@H]4CC5=CC[C@@H]1[C@H](CC[C@@]23CN(C)[C@@H](C)[C@H]3CC[C@@H]12)[C@@]5(C)CC4
NCGC00166139-01,tox21-er-bla-agonist-p2,3-Hydroxy-4-butyrophenetidide,activity,inactive,1083-57-4,14130.0,CCOc1ccc(cc1)NC(=O)CC(C)O
NCGC00159369-02,tox21-er-bla-agonist-p2,1-Octadecanol,activity,inactive,112-92-5,8221.0,CCCCCCCCCCCCCCCCCCO
NCGC00091380-04,tox21-er-bla-agonist-p2,"4,4'-Thiodianiline",activity,active agonist,139-65-1,8765.0,Nc1ccc(cc1)Sc2ccc(N)cc2
NCGC00254632-01,tox21-er-bla-agonist-p2,Iodosulfuron-methyl-sodium,activity,inactive,144550-36-7,16760189.0,[Na+].Cc2nc(NC(=O)[N-]S(=O)(=O)c1cc(I)ccc1C(=O)OC)nc(OC)n2
NCGC00254315-01,tox21-er-bla-agonist-p2,PFNA,activity,inactive,375-95-1,67821.0,FC(F)(C(F)(F)C(=O)O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254319-01,tox21-er-bla-agonist-p2,"2,6-Dinitrotoluene",activity,inactive,606-20-2,11813.0,Cc1c(cccc1[N+](=O)[O-])[N+]([O-])=O
NCGC00254718-01,tox21-er-bla-agonist-p2,Calcium nitrate,activity,inactive,10124-37-5,24963.0,[Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O
NCGC00249607-01,tox21-er-bla-agonist-p2,Dimethyl chloromalonate,activity,inactive,28868-76-0,120070.0,COC(=O)C(Cl)C(=O)OC
NCGC00255302-01,tox21-er-bla-agonist-p2,Dihexylamine,activity,inactive,143-16-8,8920.0,CCCCCCNCCCCCC
NCGC00254001-01,tox21-er-bla-agonist-p2,Undecane,activity,inactive,1120-21-4,14257.0,CCCCCCCCCCC
NCGC00255130-01,tox21-er-bla-agonist-p2,"3-Bromo-1-chloro-5,5-dimethylhydantoin",activity,inactive,126-06-7,31335.0,CC1(C)C(=O)N(Br)C(=O)N1Cl
NCGC00181347-01,tox21-er-bla-agonist-p2,Acipimox,activity,inactive,51037-30-0,5310993.0,[O-][n+]1cc(ncc1C)C(O)=O
NCGC00182075-03,tox21-er-bla-agonist-p2,Oxomemazine hydrochloride,activity,inactive,4784-40-1,3083870.0,Cl.CN(C)CC(C)CN2c1ccccc1S(=O)(=O)c3ccccc23
NCGC00182966-01,tox21-er-bla-agonist-p2,trans-Aconitic acid,activity,inactive,4023-65-8,444212.0,OC(=O)C(\CC(=O)O)=C\C(=O)O
NCGC00259646-01,tox21-er-bla-agonist-p2,Biochanin A,activity,active agonist,491-80-5,5280373.0,COc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O
NCGC00258466-01,tox21-er-bla-agonist-p2,Toxaphene,activity,active agonist,8001-35-2,5284469.0,ClC2(Cl)C1(Cl)C(Cl)C(Cl)C2(Cl)C(=C)C1(CCl)CCl
NCGC00260646-01,tox21-er-bla-agonist-p2,NTP Mix87 ER AR1 18-EQC,activity,inconclusive agonist,NOCAS_49542,,
NCGC00258699-01,tox21-er-bla-agonist-p2,4-(Benzyloxyl)phenol,activity,active agonist,103-16-2,7638.0,Oc2ccc(OCc1ccccc1)cc2
NCGC00016483-01,tox21-er-bla-agonist-p2,Trimipramine maleate,activity,inactive,521-78-8,5282318.0,O=C(O)/C=C\C(=O)O.CN(C)CC(C)CN2c3ccccc3CCc1ccccc12
NCGC00255475-01,tox21-er-bla-agonist-p2,Zinc acetate,activity,inactive,557-34-6,11192.0,[Zn+2].[O-]C(C)=O.[O-]C(C)=O
NCGC00255629-01,tox21-er-bla-agonist-p2,Leptophos,activity,inactive,21609-90-5,30709.0,Clc2cc(OP(=S)(OC)c1ccccc1)c(Cl)cc2Br
NCGC00257674-01,tox21-er-bla-agonist-p2,Piperonal,activity,inactive,120-57-0,8438.0,O=Cc1ccc2OCOc2c1
NCGC00257771-01,tox21-er-bla-agonist-p2,Benzyl cyanide,activity,inactive,140-29-4,8794.0,N#CCc1ccccc1
NCGC00256831-01,tox21-er-bla-agonist-p2,(2E)-3-Phenylprop-2-en-1-yl propanoate,activity,inactive,78761-38-3,5355850.0,CCC(=O)OC\C=C\c1ccccc1
NCGC00257942-01,tox21-er-bla-agonist-p2,4-Vinylcyclohexene,activity,inactive,100-40-3,7499.0,C=CC1CC=CCC1
NCGC00257614-01,tox21-er-bla-agonist-p2,"3,3-Dimethyl-2-butanone",activity,inactive,75-97-8,6416.0,CC(C)(C)C(C)=O
NCGC00256758-01,tox21-er-bla-agonist-p2,2-Methylbenzenethiol,activity,inactive,137-06-4,8712.0,Cc1ccccc1S
NCGC00256688-01,tox21-er-bla-agonist-p2,Trithioacetone,activity,inactive,828-26-2,13233.0,CC1(C)SC(C)(C)SC(C)(C)S1
NCGC00256710-01,tox21-er-bla-agonist-p2,(3Z)-Hex-3-en-1-yl hexanoate,activity,inactive,31501-11-8,5352543.0,O=C(CCCCC)OCC/C=C\CC
NCGC00256723-01,tox21-er-bla-agonist-p2,2-Propylphenol,activity,inactive,644-35-9,12570.0,Oc1ccccc1CCC
NCGC00257156-01,tox21-er-bla-agonist-p2,2-Methylpropanenitrile,activity,inactive,78-82-0,6559.0,CC(C)C#N
NCGC00257943-01,tox21-er-bla-agonist-p2,Allyl glycidyl ether,activity,inactive,106-92-3,7838.0,C=CCOCC1CO1
NCGC00257945-01,tox21-er-bla-agonist-p2,Acifluorfen-sodium,activity,inactive,62476-59-9,44072.0,[Na+].Clc2cc(ccc2Oc1cc(C([O-])=O)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00257073-01,tox21-er-bla-agonist-p2,Isopropyl acetate,activity,inactive,108-21-4,7915.0,CC(=O)OC(C)C
NCGC00258189-01,tox21-er-bla-agonist-p2,Succinonitrile,activity,inactive,110-61-2,8062.0,N#CCCC#N
NCGC00258529-01,tox21-er-bla-agonist-p2,Propargyl alcohol,activity,inactive,107-19-7,7859.0,C#CCO
NCGC00259049-01,tox21-er-bla-agonist-p2,4-Methoxyaniline hydrochloride,activity,inactive,20265-97-8,2734956.0,Cl.Nc1ccc(OC)cc1
NCGC00258431-01,tox21-er-bla-agonist-p2,3-Methylpiperidine,activity,inactive,626-56-2,79081.0,CC1CCCNC1
NCGC00258877-01,tox21-er-bla-agonist-p2,"2H-3,1-Benzoxazine-2,4(1H)-dione",activity,inactive,118-48-9,8359.0,O=C1OC(=O)Nc2ccccc12
NCGC00259257-01,tox21-er-bla-agonist-p2,4-Nitrosodiphenylamine,activity,active agonist,156-10-5,9074.0,O=Nc2ccc(Nc1ccccc1)cc2
NCGC00260126-01,tox21-er-bla-agonist-p2,"Benzene, 1,1'-(1-methylethylidene)bis[3,5-dibromo-4-(2-propenyloxy)-",activity,inactive,25327-89-3,61972.0,Brc1cc(cc(Br)c1OCC=C)C(C)(C)c2cc(Br)c(OCC=C)c(Br)c2
NCGC00260132-01,tox21-er-bla-agonist-p2,Antimony potassium tartrate trihydrate,activity,inactive,28300-74-5,16682736.0,[K+].[K+].O.O.O.[O-]C(=O)C2O[Sb]3OC(C(O[Sb]1OC(=O)C2O1)C([O-])=O)C(=O)O3
NCGC00259392-01,tox21-er-bla-agonist-p2,Bis(2-butoxyethyl) phthalate,activity,inactive,117-83-9,8345.0,O=C(OCCOCCCC)c1ccccc1C(=O)OCCOCCCC
NCGC00259837-01,tox21-er-bla-agonist-p2,"2,2',4,4'-Tetrahydroxybenzophenone",activity,active agonist,131-55-5,8571.0,O=C(c1ccc(O)cc1O)c2ccc(O)cc2O
NCGC00259121-01,tox21-er-bla-agonist-p2,Molinate,activity,inactive,2212-67-1,16653.0,O=C(SCC)N1CCCCCC1
NCGC00259212-01,tox21-er-bla-agonist-p2,N-Nitrosodimethylamine,activity,inactive,62-75-9,6124.0,CN(C)N=O
NCGC00260319-01,tox21-er-bla-agonist-p2,"Poly(oxy-1,2-ethanediyl), .alpha.-octadecyl-.omega.-hydroxy-",activity,inactive,9005-00-9,75050.0,OCCOCCCCCCCCCCCCCCCCCC
NCGC00260581-01,tox21-er-bla-agonist-p2,NTP Mix41 CT1 3-EQP,activity,inactive,NOCAS_49477,,
NCGC00260598-01,tox21-er-bla-agonist-p2,NTP Mix1 AR1 4-EQP,activity,active agonist,NOCAS_49494,,
NCGC00260615-01,tox21-er-bla-agonist-p2,NTP Mix18 AR1 8-EQC,activity,inactive,NOCAS_49511,,
NCGC00015321-04,tox21-er-bla-agonist-p2,Dobutamine,activity,inactive,34368-04-2,36811.0,Oc2ccc(CCNC(C)CCc1ccc(O)cc1)cc2O
NCGC00015715-04,tox21-er-bla-agonist-p2,Nisoxetine,activity,inactive,53179-07-0,4500.0,COc2ccccc2OC(CCNC)c1ccccc1
NCGC00015520-03,tox21-er-bla-agonist-p2,Hydroxyurea,activity,inactive,127-07-1,3657.0,NC(=O)NO
NCGC00016280-02,tox21-er-bla-agonist-p2,Zoxazolamine,activity,inactive,61-80-3,6103.0,Clc1cc2nc(N)oc2cc1
NCGC00016429-05,tox21-er-bla-agonist-p2,Dexpropranolol,activity,inactive,5051-22-9,21138.0,CC(C)NC[C@@H](O)COc2cccc1ccccc12
NCGC00166215-02,tox21-er-bla-agonist-p2,2-Phenylethanol,activity,inactive,60-12-8,6054.0,OCCc1ccccc1
NCGC00166411-01,tox21-er-bla-agonist-p2,Oxeladin citrate,activity,active agonist,52432-72-1,9936727.0,CCC(CC)(C(=O)OCCOCCN(CC)CC)c1ccccc1.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00256033-01,tox21-er-bla-agonist-p2,2-{[2-(Dimethylamino)ethyl](methyl)amino}ethanol,activity,inactive,2212-32-0,75171.0,CN(C)CCN(C)CCO
NCGC00255001-01,tox21-er-bla-agonist-p2,Vinclozolin,activity,inactive,50471-44-8,39676.0,O=C1N(C(=O)OC1(C)C=C)c2cc(Cl)cc(Cl)c2
NCGC00254988-01,tox21-er-bla-agonist-p2,Buprofezin,activity,inactive,69327-76-0,50367.0,CC(C)(C)/N=C2\SCN(c1ccccc1)C(=O)N2C(C)C
NCGC00254351-01,tox21-er-bla-agonist-p2,"Diisononyl cyclohexane-1,2-dicarboxylate",activity,inactive,166412-78-8,11524680.0,CC(C)CCCCCCOC(=O)C1CCCCC1C(=O)OCCCCCCC(C)C
NCGC00254361-01,tox21-er-bla-agonist-p2,PFHS-K,activity,inactive,3871-99-6,23678874.0,[K+].FC(F)(C(F)(F)S([O-])(=O)=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00254405-01,tox21-er-bla-agonist-p2,p-Bromodiphenyl ether,activity,inactive,101-55-3,7565.0,Brc2ccc(Oc1ccccc1)cc2
NCGC00254275-01,tox21-er-bla-agonist-p2,Genistein,activity,active agonist,446-72-0,5280961.0,Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O
NCGC00016690-01,tox21-er-bla-agonist-p2,Tribenoside,activity,inactive,10310-32-4,5284629.0,O[C@@H]2[C@@H](OCc1ccccc1)[C@H](O[C@H]2OCC)C(COCc3ccccc3)OCc4ccccc4
NCGC00160510-01,tox21-er-bla-agonist-p2,Etocarlide,activity,inactive,1234-30-6,667483.0,CCOc1ccc(cc1)NC(=S)Nc2ccc(OCC)cc2
NCGC00163177-01,tox21-er-bla-agonist-p2,Naloxone methyliodide,activity,inactive,93302-47-7,45055378.0,CI.O=C1CC[C@@]5(O)[C@H]2Cc4ccc(O)c3O[C@@H]1[C@]5(CCN2CC=C)c34
NCGC00164465-01,tox21-er-bla-agonist-p2,Imiprothrin,activity,inactive,72963-72-5,16722126.0,O=C2CN(CC#C)C(=O)N2COC(=O)[C@@H]1[C@@H](/C=C(\C)C)C1(C)C
NCGC00165993-01,tox21-er-bla-agonist-p2,Picolinic acid,activity,inactive,98-98-6,1018.0,O=C(O)c1ccccn1
NCGC00183024-01,tox21-er-bla-agonist-p2,Proglumetacin,activity,active agonist,57132-53-3,4921.0,CCCN(CCC)C(=O)C(NC(=O)c1ccccc1)CCC(=O)OCCCN5CCN(CCOC(=O)Cc4c2cc(OC)ccc2n(C(=O)c3ccc(Cl)cc3)c4C)CC5
NCGC00249415-01,tox21-er-bla-agonist-p2,Fabesetron,activity,inactive,129300-27-2,208947.0,Cc4ncnc4C[C@H]3CCc2c(C)c1ccccc1n2C3=O
NCGC00254977-01,tox21-er-bla-agonist-p2,Cyclanilide,activity,inactive,113136-77-9,11097730.0,O=C(O)C1(CC1)C(=O)Nc2ccc(Cl)cc2Cl
NCGC00259663-01,tox21-er-bla-agonist-p2,Triphenylphosphine,activity,inactive,603-35-0,11776.0,c1ccccc1P(c2ccccc2)c3ccccc3
NCGC00260066-01,tox21-er-bla-agonist-p2,Glyoxal,activity,inactive,107-22-2,7860.0,O=CC=O
NCGC00016653-01,tox21-er-bla-agonist-p2,cis-Nanophine hydrochloride,activity,inactive,5072-45-7,6420071.0,Cl.C[C@@H]1CCC[C@H](C)N1
NCGC00095842-01,tox21-er-bla-agonist-p2,Rifaximin,activity,inactive,80621-81-4,6436173.0,CC(=O)O[C@@H]1[C@H](C)[C@@H](OC)C=CO[C@@]5(C)Oc4c(C)c(O)c3c(O)c(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]1C)c2n6ccc(C)cc6nc2c3c4C5=O
NCGC00254245-01,tox21-er-bla-agonist-p2,Tridecafluorohexylethyl methacrylate,activity,inactive,2144-53-8,75066.0,FC(F)(CCOC(=O)C(=C)C)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00074024-02,tox21-er-bla-agonist-p2,Rufloxacin hydrochloride,activity,inactive,106017-08-7,176015.0,Cl.CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)CCSc34
NCGC00090987-03,tox21-er-bla-agonist-p2,1-Naphthaleneacetic acid,activity,inactive,86-87-3,6862.0,O=C(O)Cc2cccc1ccccc12
NCGC00016984-01,tox21-er-bla-agonist-p2,Alclometasone dipropionate,activity,inactive,66734-13-2,636374.0,CCC(=O)OCC(=O)[C@@]4(OC(=O)CC)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3[C@H](Cl)CC1=CC(=O)C=C[C@@]12C
NCGC00017048-01,tox21-er-bla-agonist-p2,Levopropoxyphene napsylate,activity,inactive,5714-90-9,6604497.0,CN(C)C[C@H](C)[C@@](Cc1ccccc1)(OC(=O)CC)c2ccccc2.O=S(=O)(O)c1ccc2ccccc2c1
NCGC00017117-01,tox21-er-bla-agonist-p2,Betahistine mesylate,activity,inactive,54856-23-4,6420033.0,CS(=O)(=O)O.CNCCc1ccccn1
NCGC00023673-05,tox21-er-bla-agonist-p2,Adenosine,activity,inactive,58-61-7,60961.0,Nc3ncnc2c3ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
NCGC00256779-01,tox21-er-bla-agonist-p2,Ammonium glycyrrhizinate trihydrate,activity,inactive,911217-00-0,60196433.0,[NH4+].O.O.O.O=C(O)[C@@]6(C)CC[C@]7(C)CC[C@]5(C)C(=CC(=O)[C@H]4[C@@]5(C)CC[C@@H]3[C@]4(C)CC[C@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)[C@@]3(C)C)[C@@H]7C6
NCGC00258411-01,tox21-er-bla-agonist-p2,Selenourea,activity,inactive,630-10-4,6327594.0,NC(N)=[Se]
NCGC00258538-01,tox21-er-bla-agonist-p2,4-Chloro-4'-aminodiphenyl ether,activity,inactive,101-79-1,7578.0,Clc2ccc(Oc1ccc(N)cc1)cc2
NCGC00258609-01,tox21-er-bla-agonist-p2,Xylitol,activity,inactive,87-99-0,6912.0,O[C@H](CO)[C@H](O)[C@@H](O)CO
NCGC00258616-01,tox21-er-bla-agonist-p2,"2,4,6-Trichloroaniline",activity,inactive,634-93-5,12471.0,Clc1cc(Cl)cc(Cl)c1N
NCGC00257172-01,tox21-er-bla-agonist-p2,2-Chloropyridine,activity,inactive,109-09-1,7977.0,Clc1ccccn1
NCGC00257182-01,tox21-er-bla-agonist-p2,Cyanoacetic acid,activity,inactive,372-09-8,9740.0,N#CCC(=O)O
NCGC00257203-01,tox21-er-bla-agonist-p2,4-Chlorophenyl methyl sulfone,activity,inactive,98-57-7,7395.0,O=S(C)(=O)c1ccc(Cl)cc1
NCGC00257926-01,tox21-er-bla-agonist-p2,"1,4-Dimethyl-2-nitrobenzene",activity,inactive,89-58-7,6974.0,Cc1ccc(C)cc1[N+](=O)[O-]
NCGC00256742-01,tox21-er-bla-agonist-p2,trans-2-Ethoxy-5-(1-propenyl)phenol,activity,inactive,NOCAS_47726,16666638.0,CCOc1ccc(cc1O)/C=C\C
NCGC00256439-01,tox21-er-bla-agonist-p2,2-Ethylphenol,activity,inactive,90-00-6,6997.0,CCc1ccccc1O
NCGC00256506-01,tox21-er-bla-agonist-p2,Thiosemicarbazide,activity,inactive,79-19-6,2723789.0,NC(=S)NN
NCGC00255950-01,tox21-er-bla-agonist-p2,Cromolyn sodium,activity,inactive,15826-37-6,27503.0,[Na+].[Na+].[O-]C(=O)C=4Oc3cccc(OCC(O)COc1cccc2OC(=CC(=O)c12)C([O-])=O)c3C(=O)C=4
NCGC00256241-01,tox21-er-bla-agonist-p2,alpha-Irone,activity,inactive,79-69-6,5371002.0,CC1CC=C(C)C(/C=C/C(C)=O)C1(C)C
NCGC00255700-01,tox21-er-bla-agonist-p2,Thiamine nitrate,activity,inactive,532-43-4,10762.0,[O-][N+]([O-])=O.Cc2nc(N)c(C[n+]1csc(CCO)c1C)cn2
NCGC00258983-01,tox21-er-bla-agonist-p2,Deltamethrin,activity,inactive,52918-63-5,40585.0,Br/C(Br)=C/[C@H]3[C@@H](C(=O)O[C@H](C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00260443-01,tox21-er-bla-agonist-p2,2-Chloroethyl acrylate,activity,inactive,2206-89-5,16627.0,C=CC(=O)OCCCl
NCGC00259871-01,tox21-er-bla-agonist-p2,Trichloromethylstannane,activity,inactive,993-16-8,101940.0,C[Sn](Cl)(Cl)Cl
NCGC00260120-01,tox21-er-bla-agonist-p2,"2-(2H-Benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol",activity,inactive,70321-86-7,112412.0,CC(C)(c1ccccc1)c2cc(c(O)c(c2)C(C)(C)c3ccccc3)n4nc5ccccc5n4
NCGC00260173-01,tox21-er-bla-agonist-p2,"1,2-Dimethyl-3-propylimidazolium bis(trifluoromethylsulfonyl)imide",activity,inactive,169051-76-7,11750474.0,Cc1[n+](CCC)ccn1C.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00260322-01,tox21-er-bla-agonist-p2,"Formic acid, potassium salt",activity,inactive,590-29-4,2735122.0,[K+].[O-]C=O
NCGC00254655-01,tox21-er-bla-agonist-p2,"1,3-Propanediol",activity,inactive,504-63-2,10442.0,OCCCO
NCGC00254696-01,tox21-er-bla-agonist-p2,Methyl phenylacetate,activity,inactive,101-41-7,7559.0,O=C(OC)Cc1ccccc1
NCGC00254849-01,tox21-er-bla-agonist-p2,Epoxiconazole,activity,inactive,133855-98-8,3317081.0,Fc1ccc(cc1)C4(Cn2cncn2)OC4c3ccccc3Cl
NCGC00254856-01,tox21-er-bla-agonist-p2,Undecanedioic acid,activity,inactive,1852-04-6,15816.0,O=C(O)CCCCCCCCCC(=O)O
NCGC00256335-01,tox21-er-bla-agonist-p2,"2,4-D 1-butyl ester",activity,inactive,94-80-4,7206.0,Clc1cc(Cl)ccc1OCC(=O)OCCCC
NCGC00255103-01,tox21-er-bla-agonist-p2,Amiprofos-methyl,activity,active agonist,36001-88-4,100524.0,S=P(Oc1ccc(C)cc1[N+]([O-])=O)(NC(C)C)OC
NCGC00255220-01,tox21-er-bla-agonist-p2,Metepa,activity,inactive,57-39-6,60976.0,CC1CN1P(=O)(N2CC2C)N3CC3C
NCGC00255861-01,tox21-er-bla-agonist-p2,N-(Chloromethylidene)-N-methylmethanaminium chloride,activity,inactive,3724-43-4,77311.0,[Cl-].C/[N+](C)=C\Cl
NCGC00255969-01,tox21-er-bla-agonist-p2,"5-Bromo-5-nitro-1,3-dioxane",activity,inactive,30007-47-7,1807.0,O=[N+]([O-])C1(Br)COCOC1
NCGC00254615-01,tox21-er-bla-agonist-p2,4-Dimethylaminobenzaldehyde,activity,inactive,100-10-7,7479.0,CN(C)c1ccc(C=O)cc1
NCGC00091414-02,tox21-er-bla-agonist-p2,Salicylamide,activity,inactive,65-45-2,5147.0,O=C(N)c1ccccc1O
NCGC00093985-07,tox21-er-bla-agonist-p2,Metolazone,activity,inactive,17560-51-9,4170.0,NS(=O)(=O)c1cc2C(=O)N(C(C)Nc2cc1Cl)c3ccccc3C
NCGC00164531-01,tox21-er-bla-agonist-p2,L-Cystine,activity,inactive,56-89-3,67678.0,N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O
NCGC00095071-01,tox21-er-bla-agonist-p2,Amcinonide,activity,inactive,51022-69-6,443958.0,CC(=O)OCC(=O)[C@@]65OC1(CCCC1)O[C@@H]6C[C@@H]4[C@]5(C)C[C@H](O)[C@@]3(F)[C@H]4CCC2=CC(=O)C=C[C@@]23C
NCGC00164583-01,tox21-er-bla-agonist-p2,Amdinocillin,activity,inactive,32887-01-7,36273.0,OC(=O)[C@@H]2N3C(=O)[C@@H](/N=C/N1CCCCCC1)[C@H]3SC2(C)C
NCGC00164589-01,tox21-er-bla-agonist-p2,Phenprobamate,activity,inactive,673-31-4,4770.0,NC(=O)OCCCc1ccccc1
NCGC00167488-01,tox21-er-bla-agonist-p2,Sorafenib tosylate,activity,inactive,475207-59-1,406563.0,O=C(NC)c3cc(Oc2ccc(NC(=O)Nc1cc(c(Cl)cc1)C(F)(F)F)cc2)ccn3.O=S(=O)(O)c1ccc(C)cc1
NCGC00164618-01,tox21-er-bla-agonist-p2,Raltitrexed,activity,inactive,112887-68-0,104758.0,O=C(N[C@@H](CCC(=O)O)C(=O)O)c1ccc(s1)N(C)Cc2ccc3N=C(C)NC(=O)c3c2
NCGC00164622-01,tox21-er-bla-agonist-p2,Voriconazole,activity,inactive,137234-62-9,71616.0,O[C@](Cn1cncn1)([C@@H](C)c2ncncc2F)c3ccc(F)cc3F
NCGC00168264-01,tox21-er-bla-agonist-p2,"1,3-Benzodioxole-5-ethanamine, alpha-methyl-, hydrochloride (1:1)",activity,inactive,6292-91-7,110823.0,Cl.CC(N)Cc1ccc2OCOc2c1
NCGC00095714-01,tox21-er-bla-agonist-p2,Limoni,activity,inactive,1180-71-8,179651.0,C[C@]35CC[C@@H]1[C@@]76COC(=O)C[C@@H]7OC(C)(C)[C@@H]6CC(=O)[C@@]1(C)[C@@]45O[C@@H]4C(=O)O[C@H]3c2ccoc2
NCGC00160547-01,tox21-er-bla-agonist-p2,Fomocaine,activity,inactive,17692-39-6,71693.0,C(CCN1CCOCC1)c3ccc(COc2ccccc2)cc3
NCGC00160646-01,tox21-er-bla-agonist-p2,Pipofezine,activity,inactive,24886-52-0,159977.0,CN1CCN(CC1)c2cc3N(C)c4ccccc4Oc3nn2
NCGC00163168-01,tox21-er-bla-agonist-p2,Mesulergine,activity,inactive,64795-35-3,68848.0,CN(C)S(=O)(=O)N[C@H]2C[C@@H]3c4cccc1c4c(cn1C)C[C@H]3N(C)C2
NCGC00182622-01,tox21-er-bla-agonist-p2,Efloxate,activity,inactive,119-41-5,8395.0,O=C(OCC)COc1ccc2c(c1)OC(=CC2=O)c3ccccc3
NCGC00183010-01,tox21-er-bla-agonist-p2,Pelubiprofen,activity,inactive,69956-77-0,5282203.0,O=C(O)C(C)c1ccc(cc1)\C=C2/CCCCC2=O
NCGC00183096-01,tox21-er-bla-agonist-p2,Cefcapene pivoxil hydrochloride,activity,inactive,147816-23-7,6918126.0,Cl.Nc1scc(n1)\C(=C\CC)C(=O)N[C@@H]3C(=O)N2C(=C(COC(N)=O)CS[C@@H]23)C(=O)OCOC(=O)C(C)(C)C
NCGC00183858-01,tox21-er-bla-agonist-p2,Blonanserin,activity,inactive,132810-10-7,125564.0,CCN1CCN(CC1)c3cc(c2ccc(F)cc2)c4CCCCCCc4n3
NCGC00254970-01,tox21-er-bla-agonist-p2,"1,1,1,3,5,5,5-Heptamethyltrisiloxane",activity,inactive,1873-88-7,6327366.0,C[Si](C)(C)O[SiH](C)O[Si](C)(C)C
NCGC00255368-01,tox21-er-bla-agonist-p2,Levothyroxine,activity,inactive,51-48-9,5819.0,O=C(O)[C@@H](N)Cc2cc(I)c(Oc1cc(I)c(O)c(I)c1)c(I)c2
NCGC00254328-01,tox21-er-bla-agonist-p2,Carbendazim,activity,inactive,10605-21-7,25429.0,O=C(OC)Nc1nc2ccccc2n1
NCGC00253979-01,tox21-er-bla-agonist-p2,Pentanal,activity,inactive,110-62-3,8063.0,CCCCC=O
NCGC00253983-01,tox21-er-bla-agonist-p2,"3,4-Dimethylphenol",activity,inactive,95-65-8,7249.0,Cc1cc(O)ccc1C
NCGC00254866-01,tox21-er-bla-agonist-p2,2-Chloro-N-(hydroxymethyl)acetamide,activity,inactive,2832-19-1,62466.0,ClCC(=O)NCO
NCGC00255242-01,tox21-er-bla-agonist-p2,Sodium ethenesulfonate,activity,inactive,3039-83-6,3270262.0,[Na+].[O-]S(=O)(=O)C=C
NCGC00254087-01,tox21-er-bla-agonist-p2,"1H-1,2,4-Triazole",activity,inactive,288-88-0,9257.0,c1ncnn1
NCGC00255325-01,tox21-er-bla-agonist-p2,Dimethylaniline,activity,inactive,1300-73-8,6893.0,Cc1cccc(N)c1C
NCGC00254952-01,tox21-er-bla-agonist-p2,Hexythiazox,activity,inactive,78587-05-0,13218777.0,Clc1ccc(cc1)[C@@H]2SC(=O)N([C@H]2C)C(=O)NC3CCCCC3
NCGC00183045-01,tox21-er-bla-agonist-p2,Naphazoline,activity,inactive,835-31-4,610682.0,c2cc(CC1=NCCN1)cc3ccccc23
NCGC00016858-01,tox21-er-bla-agonist-p2,Cefadroxil,activity,inactive,50370-12-2,47965.0,CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccc(O)cc1)C=3C(=O)O
NCGC00259623-01,tox21-er-bla-agonist-p2,Bis(2-chloroethyl) ether,activity,inactive,111-44-4,8115.0,ClCCOCCCl
NCGC00258031-01,tox21-er-bla-agonist-p2,"Dimethyl trans-cyclohexane-1,4-dicarboxylate",activity,inactive,3399-22-2,7198.0,COC(=O)[C@H]1CC[C@@H](CC1)C(=O)OC
NCGC00260364-01,tox21-er-bla-agonist-p2,Fluorescein 5(6)-isothiocyanate,activity,inactive,27072-45-3,18730.0,Oc4cc5Oc1cc(O)ccc1C3(OC(=O)c2cc(\N=C=S)ccc23)c5cc4
NCGC00015240-06,tox21-er-bla-agonist-p2,Cimetidine,activity,inactive,51481-61-9,2756.0,N#C\N=C(/NC)NCCSCc1ncnc1C
NCGC00015519-05,tox21-er-bla-agonist-p2,Dopamine,activity,inactive,51-61-6,681.0,Oc1ccc(CCN)cc1O
NCGC00259223-01,tox21-er-bla-agonist-p2,Ammonium sulfamate,activity,inactive,7773-06-0,24482.0,[NH4+].[O-]S(N)(=O)=O
NCGC00259512-01,tox21-er-bla-agonist-p2,Valproic acid,activity,inactive,99-66-1,3121.0,CCCC(CCC)C(=O)O
NCGC00182054-02,tox21-er-bla-agonist-p2,Aranidipine,activity,inactive,86780-90-7,2225.0,CC=1NC(C)=C(C(C=1C(=O)OCC(C)=O)c2ccccc2[N+]([O-])=O)C(=O)OC
NCGC00257376-01,tox21-er-bla-agonist-p2,Oxalic acid,activity,inactive,144-62-7,971.0,O=C(O)C(=O)O
NCGC00256693-01,tox21-er-bla-agonist-p2,"2,2'-[(4-Methylphenyl)imino]diethanol",activity,inactive,3077-12-1,76497.0,OCCN(CCO)c1ccc(C)cc1
NCGC00257394-01,tox21-er-bla-agonist-p2,2-Octanol,activity,inactive,123-96-6,20083.0,CC(O)CCCCCC
NCGC00257272-01,tox21-er-bla-agonist-p2,Linalyl formate,activity,inactive,115-99-1,61040.0,O=COC(C)(CC\C=C(\C)C)C=C
NCGC00257314-01,tox21-er-bla-agonist-p2,"N,N,N',N'-Tetrabutyl-1,6-hexanediamine",activity,inactive,27090-63-7,94377.0,CCCCN(CCCC)CCCCCCN(CCCC)CCCC
NCGC00016271-01,tox21-er-bla-agonist-p2,Tolazoline hydrochloride,activity,inactive,59-97-2,6048.0,Cl.c2cc(CC1=NCCN1)ccc2
NCGC00256499-01,tox21-er-bla-agonist-p2,4-Chloro-2-methylphenol,activity,inactive,1570-64-5,14855.0,Cc1cc(Cl)ccc1O
NCGC00168259-02,tox21-er-bla-agonist-p2,"4-Bromo-2,5-dimethoxyamphetamine hydrochloride",activity,inactive,29705-96-2,151318.0,Cl.COc1cc(CCN)c(cc1Br)OC
NCGC00254577-01,tox21-er-bla-agonist-p2,Barban,activity,inactive,101-27-9,7551.0,Clc1cc(NC(=O)OCC#CCCl)ccc1
NCGC00255235-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) tetrabromophthalate,activity,inactive,26040-51-7,117291.0,Brc1c(c(c(Br)c(Br)c1Br)C(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC
NCGC00256889-01,tox21-er-bla-agonist-p2,epsilon-Decalactone,activity,inactive,5579-78-2,62583.0,O=C1CCCCC(CCCC)O1
NCGC00257664-01,tox21-er-bla-agonist-p2,Chloral hydrate,activity,inactive,302-17-0,2707.0,ClC(Cl)(Cl)C(O)O
NCGC00257852-01,tox21-er-bla-agonist-p2,N-Methylaniline,activity,inactive,100-61-8,7515.0,CNc1ccccc1
NCGC00257490-01,tox21-er-bla-agonist-p2,Flucarbazone-sodium,activity,inactive,181274-17-9,12056760.0,[Na+].COC2=NN(C(=O)[N-]S(=O)(=O)c1ccccc1OC(F)(F)F)C(=O)N2C
NCGC00257969-01,tox21-er-bla-agonist-p2,2-Hydroxyethyl methacrylate,activity,inactive,868-77-9,13360.0,C=C(C)C(=O)OCCO
NCGC00257883-01,tox21-er-bla-agonist-p2,alpha-Naphylisothiocyanate,activity,inactive,551-06-4,11080.0,S=C=N\c2cccc1ccccc12
NCGC00257763-01,tox21-er-bla-agonist-p2,N-(Hydroxyethyl)ethylenediamine,activity,inactive,111-41-1,8112.0,NCCNCCO
NCGC00257777-01,tox21-er-bla-agonist-p2,1-Ethylpyridinium hexafluorophosphate,activity,inactive,103173-73-5,23160050.0,F[P-](F)(F)(F)(F)F.CC[n+]1ccccc1
NCGC00258934-01,tox21-er-bla-agonist-p2,Octabenzone,activity,inactive,1843-05-6,15797.0,O=C(c1ccc(cc1O)OCCCCCCCC)c2ccccc2
NCGC00259089-01,tox21-er-bla-agonist-p2,FD&C Yellow 5,activity,inactive,1934-21-0,5359657.0,[Na+].[Na+].[Na+].[O-]S(=O)(=O)c1ccc(cc1)/N=N/C3=C(NN(c2ccc(cc2)S([O-])(=O)=O)C3=O)C([O-])=O
NCGC00258669-01,tox21-er-bla-agonist-p2,tert-Butyl acrylate,activity,inactive,1663-39-4,15458.0,C=CC(=O)OC(C)(C)C
NCGC00259240-01,tox21-er-bla-agonist-p2,Butyl propionate,activity,inactive,590-01-2,11529.0,CCC(=O)OCCCC
NCGC00259763-01,tox21-er-bla-agonist-p2,"1,3-Isobenzofurandione, 5-methyl-",activity,inactive,19438-61-0,88069.0,Cc1ccc2C(=O)OC(=O)c2c1
NCGC00259425-01,tox21-er-bla-agonist-p2,"1,2,3-Benzotriazin-4(1H)-one",activity,inactive,90-16-4,7006.0,O=C2N=NNc1ccccc12
NCGC00260121-01,tox21-er-bla-agonist-p2,"Methanaminium, N,N,N-trimethyl-, hydroxide",activity,inactive,75-59-2,60966.0,[OH-].C[N+](C)(C)C
NCGC00260520-01,tox21-er-bla-agonist-p2,"2,3,3-Trimethylindolenine",activity,inactive,1640-39-7,15427.0,CC1(C)c2ccccc2N=C1C
NCGC00260185-01,tox21-er-bla-agonist-p2,"1-Ethyl-2,3-dimethylimidazolium trifluoromethanesulfonate",activity,inactive,174899-72-0,16210995.0,C[n+]1ccn(CC)c1C.FC(F)(F)S([O-])(=O)=O
NCGC00258782-01,tox21-er-bla-agonist-p2,"2,4-Dimethoxyaniline hydrochloride",activity,inactive,54150-69-5,5284385.0,Cl.Nc1ccc(cc1OC)OC
NCGC00013724-01,tox21-er-bla-agonist-p2,Scopolamine methylbromide,activity,inactive,155-41-9,5459110.0,[Br-].OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@@H]3[C@H]4O[C@H]4[C@H](C2)[N+]3(C)C
NCGC00015466-08,tox21-er-bla-agonist-p2,Gabapentin,activity,inactive,60142-96-3,3446.0,NCC1(CC(=O)O)CCCCC1
NCGC00016268-02,tox21-er-bla-agonist-p2,Nicotinic acid,activity,inactive,59-67-6,938.0,O=C(O)c1cccnc1
NCGC00016309-02,tox21-er-bla-agonist-p2,Sulfathiazole,activity,inactive,72-14-0,5340.0,O=S(=O)(Nc1nccs1)c2ccc(N)cc2
NCGC00016358-01,tox21-er-bla-agonist-p2,Allantoin,activity,inactive,97-59-6,204.0,O=C1NC(=O)NC1NC(=O)N
NCGC00016407-05,tox21-er-bla-agonist-p2,Sulfamethizole,activity,inactive,144-82-1,5328.0,Cc2nnc(NS(=O)(=O)c1ccc(N)cc1)s2
NCGC00016414-01,tox21-er-bla-agonist-p2,Acenocoumarol,activity,inactive,152-72-7,54676537.0,[O-][N+](=O)c1ccc(cc1)C(CC(C)=O)C2=C(O)c3ccccc3OC2=O
NCGC00016622-02,tox21-er-bla-agonist-p2,Hycanthone,activity,inactive,3105-97-3,3634.0,CCN(CC)CCNc1ccc(CO)c2Sc3ccccc3C(=O)c12
NCGC00016681-01,tox21-er-bla-agonist-p2,Methotrimeprazine maleate,activity,inactive,7104-38-3,5282484.0,O=C(O)/C=C\C(=O)O.CN(C)C[C@@H](C)CN1c3ccccc3Sc2ccc(OC)cc12
NCGC00181083-01,tox21-er-bla-agonist-p2,Piperilate hydrochloride,activity,inactive,4544-15-4,23724801.0,Cl.OC(c1ccccc1)(c2ccccc2)C(=O)OCCN3CCCCC3
NCGC00183133-01,tox21-er-bla-agonist-p2,Eprinomectin B1a,activity,inactive,133305-88-1,44460585.0,CC(=O)N[C@H]1[C@@H](OC)C[C@@H](O[C@H]1C)O[C@@H]2[C@@H](OC)C[C@@H](O[C@H]2C)O[C@@H]3C(C)=CC[C@@H]6C[C@H](OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OCC(=CC=C[C@@H]3C)[C@@]45O)C[C@@]7(O6)C=C[C@H](C)[C@H](O7)C(C)CC
NCGC00183596-01,tox21-er-bla-agonist-p2,Maxacalcitol,activity,inactive,103909-75-7,6398761.0,C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)OCCC(C)(C)O
NCGC00247700-01,tox21-er-bla-agonist-p2,"(+)-2,5-Dimethoxyamphetamine hydrochloride",activity,inactive,50505-85-6,60196327.0,Cl.COc1ccc(cc1C[C@H](C)N)OC
NCGC00256301-01,tox21-er-bla-agonist-p2,2-(Phenylsulfonyl)aniline,activity,inactive,4273-98-7,77956.0,Nc1ccccc1S(=O)(=O)c2ccccc2
NCGC00254925-01,tox21-er-bla-agonist-p2,Lansoprazole,activity,inactive,103577-45-3,3883.0,FC(F)(F)COc3ccnc(CS(=O)c1nc2ccccc2n1)c3C
NCGC00256316-01,tox21-er-bla-agonist-p2,Meloxicam,activity,inactive,71125-38-7,54677470.0,Cc3cnc(NC(=O)C2=C(O)c1ccccc1S(=O)(=O)N2C)s3
NCGC00254519-01,tox21-er-bla-agonist-p2,"2,4,7,9-Tetramethyl-5-decyne-4,7-diol",activity,inactive,126-86-3,31362.0,CC(O)(C#CC(C)(O)CC(C)C)CC(C)C
NCGC00254394-01,tox21-er-bla-agonist-p2,"4,4'-Bipyridine",activity,inactive,553-26-4,11107.0,c1cc(ccn1)c2ccncc2
NCGC00254425-01,tox21-er-bla-agonist-p2,p-Cymene,activity,inactive,99-87-6,7463.0,Cc1ccc(cc1)C(C)C
NCGC00254668-01,tox21-er-bla-agonist-p2,Flufenoxuron,activity,inactive,101463-69-8,91766.0,Clc3cc(ccc3Oc2ccc(NC(=O)NC(=O)c1c(F)cccc1F)c(F)c2)C(F)(F)F
NCGC00254717-01,tox21-er-bla-agonist-p2,N-Butyldiethanolamine,activity,inactive,102-79-4,7620.0,OCCN(CCCC)CCO
NCGC00254222-01,tox21-er-bla-agonist-p2,Nelivaptan,activity,inactive,439687-69-1,9895468.0,CN(C)C(=O)[C@@H]1C[C@@H](O)CN1[C@]3(c2cc(Cl)ccc2N(C3=O)S(=O)(=O)c4ccc(OC)cc4OC)c5ccccc5OC
NCGC00254258-01,tox21-er-bla-agonist-p2,Sodium dimethyldithiocarbamate,activity,inactive,128-04-1,560256.0,[Na+].CN(C)C([S-])=S
NCGC00015300-05,tox21-er-bla-agonist-p2,GBR 12909 dihydrochloride,activity,inactive,67469-78-7,104920.0,Cl.Cl.Fc1ccc(cc1)C(OCCN2CCN(CC2)CCCc3ccccc3)c4ccc(F)cc4
NCGC00015821-02,tox21-er-bla-agonist-p2,Piracetam,activity,inactive,7491-74-9,4843.0,O=C1CCCN1CC(=O)N
NCGC00091009-05,tox21-er-bla-agonist-p2,17-Methyltestosterone,activity,active agonist,58-18-4,6010.0,O=C4CC[C@@]3(C)C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@]1(C)O)=C4
NCGC00167821-01,tox21-er-bla-agonist-p2,Cabergoline,activity,inactive,81409-90-7,54746.0,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C1)CC=C)c34
NCGC00181014-01,tox21-er-bla-agonist-p2,Alfacalcidol,activity,inactive,41294-56-8,5284515.0,C=C1C(\C[C@@H](O)C[C@@H]1O)=C\C=C2\CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)CCCC(C)C
NCGC00183134-01,tox21-er-bla-agonist-p2,Gomisin A,activity,inactive,58546-54-6,68781.0,C[C@@H]1Cc3cc4OCOc4c(OC)c3c2c(OC)c(OC)c(OC)cc2C[C@@]1(C)O
NCGC00247712-01,tox21-er-bla-agonist-p2,R-(+)-Secobarbital,activity,inactive,22328-94-5,30019.0,O=C1NC(=O)NC(=O)C1(CC=C)[C@@H](C)CCC
NCGC00254901-01,tox21-er-bla-agonist-p2,"1,2,6-Hexanetriol",activity,inactive,106-69-4,7823.0,OCCCCC(O)CO
NCGC00259383-01,tox21-er-bla-agonist-p2,Pyrimethamine,activity,inactive,58-14-0,4993.0,CCc1nc(N)nc(N)c1c2ccc(Cl)cc2
NCGC00259413-01,tox21-er-bla-agonist-p2,3-Iodo-2-propynyl-N-butylcarbamate,activity,inactive,55406-53-6,62097.0,O=C(NCCCC)OCC#CI
NCGC00259948-01,tox21-er-bla-agonist-p2,2-Butoxyethanol,activity,inactive,111-76-2,8133.0,CCCCOCCO
NCGC00260653-01,tox21-er-bla-agonist-p2,NTP Mix94 ER AR1 18-EQP,activity,inconclusive agonist (fluorescent),NOCAS_49549,,
NCGC00091583-02,tox21-er-bla-agonist-p2,3-Ethoxy-4-hydroxybenzaldehyde,activity,inactive,121-32-4,8467.0,CCOc1cc(ccc1O)C=O
NCGC00163245-01,tox21-er-bla-agonist-p2,Gallamine triethiodide,activity,inactive,65-29-2,6172.0,[I-].[I-].[I-].CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC
NCGC00168779-01,tox21-er-bla-agonist-p2,Valganciclovir hydrochloride,activity,inactive,175865-59-5,110632.0,Cl.CC(C)[C@H](N)C(=O)OCC(CO)OCn2cnc1c2NC(N)=NC1=O
NCGC00254189-01,tox21-er-bla-agonist-p2,Diisodecyl hexanedioate,activity,inactive,27178-16-1,33733.0,CC(C)CCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC(C)C
NCGC00254711-01,tox21-er-bla-agonist-p2,Prometryn,activity,inactive,7287-19-6,4929.0,CSc1nc(NC(C)C)nc(NC(C)C)n1
NCGC00074022-02,tox21-er-bla-agonist-p2,Pyricarbate,activity,inactive,1882-26-4,4990.0,CNC(=O)OCc1cccc(COC(=O)NC)n1
NCGC00017013-01,tox21-er-bla-agonist-p2,Thiamine hydrochloride,activity,inactive,67-03-8,6202.0,[Cl-].Cl.Cc2nc(N)c(C[n+]1csc(CCO)c1C)cn2
NCGC00017106-01,tox21-er-bla-agonist-p2,Azlocillin sodium,activity,inactive,37091-65-9,23684677.0,[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)[C@@H](NC(=O)N1CCNC1=O)c2ccccc2)[C@H]4SC3(C)C
NCGC00021394-03,tox21-er-bla-agonist-p2,Anisotropine methylbromide,activity,inactive,80-50-2,657201.0,[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CCC)CCC
NCGC00024359-04,tox21-er-bla-agonist-p2,D-Penicillamine,activity,inactive,52-67-5,5852.0,O=C(O)[C@H](N)C(C)(C)S
NCGC00063341-02,tox21-er-bla-agonist-p2,Giparmen,activity,inactive,67268-43-3,68872.0,C#CCOc1ccc2c(c1)OC(=O)C=C2C
NCGC00016898-01,tox21-er-bla-agonist-p2,Sulconazole nitrate,activity,inactive,61318-91-0,65495.0,[O-][N+](=O)O.Clc3ccc(C(SCc1ccc(Cl)cc1)Cn2ccnc2)c(Cl)c3
NCGC00256850-01,tox21-er-bla-agonist-p2,4-(tert-Pentyl)-cyclohexanone,activity,inactive,16587-71-6,27941.0,CCC(C)(C)C1CCC(=O)CC1
NCGC00256941-01,tox21-er-bla-agonist-p2,2-Bromopropionic acid,activity,inactive,598-72-1,11729.0,BrC(C)C(=O)O
NCGC00256953-01,tox21-er-bla-agonist-p2,Trimellitic anhydride,activity,inactive,552-30-7,11089.0,O=C(O)c1ccc2C(=O)OC(=O)c2c1
NCGC00258373-01,tox21-er-bla-agonist-p2,Butyl dipropasol solvent,activity,inactive,29911-27-1,121752.0,OC(C)COC(C)COCCC
NCGC00257064-01,tox21-er-bla-agonist-p2,Phenolsulfonic acid,activity,inactive,1333-39-7,11867.0,Oc1ccccc1S(O)(=O)=O
NCGC00257071-01,tox21-er-bla-agonist-p2,Phosphoric acid,activity,inactive,7664-38-2,1004.0,O=P(O)(O)O
NCGC00257323-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(2,6-di-t-butylphenol)",activity,inactive,118-82-1,8372.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)Cc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C
NCGC00257661-01,tox21-er-bla-agonist-p2,Cyhalothrin,activity,inactive,68085-85-8,6440556.0,Cl\C(=C/[C@@H]3[C@H](C(=O)O[C@H](C#N)c2cccc(Oc1ccccc1)c2)C3(C)C)C(F)(F)F
NCGC00258273-01,tox21-er-bla-agonist-p2,"N,N-Dimethylbenzylamine",activity,inactive,103-83-3,7681.0,CN(C)Cc1ccccc1
NCGC00256075-01,tox21-er-bla-agonist-p2,4-Ethylbenzaldehyde,activity,inactive,4748-78-1,20861.0,CCc1ccc(C=O)cc1
NCGC00256161-01,tox21-er-bla-agonist-p2,"2,5-Bis(2-methylbutan-2-yl)benzene-1,4-diol",activity,inactive,79-74-3,6610.0,Oc1cc(c(O)cc1C(C)(C)CC)C(C)(C)CC
NCGC00260411-01,tox21-er-bla-agonist-p2,1-Bromoundecane,activity,inactive,693-67-4,12744.0,BrCCCCCCCCCCC
NCGC00260626-01,tox21-er-bla-agonist-p2,NTP Mix102 ER1 10-EQC,activity,inactive,NOCAS_49522,,
NCGC00259456-01,tox21-er-bla-agonist-p2,2-Methoxy-5-methylaniline,activity,inactive,120-71-8,8445.0,Nc1cc(C)ccc1OC
NCGC00259509-01,tox21-er-bla-agonist-p2,Benzenesulfonic acid,activity,inactive,98-11-3,7371.0,O=S(O)(=O)c1ccccc1
NCGC00259654-01,tox21-er-bla-agonist-p2,2-(Hexyloxy)ethanol,activity,inactive,112-25-4,8170.0,OCCOCCCCCC
NCGC00259847-01,tox21-er-bla-agonist-p2,Dimethyl hexahydroterephthalate,activity,inactive,94-60-0,7198.0,COC(=O)C1CCC(CC1)C(=O)OC
NCGC00259888-01,tox21-er-bla-agonist-p2,Chlorendic acid,activity,inactive,115-28-6,8266.0,ClC2(Cl)C1(Cl)C(Cl)=C(Cl)C2(Cl)C(C1C(=O)O)C(=O)O
NCGC00260103-01,tox21-er-bla-agonist-p2,"2,4,4-Trimethylpentene",activity,inactive,25167-70-8,7868.0,C=C(C)CC(C)(C)C
NCGC00260116-01,tox21-er-bla-agonist-p2,3-(Trichlorosilyl)propyl methacrylate,activity,inactive,7351-61-3,81811.0,Cl[Si](Cl)(Cl)CCCOC(=O)C(=C)C
NCGC00260249-01,tox21-er-bla-agonist-p2,1-Hexylpyridinium trifluoromethanesulfonate,activity,inactive,623167-81-7,2734249.0,FC(F)(F)S([O-])(=O)=O.CCCCCC[n+]1ccccc1
NCGC00260309-01,tox21-er-bla-agonist-p2,"2-Propenoic acid, 2-methyl-, octadecyl ester",activity,inactive,32360-05-7,122600.0,C=C(C)C(=O)OCCCCCCCCCCCCCCCCCC
NCGC00258717-01,tox21-er-bla-agonist-p2,Kaempferol,activity,active agonist,520-18-3,5280863.0,Oc1ccc(cc1)C=3Oc2cc(O)cc(O)c2C(=O)C=3O
NCGC00255006-01,tox21-er-bla-agonist-p2,"Hexanoic acid, 2-ethyl-, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester",activity,inactive,18268-70-7,28999.0,O=C(OCCOCCOCCOCCOC(=O)C(CC)CCCC)C(CC)CCCC
NCGC00255217-01,tox21-er-bla-agonist-p2,"Acetonitrile, [ethyl(3-methylphenyl)amino]-",activity,inactive,63133-74-4,113027.0,CCN(CC#N)c1cc(C)ccc1
NCGC00255243-01,tox21-er-bla-agonist-p2,Cyphenothrin,activity,inactive,39515-40-7,38283.0,C/C(C)=C/C3C(C(=O)OC(C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00255721-01,tox21-er-bla-agonist-p2,3-Isopropylphenol,activity,inactive,618-45-1,12059.0,CC(C)c1cc(O)ccc1
NCGC00255748-01,tox21-er-bla-agonist-p2,Glyceryl monoricinoleate,activity,inactive,1323-38-2,6433266.0,OCC(O)COC(=O)CCCCCCC/C=C\C[C@H](O)CCCCCC
NCGC00254604-01,tox21-er-bla-agonist-p2,Isoxaben,activity,inactive,82558-50-7,73672.0,CCC(C)(CC)c2cc(NC(=O)c1c(OC)cccc1OC)on2
NCGC00159415-02,tox21-er-bla-agonist-p2,Methandrostenolone,activity,active agonist,72-63-9,6300.0,O=C3C=C4CC[C@@H]2[C@H](CC[C@@]1(C)[C@H]2CC[C@]1(C)O)[C@@]4(C)C=C3
NCGC00094521-05,tox21-er-bla-agonist-p2,Chlorthal-dimethyl,activity,inactive,1861-32-1,2943.0,Clc1c(C(=O)OC)c(Cl)c(Cl)c(C(=O)OC)c1Cl
NCGC00159475-02,tox21-er-bla-agonist-p2,Glisoxepide,activity,inactive,25046-79-1,32778.0,Cc1cc(no1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NN3CCCCCC3
NCGC00180998-01,tox21-er-bla-agonist-p2,Amylmetacresol,activity,inactive,1300-94-3,14759.0,Oc1cc(C)ccc1CCCCC
NCGC00181156-01,tox21-er-bla-agonist-p2,Oxabolone cipioncate,activity,active agonist,1254-35-9,68952.0,OC=5C(=O)CC[C@H]4C=5CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCC1CCCC1)CC[C@@H]23
NCGC00160444-01,tox21-er-bla-agonist-p2,Clofenamide,activity,inactive,671-95-4,69594.0,O=S(N)(=O)c1cc(ccc1Cl)S(N)(=O)=O
NCGC00160482-01,tox21-er-bla-agonist-p2,Sulfalene,activity,inactive,152-47-6,9047.0,COc2nccnc2NS(=O)(=O)c1ccc(N)cc1
NCGC00095175-01,tox21-er-bla-agonist-p2,Cefditorin pivoxil,activity,inactive,117467-28-4,6437877.0,Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(/C=C\c2scnc2C)CS[C@@H]34)C(=O)OCOC(=O)C(C)(C)C
NCGC00181042-01,tox21-er-bla-agonist-p2,Menthyl salicylate,activity,inactive,89-46-3,6970.0,O=C(OC1CC(C)CCC1C(C)C)c2ccccc2O
NCGC00095836-02,tox21-er-bla-agonist-p2,Guaiazulene,activity,inactive,489-84-9,3515.0,CC(C)c1ccc(C)c2ccc(C)c2c1
NCGC00096015-01,tox21-er-bla-agonist-p2,Aurothioglucose,activity,inactive,12192-57-3,454937.0,O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1S[Au]
NCGC00161831-02,tox21-er-bla-agonist-p2,Mefloquine hydrochloride,activity,active agonist,51773-92-3,65329.0,Cl.O[C@@H](c2cc(nc1c2cccc1C(F)(F)F)C(F)(F)F)[C@H]3CCCCN3
NCGC00166265-01,tox21-er-bla-agonist-p2,Carsalam,activity,inactive,2037-95-8,16258.0,O=C2NC(=O)Oc1ccccc12
NCGC00091253-05,tox21-er-bla-agonist-p2,"2,4,5-Trimethoxybenzaldehyde",activity,inactive,4460-86-0,20525.0,COc1cc(OC)c(cc1OC)C=O
NCGC00182986-01,tox21-er-bla-agonist-p2,Acetylpheneturide,activity,inactive,13402-08-9,1999.0,CCC(C(=O)NC(=O)NC(C)=O)c1ccccc1
NCGC00183655-01,tox21-er-bla-agonist-p2,Tazanolast,activity,inactive,82989-25-1,5380.0,O=C(OCCCC)C(=O)Nc1cccc(c1)c2nnnn2
NCGC00183847-01,tox21-er-bla-agonist-p2,Thenalidine,activity,inactive,86-12-4,27901.0,CN1CCC(CC1)N(Cc2cccs2)c3ccccc3
NCGC00254959-01,tox21-er-bla-agonist-p2,Sodium 2-formylbenzenesulfonate,activity,inactive,1008-72-6,3794540.0,[Na+].O=S([O-])(=O)c1ccccc1C=O
NCGC00254984-01,tox21-er-bla-agonist-p2,"2,6-Diisopropylnaphthalene",activity,inactive,24157-81-1,32241.0,CC(C)c1ccc2cc(ccc2c1)C(C)C
NCGC00183875-01,tox21-er-bla-agonist-p2,rac Nebivolol hydrochloride,activity,inactive,169293-50-9,11626384.0,Cl.Fc1cc2CC[C@@H](Oc2cc1)[C@@H](O)CNC[C@H](O)[C@@H]3CCc4cc(F)ccc4O3
NCGC00254128-01,tox21-er-bla-agonist-p2,"N,N,N-Trimethyl(oxiran-2-yl)methanaminium chloride",activity,inactive,3033-77-0,18205.0,[Cl-].C[N+](C)(C)CC1CO1
NCGC00255021-01,tox21-er-bla-agonist-p2,2-Phenylethyl 2-methylpropanoate,activity,inactive,103-48-0,7655.0,CC(C)C(=O)OCCc1ccccc1
NCGC00188346-01,tox21-er-bla-agonist-p2,PP242,activity,inactive,1092351-67-1,24905147.0,Oc1cc2cc(nc2cc1)c4nn(c3ncnc(N)c34)C(C)C
NCGC00254209-01,tox21-er-bla-agonist-p2,SB236057A,activity,inactive,180084-01-9,10483134.0,Cl.Cc1nnc(o1)c2cc(C)c(cc2)c3ccc(cc3)C(=O)N6CCc5cc7OCC4(CCN(CC)CC4)c7cc56
NCGC00255276-01,tox21-er-bla-agonist-p2,"1,2,4-Triazin-5(2H)-one, 4-amino-6-(1,1-dimethylethyl)-3,4-dihydro-3-thioxo-",activity,inactive,33509-43-2,676486.0,O=C1N(N)C(=S)NN=C1C(C)(C)C
NCGC00247671-01,tox21-er-bla-agonist-p2,"(4R,5S)-4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine",activity,inactive,29493-77-4,3058503.0,NC1=N[C@H](C)[C@@H](O1)c2ccccc2
NCGC00247707-01,tox21-er-bla-agonist-p2,Morphine sulfate pentahydrate,activity,inactive,6211-15-0,6321225.0,O.O.O.O.O.O=S(=O)(O)O.Oc5ccc1C[C@H]2N(C)CC[C@]43c1c5O[C@H]4[C@@H](O)C=C[C@@H]23.Oc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00253959-01,tox21-er-bla-agonist-p2,Dibutyl hexanedioate,activity,inactive,105-99-7,7784.0,O=C(CCCCC(=O)OCCCC)OCCCC
NCGC00254821-01,tox21-er-bla-agonist-p2,Trifluralin,activity,inactive,1582-09-8,5569.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCC)CCC)C(F)(F)F
NCGC00253999-01,tox21-er-bla-agonist-p2,Phenobarbital sodium,activity,inactive,57-30-7,23674889.0,[Na+].CCC1(C(=O)N=C([O-])NC1=O)c2ccccc2
NCGC00254083-01,tox21-er-bla-agonist-p2,2-Butoxyethanol,activity,inactive,111-76-2,8133.0,CCCCOCCO
NCGC00254108-01,tox21-er-bla-agonist-p2,GW473178E methyl benzene sulphonic acid,activity,inactive,263553-33-9,60196400.0,O=S(=O)(O)c1ccc(C)cc1.CC(C)N(CC)C(=O)c1cc(C)cc(c1)OC[C@H](C)Nc2ccncc2
NCGC00182049-01,tox21-er-bla-agonist-p2,Nitroscanate,activity,inactive,19881-18-6,68547.0,[O-][N+](=O)c1ccc(cc1)Oc2ccc(cc2)\N=C=S
NCGC00259713-01,tox21-er-bla-agonist-p2,2-Heptanone,activity,inactive,110-43-0,8051.0,CC(=O)CCCCC
NCGC00257868-01,tox21-er-bla-agonist-p2,Guggulsterones E,activity,inactive,39025-24-6,6439929.0,C\C=C4\C(=O)C[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CCC1=CC(=O)CC[C@@]12C
NCGC00260114-01,tox21-er-bla-agonist-p2,2-Acrylamido-2-methylpropanesulphonate sodium salt,activity,inactive,5165-97-9,23665719.0,[Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C
NCGC00258192-01,tox21-er-bla-agonist-p2,Nitrogen mustard hydrochloride,activity,inactive,55-86-7,5935.0,Cl.ClCCN(C)CCCl
NCGC00259824-01,tox21-er-bla-agonist-p2,Phenoxathiin,activity,inactive,262-20-4,9217.0,c1ccc2Sc3ccccc3Oc2c1
NCGC00259884-01,tox21-er-bla-agonist-p2,5-Fluorouracil,activity,inactive,51-21-8,3385.0,FC1=CNC(=O)NC1=O
NCGC00257143-01,tox21-er-bla-agonist-p2,Diflubenzuron,activity,inactive,35367-38-5,37123.0,Clc2ccc(NC(=O)NC(=O)c1c(F)cccc1F)cc2
NCGC00257414-01,tox21-er-bla-agonist-p2,Dicyclohexyl sodium sulfosuccinate,activity,inactive,23386-52-9,23692768.0,[Na+].O=C(OC1CCCCC1)C(CC(=O)OC2CCCCC2)S([O-])(=O)=O
NCGC00258319-01,tox21-er-bla-agonist-p2,Tetrabutylphosphonium chloride,activity,inactive,2304-30-5,75311.0,[Cl-].CCCC[P+](CCCC)(CCCC)CCCC
NCGC00257796-01,tox21-er-bla-agonist-p2,(13Z)-Docos-13-enoic acid,activity,inactive,112-86-7,5281116.0,O=C(O)CCCCCCCCCCC/C=C\CCCCCCCC
NCGC00256916-01,tox21-er-bla-agonist-p2,"Phenol, 2-(1,1-dimethylethyl)-6-methyl-",activity,inactive,2219-82-1,16678.0,CC(C)(C)c1cccc(C)c1O
NCGC00256981-01,tox21-er-bla-agonist-p2,UT-632,activity,inactive,2386-87-0,16949.0,O=C(OCC1CC2OC2CC1)C3CCC4OC4C3
NCGC00257144-01,tox21-er-bla-agonist-p2,Ethylene glycol dimethacrylate,activity,inactive,97-90-5,7355.0,O=C(OCCOC(=O)C(=C)C)C(=C)C
NCGC00257505-01,tox21-er-bla-agonist-p2,Chlorpheniramine maleate,activity,inactive,113-92-8,5284366.0,[O-]C(=O)\C=C/C(=O)O.Clc1ccc(cc1)C(CC[NH+](C)C)c2ccccn2
NCGC00256550-01,tox21-er-bla-agonist-p2,Phosphamidon,activity,inactive,13171-21-6,25750.0,COP(=O)(OC)OC(C)=C(Cl)C(=O)N(CC)CC
NCGC00258982-01,tox21-er-bla-agonist-p2,Diisodecyl phthalate,activity,inactive,26761-40-0,22833326.0,CC(C)(C)CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCC(C)(C)C
NCGC00090701-06,tox21-er-bla-agonist-p2,Indole-3-carbinol,activity,active agonist,700-06-1,3712.0,OCc2cnc1ccccc12
NCGC00255684-01,tox21-er-bla-agonist-p2,2-Methyl-4-isothiazolin-3-one hydrochloride,activity,inactive,26172-54-3,117746.0,Cl.O=C1C=CSN1C
NCGC00255521-01,tox21-er-bla-agonist-p2,"C.I. Acid Yellow 34, monosodium salt",activity,inactive,6359-90-6,23675737.0,[Na+].[O-]S(=O)(=O)c1ccc(Cl)c(c1)N3N=C(C)C(/N=N/c2ccccc2)C3=O
NCGC00255605-01,tox21-er-bla-agonist-p2,2-Ethylhexyl benzoate,activity,inactive,5444-75-7,94310.0,CCC(COC(=O)c1ccccc1)CCCC
NCGC00256328-01,tox21-er-bla-agonist-p2,Phenylhydrazine hydrochloride,activity,inactive,59-88-1,60962.0,Cl.NNc1ccccc1
NCGC00256137-01,tox21-er-bla-agonist-p2,"3,6,9,12-Tetraoxatetradeca-1,13-diene",activity,inactive,765-12-8,3033992.0,C=COCCOCCOCCOC=C
NCGC00256399-01,tox21-er-bla-agonist-p2,3-Methyl-2-butanone,activity,inactive,563-80-4,11251.0,CC(C)C(C)=O
NCGC00256898-01,tox21-er-bla-agonist-p2,(Methylthio)methylpyrazine,activity,inactive,67952-65-2,528143.0,Cc1cnc(SC)cn1
NCGC00256619-01,tox21-er-bla-agonist-p2,"2,4,5-Trimethyl-3-oxazoline",activity,inactive,22694-96-8,31492.0,CC1OC(C)N=C1C
NCGC00256661-01,tox21-er-bla-agonist-p2,Cyclopentadecanone,activity,inactive,502-72-7,10409.0,O=C1CCCCCCCCCCCCCC1
NCGC00257180-01,tox21-er-bla-agonist-p2,Haloxyfop-methyl,activity,inactive,69806-40-2,50896.0,O=C(OC)C(C)Oc1ccc(cc1)Oc2ncc(cc2Cl)C(F)(F)F
NCGC00257417-01,tox21-er-bla-agonist-p2,"2,4,6-Trimethylbenzoic acid",activity,inactive,480-63-7,10194.0,Cc1cc(C)cc(C)c1C(O)=O
NCGC00257451-01,tox21-er-bla-agonist-p2,YM218,activity,inactive,NOCAS_48176,11982778.0,O=C(O)/C=C/C(=O)O.Cc6occc6C(=O)Nc1ccc(cc1)C(=O)N5CCC(F)(F)C(=C\C(=O)N2CCC(CC2)N3CCCCC3)/c4ccccc45.O=C(\C=C2\c1ccccc1N(CCC2(F)F)C(=O)c3ccc(cc3)NC(=O)c4ccoc4C)N5CCC(CC5)N6CCCCC6
NCGC00257540-01,tox21-er-bla-agonist-p2,1-Amino-2-propanol,activity,inactive,78-96-6,4.0,CC(O)CN
NCGC00257776-01,tox21-er-bla-agonist-p2,Decalin,activity,inactive,91-17-8,7044.0,C1CCC2CCCCC2C1
NCGC00258326-01,tox21-er-bla-agonist-p2,(E)-beta-Nitrostyrene,activity,inactive,5153-67-3,5284459.0,[O-][N+](=O)/C=C/c1ccccc1
NCGC00259091-01,tox21-er-bla-agonist-p2,2-Ethylhexyl sulfanylacetate,activity,inactive,7659-86-1,24309.0,CCC(CCCC)COC(=O)CS
NCGC00258424-01,tox21-er-bla-agonist-p2,Octopamine hydrochloride,activity,inactive,770-05-8,102484.0,Cl.OC(CN)c1ccc(O)cc1
NCGC00258626-01,tox21-er-bla-agonist-p2,Methanesulfonic acid,activity,inactive,75-75-2,6395.0,CS(=O)(=O)O
NCGC00258840-01,tox21-er-bla-agonist-p2,"1,4-Dibromobenzene",activity,inactive,106-37-6,7804.0,Brc1ccc(Br)cc1
NCGC00258035-01,tox21-er-bla-agonist-p2,Potassium thiocyanate,activity,inactive,333-20-0,516872.0,[K+].[S-]C#N
NCGC00258207-01,tox21-er-bla-agonist-p2,3-Amino-4-ethoxyacetanilide,activity,inactive,17026-81-2,28207.0,CCOc1ccc(cc1N)NC(C)=O
NCGC00259234-01,tox21-er-bla-agonist-p2,Caffeine,activity,inactive,58-08-2,2519.0,O=C2c1n(C)cnc1N(C)C(=O)N2C
NCGC00259863-01,tox21-er-bla-agonist-p2,Butylphthalyl butylglycolate,activity,inactive,85-70-1,6819.0,O=C(OCCCC)COC(=O)c1ccccc1C(=O)OCCCC
NCGC00260125-01,tox21-er-bla-agonist-p2,"2-Anthracenesulfonic acid, 1-amino-4-bromo-9,10-dihydro-9,10-dioxo-, monosodium salt",activity,inactive,6258-06-6,5076555.0,[Na+].[O-]S(=O)(=O)c3cc(Br)c2c(C(=O)c1ccccc1C2=O)c3N
NCGC00260013-01,tox21-er-bla-agonist-p2,Piperonal acetone,activity,inactive,3160-37-0,18480.0,CC(=O)C=Cc1ccc2OCOc2c1
NCGC00260297-01,tox21-er-bla-agonist-p2,"Hexadecane, 1-chloro-",activity,inactive,4860-03-1,20993.0,CCCCCCCCCCCCCCCCCl
NCGC00260349-01,tox21-er-bla-agonist-p2,Ammonium tetrachloroplatinate(II),activity,inactive,13820-41-2,,[NH4+].[NH4+].[Cl-][Pt+2]([Cl-])([Cl-])[Cl-]
NCGC00260635-01,tox21-er-bla-agonist-p2,NTP Mix111 ER1 10-EQC,activity,active agonist,NOCAS_49531,,
NCGC00260497-01,tox21-er-bla-agonist-p2,7-Methyladenine,activity,inactive,935-69-3,71593.0,Nc1ncnc2ncn(C)c12
NCGC00260565-01,tox21-er-bla-agonist-p2,NTP Mix73 CT1 62-EQP,activity,inactive,NOCAS_49461,,
NCGC00015656-06,tox21-er-bla-agonist-p2,Mianserin,activity,inactive,24219-97-4,4184.0,CN1CC2N(CC1)c4ccccc4Cc3ccccc23
NCGC00015279-02,tox21-er-bla-agonist-p2,Meclofenoxate hydrochloride,activity,inactive,3685-84-5,19379.0,Cl.Clc1ccc(OCC(=O)OCCN(C)C)cc1
NCGC00016554-01,tox21-er-bla-agonist-p2,Nifuroxazide,activity,inactive,965-52-6,13764.0,O=[N+]([O-])c2ccc(\C=N/NC(=O)c1ccc(O)cc1)o2
NCGC00016384-03,tox21-er-bla-agonist-p2,Sulfisoxazole,activity,inactive,127-69-5,5344.0,Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C
NCGC00016521-01,tox21-er-bla-agonist-p2,Proxyphylline,activity,inactive,603-00-9,4977.0,CC(O)Cn2cnc1c2C(=O)N(C)C(=O)N1C
NCGC00094576-01,tox21-er-bla-agonist-p2,Acetohydroxamic acid,activity,inactive,546-88-3,1990.0,CC(=O)NO
NCGC00181786-01,tox21-er-bla-agonist-p2,Naratriptan hydrochloride,activity,inactive,143388-64-1,60875.0,Cl.CN1CCC(CC1)c2cnc3ccc(CCS(=O)(=O)NC)cc23
NCGC00255766-01,tox21-er-bla-agonist-p2,Pentaerythritol tetraacrylate,activity,active agonist,4986-89-4,62556.0,O=C(C=C)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C
NCGC00255906-01,tox21-er-bla-agonist-p2,Triphenyltin fluoride,activity,active agonist,379-52-2,9786.0,F[Sn](c1ccccc1)(c2ccccc2)c3ccccc3
NCGC00254737-01,tox21-er-bla-agonist-p2,Isazofos,activity,inactive,42509-80-8,39223.0,CC(C)n1nc(OP(=S)(OCC)OCC)nc1Cl
NCGC00255409-01,tox21-er-bla-agonist-p2,Bromophenol blue,activity,inactive,115-39-9,8272.0,Brc1cc(cc(Br)c1O)C3(OS(=O)(=O)c2ccccc23)c4cc(Br)c(O)c(Br)c4
NCGC00255438-01,tox21-er-bla-agonist-p2,L-Verbenone,activity,inactive,1196-01-6,92874.0,CC2(C)[C@H]1C[C@@H]2C(=O)C=C1C
NCGC00025167-01,tox21-er-bla-agonist-p2,Formoterol hemifumarate dihydrate,activity,inactive,183814-30-4,60196271.0,O.O.Oc1ccc(cc1NC=O)[C@H](O)CN[C@@H](C)Cc2ccc(OC)cc2.O=C(O)/C=C/C(=O)O.COc1ccc(cc1)C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2
NCGC00164590-01,tox21-er-bla-agonist-p2,Drospirenone,activity,inactive,67392-87-4,68873.0,O=C1CC[C@]6(O1)[C@H]2C[C@H]2[C@H]5[C@@H]7[C@H]3C[C@H]3C4=CC(=O)CC[C@]4(C)[C@H]7CC[C@@]56C
NCGC00254824-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, 3-[(ethylphenylamino)methyl]-",activity,inactive,101-11-1,66858.0,OS(=O)(=O)c2cc(CN(CC)c1ccccc1)ccc2
NCGC00259813-01,tox21-er-bla-agonist-p2,Promethazine hydrochloride,activity,inactive,58-33-3,6014.0,Cl.CN(C)C(C)CN1c3ccccc3Sc2ccccc12
NCGC00015859-07,tox21-er-bla-agonist-p2,Procainamide,activity,inactive,51-06-9,4913.0,O=C(NCCN(CC)CC)c1ccc(N)cc1
NCGC00160675-01,tox21-er-bla-agonist-p2,Carminomycin,activity,active agonist,50935-04-1,443831.0,CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(O)cccc2C(=O)c3c(O)c5C4
NCGC00181036-01,tox21-er-bla-agonist-p2,Fenipentol,activity,inactive,583-03-9,3338.0,OC(CCCC)c1ccccc1
NCGC00183832-01,tox21-er-bla-agonist-p2,Ro 22-9194,activity,inactive,106134-33-2,129209.0,Cl.Cl.CC(N)C(=O)N(CCCc1cccnc1)c2c(C)cccc2C
NCGC00253935-01,tox21-er-bla-agonist-p2,N-Methyl-2-pyrrolidone,activity,inactive,872-50-4,13387.0,O=C1CCCN1C
NCGC00254342-01,tox21-er-bla-agonist-p2,3-Hydroxyfluorene,activity,active agonist,6344-67-8,96088.0,Oc1cc2c3ccccc3Cc2cc1
NCGC00016936-01,tox21-er-bla-agonist-p2,Aztreonam,activity,inactive,78110-38-0,54117.0,Nc1nc(cs1)/C(=N\OC(C)(C)C(=O)O)C(=O)N[C@@H]2C(=O)N([C@H]2C)S(=O)(=O)O
NCGC00090921-01,tox21-er-bla-agonist-p2,Polybrene,activity,inactive,28728-55-4,24769.0,CN(C)CCCCCCN(C)C.BrCCCBr
NCGC00017062-01,tox21-er-bla-agonist-p2,Meclofenamate sodium,activity,inactive,6385-02-0,23663959.0,[Na+].O.Clc2ccc(C)c(Cl)c2Nc1ccccc1C([O-])=O
NCGC00024503-01,tox21-er-bla-agonist-p2,Glycine,activity,inactive,56-40-6,750.0,NCC(=O)O
NCGC00024777-02,tox21-er-bla-agonist-p2,SNC 80,activity,inactive,156727-74-1,123924.0,CCN(CC)C(=O)c1ccc(cc1)[C@H](c2cc(OC)ccc2)N3C[C@@H](C)N(C[C@@H]3C)CC=C
NCGC00258624-01,tox21-er-bla-agonist-p2,Propanal,activity,inactive,123-38-6,527.0,CCC=O
NCGC00257274-01,tox21-er-bla-agonist-p2,Potassium nitrate,activity,inactive,7757-79-1,24434.0,[K+].[O-][N+]([O-])=O
NCGC00257346-01,tox21-er-bla-agonist-p2,Allyl isovalerate,activity,inactive,2835-39-4,17816.0,CC(C)CC(=O)OCC=C
NCGC00257435-01,tox21-er-bla-agonist-p2,4-Toluenesulfonamide,activity,inactive,70-55-3,6269.0,Cc1ccc(cc1)S(=O)(N)=O
NCGC00257719-01,tox21-er-bla-agonist-p2,"2,2,6,6-Tetramethyl- 4-piperidinol",activity,inactive,2403-88-5,75471.0,OC1CC(C)(C)NC(C)(C)C1
NCGC00257912-01,tox21-er-bla-agonist-p2,"2,2-Dimethylbutane",activity,inactive,75-83-2,6403.0,CC(C)(C)CC
NCGC00258105-01,tox21-er-bla-agonist-p2,Pentylparaben,activity,active agonist,6521-29-5,23019.0,Oc1ccc(cc1)C(=O)OCCCCC
NCGC00258177-01,tox21-er-bla-agonist-p2,Carisoprodol,activity,inactive,78-44-4,2576.0,O=C(NC(C)C)OCC(C)(COC(=O)N)CCC
NCGC00258243-01,tox21-er-bla-agonist-p2,Testosterone,activity,active agonist,58-22-0,6013.0,O=C4CC[C@@]3(C)C(CC[C@@H]1[C@@H]3CC[C@]2(C)[C@@H](O)CC[C@@H]12)=C4
NCGC00258302-01,tox21-er-bla-agonist-p2,"2,5,8,11-Tetraoxatridecan-13-ol",activity,inactive,23783-42-8,90263.0,COCCOCCOCCOCCO
NCGC00258331-01,tox21-er-bla-agonist-p2,Hexane,activity,inactive,110-54-3,8058.0,CCCCCC
NCGC00256746-01,tox21-er-bla-agonist-p2,3-Ethyl-2-methylpyrazine,activity,inactive,15707-23-0,27457.0,Cc1nccnc1CC
NCGC00256753-01,tox21-er-bla-agonist-p2,Linalyl isobutyrate,activity,inactive,78-35-3,6532.0,O=C(OC(C)(CC\C=C(\C)C)C=C)C(C)C
NCGC00255754-01,tox21-er-bla-agonist-p2,5-Methylhexanoic acid,activity,inactive,628-46-6,12344.0,CC(C)CCCC(=O)O
NCGC00256489-01,tox21-er-bla-agonist-p2,Cyclohexanone,activity,inactive,108-94-1,7967.0,O=C1CCCCC1
NCGC00256539-01,tox21-er-bla-agonist-p2,Corticosterone,activity,inactive,50-22-6,5753.0,OCC(=O)[C@H]4CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00255825-01,tox21-er-bla-agonist-p2,4-Dodecylmorpholine,activity,inactive,1541-81-7,73764.0,CCCCCCCCCCCCN1CCOCC1
NCGC00255929-01,tox21-er-bla-agonist-p2,Kadethrin,activity,inactive,58769-20-3,16722125.0,O=C(OCc2cc(Cc1ccccc1)oc2)[C@H]4[C@@H](\C=C3/CCSC3=O)C4(C)C
NCGC00255998-01,tox21-er-bla-agonist-p2,"2-Butyl-1H-isoindole-1,3(2H)-dione",activity,inactive,1515-72-6,73812.0,O=C2c1ccccc1C(=O)N2CCCC
NCGC00256108-01,tox21-er-bla-agonist-p2,Sodium O-ethyl carbonodithioate,activity,inactive,140-90-9,23690437.0,[Na+].[S-]C(=S)OCC
NCGC00256193-01,tox21-er-bla-agonist-p2,Methyl 2-chlorobenzoate,activity,inactive,610-96-8,11895.0,Clc1ccccc1C(=O)OC
NCGC00256197-01,tox21-er-bla-agonist-p2,"1,3,5-Tribromo-2-(prop-2-en-1-yloxy)benzene",activity,inactive,3278-89-5,76767.0,Brc1cc(Br)cc(Br)c1OCC=C
NCGC00256265-01,tox21-er-bla-agonist-p2,"1,3,5-Tribromo-2-methoxy-4-methylbenzene",activity,inactive,41424-36-6,5067511.0,COc1c(Br)c(C)c(Br)cc1Br
NCGC00256272-01,tox21-er-bla-agonist-p2,"2,2',2''-[Methanetriyltris(benzene-4,1-diyloxymethanediyl)]trioxirane",activity,inactive,66072-38-6,4320947.0,c2cc(OCC1CO1)ccc2C(c4ccc(OCC3CO3)cc4)c6ccc(OCC5CO5)cc6
NCGC00256341-01,tox21-er-bla-agonist-p2,"3,4-Dichloroaniline",activity,inactive,95-76-1,7257.0,Nc1cc(Cl)c(Cl)cc1
NCGC00258793-01,tox21-er-bla-agonist-p2,4-Nonylphenol,activity,inactive,104-40-5,1752.0,Oc1ccc(CCCCCCCCC)cc1
NCGC00259052-01,tox21-er-bla-agonist-p2,"1,2,3-Benzotriazole",activity,inactive,95-14-7,7220.0,c1cccc2nnnc12
NCGC00259055-01,tox21-er-bla-agonist-p2,Imidazole,activity,inactive,288-32-4,795.0,c1cncn1
NCGC00259213-01,tox21-er-bla-agonist-p2,Propham,activity,inactive,122-42-9,24685.0,CC(C)OC(=O)Nc1ccccc1
NCGC00259594-01,tox21-er-bla-agonist-p2,Dibenzo-p-dioxin,activity,inactive,262-12-4,9216.0,c1ccc2Oc3ccccc3Oc2c1
NCGC00259794-01,tox21-er-bla-agonist-p2,"1,4-Butanediol",activity,inactive,110-63-4,8064.0,OCCCCO
NCGC00260023-01,tox21-er-bla-agonist-p2,2-Methyl-1-nitroanthraquinone,activity,inactive,129-15-7,31426.0,[O-][N+](=O)c3c(C)ccc2C(=O)c1ccccc1C(=O)c23
NCGC00260058-01,tox21-er-bla-agonist-p2,Diundecyl phthalate,activity,inactive,3648-20-2,19283.0,O=C(OCCCCCCCCCCC)c1ccccc1C(=O)OCCCCCCCCCCC
NCGC00260325-01,tox21-er-bla-agonist-p2,Ammonium citrate (2:1),activity,inactive,3012-65-5,5284342.0,[NH4+].[NH4+].O=C([O-])CC(O)(CC(O)=O)C([O-])=O
NCGC00260345-01,tox21-er-bla-agonist-p2,Lithium sulfate,activity,inactive,10377-48-7,66320.0,[Li+].[Li+].[O-]S([O-])(=O)=O
NCGC00260357-01,tox21-er-bla-agonist-p2,"Cyanamide,cyano-,sodium salt",activity,inactive,1934-75-4,4350929.0,[Na+].N#C[N-]C#N
NCGC00258680-01,tox21-er-bla-agonist-p2,Phenyl isothiocyanate,activity,inactive,103-72-0,7673.0,S=C=N/c1ccccc1
NCGC00254726-01,tox21-er-bla-agonist-p2,Thiazopyr,activity,inactive,117718-60-2,91776.0,CC(C)Cc1c(c(nc(C(F)F)c1C(=O)OC)C(F)(F)F)C2=NCCS2
NCGC00256355-01,tox21-er-bla-agonist-p2,Cyanoguanidine,activity,inactive,461-58-5,10005.0,N=C(N)NC#N
NCGC00254972-01,tox21-er-bla-agonist-p2,Deethylatrazine,activity,inactive,6190-65-4,22563.0,Nc1nc(NC(C)C)nc(Cl)n1
NCGC00255150-01,tox21-er-bla-agonist-p2,Aminocarb,activity,inactive,2032-59-9,16247.0,O=C(Oc1cc(C)c(cc1)N(C)C)NC
NCGC00255174-01,tox21-er-bla-agonist-p2,"Thiocyanic acid, ammonium salt",activity,inactive,1762-95-4,15666.0,[NH4+].[S-]C#N
NCGC00255840-01,tox21-er-bla-agonist-p2,Glyceryl monooctanoate,activity,inactive,26402-26-6,3033877.0,OCC(O)COC(=O)CCCCCCC
NCGC00256004-01,tox21-er-bla-agonist-p2,"2,2,6,6-Tetramethylpiperidin-4-amine",activity,inactive,36768-62-4,37524.0,NC1CC(C)(C)NC(C)(C)C1
NCGC00256178-01,tox21-er-bla-agonist-p2,3-{[3-(Dimethylamino)propyl]amino}propanenitrile,activity,inactive,69852-45-5,112322.0,CN(C)CCCNCCC#N
NCGC00256198-01,tox21-er-bla-agonist-p2,"2,2-Bis{[(3-sulfanylpropanoyl)oxy]methyl}butyl 3-sulfanylpropanoate",activity,inactive,33007-83-9,118379.0,SCCC(=O)OCC(COC(=O)CCS)(COC(=O)CCS)CC
NCGC00254542-01,tox21-er-bla-agonist-p2,Dodecylbenzene sulfonate triethanolamine (1:1),activity,inactive,27323-41-7,24180686.0,OS(=O)(=O)c1ccc(cc1)C(CC)CCCCCCCCC.OCCN(CCO)CCO
NCGC00254578-01,tox21-er-bla-agonist-p2,Triallylamine,activity,inactive,102-70-5,7617.0,C=CCN(CC=C)CC=C
NCGC00094393-02,tox21-er-bla-agonist-p2,Trihexyphenidyl hydrochloride,activity,inactive,52-49-3,66007.0,Cl.OC(CCN1CCCCC1)(c2ccccc2)C3CCCCC3
NCGC00094400-01,tox21-er-bla-agonist-p2,Trepipam maleate,activity,inactive,39624-66-3,6434250.0,O=C(O)/C=C\C(=O)O.COc1cc2CCN(C)C[C@@H](c2cc1OC)c3ccccc3
NCGC00163597-02,tox21-er-bla-agonist-p2,Myriocin,activity,inactive,35891-70-4,6438394.0,O[C@@H]([C@H](O)C\C=C\CCCCCCC(=O)CCCCCC)[C@@](N)(CO)C(=O)O
NCGC00094574-06,tox21-er-bla-agonist-p2,Fipronil,activity,inactive,120068-37-3,3352.0,FC(F)(F)S(=O)c1c(N)n(nc1C#N)c2c(Cl)cc(cc2Cl)C(F)(F)F
NCGC00094655-01,tox21-er-bla-agonist-p2,Dihydrostreptomycin sulfate,activity,inactive,5490-27-7,21653.0,OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)CO.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)CO
NCGC00159524-01,tox21-er-bla-agonist-p2,Thiopental sodium,activity,inactive,71-73-8,23665410.0,[Na+].O=C1NC([S-])=NC(=O)C1(CC)C(C)CCC
NCGC00095118-01,tox21-er-bla-agonist-p2,Rofecoxib,activity,inactive,162011-90-7,5090.0,CS(=O)(=O)c1ccc(cc1)C=2COC(=O)C=2c3ccccc3
NCGC00160452-01,tox21-er-bla-agonist-p2,Clopirac,activity,inactive,42779-82-8,39299.0,O=C(O)Cc2cc(C)n(c1ccc(Cl)cc1)c2C
NCGC00164572-01,tox21-er-bla-agonist-p2,Rimonabant,activity,inactive,168273-06-1,104850.0,O=C(NN1CCCCC1)c4nn(c2ccc(Cl)cc2Cl)c(c3ccc(Cl)cc3)c4C
NCGC00160541-01,tox21-er-bla-agonist-p2,Romazarit,activity,inactive,109543-76-2,71321.0,O=C(O)C(C)(C)OCc1oc(nc1C)c2ccc(Cl)cc2
NCGC00181049-01,tox21-er-bla-agonist-p2,Sodium urate,activity,inactive,1198-77-2,23697816.0,[Na+].O=C1NC(=O)NC=2[N-]C(=O)NC1=2
NCGC00095716-01,tox21-er-bla-agonist-p2,beta-Sitosterol,activity,inactive,83-46-5,222284.0,CC(C)[C@H](CC)CC[C@@H](C)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00167526-01,tox21-er-bla-agonist-p2,Camostat mesylate,activity,inactive,59721-29-8,5284360.0,O=C(Oc1ccc(cc1)CC(=O)OCC(=O)N(C)C)c2ccc(NC(=N)N)cc2.CS(=O)(=O)O
NCGC00166122-01,tox21-er-bla-agonist-p2,Perflexane,activity,inactive,355-42-0,9639.0,FC(F)(C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00167568-01,tox21-er-bla-agonist-p2,Colfosceril palmitate,activity,inactive,63-89-8,452110.0,C[N+](C)(C)CCOP([O-])(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
NCGC00159363-02,tox21-er-bla-agonist-p2,Ethisterone,activity,active agonist,434-03-7,5284557.0,O=C4CC[C@@]3(C)C(CC[C@@H]2[C@@H]3CC[C@@]1(C)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00091351-03,tox21-er-bla-agonist-p2,"1,3-Dinitrobenzene",activity,inactive,99-65-0,7452.0,O=[N+]([O-])c1cccc(c1)[N+]([O-])=O
NCGC00184993-02,tox21-er-bla-agonist-p2,Amfenac sodium,activity,inactive,61941-56-8,23665728.0,[Na+].Nc1c(cccc1CC([O-])=O)C(=O)c2ccccc2
NCGC00185773-02,tox21-er-bla-agonist-p2,Clindamycin palmitate hydrochloride,activity,inactive,25507-04-4,16052038.0,Cl.CS[C@H]1O[C@@H]([C@H](O)[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC)[C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl
NCGC00255040-01,tox21-er-bla-agonist-p2,2-Chloro-4-nitrobenzamide,activity,inactive,3011-89-0,2075.0,O=C(N)c1ccc(cc1Cl)[N+]([O-])=O
NCGC00255044-01,tox21-er-bla-agonist-p2,Butafenacil,activity,inactive,134605-64-4,11826859.0,O=C(OCC=C)C(C)(C)OC(=O)c1cc(ccc1Cl)N2C(=O)C=C(N(C)C2=O)C(F)(F)F
NCGC00188435-01,tox21-er-bla-agonist-p2,2-Hydroxyethyl octadecanoate,activity,inactive,111-60-4,24762.0,O=C(CCCCCCCCCCCCCCCCC)OCCO
NCGC00247726-01,tox21-er-bla-agonist-p2,"N,N-Dimethyltryptamine fumarate",activity,inactive,68677-26-9,60196335.0,O=C(O)/C=C/C(=O)O.CN(C)CCc2cnc1ccccc12
NCGC00254344-01,tox21-er-bla-agonist-p2,Sodium 4-nitrophenolate,activity,inactive,824-78-2,13214.0,[Na+].O=[N+]([O-])c1ccc([O-])cc1
NCGC00253963-01,tox21-er-bla-agonist-p2,Bis(2-methoxyethyl) ether,activity,inactive,111-96-6,8150.0,COCCOCCOC
NCGC00254437-01,tox21-er-bla-agonist-p2,Decanoic acid,activity,inactive,334-48-5,2969.0,O=C(O)CCCCCCCCC
NCGC00255088-01,tox21-er-bla-agonist-p2,Diphenylsulfone,activity,inactive,127-63-9,31386.0,O=S(=O)(c1ccccc1)c2ccccc2
NCGC00254075-01,tox21-er-bla-agonist-p2,Indomethacin,activity,inactive,53-86-1,3715.0,Clc1ccc(cc1)C(=O)n3c2ccc(cc2c(CC(=O)O)c3C)OC
NCGC00182980-01,tox21-er-bla-agonist-p2,Fominoben hydrochloride,activity,inactive,24600-36-0,3015003.0,Cl.O=C(CN(C)Cc2c(NC(=O)c1ccccc1)cccc2Cl)N3CCOCC3
NCGC00259928-01,tox21-er-bla-agonist-p2,6-Methylquinoline,activity,inactive,91-62-3,7059.0,Cc1ccc2ncccc2c1
NCGC00260011-01,tox21-er-bla-agonist-p2,N-Vinyl-2-pyrrolidone,activity,inactive,88-12-0,6917.0,O=C1CCCN1C=C
NCGC00256576-01,tox21-er-bla-agonist-p2,Propham,activity,inactive,122-42-9,24685.0,CC(C)OC(=O)Nc1ccccc1
NCGC00257919-01,tox21-er-bla-agonist-p2,2-Nitropropane,activity,inactive,79-46-9,398.0,CC(C)[N+]([O-])=O
NCGC00260113-01,tox21-er-bla-agonist-p2,"Ethanaminium, N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, chloride",activity,inactive,5039-78-1,78738.0,[Cl-].C[N+](C)(C)CCOC(=O)C(=C)C
NCGC00167817-01,tox21-er-bla-agonist-p2,Bucindolol,activity,inactive,71119-11-4,51045.0,N#Cc3ccccc3OCC(O)CNC(C)(C)Cc2cnc1ccccc12
NCGC00257013-01,tox21-er-bla-agonist-p2,"1,3-Dimethyl-4-nitrobenzene",activity,inactive,89-87-2,6991.0,Cc1cc(C)ccc1[N+](=O)[O-]
NCGC00257008-01,tox21-er-bla-agonist-p2,Dicyclohexyl phthalate,activity,inactive,84-61-7,6777.0,O=C(OC1CCCCC1)c3ccccc3C(=O)OC2CCCCC2
NCGC00257221-01,tox21-er-bla-agonist-p2,Acetyl tributyl citrate,activity,inactive,77-90-7,6505.0,CCCCOC(=O)CC(CC(=O)OCCCC)(OC(C)=O)C(=O)OCCCC
NCGC00257590-01,tox21-er-bla-agonist-p2,Hexylamine,activity,inactive,111-26-2,8102.0,CCCCCCN
NCGC00259873-01,tox21-er-bla-agonist-p2,"(1,1,3,3-Tetramethylbutyl)phenol",activity,active agonist,27193-28-8,62530.0,Oc1ccccc1C(C)(C)CC(C)(C)C
NCGC00257821-01,tox21-er-bla-agonist-p2,N-Nitrosopiperidine,activity,inactive,100-75-4,7526.0,O=NN1CCCCC1
NCGC00257411-01,tox21-er-bla-agonist-p2,Fadrozole hydrochloride,activity,inactive,102676-31-3,59694.0,Cl.N#Cc1ccc(cc1)C3CCCc2cncn23
NCGC00015155-03,tox21-er-bla-agonist-p2,Bepridil,activity,inactive,64706-54-3,2351.0,CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3
NCGC00258657-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium hydrogensulfate,activity,inactive,262297-13-2,11424880.0,CCCCn1cc[n+](C)c1.[O-]S(=O)(=O)O
NCGC00257524-01,tox21-er-bla-agonist-p2,4-Biphenylamine hydrochloride,activity,inactive,2113-61-3,5284341.0,Cl.Nc1ccc(cc1)c2ccccc2
NCGC00254045-01,tox21-er-bla-agonist-p2,Cumene hydroperoxide,activity,inactive,80-15-9,6629.0,OOC(C)(C)c1ccccc1
NCGC00254350-01,tox21-er-bla-agonist-p2,Candoxatril,activity,inactive,123122-55-4,5362417.0,O=C(N[C@@H]1CC[C@@H](CC1)C(=O)O)C4(C[C@@H](COCCOC)C(=O)Oc2cc3CCCc3cc2)CCCC4
NCGC00255489-01,tox21-er-bla-agonist-p2,Flurenol-methyl,activity,inactive,1216-44-0,267210.0,O=C(OC)C3(O)c1ccccc1c2ccccc23
NCGC00256527-01,tox21-er-bla-agonist-p2,Phenazone,activity,inactive,60-80-0,2206.0,O=C2C=C(C)N(C)N2c1ccccc1
NCGC00256775-01,tox21-er-bla-agonist-p2,cis-Nerolidol,activity,inactive,3790-78-1,5320128.0,C/C(C)=C\CCC(/C)=C\CCC(C)(O)C=C
NCGC00256227-01,tox21-er-bla-agonist-p2,Tetrahydrofurfuryl acrylate,activity,inactive,2399-48-6,94232.0,O=C(OCC1CCCO1)C=C
NCGC00256832-01,tox21-er-bla-agonist-p2,"2-(2-Butyl)-4,5-dimethyl-3-thiazoline",activity,inactive,65894-82-8,5362564.0,CC1=NC(SC1C)C(C)CC
NCGC00255884-01,tox21-er-bla-agonist-p2,"Methyl 3,5-dichlorobenzoate",activity,inactive,2905-67-1,76192.0,Clc1cc(cc(Cl)c1)C(=O)OC
NCGC00257665-01,tox21-er-bla-agonist-p2,(9Z)-Octadec-9-en-1-ol,activity,inactive,143-28-2,5284499.0,CCCCCCCC\C=C/CCCCCCCCO
NCGC00257857-01,tox21-er-bla-agonist-p2,Neohesperidin dihydrochalcone,activity,inactive,20702-77-6,30231.0,COc1ccc(cc1O)CCC(=O)c2c(O)cc(cc2O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O
NCGC00257697-01,tox21-er-bla-agonist-p2,Benzenesulfonyl chloride,activity,inactive,98-09-9,7369.0,O=S(=O)(Cl)c1ccccc1
NCGC00257311-01,tox21-er-bla-agonist-p2,Ethyl 4-chlorophenyl ketone,activity,inactive,6285-05-8,22697.0,O=C(CC)c1ccc(Cl)cc1
NCGC00257321-01,tox21-er-bla-agonist-p2,Sodium 6-hydroxynaphthalene-2-sulfonate,activity,inactive,135-76-2,23667648.0,[Na+].[O-]S(=O)(=O)c1ccc2cc(O)ccc2c1
NCGC00257999-01,tox21-er-bla-agonist-p2,2-Oxepanone,activity,inactive,502-44-3,10401.0,O=C1CCCCCO1
NCGC00257564-01,tox21-er-bla-agonist-p2,Menthol,activity,inactive,1490-04-6,1254.0,CC(C)C1CCC(C)CC1O
NCGC00256976-01,tox21-er-bla-agonist-p2,2-Methyl-1-butanol,activity,inactive,137-32-6,8723.0,CC(CC)CO
NCGC00257028-01,tox21-er-bla-agonist-p2,"N,N,N',N',N'',N''-Hexakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine",activity,inactive,3089-11-0,62479.0,COCN(COC)c1nc(nc(n1)N(COC)COC)N(COC)COC
NCGC00258222-01,tox21-er-bla-agonist-p2,Diglycidyl resorcinol ether,activity,inactive,101-90-6,7586.0,c1ccc(cc1OCC2CO2)OCC3CO3
NCGC00258088-01,tox21-er-bla-agonist-p2,Propanedioic acid,activity,inactive,141-82-2,867.0,O=C(O)CC(=O)O
NCGC00258233-01,tox21-er-bla-agonist-p2,1-Isocyanato-3-(trifluoromethyl)benzene,activity,inactive,329-01-1,9483.0,O=C=N/c1cc(ccc1)C(F)(F)F
NCGC00258244-01,tox21-er-bla-agonist-p2,Valeryl chloride,activity,inactive,638-29-9,61186.0,CCCCC(Cl)=O
NCGC00258937-01,tox21-er-bla-agonist-p2,Amiloride hydrochloride,activity,inactive,2016-88-8,16230.0,Cl.Clc1nc(C(=O)NC(=N)N)c(N)nc1N
NCGC00258347-01,tox21-er-bla-agonist-p2,4-Aminopyridine,activity,inactive,504-24-5,1727.0,Nc1ccncc1
NCGC00258549-01,tox21-er-bla-agonist-p2,Sodium 2-(methylamino)ethanesulfonate,activity,inactive,4316-74-9,23684896.0,[Na+].[O-]S(=O)(=O)CCNC
NCGC00258577-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium dicyanamide,activity,inactive,370865-89-7,11159638.0,C[n+]1ccn(CC)c1.N#C\N=C=[N-]
NCGC00258777-01,tox21-er-bla-agonist-p2,S-Ethyl chlorothioformic acid,activity,inactive,2941-64-2,18056.0,ClC(=O)SCC
NCGC00258422-01,tox21-er-bla-agonist-p2,alpha-Thujone,activity,inactive,546-80-5,261491.0,C[C@H]1C(=O)C[C@@]2(C[C@H]12)C(C)C
NCGC00258966-01,tox21-er-bla-agonist-p2,Octanal,activity,inactive,124-13-0,454.0,CCCCCCCC=O
NCGC00258463-01,tox21-er-bla-agonist-p2,"2,3-Dichlorophenol",activity,inactive,576-24-9,11334.0,Oc1cccc(Cl)c1Cl
NCGC00258471-01,tox21-er-bla-agonist-p2,2-Nitrosotoluene,activity,inactive,611-23-4,11909.0,Cc1ccccc1N=O
NCGC00259886-01,tox21-er-bla-agonist-p2,Auramine hydrochloride,activity,inactive,2465-27-2,17170.0,Cl.CN(C)c1ccc(cc1)C(=N)c2ccc(cc2)N(C)C
NCGC00259893-01,tox21-er-bla-agonist-p2,Tris(2-methoxyethoxy)vinylsilane,activity,inactive,1067-53-4,14025.0,COCCO[Si](OCCOC)(C=C)OCCOC
NCGC00260256-01,tox21-er-bla-agonist-p2,1-Methyl-1-propylpyrrolidinium chloride,activity,inactive,528818-82-8,60196394.0,[Cl-].C[N+]1(CCC)CCCC1
NCGC00260668-01,tox21-er-bla-agonist-p2,5-(Hydroxymethyl-2-furoyl)glycine,activity,inactive,38716-68-6,6537488.0,O=C(NCC(=O)O)c1ccc(CO)o1
NCGC00260235-01,tox21-er-bla-agonist-p2,1-Butyl-4-methylpyridinium hexafluorophosphate,activity,inactive,401788-99-6,11254899.0,Cc1cc[n+](CCCC)cc1.F[P-](F)(F)(F)(F)F
NCGC00260238-01,tox21-er-bla-agonist-p2,1-Butyl-4-methylpyridinium tetrafluoroborate,activity,inactive,343952-33-0,11492406.0,Cc1cc[n+](CCCC)cc1.F[B-](F)(F)F
NCGC00013015-01,tox21-er-bla-agonist-p2,"D-Gluconic acid, barium salt",activity,inactive,5328-41-6,89753.0,[Ba+2].O[C@H]([C@@H](O)C([O-])=O)[C@H](O)[C@H](O)CO.[O-]C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
NCGC00015801-02,tox21-er-bla-agonist-p2,Pentoxifylline,activity,inactive,6493-05-6,4740.0,CC(=O)CCCCN2C(=O)c1n(C)cnc1N(C)C2=O
NCGC00015074-10,tox21-er-bla-agonist-p2,Acetazolamide,activity,inactive,59-66-5,1986.0,O=S(N)(=O)c1nnc(NC(C)=O)s1
NCGC00016777-01,tox21-er-bla-agonist-p2,Probucol,activity,inactive,23288-49-5,4912.0,CC(C)(C)c2cc(SC(C)(C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)cc(c2O)C(C)(C)C
NCGC00016646-02,tox21-er-bla-agonist-p2,Bromopride,activity,inactive,4093-35-0,2446.0,Nc1cc(OC)c(cc1Br)C(=O)NCCN(CC)CC
NCGC00016845-01,tox21-er-bla-agonist-p2,Talampicillin hydrochloride,activity,inactive,39878-70-1,20055558.0,Cl.NC(c1ccccc1)C(=O)N[C@@H]5C(=O)N4[C@@H](C(=O)OC3OC(=O)c2ccccc23)C(C)(C)S[C@@H]45
NCGC00016860-01,tox21-er-bla-agonist-p2,Butirosin disulfate,activity,inactive,51022-98-1,60196265.0,O=S(=O)(O)O.O=S(=O)(O)O.NCC[C@H](O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1N)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H]3O
NCGC00026844-02,tox21-er-bla-agonist-p2,Nixylic acid,activity,inactive,4394-05-2,71827.0,O=C(O)c2cccnc2Nc1cccc(C)c1C
NCGC00254652-01,tox21-er-bla-agonist-p2,MCPA,activity,inactive,94-74-6,7204.0,Clc1cc(C)c(OCC(=O)O)cc1
NCGC00254390-01,tox21-er-bla-agonist-p2,Phenylmercuric acetate,activity,active agonist,62-38-4,16682730.0,CC(=O)O[Hg]c1ccccc1
NCGC00254459-01,tox21-er-bla-agonist-p2,Thymol,activity,inactive,89-83-8,6989.0,CC(C)c1ccc(C)cc1O
NCGC00255427-01,tox21-er-bla-agonist-p2,Diofenolan,activity,inactive,63837-33-2,4578030.0,CCC3OC(COc2ccc(Oc1ccccc1)cc2)CO3
NCGC00091196-01,tox21-er-bla-agonist-p2,"2,4,5-Trichlorophenol",activity,inactive,95-95-4,7271.0,Oc1cc(Cl)c(Cl)cc1Cl
NCGC00167554-01,tox21-er-bla-agonist-p2,C.I. Direct Blue 14,activity,inactive,72-57-1,6364560.0,[Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)c5cc(N)c6c(O)c(/N=N/c1ccc(cc1C)c4ccc(/N=N/c3c(O)c2c(cc(cc2N)S([O-])(=O)=O)cc3S([O-])(=O)=O)c(C)c4)c(cc6c5)S([O-])(=O)=O
NCGC00254818-01,tox21-er-bla-agonist-p2,"2,3,5-Triiodobenzoic acid",activity,inactive,88-82-4,6948.0,Ic1c(cc(I)cc1I)C(=O)O
NCGC00254891-01,tox21-er-bla-agonist-p2,Biurea,activity,inactive,110-21-4,8039.0,NC(=O)NNC(N)=O
NCGC00255057-01,tox21-er-bla-agonist-p2,Betaine,activity,inactive,107-43-7,247.0,C[N+](C)(C)CC([O-])=O
NCGC00259708-01,tox21-er-bla-agonist-p2,"3,4-Dinitrotoluene",activity,inactive,610-39-9,11883.0,O=[N+]([O-])c1cc(C)ccc1[N+]([O-])=O
NCGC00015959-03,tox21-er-bla-agonist-p2,Sanguinarine,activity,active agonist,2447-54-3,5154.0,C[n+]2cc1c6OCOc6ccc1c3ccc4cc5OCOc5cc4c23
NCGC00160564-01,tox21-er-bla-agonist-p2,Diphenan,activity,active agonist,101-71-3,7572.0,O=C(N)Oc1ccc(cc1)Cc2ccccc2
NCGC00166135-01,tox21-er-bla-agonist-p2,Saralasin,activity,inactive,34273-10-4,6324663.0,O=C(N[C@@H](C)C(=O)O)[C@@H]3CCCN3C(=O)[C@H](Cc1cncn1)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(C)C
NCGC00181783-02,tox21-er-bla-agonist-p2,Iguratimod,activity,inactive,123663-49-0,124246.0,CS(=O)(=O)Nc2cc3OC=C(NC=O)C(=O)c3cc2Oc1ccccc1
NCGC00254631-01,tox21-er-bla-agonist-p2,"2,2-Bis(4-chlorophenyl)ethanol",activity,inactive,2642-82-2,17533.0,Clc1ccc(cc1)C(CO)c2ccc(Cl)cc2
NCGC00017128-01,tox21-er-bla-agonist-p2,Cefotaxime sodium,activity,inactive,64485-93-4,23672566.0,[Na+].Nc1scc(n1)/C(=N\OC)C(=O)N[C@@H]3C(=O)N2C(=C(COC(C)=O)CS[C@@H]23)C([O-])=O
NCGC00018221-06,tox21-er-bla-agonist-p2,Cinchophen,activity,inactive,132-60-5,8593.0,O=C(O)c1cc(nc2ccccc12)c3ccccc3
NCGC00024257-04,tox21-er-bla-agonist-p2,Phenylephrine hydrochloride,activity,inactive,61-76-7,5284443.0,Cl.O[C@@H](CNC)c1cc(O)ccc1
NCGC00258567-01,tox21-er-bla-agonist-p2,HC Yellow 4,activity,inactive,59820-43-8,62158.0,[O-][N+](=O)c1cc(OCCO)c(cc1)NCCO
NCGC00257484-01,tox21-er-bla-agonist-p2,Ronidazole,activity,inactive,7681-76-7,5094.0,Cn1c(cnc1COC(N)=O)[N+]([O-])=O
NCGC00257503-01,tox21-er-bla-agonist-p2,Octylparaben,activity,active agonist,1219-38-1,14642.0,Oc1ccc(cc1)C(=O)OCCCCCCCC
NCGC00257894-01,tox21-er-bla-agonist-p2,2-Nitrobenzoyl chloride,activity,inactive,610-14-0,11875.0,O=[N+]([O-])c1ccccc1C(Cl)=O
NCGC00258049-01,tox21-er-bla-agonist-p2,Dicyclopentadiene dioxide,activity,inactive,81-21-0,6673.0,O1C2CC3C(C12)C5CC3C4OC45
NCGC00258266-01,tox21-er-bla-agonist-p2,"1,3-Bis(2-methylphenyl)guanidine",activity,inactive,97-39-2,7333.0,Cc2ccccc2NC(=N)Nc1ccccc1C
NCGC00255733-01,tox21-er-bla-agonist-p2,Isononanamine,activity,inactive,27775-00-4,119716.0,CC(C)CCCCCCN
NCGC00255921-01,tox21-er-bla-agonist-p2,Tripropyl orthoformate,activity,inactive,621-76-1,69311.0,CCCOC(OCCC)OCCC
NCGC00255986-01,tox21-er-bla-agonist-p2,2-Ethoxyphenol,activity,inactive,94-71-3,66755.0,CCOc1ccccc1O
NCGC00256189-01,tox21-er-bla-agonist-p2,Hydrocinnamic acid,activity,inactive,501-52-0,107.0,O=C(O)CCc1ccccc1
NCGC00256354-01,tox21-er-bla-agonist-p2,Phenylhydrazine,activity,inactive,100-63-0,7516.0,NNc1ccccc1
NCGC00255662-01,tox21-er-bla-agonist-p2,"2,4,5-T-2-ethylhexyl",activity,inactive,1928-47-8,15998.0,Clc1cc(OCC(=O)OCC(CC)CCCC)c(Cl)cc1Cl
NCGC00258789-01,tox21-er-bla-agonist-p2,"2,4-D 1-butyl ester",activity,inactive,94-80-4,7206.0,Clc1cc(Cl)ccc1OCC(=O)OCCCC
NCGC00258844-01,tox21-er-bla-agonist-p2,"3,3'-Dimethylbenzidine",activity,active agonist,119-93-7,8413.0,Cc1cc(ccc1N)c2ccc(N)c(C)c2
NCGC00258850-01,tox21-er-bla-agonist-p2,Picloram,activity,inactive,1918-02-1,15965.0,Nc1c(Cl)c(nc(Cl)c1Cl)C(=O)O
NCGC00258940-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(N,N-dimethylaniline)",activity,inactive,101-61-1,7567.0,CN(C)c2ccc(Cc1ccc(cc1)N(C)C)cc2
NCGC00259216-01,tox21-er-bla-agonist-p2,Mecoprop,activity,inactive,93-65-2,7153.0,Clc1cc(C)c(OC(C)C(=O)O)cc1
NCGC00259232-01,tox21-er-bla-agonist-p2,Piperonyl acetate,activity,inactive,326-61-4,9473.0,CC(=O)OCc1ccc2OCOc2c1
NCGC00259327-01,tox21-er-bla-agonist-p2,Decanedioic acid,activity,inactive,111-20-6,5192.0,O=C(O)CCCCCCCCC(=O)O
NCGC00259754-01,tox21-er-bla-agonist-p2,Alachlor,activity,inactive,15972-60-8,2078.0,ClCC(=O)N(COC)c1c(cccc1CC)CC
NCGC00259829-01,tox21-er-bla-agonist-p2,Di(propylene glycol) dibenzoate,activity,inactive,27138-31-4,101560.0,CC(OC(=O)c1ccccc1)COCC(C)OC(=O)c2ccccc2
NCGC00259830-01,tox21-er-bla-agonist-p2,Methacrylamide,activity,inactive,79-39-0,6595.0,C=C(C)C(N)=O
NCGC00259946-01,tox21-er-bla-agonist-p2,Thiabendazole,activity,inactive,148-79-8,5430.0,n1c3ccccc3nc1c2cscn2
NCGC00259971-01,tox21-er-bla-agonist-p2,Acetophenone,activity,inactive,98-86-2,7410.0,CC(=O)c1ccccc1
NCGC00258667-01,tox21-er-bla-agonist-p2,"m,p-Cresol mixture",activity,inactive,NOCAS_24858,2879.0,Cc1ccc(O)cc1
NCGC00254796-01,tox21-er-bla-agonist-p2,Cypermethrin,activity,inactive,52315-07-8,2912.0,Cl/C(Cl)=C/C3C(C(=O)OC(C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00254838-01,tox21-er-bla-agonist-p2,2-(Pyridin-2-yl)ethanol,activity,inactive,103-74-2,7675.0,OCCc1ccccn1
NCGC00255118-01,tox21-er-bla-agonist-p2,Indium(III) phosphide,activity,inactive,22398-80-7,31170.0,[In]#P
NCGC00255193-01,tox21-er-bla-agonist-p2,Estriol,activity,active agonist,50-27-1,5756.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)[C@H](O)C[C@@H]12)c4cc3
NCGC00255506-01,tox21-er-bla-agonist-p2,Bis(ethylxanthogen),activity,inactive,502-55-6,10404.0,CCOC(=S)SSC(=S)OCC
NCGC00255520-01,tox21-er-bla-agonist-p2,L-3-(2'-Piperidyl)pyridine,activity,inactive,494-52-0,205586.0,n1cc(ccc1)[C@@H]2CCCCN2
NCGC00255580-01,tox21-er-bla-agonist-p2,Propamocarb,activity,inactive,24579-73-5,32490.0,O=C(NCCCN(C)C)OCCC
NCGC00255657-01,tox21-er-bla-agonist-p2,"1,4-Dioxane-2,3-diol",activity,inactive,4845-50-5,96170.0,OC1OCCOC1O
NCGC00255869-01,tox21-er-bla-agonist-p2,Pentaerythritol allyl ether,activity,inactive,91648-24-7,73854.0,C=CCOCC(COCC=C)(CO)COCC=C
NCGC00254505-01,tox21-er-bla-agonist-p2,6-Methyl-2-thiouracil,activity,inactive,56-04-2,667493.0,O=C1C=C(C)NC(=S)N1
NCGC00254561-01,tox21-er-bla-agonist-p2,"1H-1,2,4-Triazole-3-carboxylic acid, 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-, ethyl ester",activity,inactive,103112-35-2,3033865.0,ClC(Cl)(Cl)c2nc(nn2c1ccc(Cl)cc1Cl)C(=O)OCC
NCGC00159412-02,tox21-er-bla-agonist-p2,Tromethamine,activity,inactive,77-86-1,6503.0,OCC(N)(CO)CO
NCGC00167422-01,tox21-er-bla-agonist-p2,Enflurane,activity,inactive,13838-16-9,3226.0,FC(Cl)C(F)(F)OC(F)F
NCGC00167462-01,tox21-er-bla-agonist-p2,Acamprosate calcium,activity,inactive,77337-73-6,155434.0,[Ca+2].O=C(C)NCCCS(=O)(=O)[O-].CC(=O)NCCCS([O-])(=O)=O
NCGC00159484-02,tox21-er-bla-agonist-p2,Chloralose,activity,inactive,15879-93-3,7057995.0,OC[C@@H](O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl
NCGC00181021-01,tox21-er-bla-agonist-p2,Bufogenin,activity,inactive,465-39-4,6917974.0,O=C1C=CC(=CO1)[C@H]3C[C@H]2O[C@]24[C@@H]5CC[C@@H]6C[C@@H](O)CC[C@]6(C)[C@H]5CC[C@]34C
NCGC00094806-01,tox21-er-bla-agonist-p2,2-Aminoheptane sulfate,activity,inactive,6411-75-2,44134533.0,NC(C)CCCCC.O=S(=O)(O)O.CC(N)CCCCC
NCGC00159503-02,tox21-er-bla-agonist-p2,Methylprednisolone acetate,activity,inactive,53-36-1,5877.0,CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](C)C1=CC(=O)C=C[C@@]12C
NCGC00160365-01,tox21-er-bla-agonist-p2,DL-Cysteine,activity,inactive,3374-22-9,594.0,O=C(O)C(N)CS
NCGC00167507-01,tox21-er-bla-agonist-p2,Lapatinib,activity,inactive,231277-92-2,208908.0,Fc1cccc(c1)COc2ccc(cc2Cl)Nc3ncnc4ccc(cc34)c5ccc(CNCCS(C)(=O)=O)o5
NCGC00095125-01,tox21-er-bla-agonist-p2,Losartan,activity,inactive,114798-26-4,3961.0,OCc4c(Cl)nc(CCCC)n4Cc1ccc(cc1)c2ccccc2c3nnnn3
NCGC00168258-01,tox21-er-bla-agonist-p2,Triazolam,activity,inactive,28911-01-5,5556.0,Clc4ccccc4C1=NCc3nnc(C)n3c2ccc(Cl)cc12
NCGC00164629-01,tox21-er-bla-agonist-p2,Alibendol,activity,inactive,26750-81-2,71916.0,Oc1c(cc(cc1OC)CC=C)C(=O)NCCO
NCGC00095303-02,tox21-er-bla-agonist-p2,Cloxyquin,activity,inactive,130-16-5,2817.0,Oc1ccc(Cl)c2cccnc12
NCGC00165978-01,tox21-er-bla-agonist-p2,Sodium 4-vinylbenzenesulfonate,activity,inactive,2695-37-6,3571582.0,[Na+].O=S([O-])(=O)c1ccc(C=C)cc1
NCGC00142484-03,tox21-er-bla-agonist-p2,Thymidine,activity,inactive,50-89-5,5789.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00167564-01,tox21-er-bla-agonist-p2,8-Bromotheophylline,activity,inactive,10381-75-6,11808.0,O=C2c1nc(Br)nc1N(C)C(=O)N2C
NCGC00091238-02,tox21-er-bla-agonist-p2,"2,2'-Dithiobisbenzothiazole",activity,inactive,120-78-5,8447.0,c1cccc2sc(nc12)SSc3nc4ccccc4s3
NCGC00091695-01,tox21-er-bla-agonist-p2,Triethylenetetramine,activity,inactive,112-24-3,5565.0,NCCNCCNCCN
NCGC00182709-01,tox21-er-bla-agonist-p2,Landiolol hydrochloride,activity,inactive,144481-98-1,164457.0,Cl.CC3(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N1CCOCC1)cc2)O3
NCGC00182984-01,tox21-er-bla-agonist-p2,Tolindate,activity,inactive,27877-51-6,34051.0,Cc1cc(ccc1)N(C)C(=S)Oc2ccc3CCCc3c2
NCGC00183011-01,tox21-er-bla-agonist-p2,Itasetron,activity,inactive,123258-84-4,6918106.0,CN4[C@@H]1CC[C@H]4C[C@H](C1)NC(=O)N2c3ccccc3NC2=O
NCGC00254576-01,tox21-er-bla-agonist-p2,Oxadiazon,activity,inactive,19666-30-9,29732.0,O=C2OC(=NN2c1cc(OC(C)C)c(Cl)cc1Cl)C(C)(C)C
NCGC00254190-01,tox21-er-bla-agonist-p2,"1-(Hydroxymethyl)-5,5-dimethylhydantoin",activity,inactive,116-25-6,67000.0,CC1(C)C(=O)NC(=O)N1CO
NCGC00253912-01,tox21-er-bla-agonist-p2,Acetaminophen,activity,inactive,103-90-2,1983.0,Oc1ccc(NC(C)=O)cc1
NCGC00253928-01,tox21-er-bla-agonist-p2,Diclofenac sodium,activity,inactive,15307-79-6,5018304.0,[Na+].Clc2cccc(Cl)c2Nc1ccccc1CC([O-])=O
NCGC00253973-01,tox21-er-bla-agonist-p2,Chlorendic acid,activity,inactive,115-28-6,8266.0,ClC2(Cl)C1(Cl)C(Cl)=C(Cl)C2(Cl)C(C1C(=O)O)C(=O)O
NCGC00253976-01,tox21-er-bla-agonist-p2,"4,4'-Methylenebis(N,N-dimethylaniline)",activity,inactive,101-61-1,7567.0,CN(C)c2ccc(Cc1ccc(cc1)N(C)C)cc2
NCGC00254823-01,tox21-er-bla-agonist-p2,Resmethrin,activity,inactive,10453-86-8,5053.0,O=C(OCc2cc(Cc1ccccc1)oc2)C3C(/C=C(\C)C)C3(C)C
NCGC00254908-01,tox21-er-bla-agonist-p2,"Sulfuric acid, monononyl ester, sodium salt",activity,inactive,1072-15-7,23677967.0,[Na+].[O-]S(=O)(=O)OCCCCCCCCC
NCGC00183037-01,tox21-er-bla-agonist-p2,Dextrorphan tartrate,activity,inactive,143-98-6,5484438.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.Oc3ccc4C[C@@H]1N(C)CC[C@]2(CCCC[C@H]12)c4c3
NCGC00181765-01,tox21-er-bla-agonist-p2,Pranlukast,activity,inactive,103177-37-3,4887.0,O=C(Nc3cccc1c3OC(=CC1=O)c2nnnn2)c5ccc(OCCCCc4ccccc4)cc5
NCGC00181767-01,tox21-er-bla-agonist-p2,Tolcapone,activity,inactive,134308-13-7,4659569.0,Oc1cc(cc([N+]([O-])=O)c1O)C(=O)c2ccc(C)cc2
NCGC00016433-01,tox21-er-bla-agonist-p2,Isoflupredone acetate,activity,inactive,338-98-7,224246.0,CC(=O)OCC(=O)[C@@]4(O)CC[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00259500-01,tox21-er-bla-agonist-p2,Bentazone,activity,inactive,25057-89-0,2328.0,CC(C)N1C(=O)c2ccccc2NS1(=O)=O
NCGC00259689-01,tox21-er-bla-agonist-p2,Fluorene,activity,inactive,86-73-7,6853.0,c1cccc2Cc3ccccc3c12
NCGC00260146-01,tox21-er-bla-agonist-p2,"3,3',4,4'-Tetraaminobiphenyl tetrahydrochloride",activity,inactive,7411-49-6,23892.0,Cl.Cl.Cl.Cl.Nc1ccc(cc1N)c2ccc(N)c(N)c2
NCGC00159328-02,tox21-er-bla-agonist-p2,Estradiol dipropionate,activity,active agonist,113-38-2,8225.0,CCC(=O)Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CC)c4cc3
NCGC00258610-01,tox21-er-bla-agonist-p2,"4-H-Cyclopenta(d,e,f)phenanthrene",activity,inactive,203-64-5,9147.0,c1cc2cccc3Cc4cccc1c4c23
NCGC00258678-01,tox21-er-bla-agonist-p2,N-Methyl-N'-nitro-N-nitrosoguanidine,activity,inactive,70-25-7,9562060.0,N=C(N[N+](=O)[O-])N(C)N=O
NCGC00256865-01,tox21-er-bla-agonist-p2,"3,3'-(4-Methylbenzene-1,3-diyl)bis(1,1-dimethylurea)",activity,inactive,17526-94-2,87146.0,O=C(Nc1cc(ccc1C)NC(=O)N(C)C)N(C)C
NCGC00258893-01,tox21-er-bla-agonist-p2,Methimazole,activity,inactive,60-56-0,1349907.0,S=C1NC=CN1C
NCGC00259581-01,tox21-er-bla-agonist-p2,Dimethyl sulfate,activity,inactive,77-78-1,6497.0,O=S(=O)(OC)OC
NCGC00258559-01,tox21-er-bla-agonist-p2,beta-Cyclodextrin,activity,inactive,7585-39-9,444041.0,OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O
NCGC00015344-03,tox21-er-bla-agonist-p2,Doxepin hydrochloride,activity,inactive,1229-29-4,6419921.0,Cl.CN(C)CC\C=C1\c3ccccc3OCc2ccccc12
NCGC00256133-01,tox21-er-bla-agonist-p2,"2,3,4,5-Tetrachloro-6-(trichloromethyl)pyridine",activity,inactive,1134-04-9,70811.0,Clc1c(Cl)c(nc(Cl)c1Cl)C(Cl)(Cl)Cl
NCGC00256290-01,tox21-er-bla-agonist-p2,"1,3-Dioxane-5,5-diyldimethanol",activity,inactive,6228-25-7,80373.0,OCC1(CO)COCOC1
NCGC00257659-01,tox21-er-bla-agonist-p2,"2,3,4,5-Tetrachlorophenol",activity,inactive,4901-51-3,21013.0,Clc1c(O)cc(Cl)c(Cl)c1Cl
NCGC00256755-01,tox21-er-bla-agonist-p2,sodium 4-isopropylbenzenesulfonate,activity,inactive,15763-76-5,23679813.0,[Na+].O=S([O-])(=O)c1ccc(cc1)C(C)C
NCGC00256973-01,tox21-er-bla-agonist-p2,"(E)-1,2-Dichloroethylene",activity,inactive,156-60-5,638186.0,Cl\C=C\Cl
NCGC00256761-01,tox21-er-bla-agonist-p2,"(1E)-1-(4-Chlorophenyl)-4,4-dimethylpent-1-en-3-one",activity,inactive,1577-03-3,5388510.0,Clc1ccc(/C=C/C(=O)C(C)(C)C)cc1
NCGC00256797-01,tox21-er-bla-agonist-p2,"4,4'-Diazene-1,2-diylbis(4-cyanopentanoic acid)",activity,inactive,2638-94-0,92938.0,O=C(O)CCC(C)(/N=N/C(C)(C#N)CCC(=O)O)C#N
NCGC00259187-01,tox21-er-bla-agonist-p2,Phenanthrene,activity,inactive,85-01-8,995.0,c2cc3ccc1ccccc1c3cc2
NCGC00260194-01,tox21-er-bla-agonist-p2,1-Hexadecyl-3-methylimidazolium hexafluorophosphate,activity,inactive,219947-95-2,50878565.0,F[P-](F)(F)(F)(F)F.C[n+]1ccn(CCCCCCCCCCCCCCCC)c1
NCGC00015339-02,tox21-er-bla-agonist-p2,Dequalinium dichloride,activity,inactive,522-51-0,10649.0,[Cl-].[Cl-].Nc4cc(C)[n+](CCCCCCCCCC[n+]2c1ccccc1c(N)cc2C)c3ccccc34
NCGC00256581-01,tox21-er-bla-agonist-p2,Nalidixic acid,activity,inactive,389-08-2,4421.0,O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O
NCGC00183006-01,tox21-er-bla-agonist-p2,"1H-Indole-2-carboxamide, N-[(3R)-1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxopyrrolo[3,2,1-jk][1,4]benzodiazepin-3-yl]-",activity,inactive,167820-10-2,10455790.0,Fc6ccccc6C3=N[C@@H](NC(=O)c1cc2ccccc2n1)C(=O)N5CCc4cccc3c45
NCGC00254117-01,tox21-er-bla-agonist-p2,"1,3-Propane sultone",activity,inactive,1120-71-4,14264.0,O=S1(=O)CCCO1
NCGC00255632-01,tox21-er-bla-agonist-p2,Sodium bromide,activity,inactive,7647-15-6,253881.0,[Na+].[Br-]
NCGC00255434-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarboxylic acid, dihydrazide",activity,inactive,2760-98-7,72700.0,O=C(NN)c1cccc(c1)C(=O)NN
NCGC00256766-01,tox21-er-bla-agonist-p2,Hexyl 2-methylbutanoate,activity,inactive,10032-15-2,24838.0,O=C(OCCCCCC)C(C)CC
NCGC00256642-01,tox21-er-bla-agonist-p2,3-(Octyloxy)propanenitrile,activity,inactive,16728-49-7,85576.0,CCCCCCCCOCCC#N
NCGC00256878-01,tox21-er-bla-agonist-p2,"3,7-Dimethylocta-1,6-dien-3-yl propanoate",activity,inactive,144-39-8,61098.0,O=C(CC)OC(C)(CC\C=C(\C)C)C=C
NCGC00256711-01,tox21-er-bla-agonist-p2,2-Methylhexanoic acid,activity,inactive,4536-23-6,20653.0,CC(CCCC)C(=O)O
NCGC00256716-01,tox21-er-bla-agonist-p2,4-Isopropylcyclohexanol,activity,inactive,4621-04-9,20739.0,CC(C)C1CCC(O)CC1
NCGC00257473-01,tox21-er-bla-agonist-p2,1-Cedr-8-en-9-ylethanone,activity,inactive,32388-55-9,16220111.0,CC(=O)C=1C[C@]23C[C@@H](C=1C)C(C)(C)[C@@H]3CC[C@H]2C
NCGC00257715-01,tox21-er-bla-agonist-p2,Butyl methacrylate,activity,inactive,97-88-1,7354.0,CC(=C)C(=O)OCCCC
NCGC00257318-01,tox21-er-bla-agonist-p2,Phenethyl anthranilate,activity,inactive,133-18-6,8615.0,Nc2ccccc2C(=O)OCCc1ccccc1
NCGC00257027-01,tox21-er-bla-agonist-p2,2-Aminobenzimidazole,activity,inactive,934-32-7,13624.0,Nc1nc2ccccc2n1
NCGC00258904-01,tox21-er-bla-agonist-p2,Trifluralin,activity,inactive,1582-09-8,5569.0,[O-][N+](=O)c1cc(cc([N+]([O-])=O)c1N(CCC)CCC)C(F)(F)F
NCGC00258345-01,tox21-er-bla-agonist-p2,1-Chloro-2-nitrobenzene,activity,inactive,88-73-3,6945.0,O=[N+]([O-])c1ccccc1Cl
NCGC00258768-01,tox21-er-bla-agonist-p2,"Dihydro-3-(tetrapropenyl)- 2,5-furandione",activity,inactive,26544-38-7,22833321.0,O=C1CC(C(/C)=C/C(C)CC(C)CC(C)C)C(=O)O1
NCGC00258769-01,tox21-er-bla-agonist-p2,"2,4-Dichlorobenzaldehyde",activity,inactive,874-42-0,13404.0,O=Cc1ccc(Cl)cc1Cl
NCGC00258572-01,tox21-er-bla-agonist-p2,Hexanamide,activity,inactive,628-02-4,12332.0,CCCCCC(N)=O
NCGC00258802-01,tox21-er-bla-agonist-p2,3-Methoxypropylamine,activity,inactive,5332-73-0,1672.0,NCCCOC
NCGC00258608-01,tox21-er-bla-agonist-p2,L-Cichoric acid,activity,inactive,70831-56-0,5281764.0,Oc2ccc(/C=C/C(=O)O[C@@H](C(=O)O)[C@@H](OC(=O)/C=C/c1ccc(O)c(O)c1)C(=O)O)cc2O
NCGC00259081-01,tox21-er-bla-agonist-p2,Fenpropathrin,activity,inactive,39515-41-8,47326.0,CC3(C)C(C(=O)OC(C#N)c2cccc(Oc1ccccc1)c2)C3(C)C
NCGC00258199-01,tox21-er-bla-agonist-p2,Ethyl acetoacetate,activity,inactive,141-97-9,8868.0,CC(=O)CC(=O)OCC
NCGC00259250-01,tox21-er-bla-agonist-p2,Diethanolamine,activity,inactive,111-42-2,8113.0,OCCNCCO
NCGC00259817-01,tox21-er-bla-agonist-p2,Dimethyl terephthalate,activity,inactive,120-61-6,8441.0,COC(=O)c1ccc(cc1)C(=O)OC
NCGC00259826-01,tox21-er-bla-agonist-p2,Diphenyl oxide,activity,inactive,101-84-8,7583.0,c1ccccc1Oc2ccccc2
NCGC00260112-01,tox21-er-bla-agonist-p2,"1-Propanaminium, 3-chloro-2-hydroxy-N,N,N-trimethyl-, chloride",activity,inactive,3327-22-8,18732.0,[Cl-].C[N+](C)(C)CC(O)CCl
NCGC00260072-01,tox21-er-bla-agonist-p2,Methanol,activity,inactive,67-56-1,887.0,CO
NCGC00260315-01,tox21-er-bla-agonist-p2,Methyl hexadecanoate,activity,inactive,112-39-0,8181.0,O=C(CCCCCCCCCCCCCCC)OC
NCGC00260320-01,tox21-er-bla-agonist-p2,"Benzenamine, 4-(1,1,3,3-tetramethylbutyl)-N-[4-(1,1,3,3-tetramethylbutyl)phenyl]-",activity,inactive,15721-78-5,85069.0,CC(C)(C)CC(C)(C)c1ccc(cc1)Nc2ccc(cc2)C(C)(C)CC(C)(C)C
NCGC00260383-01,tox21-er-bla-agonist-p2,2-Methyl-2-butenal,activity,inactive,497-03-0,5321950.0,C[C@H]=C(C)C=O
NCGC00260661-01,tox21-er-bla-agonist-p2,NTP Mix27 AR2 2-EQP,activity,inactive,NOCAS_49557,,
NCGC00260477-01,tox21-er-bla-agonist-p2,"2-Amino-4,6-dichloropyrimidine",activity,inactive,56-05-3,65522.0,Clc1cc(Cl)nc(N)n1
NCGC00260231-01,tox21-er-bla-agonist-p2,1-Butyl-4-methylpyridinium bromide,activity,inactive,65350-59-6,13487610.0,[Br-].Cc1cc[n+](CCCC)cc1
NCGC00015277-02,tox21-er-bla-agonist-p2,Cinoxacin,activity,inactive,28657-80-9,2762.0,O=C(O)C2=NN(CC)c1cc3OCOc3cc1C2=O
NCGC00014961-02,tox21-er-bla-agonist-p2,Flavopiridol hydrochloride,activity,inactive,131740-09-5,9910986.0,Cl.CN4CC[C@H](c3c(O)cc(O)c1c3OC(=CC1=O)c2ccccc2Cl)[C@H](O)C4
NCGC00015469-05,tox21-er-bla-agonist-p2,Guanfacine hydrochloride,activity,inactive,29520-14-7,71401.0,Cl.Clc1cccc(Cl)c1CC(=O)NC(=N)N
NCGC00016273-01,tox21-er-bla-agonist-p2,Methimazole,activity,inactive,60-56-0,1349907.0,S=C1NC=CN1C
NCGC00016660-01,tox21-er-bla-agonist-p2,Felbinac,activity,inactive,5728-52-9,3332.0,OC(=O)Cc1ccc(cc1)c2ccccc2
NCGC00167493-01,tox21-er-bla-agonist-p2,Manidipine dihydrochloride,activity,inactive,89226-75-5,150762.0,Cl.Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCN3CCN(CC3)C(c4ccccc4)c5ccccc5
NCGC00256015-01,tox21-er-bla-agonist-p2,"2,2'-Sulfanediyldiethanethiol",activity,inactive,3570-55-6,77117.0,SCCSCCS
NCGC00254980-01,tox21-er-bla-agonist-p2,Orphenadrine dihydrogen citrate,activity,inactive,4682-36-4,83823.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C
NCGC00255258-01,tox21-er-bla-agonist-p2,Leucomalachite green,activity,inactive,129-73-7,67215.0,CN(C)c1ccc(cc1)C(c2ccccc2)c3ccc(cc3)N(C)C
NCGC00255471-01,tox21-er-bla-agonist-p2,Demeton-S-methylsulphon,activity,inactive,17040-19-6,28213.0,O=S(=O)(CCSP(=O)(OC)OC)CC
NCGC00016250-01,tox21-er-bla-agonist-p2,Demecarium bromide,activity,inactive,56-94-0,45105092.0,[Br-].[Br-].O=C(Oc1ccccc1[N+](C)(C)C)N(C)CCCCCCCCCCN(C)C(=O)Oc2ccccc2[N+](C)(C)C
NCGC00016348-02,tox21-er-bla-agonist-p2,Ethoxyquin,activity,inactive,91-53-2,3293.0,CCOc1ccc2NC(C)(C)C=C(C)c2c1
NCGC00016657-01,tox21-er-bla-agonist-p2,Cefalonium,activity,inactive,5575-21-3,21743.0,NC(=O)c4cc[n+](CC=2CS[C@@H]3[C@H](NC(=O)Cc1cccs1)C(=O)N3C=2C([O-])=O)cc4
NCGC00016889-01,tox21-er-bla-agonist-p2,Tenoxicam,activity,inactive,59804-37-4,54677971.0,OC=2c1sccc1S(=O)(=O)N(C)C=2C(=O)Nc3ccccn3
NCGC00160579-01,tox21-er-bla-agonist-p2,Mexenone,activity,inactive,1641-17-4,71645.0,O=C(c1ccc(cc1O)OC)c2ccc(C)cc2
NCGC00247697-01,tox21-er-bla-agonist-p2,N-Phenyl-N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propanamide hydrochloride,activity,inactive,79278-88-9,60196324.0,Cl.CCC(=O)N(c1ccccc1)C2CCN(CC2)CCc3cccs3
NCGC00259791-01,tox21-er-bla-agonist-p2,Piperazine,activity,inactive,110-85-0,4837.0,C1CNCCN1
NCGC00260233-01,tox21-er-bla-agonist-p2,1-Butyl-4-methylpyridinium chloride,activity,active agonist,112400-86-9,11074101.0,[Cl-].Cc1cc[n+](CCCC)cc1
NCGC00260332-01,tox21-er-bla-agonist-p2,N-Nitrosopiperazine,activity,inactive,5632-47-3,21845.0,O=NN1CCNCC1
NCGC00260637-01,tox21-er-bla-agonist-p2,NTP Mix113 ER1 10-EQC,activity,active agonist,NOCAS_49533,,
NCGC00095271-01,tox21-er-bla-agonist-p2,Aloin A,activity,inactive,1415-73-2,12305761.0,O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)[C@H]4c2cccc(O)c2C(=O)c3c(O)cc(CO)cc34
NCGC00160418-01,tox21-er-bla-agonist-p2,Pincainide,activity,inactive,83471-41-4,71267.0,Cc2cccc(C)c2NC(=O)CN1CCCCCC1
NCGC00254367-01,tox21-er-bla-agonist-p2,Oxytetracycline hydrochloride,activity,inactive,2058-46-0,54680782.0,Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@@](C)(O)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00016934-01,tox21-er-bla-agonist-p2,Nizatidine,activity,inactive,76963-41-2,4513.0,CN(C)Cc1nc(CSCCNC(=C[N+]([O-])=O)NC)cs1
NCGC00090905-06,tox21-er-bla-agonist-p2,Busulfan,activity,inactive,55-98-1,2478.0,O=S(C)(=O)OCCCCOS(C)(=O)=O
NCGC00017014-01,tox21-er-bla-agonist-p2,Prenylamine lactate,activity,inactive,69-43-2,6604472.0,O=C(O)[C@H](C)O.C[C@@H](Cc1ccccc1)NCCC(c2ccccc2)c3ccccc3
NCGC00256893-01,tox21-er-bla-agonist-p2,2-Heptanol,activity,inactive,543-49-7,10976.0,CC(O)CCCCC
NCGC00258458-01,tox21-er-bla-agonist-p2,4-Octyloxybenzoic acid,activity,inactive,2493-84-7,17231.0,O=C(O)c1ccc(OCCCCCCCC)cc1
NCGC00257039-01,tox21-er-bla-agonist-p2,Bisphenol A diglycidyl ether,activity,inactive,1675-54-3,2286.0,CC(C)(c2ccc(OCC1CO1)cc2)c4ccc(OCC3CO3)cc4
NCGC00257939-01,tox21-er-bla-agonist-p2,3-Chlorobenzotrifluoride,activity,inactive,98-15-7,7374.0,FC(F)(F)c1cc(Cl)ccc1
NCGC00257991-01,tox21-er-bla-agonist-p2,Butyl isocyanate,activity,inactive,111-36-4,8110.0,CCCC\N=C=O
NCGC00258193-01,tox21-er-bla-agonist-p2,Fumaryl chloride,activity,inactive,627-63-4,5325504.0,ClC(=O)/C=C/C(Cl)=O
NCGC00258214-01,tox21-er-bla-agonist-p2,Tetramethylammonium chloride,activity,inactive,75-57-0,6379.0,[Cl-].C[N+](C)(C)C
NCGC00255759-01,tox21-er-bla-agonist-p2,Tetraiodoethene,activity,inactive,513-92-8,10568.0,I/C(I)=C(/I)I
NCGC00255774-01,tox21-er-bla-agonist-p2,Tromethamine hydrochloride,activity,inactive,1185-53-1,93573.0,Cl.OCC(N)(CO)CO
NCGC00255808-01,tox21-er-bla-agonist-p2,Methyl 3-sulfamoylthiophene-2-carboxylate,activity,inactive,59337-93-8,101012.0,O=S(N)(=O)c1ccsc1C(=O)OC
NCGC00256068-01,tox21-er-bla-agonist-p2,"Ethyl 2-cyano-3,3-diphenylacrylate",activity,active agonist,5232-99-5,243274.0,O=C(OCC)C(\C#N)=C(\c1ccccc1)c2ccccc2
NCGC00256138-01,tox21-er-bla-agonist-p2,"2,2-Bis[(prop-2-en-1-yloxy)methyl]butan-1-ol",activity,inactive,682-09-7,61196.0,C=CCOCC(COCC=C)(CC)CO
NCGC00256152-01,tox21-er-bla-agonist-p2,Tricyclodecanedimethanol,activity,inactive,26896-48-0,160138.0,OCC2CCC3C1CC(CC1CO)C23
NCGC00256203-01,tox21-er-bla-agonist-p2,"3,5,5-Trimethyl-2-cyclohexen-1-ol",activity,inactive,470-99-5,79016.0,CC1(C)CC(C)=CC(O)C1
NCGC00255663-01,tox21-er-bla-agonist-p2,Chlordimeform,activity,inactive,6164-98-3,22544.0,Clc1cc(C)c(/N=C/N(C)C)cc1
NCGC00259151-01,tox21-er-bla-agonist-p2,Diisopropanolamine,activity,inactive,110-97-4,8086.0,CC(O)CNCC(C)O
NCGC00259324-01,tox21-er-bla-agonist-p2,"4,4'-Dithiodimorpholine",activity,inactive,103-34-4,7648.0,S(SN1CCOCC1)N2CCOCC2
NCGC00259447-01,tox21-er-bla-agonist-p2,"N,N-Dimethylacetoacetamide",activity,inactive,2044-64-6,16278.0,CC(=O)CC(=O)N(C)C
NCGC00259526-01,tox21-er-bla-agonist-p2,Phenylhydrazine,activity,inactive,100-63-0,7516.0,NNc1ccccc1
NCGC00259543-01,tox21-er-bla-agonist-p2,2-Propoxyethanol,activity,inactive,2807-30-9,17756.0,CCCOCCO
NCGC00259678-01,tox21-er-bla-agonist-p2,"N,N-Dimethyl-4-nitrosoaniline",activity,inactive,138-89-6,8749.0,CN(C)c1ccc(N=O)cc1
NCGC00259751-01,tox21-er-bla-agonist-p2,Caprolactam,activity,inactive,105-60-2,7768.0,O=C1CCCCCN1
NCGC00260108-01,tox21-er-bla-agonist-p2,Octadecanenitrile,activity,inactive,638-65-3,12532.0,CCCCCCCCCCCCCCCCCC#N
NCGC00260280-01,tox21-er-bla-agonist-p2,"Benzo(g,h,i)perylene",activity,inactive,191-24-2,9117.0,c3cc2ccc1cccc6c1c2c4c3ccc5cccc6c45
NCGC00254738-01,tox21-er-bla-agonist-p2,Fluthiacet-methyl,activity,inactive,117337-19-6,93542.0,O=C(OC)CSc3cc(/N=C1\SC(=O)N2CCCCN12)c(F)cc3Cl
NCGC00255455-01,tox21-er-bla-agonist-p2,Coumachlor,activity,inactive,81-82-3,54682651.0,Clc1ccc(cc1)C(CC(C)=O)C2=C(O)c3ccccc3OC2=O
NCGC00159425-02,tox21-er-bla-agonist-p2,10-Undecenoic acid,activity,inactive,112-38-9,5634.0,O=C(O)CCCCCCCCC=C
NCGC00094424-01,tox21-er-bla-agonist-p2,Trequinsin hydrochloride,activity,inactive,78416-81-6,3060974.0,Cl.Cc4cc(C)cc(C)c4\N=C2/C=C1c3cc(OC)c(OC)cc3CCN1C(=O)N2C
NCGC00159460-02,tox21-er-bla-agonist-p2,Indinavir sulfate,activity,inactive,157810-81-6,5462355.0,O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc2cccnc2)C[C@@H](Cc3ccccc3)C(=O)N[C@H]4c5ccccc5C[C@H]4O.O=S(=O)(O)O
NCGC00181140-01,tox21-er-bla-agonist-p2,Carboquone,activity,inactive,24279-91-2,2569.0,NC(=O)OCC(OC)C=1C(=O)C(=C(C)C(=O)C=1N2CC2)N3CC3
NCGC00094882-01,tox21-er-bla-agonist-p2,Drofenine hydrochloride,activity,inactive,548-66-3,92806.0,Cl.CCN(CC)CCOC(=O)C(c1ccccc1)C2CCCCC2
NCGC00160358-01,tox21-er-bla-agonist-p2,Diftalone,activity,inactive,21626-89-1,30717.0,O=C1c4ccccc4CN2C(=O)c3ccccc3CN12
NCGC00167838-01,tox21-er-bla-agonist-p2,Cilastatin sodium,activity,inactive,81129-83-1,23663403.0,[Na+].O=C(N/C(=C\CCCCSC[C@H](N)C(=O)O)C([O-])=O)[C@H]1CC1(C)C
NCGC00164525-01,tox21-er-bla-agonist-p2,Muromonab-CD3,activity,inactive,140608-64-6,,
NCGC00095068-01,tox21-er-bla-agonist-p2,Naproxol,activity,inactive,26159-36-4,3032818.0,C[C@H](CO)c1ccc2cc(ccc2c1)OC
NCGC00168252-01,tox21-er-bla-agonist-p2,Fentanyl,activity,inactive,437-38-7,3345.0,CCC(=O)N(C2CCN(CCc1ccccc1)CC2)c3ccccc3
NCGC00168342-02,tox21-er-bla-agonist-p2,Triticonazole,activity,inactive,131983-72-7,86233.0,Clc1ccc(cc1)C=C3CCC(C)(C)C3(O)Cn2cncn2
NCGC00095165-01,tox21-er-bla-agonist-p2,Carmofur,activity,inactive,61422-45-5,2577.0,O=C1NC(=O)C(F)=CN1C(=O)NCCCCCC
NCGC00160528-01,tox21-er-bla-agonist-p2,Nuclomedone,activity,inactive,75963-52-9,128798.0,Clc1ccc(cc1)CC3C(=O)N=C2SCCN2C3=O
NCGC00164632-01,tox21-er-bla-agonist-p2,Tibolone,activity,active agonist,5630-53-5,444008.0,O=C1CC=2C[C@@H](C)[C@H]3[C@@H]4CC[C@@](O)(C#C)[C@@]4(C)CC[C@@H]3C=2CC1
NCGC00160584-01,tox21-er-bla-agonist-p2,"1,2-Propanediol, 3-(4-chlorophenoxy)-",activity,inactive,104-29-0,7697.0,Clc1ccc(OCC(O)CO)cc1
NCGC00167531-01,tox21-er-bla-agonist-p2,Rivastigmine tartrate,activity,inactive,129101-54-8,77990.0,O=C(Oc1cc(ccc1)[C@H](C)N(C)C)N(C)CC.O=C(O)[C@@H](O)[C@H](O)C(=O)O
NCGC00095792-01,tox21-er-bla-agonist-p2,2-Hydroxy-3-methylbenzoic acid,activity,inactive,83-40-9,6738.0,OC(=O)c1cccc(C)c1O
NCGC00168348-01,tox21-er-bla-agonist-p2,Isbufylline,activity,inactive,90162-60-0,65681.0,CC(C)Cn2cnc1c2C(=O)N(C)C(=O)N1C
NCGC00178624-02,tox21-er-bla-agonist-p2,Zinc salicylate,activity,inactive,16283-36-6,54693468.0,[Zn+2].O=C([O-])c1ccccc1O.[O-]C(=O)c1ccccc1O
NCGC00159339-02,tox21-er-bla-agonist-p2,Streptomycin sulfate (2:3),activity,inactive,3810-74-0,19648.0,OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]2NC(N)=N)O[C@@H](C)[C@]1(O)C=O
NCGC00166261-01,tox21-er-bla-agonist-p2,Idramantone,activity,inactive,20098-14-0,64184.0,O=C3C1CC2CC(O)(C1)CC3C2
NCGC00167558-01,tox21-er-bla-agonist-p2,Fleroxacin,activity,inactive,79660-72-3,3357.0,CN1CCN(CC1)c2c(F)c3c(cc2F)C(=O)C(=CN3CCF)C(=O)O
NCGC00091575-01,tox21-er-bla-agonist-p2,"2-Ethyl-1,3-hexanediol",activity,inactive,94-96-2,7211.0,CCCC(O)C(CC)CO
NCGC00182999-01,tox21-er-bla-agonist-p2,Flomoxef,activity,inactive,99665-00-6,20056549.0,O=C2N1C(=C(CO[C@H]1[C@@]2(OC)NC(=O)CSC(F)F)CSc3nnnn3CCO)C(=O)O
NCGC00183101-01,tox21-er-bla-agonist-p2,Fursultiamine hydrochloride,activity,inactive,2105-43-3,9845819.0,Cl.Cc2ncc(CN(C=O)C(/C)=C(/SSCC1CCCO1)CCO)c(N)n2
NCGC00254560-01,tox21-er-bla-agonist-p2,"2,4-Dichloro-6-nitroaniline",activity,inactive,2683-43-4,75893.0,Nc1c(cc(Cl)cc1Cl)[N+]([O-])=O
NCGC00185748-01,tox21-er-bla-agonist-p2,Paramethasone acetate,activity,inactive,1597-82-6,443928.0,CC(=O)OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00185774-01,tox21-er-bla-agonist-p2,Erdosteine,activity,inactive,84611-23-4,65632.0,O=C1SCCC1NC(=O)CSCC(=O)O
NCGC00242597-01,tox21-er-bla-agonist-p2,Saxagliptin,activity,inactive,361442-04-8,11243969.0,O=C([C@@H](N)C13CC2CC(C1)CC(O)(C2)C3)N5[C@H](C#N)C[C@@H]4C[C@@H]45
NCGC00254312-01,tox21-er-bla-agonist-p2,"1H,1H,2H,2H-Perfluorooctyl iodide",activity,inactive,2043-57-4,74888.0,FC(F)(C(F)(F)CCI)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
NCGC00253921-01,tox21-er-bla-agonist-p2,"2,2-Dibromo-3-nitrilopropionamide",activity,inactive,10222-01-2,25059.0,BrC(Br)(C#N)C(N)=O
NCGC00253978-01,tox21-er-bla-agonist-p2,Styrene oxide,activity,inactive,96-09-3,7276.0,c1ccccc1C2CO2
NCGC00254393-01,tox21-er-bla-agonist-p2,"1,2-Dinitrobenzene",activity,inactive,528-29-0,10707.0,O=[N+]([O-])c1ccccc1[N+]([O-])=O
NCGC00254484-01,tox21-er-bla-agonist-p2,Methyl octanoate,activity,inactive,111-11-5,8091.0,O=C(CCCCCCC)OC
NCGC00254509-01,tox21-er-bla-agonist-p2,Trioctyl trimellitate,activity,inactive,89-04-3,6960.0,O=C(OCCCCCCCC)c1cc(C(=O)OCCCCCCCC)c(cc1)C(=O)OCCCCCCCC
NCGC00255332-01,tox21-er-bla-agonist-p2,"O,O-Diethyl dithiophosphate",activity,inactive,298-06-6,9274.0,CCOP(=S)(S)OCC
NCGC00183038-01,tox21-er-bla-agonist-p2,Erythromycin ethylsuccinate,activity,inactive,1264-62-6,443953.0,O=C(OCC)CCC(=O)O[C@@H]3[C@H](C[C@@H](C)O[C@H]3O[C@@H]2[C@@H](C)[C@H](O[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C
NCGC00181761-01,tox21-er-bla-agonist-p2,Lysozyme hydrochloride,activity,inactive,9066-59-5,,
NCGC00181777-01,tox21-er-bla-agonist-p2,Gomisin A,activity,inactive,58546-54-6,68781.0,C[C@@H]1Cc3cc4OCOc4c(OC)c3c2c(OC)c(OC)c(OC)cc2C[C@@]1(C)O
NCGC00016511-02,tox21-er-bla-agonist-p2,Chlorotrianisene,activity,inactive,569-57-3,11289.0,COc1ccc(cc1)C(\Cl)=C(/c2ccc(OC)cc2)c3ccc(OC)cc3
NCGC00258121-01,tox21-er-bla-agonist-p2,2-Methyl phenanthrene,activity,inactive,2531-84-2,17321.0,Cc1cc2ccc3ccccc3c2cc1
NCGC00260092-01,tox21-er-bla-agonist-p2,Trichloroethylene,activity,inactive,79-01-6,6575.0,Cl\C=C(/Cl)Cl
NCGC00259372-01,tox21-er-bla-agonist-p2,dl-Menthol,activity,inactive,89-78-1,16666.0,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
NCGC00259399-01,tox21-er-bla-agonist-p2,Oxytetracycline hydrochloride,activity,inactive,2058-46-0,54680782.0,Cl.NC(=O)C=3C(=O)[C@@]4(O)C(O)=C2C(=O)c1c(O)cccc1[C@@](C)(O)[C@H]2[C@H](O)[C@H]4[C@@H](C=3O)N(C)C
NCGC00259433-01,tox21-er-bla-agonist-p2,2-Naphthalenol,activity,active agonist,135-19-3,8663.0,Oc1ccc2ccccc2c1
NCGC00257283-01,tox21-er-bla-agonist-p2,Norgestrel,activity,active agonist,797-63-7,13109.0,O=C4CC[C@H]3C(CC[C@@H]2[C@@H]3CC[C@@]1(CC)[C@H]2CC[C@@]1(O)C#C)=C4
NCGC00258731-01,tox21-er-bla-agonist-p2,Succinic anhydride,activity,inactive,108-30-5,7922.0,O=C1CCC(=O)O1
NCGC00260291-01,tox21-er-bla-agonist-p2,"Glycine, N-(carboxymethyl)-",activity,inactive,142-73-4,8897.0,O=C(O)CNCC(=O)O
NCGC00257639-01,tox21-er-bla-agonist-p2,"3,4-Dichlorophenyl isocyanate",activity,inactive,102-36-3,7607.0,Clc1ccc(/N=C=O)cc1Cl
NCGC00257103-01,tox21-er-bla-agonist-p2,"2,3,5,6-Tetrachlorobenzene-1,4-dicarbonyl dichloride",activity,inactive,719-32-4,12868.0,Clc1c(C(Cl)=O)c(Cl)c(Cl)c(C(Cl)=O)c1Cl
NCGC00257958-01,tox21-er-bla-agonist-p2,2-Chlorobutane,activity,inactive,78-86-4,6563.0,CC(Cl)CC
NCGC00258687-01,tox21-er-bla-agonist-p2,Propionitrile,activity,inactive,107-12-0,7854.0,CCC#N
NCGC00256617-01,tox21-er-bla-agonist-p2,2-Pentanone,activity,inactive,107-87-9,7895.0,CC(=O)CCC
NCGC00259224-01,tox21-er-bla-agonist-p2,Dibutyltin dichloride,activity,active agonist,683-18-1,12688.0,CCCC[Sn](Cl)(Cl)CCCC
NCGC00254022-01,tox21-er-bla-agonist-p2,2-Chloroethanol,activity,inactive,107-07-3,34.0,ClCCO
NCGC00255666-01,tox21-er-bla-agonist-p2,"C.I. Acid Yellow 17, disodium salt",activity,inactive,6359-98-4,22842.0,[Na+].[Na+].[O-]S(=O)(=O)c1ccc(cc1)/N=N/C2C(=O)N(N=C2C)c3cc(Cl)c(cc3Cl)S([O-])(=O)=O
NCGC00255789-01,tox21-er-bla-agonist-p2,C.I. Disperse Orange 37,activity,inactive,13301-61-6,83322.0,Clc2cc(cc(Cl)c2/N=N/c1ccc(cc1)N(CC)CCC#N)[N+]([O-])=O
NCGC00256080-01,tox21-er-bla-agonist-p2,"[(1R)-2,2,3-Trimethylcyclopent-3-en-1-yl]acetaldehyde",activity,inactive,4501-58-0,1252759.0,CC1(C)C(C)=CC[C@@H]1CC=O
NCGC00256777-01,tox21-er-bla-agonist-p2,Pluronic F-127,activity,inactive,9003-11-6,10154203.0,OCCOC(C)COCCO
NCGC00256610-01,tox21-er-bla-agonist-p2,Dodecanenitrile,activity,inactive,2437-25-4,17092.0,CCCCCCCCCCCC#N
NCGC00256808-01,tox21-er-bla-agonist-p2,Dimethyl dihydrogen diphosphate,activity,inactive,26644-00-8,97004.0,O=P(O)(OC)OP(O)(=O)OC
NCGC00256925-01,tox21-er-bla-agonist-p2,"3,3'-(1,1,3,3-Tetramethyldisiloxane-1,3-diyl)dipropan-1-amine",activity,inactive,2469-55-8,17181.0,C[Si](C)(CCCN)O[Si](C)(C)CCCN
NCGC00256480-01,tox21-er-bla-agonist-p2,4-Chloroaniline hydrochloride,activity,inactive,20265-96-7,5284363.0,Cl.Nc1ccc(Cl)cc1
NCGC00257101-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-nitro-, disodium salt",activity,inactive,3709-43-1,19458.0,[Na+].[Na+].O=S([O-])(=O)c2cc(ccc2C=Cc1ccc(cc1S([O-])(=O)=O)[N+]([O-])=O)[N+]([O-])=O
NCGC00257810-01,tox21-er-bla-agonist-p2,Thallium nitrate,activity,inactive,10102-45-1,24937.0,[Tl+].[O-][N+]([O-])=O
NCGC00257432-01,tox21-er-bla-agonist-p2,PharmaGSID_48521,activity,inactive,1191914-21-2,44555481.0,Cc1ncnc(C)c1C(=O)N2CCC(C)(CC2)N3CCC4(CC3)OC(=O)N(C[C@@H]4CCCC)CC5CCOCC5
NCGC00257261-01,tox21-er-bla-agonist-p2,Polysorbate 80,activity,inactive,9005-65-6,5284448.0,OCCOC1CC(OCCO)C(O1)C(COCCOC(=O)CCCCCCC\C=C\CCCCCCCC)OCCO
NCGC00257780-01,tox21-er-bla-agonist-p2,"3,3'-Thiodipropionitrile",activity,inactive,111-97-7,8151.0,N#CCCSCCC#N
NCGC00258075-01,tox21-er-bla-agonist-p2,"2,6-Bis-(1,1-dimethylethyl)-2,5-cyclohexadiene-1,4-dione",activity,inactive,719-22-2,12867.0,CC(C)(C)C1=CC(=O)C=C(C1=O)C(C)(C)C
NCGC00258489-01,tox21-er-bla-agonist-p2,2-Methylpentanoic acid,activity,inactive,97-61-0,7341.0,CC(CCC)C(=O)O
NCGC00258993-01,tox21-er-bla-agonist-p2,2-Nitrophenol,activity,inactive,88-75-5,6947.0,O=[N+]([O-])c1ccccc1O
NCGC00258796-01,tox21-er-bla-agonist-p2,Terbacil,activity,inactive,5902-51-2,22188.0,O=C1NC(C)=C(Cl)C(=O)N1C(C)(C)C
NCGC00258659-01,tox21-er-bla-agonist-p2,1-Pentanol,activity,inactive,71-41-0,6276.0,CCCCCO
NCGC00258856-01,tox21-er-bla-agonist-p2,Dodecanenitrile,activity,inactive,2437-25-4,17092.0,CCCCCCCCCCCC#N
NCGC00259189-01,tox21-er-bla-agonist-p2,3-Chloro-2-methylpropene,activity,inactive,563-47-3,11241.0,C=C(C)CCl
NCGC00259244-01,tox21-er-bla-agonist-p2,Dimethyldiallylammonium chloride,activity,inactive,7398-69-8,33286.0,[Cl-].C=CC[N+](C)(C)CC=C
NCGC00260047-01,tox21-er-bla-agonist-p2,Chromium(III) acetate,activity,inactive,1066-30-4,14012.0,[Cr+3].O=C([O-])C.[O-]C(C)=O.[O-]C(C)=O
NCGC00260312-01,tox21-er-bla-agonist-p2,"Phenol, isopropylated, phosphate (3:1)",activity,inactive,68937-41-7,75628.0,CC(C)c1ccc(cc1)OP(=O)(Oc2ccc(cc2)C(C)C)Oc3ccc(cc3)C(C)C
NCGC00260580-01,tox21-er-bla-agonist-p2,NTP Mix40 CT1 3-EQP,activity,inactive,NOCAS_49476,,
NCGC00015608-04,tox21-er-bla-agonist-p2,Loperamide,activity,inactive,53179-11-6,3955.0,CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4
NCGC00015987-05,tox21-er-bla-agonist-p2,Telenzepine,activity,inactive,80880-90-6,5387.0,CN1CCN(CC1)CC(=O)N3c2c(csc2C)C(=O)Nc4ccccc34
NCGC00016492-01,tox21-er-bla-agonist-p2,Methocarbamol,activity,inactive,532-03-6,4107.0,NC(=O)OCC(O)COc1ccccc1OC
NCGC00016537-01,tox21-er-bla-agonist-p2,Rolitetracycline,activity,inactive,751-97-3,54680694.0,O=C(NCN1CCCC1)C4=C(O)[C@@H](N(C)C)[C@@H]5CC3C(C(=O)c2c(O)cccc2[C@@]3(C)O)=C(O)[C@]5(O)C4=O
NCGC00096059-01,tox21-er-bla-agonist-p2,Trimebutine maleate,activity,inactive,34140-59-5,5388977.0,COc1c(cc(cc1OC)C(=O)OCC(CC)(c2ccccc2)N(C)C)OC.O=C(O)/C=C\C(=O)O
NCGC00255568-01,tox21-er-bla-agonist-p2,Fumagillin,activity,inactive,23110-15-8,6917655.0,C[C@@]1(O[C@@H]1C\C=C(\C)C)[C@H]3[C@H](OC)[C@H](OC(=O)\C=C\C=C\C=C\C=C\C(=O)O)CC[C@@]23CO2
NCGC00255749-01,tox21-er-bla-agonist-p2,Sodium 4-methylbenzenesulfonate,activity,inactive,657-84-1,3720192.0,[Na+].Cc1ccc(cc1)S(=O)([O-])=O
NCGC00255835-01,tox21-er-bla-agonist-p2,Pantoprazole sodium,activity,inactive,138786-67-1,15008962.0,[Na+].COc3c(OC)ccnc3CS(=O)c1[n-]c2ccc(cc2n1)OC(F)F
NCGC00254867-01,tox21-er-bla-agonist-p2,Diphenyl phosphite,activity,inactive,4712-55-4,6327546.0,O=P(Oc1ccccc1)Oc2ccccc2
NCGC00254481-01,tox21-er-bla-agonist-p2,Carbofuran,activity,inactive,1563-66-2,2566.0,CNC(=O)Oc1cccc2CC(C)(C)Oc12
NCGC00254375-01,tox21-er-bla-agonist-p2,CP-283097,activity,inactive,171866-31-2,10021362.0,Fc1ccc(cc1)C2(O)CCN(CC2)[C@@H]4COc3cc(O)ccc3[C@@H]4O
NCGC00254683-01,tox21-er-bla-agonist-p2,Diclofop-methyl,activity,inactive,51338-27-3,39985.0,Clc2cc(Cl)ccc2Oc1ccc(OC(C)C(=O)OC)cc1
NCGC00255053-01,tox21-er-bla-agonist-p2,Thiobencarb,activity,inactive,28249-77-6,34192.0,Clc1ccc(CSC(=O)N(CC)CC)cc1
NCGC00024842-02,tox21-er-bla-agonist-p2,Clomethiazole,activity,inactive,533-45-9,10783.0,ClCCc1scnc1C
NCGC00093636-03,tox21-er-bla-agonist-p2,R-(+)-Atenolol,activity,inactive,56715-13-0,180559.0,CC(C)NC[C@@H](O)COc1ccc(cc1)CC(N)=O
NCGC00159354-02,tox21-er-bla-agonist-p2,Bornyl acetate,activity,inactive,76-49-3,442460.0,CC(=O)O[C@@H]1CC2CCC1(C)C2(C)C
NCGC00160162-02,tox21-er-bla-agonist-p2,Hordenine,activity,inactive,539-15-1,68313.0,Oc1ccc(CCN(C)C)cc1
NCGC00160647-01,tox21-er-bla-agonist-p2,Cypromid,activity,inactive,2759-71-9,17693.0,O=C(Nc1cc(Cl)c(Cl)cc1)C2CC2
NCGC00163225-01,tox21-er-bla-agonist-p2,Stilonium iodide,activity,inactive,77257-42-2,6433339.0,[I-].CC[N+](CCOc1ccc(cc1)/C=C/c2ccccc2)(CC)CC
NCGC00167984-01,tox21-er-bla-agonist-p2,Tiquizium bromide,activity,inactive,71731-58-3,72159.0,[Br-].C[N@@+]14CCCC[C@@H]4CC\C(C1)=C(/c2sccc2)c3cccs3
NCGC00247723-01,tox21-er-bla-agonist-p2,"1-(1,3-Benzodioxol-5-yl)-N-ethylpropan-2-amine hydrochloride",activity,inactive,74341-78-9,3057998.0,Cl.CC(NCC)Cc1ccc2OCOc2c1
NCGC00260068-01,tox21-er-bla-agonist-p2,Halazone,activity,inactive,80-13-7,3552.0,O=S(=O)(N(Cl)Cl)c1ccc(cc1)C(=O)O
NCGC00260091-01,tox21-er-bla-agonist-p2,Titanocene dichloride,activity,inactive,1271-19-8,5284468.0,[Cl-].[Cl-].C=2CC([Ti+2]C1=CC=CC1)=CC=2
NCGC00260222-01,tox21-er-bla-agonist-p2,1-Butyl-2-methylpyridinium bromide,activity,inactive,26576-84-1,13240377.0,[Br-].Cc1cccc[n+]1CCCC
NCGC00260361-01,tox21-er-bla-agonist-p2,"Benzoic acid,4-(bromomethyl)-,methylester",activity,inactive,2417-72-3,256687.0,BrCc1ccc(cc1)C(=O)OC
NCGC00260474-01,tox21-er-bla-agonist-p2,9-Methylguanine,activity,inactive,5502-78-3,79639.0,NC=2Nc1c(ncn1C)C(=O)N=2
NCGC00016582-01,tox21-er-bla-agonist-p2,Bacitracin,activity,inactive,1405-87-4,60196264.0,O=C(O)C[C@H]3NC(=O)[C@@H](Cc1cncn1)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](NC(=O)[C@@H](CCCN)NC(=O)[C@@H](CCCCNC(=O)[C@@H](CC(N)=O)NC3=O)NC(=O)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]4N=C(SC4)[C@H](N)[C@H](C)CC)[C@@H](C)CC)[C@H](C)CC
NCGC00018181-08,tox21-er-bla-agonist-p2,Nalidixic acid,activity,inactive,389-08-2,4421.0,O=C(O)C2=CN(CC)c1nc(C)ccc1C2=O
NCGC00159522-02,tox21-er-bla-agonist-p2,Cephalexin,activity,inactive,15686-71-2,27447.0,CC=3CS[C@H]2N(C(=O)[C@H]2NC(=O)[C@H](N)c1ccccc1)C=3C(=O)O
NCGC00167553-01,tox21-er-bla-agonist-p2,Norfenefrine hydrochloride,activity,inactive,4779-94-6,3016408.0,Cl.OC(CN)c1cc(O)ccc1
NCGC00181312-01,tox21-er-bla-agonist-p2,Biperiden hydrochloride,activity,inactive,1235-82-1,92151.0,Cl.OC(CCN1CCCCC1)(c2ccccc2)C4CC3C=CC4C3
NCGC00017029-01,tox21-er-bla-agonist-p2,Cloxacillin sodium,activity,inactive,642-78-4,23675320.0,[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1ccccc1Cl)[C@H]4SC3(C)C
NCGC00017030-01,tox21-er-bla-agonist-p2,Fusidate sodium,activity,inactive,751-94-0,23672955.0,[Na+].[O-]C(=O)C(\CC\C=C(/C)C)=C4/[C@@H](OC(C)=O)C[C@@]1(C)[C@H]4C[C@@H](O)[C@H]2[C@@]3(C)CC[C@@H](O)[C@@H](C)[C@@H]3CC[C@]12C
NCGC00017034-01,tox21-er-bla-agonist-p2,Diethylcarbamazine citrate,activity,inactive,1642-54-2,15432.0,O=C(N1CCN(C)CC1)N(CC)CC.O=C(O)C(O)(CC(=O)O)CC(=O)O
NCGC00024876-03,tox21-er-bla-agonist-p2,Dizocilpine maleate,activity,inactive,77086-22-7,6420042.0,O=C(O)/C=C\C(=O)O.C[C@@]42N[C@H](Cc1ccccc12)c3ccccc34
NCGC00256802-01,tox21-er-bla-agonist-p2,Maltol isobutyrate,activity,inactive,65416-14-0,3354132.0,O=C1C=COC(C)=C1OC(=O)C(C)C
NCGC00256971-01,tox21-er-bla-agonist-p2,Carvyl acetate,activity,inactive,97-42-7,7335.0,O=C(C)OC1CC(CC=C1C)C(=C)C
NCGC00258433-01,tox21-er-bla-agonist-p2,Methyl carbazate,activity,inactive,6294-89-9,80519.0,NNC(=O)OC
NCGC00257138-01,tox21-er-bla-agonist-p2,4-Ethoxyaniline,activity,inactive,156-43-4,9076.0,CCOc1ccc(N)cc1
NCGC00257188-01,tox21-er-bla-agonist-p2,Sodium phenolate,activity,inactive,139-02-6,4445035.0,[Na+].[O-]c1ccccc1
NCGC00257487-01,tox21-er-bla-agonist-p2,Ethylenediaminetetraacetic acid ferric sodium salt,activity,inactive,15708-41-5,27461.0,[Fe+3].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O
NCGC00257489-01,tox21-er-bla-agonist-p2,Sulfamic acid,activity,inactive,5329-14-6,5987.0,NS(=O)(=O)O
NCGC00257830-01,tox21-er-bla-agonist-p2,Epichlorohydrin,activity,inactive,106-89-8,7835.0,ClCC1CO1
NCGC00258099-01,tox21-er-bla-agonist-p2,Phenylparaben,activity,active agonist,17696-62-7,87250.0,O=C(Oc1ccccc1)c2ccc(O)cc2
NCGC00256673-01,tox21-er-bla-agonist-p2,L-Glutamic acid hydrochloride,activity,inactive,138-15-8,2723891.0,Cl.OC(=O)CC[C@H](N)C(=O)O
NCGC00255872-01,tox21-er-bla-agonist-p2,"Ethanol, 2,2',2'',2'''-(1,2-ethanediyldinitrilo)tetrakis-",activity,inactive,140-07-8,67322.0,OCCN(CCN(CCO)CCO)CCO
NCGC00255931-01,tox21-er-bla-agonist-p2,5-Amino-2-methylbenzenesulfonic acid,activity,inactive,118-88-7,67054.0,Cc1ccc(N)cc1S(O)(=O)=O
NCGC00255940-01,tox21-er-bla-agonist-p2,2-Isopropylphenol,activity,inactive,88-69-7,6943.0,CC(C)c1ccccc1O
NCGC00255988-01,tox21-er-bla-agonist-p2,Minocycline hydrochloride,activity,inactive,13614-98-7,54685925.0,Cl.CN(C)c2ccc(O)c1C(=O)C3=C(O)[C@]4(O)C(=O)C(=C(O)[C@@H](N(C)C)[C@@H]4C[C@@H]3Cc12)C(N)=O
NCGC00256063-01,tox21-er-bla-agonist-p2,dl-Tartaric acid,activity,inactive,133-37-9,875.0,O=C(O)C(O)C(O)C(O)=O
NCGC00256266-01,tox21-er-bla-agonist-p2,"4,4'-Propane-1,3-diyldipyridine",activity,inactive,17252-51-6,87019.0,C(CCc1ccncc1)c2ccncc2
NCGC00260535-01,tox21-er-bla-agonist-p2,2-Methoxyphenol,activity,inactive,90-05-1,460.0,Oc1ccccc1OC
NCGC00260553-01,tox21-er-bla-agonist-p2,NTP Mix61 CT1 62-EQP,activity,inactive,NOCAS_49449,,
NCGC00260662-01,tox21-er-bla-agonist-p2,NTP Mix32 AR2 7-EQP,activity,inconclusive agonist,NOCAS_49558,,
NCGC00259075-01,tox21-er-bla-agonist-p2,Methyl disulfide,activity,inactive,624-92-0,12232.0,CSSC
NCGC00259345-01,tox21-er-bla-agonist-p2,Pebulate,activity,inactive,1114-71-2,14215.0,O=C(SCCC)N(CCCC)CC
NCGC00254830-01,tox21-er-bla-agonist-p2,1-(4-Methoxyphenyl)-1-pentene-3-one,activity,inactive,104-27-8,61008.0,COc1ccc(C=CC(=O)CC)cc1
NCGC00255146-01,tox21-er-bla-agonist-p2,Ammonium xylene sulfonate,activity,inactive,26447-10-9,22833320.0,[NH4+].Cc1c(C)cccc1S(=O)([O-])=O
NCGC00255387-01,tox21-er-bla-agonist-p2,2-Butanamine,activity,inactive,13952-84-6,24874.0,CC(N)CC
NCGC00255400-01,tox21-er-bla-agonist-p2,"Butanenitrile, 2-amino-2,3-dimethyl-",activity,inactive,13893-53-3,94355.0,CC(C)C(C)(N)C#N
NCGC00255511-01,tox21-er-bla-agonist-p2,Dinitramine,activity,active agonist,29091-05-2,34468.0,CCN(CC)c1c(cc(c(N)c1[N+]([O-])=O)C(F)(F)F)[N+]([O-])=O
NCGC00255665-01,tox21-er-bla-agonist-p2,2-Methyl-2-butanol,activity,inactive,75-85-4,6405.0,CC(C)(O)CC
NCGC00255880-01,tox21-er-bla-agonist-p2,N-Methylpyrrolidine,activity,inactive,120-94-5,8454.0,CN1CCCC1
NCGC00091839-03,tox21-er-bla-agonist-p2,"2',4',5'-Trihydroxybutyrophenone",activity,inactive,1421-63-2,15008.0,Oc1cc(C(=O)CCC)c(O)cc1O
NCGC00092329-02,tox21-er-bla-agonist-p2,Eliprodil,activity,inactive,119431-25-3,60703.0,OC(CN1CCC(CC1)Cc2ccc(F)cc2)c3ccc(Cl)cc3
NCGC00159450-02,tox21-er-bla-agonist-p2,Parethoxycaine,activity,inactive,94-23-5,7183.0,CCOc1ccc(cc1)C(=O)OCCN(CC)CC
NCGC00167448-01,tox21-er-bla-agonist-p2,Trepibutone,activity,inactive,41826-92-0,5536.0,CCOc1cc(OCC)c(cc1OCC)C(=O)CCC(=O)O
NCGC00159471-02,tox21-er-bla-agonist-p2,Benztropine,activity,inactive,86-13-5,1201549.0,CN4[C@H]1CC[C@@H]4C[C@@H](C1)OC(c2ccccc2)c3ccccc3
NCGC00159495-03,tox21-er-bla-agonist-p2,Albutoin,activity,inactive,830-89-7,3032361.0,S=C1NC(CC(C)C)C(=O)N1CC=C
NCGC00164499-01,tox21-er-bla-agonist-p2,DL-alpha Tocopheryl nicotinate,activity,inactive,43119-47-7,27990.0,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc3c(O1)c(C)c(C)c(OC(=O)c2cccnc2)c3C
NCGC00167808-01,tox21-er-bla-agonist-p2,Fananserin,activity,inactive,127625-29-0,60785.0,Fc1ccc(cc1)N2CCN(CC2)CCCN5c4cccc3cccc(c34)S5(=O)=O
NCGC00164577-01,tox21-er-bla-agonist-p2,Nimetazepam,activity,inactive,2011-67-8,4496.0,[O-][N+](=O)c1ccc2c(c1)C(=NCC(=O)N2C)c3ccccc3
NCGC00164639-01,tox21-er-bla-agonist-p2,Arsenic trioxide,activity,inactive,1327-53-3,518605.0,O1[As]2O[As]3O[As]1O[As](O2)O3
NCGC00160575-01,tox21-er-bla-agonist-p2,Uracil mustard,activity,inactive,66-75-1,6194.0,O=C1NC(=O)NC=C1N(CCCl)CCCl
NCGC00165983-01,tox21-er-bla-agonist-p2,Amaranth,activity,inactive,915-67-3,5359521.0,[Na+].[Na+].[Na+].[O-]S(=O)(=O)c4ccc(/N=N\c1c2ccc(cc2cc(c1O)S([O-])(=O)=O)S([O-])(=O)=O)c3ccccc34
NCGC00162100-02,tox21-er-bla-agonist-p2,Dexbrompheniramine maleate,activity,inactive,2391-03-9,6433334.0,O=C(O)/C=C\C(=O)O.Brc1ccc(cc1)[C@H](CCN(C)C)c2ccccn2
NCGC00163125-02,tox21-er-bla-agonist-p2,Pregnenolone,activity,active agonist,145-13-1,8955.0,CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00163150-01,tox21-er-bla-agonist-p2,Clenbuterol,activity,inactive,37148-27-9,2783.0,Clc1cc(cc(Cl)c1N)C(O)CNC(C)(C)C
NCGC00254166-01,tox21-er-bla-agonist-p2,Dicumyl peroxide,activity,active agonist,80-43-3,6641.0,CC(C)(OOC(C)(C)c1ccccc1)c2ccccc2
NCGC00254186-01,tox21-er-bla-agonist-p2,"4-Amino-1,2,4-triazole",activity,inactive,584-13-4,11432.0,Nn1cnnc1
NCGC00255181-01,tox21-er-bla-agonist-p2,Atorvastatin,activity,inactive,134523-00-5,60823.0,O[C@H](CCn1c(c(c(c1C(C)C)C(=O)Nc2ccccc2)c3ccccc3)c4ccc(F)cc4)C[C@@H](O)CC(=O)O
NCGC00253933-01,tox21-er-bla-agonist-p2,Caprolactam,activity,inactive,105-60-2,7768.0,O=C1CCCCCN1
NCGC00253970-01,tox21-er-bla-agonist-p2,SSR504734,activity,inactive,742693-38-5,9954540.0,FC(F)(F)c3cccc(C(=O)N[C@H]([C@@H]1CCCCN1)c2ccccc2)c3Cl
NCGC00254104-01,tox21-er-bla-agonist-p2,Methyl salicylate,activity,inactive,119-36-8,4133.0,Oc1ccccc1C(=O)OC
NCGC00182972-01,tox21-er-bla-agonist-p2,Hexocyclium,activity,inactive,115-63-9,101587.0,OC(CN1CC[N+](C)(C)CC1)(c2ccccc2)C3CCCCC3.[O-]S(=O)(=O)OC
NCGC00259499-01,tox21-er-bla-agonist-p2,Praziquantel,activity,inactive,55268-74-1,4891.0,O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4
NCGC00257790-01,tox21-er-bla-agonist-p2,"2-Ethylhexyl-2-cyano-3,3-diphenylacrylate",activity,inactive,6197-30-4,22571.0,CCC(CCCC)COC(=O)C(\C#N)=C(\c1ccccc1)c2ccccc2
NCGC00258161-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium bis(trifluoromethylsulfonyl)imide",activity,inactive,350493-08-2,11212667.0,CCCCn1cc[n+](C)c1C.FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
NCGC00258280-01,tox21-er-bla-agonist-p2,2-Aminothiazole,activity,inactive,96-50-4,2155.0,Nc1nccs1
NCGC00014496-01,tox21-er-bla-agonist-p2,Tramazoline tosylate,activity,inactive,102280-49-9,298391.0,O=S(=O)(O)c1ccc(C)cc1.C2CCCc3cccc(NC1=NCCN1)c23
NCGC00258739-01,tox21-er-bla-agonist-p2,"1,1,1,2-Tetrabromoethane",activity,inactive,630-16-0,61179.0,BrC(Br)(Br)CBr
NCGC00259115-01,tox21-er-bla-agonist-p2,Veratraldehyde,activity,inactive,120-14-9,8419.0,COc1cc(ccc1OC)C=O
NCGC00259215-01,tox21-er-bla-agonist-p2,"N-(4-Chloro-2,5-dimethoxyphenyl)-3-oxobutanamide",activity,inactive,4433-79-8,78170.0,COc1cc(NC(=O)CC(C)=O)c(cc1Cl)OC
NCGC00259374-01,tox21-er-bla-agonist-p2,Acenaphthylene,activity,inactive,208-96-8,9161.0,c1cc2cccc3C=Cc(c1)c23
NCGC00181296-01,tox21-er-bla-agonist-p2,"(+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid",activity,inactive,112665-43-7,2449.0,O=C2C(C)=C(C)C(=O)C(C)=C2C(CCCCCC(=O)O)c1ccccc1
NCGC00164545-01,tox21-er-bla-agonist-p2,Lacidipine,activity,active agonist,103890-78-4,5311217.0,CC=1NC(C)=C(C(C=1C(=O)OCC)c2ccccc2/C=C/C(=O)OC(C)(C)C)C(=O)OCC
NCGC00166087-01,tox21-er-bla-agonist-p2,L-Thioproline,activity,inactive,34592-47-7,93176.0,O=C(O)[C@@H]1CSCN1
NCGC00256788-01,tox21-er-bla-agonist-p2,4-Methyl-1-phenyl-2-pentanol,activity,inactive,7779-78-4,62661.0,OC(Cc1ccccc1)CC(C)C
NCGC00257279-01,tox21-er-bla-agonist-p2,Heptylparaben,activity,active agonist,1085-12-7,14138.0,Oc1ccc(cc1)C(=O)OCCCCCCC
NCGC00258061-01,tox21-er-bla-agonist-p2,2-Amino-1-naphthalenesulfonic acid,activity,inactive,81-16-3,6670.0,O=S(=O)(O)c2c(N)ccc1ccccc12
NCGC00014529-01,tox21-er-bla-agonist-p2,Mesoridazine,activity,inactive,5588-33-0,4078.0,CS(=O)c2cc3N(CCC1CCCCN1C)c4ccccc4Sc3cc2
NCGC00258425-01,tox21-er-bla-agonist-p2,"1,2-Epoxy-3-butene",activity,inactive,930-22-3,13586.0,C=CC1CO1
NCGC00256574-01,tox21-er-bla-agonist-p2,"1,2,3-Benzotriazole",activity,inactive,95-14-7,7220.0,c1cccc2nnnc12
NCGC00258885-01,tox21-er-bla-agonist-p2,Hydroquinone dimethyl ether,activity,inactive,150-78-7,9016.0,COc1ccc(OC)cc1
NCGC00259193-01,tox21-er-bla-agonist-p2,Dimethipin,activity,inactive,55290-64-7,41385.0,O=S1(=O)CCS(=O)(=O)C(C)=C1C
NCGC00183009-01,tox21-er-bla-agonist-p2,Pranazepide,activity,inactive,150408-73-4,132916.0,Fc6ccccc6C3=N[C@H](NC(=O)c1cc2ccccc2n1)C(=O)N5CCc4cccc3c45
NCGC00255115-01,tox21-er-bla-agonist-p2,Isooctadecanoic acid,activity,inactive,30399-84-9,21859.0,O=C(O)CCCCCCCCCCCCCCC(C)C
NCGC00256903-01,tox21-er-bla-agonist-p2,"Pyrimidine-2,4,5,6(1H,3H)-tetrone tetrahydrate",activity,inactive,6010-91-9,12338093.0,O.O.O.O.O=C1C(=O)NC(=O)NC1=O
NCGC00256214-01,tox21-er-bla-agonist-p2,1-(2-Aminoethyl)imidazolidin-2-one,activity,inactive,6281-42-1,80480.0,O=C1NCCN1CCN
NCGC00256251-01,tox21-er-bla-agonist-p2,Bis(methacryloyloxyethyl) hydrogen phosphate,activity,inactive,32435-46-4,122612.0,O=C(OCCOP(O)(=O)OCCOC(=O)C(=C)C)C(=C)C
NCGC00256820-01,tox21-er-bla-agonist-p2,Decyl acetate,activity,inactive,112-17-4,8167.0,CC(=O)OCCCCCCCCCC
NCGC00256284-01,tox21-er-bla-agonist-p2,"3-(5,5,6-Trimethylbicyclo[2.2.1]hept-2-yl)cyclohexanol",activity,active agonist,3407-42-9,103005.0,OC1CC(CCC1)C2CC3CC2C(C)C3(C)C
NCGC00257396-01,tox21-er-bla-agonist-p2,"3,5-Dimethylphenol",activity,inactive,108-68-9,7948.0,Cc1cc(O)cc(C)c1
NCGC00257213-01,tox21-er-bla-agonist-p2,Hexyl methacrylate,activity,inactive,142-09-6,8872.0,O=C(OCCCCCC)C(=C)C
NCGC00257879-01,tox21-er-bla-agonist-p2,3-Chlorobenzoic acid,activity,inactive,535-80-8,447.0,OC(=O)c1cc(Cl)ccc1
NCGC00257353-01,tox21-er-bla-agonist-p2,2-Acetylthiazole,activity,inactive,24295-03-2,520108.0,CC(=O)c1nccs1
NCGC00258892-01,tox21-er-bla-agonist-p2,"2-(Morpholin-4-yldithio)-1,3-benzothiazole",activity,inactive,95-32-9,7231.0,c1cccc2sc(nc12)SSN3CCOCC3
NCGC00258605-01,tox21-er-bla-agonist-p2,Butyl acetate,activity,inactive,123-86-4,31272.0,CC(=O)OCCCC
NCGC00258151-01,tox21-er-bla-agonist-p2,Butyltrimethylammonium bis(trifluoromethylsulfonyl)imide,activity,inactive,258273-75-5,12991988.0,FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F.CCCC[N+](C)(C)C
NCGC00259967-01,tox21-er-bla-agonist-p2,Thiouracil,activity,inactive,141-90-2,1269845.0,O=C1C=CNC(=S)N1
NCGC00259905-01,tox21-er-bla-agonist-p2,N-Nitrosopyrrolidine,activity,inactive,930-55-2,13591.0,O=NN1CCCC1
NCGC00259706-01,tox21-er-bla-agonist-p2,"1,2-Dichlorobenzene",activity,inactive,95-50-1,7239.0,Clc1ccccc1Cl
NCGC00260014-01,tox21-er-bla-agonist-p2,"1,1,2-Trichloroethane",activity,inactive,79-00-5,6574.0,ClCC(Cl)Cl
NCGC00260204-01,tox21-er-bla-agonist-p2,1-Methyl-3-propylimidazolium tetrafluoroborate,activity,inactive,244193-48-4,11171853.0,C[n+]1ccn(CCC)c1.F[B-](F)(F)F
NCGC00260212-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpiperidinium bromide,activity,inactive,94280-72-5,19838382.0,[Br-].C[N+]1(CCCC)CCCCC1
NCGC00260398-01,tox21-er-bla-agonist-p2,"1,5-Hexadiene",activity,inactive,592-42-7,11598.0,C=CCCC=C
NCGC00260408-01,tox21-er-bla-agonist-p2,"Hexane,1-iodo-",activity,inactive,638-45-9,12527.0,CCCCCCI
NCGC00260414-01,tox21-er-bla-agonist-p2,Copper(II) chloride,activity,inactive,7447-39-4,169664.0,[Cu+2].[Cl-].[Cl-]
NCGC00260665-01,tox21-er-bla-agonist-p2,NTP Mix31 AR2 7-EQC,activity,inactive,NOCAS_49561,,
NCGC00260612-01,tox21-er-bla-agonist-p2,NTP Mix15 AR1 8-EQC,activity,inactive,NOCAS_49508,,
NCGC00015191-06,tox21-er-bla-agonist-p2,Chlormezanone,activity,inactive,80-77-3,2717.0,O=C1CCS(=O)(=O)C(N1C)c2ccc(Cl)cc2
NCGC00016270-04,tox21-er-bla-agonist-p2,L-Dopa,activity,inactive,59-92-7,6047.0,Oc1ccc(C[C@H](N)C(=O)O)cc1O
NCGC00016278-07,tox21-er-bla-agonist-p2,Mefenamic acid,activity,inactive,61-68-7,4044.0,O=C(O)c2ccccc2Nc1cccc(C)c1C
NCGC00016552-01,tox21-er-bla-agonist-p2,7-Aminocephalosporanic acid,activity,inactive,957-68-6,441328.0,O=C(O)C=1N2C(=O)[C@@H](N)[C@H]2SCC=1COC(C)=O
NCGC00016837-01,tox21-er-bla-agonist-p2,Bacampicillin hydrochloride,activity,inactive,37661-08-8,441398.0,Cl.N[C@H](c1ccccc1)C(=O)N[C@@H]3C(=O)N2[C@@H](C(=O)OC(C)OC(=O)OCC)C(C)(C)S[C@@H]23
NCGC00026132-02,tox21-er-bla-agonist-p2,Metanixin,activity,inactive,4394-04-1,10466908.0,O=C(O)c2cccnc2Nc1c(C)cccc1C
NCGC00094390-01,tox21-er-bla-agonist-p2,1-(2-Methoxyphenyl)piperazine hydrochloride,activity,inactive,5464-78-8,9899402.0,Cl.COc1ccccc1N2CCNCC2
NCGC00164321-01,tox21-er-bla-agonist-p2,Sodium 2-phenylphenate tetrahydrate,activity,inactive,6152-33-6,517383.0,[Na+].O.O.O.O.[O-]c2ccccc2c1ccccc1
NCGC00255987-01,tox21-er-bla-agonist-p2,Levomenol,activity,inactive,23089-26-1,442343.0,CC1=CC[C@H](CC1)[C@](O)(C)CC\C=C(/C)C
NCGC00254782-01,tox21-er-bla-agonist-p2,"Mercury, chlorophenyl-",activity,active agonist,100-56-1,7511.0,Cl[Hg]c1ccccc1
NCGC00255206-01,tox21-er-bla-agonist-p2,Dicyclohexyl,activity,inactive,92-51-3,7094.0,C1CC(CCC1)C2CCCCC2
NCGC00255537-01,tox21-er-bla-agonist-p2,"2,4-Dinitroanisole",activity,inactive,119-27-7,8385.0,COc1ccc(cc1[N+]([O-])=O)[N+]([O-])=O
NCGC00016393-01,tox21-er-bla-agonist-p2,"2,2'-Dihydroxy-4-methoxybenzophenone",activity,inactive,131-53-3,8569.0,O=C(c1ccc(cc1O)OC)c2ccccc2O
NCGC00016602-01,tox21-er-bla-agonist-p2,Benperidol,activity,inactive,2062-84-2,16363.0,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)N3c4ccccc4NC3=O
NCGC00016747-03,tox21-er-bla-agonist-p2,Dilazep,activity,inactive,35898-87-4,3074.0,COc1cc(cc(OC)c1OC)C(=O)OCCCN3CCCN(CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)CC3
NCGC00095131-01,tox21-er-bla-agonist-p2,Pioglitazone hydrochloride,activity,inactive,112529-15-4,60560.0,Cl.CCc1ccc(nc1)CCOc3ccc(CC2SC(=O)NC2=O)cc3
NCGC00095164-01,tox21-er-bla-agonist-p2,Prothionamide,activity,inactive,14222-60-7,666418.0,CCCc1cc(ccn1)C(N)=S
NCGC00095188-01,tox21-er-bla-agonist-p2,Pantoprazole,activity,inactive,102625-70-7,4679.0,COc3c(OC)ccnc3CS(=O)c1nc2cc(ccc2n1)OC(F)F
NCGC00182704-03,tox21-er-bla-agonist-p2,Luliconazole,activity,inactive,187164-19-8,3003141.0,N#C/C(=C1/SC[C@H](S1)c2ccc(Cl)cc2Cl)n3ccnc3
NCGC00259776-01,tox21-er-bla-agonist-p2,Aldicarb,activity,inactive,116-06-3,2086.0,CC(C)(\C=N\OC(=O)NC)SC
NCGC00024246-05,tox21-er-bla-agonist-p2,Daunorubicin,activity,active agonist,20830-81-3,30323.0,CC(=O)[C@@]4(O)C[C@H](O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)c5c(O)c3C(=O)c2c(OC)cccc2C(=O)c3c(O)c5C4
NCGC00094849-01,tox21-er-bla-agonist-p2,Oftasceine,activity,inactive,1461-15-0,60196279.0,O=C(O)CN(CC(=O)O)CC5=CC4C(Oc1cc(O)c(cc1C43OC(=O)c2ccccc23)CN(CC(=O)O)CC(=O)O)=CC5=O
NCGC00166086-01,tox21-er-bla-agonist-p2,2-Amino-6-methylheptane,activity,inactive,543-82-8,10982.0,CC(C)CCCC(C)N
NCGC00167459-01,tox21-er-bla-agonist-p2,Doxapram hydrochloride,activity,inactive,113-07-5,64647.0,Cl.O=C4N(CC)CC(CCN1CCOCC1)C4(c2ccccc2)c3ccccc3
NCGC00186462-01,tox21-er-bla-agonist-p2,Abiraterone acetate,activity,active agonist,154229-18-2,9821849.0,CC(=O)O[C@@H]2CC3=CC[C@H]4[C@@H]5CC=C(c1cccnc1)[C@@]5(C)CC[C@@H]4[C@@]3(C)CC2
NCGC00080392-01,tox21-er-bla-agonist-p2,Phosmet,activity,inactive,732-11-6,12901.0,COP(=S)(OC)SCN2C(=O)c1ccccc1C2=O
NCGC00258386-01,tox21-er-bla-agonist-p2,p-Tolylurea,activity,inactive,622-51-5,12148.0,O=C(N)Nc1ccc(C)cc1
NCGC00258535-01,tox21-er-bla-agonist-p2,"N,N,N',N`-Tetramethylhexanediamine",activity,inactive,111-18-2,8097.0,CN(C)CCCCCCN(C)C
NCGC00258555-01,tox21-er-bla-agonist-p2,Isobutyric anhydride,activity,inactive,97-72-3,7346.0,CC(C)C(=O)OC(=O)C(C)C
NCGC00258573-01,tox21-er-bla-agonist-p2,2-Nitrobenzoic acid,activity,inactive,552-16-9,11087.0,O=[N+]([O-])c1ccccc1C(=O)O
NCGC00257059-01,tox21-er-bla-agonist-p2,Dodecyl 2-methylacrylate,activity,inactive,142-90-5,8906.0,C=C(C)C(=O)OCCCCCCCCCCCC
NCGC00257251-01,tox21-er-bla-agonist-p2,PharmaGSID_48509,activity,inactive,NOCAS_48509,10287749.0,O=C(C1CCNCC1)N2CCC(CC2)N(CCC)[C@H]3Cc4cc(OC)ccc4CC3
NCGC00257284-01,tox21-er-bla-agonist-p2,"Glycine, N-phenyl-, monopotassium salt",activity,inactive,19525-59-8,23672325.0,[K+].[O-]C(=O)CNc1ccccc1
NCGC00257344-01,tox21-er-bla-agonist-p2,Imidazole,activity,inactive,288-32-4,795.0,c1cncn1
NCGC00257418-01,tox21-er-bla-agonist-p2,Dihexyl nonanedioate,activity,inactive,109-31-9,7985.0,O=C(CCCCCCCC(=O)OCCCCCC)OCCCCCC
NCGC00257469-01,tox21-er-bla-agonist-p2,"1,2-Ethanediol diacetate",activity,inactive,111-55-7,8121.0,CC(=O)OCCOC(=O)C
NCGC00257798-01,tox21-er-bla-agonist-p2,Cyclopentanone,activity,inactive,120-92-3,8452.0,O=C1CCCC1
NCGC00257864-01,tox21-er-bla-agonist-p2,tert-Butyl phenyl glycidyl ether,activity,inactive,3101-60-8,18360.0,CC(C)(C)c2ccc(OCC1CO1)cc2
NCGC00257886-01,tox21-er-bla-agonist-p2,Meprobamate,activity,inactive,57-53-4,4064.0,O=C(N)OCC(C)(COC(=O)N)CCC
NCGC00257983-01,tox21-er-bla-agonist-p2,Gluconolactone,activity,inactive,90-80-2,7027.0,O[C@H]1[C@H](O)[C@@H](O)C(=O)O[C@@H]1CO
NCGC00258360-01,tox21-er-bla-agonist-p2,Bromodichloromethane,activity,inactive,75-27-4,6359.0,BrC(Cl)Cl
NCGC00256646-01,tox21-er-bla-agonist-p2,Glycocholic acid,activity,inactive,475-31-0,10140.0,O=C(O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
NCGC00256683-01,tox21-er-bla-agonist-p2,3-Phenylpropanal,activity,inactive,104-53-0,7707.0,O=CCCc1ccccc1
NCGC00256702-01,tox21-er-bla-agonist-p2,"2,4-DB-isooctyl ester",activity,inactive,1320-15-6,60196431.0,Clc1cc(Cl)ccc1OCCCC(=O)OC(CC)CCCCC
NCGC00255793-01,tox21-er-bla-agonist-p2,Citral oxime,activity,inactive,13372-77-5,114644.0,C/C(C)=C\CCC(C)=C\C=N\O
NCGC00255902-01,tox21-er-bla-agonist-p2,"2,2'-[Ethane-1,2-diylbis(oxy)]diethanethiol",activity,inactive,14970-87-7,84733.0,SCCOCCOCCS
NCGC00256250-01,tox21-er-bla-agonist-p2,4-Methyl-1-(propan-2-yl)cyclohex-3-en-1-ol,activity,inactive,562-74-3,11230.0,CC(C)C1(O)CC=C(C)CC1
NCGC00256288-01,tox21-er-bla-agonist-p2,Ethyl levulinate,activity,inactive,539-88-8,10883.0,O=C(C)CCC(=O)OCC
NCGC00256356-01,tox21-er-bla-agonist-p2,"3,4-Dihydrocoumarin",activity,inactive,119-84-6,660.0,O=C1CCc2ccccc2O1
NCGC00260617-01,tox21-er-bla-agonist-p2,NTP Mix20 AR1 8-EQC,activity,active agonist,NOCAS_49513,,
NCGC00259361-01,tox21-er-bla-agonist-p2,"1,2-Propylene glycol",activity,inactive,57-55-6,1030.0,CC(O)CO
NCGC00259722-01,tox21-er-bla-agonist-p2,Heptanal,activity,inactive,111-71-7,8130.0,CCCCCCC=O
NCGC00260059-01,tox21-er-bla-agonist-p2,Ethanol,activity,inactive,64-17-5,702.0,CCO
NCGC00258672-01,tox21-er-bla-agonist-p2,"1,4,5-Trihydroxynaphthalene",activity,inactive,481-40-3,3083585.0,Oc1ccc(O)c2cccc(O)c12
NCGC00254708-01,tox21-er-bla-agonist-p2,Crotamiton,activity,inactive,483-63-6,2883.0,CCN(C(=O)C=CC)c1ccccc1C
NCGC00254714-01,tox21-er-bla-agonist-p2,Ethyl phenylacetate,activity,inactive,101-97-3,7590.0,O=C(OCC)Cc1ccccc1
NCGC00254874-01,tox21-er-bla-agonist-p2,"1,4-Dioxacycloheptadecane-5,17-dione",activity,inactive,105-95-3,61014.0,O=C1CCCCCCCCCCCC(=O)OCCO1
NCGC00255018-01,tox21-er-bla-agonist-p2,Methomyl,activity,inactive,16752-77-5,4109.0,C\C(=N\OC(=O)NC)SC
NCGC00255128-01,tox21-er-bla-agonist-p2,Diethylene glycol diethyl ether,activity,inactive,112-36-7,8179.0,CCOCCOCCOCC
NCGC00255313-01,tox21-er-bla-agonist-p2,tert-Butyl acetate,activity,inactive,540-88-5,10908.0,CC(=O)OC(C)(C)C
NCGC00255343-01,tox21-er-bla-agonist-p2,Guaifenesin,activity,inactive,93-14-1,3516.0,OCC(O)COc1ccccc1OC
NCGC00255633-01,tox21-er-bla-agonist-p2,"2,5,8,11,14-Pentaoxahexadecan-16-ol",activity,inactive,23778-52-1,90255.0,COCCOCCOCCOCCOCCO
NCGC00255844-01,tox21-er-bla-agonist-p2,Ethyl diethanolamine,activity,inactive,139-87-7,8769.0,CCN(CCO)CCO
NCGC00254506-01,tox21-er-bla-agonist-p2,N-Ethyl-3-methylaniline,activity,inactive,102-27-2,7603.0,CCNc1cc(C)ccc1
NCGC00254548-01,tox21-er-bla-agonist-p2,PFHxA,activity,inactive,307-24-4,67542.0,FC(F)(C(F)(F)C(=O)O)C(F)(F)C(F)(F)C(F)(F)F
NCGC00160454-01,tox21-er-bla-agonist-p2,Felbinac ethyl,activity,inactive,14062-23-8,26436.0,O=C(OCC)Cc1ccc(cc1)c2ccccc2
NCGC00167497-01,tox21-er-bla-agonist-p2,Acipimox,activity,inactive,51037-30-0,5310993.0,[O-][n+]1cc(ncc1C)C(O)=O
NCGC00160499-01,tox21-er-bla-agonist-p2,Dicarbine,activity,inactive,17411-19-7,65684.0,Cc3cc1c(NC2CCN(C)CC12)cc3
NCGC00095597-01,tox21-er-bla-agonist-p2,Andrographolide,activity,inactive,5508-58-7,5318517.0,O[C@@H]3COC(=O)\C3=C\C[C@@H]1C(=C)CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]12C
NCGC00096049-01,tox21-er-bla-agonist-p2,"1,1-Diethyl-2-hydroxy-2-nitrosohydrazine diethylamine",activity,inactive,372965-00-9,9920715.0,CCN(CC)N(O)N=O.CCNCC
NCGC00160593-01,tox21-er-bla-agonist-p2,Oletimol,activity,inactive,5879-67-4,5358237.0,Oc2ccccc2C(\C)=N\Cc1ccccc1
NCGC00160651-01,tox21-er-bla-agonist-p2,Sulfasuccinamide,activity,inactive,3563-14-2,60582.0,O=S(N)(=O)c1ccc(NC(=O)CCC(=O)O)cc1
NCGC00166213-01,tox21-er-bla-agonist-p2,2-Octyl-1-dodecanol,activity,inactive,5333-42-6,21414.0,CCCCCCCCC(CCCCCCCCCC)CO
NCGC00181129-01,tox21-er-bla-agonist-p2,Dasatinib,activity,inactive,302962-49-8,3062316.0,Cc4cccc(Cl)c4NC(=O)c3cnc(Nc1nc(C)nc(c1)N2CCN(CCO)CC2)s3
NCGC00181911-01,tox21-er-bla-agonist-p2,Bucolome,activity,inactive,841-73-6,2461.0,O=C2C(CCCC)C(=O)NC(=O)N2C1CCCCC1
NCGC00182994-01,tox21-er-bla-agonist-p2,Anacolin,activity,inactive,21216-78-4,210301.0,[I-].C[N+]1(CCCCC1)CC2COC(O2)(c3ccccc3)c4ccccc4
NCGC00182996-01,tox21-er-bla-agonist-p2,Pamicogrel,activity,inactive,101001-34-7,65870.0,O=C(OCC)Cn1cccc1c2nc(c(s2)c3ccc(OC)cc3)c4ccc(OC)cc4
NCGC00254974-01,tox21-er-bla-agonist-p2,Flufenacet,activity,inactive,142459-58-3,86429.0,O=C(COc1nnc(s1)C(F)(F)F)N(c2ccc(F)cc2)C(C)C
NCGC00185771-01,tox21-er-bla-agonist-p2,Sultopride hydrochloride,activity,inactive,23694-17-9,3082221.0,Cl.CCN2CCCC2CNC(=O)c1cc(ccc1OC)S(=O)(=O)CC
NCGC00254162-01,tox21-er-bla-agonist-p2,1-Tridecanol,activity,inactive,112-70-9,8207.0,CCCCCCCCCCCCCO
NCGC00254218-01,tox21-er-bla-agonist-p2,Quercetin,activity,active agonist,117-39-5,5280343.0,Oc1ccc(cc1O)C=3Oc2cc(O)cc(O)c2C(=O)C=3O
NCGC00229703-01,tox21-er-bla-agonist-p2,Cycloguanil hydrochloride,activity,inactive,152-53-4,9048.0,Cl.Clc1ccc(cc1)N2C(N)=NC(N)=NC2(C)C
NCGC00254227-01,tox21-er-bla-agonist-p2,"1,3-Dibromo-5,5-dimethylhydantoin",activity,inactive,77-48-5,6479.0,O=C1N(Br)C(=O)N(Br)C1(C)C
NCGC00254649-01,tox21-er-bla-agonist-p2,Dinoterb,activity,inactive,1420-07-1,14994.0,O=[N+]([O-])c1cc(cc(c1O)C(C)(C)C)[N+]([O-])=O
NCGC00254679-01,tox21-er-bla-agonist-p2,"2,5-Dichloro-3-nitrobenzoic acid",activity,inactive,88-86-8,6951.0,O=[N+]([O-])c1cc(Cl)cc(C(=O)O)c1Cl
NCGC00247716-01,tox21-er-bla-agonist-p2,(+)-Pentazocine succinate,activity,inactive,124819-26-7,12259684.0,O=C(O)CCC(=O)O.C/C(C)=C\CN2CC[C@]1(C)c3cc(O)ccc3C[C@H]2[C@H]1C
NCGC00255399-01,tox21-er-bla-agonist-p2,Purpurin,activity,inactive,81-54-9,6683.0,O=C2c1ccccc1C(=O)c3c2c(O)cc(O)c3O
NCGC00253914-01,tox21-er-bla-agonist-p2,"1,2-Dichlorobenzene",activity,inactive,95-50-1,7239.0,Clc1ccccc1Cl
NCGC00253990-01,tox21-er-bla-agonist-p2,CP-465394,activity,inactive,NOCAS_47255,60196399.0,[Na+].OC(C)(C)c1coc(c1)S(=O)(=O)[N-]C(=O)Nc2c(cccc2C(C)C)C(C)C
NCGC00254003-01,tox21-er-bla-agonist-p2,2-(2-Ethoxyethoxy)ethanol,activity,inactive,111-90-0,8146.0,OCCOCCOCC
NCGC00254050-01,tox21-er-bla-agonist-p2,Farglitazar,activity,inactive,196808-45-4,170364.0,O=C(O)[C@@H](Nc2ccccc2C(=O)c1ccccc1)Cc3ccc(cc3)OCCc4nc(oc4C)c5ccccc5
NCGC00254057-01,tox21-er-bla-agonist-p2,Caffeine,activity,inactive,58-08-2,2519.0,O=C2c1n(C)cnc1N(C)C(=O)N2C
NCGC00259466-01,tox21-er-bla-agonist-p2,"3-(Dodecenyl)dihydro-2,5-furandione",activity,inactive,25377-73-5,32933.0,O=C1OC(=O)CC1C=CCCCCCCCCCC
NCGC00256603-01,tox21-er-bla-agonist-p2,Nitroethane,activity,inactive,79-24-3,6587.0,[O-][N+](=O)CC
NCGC00260166-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium iodide,activity,inactive,65039-05-6,11448496.0,[I-].CCCCn1cc[n+](C)c1
NCGC00260393-01,tox21-er-bla-agonist-p2,Iminobis-3-propylamine,activity,inactive,56-18-8,5942.0,NCCCNCCCN
NCGC00260568-01,tox21-er-bla-agonist-p2,NTP Mix76 CT1 62-EQP,activity,inactive,NOCAS_49464,,
NCGC00161328-03,tox21-er-bla-agonist-p2,"24R,25-Dihydroxyvitamin D3",activity,inactive,55721-11-4,5283748.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)CC[C@@H](O)C(C)(C)O
NCGC00256620-01,tox21-er-bla-agonist-p2,Methapyrilene fumarate,activity,inactive,33032-12-1,6436730.0,O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.CN(C)CCN(Cc1cccs1)c2ccccn2.CN(C)CCN(Cc1cccs1)c2ccccn2
NCGC00257201-01,tox21-er-bla-agonist-p2,"1,4-Dibromobenzene",activity,inactive,106-37-6,7804.0,Brc1ccc(Br)cc1
NCGC00257822-01,tox21-er-bla-agonist-p2,"4,4'-Diphenylmethane diisocyanate",activity,inactive,101-68-8,7570.0,O=C=N/c1ccc(cc1)Cc2ccc(/N=C=O)cc2
NCGC00257461-01,tox21-er-bla-agonist-p2,"2,2',6,6'-Tetrachlorobisphenol A",activity,active agonist,79-95-8,6619.0,Clc1cc(cc(Cl)c1O)C(C)(C)c2cc(Cl)c(O)c(Cl)c2
NCGC00257721-01,tox21-er-bla-agonist-p2,"3,4-Dihydroxybenzoic acid",activity,inactive,99-50-3,72.0,Oc1ccc(cc1O)C(=O)O
NCGC00258254-01,tox21-er-bla-agonist-p2,Oxazepam,activity,inactive,604-75-1,4616.0,Clc1ccc2NC(=O)C(O)N=C(c2c1)c3ccccc3
NCGC00257241-01,tox21-er-bla-agonist-p2,3-Methyl-2-buten-1-ol,activity,inactive,556-82-1,11173.0,C/C(C)=C\CO
NCGC00258563-01,tox21-er-bla-agonist-p2,Dacarbazine,activity,inactive,4342-03-4,5281007.0,CN(C)/N=N/c1ncnc1C(N)=O
NCGC00258681-01,tox21-er-bla-agonist-p2,Allyl anthranilate,activity,inactive,7493-63-2,24116.0,Nc1ccccc1C(=O)OCC=C
NCGC00256561-01,tox21-er-bla-agonist-p2,"(1R,2S,5R)-(-)-Menthol",activity,inactive,2216-51-5,16666.0,CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O
NCGC00254107-01,tox21-er-bla-agonist-p2,Sodium (2-pyridylthio)-N-oxide,activity,inactive,3811-73-2,19658.0,[Na+].[O-][n+]1ccccc1[S-]
NCGC00254374-01,tox21-er-bla-agonist-p2,"Hexane-1,6-diyl dibenzoate",activity,inactive,22915-73-7,261668.0,O=C(OCCCCCCOC(=O)c1ccccc1)c2ccccc2
NCGC00256141-01,tox21-er-bla-agonist-p2,Aluminum triformate,activity,inactive,7360-53-4,16700308.0,O=CO[Al](OC=O)OC=O
NCGC00256950-01,tox21-er-bla-agonist-p2,Dodecyl sulfate triethanolamine,activity,inactive,139-96-8,8777.0,OCCN(CCO)CCO.OS(=O)(=O)OCCCCCCCCCCCC
NCGC00256892-01,tox21-er-bla-agonist-p2,Benzyl 3-methylbutanoate,activity,inactive,103-38-8,7651.0,CC(C)CC(=O)OCc1ccccc1
NCGC00256982-01,tox21-er-bla-agonist-p2,Isobutyl methacrylate,activity,inactive,97-86-9,7352.0,CC(=C)C(=O)OCC(C)C
NCGC00257133-01,tox21-er-bla-agonist-p2,Sodium dichloroisocyanurate,activity,inactive,2893-78-9,517121.0,[Na+].ClN1C(=O)[N-]C(=O)N(Cl)C1=O
NCGC00257599-01,tox21-er-bla-agonist-p2,"1H,3H-Naphtho(1,8-cd)pyran-1,3-dione",activity,inactive,81-84-5,6693.0,O=C3OC(=O)c2cccc1cccc3c12
NCGC00257710-01,tox21-er-bla-agonist-p2,"2,2',4,4',5-Pentabromodiphenyl ether",activity,inactive,60348-60-9,36159.0,Brc2cc(Oc1ccc(Br)cc1Br)c(Br)cc2Br
NCGC00257752-01,tox21-er-bla-agonist-p2,4-Hydrazinobenzoic acid,activity,inactive,619-67-0,12089.0,NNc1ccc(cc1)C(=O)O
NCGC00257545-01,tox21-er-bla-agonist-p2,Thiamine thiozole,activity,inactive,137-00-8,1136.0,OCCc1scnc1C
NCGC00257769-01,tox21-er-bla-agonist-p2,3-Methylaniline hydrochloride,activity,inactive,638-03-9,522105.0,Cl.Cc1cc(N)ccc1
NCGC00258070-01,tox21-er-bla-agonist-p2,Tetracycline hydrochloride,activity,inactive,64-75-5,54704426.0,Cl.NC(=O)C1=C(O)[C@@H](N(C)C)[C@@H]2C[C@H]4C(=C(O)[C@]2(O)C1=O)C(=O)c3c(O)cccc3[C@@]4(C)O
NCGC00258493-01,tox21-er-bla-agonist-p2,"2,4-Dichloro-1-(trichloromethyl)benzene",activity,inactive,13014-18-1,25607.0,ClC(Cl)(Cl)c1ccc(Cl)cc1Cl
NCGC00259087-01,tox21-er-bla-agonist-p2,"2,6,8-Trimethyl-4-nonanone",activity,inactive,123-18-2,61057.0,CC(C)CC(C)CC(=O)CC(C)C
NCGC00258033-01,tox21-er-bla-agonist-p2,4-Methylmorpholine 4-oxide,activity,inactive,7529-22-8,82029.0,[O-][N+]1(C)CCOCC1
NCGC00259238-01,tox21-er-bla-agonist-p2,Meloxicam,activity,inactive,71125-38-7,54677470.0,Cc3cnc(NC(=O)C2=C(O)c1ccccc1S(=O)(=O)N2C)s3
NCGC00259535-01,tox21-er-bla-agonist-p2,Atrazine,activity,inactive,1912-24-9,2256.0,Clc1nc(NCC)nc(NC(C)C)n1
NCGC00259878-01,tox21-er-bla-agonist-p2,4-tert-Butyltoluene,activity,inactive,98-51-1,7390.0,Cc1ccc(cc1)C(C)(C)C
NCGC00259459-01,tox21-er-bla-agonist-p2,Ziram,activity,active agonist,137-30-4,8722.0,[Zn+2].S=C([S-])N(C)C.CN(C)C([S-])=S
NCGC00260488-01,tox21-er-bla-agonist-p2,9-Anthracenecarboxylic acid,activity,inactive,723-62-6,2201.0,O=C(O)c2c3ccccc3cc1ccccc12
NCGC00260168-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylimidazolium tetrachloroferrate (III),activity,inactive,359845-21-9,11674455.0,CCCCn1cc[n+](C)c1.Cl[Fe-](Cl)(Cl)Cl
NCGC00015741-06,tox21-er-bla-agonist-p2,Masoprocol,activity,inactive,27686-84-6,71398.0,Oc2ccc(C[C@@H](C)[C@@H](C)Cc1ccc(O)c(O)c1)cc2O
NCGC00015479-09,tox21-er-bla-agonist-p2,Genistein,activity,active agonist,446-72-0,5280961.0,Oc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O
NCGC00016055-05,tox21-er-bla-agonist-p2,Trimethoprim,activity,inactive,738-70-5,5578.0,Nc2nc(N)ncc2Cc1cc(OC)c(OC)c(OC)c1
NCGC00016240-01,tox21-er-bla-agonist-p2,Nadide,activity,inactive,53-84-9,5892.0,NC(=O)c1ccc[n+](c1)[C@@H]5O[C@H](COP([O-])(=O)OP(=O)(O)OC[C@H]4O[C@@H](n3cnc2c(N)ncnc23)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]5O
NCGC00016421-01,tox21-er-bla-agonist-p2,Cyclizine hydrochloride,activity,inactive,303-25-3,67533.0,Cl.Cl.CN1CCN(CC1)C(c2ccccc2)c3ccccc3
NCGC00016687-01,tox21-er-bla-agonist-p2,Spiramycin,activity,inactive,8025-81-8,5284619.0,CN(C)[C@H]1CC[C@H](O[C@@H]1C)O[C@H]4C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@H](OC)[C@@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]3O)N(C)C)[C@@H](CC=O)C[C@H]4C
NCGC00016709-01,tox21-er-bla-agonist-p2,Benserazide hydrochloride,activity,inactive,14919-77-8,26964.0,Cl.Oc1ccc(CNNC(=O)C(N)CO)c(O)c1O
NCGC00016046-02,tox21-er-bla-agonist-p2,Tyrphostin 25,activity,inactive,118409-58-8,2061.0,Oc1cc(\C=C(/C#N)C#N)cc(O)c1O
NCGC00159410-03,tox21-er-bla-agonist-p2,D-Galactitol,activity,inactive,608-66-2,11850.0,O[C@H]([C@@H](O)CO)[C@@H](O)[C@H](O)CO
NCGC00166236-01,tox21-er-bla-agonist-p2,Potassium oxonate,activity,inactive,2207-75-2,2723920.0,[K+].O=C([O-])c1nc(O)nc(O)n1
NCGC00255095-01,tox21-er-bla-agonist-p2,"3,7-Dimethyloct-6-en-3-ol",activity,inactive,18479-51-1,86749.0,CCC(C)(O)CC\C=C(\C)C
NCGC00256153-01,tox21-er-bla-agonist-p2,"2,2'-[Ethane-1,2-diylbis(oxy)]diethanamine",activity,inactive,929-59-9,70248.0,NCCOCCOCCN
NCGC00254348-01,tox21-er-bla-agonist-p2,PHA-00568487,activity,inactive,527680-56-4,9932000.0,O=C(N[C@H]2CN1CCC2CC1)c3ccc4OCCOc4c3
NCGC00254453-01,tox21-er-bla-agonist-p2,"2,4,6-Trimethylphenol",activity,inactive,527-60-6,10698.0,Cc1cc(C)c(O)c(C)c1
NCGC00255113-01,tox21-er-bla-agonist-p2,2-Hydrazino-4-(4-nitrophenyl)thiazole,activity,inactive,26049-70-7,4373502.0,NNc1nc(cs1)c2ccc(cc2)[N+]([O-])=O
NCGC00255502-01,tox21-er-bla-agonist-p2,MCPA-sodium,activity,inactive,3653-48-3,2724048.0,[Na+].Clc1cc(C)c(OCC([O-])=O)cc1
NCGC00255545-01,tox21-er-bla-agonist-p2,C.I. Acid Yellow 3 disodium salt,activity,inactive,8004-92-0,24671.0,[Na+].[Na+].[O-]S(=O)(=O)c1cc(cc2ccc(nc12)C4C(=O)c3ccccc3C4=O)S([O-])(=O)=O
NCGC00254191-01,tox21-er-bla-agonist-p2,CI-1018,activity,inactive,NOCAS_47248,9865514.0,Cc2cc3C(=N[C@@H](NC(=O)c1ccncc1)C(=O)N4CCc(c2)c34)c5ccccc5
NCGC00254303-01,tox21-er-bla-agonist-p2,Fluorene,activity,inactive,86-73-7,6853.0,c1cccc2Cc3ccccc3c12
NCGC00091183-02,tox21-er-bla-agonist-p2,"2,4,6-Tribromophenol",activity,inactive,118-79-6,1483.0,Brc1cc(Br)cc(Br)c1O
NCGC00094673-01,tox21-er-bla-agonist-p2,Estradiol valerate,activity,active agonist,979-32-8,13791.0,CCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C
NCGC00094747-01,tox21-er-bla-agonist-p2,Oxidopamine hydrochloride,activity,inactive,28094-15-7,160157.0,Cl.Oc1cc(CCN)c(O)cc1O
NCGC00160504-01,tox21-er-bla-agonist-p2,Testosterone 17-phenylpropionate,activity,active agonist,1255-49-8,14743.0,O=C5CC[C@@]4(C)C(CC[C@@H]2[C@@H]4CC[C@]3(C)[C@@H](OC(=O)CCc1ccccc1)CC[C@@H]23)=C5
NCGC00183119-01,tox21-er-bla-agonist-p2,Altrenogest,activity,active agonist,850-52-2,10041070.0,O=C3C=C4CC[C@@H]2C(C=C[C@@]1(C)[C@H]2CC[C@@]1(O)CC=C)=C4CC3
NCGC00254029-01,tox21-er-bla-agonist-p2,"2-(Hydroxymethyl)-2-nitro-1,3-propanediol",activity,inactive,126-11-4,31337.0,O=[N+]([O-])C(CO)(CO)CO
NCGC00254798-01,tox21-er-bla-agonist-p2,Sulfaquinoxaline,activity,inactive,59-40-5,5338.0,Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2
NCGC00255039-01,tox21-er-bla-agonist-p2,Icaridin,activity,inactive,119515-38-7,125098.0,CC(OC(=O)N1CCCCC1CCO)CC
NCGC00255045-01,tox21-er-bla-agonist-p2,Diphenylmethane,activity,inactive,101-81-5,7580.0,c1ccccc1Cc2ccccc2
NCGC00259539-01,tox21-er-bla-agonist-p2,Piperine,activity,inactive,94-62-2,638024.0,O=C(/C=C/C=C/c1ccc2OCOc2c1)N3CCCCC3
NCGC00260438-01,tox21-er-bla-agonist-p2,6-Amino-4-chloro-1-phenol-2-sulfonic acid,activity,inactive,88-23-3,6927.0,OS(=O)(=O)c1cc(Cl)cc(N)c1O
NCGC00260643-01,tox21-er-bla-agonist-p2,NTP Mix84 ER AR1 18-EQC,activity,active agonist,NOCAS_49539,,
NCGC00014017-01,tox21-er-bla-agonist-p2,Proline,activity,inactive,609-36-9,614.0,O=C(O)C1CCCN1
NCGC00016193-02,tox21-er-bla-agonist-p2,Pempidine d-tartaric acid,activity,inactive,546-48-5,60196260.0,CC1(C)CCCC(C)(C)N1C.O=C(O)[C@@H](O)[C@H](O)C(=O)O
NCGC00016604-01,tox21-er-bla-agonist-p2,Flumethasone,activity,inactive,2135-17-3,16490.0,OCC(=O)[C@@]4(O)[C@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3C[C@H](F)C1=CC(=O)C=C[C@@]12C
NCGC00016755-01,tox21-er-bla-agonist-p2,Oxamniquine,activity,inactive,21738-42-1,4612.0,[O-][N+](=O)c1cc2NC(CCc2cc1CO)CNC(C)C
NCGC00016922-01,tox21-er-bla-agonist-p2,Florfenicol,activity,inactive,73231-34-2,114811.0,O=S(C)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl
NCGC00017122-02,tox21-er-bla-agonist-p2,Piperacillin sodium salt,activity,inactive,59703-84-3,60196356.0,[Na+].O=C([O-])[C@H]3N4C(=O)[C@@H](NC(=O)[C@H](NC(=O)N1CCN(CC)C(=O)C1=O)c2ccccc2)[C@H]4SC3(C)C
NCGC00094720-01,tox21-er-bla-agonist-p2,Methicillin sodium hydrate,activity,inactive,7246-14-2,23678596.0,[Na+].O.O=C([O-])[C@@H]2N3C(=O)[C@@H](NC(=O)c1c(OC)cccc1OC)[C@H]3SC2(C)C
NCGC00163230-01,tox21-er-bla-agonist-p2,Chlorisondamine chloride,activity,inactive,69-27-2,6243.0,[Cl-].[Cl-].C[N+](C)(C)CC[N+]1(C)Cc2c(Cl)c(Cl)c(Cl)c(Cl)c2C1
NCGC00183867-01,tox21-er-bla-agonist-p2,Aloin,activity,inactive,8015-61-0,12305761.0,O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@@H]1CO)[C@H]4c2cccc(O)c2C(=O)c3c(O)cc(CO)cc34
NCGC00254176-01,tox21-er-bla-agonist-p2,"p,p'-DDT",activity,active agonist,50-29-3,3036.0,Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl
NCGC00254282-01,tox21-er-bla-agonist-p2,5HPP-33,activity,active agonist,105624-86-0,11723708.0,CC(C)c1cccc(C(C)C)c1N3C(=O)c2ccc(O)cc2C3=O
NCGC00254590-01,tox21-er-bla-agonist-p2,"5-Ethyl-2,3-pyridinedicarboxylic acid",activity,inactive,102268-15-5,113606.0,OC(=O)c1ncc(cc1C(=O)O)CC
NCGC00090892-01,tox21-er-bla-agonist-p2,Urea,activity,inactive,57-13-6,1176.0,NC(N)=O
NCGC00025346-02,tox21-er-bla-agonist-p2,Mirtazapine,activity,inactive,61337-67-5,4205.0,CN1CC2N(CC1)c4ncccc4Cc3ccccc23
NCGC00256993-01,tox21-er-bla-agonist-p2,Tolyltriazole,activity,inactive,29385-43-1,122499.0,Cc1cccc2nnnc12
NCGC00258380-01,tox21-er-bla-agonist-p2,Methacrylic acid,activity,inactive,79-41-4,4093.0,C=C(C)C(=O)O
NCGC00258576-01,tox21-er-bla-agonist-p2,Uracil,activity,inactive,66-22-8,1174.0,O=C1C=CNC(=O)N1
NCGC00257220-01,tox21-er-bla-agonist-p2,2-[2-(2-Methoxyethoxy)ethoxy]ethanol,activity,inactive,112-35-6,8178.0,OCCOCCOCCOC
NCGC00257722-01,tox21-er-bla-agonist-p2,"1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene",activity,inactive,76150-91-9,5382.0,Clc3cc(Cl)cnc3Oc1ccc(cc1)Oc2ncc(Cl)cc2Cl
NCGC00258122-01,tox21-er-bla-agonist-p2,D-alpha-Tocopheryl succinate,activity,inactive,4345-03-3,20353.0,O=C(O)CCC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00258237-01,tox21-er-bla-agonist-p2,8-Nitroquinoline,activity,inactive,607-35-2,11830.0,[O-][N+](=O)c1cccc2cccnc12
NCGC00256369-01,tox21-er-bla-agonist-p2,"1,2,3-Trichloropropane",activity,inactive,96-18-4,7285.0,ClCC(Cl)CCl
NCGC00256422-01,tox21-er-bla-agonist-p2,Praziquantel,activity,inactive,55268-74-1,4891.0,O=C2CN(CC1c3ccccc3CCN12)C(=O)C4CCCCC4
NCGC00256430-01,tox21-er-bla-agonist-p2,Nitrosomethylaniline,activity,inactive,614-00-6,11957.0,O=NN(C)c1ccccc1
NCGC00256093-01,tox21-er-bla-agonist-p2,Thiocyclam oxalate,activity,inactive,31895-22-4,35969.0,CN(C)C1CSSSC1.O=C(O)C(=O)O
NCGC00256231-01,tox21-er-bla-agonist-p2,2-Chlorobenzenesulfonamide,activity,inactive,6961-82-6,81410.0,O=S(N)(=O)c1ccccc1Cl
NCGC00256276-01,tox21-er-bla-agonist-p2,Ethyl benzoylacetate,activity,inactive,94-02-0,7170.0,O=C(CC(=O)OCC)c1ccccc1
NCGC00255681-01,tox21-er-bla-agonist-p2,2-Octyl-1-dodecanol,activity,inactive,5333-42-6,21414.0,CCCCCCCCC(CCCCCCCCCC)CO
NCGC00259200-01,tox21-er-bla-agonist-p2,tert-Nonanethiol,activity,inactive,25360-10-5,520196.0,CC(C)(S)CCCCCC
NCGC00259202-01,tox21-er-bla-agonist-p2,"Propanol, 1(or 2)-(2-methoxymethylethoxy)-",activity,inactive,34590-94-8,22833331.0,COCCCOC(O)CC
NCGC00259274-01,tox21-er-bla-agonist-p2,"Hexachloro-1,3-butadiene",activity,inactive,87-68-3,6901.0,Cl/C(Cl)=C(\Cl)C(\Cl)=C(\Cl)Cl
NCGC00259434-01,tox21-er-bla-agonist-p2,2-[2-(2-Butoxyethoxy)ethoxy]ethanol,activity,inactive,143-22-6,8923.0,OCCOCCOCCOCCCC
NCGC00259766-01,tox21-er-bla-agonist-p2,Nitroethane,activity,inactive,79-24-3,6587.0,[O-][N+](=O)CC
NCGC00259880-01,tox21-er-bla-agonist-p2,Tebuconazole,activity,inactive,107534-96-3,86102.0,OC(Cn1cncn1)(CCc2ccc(Cl)cc2)C(C)(C)C
NCGC00259907-01,tox21-er-bla-agonist-p2,4-Chlorophenyl methyl sulfide,activity,inactive,123-09-1,31243.0,CSc1ccc(Cl)cc1
NCGC00260128-01,tox21-er-bla-agonist-p2,"Propane, 1-(ethenyloxy)-2-methyl-",activity,inactive,109-53-5,7992.0,CC(C)COC=C
NCGC00254865-01,tox21-er-bla-agonist-p2,gamma-Terpinene,activity,inactive,99-85-4,7461.0,CC1=CCC(=CC1)C(C)C
NCGC00254919-01,tox21-er-bla-agonist-p2,Tetramethrin,activity,inactive,7696-12-0,83975.0,C\C(C)=C/C3C(C(=O)OCN2C(=O)C=1CCCCC=1C2=O)C3(C)C
NCGC00255096-01,tox21-er-bla-agonist-p2,N-Benzylethanolamine,activity,inactive,104-63-2,4348.0,OCCNCc1ccccc1
NCGC00255688-01,tox21-er-bla-agonist-p2,Benazolin-ethyl,activity,inactive,25059-80-7,3034351.0,O=C(OCC)CN2c1c(cccc1Cl)SC2=O
NCGC00091073-01,tox21-er-bla-agonist-p2,Diazinon,activity,inactive,333-41-5,3017.0,Cc1cc(OP(=S)(OCC)OCC)nc(n1)C(C)C
NCGC00091810-01,tox21-er-bla-agonist-p2,"1-Fluoro-2,4-dinitrobenzene",activity,inactive,70-34-8,6264.0,Fc1ccc(cc1[N+](=O)[O-])[N+]([O-])=O
NCGC00091925-01,tox21-er-bla-agonist-p2,Cobalt sulfate heptahydrate,activity,inactive,10026-24-1,61444.0,O.O.O.O.[Co+2].O.O.O.[O-]S([O-])(=O)=O
NCGC00094324-02,tox21-er-bla-agonist-p2,Pyridostigmine bromide,activity,inactive,101-26-8,7550.0,[Br-].O=C(Oc1ccc[n+](C)c1)N(C)C
NCGC00164240-01,tox21-er-bla-agonist-p2,"Sorbitan, mono-(9Z)-9-octadecenoate",activity,inactive,1338-43-8,9920342.0,O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O
NCGC00094703-01,tox21-er-bla-agonist-p2,Isosorbide dinitrate,activity,inactive,87-33-2,6883.0,[O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+]([O-])=O)CO[C@H]12
NCGC00094810-01,tox21-er-bla-agonist-p2,Warfarin,activity,inactive,81-81-2,54678486.0,CC(=O)CC(C1=C(O)c2ccccc2OC1=O)c3ccccc3
NCGC00164429-01,tox21-er-bla-agonist-p2,Ethylenediaminetetraacetic acid ferric sodium salt,activity,inactive,15708-41-5,27461.0,[Fe+3].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O
NCGC00164602-01,tox21-er-bla-agonist-p2,Ractopamine hydrochloride,activity,inactive,90274-24-1,14010333.0,Cl.OC(CNC(C)CCc1ccc(O)cc1)c2ccc(O)cc2
NCGC00165808-01,tox21-er-bla-agonist-p2,Ilmofosine,activity,inactive,83519-04-4,55008.0,C[N+](C)(C)CCOP([O-])(=O)OCC(COC)CSCCCCCCCCCCCCCCCC
NCGC00168777-01,tox21-er-bla-agonist-p2,Etonogestrel,activity,active agonist,54048-10-1,6917715.0,C=C3C[C@@]1(CC)[C@@H](CC[C@@]1(O)C#C)[C@@H]4CCC2=CC(=O)CC[C@@H]2[C@@H]34
NCGC00168780-01,tox21-er-bla-agonist-p2,Milnacipran hydrochloride,activity,inactive,101152-94-7,163701.0,Cl.O=C(N(CC)CC)[C@@]1(C[C@@H]1CN)c2ccccc2
NCGC00142580-03,tox21-er-bla-agonist-p2,Pyridoxal,activity,inactive,66-72-8,1050.0,Oc1c(C=O)c(cnc1C)CO
NCGC00181092-01,tox21-er-bla-agonist-p2,Ipodate sodium,activity,inactive,1221-56-3,23671932.0,[Na+].[O-]C(=O)CCc1c(I)c(/N=C/N(C)C)c(I)cc1I
NCGC00183862-01,tox21-er-bla-agonist-p2,Tolrestat,activity,inactive,75820-08-5,53359.0,O=C(O)CN(C)C(=S)c2cccc1c2ccc(OC)c1C(F)(F)F
NCGC00185770-01,tox21-er-bla-agonist-p2,"Sucrose octasulfate, sodium salt",activity,active agonist,74135-10-7,60196368.0,[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)O[C@H]1[C@H](O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]1OS([O-])=O)O[C@]2(COS([O-])=O)O[C@H](COS([O-])=O)[C@@H](OS([O-])=O)[C@@H]2OS([O-])=O
NCGC00255275-01,tox21-er-bla-agonist-p2,Felbamate,activity,inactive,25451-15-4,3331.0,NC(=O)OCC(COC(N)=O)c1ccccc1
NCGC00254239-01,tox21-er-bla-agonist-p2,Benzyloctyl adipate,activity,inactive,58394-64-2,94037.0,CCC(CCCC)COC(=O)CCCCC(=O)OCc1ccccc1
NCGC00247680-01,tox21-er-bla-agonist-p2,Dextromoramide tartrate,activity,inactive,2922-44-3,92942.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.C[C@H](CN1CCOCC1)C(c2ccccc2)(c3ccccc3)C(=O)N4CCCC4
NCGC00247735-01,tox21-er-bla-agonist-p2,Varenicline dihydrochloride,activity,inactive,230615-23-3,50878597.0,Cl.c1c4c(cc2nccnc12)C3CC4CNC3
NCGC00254883-01,tox21-er-bla-agonist-p2,"3,4,5,6-Tetrachloropyridine-2-carboxylic acid",activity,inactive,10469-09-7,82646.0,Clc1c(Cl)c(nc(Cl)c1Cl)C(=O)O
NCGC00254110-01,tox21-er-bla-agonist-p2,SSR180711,activity,inactive,298198-52-4,9797360.0,Brc1ccc(cc1)OC(=O)N3CCN2CCC3CC2
NCGC00259365-01,tox21-er-bla-agonist-p2,3-Hydroxy-4-butyrophenetidide,activity,inactive,1083-57-4,14130.0,CCOc1ccc(cc1)NC(=O)CC(C)O
NCGC00258259-01,tox21-er-bla-agonist-p2,Ninhydrin,activity,inactive,485-47-2,10236.0,O=C2c1ccccc1C(=O)C2(O)O
NCGC00260247-01,tox21-er-bla-agonist-p2,1-Hexylpyridinium iodide,activity,inactive,7324-00-7,21917397.0,[I-].CCCCCC[n+]1ccccc1
NCGC00260424-01,tox21-er-bla-agonist-p2,"(4R,5S)-(-)-1,5-Dimethyl-4-phenyl-2-imidazolidinone",activity,inactive,92841-65-1,6931391.0,C[C@@H]2N(C)C(O)=N[C@@H]2c1ccccc1
NCGC00258536-01,tox21-er-bla-agonist-p2,3-Methylbutyl nitrite,activity,inactive,110-46-3,8053.0,CC(C)CCON=O
NCGC00258721-01,tox21-er-bla-agonist-p2,"2,2'-Dihydroxybenzophenone",activity,inactive,835-11-0,70038.0,O=C(c1ccccc1O)c2ccccc2O
NCGC00016543-01,tox21-er-bla-agonist-p2,Phenformin hydrochloride,activity,inactive,834-28-6,13266.0,Cl.N=C(N)NC(=N)NCCc1ccccc1
NCGC00259356-01,tox21-er-bla-agonist-p2,2-Methylbutanoic acid,activity,inactive,116-53-0,8314.0,CC(CC)C(=O)O
NCGC00259393-01,tox21-er-bla-agonist-p2,Isopropyl formate,activity,inactive,625-55-8,12257.0,CC(C)OC=O
NCGC00182056-03,tox21-er-bla-agonist-p2,Dioctyldimethylammonium chloride,activity,inactive,5538-94-3,62581.0,[Cl-].C[N+](C)(CCCCCCCC)CCCCCCCC
NCGC00182707-01,tox21-er-bla-agonist-p2,Atipamezole,activity,inactive,104054-27-5,71310.0,CCC1(Cc2ccccc2C1)c3cncn3
NCGC00256747-01,tox21-er-bla-agonist-p2,Corodane,activity,inactive,13380-94-4,96509.0,O=C1CC2CC1C3CCCC23
NCGC00256609-01,tox21-er-bla-agonist-p2,"1,4-Diazabicyclo[2.2.2]octane",activity,inactive,280-57-9,9237.0,C1CN2CCN1CC2
NCGC00257069-01,tox21-er-bla-agonist-p2,Aluminum tributoxide,activity,inactive,3085-30-1,16684880.0,CCCCO[Al](OCCCC)OCCCC
NCGC00257337-01,tox21-er-bla-agonist-p2,2-Pentylfuran,activity,inactive,3777-69-3,19602.0,CCCCCc1ccco1
NCGC00015580-08,tox21-er-bla-agonist-p2,Ketotifen,activity,inactive,34580-13-7,3827.0,CN1CC/C(CC1)=C3\c4ccccc4CC(=O)c2sccc23
NCGC00164164-02,tox21-er-bla-agonist-p2,N-Methylphthalimide,activity,inactive,550-44-7,11074.0,O=C2c1ccccc1C(=O)N2C
NCGC00247683-01,tox21-er-bla-agonist-p2,1-Methyl-4-phenyl-4-propionoxypiperidine hydrochloride,activity,inactive,4968-48-3,3030770.0,Cl.CN1CCC(OC(=O)CC)(CC1)c2ccccc2
NCGC00255728-01,tox21-er-bla-agonist-p2,"Potassium 2,5-dihydroxybenzenesulfonate",activity,inactive,21799-87-1,23672329.0,[K+].Oc1ccc(O)cc1S(=O)([O-])=O
NCGC00255618-01,tox21-er-bla-agonist-p2,Chlorfluazuron,activity,inactive,71422-67-8,91708.0,Fc1cccc(F)c1C(=O)NC(=O)Nc3cc(Cl)c(Oc2ncc(cc2Cl)C(F)(F)F)c(Cl)c3
NCGC00256120-01,tox21-er-bla-agonist-p2,"3,3,5-Trimethylcyclohexyl 2-methylprop-2-enoate",activity,inactive,7779-31-9,111032.0,O=C(OC1CC(C)CC(C)(C)C1)C(=C)C
NCGC00256458-01,tox21-er-bla-agonist-p2,Biochanin A,activity,active agonist,491-80-5,5280373.0,COc1ccc(cc1)C3=COc2cc(O)cc(O)c2C3=O
NCGC00257094-01,tox21-er-bla-agonist-p2,2-Mercaptobenzimidazole,activity,inactive,583-39-1,707035.0,S=C1Nc2ccccc2N1
NCGC00257199-01,tox21-er-bla-agonist-p2,Pentaethylene glycol,activity,inactive,4792-15-8,62551.0,OCCOCCOCCOCCOCCO
NCGC00257758-01,tox21-er-bla-agonist-p2,"2,4-Dichloronitrobenzene",activity,inactive,611-06-3,11899.0,O=[N+]([O-])c1ccc(Cl)cc1Cl
NCGC00256965-01,tox21-er-bla-agonist-p2,2-Ethylhexanal,activity,inactive,123-05-7,31241.0,CCC(CCCC)C=O
NCGC00258164-01,tox21-er-bla-agonist-p2,1-Butylpyridinium bromide,activity,inactive,874-80-6,2734238.0,[Br-].CCCC[n+]1ccccc1
NCGC00258495-01,tox21-er-bla-agonist-p2,"1,2-Benzenedicarboxylic acid, di-C6-8-branched alkyl esters, C7-rich",activity,inactive,71888-89-6,591200.0,CC(C)CCCCOC(=O)c1ccccc1C(=O)OCCCCC(C)C
NCGC00258703-01,tox21-er-bla-agonist-p2,Fumaronitrile,activity,active agonist,764-42-1,637930.0,N#C\C=C\C#N
NCGC00258713-01,tox21-er-bla-agonist-p2,Diammonium peroxydisulfate,activity,inactive,7727-54-0,62648.0,[NH4+].[NH4+].O=S(=O)([O-])OOS([O-])(=O)=O
NCGC00258720-01,tox21-er-bla-agonist-p2,Carbon disulfide,activity,inactive,75-15-0,6348.0,S=C=S
NCGC00259668-01,tox21-er-bla-agonist-p2,Citronellol,activity,inactive,106-22-9,8842.0,C\C(C)=C\CCC(C)CCO
NCGC00259991-01,tox21-er-bla-agonist-p2,Tribromsalan,activity,inactive,87-10-5,14868.0,Oc1c(cc(Br)cc1Br)C(=O)Nc2ccc(Br)cc2
NCGC00260225-01,tox21-er-bla-agonist-p2,1-Butyl-2-methylpyridinium trifluoromethanesulfonate,activity,inactive,NOCAS_49388,60196390.0,Cc1cccc[n+]1CCCC.FC(F)(F)S([O-])(=O)=O
NCGC00260366-01,tox21-er-bla-agonist-p2,"Benzaldehyde,2-bromo-5-hydroxy-",activity,inactive,2973-80-0,387179.0,O=Cc1cc(O)ccc1Br
NCGC00260630-01,tox21-er-bla-agonist-p2,NTP Mix106 ER1 10-EQC,activity,inactive,NOCAS_49526,,
NCGC00260593-01,tox21-er-bla-agonist-p2,NTP Mix49 CT1 3-EQP,activity,inactive,NOCAS_49489,,
NCGC00014437-01,tox21-er-bla-agonist-p2,"1-(3-Carboxyphenyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid, strychnidin-10-one (1:1)",activity,inactive,NOCAS_45108,16678045.0,O=C(O)c1cc(ccc1)n2c(C)cc(C(=O)O)c2C.O=C2C[C@@H]7OCC=C6CN4CC[C@@]53c1ccccc1N2[C@H]3[C@H]7[C@H]6C[C@H]45
NCGC00016720-01,tox21-er-bla-agonist-p2,Iocetamic acid,activity,inactive,16034-77-8,27648.0,O=C(O)C(C)CN(C(C)=O)c1c(I)cc(I)c(N)c1I
NCGC00016416-01,tox21-er-bla-agonist-p2,Phenylpropanolamine hydrochloride,activity,inactive,154-41-6,6433169.0,Cl.O[C@H]([C@@H](C)N)c1ccccc1
NCGC00016431-01,tox21-er-bla-agonist-p2,Triflusal,activity,inactive,322-79-2,9458.0,O=C(C)Oc1cc(ccc1C(=O)O)C(F)(F)F
NCGC00016801-01,tox21-er-bla-agonist-p2,Levobunolol hydrochloride,activity,inactive,27912-14-7,5284409.0,Cl.CC(C)(C)NC[C@H](O)COc2cccc1c2CCCC1=O
NCGC00016533-05,tox21-er-bla-agonist-p2,Sulfamethoxazole,activity,inactive,723-46-6,5329.0,Cc2cc(NS(=O)(=O)c1ccc(N)cc1)no2
NCGC00016302-01,tox21-er-bla-agonist-p2,Vitamin B12,activity,inactive,68-19-9,5311498.0,NC(=O)CC[C@@H]8C=2N=C(C(C)=C1[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@](C)(N1[Co+]C#N)[C@@H]7N=C(C(C)=C3N=C(C=2)C(C)(C)[C@@H]3CCC(N)=O)[C@](C)(CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@H](n5cnc4cc(C)c(C)cc45)[C@@H]6O)[C@H]7CC(N)=O)[C@@]8(C)CC(N)=O
NCGC00160472-01,tox21-er-bla-agonist-p2,Adrenone,activity,inactive,99-45-6,7436.0,Oc1ccc(cc1O)C(=O)CNC
NCGC00255677-01,tox21-er-bla-agonist-p2,N-(9-Fluorenylmethoxycarbonyl)-L-leucine,activity,inactive,35661-60-0,1549133.0,O=C(O)[C@H](CC(C)C)NC(=O)OCC3c1ccccc1c2ccccc23
NCGC00255032-01,tox21-er-bla-agonist-p2,Spirodiclofen,activity,inactive,148477-71-8,22833506.0,CC(C)(CC)C(=O)OC2=C(C(=O)OC12CCCCC1)c3cc(Cl)cc(Cl)c3
NCGC00255143-01,tox21-er-bla-agonist-p2,Sulindac,activity,inactive,38194-50-2,1548887.0,CS(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C
NCGC00255234-01,tox21-er-bla-agonist-p2,Denatonium saccharide,activity,inactive,90823-38-4,64772.0,CC[N+](Cc1ccccc1)(CC)CC(=O)Nc2c(C)cccc2C.O=C1[N-]S(=O)(=O)c2ccccc12
NCGC00255713-01,tox21-er-bla-agonist-p2,Potassium dicyanoaurate,activity,active agonist,13967-50-5,6857648.0,[K+].N#C[Au-]C#N
NCGC00255914-01,tox21-er-bla-agonist-p2,Zoalene,activity,inactive,148-01-6,3092.0,Cc1c(cc(cc1[N+](=O)[O-])[N+]([O-])=O)C(N)=O
NCGC00254427-01,tox21-er-bla-agonist-p2,Octanal,activity,inactive,124-13-0,454.0,CCCCCCCC=O
NCGC00254451-01,tox21-er-bla-agonist-p2,Methyldopa sesquihydrate,activity,inactive,41372-08-1,38852.0,O.O.O.Oc1ccc(C[C@](C)(N)C(=O)O)cc1O.O=C(O)[C@@](C)(N)Cc1cc(O)c(O)cc1
NCGC00254598-01,tox21-er-bla-agonist-p2,4-Nitropyridine-1-oxide,activity,inactive,1124-33-0,14300.0,[O-][n+]1ccc(cc1)[N+](=O)[O-]
NCGC00255071-01,tox21-er-bla-agonist-p2,alpha-Ionone,activity,inactive,127-41-3,5282108.0,CC1(C)CCC=C(C)C1/C=C/C(C)=O
NCGC00255074-01,tox21-er-bla-agonist-p2,Buturon,activity,inactive,3766-60-7,19587.0,Clc1ccc(NC(=O)N(C)C(C)C#C)cc1
NCGC00255497-01,tox21-er-bla-agonist-p2,4-Anilinophenol,activity,active agonist,122-37-2,31208.0,Oc2ccc(Nc1ccccc1)cc2
NCGC00254279-01,tox21-er-bla-agonist-p2,"Pentane-1,5-diyl dibenzoate",activity,inactive,6624-73-3,243694.0,O=C(OCCCCCOC(=O)c1ccccc1)c2ccccc2
NCGC00015075-04,tox21-er-bla-agonist-p2,Arecoline,activity,inactive,63-75-2,2230.0,CN1CC(=CCC1)C(=O)OC
NCGC00015931-04,tox21-er-bla-agonist-p2,SR 57227A hydrochloride,activity,inactive,77145-61-0,131746.0,Cl.Clc1nc(ccc1)N2CCC(N)CC2
NCGC00159317-02,tox21-er-bla-agonist-p2,Hydrocodone triphosphate,activity,inactive,NOCAS_47802,25234023.0,O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=C1CC[C@H]5[C@H]2Cc3ccc(OC)c4O[C@@H]1[C@]5(CCN2C)c34.O=C1CC[C@H]5[C@H]2Cc4ccc(OC)c3O[C@@H]1[C@]5(CCN2C)c34
NCGC00160398-01,tox21-er-bla-agonist-p2,Nafamostat mesylate,activity,inactive,82956-11-4,9868041.0,CS(=O)(=O)O.N=C(N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N
NCGC00164573-01,tox21-er-bla-agonist-p2,Flurazepam,activity,inactive,17617-23-1,3393.0,Fc3ccccc3C2=NCC(=O)N(CCN(CC)CC)c1ccc(Cl)cc12
NCGC00164631-01,tox21-er-bla-agonist-p2,Sunitinib malate,activity,inactive,341031-54-7,60196290.0,O=C(O)C(O)CC(=O)O.CCN(CC)CCNC(=O)C1C(C)=C(N=C1C)/C=C2/c3cc(F)ccc3NC2=O
NCGC00181032-01,tox21-er-bla-agonist-p2,Uric acid,activity,inactive,69-93-2,1175.0,O=C1NC(=O)NC=2NC(=O)NC1=2
NCGC00185749-01,tox21-er-bla-agonist-p2,Tylosin tartrate,activity,inactive,74610-55-2,60196281.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.CN(C)[C@@H]2[C@@H](O)[C@@H](O[C@H](C)[C@H]2O[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1)O[C@H]4[C@@H](CC=O)C[C@@H](C)C(=O)C=CC(C)=C[C@H](CO[C@@H]3O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]3OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]4C
NCGC00188864-01,tox21-er-bla-agonist-p2,Iloperidone,activity,inactive,133454-47-4,71360.0,CC(=O)c4ccc(OCCCN1CCC(CC1)c3noc2cc(F)ccc23)c(OC)c4
NCGC00247689-01,tox21-er-bla-agonist-p2,N-(1-Benzyl-4-piperidyl)-N-phenylpropanamide hydrochloride,activity,inactive,5156-58-1,60196318.0,Cl.CCC(=O)N(C2CCN(Cc1ccccc1)CC2)c3ccccc3
NCGC00254936-01,tox21-er-bla-agonist-p2,Ethylene thiourea,activity,inactive,96-45-7,2723650.0,S=C1NCCN1
NCGC00259401-01,tox21-er-bla-agonist-p2,Tetradecanoic acid,activity,inactive,544-63-8,11005.0,O=C(O)CCCCCCCCCCCCC
NCGC00016784-01,tox21-er-bla-agonist-p2,Articaine hydrochloride,activity,inactive,23964-57-0,32169.0,Cl.O=C(Nc1c(scc1C)C(=O)OC)C(C)NCCC
NCGC00091210-02,tox21-er-bla-agonist-p2,"1,3-Dinitronaphthalene",activity,inactive,606-37-1,11818.0,[O-][N+](=O)c2cc(cc1ccccc12)[N+]([O-])=O
NCGC00166231-01,tox21-er-bla-agonist-p2,Methyl 10-undecenoate,activity,inactive,111-81-9,8138.0,O=C(CCCCCCCCC=C)OC
NCGC00181750-01,tox21-er-bla-agonist-p2,Cefozopran hydrochloride,activity,inactive,113981-44-5,6918222.0,Cl.CO\N=C(/c1nc(N)sn1)C(=O)N[C@@H]5C(=O)N4C(C([O-])=O)=C(C[n+]3ccn2ncccc23)CS[C@@H]45
NCGC00182714-01,tox21-er-bla-agonist-p2,Varenicline tartrate,activity,inactive,375815-87-5,9906942.0,O=C(O)[C@H](O)[C@@H](O)C(=O)O.c1c4c(cc2nccnc12)C3CC4CNC3
NCGC00254653-01,tox21-er-bla-agonist-p2,Simazine,activity,inactive,122-34-9,5216.0,Clc1nc(NCC)nc(NCC)n1
NCGC00017325-03,tox21-er-bla-agonist-p2,Kojic acid,activity,inactive,501-30-4,3840.0,O=C1C=C(CO)OC=C1O
NCGC00024502-03,tox21-er-bla-agonist-p2,L-Glutamic acid,activity,inactive,56-86-0,33032.0,OC(=O)CC[C@H](N)C(=O)O
NCGC00025070-01,tox21-er-bla-agonist-p2,Selfotel,activity,inactive,110347-85-8,68736.0,OP(=O)(O)C[C@H]1C[C@H](NCC1)C(=O)O
NCGC00027930-02,tox21-er-bla-agonist-p2,Moclobemide,activity,inactive,71320-77-9,4235.0,Clc1ccc(cc1)C(=O)NCCN2CCOCC2
NCGC00256879-01,tox21-er-bla-agonist-p2,"Hexanedioic acid, di-C7-9-branched and linear alkyl esters",activity,inactive,68515-75-3,14306122.0,O=C(OCCCCCCC)CCCCC(=O)OCCCCCCCCC
NCGC00258522-01,tox21-er-bla-agonist-p2,4-Bromotoluene,activity,inactive,106-38-7,7805.0,Cc1ccc(Br)cc1
NCGC00257065-01,tox21-er-bla-agonist-p2,Salicylic acid,activity,inactive,69-72-7,338.0,OC(=O)c1ccccc1O
NCGC00257088-01,tox21-er-bla-agonist-p2,Imidodicarbonic diamide,activity,inactive,108-19-0,7913.0,NC(=O)NC(N)=O
NCGC00257570-01,tox21-er-bla-agonist-p2,(N-6)-Methyladenine,activity,inactive,443-72-1,67955.0,CNc2ncnc1ncnc12
NCGC00257735-01,tox21-er-bla-agonist-p2,Tetrachlorostannane,activity,inactive,7646-78-8,24287.0,Cl[Sn](Cl)(Cl)Cl
NCGC00257788-01,tox21-er-bla-agonist-p2,Isocyanatocyclohexane,activity,inactive,3173-53-3,18502.0,O=C=N/C1CCCCC1
NCGC00257859-01,tox21-er-bla-agonist-p2,Alizarin Yellow R,activity,inactive,2243-76-7,5918804.0,OC(=O)c1cc(ccc1O)/N=N/c2ccc(cc2)[N+]([O-])=O
NCGC00258079-01,tox21-er-bla-agonist-p2,"2,2-Dimethylpentanedioic acid",activity,inactive,681-57-2,12681.0,CC(C)(CCC(O)=O)C(=O)O
NCGC00256691-01,tox21-er-bla-agonist-p2,Rhodinol,activity,inactive,141-25-3,81263.0,CC(=C)CCC[C@H](C)CCO
NCGC00256367-01,tox21-er-bla-agonist-p2,1-Decanamine,activity,inactive,2016-57-1,8916.0,CCCCCCCCCCN
NCGC00256388-01,tox21-er-bla-agonist-p2,3-Ethylphenol,activity,inactive,620-17-7,12101.0,CCc1cc(O)ccc1
NCGC00256516-01,tox21-er-bla-agonist-p2,Tetranitromethane,activity,inactive,509-14-8,10509.0,O=[N+]([O-])C([N+]([O-])=O)([N+](=O)[O-])[N+]([O-])=O
NCGC00255810-01,tox21-er-bla-agonist-p2,Tripropylene glycol butyl ether,activity,inactive,55934-93-5,60196418.0,OC(OCC(C)OC(CC)OCCCC)CC
NCGC00255899-01,tox21-er-bla-agonist-p2,Fenson,activity,inactive,80-38-6,6636.0,Clc2ccc(OS(=O)(=O)c1ccccc1)cc2
NCGC00256151-01,tox21-er-bla-agonist-p2,Meclofenoxate hydrochloride,activity,inactive,3685-84-5,19379.0,Cl.Clc1ccc(OCC(=O)OCCN(C)C)cc1
NCGC00256186-01,tox21-er-bla-agonist-p2,Calcium neodecanoate,activity,inactive,27253-33-4,60196426.0,[Ca+2].[O-]C(=O)C(C)(CC)CCC(C)C.CC(C)CCC(C)(CC)C([O-])=O
NCGC00255692-01,tox21-er-bla-agonist-p2,"3,5-Dibromo-4-hydroxybenzoic acid",activity,inactive,3337-62-0,76857.0,Brc1cc(cc(Br)c1O)C(=O)O
NCGC00258812-01,tox21-er-bla-agonist-p2,"p,p'-DDE",activity,inactive,72-55-9,3035.0,Clc1ccc(cc1)\C(=C(/Cl)Cl)c2ccc(Cl)cc2
NCGC00259555-01,tox21-er-bla-agonist-p2,Metribuzin,activity,inactive,21087-64-9,30479.0,O=C1C(=NN=C(SC)N1N)C(C)(C)C
NCGC00259793-01,tox21-er-bla-agonist-p2,"2,2'-Dichlorobiphenyl",activity,active agonist,13029-08-8,25622.0,Clc2ccccc2c1ccccc1Cl
NCGC00260264-01,tox21-er-bla-agonist-p2,"1,3-Dibromopropane",activity,inactive,109-64-8,8001.0,BrCCCBr
NCGC00258670-01,tox21-er-bla-agonist-p2,"2,4,5-Trimethylaniline",activity,inactive,137-17-7,8717.0,Cc1cc(C)c(N)cc1C
NCGC00258694-01,tox21-er-bla-agonist-p2,"8-Hydroxy-5,7-dinitro-2-naphthalenesulfonic acid",activity,inactive,483-84-1,10226.0,[O-][N+](=O)c1cc(c2ccc(cc2c1O)S(=O)(=O)O)[N+]([O-])=O
NCGC00255066-01,tox21-er-bla-agonist-p2,Dipropyl hexanedioate,activity,inactive,106-19-4,7790.0,O=C(CCCCC(=O)OCCC)OCCC
NCGC00255478-01,tox21-er-bla-agonist-p2,4-(4-(Acetyloxy)phenyl)-2-butanone,activity,inactive,3572-06-3,19137.0,O=C(C)Oc1ccc(cc1)CCC(C)=O
NCGC00255500-01,tox21-er-bla-agonist-p2,"Butanamide, N-(2,4-dimethylphenyl)-3-oxo-",activity,inactive,97-36-9,222464.0,O=C(Nc1ccc(C)cc1C)CC(C)=O
NCGC00091202-01,tox21-er-bla-agonist-p2,Trichloroethylene,activity,inactive,79-01-6,6575.0,Cl\C=C(/Cl)Cl
NCGC00091544-04,tox21-er-bla-agonist-p2,17beta-Estradiol,activity,active agonist,50-28-2,5757.0,Oc3cc4CC[C@@H]1[C@H](CC[C@]2(C)[C@@H](O)CC[C@@H]12)c4cc3
NCGC00091902-05,tox21-er-bla-agonist-p2,Malathion,activity,inactive,121-75-5,4004.0,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC
NCGC00091921-01,tox21-er-bla-agonist-p2,Ammonium nitrate,activity,inactive,6484-52-2,22985.0,[NH4+].[O-][N+]([O-])=O
NCGC00093664-01,tox21-er-bla-agonist-p2,Butaclamol hydrochloride,activity,inactive,36504-94-6,6852400.0,Cl.CC(C)(C)[C@]4(O)CCN5C[C@@H]2c3c(cccc3CCc1ccccc12)[C@@H]5C4
NCGC00166310-01,tox21-er-bla-agonist-p2,Marbofloxacin,activity,inactive,115550-35-1,60651.0,CN1CCN(CC1)c4c(F)cc2c3N(C=C(C2=O)C(=O)O)N(C)COc34
NCGC00167445-01,tox21-er-bla-agonist-p2,Eprazinone dihydrochloride,activity,inactive,10402-53-6,73356.0,Cl.Cl.O=C(c1ccccc1)C(C)CN3CCN(CC(OCC)c2ccccc2)CC3
NCGC00159515-02,tox21-er-bla-agonist-p2,Eszopiclone,activity,inactive,138729-47-2,969472.0,CN1CCN(CC1)C(=O)O[C@H]4c2nccnc2C(=O)N4c3ccc(Cl)cn3
NCGC00159519-02,tox21-er-bla-agonist-p2,Tolterodine,activity,inactive,124937-51-5,443879.0,Oc1ccc(C)cc1[C@H](CCN(C(C)C)C(C)C)c2ccccc2
NCGC00094969-01,tox21-er-bla-agonist-p2,Anisindione,activity,inactive,117-37-3,2197.0,COc1ccc(cc1)C3C(=O)c2ccccc2C3=O
NCGC00160417-02,tox21-er-bla-agonist-p2,(7S)-Hydroprene,activity,inactive,65733-18-8,5282198.0,C\C(C=C/C[C@@H](C)CCCC(C)C)=C/C(=O)OCC
NCGC00164550-01,tox21-er-bla-agonist-p2,Lafutidine,activity,inactive,118288-08-7,5282136.0,O=S(CC(=O)NC/C=C\COc2cc(CN1CCCCC1)ccn2)Cc3ccco3
NCGC00181167-01,tox21-er-bla-agonist-p2,Isoniazid sodium methanesulfonate,activity,inactive,3804-89-5,23691029.0,[Na+].O=C(NNCS([O-])(=O)=O)c1ccncc1
NCGC00164561-01,tox21-er-bla-agonist-p2,Zanamivir,activity,inactive,139110-80-8,60855.0,O[C@@H]([C@@H]1OC(=C[C@H](NC(=N)N)[C@H]1NC(C)=O)C(=O)O)[C@H](O)CO
NCGC00164603-01,tox21-er-bla-agonist-p2,Ebastine,activity,inactive,90729-43-4,3191.0,CC(C)(C)c1ccc(cc1)C(=O)CCCN2CCC(CC2)OC(c3ccccc3)c4ccccc4
NCGC00160519-01,tox21-er-bla-agonist-p2,Acipimox,activity,inactive,51037-30-0,5310993.0,[O-][n+]1cc(ncc1C)C(O)=O
NCGC00160536-01,tox21-er-bla-agonist-p2,Colestolone,activity,inactive,50673-97-7,10046567.0,CC(C)CCC[C@@H](C)[C@H]2CC(=O)C1=C3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C
NCGC00169077-02,tox21-er-bla-agonist-p2,Potassium ricinoleate,activity,inactive,7492-30-0,23716429.0,[K+].CCCCCC[C@@H](O)C/C=C\CCCCCCCC([O-])=O
NCGC00159353-02,tox21-er-bla-agonist-p2,Acarbose,activity,active agonist,56180-94-0,444254.0,OCC4=C[C@H](N[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]1C)O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]3O)[C@H](O)[C@@H](O)[C@@H]4O
NCGC00090991-02,tox21-er-bla-agonist-p2,"N,N-Dimethylbenzylamine",activity,inactive,103-83-3,7681.0,CN(C)Cc1ccccc1
NCGC00183849-01,tox21-er-bla-agonist-p2,Flosequinan,activity,inactive,76568-02-0,4474062.0,CS(=O)C2=CN(C)c1cc(F)ccc1C2=O
NCGC00184994-01,tox21-er-bla-agonist-p2,Cidofovir,activity,active agonist,113852-37-2,60613.0,O=P(O)(O)CO[C@@H](CN1C=CC(N)=NC1=O)CO
NCGC00255268-01,tox21-er-bla-agonist-p2,"1,4-bis(3-Aminopropyl)piperazine",activity,inactive,7209-38-3,81629.0,NCCCN1CCN(CCCN)CC1
NCGC00254320-01,tox21-er-bla-agonist-p2,CI-959,activity,inactive,104795-68-8,13961743.0,[Na+].CC(C)Oc1c3cc(ccc3sc1C(=O)Nc2[n-]nnn2)OC
NCGC00253940-01,tox21-er-bla-agonist-p2,Diethyl sulfate,activity,inactive,64-67-5,6163.0,O=S(=O)(OCC)OCC
NCGC00253957-01,tox21-er-bla-agonist-p2,Sorbic acid,activity,inactive,110-44-1,643460.0,C\C=C\C=C\C(=O)O
NCGC00254772-01,tox21-er-bla-agonist-p2,Lactofen,activity,inactive,77501-63-4,62276.0,Clc2cc(ccc2Oc1cc(C(=O)OC(C)C(=O)OCC)c(cc1)[N+]([O-])=O)C(F)(F)F
NCGC00255194-01,tox21-er-bla-agonist-p2,"1,1-Dimethylhydrazine",activity,inactive,57-14-7,5976.0,CN(C)N
NCGC00253998-01,tox21-er-bla-agonist-p2,6-Methylquinoline,activity,inactive,91-62-3,7059.0,Cc1ccc2ncccc2c1
NCGC00254072-01,tox21-er-bla-agonist-p2,Sodium benzoate,activity,inactive,532-32-1,517055.0,[Na+].[O-]C(=O)c1ccccc1
NCGC00254086-01,tox21-er-bla-agonist-p2,Sodium xylenesulfonate,activity,inactive,1300-72-7,23668192.0,[Na+].Cc1ccc(cc1C)S(=O)([O-])=O
NCGC00181345-01,tox21-er-bla-agonist-p2,Temocapril hydrochloride,activity,inactive,110221-44-8,443873.0,Cl.O=C(OCC)[C@@H](N[C@H]1CS[C@@H](CN(CC(=O)O)C1=O)c2cccs2)CCc3ccccc3
NCGC00181795-01,tox21-er-bla-agonist-p2,Lumiracoxib,activity,inactive,220991-20-8,151166.0,Clc2cccc(F)c2Nc1ccc(C)cc1CC(=O)O
NCGC00255536-01,tox21-er-bla-agonist-p2,C.I. Direct Yellow 12,activity,inactive,2870-32-8,17880.0,[Na+].[Na+].O=S([O-])(=O)c3cc(ccc3C=Cc2ccc(/N=N/c1ccc(OCC)cc1)cc2S([O-])(=O)=O)/N=N/c4ccc(OCC)cc4
NCGC00258562-01,tox21-er-bla-agonist-p2,4-Benzylphenol,activity,active agonist,101-53-1,7563.0,Oc2ccc(Cc1ccccc1)cc2
NCGC00258732-01,tox21-er-bla-agonist-p2,Verapamil hydrochloride,activity,inactive,152-11-4,62969.0,Cl.COc1cc(ccc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C
NCGC00016083-09,tox21-er-bla-agonist-p2,Verapamil,activity,inactive,52-53-9,2520.0,COc1cc(ccc1OC)C(C#N)(CCCN(C)CCc2ccc(OC)c(OC)c2)C(C)C
NCGC00259956-01,tox21-er-bla-agonist-p2,Diethylstilbestrol,activity,active agonist,56-53-1,448537.0,Oc1ccc(cc1)C(\CC)=C(/CC)c2ccc(O)cc2
NCGC00260439-01,tox21-er-bla-agonist-p2,Sodium arsanilate,activity,inactive,127-85-5,23670523.0,[Na+].O=[As]([O-])(O)c1ccc(N)cc1
NCGC00015774-03,tox21-er-bla-agonist-p2,Oxatomide,activity,inactive,60607-34-3,4615.0,O=C5Nc1ccccc1N5CCCN2CCN(CC2)C(c3ccccc3)c4ccccc4
NCGC00257498-01,tox21-er-bla-agonist-p2,PharmaGSID_48506,activity,inactive,588941-45-1,59086459.0,O=C(Nc1cnccn1)[C@H](CC2CCCC2)c3ccc(c(Cl)c3)S(C)(=O)=O
NCGC00182036-01,tox21-er-bla-agonist-p2,Peplomycin sulfate,activity,inactive,70384-29-1,20055528.0,O=C(N)C(N)CNC(CC(=O)N)c1nc(N)c(C)c(n1)C(=O)NC(C(O[C@@H]3O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]2O)c4cncn4)C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc5nc(cs5)c6nc(cs6)C(=O)NCCCN[C@@H](C)c7ccccc7)C(C)O.O=S(=O)(O)O
NCGC00257020-01,tox21-er-bla-agonist-p2,"2,4,6-Tris(dimethylaminomethyl)phenol",activity,inactive,90-72-2,7026.0,Oc1c(cc(cc1CN(C)C)CN(C)C)CN(C)C
NCGC00256542-01,tox21-er-bla-agonist-p2,Cadmium chloride,activity,active agonist,10108-64-2,24633.0,[Cd+2].[Cl-].[Cl-]
NCGC00256598-01,tox21-er-bla-agonist-p2,Chlorfenson,activity,inactive,80-33-1,6635.0,Clc1ccc(cc1)S(=O)(=O)Oc2ccc(Cl)cc2
NCGC00257987-01,tox21-er-bla-agonist-p2,"1,4-Cyclohexanedimethanol",activity,inactive,105-08-8,7735.0,OCC1CCC(CO)CC1
NCGC00257768-01,tox21-er-bla-agonist-p2,Iodoacetamide,activity,inactive,144-48-9,3727.0,ICC(N)=O
NCGC00254067-01,tox21-er-bla-agonist-p2,"2,6-Di-tert-butylphenol",activity,inactive,128-39-2,31405.0,CC(C)(C)c1cccc(c1O)C(C)(C)C
NCGC00257253-01,tox21-er-bla-agonist-p2,"Cyclohexanemethanol, 4-[(ethenyloxy)methyl]-",activity,inactive,114651-37-5,163934.0,OCC1CCC(COC=C)CC1
NCGC00257686-01,tox21-er-bla-agonist-p2,Dihydromyrcenol,activity,inactive,18479-58-8,29096.0,CC(C)(O)CCCC(C)C=C
NCGC00257762-01,tox21-er-bla-agonist-p2,Flecainide acetate,activity,inactive,54143-56-5,41022.0,CC(=O)O.FC(F)(F)COc2cc(C(=O)NCC1CCCCN1)c(OCC(F)(F)F)cc2
NCGC00255686-01,tox21-er-bla-agonist-p2,1-Octen-3-ol,activity,inactive,3391-86-4,18827.0,C=CC(O)CCCCC
NCGC00255515-01,tox21-er-bla-agonist-p2,Diethofencarb,activity,inactive,87130-20-9,91742.0,CCOc1cc(ccc1OCC)NC(=O)OC(C)C
NCGC00256726-01,tox21-er-bla-agonist-p2,"2,2,2-Trichloro-1-phenylethyl acetate",activity,inactive,90-17-5,7007.0,ClC(Cl)(Cl)C(OC(C)=O)c1ccccc1
NCGC00256730-01,tox21-er-bla-agonist-p2,"3-Oxo-N-(2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)butanamide",activity,inactive,26576-46-5,117822.0,CC(=O)CC(=O)Nc1ccc2NC(=O)Nc2c1
NCGC00256786-01,tox21-er-bla-agonist-p2,"3-Methyl-1,2-cyclopentanedione",activity,inactive,765-70-8,61209.0,O=C1C(=O)CCC1C
NCGC00256596-01,tox21-er-bla-agonist-p2,Auramine hydrochloride,activity,inactive,2465-27-2,17170.0,Cl.CN(C)c1ccc(cc1)C(=N)c2ccc(cc2)N(C)C
NCGC00256645-01,tox21-er-bla-agonist-p2,Pyrazinyl methyl sulfide,activity,inactive,21948-70-9,519907.0,CSc1cnccn1
NCGC00257042-01,tox21-er-bla-agonist-p2,1-Tetradecene,activity,inactive,1120-36-1,14260.0,CCCCCCCCCCCCC=C
NCGC00257383-01,tox21-er-bla-agonist-p2,4-Propylaniline,activity,inactive,2696-84-6,75908.0,Nc1ccc(CCC)cc1
NCGC00258215-01,tox21-er-bla-agonist-p2,Hexahydrophthalic anhydride,activity,inactive,85-42-7,85689.0,O=C1OC(=O)C2CCCCC12
NCGC00258890-01,tox21-er-bla-agonist-p2,Aldoxycarb,activity,inactive,1646-88-4,9570093.0,CC(C)(/C=N/OC(=O)NC)S(C)(=O)=O
NCGC00258317-01,tox21-er-bla-agonist-p2,2-(Diethylamino)ethyl methacrylate,activity,inactive,105-16-8,61012.0,O=C(OCCN(CC)CC)C(=C)C
NCGC00259104-01,tox21-er-bla-agonist-p2,Diallylamine,activity,inactive,124-02-7,31279.0,C=CCNCC=C
NCGC00258671-01,tox21-er-bla-agonist-p2,3-Hexanone,activity,inactive,589-38-8,11509.0,CCC(=O)CCC
NCGC00259506-01,tox21-er-bla-agonist-p2,2-(2-Butoxyethoxy)ethyl acetate,activity,inactive,124-17-4,31288.0,CCCCOCCOCCOC(C)=O
NCGC00259458-01,tox21-er-bla-agonist-p2,3-(Trifluoromethyl)aniline,activity,inactive,98-16-8,7375.0,FC(F)(F)c1cc(N)ccc1
NCGC00260471-01,tox21-er-bla-agonist-p2,5-Nitroindazole,activity,inactive,5401-94-5,21501.0,[O-][N+](=O)c1cc2cnnc2cc1
NCGC00260572-01,tox21-er-bla-agonist-p2,NTP Mix80 CT1 62-EQP,activity,inactive,NOCAS_49468,,
NCGC00015691-03,tox21-er-bla-agonist-p2,Cysteamine,activity,inactive,60-23-1,6058.0,NCCS
NCGC00015288-06,tox21-er-bla-agonist-p2,Cyclothiazide,activity,inactive,2259-96-3,2910.0,NS(=O)(=O)c4cc1c(NC(NS1(=O)=O)C3CC2C=CC3C2)cc4Cl
NCGC00014482-01,tox21-er-bla-agonist-p2,Methdilazine hydrochloride,activity,inactive,1229-35-2,14676.0,Cl.CN1CCC(C1)CN2c4ccccc4Sc3ccccc23
NCGC00015883-05,tox21-er-bla-agonist-p2,Risperidone,activity,inactive,106266-06-2,5073.0,CC=5N=C1CCCCN1C(=O)C=5CCN2CCC(CC2)c4noc3cc(F)ccc34
NCGC00015893-02,tox21-er-bla-agonist-p2,Ropinirole,activity,inactive,91374-21-9,5095.0,CCCN(CCC)CCc1cccc2NC(=O)Cc12
NCGC00015453-05,tox21-er-bla-agonist-p2,Fexofenadine hydrochloride,activity,inactive,153439-40-8,63002.0,Cl.O=C(O)C(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4
NCGC00015100-02,tox21-er-bla-agonist-p2,Hexamethylmelamine,activity,inactive,645-05-6,2123.0,CN(C)c1nc(nc(n1)N(C)C)N(C)C
NCGC00016598-01,tox21-er-bla-agonist-p2,Tranylcypromine hydrochloride,activity,inactive,1986-47-6,2723716.0,Cl.N[C@@H]2C[C@H]2c1ccccc1
NCGC00016695-01,tox21-er-bla-agonist-p2,Vitamin K2,activity,inactive,11032-49-8,5282367.0,C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CCC(\C)=C\CC2=C(C)C(=O)c1ccccc1C2=O
NCGC00091942-01,tox21-er-bla-agonist-p2,Methylphenidate hydrochloride,activity,inactive,298-59-9,9280.0,Cl.O=C(OC)C(C1CCCCN1)c2ccccc2
NCGC00181308-01,tox21-er-bla-agonist-p2,Sorbitan monohexadecanoate,activity,inactive,26266-57-9,16212480.0,O[C@H](COC(=O)CCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O
NCGC00255116-01,tox21-er-bla-agonist-p2,Formalin,activity,inactive,NOCAS_47796,712.0,C=O
NCGC00256191-01,tox21-er-bla-agonist-p2,3-Methyl-N-phenylaniline,activity,inactive,1205-64-7,14569.0,Cc2cc(Nc1ccccc1)ccc2
NCGC00254662-01,tox21-er-bla-agonist-p2,Glybenclamide,activity,inactive,10238-21-8,3488.0,O=C(NC1CCCCC1)NS(=O)(=O)c3ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc3
NCGC00254476-01,tox21-er-bla-agonist-p2,"1,3-Diisopropylbenzene",activity,inactive,99-62-7,7450.0,CC(C)c1cccc(c1)C(C)C
NCGC00255065-01,tox21-er-bla-agonist-p2,Diethyl decanedioate,activity,inactive,110-40-7,8049.0,O=C(CCCCCCCCC(=O)OCC)OCC
NCGC00254129-01,tox21-er-bla-agonist-p2,PharmaGSID_47315,activity,active agonist,444610-91-7,10233356.0,O=C(O)COc1ccc(cc1CC)SCc4sc(nc4CN2CCN(CC2)c3ccc(OC)cc3)c5ccc(cc5)C(F)(F)F
NCGC00015705-04,tox21-er-bla-agonist-p2,Memantine,activity,inactive,19982-08-2,4054.0,CC13CC2(C)CC(N)(C1)CC(C2)C3
NCGC00016512-01,tox21-er-bla-agonist-p2,Isoxsuprine hydrochloride,activity,inactive,579-56-6,11368.0,Cl.Oc1ccc(cc1)C(O)C(C)NC(C)COc2ccccc2
NCGC00094011-01,tox21-er-bla-agonist-p2,3-Iodobenzylguanidine hemisulfate,activity,inactive,87862-25-7,11957572.0,Ic1cc(CNC(=N)N)ccc1.O=S(=O)(O)O.N=C(N)NCc1cc(I)ccc1
NCGC00159408-02,tox21-er-bla-agonist-p2,DL-Glucose,activity,inactive,58367-01-4,5793.0,O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O
NCGC00181084-01,tox21-er-bla-agonist-p2,"N,N-Dimethyl-1,2-diphenylethanamine",activity,inactive,6319-84-2,443970.0,CN(C)[C@H](Cc1ccccc1)c2ccccc2
NCGC00185769-01,tox21-er-bla-agonist-p2,Stiripentol,activity,inactive,49763-96-4,5311454.0,CC(C)(C)C(O)/C=C/c1ccc2OCOc2c1
NCGC00253969-01,tox21-er-bla-agonist-p2,CP-457920,activity,inactive,220860-50-4,9831581.0,CCOc1ccc2NC=C(C(=O)c2n1)C(=O)NCc3ccccc3
NCGC00159367-02,tox21-er-bla-agonist-p2,Paraldehyde,activity,inactive,123-63-7,31264.0,CC1OC(C)OC(C)O1
NCGC00167571-01,tox21-er-bla-agonist-p2,Dexamethazone metasulfobenzoate sodium,activity,inactive,3936-02-5,23672582.0,[Na+].[O-]S(=O)(=O)c1cccc(c1)C(=O)OCC(=O)[C@@]5(O)[C@H](C)C[C@@H]4[C@]5(C)C[C@H](O)[C@@]3(F)[C@H]4CCC2=CC(=O)C=C[C@@]23C
NCGC00025357-01,tox21-er-bla-agonist-p2,Nicorandil,activity,inactive,65141-46-0,47528.0,O=C(NCCO[N+]([O-])=O)c1cccnc1
NCGC00256785-01,tox21-er-bla-agonist-p2,Heptyl acetate,activity,inactive,112-06-1,8159.0,CCCCCCCOC(C)=O
NCGC00258436-01,tox21-er-bla-agonist-p2,"5,7-Dihydroxy-4-methylcoumarin",activity,inactive,2107-76-8,5354284.0,Oc2cc(O)cc1OC(=O)C=C(C)c12
NCGC00258606-01,tox21-er-bla-agonist-p2,Ethyl chloroacetate,activity,inactive,105-39-5,7751.0,ClCC(=O)OCC
NCGC00257175-01,tox21-er-bla-agonist-p2,Tridecane,activity,inactive,629-50-5,12388.0,CCCCCCCCCCCCC
NCGC00257636-01,tox21-er-bla-agonist-p2,Codeine,activity,inactive,76-57-3,5284371.0,COc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45
NCGC00258092-01,tox21-er-bla-agonist-p2,Undecanal,activity,inactive,112-44-7,8186.0,CCCCCCCCCCC=O
NCGC00256744-01,tox21-er-bla-agonist-p2,4-Octanolide,activity,inactive,104-50-7,7704.0,CCCCC1CCC(=O)O1
NCGC00255764-01,tox21-er-bla-agonist-p2,Indinavir sulfate,activity,inactive,157810-81-6,5462355.0,O[C@H](CN1CCN(C[C@H]1C(=O)NC(C)(C)C)Cc2cccnc2)C[C@@H](Cc3ccccc3)C(=O)N[C@H]4c5ccccc5C[C@H]4O.O=S(=O)(O)O
NCGC00256428-01,tox21-er-bla-agonist-p2,3'-Methyl-4-dimethylaminoazobenzene,activity,inactive,55-80-1,5934.0,CN(C)c2ccc(/N=N/c1cc(C)ccc1)cc2
NCGC00255781-01,tox21-er-bla-agonist-p2,3-Methyl-1-phenyl-1H-pyrazol-5-amine,activity,inactive,1131-18-6,70801.0,Nc2cc(C)nn2c1ccccc1
NCGC00256329-01,tox21-er-bla-agonist-p2,Saccharin,activity,inactive,81-07-2,5143.0,O=C2NS(=O)(=O)c1ccccc12
NCGC00260394-01,tox21-er-bla-agonist-p2,"Pentane,3,3-dimethyl-",activity,inactive,562-49-2,11229.0,CC(C)(CC)CC
NCGC00260528-01,tox21-er-bla-agonist-p2,Tris(2-chloroisopropyl)phosphate,activity,inactive,13674-84-5,26176.0,ClCC(C)OP(=O)(OC(C)CCl)OC(C)CCl
NCGC00260039-01,tox21-er-bla-agonist-p2,Boron trifluoride dihydrate,activity,inactive,13319-75-0,61591.0,O.O.FB(F)F
NCGC00260043-01,tox21-er-bla-agonist-p2,Chloroform,activity,inactive,67-66-3,6212.0,ClC(Cl)Cl
NCGC00260100-01,tox21-er-bla-agonist-p2,Isopropyl ether,activity,inactive,108-20-3,7914.0,CC(C)OC(C)C
NCGC00260157-01,tox21-er-bla-agonist-p2,Isopropyl methacrylate,activity,inactive,4655-34-9,20769.0,C=C(C)C(=O)OC(C)C
NCGC00260188-01,tox21-er-bla-agonist-p2,1-Ethyl-3-methylimidazolium methanesulfonate,activity,inactive,145022-45-3,16211849.0,C[n+]1ccn(CC)c1.[O-]S(C)(=O)=O
NCGC00260202-01,tox21-er-bla-agonist-p2,1-Methyl-3-propylimidazolium iodide,activity,inactive,119171-18-5,12971008.0,[I-].C[n+]1ccn(CCC)c1
NCGC00260226-01,tox21-er-bla-agonist-p2,1-Butyl-2-methylpyridinium hexafluorophosphate,activity,inactive,NOCAS_49389,60196391.0,Cc1cccc[n+]1CCCC.F[P-](F)(F)(F)(F)F
NCGC00258648-01,tox21-er-bla-agonist-p2,N-Ethyl-N-butylamine,activity,inactive,13360-63-9,25914.0,CCNCCCC
NCGC00258716-01,tox21-er-bla-agonist-p2,Dibromomannitol,activity,inactive,488-41-5,656655.0,O[C@H]([C@H](O)CBr)[C@H](O)[C@H](O)CBr
NCGC00254754-01,tox21-er-bla-agonist-p2,Asulam,activity,inactive,3337-71-1,18752.0,Nc1ccc(cc1)S(=O)(=O)NC(=O)OC
NCGC00254879-01,tox21-er-bla-agonist-p2,"2,6-Dimethyloctan-2-ol",activity,inactive,18479-57-7,86751.0,CC(C)(O)CCCC(C)CC
NCGC00256304-01,tox21-er-bla-agonist-p2,"N,N'-Di-tert-butylethane-1,2-diamine",activity,inactive,4062-60-6,77680.0,CC(C)(C)NCCNC(C)(C)C
NCGC00256438-01,tox21-er-bla-agonist-p2,"1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene",activity,inactive,76150-91-9,5382.0,Clc3cc(Cl)cnc3Oc1ccc(cc1)Oc2ncc(Cl)cc2Cl
NCGC00255030-01,tox21-er-bla-agonist-p2,Butylamine,activity,inactive,109-73-9,8007.0,CCCCN
NCGC00255035-01,tox21-er-bla-agonist-p2,"Ethanol, 2-(1-methylethoxy)-",activity,inactive,109-59-1,7996.0,CC(C)OCCO
NCGC00255151-01,tox21-er-bla-agonist-p2,Hexyl acrylate,activity,inactive,2499-95-8,17259.0,O=C(C=C)OCCCCCC
NCGC00255160-01,tox21-er-bla-agonist-p2,2-Undecanone,activity,inactive,112-12-9,8163.0,CC(=O)CCCCCCCCC
NCGC00255941-01,tox21-er-bla-agonist-p2,"alpha-Methyl-3,4-methylene-dioxyhydrocinnamic aldehyde",activity,inactive,1205-17-0,64805.0,O=CC(C)Cc1ccc2OCOc2c1
NCGC00256035-01,tox21-er-bla-agonist-p2,"1,3-Bis(isocyanatomethyl)cyclohexane",activity,inactive,38661-72-2,53172.0,O=C=N\CC1CCCC(C\N=C=O)C1
NCGC00254523-01,tox21-er-bla-agonist-p2,Heptachlor,activity,inactive,76-44-8,3589.0,ClC2=C(Cl)C3(Cl)C1C=CC(Cl)C1C2(Cl)C3(Cl)Cl
NCGC00091106-02,tox21-er-bla-agonist-p2,Methyl salicylate,activity,inactive,119-36-8,4133.0,Oc1ccccc1C(=O)OC
NCGC00091108-01,tox21-er-bla-agonist-p2,Carbon disulfide,activity,inactive,75-15-0,6348.0,S=C=S
NCGC00093556-01,tox21-er-bla-agonist-p2,Amperozide hydrochloride,activity,inactive,75529-73-6,73334.0,Cl.Fc1ccc(cc1)C(CCCN2CCN(CC2)C(=O)NCC)c3ccc(F)cc3
NCGC00159411-02,tox21-er-bla-agonist-p2,Triethanolamine,activity,inactive,102-71-6,7618.0,OCCN(CCO)CCO
NCGC00163232-01,tox21-er-bla-agonist-p2,Pancuronium bromide,activity,inactive,15500-66-0,27350.0,[Br-].[Br-].C[N+]1(CCCCC1)[C@H]6C[C@@]5(C)[C@@H](CC[C@@H]3[C@@H]5CC[C@]2(C)[C@@H](OC(C)=O)[C@H](C[C@H]23)[N+]4(C)CCCCC4)C[C@@H]6OC(C)=O
NCGC00163318-01,tox21-er-bla-agonist-p2,Suramin,activity,inactive,145-63-1,5361.0,O=S(=O)(O)c1cc(cc2c1c(ccc2S(=O)(=O)O)NC(=O)c8cc(NC(=O)c3cc(ccc3)NC(=O)Nc4cccc(c4)C(=O)Nc5cc(ccc5C)C(=O)Nc7ccc(c6cc(cc(c67)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)c(C)cc8)S(=O)(=O)O
NCGC00166397-02,tox21-er-bla-agonist-p2,Lofepramine hydrochloride,activity,inactive,26786-32-3,33611.0,Cl.Clc1ccc(cc1)C(=O)CN(C)CCCN3c4ccccc4CCc2ccccc23
NCGC00094476-03,tox21-er-bla-agonist-p2,Terguride,activity,inactive,37686-84-3,443951.0,CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4ncc(C[C@H]2N(C)C1)c34
NCGC00163771-03,tox21-er-bla-agonist-p2,Diethylene glycol monomethyl ether,activity,inactive,111-77-3,8134.0,OCCOCCOC
NCGC00167444-01,tox21-er-bla-agonist-p2,Cefpiramide acid,activity,inactive,70797-11-4,636405.0,Oc1cc(C)ncc1C(=O)N[C@H](c2ccc(O)cc2)C(=O)N[C@@H]5C(=O)N4C(=C(CSc3nnnn3C)CS[C@@H]45)C(=O)O
NCGC00181026-01,tox21-er-bla-agonist-p2,Robenidine,activity,inactive,25875-51-8,60196301.0,Clc2ccc(/C=N/NC(=N)N\N=C/c1ccc(Cl)cc1)cc2
NCGC00159512-02,tox21-er-bla-agonist-p2,Cefdinir,activity,inactive,91832-40-5,6398970.0,Nc1scc(n1)/C(=N\O)C(=O)N[C@@H]3C(=O)N2C(=C(C=C)CS[C@@H]23)C(=O)O
NCGC00160198-01,tox21-er-bla-agonist-p2,6-Aminopenicillanic acid,activity,inactive,551-16-6,11082.0,OC(=O)[C@@H]1N2C(=O)[C@@H](N)[C@H]2SC1(C)C
NCGC00094989-01,tox21-er-bla-agonist-p2,Chromocarb,activity,inactive,4940-39-0,2741.0,O=C(O)C1=CC(=O)c2ccccc2O1
NCGC00164587-01,tox21-er-bla-agonist-p2,Isepamicin sulfate,activity,inactive,67814-76-0,20056587.0,O=S(=O)(O)O.NCC(O)C(=O)N[C@@H]3C[C@H](N)[C@@H](O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H]3O[C@H]2OC[C@](C)(O)[C@H](NC)[C@H]2O
NCGC00095137-01,tox21-er-bla-agonist-p2,Ceftibuten,activity,inactive,97519-39-6,5282242.0,O=C(O)C\C=C(\c1csc(N)n1)C(=O)N[C@@H]3C(=O)N2C(=CCS[C@@H]23)C(=O)O
NCGC00095160-01,tox21-er-bla-agonist-p2,Aspartame,activity,inactive,22839-47-0,134601.0,O=C(O)C[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC
NCGC00168255-01,tox21-er-bla-agonist-p2,Nalorphine hydrochloride,activity,inactive,57-29-4,5484366.0,Cl.Oc1ccc2C[C@H]4N(CC[C@@]35[C@@H](Oc1c23)[C@@H](O)C=C[C@@H]45)CC=C
NCGC00095173-01,tox21-er-bla-agonist-p2,Azelastine hydrochloride,activity,inactive,79307-93-0,54360.0,Cl.Clc1ccc(cc1)CC3=NN(C(=O)c2ccccc23)C4CCCN(C)CC4
NCGC00095256-01,tox21-er-bla-agonist-p2,Quinine ethyl carbonate,activity,inactive,83-75-0,6975516.0,COc1cc2c(cc1)nccc2[C@@H](OC(=O)OCC)[C@@H]4C[C@@H]3CC[N@]4C[C@@H]3C=C
NCGC00095775-01,tox21-er-bla-agonist-p2,Tripelennamine citrate,activity,inactive,6138-56-3,197066.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCN(Cc1ccccc1)c2ccccn2
NCGC00160553-01,tox21-er-bla-agonist-p2,Diphacinone,activity,inactive,82-66-6,6719.0,O=C2c1ccccc1C(=O)C2C(=O)C(c3ccccc3)c4ccccc4
NCGC00166018-01,tox21-er-bla-agonist-p2,Actinoquinol,activity,active agonist,15301-40-3,23674.0,O=S(=O)(O)c1ccc(OCC)c2ncccc12
NCGC00166216-01,tox21-er-bla-agonist-p2,Pentylcinnamaldehyde,activity,inactive,122-40-7,31209.0,O=CC(CCCCC)=Cc1ccccc1
NCGC00159350-02,tox21-er-bla-agonist-p2,L-Tyrosine,activity,inactive,60-18-4,6057.0,Oc1ccc(C[C@H](N)C(=O)O)cc1
NCGC00167556-01,tox21-er-bla-agonist-p2,Carumonam sodium,activity,inactive,86832-68-0,9568618.0,[Na+].[Na+].Nc1nc(cs1)\C(=N\OCC([O-])=O)C(=O)N[C@@H]2C(=O)N(S([O-])(=O)=O)[C@@H]2COC(N)=O
NCGC00167569-01,tox21-er-bla-agonist-p2,Mefeserpine,activity,inactive,3735-85-1,3045407.0,COc1ccc(cc1)OCC(=O)O[C@@H]3C[C@@H]4CN5CCc2c6ccc(OC)cc6nc2[C@H]5C[C@@H]4[C@@H]([C@H]3OC)C(=O)OC
NCGC00159378-02,tox21-er-bla-agonist-p2,Phenylhydrazine hydrochloride,activity,inactive,59-88-1,60962.0,Cl.NNc1ccccc1
NCGC00183273-01,tox21-er-bla-agonist-p2,Chloroprocaine hydrochloride,activity,inactive,3858-89-7,441348.0,Cl.Clc1cc(N)ccc1C(=O)OCCN(CC)CC
NCGC00183848-01,tox21-er-bla-agonist-p2,Troxacitabine,activity,inactive,145918-75-8,151173.0,OC[C@H]1OCC(O1)[N@@]2C=CC(N)=NC2=O
NCGC00185736-01,tox21-er-bla-agonist-p2,Posaconazole,activity,inactive,171228-49-2,147912.0,C[C@H](O)[C@H](CC)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(cc4)OCC6C[C@@](Cn5cncn5)(OC6)c7ccc(F)cc7F
NCGC00254136-01,tox21-er-bla-agonist-p2,Kepone,activity,active agonist,143-50-0,299.0,O=C2C1(Cl)C3(Cl)C5(Cl)C1(Cl)C4(Cl)C2(Cl)C3(Cl)C4(Cl)C5(Cl)Cl
NCGC00255031-01,tox21-er-bla-agonist-p2,Propoxycarbazone-sodium,activity,inactive,181274-15-7,12056759.0,[Na+].O=C([N-]S(=O)(=O)c1ccccc1C(=O)OC)N2N=C(OCCC)N(C)C2=O
NCGC00255056-01,tox21-er-bla-agonist-p2,Di(propylene glycol) dimethyl ether,activity,inactive,111109-77-4,86302.0,COCCCOCCCOC
NCGC00247702-01,tox21-er-bla-agonist-p2,(-)-Heroin hydrochloride,activity,inactive,1502-95-0,9844225.0,Cl.CC(=O)Oc1ccc2C[C@H]4N(C)CC[C@@]35[C@@H](Oc1c23)[C@H](C=C[C@@H]45)OC(C)=O
NCGC00254257-01,tox21-er-bla-agonist-p2,3-Phenoxybenzoic acid,activity,inactive,3739-38-6,19539.0,O=C(O)c2cc(Oc1ccccc1)ccc2
NCGC00255175-01,tox21-er-bla-agonist-p2,Flufenamic acid,activity,inactive,530-78-9,3371.0,FC(F)(F)c1cc(ccc1)Nc2ccccc2C(=O)O
NCGC00254329-01,tox21-er-bla-agonist-p2,"N,N-Dimethyloctylamine",activity,inactive,7378-99-6,16224.0,CN(C)CCCCCCCC
NCGC00254330-01,tox21-er-bla-agonist-p2,N-Nitrosodibutylamine,activity,inactive,924-16-3,13542.0,CCCCN(CCCC)N=O
NCGC00254335-01,tox21-er-bla-agonist-p2,Picoxystrobin,activity,active agonist,117428-22-5,11285653.0,O=C(OC)\C(=C\OC)c2ccccc2COc1cccc(n1)C(F)(F)F
NCGC00253952-01,tox21-er-bla-agonist-p2,Catechol,activity,active agonist,120-80-9,289.0,Oc1ccccc1O
NCGC00254807-01,tox21-er-bla-agonist-p2,2-Propyl-1-heptanol,activity,inactive,10042-59-8,24847.0,CCCCCC(CCC)CO
NCGC00182977-01,tox21-er-bla-agonist-p2,Trimethoquinol,activity,inactive,18559-59-6,656634.0,Cl.COc1cc(cc(OC)c1OC)C[C@@H]2NCCc3cc(O)c(O)cc23
NCGC00260600-01,tox21-er-bla-agonist-p2,NTP Mix3 AR1 8-EQC,activity,inactive,NOCAS_49496,,
NCGC00258770-01,tox21-er-bla-agonist-p2,"2,3-Butanedione",activity,inactive,431-03-8,650.0,CC(=O)C(C)=O
NCGC00258030-01,tox21-er-bla-agonist-p2,"1,4-Bis(2-hydroxy-2-propyl)benzene",activity,inactive,2948-46-1,18062.0,OC(C)(C)c1ccc(cc1)C(C)(C)O
NCGC00259448-01,tox21-er-bla-agonist-p2,"1,4-Benzenedicarbonyl dichloride",activity,inactive,100-20-9,7488.0,O=C(Cl)c1ccc(cc1)C(Cl)=O
NCGC00260363-01,tox21-er-bla-agonist-p2,Kanamycin A sulfate,activity,inactive,25389-94-0,441374.0,O=S(=O)(O)O.O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@H]2[C@H](O)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O)[C@H](N)C[C@@H]2N
NCGC00260555-01,tox21-er-bla-agonist-p2,NTP Mix63 CT1 62-EQP,activity,inactive,NOCAS_49451,,
NCGC00257090-01,tox21-er-bla-agonist-p2,Emodin,activity,active agonist,518-82-1,3220.0,Cc3cc2C(=O)c1cc(O)cc(O)c1C(=O)c2c(O)c3
NCGC00256625-01,tox21-er-bla-agonist-p2,"6-Methyl-1,2,3,4-tetrahydroquinoline",activity,inactive,91-61-2,66678.0,Cc1ccc2NCCCc2c1
NCGC00257655-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium trifluoromethanesulfonate,activity,inactive,460345-16-8,2734247.0,FC(F)(F)S([O-])(=O)=O.C[n+]1ccn(CCCCCC)c1
NCGC00258115-01,tox21-er-bla-agonist-p2,Menthyl anthranilate,activity,active agonist,134-09-8,8633.0,O=C(OC1CC(C)CCC1C(C)C)c2ccccc2N
NCGC00259781-01,tox21-er-bla-agonist-p2,7-Amino-4-hydroxynaphthalene-2-sulfonic acid,activity,inactive,87-02-5,6868.0,O=S(=O)(O)c1cc(O)c2ccc(N)cc2c1
NCGC00257631-01,tox21-er-bla-agonist-p2,"2,4,4-Trimethyl-2-pentanamine",activity,inactive,107-45-9,61017.0,CC(C)(C)CC(C)(C)N
NCGC00257767-01,tox21-er-bla-agonist-p2,2-[4-(Dibutylamino)-2-hydroxybenzoyl]benzoic acid,activity,inactive,54574-82-2,1910825.0,O=C(c1ccc(cc1O)N(CCCC)CCCC)c2ccccc2C(=O)O
NCGC00255648-01,tox21-er-bla-agonist-p2,Tetraethylammonium chloride,activity,inactive,56-34-8,5946.0,[Cl-].CC[N+](CC)(CC)CC
NCGC00256874-01,tox21-er-bla-agonist-p2,Igepal CO-890,activity,inactive,NOCAS_47708,10470544.0,CC(C)CCCCCCc1ccc(OCCOCCO)cc1
NCGC00256875-01,tox21-er-bla-agonist-p2,"(2E)-3,7-Dimethylocta-2,6-dien-1-yl formate",activity,inactive,105-86-2,5282109.0,C\C(C)=C\CCC(\C)=C\COC=O
NCGC00256939-01,tox21-er-bla-agonist-p2,Methyl benzoate,activity,inactive,93-58-3,7150.0,COC(=O)c1ccccc1
NCGC00258011-01,tox21-er-bla-agonist-p2,"2,3-Diaminotoluene",activity,inactive,2687-25-4,17593.0,Cc1cccc(N)c1N
NCGC00257482-01,tox21-er-bla-agonist-p2,3-(Trimethoxysilyl)propyl methacrylate,activity,inactive,2530-85-0,17318.0,CO[Si](CCCOC(=O)C(=C)C)(OC)OC
NCGC00257294-01,tox21-er-bla-agonist-p2,2-Pentyl-2-cyclopenten-1-one,activity,inactive,25564-22-1,117549.0,O=C1CCC=C1CCCCC
NCGC00257518-01,tox21-er-bla-agonist-p2,4-Isopropylbenzaldehyde,activity,inactive,122-03-2,326.0,CC(C)c1ccc(C=O)cc1
NCGC00258684-01,tox21-er-bla-agonist-p2,"1,8-Diamino-p-menthane",activity,inactive,80-52-4,6650.0,CC1(N)CCC(CC1)C(C)(C)N
NCGC00258367-01,tox21-er-bla-agonist-p2,"Polyphosphoric acids, sodium salts",activity,inactive,68915-31-1,24451.0,[Na+].[Na+].[O-]P(=O)(O)OP([O-])(=O)O
NCGC00258579-01,tox21-er-bla-agonist-p2,Tetrahydrofuran,activity,inactive,109-99-9,8028.0,C1CCCO1
NCGC00259195-01,tox21-er-bla-agonist-p2,Tromethamine,activity,inactive,77-86-1,6503.0,OCC(N)(CO)CO
NCGC00259735-01,tox21-er-bla-agonist-p2,1-Decanol,activity,inactive,112-30-1,8174.0,CCCCCCCCCCO
NCGC00259666-01,tox21-er-bla-agonist-p2,Aspirin,activity,inactive,50-78-2,2244.0,O=C(C)Oc1ccccc1C(=O)O
NCGC00259876-01,tox21-er-bla-agonist-p2,2-Ethylphenol,activity,inactive,90-00-6,6997.0,CCc1ccccc1O
NCGC00259461-01,tox21-er-bla-agonist-p2,Dimethyl adipate,activity,inactive,627-93-0,12329.0,O=C(CCCCC(=O)OC)OC
NCGC00259674-01,tox21-er-bla-agonist-p2,3-Ethoxy-4-hydroxybenzaldehyde,activity,inactive,121-32-4,8467.0,CCOc1cc(ccc1O)C=O
NCGC00260353-01,tox21-er-bla-agonist-p2,"N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate",activity,inactive,14933-08-5,84703.0,[O-]S(=O)(=O)CCC[N+](C)(C)CCCCCCCCCCCC
NCGC00260268-01,tox21-er-bla-agonist-p2,Dipivaloylmethane,activity,inactive,1118-71-4,70700.0,CC(C)(C)C(=O)CC(=O)C(C)(C)C
NCGC00260640-01,tox21-er-bla-agonist-p2,NTP Mix116 ER1 10-EQC,activity,active agonist,NOCAS_49536,,
NCGC00260164-01,tox21-er-bla-agonist-p2,"1-Butyl-2,3-dimethylimidazolium trifluoromethanesulfonate",activity,inactive,765910-73-4,2734250.0,CCCCn1cc[n+](C)c1C.FC(F)(F)S([O-])(=O)=O
NCGC00260176-01,tox21-er-bla-agonist-p2,1-Dodecyl-3-methylimidazolium bromide,activity,inactive,61546-00-7,16749605.0,[Br-].C[n+]1ccn(CCCCCCCCCCCC)c1
NCGC00260236-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylpyridinium trifluoromethanesulfonate,activity,inactive,857841-32-8,23079882.0,Cc1ccc[n+](CCCC)c1.FC(F)(F)S([O-])(=O)=O
NCGC00013725-01,tox21-er-bla-agonist-p2,Atropine methylbromide,activity,inactive,2870-71-5,656597.0,[Br-].C[N+]2(C)[C@H]1C[C@@H](C[C@@H]2CC1)OC(=O)C(CO)c3ccccc3
NCGC00015441-04,tox21-er-bla-agonist-p2,Fusaric acid,activity,inactive,536-69-6,3442.0,OC(=O)c1ccc(CCCC)cn1
NCGC00014918-01,tox21-er-bla-agonist-p2,3'-Azido-3'-deoxythymidine,activity,inactive,30516-87-1,35370.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H](\N=[N+]=[N-])[C@@H](CO)O2
NCGC00015948-02,tox21-er-bla-agonist-p2,Spironolactone,activity,inactive,52-01-7,5833.0,CC(=O)S[C@@H]4CC1=CC(=O)CC[C@]1(C)[C@H]5CC[C@@]3(C)[C@@H](CC[C@]23CCC(=O)O2)[C@H]45
NCGC00015156-11,tox21-er-bla-agonist-p2,Baclofen,activity,inactive,1134-47-0,2284.0,Clc1ccc(cc1)C(CN)CC(=O)O
NCGC00016320-01,tox21-er-bla-agonist-p2,Ethosuximide,activity,inactive,77-67-8,3291.0,CC1(CC)CC(=O)NC1=O
NCGC00016351-01,tox21-er-bla-agonist-p2,p-Synephrine,activity,inactive,94-07-5,7172.0,OC(CNC)c1ccc(O)cc1
NCGC00016547-06,tox21-er-bla-agonist-p2,Clofibric acid,activity,inactive,882-09-7,2797.0,Clc1ccc(OC(C)(C)C(=O)O)cc1
NCGC00016611-01,tox21-er-bla-agonist-p2,Bufexamac,activity,inactive,2438-72-4,2466.0,ONC(=O)Cc1ccc(OCCCC)cc1
NCGC00016794-09,tox21-er-bla-agonist-p2,Gemfibrozil,activity,inactive,25812-30-0,3463.0,O=C(O)C(C)(C)CCCOc1cc(C)ccc1C
NCGC00015989-09,tox21-er-bla-agonist-p2,Thalidomide,activity,inactive,50-35-1,5426.0,O=C1NC(=O)CCC1N3C(=O)c2ccccc2C3=O
NCGC00256234-01,tox21-er-bla-agonist-p2,"Hex-3-yne-2,5-diol",activity,inactive,3031-66-1,18198.0,CC(O)C#CC(C)O
NCGC00256351-01,tox21-er-bla-agonist-p2,C.I. Acid Red 114,activity,inactive,6459-94-5,5479172.0,[Na+].[Na+].[O-]S(=O)(=O)c5cc(cc6ccc(O)c(/N=N/c1ccc(cc1C)c4ccc(/N=N/c3ccc(OS(=O)(=O)c2ccc(C)cc2)cc3)c(C)c4)c56)S([O-])(=O)=O
NCGC00254381-01,tox21-er-bla-agonist-p2,PD 0343701,activity,inactive,676116-04-4,9984487.0,CS(=O)(=O)O.Cc2cc(cc1c2NC(=O)CC1(C)C)CCN3CCN(CC3)c5nsc4ccccc45
NCGC00254445-01,tox21-er-bla-agonist-p2,CP-409092,activity,inactive,194098-25-4,9839190.0,CNCc1ccc(cc1)NC(=O)c3cnc2CCCC(=O)c23
NCGC00015904-02,tox21-er-bla-agonist-p2,Ribavirin,activity,inactive,36791-04-5,37542.0,NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
NCGC00016233-01,tox21-er-bla-agonist-p2,Lynestrenol,activity,active agonist,52-76-6,5284486.0,C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@]2(O)C#C
NCGC00017146-01,tox21-er-bla-agonist-p2,Canrenoate potassium,activity,inactive,2181-04-6,23671691.0,[K+].[O-]C(=O)CC[C@]3(O)CC[C@H]2[C@@H]4C=CC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@@]23C
NCGC00164533-01,tox21-er-bla-agonist-p2,Buformin,activity,inactive,692-13-7,2468.0,NC(=N)NC(=N)NCCCC
NCGC00166259-01,tox21-er-bla-agonist-p2,"Ethyl 2-cyano-3,3-diphenylacrylate",activity,active agonist,5232-99-5,243274.0,O=C(OCC)C(\C#N)=C(\c1ccccc1)c2ccccc2
NCGC00181350-01,tox21-er-bla-agonist-p2,Vatalanib,activity,inactive,212141-54-3,151194.0,Clc1ccc(cc1)Nc4nnc(Cc2ccncc2)c3ccccc34
NCGC00181356-01,tox21-er-bla-agonist-p2,Oxapium iodide,activity,inactive,6577-41-9,168884.0,[I-].C[N+]1(CCCCC1)CC2COC(O2)(C3CCCCC3)c4ccccc4
NCGC00249417-01,tox21-er-bla-agonist-p2,Ataciguat,activity,inactive,254877-67-3,213037.0,O=S(=O)(Nc3ccc(Cl)cc3C(=O)Nc1ccc(cc1)S(=O)(=O)N2CCOCC2)c4ccc(Cl)s4
NCGC00259264-01,tox21-er-bla-agonist-p2,1-Chlorooctane,activity,inactive,111-85-3,8142.0,CCCCCCCCCl
NCGC00259883-01,tox21-er-bla-agonist-p2,N-Nitrosodibutylamine,activity,inactive,924-16-3,13542.0,CCCCN(CCCC)N=O
NCGC00015426-04,tox21-er-bla-agonist-p2,Furafylline,activity,inactive,80288-49-9,3433.0,Cc2nc3N(Cc1ccco1)C(=O)N(C)C(=O)c3n2
NCGC00016239-01,tox21-er-bla-agonist-p2,Methantheline bromide,activity,inactive,53-46-3,5883.0,[Br-].CC[N+](C)(CC)CCOC(=O)C1c3ccccc3Oc2ccccc12
NCGC00016831-01,tox21-er-bla-agonist-p2,Buflomedil hydrochloride,activity,inactive,35543-24-9,6420013.0,Cl.COc2cc(OC)cc(OC)c2C(=O)CCCN1CCCC1
NCGC00159330-02,tox21-er-bla-agonist-p2,Doxofylline,activity,inactive,69975-86-6,50942.0,O=C2c1n(cnc1N(C)C(=O)N2C)CC3OCCO3
NCGC00160453-01,tox21-er-bla-agonist-p2,Morphazinamide,activity,inactive,952-54-5,70374.0,O=C(NCN1CCOCC1)c2cnccn2
NCGC00181148-01,tox21-er-bla-agonist-p2,Metharbital,activity,inactive,50-11-3,4099.0,O=C1NC(=O)N(C)C(=O)C1(CC)CC
NCGC00254040-01,tox21-er-bla-agonist-p2,Theophylline,activity,inactive,58-55-9,2153.0,O=C2c1ncnc1N(C)C(=O)N2C
NCGC00254477-01,tox21-er-bla-agonist-p2,PD-0333941,activity,inactive,501027-49-2,10134976.0,O=C(O)CCn4ccc3c4cccc3OCCc1nc(oc1C)c2ccccc2
NCGC00017018-01,tox21-er-bla-agonist-p2,Mercurochrome,activity,inactive,129-16-8,8505.0,[Na+].[Na+].[O-]c4cc5Oc1c(cc(Br)c([O-])c1[Hg]O)C3(OC(=O)c2ccccc23)c5cc4Br
NCGC00017114-01,tox21-er-bla-agonist-p2,Cefsulodin sodium,activity,inactive,52152-93-9,6604087.0,[Na+].[O-]S(=O)(=O)[C@@H](c1ccccc1)C(=O)N[C@@H]4C(=O)N3[C@H]4SCC(C[n+]2ccc(cc2)C(N)=O)=C3C([O-])=O
NCGC00018172-03,tox21-er-bla-agonist-p2,Indapamide,activity,inactive,26807-65-8,3702.0,NS(=O)(=O)c1cc(ccc1Cl)C(=O)NN2c3ccccc3CC2C
NCGC00016871-01,tox21-er-bla-agonist-p2,Ribostamycin sulfate,activity,inactive,53797-35-6,20056828.0,O=S(=O)(O)O.N[C@@H]3[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]3O[C@@H]2[C@@H](N)C[C@@H](N)C(O)[C@H]2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
NCGC00256815-01,tox21-er-bla-agonist-p2,"4,5-Dimethyl-3-hydroxy-2,5-dihydrofuran-2-one",activity,inactive,28664-35-9,62835.0,O=C1OC(C)C(C)=C1O
NCGC00256827-01,tox21-er-bla-agonist-p2,Pentyl hexanoate,activity,inactive,540-07-8,10886.0,O=C(CCCCC)OCCCCC
NCGC00256840-01,tox21-er-bla-agonist-p2,Octyl decyl phthalate,activity,inactive,119-07-3,8380.0,O=C(OCCCCCCCC)c1ccccc1C(=O)OCCCCCCCCCC
NCGC00256994-01,tox21-er-bla-agonist-p2,4-tert-Butyltoluene,activity,inactive,98-51-1,7390.0,Cc1ccc(cc1)C(C)(C)C
NCGC00258459-01,tox21-er-bla-agonist-p2,"2,2,2-Trifluoroethanol",activity,inactive,75-89-8,6409.0,FC(F)(F)CO
NCGC00257137-01,tox21-er-bla-agonist-p2,Phthalimide,activity,inactive,85-41-6,6809.0,O=C1NC(=O)c2ccccc12
NCGC00257158-01,tox21-er-bla-agonist-p2,Piperonyl acetate,activity,inactive,326-61-4,9473.0,CC(=O)OCc1ccc2OCOc2c1
NCGC00257434-01,tox21-er-bla-agonist-p2,Tetrac,activity,inactive,67-30-1,65552.0,O=C(O)Cc2cc(I)c(Oc1cc(I)c(O)c(I)c1)c(I)c2
NCGC00257463-01,tox21-er-bla-agonist-p2,Bisphenol AF,activity,active agonist,1478-61-1,73864.0,Oc1ccc(cc1)C(c2ccc(O)cc2)(C(F)(F)F)C(F)(F)F
NCGC00257536-01,tox21-er-bla-agonist-p2,2-Acetamidophenol,activity,inactive,614-80-2,11972.0,Oc1ccccc1NC(C)=O
NCGC00257626-01,tox21-er-bla-agonist-p2,2-Nitroacetophenone,activity,inactive,577-59-3,11346.0,O=[N+]([O-])c1ccccc1C(C)=O
NCGC00257727-01,tox21-er-bla-agonist-p2,Allyl nonanoate,activity,inactive,7493-72-3,61410.0,O=C(CCCCCCCC)OCC=C
NCGC00257871-01,tox21-er-bla-agonist-p2,2-Methyl-2-butenenitrile,activity,inactive,4403-61-6,6028739.0,C\C=C(\C)C#N
NCGC00258103-01,tox21-er-bla-agonist-p2,"2,4-Dimethoxy-4'-hydroxy benzophenone",activity,active agonist,41351-30-8,56638112.0,COc2cc(ccc2C(=O)c1cccc(O)c1)OC
NCGC00258108-01,tox21-er-bla-agonist-p2,"3,3'-Dimethylbisphenol A",activity,active agonist,79-97-0,6620.0,Cc1cc(ccc1O)C(C)(C)c2ccc(O)c(C)c2
NCGC00258129-01,tox21-er-bla-agonist-p2,Triisobutylmethylphosphonium tosylate,activity,inactive,344774-05-6,16218739.0,Cc1ccc(cc1)S(=O)([O-])=O.CC(C)C[P+](C)(CC(C)C)CC(C)C
NCGC00258270-01,tox21-er-bla-agonist-p2,"4,4'-Diaminobenzanilide",activity,inactive,785-30-8,69917.0,O=C(Nc1ccc(N)cc1)c2ccc(N)cc2
NCGC00255727-01,tox21-er-bla-agonist-p2,Piracetam,activity,inactive,7491-74-9,4843.0,O=C1CCCN1CC(=O)N
NCGC00256454-01,tox21-er-bla-agonist-p2,Dimethylaminoethanol,activity,inactive,108-01-0,7902.0,CN(C)CCO
NCGC00256470-01,tox21-er-bla-agonist-p2,Suxibuzone,activity,inactive,27470-51-5,5362.0,O=C(O)CCC(=O)OCC2(CCCC)C(=O)N(c1ccccc1)N(C2=O)c3ccccc3
NCGC00256496-01,tox21-er-bla-agonist-p2,Phenylephrine hydrochloride,activity,inactive,61-76-7,5284443.0,Cl.O[C@@H](CNC)c1cc(O)ccc1
NCGC00255862-01,tox21-er-bla-agonist-p2,"Benzenecarboximidamide, monohydrochloride",activity,inactive,1670-14-0,80289.0,Cl.N=C(N)c1ccccc1
NCGC00255938-01,tox21-er-bla-agonist-p2,Etaconazole,activity,inactive,60207-93-4,91673.0,Clc1ccc(c(Cl)c1)C3(Cn2ncnc2)OCC(CC)O3
NCGC00256011-01,tox21-er-bla-agonist-p2,Benzyl propanoate,activity,inactive,122-63-4,31219.0,CCC(=O)OCc1ccccc1
NCGC00256064-01,tox21-er-bla-agonist-p2,D-Lactitol monohydrate,activity,inactive,81025-04-9,3067270.0,O.OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO
NCGC00259253-01,tox21-er-bla-agonist-p2,4-Chlorophenol,activity,inactive,106-48-9,4684.0,Oc1ccc(Cl)cc1
NCGC00259409-01,tox21-er-bla-agonist-p2,N-Nitrosodipropylamine,activity,inactive,621-64-7,12130.0,CCCN(CCC)N=O
NCGC00259691-01,tox21-er-bla-agonist-p2,4-Methylaniline,activity,inactive,106-49-0,7813.0,Cc1ccc(N)cc1
NCGC00258714-01,tox21-er-bla-agonist-p2,4-Azoxyanisole,activity,inactive,1562-94-3,15277.0,COc2ccc(\N=[N+](\[O-])c1ccc(OC)cc1)cc2
NCGC00258776-01,tox21-er-bla-agonist-p2,Toluene,activity,inactive,108-88-3,1140.0,Cc1ccccc1
NCGC00254825-01,tox21-er-bla-agonist-p2,Isoxaflutole,activity,inactive,141112-29-0,84098.0,O=C(c2cnoc2C1CC1)c3ccc(cc3S(C)(=O)=O)C(F)(F)F
NCGC00255078-01,tox21-er-bla-agonist-p2,Ethyl decanoate,activity,inactive,110-38-3,8048.0,O=C(CCCCCCCCC)OCC
NCGC00255395-01,tox21-er-bla-agonist-p2,4-tert-Butylstyrene,activity,inactive,1746-23-2,15627.0,CC(C)(C)c1ccc(C=C)cc1
NCGC00255627-01,tox21-er-bla-agonist-p2,Atraton,activity,inactive,1610-17-9,15359.0,COc1nc(NCC)nc(NC(C)C)n1
NCGC00256114-01,tox21-er-bla-agonist-p2,6-Aminonaphthalene-2-sulfonic acid,activity,inactive,93-00-5,7116.0,O=S(=O)(O)c1ccc2cc(N)ccc2c1
NCGC00254562-01,tox21-er-bla-agonist-p2,3-(Trifluoromethyl)benzoic acid,activity,inactive,454-92-2,9963.0,FC(F)(F)c1cccc(c1)C(=O)O
NCGC00091116-01,tox21-er-bla-agonist-p2,Pentane,activity,inactive,109-66-0,8003.0,CCCCC
NCGC00163424-01,tox21-er-bla-agonist-p2,Tanespimycin,activity,inactive,75747-14-7,6505803.0,NC(=O)O[C@H]1C(C)=C[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)C(C)=CC=C[C@@H]1OC)C2=O
NCGC00094363-03,tox21-er-bla-agonist-p2,D-Serine,activity,inactive,312-84-5,71077.0,O=C(O)[C@H](N)CO
NCGC00094570-01,tox21-er-bla-agonist-p2,Imidacloprid,activity,inactive,138261-41-3,86418.0,[O-][N+](=O)/N=C2\NCCN2Cc1cnc(Cl)cc1
NCGC00094745-01,tox21-er-bla-agonist-p2,Orphenadrine dihydrogen citrate,activity,inactive,4682-36-4,83823.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CN(C)CCOC(c1ccccc1)c2ccccc2C
NCGC00164498-01,tox21-er-bla-agonist-p2,Tolpentamide,activity,inactive,1027-87-8,3083671.0,O=C(NS(=O)(=O)c1ccc(C)cc1)NC2CCCC2
NCGC00167834-01,tox21-er-bla-agonist-p2,Moexipril hydrochloride,activity,inactive,82586-52-5,54889.0,Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3cc(OC)c(OC)cc3C[C@H]2C(=O)O
NCGC00095135-01,tox21-er-bla-agonist-p2,Almotriptan,activity,inactive,154323-57-6,123606.0,O=S(=O)(Cc1ccc2ncc(CCN(C)C)c2c1)N3CCCC3
NCGC00095150-01,tox21-er-bla-agonist-p2,Telmisartan,activity,inactive,144701-48-4,65999.0,O=C(O)c1ccccc1c2ccc(cc2)Cn3c4cc(cc(C)c4nc3CCC)c6nc5ccccc5n6C
NCGC00168346-01,tox21-er-bla-agonist-p2,1-Phenyl-1H-tetrazole,activity,inactive,5378-52-9,138477.0,c1ccc(cc1)n2cnnn2
NCGC00095186-01,tox21-er-bla-agonist-p2,Pregabalin,activity,inactive,148553-50-8,5486971.0,NC[C@@H](CC(C)C)CC(=O)O
NCGC00095189-01,tox21-er-bla-agonist-p2,Topotecan hydrochloride,activity,inactive,119413-54-6,60699.0,Cl.CN(C)Cc1c2cc3CN4C(=O)C=5COC(=O)[C@](O)(CC)C=5C=C4c3nc2ccc1O
NCGC00095196-01,tox21-er-bla-agonist-p2,Tilorone,activity,inactive,27591-97-5,5475.0,CCN(CC)CCOc2ccc3c1ccc(cc1C(=O)c3c2)OCCN(CC)CC
NCGC00164633-01,tox21-er-bla-agonist-p2,Nisoldipine,activity,inactive,63675-72-9,4499.0,CC=1NC(C)=C(C(C=1C(=O)OCC(C)C)c2ccccc2[N+]([O-])=O)C(=O)OC
NCGC00165714-02,tox21-er-bla-agonist-p2,Adrafinil,activity,inactive,63547-13-7,3033226.0,O=S(CC(=O)NO)C(c1ccccc1)c2ccccc2
NCGC00181045-01,tox21-er-bla-agonist-p2,Pyridoxamine phosphate,activity,inactive,529-96-4,1053.0,Oc1c(CN)c(cnc1C)COP(=O)(O)O
NCGC00095762-01,tox21-er-bla-agonist-p2,Creatinine,activity,inactive,60-27-5,588.0,N=C1NC(=O)CN1C
NCGC00165997-01,tox21-er-bla-agonist-p2,Bismuth(III) carbonate,activity,inactive,5892-10-4,16683095.0,O=C(O[Bi]=O)O[Bi]=O
NCGC00167514-01,tox21-er-bla-agonist-p2,Ethylestrenol,activity,active agonist,965-90-2,13765.0,C[C@]32CC[C@@H]1[C@H]4CCCC=C4CC[C@H]1[C@@H]3CC[C@@]2(O)CC
NCGC00160608-01,tox21-er-bla-agonist-p2,Rolicyprine,activity,inactive,2829-19-8,60196287.0,O=C1CC[C@H](N1)C(=O)N[C@H]3C[C@@H]3c2ccccc2
NCGC00181096-01,tox21-er-bla-agonist-p2,Chlophedianol,activity,inactive,791-35-5,2795.0,OC(CCN(C)C)(c1ccccc1Cl)c2ccccc2
NCGC00159358-02,tox21-er-bla-agonist-p2,Nitrazepam,activity,inactive,146-22-5,4506.0,[O-][N+](=O)c1ccc2NC(=O)CN=C(c2c1)c3ccccc3
NCGC00091666-01,tox21-er-bla-agonist-p2,"1,8-Cineol",activity,inactive,470-82-6,2758.0,CC2(C)OC1(C)CCC2CC1
NCGC00182028-01,tox21-er-bla-agonist-p2,Tipranavir,activity,inactive,174484-41-4,54682461.0,CCC[C@]1(CC(O)=C(C(=O)O1)[C@H](CC)c3cccc(NS(=O)(=O)c2ccc(cn2)C(F)(F)F)c3)CCc4ccccc4
NCGC00254200-01,tox21-er-bla-agonist-p2,N-Vinyl-2-pyrrolidone,activity,inactive,88-12-0,6917.0,O=C1CCCN1C=C
NCGC00254241-01,tox21-er-bla-agonist-p2,CP-114271,activity,inactive,113734-18-2,18551400.0,OC(CNC(C)Cc1ccc(OCC(=O)O)cc1)c2csc(n2)C(F)(F)F
NCGC00254701-01,tox21-er-bla-agonist-p2,2-Methoxyethyl cyanoacetate,activity,inactive,10258-54-5,25106.0,O=C(CC#N)OCCOC
NCGC00255382-01,tox21-er-bla-agonist-p2,Tetrakis(hydroxymethyl)phosphonium chloride,activity,inactive,124-64-1,31298.0,[Cl-].OC[P+](CO)(CO)CO
NCGC00254341-01,tox21-er-bla-agonist-p2,UK-343664,activity,inactive,215297-27-1,9959619.0,O=S(=O)(c4cc(C3=Nc2c(CC)n(Cc1ccccn1)nc2C(=O)N3)c(OCCC)cc4)N5CCN(CC)CC5
NCGC00254464-01,tox21-er-bla-agonist-p2,Methyl dodecanoate,activity,inactive,111-82-0,8139.0,O=C(CCCCCCCCCCC)OC
NCGC00255224-01,tox21-er-bla-agonist-p2,"5,5-Dimethylbarbituric acid",activity,inactive,24448-94-0,90509.0,CC1(C)C(=O)NC(=O)NC1=O
NCGC00255247-01,tox21-er-bla-agonist-p2,Chlorophacinone,activity,inactive,3691-35-8,19402.0,Clc1ccc(cc1)C(c2ccccc2)C(=O)C4C(=O)c3ccccc3C4=O
NCGC00254097-01,tox21-er-bla-agonist-p2,Triethylene glycol,activity,inactive,112-27-6,8172.0,OCCOCCOCCO
NCGC00181353-01,tox21-er-bla-agonist-p2,Norgestimate,activity,active agonist,35189-28-7,6540478.0,CC(=O)O[C@@]3(C#C)CC[C@H]2[C@@H]4CCC1=CC(\CC[C@@H]1[C@H]4CC[C@@]23CC)=N\O
NCGC00017074-02,tox21-er-bla-agonist-p2,Hydergine,activity,inactive,8067-24-1,168870.0,CS(=O)(=O)O.CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]7(O[C@]6(O)N([C@H](C(=O)N5CCC[C@H]56)C(C)C)C7=O)C(C)C
NCGC00259741-01,tox21-er-bla-agonist-p2,"N-Ethyl-N-(3-methylphenyl)ethane-1,2-diamine",activity,inactive,19248-13-6,87984.0,CCN(CCN)c1cc(C)ccc1
NCGC00015747-03,tox21-er-bla-agonist-p2,Nicardipine,activity,inactive,55985-32-5,4474.0,CC=2NC(C)=C(C(C=2C(=O)OCCN(C)Cc1ccccc1)c3cccc(c3)[N+]([O-])=O)C(=O)OC
NCGC00258881-01,tox21-er-bla-agonist-p2,2-(Chloromethyl)pyridine hydrochloride,activity,inactive,6959-47-3,23392.0,Cl.ClCc1ccccn1
NCGC00258999-01,tox21-er-bla-agonist-p2,Oxyfluorfen,activity,inactive,42874-03-3,39327.0,Clc2cc(ccc2Oc1ccc([N+]([O-])=O)c(OCC)c1)C(F)(F)F
NCGC00259206-01,tox21-er-bla-agonist-p2,Methyl 2-aminobenzoate,activity,inactive,134-20-3,8635.0,Nc1ccccc1C(=O)OC
NCGC00259892-01,tox21-er-bla-agonist-p2,Disulfoton,activity,inactive,298-04-4,3118.0,CCSCCSP(=S)(OCC)OCC
NCGC00260056-01,tox21-er-bla-agonist-p2,Digitonin,activity,active agonist,11024-24-1,6537502.0,[H][C@@]12O[C@]3(CC[C@@]([H])(C)CO3)[C@@H](C)[C@]1([H])[C@@]1(C)CC[C@@]3([H])[C@@]([H])(CC[C@@]4([H])C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]34C)[C@]1([H])[C@@H]2O
NCGC00256605-01,tox21-er-bla-agonist-p2,Sulfisoxazole,activity,inactive,127-69-5,5344.0,Cc2c(NS(=O)(=O)c1ccc(N)cc1)onc2C
NCGC00256684-01,tox21-er-bla-agonist-p2,"Benzenemethanol, ar-methoxy-",activity,inactive,1331-81-3,7738.0,COc1ccc(CO)cc1
NCGC00256748-01,tox21-er-bla-agonist-p2,4-Propylphenol,activity,inactive,645-56-7,12580.0,Oc1ccc(CCC)cc1
NCGC00256920-01,tox21-er-bla-agonist-p2,Oxacycloheptadecan-2-one,activity,inactive,109-29-5,7984.0,O=C1CCCCCCCCCCCCCCCO1
NCGC00256944-01,tox21-er-bla-agonist-p2,Methyl 12-hydroxyoctadecanoate,activity,inactive,141-23-1,8840.0,O=C(CCCCCCCCCCC(O)CCCCCC)OC
NCGC00015846-11,tox21-er-bla-agonist-p2,Phenylbutazone,activity,inactive,50-33-9,4781.0,O=C3C(CCCC)C(=O)N(c1ccccc1)N3c2ccccc2
NCGC00258586-01,tox21-er-bla-agonist-p2,Dihydrokavain,activity,inactive,587-63-3,98356.0,O=C2C=C(CC(CCc1ccccc1)O2)OC
NCGC00255519-01,tox21-er-bla-agonist-p2,Tolclofos-methyl,activity,inactive,57018-04-9,91664.0,Clc1cc(C)cc(Cl)c1OP(=S)(OC)OC
NCGC00255436-01,tox21-er-bla-agonist-p2,Pregnenolone,activity,active agonist,145-13-1,8955.0,CC(=O)[C@H]4CC[C@@H]3[C@]4(C)CC[C@H]2[C@H]3CC=C1C[C@@H](O)CC[C@@]12C
NCGC00256082-01,tox21-er-bla-agonist-p2,"2-Chloro-1,4-diethoxybenzene",activity,inactive,52196-74-4,40273.0,Clc1cc(ccc1OCC)OCC
NCGC00256572-01,tox21-er-bla-agonist-p2,5-Methyl-2-hexanone,activity,inactive,110-12-3,8034.0,CC(C)CCC(C)=O
NCGC00256896-01,tox21-er-bla-agonist-p2,Butyl undec-10-enoate,activity,inactive,109-42-2,61027.0,O=C(CCCCCCCCC=C)OCCCC
NCGC00256795-01,tox21-er-bla-agonist-p2,"Ethyl 2,4-dimethyl-1,3-dioxolane-2-acetate",activity,inactive,6290-17-1,95392.0,O=C(OCC)CC1(C)OCC(C)O1
NCGC00256449-01,tox21-er-bla-agonist-p2,Phenylbutazone,activity,inactive,50-33-9,4781.0,O=C3C(CCCC)C(=O)N(c1ccccc1)N3c2ccccc2
NCGC00256921-01,tox21-er-bla-agonist-p2,5-Methyl-2-thiophenecarboxaldehyde,activity,inactive,13679-70-4,61663.0,Cc1ccc(C=O)s1
NCGC00256936-01,tox21-er-bla-agonist-p2,"2,6,8-Trimethyl-4-nonanone",activity,inactive,123-18-2,61057.0,CC(C)CC(C)CC(=O)CC(C)C
NCGC00257841-01,tox21-er-bla-agonist-p2,1(2H)-Phthalazinone,activity,inactive,119-39-1,8394.0,O=C1NN=Cc2ccccc12
NCGC00257420-01,tox21-er-bla-agonist-p2,4-Nonylphenol,activity,inactive,104-40-5,1752.0,Oc1ccc(CCCCCCCCC)cc1
NCGC00257963-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarboxylic acid",activity,inactive,121-91-5,8496.0,OC(=O)c1cccc(c1)C(=O)O
NCGC00257277-01,tox21-er-bla-agonist-p2,Flubendiamide,activity,inactive,272451-65-7,11193251.0,O=C(Nc1ccc(cc1C)C(F)(C(F)(F)F)C(F)(F)F)c2cccc(I)c2C(=O)NC(C)(C)CS(C)(=O)=O
NCGC00257504-01,tox21-er-bla-agonist-p2,dl-alpha-Tocopheryl acetate,activity,inactive,52225-20-4,86472.0,CC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00257981-01,tox21-er-bla-agonist-p2,Didecyl phthalate,activity,inactive,84-77-5,6788.0,O=C(OCCCCCCCCCC)c1ccccc1C(=O)OCCCCCCCCCC
NCGC00257797-01,tox21-er-bla-agonist-p2,2-[2-(Dimethylamino)ethoxy]ethanol,activity,inactive,1704-62-7,74348.0,CN(C)CCOCCO
NCGC00258504-01,tox21-er-bla-agonist-p2,"3,3'-Dithiodipropionic acid",activity,inactive,1119-62-6,95116.0,OC(=O)CCSSCCC(=O)O
NCGC00258772-01,tox21-er-bla-agonist-p2,Dibenzoyl-L-tartaric acid,activity,inactive,2743-38-6,75969.0,O=C(O)[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c2ccccc2)C(=O)O
NCGC00259067-01,tox21-er-bla-agonist-p2,Hexanoic acid,activity,inactive,142-62-1,8892.0,CCCCCC(=O)O
NCGC00258052-01,tox21-er-bla-agonist-p2,"Ethylene glycol, cyclic sulfate",activity,inactive,1072-53-3,14075.0,O=S1(=O)OCCO1
NCGC00259183-01,tox21-er-bla-agonist-p2,Terbufos,activity,inactive,13071-79-9,25670.0,CC(C)(C)SCSP(=S)(OCC)OCC
NCGC00259565-01,tox21-er-bla-agonist-p2,Sodium xylenesulfonate,activity,inactive,1300-72-7,23668192.0,[Na+].Cc1ccc(cc1C)S(=O)([O-])=O
NCGC00259578-01,tox21-er-bla-agonist-p2,"(2Z)-3,7-Dimethylocta-2,6-dien-1-ol",activity,inactive,106-25-2,643820.0,C\C(C)=C\CCC(/C)=C\CO
NCGC00260302-01,tox21-er-bla-agonist-p2,"Propanoic acid, 3,3'-thiobis-, ditridecyl ester",activity,inactive,10595-72-9,82751.0,O=C(OCCCCCCCCCCCCC)CCSCCC(=O)OCCCCCCCCCCCCC
NCGC00260303-01,tox21-er-bla-agonist-p2,"Propanenitrile, 2-amino-2-methyl-",activity,inactive,19355-69-2,88022.0,N#CC(C)(C)N
NCGC00260478-01,tox21-er-bla-agonist-p2,FD&C Red 3,activity,inactive,16423-68-0,27872.0,[Na+].[Na+].[O-]C(=O)c4ccccc4C=2c3cc(I)c([O-])c(I)c3OC=1C=2C=C(I)C(=O)C=1I
NCGC00260230-01,tox21-er-bla-agonist-p2,1-Butyl-3-methylpyridinium hexafluorophosphate,activity,inactive,845835-03-2,57358854.0,Cc1ccc[n+](CCCC)c1.F[P-](F)(F)(F)(F)F
NCGC00015678-02,tox21-er-bla-agonist-p2,Moxisylyte hydrochloride,activity,inactive,964-52-3,6420039.0,Cl.CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
NCGC00013216-01,tox21-er-bla-agonist-p2,Dimercaprol,activity,inactive,59-52-9,3080.0,OCC(S)CS
NCGC00015786-11,tox21-er-bla-agonist-p2,Pindolol,activity,inactive,13523-86-9,4828.0,CC(C)NCC(O)COc2cccc1nccc12
NCGC00015278-09,tox21-er-bla-agonist-p2,Carisoprodol,activity,inactive,78-44-4,2576.0,O=C(NC(C)C)OCC(C)(COC(=O)N)CCC
NCGC00015714-09,tox21-er-bla-agonist-p2,Nimodipine,activity,inactive,66085-59-4,4497.0,CC=1NC(C)=C(C(C=1C(=O)OC(C)C)c2cccc(c2)[N+]([O-])=O)C(=O)OCCOC
NCGC00015451-03,tox21-er-bla-agonist-p2,Flupirtine maleate,activity,inactive,75507-68-5,6435335.0,Nc1nc(ccc1NC(=O)OCC)NCc2ccc(F)cc2.O=C(O)/C=C\C(=O)O
NCGC00015500-10,tox21-er-bla-agonist-p2,Haloperidol,activity,inactive,52-86-8,3559.0,Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3
NCGC00015073-02,tox21-er-bla-agonist-p2,Amifostine,activity,inactive,20537-88-6,2141.0,OP(=O)(O)SCCNCCCN
NCGC00015919-04,tox21-er-bla-agonist-p2,Sotalol,activity,inactive,3930-20-9,5253.0,O=S(C)(=O)Nc1ccc(cc1)C(O)CNC(C)C
NCGC00016089-05,tox21-er-bla-agonist-p2,Nonivamide,activity,inactive,2444-46-4,2998.0,Oc1ccc(cc1OC)CNC(=O)CCCCCCCC
NCGC00016354-03,tox21-er-bla-agonist-p2,Butylparaben,activity,active agonist,94-26-8,7184.0,Oc1ccc(cc1)C(=O)OCCCC
NCGC00016367-01,tox21-er-bla-agonist-p2,Succinylsulfathiazole,activity,inactive,116-43-8,5315.0,O=S(=O)(Nc1nccs1)c2ccc(NC(=O)CCC(=O)O)cc2
NCGC00095289-01,tox21-er-bla-agonist-p2,Exemestane,activity,inactive,107868-30-4,60198.0,O=C3C=C4C(=C)C[C@@H]1[C@H](CC[C@]2(C)C(=O)CC[C@@H]12)[C@@]4(C)C=C3
NCGC00255752-01,tox21-er-bla-agonist-p2,"1,1,3,3-Tetrabutylurea",activity,inactive,4559-86-8,20691.0,CCCCN(CCCC)C(=O)N(CCCC)CCCC
NCGC00254929-01,tox21-er-bla-agonist-p2,2-Phenylethyl acetate,activity,inactive,103-45-7,7654.0,CC(=O)OCCc1ccccc1
NCGC00254968-01,tox21-er-bla-agonist-p2,(7S)-Hydroprene,activity,inactive,65733-18-8,5282198.0,C\C(C=C/C[C@@H](C)CCCC(C)C)=C/C(=O)OCC
NCGC00255158-01,tox21-er-bla-agonist-p2,1-Ethynylcyclohexanol,activity,inactive,78-27-3,6525.0,C#CC1(O)CCCCC1
NCGC00255340-01,tox21-er-bla-agonist-p2,Desmedipham,activity,inactive,13684-56-5,24743.0,O=C(Oc1cccc(c1)NC(=O)OCC)Nc2ccccc2
NCGC00256263-01,tox21-er-bla-agonist-p2,"Butane-1,4-diyl bis(2-methylprop-2-enoate)",activity,inactive,2082-81-7,16387.0,O=C(OCCCCOC(=O)C(=C)C)C(=C)C
NCGC00254475-01,tox21-er-bla-agonist-p2,Butam,activity,inactive,35256-85-0,92299.0,CC(C)(C)C(=O)N(Cc1ccccc1)C(C)C
NCGC00254503-01,tox21-er-bla-agonist-p2,Haloperidol,activity,inactive,52-86-8,3559.0,Fc1ccc(cc1)C(=O)CCCN2CCC(O)(CC2)c3ccc(Cl)cc3
NCGC00254896-01,tox21-er-bla-agonist-p2,Carfentrazone-ethyl,activity,inactive,128639-02-1,86222.0,O=C(OCC)C(Cl)Cc1cc(c(F)cc1Cl)N2N=C(C)N(C2=O)C(F)F
NCGC00255315-01,tox21-er-bla-agonist-p2,Nicotine sulfate,activity,inactive,65-30-5,2735101.0,CN2CCC[C@H]2c1cnccc1.O=S(=O)(O)O.CN2CCC[C@H]2c1cccnc1
NCGC00016998-01,tox21-er-bla-agonist-p2,Cefotiam hydrochloride,activity,inactive,66309-69-1,20848883.0,Cl.Nc1scc(n1)CC(=O)N[C@@H]4C(=O)N3C(=C(CSc2nnnn2CCN(C)C)CS[C@@H]34)C(=O)O
NCGC00018185-05,tox21-er-bla-agonist-p2,Tranilast,activity,inactive,53902-12-8,5282230.0,COc1cc(ccc1OC)/C=C/C(=O)Nc2ccccc2C(=O)O
NCGC00095252-01,tox21-er-bla-agonist-p2,Bisabolol,activity,inactive,515-69-5,1549992.0,CC1=CC[C@@H](CC1)[C@@](O)(C)CC\C=C(/C)C
NCGC00160558-01,tox21-er-bla-agonist-p2,Diamfenetide,activity,inactive,36141-82-9,37384.0,CC(=O)Nc1ccc(cc1)OCCOCCOc2ccc(cc2)NC(C)=O
NCGC00163953-03,tox21-er-bla-agonist-p2,Allethrin,activity,inactive,584-79-2,11442.0,O=C2CC(OC(=O)C1C(/C=C(\C)C)C1(C)C)C(C)=C2CC=C
NCGC00253960-01,tox21-er-bla-agonist-p2,"1,3-Dichlorobenzene",activity,inactive,541-73-1,10943.0,Clc1cccc(Cl)c1
NCGC00254062-01,tox21-er-bla-agonist-p2,4-(Butan-2-yl)phenol,activity,inactive,99-71-8,7453.0,Oc1ccc(cc1)C(C)CC
NCGC00260089-01,tox21-er-bla-agonist-p2,"Tetrabromobisphenol A-bis(2,3-dibromopropyl ether)",activity,inactive,21850-44-2,62753.0,Brc1cc(cc(Br)c1OCC(Br)CBr)C(C)(C)c2cc(Br)c(OCC(Br)CBr)c(Br)c2
NCGC00016741-01,tox21-er-bla-agonist-p2,Tinidazole,activity,active agonist,19387-91-8,5479.0,O=S(=O)(CCn1c(cnc1C)[N+]([O-])=O)CC
NCGC00159455-02,tox21-er-bla-agonist-p2,Gefitinib,activity,inactive,184475-35-2,123631.0,Fc1ccc(cc1Cl)Nc2ncnc3cc(OC)c(cc23)OCCCN4CCOCC4
NCGC00163778-02,tox21-er-bla-agonist-p2,Imazalil sulfate,activity,inactive,58594-72-2,173636.0,O=S(=O)(O)O.Clc2ccc(C(OCC=C)Cn1ccnc1)c(Cl)c2
NCGC00181302-01,tox21-er-bla-agonist-p2,Cytochrome C,activity,inactive,9007-43-6,,
NCGC00254646-01,tox21-er-bla-agonist-p2,Methamidophos,activity,inactive,10265-92-6,4096.0,NP(=O)(OC)SC
NCGC00016927-01,tox21-er-bla-agonist-p2,Enoxacin,activity,inactive,74011-58-8,3229.0,O=C(O)C2=CN(CC)c1nc(c(F)cc1C2=O)N3CCNCC3
NCGC00016945-01,tox21-er-bla-agonist-p2,Racecadotril,activity,inactive,81110-73-8,60561.0,CC(=O)SC[C@@H](Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2
NCGC00017041-01,tox21-er-bla-agonist-p2,Ethamsylate,activity,inactive,2624-44-4,17506.0,Oc1ccc(O)cc1S(O)(=O)=O.CCNCC
NCGC00018160-02,tox21-er-bla-agonist-p2,Ampicillin,activity,inactive,69-53-4,6249.0,OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)[C@H](N)c1ccccc1)[C@H]3SC2(C)C
NCGC00025188-04,tox21-er-bla-agonist-p2,Pinacidil monohydrate,activity,inactive,85371-64-8,55329.0,O.CC(C)(C)C(C)N/C(Nc1ccncc1)=N\C#N
NCGC00065440-02,tox21-er-bla-agonist-p2,Trimecaine monohydrochloride,activity,inactive,1027-14-1,2843496.0,Cl.O=C(Nc1c(C)cc(C)cc1C)CN(CC)CC
NCGC00256756-01,tox21-er-bla-agonist-p2,Tetronic 701,activity,inactive,110617-70-4,20641892.0,OCCOC(C)CN(CCN(CC(C)OCCO)CC(C)OCCO)CC(C)OCCO
NCGC00256769-01,tox21-er-bla-agonist-p2,Decanal,activity,inactive,112-31-2,8175.0,CCCCCCCCCC=O
NCGC00256906-01,tox21-er-bla-agonist-p2,"3,5,5-Trimethylhexanal",activity,inactive,5435-64-3,21574.0,CC(C)(C)CC(C)CC=O
NCGC00256914-01,tox21-er-bla-agonist-p2,Acetoin,activity,inactive,513-86-0,179.0,CC(=O)C(C)O
NCGC00257282-01,tox21-er-bla-agonist-p2,Fenchol,activity,inactive,1632-73-1,15406.0,CC12CCC(C1)C(C)(C)C2O
NCGC00257348-01,tox21-er-bla-agonist-p2,"2,6-Di-tert-butyl-4-ethylphenol",activity,inactive,4130-42-1,20087.0,CC(C)(C)c1cc(cc(c1O)C(C)(C)C)CC
NCGC00257389-01,tox21-er-bla-agonist-p2,PharmaGSID_48505,activity,active agonist,NOCAS_48505,9884915.0,[O-][N+](=O)c1cc2C(=Nc3c(Nc2cc1)nnc3C)c4ccccc4Cl
NCGC00257478-01,tox21-er-bla-agonist-p2,"4,4'-Di-tert-butylbiphenyl",activity,inactive,1625-91-8,74195.0,CC(C)(C)c1ccc(cc1)c2ccc(cc2)C(C)(C)C
NCGC00257760-01,tox21-er-bla-agonist-p2,R-(+)-Pulegone,activity,inactive,89-82-7,442495.0,C/C(C)=C1/CC[C@@H](C)CC1=O
NCGC00257835-01,tox21-er-bla-agonist-p2,"2,5-Dimethylhexane-2,5-diol",activity,inactive,110-03-2,8031.0,CC(O)(C)CCC(C)(C)O
NCGC00257890-01,tox21-er-bla-agonist-p2,2-Chloro-2-nitropropane,activity,inactive,594-71-8,11673.0,CC(C)(Cl)[N+]([O-])=O
NCGC00258015-01,tox21-er-bla-agonist-p2,Bis(2-ethylhexyl) terephthalate,activity,inactive,6422-86-2,22932.0,CCC(CCCC)COC(=O)c1ccc(cc1)C(=O)OCC(CC)CCCC
NCGC00258246-01,tox21-er-bla-agonist-p2,2-Amino-4-methylphenol,activity,inactive,95-84-1,7264.0,Cc1ccc(O)c(N)c1
NCGC00256700-01,tox21-er-bla-agonist-p2,"1,1'-Oxybis(2,3,4,5-tetrabromobenzene)",activity,inactive,85446-17-9,6537506.0,Brc1c(cc(Br)c(Br)c1Br)Oc2cc(Br)c(Br)c(Br)c2Br
NCGC00255715-01,tox21-er-bla-agonist-p2,"N,N-Dimethyldecylamine oxide",activity,inactive,2605-79-0,62452.0,C[N+]([O-])(C)CCCCCCCCCC
NCGC00256514-01,tox21-er-bla-agonist-p2,2-Methoxyaniline hydrochloride,activity,inactive,134-29-2,8638.0,Cl.Nc1ccccc1OC
NCGC00256546-01,tox21-er-bla-agonist-p2,Chloranocryl,activity,inactive,2164-09-2,16560.0,Clc1ccc(NC(=O)C(=C)C)cc1Cl
NCGC00255865-01,tox21-er-bla-agonist-p2,Methyl hexanedioate,activity,inactive,627-91-8,12328.0,O=C(CCCCC(=O)O)OC
NCGC00255878-01,tox21-er-bla-agonist-p2,D&C Blue No. 9,activity,inactive,130-20-1,8532.0,O=C4c3c2Nc6c(Cl)cc1C(=O)c7ccccc7C(=O)c1c6Nc2c(Cl)cc3C(=O)c5ccccc45
NCGC00255967-01,tox21-er-bla-agonist-p2,Betaine hydrochloride,activity,inactive,590-46-5,11545.0,[Cl-].C[N+](C)(C)CC(=O)O
NCGC00256110-01,tox21-er-bla-agonist-p2,Methyl 5-chloro-2-nitrobenzoate,activity,inactive,51282-49-6,171018.0,O=[N+]([O-])c1ccc(Cl)cc1C(=O)OC
NCGC00258919-01,tox21-er-bla-agonist-p2,Isoniazid,activity,inactive,54-85-3,3767.0,O=C(NN)c1ccncc1
NCGC00260540-01,tox21-er-bla-agonist-p2,Hexachlorobenzene,activity,inactive,118-74-1,8370.0,Clc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl
NCGC00259679-01,tox21-er-bla-agonist-p2,"2,3-Dichloro-p-dioxane",activity,inactive,3883-43-0,5284382.0,Cl[C@H]1OCCO[C@@H]1Cl
NCGC00256469-01,tox21-er-bla-agonist-p2,Dehydroacetic acid,activity,inactive,520-45-6,122903.0,O=C(C)C1C(=O)C=C(C)OC1=O
NCGC00254979-01,tox21-er-bla-agonist-p2,Dicrotophos,activity,inactive,141-66-2,5371560.0,O=P(OC)(OC)OC(\C)=C\C(=O)N(C)C
NCGC00255043-01,tox21-er-bla-agonist-p2,Diquat dibromide monohydrate,activity,inactive,6385-62-2,115268.0,[Br-].[Br-].O.c1cccc2c3cccc[n+]3CC[n+]12
NCGC00255195-01,tox21-er-bla-agonist-p2,Betamethasone,activity,inactive,378-44-9,9782.0,OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00254581-01,tox21-er-bla-agonist-p2,"Ethyl (2E,4Z)-deca-2,4-dienoate",activity,inactive,3025-30-7,5281162.0,O=C(\C=C\C=C/CCCCC)OCC
NCGC00092384-02,tox21-er-bla-agonist-p2,Fenobam,activity,inactive,57653-26-6,162834.0,O=C2N=C(NC(=O)Nc1cccc(Cl)c1)N(C)C2
NCGC00167431-01,tox21-er-bla-agonist-p2,Rifapentine,activity,inactive,61379-65-5,6540548.0,CC(=O)O[C@@H]1[C@H](C)[C@@H](OC)C=CO[C@@]6(C)Oc5c(C)c(O)c4c(O)c(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]1C)c(/C=N/N2CCN(CC2)C3CCCC3)c(O)c4c5C6=O
NCGC00159495-02,tox21-er-bla-agonist-p2,Albutoin,activity,inactive,830-89-7,3032361.0,S=C1NC(CC(C)C)C(=O)N1CC=C
NCGC00164379-01,tox21-er-bla-agonist-p2,Amrinone,activity,inactive,60719-84-8,3698.0,NC1=CC(=CNC1=O)c2ccncc2
NCGC00164401-01,tox21-er-bla-agonist-p2,Betamethasone,activity,inactive,378-44-9,9782.0,OCC(=O)[C@@]4(O)[C@@H](C)C[C@@H]3[C@]4(C)C[C@H](O)[C@@]2(F)[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00160264-01,tox21-er-bla-agonist-p2,"6,7-Dimethoxyquinazoline-2,4(1H,3H)-dione",activity,inactive,28888-44-0,120081.0,COc1cc2c(cc1OC)NC(=O)NC2=O
NCGC00167968-01,tox21-er-bla-agonist-p2,Valnemulin,activity,inactive,101312-92-9,9850878.0,CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]2C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]31CCC(=O)[C@H]1[C@@]2(C)[C@H](C)CC3
NCGC00094997-01,tox21-er-bla-agonist-p2,Quinapril hydrochloride,activity,inactive,82586-55-8,54891.0,Cl.O=C(OCC)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O
NCGC00095029-01,tox21-er-bla-agonist-p2,Lasalocid sodium,activity,inactive,25999-20-6,6426773.0,[Na+].C[C@H]2C[C@](CC)(O[C@@H]2[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C([O-])=O)[C@H]3CC[C@](O)(CC)[C@H](C)O3
NCGC00164551-01,tox21-er-bla-agonist-p2,Biapenem,activity,inactive,120410-24-4,71339.0,[O-]C(=O)C=4N1C(=O)[C@H]([C@@H](C)O)[C@H]1[C@@H](C)C=4SC2C[n+]3cncn3C2
NCGC00095070-01,tox21-er-bla-agonist-p2,Ethidium bromide,activity,active agonist,1239-45-8,14710.0,[Br-].CC[n+]3c4cc(N)ccc4c1ccc(N)cc1c3c2ccccc2
NCGC00095080-01,tox21-er-bla-agonist-p2,Cyproterone,activity,inactive,2098-66-0,5284537.0,CC(=O)[C@@]4(O)CC[C@H]3[C@@H]5C=C(Cl)C2=CC(=O)[C@@H]1C[C@@H]1[C@]2(C)[C@H]5CC[C@@]34C
NCGC00095154-01,tox21-er-bla-agonist-p2,Telithromycin,activity,inactive,191114-48-4,3002190.0,CN(C)[C@H]5C[C@@H](C)O[C@@H](O[C@@H]3[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]4(C)OC(=O)N(CCCCn1cc(nc1)c2cccnc2)[C@@H]4[C@@H](C)C(=O)[C@H](C)C[C@@]3(C)OC)[C@@H]5O
NCGC00095159-01,tox21-er-bla-agonist-p2,Pefloxacin mesylate,activity,inactive,70458-95-6,119525.0,CN1CCN(CC1)c2cc3N(CC)C=C(C(=O)O)C(=O)c3cc2F.CS(=O)(=O)O
NCGC00160471-01,tox21-er-bla-agonist-p2,Crocin,activity,inactive,42553-65-1,5281233.0,O=C(O[C@@H]2O[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@@H](O)[C@H](O)[C@H]2O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)O[C@@H]4O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]4O
NCGC00160474-01,tox21-er-bla-agonist-p2,Benzetimide,activity,inactive,14051-33-3,21847.0,O=C4NC(=O)CCC4(C2CCN(Cc1ccccc1)CC2)c3ccccc3
NCGC00165899-01,tox21-er-bla-agonist-p2,Sulprostone,activity,inactive,60325-46-4,51668574.0,O[C@@H]2CC(=O)[C@H](C/C=C\CCCC(=O)NS(C)(=O)=O)[C@H]2/C=C/[C@H](O)COc1ccccc1
NCGC00160590-01,tox21-er-bla-agonist-p2,Bromindione,activity,inactive,1146-98-1,14369.0,Brc1ccc(cc1)C3C(=O)c2ccccc2C3=O
NCGC00168747-01,tox21-er-bla-agonist-p2,Methoxyflurane,activity,inactive,76-38-0,4116.0,ClC(Cl)C(F)(F)OC
NCGC00096074-01,tox21-er-bla-agonist-p2,Pentobarbital,activity,inactive,76-74-4,4737.0,O=C1NC(O)=NC(=O)C1(CC)C(C)CCC
NCGC00166205-01,tox21-er-bla-agonist-p2,Fluazuron,activity,inactive,86811-58-7,65651.0,Fc1cccc(F)c1C(=O)NC(=O)Nc3cc(Oc2ncc(cc2Cl)C(F)(F)F)c(Cl)cc3
NCGC00181121-01,tox21-er-bla-agonist-p2,Carphenazine dimaleate,activity,inactive,2975-34-0,6433356.0,O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.CCC(=O)c2cc3N(CCCN1CCN(CCO)CC1)c4ccccc4Sc3cc2
NCGC00166226-01,tox21-er-bla-agonist-p2,4-Propylbenzoic acid,activity,inactive,2438-05-3,137601.0,CCCc1ccc(cc1)C(=O)O
NCGC00167573-01,tox21-er-bla-agonist-p2,Flavin adenine dinucleotide disodium,activity,inactive,84366-81-4,2734019.0,[Na+].[Na+].Cc5cc6N=C1C(=O)NC(=O)N=C1N(C[C@H](O)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OC[C@H]4O[C@@H](n3cnc2c(N)ncnc23)[C@H](O)[C@@H]4O)c6cc5C
NCGC00162150-01,tox21-er-bla-agonist-p2,Cilnidipine,activity,inactive,132203-70-4,5282138.0,CC=1NC(C)=C(C(C=1C(=O)OCCOC)c2cccc(c2)[N+]([O-])=O)C(=O)OC/C=C/c3ccccc3
NCGC00163135-01,tox21-er-bla-agonist-p2,Niguldipine hydrochloride,activity,inactive,102992-93-8,357904.0,Cl.[O-][N+](=O)c1cccc(c1)C2C(C(=O)OC)=C(C)NC(C)=C2C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5
NCGC00163163-01,tox21-er-bla-agonist-p2,Dihydroergocristine,activity,inactive,17479-19-5,107715.0,CN1C[C@@H](C[C@@H]2c3cccc4ncc(C[C@@H]12)c34)C(=O)N[C@@]8(O[C@]7(O)N([C@@H](Cc5ccccc5)C(=O)N6CCC[C@H]67)C8=O)C(C)C
NCGC00182027-01,tox21-er-bla-agonist-p2,Amogastrin,activity,inactive,16870-37-4,71884.0,NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)OC(C)(C)CC)Cc3cnc2ccccc23
NCGC00183002-01,tox21-er-bla-agonist-p2,Safrazine hydrochloride,activity,inactive,7296-30-2,636399.0,Cl.CC(NN)CCc1ccc2OCOc2c1
NCGC00183012-01,tox21-er-bla-agonist-p2,Penflutizide,activity,inactive,1766-91-2,4726.0,FC(F)(F)c1cc2NC(NS(=O)(=O)c2cc1S(N)(=O)=O)CCCCC
NCGC00183361-01,tox21-er-bla-agonist-p2,Oxacillin sodium salt,activity,inactive,1173-88-2,23667631.0,[Na+].O=C([O-])[C@@H]3N4C(=O)[C@@H](NC(=O)c2c(C)onc2c1ccccc1)[C@H]4SC3(C)C
NCGC00183840-01,tox21-er-bla-agonist-p2,"Androstane-3,17-diol, 2,16-di-1-piperidinyl-, 3-acetate 17-propanoate, (2beta,3alpha,5alpha,16beta,17beta)-",activity,inactive,13522-19-5,53948566.0,CC(=O)O[C@H]5C[C@@H]6CC[C@@H]2[C@H](CC[C@]1(C)[C@@H](OC(=O)CC)[C@H](C[C@H]12)N3CCCCC3)[C@@]6(C)C[C@@H]5N4CCCCC4
NCGC00254973-01,tox21-er-bla-agonist-p2,2-(Thiocyanomethylthio)benzothiazole,activity,inactive,21564-17-0,30692.0,N#CSCSc1nc2ccccc2s1
NCGC00255348-01,tox21-er-bla-agonist-p2,Famotidine,activity,inactive,76824-35-6,3325.0,N/C(N)=N/c1nc(CSCCC(\N)=N/S(N)(=O)=O)cs1
NCGC00254267-01,tox21-er-bla-agonist-p2,Heptanoic acid,activity,inactive,111-14-8,8094.0,CCCCCCC(=O)O
NCGC00255157-01,tox21-er-bla-agonist-p2,Ethyl hexanoate,activity,inactive,123-66-0,31265.0,O=C(CCCCC)OCC
NCGC00249608-01,tox21-er-bla-agonist-p2,Butafosfan,activity,inactive,17316-67-5,6328684.0,CCCCNC(C)(C)P(=O)O
NCGC00255207-01,tox21-er-bla-agonist-p2,Hexyl benzoate,activity,inactive,6789-88-4,23235.0,O=C(OCCCCCC)c1ccccc1
NCGC00253995-01,tox21-er-bla-agonist-p2,1-Chloro-4-nitrobenzene,activity,inactive,100-00-5,7474.0,O=[N+]([O-])c1ccc(Cl)cc1
NCGC00254525-01,tox21-er-bla-agonist-p2,Mirex,activity,inactive,2385-85-5,16945.0,ClC53C1(Cl)C4(Cl)C2(Cl)C1(Cl)C(Cl)(Cl)C5(Cl)C2(Cl)C3(Cl)C4(Cl)Cl
NCGC00181743-01,tox21-er-bla-agonist-p2,Lypressin,activity,inactive,50-57-7,644076.0,NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00182975-01,tox21-er-bla-agonist-p2,Amoebicon,activity,inactive,116-49-4,16682839.0,O=C(Nc1ccc(cc1)[As](O)(=O)O[Bi]=O)CO
NCGC00183046-01,tox21-er-bla-agonist-p2,Mequitazine,activity,inactive,29216-28-2,4066.0,c3ccc4Sc5ccccc5N(CC2CN1CCC2CC1)c4c3
NCGC00181793-01,tox21-er-bla-agonist-p2,Cetirizine amide dihydrochloride,activity,inactive,200707-85-3,60196365.0,Cl.Cl.NC(=O)COCCN1CCN(CC1)C(c2ccc(Cl)cc2)c3ccccc3
NCGC00259454-01,tox21-er-bla-agonist-p2,Sulfamic acid,activity,inactive,5329-14-6,5987.0,NS(=O)(=O)O
NCGC00259696-01,tox21-er-bla-agonist-p2,Fluorosulfonic acid,activity,inactive,7789-21-1,24603.0,FS(=O)(=O)O
NCGC00258272-01,tox21-er-bla-agonist-p2,1-Hexyl-3-methylimidazolium chloride,activity,inactive,171058-17-6,2734163.0,[Cl-].C[n+]1ccn(CCCCCC)c1
NCGC00260329-01,tox21-er-bla-agonist-p2,Bis(1-piperidinylthioxomethyl)hexasulfide,activity,inactive,971-15-3,70414.0,S=C(SSSSSSC(=S)N1CCCCC1)N2CCCCC2
NCGC00015014-05,tox21-er-bla-agonist-p2,Acetohexamide,activity,inactive,968-81-0,1989.0,O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(cc2)C(C)=O
NCGC00256594-01,tox21-er-bla-agonist-p2,Streptozocin,activity,inactive,18883-66-4,29327.0,O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(=O)N(C)N=O
NCGC00259494-01,tox21-er-bla-agonist-p2,2-Methyl-5-nitroaniline,activity,inactive,99-55-8,7444.0,Cc1ccc(cc1N)[N+]([O-])=O
NCGC00256555-01,tox21-er-bla-agonist-p2,Ferric chloride,activity,inactive,7705-08-0,166033.0,[Fe+3].[Cl-].[Cl-].[Cl-]
NCGC00256796-01,tox21-er-bla-agonist-p2,Isolongifolanone,activity,inactive,29461-14-1,86287524.0,CC3(C)C1CC2(CC1)[C@H]3C(=O)CCC2(C)C
NCGC00257782-01,tox21-er-bla-agonist-p2,4-Hydroxyacetophenone,activity,inactive,99-93-4,7469.0,O=C(C)c1ccc(O)cc1
NCGC00256809-01,tox21-er-bla-agonist-p2,1-Octen-3-one,activity,inactive,4312-99-6,61346.0,C=CC(=O)CCCCC
NCGC00259622-01,tox21-er-bla-agonist-p2,N-Phenyl-1-naphthylamine,activity,active agonist,90-30-2,7013.0,c1ccc3ccccc3c1Nc2ccccc2
NCGC00257239-01,tox21-er-bla-agonist-p2,4-(2-Phenylpropan-2-yl)-N-[4-(2-phenylpropan-2-yl)phenyl]aniline,activity,inactive,10081-67-1,82343.0,CC(C)(c1ccccc1)c2ccc(cc2)Nc3ccc(cc3)C(C)(C)c4ccccc4
NCGC00016056-02,tox21-er-bla-agonist-p2,Atomoxetine hydrochloride,activity,inactive,82248-59-7,54840.0,Cl.Cc2ccccc2O[C@H](CCNC)c1ccccc1
NCGC00254478-01,tox21-er-bla-agonist-p2,1-Pentadecanol,activity,inactive,629-76-5,12397.0,CCCCCCCCCCCCCCCO
NCGC00257742-01,tox21-er-bla-agonist-p2,"3,4,5-Trichlorophenol",activity,active agonist,609-19-8,11859.0,Oc1cc(Cl)c(Cl)c(Cl)c1
NCGC00256621-01,tox21-er-bla-agonist-p2,"Trimethyl benzene-1,2,4-tricarboxylate",activity,inactive,2459-10-1,17159.0,COC(=O)c1cc(ccc1C(=O)OC)C(=O)OC
NCGC00255483-01,tox21-er-bla-agonist-p2,"2,4-Dichlorophenylacetic acid",activity,inactive,19719-28-9,88209.0,Clc1cc(Cl)ccc1CC(=O)O
NCGC00255573-01,tox21-er-bla-agonist-p2,N-Benzyl-9-(tetrahydro-2H-pyran-2-yl)adenine,activity,inactive,2312-73-4,16834.0,n3cn(C1CCCCO1)c4ncnc(NCc2ccccc2)c34
NCGC00255423-01,tox21-er-bla-agonist-p2,"2,4,5-T-butotyl",activity,inactive,2545-59-7,17349.0,Clc1cc(OCC(=O)OCCOCCCC)c(Cl)cc1Cl
NCGC00256055-01,tox21-er-bla-agonist-p2,"2,2'-(Oxydimethanediyl)bis(2-ethylpropane-1,3-diol)",activity,inactive,23235-61-2,90038.0,OCC(COCC(CO)(CC)CO)(CC)CO
NCGC00256872-01,tox21-er-bla-agonist-p2,Isoquinoline,activity,inactive,119-65-3,8405.0,c1cccc2ccncc12
NCGC00257122-01,tox21-er-bla-agonist-p2,Tris(2-methoxyethoxy)vinylsilane,activity,inactive,1067-53-4,14025.0,COCCO[Si](OCCOC)(C=C)OCCOC
NCGC00257824-01,tox21-er-bla-agonist-p2,Triallyl isocyanurate,activity,inactive,1025-15-6,13931.0,C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O
NCGC00257984-01,tox21-er-bla-agonist-p2,Methyl alpha-D-glucopyranoside,activity,inactive,97-30-3,64947.0,O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC
NCGC00257870-01,tox21-er-bla-agonist-p2,Crotonaldehyde,activity,inactive,4170-30-3,20138.0,CC=CC=O
NCGC00257559-01,tox21-er-bla-agonist-p2,"1,2-Cyclohexanedicarboxylic acid, bis(oxiranylmethyl) ester",activity,inactive,5493-45-8,21660.0,O=C(OCC1CO1)C2CCCCC2C(=O)OCC3CO3
NCGC00257784-01,tox21-er-bla-agonist-p2,Isonicotinamide,activity,inactive,1453-82-3,15074.0,NC(=O)c1ccncc1
NCGC00258082-01,tox21-er-bla-agonist-p2,Isovaleronitrile,activity,inactive,625-28-5,12244.0,CC(C)CC#N
NCGC00258183-01,tox21-er-bla-agonist-p2,"3,5-Dichlorobenzoyl chloride",activity,inactive,2905-62-6,76191.0,Clc1cc(cc(Cl)c1)C(Cl)=O
NCGC00258236-01,tox21-er-bla-agonist-p2,Cinnamyl anthranilate,activity,inactive,87-29-6,6881.0,Nc2ccccc2C(=O)OCC=Cc1ccccc1
NCGC00259125-01,tox21-er-bla-agonist-p2,Trimethyl phosphate,activity,inactive,512-56-1,10541.0,O=P(OC)(OC)OC
NCGC00259330-01,tox21-er-bla-agonist-p2,2-Acrylamido-2-methyl-1-propanesulfonic acid,activity,inactive,15214-89-8,65360.0,O=C(NC(C)(C)CS(=O)(=O)O)C=C
NCGC00260213-01,tox21-er-bla-agonist-p2,1-Butyl-1-methylpiperidinium trifluoromethanesulfonate,activity,inactive,NOCAS_49384,60196383.0,FC(F)(F)S([O-])(=O)=O.C[N+]1(CCCC)CCCCC1
NCGC00014711-01,tox21-er-bla-agonist-p2,Oxaprozin,activity,inactive,21256-18-8,4614.0,OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3
NCGC00015462-07,tox21-er-bla-agonist-p2,Glipizide,activity,inactive,29094-61-9,3478.0,Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3
NCGC00016765-01,tox21-er-bla-agonist-p2,Diflunisal,activity,inactive,22494-42-4,3059.0,OC(=O)c1cc(ccc1O)c2ccc(F)cc2F
NCGC00016047-03,tox21-er-bla-agonist-p2,1-[2-(Trifluoromethyl)phenyl]-1H-imidazole,activity,inactive,25371-96-4,1359.0,FC(F)(F)c1ccccc1n2ccnc2
NCGC00024923-02,tox21-er-bla-agonist-p2,Isamoltan,activity,inactive,116861-00-8,127404.0,CC(C)NCC(O)COc1ccccc1n2cccc2
NCGC00095179-01,tox21-er-bla-agonist-p2,Zolpidem,activity,inactive,82626-48-0,5732.0,CN(C)C(=O)Cc1c(nc2ccc(C)cn12)c3ccc(C)cc3
NCGC00159449-02,tox21-er-bla-agonist-p2,Thiphenamil,activity,inactive,82-99-5,11061.0,CCN(CC)CCSC(=O)C(c1ccccc1)c2ccccc2
NCGC00160437-01,tox21-er-bla-agonist-p2,Ethebenecid,activity,inactive,1213-06-5,14604.0,O=S(=O)(N(CC)CC)c1ccc(cc1)C(=O)O
NCGC00167441-01,tox21-er-bla-agonist-p2,Pramipexole,activity,inactive,104632-26-0,119570.0,CCCN[C@@H]1Cc2sc(N)nc2CC1
NCGC00255595-01,tox21-er-bla-agonist-p2,Chloroallyl methenamine chloride,activity,inactive,51229-78-8,6435993.0,[Cl-].Cl\C=C/C[N+]13CN2CN(CN(C1)C2)C3
NCGC00255979-01,tox21-er-bla-agonist-p2,L-Glucitol,activity,inactive,6706-59-8,82170.0,O[C@@H]([C@@H](O)CO)[C@@H](O)[C@H](O)CO
NCGC00256149-01,tox21-er-bla-agonist-p2,"Trimethylhexane-1,6-diamine",activity,inactive,25620-58-0,76714.0,CC(CC(C)(C)CCN)CN
NCGC00256330-01,tox21-er-bla-agonist-p2,(E)-Hexadec-9-enoic acid,activity,inactive,10030-73-6,5282745.0,O=C(O)CCCCCCC\C=C\CCCCCC
NCGC00254428-01,tox21-er-bla-agonist-p2,Dipropylene glycol,activity,inactive,25265-71-8,6537503.0,CCC(O)OC(O)CC
NCGC00254961-01,tox21-er-bla-agonist-p2,Fosthiazate,activity,inactive,98886-44-3,91758.0,CC(CC)SP(=O)(OCC)N1CCSC1=O
NCGC00254963-01,tox21-er-bla-agonist-p2,Flumioxazin,activity,inactive,103361-09-7,92425.0,O=C4C=1CCCCC=1C(=O)N4c2cc3c(cc2F)OCC(=O)N3CC#C
NCGC00160588-02,tox21-er-bla-agonist-p2,"2,2-Di-4-tolylpropane",activity,inactive,1823-31-0,264852.0,Cc1ccc(cc1)C(C)(C)c2ccc(C)cc2
NCGC00163240-01,tox21-er-bla-agonist-p2,Neostigmine bromide,activity,inactive,114-80-7,8246.0,[Br-].O=C(Oc1cccc(c1)[N+](C)(C)C)N(C)C
NCGC00167489-01,tox21-er-bla-agonist-p2,Sarpogrelate hydrochloride,activity,inactive,135159-51-2,444005.0,Cl.O=C(O)CCC(=O)OC(COc2ccccc2CCc1cccc(OC)c1)CN(C)C
NCGC00181794-01,tox21-er-bla-agonist-p2,Dimethyl(2-phenoxyethyl)-2-thenylammonium iodide,activity,inactive,109732-56-1,57372628.0,[I-].C[N+](C)(Cc1cccs1)CCOc2ccccc2
NCGC00185758-01,tox21-er-bla-agonist-p2,Sodium ethenesulfonate,activity,inactive,3039-83-6,3270262.0,[Na+].[O-]S(=O)(=O)C=C
NCGC00254831-01,tox21-er-bla-agonist-p2,Azinphos-methyl,activity,inactive,86-50-0,2268.0,COP(=S)(OC)SCN1N=Nc2ccccc2C1=O
NCGC00255097-01,tox21-er-bla-agonist-p2,N-Hydroxy-4-methylpentan-2-imine,activity,inactive,105-44-2,7756.0,CC(C)CC(\C)=N\O
NCGC00255138-01,tox21-er-bla-agonist-p2,"Acetonitrile, 2,2',2'',2'''-(1,2-ethanediyldinitrilo)tetrakis-",activity,inactive,5766-67-6,21984.0,N#CCN(CCN(CC#N)CC#N)CC#N
NCGC00259505-01,tox21-er-bla-agonist-p2,"1-Chloro-2,4-dinitrobenzene",activity,inactive,97-00-7,6.0,O=[N+]([O-])c1cc(ccc1Cl)[N+]([O-])=O
NCGC00259843-01,tox21-er-bla-agonist-p2,Phosalone,activity,inactive,2310-17-0,4793.0,CCOP(=S)(OCC)SCN1c2ccc(Cl)cc2OC1=O
NCGC00016306-01,tox21-er-bla-agonist-p2,Cycloserine,activity,inactive,68-41-7,6234.0,N[C@@H]1CONC1=O
NCGC00016527-01,tox21-er-bla-agonist-p2,Clopamide,activity,inactive,636-54-4,2804.0,O=C(NN1C(C)CCCC1C)c2ccc(Cl)c(c2)S(N)(=O)=O
NCGC00016968-01,tox21-er-bla-agonist-p2,Ondansetron hydrochloride dihydrate,activity,inactive,103639-04-9,59774.0,Cl.O.O.O=C1C(CCc3c1c2ccccc2n3C)Cn4ccnc4C
NCGC00017020-01,tox21-er-bla-agonist-p2,Amprolium hydrochloride,activity,inactive,137-88-2,8732.0,[Cl-].Cl.CCCc1nc(N)c(cn1)C[n+]2ccccc2C
NCGC00094985-01,tox21-er-bla-agonist-p2,Zoalene,activity,inactive,148-01-6,3092.0,Cc1c(cc(cc1[N+](=O)[O-])[N+]([O-])=O)C(N)=O
NCGC00166005-01,tox21-er-bla-agonist-p2,Methyl L-cysteinate hydrochloride,activity,inactive,18598-63-5,2733208.0,Cl.O=C(OC)[C@@H](N)CS
NCGC00166239-01,tox21-er-bla-agonist-p2,4-Ethylbenzenesulfonic acid,activity,active agonist,98-69-1,7402.0,OS(=O)(=O)c1ccc(CC)cc1
NCGC00167453-01,tox21-er-bla-agonist-p2,Clinofibrate,activity,inactive,30299-08-2,2787.0,O=C(O)C(C)(CC)Oc1ccc(cc1)C2(CCCCC2)c3ccc(OC(C)(CC)C(=O)O)cc3
NCGC00167979-01,tox21-er-bla-agonist-p2,Methenolone enanthate,activity,active agonist,303-42-4,248271.0,CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CC[C@H]1CC(=O)C=C(C)[C@]1(C)[C@H]4CC[C@]23C
NCGC00188439-01,tox21-er-bla-agonist-p2,Argipressin,activity,inactive,113-79-1,644077.0,NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]4CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N4
NCGC00090950-03,tox21-er-bla-agonist-p2,Glycerol,activity,inactive,56-81-5,753.0,OCC(O)CO
NCGC00018193-06,tox21-er-bla-agonist-p2,Fluvoxamine,activity,inactive,54739-18-3,5324346.0,FC(F)(F)c1ccc(cc1)C(\CCCCOC)=N\OCCN
NCGC00021123-02,tox21-er-bla-agonist-p2,Diatrizoic acid dihydrate,activity,inactive,50978-11-5,12598086.0,O.O.O=C(C)Nc1c(I)c(c(I)c(NC(C)=O)c1I)C(=O)O
NCGC00024824-01,tox21-er-bla-agonist-p2,Ponalrestat,activity,inactive,72702-95-5,5278.0,O=C(O)CC3=NN(Cc1ccc(Br)cc1F)C(=O)c2ccccc23
NCGC00024846-03,tox21-er-bla-agonist-p2,Guanabenz,activity,inactive,5051-62-7,3517.0,Clc1cccc(Cl)c1/C=N/NC(=N)N
NCGC00258501-01,tox21-er-bla-agonist-p2,3-Bromobenzaldehyde,activity,inactive,3132-99-8,76583.0,O=Cc1cc(Br)ccc1
NCGC00258560-01,tox21-er-bla-agonist-p2,"Potassium 1,3-dioxo-1,3-dihydroisoindol-2-ide",activity,inactive,1074-82-4,3356745.0,[K+].O=C1[N-]C(=O)c2ccccc12
NCGC00257078-01,tox21-er-bla-agonist-p2,"2,5-Dichlorophenol",activity,inactive,583-78-8,66.0,Clc1ccc(Cl)c(O)c1
NCGC00257423-01,tox21-er-bla-agonist-p2,Isobornyl acetate,activity,inactive,125-12-2,637531.0,CC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C
NCGC00257757-01,tox21-er-bla-agonist-p2,2-Methylfuran,activity,inactive,534-22-5,10797.0,Cc1ccco1
NCGC00257803-01,tox21-er-bla-agonist-p2,"3-Bromo-2,2-bis(bromomethyl)propanol",activity,inactive,1522-92-5,15206.0,BrCC(CBr)(CBr)CO
NCGC00257940-01,tox21-er-bla-agonist-p2,3-Nitroaniline,activity,inactive,99-09-2,7423.0,O=[N+]([O-])c1cccc(N)c1
NCGC00258007-01,tox21-er-bla-agonist-p2,Trimethoxymethylsilane,activity,inactive,1185-55-3,14456.0,C[Si](OC)(OC)OC
NCGC00258072-01,tox21-er-bla-agonist-p2,"1,2,4-Trimethylbenzene",activity,inactive,95-63-6,7247.0,Cc1cc(C)c(C)cc1
NCGC00258171-01,tox21-er-bla-agonist-p2,"N,N,N',N'-Tetramethyl-p-phenylenediamine",activity,inactive,100-22-1,7490.0,CN(C)c1ccc(cc1)N(C)C
NCGC00258350-01,tox21-er-bla-agonist-p2,"(2Z)-1,4-Dichlorobut-2-ene",activity,inactive,1476-11-5,6432115.0,ClC\C=C/CCl
NCGC00256685-01,tox21-er-bla-agonist-p2,Nonyl acetate,activity,inactive,143-13-5,8918.0,CC(=O)OCCCCCCCCC
NCGC00255726-01,tox21-er-bla-agonist-p2,Phenylpyruvic acid,activity,inactive,156-06-9,997.0,O=C(Cc1ccccc1)C(=O)O
NCGC00256400-01,tox21-er-bla-agonist-p2,Aniline hydrochloride,activity,inactive,142-04-1,8870.0,Cl.Nc1ccccc1
NCGC00256517-01,tox21-er-bla-agonist-p2,Doxylamine succinate,activity,inactive,562-10-7,11224.0,O=C(O)CCC(=O)O.CN(C)CCOC(C)(c1ccccn1)c2ccccc2
NCGC00256076-01,tox21-er-bla-agonist-p2,Longifolene,activity,inactive,475-20-7,1796220.0,C[C@@]32CCCC(C)(C)[C@H]1[C@H](CC[C@H]12)C3=C
NCGC00256145-01,tox21-er-bla-agonist-p2,Tembotrione,activity,inactive,335104-84-2,11556911.0,O=C2CCCC(=O)C2C(=O)c1ccc(c(COCC(F)(F)F)c1Cl)S(C)(=O)=O
NCGC00256146-01,tox21-er-bla-agonist-p2,Butane-1-sulfonyl chloride,activity,inactive,2386-60-9,75430.0,CCCCS(Cl)(=O)=O
NCGC00256171-01,tox21-er-bla-agonist-p2,4-{2-Oxo-2-[3-(trifluoromethyl)phenyl]ethyl}benzonitrile,activity,inactive,146653-56-7,11437710.0,FC(F)(F)c1cccc(c1)C(=O)Cc2ccc(C#N)cc2
NCGC00256184-01,tox21-er-bla-agonist-p2,21-Hydroxyprogesterone,activity,inactive,64-85-7,6166.0,OCC(=O)[C@H]2CC[C@H]3[C@@H]4CCC1=CC(=O)CC[C@]1(C)[C@H]4CC[C@]23C
NCGC00256226-01,tox21-er-bla-agonist-p2,Diprop-2-en-1-yl (2Z)-but-2-enedioate,activity,inactive,999-21-3,5354266.0,O=C(\C=C/C(=O)OCC=C)OCC=C
NCGC00258968-01,tox21-er-bla-agonist-p2,2-Bromopropionic acid,activity,inactive,598-72-1,11729.0,BrC(C)C(=O)O
NCGC00260419-01,tox21-er-bla-agonist-p2,1-Octyn-3-ol,activity,inactive,818-72-4,13166.0,C#CC(O)CCCCC
NCGC00259107-01,tox21-er-bla-agonist-p2,2-Methyl-1-butanol,activity,inactive,137-32-6,8723.0,CC(CC)CO
NCGC00259110-01,tox21-er-bla-agonist-p2,Pentanoic acid,activity,inactive,109-52-4,7991.0,CCCCC(=O)O
NCGC00259366-01,tox21-er-bla-agonist-p2,Tri-allate,activity,inactive,2303-17-5,5543.0,Cl/C(Cl)=C(\Cl)CSC(=O)N(C(C)C)C(C)C
NCGC00259617-01,tox21-er-bla-agonist-p2,Diazolidinyl urea,activity,inactive,78491-02-8,62277.0,OCN1C(=O)N(CO)C(=O)C1N(CO)C(=O)NCO
NCGC00260350-01,tox21-er-bla-agonist-p2,Potassium tetrafluoroborate,activity,inactive,14075-53-7,518872.0,[K+].F[B-](F)(F)F
NCGC00258692-01,tox21-er-bla-agonist-p2,"1,3-Dichloropropane",activity,inactive,142-28-9,8881.0,ClCCCCl
NCGC00254763-01,tox21-er-bla-agonist-p2,Trichlorfon,activity,inactive,52-68-6,5853.0,OC(C(Cl)(Cl)Cl)P(=O)(OC)OC
NCGC00254779-01,tox21-er-bla-agonist-p2,gamma-Caprolactone,activity,inactive,695-06-7,12756.0,O=C1CCC(CC)O1
NCGC00254903-01,tox21-er-bla-agonist-p2,Imazapyr,activity,inactive,81334-34-1,54738.0,CC1(N=C(NC1=O)c2ncccc2C(=O)O)C(C)C
NCGC00255139-01,tox21-er-bla-agonist-p2,"1-Phenyl-3,3-dimethyltriazene",activity,inactive,7227-91-0,23654.0,CN(C)/N=N/c1ccccc1
NCGC00091151-01,tox21-er-bla-agonist-p2,Phenoxyacetic acid,activity,inactive,122-59-8,19188.0,O=C(O)COc1ccccc1
NCGC00093576-02,tox21-er-bla-agonist-p2,Tetramethylenediguanide sulfate,activity,active agonist,36587-93-6,119020.0,O=S(=O)(O)O.N=C(N)NCCCCNC(=N)N
NCGC00159430-02,tox21-er-bla-agonist-p2,Hexobarbital,activity,inactive,56-29-1,3608.0,CC1(C(=O)N=C(O)N(C)C1=O)C2=CCCCC2
NCGC00159454-03,tox21-er-bla-agonist-p2,Ticrynafen,activity,inactive,40180-04-9,38409.0,O=C(c1ccc(OCC(=O)O)c(Cl)c1Cl)c2cccs2
NCGC00094620-01,tox21-er-bla-agonist-p2,Chloramphenicol,activity,inactive,56-75-7,5959.0,O=[N+]([O-])c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl
NCGC00159472-02,tox21-er-bla-agonist-p2,Sodium 4-aminosalicylate,activity,inactive,133-10-8,2724368.0,[Na+].O=C([O-])c1ccc(N)cc1O
NCGC00164329-02,tox21-er-bla-agonist-p2,"9-Octadecen-1-amine, (9Z)-",activity,inactive,112-90-3,5356789.0,CCCCCCCC\C=C/CCCCCCCCN
NCGC00164483-01,tox21-er-bla-agonist-p2,Amindocate,activity,inactive,31386-24-0,178144.0,CN(C)CCOC(=O)c1cc2c(cc1)n(CCN(C)C)c(C)c2C
NCGC00164549-01,tox21-er-bla-agonist-p2,Dofetilide,activity,inactive,115256-11-6,71329.0,CS(=O)(=O)Nc1ccc(cc1)CCN(C)CCOc2ccc(cc2)NS(C)(=O)=O
NCGC00095054-01,tox21-er-bla-agonist-p2,Resorcinol monoacetate,activity,inactive,102-29-4,5055.0,O=C(C)Oc1cccc(O)c1
NCGC00095066-01,tox21-er-bla-agonist-p2,Selamectin,activity,inactive,165108-07-6,9578507.0,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]2C(C)=CC[C@@H]5C[C@H](OC(=O)[C@@H]3C=C(C)\C(=N\O)[C@H]4OCC(=CC=C[C@@H]2C)[C@@]34O)C[C@@]6(O5)CC[C@H](C)[C@H](O6)C7CCCCC7
NCGC00160467-01,tox21-er-bla-agonist-p2,Tenocyclidine,activity,inactive,1867-65-8,62751.0,C1CCC(CC1)(c2cccs2)N3CCCCC3
NCGC00164594-01,tox21-er-bla-agonist-p2,Loteprednol etabonate,activity,active agonist,82034-46-6,444025.0,O=C(OCCl)[C@@]4(OC(=O)OCC)CC[C@@H]3[C@]4(C)C[C@H](O)[C@H]2[C@H]3CCC1=CC(=O)C=C[C@@]12C
NCGC00095312-01,tox21-er-bla-agonist-p2,Deracoxib,activity,inactive,169590-41-4,3058754.0,NS(=O)(=O)c1ccc(cc1)n3nc(cc3c2ccc(OC)c(F)c2)C(F)F
NCGC00167543-01,tox21-er-bla-agonist-p2,Ceftiofur,activity,inactive,80370-57-6,6328657.0,Nc1scc(n1)\C(=N\OC)C(=O)N[C@@H]4C(=O)N3C(=C(CSC(=O)c2ccco2)CS[C@@H]34)C(=O)O
NCGC00160681-01,tox21-er-bla-agonist-p2,Risocaine,activity,inactive,94-12-2,7174.0,Nc1ccc(cc1)C(=O)OCCC
NCGC00159395-03,tox21-er-bla-agonist-p2,Phenicarbazide,activity,inactive,103-03-7,61002.0,NC(=O)NNc1ccccc1
NCGC00163165-01,tox21-er-bla-agonist-p2,Ergonovine,activity,inactive,60-79-7,443884.0,C[C@@H](CO)NC(=O)[C@@H]2C=C1c3cccc4ncc(C[C@H]1N(C)C2)c34
NCGC00185760-01,tox21-er-bla-agonist-p2,Maduramicin ammonium,activity,inactive,84878-61-5,20054964.0,[NH4+].O[C@]1(CC([O-])=O)O[C@H]([C@H](OC)[C@@H](OC)[C@@H]1C)[C@H](C)[C@H]2O[C@]3(C[C@H](O)[C@H]2C)CC[C@](C)(O3)[C@H]4CC[C@](C)(O4)[C@@H]6O[C@H](C[C@@H]6OC5C[C@H](OC)[C@@H](OC)[C@H](C)O5)[C@H]7O[C@](C)(O)[C@H](C)C[C@@H]7C
NCGC00255026-01,tox21-er-bla-agonist-p2,Cinmethylin,activity,inactive,87818-31-3,16004722.0,C[C@]32CC[C@@](C[C@@H]2OCc1ccccc1C)(O3)C(C)C
NCGC00254224-01,tox21-er-bla-agonist-p2,Dihexyl phthalate,activity,inactive,84-75-3,6786.0,O=C(OCCCCCC)c1ccccc1C(=O)OCCCCCC
NCGC00254792-01,tox21-er-bla-agonist-p2,Monobutyl phthalate,activity,inactive,131-70-4,8575.0,O=C(O)c1ccccc1C(=O)OCCCC
NCGC00253996-01,tox21-er-bla-agonist-p2,Diethylene glycol,activity,inactive,111-46-6,8117.0,OCCOCCO
NCGC00255114-01,tox21-er-bla-agonist-p2,Cinnamic acid,activity,inactive,140-10-3,444539.0,O=C(O)/C=C/c1ccccc1
NCGC00254093-01,tox21-er-bla-agonist-p2,"N,N-Dimethylformamide",activity,inactive,68-12-2,6228.0,CN(C)C=O
NCGC00254897-01,tox21-er-bla-agonist-p2,Tetraconazole,activity,inactive,112281-77-3,80277.0,FC(F)C(F)(F)OCC(Cn1cncn1)c2ccc(Cl)cc2Cl
NCGC00254098-01,tox21-er-bla-agonist-p2,Diethyl phthalate,activity,inactive,84-66-2,6781.0,O=C(OCC)c1ccccc1C(=O)OCC
NCGC00182060-02,tox21-er-bla-agonist-p2,l-Oxyfedrine hydrochloride,activity,inactive,16777-42-7,5489012.0,Cl.COc1cc(ccc1)C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2
NCGC00259782-01,tox21-er-bla-agonist-p2,Dioctyl phthalate,activity,inactive,117-84-0,8346.0,O=C(OCCCCCCCC)c1ccccc1C(=O)OCCCCCCCC
NCGC00260289-01,tox21-er-bla-agonist-p2,Sodium acetate,activity,inactive,127-09-3,517045.0,[Na+].[O-]C(C)=O
NCGC00259225-01,tox21-er-bla-agonist-p2,Iprodione,activity,inactive,36734-19-7,37517.0,O=C2CN(C(=O)NC(C)C)C(=O)N2c1cc(Cl)cc(Cl)c1
NCGC00258089-01,tox21-er-bla-agonist-p2,Tribromoacetaldehyde,activity,active agonist,115-17-3,8256.0,BrC(Br)(Br)C=O
NCGC00257275-01,tox21-er-bla-agonist-p2,Butylated hydroxytoluene,activity,inactive,128-37-0,31404.0,CC(C)(C)c1cc(C)cc(c1O)C(C)(C)C
NCGC00260326-01,tox21-er-bla-agonist-p2,Copper dimethyldithiocarbamate,activity,active agonist,137-29-1,472181.0,[Cu+2].S=C([S-])N(C)C.CN(C)C([S-])=S
NCGC00255540-01,tox21-er-bla-agonist-p2,Tacrine,activity,inactive,321-64-2,1935.0,Nc1c3ccccc3nc2CCCCc12
NCGC00256418-01,tox21-er-bla-agonist-p2,"(2Z)-2,3-Dichloro-4-oxobut-2-enoic acid",activity,inactive,87-56-9,2771871.0,O=CC(\Cl)=C(\Cl)C(=O)O
NCGC00013495-01,tox21-er-bla-agonist-p2,Benztropine methylsulfonate,activity,inactive,132-17-2,3246155.0,CN4[C@H]1CC[C@@H]4C[C@@H](C1)OC(c2ccccc2)c3ccccc3.CS(=O)(=O)O
NCGC00256553-01,tox21-er-bla-agonist-p2,Tris(2-butoxyethyl) phosphate,activity,inactive,78-51-3,6540.0,CCCCOCCOP(=O)(OCCOCCCC)OCCOCCCC
NCGC00259145-01,tox21-er-bla-agonist-p2,"1,3-Benzenedicarbonyl dichloride",activity,inactive,99-63-8,7451.0,O=C(Cl)c1cccc(c1)C(Cl)=O
NCGC00256961-01,tox21-er-bla-agonist-p2,Phenoxathiin,activity,inactive,262-20-4,9217.0,c1ccc2Sc3ccccc3Oc2c1
NCGC00257167-01,tox21-er-bla-agonist-p2,Dicyclohexylcarbodiimide,activity,inactive,538-75-0,10868.0,N(=C=N\C1CCCCC1)\C2CCCCC2
NCGC00257045-01,tox21-er-bla-agonist-p2,Bixin,activity,inactive,6983-79-5,6537494.0,C/C(=C\C=C\C(=O)OC)/C=C/C=C(\C)/C=C\C=C(/C)\C=C/C=C(/C)\C=C/C(=O)O
NCGC00257475-01,tox21-er-bla-agonist-p2,Ammonium nitrate,activity,inactive,6484-52-2,22985.0,[NH4+].[O-][N+]([O-])=O
NCGC00254217-01,tox21-er-bla-agonist-p2,2-Methyl-5-nitroaniline,activity,inactive,99-55-8,7444.0,Cc1ccc(cc1N)[N+]([O-])=O
NCGC00255333-01,tox21-er-bla-agonist-p2,Estradiol cypionate,activity,active agonist,313-06-4,9403.0,Oc4cc5CC[C@@H]1[C@H](CC[C@]2(C)[C@H](CC[C@@H]12)OC(=O)CCC3CCCC3)c5cc4
NCGC00255606-01,tox21-er-bla-agonist-p2,1-Allyloxy-3-chloro-2-propanol,activity,inactive,4638-03-3,95402.0,ClCC(O)COCC=C
NCGC00255442-01,tox21-er-bla-agonist-p2,N-Octyl-2-pyrrolidone,activity,inactive,2687-94-7,3033871.0,O=C1CCCN1CCCCCCCC
NCGC00256960-01,tox21-er-bla-agonist-p2,2-Ethylhexyl acrylate,activity,inactive,103-11-7,7636.0,O=C(C=C)OCC(CCCC)CC
NCGC00256899-01,tox21-er-bla-agonist-p2,Acamprosate calcium,activity,inactive,77337-73-6,155434.0,[Ca+2].O=C(C)NCCCS(=O)(=O)[O-].CC(=O)NCCCS([O-])(=O)=O
NCGC00257397-01,tox21-er-bla-agonist-p2,1-Methoxy-4-tert-pentylcyclohexane,activity,inactive,199584-38-8,3420996.0,COC1CCC(CC1)C(C)(C)CC
NCGC00258013-01,tox21-er-bla-agonist-p2,"Sodium 3,5-bis(methoxycarbonyl)benzenesulfonate",activity,inactive,3965-55-7,23675796.0,[Na+].O=S([O-])(=O)c1cc(cc(c1)C(=O)OC)C(=O)OC
NCGC00258018-01,tox21-er-bla-agonist-p2,"2-Butanone, O,O',O''-(methylsilylidyne)trioxime",activity,inactive,22984-54-9,9568808.0,CCC(\C)=N\O[Si](C)(O\N=C(/C)CC)O\N=C(/C)CC
NCGC00257431-01,tox21-er-bla-agonist-p2,2-Hydroxybenzophenone,activity,inactive,117-99-7,8348.0,O=C(c1ccccc1O)c2ccccc2
NCGC00257917-01,tox21-er-bla-agonist-p2,Methyl vinyl ketone,activity,inactive,78-94-4,6570.0,C=CC(C)=O
NCGC00257761-01,tox21-er-bla-agonist-p2,"1,2-Epoxybutane",activity,inactive,106-88-7,7834.0,CCC1CO1
NCGC00257339-01,tox21-er-bla-agonist-p2,Potassium 6-hydroxynaphthalene-2-sulfonate,activity,inactive,833-66-9,23677963.0,[K+].[O-]S(=O)(=O)c1ccc2cc(O)ccc2c1
NCGC00257787-01,tox21-er-bla-agonist-p2,2-Amino-4-methylbenzothiazole,activity,inactive,1477-42-5,15132.0,Cc1cccc2sc(N)nc12
NCGC00256964-01,tox21-er-bla-agonist-p2,2-Isopropyl-6-methyl-4-pyrimidone,activity,inactive,2814-20-2,17777.0,O=C1C=C(C)NC(=N1)C(C)C
NCGC00256969-01,tox21-er-bla-agonist-p2,Diphenamid,activity,inactive,957-51-7,13728.0,O=C(C(c1ccccc1)c2ccccc2)N(C)C
NCGC00257076-01,tox21-er-bla-agonist-p2,4-Methoxybenzaldehyde,activity,inactive,123-11-5,31244.0,COc1ccc(C=O)cc1
NCGC00258180-01,tox21-er-bla-agonist-p2,1-Ethyl-1-methylpyrrolidinium iodide,activity,inactive,4186-68-9,12059921.0,[I-].C[N+]1(CC)CCCC1
NCGC00258481-01,tox21-er-bla-agonist-p2,Diethyl sulfide,activity,inactive,352-93-2,9609.0,CCSCC
NCGC00258693-01,tox21-er-bla-agonist-p2,Pentachloroethane,activity,inactive,76-01-7,6419.0,ClC(Cl)C(Cl)(Cl)Cl
NCGC00258383-01,tox21-er-bla-agonist-p2,Benzoic anhydride,activity,inactive,93-97-0,7167.0,O=C(OC(=O)c1ccccc1)c2ccccc2
NCGC00258832-01,tox21-er-bla-agonist-p2,N-(2-Methoxyphenyl)-3-oxobutanamide,activity,inactive,92-15-9,7078.0,COc1ccccc1NC(=O)CC(C)=O
NCGC00258100-01,tox21-er-bla-agonist-p2,Dodecylparaben,activity,inactive,2664-60-0,17569.0,Oc1ccc(cc1)C(=O)OCCCCCCCCCCCC
NCGC00259727-01,tox21-er-bla-agonist-p2,(E)-Hexadec-9-enoic acid,activity,inactive,10030-73-6,5282745.0,O=C(O)CCCCCCC\C=C\CCCCCC
NCGC00259809-01,tox21-er-bla-agonist-p2,"3,5,5-Trimethyl-1-hexanol",activity,inactive,3452-97-9,18938.0,CC(C)(C)CC(C)CCO
NCGC00260150-01,tox21-er-bla-agonist-p2,Rutin trihydrate,activity,inactive,153-18-4,5280805.0,Oc1ccc(cc1O)C=4Oc5cc(O)cc(O)c5C(=O)C=4O[C@@H]3O[C@H](CO[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]3O
NCGC00259867-01,tox21-er-bla-agonist-p2,Methylparaben,activity,inactive,99-76-3,7456.0,Oc1ccc(cc1)C(=O)OC
NCGC00259168-01,tox21-er-bla-agonist-p2,Cyanazine,activity,inactive,21725-46-2,30773.0,Clc1nc(NCC)nc(NC(C)(C)C#N)n1
NCGC00260355-01,tox21-er-bla-agonist-p2,Tetrabutylthiuram disulfide,activity,inactive,1634-02-2,15412.0,S=C(SSC(=S)N(CCCC)CCCC)N(CCCC)CCCC
NCGC00260675-01,tox21-er-bla-agonist-p2,Bismuth oxychloride,activity,inactive,7787-59-9,6328152.0,Cl[Bi]=O
NCGC00013051-05,tox21-er-bla-agonist-p2,tert-Butylhydroquinone,activity,inactive,1948-33-0,16043.0,CC(C)(C)c1cc(O)ccc1O
NCGC00013217-01,tox21-er-bla-agonist-p2,"(2R,3R)-2,3-Dimercaptosuccinic acid",activity,inactive,27887-84-9,197883.0,O=C(O)[C@@H](S)[C@H](S)C(O)=O
NCGC00013289-01,tox21-er-bla-agonist-p2,Pridinol,activity,inactive,511-45-5,4904.0,OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3
NCGC00015389-08,tox21-er-bla-agonist-p2,Propofol,activity,inactive,2078-54-8,4943.0,CC(C)c1cccc(C(C)C)c1O
NCGC00015846-10,tox21-er-bla-agonist-p2,Phenylbutazone,activity,inactive,50-33-9,4781.0,O=C3C(CCCC)C(=O)N(c1ccccc1)N3c2ccccc2
NCGC00016778-01,tox21-er-bla-agonist-p2,Nefopam hydrochloride,activity,inactive,23327-57-3,155290.0,Cl.CN1Cc3ccccc3C(OCC1)c2ccccc2
NCGC00016614-01,tox21-er-bla-agonist-p2,Methyldopate hydrochloride,activity,inactive,2508-79-4,17276.0,Cl.Oc1ccc(C[C@](C)(N)C(=O)OCC)cc1O
NCGC00016290-01,tox21-er-bla-agonist-p2,Demeclocycline hydrochloride,activity,inactive,64-73-3,54686764.0,Cl.NC(=O)C=2C(=O)[C@@]3(O)C(O)=C4C(=O)c1c(c(Cl)ccc1O)[C@@H](O)[C@H]4C[C@H]3[C@@H](C=2O)N(C)C
NCGC00160597-01,tox21-er-bla-agonist-p2,Neocinchophen,activity,inactive,485-34-7,68089.0,O=C(OCC)c1cc(nc2ccc(C)cc12)c3ccccc3
NCGC00167561-01,tox21-er-bla-agonist-p2,D-alpha-Tocopheryl succinate,activity,inactive,4345-03-3,20353.0,O=C(O)CCC(=O)Oc2c(C)c(C)c1O[C@@](C)(CCc1c2C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C
NCGC00255711-01,tox21-er-bla-agonist-p2,Phenthoate,activity,inactive,2597-03-7,17435.0,O=C(OCC)C(SP(=S)(OC)OC)c1ccccc1
NCGC00254566-01,tox21-er-bla-agonist-p2,Fenthion,activity,inactive,55-38-9,3346.0,Cc1cc(ccc1SC)OP(=S)(OC)OC
NCGC00256437-01,tox21-er-bla-agonist-p2,"4,4'-Sulfonyldiphenol",activity,active agonist,80-09-1,6626.0,Oc1ccc(cc1)S(=O)(=O)c2ccc(O)cc2
NCGC00254608-01,tox21-er-bla-agonist-p2,Chlorpyrifos-methyl,activity,inactive,5598-13-0,21803.0,Clc1cc(Cl)c(Cl)nc1OP(=S)(OC)OC
NCGC00255136-01,tox21-er-bla-agonist-p2,Nisoldipine,activity,inactive,63675-72-9,4499.0,CC=1NC(C)=C(C(C=1C(=O)OCC(C)C)c2ccccc2[N+]([O-])=O)C(=O)OC
NCGC00255451-01,tox21-er-bla-agonist-p2,Endosulfan I,activity,inactive,959-98-8,12309460.0,ClC1=C(Cl)[C@@]3(Cl)C(Cl)(Cl)[C@]1(Cl)[C@H]2COS(=O)OC[C@H]23
NCGC00024810-02,tox21-er-bla-agonist-p2,Practolol,activity,inactive,6673-35-4,4883.0,CC(C)NCC(O)COc1ccc(cc1)NC(C)=O
NCGC00063561-02,tox21-er-bla-agonist-p2,"4,5-Diphenylimidazole",activity,inactive,668-94-0,69588.0,c1ccc(cc1)c2ncnc2c3ccccc3
NCGC00094815-01,tox21-er-bla-agonist-p2,Broxyquinoline,activity,inactive,521-74-4,2453.0,Oc1c(Br)cc(Br)c2cccnc12
NCGC00159364-02,tox21-er-bla-agonist-p2,C.I. Direct Red 28,activity,inactive,573-58-0,11313.0,[Na+].[Na+].[O-]S(=O)(=O)c5cc(/N=N/c1ccc(cc1)c2ccc(cc2)/N=N/c3cc(c4ccccc4c3N)S([O-])(=O)=O)c(N)c6ccccc56
NCGC00160410-01,tox21-er-bla-agonist-p2,Loretin,activity,inactive,547-91-1,11043.0,O=S(=O)(O)c1cc(I)c(O)c2ncccc12
NCGC00160473-01,tox21-er-bla-agonist-p2,Tiracizine,activity,inactive,83275-56-3,71264.0,CN(C)CC(=O)N2c3ccccc3CCc1ccc(NC(=O)OCC)cc12
NCGC00161327-04,tox21-er-bla-agonist-p2,Calcitriol,activity,inactive,32222-06-3,5280453.0,C=C1C(/C[C@@H](O)C[C@@H]1O)=C\C=C2/CCC[C@]3(C)[C@H](CC[C@@H]23)[C@H](C)CCCC(C)(C)O
NCGC00185761-01,tox21-er-bla-agonist-p2,Doramectin,activity,inactive,117704-25-3,9832750.0,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1O)O[C@@H]2[C@@H](OC)C[C@@H](O[C@H]2C)O[C@@H]3C(C)=CC[C@@H]6C[C@H](OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OCC(=CC=C[C@@H]3C)[C@@]45O)C[C@@]7(O6)C=C[C@H](C)[C@H](O7)C8CCCCC8
NCGC00259385-01,tox21-er-bla-agonist-p2,Carbaryl,activity,inactive,63-25-2,6129.0,CNC(=O)Oc2cccc1ccccc12
NCGC00259840-01,tox21-er-bla-agonist-p2,1-Chloro-4-nitrobenzene,activity,inactive,100-00-5,7474.0,O=[N+]([O-])c1ccc(Cl)cc1
NCGC00015834-11,tox21-er-bla-agonist-p2,Primidone,activity,inactive,125-33-7,4909.0,CCC1(C(=O)NCNC1=O)c2ccccc2
NCGC00016337-02,tox21-er-bla-agonist-p2,Phthalylsulfathiazole,activity,inactive,85-73-4,4806.0,O=S(=O)(Nc1nccs1)c3ccc(NC(=O)c2ccccc2C(=O)O)cc3
NCGC00090681-04,tox21-er-bla-agonist-p2,D-Camphor,activity,inactive,464-49-3,159055.0,CC2(C)[C@H]1CC(=O)[C@]2(C)CC1
NCGC00091351-02,tox21-er-bla-agonist-p2,"1,3-Dinitrobenzene",activity,inactive,99-65-0,7452.0,O=[N+]([O-])c1cccc(c1)[N+]([O-])=O
NCGC00095111-01,tox21-er-bla-agonist-p2,Aminolevulinic acid hydrochloride,activity,inactive,5451-09-2,123608.0,Cl.NCC(=O)CCC(=O)O
NCGC00167729-01,tox21-er-bla-agonist-p2,Lintitript,activity,inactive,136381-85-6,122077.0,O=C(Nc1nc(cs1)c2ccccc2Cl)c4cc3ccccc3n4CC(=O)O
NCGC00182967-01,tox21-er-bla-agonist-p2,dl-Homatropine,activity,inactive,87-00-3,5282593.0,CN3[C@@H]1CC[C@H]3C[C@H](C1)OC(=O)C(O)c2ccccc2
NCGC00254406-01,tox21-er-bla-agonist-p2,Octamethylcyclotetrasiloxane,activity,inactive,556-67-2,11169.0,C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1
NCGC00017025-01,tox21-er-bla-agonist-p2,Bergenin monohydrate,activity,inactive,108032-11-7,201412.0,O.Oc1c2c(cc(O)c1OC)C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]23
NCGC00023722-05,tox21-er-bla-agonist-p2,Floxuridine,activity,inactive,50-91-9,5790.0,FC1=CN(C(=O)NC1=O)[C@H]2C[C@H](O)[C@@H](CO)O2
NCGC00016899-01,tox21-er-bla-agonist-p2,Rolipram,activity,inactive,61413-54-5,5092.0,COc2ccc(cc2OC1CCCC1)C3CC(=O)NC3
NCGC00016923-01,tox21-er-bla-agonist-p2,Iopromide,activity,inactive,73334-07-3,3736.0,O=C(Nc1c(I)c(c(I)c(c1I)C(=O)N(C)CC(O)CO)C(=O)NCC(O)CO)COC
NCGC00256807-01,tox21-er-bla-agonist-p2,Trazodone hydrochloride,activity,inactive,25332-39-2,62935.0,Cl.Clc1cccc(c1)N2CCN(CC2)CCCN3N=C4C=CC=CN4C3=O
NCGC00256883-01,tox21-er-bla-agonist-p2,(-)-Ambroxide,activity,inactive,6790-58-5,10857465.0,CC3(C)CCC[C@@]1(C)[C@H]3CC[C@@]2(C)OCC[C@H]12
NCGC00258419-01,tox21-er-bla-agonist-p2,1-Chlorobutane,activity,inactive,109-69-3,8005.0,CCCCCl
NCGC00258443-01,tox21-er-bla-agonist-p2,Ethyl lactate,activity,inactive,97-64-3,7344.0,CC(O)C(=O)OCC
NCGC00258467-01,tox21-er-bla-agonist-p2,Tribromoacetic acid,activity,inactive,75-96-7,6415.0,BrC(Br)(Br)C(=O)O
NCGC00258499-01,tox21-er-bla-agonist-p2,"2,4-Dichlorobenzotrifluoride",activity,inactive,320-60-5,9443.0,FC(F)(F)c1ccc(Cl)cc1Cl
NCGC00257755-01,tox21-er-bla-agonist-p2,2-Methyl-6-nitrobenzoic acid,activity,inactive,13506-76-8,16097.0,O=[N+]([O-])c1cccc(C)c1C(=O)O
NCGC00257774-01,tox21-er-bla-agonist-p2,N-Methylbenzamide,activity,inactive,613-93-4,11954.0,O=C(NC)c1ccccc1
NCGC00257840-01,tox21-er-bla-agonist-p2,2-Chlorobenzoic acid,activity,inactive,118-91-2,8374.0,OC(=O)c1ccccc1Cl
NCGC00257961-01,tox21-er-bla-agonist-p2,Selenious acid,activity,inactive,7783-00-8,1091.0,O=[Se](O)O
NCGC00258119-01,tox21-er-bla-agonist-p2,Rebaudioside A,activity,inactive,58543-16-1,60196371.0,O[C@@H]8[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]8OC(=O)[C@]7(C)CCC[C@@]5(C)[C@@H]7CC[C@]16CC(=C)[C@@H](C1)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]4OC3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@@H]56
NCGC00258160-01,tox21-er-bla-agonist-p2,1-Benzyl-3-methylimidazolium chloride,activity,inactive,36443-80-8,10560335.0,[Cl-].C[n+]2ccn(Cc1ccccc1)c2
NCGC00258295-01,tox21-er-bla-agonist-p2,1-Butanol,activity,inactive,71-36-3,263.0,CCCCO
NCGC00258315-01,tox21-er-bla-agonist-p2,"2-(2,4,5-Trichlorophenoxy)propionic acid",activity,inactive,93-72-1,7158.0,Clc1cc(OC(C)C(=O)O)c(Cl)cc1Cl
NCGC00256101-01,tox21-er-bla-agonist-p2,Heptadecane,activity,inactive,629-78-7,12398.0,CCCCCCCCCCCCCCCCC
NCGC00256292-01,tox21-er-bla-agonist-p2,Scopolamine hydrochloride,activity,inactive,55-16-3,6852406.0,Cl.OC[C@H](c1ccccc1)C(=O)O[C@H]2C[C@@H]3N(C)[C@H](C2)[C@H]4O[C@@H]34
NCGC00256309-01,tox21-er-bla-agonist-p2,Sodium methacrylate,activity,inactive,5536-61-8,3255932.0,[Na+].C=C(C)C([O-])=O
NCGC00255691-01,tox21-er-bla-agonist-p2,"2,6-Octadienenitrile, 3,7-dimethyl-",activity,inactive,5146-66-7,21768.0,C\C(C)=C\CCC(C)=CC#N
NCGC00258835-01,tox21-er-bla-agonist-p2,4-Chloro-2-methylaniline hydrochloride,activity,inactive,3165-93-3,18487.0,Cl.Cc1cc(Cl)ccc1N
NCGC00258939-01,tox21-er-bla-agonist-p2,"1,3-Dimethyl-2-nitrobenzene",activity,inactive,81-20-9,6672.0,Cc1cccc(C)c1[N+](=O)[O-]
NCGC00259275-01,tox21-er-bla-agonist-p2,1-Chloro-2-bromoethane,activity,inactive,107-04-0,7849.0,BrCCCl
NCGC00259860-01,tox21-er-bla-agonist-p2,"2,2-Dichloropropane",activity,inactive,594-20-7,11660.0,CC(C)(Cl)Cl
NCGC00259897-01,tox21-er-bla-agonist-p2,Ergocalciferol,activity,inactive,50-14-6,5280793.0,C=C3CC[C@H](O)C\C3=C\C=C1/CCC[C@]2(C)[C@H](CC[C@@H]12)[C@H](C)/C=C/[C@H](C)C(C)C
NCGC00260075-01,tox21-er-bla-agonist-p2,Dichloromethane,activity,inactive,75-09-2,6344.0,ClCCl
NCGC00260084-01,tox21-er-bla-agonist-p2,Sodium cholate,activity,inactive,361-09-1,23668194.0,[Na+].[O-]C(=O)CC[C@@H](C)[C@H]2CC[C@H]1[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@@]12C
NCGC00260086-01,tox21-er-bla-agonist-p2,Sodium hydrogen sulfate,activity,inactive,7681-38-1,516919.0,[Na+].[O-]S(=O)(=O)O
NCGC00260246-01,tox21-er-bla-agonist-p2,1-Ethylpyridinium tetrafluoroborate,activity,inactive,350-48-1,12077313.0,F[B-](F)(F)F.CC[n+]1ccccc1
NCGC00260377-01,tox21-er-bla-agonist-p2,Ethylpivalate,activity,inactive,3938-95-2,19838.0,CC(C)(C)C(=O)OCC
NCGC00254816-01,tox21-er-bla-agonist-p2,Methyl isothiocyanate,activity,inactive,556-61-6,11167.0,C\N=C=S
NCGC00256312-01,tox21-er-bla-agonist-p2,Acid Orange 156,activity,inactive,68555-86-2,23703979.0,[Na+].O=S([O-])(=O)c3ccc(/N=N/c2cc(OC)c(/N=N/c1ccc(OC)cc1)cc2C)cc3
NCGC00254985-01,tox21-er-bla-agonist-p2,2-Methyl-3-[4-(propan-2-yl)phenyl]propanal,activity,inactive,103-95-7,517827.0,CC(C)c1ccc(CC(C)C=O)cc1
NCGC00255027-01,tox21-er-bla-agonist-p2,2-Furancarboxylic acid,activity,inactive,88-14-2,6919.0,O=C(O)c1ccco1
NCGC00255110-01,tox21-er-bla-agonist-p2,[(1S)-endo]-(-)-Borneol,activity,inactive,464-45-9,1201518.0,C[C@@]12CC[C@@H](C[C@H]1O)C2(C)C
NCGC00255137-01,tox21-er-bla-agonist-p2,Amrinone,activity,inactive,60719-84-8,3698.0,NC1=CC(=CNC1=O)c2ccncc2
NCGC00255283-01,tox21-er-bla-agonist-p2,Glycoluril,activity,inactive,496-46-8,62347.0,O=C1NC2NC(=O)NC2N1
NCGC00254549-01,tox21-er-bla-agonist-p2,Antimony trichloride,activity,inactive,10025-91-9,24814.0,Cl[Sb](Cl)Cl
NCGC00254584-01,tox21-er-bla-agonist-p2,Cloprop,activity,inactive,101-10-0,7542.0,Clc1cc(OC(C)C(=O)O)ccc1
NCGC00091080-03,tox21-er-bla-agonist-p2,Fenaminosulf,activity,inactive,140-56-7,23668198.0,[Na+].CN(C)c1ccc(/N=N/S([O-])(=O)=O)cc1
NCGC00093534-02,tox21-er-bla-agonist-p2,Acecainide hydrochloride,activity,inactive,34118-92-8,71417.0,Cl.O=C(C)Nc1ccc(cc1)C(=O)NCCN(CC)CC
NCGC00093619-02,tox21-er-bla-agonist-p2,Opipramol dihydrochloride,activity,inactive,909-39-7,71587.0,Cl.Cl.OCCN1CCN(CC1)CCCN3c4ccccc4C=Cc2ccccc23
NCGC00166409-01,tox21-er-bla-agonist-p2,"Sodium 2,3-dimercaptopropanesulfonate hydrate",activity,inactive,207233-91-8,23676755.0,[Na+].O.[O-]S(=O)(=O)CC(S)CS
NCGC00167429-01,tox21-er-bla-agonist-p2,Temozolomide,activity,inactive,85622-93-1,5394.0,NC(=O)c1ncn2C(=O)N(C)N=Nc12
NCGC00094255-01,tox21-er-bla-agonist-p2,Bisoprolol fumarate,activity,inactive,104344-23-2,5281064.0,O=C(O)/C=C/C(=O)O.CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.CC(C)NCC(O)COc1ccc(cc1)COCCOC(C)C
NCGC00163774-04,tox21-er-bla-agonist-p2,Ethoprop,activity,inactive,13194-48-4,3289.0,CCCSP(=O)(SCCC)OCC
NCGC00167470-01,tox21-er-bla-agonist-p2,Mezlocillin,activity,inactive,51481-65-3,656511.0,OC(=O)[C@@H]3N4C(=O)[C@@H](NC(=O)[C@H](NC(=O)N1CCN(C1=O)S(C)(=O)=O)c2ccccc2)[C@H]4SC3(C)C
NCGC00181018-01,tox21-er-bla-agonist-p2,Anecortave acetate,activity,inactive,7753-60-8,111332.0,CC(=O)OCC(=O)[C@@]3(O)CC[C@H]2[C@@H]4CCC1=CC(=O)CC[C@]1(C)C4=CC[C@@]23C
NCGC00181160-01,tox21-er-bla-agonist-p2,Ecabet,activity,inactive,33159-27-2,65781.0,CC(C)c2cc3CC[C@@H]1[C@](C)(CCC[C@@]1(C)C(=O)O)c3cc2S(=O)(=O)O
NCGC00160387-01,tox21-er-bla-agonist-p2,Clothiapine,activity,inactive,2058-52-8,16351.0,CN1CCN(CC1)C3=Nc4ccccc4Sc2ccc(Cl)cc23
NCGC00181165-02,tox21-er-bla-agonist-p2,Decanohydroxamic acid,activity,inactive,2259-85-0,142752.0,O=C(CCCCCCCCC)NO
NCGC00164574-01,tox21-er-bla-agonist-p2,Erlotinib,activity,inactive,183321-74-6,176870.0,C#Cc1cc(ccc1)Nc3ncnc2cc(OCCOC)c(cc23)OCCOC
NCGC00095155-01,tox21-er-bla-agonist-p2,Zolmitriptan,activity,inactive,139264-17-8,60857.0,CN(C)CCc2cnc1ccc(cc12)C[C@@H]3NC(=O)OC3
NCGC00168085-01,tox21-er-bla-agonist-p2,Suberoylanilide hydroxamic acid,activity,inactive,149647-78-9,5311.0,O=C(Nc1ccccc1)CCCCCCC(=O)NO
NCGC00160523-01,tox21-er-bla-agonist-p2,Lanatoside A,activity,inactive,17575-20-1,5284580.0,O=C1C=C(CO1)[C@H]9CC[C@@]8(O)[C@]9(C)CC[C@H]3[C@H]8CC[C@@H]2CC(CC[C@@]23C)O[C@@H]7O[C@H](C)[C@@H](O[C@@H]6O[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](OC(C)=O)C5)[C@@H](O)C6)[C@@H](O)C7
NCGC00167533-01,tox21-er-bla-agonist-p2,Vardenafil citrate,activity,inactive,1193386-64-9,23581791.0,O=C(O)C(O)(CC(=O)O)CC(=O)O.CCN1CCN(CC1)S(=O)(=O)c4cc(C2=NC(=O)c3c(C)nc(CCC)n3N2)c(OCC)cc4
NCGC00095872-01,tox21-er-bla-agonist-p2,Ipriflavone,activity,inactive,35212-22-7,3747.0,CC(C)Oc1ccc2c(c1)OC=C(C2=O)c3ccccc3
NCGC00095899-01,tox21-er-bla-agonist-p2,Rizatriptan,activity,inactive,144034-80-0,5078.0,CN(C)CCc2cnc1ccc(cc12)Cn3cncn3
NCGC00095933-01,tox21-er-bla-agonist-p2,Phenyl 4-aminosalicylate,activity,active agonist,133-11-9,8609.0,Oc2cc(N)ccc2C(=O)Oc1ccccc1
NCGC00166221-01,tox21-er-bla-agonist-p2,(S)-(+)-1-Dimethylamino-2-propanol,activity,inactive,53636-17-2,6950248.0,CN(C)C[C@H](C)O
NCGC00183125-01,tox21-er-bla-agonist-p2,Menatetrenone,activity,inactive,863-61-6,5282367.0,C/C(C)=C\CCC(\C)=C\CCC(\C)=C\CCC(\C)=C\CC2=C(C)C(=O)c1ccccc1C2=O
NCGC00183833-01,tox21-er-bla-agonist-p2,Bimosiamose,activity,inactive,187269-40-5,9811353.0,O=C(O)Cc1cccc(c1)c3cc(ccc3O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)CCCCCCc5ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(c5)c6cccc(CC(=O)O)c6
NCGC00183870-01,tox21-er-bla-agonist-p2,Ethoheptazine hydrochloride,activity,inactive,5982-61-6,23616254.0,Cl.CN1CCCC(CC1)(C(=O)OCC)c2ccccc2
NCGC00254137-01,tox21-er-bla-agonist-p2,Sodium nitrite,activity,inactive,7632-00-0,23668193.0,[Na+].[O-]N=O
NCGC00188442-01,tox21-er-bla-agonist-p2,Estradiol enanthate,activity,active agonist,4956-37-0,21070.0,CCCCCCC(=O)O[C@H]2CC[C@H]3[C@@H]4CCc1cc(O)ccc1[C@H]4CC[C@]23C
NCGC00254232-01,tox21-er-bla-agonist-p2,Pravastatin sodium,activity,inactive,81131-70-6,16759173.0,[Na+].[O-]C(=O)C[C@H](O)C[C@H](O)CC[C@H]2[C@@H](C)C=CC1=C[C@@H](O)C[C@H](OC(=O)[C@@H](C)CC)[C@@H]12
NCGC00254666-01,tox21-er-bla-agonist-p2,Butylate,activity,inactive,2008-41-5,16181.0,CC(C)CN(CC(C)C)C(=O)SCC
NCGC00254306-01,tox21-er-bla-agonist-p2,Hexadecane,activity,inactive,544-76-3,11006.0,CCCCCCCCCCCCCCCC
NCGC00254313-01,tox21-er-bla-agonist-p2,Sulfasalazine,activity,inactive,599-79-1,5359476.0,O=S(=O)(Nc1ccccn1)c3ccc(/N=N/c2cc(C(=O)O)c(O)cc2)cc3
NCGC00254733-01,tox21-er-bla-agonist-p2,(4Z)-4-Decenal,activity,inactive,21662-09-9,5362620.0,CCCCC\C=C/CCC=O
NCGC00254340-01,tox21-er-bla-agonist-p2,Pyridoxine,activity,inactive,65-23-6,1054.0,Oc1c(CO)c(cnc1C)CO
NCGC00254438-01,tox21-er-bla-agonist-p2,CP-532623,activity,inactive,261947-38-0,10145345.0,FC(F)(F)c1cc(cc(c1)C(F)(F)F)CN([C@H]3C[C@@H](CC)N(c2ccc(cc23)C(F)(F)F)C(=O)OC(C)C)C(C)=O
NCGC00254053-01,tox21-er-bla-agonist-p2,AVE2865,activity,inactive,648917-13-9,12148754.0,Fc1cc(c(Cl)cc1F)C(=O)NC(=O)Nc2cc(F)ccc2N3CCC(CC3)C(=O)O
NCGC00255233-01,tox21-er-bla-agonist-p2,Rosiglitazone maleate,activity,inactive,155141-29-0,5281055.0,O=C(O)/C=C\C(=O)O.CN(CCOc2ccc(CC1SC(=O)NC1=O)cc2)c3ccccn3
NCGC00255322-01,tox21-er-bla-agonist-p2,1-(Bromomethyl)-3-phenoxybenzene,activity,active agonist,51632-16-7,94544.0,BrCc2cc(Oc1ccccc1)ccc2
NCGC00258102-01,tox21-er-bla-agonist-p2,Nonylparaben,activity,active agonist,38713-56-3,586708.0,Oc1ccc(cc1)C(=O)OCCCCCCCCC
NCGC00255492-01,tox21-er-bla-agonist-p2,"2,6-Dichlorotoluene",activity,inactive,118-69-4,8368.0,Clc1cccc(Cl)c1C
NCGC00260284-01,tox21-er-bla-agonist-p2,Ethylenediaminetetraacetic acid,activity,inactive,60-00-4,6049.0,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O
NCGC00257634-01,tox21-er-bla-agonist-p2,C.I. Acid Red 52,activity,inactive,3520-42-1,62500.0,[Na+].O=S([O-])(=O)c4cc(ccc4c1c3cc(C)c(cc3[o+]c2cc(N(CC)CC)c(C)cc12)N(CC)CC)S([O-])(=O)=O
NCGC00258274-01,tox21-er-bla-agonist-p2,2-Nitrodiphenylamine,activity,inactive,119-75-5,8407.0,[O-][N+](=O)c2ccccc2Nc1ccccc1
NCGC00015970-02,tox21-er-bla-agonist-p2,Sulindac,activity,inactive,38194-50-2,1548887.0,CS(=O)c1ccc(cc1)/C=C3\c2ccc(F)cc2C(CC(=O)O)=C3C
NCGC00255578-01,tox21-er-bla-agonist-p2,Butylene carbonate,activity,inactive,4437-85-8,107282.0,O=C1OCC(CC)O1
NCGC00256732-01,tox21-er-bla-agonist-p2,Citronellic acid,activity,inactive,502-47-6,10402.0,O=C(O)CC(C)CC\C=C(/C)C
NCGC00256704-01,tox21-er-bla-agonist-p2,"5H-5-Methyl-6,7-dihydrocyclopenta[b]pyrazine",activity,inactive,23747-48-0,32065.0,CC2CCc1nccnc12
NCGC00256838-01,tox21-er-bla-agonist-p2,(3Z)-Hex-3-en-1-yl (2E)-2-methylbut-2-enoate,activity,inactive,67883-79-8,15461361.0,O=C(OCC/C=C\CC)C(\C)=C\C
NCGC00257033-01,tox21-er-bla-agonist-p2,Bis[2-(dimethylamino)ethyl]ether,activity,inactive,3033-62-3,18204.0,CN(C)CCOCCN(C)C
NCGC00257863-01,tox21-er-bla-agonist-p2,Methylphenidate hydrochloride,activity,inactive,298-59-9,9280.0,Cl.O=C(OC)C(C1CCCCN1)c2ccccc2
NCGC00257927-01,tox21-er-bla-agonist-p2,2-Chlorobenzaldehyde,activity,inactive,89-98-5,6996.0,O=Cc1ccccc1Cl
NCGC00257786-01,tox21-er-bla-agonist-p2,"3,5-Dimethylaniline",activity,inactive,108-69-0,7949.0,Cc1cc(N)cc(C)c1
NCGC00258905-01,tox21-er-bla-agonist-p2,Pindone,activity,inactive,83-26-1,6732.0,CC(C)(C)C(=O)C2C(=O)c1ccccc1C2=O
NCGC00258723-01,tox21-er-bla-agonist-p2,Heptanedioic acid,activity,inactive,111-16-0,385.0,O=C(O)CCCCCC(=O)O
NCGC00258456-01,tox21-er-bla-agonist-p2,Sodium 3-nitrobenzenesulfonate,activity,inactive,127-68-4,31389.0,[Na+].O=S([O-])(=O)c1cc(ccc1)[N+]([O-])=O
NCGC00258683-01,tox21-er-bla-agonist-p2,N-(4-Methoxyphenyl)acetamide,activity,inactive,51-66-1,5827.0,COc1ccc(NC(C)=O)cc1
NCGC00259127-01,tox21-er-bla-agonist-p2,Pentachloropyridine,activity,inactive,2176-62-7,16584.0,Clc1c(Cl)c(Cl)nc(Cl)c1Cl
NCGC00259349-01,tox21-er-bla-agonist-p2,Phthalimide,activity,inactive,85-41-6,6809.0,O=C1NC(=O)c2ccccc12
NCGC00260151-01,tox21-er-bla-agonist-p2,Raloxifene,activity,active agonist,84449-90-1,5035.0,Oc1ccc(cc1)c3sc2cc(O)ccc2c3C(=O)c5ccc(OCCN4CCCCC4)cc5
NCGC00260154-01,tox21-er-bla-agonist-p2,(+)-2-Methylbutyl-4-methoxybenzyladine-4'-aminocyannate,activity,inactive,24140-30-5,5702746.0,COc2ccc(/C=N/c1ccc(/C=C/C(=O)OC[C@@H](C)CC)cc1)cc2
NCGC00259390-01,tox21-er-bla-agonist-p2,Coumaphos,activity,inactive,56-72-4,2871.0,CCOP(=S)(OCC)Oc1ccc2c(c1)OC(=O)C(Cl)=C2C
NCGC00259651-01,tox21-er-bla-agonist-p2,Furfuryl alcohol,activity,inactive,98-00-0,7361.0,OCc1ccco1
NCGC00259692-01,tox21-er-bla-agonist-p2,Cyclohexanone oxime,activity,inactive,100-64-1,7517.0,O\N=C1/CCCCC1
NCGC00260019-01,tox21-er-bla-agonist-p2,"2,2',4,4',5,5'-Hexachlorobiphenyl",activity,inactive,35065-27-1,37034.0,Clc2cc(c1cc(Cl)c(Cl)cc1Cl)c(Cl)cc2Cl
NCGC00260307-01,tox21-er-bla-agonist-p2,"Benzenesulfonic acid, C10-16-alkyl derivs.",activity,inactive,68584-22-5,29249.0,OS(=O)(=O)c1ccc(cc1)C(CC)CCCCCCCCC
NCGC00013130-03,tox21-er-bla-agonist-p2,Aminoquinuride dihydrochloride,activity,inactive,5424-37-3,79472.0,Cl.Cl.Nc1cc(C)nc2ccc(cc12)NC(=O)Nc3ccc4nc(C)cc(N)c4c3
NCGC00015718-06,tox21-er-bla-agonist-p2,Naftopidil,activity,inactive,57149-07-2,4418.0,OC(CN1CCN(CC1)c2ccccc2OC)COc4cccc3ccccc34
NCGC00016069-09,tox21-er-bla-agonist-p2,Brimonidine,activity,inactive,59803-98-4,2435.0,Brc2c3nccnc3ccc2NC1=NCCN1
NCGC00016548-01,tox21-er-bla-agonist-p2,Chlorphenesin carbamate,activity,inactive,886-74-8,2724.0,Clc1ccc(OCC(O)COC(N)=O)cc1
NCGC00016379-01,tox21-er-bla-agonist-p2,Aminoglutethimide,activity,inactive,125-84-8,2145.0,CCC1(CCC(=O)NC1=O)c2ccc(N)cc2
NCGC00016575-01,tox21-er-bla-agonist-p2,Colistin sulfate,activity,inactive,1264-72-8,60196262.0,O=S(=O)(O)O.C[C@@H](CC)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC1=O)CCN)[C@H](C)O
NCGC00016403-01,tox21-er-bla-agonist-p2,Mafenide hydrochloride,activity,inactive,138-37-4,67313.0,Cl.O=S(N)(=O)c1ccc(CN)cc1
NCGC00016662-01,tox21-er-bla-agonist-p2,Orciprenaline sulfate,activity,inactive,5874-97-5,441333.0,Oc1cc(cc(O)c1)C(O)CNC(C)C.O=S(=O)(O)O.CC(C)NCC(O)c1cc(O)cc(O)c1
NCGC00018255-04,tox21-er-bla-agonist-p2,Hydroxyzine,activity,inactive,68-88-2,3658.0,Clc1ccc(cc1)C(c2ccccc2)N3CCN(CC3)CCOCCO
NCGC00022248-03,tox21-er-bla-agonist-p2,Hydrocortisone 21-hemisuccinate sodium salt,activity,inactive,125-04-2,23694214.0,[Na+].[O-]C(=O)CCC(=O)OCC(=O)[C@@]4(O)CC[C@@H]2[C@]4(C)C[C@H](O)[C@@H]1[C@@]3(C)CCC(=O)C=C3CC[C@H]12
NCGC00159516-02,tox21-er-bla-agonist-p2,Meloxicam,activity,inactive,71125-38-7,54677470.0,Cc3cnc(NC(=O)C2=C(O)c1ccccc1S(=O)(=O)N2C)s3
